PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kaji, K; Oda, S; Shikano, T; Ohnuki, T; Uematsu, Y; Sakagami, J; Tada, N; Miyazaki, S; Kudo, A				Kaji, K; Oda, S; Shikano, T; Ohnuki, T; Uematsu, Y; Sakagami, J; Tada, N; Miyazaki, S; Kudo, A			The gamete fusion process is defective in eggs of Cd9-deficient mice	NATURE GENETICS			English	Article							MOUSE EGG; CA2+ OSCILLATIONS; STEM-CELLS; FERTILIZATION; CD9; SPERM; CALCIUM; PROTEIN; ACTIVATION; COMPLEXES	The cell-surface molecule Cd9, a member of the transmembrane-4 superfamily(1), interacts with the integrin family(2) and other membrane proteins(3-5), and is postulated to participate in cell migration and adhesion(6-8). Expression of Cd9 enhances membrane fusion between muscle cells(9) and promotes viral infection in some cells(10,11). Fertilization also involves membrane fusion, between gametes. In mammals, the sperm binds to microvilli on the egg surface, and sperm-egg membrane fusion first occurs around the equatorial region of the sperm head(12). The fused membrane is then disrupted, and the sperm nucleus as well as the cytoplasm is incorporated into the egg. Cd9 is expressed on the plasma membrane of the mouse egg, and an anti-Cd9 monoclonal antibody inhibits sperm-egg surface interactions(13). We generated Cd9(-/-) mice and found that homozygous mutant females were infertile. Sperm-egg binding was normal, but sperm-egg fusion was almost entirely inhibited in eggs from Cd9(-/-) females. Intracellular Ca2+ oscillations, which signal fertilization, were absent in almost all mutant eggs; in rare cases, a response occurred after a long time period. In normal animals, Cd9 molecules were expressed on the egg microvilli and became densely concentrated at the sperm attachment site. Thus, our results show that Cd9 is important in the gamete fusion process at fertilization.	Tokyo Inst Technol, Dept Life Sci, Yokohama, Kanagawa 227, Japan; Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan; Taisho Pharmaceut Co Ltd, Med Res Labs, Omiya, Saitama, Japan; Natl Inst Physiol Sci, Dept Mol Physiol, Lab Intracellular Metab, Okazaki, Aichi 444, Japan	Tokyo Institute of Technology; Tokyo Women's Medical University; Taisho Pharmaceutical Holdings Co Ltd; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Kudo, A (corresponding author), Tokyo Inst Technol, Dept Life Sci, Yokohama, Kanagawa 227, Japan.		Kudo, Akira/C-7340-2015	Kudo, Akira/0000-0001-6289-3391				ALMEIDA EAC, 1995, CELL, V81, P1095, DOI 10.1016/S0092-8674(05)80014-5; BEGG DA, 1978, J CELL BIOL, V79, P846, DOI 10.1083/jcb.79.3.846; Berditchevski F, 1996, MOL BIOL CELL, V7, P193, DOI 10.1091/mbc.7.2.193; Chen KK, 1930, MEDICINE, V9, P1, DOI 10.1097/00005792-193002000-00001; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; FULTON BP, 1978, NATURE, V273, P149, DOI 10.1038/273149a0; HADJIARGYROU M, 1995, J NEUROSCI, V15, P574; Horvath G, 1998, J BIOL CHEM, V273, P30537, DOI 10.1074/jbc.273.46.30537; IKEYAMA S, 1993, J EXP MED, V177, P1231, DOI 10.1084/jem.177.5.1231; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Lawrence Y, 1997, DEVELOPMENT, V124, P233; Loffler S, 1997, J VIROL, V71, P42; LONGO FJ, 1985, AM J ANAT, V174, P303, DOI 10.1002/aja.1001740310; MASELLISSMITH A, 1994, J IMMUNOL, V152, P2768; MIYAZAKI S, 1993, DEV BIOL, V158, P62, DOI 10.1006/dbio.1993.1168; NAKAMURA K, 1995, J CELL BIOL, V129, P1691, DOI 10.1083/jcb.129.6.1691; Nakano Y, 1997, MOL HUM REPROD, V3, P1087, DOI 10.1093/molehr/3.12.1087; PHILLIPS DM, 1985, AM J ANAT, V174, P357, DOI 10.1002/aja.1001740314; RUBINSTEIN E, 1994, EUR J IMMUNOL, V24, P3005, DOI 10.1002/eji.1830241213; Slupsky JR, 1997, EUR J BIOCHEM, V244, P168, DOI 10.1111/j.1432-1033.1997.00168.x; Swann K, 1997, BIOESSAYS, V19, P371, DOI 10.1002/bies.950190504; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; TALBOT P, 1982, FERTIL STERIL, V37, P240; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Whittingham D G, 1971, J Reprod Fertil Suppl, V14, P7; Willett B, 1997, J GEN VIROL, V78, P611, DOI 10.1099/0022-1317-78-3-611; WRIGHT MD, 1994, IMMUNOL TODAY, V15, P588, DOI 10.1016/0167-5699(94)90222-4; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yanagimachi R., 1994, P189	29	369	389	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2000	24	3					279	282		10.1038/73502	http://dx.doi.org/10.1038/73502			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	288XW	10700183				2022-12-17	WOS:000085590600020
J	Lanford, PJ; Lan, Y; Jiang, RL; Lindsell, C; Weinmaster, G; Gridley, T; Kelley, MW				Lanford, PJ; Lan, Y; Jiang, RL; Lindsell, C; Weinmaster, G; Gridley, T; Kelley, MW			Notch signalling pathway mediates hair cell development in mammalian cochlea	NATURE GENETICS			English	Article							NEUROGENIC GENE-DELTA; DROSOPHILA; HOMOLOG; EMBRYOGENESIS; JAGGED2; LIGAND; CORTI	The mammalian cochlea contains an invariant mosaic of sensory hair cells and non-sensory supporting cells reminiscent of invertebrate structures such as the compound eye in Drosophila melanogaster(1,2). The sensory epithelium in the mammalian cochlea (the organ of Corti) contains four rows of mechanosensory hair cells: a single row of inner hair cells and three rows of outer hair cells. Each hair cell is separated from the next by an interceding supporting cell, forming an invariant and alternating mosaic that extends the length of the cochlear duct(1). Previous results suggest that determination of cell fates in the cochlear mosaic occurs via inhibitory interactions between adjacent progenitor cells(3-5) (lateral inhibition). Cells populating the cochlear epithelium appear to constitute a developmental equivalence group in which developing hair cells suppress differentiation in their immediate neighbours through lateral inhibition(6). These interactions may be mediated through the Notch signalling pathway, a molecular mechanism that is involved in the determination of a variety of cell fates(7-9) Here we show that genes encoding the receptor protein Notch1 and its ligand, lagged 2, are expressed in alternating cell types in the developing sensory epithelium. In addition, genetic deletion of Jag2 results in a significant increase in sensory hair cells, presumably as a result of a decrease in Notch activation. These results provide direct evidence for Notch-mediated lateral inhibition in a mammalian system and support a role for Notch in the development of the cochlear mosaic.	Georgetown Univ, Sch Med, Dept Cell Biol, Washington, DC 20007 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Univ Calif Los Angeles, Dept Biol Chem, Sch Med, Los Angeles, CA 90024 USA	Georgetown University; Jackson Laboratory; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kelley, MW (corresponding author), Georgetown Univ, Sch Med, Dept Cell Biol, 3900 Reservoir Rd NW, Washington, DC 20007 USA.	kelleym2@gunet.georgetown.edu		Jiang, Rulang/0000-0001-7842-4696	PHS HHS [K02] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adam J, 1998, DEVELOPMENT, V125, P4645; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; BASLER K, 1991, BIOESSAYS, V13, P621, DOI 10.1002/bies.950131202; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; CORWIN JT, 1991, CIBA F SYMP, V160, P103; delaPompa J, 1997, DEVELOPMENT, V124, P1139; DOE CQ, 1985, DEV BIOL, V111, P206, DOI 10.1016/0012-1606(85)90446-4; Dornseifer P, 1997, MECH DEVELOP, V63, P159, DOI 10.1016/S0925-4773(97)00037-3; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Haddon C, 1998, DEVELOPMENT, V125, P4637; Haddon C, 1998, DEVELOPMENT, V125, P359; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; KAUFMAN MH, 1992, ATLAS MOUSE DEV, P123; KELLEY MW, 1995, J NEUROSCI, V15, P3013; KELLEY MW, 1993, DEVELOPMENT, V119, P1041; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Kopan R, 1997, TRENDS GENET, V13, P465, DOI 10.1016/S0168-9525(97)01318-8; LEWIS J, 1991, CIBA F SYMP, V160, P25, DOI 10.4171/RMI/104; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; Lim D., 1992, DEV AUDITORY VESTIBU, P33; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Luo B, 1997, MOL CELL BIOL, V17, P6057, DOI 10.1128/MCB.17.10.6057; NADOL JB, 1988, HEARING RES, V34, P253, DOI 10.1016/0378-5955(88)90006-8; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINSTABL C, 1992, J CLIN MONITOR, V8, P116, DOI 10.1007/BF01617429; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361	30	369	390	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1999	21	3					289	292		10.1038/6804	http://dx.doi.org/10.1038/6804			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173JR	10080181				2022-12-17	WOS:000078977900022
J	Ishimaru, K; Hirotsu, N; Madoka, Y; Murakami, N; Hara, N; Onodera, H; Kashiwagi, T; Ujiie, K; Shimizu, B; Onishi, A; Miyagawa, H; Katoh, E				Ishimaru, Ken; Hirotsu, Naoki; Madoka, Yuka; Murakami, Naomi; Hara, Nao; Onodera, Haruko; Kashiwagi, Takayuki; Ujiie, Kazuhiro; Shimizu, Bun-ichi; Onishi, Atsuko; Miyagawa, Hisashi; Katoh, Etsuko			Loss of function of the IAA-glucose hydrolase gene TGW6 enhances rice grain weight and increases yield	NATURE GENETICS			English	Article							STRICTOSIDINE SYNTHASE; EXPRESSION; SIZE; IDENTIFICATION; TEMPERATURE; ENDOSPERM; ENCODES; HISTORY; STARCH; ENZYME	Increases in the yield of rice, a staple crop for more than half of the global population, are imperative to support rapid population growth. Grain weight is a major determining factor of yield. Here, we report the cloning and functional analysis of THOUSAND-GRAIN WEIGHT 6 (TGW6), a gene from the Indian landrace rice Kasalath. TGW6 encodes a novel protein with indole-3-acetic acid (IAA)-glucose hydrolase activity. In sink organs, the Nipponbare tgw6 allele affects the timing of the transition from the syncytial to the cellular phase by controlling IAA supply and limiting cell number and grain length. Most notably, loss of function of the Kasalath allele enhances grain weight through pleiotropic effects on source organs and leads to significant yield increases. Our findings suggest that TGW6 may be useful for further improvements in yield characteristics in most cultivars.	[Ishimaru, Ken; Hirotsu, Naoki; Madoka, Yuka; Murakami, Naomi; Hara, Nao; Onodera, Haruko; Kashiwagi, Takayuki; Ujiie, Kazuhiro; Katoh, Etsuko] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Shimizu, Bun-ichi] Toyo Univ, Grad Sch Life Sci, Itakura, Japan; [Onishi, Atsuko; Miyagawa, Hisashi] Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan	National Institute of Agrobiological Sciences - Japan; Toyo University	Ishimaru, K (corresponding author), Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	kenshi@nias.affrc.go.jp	Hirotsu, Naoki/C-6128-2014	Hirotsu, Naoki/0000-0002-9893-7111; Kashiwagi, Takayuki/0000-0002-0096-8113	National Bioresource Project, Ministry of Education, Culture, Sports, Science and Technology, Japan; Bio Cosmos Program and Genomics for Agricultural Innovation, Ministry of Agriculture, Forestry and Fisheries of Japan [QTL-4007]	National Bioresource Project, Ministry of Education, Culture, Sports, Science and Technology, Japan; Bio Cosmos Program and Genomics for Agricultural Innovation, Ministry of Agriculture, Forestry and Fisheries of Japan	We thank T. Meshi for helpful and important suggestions, Y. Shimoda and A. Miyamoto for help with experiments, T. Yanai and S. Yoshimizu for rice growth, K. Shimamoto (Nara Institute of Science and Technology) for providing the pANDA vector, K. Toshimitsu (Japan International Cooperation Agency) for providing seeds of NERICA and T. Kobayakawa for helpful discussions. The wild rice accessions used in this study were distributed from the National Institute of Genetics supported by the National Bioresource Project, Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was supported by grants from the Bio Cosmos Program and Genomics for Agricultural Innovation (QTL-4007), Ministry of Agriculture, Forestry and Fisheries of Japan.	Brown RC, 1996, J PLANT RES, V109, P301, DOI 10.1007/BF02344477; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dingkuhn M., 1991, CONCEPTS NEW PLANT T; Dolan MA, 2008, PROTEINS, V72, P1243, DOI 10.1002/prot.22022; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Harlan J.R., 1992, CROPS MAN; Hirose T, 2006, PHYSIOL PLANTARUM, V128, P425, DOI 10.1111/j.1399-3054.2006.00758.x; Hoshikawa K., 1989, GROWING RICE PLANT A; Hoshikawa K, 1967, JAP J CROP SCI, V36, P151, DOI [10.1626/jcs.36.151, DOI 10.1626/JCS.36.151]; Ishimaru K, 2005, J EXP BOT, V56, P2745, DOI 10.1093/jxb/eri267; Ishimaru K, 2004, PLANT PHYSIOL BIOCH, V42, P855, DOI 10.1016/j.plaphy.2004.10.008; Ishimaru K, 2003, PLANT PHYSIOL, V133, P1083, DOI 10.1104/pp.103.027607; Ishimaru K, 2007, PLANT PHYSIOL BIOCH, V45, P799, DOI 10.1016/j.plaphy.2007.07.004; Jakubowska A, 2005, J PLANT PHYSIOL, V162, P207, DOI 10.1016/j.jplph.2004.05.015; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Kurata N, 2006, PLANT PHYSIOL, V140, P12, DOI 10.1104/pp.105.063008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; LUR HS, 1993, PLANT PHYSIOL, V103, P273, DOI 10.1104/pp.103.1.273; Ma XY, 2006, PLANT CELL, V18, P907, DOI 10.1105/tpc.105.038018; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matsuda F, 2005, BIOSCI BIOTECH BIOCH, V69, P778, DOI 10.1271/bbb.69.778; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Mizutani M, 2010, J EXP BOT, V61, P791, DOI 10.1093/jxb/erp343; Nagata K, 2001, PLANT PROD SCI, V4, P173, DOI 10.1626/pps.4.173; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Scharff EI, 2001, STRUCTURE, V9, P493, DOI 10.1016/S0969-2126(01)00610-4; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Stockigt J, 2008, PLANT PHYSIOL BIOCH, V46, P340, DOI 10.1016/j.plaphy.2007.12.011; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Tsunoda Y, 2005, PROTEIN EXPRES PURIF, V42, P268, DOI 10.1016/j.pep.2005.04.002; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; Yang JC, 2002, CROP SCI, V42, P766, DOI 10.2135/cropsci2002.0766	45	368	450	17	271	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2013	45	6					707	+		10.1038/ng.2612	http://dx.doi.org/10.1038/ng.2612			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	152XA	23583977				2022-12-17	WOS:000319563900022
J	Kury, S; Dreno, B; Bezieau, S; Giraudet, S; Kharfi, M; Kamoun, R; Moisan, JP				Kury, S; Dreno, B; Bezieau, S; Giraudet, S; Kharfi, M; Kamoun, R; Moisan, JP			Identification of SLC39A4, a gene involved in acrodermatitis enteropathica	NATURE GENETICS			English	Article							ZINC TRANSPORTER; METAL TRANSPORTER; ARABIDOPSIS; PROTEIN; FAMILY; YEAST		Fac Med, Lab Etud Polymorphisme ADN, F-44035 Nantes, France; Hop Hotel Dieu, Ctr Hosp Univ, Serv Dermatol, F-44093 Nantes, France; Hop Charles Nicolle, Serv Dermatol, Tunis, Tunisia	Nantes Universite; CHU de Nantes; Universite de Tunis-El-Manar; Hopital Charles Nicolle	Kury, S (corresponding author), Fac Med, Lab Etud Polymorphisme ADN, 1 Rue Gaston Veil, F-44035 Nantes, France.		KÜRY, Sébastien/G-5971-2015; Bézieau, stéphane/G-5621-2015	KÜRY, Sébastien/0000-0001-5497-0465; Bézieau, stéphane/0000-0003-0095-1319				ATHERTON DJ, 1979, CLIN SCI, V56, P505, DOI 10.1042/cs0560505; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Guerinot ML, 1999, CURR OPIN PLANT BIOL, V2, P244, DOI 10.1016/S1369-5266(99)80042-9; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; LOMBECK I, 1975, LANCET, V1, P855; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; Wang K, 2001, AM J HUM GENET, V68, P1055, DOI 10.1086/319514; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	11	368	389	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2002	31	3					239	240		10.1038/ng913	http://dx.doi.org/10.1038/ng913			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	567PW	12068297				2022-12-17	WOS:000176494100009
J	Njajou, OT; Vaessen, N; Joosse, M; Berghuis, B; van Dongen, JWF; Breuning, MH; Snijders, PJLM; Rutten, WPF; Sandkuijl, LA; Oostra, BA; van Duijn, CM; Heutink, P				Njajou, OT; Vaessen, N; Joosse, M; Berghuis, B; van Dongen, JWF; Breuning, MH; Snijders, PJLM; Rutten, WPF; Sandkuijl, LA; Oostra, BA; van Duijn, CM; Heutink, P			A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis	NATURE GENETICS			English	Article							HEREDITARY HEMOCHROMATOSIS; IRON; GENE; TRANSPORTER; NRAMP2	Hereditary hemochromatosis (HH) is a very common disorder characterized by iron overload and multi-organ damage. Several genes involved in iron metabolism have been implicated in the pathology of HH (refs. 1-4). We report that a mutation in the gene encoding Solute Carrier family 11, member A3 (SLC11A3). also known as ferroportin. is associated with autosomal dominant hemochromatosis.	Erasmus Univ, Dept Epidemiol & Biostat, Genet Epidemiol Unit, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Leiden Univ, Med Ctr, Dept Anthropogenet, NL-2300 RA Leiden, Netherlands; Stichting Huisarts Lab, Breda, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Njajou, OT (corresponding author), Erasmus Univ, Dept Epidemiol & Biostat, Genet Epidemiol Unit, NL-3000 DR Rotterdam, Netherlands.		Breuning, Martijn H/E-3429-2010	Heutink, Peter/0000-0001-5218-1737				Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Cairo G, 2000, BIOCHEM J, V352, P241, DOI 10.1042/0264-6021:3520241; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; EASON RJ, 1990, AUST NZ J MED, V20, P226, DOI 10.1111/j.1445-5994.1990.tb01024.x; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; GOOSSENS JP, 1977, LANCET, P1106; Haile DJ, 2000, CYTOGENET CELL GENET, V88, P328, DOI 10.1159/000015522; Kaplan J, 2000, NATURE, V403, P711, DOI 10.1038/35001691; KATO J, IN PRESS AM J HUM GE; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Pietrangelo A, 1999, NEW ENGL J MED, V341, P725, DOI 10.1056/NEJM199909023411003; Roetto A, 1999, AM J HUM GENET, V64, P1388, DOI 10.1086/302379	15	368	380	1	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					213	214		10.1038/90038	http://dx.doi.org/10.1038/90038			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431687				2022-12-17	WOS:000169656400009
J	Hughes, AE; Ralston, SH; Marken, J; Bell, C; MacPherson, H; Wallace, RGH; van Hul, W; Whyte, MP; Nakatsuka, K; Hovy, L; Anderson, DM				Hughes, AE; Ralston, SH; Marken, J; Bell, C; MacPherson, H; Wallace, RGH; van Hul, W; Whyte, MP; Nakatsuka, K; Hovy, L; Anderson, DM			Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis	NATURE GENETICS			English	Article							CHROMOSOME 18Q	Familial expansile osteolysis(1,2) (FEO, MIM 174810) is a rare, autosomal dominant bone disorder characterized by focal areas of increased bone remodelling. The osteolytic lesions, which develop usually in the long bones during early adulthood, show increased osteoblast and osteoclast activity. Our previous linkage studies mapped the gene responsible for FEO to an interval of less than 5 cM between D18564 and D18551 on chromosome 18q21.2-21.3 in a large Northern Irish family(3,4). The gene encoding receptor activator of nuclear factor-kappa B (RANK; ref. 5), TNFRSF11A, maps to this region. RANK is essential in osteoclast formation(6,7). We identified two heterozygous insertion mutations in exon 1 of TNFRSF11A in affected members of four families with FEO or familial Paget disease of bone (PDB). One was a duplication of 18 bases and the other a duplication of 27 bases, both of which affected the signal peptide region of the RANK molecule. Expression of recombinant forms of the mutant RANK proteins revealed perturbations in expression levels and lack of normal cleavage of the signal peptide. Both mutations caused an increase in RANK-mediated nuclear factor-kappa B (NF-kappa B) signalling in vitro, consistent with the presence of an activating mutation.	Queens Univ Belfast, Dept Med Genet, Belfast, Antrim, North Ireland; Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland; Immunex Res & Dev Corp, Dept Mol Biol, Seattle, WA 98101 USA; Musgrave Pk Hosp, Dept Orthopaed Surg, Belfast, Antrim, North Ireland; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO USA; Osaka City Hosp, Dept Internal Med 2, Osaka, Japan; Univ Frankfurt, Orthopad Klin, Frankfurt, Germany	Queens University Belfast; University of Aberdeen; University of Antwerp; Washington University (WUSTL); Osaka City General Hospital; Goethe University Frankfurt	Hughes, AE (corresponding author), Queens Univ Belfast, Dept Med Genet, Belfast, Antrim, North Ireland.		Hughes, Anne/A-1307-2012	Van Hul, Wim/0000-0002-5065-7858				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; ENDERLE A, 1979, ARCH ORTHOP TRAUM SU, V94, P127, DOI 10.1007/BF00433578; Haslam SI, 1998, J BONE MINER RES, V13, P911, DOI 10.1359/jbmr.1998.13.6.911; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; HUGHES AE, 1994, HUM MOL GENET, V3, P359, DOI 10.1093/hmg/3.2.359; HUGHES AE, 1996, MOL BIOL PAGETS DIS, P179; Ioannou P.A., 1996, CURRENT PROTOCOLS HU; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; NILSSON I, 1994, J CELL BIOL, V126, P1127, DOI 10.1083/jcb.126.5.1127; Ogilvie D J, 1996, Methods Mol Biol, V54, P131; OSTERBERG PH, 1988, J BONE JOINT SURG BR, V70, P255, DOI 10.1302/0301-620X.70B2.3346299; OSTERBERG PH, 1976, BONE DIS CALCITONIN, P185; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4	14	368	383	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2000	24	1					45	48		10.1038/71667	http://dx.doi.org/10.1038/71667			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	271TH	10615125	Green Published			2022-12-17	WOS:000084609200013
J	Jouanguy, E; Lamhamedi-Cherradi, S; Lammas, D; Dorman, SE; Fondaneche, MC; Dupuis, S; Doffinger, R; Altare, F; Girdlestone, J; Emile, JF; Ducoulombier, H; Edgar, D; Clarke, J; Oxelius, VA; Brai, M; Novelli, V; Heyne, K; Fischer, A; Holland, SM; Kumararatne, DS; Schreiber, RD; Casanova, JL				Jouanguy, E; Lamhamedi-Cherradi, S; Lammas, D; Dorman, SE; Fondaneche, MC; Dupuis, S; Doffinger, R; Altare, F; Girdlestone, J; Emile, JF; Ducoulombier, H; Edgar, D; Clarke, J; Oxelius, VA; Brai, M; Novelli, V; Heyne, K; Fischer, A; Holland, SM; Kumararatne, DS; Schreiber, RD; Casanova, JL			A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection	NATURE GENETICS			English	Article							INTERFERON-GAMMA-RECEPTOR; CALMETTE-GUERIN INFECTION; GENE; IDENTIFICATION; RESISTANCE; SEQUENCE; BCG; DEFICIENCY; CHILDREN; BINDING	The immunogenetic basis of severe infections caused by bacille Calmette-Guerin vaccine and environmental mycobacteria in humans remains largely unknown. We describe 18 patients from several generations of 12 unrelated families who were heterozygous for 1 to 5 overlapping IFNCR1 frameshift small deletions and a wild-type IFNGR1 allele. There were 12 independent mutation events at a single mutation site, defining a small deletion hotspot. Neighbouring sequence analysis favours a small deletion model of slipped mispairing events during replication. The mutant alleles encode cell-surface IFN gamma receptors that lack the intra-cytoplasmic domain, which, through a combination of impaired recycling, abrogated signalling and normal binding to IFN gamma exert a dominant-negative effect. We thus report a hotspot for human IFNGR1 small deletions that confer dominant susceptibility to infections caused by poorly virulent mycobacteria.	Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France; Univ Birmingham, Sch Med, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England; NIH, Host Def Lab, Bethesda, MD 20892 USA; Univ Birmingham, Sch Med, Dept Anat, Birmingham B15 2TT, W Midlands, England; Hop Paul Brousse, Serv Anat Pathol, F-94804 Villejuif, France; Hop St Antoine, Serv Pediat, F-59019 Lille, France; Royal Victoria Hosp, Reg Immunol Serv, Belfast BT12 6BN, Antrim, North Ireland; Childrens Hosp, Resp & Cyst Fibrosis Unit, Birmingham B4 6NH, W Midlands, England; Univ Lund, Dept Pediat, S-22185 Lund, Sweden; Ist Patol Gen, I-90134 Palermo, Italy; Great Ormond St Hosp Children, Infect Dis Unit, London WC1N 3JH, England; Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, F-75015 Paris, France; Birmingham Heartlands Hosp, Reg Dept Immunol, Birmingham, W Midlands, England; Washington Univ, Dept Pathol, St Louis, MO 63110 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Birmingham; National Institutes of Health (NIH) - USA; University of Birmingham; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Sorbonne Universite; Lund University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Heart of England NHS Foundation Trust; University of Birmingham; Washington University (WUSTL)	Casanova, JL (corresponding author), Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France.	casanova@ceylan.necker.fr	Schreiber, Robert/Q-7550-2019; Boisson-Dupuis, Stéphanie/I-2040-2017; Schreiber, Robert D/A-1276-2013; altare, frederic/K-8664-2015; Casanova, Jean-Laurent/I-3418-2017; Boisson-Dupuis, Stephanie/AAF-5066-2021; Jouanguy, Emmanuelle/H-7901-2017	Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Schreiber, Robert D/0000-0001-6311-0432; altare, frederic/0000-0002-5077-4616; Jouanguy, Emmanuelle/0000-0002-7358-9157; Girdlestone, John/0000-0001-7422-9674; Edgar, John David Moore/0000-0003-2969-4475; Casanova, Jean-Laurent/0000-0002-7782-4169; Schreiber, Robert/0000-0003-1590-2341	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000647, Z01AI000647] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABEL L, 1988, AM J HUM GENET, V42, P256; AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; Altare F, 1998, CURR OPIN IMMUNOL, V10, P413, DOI 10.1016/S0952-7915(98)80114-3; Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Altare F, 1998, AM J HUM GENET, V62, P723, DOI 10.1086/301750; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bach EA, 1996, MOL CELL BIOL, V16, P3214; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BENNETT RL, 1995, AM J HUM GENET, V56, P745, DOI 10.1007/BF01408073; CASANOVA JL, 1995, LANCET, V346, P581, DOI 10.1016/S0140-6736(95)91421-8; Casanova JL, 1996, PEDIATRICS, V98, P774; CELADA A, 1985, J CLIN INVEST, V76, P2196, DOI 10.1172/JCI112228; Cooper DN, 1998, GENETIC BASIS HUMAN, P65; Coughlin CM, 1998, IMMUNITY, V9, P25, DOI 10.1016/S1074-7613(00)80585-3; de Jong R, 1998, SCIENCE, V280, P1435; DIGHE AS, 1993, J BIOL CHEM, V268, P10645; DIGHE AS, 1995, IMMUNITY, V3, P657, DOI 10.1016/1074-7613(95)90136-1; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; Emile JF, 1997, J PATHOL, V181, P25, DOI 10.1002/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z; FARRAR MA, 1991, J BIOL CHEM, V266, P19626; FARRAR MA, 1992, P NATL ACAD SCI USA, V89, P11706, DOI 10.1073/pnas.89.24.11706; Frucht DM, 1996, J IMMUNOL, V157, P411; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; GRUNDY CB, 1991, BLOOD, V78, P1027; HEYNE K, 1976, EUR J PEDIATR, V121, P179, DOI 10.1007/BF00445481; Holland SM, 1998, J INFECT DIS, V178, P1095, DOI 10.1086/515670; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1997, J INTERF CYTOK RES, V17, P583, DOI 10.1089/jir.1997.17.583; Kaplan DH, 1996, J BIOL CHEM, V271, P9, DOI 10.1074/jbc.271.1.9; KRAWCZAK M, 1991, HUM GENET, V86, P425; KRAWCZAK M, 1993, HUMAN GENE MUTATIONS, P163; LAMBAMEDI S, 1998, INT J MOL MED, V1, P415; LEVIN M, 1995, LANCET, V345, P79, DOI 10.1016/S0140-6736(95)90059-4; Mckusick V.A., 1994, MENDELIAN INHERITANC; Merlin G, 1997, IMMUNOGENETICS, V45, P413, DOI 10.1007/s002510050223; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Ottenhoff THM, 1998, IMMUNOL TODAY, V19, P491, DOI 10.1016/S0167-5699(98)01321-8; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; RASZKA WV, 1994, CLIN PEDIATR, V33, P611, DOI 10.1177/000992289403301007; ROESLER J, IN PRESS EXP HAEMATO; Schonell M E, 1968, Tubercle, V49, P12, DOI 10.1016/S0041-3879(68)80003-0; SHEEHAN KCF, 1988, J IMMUNOL, V140, P4231; STEAD WW, 1992, ANN INTERN MED, V116, P937, DOI 10.7326/0003-4819-116-11-937; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; WEAVER DT, 1982, J BIOL CHEM, V257, P2075; Winfield JB, 1997, CLIN EXP IMMUNOL, V109, P1, DOI 10.1046/j.1365-2249.1997.00439.x	50	368	383	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	1999	21	4					370	378		10.1038/7701	http://dx.doi.org/10.1038/7701			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	181KC	10192386				2022-12-17	WOS:000079439700017
J	Strom, TM; Nyakatura, G; Apfelstedt-Sylla, E; Hellebrand, H; Lorenz, B; Weber, BHF; Wutz, K; Gutwillinger, N; Ruther, K; Drescher, B; Sauer, C; Zrenner, E; Meitinger, T; Rosenthal, A; Meindl, A				Strom, TM; Nyakatura, G; Apfelstedt-Sylla, E; Hellebrand, H; Lorenz, B; Weber, BHF; Wutz, K; Gutwillinger, N; Ruther, K; Drescher, B; Sauer, C; Zrenner, E; Meitinger, T; Rosenthal, A; Meindl, A			An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness	NATURE GENETICS			English	Article							BETA-SUBUNIT; REGION; RP3	The locus for the incomplete form of X-linked congenital stationary night blindness (CSNB2) maps to a 1.1-Mb region in Xp11.23 between markers DXS722 and DXS255. We identified a retina-specific calcium channel alpha(1)-subunit gene (CACNA1F) in this region, consisting of 48 exons encoding 1966 amino acids and showing high homology to L-type calcium channel alpha(1)-subunits. Mutation analysis in 13 families with CSNB2 revealed nine different mutations in 10 families, including three nonsense and one frameshift mutation. These data indicate that aberrations in a voltage-gated calcium channel. presumably causing a decrease in neurotransmitter release from photoreceptor presynaptic terminals, are a frequent cause of CSNB2.	Univ Munich, Abt Med Genet, D-80336 Munchen, Germany; Univ Tubingen, Augenklin, D-72076 Tubingen, Germany; Inst Mol Biotechnol, D-07745 Jena, Germany; Univ Regensburg, Augenklin, D-93042 Regensburg, Germany; Inst Humangenet, D-97074 Wurzburg, Germany	University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg	Meindl, A (corresponding author), Univ Munich, Abt Med Genet, Goethestr 29, D-80336 Munchen, Germany.	alfons@pedgen.med.uni-muenchen.de	Meitinger, Thomas/O-1318-2015	Weber, Bernhard H.F./0000-0002-8808-7723; Meitinger, Thomas/0000-0002-8838-8403				BECHHANSEN NT, 1993, AM J HUM GENET, V52, P71; BERGEN AAB, 1995, HUM MOL GENET, V4, P931, DOI 10.1093/hmg/4.5.931; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Boycott KM, 1998, AM J HUM GENET, V62, P865, DOI 10.1086/301781; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Craxton M, 1993, Methods Mol Biol, V23, P149; Fisher SE, 1997, GENOMICS, V45, P340, DOI 10.1006/geno.1997.4941; HOGAN K, 1994, GENOMICS, V24, P608, DOI 10.1006/geno.1994.1677; HOOD DC, 1990, VISION RES, V30, P51, DOI 10.1016/0042-6989(90)90127-7; LEIMEISTER C, IN PRESS MECH DEV; Lorenz B, 1996, KLIN MONATSBL AUGENH, V208, P48, DOI 10.1055/s-2008-1035167; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MIYAKE Y, 1987, INVEST OPHTH VIS SCI, V28, P1816; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Ruether K, 1993, Ger J Ophthalmol, V2, P429; Schindelhauer D, 1996, GENOME RES, V6, P1056, DOI 10.1101/gr.6.11.1056; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; SCHULTZ D, 1993, P NATL ACAD SCI USA, V90, P6228, DOI 10.1073/pnas.90.13.6228; Schuster A, 1996, EMBO J, V15, P2365, DOI 10.1002/j.1460-2075.1996.tb00592.x; Sinnegger MJ, 1997, J BIOL CHEM, V272, P27686, DOI 10.1074/jbc.272.44.27686; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Witkovsky P, 1997, J NEUROSCI, V17, P7297	26	368	377	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1998	19	3					260	263		10.1038/940	http://dx.doi.org/10.1038/940			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662399				2022-12-17	WOS:000074565900022
J	TROTTIER, Y; DEVYS, D; IMBERT, G; SAUDOU, F; AN, I; LUTZ, Y; WEBER, C; AGID, Y; HIRSCH, EC; MANDEL, JL				TROTTIER, Y; DEVYS, D; IMBERT, G; SAUDOU, F; AN, I; LUTZ, Y; WEBER, C; AGID, Y; HIRSCH, EC; MANDEL, JL			CELLULAR-LOCALIZATION OF THE HUNTINGTONS-DISEASE PROTEIN AND DISCRIMINATION OF THE NORMAL AND MUTATED FORM	NATURE GENETICS			English	Article							TRINUCLEOTIDE CAG REPEAT; GENE; NEURONS; EXPRESSION; EXPANSION; MECHANISM; TISSUES; LENGTH	Huntington's disease (HD) results from the expansion of a polyglutamine encoding CAG repeat in a gene of unknown function. The wide expression of this transcript does not correlate with the pattern of neuropathology in HD. To study the HD gene product (huntingtin), we have developed monoclonal antibodies raised against four different regions of the protein. On western blots, these monoclonals detect the similar to 350 kD huntingtin protein in various human cell lines and in neural and non-neural rodent tissues. In cell lines from HD patients, a doublet protein is detected corresponding to the mutated and normal huntingtin. Immunohistochemical studies in the human brain using two of these antibodies detects the huntingtin in perikarya of some neurons, neuropiles, varicosities and as punctate staining likely to be nerve endings.	UNIV STRASBOURG 1,INST GENET & BIOL MOLEC & CELLULAIRE,CNRS,INSERM,F-67404 ILLKIRCH GRAFFENS,FRANCE; CTR UNIV STRASBOURG,STRASBOURG,FRANCE; HOP LA PITIE SALPETRIERE,INSERM,U289,F-75651 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite			Trottier, Yvon/H-8852-2016; Hirsch, Etienne/AAC-7655-2019; SAUDOU, Frédéric/L-3454-2014	Hirsch, Etienne/0000-0003-4823-276X; SAUDOU, Frédéric/0000-0001-6107-1046; Trottier, Yvon/0000-0001-7230-4810; Devys, Didier/0000-0001-9655-3512				ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; BARNES GT, 1994, SOMAT CELL MOLEC GEN, V20, P87, DOI 10.1007/BF02290678; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; CHATRE AN, 1993, NAT GENET, V5, P84; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GORMAN CM, 1984, PHILOS T ROY SOC B, V307, P343, DOI 10.1098/rstb.1984.0137; GRAYBIEL AM, 1987, P NATL ACAD SCI USA, V84, P303, DOI 10.1073/pnas.84.1.303; GREEN H, 1993, CELL, V74, P955, DOI 10.1016/0092-8674(93)90718-6; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GUSELLA JF, 1994, NEW ENGL J MED, V330, P1450, DOI 10.1056/NEJM199405193302011; HARPER PS, 1992, HUM GENET, V89, P365; Harper PS, 1991, HUNTINGTONS DISEASE; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; IMBERT G, 1994, GENOMICS, V21, P667, DOI 10.1006/geno.1994.1335; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; KAWAGUCHI Y, 1995, NAT GENET, V8, P221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KREMER B, 1994, NEW ENGL J MED, V330, P1402; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; 1993, CELL, V72, P971	39	368	388	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					104	110		10.1038/ng0595-104	http://dx.doi.org/10.1038/ng0595-104			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647777				2022-12-17	WOS:A1995QX57300024
J	Schumacher, FR; Al Olama, AA; Berndt, SI; Benlloch, S; Ahmed, M; Saunders, EJ; Dadaev, T; Leongamornlert, D; Anokian, E; Cieza-Borrella, C; Goh, C; Brook, MN; Sheng, X; Fachal, L; Dennis, J; Tyrer, J; Muir, K; Lophatananon, A; Stevens, VL; Gapstur, SM; Carter, BD; Tangen, CM; Goodman, PJ; Thompson, IM; Batra, J; Chambers, S; Moya, L; Clements, J; Horvath, L; Tilley, W; Risbridger, GP; Gronberg, H; Aly, M; Nordstrom, T; Pharoah, P; Pashayan, N; Schleutker, J; Tammela, TLJ; Sipeky, C; Auvinen, A; Albanes, D; Weinstein, S; Wolk, A; Hakansson, N; West, CML; Dunning, AM; Burnet, N; Mucci, LA; Giovannucci, E; Andriole, GL; Cussenot, O; Cancel-Tassin, G; Koutros, S; Freeman, LEB; Sorensen, KD; Orntoft, TF; Borre, M; Maehle, L; Grindedal, EM; Neal, DE; Donovan, JL; Hamdy, FC; Martin, RM; Travis, RC; Key, TJ; Hamilton, RJ; Fleshner, NE; Finelli, A; Ingles, SA; Stern, MC; Rosenstein, BS; Kerns, SL; Ostrer, H; Lu, YJ; Zhang, HW; Feng, NH; Mao, XY; Guo, X; Wang, GM; Sun, Z; Giles, GG; Southey, MC; MacInnis, RJ; FitzGerald, LM; Kibel, AS; Drake, BF; Vega, A; Gomez-Caamano, A; Szulkin, R; Eklund, M; Kogevinas, M; Llorca, J; Castano-Vinyals, G; Penney, KL; Stampfer, M; Park, JY; Sellers, TA; Lin, HY; Stanford, JL; Cybulski, C; Wokolorczyk, D; Lubinski, J; Ostrander, EA; Geybels, MS; Nordestgaard, BG; Nielsen, SF; Weischer, M; Bisbjerg, R; Roder, MA; Iversen, P; Brenner, H; Cuk, K; Holleczek, B; Maier, C; Luedeke, M; Schnoeller, T; Kim, J; Logothetis, CJ; John, EM; Teixeira, MR; Paulo, P; Cardoso, M; Neuhausen, SL; Steele, L; Ding, YC; De Ruyck, K; De Meerleer, G; Ost, P; Razack, A; Lim, J; Teo, SH; Lin, DW; Newcomb, LF; Lessel, D; Gamulin, M; Kulis, T; Kaneva, R; Usmani, N; Singhal, S; Slavov, C; Mitev, V; Parliament, M; Claessens, F; Joniau, S; Van den Broeck, T; Larkin, S; Townsend, PA; Aukim-Hastie, C; Dominguez, MG; Castelao, JE; Martinez, ME; Roobol, MJ; Jenster, G; van Schaik, RHN; Menegaux, F; Truong, T; Koudou, YA; Xu, JF; Khaw, KT; Cannon-Albright, L; Pandha, H; Michael, A; Thibodeau, SN; McDonnell, SK; Schaid, DJ; Lindstrom, S; Turman, C; Ma, J; Hunter, DJ; Riboli, E; Siddiq, A; Canzian, F; Kolonel, LN; Le Marchand, L; Hoover, RN; Machiela, MJ; Cui, ZX; Kraft, P; Conti, DV; Easton, DF; Wiklund, F; Chanock, SJ; Henderson, BE; Kote-Jarai, Z; Haiman, CA; Eeles, RA				Schumacher, Fredrick R.; Al Olama, Ali Amin; Berndt, Sonja I.; Benlloch, Sara; Ahmed, Mahbubl; Saunders, Edward J.; Dadaev, Tokhir; Leongamornlert, Daniel; Anokian, Ezequiel; Cieza-Borrella, Clara; Goh, Chee; Brook, Mark N.; Sheng, Xin; Fachal, Laura; Dennis, Joe; Tyrer, Jonathan; Muir, Kenneth; Lophatananon, Artitaya; Stevens, Victoria L.; Gapstur, Susan M.; Carter, Brian D.; Tangen, Catherine M.; Goodman, Phyllis J.; Thompson, Ian M., Jr.; Batra, Jyotsna; Chambers, Suzanne; Moya, Leire; Clements, Judith; Horvath, Lisa; Tilley, Wayne; Risbridger, Gail P.; Gronberg, Henrik; Aly, Markus; Nordstrom, Tobias; Pharoah, Paul; Pashayan, Nora; Schleutker, Johanna; Tammela, Teuvo L. J.; Sipeky, Csilla; Auvinen, Anssi; Albanes, Demetrius; Weinstein, Stephanie; Wolk, Alicja; Hakansson, Niclas; West, Catharine M. L.; Dunning, Alison M.; Burnet, Neil; Mucci, Lorelei A.; Giovannucci, Edward; Andriole, Gerald L.; Cussenot, Olivier; Cancel-Tassin, Geraldine; Koutros, Stella; Freeman, Laura E. Beane; Sorensen, Karina Dalsgaard; Orntoft, Torben Falck; Borre, Michael; Maehle, Lovise; Grindedal, Eli Marie; Neal, David E.; Donovan, Jenny L.; Hamdy, Freddie C.; Martin, Richard M.; Travis, Ruth C.; Key, Tim J.; Hamilton, Robert J.; Fleshner, Neil E.; Finelli, Antonio; Ingles, Sue Ann; Stern, Mariana C.; Rosenstein, Barry S.; Kerns, Sarah L.; Ostrer, Harry; Lu, Yong-Jie; Zhang, Hong-Wei; Feng, Ninghan; Mao, Xueying; Guo, Xin; Wang, Guomin; Sun, Zan; Giles, Graham G.; Southey, Melissa C.; MacInnis, Robert J.; FitzGerald, Liesel M.; Kibel, Adam S.; Drake, Bettina F.; Vega, Ana; Gomez-Caamano, Antonio; Szulkin, Robert; Eklund, Martin; Kogevinas, Manolis; Llorca, Javier; Castano-Vinyals, Gemma; Penney, Kathryn L.; Stampfer, Meir; Park, Jong Y.; Sellers, Thomas A.; Lin, Hui-Yi; Stanford, Janet L.; Cybulski, Cezary; Wokolorczyk, Dominika; Lubinski, Jan; Ostrander, Elaine A.; Geybels, Milan S.; Nordestgaard, Borge G.; Nielsen, Sune F.; Weischer, Maren; Bisbjerg, Rasmus; Roder, Martin Andreas; Iversen, Peter; Brenner, Hermann; Cuk, Katarina; Holleczek, Bernd; Maier, Christiane; Luedeke, Manuel; Schnoeller, Thomas; Kim, Jeri; Logothetis, Christopher J.; John, Esther M.; Teixeira, Manuel R.; Paulo, Paula; Cardoso, Marta; Neuhausen, Susan L.; Steele, Linda; Ding, Yuan Chun; De Ruyck, Kim; De Meerleer, Gert; Ost, Piet; Razack, Azad; Lim, Jasmine; Teo, Soo-Hwang; Lin, Daniel W.; Newcomb, Lisa F.; Lessel, Davor; Gamulin, Marija; Kulis, Tomislav; Kaneva, Radka; Usmani, Nawaid; Singhal, Sandeep; Slavov, Chavdar; Mitev, Vanio; Parliament, Matthew; Claessens, Frank; Joniau, Steven; Van den Broeck, Thomas; Larkin, Samantha; Townsend, Paul A.; Aukim-Hastie, Claire; Dominguez, Manuela Gago; Castelao, Jose Esteban; Martinez, Maria Elena; Roobol, Monique J.; Jenster, Guido; van Schaik, Ron H. N.; Menegaux, Florence; Truong, Therese; Koudou, Yves Akoli; Xu, Jianfeng; Khaw, Kay-Tee; Cannon-Albright, Lisa; Pandha, Hardev; Michael, Agnieszka; Thibodeau, Stephen N.; McDonnell, Shannon K.; Schaid, Daniel J.; Lindstrom, Sara; Turman, Constance; Ma, Jing; Hunter, David J.; Riboli, Elio; Siddiq, Afshan; Canzian, Federico; Kolonel, Laurence N.; Le Marchand, Loic; Hoover, Robert N.; Machiela, Mitchell J.; Cui, Zuxi; Kraft, Peter; Conti, David V.; Easton, Douglas F.; Wiklund, Fredrik; Chanock, Stephen J.; Henderson, Brian E.; Kote-Jarai, Zsofia; Haiman, Christopher A.; Eeles, Rosalind A.		Profile Study; APCB; IMPACT Study; Canary PASS Investigators; Breast Prostate Canc Cohort Consor; PRACTICAL Prostate Canc As; Canc Prostate Sweden CAPS; Prostate Canc Genome-wide As; Genetic Assoc Mech Oncology GAME-	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MULTIPLE LOCI; RISK; GENE; METAANALYSIS; VARIANTS; PATHWAY; IDENTIFICATION; CONSORTIUM; PREDICTION	Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data from a custom high-density array of 46,939 PrCa cases and 27,910 controls of European ancestry with previously genotyped data of 32,255 PrCa cases and 33,202 controls of European ancestry. Our analysis identified 62 novel loci associated (P < 5.0 x 10(-8)) with PrCa and one locus significantly associated with early-onset PrCa (<= 55 years). Our findings include missense variants rs1800057 (odds ratio (OR) = 1.16; P = 8.2 x 10(-9); G>C, p.Pro1054Arg) in ATM and rs2066827 (OR = 1.06; P = 2.3 x 10(-9); T>G, p.Val109Gly) in CDKN1B. The combination of all loci captured 28.4% of the PrCa familial relative risk, and a polygenic risk score conferred an elevated PrCa risk for men in the ninetieth to ninety-ninth percentiles (relative risk = 2.69; 95% confidence interval (CI): 2.55-2.82) and first percentile (relative risk = 5.71; 95% CI: 5.04-6.48) risk stratum compared with the population average. These findings improve risk prediction, enhance fine-mapping, and provide insight into the underlying biology of PrCa1.	[Schumacher, Fredrick R.; Cui, Zuxi] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Schumacher, Fredrick R.] Univ Hosp, Seidman Canc Ctr, Cleveland, OH USA; [Al Olama, Ali Amin; Benlloch, Sara; Dennis, Joe; Tyrer, Jonathan; Pharoah, Paul; Easton, Douglas F.] Univ Cambridge, Strangeways Res Lab, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Al Olama, Ali Amin] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Berndt, Sonja I.; Albanes, Demetrius; Weinstein, Stephanie; Koutros, Stella; Freeman, Laura E. Beane; Finelli, Antonio; Rosenstein, Barry S.; Ostrer, Harry; Zhang, Hong-Wei; Gamulin, Marija; Hoover, Robert N.; Machiela, Mitchell J.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Benlloch, Sara; Ahmed, Mahbubl; Saunders, Edward J.; Dadaev, Tokhir; Leongamornlert, Daniel; Anokian, Ezequiel; Cieza-Borrella, Clara; Goh, Chee; Brook, Mark N.; Kote-Jarai, Zsofia; Eeles, Rosalind A.] Inst Canc Res, London, England; [Sheng, Xin; Ingles, Sue Ann; Stern, Mariana C.; Conti, David V.; Henderson, Brian E.; Haiman, Christopher A.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Fachal, Laura] Fdn Publ Galega Med Xenom SERGAS, CIBERER, Grp Med Xenom, IDIS, Santiago De Compostela, Spain; [Fachal, Laura; Pharoah, Paul; Pashayan, Nora; Dunning, Alison M.; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Strangeways Lab, Cambridge, England; [Muir, Kenneth; Lophatananon, Artitaya] Univ Manchester, Div Populat Hlth, Hlth Serv Res & Primary Care, Manchester, Lancs, England; [Muir, Kenneth; Lophatananon, Artitaya] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Stevens, Victoria L.; Gapstur, Susan M.; Carter, Brian D.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Tangen, Catherine M.; Goodman, Phyllis J.] Fred Hutchinson Canc Res Ctr, SWOG Stat Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Thompson, Ian M., Jr.] CHRISTUS Santa Rosa Hosp Med Ctr, San Antonio, TX USA; [Batra, Jyotsna; Moya, Leire; Clements, Judith] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Batra, Jyotsna; Moya, Leire; Clements, Judith] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia; [Batra, Jyotsna; Moya, Leire; Clements, Judith] Australian Prostate Canc Res Ctr Qld, Translat Res Inst, Brisbane, Qld, Australia; [Chambers, Suzanne] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia; [Chambers, Suzanne] Canc Council Queensland, Fortitude Valley, Qld, Australia; [Horvath, Lisa] Chris OBrien Lifehouse COBLH, Camperdown, NSW, Australia; [Horvath, Lisa] Garvan Inst Med Res, Sydney, NSW, Australia; [Tilley, Wayne] Univ Adelaide, Dame Roma Mitchell Canc Res Ctr, Adelaide, SA, Australia; [Risbridger, Gail P.] Monash Univ, Dept Anat & Dev Biol, Prostate Canc Res Program, Monash Biomed Discovery Inst Canc Program, Clayton, Vic, Australia; [Risbridger, Gail P.] Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic, Australia; [Gronberg, Henrik; Nordstrom, Tobias; Eklund, Martin; Wiklund, Fredrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Aly, Markus] Karolinska Univ Hosp, Dept Urol, Stockholm, Sweden; [Aly, Markus] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Nordstrom, Tobias] Karolinska Inst, Danderyds Hosp, Dept Clin Sci, Stockholm, Sweden; [Pashayan, Nora] UCL, Dept Appl Hlth Res, London, England; [Schleutker, Johanna; Sipeky, Csilla] Univ Turku, Inst Biomed, Turku, Finland; [Schleutker, Johanna] Turku Univ Hosp, Dept Med Genet, Tyks Microbiol & Genet, Turku, Finland; [Tammela, Teuvo L. J.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Tammela, Teuvo L. J.] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Auvinen, Anssi] Univ Tampere, Sch Hlth Sci, Dept Epidemiol, Tampere, Finland; [Wolk, Alicja; Hakansson, Niclas] Karolinska Inst, Inst Environm Med, Div Nutr Epidemiol, Stockholm, Sweden; [Wolk, Alicja] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [West, Catharine M. L.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester Canc Res Ctr, Div Canc Sci, Manchester, Lancs, England; [West, Catharine M. L.] Univ Manchester, Christie NHS Fdn Trust, Manchester, Lancs, England; [Burnet, Neil] Univ Cambridge, Cambridge Univ Hosp NHS Fdn Trust, Ctr Oncol, Dept Oncol, Cambridge, England; [Mucci, Lorelei A.; Giovannucci, Edward] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Andriole, Gerald L.; Drake, Bettina F.] Washington Univ, Sch Med, St Louis, MO USA; [Cussenot, Olivier; Cancel-Tassin, Geraldine] UPMC, Sorbonne Univ, Tenon Hosp, GRC ONCOTYPE URO 5, Paris, France; [Cussenot, Olivier; Cancel-Tassin, Geraldine] Tenon Hosp, CeRePP, Paris, France; [Sorensen, Karina Dalsgaard; Orntoft, Torben Falck] Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark; [Sorensen, Karina Dalsgaard; Orntoft, Torben Falck; Borre, Michael] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Borre, Michael] Aarhus Univ Hosp, Dept Urol, Aarhus, Denmark; [Maehle, Lovise; Grindedal, Eli Marie] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge, England; [Neal, David E.] Canc Res UK, Cambridge Res Inst, Cambridge, England; [Neal, David E.; Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Neal, David E.; Hamdy, Freddie C.] Univ Oxford, John Radcliffe Hosp, Fac Med Sci, Oxford, England; [Donovan, Jenny L.; Martin, Richard M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Travis, Ruth C.; Key, Tim J.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Hamilton, Robert J.; Fleshner, Neil E.] Princess Margaret Canc Ctr, Dept Surg Oncol, Toronto, ON, Canada; [Finelli, Antonio] Princess Margaret Canc Ctr, Div Urol, Toronto, ON, Canada; [Rosenstein, Barry S.] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA; [Rosenstein, Barry S.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kerns, Sarah L.] Univ Rochester, Med Ctr, Dept Radiat Oncol, Rochester, NY 14642 USA; [Ostrer, Harry] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Lu, Yong-Jie; Mao, Xueying] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England; [Zhang, Hong-Wei] Second Mil Med Univ, Shanghai, Peoples R China; [Feng, Ninghan] Nanjing Med Univ, Wuxi Hosp 2, Wuxi, Peoples R China; [Guo, Xin] Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing, Peoples R China; [Wang, Guomin] Fudan Univ, Zhongshan Hosp, Dept Urol, Med Coll, Shanghai, Peoples R China; [Sun, Zan] China Med Univ, Peoples Hosp, Peoples Hosp Liaoning Prov, Shenyang, Peoples R China; [Giles, Graham G.; MacInnis, Robert J.; FitzGerald, Liesel M.] Canc Council Victoria, Canc Epidemiol & Intelligence Div, Melbourne, Vic, Australia; [Giles, Graham G.; MacInnis, Robert J.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostati, Melbourne, Vic, Australia; [Southey, Melissa C.] Monash Univ, Sch Clin Sci Monash Hlth, Precis Med, Clayton, Vic, Australia; [FitzGerald, Liesel M.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Kibel, Adam S.] Brigham & Womens Hosp, Div Urol Surg, 75 Francis St, Boston, MA 02115 USA; [Vega, Ana] Fdn Publ Galega Med Xenomica SERGAS, Grp Med Xenom, CIBERER, IDIS, Santiago De Compostela, Spain; [Gomez-Caamano, Antonio] SERGAS, Dept Radiat Oncol, Complexo Hosp Univ Santiago, Santiago De Compostela, Spain; [Szulkin, Robert] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med, Huddinge, Sweden; [Szulkin, Robert] Scandinavian Dev Serv, Danderyd, Sweden; [Kogevinas, Manolis; Castano-Vinyals, Gemma] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis; Llorca, Javier; Castano-Vinyals, Gemma] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Kogevinas, Manolis; Castano-Vinyals, Gemma] Hosp del Mar, Res Inst, IMIM, Barcelona, Spain; [Kogevinas, Manolis; Castano-Vinyals, Gemma] Univ Pompeu Fabra, Barcelona, Spain; [Llorca, Javier] Univ Cantabria, IDIVAL, Santander, Spain; [Penney, Kathryn L.; Stampfer, Meir; Ma, Jing] Brigham & Womens Hosp, Dept Med, Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Penney, Kathryn L.; Stampfer, Meir; Ma, Jing] Harvard Med Sch, Boston, MA USA; [Park, Jong Y.; Sellers, Thomas A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Lin, Hui-Yi] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, Biostat Program, New Orleans, LA USA; [Stanford, Janet L.; Geybels, Milan S.; Lin, Daniel W.; Newcomb, Lisa F.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Stanford, Janet L.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Cybulski, Cezary; Wokolorczyk, Dominika; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [Ostrander, Elaine A.] NHGRI, NIH, Bethesda, MD 20892 USA; [Nordestgaard, Borge G.; Nielsen, Sune F.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nordestgaard, Borge G.; Nielsen, Sune F.; Weischer, Maren] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark; [Bisbjerg, Rasmus] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Urol, Herlev, Denmark; [Roder, Martin Andreas; Iversen, Peter] Copenhagen Univ Hosp, Rigshosp, Dept Urol, Copenhagen Prostate Canc Ctr, Copenhagen, Denmark; [Brenner, Hermann; Cuk, Katarina] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Maier, Christiane; Luedeke, Manuel] Univ Hosp Ulm, Inst Human Genet, Ulm, Germany; [Schnoeller, Thomas] Univ Hosp Ulm, Dept Urol, Ulm, Germany; [Kim, Jeri; Logothetis, Christopher J.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA USA; [Teixeira, Manuel R.; Paulo, Paula; Cardoso, Marta] Portuguese Oncol Inst Porto, Dept Genet, Porto, Portugal; [Teixeira, Manuel R.] Univ Porto, Biomed Sci Inst ICBAS, Porto, Portugal; [Neuhausen, Susan L.; Steele, Linda; Ding, Yuan Chun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA; [De Ruyck, Kim; De Meerleer, Gert] Univ Ghent, Fac Med & Hlth Sci, Basic Med Sci, Ghent, Belgium; [Ost, Piet] Ghent Univ Hosp, Dept Radiotherapy, Ghent, Belgium; [Razack, Azad; Lim, Jasmine] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur, Malaysia; [Teo, Soo-Hwang] Subang Jaya Med Ctr, Outpatient Ctr, CRM, Selangor, Malaysia; [Lin, Daniel W.; Newcomb, Lisa F.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Lessel, Davor] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Gamulin, Marija] Univ Hosp Ctr Zagreb, Div Med Oncol, Urogenital Unit, Dept Oncol, Zagreb, Croatia; [Kulis, Tomislav] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Dept Urol, Zagreb, Croatia; [Kaneva, Radka; Mitev, Vanio] Med Univ Sofia, Dept Med Chem & Biochem, Mol Med Ctr, Sofia, Bulgaria; [Usmani, Nawaid; Singhal, Sandeep; Parliament, Matthew] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada; [Usmani, Nawaid; Singhal, Sandeep; Parliament, Matthew] Cross Canc Inst, Div Radiat Oncol, Edmonton, AB, Canada; [Slavov, Chavdar] Med Univ Sofia, Dept Urol, Sofia, Bulgaria; [Slavov, Chavdar] Med Univ Sofia, Alexandrovska Univ Hosp, Sofia, Bulgaria; [Claessens, Frank; Van den Broeck, Thomas] Katholieke Univ Leuven, Dept Cellular & Mol Med, Mol Endocrinol Lab, Leuven, Belgium; [Joniau, Steven; Van den Broeck, Thomas] Univ Hosp Leuven, Dept Urol, Leuven, Belgium; [Larkin, Samantha] Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England; [Townsend, Paul A.] Univ Manchester, Div Canc Sci,Hlth Innovat Manchester, Manchester Canc Res Ctr,NIHR Manchester Biomed Re, Fac Biol Med & Hlth,Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Aukim-Hastie, Claire; Pandha, Hardev; Michael, Agnieszka] Univ Surrey, Guildford, Surrey, England; [Dominguez, Manuela Gago] Galician Fdn Genom Med, Genom Med Grp,SERGAS, Inst Invest Sanitaria Santiago de Compostela IDIS, Complejo Hosp Univ Santiago,Serv Galego Saude, Santiago De Compostela, Spain; [Dominguez, Manuela Gago] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Castelao, Jose Esteban] Complexo Hosp Univ Vigo, Inst Invest Biomed Galicia IISGS, CHUVI Hosp, Genet Oncol Unit, Vigo, Spain; [Martinez, Maria Elena] Univ Calif San Diego, Moores Canc Ctr, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Roobol, Monique J.; Jenster, Guido] Erasmus Univ, Med Ctr, Dept Urol, Rotterdam, Netherlands; [van Schaik, Ron H. N.] Erasmus Univ, Med Ctr, Dept Clin Chem, Rotterdam, Netherlands; [Menegaux, Florence; Truong, Therese; Koudou, Yves Akoli] Univ Paris Saclay, Univ Paris Sud, INSERM, Canc & Environm Grp,Ctr Res Epidemiol & Populat H, Villejuif, France; [Xu, Jianfeng] NorthShore Univ HealthSyst, Program Personalized Canc Care, Evanston, IL USA; [Khaw, Kay-Tee] Univ Cambridge, Clin Gerontol Unit, Cambridge, England; [Cannon-Albright, Lisa] Univ Utah, Sch Med, Dept Med, Div Genet Epidemiol, Salt Lake City, UT USA; [Cannon-Albright, Lisa] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA; [Thibodeau, Stephen N.; Schaid, Daniel J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [McDonnell, Shannon K.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Lindstrom, Sara] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Turman, Constance; Hunter, David J.; Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Program Genet Epidemiol & Stat Genet, Boston, MA USA; [Riboli, Elio] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Siddiq, Afshan] Queen Mary Univ London, Genom England, London, England; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Epidemiol Program, Honolulu, HI 96822 USA; Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Lebanon, NH USA; Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH USA; [Genetic Assoc Mech Oncology GAME-] Geisel Sch Med, Norris Cotton Canc Ctr, Lebanon, NH USA; [Schumacher, Fredrick R.; Al Olama, Ali Amin; Berndt, Sonja I.; Eeles, Rosalind A.] Royal Marsden NHS Fdn Trust, London, England	Case Western Reserve University; University Hospitals of Cleveland; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Southern California; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; University of Cambridge; University of Manchester; University of Warwick; American Cancer Society; Fred Hutchinson Cancer Center; Southwest Oncology Group; Queensland University of Technology (QUT); Queensland University of Technology (QUT); Griffith University; Cancer Council Queensland; University of Sydney; Garvan Institute of Medical Research; University of Adelaide; Monash University; Peter Maccallum Cancer Center; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; University of London; University College London; University of Turku; University of Turku; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Karolinska Institutet; Uppsala University; University of Manchester; Christie NHS Foundation Trust; University of Manchester; University of Cambridge; Harvard University; Harvard T.H. Chan School of Public Health; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Aarhus University; Aarhus University; Aarhus University; University of Oslo; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Oxford; University of Oxford; University of Bristol; University of Oxford; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Rochester; Yeshiva University; Albert Einstein College of Medicine; University of London; Queen Mary University London; Naval Medical University; Nanjing Medical University; Chongqing Medical University; Fudan University; China Medical University; Cancer Council Victoria; University of Melbourne; Monash University; University of Tasmania; Menzies Institute for Medical Research; Harvard University; Brigham & Women's Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Karolinska Institutet; Scandinavian Development Services AB; ISGlobal; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Universidad de Cantabria; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; H Lee Moffitt Cancer Center & Research Institute; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Pomeranian Medical University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ulm University; Ulm University; University of Texas System; UTMD Anderson Cancer Center; Cancer Prevention Institute of California; Stanford University; Stanford Cancer Institute; Stanford University; Portuguese Institute of Oncology; Universidade do Porto; City of Hope; Beckman Research Institute of City of Hope; Ghent University; Ghent University; Ghent University Hospital; Universiti Malaya; University of Washington; University of Washington Seattle; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zagreb; University of Zagreb; Medical University Sofia; University of Alberta; University of Alberta; Medical University Sofia; Medical University Sofia; KU Leuven; KU Leuven; University Hospital Leuven; University of Southampton; University of Manchester; University of Surrey; Complexo Hospitalario Universitario de Santiago de Compostela; University of California System; University of California San Diego; Complexo Hospitalario Universitario de Vigo; University of California System; University of California San Diego; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; NorthShore University Health System; University of Cambridge; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Mayo Clinic; Mayo Clinic; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; University of London; Queen Mary University London; Helmholtz Association; German Cancer Research Center (DKFZ); Cancer Research Center of Hawaii; University of Hawaii System; Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Royal Marsden NHS Foundation Trust	Schumacher, FR (corresponding author), Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA.; Schumacher, FR (corresponding author), Univ Hosp, Seidman Canc Ctr, Cleveland, OH USA.; Al Olama, AA (corresponding author), Univ Cambridge, Strangeways Res Lab, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England.; Al Olama, AA (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.; Eeles, RA (corresponding author), Inst Canc Res, London, England.; Schumacher, FR; Al Olama, AA; Eeles, RA (corresponding author), Royal Marsden NHS Fdn Trust, London, England.	frs2@case.edu; aa461@medschl.cam.ac.uk; ros.eeles@icr.ac.uk	JASMINE, LIM/F-7404-2015; Schumacher, Fredrick/R-6043-2019; Auvinen, Anssi/AAD-9311-2020; van Schaik, Ron H.N./G-6816-2013; Townsend, Paul/AAF-8234-2020; Machiela, Mitchell J/H-7335-2019; Razack, Azad HA/B-8152-2009; Gago-Dominguez, Manuela/AAP-6611-2021; Fachal, Laura/N-5560-2014; Auvinen, Anssi/AAL-2111-2020; Menegaux, Florence/H-4261-2018; Kaneva, Radka/AAT-5322-2021; Vega, Ana/R-4758-2019; Teixeira, Manuel AC/AAZ-7251-2020; Kulis, Tomislav/AAF-5565-2020; Castaño-Vinyals, Gemma/N-3885-2019; Kraft, Peter/GQH-8448-2022; Drake, Bettina/O-2072-2019; Brenner, Hermann/ABE-6383-2020; Khaw, Kay-Tee/AAZ-3209-2021; Teo, Soo-hwang/H-2353-2014; Chambers, Suzanne K/H-5957-2012; Koutros, Stella/W-5788-2019; Castaño-Vinyals, Gemma/H-7021-2017; Brenner, Hermann/B-4627-2017; Lessel, Davor/ABD-6088-2021; Feng, ninghan/ABB-3726-2021; Weinstein, Stephanie J/P-1627-2017; T, N/HCH-1584-2022; Risbridger, Gail P/B-8655-2008; Llorca, Javier/F-7371-2011; truong, therese/A-2837-2013; Pharoah, Paul/V-6658-2019; Feng, Ninghan/ABA-8996-2021; Kaneva, Radka P/V-6535-2017; Kogevinas, Manolis/C-3918-2017; Nordestgaard, Borge Gronne/ABF-1310-2020; Kaneva, Radka P/AGS-5076-2022; Røder, M. Andreas/H-7701-2019; Joniau, Steven/K-7655-2013; Teixeira, Manuel António Rodrigues/E-4885-2011; Burnet, Neil/L-1025-2019; Hakansson, Niclas/L-7913-2013; West, Catharine/J-4152-2012; Claessens, Frank/M-8565-2016; /F-1441-2016	JASMINE, LIM/0000-0002-7501-1834; Schumacher, Fredrick/0000-0002-3073-7463; Machiela, Mitchell J/0000-0001-6538-9705; Razack, Azad HA/0000-0002-4237-6511; Fachal, Laura/0000-0002-7256-9752; Auvinen, Anssi/0000-0003-1125-4818; Menegaux, Florence/0000-0003-3363-6411; Teixeira, Manuel AC/0000-0002-1959-0624; Castaño-Vinyals, Gemma/0000-0003-4468-1816; Drake, Bettina/0000-0001-9340-5848; Brenner, Hermann/0000-0002-6129-1572; Chambers, Suzanne K/0000-0003-2369-6111; Koutros, Stella/0000-0001-5294-5485; Castaño-Vinyals, Gemma/0000-0003-4468-1816; Brenner, Hermann/0000-0002-6129-1572; Weinstein, Stephanie J/0000-0002-3834-1535; Risbridger, Gail P/0000-0003-3089-4028; Llorca, Javier/0000-0001-8569-861X; truong, therese/0000-0002-2943-6786; Pharoah, Paul/0000-0001-8494-732X; Kaneva, Radka P/0000-0002-1437-1393; Kogevinas, Manolis/0000-0002-9605-0461; Kaneva, Radka P/0000-0002-1437-1393; Røder, M. Andreas/0000-0002-0019-5333; Joniau, Steven/0000-0003-3195-9890; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Carter, Brian/0000-0003-1166-6521; Southey, Melissa/0000-0002-6313-9005; Hakansson, Niclas/0000-0001-7673-5554; Nordestgaard, Borge/0000-0002-1954-7220; Teo, Soo/0000-0002-0444-590X; Saunders, Ed/0000-0003-4343-3570; McDonnell, Shannon/0000-0001-6201-369X; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Ostrander, Elaine/0000-0001-6075-9738; West, Catharine/0000-0002-0839-3449; Claessens, Frank/0000-0002-8676-7709; Canzian, Federico/0000-0002-4261-4583; Lubinski, Jan/0000-0003-2931-3003; Cardoso, Marta/0000-0002-3633-1659; Castelao, Jose E/0000-0001-7110-1376; Schleutker, Johanna/0000-0002-1863-0305; Gomez-Caamano, Antonio/0000-0002-9773-4590; /0000-0001-8387-2127; cussenot, olivier/0000-0002-9912-0533; Eeles, Rosalind/0000-0002-3698-6241; Pashayan, Nora/0000-0003-0843-2468; BURNET, NEIL/0000-0001-9692-706X; Leongamornlert, Daniel/0000-0002-3486-3168; Borre, Michael/0000-0002-1519-9185; De Ruyck, Kim/0000-0001-9921-644X; batra, Jyotsna/0000-0003-4646-6247; Sorensen, Karina Dalsgaard/0000-0002-4902-5490; Cieza-Borrella, Clara/0000-0003-2739-1040; Lin, Hui-Yi/0000-0002-3307-5549; Siddiq, Afshan/0000-0002-9110-1434; Hamdy, Freddie/0000-0003-2627-2154; , IIS Galicia Sur/0000-0003-3812-7413; Gago, Manuela/0000-0001-6713-4351; Mitev, Vanyo/0000-0001-7528-590X; Tilley, Wayne/0000-0003-1893-2626; Martin, Richard/0000-0002-7992-7719; Townsend, Paul/0000-0001-8956-9508; Riboli, Elio/0000-0001-6795-6080; Kraft, Peter/0000-0002-4472-8103; Lessel, Davor/0000-0003-4496-244X; Michael, Agnieszka/0000-0002-7262-6227; Brook, Mark/0000-0002-8969-2378; Horvath, Lisa/0000-0001-6842-9223	US National Institutes of Health (NIH) [U19 CA 148537, X01HG007492, HHSN268201200008I]; NIH NCI [U01 CA188392]; European Community's Seventh Framework Programme [223175 (HEALTH-F2-2009-223175)]; Cancer Research UK [C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565, C5047/A7357, C1287/A16563, C5047/A3354, C16913/A6135]; NIH [CA128978]; Post-Cancer GWAS Initiative [1U19 CA148537, 1U19 CA148065, 1U19 CA148112]; Department of Defense [W81XWH-10-1-0341]; Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure; Breast Cancer Research Foundation; Ovarian Cancer Research Fund; Canadian Institutes of Health Research; European Commission's Seventh Framework Programme [223175 (HEALTH-F2-2009-223175)]; NIH Cancer Post-Cancer GWAS initiative [1 U19 CA 148537-01]; Institute of Cancer Research; Everyman Campaign; Prostate Cancer Research Foundation; Prostate Research Campaign UK (now Prostate Action); Orchid Cancer Appeal; National Cancer Research Network UK; National Cancer Research Institute (NCRI) UK; NIHR; Royal Marsden NHS Foundation Trust; National Health and Medical Research Council, Australia [126402, 209057, 251533, 396414, 450104, 504700, 504702, 504715, 623204, 940394, 614296]; VicHealth; Cancer Council Victoria; Prostate Cancer Foundation of Australia; Whitten Foundation, PricewaterhouseCoopers; Tattersall's; Intramural Program of the National Human Genome Research Institute; NIH; National Cancer Institute [U01-CA98233, U01-CA98710, U01-CA98216, U01-CA98758]; Swedish Cancer Foundation [09-0677, 11484, 12-823]; Cancer Risk Prediction Center (CRisP); Linneus Centre grant - Swedish Research Council [ID 70867902]; wedish Research Council [K2010 70X-20430-04-3, 2014-2269]; Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [K07CA187546, U01CA188392, K05CA175147, ZIACP010152, UM1CA182883, UG1CA189974] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325] Funding Source: NIH RePORTER; Cancer Research UK [16561, 10118, 15007, 16565, 14136, 17528, 16491, 19169, 21332] Funding Source: researchfish; Medical Research Council [G0401527, G1000143, MR/N003284/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10121, NF-SI-0509-10242, NF-SI-0510-10096, NF-SI-0512-10114] Funding Source: researchfish; The Danish Cancer Society [R130-A8338, R130-A8313] Funding Source: researchfish; The Francis Crick Institute [10119] Funding Source: researchfish; MRC [MR/N003284/1] Funding Source: UKRI	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Community's Seventh Framework Programme(European Commission); Cancer Research UK(Cancer Research UK); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Post-Cancer GWAS Initiative; Department of Defense(United States Department of Defense); Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure; Breast Cancer Research Foundation; Ovarian Cancer Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European Commission's Seventh Framework Programme(European Commission); NIH Cancer Post-Cancer GWAS initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Cancer Research; Everyman Campaign; Prostate Cancer Research Foundation; Prostate Research Campaign UK (now Prostate Action); Orchid Cancer Appeal; National Cancer Research Network UK; National Cancer Research Institute (NCRI) UK; NIHR(National Institute for Health Research (NIHR)); Royal Marsden NHS Foundation Trust(Royal Society of New ZealandMarsden Fund (NZ)); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); VicHealth; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Prostate Cancer Foundation of Australia; Whitten Foundation, PricewaterhouseCoopers; Tattersall's; Intramural Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Cancer Foundation; Cancer Risk Prediction Center (CRisP); Linneus Centre grant - Swedish Research Council; wedish Research Council(Swedish Research Council Formas); Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); The Danish Cancer Society(Danish Cancer Society); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We pay tribute to Brian Henderson for his vision and leadership; he was a driving force behind the OncoArray project and he unfortunately passed away before seeing its fruition. We also thank the individuals who participated in these studies enabling this work.r Genotyping of the OncoArray was funded by the US National Institutes of Health (NIH) (U19 CA 148537 for the ELLIPSE project and X01HG007492 to the Center for Inherited Disease Research (CIDR) under contract no. HHSN268201200008I. Additional analytical support was provided by NIH NCI U01 CA188392 (to F.A.S.).r Funding for the iCOGS infrastructure came from the European Community's Seventh Framework Programme under grant agreement no. 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, and C8197/A16565), the NIH (CA128978) and Post-Cancer GWAS Initiative (1U19 CA148537, 1U19 CA148065, and 1U19 CA148112; the GAME-ON initiative), the Department of Defense (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, Komen Foundation for the Cure, the Breast Cancer Research Foundation, and the Ovarian Cancer Research Fund.r This work was supported by the Canadian Institutes of Health Research; the European Commission's Seventh Framework Programme grant agreement no. 223175 (HEALTH-F2-2009-223175); Cancer Research UK grants C5047/A7357, C1287/A10118, C1287/A16563, C5047/A3354, C5047/A10692, and C16913/A6135; and NIH Cancer Post-Cancer GWAS initiative grant no. 1 U19 CA 148537-01 (the GAME-ON initiative).r We also thank the following for funding support: the Institute of Cancer Research and the Everyman Campaign, the Prostate Cancer Research Foundation, Prostate Research Campaign UK (now Prostate Action), the Orchid Cancer Appeal, the National Cancer Research Network UK, and the National Cancer Research Institute (NCRI) UK. We are grateful for the support of NIHR funding to the NIHR Biomedical Research Centre at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust.r The Prostate Cancer Program of Cancer Council Victoria also acknowledges grant support from the National Health and Medical Research Council, Australia (126402, 209057, 251533, 396414, 450104, 504700, 504702, 504715, 623204, 940394, and 614296), VicHealth, Cancer Council Victoria, the Prostate Cancer Foundation of Australia, the Whitten Foundation, PricewaterhouseCoopers, and Tattersall's. E.A.O., D.M.K., and E.M.K. acknowledge the Intramural Program of the National Human Genome Research Institute for support.r The BPC3 was supported by the NIH, National Cancer Institute (cooperative agreements U01-CA98233 to D.J.H., U01-CA98710 to S.M.G., U01-CA98216 to E.R., and U01-CA98758 to B.E.H., and the Intramural Research Program of the NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics).r The CAPS GWAS study was supported by the Swedish Cancer Foundation (grant nos. 09-0677, 11484, and 12-823), the Cancer Risk Prediction Center (CRisP; http://ki.se/en/meb/crisp/), a Linneus Centre grant (contract ID 70867902) financed by the Swedish Research Council, and the Swedish Research Council (grant nos. K2010 70X-20430-04-3, and 2014-2269).r PEGASUS was supported by the Intramural Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH.r A full description of funding and acknowledgements can be found in the Supplementary Note.	Al Olama AA, 2015, CANCER EPIDEM BIOMAR, V24, P1121, DOI 10.1158/1055-9965.EPI-14-0317; Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; Al Olama AA, 2013, HUM MOL GENET, V22, P408, DOI 10.1093/hmg/dds425; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Albright F, 2015, PROSTATE, V75, P390, DOI 10.1002/pros.22925; Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Altekruse SF, 2010, CANCER EPIDEM BIOMAR, V19, P1460, DOI 10.1158/1055-9965.EPI-09-1310; Amos CI, 2017, CANCER EPIDEM BIOMAR, V26, P126, DOI 10.1158/1055-9965.EPI-16-0106; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basta J, 2015, TRANSL RES, V165, P36, DOI 10.1016/j.trsl.2014.05.003; Bunker CH, 2002, CANCER EPIDEM BIOMAR, V11, P726; Cuzick J, 2014, LANCET ONCOL, V15, pE484, DOI 10.1016/S1470-2045(14)70211-6; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Eeles R, 2014, NAT REV UROL, V11, P18, DOI 10.1038/nrurol.2013.266; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Ghadirian P, 1997, INT J CANCER, V70, P679, DOI 10.1002/(SICI)1097-0215(19970317)70:6<679::AID-IJC9>3.3.CO;2-3; Goh CL, 2012, J INTERN MED, V271, P353, DOI 10.1111/j.1365-2796.2012.02511.x; Gronberg H, 1996, CANCER, V77, P138, DOI 10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Kicinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027130; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Kudo T, 2012, CANCER RES, V72, P2901, DOI 10.1158/0008-5472.CAN-12-0572; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Leongamornlert D, 2014, BRIT J CANCER, V110, P1663, DOI 10.1038/bjc.2014.30; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Matikainen MP, 2001, CANCER CAUSE CONTROL, V12, P223, DOI 10.1023/A:1011283123610; McDermott DF, 2013, CANCER MED-US, V2, P662, DOI 10.1002/cam4.106; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Meyer A, 2007, RADIOTHER ONCOL, V83, P283, DOI 10.1016/j.radonc.2007.04.029; Romero P, 2005, GENOME BIOL, V6; Sanchez-Huertas C, 2015, CURR BIOL, V25, pR294, DOI 10.1016/j.cub.2015.02.006; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stanford JL, 2001, EPIDEMIOL REV, V23, P19, DOI 10.1093/oxfordjournals.epirev.a000789; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Volodko N, 2014, FEBS LETT, V588, P2671, DOI 10.1016/j.febslet.2014.02.041; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang ML, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9469; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yee DS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-162; Zhong H, 2008, BIOSTATISTICS, V9, P621, DOI 10.1093/biostatistics/kxn001	64	367	369	3	72	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2018	50	7					928	+		10.1038/s41588-018-0142-8	http://dx.doi.org/10.1038/s41588-018-0142-8			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GL5QU	29892016	Green Submitted, Green Published, Green Accepted			2022-12-17	WOS:000437224400007
J	Lemmers, RJLF; Tawil, R; Petek, LM; Balog, J; Block, GJ; Santen, GWE; Amell, AM; van der Vliet, PJ; Almomani, R; Straasheijm, KR; Krom, YD; Klooster, R; Sun, Y; den Dunnen, JT; Helmer, Q; Donlin-Smith, CM; Padberg, GW; van Engelen, BGM; de Greef, JC; Aartsma-Rus, AM; Frants, RR; de Visser, M; Desnuelle, C; Sacconi, S; Filippova, GN; Bakker, B; Bamshad, MJ; Tapscott, SJ; Miller, DG; van der Maarel, SM				Lemmers, Richard J. L. F.; Tawil, Rabi; Petek, Lisa M.; Balog, Judit; Block, Gregory J.; Santen, Gijs W. E.; Amell, Amanda M.; van der Vliet, Patrick J.; Almomani, Rowida; Straasheijm, Kirsten R.; Krom, Yvonne D.; Klooster, Rinse; Sun, Yu; den Dunnen, Johan T.; Helmer, Quinta; Donlin-Smith, Colleen M.; Padberg, George W.; van Engelen, Baziel G. M.; de Greef, Jessica C.; Aartsma-Rus, Annemieke M.; Frants, Rune R.; de Visser, Marianne; Desnuelle, Claude; Sacconi, Sabrina; Filippova, Galina N.; Bakker, Bert; Bamshad, Michael J.; Tapscott, Stephen J.; Miller, Daniel G.; van der Maarel, Silvere M.			Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2	NATURE GENETICS			English	Article							CHROMOSOMES HINGE DOMAIN; GENE-EXPRESSION; DOSAGE COMPENSATION; DNA REARRANGEMENTS; CONDENSIN SUBUNIT; CANDIDATE GENE; LOCUS; DUX4; VARIEGATION; SEQUENCE	Facioscapulohumeral dystrophy (FSHD) is characterized by chromatin relaxation of the D4Z4 macrosatellite array on chromosome 4 and expression of the D4Z4-encoded DUX4 gene in skeletal muscle. The more common form, autosomal dominant FSHD1, is caused by contraction of the D4Z4 array, whereas the genetic determinants and inheritance of D4Z4 array contraction-independent FSHD2 are unclear. Here, we show that mutations in SMCHD1 (encoding structural maintenance of chromosomes flexible hinge domain containing 1) on chromosome 18 reduce SMCHD1 protein levels and segregate with genome-wide D4Z4 CpG hypomethylation in human kindreds. FSHD2 occurs in individuals who inherited both the SMCHD1 mutation and a normal-sized D4Z4 array on a chromosome 4 haplotype permissive for DUX4 expression. Reducing SMCHD1 levels in skeletal muscle results in D4Z4 contraction-independent DUX4 expression. Our study identifies SMCHD1 as an epigenetic modifier of the D4Z4 metastable epiallele and as a causal genetic determinant of FSHD2 and possibly other human diseases subject to epigenetic regulation.	[Lemmers, Richard J. L. F.; Balog, Judit; van der Vliet, Patrick J.; Straasheijm, Kirsten R.; Krom, Yvonne D.; Klooster, Rinse; Sun, Yu; den Dunnen, Johan T.; de Greef, Jessica C.; Aartsma-Rus, Annemieke M.; Frants, Rune R.; van der Maarel, Silvere M.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Tawil, Rabi; Donlin-Smith, Colleen M.] Univ Rochester, Med Ctr, Dept Neurol, Neuromuscular Dis Unit, Rochester, NY 14642 USA; [Petek, Lisa M.; Block, Gregory J.; Amell, Amanda M.; Bamshad, Michael J.; Miller, Daniel G.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Santen, Gijs W. E.; Almomani, Rowida; den Dunnen, Johan T.; Bakker, Bert] Leiden Univ, Dept Clin Genet, Med Ctr, Leiden, Netherlands; [Helmer, Quinta] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands; [Padberg, George W.; van Engelen, Baziel G. M.] Radboud Univ Nijmegen, Med Ctr, Neuromuscular Ctr Nijmegen, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [de Visser, Marianne] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Desnuelle, Claude; Sacconi, Sabrina] Nice Univ Hosp, Ctr Reference Malad Neuromusculaires, Nice, France; [Desnuelle, Claude; Sacconi, Sabrina] Nice Univ Hosp, CNRS, Unite Mixte Rech UMR 7277, Nice, France; [Filippova, Galina N.; Tapscott, Stephen J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Rochester; University of Washington; University of Washington Seattle; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	van der Maarel, SM (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands.	stapscot@fhcrc.org; maarel@lumc.nl	van der Maarel, Silvere/X-3631-2018; van Engelen, Baziel/H-8027-2014; Bakker, Egbert/D-3525-2009; Padberg, G.W.A.M./H-8079-2014; de Greef, Jessica/AAN-2716-2020; SACCONI, Sabrina/AFT-1096-2022; dunnen, johan den/ABH-4228-2020	van der Maarel, Silvere/0000-0001-8103-711X; van Engelen, Baziel/0000-0001-9867-9047; Bakker, Egbert/0000-0002-2843-7357; de Greef, Jessica/0000-0002-2819-6098; SACCONI, Sabrina/0000-0002-0246-1455; dunnen, johan den/0000-0002-6304-1710; Miller, Daniel/0000-0002-5700-3048; Aartsma-Rus, Annemieke/0000-0003-1565-654X; Sun, Yu/0000-0002-2938-0233; Tapscott, Stephen/0000-0002-0319-0968	US National Institutes of Health (NIH) (National Institute of Neurological Disorders and Stroke (NINDS)) [P01NS069539]; US National Institutes of Health (NIH) (Clinical & Translational Science Award (CTSA)) [UL1RR024160]; US National Institutes of Health (NIH) (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)) [R01AR045203]; US National Institutes of Health (NIH) (National Human Genome Research Institute (NHGRI)) [HG005608, HG006493]; Netherlands Genomics Initiative (NGI) [93515504]; University of Washington Center for Mendelian Genomics; Muscular Dystrophy Association (MDA) [217596]; Fields Center for FSHD Research; Geraldi Norton and Eklund family foundation; FSH Society; Friends of FSH Research; European Union [223026, 223143, 2012-305121]; Stichting FSHD; China Scholarship Council; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493, U54HG006493, RC2HG005608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066248, R01AR045203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS069539] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) (National Institute of Neurological Disorders and Stroke (NINDS))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health (NIH) (Clinical & Translational Science Award (CTSA)); US National Institutes of Health (NIH) (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US National Institutes of Health (NIH) (National Human Genome Research Institute (NHGRI)); Netherlands Genomics Initiative (NGI); University of Washington Center for Mendelian Genomics; Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Fields Center for FSHD Research; Geraldi Norton and Eklund family foundation; FSH Society; Friends of FSH Research; European Union(European Commission); Stichting FSHD; China Scholarship Council(China Scholarship Council); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank all subjects and family members for their participation. We thank D. Nickerson and). Shendure for excellent assistance and B. Trask for helpful discussions and critical reading of the manuscript. This work was supported by grants from the US National Institutes of Health (NIH) (National Institute of Neurological Disorders and Stroke (NINDS) P01NS069539, Clinical & Translational Science Award (CTSA) UL1RR024160, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01AR045203 and National Human Genome Research Institute (NHGRI) HG005608 and HG006493), a Netherlands Genomics Initiative (NGI) Horizon Valorization Project Grant (93515504), The University of Washington Center for Mendelian Genomics, the Muscular Dystrophy Association (MDA; 217596), the Fields Center for FSHD Research, the Geraldi Norton and Eklund family foundation, the FSH Society, The Friends of FSH Research, European Union Framework Programme 7 agreements 223026 (NMD-chip), 223143 (TechGene) and 2012-305121 (NEUROMICS) and the Stichting FSHD. Y.S. is supported by the China Scholarship Council.	Balog J, 2012, EPIGENETICS-US, V7, P579, DOI 10.4161/epi.20001; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; Dej KJ, 2004, GENETICS, V168, P895, DOI 10.1534/genetics.104.030908; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gendrel AV, 2012, DEV CELL, V23, P265, DOI 10.1016/j.devcel.2012.06.011; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lieb JD, 1996, SCIENCE, V274, P1732, DOI 10.1126/science.274.5293.1732; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Scionti I, 2012, J MED GENET, V49, P171, DOI 10.1136/jmedgenet-2011-100454; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Spurlock G, 2010, MUSCLE NERVE, V42, P820, DOI 10.1002/mus.21766; Statland JM, 2011, CURR OPIN NEUROL, V24, P423, DOI 10.1097/WCO.0b013e32834959af; Thomas NST, 2007, J MED GENET, V44, P215, DOI 10.1136/jmg.2006.042804; van der Maarel SM, 2007, BBA-MOL BASIS DIS, V1772, P186, DOI 10.1016/j.bbadis.2006.05.009; van der Maarel SM, 2011, TRENDS MOL MED, V17, P252, DOI 10.1016/j.molmed.2011.01.001; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wuebbles RD, 2010, INT J CLIN EXP PATHO, V3, P386; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	42	367	385	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1370	1374		10.1038/ng.2454	http://dx.doi.org/10.1038/ng.2454			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23143600	Green Accepted			2022-12-17	WOS:000311713200018
J	Kuramochi, M; Fukuhara, H; Nobukuni, T; Kanbe, T; Maruyama, T; Ghosh, HP; Pletcher, M; Isomura, M; Onizuka, M; Kitamura, T; Sekiya, T; Reeves, RH; Murakami, Y				Kuramochi, M; Fukuhara, H; Nobukuni, T; Kanbe, T; Maruyama, T; Ghosh, HP; Pletcher, M; Isomura, M; Onizuka, M; Kitamura, T; Sekiya, T; Reeves, RH; Murakami, Y			TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer	NATURE GENETICS			English	Article							NUDE-MICE; LINES; METHYLATION; HMLH1; HETEROZYGOSITY; ADENOCARCINOMA; TUMORIGENICITY; LOCALIZATION; CISPLATIN; FRAGMENTS	The existence of tumor-suppressor genes was originally demonstrated by functional complementation through whole-cell and microcell fusion(1,2). Transfer of chromosome 11 into a human non-small-cell lung cancer (NSCLC) cell line, A549, suppresses tumorigenicity(3). Loss of heterozygosity (LOH) on the long arm of chromosome 11 has been reported in NSCLC and other cancers(4-6). Several independent studies indicate that multiple tumor-suppressor genes are found in this region, including the gene PPP2R1B at 11q23-24 (ref. 7). Linkage studies of NSCLC are precluded because no hereditary forms are known(8,9). We previously identified a region of 700 kb on 11q23.2 that completely suppresses tumorigenicity of A549 human NSCLC cells(10). Most of this tumor-suppressor activity localizes to a 100-kb segment by functional complementation. Here we report that this region contains a single confirmed gene, TSLC1, whose expression is reduced or absent in A549 and several other NSCLC, hepatocellular carcinoma (HCC) and pancreatic cancer (PaC) cell lines. TSLC1 expression or suppression is correlated with promoter methylation state in these cell lines. Restoration of TSLC1 expression to normal or higher levels suppresses tumor formation by A549 cells in nude mice. Only 2 inactivating mutations of TSLC1 were discovered in 161 tumors and tumor cell lines, both among the 20 primary tumors with LOH for 11q23.2. Promoter methylation was observed in 15 of the other 18 primary NSCLC, HCC and Pac tumors with LOH for 11q23.2. Thus, attenuation of TSLC1 expression occurred in 85% of primary tumors with LOH. Hypermethylation of the TSLC1 promoter would seem to represent the 'second hit' in NSCLC with LOH.	Natl Canc Ctr, Res Inst, Tumor Suppress & Funct Genom Project, Tokyo 104, Japan; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; Univ Tsukuba, Inst Clin Med, Dept Surg, Ibaraki, Osaka, Japan; Univ Tokyo, Fac Med, Dept Urol, Tokyo 113, Japan	National Cancer Center - Japan; Johns Hopkins University; University of Tokyo; University of Tsukuba; University of Tokyo	Murakami, Y (corresponding author), Natl Canc Ctr, Res Inst, Tumor Suppress & Funct Genom Project, Tokyo 104, Japan.		Kitamura, Toshio/AAA-2071-2021		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024605] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-24605] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aoe K, 1999, ANTICANCER RES, V19, P291; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Ghosh K, 1999, BIOCHEM CELL BIOL, V77, P165; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; HARRIS H, 1969, NATURE, V223, P363, DOI 10.1038/223363a0; HIRAI KI, 1991, CLIN EXP METASTAS, V9, P517, DOI 10.1007/BF01768580; IHDE DC, 1991, CURR PROB CANCER, V15, P61; IIZUKA M, 1995, GENE CHROMOSOME CANC, V13, P40; Kanamori M, 2000, ONCOGENE, V19, P1564, DOI 10.1038/sj.onc.1203454; Kane MF, 1997, CANCER RES, V57, P808; Kukita Y, 1997, HUM MUTAT, V10, P400, DOI 10.1002/(SICI)1098-1004(1997)10:5<400::AID-HUMU11>3.3.CO;2-1; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Murakami Y, 1998, P NATL ACAD SCI USA, V95, P8153, DOI 10.1073/pnas.95.14.8153; Murakami Y, 1998, MUTAT RES-FUND MOL M, V400, P421, DOI 10.1016/S0027-5107(98)00031-1; MURAKAMI YS, 1995, CANCER RES, V55, P3389; Ohsaki Y, 1996, ONCOLOGY, V53, P327; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RASIO D, 1995, CANCER RES, V55, P3988; SAKAI T, 1991, AM J HUM GENET, V48, P880; SANTON JB, 1986, CANCER RES, V46, P4701; SATOH H, 1993, MOL CARCINOGEN, V7, P157, DOI 10.1002/mc.2940070306; Schutte M, 1997, CANCER RES, V57, P3126; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wang SSQ, 1999, GENE CHROMOSOME CANC, V25, P154, DOI 10.1002/(SICI)1098-2264(199906)25:2<154::AID-GCC11>3.3.CO;2-N; WEISBERG LA, 1987, COMPUT RADIOL, V11, P175, DOI 10.1016/0730-4862(87)90047-3; Yamori T, 1997, JPN J CANCER RES, V88, P1205, DOI 10.1111/j.1349-7006.1997.tb00350.x	29	367	402	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					427	430		10.1038/86934	http://dx.doi.org/10.1038/86934			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279526	Green Submitted			2022-12-17	WOS:000167811200019
J	Liu, HX; Cartegni, L; Zhang, MQ; Krainer, AR				Liu, HX; Cartegni, L; Zhang, MQ; Krainer, AR			A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes	NATURE GENETICS			English	Article							PRE-MESSENGER-RNA; SPLICE-SITE SELECTION; SINGLE-NUCLEOTIDE POLYMORPHISMS; SR PROTEINS; ENHANCER; SEQUENCES; IDENTIFICATION; ELEMENTS; SURVEILLANCE; CONSEQUENCES	Point mutations can generate defective and sometimes harmful proteins. The nonsense-mediated mRNA decay (NMD) pathway minimizes the potential damage caused by nonsense mutations(1-4). In-frame nonsense codons located at a minimum distance upstream of the last exon-exon junction are recognized as premature termination codons (PTCs), targeting the mRNA for degradation. Some nonsense mutations cause skipping of one or more exons, presumably during pre-mRNA splicing in the nucleus; this phenomenon is termed nonsense-mediated altered splicing (NAS), and its underlying mechanism is unclear(1,2,5,6). By analyzing NAS in BRCA1, we show here that inappropriate exon skipping can be reproduced in vitro, and results from disruption of a splicing enhancer in the coding sequence. Enhancers can be disrupted by single nonsense, missense and translationally silent point mutations, without recognition of an open reading frame as such. These results argue against a nuclear reading-frame scanning mechanism for NAS. Coding-region single-nucleotide polymorphisms(7) (cSNPs) within exonic splicing enhancers or silencers may affect the patterns or efficiency of mRNA splicing, which may in turn cause phenotypic variability and variable penetrance of mutations elsewhere in a gene.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Krainer, AR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Krainer, Adrian/0000-0001-9024-9501	NCI NIH HHS [CA13106] Funding Source: Medline; NHGRI NIH HHS [HG01696] Funding Source: Medline; NIGMS NIH HHS [GM42699] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042699] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; CACERES JF, 1997, EUKARYOTIC MRNA PROC, P174; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Dietz HC, 1997, AM J HUM GENET, V60, P729; Gersappe A, 1999, MOL CELL BIOL, V19, P1640; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; KRAWCZAK M, 1992, HUM GENET, V90, P41; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Liu HX, 2000, MOL CELL BIOL, V20, P1063, DOI 10.1128/MCB.20.3.1063-1071.2000; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Maquat LE, 1996, AM J HUM GENET, V59, P279; Mayeda A, 1999, MOL CELL BIOL, V19, P1853; Mayeda A, 1999, METH MOL B, V118, P315; Mayeda A, 1999, METH MOL B, V118, P309; Mazoyer S, 1998, AM J HUM GENET, V62, P713, DOI 10.1086/301768; Muro AF, 1999, MOL CELL BIOL, V19, P2657; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; Schaal TD, 1999, MOL CELL BIOL, V19, P261; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Shiga N, 1997, J CLIN INVEST, V100, P2204, DOI 10.1172/JCI119757; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; TIAN HC, 1995, MOL CELL BIOL, V15, P6291; Valcarcel J, 1996, TRENDS BIOCHEM SCI, V21, P296, DOI 10.1016/0968-0004(96)10039-6; Valentine CR, 1998, MUTAT RES-REV MUTAT, V411, P87, DOI 10.1016/S1383-5742(98)00010-6; Vuillaumier-Barrot S, 1999, Hum Mutat, V14, P543, DOI 10.1002/(SICI)1098-1004(199912)14:6<543::AID-HUMU17>3.0.CO;2-S; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407	30	367	394	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					55	58		10.1038/83762	http://dx.doi.org/10.1038/83762			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11137998				2022-12-17	WOS:000166187900015
J	Houten, SM; Kuis, W; Duran, M; de Koning, TJ; van Royen-Kerkhof, A; Romeijn, GJ; Frenkel, J; Dorland, L; de Barse, MMJ; Huijbers, WAR; Rijkers, GT; Waterham, HR; Wanders, RJA; Poll-The, BT				Houten, SM; Kuis, W; Duran, M; de Koning, TJ; van Royen-Kerkhof, A; Romeijn, GJ; Frenkel, J; Dorland, L; de Barse, MMJ; Huijbers, WAR; Rijkers, GT; Waterham, HR; Wanders, RJA; Poll-The, BT			Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome	NATURE GENETICS			English	Article							ACIDURIA; IDENTIFICATION; CHOLESTEROL; DEFICIENCY	Hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS; MIM 260920) is an autosomal recessive disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash(1,) (2). Diagnostic hallmark of HIDS is a constitutively elevated level of serum immunoglobulin D (IgD), although patients have been reported with normal IgD levels'. To determine the underlying defect in HIDS, we analysed urine of several patients and discovered increased concentrations of mevalonic acid during severe episodes of fever, but not between crises. Subsequent analysis of cells from four unrelated HIDS patients revealed reduced activities of mevalonate kinase (MK; encoded by the gene MVK), a key enzyme of isoprenoid biosynthesis. Sequence analysis of MVK cDNA from the patients identified three different mutations, one of which was common to all patients. Expression of the mutant cDNAs in Escherichia coli showed that all three mutations affect the activity of the encoded proteins. Moreover, immunoblot analysis demonstrated a deficiency of MK protein in patient fibroblasts, indicating a protein-destabilizing effect of the mutations.	Univ Utrecht, Childrens Hosp Het Wilhelmina Kinderziekenhuis, Dept Metab Disorders, Utrecht, Netherlands; Univ Utrecht, Childrens Hosp Het Wilhelmina Kinderziekenhuis, Dept Immunol, Utrecht, Netherlands; Univ Utrecht, Childrens Hosp Het Wilhelmina Kinderziekenhuis, Dept Gen Pediat, Utrecht, Netherlands; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Beatrix Hosp, Gorinchem, Netherlands	Utrecht University; Utrecht University; Utrecht University; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Waterham, HR (corresponding author), Univ Utrecht, Childrens Hosp Het Wilhelmina Kinderziekenhuis, Dept Metab Disorders, Utrecht, Netherlands.	h.r.waterham@amc.uva.nl; b.pollthe@wkz.azu.nl	Rijkers, Ger/R-7236-2019; Rijkers, Ger/AAW-6143-2020; De Koning, Tom J/AAE-1323-2020; Houten, Sander/Y-3599-2019	Rijkers, Ger/0000-0001-6948-6123; De Koning, Tom J/0000-0001-5609-1309; Houten, Sander/0000-0002-6167-9147; Poll-The, Bwee Tien/0000-0002-8118-5419				BIARDI L, 1994, J BIOL CHEM, V269, P1197; Centola M, 1998, HUM MOL GENET, V7, P1581, DOI 10.1093/hmg/7.10.1581; DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hinson DD, 1997, J BIOL CHEM, V272, P26756, DOI 10.1074/jbc.272.42.26756; HOFFMAN G, 1986, NEW ENGL J MED, V314, P1610, DOI 10.1056/NEJM198606193142504; HOFFMANN GF, 1992, J INHERIT METAB DIS, V15, P738, DOI 10.1007/BF01800016; HOFFMANN GF, 1993, PEDIATRICS, V91, P915; IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7; Lindenthal B, 1996, J LIPID RES, V37, P2193; SCHAFER BL, 1992, J BIOL CHEM, V267, P13229; VANDERMEER JWM, 1984, LANCET, V1, P1087	13	367	377	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1999	22	2					175	177		10.1038/9691	http://dx.doi.org/10.1038/9691			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369261				2022-12-17	WOS:000080680900024
J	Fisher, SE; Vargha-Khadem, F; Watkins, KE; Monaco, AP; Pembrey, ME				Fisher, SE; Vargha-Khadem, F; Watkins, KE; Monaco, AP; Pembrey, ME			Localisation of a gene implicated in a severe speech and language disorder	NATURE GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; HUMAN GENOME; DEFECTS; MAP	Between 2 and 5% of children who are otherwise unimpaired have significant difficulties in acquiring expressive and/or receptive language, despite adequate intelligence and opportunity(1,2) While twin studies indicate a significant role for genetic factors in developmental disorders of speech and language(1), the majority of families segregating such disorders show complex patterns of inheritance, and are thus not amenable for conventional linkage analysis(2). A rare exception is the KE family, a large three-generation pedigree in which approximately half of the members are affected with a severe speech and language disorder which appears to be transmitted as an autosomal dominant monogenic trait(3). This family has been widely publicised as suffering primarily from a defect in the use of grammatical suffixation rules(4-7), thus supposedly supporting the existence of genes specific to grammar. The phenotype, however, is broader in nature, with virtually every aspect of grammar and of language affected(8-10). in addition, affected members have a severe orofacial dyspraxia, and their speech is largely incomprehensible to the naive listener(10). We initiated a genome-wide search for linkage in the KE family and have identified a region on chromosome 7 which co-segregates with the speech and language disorder (maximum lod score = 6.62 at theta = 0.0), confirming autosomal dominant inheritance with full penetrance. Further analysis of microsatellites from within the region enabled us to fine map the locus responsible (designated SPCH1) to a 5.6-cM interval in 7q31, thus providing an important step towards its identification. Isolation of SPCH1 may offer the first insight into the molecular genetics of the developmental process that culminates in speech and language.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Inst Child Hlth, Wolfson Ctr, Cognit Neurosci Unit, London WC1N 2AP, England; Inst Child Hlth, Mothercare Unit Clin Genet & Fetal Med, London WC1N 1EH, England	University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London; University of London; University College London	Pembrey, ME (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Windmill Rd, Oxford OX3 7BN, England.		Monaco, Anthony P/A-4495-2010; Fisher, Simon E./E-9130-2012; Watkins, Kate E/A-6559-2012; Vargha-Khadem, Faraneh/C-2558-2008	Monaco, Anthony P/0000-0001-7480-3197; Fisher, Simon E./0000-0002-3132-1996; Watkins, Kate E/0000-0002-2621-482X; vargha-khadem, faraneh/0000-0003-4890-8379	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; Bouffard GG, 1997, GENOME RES, V7, P673, DOI 10.1101/gr.7.7.673; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FLETCHER P, 1990, NATURE, V346, P226, DOI 10.1038/346226a0; GOPNIK M, 1990, NATURE, V344, P715, DOI 10.1038/344715a0; GOPNIK M, 1991, COGNITION, V39, P1, DOI 10.1016/0010-0277(91)90058-C; *INT MOL GEN STUD, IN PRESS HUM MOL GEN; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PINKER S, 1991, SCIENCE, V253, P530, DOI 10.1126/science.1857983; Pinker S., 1994, LANGUAGE INSTINCT; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; SARDA P, 1988, ANN GENET-PARIS, V31, P258; SCHINZEL A, 1997, HUMAN GENETICS DATAB; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SMITH SD, 1996, PRINCIPLES PRACTICE, P1767; Sobel E, 1996, AM J HUM GENET, V58, P1323; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; VARGHAKHADEM F, 1990, NATURE, V346, P226, DOI 10.1038/346226c0; [No title captured]	21	367	378	0	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					168	170		10.1038/ng0298-168	http://dx.doi.org/10.1038/ng0298-168			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462748	Green Published			2022-12-17	WOS:000071779500027
J	Kang, S; Graham, JM; Olney, AH; Biesecker, LG				Kang, S; Graham, JM; Olney, AH; Biesecker, LG			GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome	NATURE GENETICS			English	Article							CONGENITAL HYPOTHALAMIC HAMARTOBLASTOMA; GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; IMPERFORATE ANUS; GENE; HYPOPITUITARISM; LOCALIZATION; DELETION; 7P13	Pallister-Hail syndrome (PHS, M146510) was first described in 1980 in six newborns. It is a pleiotropic disorder of human development that comprises hypothalamic hamartoma, central polydactyly, and other malformations(1,2). This disorder is inherited as an autosomal dominant trait and has been mapped to 7p13 (S. Kang et al. Autosomal dominant Pallister-Hail syndrome maps to 7p13. Am. J. Hum. Genet. 59, A81 (1996)). colocalizing the PHS locus and the GLI3 zinc finger transcription factor gene(3). Large deletions or translocations resulting in haploinsufficiency of the GLI3 gene have been associated with Greig cephalopolysyndactyly syndrome (GCPS; M175700)(4-6) although no mutations have been identified in GCPS patients with normal karyotypes. Both PHS and GCPS have polysyndactyly, abnormal craniofacial features and are inherited in an autosomal dominant pattern, but they are clinically distinct(7,8). The polydactyly of CCPS is commonly preaxial and that of PHS is typically central or postaxial. No reported cases of CCPS have hypothalamic hamartoma and PHS does not cause hypertelorism or broadening of the nasal root or forehead. The co-localization of the loci for PHS and GCPS led us to investigate GLI3 as a candidate gene for PHS. Herein we report two PHS families with frameshift mutations in GLI3 that are 3' of the zinc finger-encoding domains, including one family with a de novo mutation. These data implicate mutations in GLI3 as the cause of autosomal dominant PHS, and suggest that frameshift mutations of the GLI3 transcription factor gene can alter the development of multiple organ systems in vertebrates.	NIH, NATL HUMAN GENOME RES INST, LAB GENET DIS RES, BETHESDA, MD 20892 USA; CEDARS SINAI MED CTR, DEPT PEDIAT, CTR MED GENET BIRTH DEFECTS, LOS ANGELES, CA 90048 USA; UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA 90048 USA; UNIV NEBRASKA, SCH MED, CTR HUMAN GENET, OMAHA, NE 68198 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Nebraska System			Graham, John M./J-1429-2019					Biesecker LG, 1996, J MED GENET, V33, P585, DOI 10.1136/jmg.33.7.585; Biesecker LG, 1996, AM J MED GENET, V65, P76, DOI 10.1002/(SICI)1096-8628(19961002)65:1<76::AID-AJMG12>3.0.CO;2-O; Biesecker LG, 1996, J MED GENET, V33, P947, DOI 10.1136/jmg.33.11.947; BRUETON L, 1988, AM J MED GENET, V31, P799, DOI 10.1002/ajmg.1320310412; BRUETON LA, 1992, J MED GENET, V29, P635, DOI 10.1136/jmg.29.9.635; CLARREN SK, 1980, AM J MED GENET, V7, P75, DOI 10.1002/ajmg.1320070111; COHN DH, 1990, AM J HUM GENET, V46, P591; Dracopoli NC, 1994, CURRENT PROTOCOLS HU; DUNCAN PA, 1979, AM J DIS CHILD, V133, P818, DOI 10.1001/archpedi.1979.02130080058010; Grebe TA, 1996, AM J MED GENET, V66, P129, DOI 10.1002/(SICI)1096-8628(19961211)66:2<129::AID-AJMG2>3.0.CO;2-M; HALL JG, 1980, AM J MED GENET, V7, P47, DOI 10.1002/ajmg.1320070110; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; PETTIGREW AL, 1991, HUM GENET, V87, P452; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; TOPF KF, 1993, J PEDIATR-US, V123, P943, DOI 10.1016/S0022-3476(05)80392-0; VERLOES A, 1995, J MED GENET, V32, P605, DOI 10.1136/jmg.32.8.605; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; [No title captured]	18	367	376	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1997	15	3					266	268		10.1038/ng0397-266	http://dx.doi.org/10.1038/ng0397-266			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK386	9054938				2022-12-17	WOS:A1997WK38600015
J	Simon, MP; Pedeutour, F; Sirvent, N; Grosgeorge, J; Minoletti, F; Coindre, JM; TerrierLacombe, MJ; Mandahl, N; Craver, RD; Blin, N; Sozzi, G; TurcCarel, C; OBrien, KP; Kedra, D; Fransson, I; Guilbaud, C; Dumanski, JP				Simon, MP; Pedeutour, F; Sirvent, N; Grosgeorge, J; Minoletti, F; Coindre, JM; TerrierLacombe, MJ; Mandahl, N; Craver, RD; Blin, N; Sozzi, G; TurcCarel, C; OBrien, KP; Kedra, D; Fransson, I; Guilbaud, C; Dumanski, JP			Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma	NATURE GENETICS			English	Article							SIMIAN SARCOMA-VIRUS; SIS; CHROMOSOME-17; TRANSLOCATION; EXPRESSION; SEQUENCES; CONTIG; REGION; LOCUS; RANGE	Dermatofibrosarcoma protuberans (DP), an infiltrative skin tumour of intermediate malignancy(1). presents specific features such as reciprocal translocations t(17;22)(q22;q13) and supernumerary ring chromosomes derived from the t(17;22)(2,3). In this report, the breakpoints from translocations and rings in DP and its juvenile form. giant cell fibroblastoma (GCF)(4.5), were characterised on the genomic and RNA level. These rearrangements fuse the platelet-derived growth factor B-chain (PDGFB, c-sis proto-oncogene) and the collagen type I alpha 1 (COL1A1) genes. PDGFB has transforming activity and is a potent mitogen for a number of cell types. but its role in oncogenic processes is not fully understood(6,7). COL1A1 is a major constituent of the connective tissue matrix(8). Neither PDGFB nor COL1A1 have so far been implicated in any tumour translocations. These gene fusions delete exon 1 of PDGFB, and release this growth factor from its normal regulation.	FAC MED NICE,CNRS URA 1462,LAB GENET CHROMOSOM TUMEURS,F-06107 NICE 02,FRANCE; IST NAZL TUMORI,DIV ONCOL SPERIMENTALE A,I-20133 MILAN,ITALY; INST BERGONIE,ANAT PATHOL LAB,F-33076 BORDEAUX,FRANCE; INST GUSTAVE ROUSSY,LAB HISTOPATHOL A,F-94905 VILLEJUIF,FRANCE; UNIV LUND HOSP,DEPT CLIN GENET,S-22185 LUND,SWEDEN; NEW ORLEANS CHILDRENS HOSP,DEPT PATHOL,NEW ORLEANS,LA 70118; UNIV TUBINGEN,ABT MOL GENET,D-72074 TUBINGEN,GERMANY; KAROLINSKA HOSP,CLIN GENET UNIT,DEPT MOL MED,S-17176 STOCKHOLM,SWEDEN	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Fondazione IRCCS Istituto Nazionale Tumori Milan; UNICANCER; Institut Bergonie; UNICANCER; Gustave Roussy; Lund University; Skane University Hospital; Children's Hospital of New Orleans; Eberhard Karls University of Tubingen; Karolinska Institutet; Karolinska University Hospital			SIMON, Marie-Pierre/B-8017-2012; Kedra, Darek/H-7641-2012; sozzi, gabriella/G-8259-2011	Kedra, Darek/0000-0002-9723-4465; sozzi, gabriella/0000-0001-9360-6914; Dumanski, Jan Piotr/0000-0002-1489-1452				BLIN N, 1993, CANCER GENET CYTOGEN, V70, P108, DOI 10.1016/0165-4608(93)90177-N; CHU ML, 1993, CONNECTIVE TISSUE IT; COLLINS JE, 1995, NATURE, V377, P367; CRAVER RD, 1995, CANCER GENET CYTOGEN, V80, P20, DOI 10.1016/0165-4608(94)00152-2; DalCin P, 1996, GENE CHROMOSOME CANC, V15, P73; DIRKS RPH, 1993, EUR J BIOCHEM, V216, P487, DOI 10.1111/j.1432-1033.1993.tb18167.x; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; Enzinger FM, 1995, SOFT TISSUE TUMORS, V3rd; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; JEFFREYS AJ, 1984, NUCLEIC ACIDS RES, V12, P3235, DOI 10.1093/nar/12.7.3235; Kedra D, 1996, HUM MOL GENET, V5, P625, DOI 10.1093/hmg/5.5.625; KIKUCHI K, 1993, BIOCHEM BIOPH RES CO, V196, P409, DOI 10.1006/bbrc.1993.2264; MINOLETTI F, 1995, GENE CHROMOSOME CANC, V13, P62, DOI 10.1002/gcc.2870130110; PDEUTOUR F, 1996, CELL GENET, V72, P171; PEDEUTOUR F, 1995, CANCER RES, V55, P2400; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RAO CD, 1988, MOL CELL BIOL, V8, P284, DOI 10.1128/MCB.8.1.284; RATNER L, 1985, NUCLEIC ACIDS RES, V13, P5007, DOI 10.1093/nar/13.14.5007; RAYNAUD SD, 1993, GENE CHROMOSOME CANC, V8, P80, DOI 10.1002/gcc.2870080204; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; ROYCE PM, 1993, CONNECTIVE TISSUE IT, P1; Sambrook J, 1989, MOL CLONING LAB MANU; SMITS A, 1992, AM J PATHOL, V140, P639; Soenen V, 1996, GENE CHROMOSOME CANC, V15, P191, DOI 10.1002/(SICI)1098-2264(199603)15:3<191::AID-GCC9>3.0.CO;2-Y; Staden R, 1994, Methods Mol Biol, V25, P9; VANDENOUWELAND AMW, 1985, BIOCHIM BIOPHYS ACTA, V825, P140, DOI 10.1016/0167-4781(85)90097-1; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; Westermark B, 1993, CYTOKINES, V5, P1; XIE YG, 1993, HUM MOL GENET, V2, P1361; YAN XQ, 1994, ONCOGENE, V9, P163	30	367	387	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					95	98		10.1038/ng0197-95	http://dx.doi.org/10.1038/ng0197-95			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988177				2022-12-17	WOS:A1997WA37300029
J	TREMBLAY, KD; SAAM, JR; INGRAM, RS; TILGHMAN, SM; BARTOLOMEI, MS				TREMBLAY, KD; SAAM, JR; INGRAM, RS; TILGHMAN, SM; BARTOLOMEI, MS			A PATERNAL-SPECIFIC METHYLATION IMPRINT MARKS THE ALLELES OF THE MOUSE H19 GENE	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; DNA METHYLATION; EXPRESSION; TRANSGENE; LOCUS	Imprinting, the differential expression of the two alleles of a gene based on their parental origin, requires that the alleles be distinguished or marked. A candidate for the differentiating mark is DNA methylation. The maternally expressed H19 gene is hypermethylated on the inactive paternal allele in somatic tissues and sperm, but to serve as the mark that designates the imprint, differential methylation must also be present in the gametes and the pre-implantation embryo. We now show that the pattern of differential methylation in the 5' portion of H19 is established in the gametes and a subset is maintained in the pre-implanation embryo. That subset is sufficient to confer monoallelic expression to the gene in blastocysts. We propose that paternal-specific methylation of the far 5' region is the mark that distinguishes the two alleles of H19.	UNIV PENN,SCH MED,DEPT DEV & CELL BIOL,PHILADELPHIA,PA 19104; PRINCETON UNIV,HOWARD HUGHES MED INST,PRINCETON,NJ 08544; PRINCETON UNIV,DEPT BIOL MOLEC,PRINCETON,NJ 08544	University of Pennsylvania; Howard Hughes Medical Institute; Princeton University; Princeton University				Tremblay, Kimberly/0000-0002-3059-9910	NCI NIH HHS [CA44976] Funding Source: Medline; NIGMS NIH HHS [GM51279, GM51460] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA044976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051460, R01GM051279] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARLOW DP, 1994, TRENDS GENET, V10, P194, DOI 10.1016/0168-9525(94)90255-0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BESTOR TH, 1983, P NATL ACAD SCI USA, V82, P2674; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; BUSSLINGER M, 1983, CELL, V34, P197, DOI 10.1016/0092-8674(83)90150-2; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; FEIL R, 1994, DEVELOPMENT, V120, P2933; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; HATADA I, 1993, NUCLEIC ACIDS RES, V21, P5577, DOI 10.1093/nar/21.24.5577; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; LATHAM KE, 1994, GENE DEV, V8, P290, DOI 10.1101/gad.8.3.290; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MONK M, 1987, DEVELOPMENT, V99, P371; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SINGERSAM J, 1990, MOL CELL BIOL, V10, P4987, DOI 10.1128/MCB.10.9.4987; SINGERSAM J, 1989, NUCLEIC ACIDS RES, V18, P687; SOLTER D, 1988, ANNU REV GENET, V22, P127; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; SZABO P, 1994, DEVELOPMENT, V120, P1651; VILLAR AJ, 1994, NAT GENET, V8, P373, DOI 10.1038/ng1294-373; WAHL GM, P NATN ACAD SCI US, V76; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; ZHANG YH, 1993, AM J HUM GENET, V53, P113	40	367	374	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1995	9	4					407	413		10.1038/ng0495-407	http://dx.doi.org/10.1038/ng0495-407			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795647				2022-12-17	WOS:A1995QQ75300019
J	Erdmann, J; Grosshennig, A; Braund, PS; Konig, IR; Hengstenberg, C; Hall, AS; Linsel-Nitschke, P; Kathiresan, S; Wright, B; Tregouet, DA; Cambien, F; Bruse, P; Aherrahrou, Z; Wagner, AK; Stark, K; Schwartz, SM; Salomaa, V; Elosua, R; Melander, O; Voight, BF; O'Donnell, CJ; Peltonen, L; Siscovick, DS; Altshuler, D; Merlini, PA; Peyvandi, F; Bernardinelli, L; Ardissino, D; Schillert, A; Blankenberg, S; Zeller, T; Wild, P; Schwarz, DF; Tiret, L; Perret, C; Schreiber, S; El Mokhtari, NE; Schafer, A; Marz, W; Renner, W; Bugert, P; Kluter, H; Schrezenmeir, J; Rubin, D; Ball, SG; Balmforth, AJ; Wichmann, HE; Meitinger, T; Fischer, M; Meisinger, C; Baumert, J; Peters, A; Ouwehand, WH; Deloukas, P; Thompson, JR; Ziegler, A; Samani, NJ; Schunkert, H				Erdmann, Jeanette; Grosshennig, Anika; Braund, Peter S.; Koenig, Inke R.; Hengstenberg, Christian; Hall, Alistair S.; Linsel-Nitschke, Patrick; Kathiresan, Sekar; Wright, Ben; Tregouet, David-Alexandre; Cambien, Francois; Bruse, Petra; Aherrahrou, Zouhair; Wagner, Arnika K.; Stark, Klaus; Schwartz, Stephen M.; Salomaa, Veikko; Elosua, Roberto; Melander, Olle; Voight, Benjamin F.; O'Donnell, Christopher J.; Peltonen, Leena; Siscovick, David S.; Altshuler, David; Merlini, Piera Angelica; Peyvandi, Flora; Bernardinelli, Luisa; Ardissino, Diego; Schillert, Arne; Blankenberg, Stefan; Zeller, Tanja; Wild, Philipp; Schwarz, Daniel F.; Tiret, Laurence; Perret, Claire; Schreiber, Stefan; El Mokhtari, Nour Eddine; Schaefer, Arne; Maerz, Winfried; Renner, Wilfried; Bugert, Peter; Klueter, Harald; Schrezenmeir, Juergen; Rubin, Diana; Ball, Stephen G.; Balmforth, Anthony J.; Wichmann, H-Erich; Meitinger, Thomas; Fischer, Marcus; Meisinger, Christa; Baumert, Jens; Peters, Annette; Ouwehand, Willem H.; Deloukas, Panos; Thompson, John R.; Ziegler, Andreas; Samani, Nilesh J.; Schunkert, Heribert		Italian Atherosclerosis Thrombosis; Myocardial Infarction Genetics Con; Wellcome Trust Case Control Consor; Cardiogenics Consortium	New susceptibility locus for coronary artery disease on chromosome 3q22.3	NATURE GENETICS			English	Article							ASSOCIATION; GENOME	We present a three-stage analysis of genome-wide SNP data in 1,222 German individuals with myocardial infarction and 1,298 controls, in silico replication in three additional genome-wide datasets of coronary artery disease (CAD) and subsequent replication in similar to 25,000 subjects. We identified one new CAD risk locus on 3q22.3 in MRAS (P = 7.44 x 10(-13); OR = 1.15, 95% CI = 1.11-1.19), and suggestive association with a locus on 12q24.31 near HNF1A-C12orf43 (P = 4.81 x 10(-7); OR = 1.08, 95% CI = 1.05-1.11).	[Erdmann, Jeanette; Grosshennig, Anika; Linsel-Nitschke, Patrick; Bruse, Petra; Aherrahrou, Zouhair; Wagner, Arnika K.; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Grosshennig, Anika; Koenig, Inke R.; Schillert, Arne; Schwarz, Daniel F.; Ziegler, Andreas] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Braund, Peter S.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Ctr, Glenfield Hosp, Leicester LE3 9QP, Leics, England; [Hengstenberg, Christian; Stark, Klaus; Fischer, Marcus] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93053 Regensburg, Germany; [Hall, Alistair S.; Ball, Stephen G.; Balmforth, Anthony J.] Univ Leeds, LIGHT, Leeds LS1 3EX, W Yorkshire, England; [Kathiresan, Sekar] Harvard Univ, Sch Med, Cardiovasc Res Ctr, Boston, MA 02115 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Ctr Human Genet Res, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Wright, Ben; Thompson, John R.] Univ Leicester, Dept Hlth Sci & Genet, Leicester LE1 7RH, Leics, England; [Tregouet, David-Alexandre; Cambien, Francois; Tiret, Laurence; Perret, Claire] Univ Paris 06, INSERM, UMR S 525, Paris, France; [Schwartz, Stephen M.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98109 USA; [Schwartz, Stephen M.; Siscovick, David S.] Univ Washington, Dept Gen Med, Seattle, WA 98109 USA; [Salomaa, Veikko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Chron Dis Epidemiol Unit, FI-00271 Helsinki, Finland; [Elosua, Roberto] Inst Municipal Invest Med, Cardiovasc Epidemiol & Genet Grp, Barcelona 08036, Spain; [Elosua, Roberto] Ciber Epidemiol & Salud Publ, CIBERESP, Barcelona, Spain; [Melander, Olle] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Hypertens & Cardiovasc Dis, SE-20502 Malmo, Sweden; [Voight, Benjamin F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [O'Donnell, Christopher J.] NHLBI, NIH, Bethesda, MD 20824 USA; [Peltonen, Leena; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Altshuler, David] Harvard Univ, Sch Med, Dept Mol Biol, Boston, MA 02115 USA; [Altshuler, David] Harvard Univ, Sch Med, Ctr Human Genet Res, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Merlini, Piera Angelica] Azienda Osped Niguarda Ca Granda, Div Cardiol, I-20162 Milan, Italy; [Peyvandi, Flora] Univ Milan, Osped Maggiore Mangiagalli & Regina Elena, Fdn Ist Ricovera & Cura Carattere Sci, Dept Internal Med & Med Special, I-20162 Milan, Italy; [Bernardinelli, Luisa] Univ Pavia, Dept Appl Hlth Sci, I-27100 Pavia, Italy; [Bernardinelli, Luisa] MRC, Biostat Unit, Cambridge CB2 0SR, England; [Ardissino, Diego] Univ Parma, Azienda Osped, Div Cardiol, I-43100 Parma, Italy; [Blankenberg, Stefan; Zeller, Tanja; Wild, Philipp] Johannes Gutenberg Univ Mainz, Dept Med 2, D-55099 Mainz, Germany; [Schreiber, Stefan; El Mokhtari, Nour Eddine; Schaefer, Arne] Univ Kiel, Inst Klin Mol Biol, D-24118 Kiel, Germany; [Maerz, Winfried] Synlab Ctr Lab Diagnost Heidelberg, D-69037 Heidelberg, Germany; [Renner, Wilfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria; [Maerz, Winfried] Univ Heidelberg, Dept Publ Hlth Social & Prevent Med, D-69117 Heidelberg, Germany; [Bugert, Peter; Klueter, Harald] Univ Heidelberg, Inst Transfus Med & Immunol, D-69117 Heidelberg, Germany; [Bugert, Peter; Klueter, Harald] Med Fac Mannheim, D-68131 Mannheim, Germany; [Schrezenmeir, Juergen; Rubin, Diana] Inst Physiol & Biochem Ernahrung, Bundesforsch Sanstalt Ernahrung & Lebensmittel, D-24118 Kiel, Germany; [Wichmann, H-Erich; Meisinger, Christa; Baumert, Jens; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Neuherberg, Germany; [Wichmann, H-Erich] LMU, Inst Med Informat Sci Biometry & Epidemiol, D-80539 Munich, Germany; [Meitinger, Thomas] Deutsch Forschungszentrum Umwelt & Gesundheit, Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Humangenet, D-80333 Munich, Germany; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 2PT, England	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Lubeck; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Regensburg; University of Leeds; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Leicester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Finland National Institute for Health & Welfare; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Lund University; Skane University Hospital; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wellcome Trust Sanger Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Milan; University of Pavia; MRC Biostatistics Unit; University of Parma; University Hospital of Parma; Johannes Gutenberg University of Mainz; University of Kiel; SYNLAB Group; Medical University of Graz; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Cambridge	Erdmann, J (corresponding author), Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany.	j.erdmann@cardiogenics.eu	Meisinger, Christine/B-5358-2014; Wang, Weili/D-1546-2011; Stark, Klaus/D-3813-2009; Altshuler, David M/A-4476-2009; Bernardinelli, Luisa/AAL-5750-2021; Erdmann, Jeanette/P-7513-2014; Tregouet, David-Alexandre/E-3961-2016; Trégouët, David-Alexandre/P-9210-2019; Wild, Philipp S./M-2106-2019; Cambien, Francois/AAP-9751-2020; Voight, Benjamin/F-1775-2011; Meitinger, Thomas/O-1318-2015; Ardissino, Diego/AAC-4041-2022; Peters, Annette/A-6117-2011; Stark, Klaus/L-7367-2013; König, Inke R/A-4544-2009; Hengstenberg, Christian/U-5485-2019; Hall, Alistair/K-1953-2019; Wichmann, Heinz Erich/AAA-5695-2022; Erdmann, Jeanette/A-4417-2009; Deloukas, Panos/B-2922-2013; Peyvandi, Flora/AAK-7437-2020; Ziegler, Andreas/G-4246-2012	Stark, Klaus/0000-0002-7832-1942; Altshuler, David M/0000-0002-7250-4107; Erdmann, Jeanette/0000-0002-4486-6231; Trégouët, David-Alexandre/0000-0001-9084-7800; Peters, Annette/0000-0001-6645-0985; Stark, Klaus/0000-0002-7832-1942; König, Inke R/0000-0003-0504-6465; Deloukas, Panos/0000-0001-9251-070X; Peyvandi, Flora/0000-0001-7423-9864; Wagner, Arnika/0000-0002-0339-8259; Wild, Philipp/0000-0003-4413-9752; Aherrahrou, Zouhair/0000-0002-1241-8733; solinas, emilia/0000-0003-3532-1317; Meitinger, Thomas/0000-0002-8838-8403; Schaefer, Arne/0000-0001-5816-6765; Ziegler, Andreas/0000-0002-8386-5397; Zeller, Tanja/0000-0003-3379-2641; Meisinger, Christa/0000-0002-9026-6544; Hall, Alistair/0000-0003-0306-7887; Voight, Benjamin/0000-0002-6205-9994; Melander, Olle/0000-0002-2581-484X	British Heart Foundation Funding Source: Medline; Medical Research Council Funding Source: Medline; NCRR NIH HHS [U54RR020278, U54 RR020278] Funding Source: Medline; NHLBI NIH HHS [R01 HL087676, R01 HL056931-03, R01 HL056931-04, R01HL087676, R01 HL056931-02] Funding Source: Medline; Wellcome Trust [076113, 089061, 077011] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056931, R01HL087676] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome Trust); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*ARTH THROMB VASC, 2003, CIRCULATION, V107, P111; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NEW ENGL J MED, V358, P2299, DOI 10.1056/NEJMc0707445; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Yoshikawa Y, 2007, MOL BIOL CELL, V18, P2949, DOI 10.1091/mbc.E07-03-0250	14	366	379	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2009	41	3					280	282		10.1038/ng.307	http://dx.doi.org/10.1038/ng.307			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19198612	Green Accepted			2022-12-17	WOS:000263640200006
J	Balbin, M; Fueyo, A; Tester, AM; Pendas, AM; Pitiot, AS; Astudillo, A; Overall, CM; Shapiro, SD; Lopez-Otin, C				Balbin, M; Fueyo, A; Tester, AM; Pendas, AM; Pitiot, AS; Astudillo, A; Overall, CM; Shapiro, SD; Lopez-Otin, C			Loss of collagenase-2 confers increased skin tumor susceptibility to male mice	NATURE GENETICS			English	Article							EXPRESSION; MMP-8; INHIBITION; CHEMOKINES; INFLAMMATION; CANCER; CELLS; GAMMA	Matrix metalloproteinases (MMPs) have fundamental roles in tumor progression(1,2), but most clinical trials with MMP inhibitors have not shown improvements in individuals with cancer(3). This may be partly because broad-range inhibitors also reduce host-protective antitumor properties of individual MMPs. We generated mice deficient in collagenase-2 (Mmp8), an MMP mainly produced by neutrophils in inflammatory reactions and detected in some malignant tumors(1,4). Loss of Mmp8 did not cause abnormalities during embryonic development or in adult mice. Contrary to previous studies with MMP-deficient mice, however, the absence of Mmp8 strongly increased the incidence of skin tumors in male Mmp8 / mice. Female Mmp8 / mice whose ovaries were removed or were treated with tamoxifen were also more susceptible to tumors compared with wild-type mice. Bone marrow transplantation experiments confirmed that Mmp8 supplied by neutrophils was sufficient to restore the natural protection against tumor development mediated by this protease in male mice. Histopathological analysis showed that mutant mice had abnormalities in the inflammatory response induced by carcinogens. Our study identifies a paradoxical protective role for Mmp8 in cancer and provides a genetic model to evaluate the molecular basis of gender differences in cancer susceptibility.	Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Biol Func, E-33006 Oviedo, Spain; Univ British Columbia, CIHR Grp Matrix Dynam, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, CIHR Grp Matrix Dynam, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; Hosp Cent Asturias, Serv Anat Patol, Oviedo, Spain; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pulm & Crit Care Med, Boston, MA 02115 USA	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of British Columbia; University of British Columbia; Central University Hospital Asturias; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	CLO@correo.uniovi.es	López-Otín, Carlos/AAB-2106-2020; Pendas, Alberto M/L-1017-2014; Balbín, Milagros/I-4206-2015; Pitiot, Ana S/AAA-9161-2020; Fueyo, Antonio/ABH-3243-2020	López-Otín, Carlos/0000-0001-6964-1904; Balbín, Milagros/0000-0001-5325-0407; Pitiot, Ana S/0000-0002-5318-3168; Fueyo, Antonio/0000-0002-7121-9398; Pendas, Alberto M/0000-0001-9264-3721; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809				Balbin M, 1998, J BIOL CHEM, V273, P23959, DOI 10.1074/jbc.273.37.23959; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Coussens LM, 2000, METH MOL B, V151, P149, DOI 10.1385/1-59259-046-2:149; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; DEVARAJAN P, 1991, BLOOD, V77, P2731; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Herman MP, 2001, CIRCULATION, V104, P1899, DOI 10.1161/hc4101.097419; Kiili M, 2002, J CLIN PERIODONTOL, V29, P224, DOI 10.1034/j.1600-051x.2002.290308.x; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Moilanen M, 2002, J PATHOL, V197, P72, DOI 10.1002/path.1078; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pirila E, 2003, DIGEST DIS SCI, V48, P93, DOI 10.1023/A:1021790532723; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Qin ZH, 2002, J EXP MED, V195, P1479, DOI 10.1084/jem.20011887; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Ridger VC, 2001, J IMMUNOL, V166, P3484, DOI 10.4049/jimmunol.166.5.3484; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; Wuyts A, 1999, J IMMUNOL, V163, P6155; Wuyts A, 1999, EUR J BIOCHEM, V260, P421, DOI 10.1046/j.1432-1327.1999.00166.x	25	366	386	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2003	35	3					252	257		10.1038/ng1249	http://dx.doi.org/10.1038/ng1249			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14517555				2022-12-17	WOS:000186273300021
J	Michailidou, K; Beesley, J; Lindstrom, S; Canisius, S; Dennis, J; Lush, MJ; Maranian, MJ; Bolla, MK; Wang, Q; Shah, M; Perkins, BJ; Czene, K; Eriksson, M; Darabi, H; Brand, JS; Bojesen, SE; Nordestgaard, BG; Flyger, H; Nielsen, SF; Rahman, N; Turnbull, C; Fletcher, O; Peto, J; Gibson, L; dos-Santos-Silva, I; Chang-Claude, J; Flesch-Janys, D; Rudolph, A; Eilber, U; Behrens, S; Nevanlinna, H; Muranen, TA; Aittomaki, K; Blomqvist, C; Khan, S; Aaltonen, K; Ahsan, H; Kibriya, MG; Whittemore, AS; John, EM; Malone, KE; Gammon, MD; Santella, RM; Ursin, G; Makalic, E; Schmidt, DF; Casey, G; Hunter, DJ; Gapstur, SM; Gaudet, MM; Diver, WR; Haiman, CA; Schumacher, F; Henderson, BE; Le Marchand, L; Berg, CD; Chanock, SJ; Figueroa, J; Hoover, RN; Lambrechts, D; Neven, P; Wildiers, H; van Limbergen, E; Schmidt, MK; Broeks, A; Verhoef, S; Cornelissen, S; Couch, FJ; Olson, JE; Hallberg, E; Vachon, C; Waisfisz, Q; Meijers-Heijboer, H; Adank, MA; van der Luijt, RB; Li, JM; Liu, JJ; Humphreys, K; Kang, D; Choi, JY; Park, SK; Yoo, KY; Matsuo, K; Ito, H; Iwata, H; Tajima, K; Guenel, P; Truong, T; Mulot, C; Sanchez, M; Burwinkel, B; Marme, F; Surowy, H; Sohn, C; Wu, AH; Tseng, CC; Van den Berg, D; Stram, DO; Gonzalez-Neira, A; Benitez, J; Zamora, MP; Perez, JIA; Shu, XO; Lu, W; Gao, YT; Cai, H; Cox, A; Cross, SS; Reed, MWR; Andrulis, IL; Knight, JA; Glendon, G; Mulligan, AM; Sawyer, EJ; Tomlinson, I; Kerin, MJ; Miller, N; Lindblom, A; Margolin, S; Teo, SH; Yip, CH; Taib, NAM; Tan, GH; Hooning, MJ; Hollestelle, A; Martens, JWM; Collee, JM; Blot, W; Signorello, LB; Cai, QY; Hopper, JL; Southey, MC; Tsimiklis, H; Apicella, C; Shen, CY; Hsiung, CN; Wu, PE; Hou, MF; Kristensen, VN; Nord, S; Alnaes, GIG; Giles, GG; Milne, RL; McLean, C; Canzian, F; Trichopoulos, D; Peeters, P; Lund, E; Sund, M; Khaw, KT; Gunter, MJ; Palli, D; Mortensen, LM; Dossus, L; Huerta, JM; Meindl, A; Schmutzler, RK; Sutter, C; Yang, R; Muir, K; Lophatananon, A; Stewart-Brown, S; Siriwanarangsan, P; Hartman, M; Miao, H; Chia, KS; Chan, CW; Fasching, PA; Hein, A; Beckmann, MW; Haeberle, L; Brenner, H; Dieffenbach, AK; Arndt, V; Stegmaier, C; Ashworth, A; Orr, N; Schoemaker, MJ; Swerdlow, AJ; Brinton, L; Garcia-Closas, M; Zheng, W; Halverson, SL; Shrubsole, M; Long, J; Goldberg, MS; Labreche, F; Dumont, M; Winqvist, R; Pylkas, K; Jukkola-Vuorinen, A; Grip, M; Brauch, H; Hamann, U; Bruning, T; Radice, P; Peterlongo, P; Manoukian, S; Bernard, L; Bogdanova, NV; Dork, T; Mannermaa, A; Kataja, V; Kosma, VM; Hartikainen, JM; Devilee, P; Tollenaar, RAEM; Seynaeve, C; Van Asperen, CJ; Jakubowska, A; Lubinski, J; Jaworska, K; Huzarski, T; Sangrajrang, S; Gaborieau, V; Brennan, P; Mckay, J; Slager, S; Toland, AE; Ambrosone, CB; Yannoukakos, D; Kabisch, M; Torres, D; Neuhausen, SL; Anton-Culver, H; Luccarini, C; Baynes, C; Ahmed, S; Healey, CS; Tessier, DC; Vincent, D; Bacot, F; Pita, G; Alonso, MR; Alvarez, N; Herrero, D; Simard, J; Pharoah, PPDP; Kraft, P; Dunning, AM; Chenevix-Trench, G; Hall, P; Easton, DF				Michailidou, Kyriaki; Beesley, Jonathan; Lindstrom, Sara; Canisius, Sander; Dennis, Joe; Lush, Michael J.; Maranian, Mel J.; Bolla, Manjeet K.; Wang, Qin; Shah, Mitul; Perkins, Barbara J.; Czene, Kamila; Eriksson, Mikael; Darabi, Hatef; Brand, Judith S.; Bojesen, Stig E.; Nordestgaard, Borge G.; Flyger, Henrik; Nielsen, Sune F.; Rahman, Nazneen; Turnbull, Clare; Fletcher, Olivia; Peto, Julian; Gibson, Lorna; dos-Santos-Silva, Isabel; Chang-Claude, Jenny; Flesch-Janys, Dieter; Rudolph, Anja; Eilber, Ursula; Behrens, Sabine; Nevanlinna, Heli; Muranen, Taru A.; Aittomaki, Kristiina; Blomqvist, Carl; Khan, Sofia; Aaltonen, Kirsimari; Ahsan, Habibul; Kibriya, Muhammad G.; Whittemore, Alice S.; John, Esther M.; Malone, Kathleen E.; Gammon, Marilie D.; Santella, Regina M.; Ursin, Giske; Makalic, Enes; Schmidt, Daniel F.; Casey, Graham; Hunter, David J.; Gapstur, Susan M.; Gaudet, Mia M.; Diver, W. Ryan; Haiman, Christopher A.; Schumacher, Fredrick; Henderson, Brian E.; Le Marchand, Loic; Berg, Christine D.; Chanock, Stephen J.; Figueroa, Jonine; Hoover, Robert N.; Lambrechts, Diether; Neven, Patrick; Wildiers, Hans; van Limbergen, Erik; Schmidt, Marjanka K.; Broeks, Annegien; Verhoef, Senno; Cornelissen, Sten; Couch, Fergus J.; Olson, Janet E.; Hallberg, Emily; Vachon, Celine; Waisfisz, Quinten; Meijers-Heijboer, Hanne; Adank, Muriel A.; van der Luijt, Rob B.; Li, Jingmei; Liu, Jianjun; Humphreys, Keith; Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.; Yoo, Keun-Young; Matsuo, Keitaro; Ito, Hidemi; Iwata, Hiroji; Tajima, Kazuo; Guenel, Pascal; Truong, Therese; Mulot, Claire; Sanchez, Marie; Burwinkel, Barbara; Marme, Frederik; Surowy, Harald; Sohn, Christof; Wu, Anna H.; Tseng, Chiu-chen; Van den Berg, David; Stram, Daniel O.; Gonzalez-Neira, Anna; Benitez, Javier; Zamora, M. Pilar; Arias Perez, Jose Ignacio; Shu, Xiao-Ou; Lu, Wei; Gao, Yu-Tang; Cai, Hui; Cox, Angela; Cross, Simon S.; Reed, Malcolm W. R.; Andrulis, Irene L.; Knight, Julia A.; Glendon, Gord; Mulligan, Anna Marie; Sawyer, Elinor J.; Tomlinson, Ian; Kerin, Michael J.; Miller, Nicola; Lindblom, Annika; Margolin, Sara; Teo, Soo Hwang; Yip, Cheng Har; Taib, Nur Aishah Mohd; Tan, Gie-Hooi; Hooning, Maartje J.; Hollestelle, Antoinette; Martens, John W. M.; Collee, J. Margriet; Blot, William; Signorello, Lisa B.; Cai, Qiuyin; Hopper, John L.; Southey, Melissa C.; Tsimiklis, Helen; Apicella, Carmel; Shen, Chen-Yang; Hsiung, Chia-Ni; Wu, Pei-Ei; Hou, Ming-Feng; Kristensen, Vessela N.; Nord, Silje; Alnaes, Grethe I. Grenaker; Giles, Graham G.; Milne, Roger L.; McLean, Catriona; Canzian, Federico; Trichopoulos, Dimitrios; Peeters, Petra; Lund, Eiliv; Sund, Malin; Khaw, Kay-Tee; Gunter, Marc J.; Palli, Domenico; Mortensen, Lotte Maxild; Dossus, Laure; Huerta, Jose-Maria; Meindl, Alfons; Schmutzler, Rita K.; Sutter, Christian; Yang, Rongxi; Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah; Siriwanarangsan, Pornthep; Hartman, Mikael; Miao, Hui; Chia, Kee Seng; Chan, Ching Wan; Fasching, Peter A.; Hein, Alexander; Beckmann, Matthias W.; Haeberle, Lothar; Brenner, Hermann; Dieffenbach, Aida Karina; Arndt, Volker; Stegmaier, Christa; Ashworth, Alan; Orr, Nick; Schoemaker, Minouk J.; Swerdlow, Anthony J.; Brinton, Louise; Garcia-Closas, Montserrat; Zheng, Wei; Halverson, Sandra L.; Shrubsole, Martha; Long, Jirong; Goldberg, Mark S.; Labreche, France; Dumont, Martine; Winqvist, Robert; Pylkas, Katri; Jukkola-Vuorinen, Arja; Grip, Mervi; Brauch, Hiltrud; Hamann, Ute; Bruening, Thomas; Radice, Paolo; Peterlongo, Paolo; Manoukian, Siranoush; Bernard, Loris; Bogdanova, Natalia V.; Doerk, Thilo; Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.; Devilee, Peter; Tollenaar, Robert A. E. M.; Seynaeve, Caroline; Van Asperen, Christi J.; Jakubowska, Anna; Lubinski, Jan; Jaworska, Katarzyna; Huzarski, Tomasz; Sangrajrang, Suleeporn; Gaborieau, Valerie; Brennan, Paul; Mckay, James; Slager, Susan; Toland, Amanda E.; Ambrosone, Christine B.; Yannoukakos, Drakoulis; Kabisch, Maria; Torres, Diana; Neuhausen, Susan L.; Anton-Culver, Hoda; Luccarini, Craig; Baynes, Caroline; Ahmed, Shahana; Healey, Catherine S.; Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois; Pita, Guillermo; Rosario Alonso, M.; Alvarez, Nuria; Herrero, Daniel; Simard, Jacques; Pharoah, Paul P. D. P.; Kraft, Peter; Dunning, Alison M.; Chenevix-Trench, Georgia; Hall, Per; Easton, Douglas F.		BOCS; KConFab Investigators; AOCS Grp; NBCS; GENICA Network	Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer	NATURE GENETICS			English	Article							CONFER SUSCEPTIBILITY; GENOTYPE IMPUTATION; COMMON VARIANTS; OVARIAN-CANCER; RISK; ESTROGEN; CHEK2-ASTERISK-1100DELC; METAANALYSIS; ALLELES; BRCA1	Genome-wide association studies (GWAS) and large-scale replication studies have identified common variants in 79 loci associated with breast cancer, explaining similar to 14% of the familial risk of the disease. To identify new susceptibility loci, we performed a meta-analysis of 11 GWAS, comprising 15,748 breast cancer cases and 18,084 controls together with 46,785 cases and 42,892 controls from 41 studies genotyped on a 211,155-marker custom array (iCOGS). Analyses were restricted to women of European ancestry. We generated genotypes for more than 11 million SNPs by imputation using the 1000 Genomes Project reference panel, and we identified 15 new loci associated with breast cancer at P < 5 x 10(-8). Combining association analysis with ChIP-seq chromatin binding data in mammary cell lines and ChIA-PET chromatin interaction data from ENCODE, we identified likely target genes in two regions: SETBP1 at 18q12.3 and RNF115 and PDZK1 at 1q21.1. One association appears to be driven by an amino acid substitution encoded in EXO1.	[Michailidou, Kyriaki; Dennis, Joe; Lush, Michael J.; Bolla, Manjeet K.; Wang, Qin; Pharoah, Paul P. D. P.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Beesley, Jonathan; Chenevix-Trench, Georgia] Queensland Inst Med Res, Berghofer Med Res Inst, Dept Genet, Brisbane, Qld 4006, Australia; [Lindstrom, Sara; Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Canisius, Sander] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Maranian, Mel J.; Shah, Mitul; Perkins, Barbara J.; Luccarini, Craig; Baynes, Caroline; Ahmed, Shahana; Healey, Catherine S.; Pharoah, Paul P. D. P.; Dunning, Alison M.; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Czene, Kamila; Eriksson, Mikael; Darabi, Hatef; Brand, Judith S.; Li, Jingmei; Humphreys, Keith; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, Herlev, Denmark; [Rahman, Nazneen; Turnbull, Clare; Schoemaker, Minouk J.; Swerdlow, Anthony J.; Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Fletcher, Olivia; Ashworth, Alan; Orr, Nick; Garcia-Closas, Montserrat] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Peto, Julian; Gibson, Lorna; dos-Santos-Silva, Isabel] London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol, London WC1, England; [Chang-Claude, Jenny; Rudolph, Anja; Eilber, Ursula; Behrens, Sabine] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Dept Canc Epidemiol, Clin Canc Registry, Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Nevanlinna, Heli; Muranen, Taru A.; Khan, Sofia; Aaltonen, Kirsimari] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Nevanlinna, Heli; Muranen, Taru A.; Blomqvist, Carl; Khan, Sofia; Aaltonen, Kirsimari] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Aittomaki, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Blomqvist, Carl] Univ Helsinki, Dept Oncol, Helsinki, Finland; [Ahsan, Habibul; Kibriya, Muhammad G.] Univ Chicago, Ctr Canc Epidemiol & Prevent, Chicago, IL 60637 USA; [Ahsan, Habibul; Kibriya, Muhammad G.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Whittemore, Alice S.; John, Esther M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [Whittemore, Alice S.; John, Esther M.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [John, Esther M.] Canc Prevent Inst Calif, Dept Epidemiol, Fremont, CA USA; [Malone, Kathleen E.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Gammon, Marilie D.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Santella, Regina M.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [Ursin, Giske] Canc Registry Norway, Oslo, Norway; [Makalic, Enes; Schmidt, Daniel F.] Melbourne Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Casey, Graham; Haiman, Christopher A.; Schumacher, Fredrick; Henderson, Brian E.; Wu, Anna H.; Tseng, Chiu-chen; Van den Berg, David; Stram, Daniel O.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Gapstur, Susan M.; Gaudet, Mia M.; Diver, W. Ryan] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Berg, Christine D.] Johns Hopkins Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA; [Chanock, Stephen J.; Figueroa, Jonine; Hoover, Robert N.; Brinton, Louise] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Lambrechts, Diether] VIB, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Neven, Patrick; Wildiers, Hans; van Limbergen, Erik] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium; [Schmidt, Marjanka K.; Broeks, Annegien; Cornelissen, Sten] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Olson, Janet E.; Hallberg, Emily; Vachon, Celine; Slager, Susan] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Waisfisz, Quinten; Meijers-Heijboer, Hanne; Adank, Muriel A.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Oncogenet, Amsterdam, Netherlands; [van der Luijt, Rob B.] Univ Med Ctr Utrecht, Div Biomed Genet, Utrecht, Netherlands; [Liu, Jianjun] Genome Inst Singapore, Human Genet Div, Singapore, Singapore; [Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kang, Daehee; Choi, Ji-Yeob; Park, Sue K.; Surowy, Harald] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Yoo, Keun-Young] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Matsuo, Keitaro] Kyushu Univ, Fac Med Sci, Dept Prevent Med, Fukuoka 812, Japan; [Ito, Hidemi] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 464, Japan; [Tajima, Kazuo] Mie Univ Hosp, Epidemiol Ctr Dis Control & Prevent, Tsu, Mie, Japan; [Guenel, Pascal; Truong, Therese; Sanchez, Marie] INSERM, Environm Epidemiol Canc, CESP, Ctr Res Epidemiol & Populat Hlth,U1018, Villejuif, France; [Guenel, Pascal; Truong, Therese; Sanchez, Marie] Univ Paris Sud, UMRS 1018, Villejuif, France; [Mulot, Claire] Univ Paris Sorbonne Cite, INSERM, UMRS 775, Paris, France; [Burwinkel, Barbara; Marme, Frederik; Surowy, Harald; Sohn, Christof; Yang, Rongxi] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Burwinkel, Barbara; Yang, Rongxi] German Canc Res Ctr, Mol Epidemiol Grp, Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany; [Gonzalez-Neira, Anna; Benitez, Javier; Pita, Guillermo; Rosario Alonso, M.; Alvarez, Nuria; Herrero, Daniel] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genotyping CEGEN Unit, Madrid, Spain; [Benitez, Javier] Ctr Invest Red Enfermedades Raras CIBERER, Valencia, Spain; [Zamora, M. Pilar] Hosp Univ La Paz, Med Oncol Serv, Madrid, Spain; [Arias Perez, Jose Ignacio] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo, Spain; [Shu, Xiao-Ou; Cai, Hui; Blot, William; Cai, Qiuyin; Zheng, Wei; Halverson, Sandra L.; Shrubsole, Martha; Long, Jirong] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Shu, Xiao-Ou; Cai, Hui; Blot, William; Cai, Qiuyin; Zheng, Wei; Halverson, Sandra L.; Shrubsole, Martha; Long, Jirong] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Lu, Wei] Shanghai Ctr Dis Control & Prevent, Changning, Peoples R China; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Cox, Angela; Reed, Malcolm W. R.] Univ Sheffield, Sheffield Canc Res Ctr, Sheffield, S Yorkshire, England; [Cox, Angela; Reed, Malcolm W. R.] Univ Sheffield, Dept Oncol, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Dept Neurosci, Acad Unit Pathol, Sheffield, S Yorkshire, England; [Andrulis, Irene L.; Glendon, Gord] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Knight, Julia A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Knight, Julia A.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Sawyer, Elinor J.] Guys Hosp, Kings Coll London, Div Canc Studies, Res Oncol, London SE1 9RT, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Kerin, Michael J.; Miller, Nicola] Natl Univ Ireland, Sch Med, Dept Surg, Galway, Ireland; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Teo, Soo Hwang] Canc Res Initiat Fdn, Sime Darby Med Ctr, Subang Jaya, Malaysia; [Teo, Soo Hwang; Yip, Cheng Har; Taib, Nur Aishah Mohd; Tan, Gie-Hooi] Univ Malaya Med Ctr, Canc Res Inst, Breast Canc Res Unit, Kuala Lumpur, Malaysia; [Hooning, Maartje J.; Hollestelle, Antoinette; Martens, John W. M.] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [Collee, J. Margriet] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Blot, William] Int Epidemiol Inst, Rockville, MD USA; [Signorello, Lisa B.; Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hopper, John L.; Apicella, Carmel; Giles, Graham G.; Milne, Roger L.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Southey, Melissa C.; Tsimiklis, Helen] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Shen, Chen-Yang; Wu, Pei-Ei] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei, Taiwan; [Shen, Chen-Yang; Hsiung, Chia-Ni; Wu, Pei-Ei] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Shen, Chen-Yang] China Med Univ, Sch Publ Hlth, Taichung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Ctr Canc, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Kristensen, Vessela N.; Nord, Silje; Alnaes, Grethe I. Grenaker] Oslo Univ Hosp, Dept Genet, Inst Canc Res, Radiumhosp, N-0450 Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Dept Clin Mol Biol EpiGen, Oslo, Norway; [Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [McLean, Catriona] Monash Univ, Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3181, Australia; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Trichopoulos, Dimitrios] Acad Athens, Bureau Epidemiol Res, Athens, Greece; [Trichopoulos, Dimitrios] Hellen Hlth Fdn, Athens, Greece; [Peeters, Petra] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Peeters, Petra; Gunter, Marc J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Lund, Eiliv] Univ Tromso, Arct Univ Norway, Fac Hlth Sci, Dept Commun Med, Tromso, Norway; [Sund, Malin] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Khaw, Kay-Tee] Univ Cambridge, Cambridge Inst Publ Hlth, Sch Clin Med, Cambridge, England; [Palli, Domenico] Ist Studio Prevenz Oncol, Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Mortensen, Lotte Maxild] Aarhus Univ, Sect Epidemiol, Aarhus, Denmark; [Dossus, Laure] INSERM, Ctr Res Epidemiol & Populat Hlth CESP, Nutr Hormones & Womens Hlth Team, U1018, Villejuif, France; [Dossus, Laure] Univ Paris 11, Villejuif, France; [Huerta, Jose-Maria] CIBER Epidemiol & Salud Publ, Consejeria Sanidad & Polit Social, Dept Epidemiol, Murcia, Spain; [Meindl, Alfons] Tech Univ Munich, Div Gynaecol & Obstet, D-80290 Munich, Germany; [Schmutzler, Rita K.; Radice, Paolo] Univ Hosp Cologne, Ctr Hereditary Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp Cologne, Ctr Integrated Oncol, Cologne, Germany; [Schmutzler, Rita K.] Univ Cologne, Fac Med, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Sutter, Christian] Univ Heidelberg Hosp, Inst Human Genet, Heidelberg, Germany; [Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Siriwanarangsan, Pornthep] Minist Publ Hlth, Nonthaburi, Thailand; [Hartman, Mikael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Hartman, Mikael; Miao, Hui; Chia, Kee Seng] Natl Univ Hlth Syst, Singapore, Singapore; [Hartman, Mikael; Miao, Hui; Chia, Kee Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Chan, Ching Wan] Natl Univ Hlth Syst, Div Gen Surg, Singapore, Singapore; [Fasching, Peter A.; Hein, Alexander; Beckmann, Matthias W.; Haeberle, Lothar] Univ Erlangen Nurnberg, Comprehens Canc Ctr Erlangen Nuremberg Metropolit, Univ Hosp Erlangen, Dept Gynecol & Obstet,Univ Breast,Ctr Franconia, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Brenner, Hermann; Dieffenbach, Aida Karina; Arndt, Volker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann; Dieffenbach, Aida Karina; Brauch, Hiltrud] German Canc Consortium DKTK, Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany; [Swerdlow, Anthony J.] Inst Canc Res, Div Breast Canc Res, London SW3 6JB, England; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goldberg, Mark S.] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Ecole Sante Publ, Dept Sante Environnementale & Sante Travail, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Ecole Sante Publ, Dept Social & Prevent Med, Montreal, PQ, Canada; [Dumont, Martine; Simard, Jacques] Ctr Hosp Univ Quebec, Res Ctr, Quebec City, PQ, Canada; [Dumont, Martine; Simard, Jacques] Univ Laval, Dept Mol Med, Quebec City, PQ, Canada; [Winqvist, Robert] Univ Oulu, Dept Clin Chem & Bioctr Oulu, Lab Canc Genet & Tumor Biol, NordLab Oulu,Oulu Univ Hosp, Oulu, Finland; [Pylkas, Katri; Jukkola-Vuorinen, Arja] Univ Oulu, Oulu Univ Hosp, Dept Oncol, Oulu, Finland; [Grip, Mervi] Univ Oulu, Dept Surg, Oulu Univ Hosp, Oulu, Finland; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Brauch, Hiltrud] German Canc Res Ctr, Heidelberg, Germany; [Hamann, Ute; Kabisch, Maria; Torres, Diana] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [Bruening, Thomas] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med, German Social Accid Insurance, Bochum, Germany; [Radice, Paolo] Ist Nazl Tumori, Unit Mol Bases Genet Risk & Genet Testing, Dept Prevent & Predict Med, Fdn IRCCS, I-20133 Milan, Italy; [Peterlongo, Paolo] Italian Fdn Canc Res Oncol Mol IFOM, Fdn Ist FIRC, Milan, Italy; [Manoukian, Siranoush] Ist Nazl Tumori, Unit Med Genet, Dept Prevent & Predict Med, Fdn IRCCS, I-20133 Milan, Italy; [Bernard, Loris] Ist Europeo Oncol, Dept Expt Oncol, Milan, Italy; [Bernard, Loris] Cogentech Canc Genet Test Lab, Milan, Italy; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, Hannover, Germany; [Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Univ Eastern Finland, Sch Med, Inst Clin Med Pathol & Forens Med, Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, SF-70210 Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland; [Kataja, Vesa] Jyvaskyla Cent Hosp, Cent Finland Hosp Dist, Jyvaskyla, Finland; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Tollenaar, Robert A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands; [Seynaeve, Caroline] Erasmus MC Canc Inst, Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands; [Van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Jakubowska, Anna; Lubinski, Jan; Jaworska, Katarzyna; Huzarski, Tomasz] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Sangrajrang, Suleeporn] Natl Canc Inst Thailand, Bangkok, Thailand; [Gaborieau, Valerie; Brennan, Paul; Mckay, James] Int Agcy Res Canc, F-69372 Lyon, France; [Toland, Amanda E.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Yannoukakos, Drakoulis] Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, Inst Radioisotopes & Radiodiagnost Prod, Athens, Greece; [Torres, Diana] Pontificia Univ Javeriana, Inst Human Genet, Bogota, Colombia; [Neuhausen, Susan L.] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois] McGill Univ, Montreal, PQ, Canada; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois] Genome Quebec Innovat Ctr, Montreal, PQ, Canada	University of Cambridge; QIMR Berghofer Medical Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Netherlands Cancer Institute; University of Cambridge; Karolinska Institutet; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Chicago; University of Chicago; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Stanford University; Stanford Cancer Institute; Stanford University; Cancer Prevention Institute of California; Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Columbia University; University of Oslo; University of Southern California; American Cancer Society; Cancer Research Center of Hawaii; University of Hawaii System; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Netherlands Cancer Institute; Mayo Clinic; Mayo Clinic; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyushu University; Aichi Cancer Center; Aichi Cancer Center; Mie University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; Vanderbilt University; Vanderbilt University; Shanghai Center for Disease Control & Prevention; Shanghai Jiao Tong University; University of Sheffield; University of Sheffield; University of Sheffield; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ollscoil na Gaillimhe-University of Galway; Karolinska Institutet; Karolinska Institutet; Universiti Malaya; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; University of Melbourne; University of Melbourne; Academia Sinica - Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Oslo; University of Oslo; University of Oslo; Cancer Council Victoria; Florey Institute of Neuroscience & Mental Health; Monash University; Helmholtz Association; German Cancer Research Center (DKFZ); Academy of Athens; Utrecht University; Utrecht University Medical Center; Imperial College London; UiT The Arctic University of Tromso; Umea University; University of Cambridge; Aarhus University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Technical University of Munich; University of Cologne; University of Cologne; University of Cologne; Ruprecht Karls University Heidelberg; University of Warwick; University of Manchester; Ministry of Public Health - Thailand; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; McGill University; McGill University; Royal Victoria Hospital; Universite de Montreal; Universite de Montreal; Laval University; Laval University; University of Oulu; University of Oulu; University of Oulu; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruhr University Bochum; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS European Institute of Oncology (IEO); Hannover Medical School; Hannover Medical School; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Central Finland Central Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Pomeranian Medical University; National Cancer Institute - Thailand; World Health Organization; International Agency for Research on Cancer (IARC); University System of Ohio; Ohio State University; Roswell Park Cancer Institute; National Centre of Scientific Research "Demokritos"; Pontificia Universidad Javeriana; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Irvine; McGill University	Easton, DF (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England.	dfe20@medschl.cam.ac.uk	Dossus, Laure/AAW-9097-2021; Figueroa, Jonine/GWD-1322-2022; Van Den Berg, David J/G-8598-2017; wildiers, hans/AAV-8158-2021; Pharoah, Paul/V-6658-2019; Miller, Nicola/F-4009-2018; Figueroa, Jonine/AFK-2752-2022; Brenner, Hermann/ABE-6383-2020; Hartikainen, Jaana M/E-6256-2015; Liu, Jianjun/AAK-4989-2020; Haviv, Izhak/E-3782-2015; Arndt, Volker/AAI-7282-2020; Peterlongo, Paolo/Q-4717-2018; Knight, Julia/A-6843-2012; Shrubsole, Martha J/K-5052-2015; truong, therese/A-2837-2013; Diver, Ryan/AAG-3469-2019; Turnbull, Clare/AAA-6596-2019; Khaw, Kay-Tee/AAZ-3209-2021; Guenel, Pascal/AAS-7688-2021; Saunders, Christobel M/H-5779-2014; Brenner, Hermann/B-4627-2017; Teo, Soo-hwang/H-2353-2014; Muranen, Taru/AAC-8418-2019; Tischkowitz, Marc/O-4452-2018; manoukian, siranoush/E-7132-2017; Bowtell, David/H-1007-2016; Arndt, Volker/B-4999-2014; Dörk, Thilo/J-8620-2012; Radice, Paolo/O-3119-2013; /AAM-5330-2020; Li, Jingmei/I-2904-2012; Brinton, Louise A/G-7486-2015; Fasching, Peter A/ABH-9912-2020; Nordestgaard, Borge Gronne/ABF-1310-2020; Margolin, Sara/AAX-9034-2020; Garcia-Closas, Montserrat/F-3871-2015; Hein, Alexander/F-6999-2010; Zheng, Wei/O-3351-2013; Andrulis, Irene L./E-7267-2013; Schmidt, Marjanka K/G-9058-2011; wang, edwin/G-5372-2010; Huerta, José María/N-8654-2015; DEVILEE, PETER/ABR-2140-2022; Devilee, Peter/GXV-8005-2022; Nord, Silje/R-5212-2016; Huzarski, Tomasz/AAQ-2161-2021; Lambrechts, Diether/AAJ-3167-2020; zhang, weihua/GXV-1334-2022; Ursin, Giske/U-6637-2017; Bogdanova, Natalia V./Y-2205-2019; Matsuo, Keitaro/H-6758-2019; gao, yi/HCI-8298-2022; Knight, Julia/R-5617-2019; Gonzalez-Neira, Anna/C-5791-2015; Chan, Ching Wan/C-7606-2011; Garcia-Closas, Montserrat/AAZ-6930-2021; Chenevix-Trench, Georgia/AAV-2014-2020; Michailidou, Kyriaki/ABD-5122-2020; Lu, Wei/AAE-2921-2022; Figueroa, Jonine/AAG-1065-2022; Flyger, Henrik/AAM-6494-2021; Helland, Åslaug/H-3910-2015; Kraft, Peter/GQH-8448-2022; Yip, Cheng-Har/B-1909-2010; Reed, Malcolm Walter/AAG-9219-2020; Brüning, Thomas/G-8120-2015; van Asperen, Christi J/D-3970-2012; Guenel, Pascal/H-3728-2018; Jakubowska, Anna/O-8050-2014; Gunter, Marc/AAP-8621-2020; Gao, Yu/HGE-1937-2022; Taib, Nur Aishah Mohd/B-2370-2010; Gao, Y./GWZ-3665-2022; Schumacher, Fredrick/R-6043-2019; Rahman, Nazneen/D-2802-2013; benitez, javier/H-5232-2015; Hartman, Mikael/B-4324-2011	Dossus, Laure/0000-0003-2716-5748; Figueroa, Jonine/0000-0002-5100-623X; Van Den Berg, David J/0000-0002-5404-5218; Pharoah, Paul/0000-0001-8494-732X; Miller, Nicola/0000-0002-5416-7047; Figueroa, Jonine/0000-0002-5100-623X; Brenner, Hermann/0000-0002-6129-1572; Hartikainen, Jaana M/0000-0001-8267-1905; Liu, Jianjun/0000-0002-3255-3019; Haviv, Izhak/0000-0002-0837-5005; Arndt, Volker/0000-0001-9320-8684; Peterlongo, Paolo/0000-0001-6951-6855; Shrubsole, Martha J/0000-0002-5591-7575; truong, therese/0000-0002-2943-6786; Diver, Ryan/0000-0002-5418-9000; Guenel, Pascal/0000-0002-8359-518X; Saunders, Christobel M/0000-0003-2281-9829; Brenner, Hermann/0000-0002-6129-1572; Muranen, Taru/0000-0002-5895-1808; Tischkowitz, Marc/0000-0002-7880-0628; manoukian, siranoush/0000-0002-6034-7562; Bowtell, David/0000-0001-9089-7525; Arndt, Volker/0000-0001-9320-8684; Dörk, Thilo/0000-0002-9458-0282; Radice, Paolo/0000-0001-6298-4111; Li, Jingmei/0000-0001-8587-7511; Brinton, Louise A/0000-0003-3853-8562; Fasching, Peter A/0000-0003-4885-8471; Garcia-Closas, Montserrat/0000-0003-1033-2650; Hein, Alexander/0000-0003-2601-3398; Zheng, Wei/0000-0003-1226-070X; Schmidt, Marjanka K/0000-0002-2228-429X; Huerta, José María/0000-0002-9637-3869; Nord, Silje/0000-0002-3271-5356; Huzarski, Tomasz/0000-0003-3857-4854; Lambrechts, Diether/0000-0002-3429-302X; Ursin, Giske/0000-0002-0835-9507; Matsuo, Keitaro/0000-0003-1761-6314; Knight, Julia/0000-0002-7610-7635; Gonzalez-Neira, Anna/0000-0002-5421-2020; Chan, Ching Wan/0000-0002-9250-1296; Garcia-Closas, Montserrat/0000-0003-1033-2650; Chenevix-Trench, Georgia/0000-0002-1878-2587; Michailidou, Kyriaki/0000-0001-7065-1237; Lu, Wei/0000-0002-4150-8674; Figueroa, Jonine/0000-0002-5100-623X; Helland, Åslaug/0000-0002-5520-0275; Reed, Malcolm Walter/0000-0001-7442-2132; Brüning, Thomas/0000-0001-9560-5464; van Asperen, Christi J/0000-0002-1436-7650; Guenel, Pascal/0000-0002-8359-518X; Jakubowska, Anna/0000-0002-5650-0501; Taib, Nur Aishah Mohd/0000-0001-8419-0478; Schumacher, Fredrick/0000-0002-3073-7463; eriksson, mikael/0000-0001-8135-4270; Kerin, Michael/0000-0003-4164-5561; Devilee, Peter/0000-0002-8023-2009; Labreche, France/0000-0001-8722-0433; Khan, Sofia/0000-0003-4185-8882; Hou, Ming-Feng/0000-0001-6030-9702; Margolin, Sara/0000-0002-5526-5570; Hollestelle, Antoinette/0000-0003-1166-1966; dos Santos Silva, Isabel/0000-0002-6596-8798; Cross, Simon/0000-0003-2044-1754; Turnbull, Clare/0000-0002-1734-5772; Bojesen, Stig/0000-0002-4061-4133; Beesley, Jonathan/0000-0003-1942-325X; Fletcher, Olivia/0000-0001-9387-7116; Rahman, Nazneen/0000-0003-4376-0440; Nordestgaard, Borge/0000-0002-1954-7220; benitez, javier/0000-0002-0923-7202; Southey, Melissa/0000-0002-6313-9005; Adlard, Julian/0000-0002-1693-0435; Swerdlow, Anthony/0000-0001-5550-4159; Brand, Judith S./0000-0002-3720-1274; Pylkas, Katri/0000-0002-2449-0521; Blomqvist, Carl/0000-0003-3041-1938; Lund, Eiliv/0000-0002-8071-8711; Schoemaker, Minouk/0000-0001-8403-2234; Winqvist, Robert/0000-0003-0932-9104; Kang, Daehee/0000-0003-4031-5878; Evans, Gareth/0000-0002-8482-5784; Kleivi Sahlberg, Kristine/0000-0002-7281-2759; Canzian, Federico/0000-0002-4261-4583; Long, Jirong/0000-0002-7433-9766; Simard, Jacques/0000-0001-6906-3390; Gunter, Marc/0000-0001-5472-6761; Waisfisz, Quinten/0000-0002-7384-9182; McLean, Catriona/0000-0002-0302-5727; Yannoukakos, Drakoulis/0000-0001-7509-3510; Kataja, Vesa/0000-0003-4846-4843; Pita, Guillermo/0000-0003-2393-0510; van der Luijt, Rob/0000-0002-0018-1089; Makalic, Enes/0000-0003-3017-0871; Torres-Lopez, Diana Maria/0000-0002-9879-9775; Hartman, Mikael/0000-0001-5726-9965; Thorne, Heather/0000-0003-3610-2511; Lubinski, Jan/0000-0003-2931-3003; Ito, Hidemi/0000-0002-8023-4581; Brauch, Hiltrud/0000-0001-7531-2736; Mulligan, Anna Marie/0000-0002-7239-5297; Sawyer, Elinor/0000-0001-8285-4111; Cox, Angela/0000-0002-5138-1099; tumino, rosario/0000-0003-2666-414X; Dunning, Alison Margaret/0000-0001-6651-7166; Durocher, Francine/0000-0001-8012-4641; Lotz, Anne/0000-0002-8715-0743; PALLI, Domenico/0000-0002-5558-2437; Surowy, Harald/0000-0002-3595-9188	Cancer Research UK [C1287/A10118, C1287/A12014, C1287/A10710, C8197/A16565]; European Community's Seventh Framework Programme [223175 (HEALTH-F2-2009-223175) (COGS)]; European Union COST programme [BM0606]; European Union [HEALTH-F2-2009-223175]; Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer program; Ministry of Economic Development, Innovation and Export Trade of Quebec [PSR-SIIRI-701]; US National Institutes of Health (NIH) Cancer Post-Cancer GWAS initiative [1 U19 CA148065-01 (DRIVE, part of the GAME-ON initiative)]; MRC [MC_PC_14105, G0700491] Funding Source: UKRI; Cancer Research UK [16565, 16561, 14136, 16563, 15106] Funding Source: researchfish; Medical Research Council [G0401527, G1000143, G0700491, MC_PC_14105] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, 03/DHCS/03/G121/51] Funding Source: researchfish; Cancer Foundation Finland sr [130168] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA148667, UM1CA164920, ZIACP010126, P50CA116201, P30CA016056, R01CA092447, R01CA176785, U01CA116167, U19CA148065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); European Community's Seventh Framework Programme(European Commission); European Union COST programme; European Union(European Commission); Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer program(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Export Trade of Quebec; US National Institutes of Health (NIH) Cancer Post-Cancer GWAS initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Foundation Finland sr; The Francis Crick Institute; National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	BCAC is funded by Cancer Research UK (C1287/A10118, C1287/A12014) and by the European Community's Seventh Framework Programme under grant agreement 223175 (HEALTH-F2-2009-223175) (COGS). Meetings of the BCAC have been funded by the European Union COST programme (BM0606). Genotyping on the iCOGS array was funded by the European Union (HEALTH-F2-2009-223175), Cancer Research UK (C1287/A10710, C8197/A16565), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer program and the Ministry of Economic Development, Innovation and Export Trade of Quebec, grant PSR-SIIRI-701. Combination of the GWAS data was supported in part by the US National Institutes of Health (NIH) Cancer Post-Cancer GWAS initiative, grant 1 U19 CA148065-01 (DRIVE, part of the GAME-ON initiative). For a full description of funding and acknowledgments, see the the Supplementary Note.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Ahsan H, 2014, CANCER EPIDEM BIOMAR, V23, P658, DOI 10.1158/1055-9965.EPI-13-0340; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Cai QY, 2014, NAT GENET, V46, P886, DOI 10.1038/ng.3041; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kim HY, 2013, MOL MED, V19, P253, DOI 10.2119/molmed.2011.00001; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Lin WY, 2015, HUM MOL GENET, V24, P285, DOI 10.1093/hmg/ddu431; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Milne RL, 2014, HUM MOL GENET, V23, P6096, DOI 10.1093/hmg/ddu311; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Udler MS, 2010, GENET EPIDEMIOL, V34, P463, DOI 10.1002/gepi.20504; Wang ZH, 2013, NEOPLASIA, V15, P1028, DOI 10.1593/neo.13678; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	38	365	374	2	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2015	47	4					373	U127		10.1038/ng.3242	http://dx.doi.org/10.1038/ng.3242			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CE6CH	25751625	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000351922900013
J	Comino-Mendez, I; Gracia-Aznarez, FJ; Schiavi, F; Landa, I; Leandro-Garcia, LJ; Leton, R; Honrado, E; Ramos-Medina, R; Caronia, D; Pita, G; Gomez-Grana, A; de Cubas, AA; Inglada-Perez, L; Maliszewska, A; Taschin, E; Bobisse, S; Pica, G; Loli, P; Hernandez-Lavado, R; Diaz, JA; Gomez-Morales, M; Gonzalez-Neira, A; Roncador, G; Rodriguez-Antona, C; Benitez, J; Mannelli, M; Opocher, G; Robledo, M; Cascon, A				Comino-Mendez, Inaki; Gracia-Aznarez, Francisco J.; Schiavi, Francesca; Landa, Inigo; Leandro-Garcia, Luis J.; Leton, Roco; Honrado, Emiliano; Ramos-Medina, Rocio; Caronia, Daniela; Pita, Guillermo; Gomez-Grana, Alvaro; de Cubas, Aguirre A.; Inglada-Perez, Lucia; Maliszewska, Agnieszka; Taschin, Elisa; Bobisse, Sara; Pica, Giuseppe; Loli, Paola; Hernandez-Lavado, Rafael; Diaz, Jose A.; Gomez-Morales, Mercedes; Gonzalez-Neira, Anna; Roncador, Giovanna; Rodriguez-Antona, Cristina; Benitez, Javier; Mannelli, Massimo; Opocher, Giuseppe; Robledo, Mercedes; Cascon, Alberto			Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma	NATURE GENETICS			English	Article							UNIPARENTAL DISOMY; C-MYC; DIMERIZATION PARTNER; CELL-LINE; PARAGANGLIOMA; GENE; TUMOR; TRANSCRIPTION; ACTIVATION; COMPLEX	Hereditary pheochromocytoma (PCC) is often caused by germline mutations in one of nine susceptibility genes described to date(1-4), but there are familial cases without mutations in these known genes. We sequenced the exomes of three unrelated individuals with hereditary PCC (cases) and identified mutations in MAX, the MYC associated factor X gene. Absence of MAX protein in the tumors and loss of heterozygosity caused by uniparental disomy supported the involvement of MAX alterations in the disease. A follow-up study of a selected series of 59 cases with PCC identified five additional MAX mutations and suggested an association with malignant outcome and preferential paternal transmission of MAX mutations. The involvement of the MYC-MAX-MXD1 network in the development and progression of neural crest cell tumors is further supported by the lack of functional MAX in rat PCC (PC12) cells(5) and by the amplification of MYCN in neuroblastoma(6) and suggests that loss of MAX function is correlated with metastatic potential.	[Comino-Mendez, Inaki; Landa, Inigo; Leandro-Garcia, Luis J.; Leton, Roco; Gomez-Grana, Alvaro; de Cubas, Aguirre A.; Inglada-Perez, Lucia; Maliszewska, Agnieszka; Rodriguez-Antona, Cristina; Robledo, Mercedes; Cascon, Alberto] Spanish Natl Canc Res Ctr CNIO, Hereditary Endocrine Canc Grp, Madrid, Spain; [Comino-Mendez, Inaki; Gracia-Aznarez, Francisco J.; Inglada-Perez, Lucia; Rodriguez-Antona, Cristina; Benitez, Javier; Robledo, Mercedes; Cascon, Alberto] CIBERER, Madrid, Spain; [Gracia-Aznarez, Francisco J.; Benitez, Javier] Spanish Natl Canc Res Ctr, Human Genet Grp, Madrid, Spain; [Schiavi, Francesca; Taschin, Elisa; Bobisse, Sara; Opocher, Giuseppe] Veneto Inst Oncol, Familial Canc Clin, Padua, Italy; [Honrado, Emiliano] Hosp Leon, Serv Anat Pathol, Leon, Spain; [Ramos-Medina, Rocio; Roncador, Giovanna] Spanish Natl Canc Res Ctr, Biotechnol Programme, Monoclonal Antibodies Unit, Madrid, Spain; [Caronia, Daniela; Pita, Guillermo; Gonzalez-Neira, Anna] Spanish Natl Canc Ctr, Human Genotyping Unit CeGen, Human Canc Genet Programme, Madrid, Spain; [Pica, Giuseppe] Univ Foggia, Foggia, Italy; [Loli, Paola] Osped Niguarda Ca Granda, Dept Endocrinol, Milan, Italy; [Hernandez-Lavado, Rafael] Hosp Infanta Cristina, Endocrinol Sect, Badajoz, Spain; [Diaz, Jose A.] Hosp Univ Clin San Carlos, Dept Endocrinol, Madrid, Spain; [Gomez-Morales, Mercedes] Univ Granada, Univ Hosp, Dept Pathol, Granada, Spain; [Mannelli, Massimo] Univ Florence, Dept Clin Pathophysiol, Florence, Italy; [Mannelli, Massimo] Ist Toscano Tumori, Florence, Italy; [Opocher, Giuseppe] Univ Padua, Dept Med & Surg Sci, Padua, Italy	Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Oncologicas (CNIO); IRCCS Istituto Oncologico Veneto (IOV); Universidad de Leon; Hospital de Leon; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Foggia; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Granada; University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Padua	Cascon, A (corresponding author), Spanish Natl Canc Res Ctr CNIO, Hereditary Endocrine Canc Grp, Madrid, Spain.	mrobledo@cnio.es; acascon@cnio.es	Roncador, Giovanna/L-1764-2014; Landa, Iñigo/AAK-8789-2020; Opocher, Giuseppe/F-3950-2014; Pinheiro, Maísa/E-7424-2012; Rodriguez-Antona, Cristina/E-1073-2011; Cascon, Alberto/G-3160-2014; Inglada-Perez, Lucia/Z-3020-2019; Gracia Aznarez, Francisco Javier/AFV-2344-2022; Robledo, Mercedes/O-2230-2013; Schiavi, Francesca/AAB-9908-2022; Leandro-García, Luis Javier/B-4229-2019; inglada-perez, lucia/H-5378-2015; Gonzalez-Neira, Anna/C-5791-2015; taschin, elisa/K-3847-2016	Roncador, Giovanna/0000-0002-9807-2875; Landa, Iñigo/0000-0002-2817-8295; Opocher, Giuseppe/0000-0002-9845-9623; Rodriguez-Antona, Cristina/0000-0001-8750-7338; Cascon, Alberto/0000-0003-2119-891X; Robledo, Mercedes/0000-0001-6256-5902; Schiavi, Francesca/0000-0001-8529-4455; Leandro-García, Luis Javier/0000-0002-7757-2408; Gonzalez-Neira, Anna/0000-0002-5421-2020; Inglada-Perez, Lucia/0000-0001-9814-4368; COMINO-MENDEZ, INAKI/0000-0003-1926-9432; taschin, elisa/0000-0001-9426-4071; INGLADA, LUCIA/0000-0001-9523-2717; Honrado Franco, Emiliano/0000-0001-5668-4083; Ramos-Medina, Rocio/0000-0001-6059-4152; Mannelli, Massimo/0000-0002-8001-9857	Fondo de Investigaciones Sanitarias [PS09/00942, P1080883]; Mutua Madrilena [AP2775/2008]; FP7 [HEALTH-F2-2010-259735]; Center for Biomedical Research on Rare Diseases [INTRA-706-2 ISCIII CIBER-ER]; CIBER-ER	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Mutua Madrilena; FP7; Center for Biomedical Research on Rare Diseases; CIBER-ER	This work was supported in part by the Fondo de Investigaciones Sanitarias (projects PS09/00942 and P1080883 to A.C. and M.R., respectively), Mutua Madrilena (project AP2775/2008 to M.R.), FP7-Grant (ENS@T-CANCER; HEALTH-F2-2010-259735) and Innovation project INTRA-706-2 ISCIII CIBER-ER (Center for Biomedical Research on Rare Diseases). I.C.-M. holds a shuttle CIBER-ER fellowship.	Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; ATCHLEY WR, 1995, P NATL ACAD SCI USA, V92, P10217, DOI 10.1073/pnas.92.22.10217; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BOUSSET K, 1993, ONCOGENE, V8, P3211; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Cascon A, 2006, GENE CHROMOSOME CANC, V45, P213, DOI 10.1002/gcc.20283; Cascon A, 2009, J CLIN ENDOCR METAB, V94, P1701, DOI 10.1210/jc.2008-2756; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; Favier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007094; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; HOPEWELL R, 1995, MOL CELL BIOL, V15, P3470; Jimenez RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009084; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; Kurosawa K, 2002, AM J MED GENET, V110, P268, DOI 10.1002/ajmg.10404; Landa I, 2010, ENDOCR-RELAT CANCER, V17, P317, DOI 10.1677/ERC-09-0016; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lopez-Jimenez E, 2010, MOL ENDOCRINOL, V24, P2382, DOI 10.1210/me.2010-0256; Mannelli M, 2009, J CLIN ENDOCR METAB, V94, P1541, DOI 10.1210/jc.2008-2419; Murthy SK, 2002, MODERN PATHOL, V15, P1241, DOI 10.1097/01.MP.0000032535.62750.D1; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; PRENDERGAST GC, 1992, GENE DEV, V6, P2429, DOI 10.1101/gad.6.12a.2429; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; RIBON V, 1994, MOL CELL NEUROSCI, V5, P277, DOI 10.1006/mcne.1994.1032; Sambrook J, 1989, MOL CLONING LAB MANU, VIII, P1647; Segouffin-Cariou C, 2000, J BIOL CHEM, V275, P3568, DOI 10.1074/jbc.275.5.3568; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; Tiu RV, 2009, J CLIN ONCOL, V27, P5219, DOI 10.1200/JCO.2009.21.9840; Vaque JP, 2008, MOL CANCER RES, V6, P325, DOI 10.1158/1541-7786.MCR-07-0180; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilson M, 2008, AM J MED GENET A, V146A, P137, DOI 10.1002/ajmg.a.32172; Yao L, 2010, JAMA-J AM MED ASSOC, V304, P2611, DOI 10.1001/jama.2010.1830; Zhu JD, 2008, P NATL ACAD SCI USA, V105, P6584, DOI 10.1073/pnas.0802785105	37	365	371	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2011	43	7					663	U189		10.1038/ng.861	http://dx.doi.org/10.1038/ng.861			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21685915				2022-12-17	WOS:000292184600010
J	Elks, CE; Perry, JRB; Sulem, P; Chasman, DI; Franceschini, N; He, CY; Lunetta, KL; Visser, JA; Byrne, EM; Cousminer, DL; Gudbjartsson, DF; Esko, T; Feenstra, B; Hottenga, JJ; Koller, DL; Kutalik, Z; Lin, P; Mangino, M; Marongiu, M; McArdle, PF; Smith, AV; Stolk, L; Van Wingerden, SH; Zhao, JH; Albrecht, E; Corre, T; Ingelsson, E; Hayward, C; Magnusson, PKE; Smith, EN; Ulivi, S; Warrington, NM; Zgaga, L; Alavere, H; Amin, N; Aspelund, T; Bandinelli, S; Barroso, I; Berenson, GS; Bergmann, S; Blackburn, H; Boerwinkle, E; Buring, JE; Busonero, F; Campbell, H; Chanock, SJ; Chen, W; Cornelis, MC; Couper, D; Coviello, AD; d'Adamo, P; de Faire, U; de Geus, EJC; Deloukas, P; Doring, A; Smith, GD; Easton, DF; Eiriksdottir, G; Emilsson, V; Eriksson, J; Ferrucci, L; Folsom, AR; Foroud, T; Garcia, M; Gasparini, P; Geller, F; Gieger, C; Gudnason, V; Hall, P; Hankinson, SE; Ferreli, L; Heath, AC; Hernandez, DG; Hofman, A; Hu, FB; Illig, T; Jarvelin, MR; Johnson, AD; Karasik, D; Khaw, KT; Kiel, DP; Kilpelainen, TO; Kolcic, I; Kraft, P; Launer, LJ; Laven, JSE; Li, SX; Liu, JJ; Levy, D; Martin, NG; McArdle, WL; Melbye, M; Mooser, V; Murray, JC; Murray, SS; Nalls, MA; Navarro, P; Nelis, M; Ness, AR; Northstone, K; Oostra, BA; Peacock, M; Palmer, LJ; Palotie, A; Pare, G; Parker, AN; Pedersen, NL; Peltonen, L; Pennell, CE; Pharoah, P; Polasek, O; Plump, AS; Pouta, A; Porcu, E; Rafnar, T; Rice, JP; Ring, SM; Rivadeneira, F; Rudan, I; Sala, C; Salomaa, V; Sanna, S; Schlessinger, D; Schork, NJ; Scuteri, A; Segre, AV; Shuldiner, AR; Soranzo, N; Sovio, U; Srinivasan, SR; Strachan, DP; Tammesoo, ML; Tikkanen, E; Toniolo, D; Tsui, K; Tryggvadottir, L; Tyrer, J; Uda, M; van Dam, RM; van Meurs, JBJ; Vollenweider, P; Waeber, G; Wareham, NJ; Waterworth, DM; Weedon, MN; Wichmann, HE; Willemsen, G; Wilson, JF; Wright, AF; Young, L; Zhai, GJ; Zhuang, WV; Bierut, LJ; Boomsma, DI; Boyd, HA; Crisponi, L; Demerath, EW; van Duijn, CM; Econs, MJ; Harris, TB; Hunter, DJ; Loos, RJF; Metspalu, A; Montgomery, GW; Ridker, PM; Spector, TD; Streeten, EA; Stefansson, K; Thorsteinsdottir, U; Uitterlinden, AG; Widen, E; Murabito, JM; Ong, KK; Murray, A				Elks, Cathy E.; Perry, John R. B.; Sulem, Patrick; Chasman, Daniel I.; Franceschini, Nora; He, Chunyan; Lunetta, Kathryn L.; Visser, Jenny A.; Byrne, Enda M.; Cousminer, Diana L.; Gudbjartsson, Daniel F.; Esko, Tonu; Feenstra, Bjarke; Hottenga, Jouke-Jan; Koller, Daniel L.; Kutalik, Zoltan; Lin, Peng; Mangino, Massimo; Marongiu, Mara; McArdle, Patrick F.; Smith, Albert V.; Stolk, Lisette; Van Wingerden, Sophie H.; Zhao, Jing Hua; Albrecht, Eva; Corre, Tanguy; Ingelsson, Erik; Hayward, Caroline; Magnusson, Patrik K. E.; Smith, Erin N.; Ulivi, Shelia; Warrington, Nicole M.; Zgaga, Lina; Alavere, Helen; Amin, Najaf; Aspelund, Thor; Bandinelli, Stefania; Barroso, Ines; Berenson, Gerald S.; Bergmann, Sven; Blackburn, Hannah; Boerwinkle, Eric; Buring, Julie E.; Busonero, Fabio; Campbell, Harry; Chanock, Stephen J.; Chen, Wei; Cornelis, Marilyn C.; Couper, David; Coviello, Andrea D.; d'Adamo, Pio; de Faire, Ulf; de Geus, Eco J. C.; Deloukas, Panos; Doering, Angela; Smith, George Davey; Easton, Douglas F.; Eiriksdottir, Gudny; Emilsson, Valur; Eriksson, Johan; Ferrucci, Luigi; Folsom, Aaron R.; Foroud, Tatiana; Garcia, Melissa; Gasparini, Paolo; Geller, Frank; Gieger, Christian; Gudnason, Vilmundur; Hall, Per; Hankinson, Susan E.; Ferreli, Liana; Heath, Andrew C.; Hernandez, Dena G.; Hofman, Albert; Hu, Frank B.; Illig, Thomas; Jaervelin, Marjo-Riitta; Johnson, Andrew D.; Karasik, David; Khaw, Kay-Tee; Kiel, Douglas P.; Kilpelaeinen, Tuomas O.; Kolcic, Ivana; Kraft, Peter; Launer, Lenore J.; Laven, Joop S. E.; Li, Shengxu; Liu, Jianjun; Levy, Daniel; Martin, Nicholas G.; McArdle, Wendy L.; Melbye, Mads; Mooser, Vincent; Murray, Jeffrey C.; Murray, Sarah S.; Nalls, Michael A.; Navarro, Pau; Nelis, Mari; Ness, Andrew R.; Northstone, Kate; Oostra, Ben A.; Peacock, Munro; Palmer, Lyle J.; Palotie, Aarno; Pare, Guillaume; Parker, Alex N.; Pedersen, Nancy L.; Peltonen, Leena; Pennell, Craig E.; Pharoah, Paul; Polasek, Ozren; Plump, Andrew S.; Pouta, Anneli; Porcu, Eleonora; Rafnar, Thorunn; Rice, John P.; Ring, Susan M.; Rivadeneira, Fernando; Rudan, Igor; Sala, Cinzia; Salomaa, Veikko; Sanna, Serena; Schlessinger, David; Schork, Nicholas J.; Scuteri, Angelo; Segre, Ayellet V.; Shuldiner, Alan R.; Soranzo, Nicole; Sovio, Ulla; Srinivasan, Sathanur R.; Strachan, David P.; Tammesoo, Mar-Liis; Tikkanen, Emmi; Toniolo, Daniela; Tsui, Kim; Tryggvadottir, Laufey; Tyrer, Jonathon; Uda, Manuela; van Dam, Rob M.; van Meurs, Joyce B. J.; Vollenweider, Peter; Waeber, Gerard; Wareham, Nicholas J.; Waterworth, Dawn M.; Weedon, Michael N.; Wichmann, H. Erich; Willemsen, Gonneke; Wilson, James F.; Wright, Alan F.; Young, Lauren; Zhai, Guangju; Zhuang, Wei Vivian; Bierut, Laura J.; Boomsma, Dorret I.; Boyd, Heather A.; Crisponi, Laura; Demerath, Ellen W.; van Duijn, Cornelia M.; Econs, Michael J.; Harris, Tamara B.; Hunter, David J.; Loos, Ruth J. F.; Metspalu, Andres; Montgomery, Grant W.; Ridker, Paul M.; Spector, Tim D.; Streeten, Elizabeth A.; Stefansson, Kari; Thorsteinsdottir, Unnur; Uitterlinden, Andre G.; Widen, Elisabeth; Murabito, Joanne M.; Ong, Ken K.; Murray, Anna		GIANT Consortium	Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies	NATURE GENETICS			English	Article							FOLLICLE-STIMULATING-HORMONE; ENERGY-BALANCE; SEQUENCE VARIANTS; INHIBIN-B; PUBERTY; WOMEN; GIRLS; GENE; HERITABILITY; CHILDHOOD	To identify loci for age at menarche, we performed a meta-analysis of 32 genome-wide association studies in 87,802 women of European descent, with replication in up to 14,731 women. In addition to the known loci at LIN28B (P = 5.4 x 10(-60)) and 9q31.2 (P = 2.2 x 10(-33)), we identified 30 new menarche loci (all P < 5 x 10(-8)) and found suggestive evidence for a further 10 loci (P < 1.9 x 10(-6)). The new loci included four previously associated with body mass index (in or near FTO, SEC16B, TRA2B and TMEM18), three in or near other genes implicated in energy homeostasis (BSX, CRTC1 and MCHR2) and three in or near genes implicated in hormonal regulation (INHBA, PCSK2 and RXRG). Ingenuity and gene-set enrichment pathway analyses identified coenzyme A and fatty acid biosynthesis as biological processes related to menarche timing.	[Lunetta, Kathryn L.; Johnson, Andrew D.; Levy, Daniel; Murabito, Joanne M.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Elks, Cathy E.; Zhao, Jing Hua; Kilpelaeinen, Tuomas O.; Li, Shengxu; Wareham, Nicholas J.; Loos, Ruth J. F.; Montgomery, Grant W.; Ong, Ken K.] Addenbrookes Hosp, Epidemiol Unit, MRC, Inst Metab Sci, Cambridge, England; [Perry, John R. B.; Weedon, Michael N.; Ridker, Paul M.; Murray, Anna] Univ Exeter, Peninsula Med Sch, Exeter EX4 4QJ, Devon, England; [Sulem, Patrick; Gudbjartsson, Daniel F.; Rafnar, Thorunn; Stefansson, Kari; Thorsteinsdottir, Unnur] deCODE Genet, Reykjavik, Iceland; [Chasman, Daniel I.; Buring, Julie E.; Pare, Guillaume; Ridker, Paul M.; Ong, Ken K.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Chasman, Daniel I.; Buring, Julie E.; Pare, Guillaume; Peltonen, Leena; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA USA; [Elks, Cathy E.; Perry, John R. B.; Sulem, Patrick; Franceschini, Nora] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [He, Chunyan] Indiana Univ, Sch Med, Dept Publ Hlth, Indiana, PA USA; [He, Chunyan] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indiana, PA USA; [Lunetta, Kathryn L.; Zhuang, Wei Vivian] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Visser, Jenny A.; Stolk, Lisette; Rivadeneira, Fernando; van Meurs, Joyce B. J.; Uitterlinden, Andre G.] Erasmus Med Ctr MC, Dept Internal Med, Rotterdam, Netherlands; [Byrne, Enda M.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Byrne, Enda M.] Univ Queensland, Brisbane, Qld, Australia; [Cousminer, Diana L.; Palotie, Aarno; Peltonen, Leena; Tikkanen, Emmi; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00014 Helsinki, Finland; [Esko, Tonu; Alavere, Helen; Nelis, Mari; Tammesoo, Mar-Liis; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, EE-50090 Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Metspalu, Andres] Estonian Bioctr, Genotyping Core Facil, Tartu, Estonia; [Feenstra, Bjarke; Geller, Frank; Melbye, Mads; Boyd, Heather A.] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Hottenga, Jouke-Jan; de Geus, Eco J. C.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Koller, Daniel L.; Foroud, Tatiana] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Kutalik, Zoltan; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Kutalik, Zoltan; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Lin, Peng; Rice, John P.; Bierut, Laura J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Mangino, Massimo; Soranzo, Nicole; Zhai, Guangju; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Marongiu, Mara; Busonero, Fabio; Ferreli, Liana; Porcu, Eleonora; Sanna, Serena; Scuteri, Angelo; Uda, Manuela; Crisponi, Laura] CNR, Ist Neurogenet & Neurofarmacol, Cagliari, Italy; [McArdle, Patrick F.; Shuldiner, Alan R.; Streeten, Elizabeth A.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Smith, Albert V.; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Aspelund, Thor; Gudnason, Vilmundur; Econs, Michael J.] Univ Iceland, Reykjavik, Iceland; [Stolk, Lisette; Hofman, Albert; Rivadeneira, Fernando; van Meurs, Joyce B. J.; van Duijn, Cornelia M.; Uitterlinden, Andre G.] Netherlands Consortium Healthy Aging, Rotterdam, Netherlands; [Van Wingerden, Sophie H.; Amin, Najaf; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus Univ, Dept Epidemiol, Med Ctr, Genet Epidemiol Unit, Rotterdam, Netherlands; [Albrecht, Eva; Doering, Angela; Gieger, Christian; Illig, Thomas; Wichmann, H. Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Corre, Tanguy; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Ingelsson, Erik; Magnusson, Patrik K. E.; Hall, Per; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hayward, Caroline; Navarro, Pau; Wright, Alan F.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Smith, Erin N.; Murray, Sarah S.; Schork, Nicholas J.] Scripps Genom Med, La Jolla, CA USA; [Smith, Erin N.; Murray, Sarah S.; Schork, Nicholas J.] Scripps Translat Sci Inst, La Jolla, CA USA; [Smith, Erin N.; Murray, Sarah S.; Schork, Nicholas J.] Scripps Res Inst, La Jolla, CA 92037 USA; [Ulivi, Shelia; d'Adamo, Pio; Gasparini, Paolo] Univ Trieste, Dept Reprod Sci & Dev, Trieste, Italy; [Warrington, Nicole M.; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Crawley, WA, Australia; [Zgaga, Lina; Campbell, Harry; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, Florence, Italy; [Barroso, Ines; Blackburn, Hannah; Deloukas, Panos; Palotie, Aarno; Peltonen, Leena; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge, England; [Berenson, Gerald S.; Chen, Wei; Srinivasan, Sathanur R.] Tulane Univ, New Orleans, LA 70118 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Buring, Julie E.; Hankinson, Susan E.; Hu, Frank B.; Kraft, Peter; Hunter, David J.; Ridker, Paul M.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chanock, Stephen J.; Hunter, David J.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Cornelis, Marilyn C.; Hu, Frank B.; Kraft, Peter; van Dam, Rob M.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Couper, David] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA; [Coviello, Andrea D.; Murabito, Joanne M.] Boston Univ, Sch Med, Dept Med, Sect Gen Internal Med Prevent Med & Endocrinol, Boston, MA 02118 USA; [de Faire, Ulf] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Smith, George Davey] Univ Bristol, Dept Social Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Easton, Douglas F.; Pharoah, Paul; Tyrer, Jonathon] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Easton, Douglas F.; Pharoah, Paul; Tyrer, Jonathon] Univ Cambridge, Dept Oncol, Strangeways Res Labs, Cambridge, England; [Emilsson, Valur] Merck & Co Inc, MPRI, Rahway, NJ 07065 USA; [Eriksson, Johan; Peltonen, Leena; Pouta, Anneli; Salomaa, Veikko; Tikkanen, Emmi] Natl Inst Hlth & Welf, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan] Folkhalsan Res Ctr, Helsinki, Finland; [Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, Baltimore, MD 21224 USA; [Folsom, Aaron R.; Demerath, Ellen W.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Garcia, Melissa; Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Hankinson, Susan E.; Hu, Frank B.; Kraft, Peter; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Hankinson, Susan E.; Hu, Frank B.; Karasik, David; Kiel, Douglas P.; Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Hernandez, Dena G.] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Jaervelin, Marjo-Riitta; Sovio, Ulla] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Johnson, Andrew D.; Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Karasik, David; Kiel, Douglas P.] Harvard Univ, Hebrew Senior Life Inst Aging Res, Boston, MA 02115 USA; [Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Kolcic, Ivana; Polasek, Ozren] Univ Zagreb, Sch Med, Zagreb 41001, Croatia; [Laven, Joop S. E.] Erasmus, MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands; [Liu, Jianjun] Genome Inst Singapore, Singapore, Singapore; [Levy, Daniel] Boston Univ, Sch Med, Div Cardiol, Boston, MA 02118 USA; [Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [McArdle, Wendy L.; Northstone, Kate; Ring, Susan M.] Univ Bristol, Dept Social Med, ALSPAC, Bristol, Avon, England; [Mooser, Vincent; Waterworth, Dawn M.] GlaxoSmithKline, Div Genet, King Of Prussia, PA USA; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Nalls, Michael A.] NIA, Neurogenet Lab, Intramural Res Program, Bethesda, MD 20892 USA; [Ness, Andrew R.] Univ Bristol, Dept Oral & Dent Sci, Bristol, Avon, England; [Oostra, Ben A.] Erasmus Univ, Dept Clin Genet, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Peacock, Munro; Econs, Michael J.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; [Palotie, Aarno; Peltonen, Leena; Segre, Ayellet V.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Pare, Guillaume] McMaster Univ, Genet & Mol Epidemiol Lab, Hamilton, ON, Canada; [Parker, Alex N.; Tsui, Kim; Young, Lauren] Amgen Inc, Cambridge, MA USA; [Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA, Australia; [Polasek, Ozren] Gen Info Ltd, Zagreb, Croatia; [Plump, Andrew S.] Merck Res Lab, Rahway, NJ USA; [Rudan, Igor] Univ Split, Croatian Ctr Global Hlth, Sch Med, Split, Croatia; [Schlessinger, David] NIA, Gerontol Res Ctr, Bethesda, MD 20892 USA; [Scuteri, Angelo] IRCCS, INRCA, Unita Operativa Geriatr, Rome, Italy; [Segre, Ayellet V.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21218 USA; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England; [Tryggvadottir, Laufey] Iceland Canc Registry, Reykjavik, Iceland; [van Dam, Rob M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [van Dam, Rob M.] Natl Univ Singapore, Dept Med, Singapore 117595, Singapore; [Vollenweider, Peter; Waeber, Gerard] BH 10 Ctr Hosp Univ Vaudois CHUV, Dept Internal Med, Lausanne, Switzerland; [Wichmann, H. Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; [Stefansson, Kari; Thorsteinsdottir, Unnur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Ong, Ken K.] Univ Cambridge, Dept Paediat, Cambridge, England	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Exeter; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; Boston University; Erasmus University Rotterdam; Erasmus MC; QIMR Berghofer Medical Research Institute; University of Queensland; University of Helsinki; University of Tartu; University of Tartu; Estonian Biocentre; Statens Serum Institut; Vrije Universiteit Amsterdam; Indiana University System; Indiana University-Purdue University Indianapolis; University of Lausanne; Swiss Institute of Bioinformatics; Washington University (WUSTL); University of London; King's College London; Consiglio Nazionale delle Ricerche (CNR); University System of Maryland; University of Maryland Baltimore; Icelandic Heart Association; University of Iceland; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Karolinska Institutet; University of Edinburgh; Scripps Research Institute; Scripps Research Institute; University of Trieste; University of Western Australia; University of Edinburgh; Azienda Sanitaria di Firenze; Wellcome Trust Sanger Institute; Tulane University; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; Boston University; Karolinska Institutet; University of Bristol; University of Cambridge; University of Cambridge; Merck & Company; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Erasmus University Rotterdam; Erasmus MC; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; Hebrew SeniorLife; University of Cambridge; University of Zagreb; Erasmus University Rotterdam; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Boston University; QIMR Berghofer Medical Research Institute; University of Bristol; GlaxoSmithKline; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Bristol; Erasmus University Rotterdam; Erasmus MC; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; McMaster University; Amgen; University of Western Australia; Merck & Company; University of Split; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); IRCCS INRCA; Harvard University; Massachusetts General Hospital; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of London; National University of Singapore; National University of Singapore; University of Munich; University of Munich; Harvard University; Brigham & Women's Hospital; University of Iceland; University of Cambridge	Murabito, JM (corresponding author), NHLBI, Framingham Heart Study, Framingham, MA USA.	murabito@bu.edu; ken.ong@mrc-epid.cam.ac.uk; anna.murray@pms.ac.uk	Campbell, Harry/E-2959-2010; Aspelund, Thor/F-4826-2011; Wichmann, Heinz Erich/AAA-5695-2022; Palmer, Lyle John/K-3196-2014; Zgaga, Lina/Q-9415-2018; Toniolo, Daniela/AAE-2969-2019; Lin, P/G-7702-2014; Loos, Ruth/GON-5877-2022; Montgomery, Grant W/B-7148-2008; Loos, Ruth J F/Q-2862-2016; Gudnason, Vilmundur/K-6885-2015; Deloukas, Panos/B-2922-2013; Khaw, Kay-Tee/AAZ-3209-2021; Visser, Jenny A./F-8156-2011; Johnson, Andrew D/G-6520-2013; Levy, Daniel/ABF-6873-2021; Marongiu, Mara/H-9437-2019; Kolcic, Ivana/E-2713-2017; Hayward, Caroline/M-8818-2016; sanna, serena/H-3009-2019; Colaus, PsyColaus/K-6607-2013; Study, Raine/K-4517-2013; Liu, Jianjun/AAK-4989-2020; Byrne, Enda/J-6068-2014; Warrington, Nicole/P-4868-2014; Crisponi, Laura/AAC-2642-2019; Ulivi, Sheila/H-3700-2013; d'Adamo, Adamo Pio/G-4064-2011; Pennell, Craig/ABD-6902-2020; Amin, Najaf N/D-1859-2012; Navarro, Pau/AAJ-8091-2021; Ness, Andy R/M-7612-2013; Northstone, Kate/A-8165-2011; Polasek, Ozren/B-6002-2011; Davey Smith, George/A-7407-2013; Wilson, James F/A-5704-2009; de Geus, Eco J.C./M-9318-2015; Pharoah, Paul/V-6658-2019; Sala, Cinzia Felicita/AAN-1900-2020; Rivadeneira, Fernando/O-5385-2015; van Dam, Rob M/F-9674-2010; Gudnason, Vilmundur/AAE-7126-2019; Kilpeläinen, Tuomas/F-8569-2012; Sovio, Ulla/H-8532-2019; Uda, Manuela/AAC-2645-2019; Aspelund, Thor/K-7022-2019; Palmer, Lyle John/N-1948-2019; Stefansson, Kari/AAE-7187-2019; Magnusson, Patrik KE/C-4458-2017; Aspelund, Thor/C-5983-2008; Nelis, Mari/ABG-7775-2020; Levy, Daniel/ABB-2752-2021; Bierut, Laura Jean/W-6806-2019; Gasparini, Paolo/B-6173-2014; bandinelli, stefania/AAL-4570-2020; Smith, Albert Vernon/K-5150-2015; Rudan, Igor/I-1467-2012; Pare, Guillaume/T-9631-2018; Mangino, Massimo/F-5134-2011; Boomsma, Dorret I/AAX-4470-2020; Smith, Erin/E-5933-2011	Campbell, Harry/0000-0002-6169-6262; Palmer, Lyle John/0000-0002-1628-3055; Zgaga, Lina/0000-0003-4089-9703; Toniolo, Daniela/0000-0001-9545-6032; Montgomery, Grant W/0000-0002-4140-8139; Loos, Ruth J F/0000-0002-8532-5087; Gudnason, Vilmundur/0000-0001-5696-0084; Deloukas, Panos/0000-0001-9251-070X; Johnson, Andrew D/0000-0001-6369-5178; Levy, Daniel/0000-0003-1843-8724; Marongiu, Mara/0000-0002-7321-2384; Kolcic, Ivana/0000-0001-7918-6052; Hayward, Caroline/0000-0002-9405-9550; sanna, serena/0000-0002-3768-1749; Liu, Jianjun/0000-0002-3255-3019; Byrne, Enda/0000-0002-9491-7797; Warrington, Nicole/0000-0003-4195-775X; Crisponi, Laura/0000-0001-9128-8537; Ulivi, Sheila/0000-0003-3606-835X; d'Adamo, Adamo Pio/0000-0001-9367-4909; Pennell, Craig/0000-0002-0937-6165; Navarro, Pau/0000-0001-5576-8584; Ness, Andy R/0000-0003-3548-9523; Northstone, Kate/0000-0002-0602-1983; Polasek, Ozren/0000-0002-5765-1862; Davey Smith, George/0000-0002-1407-8314; Wilson, James F/0000-0001-5751-9178; de Geus, Eco J.C./0000-0001-6022-2666; Pharoah, Paul/0000-0001-8494-732X; Rivadeneira, Fernando/0000-0001-9435-9441; van Dam, Rob M/0000-0002-7354-8734; Gudnason, Vilmundur/0000-0001-5696-0084; Kilpeläinen, Tuomas/0000-0002-8349-3028; Sovio, Ulla/0000-0002-0799-1105; Uda, Manuela/0000-0002-4890-6456; Aspelund, Thor/0000-0002-7998-5433; Palmer, Lyle John/0000-0002-1628-3055; Magnusson, Patrik KE/0000-0002-7315-7899; Aspelund, Thor/0000-0002-7998-5433; Nelis, Mari/0000-0001-9748-1020; Bierut, Laura Jean/0000-0002-9952-4810; Smith, Albert Vernon/0000-0003-1942-5845; Rudan, Igor/0000-0001-6993-6884; Pare, Guillaume/0000-0002-6795-4760; Mangino, Massimo/0000-0002-2167-7470; Willemsen, Gonneke/0000-0003-3755-0236; melbye, mads/0000-0001-8264-6785; Feenstra, Bjarke/0000-0003-1478-649X; Kiel, Douglas/0000-0001-8474-0310; Murabito, Joanne/0000-0002-0192-7516; Geller, Frank/0000-0002-9238-3269; Barroso, Ines/0000-0001-5800-4520; Martin, Nicholas/0000-0003-4069-8020; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Demerath, Ellen/0000-0002-4585-4064; Soranzo, Nicole/0000-0003-1095-3852; s, hema/0000-0002-3440-9475; Eriksson, Johan/0000-0002-2516-2060; Emilsson, Valur/0000-0001-9982-0524; Lunetta, Kathryn/0000-0002-9268-810X; Schork, Nicholas/0000-0003-0920-5013; Murray, Anna/0000-0002-2351-2522; Weedon, Michael/0000-0002-6174-6135; SCUTERI, ANGELO/0000-0003-4784-5441; Gieger, Christian/0000-0001-6986-9554; Bergmann, Sven/0000-0002-6785-9034; Palotie, Aarno/0000-0002-2527-5874; Ballantyne, Christie/0000-0002-6432-1730; Amin, Najaf/0000-0002-8944-1771; Coviello, Andrea/0000-0003-0244-9787; Karasik, David/0000-0002-8826-0530; Gasparini, Paolo/0000-0002-0859-0856; Zhuang, Wei/0000-0002-9998-4753; van Meurs, Joyce/0000-0001-6245-2123; Boyd, Heather/0000-0001-6849-9985; Shuldiner, Alan/0000-0001-9921-4305; Van Duijn, Cornelia/0000-0002-2374-9204; Esko, Tonu/0000-0003-1982-6569; Gudbjartsson, Daniel/0000-0002-5222-9857; Tryggvadottir, Laufey/0000-0001-8067-9030; Waeber, Gerard/0000-0003-4193-788X	Academy of Finland (Finnish Centre of Excellence in Complex Disease Genetics) [129680, 120315, 129287, 129494]; Affymetrix [N02-HL-6-4278]; Agency of Science, Technology and Research of Singapore (A*STAR); Althingi (the Icelandic Parliament); American Heart Association [0855082E]; Amgen; Augustinus Foundation; Australian National Health and Medical Research Council [241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498, 619667]; Australian Research Council [A7960034, A79801419, A79906588, DP0212016, DP0343921, DP0770096]; Baltimore Veterans Administration Medical Center Geriatrics Research; Canadian Institutes of Health Research [166067]; Cancer Research United Kingdom; Cariplo Foundation; Center for Disease Control and Prevention (USA), Centre for Medical Systems Biology (CMSB); Chief Scientist Office of the Scottish Government; Clinical Nutrition Research Unit of Maryland [P30 DK072488]; Danish National Research Foundation; Danish Pharmacists' Fund; Egmont Foundation; Erasmus Medical Center; Erasmus University; Estonian Government [SF0180142s08]; European Commision [212111 BBMRI, 205419 ECOGENE, 201413 ENGAGE, HEALTH-F2-2008-201865-GEFOS, HEALTH-F2-2008-35627, HEALTH-F4-2007-201413, HEALTH-F4-2007-201550 HYPERGENES, 245536 OPENGENE, TREAT-OA, QLG2-CT-2002-01254, EU/QLRT-2001-01254, ERC-230374]; European Union [LSHG-CT-2006-018947, LSHM-CT-2003-503041]; European Regional Development Fund; Faculty of Biology and Medicine of Lausanne, Switzerland; Fondazione Compagnia di San Paolo Health Ministry, Framingham Heart Study [N01-HC-25195]; GENEVA Coordinating Center [U01HG004446]; German Federal Ministry of Education and Research; German National Genome Research Network [NGFN-2, 01GS0823]; Giorgi-Cavaglieri Foundation; GlaxoSmithKline; Health Fund of the Danish Health Insurance Societies; Helmholtz Zentrum Munchen-German Research Center for Environmental Health; Hjartavernd (the Icelandic Heart Association); Italian Ministry of Health [ICS110.1/RF97.71, RF-FSR-2007-647201]; Juvenile Diabetes Research Foundation International (JDRF); Leenaards Foundation; March of Dimes Birth Defects Foundation; Medical Research Council [G0000934, G0500539, G0701863]; National Cancer Institute [CA40356, CA98233, P01CA087969, P01CA055075, CA047988, CA63464, CA54281, CA136792, CA089392, CA104021]; Munich Center of Health Sciences (MC Health, LMUinnovativ); National Health and Medical Research Council of Australia [572613, 003209]; National Heart, Lung, and Blood Institute [HL043851, HL087679, HL69757, N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, R01HL086694, RC2 HL102419]; National Human Genome Research Institute (NHGRI); National Institute of Aging [263 MD 9164, 263 MD 821336, N.1-AG-1-1, N.1-AG-1-2111, N01-AG-5-0002, AG-16592, R21AG032598]; National Institute of Arthritis and Musculoskeletal and Skin Diseases and National Institute on Aging ((NIAMS/NIA) [R01 AR/AG 41398)]; National Institute of Child Health and Human Development [HD-061437]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK058845, U01 DK062418]; National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA); National Institutes of Health [U01HG004446, AA07535, AA10248, AA13320, AA13321, AA13326, AA14041, HHSN268200782096C, M01 RR-00750, MH66206, N01-AG-12100, N01-AG-1-2109, P01-AG-18397, R01-088119, R01-DA013423, RFAHG006033, U01DE018993, U01DE018903, U01HG004422, U01HL72515, U01 HL84756, U01HG004399, U01HG004402, U01HG004415, U01HG004423, U01HG004436, U01HG004438, U01HG004726, U01HG004728, U01HG004729, U01HG004735, U01HG004738, U01HG04424, U10AA008401, U54RR025204-01, UL1RR025005, UL1 RR025774, Z01CP010200, HHSN268200625226C]; National Institute for Health Research Cambridge Biomedical Research Centre; Netherlands Organization for Scientific Research [904-61-193, 575-25-006, 480-04-004, 56-464-14192, NWO 480-05-003, 175.010.2005.011, 911-03-012, 014-93-015]; Netherlands Genomic Initiative (NGI) [050-060-810]; National Institute on Aging (NIA); Laboratory of Neurogenetics; US National Institutes of Health Genes, Environment and Health Initiative; Republic of Croatia Ministry of Science, Education and Sports [108-1080315-0302]; Robert Dawson Evans Endowment; Royal Society, Royal Swedish Academy of Science; State of Bavaria, Germany; Susan G. Komen Breast Cancer Foundation; Swedish Foundation for Strategic Research (SSF); Swedish Heart-Lung Foundation; Swedish Ministry of Higher Education and Research; Swedish Research Council; Swedish Society of Medicine; Swiss National Science Foundation [33CSCO-122661, 3100AO-116323/1]; University of Bristol, University of Maryland General Clinical Research Center [M01 RR 16500]; Wellcome Trust [068545/Z/02, 076467/Z/05/Z, 077016/Z/05/Z, 89061/Z/09/Z, 079895]; Western Australian DNA Bank; Western Australian Genetic Epidemiology Resource; Cancer Research UK [11022, 10118] Funding Source: researchfish; Medical Research Council [G9815508, MC_U106179472, MC_U106188470, G0401527, G0801056B, G0600705, MC_U106179471, MC_U127561128] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055022, N01HC055019, N01HC055018, N01HC055016, N01HC025195, N01HC055020, N01HC055021] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD061437] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA055075, R01CA040356, R01CA104021, R01CA054281, R01CA047988, ZIACP010201, R01CA063464, U01CA098233, P01CA089392, U01CA063464, P01CA087969, R37CA040356, Z01CP010200, ZIACP010200, R37CA054281, U01CA136792] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774, M01RR016500, M01RR000750, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072515, R41HL055018, U19HL069757, R01HL087641, R42HL055018, RC2HL102419, R01HL064278, R01HL043851, R01HL086694, R01HL088119, U01HL084756, U01HL069757, ZIAHL006001, R01HL059367, R41HL055019, R01HL087679] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402, U01HG004735, U01HG004738, U01HG004399, U01HG004728, U01HG004438, U01HG004415, U01HG004726, U01HG004424, U01HG004446, U01HG004422, U01HG004436, U01HG004423, U01HG004729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE018993, U01DE018903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418, P30DK072488, R01DK058845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592, ZIAAG006000, R01AG041517, P01AG025204, R21AG032598, ZIAAG001050, N01AG012100, P01AG018397, ZIAAG007380, N01AG012111, ZIAAG000647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013321, U10AA008401, R01AA014041, R01AA013320, R01AA013326, K05AA017688, R01AA007535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019963, R01DA012854, R01DA013423] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER; MRC [MC_U106179472, G0000934, G0600705, G0701863, MC_U106188470, MC_U127561128] Funding Source: UKRI	Academy of Finland (Finnish Centre of Excellence in Complex Disease Genetics)(Academy of Finland); Affymetrix; Agency of Science, Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); Althingi (the Icelandic Parliament); American Heart Association(American Heart Association); Amgen(Amgen); Augustinus Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Baltimore Veterans Administration Medical Center Geriatrics Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research United Kingdom(Cancer Research UK); Cariplo Foundation(Fondazione Cariplo); Center for Disease Control and Prevention (USA), Centre for Medical Systems Biology (CMSB); Chief Scientist Office of the Scottish Government; Clinical Nutrition Research Unit of Maryland; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Pharmacists' Fund; Egmont Foundation; Erasmus Medical Center; Erasmus University; Estonian Government; European Commision; European Union(European Commission); European Regional Development Fund(European Commission); Faculty of Biology and Medicine of Lausanne, Switzerland; Fondazione Compagnia di San Paolo Health Ministry, Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); GENEVA Coordinating Center; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; Giorgi-Cavaglieri Foundation; GlaxoSmithKline(GlaxoSmithKline); Health Fund of the Danish Health Insurance Societies; Helmholtz Zentrum Munchen-German Research Center for Environmental Health(Helmholtz Association); Hjartavernd (the Icelandic Heart Association); Italian Ministry of Health(Ministry of Health, Italy); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Leenaards Foundation; March of Dimes Birth Defects Foundation(March of Dimes); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Munich Center of Health Sciences (MC Health, LMUinnovativ); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases and National Institute on Aging ((NIAMS/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomic Initiative (NGI); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Laboratory of Neurogenetics; US National Institutes of Health Genes, Environment and Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Republic of Croatia Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); Robert Dawson Evans Endowment; Royal Society, Royal Swedish Academy of Science(Royal Society of London); State of Bavaria, Germany; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Ministry of Higher Education and Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Bristol, University of Maryland General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wellcome Trust(Wellcome Trust); Western Australian DNA Bank; Western Australian Genetic Epidemiology Resource; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; Chief Scientist Office; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Academy of Finland (Finnish Centre of Excellence in Complex Disease Genetics 129680, 120315, 129287, 129494); Affymetrix (N02-HL-6-4278); Agency of Science, Technology and Research of Singapore (A*STAR); Althingi (the Icelandic Parliament); American Heart Association (0855082E); Amgen; Augustinus Foundation; Australian National Health and Medical Research Council (241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498, 619667); Australian Research Council (A7960034, A79801419, A79906588, DP0212016, DP0343921, DP0770096); Baltimore Veterans Administration Medical Center Geriatrics Research; Canadian Institutes of Health Research (grant ID 166067); Cancer Research United Kingdom; the Cariplo Foundation; Center for Disease Control and Prevention (USA), Centre for Medical Systems Biology (CMSB); the Chief Scientist Office of the Scottish Government; Clinical Nutrition Research Unit of Maryland (P30 DK072488); Danish National Research Foundation; Danish Pharmacists' Fund; the Egmont Foundation; Erasmus Medical Center; Erasmus University; Estonian Government (SF0180142s08); the European Commision (212111 BBMRI, 205419 ECOGENE, 201413 ENGAGE, HEALTH-F2-2008-201865-GEFOS, HEALTH-F2-2008-35627, HEALTH-F4-2007-201413, HEALTH-F4-2007-201550 HYPERGENES, 245536 OPENGENE, TREAT-OA, GenomEUtwin Project QLG2-CT-2002-01254, EU/QLRT-2001-01254; ERC-230374); European Union framework program 6 EUROSPAN project (LSHG-CT-2006-018947, LSHM-CT-2003-503041); European Regional Development Fund; Faculty of Biology and Medicine of Lausanne, Switzerland; Fondazione Compagnia di San Paolo Health Ministry, Framingham Heart Study (N01-HC-25195); GENEVA Coordinating Center (U01HG004446); German Federal Ministry of Education and Research; German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823); Giorgi-Cavaglieri Foundation; GlaxoSmithKline; Health Fund of the Danish Health Insurance Societies; Helmholtz Zentrum Munchen-German Research Center for Environmental Health; Hjartavernd (the Icelandic Heart Association); Italian Ministry of Health (ICS110.1/RF97.71, RF-FSR-2007-647201); Juvenile Diabetes Research Foundation International (JDRF); Leenaards Foundation; March of Dimes Birth Defects Foundation; the Medical Research Council (G0000934, G0500539, G0701863); National Cancer Institute (CA40356, CA98233, P01CA087969, P01CA055075, CA047988, CA63464, CA54281, CA136792, CA089392, CA104021); Munich Center of Health Sciences (MC Health, LMUinnovativ); National Health and Medical Research Council of Australia (572613 and 003209); National Heart, Lung, and Blood Institute (HL043851, HL087679, HL69757, N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01HL087641, R01HL59367, R01HL086694, RC2 HL102419); National Human Genome Research Institute (NHGRI); National Institute of Aging (263 MD 9164, 263 MD 821336, N.1-AG-1-1, N.; 1-AG-1-2111, N01-AG-5-0002, AG-16592, Genetics of Reproductive Life Period and Health Outcomes R21AG032598); National Institute of Arthritis and Musculoskeletal and Skin Diseases and National Institute on Aging ((NIAMS/NIA) R01 AR/AG 41398); National Institute of Child Health and Human Development (HD-061437); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, R01DK058845, U01 DK062418); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA); National Institutes of Health (AA07535, AA10248, AA13320, AA13321, AA13326, AA14041, HHS268200782096C, M01 RR-00750, MH66206, N01-AG-12100, N01-AG-1-2109, P01-AG-18397, R01-088119, R01-DA013423, RFAHG006033, U01DE018993, U01DE018903, U01HG004422, U01HG004446, U01HL72515, U01 HL84756, U01HG004399, U01HG004402, U01HG004415, U01HG004423, U01HG004436, U01HG004438, U01HG004402, U01HG004446, U01HG004726, U01HG004728, U01HG004729, U01HG004735, U01HG004738, U01HG04424, U10AA008401, U54RR025204-01, UL1RR025005, UL1 RR025774, Z01CP010200, HHSN268200625226C); the National Institute for Health Research Cambridge Biomedical Research Centre; Netherlands Organization for Scientific Research (904-61-193, 575-25-006, 480-04-004, 56-464-14192, NWO 480-05-003, 175.010.2005.011, 911-03-012, 014-93-015); Netherlands Genomic Initiative (NGI, 050-060-810), National Institute on Aging (NIA) Intramural Research Program; and Laboratory of Neurogenetics; US National Institutes of Health Genes, Environment and Health Initiative; Republic of Croatia Ministry of Science, Education and Sports (108-1080315-0302); Robert Dawson Evans Endowment; the Royal Society, Royal Swedish Academy of Science; State of Bavaria, Germany; Susan G. Komen Breast Cancer Foundation; Swedish Foundation for Strategic Research (SSF); Swedish Heart-Lung Foundation; Swedish Ministry of Higher Education and Research; Swedish Research Council; Swedish Society of Medicine; Swiss National Science Foundation (Ref: 33CSCO-122661, 3100AO-116323/1); the University of Bristol, University of Maryland General Clinical Research Center (M01 RR 16500); the Wellcome Trust (068545/Z/02, 076467/Z/05/Z, 077016/Z/05/Z, 89061/Z/09/Z, strategic award 079895); Western Australian DNA Bank; Western Australian Genetic Epidemiology Resource (see Supplementary Note for extended acknowledgments).	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; BURGER HG, 1993, HUM REPROD, V8, P129, DOI 10.1093/humrep/8.suppl_2.129; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Crofton PM, 1997, CLIN ENDOCRINOL, V46, P109, DOI 10.1046/j.1365-2265.1997.d01-1744.x; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Dolle Pascal, 2009, Nucl Recept Signal, V7, pe006, DOI 10.1621/nrs.07006; Drouin J, 1998, MOL CELL ENDOCRINOL, V140, P31, DOI 10.1016/S0303-7207(98)00026-4; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gajdos ZKZ, 2008, J CLIN ENDOCR METAB, V93, P4290, DOI 10.1210/jc.2008-0981; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; KAPRIO J, 1995, HUM BIOL, V67, P739; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; KVALE G, 1992, ACTA ONCOL, V31, P187, DOI 10.3109/02841869209088901; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Must A, 2002, AM J EPIDEMIOL, V155, P672, DOI 10.1093/aje/155.7.672; Ong KK, 2007, PLOS MED, V4, P737, DOI 10.1371/journal.pmed.0040132; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Onland-Moret NC, 2005, AM J EPIDEMIOL, V162, P623, DOI 10.1093/aje/kwi260; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Pissios P, 2006, ENDOCR REV, V27, P606, DOI 10.1210/er.2006-0021; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Purdie DM, 2001, BEST PRACT RES CL OB, V15, P341, DOI 10.1053/beog.2000.0180; Raivio T, 2002, BEST PRACT RES CL EN, V16, P43, DOI 10.1053/beem.2001.0179; Sakkou M, 2007, CELL METAB, V5, P450, DOI 10.1016/j.cmet.2007.05.007; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Sehested A, 2000, J CLIN ENDOCR METAB, V85, P1634, DOI 10.1210/jc.85.4.1634; Stavrou I, 2002, HUM REPROD, V17, P1101, DOI 10.1093/humrep/17.4.1101; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Sulzbacher S, 2009, STEM CELL REV REP, V5, P159, DOI 10.1007/s12015-009-9061-5; Temple IK, 2007, J MED GENET, V44, P637, DOI 10.1136/jmg.2007.050807; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Widen E, 2010, AM J HUM GENET, V86, P773, DOI 10.1016/j.ajhg.2010.03.010; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu M, 2009, P NATL ACAD SCI USA, V106, P17217, DOI 10.1073/pnas.0908200106; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073	44	365	379	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1077	U73		10.1038/ng.714	http://dx.doi.org/10.1038/ng.714			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21102462	Green Accepted, Green Submitted			2022-12-17	WOS:000284578800010
J	Morgan, NV; Westaway, SK; Morton, JEV; Gregory, A; Gissen, P; Sonek, S; Cangul, H; Coryell, J; Canham, N; Nardocci, N; Zorzi, G; Pasha, S; Rodriguez, D; Desguerre, I; Mubaidin, A; Bertini, E; Trembath, RC; Simonati, A; Schanen, C; Johnson, CA; Levinson, B; Woods, CG; Wilmot, B; Kramer, P; Gitschier, J; Maher, ER; Hayflick, SJ				Morgan, Neil V.; Westaway, Shawn K.; Morton, Jenny E. V.; Gregory, Allison; Gissen, Paul; Sonek, Scott; Cangul, Hakan; Coryell, Jason; Canham, Natalie; Nardocci, Nardo; Zorzi, Giovanna; Pasha, Shanaz; Rodriguez, Diana; Desguerre, Isabelle; Mubaidin, Amar; Bertini, Enrico; Trembath, Richard C.; Simonati, Alessandro; Schanen, Carolyn; Johnson, Colin A.; Levinson, Barbara; Woods, C. Geoffrey; Wilmot, Beth; Kramer, Patricia; Gitschier, Jane; Maher, Eamonn R.; Hayflick, Susan J.			PLA2G6, encoding a phospholipase A(2), is mutated in neurodegenerative disorders with high brain iron	NATURE GENETICS			English	Article							INFANTILE NEUROAXONAL DYSTROPHY; HALLERVORDEN-SPATZ-SYNDROME; INVOLVEMENT	Neurodegenerative disorders with high brain iron include Parkinson disease, Alzheimer disease and several childhood genetic disorders categorized as neuroaxonal dystrophies. We mapped a locus for infantile neuroaxonal dystrophy ( INAD) and neurodegeneration with brain iron accumulation (NBIA) to chromosome 22q12-q13 and identified mutations in PLA2G6, encoding a calcium-independent group VI phospholipase A(2), in NBIA, INAD and the related Karak syndrome. This discovery implicates phospholipases in the pathogenesis of neurodegenerative disorders with iron dyshomeostasis.	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; Univ Birmingham, Sch Med, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; Uludag Univ, Sch Med, Dept Med Genet, TR-16036 Bursa, Turkey; Ist Nazl Neurol Carlo Besta, Dept Child Neurol, I-20133 Milan, Italy; Hop Armand Trousseau, Dept Pediat Neurol, F-75571 Paris, France; Hop Necker Enfants Malad, Dept Pediat Neurol, F-75270 Paris, France; Bambino Gesu Pediat Hosp, Mol Med Unit, I-00165 Rome, Italy; King Hussein Med Ctr, Dept Neurol, Amman, Jordan; Univ London Kings Coll, Div Genet & Mol Med, Sch Med, Guys Hosp, London SE1 9RT, England; Univ Verona, Sch Med, Dept Neurol & Visual Sci, I-37129 Verona, Italy; AI DuPont Hosp Children, Nemours Res Programs, Wilmington, DE 19899 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 1TN, England; Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Dept Pediat, Portland, OR 97239 USA; Howard Hughes Med Inst, Coconut Grove, FL 33133 USA	Oregon Health & Science University; University of Birmingham; Birmingham Women's Hospital; Uludag University; IRCCS Istituto Neurologico Besta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; IRCCS Bambino Gesu; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Verona; Nemours Alfred I. duPont Hospital for Children; University of California System; University of California San Francisco; University of Cambridge; Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute	Hayflick, SJ (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA.	hayflick@ohsu.edu	MAHER, EAMONN R/A-9507-2008; Morgan, Neil V/A-5475-2009; Bertini, Enrico/A-2284-2014; Gissen, Paul/A-4352-2010; woods, christopher g/A-1361-2010; Zorzi, Giovanna/AAM-4138-2021; Bertini, Enrico/ABG-1278-2020; Nardocci, Nardo/AAB-9903-2019	MAHER, EAMONN R/0000-0002-6226-6918; Morgan, Neil V/0000-0001-6433-5692; Bertini, Enrico/0000-0001-9276-4590; Gissen, Paul/0000-0002-9712-6122; Zorzi, Giovanna/0000-0001-7041-5365; Nardocci, Nardo/0000-0001-5863-5592; Trembath, Richard/0000-0003-0550-3400	NCRR NIH HHS [M01 RR000334] Funding Source: Medline; NEI NIH HHS [R01 EY012353, R01 EY012353-07] Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NIA NIH HHS [P30 AG008017] Funding Source: Medline; NICHD NIH HHS [R01 HD050832-01A1, R01 HD050832] Funding Source: Medline; Telethon [GTF04002] Funding Source: Medline; Wellcome Trust Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050832] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000334] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012353] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008017] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Farina L, 1999, NEURORADIOLOGY, V41, P376, DOI 10.1007/s002340050768; Farooqui AA, 2004, NEUROCHEM RES, V29, P1961, DOI 10.1007/s11064-004-6871-3; Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Mubaidin A, 2003, J MED GENET, V40, P543, DOI 10.1136/jmg.40.7.543; Nardocci N, 1999, NEUROLOGY, V52, P1472, DOI 10.1212/WNL.52.7.1472; Simonati A, 1999, NEUROPEDIATRICS, V30, P151, DOI 10.1055/s-2007-973482; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	11	365	388	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					752	754		10.1038/ng1826	http://dx.doi.org/10.1038/ng1826			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16783378	Green Accepted			2022-12-17	WOS:000238669300009
J	Brett, D; Pospisil, H; Valcarcel, J; Reich, J; Bork, P				Brett, D; Pospisil, H; Valcarcel, J; Reich, J; Bork, P			Alternative splicing and genome complexity	NATURE GENETICS			English	Article							GENES	Alternative splicing of mRNA allows many gene products with different functions to be produced from a single coding sequence. It has recently been proposed as a mechanism by which higher-order diversity is generated. Here we show, using large-scale expressed sequence tag (EST) analysis, that among seven different eukaryotes the amount of alternative splicing is comparable, with no large differences between humans and other animals.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; European Mol Biol Lab, D-69012 Heidelberg, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; European Molecular Biology Laboratory (EMBL)	Brett, D (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.		Pospisil, Heike/G-7377-2016; Valcarcel, Juan/O-9814-2014; Bork, Peer/F-1813-2013	Valcarcel, Juan/0000-0001-5398-3571; Bork, Peer/0000-0002-2627-833X				Banks RE, 2000, LANCET, V356, P1749, DOI 10.1016/S0140-6736(00)03214-1; Brett D, 2001, ONCOGENE, V20, P4581, DOI 10.1038/sj.onc.1204610; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	12	365	385	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2002	30	1					29	30		10.1038/ng803	http://dx.doi.org/10.1038/ng803			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743582				2022-12-17	WOS:000173105600010
J	den Hollander, AI; ten Brink, JB; de Kok, YJM; van Soest, S; van den Born, LI; van Driel, MA; van de Pol, DJR; Payne, AM; Bhattacharya, SS; Kellner, U; Hoyng, CB; Westerveld, A; Brunner, HG; Bleeker-Wagemakers, EM; Deutman, AF; Heckenlively, JR; Cremers, FPM; Bergen, AAB				den Hollander, AI; ten Brink, JB; de Kok, YJM; van Soest, S; van den Born, LI; van Driel, MA; van de Pol, DJR; Payne, AM; Bhattacharya, SS; Kellner, U; Hoyng, CB; Westerveld, A; Brunner, HG; Bleeker-Wagemakers, EM; Deutman, AF; Heckenlively, JR; Cremers, FPM; Bergen, AAB			Mutations in a human homologue of Drosophila crumbs cause retinitis pigmentosa (RP12)	NATURE GENETICS			English	Article							EPIDERMAL GROWTH-FACTOR; EPITHELIAL-CELL LINE; PROTEIN; LAMININ; SEQUENCE; DOMAINS; GENE; PROTEOGLYCAN; EXPRESSION; RECEPTOR	Retinitis pigmentosa (RP) comprises a clinically and genetically heterogeneous group of diseases that afflicts approximately 1.5 million people worldwide. Affected individuals suffer from a progressive degeneration of the photoreceptors, eventually resulting in severe visual impairment. To isolate candidate genes for chorioretinal diseases, we cloned cDNAs specifically or preferentially expressed in the human retina and the retinal pigment epithelium (RPE) through a novel suppression subtractive hybridization (SSH) method(1,2). One of these cDNAs (RET3C11) mapped to chromosome 1q31-q32.1, a region harbouring a gene involved in a severe form of autosomal recessive RP characterized by a typical preservation of the para-arteriolar RPE (RP12; ref. 3). The full-length cDNA encodes an extracellular protein with 19 EGF-like domains, 3 laminin A G-like domains and a C-type lectin domain. This protein is homologous to the Drosophila melanogaster protein crumbs (CRB), and denoted CRB1 (crumbs homologue 1). In ten unrelated RP patients with preserved para-arteriolar RPE, we identified a homozygous AluY insertion disrupting the ORF, five homozygous missense mutations and four compound heterozygous mutations in CRB1. The similarity to CRB suggests a role for CRB1 in cell-cell interaction and possibly in the maintenance of cell polarity in the retina. The distinct RPE abnormalities observed in RP12 patients suggest that CRB1 mutations trigger a novel mechanism of photoreceptor degeneration.	Univ Nijmegen Hosp, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Netherlands Ophthalm Res Inst, NL-1100 AC Amsterdam, Netherlands; Hosp Eye, Rotterdam, Netherlands; UCL, Inst Ophthalmol, London, England; Free Univ Berlin, Univ Clin Benjamin Franklin, Dept Ophthalmol, D-1000 Berlin, Germany; Univ Nijmegen Hosp, Dept Ophthalmol, NL-6500 HB Nijmegen, Netherlands; Univ Amsterdam, Inst Human Genet, Amsterdam, Netherlands; Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA USA	Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Rotterdam Eye Hospital; University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Radboud University Nijmegen; University of Amsterdam; University of California System; University of California Los Angeles	Cremers, FPM (corresponding author), Univ Nijmegen Hosp, Dept Human Genet, Geert Grooteplein 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.	F.Cremers@antrg.azn.nl	Payne, annette/F-8877-2013; Bhattacharya, Shom/N-2926-2016; Cremers, Frans/A-5625-2014; Hollander, Anneke den/N-4911-2014; Hoyng, C.B./H-8050-2014; Brunner, Han/C-9928-2013; van Driel, Marc/D-5844-2013; Bergen, Arthur/J-3637-2013	Payne, annette/0000-0002-2009-0141; Bhattacharya, Shom/0000-0002-1601-6344; Cremers, Frans/0000-0002-4954-5592; Bergen, Arthur/0000-0002-6333-9576				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; APPELLA E, 1988, FEBS LETT, V231, P1, DOI 10.1016/0014-5793(88)80690-2; Batzer MA, 1996, J MOL EVOL, V42, P3, DOI 10.1007/BF00163204; DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955; den Hollander AI, 1999, GENOMICS, V58, P240, DOI 10.1006/geno.1999.5823; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; DOOLITTLE RF, 1984, NATURE, V307, P558, DOI 10.1038/307558a0; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; HECKENLIVELY JR, 1982, BRIT J OPHTHALMOL, V66, P26, DOI 10.1136/bjo.66.1.26; JOSEPH DR, 1992, FASEB J, V6, P2477, DOI 10.1096/fasebj.6.7.1532944; KALLUNKI P, 1992, J CELL BIOL, V116, P559, DOI 10.1083/jcb.116.2.559; KERE J, 1992, GENOMICS, V14, P241, DOI 10.1016/S0888-7543(05)80212-5; KNUST E, 1987, EMBO J, V6, P761, DOI 10.1002/j.1460-2075.1987.tb04818.x; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; PATTHY L, 1992, FEBS LETT, V298, P182, DOI 10.1016/0014-5793(92)80051-H; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; ROTHBERG JM, 1992, J MOL BIOL, V227, P367, DOI 10.1016/0022-2836(92)90891-M; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; van Soest S, 1999, CYTOGENET CELL GENET, V84, P22, DOI 10.1159/000015204; Van Soest S, 1999, SURV OPHTHALMOL, V43, P321, DOI 10.1016/S0039-6257(98)00046-0; VANDENBORN LI, 1994, AM J OPHTHALMOL, V118, P430, DOI 10.1016/S0002-9394(14)75792-7; VANSOEST S, 1994, GENOMICS, V22, P499, DOI 10.1006/geno.1994.1422; Vidaud Dominique, 1993, European Journal of Human Genetics, V1, P30; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5	30	365	375	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1999	23	2					217	221		10.1038/13848	http://dx.doi.org/10.1038/13848			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	10508521				2022-12-17	WOS:000082827500024
J	Brown, SA; Warburton, D; Brown, LY; Yu, CY; Roeder, ER; Stengel-Rutkowski, S; Hennekam, RCM; Muenke, M				Brown, SA; Warburton, D; Brown, LY; Yu, CY; Roeder, ER; Stengel-Rutkowski, S; Hennekam, RCM; Muenke, M			Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired	NATURE GENETICS			English	Article							SONIC-HEDGEHOG GENE; PROTEIN; DEFINITION; EXPRESSION; REGION; DOMAIN	Holoprosencephaly (HPE) is the most common structural anomaly of the human brain and is one of the anomalies seen in patients with deletions and duplications of chromosome 13. On the basis of molecular analysis of a series of patients with hemizygous deletions of the long arm of chromosome 13. we have defined a discrete region in band 13q32 where deletion leads to major developmental anomalies (the 13q32 deletion syndrome). This approximately 1-Mb region(1) lies between markers D13S136 and D13S147. Patients in which this region is deleted usually have major congenital malformations, including brain anomalies such as HPE or exencephaly, and digital anomalies such as absent thumbs(2). We now report that human ZIC2 maps to this critical deletion region and that heterozygous mutations in ZIC2 are associated with HPE. Haploinsufficiency for ZIC2 is likely to cause the brain malformations seen in 13q deletion patients.	Columbia Univ, Dept Obstet & Gynecol, New York, NY 10027 USA; Columbia Univ, Dept Pediat, New York, NY 10027 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10027 USA; Presbyterian Hosp, New York, NY 10032 USA; Valley Childrens Hosp, Fresno, CA 93703 USA; Kinderzentrum Munchen, Munich, Germany; Univ Amsterdam, Inst Human Genet, NL-1012 WX Amsterdam, Netherlands; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD USA	Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; University of Amsterdam; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Brown, SA (corresponding author), Columbia Univ, Dept Obstet & Gynecol, New York, NY 10027 USA.	brown@cuccfa.ccc.columbia.edu		Muenke, Maximilian/0000-0002-7719-6545	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029862, R29HD028732, R29HD032467] Funding Source: NIH RePORTER; NICHD NIH HHS [HD28732, HD32467, HD29862] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Akarsu AN, 1996, HUM MOL GENET, V5, P945, DOI 10.1093/hmg/5.7.945; Aruga J, 1996, GENE, V172, P291, DOI 10.1016/0378-1119(96)00111-4; Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; BONALDO MD, 1994, HUM MOL GENET, V3, P1663; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; BROWN S, 1993, AM J MED GENET, V45, P52, DOI 10.1002/ajmg.1320450115; BROWN S, 1995, AM J HUM GENET, V57, P859; CIMBORA DM, 1995, DEV BIOL, V169, P580, DOI 10.1006/dbio.1995.1171; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HAN KY, 1993, GENE DEV, V7, P491, DOI 10.1101/gad.7.3.491; Johnson KR, 1998, HUM MOL GENET, V7, P1033, DOI 10.1093/hmg/7.6.1033; LICHT JD, 1990, NATURE, V346, P76, DOI 10.1038/346076a0; Ming JE, 1998, MOL MED TODAY, V4, P343, DOI 10.1016/S1357-4310(98)01299-4; Muenke Maximilian, 1994, Seminars in Developmental Biology, V5, P293, DOI 10.1006/sedb.1994.1038; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Roessler E, 1998, J INHERIT METAB DIS, V21, P481, DOI 10.1023/A:1005406719292; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roessler E, 1997, HUM GENET, V100, P172, DOI 10.1007/s004390050486; Roessler E, 1997, HUM MOL GENET, V6, P1847, DOI 10.1093/hmg/6.11.1847; TAN DP, 1992, P NATL ACAD SCI USA, V89, P6280, DOI 10.1073/pnas.89.14.6280	28	365	372	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					180	183		10.1038/2484	http://dx.doi.org/10.1038/2484			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771712				2022-12-17	WOS:000076231300021
J	CASTILLA, LH; COUCH, FJ; ERDOS, MR; HOSKINS, KF; CALZONE, K; GARBER, JE; BOYD, J; LUBIN, MB; DESHANO, ML; BRODY, LC; COLLINS, FS; WEBER, BL				CASTILLA, LH; COUCH, FJ; ERDOS, MR; HOSKINS, KF; CALZONE, K; GARBER, JE; BOYD, J; LUBIN, MB; DESHANO, ML; BRODY, LC; COLLINS, FS; WEBER, BL			MUTATIONS IN THE BRCA1 GENE IN FAMILIES WITH EARLY-ONSET BREAST AND OVARIAN-CANCER	NATURE GENETICS			English	Article							CHROMOSOME-17Q21; LINKAGE; REGION; DNA	We analysed 50 probands with a family history of breast and/or ovarian cancer for germline mutations in the coding region of the BRCA1 candidate gene, using single-strand conformation polymorphism (SSCP) analysis on PCR-amplified genomic DNA. A total Of eight putative disease-causing alterations were identified: four of these are frameshifts and two are nonsense mutations. In addition, we found two missense mutations, one of which changes the final cysteine of the BRCA1 zinc finger motif to glycine. These data are consistent with a tumour suppressor model, and support the notion that this candidate gene is in fact BRCA1. The heterogeneity of mutations, coupled with the large size of the gene, indicates that clinical application of BRCA1 mutation testing will be technically challenging.	UNIV PENN,DEPT INTERNAL MED,PHILADELPHIA,PA 19104; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; UNIV MICHIGAN,DEPT BIOL,ANN ARBOR,MI 48109; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CANC EPIDEMIOL & CONTROL,BOSTON,MA 02115; UNIV PENN,DEPT OBSTET & GYNECOL,PHILADELPHIA,PA 19104; STRANG CANC PREVENT CTR,NEW YORK,NY 10021; UNIV PENN,DEPT GENET,PHILADELPHIA,PA 19104	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Pennsylvania; University of Pennsylvania				Calzone, Kathleen/0000-0002-2354-6810	NCI NIH HHS [R01-CA-57601, R01 CA-61231] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061231, R01CA057601] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; CHAMBERLAIN JS, 1993, AM J HUM GENET, V52, P792; CLAUS EB, 1991, AM J HUM GENET, V48, P232; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LOVERING R, 1993, P NATL ACAD SCI USA, V90, P2112, DOI 10.1073/pnas.90.6.2112; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1991, LANCET, V338, P82; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P1; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Sambrook J., 1989, MOL CLONING LAB MANU; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; VIDALPUIG A, 1994, BIOTECHNIQUES, V17, P490; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; 1994, PRESYMPTOMATIC GENET; 1994, JAMA-J AM MED ASSOC, V271, P785; 1994, AM J HUM GENET, V55, pR1; 1993, CELL, V72, P971	26	365	386	1	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					387	391		10.1038/ng1294-387	http://dx.doi.org/10.1038/ng1294-387			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894491				2022-12-17	WOS:A1994PV68200021
J	SUTCLIFFE, JS; NAKAO, M; CHRISTIAN, S; ORSTAVIK, KH; TOMMERUP, N; LEDBETTER, DH; BEAUDET, AL				SUTCLIFFE, JS; NAKAO, M; CHRISTIAN, S; ORSTAVIK, KH; TOMMERUP, N; LEDBETTER, DH; BEAUDET, AL			DELETIONS OF A DIFFERENTIALLY METHYLATED CPG ISLAND AT THE SNRPN GENE DEFINE A PUTATIVE IMPRINTING CONTROL REGION	NATURE GENETICS			English	Article							PRADER-WILLI SYNDROME; FAMILIAL ANGELMAN SYNDROME; NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE; DNA METHYLATION; MOLECULAR DIAGNOSIS; GEL-ELECTROPHORESIS; LINKAGE ANALYSIS; PARENTAL ORIGIN; EXPRESSION; CLONING	To determine the molecular basis of Prader-Willi syndrome (PWS) and Angelman syndrome (AS), we have isolated new transcripts from chromosome 15q11-q13. Two novel transcripts located within 300 kilobases telomeric to the small nuclear ribonucleoprotein-associated polypeptide N gene (SNRPN) were paternally expressed in cultured cells, along with SNRPN, defining a large imprinted transcriptional domain. In three PWS patients (two sibs), small deletions remove a differentially methylated CpG island containing a newly described 5' exon alpha of SNRPN, and cause loss of expression for the three imprinted transcripts and altered methylation over hundreds of kilobases. The smallest PWS deletion is familial and asymptomatic with maternal transmission. Our data imply the presence of a paternal imprinting control region near exon alpha.	BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; ULLEVAL UNIV HOSP,DEPT MED GENET,OSLO,NORWAY; JOHN F KENNEDY INST,DANISH CTR HUMAN GENOME RES,DK-2600 GLOSTRUP,DENMARK; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; University of Oslo; Aarhus University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)			Tommerup, Niels/T-8776-2017; Sutcliffe, James/C-1348-2012	Tommerup, Niels/0000-0003-2304-0112; Sutcliffe, James/0000-0001-5200-6007	NHGRI NIH HHS [HG00210] Funding Source: Medline; NICHD NIH HHS [HD20619] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020619] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; Bartolomei M.S., 1992, SEMIN DEV BIOL, V3, P107; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLAYTONSMITH J, 1992, AM J MED GENET, V44, P256, DOI 10.1002/ajmg.1320440236; DITTRICH B, 1992, HUM GENET, V90, P313; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; HOLM VA, 1993, PEDIATRICS, V91, P398; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KUWANO A, 1991, AM J HUM GENET, V49, P707; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MCALLISTER G, 1988, P NATL ACAD SCI USA, V85, P5296, DOI 10.1073/pnas.85.14.5296; MEIJERSHEIJBOER EJ, 1992, J MED GENET, V29, P853, DOI 10.1136/jmg.29.12.853; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; ORSTAVIK KH, 1992, AM J MED GENET, V44, P534; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; PETTIGREW AL, 1987, AM J MED GENET, V28, P791, DOI 10.1002/ajmg.1320280403; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; REIS A, 1994, AM J HUM GENET, V54, P741; REIS A, 1993, LANCET, V341, P122, DOI 10.1016/0140-6736(93)92606-T; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; ROKEACH LA, 1989, J BIOL CHEM, V264, P5024; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; SCHMAUSS C, 1989, NUCLEIC ACIDS RES, V17, P1733, DOI 10.1093/nar/17.4.1733; SCHMAUSS C, 1992, J BIOL CHEM, V267, P8521; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; Smith C.L., 1988, P41; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUTCLIFFE JS, 1992, GENOMICS, V13, P1303, DOI 10.1016/0888-7543(92)90051-S; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61; ZOGHBI HY, 1989, AM J HUM GENET, V44, P255	48	365	370	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					52	58		10.1038/ng0994-52	http://dx.doi.org/10.1038/ng0994-52			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987392				2022-12-17	WOS:A1994PE15700015
J	JOHNSON, LG; OLSEN, JC; SARKADI, B; MOORE, KL; SWANSTROM, R; BOUCHER, RC				JOHNSON, LG; OLSEN, JC; SARKADI, B; MOORE, KL; SWANSTROM, R; BOUCHER, RC			EFFICIENCY OF GENE-TRANSFER FOR RESTORATION OF NORMAL AIRWAY EPITHELIAL FUNCTION IN CYSTIC-FIBROSIS	NATURE GENETICS			English	Article							INTERCELLULAR COMMUNICATION; RESPIRATORY EPITHELIUM; ION PERMEABILITY; CELL-MEMBRANE; TRANSPORT; JUNCTIONS; INVITRO; CULTURE	An important issue for in vivo gene therapy for cystic fibrosis (CF) is the percentage of cells within the CF airway that will require correction. In this study, we mixed populations of a CF airway cell line expressing either the normal cystic fibrosis transmembrane conductance regulator (CFTR) cDNA (corrected cells) or a reporter gene in defined percentages. As few as 6-1 0% corrected cells within an epithelial sheet generated Cl-transport properties similar to sheets comprised of 1 00% corrected cells. Cell-cell coupling may serve as the mechanism for amplification of the functional effects of corrected cells. These data suggest that in vivo correction of all CF airway cells may not be mandatory.	UNIV N CAROLINA,DEPT BIOCHEM,CHAPEL HILL,NC 27599; UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599; NATL INST HAEMATOL & BLOOD TRANSFUS,BUDAPEST,HUNGARY	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	JOHNSON, LG (corresponding author), UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27599, USA.		Sarkadi, Balazs/I-5024-2013					Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; CARSON JL, 1989, AM J RESP CELL MOL, V1, P385, DOI 10.1165/ajrcmb/1.5.385; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; COTTON CU, 1987, J CLIN INVEST, V79, P80, DOI 10.1172/JCI112812; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; FLAGGNEWTON J, 1979, SCIENCE, V205, P404, DOI 10.1126/science.377490; INOUE S, 1974, LAB INVEST, V31, P68; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; OLSEN JC, 1992, HUM GENE THER, V3, P253, DOI 10.1089/hum.1992.3.3-253; QUINTON PM, 1983, NEW ENGL J MED, V308, P1185, DOI 10.1056/NEJM198305193082002; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; SANDERSON MJ, 1988, AM J PHYSIOL, V254, pC63, DOI 10.1152/ajpcell.1988.254.1.C63; SARKADI B, 1992, J BIOL CHEM, V267, P2087; SCHNEEBERGER EE, 1978, J CELL SCI, V32, P307; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC1045, DOI 10.1152/ajpcell.1989.256.5.C1045; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC1033, DOI 10.1152/ajpcell.1989.256.5.C1033; Willumsen NJ, 1989, AM J PHYSIOL, V256, pC1054, DOI 10.1152/ajpcell.1989.256.5.C1054; YANKASKAS JR, 1985, LANCET, V1, P954	24	365	373	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					21	25		10.1038/ng0992-21	http://dx.doi.org/10.1038/ng0992-21			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1284642				2022-12-17	WOS:A1992JM64600010
J	Azizan, EAB; Poulsen, H; Tuluc, P; Zhou, J; Clausen, MV; Lieb, A; Maniero, C; Garg, S; Bochukova, EG; Zhao, W; Shaikh, LH; Brighton, CA; Teo, AED; Davenport, AP; Dekkers, T; Tops, B; Kuusters, B; Ceral, J; Yeo, GSH; Neogi, SG; McFarlane, I; Rosenfeld, N; Marass, F; Hadfield, J; Margas, W; Chaggar, K; Solar, M; Deinum, J; Dolphin, AC; Farooqi, IS; Striessnig, J; Nissen, P; Brown, MJ				Azizan, Elena A. B.; Poulsen, Hanne; Tuluc, Petronel; Zhou, Junhua; Clausen, Michael V.; Lieb, Andreas; Maniero, Carmela; Garg, Sumedha; Bochukova, Elena G.; Zhao, Wanfeng; Shaikh, Lalarukh Haris; Brighton, Cheryl A.; Teo, Ada E. D.; Davenport, Anthony P.; Dekkers, Tanja; Tops, Bas; Kuesters, Benno; Ceral, Jiri; Yeo, Giles S. H.; Neogi, Sudeshna Guha; McFarlane, Ian; Rosenfeld, Nitzan; Marass, Francesco; Hadfield, James; Margas, Wojciech; Chaggar, Kanchan; Solar, Miroslav; Deinum, Jaap; Dolphin, Annette C.; Farooqi, I. Sadaf; Striessnig, Joerg; Nissen, Poul; Brown, Morris J.			Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension	NATURE GENETICS			English	Article							ALDOSTERONE-PRODUCING ADENOMAS; ZONA GLOMERULOSA; CA2+ CHANNELS; CALCIUM-PUMP; CELLS; OUABAIN; INHIBITION; PREVALENCE; SARCOLIPIN; POTASSIUM	At least 5% of individuals with hypertension have adrenal aldosterone-producing adenomas (APAs). Gain-of-function mutations in KCNJ5 and apparent loss-of-function mutations in ATP1A1 and ATP2A3 were reported to occur in APAs(1,2). We find that KCNJ5 mutations are common in APAs resembling cortisol-secreting cells of the adrenal zona fasciculata but are absent in a subset of APAs resembling the aldosterone-secreting cells of the adrenal zona glomerulosa(3). We performed exome sequencing of ten zona glomerulosa-like APAs and identified nine with somatic mutations in either ATP1A1, encoding the Na+/K+ ATPase alpha 1 subunit, or CACNA1D, encoding Ca(v)1.3. The ATP1A1 mutations all caused inward leak currents under physiological conditions, and the CACNA1D mutations induced a shift of voltage-dependent gating to more negative voltages, suppressed inactivation or increased currents. Many APAs with these mutations were <1 cm in diameter and had been overlooked on conventional adrenal imaging. Recognition of the distinct genotype and phenotype for this subset of APAs could facilitate diagnosis.	[Azizan, Elena A. B.; Zhou, Junhua; Maniero, Carmela; Garg, Sumedha; Bochukova, Elena G.; Shaikh, Lalarukh Haris; Brighton, Cheryl A.; Teo, Ada E. D.; Davenport, Anthony P.; Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Ctr Clin Invest, Clin Pharmacol Unit, Cambridge, England; [Poulsen, Hanne; Clausen, Michael V.; Nissen, Poul] Aarhus Univ, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Disease PUMPkin, Dept Mol Biol & Genet, Aarhus, Denmark; [Tuluc, Petronel; Lieb, Andreas; Striessnig, Joerg] Univ Innsbruck, Ctr Mol Biosci, Inst Pharm, A-6020 Innsbruck, Austria; [Garg, Sumedha; Bochukova, Elena G.; Yeo, Giles S. H.; Farooqi, I. Sadaf] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [Zhao, Wanfeng] Univ Cambridge, Addenbrookes Hosp, Fdn Trust, Hosp Natl Hlth Serv NHS,Human Res Tissue Bank, Cambridge CB2 2QQ, England; [Dekkers, Tanja; Deinum, Jaap] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Tops, Bas; Kuesters, Benno] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Ceral, Jiri; Solar, Miroslav] Charles Univ Prague, Fac Med Hradec Kralove, Dept Internal Med Cardioangiol 1, Hradec Kralove, Czech Republic; [Ceral, Jiri; Solar, Miroslav] Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Neogi, Sudeshna Guha; McFarlane, Ian] Addenbrookes Hosp, BRC, Cambridge Natl Inst Hlth Res NIHR, Dept Clin Biochem, Cambridge, England; [Rosenfeld, Nitzan; Marass, Francesco; Hadfield, James] Univ Cambridge, Li Ka Shing Ctr, Cancer Res UK Cambridge Inst, Cambridge, England; [Margas, Wojciech; Chaggar, Kanchan; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Aarhus University; Danmarks Grundforskningsfond; University of Innsbruck; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Radboud University Nijmegen; Radboud University Nijmegen; Charles University Prague; University Hospital Hradec Kralove; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; University College London	Brown, MJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Ctr Clin Invest, Clin Pharmacol Unit, Cambridge, England.	hp@mb.au.dk; m.j.brown@cai.cam.ac.uk	Dekkers, Tanja/H-3335-2015; Davenport, Anthony P./A-5773-2008; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Ceral, Jiří/P-6863-2017; Deinum, J./L-4261-2015; Dolphin, Annette C/F-7416-2010; Marass, Francesco/U-5220-2019; Striessnig, Joerg/S-9334-2017; Zhou, Junhua/E-3528-2016; O'Rahilly, Stephen/ABF-6509-2020; Solar, Miroslav/Q-1707-2017; Tops, Bastiaan/L-4697-2015	Dekkers, Tanja/0000-0002-5091-7779; Davenport, Anthony P./0000-0002-2096-3117; Ceral, Jiří/0000-0002-2636-7551; Deinum, J./0000-0003-2465-1986; Dolphin, Annette C/0000-0003-4626-4856; Marass, Francesco/0000-0002-8993-7320; Striessnig, Joerg/0000-0002-9406-7120; Zhou, Junhua/0000-0002-8593-8393; O'Rahilly, Stephen/0000-0003-2199-4449; Solar, Miroslav/0000-0002-5542-552X; Bochukova, Elena/0000-0003-0275-1548; Teo, Ada/0000-0002-8832-0409; Tuluc, Petronel/0000-0003-3660-6138; Brighton, Cheryl/0000-0002-4662-6274; Tops, Bastiaan/0000-0002-1699-8210; Yeo, Giles See How/0000-0001-8823-3615; Lieb, Andreas/0000-0001-9567-649X; Farooqi, Sadaf/0000-0001-7609-3504; Nissen, Poul/0000-0003-0948-6628; Voldsgaard Clausen, Michael/0000-0002-7176-5524	NIHR Cambridge BRC; British Heart Foundation [PG/07/085/23349]; Wellcome Trust [085686/Z/08/A, 098360/Z/12/Z]; NIHR Cambridge Biomedical Research Centre (Cardiovascular); NIHR Senior Investigator award; Austin Doyle Award; Servier Australia; Wellcome Trust PhD program in Metabolic and Cardiovascular Disease; Cambridge Overseas Trust; Sun Hung Kai Properties-Kwoks' Foundation PhD program; European Union [FP7-HEALTH-2009-241592 EurOCHIP, FP7-FOOD-266408 Full4Health]; The Carlsberg Foundation; The Lundbeck Foundation; L'Oreal/UNESCO; Austrian Science Fund [F44020]; University College London, UK; program PRVOUK [P037/03]; MRC [G0600717, MC_UU_12012/1, MC_UU_12012/5] Funding Source: UKRI; British Heart Foundation [FS/11/35/28871] Funding Source: researchfish; Cancer Research UK [11906, 22310] Funding Source: researchfish; Medical Research Council [MC_UU_12012/5, G0600717B, MC_UU_12012/1, MC_UU_12012/5/B, MR/K501050/1, G0600717] Funding Source: researchfish	NIHR Cambridge BRC; British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Cambridge Biomedical Research Centre (Cardiovascular); NIHR Senior Investigator award; Austin Doyle Award; Servier Australia(Servier); Wellcome Trust PhD program in Metabolic and Cardiovascular Disease; Cambridge Overseas Trust; Sun Hung Kai Properties-Kwoks' Foundation PhD program; European Union(European Commission); The Carlsberg Foundation(Carlsberg Foundation); The Lundbeck Foundation(Lundbeckfonden); L'Oreal/UNESCO; Austrian Science Fund(Austrian Science Fund (FWF)); University College London, UK; program PRVOUK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Cambridge, UK. We are grateful to M. Gurnell for discussion and care of many of the patients, to N. Jamieson for all the laparoscopic adrenalectomies and to A. Marker for pathological diagnosis. We thank Dr. Yasmin for providing peripheral DNA samples from healthy, normotensive subjects. We thank R. Kuc and the Human Research Tissue Bank of Addenbrooke's Hospital, which is supported by the NIHR Cambridge BRC, for help with storage of fresh adrenal tissue for the Cambridge cohort; we particularly acknowledge B. Haynes, D. Walters, K. Brown, M. Elazoui, C. Karpinskyj, M. Bromwich and K. Payne. The work was funded by the British Heart Foundation (PG/07/085/23349), the Wellcome Trust (085686/Z/08/A), the NIHR Cambridge Biomedical Research Centre (Cardiovascular) and an NIHR Senior Investigator award to M.J.B. The work was also supported by the Austin Doyle Award funded by Servier Australia (to E. A. B. A.). C. A. B. is supported by the Wellcome Trust PhD program in Metabolic and Cardiovascular Disease. J.Z. is supported by the Cambridge Overseas Trust and the Sun Hung Kai Properties-Kwoks' Foundation PhD program. G.S.H.Y. was supported by European Union FP7-HEALTH-2009-241592 EurOCHIP and FP7-FOOD-266408 Full4Health. Aarhus, Denmark. We thank J. Egebjerg Jensen for discussion of the electrophysiology data. H. P. was supported by grants from The Carlsberg Foundation, The Lundbeck Foundation and L'Oreal/UNESCO. University of Innsbruck, Austria. The work was supported by the Austrian Science Fund (F44020). University College London, UK. We thank W. Pratt for technical assistance. The work was supported by the Wellcome Trust (098360/Z/12/Z). Hradec Kralove, Czech Republic. We thank A. Ryska, who selected the most appropriate adrenal samples for the Czech cohort. Funding is provided by program PRVOUK P037/03. Nijmegen, The Netherlands. We thank J. W. M. Lenders for introducing the collaboration and for his leading role in the recruitment of the Dutch cohort.	Azizan EAB, 2012, J CLIN ENDOCR METAB, V97, pE819, DOI 10.1210/jc.2011-2965; Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Boulkroun S, 2012, HYPERTENSION, V59, P592, DOI 10.1161/HYPERTENSIONAHA.111.186478; BRALEY LM, 1978, ENDOCRINOLOGY, V103, P1997, DOI 10.1210/endo-103-6-1997; Brown MJ, 1999, POSTGRAD MED J, V75, P235, DOI 10.1136/pgmj.75.882.235; Burton TJ, 2012, J CLIN ENDOCR METAB, V97, P100, DOI 10.1210/jc.2011-1537; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; CUSHMAN P, 1969, ENDOCRINOLOGY, V84, P808, DOI 10.1210/endo-84-4-808; EFTHYMIADIS A, 1993, CELL BIOL INT, V17, P1107, DOI 10.1006/cbir.1993.1043; Funder JW, 2012, HYPERTENSION, V59, P537, DOI 10.1161/HYPERTENSIONAHA.111.187682; Hemara-Wahanui A, 2005, P NATL ACAD SCI USA, V102, P7553, DOI 10.1073/pnas.0501907102; Hoda JC, 2005, J NEUROSCI, V25, P252, DOI 10.1523/JNEUROSCI.3054-04.2005; Kau MM, 2005, J CELL PHYSIOL, V205, P393, DOI 10.1002/jcp.20415; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Lee G, 2005, ENDOCRINOLOGY, V146, P2650, DOI 10.1210/en.2004-1102; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; Mazzocchi G, 2004, PEPTIDES, V25, P1269, DOI 10.1016/j.peptides.2004.05.011; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nishimoto K, 2010, J CLIN ENDOCR METAB, V95, P2296, DOI 10.1210/jc.2009-2010; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Rossi GP, 2011, NAT REV ENDOCRINOL, V7, P485, DOI 10.1038/nrendo.2011.76; Shigematsu K, 2009, ENDOCR PATHOL, V20, P66, DOI 10.1007/s12022-009-9060-8; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Vasilyev A, 2004, J MEMBRANE BIOL, V198, P65, DOI 10.1007/s00232-004-0660-4; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Wolkersdorfer GW, 1996, J CLIN ENDOCR METAB, V81, P4129, DOI 10.1210/jc.81.11.4129; Yingst DR, 1999, METABOLISM, V48, P1167, DOI 10.1016/S0026-0495(99)90133-6	31	364	373	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2013	45	9					1055	+		10.1038/ng.2716	http://dx.doi.org/10.1038/ng.2716			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	209ID	23913004				2022-12-17	WOS:000323748200016
J	Imielinski, M; Baldassano, RN; Griffiths, A; Russell, RK; Annese, V; Dubinsky, M; Kugathasan, S; Bradfield, JP; Walters, TD; Sleiman, P; Kim, CE; Muise, A; Wang, K; Glessner, JT; Saeed, S; Zhang, HT; Frackelton, EC; Hou, CP; Flory, JH; Otieno, G; Chiavacci, RM; Grundmeier, R; Castro, M; Latiano, A; Dallapiccola, B; Stempak, J; Abrams, DJ; Taylor, K; McGovern, D; Heyman, MB; Ferry, GD; Kirschner, B; Lee, J; Essers, J; Grand, R; Stephens, M; Levine, A; Piccoli, D; Van Limbergen, J; Cucchiara, S; Monos, DS; Guthery, SL; Denson, L; Wilson, DC; Grant, SFA; Daly, M; Silverberg, MS; Satsangi, J; Hakonarson, H				Imielinski, Marcin; Baldassano, Robert N.; Griffiths, Anne; Russell, Richard K.; Annese, Vito; Dubinsky, Marla; Kugathasan, Subra; Bradfield, Jonathan P.; Walters, Thomas D.; Sleiman, Patrick; Kim, Cecilia E.; Muise, Aleixo; Wang, Kai; Glessner, Joseph T.; Saeed, Shehzad; Zhang, Haitao; Frackelton, Edward C.; Hou, Cuiping; Flory, James H.; Otieno, George; Chiavacci, Rosetta M.; Grundmeier, Robert; Castro, Massimo; Latiano, Anna; Dallapiccola, Bruno; Stempak, Joanne; Abrams, Debra J.; Taylor, Kent; McGovern, Dermot; Heyman, Melvin B.; Ferry, George D.; Kirschner, Barbara; Lee, Jessica; Essers, Jonah; Grand, Richard; Stephens, Michael; Levine, Arie; Piccoli, David; Van Limbergen, Johan; Cucchiara, Salvatore; Monos, Dimitri S.; Guthery, Stephen L.; Denson, Lee; Wilson, David C.; Grant, Struan F. A.; Daly, Mark; Silverberg, Mark S.; Satsangi, Jack; Hakonarson, Hakon		Western Reg Res Alliance Pediat IB; Int IBD Genetics Consortium	Common variants at five new loci associated with early-onset inflammatory bowel disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; SEQUENCE VARIANTS; GENE; EXPRESSION; CONTRIBUTE; AUTOPHAGY; MULTIPLE; HISTORY	The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis are common causes of morbidity in children and young adults in the western world. Here we report the results of a genome-wide association study in early-onset IBD involving 3,426 affected individuals and 11,963 genetically matched controls recruited through international collaborations in Europe and North America, thereby extending the results from a previous study of 1,011 individuals with early-onset IBD1. We have identified five new regions associated with early-onset IBD susceptibility, including 16p11 near the cytokine gene IL27 (rs8049439, P = 2.41 x 10(-9)), 22q12 (rs2412973, P = 1.55 x 10(-9)), 10q22 (rs1250550, P = 5.63 x 10(-9)), 2q37 (rs4676410, P = 3.64 x 10(-8)) and 19q13.11 (rs10500264, P = 4.26 x 10(-10)). Our scan also detected associations at 23 of 32 loci previously implicated in adult-onset Crohn's disease and at 8 of 17 loci implicated in adult-onset ulcerative colitis, highlighting the close pathogenetic relationship between early- and adult-onset IBD.	[Imielinski, Marcin; Bradfield, Jonathan P.; Sleiman, Patrick; Kim, Cecilia E.; Wang, Kai; Glessner, Joseph T.; Zhang, Haitao; Frackelton, Edward C.; Hou, Cuiping; Flory, James H.; Otieno, George; Chiavacci, Rosetta M.; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Baldassano, Robert N.; Grundmeier, Robert; Piccoli, David; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Baldassano, Robert N.; Abrams, Debra J.; Piccoli, David] Childrens Hosp Philadelphia, Div Gastroenterol, Philadelphia, PA 19104 USA; [Griffiths, Anne; Walters, Thomas D.; Muise, Aleixo] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Russell, Richard K.] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland; [Annese, Vito] CSS, IRCCS, Dept Med Sci, Gastroenterol Unit, San Giovanni Rotondo, Italy; [Dubinsky, Marla] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Dubinsky, Marla; Taylor, Kent; McGovern, Dermot] Cedars Sinai Med Ctr, Dept Common Dis Genet, Los Angeles, CA 90048 USA; [Kugathasan, Subra] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Kugathasan, Subra] Childrens Hlth Care Atlanta, Atlanta, GA USA; [Saeed, Shehzad] Univ Alabama, Dept Pediat, Birmingham, AL USA; [Grundmeier, Robert] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Castro, Massimo; Latiano, Anna] Bambino Gesu Pediat Hosp, Gastroenterol Unit, Rome, Italy; [Dallapiccola, Bruno] Univ Roma La Sapienza, Mendel Inst, IRCCS, CSS Hosp, San Giovanni Rotondo, Italy; [Stempak, Joanne; Silverberg, Mark S.] Univ Toronto, Mt Sinai Hosp, Ctr Inflammatory Bowel Dis, Toronto, ON M5G 1X5, Canada; [Heyman, Melvin B.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Ferry, George D.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Kirschner, Barbara] Univ Chicago, Comer Childrens Hosp, Chicago, IL 60637 USA; [Lee, Jessica; Essers, Jonah; Grand, Richard] Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Stephens, Michael] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Levine, Arie] Tel Aviv Univ, Wolfson Med Ctr, Pediat Gastroenterol Unit, IL-69978 Tel Aviv, Israel; [Van Limbergen, Johan; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Div Med Sci,Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Cucchiara, Salvatore] Univ Roma La Sapienza, Pediat Gastroenterol & Liver Unit, Rome, Italy; [Monos, Dimitri S.] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA; [Guthery, Stephen L.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Guthery, Stephen L.] Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA; [Denson, Lee] Cincinnati Childrens Hosp, Med Ctr, Div Gastroenterol, Ctr Inflammatory Bowel Dis, Cincinnati, OH USA; [Wilson, David C.] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Daly, Mark] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Glasgow; IRCCS Casa Sollievo Della Sofferenza; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Emory University; Children's Healthcare of Atlanta (CHOA); University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; IRCCS Bambino Gesu; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of California System; University of California San Francisco; Baylor College of Medicine; University of Chicago; Harvard University; Boston Children's Hospital; Medical College of Wisconsin; Tel Aviv University; University of Edinburgh; Sapienza University Rome; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Utah System of Higher Education; University of Utah; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Massachusetts General Hospital	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Rioux, John D/A-9599-2015; Silverberg, Mark/B-4183-2008; Annese, Vito/AGW-4200-2022; Van Limbergen, Johan/L-1855-2019; Saeed, Shehzad/R-8534-2019; Prescott, Natalie J/F-6490-2011; Latiano, Anna/R-1965-2016; Saeed, Shehzad/AGD-6642-2022; Daly, Mark J/B-2453-2017; Duerr, Richard H/B-4188-2009; Dallapiccola, Bruno/K-8692-2016; Cucchiara, Salvatore/K-1628-2016	Rioux, John D/0000-0001-7560-8326; Annese, Vito/0000-0002-0082-892X; Van Limbergen, Johan/0000-0001-5822-4371; Prescott, Natalie J/0000-0002-5901-7371; Latiano, Anna/0000-0003-3719-2061; Daly, Mark J/0000-0002-0949-8752; Duerr, Richard H/0000-0001-6586-3905; Dallapiccola, Bruno/0000-0002-5031-1013; Parkes, Miles/0000-0002-6467-0631; Grant, Struan/0000-0003-2025-5302; Hugot, Jean-Pierre/0000-0002-8446-6056; Cucchiara, Salvatore/0000-0002-2939-9698; Laukens, Debby/0000-0002-1984-5850; Georges, Michel/0000-0003-4124-2375; Glessner, Joseph/0000-0001-5131-2811; Kirschner, Barbara/0000-0003-4640-2438; Schumm, Phil/0000-0002-3050-2429	Children's Hospital of Philadelphia; Primary Children's Medical Center Foundation; National Center for Research Resources [DK069513, M01-RR00064, M01 RR002172-26, C06-RR11234]; NIH/NIDDK [DK062423]; Gale and Graham Wright Research Chair in Digestive Diseases; Canadian Association of Gastroenterology (CAG); Crohn's Colitis Foundation of Canada (CCFC); Canadian Institutes of Health Research (CIHR); Astra-Zeneca; CCFC/CAG/CIHR Transition Award; Canadian Child Health Clinician Scientist Program (CCHCSP); Children's Hospital Boston; NIDDK [DK069513, T32 DK007477]; NCRR [M01-RR00064, C06-RR11234]; Action Medical Research; Gay-Ramsay-SteelMaitland or Stafford Trust; Hazel M Wood Charitable Trust; Medical Research Council Patient Cohorts Research Initiative award [G0800675]; Wellcome Trust Programme Grant [072789/Z/03/Z]; Chief Scientist Office of the Scottish Government Health Department; University of Edinburgh Medical Faculty Fellowship; GI/Nutrition Research Fund; Child Life and Health; University of Edinburgh; MRC [G0800675, G0600329, G0800759] Funding Source: UKRI; Medical Research Council [G0800675, G0800759, G0600329] Funding Source: researchfish; Chief Scientist Office [CZB/4/540] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064, C06RR011234, M01RR002172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007477, K23DK069513, U01DK062423, P30DK040561, U01DK062420, K24DK060617, U01DK062413, P30DK043351] Funding Source: NIH RePORTER	Children's Hospital of Philadelphia; Primary Children's Medical Center Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Gale and Graham Wright Research Chair in Digestive Diseases; Canadian Association of Gastroenterology (CAG); Crohn's Colitis Foundation of Canada (CCFC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Astra-Zeneca(AstraZeneca); CCFC/CAG/CIHR Transition Award(Canadian Institutes of Health Research (CIHR)); Canadian Child Health Clinician Scientist Program (CCHCSP); Children's Hospital Boston; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Action Medical Research; Gay-Ramsay-SteelMaitland or Stafford Trust; Hazel M Wood Charitable Trust; Medical Research Council Patient Cohorts Research Initiative award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Programme Grant(Wellcome Trust); Chief Scientist Office of the Scottish Government Health Department; University of Edinburgh Medical Faculty Fellowship; GI/Nutrition Research Fund; Child Life and Health; University of Edinburgh; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all participating subjects and families. We thank the medical assistants, nursing staff and clinicians at CHOP who assisted with the recruitment of control subjects, which made this work possible; and members of the International HapMap and Wellcome Trust Case Control Consortiums for publicly providing data that were critically important for part of our analyses. The following physicians of the SIGENP (Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition) contributed by providing DNA samples and clinical information from their patients: A. Andriulli, M. R. Valvano, O. Palmieri, F. Bossa, E. Colombo, M. Pastore, M. D'Altilia, O. Borrelli, C. Bascietto, A. Ferraris, B. Papadatou, A. Diamanti, P. Lionetti, E. Pozzi, A. Barabino, A. Calvi, G. L. de' Angelis, G. Guariso, V. Lodde, G. Vieni, C. Sferlazzas, S. Accomando, G. Iacono, E. Berni Canani, A. M. Staiano, V. Rutigliano, D. De Venuto, C. Romano, G. Lombardi, S. Nobile, C. Catassi and A. Campanozzi. The following physicians of SPGHANG (Scottish Pediatric Gastroenterology, Hepatology and Nutrition Group) contributed by providing DNA samples and clinical information from their patients: W. M. Bisset, P. M. Gillett, G. Mahdi and P. McGrogan. This research was supported by the Children's Hospital of Philadelphia, the Primary Children's Medical Center Foundation and grants DK069513, M01-RR00064, M01 RR002172-26 and C06-RR11234 from the National Center for Research Resources. All genomewide genotyping was funded by an Institute Development Award from the Children's Hospital of Philadelphia. M. S. is funded by NIH/NIDDK grant DK062423 and the Gale and Graham Wright Research Chair in Digestive Diseases. T. W. received fellowship funding support jointly from the Canadian Association of Gastroenterology (CAG), Crohn's Colitis Foundation of Canada (CCFC), Canadian Institutes of Health Research (CIHR) and Astra-Zeneca. A. M. received a CCFC/CAG/CIHR Transition Award and Canadian Child Health Clinician Scientist Program (CCHCSP) Award for training. J. L. received Junior Faculty Development Award from Children's Hospital Boston. J. E. is supported by a Training grant (T32 DK007477) from NIDDK. S. L. G. received support from the Primary Children's Medical Center Foundation, NIDDK (DK069513) and NCRR (M01-RR00064 and C06-RR11234). J. V. L. was funded by a Research Training Fellowship from Action Medical Research, the Gay-Ramsay-SteelMaitland or Stafford Trust and the Hazel M Wood Charitable Trust. D. C. W. is the holder of a Medical Research Council Patient Cohorts Research Initiative award (G0800675). Financial assistance was also provided by a Wellcome Trust Programme Grant (072789/Z/03/Z), the Chief Scientist Office of the Scottish Government Health Department, a University of Edinburgh Medical Faculty Fellowship and the GI/Nutrition Research Fund, Child Life and Health, University of Edinburgh.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081; Vernier-Massouille G, 2008, GASTROENTEROLOGY, V135, P1106, DOI 10.1053/j.gastro.2008.06.079	24	364	373	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2009	41	12					1335	U107		10.1038/ng.489	http://dx.doi.org/10.1038/ng.489			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	524LN	19915574	Green Published, Green Accepted, Green Submitted			2022-12-17	WOS:000272144900017
J	Baltus, AE; Menke, DB; Hu, YC; Goodheart, ML; Carpenter, AE; de Rooij, DG; Page, DC				Baltus, Andrew E.; Menke, Douglas B.; Hu, Yueh-Chiang; Goodheart, Mary L.; Carpenter, Anne E.; de Rooij, Dirk G.; Page, David C.			In germ cells of mouse embryonic ovaries, the decision to enter meiosis precedes premeiotic DNA replication	NATURE GENETICS			English	Article							CHROMOSOME SYNAPSIS; PROTEIN; OOGENESIS; TESTIS; GENE	The transition from mitosis to meiosis is a defining juncture in the life cycle of sexually reproducing organisms. In yeast, the decision to enter meiosis is made before the single round of DNA replication that precedes the two meiotic divisions(1). We present genetic evidence of an analogous decision point in the germ line of a multicellular organism. The mouse Stra8 gene is expressed in germ cells of embryonic ovaries, where meiosis is initiated, but not in those of embryonic testes, where meiosis does not begin until after birth(2). Here we report that in female embryos lacking Stra8 gene function, the early, mitotic development of germ cells is normal, but these cells then fail to undergo premeiotic DNA replication, meiotic chromosome condensation, cohesion, synapsis and recombination. Combined with previous findings, these genetic data suggest that active differentiation of ovarian germ cells commences at a regulatory point upstream of premeiotic DNA replication.	MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Utrecht, Fac Biol, Dept Endocrinol, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Med Ctr, Dept Cell Biol, NL-3584 CH Utrecht, Netherlands	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Utrecht University; Utrecht University	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	page_admin@wi.mit.edu	de Rooij, D.G./AAW-1195-2021; Holt, Janet E/B-2415-2013; Carpenter, Anne/C-4982-2008; Hu, Yueh-Chiang/AAX-2370-2020	Carpenter, Anne/0000-0003-1555-8261; de Rooij, Dirk/0000-0003-3932-4419; Menke, Douglas/0000-0002-7109-1451; Hu, Yueh-Chiang/0000-0002-7992-0525				Adams IR, 2002, DEVELOPMENT, V129, P1155; Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Bannister LA, 2004, GENESIS, V40, P184, DOI 10.1002/gene.20085; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; CRONE M, 1965, EXP CELL RES, V39, P678, DOI 10.1016/0014-4827(65)90071-6; DEVICTOR M, 1979, J GENET HUM, V27, P21; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Fujiwara S, 2003, ZOOL SCI, V20, P809, DOI 10.2108/zsj.20.809; HARTUNG M, 1977, CYTOGENET CELL GENET, V18, P309, DOI 10.1159/000130777; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Lee J, 2003, J CELL SCI, V116, P2781, DOI 10.1242/jcs.00495; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; MOENS PB, 1995, CHROMOSOMA, V104, P175, DOI 10.1007/BF00352182; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Prieto I, 2004, CHROMOSOME RES, V12, P197, DOI 10.1023/B:CHRO.0000021945.83198.0e; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; SPEED RM, 1982, CHROMOSOMA, V85, P427, DOI 10.1007/BF00330366; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yao HHC, 2003, DEVELOPMENT, V130, P5895, DOI 10.1242/dev.00836; YOSHIDA N, 1998, REC RES DEV FERMEN 1, V1, P1; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	30	364	387	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1430	1434		10.1038/ng1919	http://dx.doi.org/10.1038/ng1919			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17115059				2022-12-17	WOS:000242404200021
J	Keshet, I; Schlesinger, Y; Farkash, S; Rand, E; Hecht, M; Segal, E; Pikarski, E; Young, RA; Niveleau, A; Cedar, H; Simon, I				Keshet, I; Schlesinger, Y; Farkash, S; Rand, E; Hecht, M; Segal, E; Pikarski, E; Young, RA; Niveleau, A; Cedar, H; Simon, I			Evidence for an instructive mechanism of de novo methylation in cancer cells	NATURE GENETICS			English	Article							DNA METHYLATION; CPG-ISLAND; DEVELOPMENTAL PATTERN; PROMOTER METHYLATION; ABERRANT METHYLATION; GENE-EXPRESSION; MOUSE EMBRYO; HYPERMETHYLATION; SITES; RECRUITMENT	DNA methylation has a role in the regulation of gene expression during normal mammalian development but can also mediate epigenetic silencing of CpG island genes in cancer and other diseases. Many individual genes ( including tumor suppressors) have been shown to undergo de novo methylation in specific tumor types, but the biological logic inherent in this process is not understood. To decipher this mechanism, we have adopted a new approach for detecting CpG island DNA methylation that can be used together with microarray technology. Genome-wide analysis by this technique demonstrated that tumor-specific methylated genes belong to distinct functional categories, have common sequence motifs in their promoters and are found in clusters on chromosomes. In addition, many are already repressed in normal cells. These results are consistent with the hypothesis that cancer-related de novo methylation may come about through an instructive mechanism.	Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Mol Biol, Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Pathol, Jerusalem, Israel; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY USA; Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; Univ Grenoble 1, Lab Virol Struct & Mol, La Tronche, France	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Rockefeller University; Massachusetts Institute of Technology (MIT); Whitehead Institute; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Keshet, I (corresponding author), Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, Jerusalem, Israel.	cedar@md.huji.ac.il	pikarsky, eli/GXV-7099-2022; Young, Richard A/F-6495-2012; Segal, Eran/AAF-4855-2019	Young, Richard A/0000-0001-8855-8647; Simon, Itamar/0000-0002-8517-1903; Segal, Eran/0000-0002-6859-1164; pikarsky, eli/0000-0003-4186-7105	NHGRI NIH HHS [R01 HG002668-03, R01 HG002668] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ahuja N, 2000, HISTOL HISTOPATHOL, V15, P835, DOI 10.14670/HH-15.835; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chan AOO, 2002, AM J PATHOL, V160, P1823, DOI 10.1016/S0002-9440(10)61128-5; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Maruyama R, 2002, CLIN CANCER RES, V8, P514; MONK M, 1987, DEVELOPMENT, V99, P371; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Notterman DA, 2001, CANCER RES, V61, P3124; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Rush LJ, 2002, ANAL BIOCHEM, V307, P191, DOI 10.1016/S0003-2697(02)00033-7; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Smiraglia DJ, 2002, ONCOGENE, V21, P5414, DOI 10.1038/sj.onc.1205608; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 1999, CANCER RES, V59, P5438; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; VIRE E, 2005, NATURE          1214, DOI DOI 10.1038/NATURE04431; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Zardo G, 2002, NAT GENET, V32, P453, DOI 10.1038/ng1007	39	364	394	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					149	153		10.1038/ng1719	http://dx.doi.org/10.1038/ng1719			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16444255				2022-12-17	WOS:000234953200007
J	Larsson, P; Oyston, PCF; Chain, P; Chu, MC; Duffield, M; Fuxelius, HH; Garcia, E; Halltorp, G; Johansson, D; Isherwood, KE; Karp, PD; Larsson, E; Liu, Y; Michell, S; Prior, J; Prior, R; Malfatti, S; Sjostedt, A; Svensson, K; Thompson, N; Vergez, L; Wagg, JK; Wren, BW; Lindler, LE; Andersson, SGE; Forsman, M; Titball, RW				Larsson, P; Oyston, PCF; Chain, P; Chu, MC; Duffield, M; Fuxelius, HH; Garcia, E; Halltorp, G; Johansson, D; Isherwood, KE; Karp, PD; Larsson, E; Liu, Y; Michell, S; Prior, J; Prior, R; Malfatti, S; Sjostedt, A; Svensson, K; Thompson, N; Vergez, L; Wagg, JK; Wren, BW; Lindler, LE; Andersson, SGE; Forsman, M; Titball, RW			The complete genome sequence of Francisella tularensis, the causative agent of tularemia	NATURE GENETICS			English	Article							INTRACELLULAR INFECTION; METABOLIC PATHWAYS; GROWTH INITIATION; VIRULENCE FACTORS; GENE; IDENTIFICATION; ESCAPE; IRON; TRANSCRIPTION; PHAGOSOME	Francisella tularensis is one of the most infectious human pathogens known. In the past, both the former Soviet Union and the US had programs to develop weapons containing the bacterium. We report the complete genome sequence of a highly virulent isolate of F. tularensis (1,892, 819 bp). The sequence uncovers previously uncharacterized genes encoding type IV pili, a surface polysaccharide and iron-acquisition systems. Several virulence-associated genes were located in a putative pathogenicity island, which was duplicated in the genome. More than 10% of the putative coding sequences contained insertion-deletion or substitution mutations and seemed to be deteriorating. The genome is rich in IS elements, including IS630 Tc-1 mariner family transposons, which are not expected in a prokaryote. We used a computational method for predicting metabolic pathways and found an unexpectedly high proportion of disrupted pathways, explaining the fastidious nutritional requirements of the bacterium. The loss of biosynthetic pathways indicates that F. tularensis is an obligate host-dependent bacterium in its natural life cycle. Our results have implications for our understanding of how highly virulent human pathogens evolve and will expedite strategies to combat them.	Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, Livermore, CA 94550 USA; Def Sci & Technol Lab, Salisbury SP4 0JQ, Wilts, England; Swedish Def Res Agcy, SE-90182 Umea, Sweden; Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA; Uppsala Univ, Dept Mol Evolut, S-75236 Uppsala, Sweden; SRI Int, Bioinformat Res Grp, Menlo Pk, CA 94025 USA; Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; Umea Univ, Dept Clin Microbiol, SE-90185 Umea, Sweden; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Defence Science & Technology Laboratory; Saab Group; Centers for Disease Control & Prevention - USA; Uppsala University; SRI International; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Umea University; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine	Titball, RW (corresponding author), Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, Livermore, CA 94550 USA.	rtitball@dstl.gov.uk	Forsman, Mats/A-1426-2016; Sjöstedt, Anders/AAC-6575-2020; chain, patrick/B-9777-2013; Chain, Patrick/O-4140-2019; Karp, Peter/C-3514-2012	Forsman, Mats/0000-0002-4466-5325; Sjöstedt, Anders/0000-0002-0768-8405; Chain, Patrick/0000-0003-3949-3634; Malfatti, Stephanie/0000-0003-4225-9857; Karp, Peter/0000-0002-5876-6418				Andersson B, 1996, ANAL BIOCHEM, V236, P107, DOI 10.1006/abio.1996.0138; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; BHATNAGAR NB, 1995, INFECT IMMUN, V63, P154, DOI 10.1128/IAI.63.1.154-159.1995; BORK P, 1994, PROTEIN SCI, V3, P1344, DOI 10.1002/pro.5560030821; Canback B, 2004, MOL BIOL EVOL, V21, P1110, DOI 10.1093/molbev/msh122; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; CIANCIOTTO NP, 1990, J INFECT DIS, V162, P121, DOI 10.1093/infdis/162.1.121; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DOAK TG, 1994, P NATL ACAD SCI USA, V91, P942, DOI 10.1073/pnas.91.3.942; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EIGELSBACH HT, 1951, J BACTERIOL, V61, P557, DOI 10.1128/JB.61.5.557-569.1951; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Enright AJ, 2003, NUCLEIC ACIDS RES, V31, P4632, DOI 10.1093/nar/gkg495; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FLEMING DE, 1955, J BACTERIOL, V70, P345, DOI 10.1128/JB.70.3.345-349.1955; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; Gil H, 2004, INFECT IMMUN, V72, P3042, DOI 10.1128/IAI.72.5.3042-3047.2004; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76; HALMANN M, 1967, J GEN MICROBIOL, V49, P461, DOI 10.1099/00221287-49-3-461; Hickey EK, 1997, INFECT IMMUN, V65, P133, DOI 10.1128/IAI.65.1.133-143.1997; HOOD AM, 1977, J HYG-CAMBRIDGE, V79, P47, DOI 10.1017/S0022172400052840; Houng HSH, 1998, MICROB PATHOGENESIS, V25, P165, DOI 10.1006/mpat.1998.0222; Krieger CJ, 2004, NUCLEIC ACIDS RES, V32, pD438, DOI 10.1093/nar/gkh100; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; MAGER J, 1964, NATURE, V203, P898, DOI 10.1038/203898a0; MAGER J, 1959, BIOCHIM BIOPHYS ACTA, V36, P529, DOI 10.1016/0006-3002(59)90195-7; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; NAGLE SC, 1960, J BACTERIOL, V79, P566, DOI 10.1128/JB.79.4.566-571.1960; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Paley SM, 2002, BIOINFORMATICS, V18, P715, DOI 10.1093/bioinformatics/18.5.715; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Romero PR, 2004, BIOINFORMATICS, V20, P709, DOI 10.1093/bioinformatics/btg471; Russell P, 1998, J ANTIMICROB CHEMOTH, V41, P461, DOI 10.1093/jac/41.4.461; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sjostedt A, 2004, BERGEYS MANUAL SYSTE, P200; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Thomas R, 2003, J CLIN MICROBIOL, V41, P50, DOI 10.1128/JCM.41.1.50-57.2003; TRAUB A, 1955, J BACTERIOL, V70, P60, DOI 10.1128/JB.70.1.60-69.1955; Viswanathan VK, 2000, INFECT IMMUN, V68, P1069, DOI 10.1128/IAI.68.3.1069-1079.2000	50	364	679	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					153	159		10.1038/ng1499	http://dx.doi.org/10.1038/ng1499			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15640799	Bronze			2022-12-17	WOS:000226690100021
J	BONNE, G; CARRIER, L; BERCOVICI, J; CRUAUD, C; RICHARD, P; HAINQUE, B; GAUTEL, M; LABEIT, S; JAMES, M; BECKMANN, J; WEISSENBACH, J; VOSBERG, HP; FISZMAN, M; KOMAJDA, M; SCHWARTZ, K				BONNE, G; CARRIER, L; BERCOVICI, J; CRUAUD, C; RICHARD, P; HAINQUE, B; GAUTEL, M; LABEIT, S; JAMES, M; BECKMANN, J; WEISSENBACH, J; VOSBERG, HP; FISZMAN, M; KOMAJDA, M; SCHWARTZ, K			CARDIAC MYOSIN BINDING PROTEIN-C GENE SPLICE ACCEPTOR SITE MUTATION IS ASSOCIATED WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY	NATURE GENETICS			English	Note							HEAVY-CHAIN; MUSCLE; PURIFICATION; EXTRACTION; MYOCYTES; VELOCITY; LOCUS; ACTIN; MAPS; CDNA		GRP HOSP PITIE SALPETRIERE,INSERM,UR153,F-75651 PARIS 13,FRANCE; GENETHON SA,CNRS,URA 1922,EVRY,FRANCE; HOP LA PITIE SALPETRIERE,SERV BIOCHIM,PARIS,FRANCE; EUROPEAN MOLEC BIOL LAB,HEIDELBERG,GERMANY; WELLCOME TRUST CTR HUMAN GENET,NUFFIELD DEPT CLIN MED,OXFORD,ENGLAND; MAX PLANCK INST PHYSIOL & CLIN RES,BAD NAUHEIM,GERMANY; HOP LA PITIE SALPETRIERE,SERV CARDIOL,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; European Molecular Biology Laboratory (EMBL); University of Oxford; Wellcome Centre for Human Genetics; Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite			Gautel, Mathias/AAB-9860-2019; Beckmann, Jacques S/A-9772-2008; Bonne, Gisèle/G-3121-2013	Beckmann, Jacques S/0000-0002-9741-1900; Bonne, Gisèle/0000-0002-2516-3258; Gautel, Mathias/0000-0003-4027-9803; Cruaud, Corinne/0000-0002-4752-7278	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BONNE G, 1995, J MED GENET, V32, P670, DOI 10.1136/jmg.32.8.670; CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; DETOMBE PP, 1992, J PHYSIOL-LONDON, V454, P619, DOI 10.1113/jphysiol.1992.sp019283; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; EINHEBER S, 1990, P NATL ACAD SCI USA, V87, P2157, DOI 10.1073/pnas.87.6.2157; FURST DO, 1992, J CELL SCI, V102, P769; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; GEISTERFERLOWRA.AA, 1990, CELL, V62, P999; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; HARTZELL HC, 1982, J BIOL CHEM, V257, P2111; HOFMANN PA, 1991, J GEN PHYSIOL, V97, P1141, DOI 10.1085/jgp.97.6.1141; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; KORETZ JF, 1982, BIOPHYS J, V37, P433, DOI 10.1016/S0006-3495(82)84689-4; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; MOOS C, 1978, J MOL BIOL, V124, P571, DOI 10.1016/0022-2836(78)90172-9; MOOS C, 1980, BIOCHIM BIOPHYS ACTA, V632, P141, DOI 10.1016/0304-4165(80)90071-9; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; OKAGAKI T, 1993, J CELL BIOL, V123, P619, DOI 10.1083/jcb.123.3.619; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; SCHWARTZ K, 1992, CIRC RES, V71, P3, DOI 10.1161/01.RES.71.1.3; STARR R, 1978, BIOCHEM J, V171, P813, DOI 10.1042/bj1710813; SWEITZER NK, 1993, CIRC RES, V73, P1150, DOI 10.1161/01.RES.73.6.1150; THIERFELDER L, 1993, P NATL ACAD SCI USA, V90, P6270, DOI 10.1073/pnas.90.13.6270; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YAMAMOTO K, 1983, J BIOL CHEM, V258, P8395	29	364	372	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					438	440		10.1038/ng1295-438	http://dx.doi.org/10.1038/ng1295-438			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493026				2022-12-17	WOS:A1995TH62900023
J	WELLS, J; WROBLEWSKI, J; KEEN, J; INGLEHEARN, C; JUBB, C; ECKSTEIN, A; JAY, M; ARDEN, G; BHATTACHARYA, S; FITZKE, F; BIRD, A				WELLS, J; WROBLEWSKI, J; KEEN, J; INGLEHEARN, C; JUBB, C; ECKSTEIN, A; JAY, M; ARDEN, G; BHATTACHARYA, S; FITZKE, F; BIRD, A			MUTATIONS IN THE HUMAN RETINAL DEGENERATION SLOW (RDS) GENE CAN CAUSE EITHER RETINITIS-PIGMENTOSA OR MACULAR DYSTROPHY	NATURE GENETICS			English	Article							RHODOPSIN GENE; DISK MEMBRANE; ONE FORM; PERIPHERIN; LOCALIZATION; LINKAGE; PRODUCT; ARM	Mutations in the RDS gene, which encodes the photoreceptor glycoprotein peripherin, have been sought in families with autosomal dominant retinal dystrophies. A cysteine deletion at codon 118/119 is associated with retinitis pigmentosa in one. Three families with similar macular dystrophy have mutations at codon 172, arginine being substituted by tryptophan in two and by glutamine in one. A stop sequence at codon 258 exists in a family with adult vitelliform macular dystrophy. These findings demonstrate that both retinitis pigmentosa and macular dystrophies are caused by mutations in RDS and that the functional significance of certain amino-acids in peripherin-RDS may be different in cones and rods.	MOORFIELDS EYE HOSP,DEPT CLIN OPHTHALMOL,CITY RD,LONDON EC1V 2PD,ENGLAND; MOORFIELDS EYE HOSP,DEPT MOLEC BIOL,LONDON EC1V 2PD,ENGLAND; MOORFIELDS EYE HOSP,DEPT ELECTRODIAGNOST,LONDON EC1V 2PD,ENGLAND; MOORFIELDS EYE HOSP,INST OPHTHALMOL,DEPT VISUAL SCI,LONDON EC1V 2PD,ENGLAND	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust			Anja, Eckstein/L-6304-2016; Fitzke, Fred/C-3535-2008	Arden, Geoffrey/0000-0001-7334-2026	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARDEN GB, 1988, CLIN VISION SCI, V2, P303; ARDEN GB, 1983, BRIT J OPHTHALMOL, V67, P419, DOI 10.1136/bjo.67.7.419; ARDEN GB, 1983, J PHYSIOL-LONDON, V341, P85, DOI 10.1113/jphysiol.1983.sp014794; AROKAWA K, 1992, J CELL BIOL, V116, P659; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; CONNELL GJ, 1990, BIOCHEMISTRY-US, V29, P4691, DOI 10.1021/bi00471a025; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; FARRAR GJ, 1991, GENOMICS, V11, P870, DOI 10.1016/0888-7543(91)90009-4; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; INGLEHEARN CF, 1992, HUM MOL GENET, V1, P41, DOI 10.1093/hmg/1.1.41; JACOBSON SG, 1986, OPHTHALMOLOGY, V93, P1604; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; KEEN J, 1991, TRENDS GENET, V7, P5; KEEN TJ, 1991, GENOMICS, V11, P199, DOI 10.1016/0888-7543(91)90119-Y; LESTER DH, 1990, AM J HUM GENET, V47, P536; MARMOR MF, 1989, ARCH OPHTHALMOL-CHIC, V107, P816, DOI 10.1007/BF00154486; MCWILLIAM P, 1989, GENOMICS, V5, P619, DOI 10.1016/0888-7543(89)90031-1; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; SANYAL S, 1988, VISION RES, V28, P1171, DOI 10.1016/0042-6989(88)90034-X; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G	26	364	370	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1993	3	3					213	218		10.1038/ng0393-213	http://dx.doi.org/10.1038/ng0393-213			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KP790	8485576				2022-12-17	WOS:A1993KP79000009
J	Lundmark, F; Duvefelt, K; Iacobaeus, E; Kockum, I; Wallstrom, E; Khademi, M; Oturai, A; Ryder, LP; Saarela, J; Harbo, HF; Celius, EG; Salter, H; Olsson, T; Hillert, J				Lundmark, Frida; Duvefelt, Kristina; Iacobaeus, Ellen; Kockum, Ingrid; Wallstroem, Erik; Khademi, Mohsen; Oturai, Annette; Ryder, Lars P.; Saarela, Janna; Harbo, Hanne F.; Celius, Elisabeth G.; Salter, Hugh; Olsson, Tomas; Hillert, Jan			Variation in interleukin 7 receptor a chain (IL7R) influences risk of multiple sclerosis	NATURE GENETICS			English	Article							TYROSINE-PHOSPHATASE; GENE; SUSCEPTIBILITY; DISEASE; POLYMORPHISMS; ASSOCIATIONS; EXPRESSION; LOCUS	Multiple sclerosis is a chronic, often disabling, disease of the central nervous system affecting more than 1 in 1,000 people in most western countries. The inflammatory lesions typical of multiple sclerosis show autoimmune features and depend partly on genetic factors. Of these genetic factors, only the HLA gene complex has been repeatedly confirmed to be associated with multiple sclerosis, despite considerable efforts. Polymorphisms in a number of non- HLA genes have been reported to be associated with multiple sclerosis, but so far confirmation has been difficult. Here, we report compelling evidence that polymorphisms in IL7R, which encodes the interleukin 7 receptor a chain ( IL7R alpha), indeed contribute to the non- HLA genetic risk in multiple sclerosis, demonstrating a role for this pathway in the pathophysiology of this disease. In addition, we report altered expression of the genes encoding IL7R alpha and its ligand, IL7, in the cerebrospinal fluid compartment of individuals with multiple sclerosis.	Karolinska Univ Hosp, Dept Clin Neurosci, Div Neurol, SE-14186 Stockholm, Sweden; Karolinska Univ Hosp, Clin Res Ctr, Mutat Anal Facil, SE-14186 Huddinge, Sweden; Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, SE-17176 Stockholm, Sweden; Copenhagen Univ Hosp, Rigshosp, Danish Multiple Sclerosis Res Ctr, DK-2100 Copenhagen, Denmark; Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; Natl Publ Hlth Inst, Dept Mol Med, FI-00290 Helsinki, Finland; Univ Oslo, Inst Immunol, N-0027 Oslo, Norway; Ulleval Hosp, Dept Neurol, N-0407 Oslo, Norway; AstraZeneca R&D, Dept Dis Biol, Pharmacogenom Sect, SE-15185 Sodertalje, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Finland National Institute for Health & Welfare; University of Oslo; University of Oslo; AstraZeneca	Hillert, J (corresponding author), Karolinska Univ Hosp, Dept Clin Neurosci, Div Neurol, SE-14186 Stockholm, Sweden.	jan.hillert@ki.se	Kockum, Ingrid/O-8781-2018; ryder, lars p/Q-2060-2015; Celius, Elisabeth Gulowsen/S-1387-2019; Saarela, Janna S/E-5369-2014	Kockum, Ingrid/0000-0002-0867-4726; ryder, lars p/0000-0002-4744-3496; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Olsson, Tomas/0000-0002-2938-1877; Khademi, Mohsen/0000-0003-0801-1444; Saarela, Janna/0000-0002-0853-6219				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Booth DR, 2005, J MOL MED, V83, P822, DOI 10.1007/s00109-005-0684-y; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burwick RM, 2006, NEUROLOGY, V66, P1373, DOI 10.1212/01.wnl.0000210531.19498.3f; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kurz T, 2006, J ALLERGY CLIN IMMUN, V118, P396, DOI 10.1016/j.jaci.2006.04.036; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OGUA Y, 2001, NATURE, V411, P603; Roxburgh RH, 2006, J NEUROIMMUNOL, V171, P193, DOI 10.1016/j.jneuroim.2005.10.006; Sawcer S, 2005, AM J HUM GENET, V77, P454; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; Teutsch SM, 2003, EUR J HUM GENET, V11, P509, DOI 10.1038/sj.ejhg.5200994; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	23	363	374	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1108	1113		10.1038/ng2106	http://dx.doi.org/10.1038/ng2106			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17660816				2022-12-17	WOS:000249122400020
J	Bell, DW; Gore, I; Okimoto, RA; Godin-Heymann, N; Sordella, R; Mulloy, R; Sharma, SV; Brannigan, BW; Mohapatra, G; Settleman, J; Haber, DA				Bell, DW; Gore, I; Okimoto, RA; Godin-Heymann, N; Sordella, R; Mulloy, R; Sharma, SV; Brannigan, BW; Mohapatra, G; Settleman, J; Haber, DA			Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR	NATURE GENETICS			English	Article							ACQUIRED-RESISTANCE; KINASE INHIBITORS; TYROSINE KINASE; RECEPTOR GENE; GEFITINIB; SENSITIVITY; ERLOTINIB	Somatic activating mutations in EGFR identify a subset of non-small cell lung cancer that respond to tyrosine kinase inhibitors. Acquisition of drug resistance is linked to a specific secondary somatic mutation, EGFR T790M. Here we describe a family with multiple cases of non-small cell lung cancer associated with germline transmission of this mutation. Four of six tumors analyzed showed a secondary somatic activating EGFR mutation, arising in cis with the germline EGFR mutation T790M. These observations implicate altered EGFR signaling in genetic susceptibility to lung cancer.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; St Vincents Hosp, Bruno Canc Ctr, Birmingham, AL 35205 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Haber, DA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, 13th St, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu						Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Blencke S, 2003, J BIOL CHEM, V278, P15435, DOI 10.1074/jbc.M211158200; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Yamamoto M, 2004, BIOCHEM BIOPH RES CO, V319, P1272, DOI 10.1016/j.bbrc.2004.05.113; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764	15	363	394	0	21	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2005	37	12					1315	1316		10.1038/ng1671	http://dx.doi.org/10.1038/ng1671			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16258541				2022-12-17	WOS:000233657300008
J	Jorde, LB; Wooding, SP				Jorde, LB; Wooding, SP			Genetic variation, classification and 'race'	NATURE GENETICS			English	Article							EVOLUTIONARY HISTORY; POPULATION-STRUCTURE; DEMOGRAPHIC HISTORY; POSITIVE SELECTION; SEQUENCE VARIATION; HUMAN-DIVERSITY; HIGH-RESOLUTION; WHITE PATIENTS; ALU-INSERTION; MITOCHONDRIAL	New genetic data has enabled scientists to re-examine the relationship between human genetic variation and 'race'. We review the results of genetic analyses that show that human genetic variation is geographically structured, in accord with historical patterns of gene flow and genetic drift. Analysis of many loci now yields reasonably accurate estimates of genetic similarity among individuals, rather than populations. Clustering of individuals is correlated with geographic origin or ancestry. These clusters are also correlated with some traditional concepts of race, but the correlations are imperfect because genetic variation tends to be distributed in a continuous, overlapping fashion among populations. Therefore, ancestry, or even race, may in some cases prove useful in the biomedical setting, but direct assessment of disease-related genetic variation will ultimately yield more accurate and beneficial information.	Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Jorde, LB (corresponding author), Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA.	lbj@genetics.utah.edu						Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BARMSHAD MJ, 2003, AM J HUM GENET, V72, P578; Blumenbach Johann Friedrich, 1969, NATURAL VARIETIES MA; Bouchard TJ, 2001, BEHAV GENET, V31, P243; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Boyd William C., 1950, GENETICS RACES MAN I; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Cooper RS, 1999, SCI AM, V280, P56, DOI 10.1038/scientificamerican0299-56; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Darwin C., 1871, P423; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Edwards AWF, 2003, BIOESSAYS, V25, P798, DOI 10.1002/bies.10315; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Excoffier L, 2003, SCIENCE, V300; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Feldman MW, 2003, NATURE, V424, P374, DOI 10.1038/424374a; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gilad Y, 2002, P NATL ACAD SCI USA, V99, P862, DOI 10.1073/pnas.022614799; Haga SB, 2003, SCIENCE, V301, P466, DOI 10.1126/science.1087004; Harpending H, 2002, P NATL ACAD SCI USA, V99, P10, DOI 10.1073/pnas.012612799; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Jorde LB, 2001, HUM MOL GENET, V10, P2199, DOI 10.1093/hmg/10.20.2199; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LI WH, 1991, GENETICS, V129, P513; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; NEI M, 1989, HUM HERED, V39, P276, DOI 10.1159/000153872; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pritchard JK, 2000, GENETICS, V155, P945; Risch N, 2002, GENOME BIOL, V3, DOI [10.1186/GB-2002-3-7-COMMENT2007, DOI 10.1186/GB-2002-3-7-C0MMENT2007, 10.1186/gb-2002-3-7-comment2007]; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sakate R, 2003, GENOME RES, V13, P1022, DOI 10.1101/gr.783103; Sankar P, 2002, SCIENCE, V298, P1337, DOI 10.1126/science.1074447; Schneider JA, 2003, MECH AGEING DEV, V124, P17, DOI 10.1016/S0047-6374(02)00165-3; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Sehgal AR, 2004, HYPERTENSION, V43, P566, DOI 10.1161/01.HYP.0000118019.28487.9c; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shriver Mark D, 2004, Hum Genomics, V1, P274; Smedley A, 1999, RACE N AM ORIGIN EVO; Strickland TL, 1997, ARCH FAM MED, V6, P371, DOI 10.1001/archfami.6.4.371; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; TISHKOFF X, 2004, NAT GENET S, V36; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Varner RV, 1998, PSYCHIAT QUART, V69, P117, DOI 10.1023/A:1024762503100; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; Watkins WS, 2001, AM J HUM GENET, V68, P738, DOI 10.1086/318793; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Wildman DE, 2002, BIOESSAYS, V24, P490, DOI 10.1002/bies.10103; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Wood AJJ, 2001, NEW ENGL J MED, V344, P1393, DOI 10.1056/NEJM200105033441811; Yu N, 2002, GENETICS, V161, P269	74	363	381	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S28	S33		10.1038/ng1435	http://dx.doi.org/10.1038/ng1435			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	15508000	Bronze			2022-12-17	WOS:000224854000008
J	Eisenberg, I; Avidan, N; Potikha, T; Hochner, H; Chen, M; Olender, T; Barash, M; Shemesh, M; Sadeh, M; Grabov-Nardini, G; Shmilevich, I; Friedmann, A; Karpati, G; Bradley, WG; Baumbach, L; Lancet, D; Ben Asher, E; Beckmann, JS; Argov, Z; Mitrani-Rosenbaum, S				Eisenberg, I; Avidan, N; Potikha, T; Hochner, H; Chen, M; Olender, T; Barash, M; Shemesh, M; Sadeh, M; Grabov-Nardini, G; Shmilevich, I; Friedmann, A; Karpati, G; Bradley, WG; Baumbach, L; Lancet, D; Ben Asher, E; Beckmann, JS; Argov, Z; Mitrani-Rosenbaum, S			The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy	NATURE GENETICS			English	Article							ACETYLNEURAMINIC ACID BIOSYNTHESIS; BIFUNCTIONAL ENZYME CATALYZES; 1ST 2 STEPS; SEQUENCE ALIGNMENTS; DISTAL MYOPATHY; RIMMED VACUOLE; RAT-LIVER; LOCUS; 2-EPIMERASE; MAPS	Hereditary inclusion body myopathy (HIBM; OMIM 600737) is a unique group of neuromuscular disorders characterized by adult onset, slowly progressive distal and proximal weakness and a typical muscle pathology including rimmed vacuoles and filamentous inclusions'. The autosomal recessive form described in Jews of Persian descent(2) is the HIBM prototype. This myopathy affects mainly leg muscles, but with an unusual distribution that spares the quadriceps(3). This particular pattern of weakness distribution, termed quadriceps-sparing myopathy (QSM), was later found in Jews originating from other Middle Eastern countries as well as in non-Jews(4). We previously localized the gene causing HIBM in Middle Eastern Jews on chromosome 9p12-13 (ref. 5) within a genomic interval of about 700 kb (ref. 6). Haplotype analysis around the HIBM gene region of 104 affected people from 47 Middle Eastern families indicates one unique ancestral founder chromosome in this community. By contrast, single non-Jewish families from India, Georgia (USA) and the Bahamas, with QSM and linkage to the same 9p12-13 region, show three distinct haplotypes. After excluding other potential candidate genes, we eventually identified mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase (GIVE) gene in the HIBM families: all patients from Middle Eastern descent shared a single homozygous missense mutation, whereas distinct compound heterozygotes were identified in affected individuals of families of other ethnic origins. our findings indicate that GIVE is the gene responsible for recessive HIBM.	Hebrew Univ Jerusalem, Hadassah Med Sch, Mol Biol Unit, IL-91010 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Neurol, IL-91010 Jerusalem, Israel; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Crown Genome Ctr, IL-76100 Rehovot, Israel; Wolfson Govt Hosp, Dept Neurol, Holon, Israel; McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; Univ Miami, Sch Med, Dept Neurol, Miami, FL USA; Univ Miami, Sch Med, Dept Pediat, Miami, FL USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science; Weizmann Institute of Science; McGill University; University of Miami; University of Miami	Mitrani-Rosenbaum, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Mol Biol Unit, IL-91010 Jerusalem, Israel.	stella@yam-suff.huji.ac.il	Beckmann, Jacques S/A-9772-2008; Barash, Mark/M-8757-2016; Shemesh, Moshe/AAR-7506-2020	Beckmann, Jacques S/0000-0002-9741-1900; Barash, Mark/0000-0002-5445-6316; Shemesh, Moshe/0000-0002-3854-6151; Mitrani-Rosenbaum, Stella/0000-0001-5335-8709				AGROV Z, 1998, CURR OPIN RHEUMATOL, V10, P543; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; ARGOV Z, 1997, INCLUSION BODY MYOSI, P200; Askanas Valerie, 1998, Current Opinion in Rheumatology, V10, P530, DOI 10.1097/00002281-199811000-00005; Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969; Effertz K, 1999, J BIOL CHEM, V274, P28771, DOI 10.1074/jbc.274.40.28771; Eisenberg I, 2001, EUR J HUM GENET, V9, P501, DOI 10.1038/sj.ejhg.5200665; Eisenberg I, 1999, GENOMICS, V55, P43, DOI 10.1006/geno.1998.5630; GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; HUMBEL R, 1975, CLIN CHIM ACTA, V60, P143, DOI 10.1016/0009-8981(75)90119-9; Ikeuchi T, 1997, ANN NEUROL, V41, P432, DOI 10.1002/ana.410410405; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Little S, 1995, CURRENT PROTOCOLS HU; MitraniRosenbaum S, 1996, HUM MOL GENET, V5, P159, DOI 10.1093/hmg/5.1.159; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; PONNAMBALAM S, 1994, GENOMICS, V24, P440, DOI 10.1006/geno.1994.1650; SADEH M, 1997, INCLUSION BODY MYOSI, P191; Salzberg SL, 2001, SCIENCE, V292, P1903, DOI 10.1126/science.1061036; Seppala R, 1999, AM J HUM GENET, V64, P1563, DOI 10.1086/302411; Stasche R, 1997, J BIOL CHEM, V272, P24319, DOI 10.1074/jbc.272.39.24319; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221	25	363	386	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2001	29	1					83	87		10.1038/ng718	http://dx.doi.org/10.1038/ng718			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528398				2022-12-17	WOS:000170781300023
J	Holt, JT; Thompson, ME; Szabo, C; RobinsonBenion, C; Arteaga, CL; King, MC; Jensen, RA				Holt, JT; Thompson, ME; Szabo, C; RobinsonBenion, C; Arteaga, CL; King, MC; Jensen, RA			Growth retardation and tumour inhibition by BRCA1	NATURE GENETICS			English	Article							FAMILIAL BREAST; CANCER	Inherited mutations in BRCA1 predispose to breast and ovarian cancer, but the role of BRCA1 in sporadic breast and ovarian cancer has previously been elusive. Here, we show that retroviral transfer of the wild-type BRCA1 gene inhibits growth in vitro of all breast and ovarian cancer cell lines tested, but not colon or lung cancer cells or fibroblasts. Mutant BRCA1 has no effect on growth of breast cancer cells; ovarian cancer cell growth is not affected by BRCA1 mutations in the 5' portion of the gene, but is inhibited by 3' BRCA1 mutations. Development of MCF-7 tumours in nude mice is inhibited when MCF-7 cells are transfected with wild-type, but not mutant, BRCA1. Most importantly, among mice with established MCF-7 tumours, peritoneal treatment with a retroviral vector expressing wild-type BRCA1 significantly inhibits tumour growth and increased survival.	VANDERBILT UNIV, SCH MED, DEPT PATHOL, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, SCH MED, DEPT MED, NASHVILLE, TN 37232 USA; UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT GENET, SEATTLE, WA 98195 USA	Vanderbilt University; Vanderbilt University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Holt, JT (corresponding author), VANDERBILT UNIV, SCH MED, DEPT CELL BIOL, 221 KIRKLAND HALL, NASHVILLE, TN 37232 USA.		Jensen, Roy A/B-9739-2011	Jensen, Roy A/0000-0003-4430-2281; King, Mary-Claire/0000-0001-9426-1743	NCI NIH HHS [R01-CA62161, R01-CA27632, F32-CA66293] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arteaga CL, 1996, CANCER RES, V56, P1098; CORNELIS RS, 1995, GENE CHROMOSOME CANC, V13, P203, DOI 10.1002/gcc.2870130310; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; Jensen RA, 1996, NAT GENET, V12, P303, DOI 10.1038/ng0396-303; JENSEN RA, 1994, P NATL ACAD SCI USA, V91, P9257, DOI 10.1073/pnas.91.20.9257; JENSEN RA, 1992, BIOCHEMISTRY-US, V31, P10887, DOI 10.1021/bi00159a032; LANE TF, 1995, GENE DEV, V9, P2712, DOI 10.1101/gad.9.21.2712; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; SOULE HD, 1980, CANCER LETT, V10, P177, DOI 10.1016/0304-3835(80)90042-7; TAKAHASHI H, 1995, CANCER RES, V55, P2998; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444	18	363	382	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					298	302		10.1038/ng0396-298	http://dx.doi.org/10.1038/ng0396-298			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589721				2022-12-17	WOS:A1996TY18300019
J	Frattini, V; Trifonov, V; Chan, JM; Castano, A; Lia, M; Abate, F; Keir, ST; Ji, AX; Zoppoli, P; Niola, F; Danussi, C; Dolgalev, I; Porrati, P; Pellegatta, S; Heguy, A; Gupta, G; Pisapia, DJ; Canoll, P; Bruce, JN; McLendon, RE; Yan, H; Aldape, K; Finocchiaro, G; Mikkelsen, T; Prive, GG; Bigner, DD; Lasorella, A; Rabadan, R; Iavarone, A				Frattini, Veronique; Trifonov, Vladimir; Chan, Joseph Minhow; Castano, Angelica; Lia, Marie; Abate, Francesco; Keir, Stephen T.; Ji, Alan X.; Zoppoli, Pietro; Niola, Francesco; Danussi, Carla; Dolgalev, Igor; Porrati, Paola; Pellegatta, Serena; Heguy, Adriana; Gupta, Gaurav; Pisapia, David J.; Canoll, Peter; Bruce, Jeffrey N.; McLendon, Roger E.; Yan, Hai; Aldape, Ken; Finocchiaro, Gaetano; Mikkelsen, Tom; Prive, Gilbert G.; Bigner, Darell D.; Lasorella, Anna; Rabadan, Raul; Iavarone, Antonio			The integrated landscape of driver genomic alterations in glioblastoma	NATURE GENETICS			English	Article							UBIQUITIN LIGASE HUWE1; HIGH-GRADE GLIOMA; DELTA-CATENIN; SOMATIC MUTATIONS; ADAPTER PROTEIN; BRAIN-TUMORS; RECEPTOR; CANCER; BCOR; DIFFERENTIATION	Glioblastoma is one of the most challenging forms of cancer to treat. Here we describe a computational platform that integrates the analysis of copy number variations and somatic mutations and unravels the landscape of in-frame gene fusions in glioblastoma. We found mutations with loss of heterozygosity in LZTR1, encoding an adaptor of CUL3-containing E3 ligase complexes. Mutations and deletions disrupt LZTR1 function, which restrains the self renewal and growth of glioma spheres that retain stem cell features. Loss-of-function mutations in CTNND2 target a neural-specific gene and are associated with the transformation of glioma cells along the very aggressive mesenchymal phenotype. We also report recurrent translocations that fuse the coding sequence of EGFR to several partners, with EGFR-SEPT14 being the most frequent functional gene fusion in human glioblastoma. EGFR-SEPT14 fusions activate STAT3 signaling and confer mitogen independence and sensitivity to EGFR inhibition. These results provide insights into the pathogenesis of glioblastoma and highlight new targets for therapeutic intervention.	[Frattini, Veronique; Castano, Angelica; Lia, Marie; Zoppoli, Pietro; Niola, Francesco; Danussi, Carla; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10027 USA; [Trifonov, Vladimir; Chan, Joseph Minhow; Abate, Francesco; Rabadan, Raul] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY USA; [Trifonov, Vladimir; Chan, Joseph Minhow; Abate, Francesco; Rabadan, Raul] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY USA; [Abate, Francesco] Politecn Torino, Dept Control & Comp Engn, Turin, Italy; [Keir, Stephen T.; McLendon, Roger E.; Yan, Hai; Bigner, Darell D.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC USA; [Keir, Stephen T.; McLendon, Roger E.; Yan, Hai; Bigner, Darell D.] Duke Univ, Med Ctr, Pediat Brain Tumor Fdn Inst, Durham, NC USA; [Keir, Stephen T.; McLendon, Roger E.; Yan, Hai; Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Ji, Alan X.; Prive, Gilbert G.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Dolgalev, Igor; Heguy, Adriana] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Porrati, Paola; Pellegatta, Serena; Finocchiaro, Gaetano] Ist Neurol C Besta, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Milan, Italy; [Gupta, Gaurav; Bruce, Jeffrey N.] Columbia Univ, Med Ctr, Dept Neurosurg, New York, NY USA; [Pisapia, David J.; Canoll, Peter; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Pathol, New York, NY USA; [Aldape, Ken] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Mikkelsen, Tom] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA; [Mikkelsen, Tom] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA; [Prive, Gilbert G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pediat, New York, NY USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA	Columbia University; Columbia University; Columbia University; Polytechnic University of Turin; Duke University; Duke University; Duke University; University of Toronto; Memorial Sloan Kettering Cancer Center; IRCCS Istituto Neurologico Besta; Columbia University; Columbia University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Columbia University; Columbia University	Lasorella, A (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10027 USA.	al2179@columbia.edu; rabadan@dbmi.columbia.edu; ai2102@columbia.edu	Finocchiaro, Gaetano/AAG-6791-2020; Pellegatta, Serena/AAL-3693-2021; Rabadan, Raul/AAZ-7367-2020; Bruce, Jeffrey N/AAC-5307-2022; Zoppoli, Pietro/J-9954-2018; Dolgalev, Igor/AAY-6406-2020; Heguy, Adriana/GPP-3907-2022	Pellegatta, Serena/0000-0001-7804-9486; Zoppoli, Pietro/0000-0002-7860-9655; Dolgalev, Igor/0000-0003-4451-126X; Iavarone, Antonio/0000-0002-0683-4634; Rabadan, Raul/0000-0001-7946-9255; Prive, Gilbert/0000-0002-0712-4319; Chan, Joseph/0000-0001-5249-7395; Finocchiaro, Gaetano/0000-0003-3583-4040	National Cancer Institute [R01CA101644, R01CA131126, R01CA085628, R01CA127643]; Stewart Foundation; Partnership for Cure; US National Institutes of Health (NIH) [NIH 1 P50 MH094267-01]; Lymphoma Research Foundation; NIH [1 U54 CA121852-05, 1R01CA164152-01]; Leukemia and Lymphoma Society; Canadian Cancer Society; Cancer Research Society; National Institute of Neurological Disorders and Stroke [R01NS061776]; Chemotherapy Foundation; Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Health; Italian Ministry of Welfare/Provincia di Benevento; Federazione Italiana Associazioni Genitori Oncoematologia Pedriatica (FIAGOP); NATIONAL CANCER INSTITUTE [R01CA127643, R01CA085628, U54CA121852, R01CA164152, R01CA190891, R01CA179044, R01CA131126, P30CA016672, R01CA101644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066955, R01NS061776, R01NS073610] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stewart Foundation; Partnership for Cure; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Canadian Cancer Society(Canadian Cancer Society (CCS)); Cancer Research Society; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Chemotherapy Foundation; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Welfare/Provincia di Benevento; Federazione Italiana Associazioni Genitori Oncoematologia Pedriatica (FIAGOP); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Cancer Institute grants R01CA101644 and R01CA131126 (A. L.) and R01CA085628 and R01CA127643 (A. I.), the Stewart Foundation (R. R.), the Partnership for Cure (R. R.), US National Institutes of Health (NIH) grant NIH 1 P50 MH094267-01 (R. R.), the Lymphoma Research Foundation (R. R.), NIH 1 U54 CA121852-05 (R. R.), NIH 1R01CA164152-01 (R. R.), the Leukemia and Lymphoma Society (R. R.), the Canadian Cancer Society (G. G. P.), the Cancer Research Society (G. G. P.), the National Institute of Neurological Disorders and Stroke R01NS061776 (A. I.) and a grant from The Chemotherapy Foundation (A. I.). G. F. was supported by grants from the Associazione Italiana per la Ricerca sul Cancro and from the Italian Ministry of Health. V. F., P.Z., C. D. and F.N. are supported by fellowships from the Italian Ministry of Welfare/Provincia di Benevento and the Federazione Italiana Associazioni Genitori Oncoematologia Pedriatica (FIAGOP) (C. D.). We thank J. Parkinson for helpful discussions on the phylogeny of LZTR1 genes, L. Bertin for help with protein blots, J. Kroll (Tumor Biology Center, Freiburg) for the LZTR1 plasmids and M. Pagano (New York University) for CUL3 expression plasmids.	Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; Arikkath J, 2009, J NEUROSCI, V29, P5435, DOI 10.1523/JNEUROSCI.0835-09.2009; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chinnaiyan AM, 2010, PROG MOL BIOL TRANSL, V95, P55, DOI 10.1016/B978-0-12-385071-3.00004-6; Christ A, 2012, DEV CELL, V22, P268, DOI 10.1016/j.devcel.2011.11.023; Cowin PA, 2012, CANCER RES, V72, P4060, DOI 10.1158/0008-5472.CAN-12-0203; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; FRIEDMAN HS, 1988, CANCER RES, V48, P4189; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Harlalka GV, 2013, J MED GENET, V50, P65, DOI 10.1136/jmedgenet-2012-101367; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Ji AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060445; Jun G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043728; Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004; Liu C, 2011, CARCINOGENESIS, V32, P129, DOI 10.1093/carcin/bgq224; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; Nacak TG, 2006, J BIOL CHEM, V281, P5065, DOI 10.1074/jbc.M509073200; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pierotti MA, 2006, CANCER LETT, V232, P90, DOI 10.1016/j.canlet.2005.07.043; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubin AF, 2009, P NATL ACAD SCI USA, V106, P21766, DOI 10.1073/pnas.0912499106; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Wamstad JA, 2007, GENE EXPR PATTERNS, V7, P550, DOI 10.1016/j.modgep.2007.01.006; Wamstad JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002814; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	65	362	392	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2013	45	10			SI		1141	U270		10.1038/ng.2734	http://dx.doi.org/10.1038/ng.2734			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	225UQ	23917401	Green Accepted			2022-12-17	WOS:000324989600009
J	Kozyrev, SV; Abelson, AK; Wojcik, J; Zaghlool, A; Reddy, MVPL; Sanchez, E; Gunnarsson, I; Svenungsson, E; Sturfelt, G; Jonsen, A; Truedsson, L; Pons-Estel, BA; Witte, T; D'Alfonso, S; Barrizzone, N; Danieli, MG; Gutierrez, C; Suarez, A; Junker, P; Laustrup, H; Gonzalez-Escribano, MF; Martin, J; Abderrahim, H; Alarcon-Riquelme, ME				Kozyrev, Sergey V.; Abelson, Anna-Karin; Wojcik, Jerome; Zaghlool, Ammar; Reddy, M. V. Prasad Linga; Sanchez, Elena; Gunnarsson, Iva; Svenungsson, Elisabet; Sturfelt, Gunnar; Jonsen, Andreas; Truedsson, Lennart; Pons-Estel, Bernardo A.; Witte, Torsten; D'Alfonso, Sandra; Barrizzone, Nadia; Danieli, Maria Giovanna; Gutierrez, Carmen; Suarez, Ana; Junker, Peter; Laustrup, Helle; Gonzalez-Escribano, Maria Francisca; Martin, Javier; Abderrahim, Hadi; Alarcon-Riquelme, Marta E.			Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus	NATURE GENETICS			English	Article							SIGNAL-TRANSDUCTION; HAPLOTYPE RECONSTRUCTION; LYN; RECEPTOR; PHOSPHORYLATION; ACTIVATION; EXPRESSION; SEQUENCE	Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease characterized by production of autoantibodies and complex genetic inheritance(1-3). In a genome-wide scan using 85,042 SNPs, we identified an association between SLE and a nonsynonymous substitution (rs10516487, R61H) in the B-cell scaffold protein with ankyrin repeats gene, BANK1. We replicated the association in four independent case-control sets (combined P = 3.7 x 10(-10); OR = 1.38). We analyzed BANK1 cDNA and found two isoforms, one full-length and the other alternatively spliced and lacking exon 2 (Delta 2), encoding a protein without a putative IP3R-binding domain. The transcripts were differentially expressed depending on a branch point-site SNP, rs17266594, in strong linkage disequilibrium (LD) with rs10516487. A third associated variant was found in the ankyrin domain (rs3733197, A383T). Our findings implicate BANK1 as a susceptibility gene for SLE, with variants affecting regulatory sites and key functional domains. The disease-associated variants could contribute to sustained B cell-receptor signaling and B-cell hyperactivity characteristic of this disease.	[Kozyrev, Sergey V.; Abelson, Anna-Karin; Zaghlool, Ammar; Reddy, M. V. Prasad Linga; Alarcon-Riquelme, Marta E.] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden; [Wojcik, Jerome; Abderrahim, Hadi] Merck Serono, CH-12202 Geneva, Switzerland; [Sanchez, Elena; Martin, Javier] Inst Biomed Lopez Neyra, Granada 18100, Spain; [Gunnarsson, Iva; Svenungsson, Elisabet] Karolinska Univ Hosp, Rheumatol Unit, Dept Med, S-17176 Solna, Sweden; [Sturfelt, Gunnar; Jonsen, Andreas] Lund Univ, Dept Rheumatol, S-22200 Lund, Sweden; [Truedsson, Lennart] Lund Univ, Dept Clin Immunol & Microbiol, S-22200 Lund, Sweden; [Pons-Estel, Bernardo A.] Sanatorio Parque, RA-2000 Rosario, Santa Fe, Argentina; [Witte, Torsten] Hannover Med Sch, D-30625 Hannover, Germany; [D'Alfonso, Sandra; Barrizzone, Nadia] Univ Piemonte Orientale, IRCAD, I-13100 Novara, Italy; [D'Alfonso, Sandra; Barrizzone, Nadia] Univ Piemonte Orientale, Dept Med Sci, I-13100 Novara, Italy; [Danieli, Maria Giovanna] Univ Politecn Marche, Dipartimento Sci Med & Chirurg, I-60121 Ancona, Italy; [Gutierrez, Carmen; Suarez, Ana] Univ Oviedo, Hosp Univ Cent Asturias, Dept Funct Biol, E-33006 Oviedo, Spain; [Junker, Peter; Laustrup, Helle] Odense Univ Hosp, Rheumatol Sect, Dept Internal Med C, DK-5000 Odense, Denmark; [Gonzalez-Escribano, Maria Francisca] Hosp Virgen Rocio, Dept Immunol, Seville 41013, Spain	Uppsala University; Merck KGaA; EMD Serono Inc.; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Karolinska Institutet; Karolinska University Hospital; Lund University; Lund University; Hannover Medical School; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Marche Polytechnic University; Central University Hospital Asturias; University of Oviedo; University of Southern Denmark; Odense University Hospital; Virgen del Rocio University Hospital	Alarcon-Riquelme, ME (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden.	marta.alarcon@genpat.uu.se	Martin, Javier/B-8141-2008; Martín, María/HDL-9512-2022; Alarcón-Riquelme, Marta E./ABF-8163-2020; Suarez, Ana/F-4492-2015; Sanchez, Elena/AAC-1985-2021; Sanchez, Elena/B-4140-2017; González-Escribano, María Francisca/X-5554-2019; Martín, Javier/AAV-5209-2021; D'Alfonso, Sandra/K-7295-2014; Witte, Torsten/B-5783-2016; REDDY, M.V. PRASAD LINGA/H-6330-2012	Martin, Javier/0000-0002-2202-0622; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Suarez, Ana/0000-0002-4452-7539; Sanchez, Elena/0000-0002-7041-5485; D'Alfonso, Sandra/0000-0002-3983-9925; Abelson, Anna-Karin/0000-0002-4205-3456; Svenungsson, Elisabet/0000-0003-3396-3244; Danieli, Maria Giovanna/0000-0002-9608-2252; Pons-Estel, Bernardo/0000-0003-2518-0266; Laustrup, Helle/0000-0002-4421-9907; Rapa, Anna/0000-0002-5523-5224; Kozyrev, Sergey/0000-0001-6209-4100				Aiba Y, 2006, IMMUNITY, V24, P259, DOI 10.1016/j.immuni.2006.01.002; Alarcon-Riquelme ME, 2006, SPRINGER SEMIN IMMUN, V28, P109, DOI 10.1007/s00281-006-0033-4; Anolik Jennifer, 2003, Curr Rheumatol Rep, V5, P350, DOI 10.1007/s11926-003-0020-x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Burge C.B., 1999, RNA WORLD, V37, P525; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Flores-Borja F, 2005, ARTHRITIS RHEUM-US, V52, P3955, DOI 10.1002/art.21416; Forner K, 2008, HUM HERED, V65, P183, DOI 10.1159/000112365; Guedj M, 2006, HUM HERED, V61, P210, DOI 10.1159/000094776; Hibbs ML, 2002, J EXP MED, V196, P1593, DOI 10.1084/jem.20020515; Hucka S, 2001, AUTOIMMUNITY, V33, P213, DOI 10.3109/08916930109008048; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Kozyrev SV, 2007, ARTHRITIS RHEUM, V56, P1234, DOI 10.1002/art.22497; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Li M, 2000, J BIOL CHEM, V275, P18079, DOI 10.1074/jbc.M910197199; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; Liossis SNC, 2001, J INVEST MED, V49, P157, DOI 10.2310/6650.2001.34042; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83	28	362	374	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					211	216		10.1038/ng.79	http://dx.doi.org/10.1038/ng.79			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18204447				2022-12-17	WOS:000252732900020
J	Nordborg, M; Borevitz, JO; Bergelson, J; Berry, CC; Chory, J; Hagenblad, J; Kreitman, M; Maloof, JN; Noyes, T; Oefner, PJ; Stahl, EA; Weigel, D				Nordborg, M; Borevitz, JO; Bergelson, J; Berry, CC; Chory, J; Hagenblad, J; Kreitman, M; Maloof, JN; Noyes, T; Oefner, PJ; Stahl, EA; Weigel, D			The extent of linkage disequilibrium in Arabidopsis thaliana	NATURE GENETICS			English	Article							FLOWERING TIME; POPULATIONS; LOCUS; POLYMORPHISMS; ECOTYPES; RECOMBINATION; DIVERGENCE; DIVERSITY; GENES	Linkage disequilibrium (LD), the nonrandom occurrence of alleles in haplotypes, has long been of interest to population geneticists. Recently, the rapidly increasing availability of genomic polymorphism data has fueled interest in LD as a tool for fine-scale mapping, in particular for human disease loci(1). The chromosomal extent of LD is crucial in this context, because it determines how dense a map must be for associations to be detected and, conversely, limits how finely loci may be mapped(2). Arabidopsis thaliana is expected to harbor unusually extensive LD because of its high degree of selfing(3). Several polymorphism studies have found very strong LD within individual loci, but also evidence of some recombination(4-6). Here we investigate the pattern of LD on a genomic scale and show that in global samples, LD decays within approximately 1 cM, or 250 kb. We also show that LD in local populations may be much stronger than that of global populations, presumably as a result of founder events. The combination of a relatively high level of polymorphism and extensive haplotype structure bodes well for developing a genome-wide LD map in A. thaliana.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; Howard Hughes Med Inst, La Jolla, CA USA; Lund Univ, Dept Genet, S-22362 Lund, Sweden; Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany	University of Southern California; Salk Institute; University of Chicago; University of California System; University of California San Diego; Howard Hughes Medical Institute; Lund University; Stanford University; Max Planck Society	Nordborg, M (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.		Weigel, Detlef/AAR-3312-2021; Borevitz, Justin/B-5423-2012; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022	Borevitz, Justin/0000-0001-8408-3699; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Hagenblad, Jenny/0000-0002-9850-5546; Nordborg, Magnus/0000-0001-7178-9748; Bergelson, Joy/0000-0001-7893-7387; Maloof, Julin/0000-0002-9623-2599				ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; Aguade M, 2001, MOL BIOL EVOL, V18, P1, DOI 10.1093/oxfordjournals.molbev.a003714; Altshuler D, 2000, NAT GENET, V26, P135, DOI 10.1038/79839; Bergelson J, 1998, GENETICS, V148, P1311; Breyne P, 1999, MOL GEN GENET, V261, P627, DOI 10.1007/s004380050005; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cho RJ, 1999, NAT GENET, V23, P203, DOI 10.1038/13833; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; HANFSTINGL U, 1994, GENETICS, V138, P811; Innan H, 1996, GENETICS, V143, P1761; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; KING G, 1993, THEOR APPL GENET, V86, P1028, DOI 10.1007/BF00211057; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Long AD, 1998, GENETICS, V149, P999; Miyashita NT, 1999, GENETICS, V152, P1723; Noel L, 1999, PLANT CELL, V11, P2099, DOI 10.1105/tpc.11.11.2099; Nordborg M, 1997, GENETICS, V146, P1501; Nordborg M, 1999, AM J BOT, V86, P470, DOI 10.2307/2656807; Nordborg M, 2000, GENETICS, V154, P923; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; TODOKORO S, 1995, JPN J GENET, V70, P543, DOI 10.1266/jjg.70.543; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	29	362	390	3	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2002	30	2					190	193		10.1038/ng813	http://dx.doi.org/10.1038/ng813			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11780140				2022-12-17	WOS:000173708700020
J	Perrault, I; Rozet, JM; Calvas, P; Gerber, S; Camuzat, A; Dollfus, H; Chatelin, S; Souied, E; Ghazi, I; Leowski, C; Bonnemaison, M; LePaslier, D; Frezal, J; Dufier, JL; Pittler, S; Munnich, A; Kaplan, J				Perrault, I; Rozet, JM; Calvas, P; Gerber, S; Camuzat, A; Dollfus, H; Chatelin, S; Souied, E; Ghazi, I; Leowski, C; Bonnemaison, M; LePaslier, D; Frezal, J; Dufier, JL; Pittler, S; Munnich, A; Kaplan, J			Retinal-specific guanylate cyclase gene mutations in Leber's congenital amaurosis	NATURE GENETICS			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; CHROMOSOME 17P13.1; ALPHA-SUBUNIT; PHOSPHODIESTERASE; LOCALIZATION; RECEPTORS; MAPS	Leber's congenital amaurosis (LCA, MIM 204000(1)), the earliest and most severe form of inherited retinopathy, accounts for at least 5% of all inherited retinal dystrophies(2,3). This autosomal recessive condition is usually recognized at birth or during the first months of life in an infant with total blindness or greatly impaired vision, normal fundus and extinguished electroretinogram (ERG(4)). Nystagmus (pendular type) and characteristic eye poking are frequently observed in the first months of life (digito-ocular sign of Franceschetti(5)). Hypermetropia and keratoconus frequently develop in the course of the disease(6,7). The observation by Waardenburg(8) of nor mal children born to affected parents supports the genetic heterogeneity of LCA. Until now, however, little was known about the pathophysiology of the disease, but LCA is usually regarded as the consequence of either impaired development of photoreceptors or extremely early degeneration of cells that have developed normally(9). We have recently mapped a gene for LCA to chromosome 1.7p13.1 (LCA1) by homozygosity mapping in consanguineous families of North African origin and provided evidence of genetic heterogeneity in our sample, as LCA I accounted for 8/15 LCA families in our series(10,11). Here, we report two missense mutations (F589S) and two frameshift mutations (nt 460 del C, nt 693 del C) of the retinal guanylate cyclase (RETGC, GDB symbol GUC2D) gene in four unrelated LCA1 probands of North African ancestry and ascribe LCA1 to an impaired production of cGMP in the retina, with permanent closure of cGMP-gated cation channels.	HOP NECKER ENFANTS MALAD,UNITE RECH HANDICAPS GENET ENFANT,INSERM U393,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,SERV OPHTALMOL,PARIS,FRANCE; INST NATL JEUNES AVEUGLES,PARIS,FRANCE; CTR ETUD POLYMORPHISME HUMAIN,F-75010 PARIS,FRANCE; DEPT BIOCHEM & MOL BIOL,MOBILE,AL; DEPT OPHTHALMOL,MOBILE,AL	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite			ROZET, Jean-Michel/E-5737-2016; perrault, isabelle/H-3047-2017; Pittler, Steven/J-7091-2013	ROZET, Jean-Michel/0000-0001-7951-7886; Dollfus, Helene/0000-0002-2249-895X; perrault, isabelle/0000-0002-8560-1379; GERBER, Sylvie/0000-0002-6827-1769; Pittler, Steven/0000-0002-8464-9303; Le Paslier, Denis/0000-0003-4335-9956	NATIONAL EYE INSTITUTE [R01EY009924] Funding Source: NIH RePORTER; NEI NIH HHS [EY 09924] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CALABRESE G, 1994, GENOMICS, V23, P286, DOI 10.1006/geno.1994.1497; Camuzat A, 1996, HUM GENET, V97, P798; CAMUZAT A, 1995, HUM MOL GENET, V4, P1447, DOI 10.1093/hmg/4.8.1447; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; FITZGIBBON J, 1994, CYTOGENET CELL GENET, V67, P205, DOI 10.1159/000133823; FOXMAN SG, 1985, ARCH OPHTHALMOL-CHIC, V103, P1502; FRANCESCHETTI A, 1958, Ophthalmologica, V135, P610; FRANCESCHETTI A, 1954, Confin Neurol, V14, P184; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; KAPLAN J, 1990, HUM GENET, V85, P635; KAREL I, 1968, OPHTHALMOLOGICA, V155, P8, DOI 10.1159/000305329; Leber T., 1869, GRAEFES ARCH KLIN EX, V15, P13, DOI 10.1007/BF0272121318; LEE N R, 1987, Investigative Ophthalmology and Visual Science, V28, P344; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; LOLLEY RN, 1990, FASEB J, V4, P3001, DOI 10.1096/fasebj.4.12.1697545; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; MIZUNO K, 1977, AM J OPHTHALMOL, V83, P32, DOI 10.1016/0002-9394(77)90188-X; MURAKAMI A, 1992, BIOCHEM BIOPH RES CO, V187, P234, DOI 10.1016/S0006-291X(05)81483-4; OLIVEIRA L, 1994, GENOMICS, V22, P478, DOI 10.1006/geno.1994.1415; ROZET JM, IN PRESS GENOMICS; SempleRowland SL, 1996, INVEST OPHTH VIS SCI, V37, P3729; SHASTRY BS, 1994, AM J MED GENET, V52, P467, DOI 10.1002/ajmg.1320520413; TOMBRANTINK J, 1994, GENOMICS, V19, P266, DOI 10.1006/geno.1994.1057; WAARDENBURG PJ, 1963, ACTA OPHTHALMOL, V41, P317; WAGNER RS, 1985, ARCH OPHTHALMOL-CHIC, V103, P1507; Yang RB, 1996, GENOMICS, V31, P367, DOI 10.1006/geno.1996.0060; YUEN PST, 1992, ANNU REV NEUROSCI, V15, P193	30	362	369	0	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					461	464		10.1038/ng1296-461	http://dx.doi.org/10.1038/ng1296-461			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944027				2022-12-17	WOS:A1996VV73000023
J	KIESEWETTER, S; MACEK, M; DAVIS, C; CURRISTIN, SM; CHU, CS; GRAHAM, C; SHRIMPTON, AE; CASHMAN, SM; TSUI, LC; MICKLE, J; AMOS, J; HIGHSMITH, WE; SHUBER, A; WITT, DR; CRYSTAL, RG; CUTTING, GR				KIESEWETTER, S; MACEK, M; DAVIS, C; CURRISTIN, SM; CHU, CS; GRAHAM, C; SHRIMPTON, AE; CASHMAN, SM; TSUI, LC; MICKLE, J; AMOS, J; HIGHSMITH, WE; SHUBER, A; WITT, DR; CRYSTAL, RG; CUTTING, GR			A MUTATION IN CFTR PRODUCES DIFFERENT PHENOTYPES DEPENDING ON CHROMOSOMAL BACKGROUND	NATURE GENETICS			English	Article							CYSTIC-FIBROSIS GENE; CONDUCTANCE REGULATOR GENE; LINKAGE DISEQUILIBRIUM; DELTA-F508 MUTATION; IDENTIFICATION; MARKER	Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene but the association between mutation (genotype) and disease presentation (phenotype) is not straightforward. We have been investigating whether variants in the CFTR gene that alter splicing efficiency of exon 9 can affect the phenotype produced by a mutation. A missense mutation, R117H, which has been observed in three phenotypes, was found to occur on two chromosome backgrounds with intron 8 variants that have profoundly different effects upon splicing efficiency. A close association is shown between chromosome background of the R117H mutation and phenotype. These findings demonstrate that the genetic context in which a mutation occurs can play a significant role in determining the type of illness produced.	JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT PEDIAT & MED,BALTIMORE,MD 21287; HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA; NHLBI,PULM BRANCH,BETHESDA,MD 20892; UNIV EDINBURGH,HUMAN GENET UNIT,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND; UNIV DUBLIN TRINITY COLL,DEPT GENET,DUBLIN 2,IRELAND; REG GENET CTR,BELFAST,NORTH IRELAND; BOSTON UNIV,SCH MED,CTR HUMAN GENET,BOSTON,MA 02118; UNIV N CAROLINA,DEPT PATHOL,CHAPEL HILL,NC 27599; INTEGRATED GENET INC,FRAMINGHAM,MA 01701; KAISER PERMANENTE,DEPT GENET,SAN JOSE,CA 95119; JOHNS HOPKINS UNIV HOSP,BALTIMORE,MD 21287	Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Edinburgh; Trinity College Dublin; Boston University; University of North Carolina; University of North Carolina Chapel Hill; Kaiser Permanente; Johns Hopkins University; Johns Hopkins Medicine			Tsui, Lap-chee/A-1081-2010; Highsmith, William E/B-6175-2008					AMOS JA, 1992, PEDIAT PULMON S, V8, P142; AUDREZET MP, 1993, HUM MOL GENET, V2, P51, DOI 10.1093/hmg/2.1.51; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CARROLL TP, IN PRESS CELL PHYSL; CHEHAB FF, 1991, AM J HUM GENET, V48, P223; CHU CS, 1991, EMBO J, V10, P1355, DOI 10.1002/j.1460-2075.1991.tb07655.x; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DORK T, 1991, HUM GENET, V87, P441; DORK T, 1992, HUM GENET, V88, P417, DOI 10.1007/BF00215676; ESTIVILL X, 1989, AM J HUM GENET, V44, P704; HAMOSH A, 1992, AM J HUM GENET, V51, P245; HAMOSH A, 1992, PEDIATR PULM S, V8, P144; Hamosh Ada, 1993, P69; Handelin B. L., 1992, American Journal of Human Genetics, V51, pA218; HORN GT, 1990, CLIN CHEM, V36, P1614; KALIN N, 1993, HUM MUT, V1, P204; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; LATHAM T, 1990, AM J HUM GENET, V47, P79; Lee R., 1992, American Journal of Human Genetics, V51, pA32; OSBORNE L, 1992, HUM GENET, V89, P653, DOI 10.1007/BF00221957; REISS J, 1991, HUM GENET, V87, P457; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; STRONG TV, 1993, HUM MOL GENET, V2, P225, DOI 10.1093/hmg/2.3.225; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Witt D. R., 1992, American Journal of Human Genetics, V51, pA16; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	34	362	368	1	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					274	278		10.1038/ng1193-274	http://dx.doi.org/10.1038/ng1193-274			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	7506096				2022-12-17	WOS:A1993MF12200019
J	Markstein, M; Pitsouli, C; Villalta, C; Celniker, SE; Perrimon, N				Markstein, Michele; Pitsouli, Chrysoula; Villalta, Christians; Celniker, Susan E.; Perrimon, Norbert			Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; WHITE GENE; CHROMOSOMAL POSITION; TRANSPOSABLE ELEMENT; REGULATORY ELEMENTS; PHI-C31 INTEGRASE; RNA INTERFERENCE; TRANSFORMATION; PROTEIN	A major obstacle to creating precisely expressed transgenes lies in the epigenetic effects of the host chromatin that surrounds them. Here we present a strategy to overcome this problem, employing a Gal4-inducible luciferase assay to systematically quantify position effects of host chromatin and the ability of insulators to counteract these effects at phiC31 integration loci randomly distributed throughout the Drosophila genome. We identify loci that can be exploited to deliver precise doses of transgene expression to specific tissues. Moreover, we uncover a previously unrecognized property of the gypsy retrovirus insulator to boost gene expression to levels severalfold greater than at most or possibly all un-insulated loci, in every tissue tested. These findings provide the first opportunity to create a battery of transgenes that can be reliably expressed at high levels in virtually any tissue by integration at a single locus, and conversely, to engineer a controlled phenotypic allelic series by exploiting several loci. The generality of our approach makes it adaptable to other model systems to identify and modify loci for optimal transgene expression.	[Markstein, Michele; Pitsouli, Chrysoula; Villalta, Christians; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Markstein, Michele; Pitsouli, Chrysoula; Villalta, Christians; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Celniker, Susan E.] Lawrence Berkeley Natl Lab, Dept Genome & Computat Biol, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Markstein, M (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mmarkstein@genetics.med.harvard.edu		Pitsouli, Chrysoula/0000-0003-4074-9684; Perrimon, Norbert/0000-0001-7542-472X; Markstein, Michele/0000-0003-2635-8118	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Allen BG, 2005, NAT METHODS, V2, P975, DOI 10.1038/NMETH814; Anderson KV, 2003, NAT GENET, V33, P285, DOI 10.1038/ng1105; Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FIETZ MJ, 1995, CURR BIOL, V5, P643, DOI 10.1016/S0960-9822(95)00129-1; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gerlitz O, 2002, INT J DEV BIOL, V46, P173; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Giraldo P, 2003, TRANSGENIC RES, V12, P751, DOI 10.1023/B:TRAG.0000005089.30408.25; GLOOR GB, 1993, GENETICS, V135, P81; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HOGAN BL, 1995, MANIPULATING MOUSE E; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kuhn EJ, 2003, EMBO J, V22, P2463, DOI 10.1093/emboj/cdg241; Ledford H, 2007, NATURE, V448, P115, DOI 10.1038/448115a; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; LEWIS EB, 1950, ADV GENET, V3, P73, DOI 10.1016/S0065-2660(08)60083-8; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; Markstein M, 2004, DEVELOPMENT, V131, P2387, DOI 10.1242/dev.01124; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PIRROTTA V, 1985, EMBO J, V4, P3501, DOI 10.1002/j.1460-2075.1985.tb04109.x; Potts W, 2000, BIOCHEM BIOPH RES CO, V273, P1015, DOI 10.1006/bbrc.2000.3013; Presente A, 2002, GENESIS, V34, P165, DOI 10.1002/gene.10149; QIANQIAN Z, 2007, FLY, V1, P55; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Reeves N, 2005, DEV CELL, V8, P413, DOI 10.1016/j.devcel.2005.01.020; ROBERTSON HM, 1988, GENETICS, V118, P461; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; SMITH PA, 1995, GENETICS, V139, P215; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; Thummel CS, 1992, DROS INF SERV, V71, P150; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Yu J, 2006, GENESIS, V44, P252, DOI 10.1002/dvg.20213	49	361	364	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					476	483		10.1038/ng.101	http://dx.doi.org/10.1038/ng.101			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311141	Green Published, Green Accepted			2022-12-17	WOS:000254388100021
J	Dreyer, SD; Zhou, G; Baldini, A; Winterpacht, A; Zabel, B; Cole, W; Johnson, RL; Lee, B				Dreyer, SD; Zhou, G; Baldini, A; Winterpacht, A; Zabel, B; Cole, W; Johnson, RL; Lee, B			Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome	NATURE GENETICS			English	Article							PROTEIN; DOMAIN; GENE	The LIM-homeodomain protein Lmx1b plays a central role in dorso-ventral patterning of the vertebrate limb(1). Targeted disruption of Lmx1b results in skeletal defects including hypoplastic nails, absent patellae and a unique form of renal dysplasia (see accompanying manuscript by Fl. Chen et al.; ref. 2). These features are reminiscent of the dominantly inherited skeletal malformation nail patella syndrome (NPS). We show that LMX1B maps to the NPS locus and that three independent NPS patients carry de novo heterozygous mutations in this gene. Functional studies show that one of these mutations disrupts sequence-specific DNA binding, while the other two mutations result in premature termination of translation. These data demonstrate a unique role for LMX1B in renal development and in patterning of the skeletal system, and suggest that alteration of Lmx1b/LMX1B function in mice and humans results in similar phenotypes, Furthermore, we provide evidence for the first described mutations in a LIM-homeodomain protein which account for an inherited form of abnormal skeletal patterning and renal failure.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Mainz, Dept Pediat, D-6500 Mainz, Germany; Hosp Sick Children, Dept Orthoped Surg, Toronto, ON M5G 1X8, Canada; Univ Texas, Sch Med, MD Anderson Cancer Ctr, Dept Biochem & Mol Biol, Houston, TX USA	Baylor College of Medicine; Johannes Gutenberg University of Mainz; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; UTMD Anderson Cancer Center	Lee, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.		genes, anthony/F-2541-2012; Baldini, Antonio/M-2355-2015	Baldini, Antonio/0000-0002-5330-0256				Ausubel FM, 1994, CURRENT PROTOCOLS MO; BALDINI A, 1994, IN SITU HYBRIDIZATIO, P75; Bang AG, 1996, CURR OPIN NEUROBIOL, V6, P25, DOI 10.1016/S0959-4388(96)80005-5; CAMPEAU E, 1995, AM J HUM GENET, V56, P243; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; DELPOZO E, 1970, AM J CLIN PATHOL, V54, P845; FEUERSTEIN R, 1994, P NATL ACAD SCI USA, V91, P10655, DOI 10.1073/pnas.91.22.10655; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Gill GN, 1995, STRUCTURE, V3, P1285, DOI 10.1016/S0969-2126(01)00265-9; HOYER JR, 1972, KIDNEY INT, V2, P231, DOI 10.1038/ki.1972.99; Johnson JD, 1997, MOL CELL BIOL, V17, P3488, DOI 10.1128/MCB.17.7.3488; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Jones K. L., 1997, SMITHS RECOGNIZABLE; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; MCINTOSH L, 1997, AM J HUM GENET, V60, P133; MORITA T, 1973, ARCH INTERN MED, V131, P271, DOI 10.1001/archinte.131.2.271; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; Schmeichel KL, 1997, MOL BIOL CELL, V8, P219, DOI 10.1091/mbc.8.2.219; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; StJacques B, 1996, CURR OPIN GENET DEV, V6, P439, DOI 10.1016/S0959-437X(96)80065-7; TAIRA M, 1995, TRENDS GENET, V11, P431, DOI 10.1016/S0168-9525(00)89139-8	22	361	374	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1998	19	1					47	50		10.1038/ng0598-47	http://dx.doi.org/10.1038/ng0598-47			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590287				2022-12-17	WOS:000073346700015
J	Sassaman, DM; Dombroski, BA; Moran, JV; Kimberland, ML; Naas, TP; DeBerardinis, RJ; Gabriel, A; Swergold, GD; Kazazian, HH				Sassaman, DM; Dombroski, BA; Moran, JV; Kimberland, ML; Naas, TP; DeBerardinis, RJ; Gabriel, A; Swergold, GD; Kazazian, HH			Many human L1 elements are capable of retrotransposition	NATURE GENETICS			English	Article							HUMAN TRANSPOSABLE ELEMENT; REVERSE-TRANSCRIPTASE; SACCHAROMYCES-CEREVISIAE; DNA-SEQUENCES; INSERTION; LINE-1; MUTAGENESIS; GENE; IDENTIFICATION; FAMILY	Using a selective screening strategy to enrich for active L1 elements, we isolated 13 full-length elements from a human genomic library. We tested these and two previously-isolated L1s (L1.3 and L1.4) for reverse transcriptase (RT) activity and the ability to retrotranspose in HeLa cells, Of the 13 newly-isolated L1s, eight had RT activity and three were able to retrotranspose. L1.3 and L1.4 possessed RT activity and retrotransposed at remarkably high frequencies. These studies bring the number of characterized active human L1 elements to seven. Based on these and other data, we estimate that 30-60 active L1 elements reside in the average diploid genome.	UNIV PENN, SCH MED, DEPT GENET, PHILADELPHIA, PA 19104 USA; RUTGERS STATE UNIV, DEPT MOL BIOL & BIOCHEM, PISCATAWAY, NJ 08855 USA; US FDA, BETHESDA, MD 20892 USA	University of Pennsylvania; Rutgers State University New Brunswick; US Food & Drug Administration (FDA)			Naas, Thierry/O-3999-2018	Naas, Thierry/0000-0001-9937-9572				ADAMS JW, 1980, NUCLEIC ACIDS RES, V8, P6113, DOI 10.1093/nar/8.24.6113; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; BRAITERMAN LT, 1994, GENE, V139, P19, DOI 10.1016/0378-1119(94)90518-5; BURTON FH, 1986, J MOL BIOL, V187, P291, DOI 10.1016/0022-2836(86)90235-4; DERR LK, 1991, CELL, V67, P355, DOI 10.1016/0092-8674(91)90187-4; DOMBROSKI BA, 1994, MOL CELL BIOL, V14, P4485, DOI 10.1128/MCB.14.7.4485; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; FANNING TG, 1987, BIOCHIM BIOPHYS ACTA, V910, P203, DOI 10.1016/0167-4781(87)90112-6; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FREEMAN JD, 1994, BIOTECHNIQUES, V17, P47; GARFINKEL DJ, 1985, CELL, V42, P507, DOI 10.1016/0092-8674(85)90108-4; GOFF S, 1981, J VIROL, V38, P239, DOI 10.1128/JVI.38.1.239-248.1981; GRIMALDI G, 1984, EMBO J, V3, P1753, DOI 10.1002/j.1460-2075.1984.tb02042.x; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; HOLMES SE, 1992, J BIOL CHEM, V267, P19765; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; HWU HR, 1986, P NATL ACAD SCI USA, V83, P3875, DOI 10.1073/pnas.83.11.3875; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; MIKI Y, 1992, CANCER RES, V52, P643; MINAKAMI R, 1992, NUCLEIC ACIDS RES, V20, P3139, DOI 10.1093/nar/20.12.3139; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; ROSE MD, 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SASSAMAN DM, 1996, THESIS J HOPKINS U B; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; TEMIN HM, 1985, MOL BIOL EVOL, V2, P455; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; [No title captured]	39	361	368	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1997	16	1					37	43		10.1038/ng0597-37	http://dx.doi.org/10.1038/ng0597-37			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140393				2022-12-17	WOS:A1997WX02400020
J	Nagle, DL; Karim, MA; Woolf, EA; Holmgren, L; Bork, P; Misumi, DJ; McGrail, SH; Dussault, BJ; Perou, CM; Boissy, RE; Duyk, GM; Spritz, RA; Moore, KJ				Nagle, DL; Karim, MA; Woolf, EA; Holmgren, L; Bork, P; Misumi, DJ; McGrail, SH; Dussault, BJ; Perou, CM; Boissy, RE; Duyk, GM; Spritz, RA; Moore, KJ			Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome	NATURE GENETICS			English	Article							PROTEIN-KINASE; FIBROBLASTS; RAPAMYCIN		MILLENNIUM PHARMACEUT INC,CAMBRIDGE,MA 02139; UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53706; UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53706; EUROPEAN MOL BIOL LABS,HEIDELBERG,GERMANY; MAX DELBRUCK CTR MOL MED,BERLIN,GERMANY; UNIV UTAH,SCH MED,DEPT PATHOL,DIV CELL BIOL & IMMUNOL,SALT LAKE CITY,UT 84132; UNIV CINCINNATI,COLL MED,DEPT DERMATOL,CINCINNATI,OH 45267	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Utah System of Higher Education; University of Utah; University System of Ohio; University of Cincinnati			Perou, Charles M/H-9934-2014; Bork, Peer/F-1813-2013	Perou, Charles M/0000-0001-9827-2247; Bork, Peer/0000-0002-2627-833X				ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Barrat FJ, 1996, AM J HUM GENET, V59, P625; Beguez-Cesar AB, 1943, B SOC CUBANA PEDIAT, V15, P900; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bork P, 1996, CURR OPIN STRUC BIOL, V6, P366, DOI 10.1016/S0959-440X(96)80057-1; Bork P, 1996, METHOD ENZYMOL, V266, P162; BRANDT EJ, 1975, J CELL BIOL, V67, P774, DOI 10.1083/jcb.67.3.774; BURKHARDT JK, 1993, J EXP MED, V178, P1845, DOI 10.1084/jem.178.6.1845; CHEDIAK M M, 1952, Rev Hematol, V7, P362; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Fukai K, 1996, AM J HUM GENET, V59, P620; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HERMAN PK, 1991, EMBO J, V10, P4049, DOI 10.1002/j.1460-2075.1991.tb04981.x; HIGASHI O, 1954, Tohoku J Exp Med, V59, P315; Holcombe R F, 1994, Immunodeficiency, V5, P131; JONES KL, 1992, CLIN IMMUNOL IMMUNOP, V65, P219, DOI 10.1016/0090-1229(92)90150-M; KLIONSKY DJ, 1990, J BIOL CHEM, V265, P5349; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; LUTZNER MA, 1966, HEREDITY, V58, P299; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; NOVAK EK, 1984, BLOOD, V63, P536; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; PENNER JD, 1987, AM J MED GENET, V28, P445, DOI 10.1002/ajmg.1320280222; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; STEIN L, 1995, UNPUB; STEINBRINCK W, 1948, DEUT ARCH KLIN MED, V193, P577; SWANK RT, 1978, AM J PATHOL, V92, P755; WILLINGHAM MC, 1981, EXP CELL RES, V136, P157, DOI 10.1016/0014-4827(81)90047-1; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; ZHAO HQ, 1994, LAB INVEST, V71, P25; ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6	37	361	374	0	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					307	311		10.1038/ng1196-307	http://dx.doi.org/10.1038/ng1196-307			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896560	Green Submitted			2022-12-17	WOS:A1996VQ14600025
J	Chen, JK; Liu, H; Liu, J; Qi, J; Wei, B; Yang, JQ; Liang, HQ; Chen, Y; Chen, J; Wu, YR; Guo, L; Zhu, JY; Zhao, XJ; Peng, TR; Zhang, YX; Chen, S; Li, XJ; Li, DW; Wang, T; Pei, DQ				Chen, Jiekai; Liu, He; Liu, Jing; Qi, Jing; Wei, Bei; Yang, Jiaqi; Liang, Hanquan; Chen, You; Chen, Jing; Wu, Yaran; Guo, Lin; Zhu, Jieying; Zhao, Xiangjie; Peng, Tianran; Zhang, Yixin; Chen, Shen; Li, Xuejia; Li, Dongwei; Wang, Tao; Pei, Duanqing			H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs	NATURE GENETICS			English	Article							PLURIPOTENT STEM-CELLS; SELF-RENEWAL; FIBROBLASTS; INDUCTION; GENERATION; KLF4	The induction of pluripotent stem cells (iPSCs) by defined factors is poorly understood stepwise. Here, we show that histone H3 lysine 9 (H3K9) methylation is the primary epigenetic determinant for the intermediate pre-iPSC state, and its removal leads to fully reprogrammed iPSCs. We generated a panel of stable pre-iPSCs that exhibit pluripotent properties but do not activate the core pluripotency network, although they remain sensitive to vitamin C for conversion into iPSCs. Bone morphogenetic proteins (BMPs) were subsequently identified in serum as critical signaling molecules in arresting reprogramming at the pre-iPSC state. Mechanistically, we identified H3K9 methyltransferases as downstream targets of BMPs and showed that they function with their corresponding demethylases as the on/off switch for the pre-iPSC fate by regulating H3K9 methylation status at the core pluripotency loci. Our results not only establish pre-iPSCs as an epigenetically stable signpost along the reprogramming road map, but they also provide mechanistic insights into the epigenetic reprogramming of cell fate.	[Chen, Jiekai; Liu, He; Liu, Jing; Qi, Jing; Wei, Bei; Yang, Jiaqi; Liang, Hanquan; Chen, You; Chen, Jing; Wu, Yaran; Guo, Lin; Zhu, Jieying; Zhao, Xiangjie; Peng, Tianran; Zhang, Yixin; Chen, Shen; Li, Xuejia; Li, Dongwei; Wang, Tao; Pei, Duanqing] Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Chen, Jiekai; Liu, He; Liu, Jing; Qi, Jing; Wei, Bei; Yang, Jiaqi; Liang, Hanquan; Chen, You; Chen, Jing; Wu, Yaran; Guo, Lin; Zhu, Jieying; Zhao, Xiangjie; Peng, Tianran; Zhang, Yixin; Chen, Shen; Li, Xuejia; Li, Dongwei; Wang, Tao; Pei, Duanqing] Chinese Acad Sci, Guangdong Prov Key Lab Stem Cell & Regenerat Med, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Pei, DQ (corresponding author), Chinese Acad Sci, Key Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Peng, Tianran/AES-0353-2022; Peng, Tianran/AAG-9825-2022	Wei, Bei/0000-0003-1516-8802; Peng, Tianran/0000-0001-8309-4652; Chen, Jiekai/0000-0001-5168-7074	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020401, XDA01020202, XDA01020302]; National Basic Research Program of China [2009CB941102, 2011CBA01106, 2011CB965204, 2012CB966802]; National Natural Science Foundation of China [31271357, 91213304]; Ministry of Science and Technology International Technology Cooperation Program [2010DFB30430, 2012DFH30050]; National Science and Technology Major Special Project on Major New Drug Innovation [2011ZX09102-010]; Bureau of Science and Technology of Guangzhou Municipality, China [2010U1-E00521]; Guangdong Science and Technology Project [2010A090603001, 2011A08030002]; Science and Technology Planning Project of Guangdong Province, China [2011A060901019]; One Hundred Person Project of The Chinese Academy of Sciences; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Pearl River Nova program [2012J2200070]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology International Technology Cooperation Program; National Science and Technology Major Special Project on Major New Drug Innovation; Bureau of Science and Technology of Guangzhou Municipality, China; Guangdong Science and Technology Project; Science and Technology Planning Project of Guangdong Province, China; One Hundred Person Project of The Chinese Academy of Sciences; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Pearl River Nova program	We are grateful to X. Shu for careful reading and critical comments of the manuscript. We appreciate the contributions of J. Nie to microarray data analysis. We thank H. Zheng, X. Liu, J. Zhao, H. Wu, F. Li, D. Qin, R. Li, M. Esteban, G. Xu and B. Qin for constructive criticism. We also thank L. Zeng, G. Zhu, S. Sun, Y. Wu, K. Lai, H. Pang, H. Zhang, W. He, A. Jiang, T. Zhou, J. Li, S. Huang, J. Xu and D. Yang for technical assistance. We deeply appreciate the assistance of H. Song, K. Mo and S. Chu in blastocyst injection. This work is supported in part by the Strategic Priority Research Program of the Chinese Academy of Sciences (grants XDA01020401, XDA01020202 and XDA01020302), the National Basic Research Program of China (grants 2009CB941102, 2011CBA01106, 2011CB965204 and 2012CB966802), the National Natural Science Foundation of China (grants 31271357 and 91213304), the Ministry of Science and Technology International Technology Cooperation Program (grants 2010DFB30430 and 2012DFH30050), the National Science and Technology Major Special Project on Major New Drug Innovation (grant 2011ZX09102-010), the Bureau of Science and Technology of Guangzhou Municipality, China (grant 2010U1-E00521), the Guangdong Science and Technology Project (grants 2010A090603001 and 2011A08030002), Science and Technology Planning Project of Guangdong Province, China (grant 2011A060901019), the One Hundred Person Project of The Chinese Academy of Sciences to D. P., the Youth Innovation Promotion Association of the Chinese Academy of Sciences and the Pearl River Nova program (grant 2012J2200070). We wish to thank all members of our laboratories for their support.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Chen JK, 2010, J BIOL CHEM, V285, P31066, DOI 10.1074/jbc.M110.139436; Childs AJ, 2010, STEM CELLS, V28, P1368, DOI 10.1002/stem.440; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Frontelo P, 2004, ONCOGENE, V23, P5242, DOI 10.1038/sj.onc.1207660; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Krishnan S, 2011, CHEMBIOCHEM, V12, P254, DOI 10.1002/cbic.201000545; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mattout A, 2011, J MOL CELL BIOL, V3, P341, DOI 10.1093/jmcb/mjr028; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229	39	360	393	3	158	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2013	45	1					34	U62		10.1038/ng.2491	http://dx.doi.org/10.1038/ng.2491			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	061HJ	23202127				2022-12-17	WOS:000312838800010
J	Van Deerlin, VM; Sleiman, PMA; Martinez-Lage, M; Chen-Plotkin, A; Wang, LS; Graff-Radford, NR; Dickson, DW; Rademakers, R; Boeve, BF; Grossman, M; Arnold, SE; Mann, DMA; Pickering-Brown, SM; Seelaar, H; Heutink, P; van Swieten, JC; Murrell, JR; Ghetti, B; Spina, S; Grafman, J; Hodges, J; Spillantini, MG; Gilman, S; Lieberman, AP; Kaye, JA; Woltjer, RL; Bigio, EH; Mesulam, M; al-Sarraj, S; Troakes, C; Rosenberg, RN; White, CL; Ferrer, I; Llado, A; Neumann, M; Kretzschmar, HA; Hulette, CM; Welsh-Bohmer, KA; Miller, BL; Alzualde, A; de Munain, AL; McKee, AC; Gearing, M; Levey, AI; Lah, JJ; Hardy, J; Rohrer, JD; Lashley, T; Mackenzie, IRA; Feldman, HH; Hamilton, RL; Dekosky, ST; van der Zee, J; Kumar-Singh, S; Van Broeckhoven, C; Mayeux, R; Vonsattel, JPG; Troncoso, JC; Kril, JJ; Kwok, JBJ; Halliday, GM; Bird, TD; Ince, PG; Shaw, PJ; Cairns, NJ; Morris, JC; McLean, CA; DeCarli, C; Ellis, WG; Freeman, SH; Frosch, MP; Growdon, JH; Perl, DP; Sano, M; Bennett, DA; Schneider, JA; Beach, TG; Reiman, EM; Woodruff, BK; Cummings, J; Vinters, HV; Miller, CA; Chui, HC; Alafuzoff, I; Hartikainen, P; Seilhean, D; Galasko, D; Masliah, E; Cotman, CW; Tunon, MT; Martinez, MCC; Munoz, DG; Carroll, SL; Marson, D; Riederer, PF; Bogdanovic, N; Schellenberg, GD; Hakonarson, H; Trojanowski, JQ; Lee, VMY				Van Deerlin, Vivianna M.; Sleiman, Patrick M. A.; Martinez-Lage, Maria; Chen-Plotkin, Alice; Wang, Li-San; Graff-Radford, Neill R.; Dickson, Dennis W.; Rademakers, Rosa; Boeve, Bradley F.; Grossman, Murray; Arnold, Steven E.; Mann, David M. A.; Pickering-Brown, Stuart M.; Seelaar, Harro; Heutink, Peter; van Swieten, John C.; Murrell, Jill R.; Ghetti, Bernardino; Spina, Salvatore; Grafman, Jordan; Hodges, John; Spillantini, Maria Grazia; Gilman, Sid; Lieberman, Andrew P.; Kaye, Jeffrey A.; Woltjer, Randall L.; Bigio, Eileen H.; Mesulam, Marsel; al-Sarraj, Safa; Troakes, Claire; Rosenberg, Roger N.; White, Charles L., III; Ferrer, Isidro; Llado, Albert; Neumann, Manuela; Kretzschmar, Hans A.; Hulette, Christine Marie; Welsh-Bohmer, Kathleen A.; Miller, Bruce L.; Alzualde, Ainhoa; Lopez de Munain, Adolfo; McKee, Ann C.; Gearing, Marla; Levey, Allan I.; Lah, James J.; Hardy, John; Rohrer, Jonathan D.; Lashley, Tammaryn; Mackenzie, Ian R. A.; Feldman, Howard H.; Hamilton, Ronald L.; Dekosky, Steven T.; van der Zee, Julie; Kumar-Singh, Samir; Van Broeckhoven, Christine; Mayeux, Richard; Vonsattel, Jean Paul G.; Troncoso, Juan C.; Kril, Jillian J.; Kwok, John B. J.; Halliday, Glenda M.; Bird, Thomas D.; Ince, Paul G.; Shaw, Pamela J.; Cairns, Nigel J.; Morris, John C.; McLean, Catriona Ann; DeCarli, Charles; Ellis, William G.; Freeman, Stefanie H.; Frosch, Matthew P.; Growdon, John H.; Perl, Daniel P.; Sano, Mary; Bennett, David A.; Schneider, Julie A.; Beach, Thomas G.; Reiman, Eric M.; Woodruff, Bryan K.; Cummings, Jeffrey; Vinters, Harry V.; Miller, Carol A.; Chui, Helena C.; Alafuzoff, Irina; Hartikainen, Paivi; Seilhean, Danielle; Galasko, Douglas; Masliah, Eliezer; Cotman, Carl W.; Tunon, M. Teresa; Martinez, M. Cristina Caballero; Munoz, David G.; Carroll, Steven L.; Marson, Daniel; Riederer, Peter F.; Bogdanovic, Nenad; Schellenberg, Gerard D.; Hakonarson, Hakon; Trojanowski, John Q.; Lee, Virginia M-Y			Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP43 inclusions	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GLOBAL GENE-EXPRESSION; GENOTYPE DATA; DEMENTIA; PROGRANULIN; MUTATIONS; CONSENSUS; DISEASE; ONSET; FAMILIES	Frontotemporal lobar degeneration (FTLD) is the second most common cause of presenile dementia. The predominant neuropathology is FTLD with TAR DNA-binding protein (TDP-43) inclusions (FTLD-TDP) 1. FTLD-TDP is frequently familial, resulting from mutations in GRN (which encodes progranulin). We assembled an international collaboration to identify susceptibility loci for FTLD-TDP through a genome-wide association study of 515 individuals with FTLD-TDP. We found that FTLD-TDP associates with multiple SNPs mapping to a single linkage disequilibrium block on 7p21 that contains TMEM106B. Three SNPs retained genome-wide significance following Bonferroni correction (top SNP rs1990622, P = 1.08 x 10(-11); odds ratio, minor allele (C) 0.61, 95% CI 0.53-0.71). The association replicated in 89 FTLD-TDP cases (rs1990622; P = 2 x 10(-4)). TMEM106B variants may confer risk of FTLD-TDP by increasing TMEM106B expression. TMEM106B variants also contribute to genetic risk for FTLD-TDP in individuals with mutations in GRN. Our data implicate variants in TMEM106B as a strong risk factor for FTLD-TDP, suggesting an underlying pathogenic mechanism.	[Van Deerlin, Vivianna M.; Martinez-Lage, Maria; Chen-Plotkin, Alice; Wang, Li-San; Schellenberg, Gerard D.; Trojanowski, John Q.; Lee, Virginia M-Y] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Ctr Appl Genom, Div Human Genet,Sch Med, Philadelphia, PA 19104 USA; [Martinez-Lage, Maria] Univ Autonoma Barcelona, Dept Neurol, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Chen-Plotkin, Alice; Grossman, Murray; Arnold, Steven E.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Graff-Radford, Neill R.] Mayo Coll Med, Dept Neurol, Jacksonville, FL USA; [Dickson, Dennis W.; Rademakers, Rosa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Boeve, Bradley F.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Arnold, Steven E.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Arnold, Steven E.] Univ Penn, Sch Med, Penn Memory Ctr, Philadelphia, PA 19104 USA; [Mann, David M. A.; Pickering-Brown, Stuart M.] Univ Manchester, Sch Community Based Med, Manchester, Lancs, England; [Seelaar, Harro; van Swieten, John C.] Erasmus MC, Rotterdam, Netherlands; [Heutink, Peter] Vrije Univ Amsterdam, Med Ctr, Sect Med Genom, Dept Clin Genet, Amsterdam, Netherlands; [Murrell, Jill R.; Ghetti, Bernardino; Spina, Salvatore] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Murrell, Jill R.; Ghetti, Bernardino; Spina, Salvatore] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN USA; [Spina, Salvatore] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy; [Grafman, Jordan] Natl Inst Neurol Disorders & Stroke, Cognit Neurosci Sect, Bethesda, MD USA; [Spillantini, Maria Grazia] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England; [Gilman, Sid] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Lieberman, Andrew P.] Univ Michigan, Dept Pathol, Ann Arbor, MI USA; [Kaye, Jeffrey A.] Oregon Hlth & Sci Univ, Dept Neurol & Biomed Engn, Portland, OR 97201 USA; [Woltjer, Randall L.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Bigio, Eileen H.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Bigio, Eileen H.; Mesulam, Marsel] Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimer Dis Ctr, Chicago, IL 60611 USA; [al-Sarraj, Safa] Kings Coll Hosp London, Inst Psychiat, Dept Clin Neuropathol, London, England; [Troakes, Claire] Kings Coll Hosp London, MRC, London Neurodegenerat Dis Brain Bank, Inst Psychiat, London, England; [Rosenberg, Roger N.] Univ Texas SW Med Ctr Dallas, Rush Alzheimers Dis Ctr, Dallas, TX 75390 USA; [White, Charles L., III] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Ferrer, Isidro] Hosp Univ Bellvitge, Inst Neuropatol, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Llado, Albert] Hosp Clin Barcelona, Alzheimers Dis & Cognit Disorders Unit, Serv Neurol, Inst Clin Neurociencies, Barcelona, Spain; [Neumann, Manuela] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Kretzschmar, Hans A.] Univ Munich, Ctr Neuropathol & Prion Res, Munich, Germany; [Hulette, Christine Marie] Duke Univ, Dept Pathol, Hlth Sci Ctr, Durham, NC 27706 USA; [Welsh-Bohmer, Kathleen A.] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [Welsh-Bohmer, Kathleen A.] Duke Univ, Med Ctr, Bryan Alzheimers Dis Res Ctr, Durham, NC 27710 USA; [Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Alzualde, Ainhoa] Hosp Donostia, Neurogenet Unit, Inst Biodonostia, San Sebastian, Spain; [Lopez de Munain, Adolfo] Hosp Donostia, Serv Neurol, San Sebastian, Spain; [McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [McKee, Ann C.] Ctr Geriatr Res Educ & Clin, Bedford Vet Adm Med Ctr, Bedford, MA USA; [Gearing, Marla] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Gearing, Marla; Levey, Allan I.] Emory Univ, Sch Med, Alzheimers Dis Res Ctr, Atlanta, GA 30322 USA; [Gearing, Marla; Levey, Allan I.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Levey, Allan I.; Lah, James J.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Hardy, John] UCL, Inst Neurol, Reta Lila Labs, London, England; [Hardy, John; Lashley, Tammaryn] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Rohrer, Jonathan D.] UCL, Inst Neurol, Dementia Res Ctr, London, England; [Lashley, Tammaryn] UCL, Inst Neurol, Queen Sq Brain Bank Neurol Disorders, London, England; [Mackenzie, Ian R. A.] Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Mackenzie, Ian R. A.; Feldman, Howard H.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Feldman, Howard H.] Vancouver Gen Hosp, Div Neurol, Vancouver, BC, Canada; [Feldman, Howard H.] Bristol Myers Squibb Co, Neurosci, Wallingford, CT 06492 USA; [Hamilton, Ronald L.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Dekosky, Steven T.] Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA 22908 USA; [van der Zee, Julie; Kumar-Singh, Samir; Van Broeckhoven, Christine] VIB, Neurodegenerat Brain Dis Grp, Dept Mol Genet, Antwerp, Belgium; [van der Zee, Julie; Kumar-Singh, Samir; Van Broeckhoven, Christine] Univ Antwerp, Inst Born Bunge, B-2020 Antwerp, Belgium; [Mayeux, Richard; Vonsattel, Jean Paul G.] Columbia Univ, Taub Inst Res Alzheimers Dis, New York, NY USA; [Vonsattel, Jean Paul G.] Columbia Univ, New York Brain Bank, New York, NY USA; [Vonsattel, Jean Paul G.] Columbia Univ, Dept Pathol, New York, NY USA; [Troncoso, Juan C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Troncoso, Juan C.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Kril, Jillian J.] Univ Sydney, Discipline Med, Sydney, NSW 2006, Australia; [Kril, Jillian J.] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia; [Kwok, John B. J.; Halliday, Glenda M.] Univ New S Wales, Prince Wales Med Res Inst, Sydney, NSW, Australia; [Bird, Thomas D.] Vet Affairs Puget Sound Hlth Care Syst, GRECC, Seattle, WA USA; [Bird, Thomas D.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Ince, Paul G.; Shaw, Pamela J.] Univ Sheffield, Dept Neurosci, Sheffield, S Yorkshire, England; [Cairns, Nigel J.; Morris, John C.] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO USA; [Cairns, Nigel J.; Morris, John C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO USA; [McLean, Catriona Ann] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic, Australia; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Alzheimers Dis Ctr, Imaging Dementia & Aging Lab,Ctr Neurosci, Sacramento, CA 95817 USA; [Ellis, William G.] Univ Calif Davis, Dept Pathol, Sacramento, CA 95817 USA; [Freeman, Stefanie H.; Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA; [Freeman, Stefanie H.; Frosch, Matthew P.; Growdon, John H.] Harvard Univ, Sch Med, Boston, MA USA; [Growdon, John H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Perl, Daniel P.] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Sano, Mary] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Sano, Mary] James J Peters Vet Affairs Med Ctr, New York, NY USA; [Bennett, David A.; Schneider, Julie A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Beach, Thomas G.] Sun Hlth Res Inst, Sun City, AZ USA; [Reiman, Eric M.] Univ Arizona, Banner Alzheimers Inst, Translat Genom Res Inst, Phoenix, AZ USA; [Reiman, Eric M.] Arizona Alzheimers Consortium, Phoenix, AZ USA; [Woodruff, Bryan K.] Mayo Clin, Scottsdale, AZ USA; [Cummings, Jeffrey] Univ Calif Los Angeles, David Geffen Sch Med, Mary S Easton Ctr Alzheimers Dis Res, Los Angeles, CA 90095 USA; [Vinters, Harry V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Vinters, Harry V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Miller, Carol A.; Chui, Helena C.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Alafuzoff, Irina] Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; [Alafuzoff, Irina] Univ Kuopio, Dept Clin Med, FIN-70211 Kuopio, Finland; [Hartikainen, Paivi] Univ Kuopio, Dept Neurol, FIN-70211 Kuopio, Finland; [Seilhean, Danielle] Univ Paris 06, Paris, France; [Seilhean, Danielle] AP HP, Paris, France; [Galasko, Douglas; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Cotman, Carl W.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Tunon, M. Teresa] Hosp Navarra Pathol Dept, Navarra, Spain; [Tunon, M. Teresa; Martinez, M. Cristina Caballero] Brain Bank Navarra, Navarra, Spain; [Martinez, M. Cristina Caballero] Navarra Hlth Serv Osasunbidea, Biomed Res Ctr, Navarra, Spain; [Munoz, David G.] Univ Toronto, St Michaels Hosp, Dept Lab Med & Pathobiol, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Carroll, Steven L.] Univ Alabama, Dept Pathol, Tuscaloosa, AL 35487 USA; [Marson, Daniel] Univ Alabama, Dept Neurol, Tuscaloosa, AL 35487 USA; [Marson, Daniel] Univ Alabama, Alzheimers Dis Res Ctr, Tuscaloosa, AL 35487 USA; [Riederer, Peter F.] Univ Wurzburg, Clin & Policlin Psychiat Psychosomat & Psychother, Wurzburg, Germany; [Bogdanovic, Nenad] Karolinska Univ Hosp, Dept Geriatr Med, Stockholm, Sweden; [Hakonarson, Hakon] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div Pulm Med,Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; University of Pennsylvania; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Pennsylvania; University of Pennsylvania; University of Manchester; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Siena; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Cambridge; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Oregon Health & Science University; Oregon Health & Science University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Zurich; University Zurich Hospital; University of Munich; Duke University; Duke University; Duke University; University of California System; University of California San Francisco; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University Hospital Donostia; Boston University; Boston University; Geriatric Research Education & Clinical Center; Emory University; Emory University; Emory University; Emory University; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of British Columbia; University of British Columbia; University of British Columbia; Bristol-Myers Squibb; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia; Flanders Institute for Biotechnology (VIB); University of Antwerp; Columbia University; Columbia University; Columbia University; Johns Hopkins University; Johns Hopkins University; University of Sydney; University of Sydney; Prince Wales Medical Research Institute; University of New South Wales Sydney; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Sheffield; Washington University (WUSTL); Washington University (WUSTL); Florey Institute of Neuroscience & Mental Health; University of California System; University of California Davis; University of California System; University of California Davis; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rush University; Banner Research; Banner Health; Banner Sun Health Research Institute; Banner Research; Banner Health; Banner Alzheimer's Institute; Translational Genomics Research Institute; University of Arizona; Mayo Clinic; Mayo Clinic Phoenix; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; Uppsala University; University of Eastern Finland; University of Eastern Finland; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Irvine; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Tuscaloosa; University of Wurzburg; Karolinska Institutet; Karolinska University Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Van Deerlin, VM (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	vivianna@mail.med.upenn.edu; trojanow@mail.med.upenn.edu	Ince, Paul G/A-5064-2009; Pickering-Brown, Stuart/D-4008-2009; Mayeux, Richard/E-9788-2013; Morris, John C/A-1686-2012; Shaw, Pamela/E-6193-2010; Van Broeckhoven, Christine/G-8362-2017; Sander-Effron, Samuel/AAX-2231-2020; White, Charles L/AAJ-1858-2021; Troakes, Claire/K-4346-2015; Perl, Daniel/GPS-9879-2022; Welsh-Bohmer, Kathleen/AAA-3178-2020; Tuñón, María Jesús/L-2456-2017; Lashley, Tammaryn/D-2583-2009; Halliday, Glenda M/E-8555-2011; Tuñón, Teresa/B-2525-2017; Van Broeckhoven, Christine/M-7853-2019; Spina, Salvatore/M-4463-2019; Seilhean, Danielle D/O-6899-2018; Kumar-Singh, Samir/G-6280-2012; Shaw, Pamela J/A-7620-2010; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; Martinez-Lage, Maria/S-6665-2019; DeCarli, Charles/B-5541-2009; Neumann, Manuela/F-6558-2011; Levey, Allan/F-2104-2011; Arnold, Steven E/J-7546-2012; Munoz, David G./AAQ-8003-2020; Hardy, John/C-2451-2009; Frosch, Matthew P/ABD-7456-2021; Cairns, Nigel/AAB-9713-2020	Ince, Paul G/0000-0001-6677-8753; Pickering-Brown, Stuart/0000-0003-1561-6054; Mayeux, Richard/0000-0001-6519-9696; Van Broeckhoven, Christine/0000-0003-0183-7665; White, Charles L/0000-0002-3870-2804; Halliday, Glenda M/0000-0003-0422-8398; Tuñón, Teresa/0000-0001-6589-1084; Van Broeckhoven, Christine/0000-0003-0183-7665; Seilhean, Danielle D/0000-0003-3498-4602; Kumar-Singh, Samir/0000-0001-9466-6732; Neumann, Manuela/0000-0002-6232-4057; Levey, Allan/0000-0002-3153-502X; Munoz, David G./0000-0003-0957-6244; Hardy, John/0000-0002-3122-0423; Frosch, Matthew P/0000-0002-3940-9861; Cairns, Nigel/0000-0001-9858-3344; Heutink, Peter/0000-0001-5218-1737; Martinez-Lage, Maria/0000-0002-5859-7562; Feldman, Howard/0000-0002-9258-4538; Dickson, Dennis W/0000-0001-7189-7917; DeKosky, Steven/0000-0003-3743-2758; Kwok, John/0000-0001-9574-6195; Shaw, Pamela/0000-0002-8925-2567; Lashley, Tammaryn/0000-0001-7389-0348; Troakes, Claire/0000-0002-1790-7376; /0000-0002-9509-4032; Rohrer, Jonathan/0000-0002-6155-8417; McLean, Catriona/0000-0002-0302-5727; Kaye, Jeffrey/0000-0002-9971-3478; Carroll, Steven/0000-0001-6714-4373; Kril, Jillian/0000-0001-9407-8674; Grafman, Jordan H./0000-0001-8645-4457	National Health and Medical Research Council of Australia; Biobank at the Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium; French clinical and genetic research network; MRC [G0301152, G9724461, G0701441, G0601943, G0600676] Funding Source: UKRI; Medical Research Council [G9724461, G0301152, G0601943, G0600676, G0701441] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS015655, P01NS015655, R01NS044266, R01NS065782, P01NS044233, ZIANS003023, P50NS053488, P50NS038372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008017, P30AG013854, P50AG005133, P50AG016582, R01AG015116, P50AG005138, P50AG005131, P01AG003949, R37AG018440, P50AG016574, P01AG019724, P50AG008702, P01AG017586, P50AG008671, P30AG010133, P30AG012300, P50AG005134, P30AG010161, P50AG016573, P50AG005142, P01AG003991, P30AG013846, P30AG019610, P50AG005136, P30AG010124, R01AG018440, P01AG002219, P30AG010129, P50AG016570, P30AG028377, P50AG005681, P50AG025688, P50AG005146, K08AG033101] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Biobank at the Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium; French clinical and genetic research network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was enabled by the contributions and efforts of many individuals in several supportive capacities. Most importantly, we extend our appreciation to the study subjects and families who made this research possible. Extensive technical assistance was provided by R. Greene, T. Unger and C. Kim and study coordination was provided by E. McCarty Wood. The following individuals contributed through sample ascertainment, epidemiology, coordination, and/or clinical evaluation of cases: S. Weintraub, N. Johnson, C. Shaw, V. Haroutunian, R. C. Petersen, D. S. Knopman, K. A. Josephs, D. Neary, J. Snowden, J. Heidebrink, N. Barbas, R. Re e, J. R. Burke, K. Hayden, J. Browndyke, P. Gaskell, M. Szymanski, J. D. Glass, M. Rossor, F. Moreno, B. Indakoetxea, M. Barandiaran, S. Engelborghs, P. P. De Deyn, W. S. Brooks, T. Chow, V. Meininger, L. Lacomblez and E. Gruenblatt. The following individuals contributed through pathological characterization and evaluation of cases: D. Clark, A. King, I. Bodi, D. Purohit, L. Kwong, J. E. Parisi, W. Kamphorst, I. Ruiz, T. Revesz, J.-J. Martin, R. Highley and C. Duyckaerts. The following individuals contributed through general technical assistance and/or genetic studies: J. Kirby, E. Moore, M. Baker, R. Crook, S. Rollinson, N. Halliwell, S. Usher, R. M. Richardson, M. Mishra, C. Foong, J. Ervin, K. Price Bryan, J. Ervin, C. Kubilus, A. Gorostidi, M. Cruts, I. Gijselinck, H. McCann, P. R. Schofield, G. Forster, K. Firch, J. Pomaician, I. Leber, V. Sazdovitch and I. Volkmann. We also thank the Brain Bank of University of Barcelona, Hospital Clinic, Clinic for Alzheimer's Disease and Related Disorders University of British Columbia, Australian Brain Donor Programs supported by the National Health and Medical Research Council of Australia, Biobank at the Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium and the French clinical and genetic research network on FTD/FTD-motor neuron disease (MND). Many grant funding agencies provided financial support for this study, including the US National Institutes of Health (NIH) (grant numbers AG10124, AG17586, AG16574, AG03949, AG17586, NS44266, AG15116, NS53488, AG10124, AG010133, AG08671, NS044233, NS15655, AG008017, AG13854, AG12300, AG028377, AG 019724, AG13846, AG025688, AG05133, AG08702, AG05146, AG005136, AG005681, AG03991, AG010129, AG05134, NS038372, AG02219, AG05138, AG10161, AG19610, AG19610, AG16570, AG16570, AG05142, AG005131, AG5131, AG18440, AG16582, AG16573, AG033101 and NIH Intramural Program). Additional funds were provided by Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program, the Pacific Alzheimer's disease Research Foundation (PARF) grant #C06-01, the Alzheimer's Research Trust, Alzheimer's Society, Medical Research Council (Programme Grant and Returning Scientist Award), Stichting Dioraphte (07010500), Hersenstichting (15F07.2.34), Prinses Beatrix Fonds (0060204), Winspear Family Center for Research on the Neuropathology of Alzheimer Disease, the McCune Foundation, Instituto Carlos III, Federal Ministry of Education and Research (01GI0505), SAIOTEK Program (Basque Government), Department of Innovation, Diputacion Foral de Gipuzkoa (DFG 0876/08), ILUNDAIN Fundazioa, Centro de Investigaciones Biomedicas en Red en Enfermededades Neurodegenerativas (CIBERNED), Wellcome Trust, Canadian Institutes of Health Research (75480), Fund for Scientific Research Flanders (FWOV), Alzheimer Research (SAO/FRMA), Interuniversity Attraction Poles (IAP) P6/43 network of the Belgian Science Policy Office (BELSPO), J.v.d.; Z receves a postdoctoral fellowship from the FWOV, the Joseph Iseman Fund, the Louis and Rachel Rudin Foundation, National Health and Medical Research Council of Australia, Veteran's Affairs Research Funds, Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011 and 05901 to the Arizona Parkinson's Disease Consortium), the Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research, the Daljits and Elaine Sarkara Chair in Diagnostic Medicine, BrainNet Europe II, Ministerio de Ciencia y Tecnologia, Ref Saud y Farmacia 2001-4888, Burroghs Wellcome Fund Career Award for Medical Scientists and Fundacion 'La Caxia'.	Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Chen-Plotkin AS, 2008, HUM MOL GENET, V17, P1349, DOI 10.1093/hmg/ddn023; Cruts M, 2008, TRENDS GENET, V24, P186, DOI 10.1016/j.tig.2008.01.004; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Falush D, 2003, GENETICS, V164, P1567; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Goldman JS, 2004, NEUROLOGIST, V10, P227, DOI 10.1097/01.nrl.0000138735.48533.26; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Le Ber I, 2009, NEUROLOGY, V72, P1669, DOI 10.1212/WNL.0b013e3181a55f1c; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mercy L, 2008, NEUROLOGY, V71, P1496, DOI 10.1212/01.wnl.0000334277.16896.fa; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pastor P, 2003, ANN NEUROL, V54, P163, DOI 10.1002/ana.10636; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Van Deerlin VM, 2007, ARCH NEUROL-CHICAGO, V64, P1148, DOI 10.1001/archneur.64.8.1148; Wijsman EM, 2005, AM J MED GENET B, V132B, P14, DOI 10.1002/ajmg.b.30087	29	360	362	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2010	42	3					234	U34		10.1038/ng.536	http://dx.doi.org/10.1038/ng.536			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20154673	Green Accepted, Green Submitted			2022-12-17	WOS:000274912400012
J	Morgante, M; Brunner, S; Pea, G; Fengler, K; Zuccolo, A; Rafalski, A				Morgante, M; Brunner, S; Pea, G; Fengler, K; Zuccolo, A; Rafalski, A			Gene duplication and exon shuffling by helitron-like transposons generate intraspecies diversity in maize	NATURE GENETICS			English	Article							ROLLING-CIRCLE TRANSPOSONS; ELEMENTS; EVOLUTION; SEQUENCES; MOVEMENT; NUMBER; RICE	We report a whole- genome comparison of gene content in allelic BAC contigs from two maize inbred lines. Genic content polymorphisms involve as many as 10,000 sequences and are mainly generated by DNA insertions. The termini of eight of the nine genic insertions that we analyzed shared the structural hallmarks of helitron rolling- circle transposons(1-3). DNA segments defined by helitron termini contained multiple gene- derived fragments and had a structure typical of nonautonomous helitron- like transposons. Closely related insertions were found in multiple genomic locations. Some of these produced transcripts containing segments of different genes, supporting the idea that these transposition events have a role in exon shuffling and the evolution of new proteins. We identified putative autonomous helitron elements and found evidence for their transcription. Helitrons in maize seem to continually produce new nonautonomous elements responsible for the duplicative insertion of gene segments into new locations and for the unprecedented genic diversity. The maize genome is in constant flux, as transposable elements continue to change both the genic and nongenic fractions of the genome, profoundly affecting genetic diversity.	Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy; DuPont Crop Genet Res, Wilmington, DE 19880 USA	University of Udine; DuPont	Morgante, M (corresponding author), Univ Udine, Dipartimento Sci Agr & Ambientali, Via Sci 208, I-33100 Udine, Italy.	michele.morgante@uniud.it	Zuccolo, Andrea/H-5636-2019	Zuccolo, Andrea/0000-0001-7574-0714; MORGANTE, Michele/0000-0003-2591-2156				Bennetzen JL, 2004, CURR OPIN PLANT BIOL, V7, P732, DOI 10.1016/j.pbi.2004.09.003; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; CRAIG NL, 2002, MOBILE DNA 2; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; Feschotte C, 2001, P NATL ACAD SCI USA, V98, P8923, DOI 10.1073/pnas.171326198; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Gardiner J, 2004, PLANT PHYSIOL, V134, P1317, DOI 10.1104/pp.103.034538; Gupta S, 2005, PLANT MOL BIOL, V57, P115, DOI 10.1007/s11103-004-6636-z; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Ilic K, 2003, P NATL ACAD SCI USA, V100, P12265, DOI 10.1073/pnas.1434476100; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Kynast RG, 2001, PLANT PHYSIOL, V125, P1216, DOI 10.1104/pp.125.3.1216; Lai JS, 2005, P NATL ACAD SCI USA, V102, P9068, DOI 10.1073/pnas.0502923102; Lai JS, 2004, GENOME RES, V14, P1924, DOI 10.1101/gr.2701104; Lal SK, 2003, PLANT CELL, V15, P381, DOI 10.1105/tpc.008375; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Meyers BC, 2004, NAT REV GENET, V5, P578, DOI 10.1038/nrg1404; Okagaki RJ, 2001, PLANT PHYSIOL, V125, P1228, DOI 10.1104/pp.125.3.1228; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Poulter RTM, 2003, GENE, V313, P201, DOI 10.1016/S0378-1119(03)00679-6; Ramakrishna W, 2002, PLANT CELL, V14, P3213, DOI 10.1105/tpc.006338; Song R, 2002, GENOME RES, V12, P1549, DOI 10.1101/gr.268302; Song RT, 2003, P NATL ACAD SCI USA, V100, P9055, DOI 10.1073/pnas.1032999100; Swigonova Z, 2005, GENETICS, V169, P891, DOI 10.1534/genetics.104.034629; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Yu ZH, 2000, GENETICS, V156, P2019	30	360	395	2	58	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					997	1002		10.1038/ng1615	http://dx.doi.org/10.1038/ng1615			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16056225				2022-12-17	WOS:000231591900027
J	Ravikumar, B; Acevedo-Arozena, A; Imarisio, S; Berger, Z; Vacher, C; O'Kane, CJ; Brown, SDM; Rubinsztein, DC				Ravikumar, B; Acevedo-Arozena, A; Imarisio, S; Berger, Z; Vacher, C; O'Kane, CJ; Brown, SDM; Rubinsztein, DC			Dynein mutations impair autophagic clearance of aggregate-prone proteins	NATURE GENETICS			English	Article							FAST AXONAL-TRANSPORT; ALPHA-SYNUCLEIN; IN-VITRO; POLYGLUTAMINE; HUNTINGTIN; NEURONS; MICROTUBULE; MICE; DEGENERATION; DISRUPTION	Mutations that affect the dynein motor machinery are sufficient to cause motor neuron disease. It is not known why there are aggregates or inclusions in affected tissues in mice with such mutations and in most forms of human motor neuron disease. Here we identify a new mechanism of inclusion formation by showing that decreased dynein function impairs autophagic clearance of aggregate- prone proteins. We show that mutations of the dynein machinery enhanced the toxicity of the mutation that causes Huntington disease in fly and mouse models. Furthermore, loss of dynein function resulted in premature aggregate formation by mutant huntingtin and increased levels of the autophagosome marker LC3- II in both cell culture and mouse models, compatible with impaired autophagosomelysosome fusion.	Addenbrookes Hosp, Dept Med Genet, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; MRC, Mammalian Genet Unit, Harwell, Oxon, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Rubinsztein, DC (corresponding author), Addenbrookes Hosp, Dept Med Genet, Cambridge Inst Med Res, Wellcome MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	dcr1000@hermes.cam.ac.uk	O'Kane, Cahir J/C-4413-2011; Rubinsztein, David C/C-3472-2011; Arozena, Abraham Acevedo/L-6584-2018; O'Kane, Cahir/Q-6681-2019	Arozena, Abraham Acevedo/0000-0001-6127-7116; O'Kane, Cahir/0000-0002-3488-2078	MRC [G0000872] Funding Source: UKRI; Medical Research Council [G0000872] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bananis E, 2000, J CELL BIOL, V151, P179, DOI 10.1083/jcb.151.1.179; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; Bauvy C, 2001, EXP CELL RES, V268, P139, DOI 10.1006/excr.2001.5285; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; EKSTROM P, 1984, J NEUROCHEM, V43, P1342, DOI 10.1111/j.1471-4159.1984.tb05392.x; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; LEIGH PN, 1991, BRAIN, V114, P775, DOI 10.1093/brain/114.2.775; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Wubbolts R, 1999, J CELL SCI, V112, P785	30	360	373	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					771	776		10.1038/ng1591	http://dx.doi.org/10.1038/ng1591			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15980862				2022-12-17	WOS:000230196400027
J	Agarwal, AK; Arioglu, E; de Almeida, S; Akkoc, N; Taylor, SI; Bowcock, AM; Barnes, RI; Garg, A				Agarwal, AK; Arioglu, E; de Almeida, S; Akkoc, N; Taylor, SI; Bowcock, AM; Barnes, RI; Garg, A			AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34	NATURE GENETICS			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASES; CDNA CLONING; EXPRESSION; LOCALIZATION; GENE	Congenital generalized lipodystrophy is an autosomal recessive disorder characterized by marked paucity of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. We report several different mutations of the gene (AGPAT2) encoding 1-acylglycerol-3-phosphate O-acyltransferase 2 in 20 affected individuals from 11 pedigrees of diverse ethnicities showing linkage to chromosome 9q34. The AGPAT2 enzyme catalyzes the acylation of lysophosphatidic acid to form phosphatidic acid, a key intermediate in the biosynthesis of triacylglycerol and glycerophospholipids. AGPAT2 mRNA is highly expressed in adipose tissue. We conclude that mutations in AGPAT2 may cause congenital generalized lipodystrophy by inhibiting triacylglycerol synthesis and storage in adipocytes.	Univ Texas, SW Med Ctr, Dept Internal Med, Div Nutr & Metab Dis, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Ctr Human Nutr, Dallas, TX 75390 USA; NIDDKD, Diabet Branch, Bethesda, MD 20892 USA; Hosp Dona Estefania, Serv Genet Med, Lisbon, Portugal; Dokuz Eylul Univ, Sch Med, Dept Internal Med, Izmir, Turkey; Washington Univ, Sch Med, Dept Genet, Div Human Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Dokuz Eylul University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Garg, A (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Nutr & Metab Dis, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	abhimanyu.garg@utsouthwestern.edu	Akkoc, Nurullah/D-9870-2011	Akkoc, Nurullah/0000-0002-3718-171X; Bowcock, Anne/0000-0001-8691-9090; Oral, Elif/0000-0002-9171-1144				Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Eberhardt C, 1999, ADV EXP MED BIOL, V469, P351; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; GARG A, 1992, J CLIN ENDOCR METAB, V75, P358, DOI 10.1210/jc.75.2.358; Garg A, 1999, J CLIN ENDOCR METAB, V84, P3390, DOI 10.1210/jc.84.9.3390; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; HUSEMAN C, 1978, J PEDIATR-US, V93, P221, DOI 10.1016/S0022-3476(78)80500-9; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Pages C, 2001, PROSTAG OTH LIPID M, V64, P1, DOI 10.1016/S0090-6980(01)00110-1; Seip M, 1996, ACTA PAEDIATR, V85, P2, DOI 10.1111/j.1651-2227.1996.tb14262.x; Vigouroux C, 1997, J CLIN ENDOCR METAB, V82, P3438, DOI 10.1210/jc.82.10.3438; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691	15	360	375	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2002	31	1					21	23		10.1038/ng880	http://dx.doi.org/10.1038/ng880			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	547ZF	11967537	Bronze			2022-12-17	WOS:000175362500009
J	Bolz, H; von Brederlow, B; Ramirez, A; Bryda, EC; Kutsche, K; Nothwang, HG; Seeliger, M; Cabrera, MDS; Vila, MC; Molina, OP; Gal, A; Kubisch, C				Bolz, H; von Brederlow, B; Ramirez, A; Bryda, EC; Kutsche, K; Nothwang, HG; Seeliger, M; Cabrera, MDS; Vila, MC; Molina, OP; Gal, A; Kubisch, C			Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D	NATURE GENETICS			English	Article							MYOSIN VIIA GENE; CELL-ADHESION MOLECULES; EXTRACELLULAR-MATRIX; RECESSIVE DEAFNESS; MAP	Usher syndrome type I (USH1) is an autosomal recessive disorder characterized by congenital sensorineural hearing loss, vestibular dysfunction and visual impairment due to early onset retinitis pigmentosa(1) (RP). So far, six loci (USH1A-USH1F) have been mapped, but only two USH1 genes have been identified: MYO7A (ref. 2) for USH1B and the gene encoding harmonin(3,4) for USH1C. We identified a Cuban pedigree linked to the locus for Usher syndrome type 1D (MIM 601067) within the q2 region of chromosome 10 (ref. 5). Affected individuals present with congenital deafness and a highly variable degree of retinal degeneration. Using a positional candidate approach, we identified a new member of the cadherin gene superfamily, CDH23. It encodes a protein of 3,354 amino acids with a single transmembrane domain and 27 cadherin repeats. In the Cuban family, we detected two different mutations: a severe course of the retinal disease was observed in individuals homozygous for what is probably a truncating splice-site mutation (c.4488G-->C), whereas mild RP is present in individuals carrying the homozygous missense mutation R1746Q. A variable expression of the retinal phenotype was seen in patients with a combination of both mutations. In addition, we identified two mutations, Delta M1281 and IVS51+5G-->A, in a German USH1 patient. Our data show that different mutations in CDH23 result in USH1D with a variable retinal phenotype. In an accompanying paper(6), it is shown that mutations in the mouse ortholog cause disorganization of inner ear stereocilia and deafness in the waltzer mouse.	Univ Hamburg, Krankenhaus Eppendorf, Inst Human Genet, D-2000 Hamburg, Germany; Univ Bonn, Inst Humangenet, D-5300 Bonn, Germany; Marshall Univ, Dept Microbiol Immunol & Mol Genet, Huntington, WV USA; MPI Mol Genet, Berlin, Germany; Univ Tubingen, Abt 2, Augenklin, Tubingen, Germany; Ctr Int REtinosis Pigmentaria, Habana, Cuba	University of Hamburg; University of Bonn; Marshall University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Gal, A (corresponding author), Univ Hamburg, Krankenhaus Eppendorf, Inst Human Genet, D-2000 Hamburg, Germany.		Kubisch, Christian/F-1893-2011; Ramirez, Alfredo/S-5126-2019; Nothwang, Hans G/C-5847-2011	Kubisch, Christian/0000-0003-4220-0978; Ramirez, Alfredo/0000-0003-4991-763X; Nothwang, Hans Gerd/0000-0001-7695-6437				Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bryda EC, 1997, MAMM GENOME, V8, P1, DOI 10.1007/s003359900336; Carrasquillo MM, 1997, HUM MOL GENET, V6, P2163, DOI 10.1093/hmg/6.12.2163; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Jain PK, 1998, GENOMICS, V50, P290, DOI 10.1006/geno.1998.5320; JONES CT, 1992, HUM MOL GENET, V1, P11, DOI 10.1093/hmg/1.1.11; Keats BJB, 1999, AM J MED GENET, V89, P158, DOI 10.1002/(SICI)1096-8628(19990924)89:3<158::AID-AJMG6>3.3.CO;2-R; Legan PK, 1997, SEMIN CELL DEV BIOL, V8, P217, DOI 10.1006/scdb.1997.0145; Liu XZ, 1998, AM J HUM GENET, V63, P909, DOI 10.1086/302026; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Mount SM, 2000, AM J HUM GENET, V67, P788, DOI 10.1086/303098; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; WAYNE S, 1996, HUM MOL GENET, V10, P1689; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; WELL D, 1997, NAT GENET, V16, P191; Yagi T, 2000, GENE DEV, V14, P1169; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	27	360	377	1	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					108	112		10.1038/83667	http://dx.doi.org/10.1038/83667			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138009				2022-12-17	WOS:000166187900026
J	Saxena, R; Brown, LG; Hawkins, T; Alagappan, RK; Skaletsky, H; Reeve, MP; Reijo, R; Rozen, S; Dinulos, MB; Disteche, CM; Page, DC				Saxena, R; Brown, LG; Hawkins, T; Alagappan, RK; Skaletsky, H; Reeve, MP; Reijo, R; Rozen, S; Dinulos, MB; Disteche, CM; Page, DC			The DAZ gene cluster on the human Y chromosome arose from an autosomal gene that was transposed, repeatedly amplified and pruned	NATURE GENETICS			English	Article							AFRICAN POPULATIONS; SEX DETERMINATION; DNA; LOCALIZATION; PROBE; MAP; DROSOPHILA; INTERVAL-6; HAPLOTYPES; DELETIONS	It is widely believed that most or all Y-chromosomal genes were once shared with the X chromosome. The DAZ gene is a candidate for the human Y-chromosomal Azoospermia Factor (AZF). We report multiple copies of DAZ (>99% identical in DNA sequence) clustered in the AZF region and a functional DAZ homologue (DAZH) on human chromosome 3. The entire gene family appears to be expressed in germ cells. Sequence analysis indicates that the Y-chromosomal DAZ cluster arose during primate evolution by (i) transposing the autosomal gene to the Y, (ii) amplifying and pruning exons within the transposed gene and (iii) amplifying the modified gene. These results challenge prevailing views of sex chromosome evolution, suggesting that acquisition of autosomal fertility genes is an important process in Y chromosome evolution.	MIT,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02142; MIT,WHITEHEAD INST,CTR GENOME RES,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02142; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle			Saxena, Richa/AAG-7279-2020; Rozen, Steven G./J-5939-2013	Saxena, Richa/0000-0003-2233-1065; Reijo Pera, Renee/0000-0002-6487-1329; Rozen, Steven G./0000-0002-4288-0056				Affara N, 1996, CYTOGENET CELL GENET, V73, P33; BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; BISHOP C, 1984, J MOL BIOL, V173, P403, DOI 10.1016/0022-2836(84)90388-7; Bull J.J., 1983, EVOLUTION SEX DETERM; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Burgoyne PS, 1996, NATURE, V381, P740, DOI 10.1038/381740a0; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; CHARLESWORTH D, 1980, GENET RES, V35, P205, DOI 10.1017/S0016672300014051; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; HACKSTEIN JHP, 1995, TRENDS GENET, V11, P195, DOI 10.1016/S0168-9525(00)89043-5; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JOHNSON MD, 1989, AM J OBSTET GYNECOL, V161, P1732, DOI 10.1016/0002-9378(89)90959-9; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; LUCOTTE G, 1991, MOL CELL PROBE, V5, P359, DOI 10.1016/S0890-8508(06)80007-1; LUCOTTE G, 1989, AM J HUM GENET, V45, P16; MA K, 1992, HUM MOL GENET, V1, P29, DOI 10.1093/hmg/1.1.29; MENKE D, IN PRESS AM J HUM GE; NGO KY, 1986, AM J HUM GENET, V38, P407; Ohno S., 1967, SEX CHROMOSOMES SEX; PAGE DC, 1987, DEVELOPMENT, V101, P151; PALMER S, 1995, NAT GENET, V10, P472, DOI 10.1038/ng0895-472; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; RUGARLI EI, 1995, NAT GENET, V10, P466, DOI 10.1038/ng0895-466; SEBOUN E, 1986, COLD SPRING HARB SYM, V51, P237, DOI 10.1101/SQB.1986.051.01.029; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; SKARE J, 1990, AM J MED GENET, V36, P394, DOI 10.1002/ajmg.1320360405; SPURDLE A, 1992, AM J HUM GENET, V50, P107; STEINEMANN M, 1992, P NATL ACAD SCI USA, V89, P7591, DOI 10.1073/pnas.89.16.7591; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; VERGNAUD G, 1986, AM J HUM GENET, V38, P109; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; Winge O, 1927, J GENET, V18, P1, DOI 10.1007/BF03052599	44	360	377	1	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					292	299		10.1038/ng1196-292	http://dx.doi.org/10.1038/ng1196-292			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896558				2022-12-17	WOS:A1996VQ14600023
J	Iqbal, Z; Caccamo, M; Turner, I; Flicek, P; McVean, G				Iqbal, Zamin; Caccamo, Mario; Turner, Isaac; Flicek, Paul; McVean, Gil			De novo assembly and genotyping of variants using colored de Bruijn graphs	NATURE GENETICS			English	Article							DIPLOID GENOME SEQUENCE; COPY-NUMBER VARIATION; HIGH-RESOLUTION HLA; STRUCTURAL VARIATION; POPULATION-SCALE; POLYMORPHIC GENOMES; CIONA-SAVIGNYI; HAPLOTYPE MAP; STRING GRAPH; GENE	Detecting genetic variants that are highly divergent from a reference sequence remains a major challenge in genome sequencing. We introduce de novo assembly algorithms using colored de Bruijn graphs for detecting and genotyping simple and complex genetic variants in an individual or population. We provide an efficient software implementation, Cortex, the first de novo assembler capable of assembling multiple eukaryotic genomes simultaneously. Four applications of Cortex are presented. First, we detect and validate both simple and complex structural variations in a high-coverage human genome. Second, we identify more than 3 Mb of sequence absent from the human reference genome, in pooled low-coverage population sequence data from the 1000 Genomes Project. Third, we show how population information from ten chimpanzees enables accurate variant calls without a reference sequence. Last, we estimate classical human leukocyte antigen (HLA) genotypes at HLA-B, the most variable gene in the human genome.	[Iqbal, Zamin; Turner, Isaac; McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Iqbal, Zamin; Flicek, Paul] European Bioinformat Inst, Hinxton, England; [Caccamo, Mario] Genome Anal Ctr, Norwich, Norfolk, England; [McVean, Gil] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; Wellcome Centre for Human Genetics; European Molecular Biology Laboratory (EMBL); The Genome Analysis Centre (TGAC); University of Oxford	McVean, G (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	mcvean@well.ox.ac.uk	Turner, Isaac/T-1092-2019	Turner, Isaac/0000-0002-2378-4886; Iqbal, Zamin/0000-0001-8466-7547; McVean, Gil/0000-0002-5012-4162; Flicek, Paul/0000-0002-3897-7955	Wellcome Trust [WT086084/Z/08/Z, 090532/Z/09/Z]; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank the members of the 1000 Genomes Project Consortium for discussion, suggestions and sequencing data. We thank B. Ahiska, A. Auton, E. Birney, R. Durbin, G. Lunter, J. Woolf and D. Zerbino for discussion, two anonymous reviewers for their comments and members of the PanMap Project and the Genomics Core at the Wellcome Trust Centre for Human Genetics for access to sequence data. Z.I. is funded by a grant from the Wellcome Trust (WT086084/Z/08/Z to G.M.). The sequencing of NA12878 was performed by the Wellcome Trust Sequencing Core at Oxford, under a grant from the Wellcome Trust (090532/Z/09/Z).	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; ALLSOPP CEM, 1991, HUM IMMUNOL, V30, P105, DOI 10.1016/0198-8859(91)90078-N; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Ding L, 2010, HUM MOL GENET, V19, pR188, DOI 10.1093/hmg/ddq391; Donmez N, 2011, LECT N BIOINFORMAT, V6577, P38, DOI 10.1007/978-3-642-20036-6_5; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge F, 2005, PLOS BIOL, V3, P1709, DOI 10.1371/journal.pbio.0030316; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Hajirasouliha I, 2010, BIOINFORMATICS, V26, P1277, DOI 10.1093/bioinformatics/btq152; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holcomb CL, 2011, TISSUE ANTIGENS, V77, P206, DOI 10.1111/j.1399-0039.2010.01606.x; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Idury R M, 1995, J Comput Biol, V2, P291, DOI 10.1089/cmb.1995.2.291; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Kim JH, 2007, GENOME RES, V17, P1101, DOI 10.1101/gr.5894107; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2009, NAT METHODS, V6, P473, DOI 10.1038/nmeth.f.256; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Peterlongo P, 2010, LECT NOTES COMPUT SC, V6393, P147, DOI 10.1007/978-3-642-16321-0_14; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Ratan A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-130; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Simpson JT, 2010, BIOINFORMATICS, V26, pi367, DOI 10.1093/bioinformatics/btq217; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407	52	359	385	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					226	232		10.1038/ng.1028	http://dx.doi.org/10.1038/ng.1028			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22231483	Green Accepted			2022-12-17	WOS:000299664400025
J	Comas, I; Borrell, S; Roetzer, A; Rose, G; Malla, B; Kato-Maeda, M; Galagan, J; Niemann, S; Gagneux, S				Comas, Inaki; Borrell, Sonia; Roetzer, Andreas; Rose, Graham; Malla, Bijaya; Kato-Maeda, Midori; Galagan, James; Niemann, Stefan; Gagneux, Sebastien			Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes	NATURE GENETICS			English	Article							ANTIBIOTIC-RESISTANCE; BIOLOGICAL COST; BEIJING GENOTYPE; EVOLUTION; FITNESS; PHYLOGEOGRAPHY; PROTEINS; GENETICS	Epidemics of drug-resistant bacteria emerge worldwide, even as resistant strains frequently have reduced fitness compared to their drug-susceptible counterparts(1). Data from model systems suggest that the fitness cost of antimicrobial resistance can be reduced by compensatory mutations(2); however, there is limited evidence that compensatory evolution has any significant role in the success of drug-resistant bacteria in human populations(3-6). Here we describe a set of compensatory mutations in the RNA polymerase genes of rifampicin-resistant M. tuberculosis, the etiologic agent of human tuberculosis (TB). M. tuberculosis strains harboring these compensatory mutations showed a high competitive fitness in vitro. Moreover, these mutations were associated with high fitness in vivo, as determined by examining their relative clinical frequency across patient populations. Of note, in countries with the world's highest incidence of multidrug-resistant (MDR) TB7, more than 30% of MDR clinical isolates had this form of mutation. Our findings support a role for compensatory evolution in the global epidemics of MDR TB8.	[Borrell, Sonia; Malla, Bijaya; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Comas, Inaki; Rose, Graham] Natl Inst Med Res, Med Res Council, Div Mycobacterial Res, London NW7 1AA, England; [Borrell, Sonia; Malla, Bijaya; Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Roetzer, Andreas; Niemann, Stefan] Res Ctr Borstel, Borstel, Germany; [Kato-Maeda, Midori] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, San Francisco, CA USA; [Galagan, James] MIT, Broad Inst, Cambridge, MA 02139 USA; [Galagan, James] Harvard Univ, Cambridge, MA 02138 USA; [Galagan, James] Boston Univ, Dept Microbiol, Boston, MA 02215 USA	University of Basel; Swiss Tropical & Public Health Institute; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Basel; Forschungszentrum Borstel; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston University	Gagneux, S (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland.	sebastien.gagneux@unibas.ch	Comas, Iñaki/F-1185-2011; Comas, Iñaki/AAA-1155-2019; Niemann, Stefan/C-9327-2011; Gagneux, Sebastien/ABE-7909-2020	Comas, Iñaki/0000-0001-5504-9408; Comas, Iñaki/0000-0001-5504-9408; Galagan, James/0000-0003-0542-3291; Gagneux, Sebastien/0000-0001-7783-9048; Niemann, Stefan/0000-0002-6604-0684; Rose, Graham/0000-0002-5097-5426	US National Institute of Allergy and Infectious Disease, US National Institutes of Health; US Department of Health and Human Services [HHSN266200400001C, AI090928, AI034238]; Medical Research Council, UK [MRC_U117588500]; Swiss National Science Foundation [PP00A-119205]; European Community [QLK-CT-2002-01612, FP7-223681]; Medical Research Council [MC_U117581288] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034238, R01AI090928] Funding Source: NIH RePORTER; MRC [MC_U117581288] Funding Source: UKRI	US National Institute of Allergy and Infectious Disease, US National Institutes of Health; US Department of Health and Human Services; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Small and C. Davis Long for stimulating discussions at the onset of this project, D. Young and M. Coscolla for reviewing the manuscript, A. Candel for advice in the interpretation of the RNA polymerase molecular structure and T. Van for technical support. We acknowledge the Wellcome Trust Sanger Institute for making available unpublished DNA sequence data (see URLs). We would like to thank T. Ubben, I. Razio and the other members of the German National Reference Center for Mycobateria for technical assistance and all partners that have contributed to previous studies in regions of high MDR TB incidence and collected some of the strains analyzed here. This project was funded wholly or in part by the US National Institute of Allergy and Infectious Disease, US National Institutes of Health and US Department of Health and Human Services (contract HHSN266200400001C, grants AI090928 and AI034238). This work was also supported by the Medical Research Council, UK (MRC_U117588500), the Swiss National Science Foundation (PP00A-119205) and the European Community LONG-DRUG (QLK-CT-2002-01612) and TB PAN-NET (FP7-223681) projects.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Bottger EC, 1998, NAT MED, V4, P1343, DOI 10.1038/3906; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cox HS, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-134; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hazbon MH, 2008, ANTIMICROB AGENTS CH, V52, P3369, DOI 10.1128/AAC.00309-08; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Kubica T, 2005, INT J TUBERC LUNG D, V9, P646; Levin BR, 2000, GENETICS, V154, P985; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Nagaev I, 2001, MOL MICROBIOL, V40, P433, DOI 10.1046/j.1365-2958.2001.02389.x; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Reynolds MG, 2000, GENETICS, V156, P1471; Sander P, 2002, ANTIMICROB AGENTS CH, V46, P1204, DOI 10.1128/AAC.46.5.1204-1211.2002; Shcherbakov D, 2010, MOL MICROBIOL, V77, P830, DOI 10.1111/j.1365-2958.2010.07218.x; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; World Health Organization, 2010, GLOB TUB CONTR SURV	39	359	372	1	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2012	44	1					106	U147		10.1038/ng.1038	http://dx.doi.org/10.1038/ng.1038			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	870JA	22179134	Green Accepted			2022-12-17	WOS:000298664000023
J	Amit, I; Citri, A; Shay, T; Lu, YL; Katz, M; Zhang, F; Tarcic, G; Siwak, D; Lahad, J; Jacob-Hirsch, J; Amariglio, N; Vaisman, N; Segal, E; Rechavi, G; Alon, U; Mills, GB; Domany, E; Yarden, Y				Amit, Ido; Citri, Ami; Shay, Tal; Lu, Yiling; Katz, Menachem; Zhang, Fan; Tarcic, Gabi; Siwak, Doris; Lahad, John; Jacob-Hirsch, Jasmine; Amariglio, Ninette; Vaisman, Nora; Segal, Eran; Rechavi, Gideon; Alon, Uri; Mills, Gordon B.; Domany, Eytan; Yarden, Yosef			A module of negative feedback regulators defines growth factor signaling	NATURE GENETICS			English	Article							KRUPPEL-LIKE FACTOR-2; NF-KAPPA-B; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MESSENGER-RNAS; C-FOS; SPECIFICITY; ACTIVATION; PROTEINS; CANCER	Signaling pathways invoke interplays between forward signaling and feedback to drive robust cellular response. In this study, we address the dynamics of growth factor signaling through profiling of protein phosphorylation and gene expression, demonstrating the presence of a kinetically defined cluster of delayed early genes that function to attenuate the early events of growth factor signaling. Using epidermal growth factor receptor signaling as the major model system and concentrating on regulation of transcription and mRNA stability, we demonstrate that a number of genes within the delayed early gene cluster function as feedback regulators of immediate early genes. Consistent with their role in negative regulation of cell signaling, genes within this cluster are downregulated in diverse tumor types, in correlation with clinical outcome. More generally, our study proposes a mechanistic description of the cellular response to growth factors by defining architectural motifs that underlie the function of signaling networks.	Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Baylor Coll Med, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; Tel Aviv Univ, Chaim Sheba Med Ctr, Dept Pediat Hematooncol & Funct Genom, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Sigma Aldrich Israel Ltd, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Comp Sci, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Merck KGaA; MilliporeSigma; Weizmann Institute of Science; Weizmann Institute of Science	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	Segal, Eran/AAF-4855-2019; YARDEN, YOSEF/K-1467-2012; DOMANY, EYTAN/K-1560-2012; Citri, Ami/R-8973-2019; Shay, Tal/J-4028-2016	Citri, Ami/0000-0002-9914-0278; Shay, Tal/0000-0003-0755-1350; Segal, Eran/0000-0002-6859-1164	NATIONAL CANCER INSTITUTE [P01CA099031, R01CA072981, R56CA102537, R37CA072981, P01CA064602, P01CA065930, R01CA102537] Funding Source: NIH RePORTER; NCI NIH HHS [CA64602, CA099031, CA102537, CA72981, CA65930] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alon U, 2006, INTRO SYSTEMS BIOL D; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Casci T, 1999, CANCER METAST REV, V18, P181, DOI 10.1023/A:1006313122373; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180, DOI 10.1128/MCB.13.11.7180; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Qu ZC, 1998, J CELL BIOL, V142, P1075, DOI 10.1083/jcb.142.4.1075; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Stephenson AJ, 2005, CANCER-AM CANCER SOC, V104, P290, DOI 10.1002/cncr.21157; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wang F, 2005, ONCOGENE, V24, P3875, DOI 10.1038/sj.onc.1208546; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; WISDOM R, 1993, MOL CELL BIOL, V13, P2635, DOI 10.1128/MCB.13.5.2635; Yates PR, 1999, EMBO J, V18, P968, DOI 10.1093/emboj/18.4.968; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	50	359	368	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					503	512		10.1038/ng1987	http://dx.doi.org/10.1038/ng1987			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17322878				2022-12-17	WOS:000245271200020
J	Spielman, RS; Bastone, LA; Burdick, JT; Morley, M; Ewens, WJ; Cheung, VG				Spielman, Richard S.; Bastone, Laurel A.; Burdick, Joshua T.; Morley, Michael; Ewens, Warren J.; Cheung, Vivian G.			Common genetic variants account for differences in gene expression among ethnic groups	NATURE GENETICS			English	Article							HUMAN GENOME; POLYMORPHISMS; PIGMENTATION; PATTERNS; HUMANS	Variation in DNA sequence contributes to individual differences in quantitative traits, but in humans the specific sequence variants are known for very few traits. We characterized variation in gene expression in cells from individuals belonging to three major population groups. This quantitative phenotype differs significantly between European-derived and Asian-derived populations for 1,097 of 4,197 genes tested. For the phenotypes with the strongest evidence of cis determinants, most of the variation is due to allele frequency differences at cis-linked regulators. The results show that specific genetic variation among populations contributes appreciably to differences in gene expression phenotypes. Populations differ in prevalence of many complex genetic diseases, such as diabetes and cardiovascular disease. As some of these are probably influenced by the level of gene expression, our results suggest that allele frequency differences at regulatory polymorphisms also account for some population differences in prevalence of complex diseases.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Cheung, VG (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	spielman@pobox.upenn.edu; vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020	Morley, Michael/0000-0002-0958-7376	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES015733-03, R01 ES015733] Funding Source: Medline; NIGMS NIH HHS [R01 GM081930, R01 GM081930-08] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McEvoy B, 2006, HUM MOL GENET, V15, pR176, DOI 10.1093/hmg/ddl217; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Osada N, 2006, MOL BIOL EVOL, V23, P1585, DOI 10.1093/molbev/msl023; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; PAW BH, 1990, AM J HUM GENET, V47, P698; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tsui Lap-Chee, 1992, Human Mutation, V1, P197, DOI 10.1002/humu.1380010304; Westfall P.H., 1992, RESAMPLING BASED MUL; Wilson W, 2004, GENOMICS, V84, P707, DOI 10.1016/j.ygeno.2004.06.011; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	20	359	376	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					226	231		10.1038/ng1955	http://dx.doi.org/10.1038/ng1955			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17206142	Green Accepted			2022-12-17	WOS:000244063900021
J	Hughes, AE; Orr, N; Esfandiary, H; Diaz-Torres, M; Goodship, T; Chakravarthy, U				Hughes, Anne E.; Orr, Nick; Esfandiary, Hossein; Diaz-Torres, Martha; Goodship, Timothy; Chakravarthy, Usha			A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration	NATURE GENETICS			English	Article							COMPLEMENT FACTOR-H; SUSCEPTIBILITY; POLYMORPHISM; MACULOPATHY; VARIANT; GENE	Age-related macular degeneration (AMD; OMIM #603075) is the most frequent cause of visual impairment in the elderly population, with severe disease affecting nearly 10% of individuals of European descent over the age of 75 years. It is a complex disease in which genetic and environmental factors contribute to susceptibility. Complement factor H (CFH) has recently been identified as a major AMD susceptibility gene, and the Y402H polymorphism has been proposed as the likely causative factor. We genotyped polymorphisms spanning the cluster of CFH and five CFH-related genes on chromosome 1q23 in 173 individuals with severe neovascular AMD and 170 elderly controls with no signs of AMD. Detailed analysis showed a common haplotype associated with decreased risk of AMD that was present on 20% of chromosomes of controls and 8% of chromosomes of individuals with AMD. We found that this haplotype carried a deletion of CFHR1 and CFHR3, and the proteins encoded by these genes were absent in serum of homozygotes. The protective effect of the deletion haplotype cannot be attributed to linkage disequilibrium with Y402H and was replicated in an independent sample.	Queens Univ Belfast, Dept Med Genet, Belfast BT12 6BL, Antrim, North Ireland; Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Queens Univ Belfast, Ctr Vis Sci & Vasc Biol, Belfast BT12 6BL, Antrim, North Ireland	Queens University Belfast; Newcastle University - UK; Queens University Belfast	Hughes, AE (corresponding author), Queens Univ Belfast, Dept Med Genet, Belfast BT12 6BL, Antrim, North Ireland.	A.Hughes@qub.ac.uk	Hughes, Anne/A-1307-2012	Chakravarthy, Usha/0000-0002-2606-3734				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; DISCIPIO RG, 1992, J IMMUNOL, V149, P2592; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Heinen Stefan, 2006, Hum Mutat, V27, P292, DOI 10.1002/humu.9408; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Jozsi M, 2005, EUR J HUM GENET, V13, P321, DOI 10.1038/sj.ejhg.5201324; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; REID KBM, 1986, IMMUNOL TODAY, V7, P230, DOI 10.1016/0167-5699(86)90110-6; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	16	359	383	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1173	1177		10.1038/ng1890	http://dx.doi.org/10.1038/ng1890			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16998489				2022-12-17	WOS:000241251100017
J	Gupta, PB; Kuperwasser, C; Brunet, JP; Ramaswamy, S; Kuo, WL; Gray, JW; Naber, SP; Weinberg, RA				Gupta, PB; Kuperwasser, C; Brunet, JP; Ramaswamy, S; Kuo, WL; Gray, JW; Naber, SP; Weinberg, RA			The melanocyte differentiation program predisposes to metastasis after neoplastic transformation	NATURE GENETICS			English	Article							TYROSINE KINASE RECEPTOR; NEURAL CREST; MALIGNANT-MELANOMA; LESS-THAN-OR-EQUAL-TO-1 MM; TUMOR PROGRESSION; EPITHELIAL-CELLS; NERVOUS-SYSTEM; BREAST-CANCER; GENE-TRANSFER; LYMPH-NODES	The aggressive clinical behavior of melanoma suggests that the developmental origins of melanocytes in the neural crest might be relevant to their metastatic propensity. Here we show that primary human melanocytes, transformed using a specific set of introduced genes, form melanomas that frequently metastasize to multiple secondary sites, whereas human fibroblasts and epithelial cells transformed using an identical set of genes generate primary tumors that rarely do so. Notably, these melanomas have a metastasis spectrum similar to that observed in humans with melanoma. These observations indicate that part of the metastatic proclivity of melanoma is attributable to lineage-specific factors expressed in melanocytes and not in other cell types analyzed. Analysis of microarray data from human nevi shows that the expression pattern of Slug, a master regulator of neural crest cell specification and migration, correlates with those of other genes that are important for neural crest cell migrations during development. Moreover, Slug is required for the metastasis of the transformed melanoma cells. These findings indicate that melanocyte-specific factors present before neoplastic transformation can have a pivotal role in governing melanoma progression.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Tufts Univ, Sch Med, New England Med Ctr, Dept Anat & Cellular Biol, Boston, MA 02111 USA; Tufts Univ, Sch Med, New England Med Ctr, Dept Radiat Oncol, Boston, MA 02111 USA; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Tufts Univ, Sch Med, New England Med Ctr, Dept Pathol, Boston, MA 02111 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Tufts Medical Center; Tufts University	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu			NATIONAL CANCER INSTITUTE [R01CA078461] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA078461] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartkova J, 1996, CANCER RES, V56, P5475; Beddingfield FC, 2003, ONCOLOGIST, V8, P459, DOI 10.1634/theoncologist.8-5-459; Bedrosian I, 2000, ANN SURG ONCOL, V7, P262, DOI 10.1007/s10434-000-0262-z; BORTOLANI A, 1994, ANN PLAS SURG, V33, P426, DOI 10.1097/00000637-199410000-00013; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Bronner-Fraser Marianne, 1993, Trends in Cell Biology, V3, P392, DOI 10.1016/0962-8924(93)90089-J; Carl TF, 1999, DEV BIOL, V213, P101, DOI 10.1006/dbio.1999.9320; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Corsetti RL, 2000, ANN SURG ONCOL, V7, P456, DOI 10.1007/s10434-000-0456-4; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Cruz J, 2003, ONCOLOGY-BASEL, V65, P72, DOI 10.1159/000071207; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Elsayed AM, 1996, AM J GASTROENTEROL, V91, P1001; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hajra KM, 2002, CANCER RES, V62, P1613; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Ikeda K, 1996, NEUROREPORT, V7, P1713; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; JOHNSON WT, 1969, CANCER, V23, P747, DOI 10.1002/1097-0142(196903)23:3<747::AID-CNCR2820230331>3.0.CO;2-9; Kuperwasser C, 2000, CANCER RES, V60, P2723; Kuperwasser C, 2000, AM J PATHOL, V157, P2151, DOI 10.1016/S0002-9440(10)64853-5; LaBonne C, 2000, DEV BIOL, V221, P195, DOI 10.1006/dbio.2000.9609; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Li G, 2001, ONCOGENE, V20, P8125, DOI 10.1038/sj.onc.1205034; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; NATALI PG, 1993, BRIT J CANCER, V68, P746, DOI 10.1038/bjc.1993.422; NESBIT M, 1998, CUTANEOUS MELANOMA, P463; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Petersen SL, 1996, ENDOCRINOLOGY, V137, P234, DOI 10.1210/en.137.1.234; PHILLIPS DL, 1987, J CLIN GASTROENTEROL, V9, P563, DOI 10.1097/00004836-198710000-00017; Rich JN, 2001, CANCER RES, V61, P3556; SHAW HM, 1987, ARCH SURG-CHICAGO, V122, P1147; Snijders AM, 2003, ONCOGENE, V22, P4370, DOI 10.1038/sj.onc.1206482; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; SUBRAMONY C, 1985, AM J CLIN PATHOL, V84, P220, DOI 10.1093/ajcp/84.2.220; Tietze MK, 2000, MOL MED TODAY, V6, P408, DOI 10.1016/S1357-4310(00)01781-0	42	359	363	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1047	1054		10.1038/ng1634	http://dx.doi.org/10.1038/ng1634			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16142232	Green Accepted			2022-12-17	WOS:000232185600015
J	Stoll, M; Corneliussen, B; Costello, CM; Waetzig, GH; Mellgard, B; Koch, WA; Rosenstiel, P; Albrecht, M; Croucher, PJP; Seegert, D; Nikolaus, S; Hampe, J; Lengauer, T; Pierrou, S; Foelsch, UR; Mathew, CG; Lagerstrom-Fermer, M; Schreiber, S				Stoll, M; Corneliussen, B; Costello, CM; Waetzig, GH; Mellgard, B; Koch, WA; Rosenstiel, P; Albrecht, M; Croucher, PJP; Seegert, D; Nikolaus, S; Hampe, J; Lengauer, T; Pierrou, S; Foelsch, UR; Mathew, CG; Lagerstrom-Fermer, M; Schreiber, S			Genetic variation in DLG5 is associated with inflammatory bowel disease	NATURE GENETICS			English	Article							CROHNS-DISEASE; FAMILY PROTEIN; SUSCEPTIBILITY; MUTATION; CANCER; CELLS	Crohn disease and ulcerative colitis are two subphenotypes of inflammatory bowel disease (IBD), a complex disorder resulting from gene-environment interaction. We refined our previously defined linkage region for IBD on chromosome 10q23 and used positional cloning to identify genetic variants in DLG5 associated with IBD. DLG5 encodes a scaffolding protein involved in the maintenance of epithelial integrity. We identified two distinct haplotypes with a replicable distortion in transmission (P = 0.000023 and P = 0.004 for association with IBD, P = 0.00012 and P = 0.04 for association with Crohn disease). One of the risk-associated DLG5 haplotypes is distinguished from the common haplotype by a nonsynonymous single-nucleotide polymorphism 113G-->A, resulting in the amino acid substitution R30Q in the DUF622 domain of DLG5. This mutation probably impedes scaffolding of DLG5. We stratified the study sample according to the presence of risk-associated CARD15 variants to study potential gene-gene interaction. We found a significant difference in association of the 113A DLG5 variant with Crohn disease in affected individuals carrying the risk-associated CARD15 alleles versus those carrying non-risk-associated CARD15 alleles. This is suggestive of a complex pattern of gene-gene interaction between DLG5 and CARD15, reflecting the complex nature of polygenic diseases. Further functional studies will evaluate the biological significance of DLG5 variants.	Univ Hosp Schleswig Holstein, Dept Med 1, D-24105 Kiel, Germany; R&D Molndal, Dept Mol Sci, Molndal, Sweden; AstraZeneca, Expt Med, Molndal, Sweden; Conaris Res Inst AG, Kiel, Germany; Max Planck Inst Informat, Saarbrucken, Germany; Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; Guys Kings & St Thomas Sch Med, London, England	University of Kiel; Schleswig Holstein University Hospital; AstraZeneca; Max Planck Society; University of Kiel; University of London; King's College London	Schreiber, S (corresponding author), Univ Hosp Schleswig Holstein, Dept Med 1, Schittenhelmstr 12, D-24105 Kiel, Germany.	s.schreiber@mucosa.de	Seegert, Dirk/B-8826-2011; Waetzig, Georg/AAV-7486-2021; Mathew, Christopher G/G-3434-2015; Rosenstiel, Philip/A-5137-2009; Albrecht, Mario/B-6694-2008; Eckhardt, Erik/G-1567-2010; Hampe, Jochen/A-2555-2010	Mathew, Christopher G/0000-0003-4178-1838; Rosenstiel, Philip/0000-0002-9692-8828; Albrecht, Mario/0000-0002-3103-9624; Hampe, Jochen/0000-0002-2421-6127				Bonen DK, 2003, GASTROENTEROLOGY, V124, P521, DOI 10.1053/gast.2003.50045; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Fisher R. A, 1946, STAT METHODS RES WOR; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lu G, 1999, GASTROENTEROLOGY, V116, P884, DOI 10.1016/S0016-5085(99)70071-5; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; Nakamura H, 1998, FEBS LETT, V433, P63, DOI 10.1016/S0014-5793(98)00882-5; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Purmonen S, 2002, INT J CANCER, V102, P1, DOI 10.1002/ijc.10665; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Shah G, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-14; TRUELOVE SC, 1976, GUT, V17, P192, DOI 10.1136/gut.17.3.192; Wakabayashi M, 2003, J BIOL CHEM, V278, P21709, DOI 10.1074/jbc.M211004200	17	359	372	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					476	480		10.1038/ng1345	http://dx.doi.org/10.1038/ng1345			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107852	Bronze			2022-12-17	WOS:000221183000019
J	Barrett, MT; Sanchez, CA; Prevo, LJ; Wong, DJ; Galipeau, PC; Paulson, TG; Rabinovitch, PS; Reid, BJ				Barrett, MT; Sanchez, CA; Prevo, LJ; Wong, DJ; Galipeau, PC; Paulson, TG; Rabinovitch, PS; Reid, BJ			Evolution of neoplastic cell lineages in Barrett oesophagus	NATURE GENETICS			English	Article							HIGH-GRADE DYSPLASIA; ALLELIC LOSSES; ENDOSCOPIC SURVEILLANCE; ESOPHAGEAL ADENOCARCINOMA; GENETIC ALTERATIONS; ULCERATIVE-COLITIS; CLONAL EVOLUTION; CANCER; PROGRESSION; POPULATIONS		Fred Hutchinson Canc Res Ctr, Program Canc Biol, GI Oncol, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, Mol & Cellular Biol Program, Seattle, WA 98104 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Genet, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Reid, BJ (corresponding author), Fred Hutchinson Canc Res Ctr, Program Canc Biol, GI Oncol, 1124 Columbia St, Seattle, WA 98104 USA.		Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X; Galipeau, Patricia/0000-0001-7961-7430	NCI NIH HHS [R01CA61202, R01 CA061202] Funding Source: Medline; NIDDK NIH HHS [DK07742-03, T32 DK007742] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007742] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barrett MT, 1996, ONCOGENE, V12, P1873; Barrett MT, 1996, CANCER RES, V56, P4351; Barrett MT, 1996, ONCOGENE, V13, P1867; Bedi GC, 1996, CANCER RES, V56, P2484; BLOUNT PL, 1993, P NATL ACAD SCI USA, V90, P3221, DOI 10.1073/pnas.90.8.3221; BLOUNT PL, 1994, CANCER RES, V54, P2292; BOLAND CR, 1995, NAT MED, V1, P902, DOI 10.1038/nm0995-902; Califano J, 1996, CANCER RES, V56, P2488; CORREA P, 1990, CANCER RES, V50, P4737; EIDE TJ, 1986, INT J CANCER, V38, P173, DOI 10.1002/ijc.2910380205; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; GAZDAR AF, 1994, COLD SPRING HARB SYM, V59, P565, DOI 10.1101/SQB.1994.059.01.063; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; LEVINE DS, 1991, GASTROENTEROLOGY, V101, P1198, DOI 10.1016/0016-5085(91)90068-V; LEVINE DS, 1993, GASTROENTEROLOGY, V105, P40, DOI 10.1016/0016-5085(93)90008-Z; Mao L, 1997, J NATL CANCER I, V89, P857, DOI 10.1093/jnci/89.12.857; NESHAT K, 1994, GASTROENTEROLOGY, V106, P1589, DOI 10.1016/0016-5085(94)90415-4; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; PETERSEN SE, 1980, FLOW CYTOMETRY, V4, P412; RABINOVITCH PS, 1989, LAB INVEST, V60, P65; REID BJ, 1992, GASTROENTEROLOGY, V102, P1212; REID BJ, 1987, GASTROENTEROLOGY, V93, P1; ROZEN P, 1995, GASTROENTEROLOGY, V108, P1361, DOI 10.1016/0016-5085(95)90683-5; SIDRANSKY D, 1992, NATURE, V355, P846, DOI 10.1038/355846a0; SPECHLER SJ, 1987, ANN INTERN MED, V106, P902, DOI 10.7326/0003-4819-106-6-902; vanderBurgh A, 1996, GUT, V39, P5, DOI 10.1136/gut.39.1.5; Wong DJ, 1997, CANCER RES, V57, P2619; Wu TT, 1998, AM J PATHOL, V153, P287, DOI 10.1016/S0002-9440(10)65570-8	29	359	366	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					106	109		10.1038/8816	http://dx.doi.org/10.1038/8816			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	10319873	Green Accepted			2022-12-17	WOS:000080096300034
J	WEKSBERG, R; SHEN, DR; FEI, YL; SONG, QL; SQUIRE, J				WEKSBERG, R; SHEN, DR; FEI, YL; SONG, QL; SQUIRE, J			DISRUPTION OF INSULIN-LIKE GROWTH FACTOR-II IMPRINTING IN BECKWITH-WIEDEMANN SYNDROME	NATURE GENETICS			English	Article							FACTOR-II GENE; AUTOSOMAL-DOMINANT INHERITANCE; WILMS-TUMOR; MATERNAL ALLELE; CHROMOSOME-11; HETEROZYGOSITY; EXPRESSION; REGION; POLYMORPHISM; DUPLICATION	To study insulin-like growth factor 2 (IGF2) imprinting in BWS (Beckwith-Wiedemann syndrome, an overgrowth syndrome associated with Wilms and other embryonal tumours), we examined allele-specific expression using an ApaI polymorphism in the 3' untranslated region of IGF2. Four of six BWS fibroblast strains demonstrated biallelic expression, as did the tongue tissue from one of these patients. Paternal heterodisomy was excluded for all BWS patients with biallelic expression, suggesting strongly that the BWS phenotype in some patients involves disruption of IGF2 imprinting. Constitutional loss of IGF2 imprinting in a subgroup of our BWS patients, and recent reports of loss of imprinting in sporadic Wilms tumour, further strengthens the view that IGF2 overexpression plays an important role in somatic overgrowth and the development of embryonal tumours.	HOSP SICK CHILDREN,DEPT PATHOL,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	WEKSBERG, R (corresponding author), HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA.		Squire, Jeremy A/A-9352-2012	Squire, Jeremy A/0000-0002-9863-468X				BELL GI, 1985, P NATL ACAD SCI USA, V82, P6450, DOI 10.1073/pnas.82.19.6450; BEST LG, 1981, AM J MED GENET, V9, P291, DOI 10.1002/ajmg.1320090405; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COPPES MJ, 1992, GENE CHROMOSOME CANC, V5, P326, DOI 10.1002/gcc.2870050408; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; EDWARDS A, 1991, AM J HUM GENET, V49, P746; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GLANNOUKAKIS N, 1993, NAT GENET, V4, P96; GRAY A, 1987, DNA-J MOLEC CELL BIO, V6, P283, DOI 10.1089/dna.1987.6.283; HENRY I, 1989, HUM GENET, V81, P273, DOI 10.1007/BF00279003; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HENRY I, 1993, NATURE, V1, P19; HOBAN PR, 1991, NUCLEIC ACIDS RES, V19, P4576, DOI 10.1093/nar/19.16.4576-a; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; Junien C, 1992, CURR OPIN GENET DEV, V2, P431, DOI 10.1016/S0959-437X(05)80154-6; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LITTLE M, 1991, NATURE, V351, P609, DOI 10.1038/351609a0; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; MANNENS M, IN PRESS EUR J HUM G; MOUTOU C, 1992, J MED GENET, V29, P217, DOI 10.1136/jmg.29.4.217; NIIKAWA N, 1986, AM J MED GENET, V24, P41, DOI 10.1002/ajmg.1320240107; NORMAN AM, 1992, AM J MED GENET, V42, P638, DOI 10.1002/ajmg.1320420441; NYSTROM A, 1992, EUR J PEDIATR, V151, P511, DOI 10.1007/BF01957756; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; OKANO Y, 1986, JPN J HUM GENET, V31, P365, DOI 10.1007/BF01907937; PETTENATI MJ, 1986, HUM GENET, V124, P140; PING AJ, 1989, AM J HUM GENET, V44, P720; PUESCHEL SM, 1984, J PEDIATR-US, V104, P484, DOI 10.1016/S0022-3476(84)81127-0; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; REEVE AE, 1985, NATURE, V317, P258, DOI 10.1038/317258a0; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; SCHNEID H, 1991, GROWTH REGULAT, V1, P168; SCOTT J, 1985, NATURE, V317, P260, DOI 10.1038/317260a0; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TURLEAU C, 1984, HUM GENET, V67, P219, DOI 10.1007/BF00273006; WAZIRI M, 1983, J PEDIATR-US, V102, P873, DOI 10.1016/S0022-3476(83)80014-6; WEKSBERG R, 1990, GENOMICS, V8, P693, DOI 10.1016/0888-7543(90)90256-T; WEKSBERG R, 1993, HUM MOL GENET, V2, P549, DOI 10.1093/hmg/2.5.549; WIEDEMANN HR, 1983, EUR J PEDIATR, V141, P129, DOI 10.1007/BF00496807; WILLIAMS JC, 1989, LANCET, V1, P283; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	46	359	365	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					143	150		10.1038/ng1093-143	http://dx.doi.org/10.1038/ng1093-143			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252039				2022-12-17	WOS:A1993MA05600011
J	Wang, SK; Li, S; Liu, Q; Wu, K; Zhang, JQ; Wang, SS; Wang, Y; Chen, XB; Zhang, Y; Gao, CX; Wang, F; Huang, HX; Fu, XD				Wang, Shaokui; Li, Shan; Liu, Qian; Wu, Kun; Zhang, Jianqing; Wang, Shuansuo; Wang, Yi; Chen, Xiangbin; Zhang, Yi; Gao, Caixia; Wang, Feng; Huang, Haixiang; Fu, Xiangdong			The OsSPL16-GW7 regulatory module determines grain shape and simultaneously improves rice yield and grain quality	NATURE GENETICS			English	Article							GREEN-REVOLUTION; ARABIDOPSIS; PROTEIN; GENE; QTL; COMPLEX; ORGANIZATION; ARCHITECTURE; ELONGATION; EXPRESSION	The deployment of heterosis in the form of hybrid rice varieties has boosted grain yield, but grain quality improvement still remains a challenge. Here we show that a quantitative trait locus for rice grain quality, qGW7, reflects allelic variation of GW7, a gene encoding a TONNEAU1-recruiting motif protein with similarity to C-terminal motifs of the human centrosomal protein CAP350. Upregulation of GW7 expression was correlated with the production of more slender grains, as a result of increased cell division in the longitudinal direction and decreased cell division in the transverse direction. OsSPL16 (GW8), an SBP-domain transcription factor that regulates grain width, bound directly to the GW7 promoter and repressed its expression. The presence of a semidominant GW7TFA allele from tropical japonica rice was associated with higher grain quality without the yield penalty imposed by the Basmati gw8 allele. Manipulation of the OsSPL16-GW7 module thus represents a new strategy to simultaneously improve rice yield and grain quality.	[Wang, Shaokui; Li, Shan; Liu, Qian; Wu, Kun; Zhang, Jianqing; Wang, Shuansuo; Wang, Yi; Chen, Xiangbin; Zhang, Yi; Gao, Caixia; Fu, Xiangdong] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Wang, Shaokui] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Wang, Feng] Acad Agr Sci, Rice Res Inst Guangdong, Guangzhou, Guangdong, Peoples R China; [Huang, Haixiang] Jiaxing Acad Agr Sci, Jiaxing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; South China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Fu, XD (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	xdfu@genetics.ac.cn	wang, shaokui/GPX-7207-2022; Li, Shan/AAU-4104-2020; Gao, Caixia/AAG-8577-2019; Qian, Liu/GPS-5502-2022	wang, shaokui/0000-0002-7767-4033; Gao, Caixia/0000-0003-3169-8248; Chen, Xiangbin/0000-0002-0725-368X; QIAN, LIU/0000-0003-0560-4287; Li, Shan/0000-0003-2837-9027; Zhang, Yi/0000-0002-0745-3497	National Natural Science Foundation of China [91335207, 31130070]; Ministry of Science and Technology of China [2012AA10A301]; National Special Project of China [2014ZX0800935B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Special Project of China	We thank G. Zhang (South China Agricultural University) for providing the single-segment substitution lines (W23-19-6-7-19-3 and W3-20-28-2-8). This work was supported by grants from the National Natural Science Foundation of China (91335207 and 31130070), the Ministry of Science and Technology of China (2012AA10A301) and the National Special Project of China (2014ZX0800935B).	AHN SN, 1993, THEOR APPL GENET, V87, P27, DOI 10.1007/BF00223739; Aluko G, 2004, THEOR APPL GENET, V109, P630, DOI 10.1007/s00122-004-1668-y; Azimzadeh J, 2008, PLANT CELL, V20, P2146, DOI 10.1105/tpc.107.056812; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Cai XL, 1998, PLANT J, V14, P459, DOI 10.1046/j.1365-313X.1998.00126.x; Chern M, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-6; Drevensek S, 2012, PLANT CELL, V24, P178, DOI 10.1105/tpc.111.089748; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Kirik A, 2012, PLANT CELL, V24, P1158, DOI 10.1105/tpc.111.094367; Lee YK, 2006, DEVELOPMENT, V133, P4305, DOI 10.1242/dev.02604; Li G, 2011, NAT CELL BIOL, V13, P616, DOI 10.1038/ncb2219; Li YB, 2014, NAT GENET, V46, P398, DOI 10.1038/ng.2923; Lu ZF, 2013, PLANT CELL, V25, P3743, DOI 10.1105/tpc.113.113639; Nelson JC, 2011, THEOR APPL GENET, V122, P291, DOI 10.1007/s00122-010-1445-z; Patel H, 2005, J CELL SCI, V118, P175, DOI 10.1242/jcs.01600; Qiu XJ, 2012, THEOR APPL GENET, V125, P1717, DOI 10.1007/s00122-012-1948-x; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Shao GN, 2012, THEOR APPL GENET, V125, P1303, DOI 10.1007/s00122-012-1914-7; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Spinner L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2831; Sun HY, 2014, NAT GENET, V46, P652, DOI 10.1038/ng.2958; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Wang LQ, 2007, THEOR APPL GENET, V115, P463, DOI 10.1007/s00122-007-0580-7; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yan XM, 2006, MOL BIOL CELL, V17, P634, DOI 10.1091/mbc.E05-08-0810; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001; Zhou LJ, 2009, THEOR APPL GENET, V118, P581, DOI 10.1007/s00122-008-0922-0	32	358	439	23	337	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					949	+		10.1038/ng.3352	http://dx.doi.org/10.1038/ng.3352			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26147620				2022-12-17	WOS:000358674100023
J	Ellinor, PT; Lunetta, KL; Glazer, NL; Pfeufer, A; Alonso, A; Chung, MK; Sinner, MF; de Bakker, PIW; Mueller, M; Lubitz, SA; Fox, E; Darbar, D; Smith, NL; Smith, JD; Schnabel, RB; Soliman, EZ; Rice, KM; Van Wagoner, DR; Beckmann, BM; van Noord, C; Wang, K; Ehret, GB; Rotter, JI; Hazen, SL; Steinbeck, G; Smith, AV; Launer, LJ; Harris, TB; Makino, S; Nelis, M; Milan, DJ; Perz, S; Esko, T; Kottgen, A; Moebus, S; Newton-Cheh, C; Li, M; Moehlenkamp, S; Wang, TJ; Kao, WHL; Vasan, RS; Nothen, MM; MacRae, CA; Stricker, BHC; Hofman, A; Uitterlinden, AG; Levy, D; Boerwinkle, E; Metspalu, A; Topol, EJ; Chakravarti, A; Gudnason, V; Psaty, BM; Roden, DM; Meitinger, T; Wichmann, HE; Witteman, JCM; Barnard, J; Arking, DE; Benjamin, EJ; Heckbert, SR; Kaab, S				Ellinor, Patrick T.; Lunetta, Kathryn L.; Glazer, Nicole L.; Pfeufer, Arne; Alonso, Alvaro; Chung, Mina K.; Sinner, Moritz F.; de Bakker, Paul I. W.; Mueller, Martina; Lubitz, Steven A.; Fox, Ervin; Darbar, Dawood; Smith, Nicholas L.; Smith, Jonathan D.; Schnabel, Renate B.; Soliman, Elsayed Z.; Rice, Kenneth M.; Van Wagoner, David R.; Beckmann, Britt-M; van Noord, Charlotte; Wang, Ke; Ehret, Georg B.; Rotter, Jerome I.; Hazen, Stanley L.; Steinbeck, Gerhard; Smith, Albert V.; Launer, Lenore J.; Harris, Tamara B.; Makino, Seiko; Nelis, Mari; Milan, David J.; Perz, Siegfried; Esko, Tonu; Koettgen, Anna; Moebus, Susanne; Newton-Cheh, Christopher; Li, Man; Moehlenkamp, Stefan; Wang, Thomas J.; Kao, W. H. Linda; Vasan, Ramachandran S.; Noethen, Markus M.; MacRae, Calum A.; Stricker, Bruno H. Ch; Hofman, Albert; Uitterlinden, Andre G.; Levy, Daniel; Boerwinkle, Eric; Metspalu, Andres; Topol, Eric J.; Chakravarti, Aravinda; Gudnason, Vilmundur; Psaty, Bruce M.; Roden, Dan M.; Meitinger, Thomas; Wichmann, H-Erich; Witteman, Jacqueline C. M.; Barnard, John; Arking, Dan E.; Benjamin, Emelia J.; Heckbert, Susan R.; Kaeaeb, Stefan			Common variants in KCNN3 are associated with lone atrial fibrillation	NATURE GENETICS			English	Article							CA2+-ACTIVATED K+ CHANNEL; FAMILIAL AGGREGATION; FUNCTIONAL ROLES; EXPRESSION; RISK; SK3; IDENTIFICATION; METAANALYSIS; DISEASE; ZFHX3	Atrial fibrillation (AF) is the most common sustained arrhythmia. Previous studies have identified several genetic loci associated with typical AF. We sought to identify common genetic variants underlying lone AF. This condition affects a subset of individuals without overt heart disease and with an increased heritability of AF. We report a meta-analysis of genome-wide association studies conducted using 1,335 individuals with lone AF (cases) and 12,844 unaffected individuals (referents). Cases were obtained from the German AF Network, Heart and Vascular Health Study, the Atherosclerosis Risk in Communities Study, the Cleveland Clinic and Massachusetts General Hospital. We identified an association on chromosome 1q21 to lone AF (rs13376333, adjusted odds ratio = 1.56; P = 6.3 x 10(-12)), and we replicated this association in two independent cohorts with lone AF (overall combined odds ratio = 1.52, 95% CI 1.40-1.64; P = 1.83 x 10(-21)). rs13376333 is intronic to KCNN3, which encodes a potassium channel protein involved in atrial repolarization.	[Ellinor, Patrick T.; Lubitz, Steven A.; Makino, Seiko; Milan, David J.; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Ellinor, Patrick T.; Milan, David J.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; [Ellinor, Patrick T.; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Lunetta, Kathryn L.; Wang, Ke] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Lunetta, Kathryn L.; Schnabel, Renate B.; Wang, Thomas J.; Vasan, Ramachandran S.; Benjamin, Emelia J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Glazer, Nicole L.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Pfeufer, Arne; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; [Pfeufer, Arne; Meitinger, Thomas] Deutsch Forschungszentrum Gesundheit & Umwelt, Inst Human Genet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Chung, Mina K.; Van Wagoner, David R.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Inst Heart & Vasc, Lerner Res Inst, Cleveland, OH 44106 USA; [Sinner, Moritz F.; Mueller, Martina; Beckmann, Britt-M; Steinbeck, Gerhard; Kaeaeb, Stefan] Univ Munich, Univ Hosp Grosshadern, Dept Med 1, Munich, Germany; [de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA; [de Bakker, Paul I. W.; Newton-Cheh, Christopher] Harvard & Massachusetts Inst Technol, Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Mueller, Martina; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Mueller, Martina; Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Lubitz, Steven A.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Fox, Ervin] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Darbar, Dawood] Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Smith, Nicholas L.; Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Smith, Nicholas L.] Dept Vet Affairs Off Res & Dev, Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA; [Smith, Jonathan D.] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44106 USA; [Soliman, Elsayed Z.] Wake Forest Univ, Bowman Gray Sch Med, Dept Epidemiol & Prevent, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC USA; [Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [van Noord, Charlotte; Stricker, Bruno H. Ch; Hofman, Albert; Uitterlinden, Andre G.; Witteman, Jacqueline C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Noord, Charlotte] Dutch Med Evaluat Board, The Hague, Netherlands; [van Noord, Charlotte; Stricker, Bruno H. Ch; Hofman, Albert; Uitterlinden, Andre G.; Witteman, Jacqueline C. M.] Netherlands Consortium Healthy Aging, Leiden, Netherlands; [Ehret, Georg B.; Chakravarti, Aravinda; Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, Intramural Res Program, Bethesda, MD 20892 USA; [Nelis, Mari; Esko, Tonu; Metspalu, Andres] Estonian Bioctr, Genotyping Core Facil, Tartu, Estonia; [Nelis, Mari; Esko, Tonu; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Perz, Siegfried] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Biol & Med Imaging, Neuherberg, Germany; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Koettgen, Anna; Li, Man; Kao, W. H. Linda] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Moebus, Susanne] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Newton-Cheh, Christopher; Wang, Thomas J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Moehlenkamp, Stefan] Univ Duisburg Essen, W German Heart Ctr Essen, Dept Cardiol, Essen, Germany; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Sect Prevent Med, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Cardiol Sect, Dept Med, Boston, MA 02118 USA; [Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Noethen, Markus M.] Life & Brain Ctr Bonn, Dept Genom, Bonn, Germany; [MacRae, Calum A.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Stricker, Bruno H. Ch; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Stricker, Bruno H. Ch] Inspectorate Hlth Care, The Hague, Netherlands; [Stricker, Bruno H. Ch] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX USA; [Topol, Eric J.] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.; Heckbert, Susan R.] Grp Hlth, Res Inst, Seattle, WA USA; [Roden, Dan M.] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Barnard, John] Cleveland Clin, Dept Quantitat Hlth Sci, Lerner Res Inst, Cleveland, OH 44106 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Cardiol & Prevent Med Div,Evans Dept Med, Boston, MA 02118 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Minnesota System; University of Minnesota Twin Cities; Cleveland Clinic Foundation; University of Munich; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Harvard University; Brigham & Women's Hospital; University of Mississippi; University of Mississippi Medical Center; Vanderbilt University; University of Washington; University of Washington Seattle; Cleveland Clinic Foundation; Wake Forest University; Wake Forest Baptist Medical Center; University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; Cedars Sinai Medical Center; Icelandic Heart Association; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Estonian Biocentre; University of Tartu; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Tartu; Johns Hopkins University; University of Duisburg Essen; Harvard University; Massachusetts General Hospital; University of Duisburg Essen; Boston University; Boston University; University of Bonn; University of Bonn; Harvard University; Brigham & Women's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Scripps Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Vanderbilt University; University of Munich; Cleveland Clinic Foundation; Boston University; Boston University	Ellinor, PT (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.	pellinor@partners.org; stefan.kaab@med.uni-muenchen.de	Alonso, Alvaro/A-4917-2010; Wichmann, Heinz Erich/AAA-5695-2022; Gudnason, Vilmundur/K-6885-2015; Launer, Lenore J/A-8218-2010; Meitinger, Thomas/O-1318-2015; Rice, Kenneth M/A-4150-2013; de Bakker, Paul IW/B-8730-2009; Van Wagoner, David R/C-6783-2008; Levy, Daniel/ABB-2752-2021; Li, Man/AAX-3400-2020; Sinner, Moritz/AAW-5043-2020; Ramachandran, Vasan/Y-2527-2019; Smith, Albert Vernon/K-5150-2015; Soliman, Elsayed Z/AAD-7135-2020; Nöthen, Markus/B-2027-2009; Schnabel, Renate B/F-6527-2014; Müller-Nurasyid, Martina/I-8735-2018; Kottgen, Anna/D-2920-2012; Levy, Daniel/ABF-6873-2021; Nelis, Mari/ABG-7775-2020; Pfeufer, Arne/B-6634-2013; Hazen, Stanley L/ABD-5845-2021; Darbar, Dawood/C-9079-2015; EHRET, Georg B/A-9532-2009; Roden, Dan/ABD-5412-2021; Kaab, Stefan/H-3915-2012; Rotter, Jerome/AAY-6598-2021; Soliman, Elsayed/D-8124-2011; Gudnason, Vilmundur/AAE-7126-2019; Schnabel, Renate B/ABE-6668-2021; Benjamin, Emelia/E-7103-2011; Smith, Jonathan D./H-9723-2013	Alonso, Alvaro/0000-0002-2225-8323; Gudnason, Vilmundur/0000-0001-5696-0084; Rice, Kenneth M/0000-0001-5779-4495; de Bakker, Paul IW/0000-0001-7735-7858; Van Wagoner, David R/0000-0001-8250-9828; Li, Man/0000-0002-3839-0281; Ramachandran, Vasan/0000-0001-7357-5970; Smith, Albert Vernon/0000-0003-1942-5845; Soliman, Elsayed Z/0000-0001-5632-8150; Nöthen, Markus/0000-0002-8770-2464; Müller-Nurasyid, Martina/0000-0003-3793-5910; Levy, Daniel/0000-0003-1843-8724; Nelis, Mari/0000-0001-9748-1020; Darbar, Dawood/0000-0002-4103-5977; EHRET, Georg B/0000-0002-5730-0675; Soliman, Elsayed/0000-0001-5632-8150; Gudnason, Vilmundur/0000-0001-5696-0084; Schnabel, Renate B/0000-0001-7170-9509; Topol, Eric/0000-0002-1478-4729; Benjamin, Emelia/0000-0003-4076-2336; Lunetta, Kathryn/0000-0002-9268-810X; Glazer, Nicole/0000-0002-6397-609X; Moebus, Susanne/0000-0002-0072-5410; Smith, Jonathan D./0000-0002-0415-386X; Ellinor, Patrick/0000-0002-2067-0533; Meitinger, Thomas/0000-0002-8838-8403; Wang, Thomas/0000-0003-4063-6508; Ballantyne, Christie/0000-0002-6432-1730; Esko, Tonu/0000-0003-1982-6569	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055018, N01HC085081, N01HC075150, N01HC085083, N01HC085082, N01HC085084, N01HC015103, N01HC055020, N01HC085079, N01HC085080, N01HC055021, N01HC025195, N01HC055222, N01HC045133, N01HC035129, N01HC085085, N01HC085086, N01HC055022, N01HC055016, N01HC055019] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, UL1RR024989, UL1RR025774, M01RR000069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL068986, R01HL087652, R01HL064278, R01HL090620, R01HL104156, P50HL077107, U10HL054512, R01HL092577, U01HL065962, R01HL076784, T32HL007575, R01HL086694, R01HL087641, RC1HL101056, ZIAHL006001, P01HL076491, R01HL092217, R01HL059367] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000, ZIAAG007270, R01AG028321, N01AG012100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026982, R21DA027021] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00069, RR025774, UL1 RR024989, UL1RR025005, M01 RR000069, UL1 RR025005-025914, UL1 RR025005, CTSA 1UL-RR024989, M01 RR000069-43, UL1 RR025005-01, UL1 RR025774, UL1 RR024989-03, UL1 RR025774-01] Funding Source: Medline; NHGRI NIH HHS [U01HG004402, U01 HG004402-01, U01 HG004402] Funding Source: Medline; NHLBI NIH HHS [N01 HC-55222, P01 HL 076491, R01 HL076784-01, P01 HL076491-01, P50 HL077107, N01 HC035129, N01 HC055022, N01-HC-25195, N02-HL-6-4278, N01-HC-85086, R01 HL086694, U01 HL080295-01, N02 HL64278, N01 HC055016, RC1 HL101056, R01 HL086694-01A1, N01 HC085085, U01 HL065962, R01 HL087652, R01 HL087641-01, N01 HC045133, R01 HL068986-05A2, R01 HL090620, T32 HL007575, U01HL65962, N01 HC085086, R01 HL059367-02, N01 HC025195, N01 HC085084, N01 HC055018, R01HL092217, RC1 HL101056-01, HL076784, N01 HC055021, N01-HC-55016, N01 HC085083, N01 HC015103, N01 HC055015, R01 HL092577, P50 HL077107-03, N01-HC-55022, N01-HC-85080, RC1HL101056, R01 HL059367, R01HL59367, N01 HC055019, R01 HL076784, N01-HC-85082, R01 HL068986, N01-HC-85081, N01 HC085082, N01-HC-55021, U01 HL065962-09, R01 HL087652-01, R01 HL092217, N01 HC055222, N01-HC-55015, U10 HL054512-05, N01 HC085080, R01 HL090620-01A1, N01 HC085079, N01-HC-85083, U10HL054512, U01 HL065962-01A1, N01-HC-75150, N01-HC-55020, N01 HC055020, R01HL087641, R01HL092577, N01-HC-55019, R01 HL092217-01A2, U01 HL080295, N01 HC075150, R01 HL104156, N01 HC085081, N01-HC-85079, P01 HL076491, R01HL086694, T32 HL007575-25, N01-HC-55018, R01 HL087641, R01 HL092577-01A1] Funding Source: Medline; NIA NIH HHS [R01 AG028321-01, 1R01AG028321, N01-AG-12100, N01 AG012100, R01 AG028321] Funding Source: Medline; NIDA NIH HHS [R21 DA027021, 1R21DA027021, R21 DA026982, R21 DA027021-01] Funding Source: Medline; NIDDK NIH HHS [R01 DK033651, P30 DK063491, P30 DK063491-02, DK063491, P30 DK063491-07] Funding Source: Medline; PHS HHS [HHSN268200625226C] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Arnar DO, 2006, EUR HEART J, V27, P708, DOI 10.1093/eurheartj/ehi727; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Darbar D, 2007, HEART RHYTHM, V4, P743, DOI 10.1016/j.hrthm.2007.02.006; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Ellinor PT, 2005, HUM GENET, V118, P179, DOI 10.1007/s00439-005-0034-8; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Heckbert SR, 2008, ARCH INTERN MED, V168, P826, DOI 10.1001/archinte.168.8.826; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; KOZLOWSKI D, 2009, HEART           0826, DOI DOI 10.1136/HRT.2009.176321; Monaghan AS, 2004, J BIOL CHEM, V279, P1003, DOI 10.1074/jbc.M308070200; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Tuteja D, 2005, AM J PHYSIOL-HEART C, V289, pH2714, DOI 10.1152/ajpheart.00534.2005; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Xu YF, 2003, J BIOL CHEM, V278, P49085, DOI 10.1074/jbc.M307508200; Zhang Q, 2008, CIRC RES, V102, P465, DOI 10.1161/CIRCRESAHA.107.161778	33	358	369	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2010	42	3					240	U36		10.1038/ng.537	http://dx.doi.org/10.1038/ng.537			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20173747	Green Accepted			2022-12-17	WOS:000274912400013
J	Keurentjes, JJB; Fu, JY; de Vos, CHR; Lommen, A; Hall, RD; Bino, RJ; van der Plas, LHW; Jansen, RC; Vreugdenhil, D; Koornneef, M				Keurentjes, Joost J. B.; Fu, Jingyuan; Ric de Vos, C. H.; Lommen, Arjen; Hall, Robert D.; Bino, Raoul J.; van der Plas, Linus H. W.; Jansen, Ritsert C.; Vreugdenhil, Dick; Koornneef, Maarten			The genetics of plant metabolism	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; INTEGRATIVE GENOMICS APPROACH; ARABIDOPSIS-THALIANA; SECONDARY METABOLISM; SHOOT DEVELOPMENT; EXPRESSION; DIVERSIFICATION; CONSTRUCTION; METABOLOMICS; ASSOCIATIONS	Variation for metabolite composition and content is often observed in plants. However, it is poorly understood to what extent this variation has a genetic basis. Here, we describe the genetic analysis of natural variation in the metabolite composition in Arabidopsis thaliana. Instead of focusing on specific metabolites, we have applied empirical untargeted metabolomics using liquid chromatography-time of flight mass spectrometry (LC-QTOF MS). This uncovered many qualitative and quantitative differences in metabolite accumulation between A. thaliana accessions. Only 13.4% of the mass peaks were detected in all 14 accessions analyzed. Quantitative trait locus (QTL) analysis of more than 2,000 mass peaks, detected in a recombinant inbred line (RIL) population derived from the two most divergent accessions, enabled the identification of QTLs for about 75% of the mass signals. More than one-third of the signals were not detected in either parent, indicating the large potential for modification of metabolic composition through classical breeding.	Univ Wageningen & Res Ctr, Genet Lab, NL-6703 BD Wageningen, Netherlands; Univ Wageningen & Res Ctr, Lab Plant Physiol, NL-6703 BD Wageningen, Netherlands; Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen Bioinformat Ctr, NL-9751 NN Haren, Netherlands; Plant Res Int, NL-6708 PB Wageningen, Netherlands; Ctr Biosyst Genom, NL-6708 PB Wageningen, Netherlands; RIKILT, Inst Food Safety, NL-6700 AE Wageningen, Netherlands; Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	Wageningen University & Research; Wageningen University & Research; University of Groningen; Centre for BioSystems Genomics; Wageningen University & Research; Max Planck Society	Koornneef, M (corresponding author), Univ Wageningen & Res Ctr, Genet Lab, Arboretumlaan 4, NL-6703 BD Wageningen, Netherlands.	maarten.koornneef@wur.nl	De Vos, Ric/F-5012-2017; Fu, Jingyuan/ABE-6868-2020; Jansen, Ritsert C/C-1160-2013; Fu, JY/GRR-6179-2022; Fu, Jingyuan/E-8980-2012; HALL, ROBERT D/B-8707-2015	Fu, Jingyuan/0000-0001-5578-1236; Jansen, Ritsert C/0000-0003-2977-9110; HALL, ROBERT D/0000-0002-5786-768X; Keurentjes, Joost/0000-0001-8918-0711; Koornneef, Maarten/0000-0002-7759-4869				Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Bentsink L, 2000, PLANT PHYSIOL, V124, P1595, DOI 10.1104/pp.124.4.1595; Bing N, 2005, GENETICS, V170, P533, DOI 10.1534/genetics.105.041103; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, GENETICS, V163, P1169; D'Auria JC, 2005, CURR OPIN PLANT BIOL, V8, P308, DOI 10.1016/j.pbi.2005.03.012; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; DeCook R, 2006, GENETICS, V172, P1155, DOI 10.1534/genetics.105.042275; Dixon RA, 2005, CURR OPIN PLANT BIOL, V8, P329, DOI 10.1016/j.pbi.2005.03.008; Hobbs DH, 2004, PLANT PHYSIOL, V136, P3341, DOI 10.1104/pp.104.049486; JANSEN RC, 1993, GENETICS, V135, P205; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kliebenstein DJ, 2001, GENETICS, V159, P359; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Lall S, 2004, GENETICS, V167, P1883, DOI 10.1534/genetics.103.025213; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; Lim EK, 2004, BIOTECHNOL BIOENG, V87, P623, DOI 10.1002/bit.20154; Loudet O, 2003, PLANT PHYSIOL, V131, P345, DOI 10.1104/pp.102.010785; Lumba S, 2005, CURR OPIN PLANT BIOL, V8, P501, DOI 10.1016/j.pbi.2005.07.015; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; Mita S, 1997, PLANT J, V11, P841, DOI 10.1046/j.1365-313X.1997.11040841.x; Mitchell-Olds T, 1998, GENETICS, V149, P739; Oksman-Caldentey KM, 2005, CURR OPIN BIOTECH, V16, P174, DOI 10.1016/j.copbio.2005.02.007; Reichelt M, 2002, PHYTOCHEMISTRY, V59, P663, DOI 10.1016/S0031-9422(02)00014-6; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Vorst O, 2005, METABOLOMICS, V1, P169, DOI 10.1007/s11306-005-4432-7; Windsor AJ, 2005, PHYTOCHEMISTRY, V66, P1321, DOI 10.1016/j.phytochem.2005.04.016; WINK M, 1988, THEOR APPL GENET, V75, P225, DOI 10.1007/BF00303957; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209	39	358	381	1	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					842	849		10.1038/ng1815	http://dx.doi.org/10.1038/ng1815			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16751770	Green Published			2022-12-17	WOS:000238669300023
J	Zhou, ZH; Toh, SY; Chen, ZM; Guo, K; Ng, CP; Ponniah, S; Lin, SC; Hong, WJ; Li, P				Zhou, ZH; Toh, SY; Chen, ZM; Guo, K; Ng, CP; Ponniah, S; Lin, SC; Hong, WJ; Li, P			Cidea-deficient mice have lean phenotype and are resistant to obesity	NATURE GENETICS			English	Article							BROWN ADIPOSE-TISSUE; MITOCHONDRIAL UNCOUPLING PROTEIN; TRANSGENIC MICE; ENERGY-BALANCE; THERMOGENESIS; APOPTOSIS; LACKING; MUSCLE; DOMAIN	The thermogenic activity of brown adipose tissue (BAT), important for adaptive thermogenesis and energy expenditure, is mediated by the mitochondrial uncoupling protein1 (Ucp1) that uncouples ATP generation and dissipates the energy as heat. We show here that Cidea, a protein of unknown function sharing sequence similarity with the N-terminal region of DNA fragmentation factors Dffb and Dffa, is expressed at high levels in BAT. Cidea-null mice had higher metabolic rate, lipolysis in BAT and core body temperature when subjected to cold treatment. Notably, Cidea-null mice are lean and resistant to diet-induced obesity and diabetes. Furthermore, we provide evidence that the role of Cidea in regulating thermogenesis, lipolysis and obesity may be mediated in part through its direct suppression of Ucp1 activity. Our data thus indicate a role for Cidea in regulating energy balance and adiposity.	Inst Cell & Mol Biol, Lab Apoptosis Regulat, Singapore 117609, Singapore; Inst Cell & Mol Biol, Lab Regulatory Biol, Singapore 117609, Singapore; Inst Cell & Mol Biol, Lab Membrane Biol, Singapore 117609, Singapore; Inst Cell & Mol Biol, In Vivo Model Unit, Singapore 117609, Singapore; Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Hong Kong University of Science & Technology	Li, P (corresponding author), Inst Cell & Mol Biol, Lab Apoptosis Regulat, 30 Med Dr, Singapore 117609, Singapore.	bolipeng@ust.hk	HONG, Wanjin/E-9927-2010; Lin, SC/G-4666-2010; Zhou, Z Hong/HDN-0747-2022	Toh, Shen Yon/0000-0002-6421-0862				Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BOUILLAUD F, 1994, EMBO J, V13, P1990, DOI 10.1002/j.1460-2075.1994.tb06468.x; Carson F. L., 1997, HISTOTECHNOLOGY SELF; Chen ZM, 2000, J BIOL CHEM, V275, P22619, DOI 10.1074/jbc.C000207200; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; DULLOO AG, 1984, CAN J PHYSIOL PHARM, V62, P235, DOI 10.1139/y84-035; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; HIMMSHAGEN J, 1990, FASEB J, V4, P2890, DOI 10.1096/fasebj.4.11.2199286; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Klingenberg M, 2001, BBA-BIOENERGETICS, V1504, P128, DOI 10.1016/S0005-2728(00)00242-5; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; KOZAK LP, 1991, GENE DEV, V5, P2256, DOI 10.1101/gad.5.12a.2256; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lowell BB, 1997, ANNU REV MED, V48, P307; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Griffiths Gareth, 1993, Trends in Cell Biology, V3, P214, DOI 10.1016/0962-8924(93)90114-G; Lugovskoy AA, 1999, CELL, V99, P747, DOI 10.1016/S0092-8674(00)81672-4; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Zhou P, 2001, P NATL ACAD SCI USA, V98, P6051, DOI 10.1073/pnas.111145098	26	358	383	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2003	35	1					49	56		10.1038/ng1225	http://dx.doi.org/10.1038/ng1225			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12910269				2022-12-17	WOS:000185018500010
J	Lu, WN; Peissel, B; Babakhanlou, H; Pavlova, A; Geng, L; Fan, XH; Larson, C; Brent, G; Zhou, J				Lu, WN; Peissel, B; Babakhanlou, H; Pavlova, A; Geng, L; Fan, XH; Larson, C; Brent, G; Zhou, J			Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY; DISEASE; GENE; CELLS; PROTEIN; PRODUCT; FETAL; ADULT	PKD1 is the most common site for mutations in human autosomal dominant polycystic kidney disease (ADPKD). ADPKD is characterized by progressive replacement of kidney tissue by epithelial cysts and eventual renal failure. Hepatic and pancreatic cysts are also common(1). The PKD1 protein, polycystin, is a cell-surface protein(2,3) of unknown function that is widely expressed in epithelia and in vascular smooth muscle and myocardium(4-9). None of the genetic forms of murine polycystic disease map to the murine Pkd1 locus. We introduced into mice by homologous recombination a Pkd1 truncation mutation, Pkd1(-), that mimics a mutation found in ADPKD. Pkd1(-) heterozygotes have no discernible phenotype, whereas homozygotes die during the perinatal period with massively enlarged cystic kidneys, pancreatic ductal cysts and pulmonary hypoplasia. Renal cyst formation begins at embryonic day 15.5 (E15.5) in proximal tubules and progresses rapidly to replace the entire renal parenchyma. The timing of cyst formation indicates that full-length polycystin is required for normal morphogenesis during elongation and maturation of tubular structures in the kidney and pancreas.	HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,DIV RENAL, BOSTON, MA 02115 USA; HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED, DIV THYROID, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School			Peissel, Bernard/E-8187-2017	Peissel, Bernard/0000-0001-9233-3571; Lu, Weining/0000-0002-6570-3044	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051050] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK51050] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Geng L, 1997, AM J PHYSIOL-RENAL, V272, pF451, DOI 10.1152/ajprenal.1997.272.4.F451; Geng L, 1996, J CLIN INVEST, V98, P2674, DOI 10.1172/JCI119090; GENG L, 1994, J AM SOC NEPHROL, V5, P622; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Griffin MD, 1996, P ASSOC AM PHYSICIAN, V108, P185; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Madsen OD, 1996, EUR J BIOCHEM, V242, P435, DOI 10.1111/j.1432-1033.1996.435rr.x; Palsson R, 1996, MOL MED, V2, P702, DOI 10.1007/BF03401654; Peral B, 1996, AM J HUM GENET, V58, P86; Peters DJM, 1996, LAB INVEST, V75, P221; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; SOROKIN L, 1992, KIDNEY INT, V41, P657, DOI 10.1038/ki.1992.101; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524	16	358	362	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1997	17	2					179	181		10.1038/ng1097-179	http://dx.doi.org/10.1038/ng1097-179			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326937				2022-12-17	WOS:A1997XZ55500023
J	Wang, J; Thingholm, LB; Skieceviciene, J; Rausch, P; Kummen, M; Hov, JR; Degenhardt, F; Heinsen, FA; Ruhlemann, MC; Szymczak, S; Holm, K; Esko, T; Sun, J; Pricop-Jeckstadt, M; Al-Dury, S; Bohov, P; Bethune, J; Sommer, F; Ellinghaus, D; Berge, RK; Hubenthal, M; Koch, M; Schwarz, K; Rimbach, G; Hubbe, P; Pan, WH; Sheibani-Tezerji, R; Hasler, R; Rosenstiel, P; D'Amato, M; Cloppenborg-Schmidt, K; Kunzel, S; Laudes, M; Marschall, HU; Lieb, W; Nothlings, U; Karlsen, TH; Baines, JF; Franke, A				Wang, Jun; Thingholm, Louise B.; Skieceviciene, Jurgita; Rausch, Philipp; Kummen, Martin; Hov, Johannes R.; Degenhardt, Frauke; Heinsen, Femke-Anouska; Ruehlemann, Malte C.; Szymczak, Silke; Holm, Kristian; Esko, Tonu; Sun, Jun; Pricop-Jeckstadt, Mihaela; Al-Dury, Samer; Bohov, Pavol; Bethune, Joern; Sommer, Felix; Ellinghaus, David; Berge, Rolf K.; Huebenthal, Matthias; Koch, Manja; Schwarz, Karin; Rimbach, Gerald; Huebbe, Patricia; Pan, Wei-Hung; Sheibani-Tezerji, Raheleh; Haesler, Robert; Rosenstiel, Philipp; D'Amato, Mauro; Cloppenborg-Schmidt, Katja; Kuenzel, Sven; Laudes, Matthias; Marschall, Hanns-Ulrich; Lieb, Wolfgang; Noethlings, Ute; Karlsen, Tom H.; Baines, John F.; Franke, Andre			Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota	NATURE GENETICS			English	Article							GENE; DISEASE; EXPRESSION; ACID; POPULATION; SHAPE; MICE; SUSCEPTIBILITY; INFLAMMATION; METABOLISM	Human gut microbiota is an important determinant for health and disease, and recent studies emphasize the numerous factors shaping its diversity. Here we performed a genome-wide association study (GWAS) of the gut microbiota using two cohorts from northern Germany totaling 1,812 individuals. Comprehensively controlling for diet and non-genetic parameters, we identify genome-wide significant associations for overall microbial variation and individual taxa at multiple genetic loci, including the VDR gene (encoding vitamin D receptor). We observe significant shifts in the microbiota of Vdr(-/-) mice relative to control mice and correlations between the microbiota and serum measurements of selected bile and fatty acids in humans, including known ligands and downstream metabolites of VDR. Genome-wide significant (P < 5 x 10(-8)) associations at multiple additional loci identify other important points of host-microbe intersection, notably several disease susceptibility genes and sterol metabolism pathway components. Non-genetic and genetic factors each account for approximately 10% of the variation in gut microbiota, whereby individual effects are relatively small.	[Wang, Jun; Rausch, Philipp; Kuenzel, Sven; Baines, John F.] Max Planck Inst Evolutionary Biol, Evolutionary Genom, Plon, Germany; [Wang, Jun; Rausch, Philipp; Cloppenborg-Schmidt, Katja; Baines, John F.] Univ Kiel, Inst Expt Med, Kiel, Germany; [Thingholm, Louise B.; Skieceviciene, Jurgita; Degenhardt, Frauke; Heinsen, Femke-Anouska; Ruehlemann, Malte C.; Szymczak, Silke; Bethune, Joern; Sommer, Felix; Ellinghaus, David; Huebenthal, Matthias; Pan, Wei-Hung; Sheibani-Tezerji, Raheleh; Haesler, Robert; Rosenstiel, Philipp; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Kummen, Martin; Hov, Johannes R.; Holm, Kristian; Karlsen, Tom H.] Norwegian PSC Res Ctr, Div Surg Inflammatory Med & Transplantat, Oslo, Norway; [Kummen, Martin; Hov, Johannes R.; Holm, Kristian; Karlsen, Tom H.] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Kummen, Martin; Hov, Johannes R.; Holm, Kristian; Karlsen, Tom H.] Univ Oslo, Inst Clin Med, KG Jebsen Inflammat Res Ctr, Oslo, Norway; [Kummen, Martin; Hov, Johannes R.; Holm, Kristian; Karlsen, Tom H.] Natl Hosp Norway, Oslo Univ Hosp, Res Inst Internal Med, Oslo, Norway; [Hov, Johannes R.; Karlsen, Tom H.] Natl Hosp Norway, Oslo Univ Hosp, Dept Transplantat Med, Sect Gastroenterol, Oslo, Norway; [Esko, Tonu] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Sun, Jun] Univ Chicago, Dept Med, Div Gastroenterol & Hepatol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Pricop-Jeckstadt, Mihaela; Noethlings, Ute] Univ Bonn, Dept Nutr & Food Sci, Nutr Epidemiol, Bonn, Germany; [Al-Dury, Samer; Marschall, Hanns-Ulrich] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Bohov, Pavol; Berge, Rolf K.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Berge, Rolf K.] Haukeland Hosp, Dept Heart Dis, Bergen, Norway; [Koch, Manja; Lieb, Wolfgang] Univ Kiel, Inst Epidemiol, Kiel, Germany; [Schwarz, Karin; Rimbach, Gerald; Huebbe, Patricia] Univ Kiel, Inst Human Nutr & Food Sci, Kiel, Germany; [D'Amato, Mauro] BioDonostia Hlth Res Inst, San Sebastian, Spain; [D'Amato, Mauro] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [D'Amato, Mauro] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Laudes, Matthias] Univ Hosp SH UKSH, Dept Internal Med 1, Campus Kiel, Kiel, Germany; [Karlsen, Tom H.] Univ Bergen, Dept Clin Med, Bergen, Norway; [Wang, Jun] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Wang, Jun] VIB, Ctr Biol Dis, Leuven, Belgium; [Szymczak, Silke] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany	Max Planck Society; University of Kiel; University of Kiel; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Tartu; University of Chicago; University of Bonn; University of Gothenburg; University of Bergen; University of Bergen; Haukeland University Hospital; University of Kiel; University of Kiel; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science; Karolinska Institutet; University of Kiel; Schleswig Holstein University Hospital; University of Bergen; KU Leuven; Flanders Institute for Biotechnology (VIB); University of Kiel	Franke, A (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	a.franke@mucosa.de	Laudes, Matthias/C-8885-2011; Baines, John F/B-3580-2010; Rimbach, Gerald/A-7178-2011; Nöthlings, Ute/B-2713-2010; Ellinghaus, David/G-4467-2012; Lieb, Wolfgang/AAC-7650-2022; Szymczak, Silke/C-6625-2013; D'Amato, Mauro/F-2450-2010; pricop-Jeckstadt, Mihaela/GRO-7319-2022; Schwarz, Karin/K-3102-2014; Szymczak, Silke/HGT-8202-2022; Sommer, Felix/I-1706-2017; Rausch, Philipp/J-4258-2017; Kummen, Martin/I-6663-2019; Sun, Jun/S-7440-2019; Häsler, Robert/A-4908-2009; D'Amato, Mauro/B-5050-2019; Franke, Andre/B-2151-2010; Rühlemann, Malte Christoph/AAA-6528-2019; Rosenstiel, Philip/A-5137-2009; Marschall, Hanns-Ulrich/K-8842-2017; Sommer, Felix/AAL-1746-2020; Pricop-Jeckstadt, Mihaela/AAP-8645-2021; Hübenthal, Matthias/M-8149-2015; Ellinghaus, David/ABC-3610-2020; Hov, Johannes R/J-1480-2019	Baines, John F/0000-0002-8132-4909; Rimbach, Gerald/0000-0001-7888-4684; D'Amato, Mauro/0000-0003-2743-5197; Schwarz, Karin/0000-0002-3943-0564; Sommer, Felix/0000-0002-6545-3487; Rausch, Philipp/0000-0003-3133-5674; Kummen, Martin/0000-0001-9660-6290; Sun, Jun/0000-0001-7465-3133; Häsler, Robert/0000-0003-4174-8229; D'Amato, Mauro/0000-0003-2743-5197; Franke, Andre/0000-0003-1530-5811; Rühlemann, Malte Christoph/0000-0002-0685-0052; Rosenstiel, Philip/0000-0002-9692-8828; Marschall, Hanns-Ulrich/0000-0001-7347-3085; Sommer, Felix/0000-0002-6545-3487; Hübenthal, Matthias/0000-0002-5956-3006; Ellinghaus, David/0000-0002-4332-6110; Hov, Johannes R/0000-0002-5900-8096; Pricop-Jeckstadt, Mihaela/0000-0003-0173-6493; Koch, Manja/0000-0002-4794-4821; Sheibani Tezerji, Raheleh/0000-0002-1025-646X; Szymczak, Silke/0000-0002-8897-9035; Heinsen, Femke-Anouska/0000-0003-3652-6402; Degenhardt, Frauke/0000-0001-7516-3179	Der Norddeutsche Verbund fur Hoch- und Hochstleistungsrechnen (HLRN); German Research Foundation (DFG) Collaborative Research Center [1182, 306]; German Federal Ministry of Education and Research (BMBF); Norwegian PSC Research Center; Western Norway Regional Health Authority [911802]; German Research Foundation (DFG); Norwegian Research Council [240787/F20]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK089010, R01DK105118] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/K032208/1] Funding Source: researchfish; EPSRC [EP/K032208/1] Funding Source: UKRI	Der Norddeutsche Verbund fur Hoch- und Hochstleistungsrechnen (HLRN); German Research Foundation (DFG) Collaborative Research Center(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Norwegian PSC Research Center; Western Norway Regional Health Authority; German Research Foundation (DFG)(German Research Foundation (DFG)); Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A.D. Paterson and colleagues for support in selection of models for GWAS. We further thank Der Norddeutsche Verbund fur Hoch- und Hochstleistungsrechnen (HLRN) and S. Knief and H. Marten for computational resources and support. This work was supported by German Research Foundation (DFG) Collaborative Research Center 1182, 'Origin and Function of Metaorganisms' (J.F.B and A.F.) and Excellence Cluster 306, 'Inflammation at Interfaces' (J.F.B. and A.F.) and by German Federal Ministry of Education and Research (BMBF) project 'SysINFLAME' (J.F.B. and A.E). Project support was also provided by the Norwegian PSC Research Center and the Western Norway Regional Health Authority (grant 911802) (T.H.K.). M.K. is the recipient of a Postdoctoral Research Fellowship from the German Research Foundation (DFG). J.R.H. was funded by the Norwegian Research Council (240787/F20).	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arimura Y, 2014, J GASTROENTEROL, V49, P1217, DOI 10.1007/s00535-013-0866-2; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Biedermann L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059260; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; D'Aldebert E, 2009, GASTROENTEROLOGY, V136, P1435, DOI 10.1053/j.gastro.2008.12.040; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Duparc T., 2016, GUT; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Jin D., 2015, CLIN THER, V37; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Krude H, 2003, ANN NY ACAD SCI, V994, P233, DOI 10.1111/j.1749-6632.2003.tb03185.x; Leamy LJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0552-6; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; Muller N, 2015, J LIPID RES, V56, P1034, DOI 10.1194/jlr.P052209; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Olivares M, 2015, GUT, V64, P406, DOI 10.1136/gutjnl-2014-306931; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Rehman A, 2016, GUT, V65, P238, DOI 10.1136/gutjnl-2014-308341; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Sato H, 2009, BIOCHEM J, V421, P17, DOI 10.1042/BJ20082429; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Srinivas G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3462; Sun J, 2016, AUTOPHAGY, V12, P1057, DOI 10.1080/15548627.2015.1072670; Terao C, 2013, AM J HUM GENET, V93, P289, DOI 10.1016/j.ajhg.2013.05.024; Tuoresmaki P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096105; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7440; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	50	357	367	10	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2016	48	11					1396	1406		10.1038/ng.3695	http://dx.doi.org/10.1038/ng.3695			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EA3XU	27723756	Green Accepted			2022-12-17	WOS:000386543400016
J	Zhou, Q; Wang, HY; Schwartz, DM; Stoffels, M; Park, YH; Zhang, Y; Yang, D; Demirkaya, E; Takeuchi, M; Tsai, WXL; Lyons, JJ; Yu, XM; Ouyang, C; Chen, C; Chin, DT; Zaal, K; Chandrasekharappa, SC; Hanson, EP; Yu, Z; Mullikin, JC; Hasni, SA; Wertz, IE; Ombrello, AK; Stone, DL; Hoffmann, P; Jones, A; Barham, BK; Leavis, HL; van Royen-Kerkof, A; Sibley, C; Batu, ED; Gul, A; Siegel, RM; Boehm, M; Milner, JD; Ozen, S; Gadina, M; Chae, J; Laxer, RM; Kastner, DL; Aksentijevich, I				Zhou, Qing; Wang, Hongying; Schwartz, Daniella M.; Stoffels, Monique; Park, Yong Hwan; Zhang, Yuan; Yang, Dan; Demirkaya, Erkan; Takeuchi, Masaki; Tsai, Wanxia Li; Lyons, Jonathan J.; Yu, Xiaomin; Ouyang, Claudia; Chen, Celeste; Chin, David T.; Zaal, Kristien; Chandrasekharappa, Settara C.; Hanson, Eric P.; Yu, Zhen; Mullikin, James C.; Hasni, Sarfaraz A.; Wertz, Ingrid E.; Ombrello, Amanda K.; Stone, Deborah L.; Hoffmann, Patrycja; Jones, Anne; Barham, Beverly K.; Leavis, Helen L.; van Royen-Kerkof, Annet; Sibley, Cailin; Batu, Ezgi D.; Guel, Ahmet; Siegel, Richard M.; Boehm, Manfred; Milner, Joshua D.; Ozen, Seza; Gadina, Massimo; Chae, JaeJin; Laxer, Ronald M.; Kastner, Daniel L.; Aksentijevich, Ivona			Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease	NATURE GENETICS			English	Article							NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NLRP3 INFLAMMASOME; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; GERMLINE MUTATIONS; TUMOR SUPPRESSION; LUBAC DEFICIENCY; UBIQUITIN; ASSOCIATION	Systemic autoinflammatory diseases are driven by abnormal activation of innate immunity(1). Herein we describe a new disease caused by high-penetrance heterozygous germline mutations in TNFAIP3, which encodes the NF-kappa B regulatory protein A20, in six unrelated families with early-onset systemic inflammation. The disorder resembles Behcet's disease, which is typically considered a polygenic disorder with onset in early adulthood(2). A20 is a potent inhibitor of the NF-kappa B signaling pathway(3). Mutant, truncated A20 proteins are likely to act through haploinsufficiency because they do not exert a dominant-negative effect in overexpression experiments. Patient-derived cells show increased degradation of I kappa B alpha and nuclear translocation of the NF-kappa B p65 subunit together with increased expression of NF-kappa B-mediated proinflammatory cytokines. A20 restricts NF-kappa B signals via its deubiquitinase activity. In cells expressing mutant A20 protein, there is defective removal of Lys63-linked ubiquitin from TRAF6, NEMO and RIP1 after stimulation with tumor necrosis factor (TNF). NF-kappa B-dependent proinflammatory cytokines are potential therapeutic targets for the patients with this disease.	[Zhou, Qing; Wang, Hongying; Stoffels, Monique; Park, Yong Hwan; Takeuchi, Masaki; Chen, Celeste; Chin, David T.; Ombrello, Amanda K.; Stone, Deborah L.; Hoffmann, Patrycja; Jones, Anne; Barham, Beverly K.; Chae, JaeJin; Kastner, Daniel L.; Aksentijevich, Ivona] NHGRI, Inflammatory Dis Sect, Bethesda, MD 20892 USA; [Schwartz, Daniella M.] Natl Inst Arthrit & Musculoskeletal & Skin Dis, Mol Immunol & Inflammat Branch, Bethesda, MD USA; [Zhang, Yuan; Lyons, Jonathan J.; Yu, Xiaomin; Milner, Joshua D.] Lab Allerg Dis, Natl Inst Allergy & Infect Dis, Genet & Pathogenesis Allergy Sect, Bethesda, MD USA; [Yang, Dan; Yu, Zhen; Boehm, Manfred] Lab Cardiovasc Regenerat Med Natl Heart Lung, Bethesda, MD USA; [Yang, Dan; Yu, Zhen; Boehm, Manfred] Blood Inst, Bethesda, MD USA; [Demirkaya, Erkan] Gulhane Mil Med Acad, FMF Arthrit Vasculitis & Orphan Dis Res Ctr FAVOR, Ankara, Turkey; [Tsai, Wanxia Li; Gadina, Massimo] Natl Inst Arthrit & Musculoskeletal & Skin Dis, Translat Immunol Sect, Bethesda, MD USA; [Ouyang, Claudia; Hanson, Eric P.; Siegel, Richard M.] Natl Inst Arthrit & Musculoskeletal & Skin Dis, Autoimmun Branch, Bethesda, MD USA; [Zaal, Kristien] Natl Inst Arthrit & Musculoskeletal & Skin Dis, Light Imaging Sect, Bethesda, MD USA; [Chandrasekharappa, Settara C.] NHGRI, Canc Genet & Comparat Genom Branch, Bethesda, MD 20892 USA; [Mullikin, James C.] NHGRI, Natl Inst Hlth Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Hasni, Sarfaraz A.] Natl Inst Arthrit & Musculoskeletal & Skin Dis, Syst Autoimmune Branch, Bethesda, MD USA; [Wertz, Ingrid E.] Genentech Inc, Dept Mol Oncol, San Francisco, CA USA; [Leavis, Helen L.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [van Royen-Kerkof, Annet] Univ Med Ctr Utrecht, Dept Pediat Immunol, Utrecht, Netherlands; [Sibley, Cailin] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA; [Batu, Ezgi D.; Ozen, Seza] Hacettepe Univ, Dept Pediat Rheumatol, Ankara, Turkey; [Guel, Ahmet] Istanbul Univ, Dept Internal Med, Istanbul, Turkey; [Laxer, Ronald M.] Univ Toronto, Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Gulhane Military Medical Academy; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Roche Holding; Genentech; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Oregon Health & Science University; Hacettepe University; Istanbul University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Aksentijevich, I (corresponding author), NHGRI, Inflammatory Dis Sect, Bethesda, MD 20892 USA.	aksentii@mail.nih.gov	Hanson, Eric/AAE-5511-2022; Zhang, Yuan/C-7777-2018; Aksentijevich, Ivona/AAF-1335-2019; Yu, Xiaomin/I-6407-2016; Batu, Ezgi Deniz/F-9761-2018; Gadina, Massimo/R-4195-2019; Gul, Ahmet/AAT-7787-2020; OZEN, SEZA/I-9096-2013; Demirkaya, Erkan/F-5082-2019	Zhang, Yuan/0000-0001-9932-917X; Batu, Ezgi Deniz/0000-0003-1065-2363; Gul, Ahmet/0000-0001-8219-3720; Demirkaya, Erkan/0000-0003-4525-1789; Lyons, Jonathan/0000-0002-2346-8189; Schwartz, Daniella/0000-0002-1660-8438; Ombrello, Amanda/0000-0001-5563-9416; Hanson, Eric/0000-0002-0318-4779	Intramural Research Programs of the National Human Genome Research Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Heart, Lung, and Blood Institute; National Institute of Allergy and Infectious Diseases; US National Institutes of Health Clinical Center; Research Fellowship Program for International Researchers - Scientific and Technological Research Council of Turkey (TUBITAK) [B.14.2.TBT.0.06.01-219-84]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006077] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200373, ZIAHG200330, ZICHG200346, ZIAHG200374, ZIBHG000196, ZIAHG000029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041186, K23AR068440, ZIAAR041133, ZIAAR041175, ZIEAR041176, ZIDAR041180, ZICAR041181, ZIAAR041187] Funding Source: NIH RePORTER	Intramural Research Programs of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Fellowship Program for International Researchers - Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank V. Dixit for helpful discussions. We also thank all the patients and their families, and the healthy children and adult controls, for their enthusiastic support during this research study. This research was supported by the Intramural Research Programs of the National Human Genome Research Institute, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Heart, Lung, and Blood Institute, the National Institute of Allergy and Infectious Diseases, and the US National Institutes of Health Clinical Center. S.O. received royalties for consulting and speaking from Novartis and SOBI. H.L.L. received royalties for consulting from Baxter. E.D. was recipient of the Research Fellowship Program for International Researchers, which is supported by the Scientific and Technological Research Council of Turkey (TUBITAK; B.14.2.TBT.0.06.01-219-84).	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Boisson B, 2015, J EXP MED, V212, P939, DOI 10.1084/jem.20141130; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Jesus AA, 2014, ANNU REV MED, V65, P223, DOI 10.1146/annurev-med-061512-150641; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kirino Y, 2013, P NATL ACAD SCI USA, V110, P8134, DOI 10.1073/pnas.1306352110; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Li LY, 2008, BBA-MOL CELL RES, V1783, P1140, DOI 10.1016/j.bbamcr.2008.01.029; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lodolce JP, 2010, J IMMUNOL, V184, P7001, DOI 10.4049/jimmunol.1000324; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Ma CA, 2011, HUM MUTAT, V32, P318, DOI 10.1002/humu.21439; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Martin F, 2011, NAT GENET, V43, P822, DOI 10.1038/ng.916; Martinon F, 2015, NAT REV RHEUMATOL, V11, P11, DOI 10.1038/nrrheum.2014.158; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Moghaddas F, 2015, CYTOKINE, V74, P237, DOI 10.1016/j.cyto.2015.02.012; Musone SL, 2011, GENES IMMUN, V12, P176, DOI 10.1038/gene.2010.64; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nititham J, 2015, GENES IMMUN, V16, P120, DOI 10.1038/gene.2014.75; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Rieux-Laucat F, 2014, SCIENCE, V345, P1560, DOI 10.1126/science.1260791; Russo RAG, 2014, RHEUMATOLOGY, V53, P1927, DOI 10.1093/rheumatology/keu170; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; van Kempen TS, 2015, NAT REV RHEUMATOL, V11, P483, DOI 10.1038/nrrheum.2015.60; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Wang HY, 2013, P NATL ACAD SCI USA, V110, P5127, DOI 10.1073/pnas.1221211110; Wang HY, 2001, J BIOL CHEM, V276, P26004, DOI 10.1074/jbc.M010738200; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013; Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361	48	357	371	7	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					67	+		10.1038/ng.3459	http://dx.doi.org/10.1038/ng.3459			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26642243	Green Accepted, Green Submitted			2022-12-17	WOS:000367255300015
J	Trevino, LR; Yang, WJ; French, D; Hunger, SP; Carroll, WL; Devidas, M; Willman, C; Neale, G; Downing, J; Raimondi, SC; Pui, CH; Evans, WE; Relling, MV				Trevino, Lisa R.; Yang, Wenjian; French, Deborah; Hunger, Stephen P.; Carroll, William L.; Devidas, Meenakshi; Willman, Cheryl; Neale, Geoffrey; Downing, James; Raimondi, Susana C.; Pui, Ching-Hon; Evans, William E.; Relling, Mary V.			Germline genomic variants associated with childhood acute lymphoblastic leukemia	NATURE GENETICS			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; MINIMAL RESIDUAL DISEASE; DNA-BINDING PROPERTIES; IKAROS GENE ENCODES; NATIONAL-INSTITUTE; BIPOLAR DISORDER; WIDE ANALYSIS; IN-VIVO; POLYMORPHISMS; EXPRESSION	Using the Affymetrix 500K Mapping array and publicly available genotypes, we identified 18 SNPs whose allele frequency differed significantly(P < 1 x 10(-5)) between pediatric acute lymphoblastic leukemia (ALL) cases (n = 317) and non-ALL controls (n = 17,958). Two SNPs in ARID5B not only differed between ALL and non-ALL groups (rs10821936, P = 1.4 x 10(-15), odds ratio (OR) = 1.91; rs10994982, P = 5.7 x 10(-9), OR = 1.62) but also distinguished B-hyperdiploid ALL from other subtypes (rs10821936, P = 1.62 x 10(-5), OR = 2.17; rs10994982, P = 0.003, OR 1.72). These ARID5B SNPs also distinguished B-hyperdiploid ALL from other subtypes in an independent validation cohort (n 124 children with ALL; P 0.003 and P = 0.0008, OR 2.45 and 2.86, respectively) and were associated with methotrexate accumulation and gene expression pattern in leukemic lymphoblasts. We conclude that germline variants affect susceptibility to, and characteristics of, specific ALL subtypes.	[Trevino, Lisa R.; Yang, Wenjian; French, Deborah; Neale, Geoffrey; Downing, James; Raimondi, Susana C.; Pui, Ching-Hon; Evans, William E.; Relling, Mary V.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Hunger, Stephen P.] Univ Colorado, Denver, CO 80202 USA; [Carroll, William L.] NYU, Med Ctr, New York, NY 10016 USA; [Devidas, Meenakshi] Univ Florida, Gainesville, FL USA; [Willman, Cheryl] Univ New Mexico, Albuquerque, NM 87131 USA	St Jude Children's Research Hospital; University of Colorado System; University of Colorado Denver; New York University; State University System of Florida; University of Florida; University of New Mexico	Relling, MV (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.	mary.relling@stjude.org	Evans, William E./C-2069-2012; Pui, Ching-Hon/N-8076-2018; Raimondi, Susana C/N-8166-2018; Devidas, Meenakshi/H-1170-2019; Relling, Mary/N-5032-2018	Evans, William E./0000-0002-9333-5322; Pui, Ching-Hon/0000-0003-0303-5658; Devidas, Meenakshi/0000-0002-1099-3478; 	Intramural NIH HHS [Z01 MH002810] Funding Source: Medline; NCI NIH HHS [CA 21765, R01 CA051001-15, R01 CA051001, U10 CA029139-22, R37 CA036401-24, R01 CA078224-10, P30 CA021765-259006, U10 CA098543, U10 CA098413, CA 51001, U10 CA098413-07, P30 CA021765, U01 CA157937, CA 36401, R01 CA078224, R37 CA036401, CA 078224, R01 CA036401, U10 CA098543-07] Funding Source: Medline; NHLBI NIH HHS [U01 HL065899-07, U01 HL65899, U01 HL065899] Funding Source: Medline; NIGMS NIH HHS [U01 GM061374-07, U01 GM061374, U01 GM61393, U01 GM061393-100007, U01GM61374, U01 GM061393] Funding Source: Medline; NIMH NIH HHS [U01 MH046276, R01 MH059548, R01 MH059588, R01 MH059566, R01 MH059571, R01 MH067257, U01 MH046318, R01 MH060870, R01 MH059565, U01 MH079469, R01 MH059567, R01 MH059553, R01 MH059586, U01 MH079470, R01 MH059556, R01 MH060879, R01 MH059535, R01 MH060068, R01 MH059533, R01 MH059587, R01 MH061675, R01 MH081800, R01 MH059545, R01 MH059534] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA078224, U10CA098413, R29CA051001, R01CA036401, R37CA036401, R01CA051001, U10CA098543, U10CA029139, U01CA157937] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374, U01GM061393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067257, R01MH060879, R01MH059587, U01MH079470, R01MH059548, R01MH059533, R01MH059545, R01MH059571, R01MH059534, R01MH059567, R01MH059565, R01MH060068, R01MH060870, U01MH046276, R01MH059566, R01MH059588, R01MH059535, R01MH059556, R01MH061675, R01MH059553, U01MH046318, Z01MH002810, R01MH081800, U01MH079469, R01MH059586] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Borowitz MJ, 2003, LEUKEMIA, V17, P1566, DOI 10.1038/sj.leu.2403001; Bourquin JP, 2006, P NATL ACAD SCI USA, V103, P3339, DOI 10.1073/pnas.0511150103; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell PJ, 2009, NAT GENET, V41, P385, DOI 10.1038/ng0409-385; Chang LW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r38; Chen HC, 2008, EUR J CANCER PREV, V17, P251, DOI 10.1097/CEJ.0b013e3282b72093; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; Dong LM, 2008, JAMA-J AM MED ASSOC, V299, P2423, DOI 10.1001/jama.299.20.2423; FABRE G, 1983, CANCER RES, V43, P4648; Greaves M, 2002, BRIT MED J, V324, P283, DOI 10.1136/bmj.324.7332.283; GREAVES MF, 1988, LEUKEMIA, V2, P120; Healy J, 2007, BLOOD, V109, P683, DOI 10.1182/blood-2006-02-003236; Kager L, 2005, J CLIN INVEST, V115, P110, DOI 10.1172/JCI200522477; Kim MS, 2008, HUM PATHOL, V39, P1059, DOI 10.1016/j.humpath.2007.11.013; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Masson E, 1996, J CLIN INVEST, V97, P73, DOI 10.1172/JCI118409; Mathonnet G, 2003, BRIT J HAEMATOL, V123, P45, DOI 10.1046/j.1365-2141.2003.04551.x; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Molnar A, 1996, J IMMUNOL, V156, P585; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nordgard SH, 2008, GENE CHROMOSOME CANC, V47, P680, DOI 10.1002/gcc.20569; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Paulsson K, 2005, GENE CHROMOSOME CANC, V44, P113, DOI 10.1002/gcc.20222; Perera FP, 1997, SCIENCE, V278, P1068, DOI 10.1126/science.278.5340.1068; Pritchard JK, 2000, GENETICS, V155, P945; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Schnakenberg E, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-23; Sobti RC, 2008, BIOMARKERS, V13, P282, DOI [10.1080/13547500701843437, 10.1080/13547500701843437 ]; Stanulla M, 2000, BLOOD, V95, P1222, DOI 10.1182/blood.V95.4.1222.004k20_1222_1228; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; SYNOLD TW, 1994, J CLIN INVEST, V94, P1996, DOI 10.1172/JCI117552; Urayama KY, 2007, CANCER EPIDEM BIOMAR, V16, P1172, DOI 10.1158/1055-9965.EPI-07-0007; Wiemels JL, 2001, P NATL ACAD SCI USA, V98, P4004, DOI 10.1073/pnas.061408298; Wilsker D, 2004, NUCLEIC ACIDS RES, V32, P1345, DOI 10.1093/nar/gkh277; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Ziino O, 2006, HAEMATOLOGICA, V91, P139	47	357	371	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1001	U67		10.1038/ng.432	http://dx.doi.org/10.1038/ng.432			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19684603	Green Accepted			2022-12-17	WOS:000269382100012
J	Xu, JF; Meyers, D; Freije, D; Isaacs, S; Wiley, K; Nusskern, D; Ewing, C; Wilkens, E; Bujnovszky, P; Bova, GS; Walsh, P; Isaacs, W; Schleutker, J; Matikainen, M; Tammela, T; Visakorpi, T; Kallioniemi, OP; Berry, R; Schaid, D; French, A; McDonnell, S; Schroeder, J; Blute, M; Thibodeau, S; Gronberg, H; Emanuelsson, M; Damber, JE; Bergh, A; Jonsson, BA; Smith, J; Bailey-Wilson, J; Carpten, J; Stephan, D; Gillanders, E; Amundson, I; Kainu, T; Freas-Lutz, D; Baffoe-Bonnie, A; Van Aucken, A; Sood, R; Collins, F; Brownstein, M; Trent, J				Xu, JF; Meyers, D; Freije, D; Isaacs, S; Wiley, K; Nusskern, D; Ewing, C; Wilkens, E; Bujnovszky, P; Bova, GS; Walsh, P; Isaacs, W; Schleutker, J; Matikainen, M; Tammela, T; Visakorpi, T; Kallioniemi, OP; Berry, R; Schaid, D; French, A; McDonnell, S; Schroeder, J; Blute, M; Thibodeau, S; Gronberg, H; Emanuelsson, M; Damber, JE; Bergh, A; Jonsson, BA; Smith, J; Bailey-Wilson, J; Carpten, J; Stephan, D; Gillanders, E; Amundson, I; Kainu, T; Freas-Lutz, D; Baffoe-Bonnie, A; Van Aucken, A; Sood, R; Collins, F; Brownstein, M; Trent, J			Evidence for a prostate cancer susceptibility locus on the X chromosome	NATURE GENETICS			English	Article							ANDROGEN-RECEPTOR GENE; LINKAGE ANALYSIS; FAMILY HISTORY; RISK; INHERITANCE; SUPPORT; HUMANS; CAG	Over 200.000 new prostate cancer cases are diagnosed in the United States each year, accounting for more than 35% of all cancer cases affecting men, and resulting in 40,000 deaths annually(1). Attempts to characterize genes predisposing to prostate cancer have been hampered by a high phenocopy rate, the late age of onset of the disease and, in the absence of distinguishing clinical features, the inability to stratify patients into subgroups relative to suspected genetic locus heterogeneity. We previously performed a genome-wide search for hereditary prostate cancer (HPC) genes, finding evidence of a prostate cancer susceptibility locus on chromosome 1 (termed HPC1; ref. 2). Here we present evidence for the location of a second prostate cancer susceptibility gene, which by heterogeneity estimates accounts for approximately 16% of HPC cases. This HPC locus resides on the X chromosome (Xq27-28), a finding consistent with results of previous population-based studies suggesting an X-linked mode of HPC inheritance. Linkage to Xq27-28 was observed in a combined study population of 360 prostate cancer families collected at four independent sites in North America, Finland and Sweden. A maximum two-point lod score of 4.60 was observed at DXS1113, theta=0.26, in the combined data set. Parametric multipoint and non-parametric analyses provided results consistent with the two-point analysis. Significant evidence for genetic locus heterogeneity was observed, with similar estimates of the proportion of linked families in each separate family collection. Genetic mapping of the locus represents an important initial step in the identification of an X-linked gene implicated in the aetiology of HPC.	Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA; Univ Maryland, Ctr Genet Asthma & Complex Dis, Baltimore, MD 21201 USA; Univ Tampere, Inst Med Technol, Canc Genet Lab, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55902 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55902 USA; Mayo Clin & Mayo Fdn, Dept Urol, Rochester, MN 55902 USA; Umea Univ, Dept Oncol, Umea, Sweden; Umea Univ, Dept Urol & Androl, Umea, Sweden; Umea Univ, Dept Pathol, Umea, Sweden; Natl Human Genome Res Inst, Canc Invest Grp, NIH, Bethesda, MD 20892 USA; Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19012 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; Tampere University; Tampere University; Tampere University Hospital; Mayo Clinic; Mayo Clinic; Mayo Clinic; Umea University; Umea University; Umea University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Fox Chase Cancer Center	Isaacs, W (corresponding author), Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21287 USA.	wisaacs@jhmi.edu	Kallioniemi, Olli P/H-5111-2011; Brownstein, Michael/B-8609-2009; Smith, Jeff/C-3484-2012	Kallioniemi, Olli P/0000-0002-3231-0332; Bailey-Wilson, Joan/0000-0002-9153-2920; Schleutker, Johanna/0000-0002-1863-0305; McDonnell, Shannon/0000-0001-6201-369X; Bova, George/0000-0003-1639-3104; Smith, Jeffrey/0000-0001-8424-910X; Visakorpi, Tapio/0000-0002-5004-0364	NATIONAL CANCER INSTITUTE [P50CA058236, R01CA072818] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG055389] Funding Source: NIH RePORTER; NCI NIH HHS [CA72818, CA58236] Funding Source: Medline; NHGRI NIH HHS [N01-HG-55389] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Collins A, 1996, GENOMICS, V36, P157, DOI 10.1006/geno.1996.0436; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Eeles RA, 1998, AM J HUM GENET, V62, P653, DOI 10.1086/301745; Giovannucci E, 1997, P NATL ACAD SCI USA, V94, P3320, DOI 10.1073/pnas.94.7.3320; Gronberg H, 1997, CANCER RES, V57, P4707; Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313; Hakimi JM, 1996, WORLD J UROL, V14, P329; HAYES RB, 1995, INT J CANCER, V60, P361, DOI 10.1002/ijc.2910600315; Hsieh CL, 1997, J NATL CANCER I, V89, P1893, DOI 10.1093/jnci/89.24.1893; IRVINE RA, 1995, CANCER RES, V55, P1937; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Ott J., 1991, ANAL HUMAN GENETIC L; Schaid DJ, 1998, AM J HUM GENET, V62, P1425, DOI 10.1086/301862; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Stanford JL, 1997, CANCER RES, V57, P1194; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; WOOLF CM, 1960, CANCER, V13, P361	28	357	362	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					175	179		10.1038/2477	http://dx.doi.org/10.1038/2477			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771711				2022-12-17	WOS:000076231300020
J	Mayer, U; Saher, G; Fassler, R; Bornemann, A; Echtermeyer, F; vonderMark, H; Miosge, N; Poschl, E; vonderMark, K				Mayer, U; Saher, G; Fassler, R; Bornemann, A; Echtermeyer, F; vonderMark, H; Miosge, N; Poschl, E; vonderMark, K			Absence of integrin alpha 7 causes a novel form of muscular dystrophy	NATURE GENETICS			English	Article							SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; MYOTENDINOUS JUNCTION; CYTOPLASMIC DOMAINS; LAMININ; EXPRESSION; GENE; MYOBLASTS; BINDING; MOTILITY	Integrin alpha 7 beta 1 is a specific cellular receptor for the basement membrane protein laminin-l (refs 1,2), as well as for the laminin isoforms -2 and -4 (ref. 3). The alpha 7 subunit is expressed mainly in skeletal and cardiac muscle(4) and has been suggested to be involved in differentiation and migration processes during myogenesis(5,6). Three cytoplasmic and two extracellular splice variants that have been described are developmentally regulated and expressed in different sites in the muscle(7-9). In adult muscle, the alpha 7A and alpha 7B subunits are concentrated in myotendinous junctions(10) but can also be detected in neuromuscular junctions and along the sarcolemmal membrane(11). To study the potential involvement of alpha 7 integrin during myogenesis and its role in muscle integrity and function, we generated a null allele of the alpha 7 gene (Itga7) in the germline of mice by homologous recombination in embryonic stent(ES) cells. Surprisingly, mice homozygous for the mutation are viable and fertile, indicating that the alpha 7 beta 1 integrin is riot essential far myogenesis. However, histological analysis of skeletal muscle revealed typical symptoms of a progressive muscular dystrophy starting soon after birth, but with a distinct variability in different muscle types. The observed histopathological changes strongly indicate an impairment of function of the myotendinous junctions, These findings demonstrate that alpha 7 beta 1 integrin represents an indispensable linkage between the muscle fibre and the extracellular matrix that is independent of the dystrophin-dystroglycan complex-mediated interaction of: the cytoskeleton with the muscle basement membrane.	UNIV TUBINGEN,INST BRAIN RES,D-72076 TUBINGEN,GERMANY; UNIV ERLANGEN NURNBERG,INST EXPT MED,D-91054 ERLANGEN,GERMANY; UNIV GOTTINGEN,INST HISTOL,D-37075 GOTTINGEN,GERMANY	Eberhard Karls University of Tubingen; University of Erlangen Nuremberg; University of Gottingen	Mayer, U (corresponding author), MAX PLANCK INST BIOCHEM,D-82152 MARTINSRIED,GERMANY.		Miosge, Nicolai/E-3244-2010; Saher, Gesine/AAH-1826-2021	Saher, Gesine/0000-0003-3507-9604; Mayer, Ulrike/0000-0003-2328-0052				BAO ZZ, 1993, J CELL SCI, V106, P579; BRABANT MC, 1993, DEV BIOL, V157, P49, DOI 10.1006/dbio.1993.1111; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; COLLO G, 1993, J BIOL CHEM, V268, P19019; Echtermeyer F, 1996, J BIOL CHEM, V271, P2071, DOI 10.1074/jbc.271.4.2071; ERICKSON HP, 1989, ANNU REV CELL BIOL, V5, P71, DOI 10.1146/annurev.cb.05.110189.000443; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GOODMAN SL, 1989, J CELL BIOL, V109, P799, DOI 10.1083/jcb.109.2.799; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KARNOVSKY M, 1965, ACTA HISTOCHEM, V88, P25; KRAMER RH, 1991, CELL REGUL, V2, P805, DOI 10.1091/mbc.2.10.805; LAW DJ, 1993, AM J PATHOL, V142, P1513; Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; OCALAN M, 1988, DEV BIOL, V125, P158, DOI 10.1016/0012-1606(88)90068-1; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; Settles DL, 1996, MUSCLE NERVE, V19, P147, DOI 10.1002/(SICI)1097-4598(199602)19:2<147::AID-MUS4>3.0.CO;2-E; SONG WK, 1993, J CELL SCI, V106, P1139; SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Talts JF, 1997, INT J DEV BIOL, V41, P39; TIDBALL JG, 1994, DEV BIOL, V163, P447, DOI 10.1006/dbio.1994.1161; VOLK T, 1990, CELL, V63, P525, DOI 10.1016/0092-8674(90)90449-O; VONDERMARK H, 1991, J BIOL CHEM, V266, P23593; Yao CC, 1996, J BIOL CHEM, V271, P25598, DOI 10.1074/jbc.271.41.25598; Ziober BL, 1996, J BIOL CHEM, V271, P22915, DOI 10.1074/jbc.271.37.22915; ZIOBER BL, 1993, J BIOL CHEM, V268, P26773	30	357	369	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					318	323		10.1038/ng1197-318	http://dx.doi.org/10.1038/ng1197-318			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354797				2022-12-17	WOS:A1997YD66700027
J	Chmielecki, J; Crago, AM; Rosenberg, M; O'Connor, R; Walker, SR; Ambrogio, L; Auclair, D; McKenna, A; Heinrich, MC; Frank, DA; Meyerson, M				Chmielecki, Juliann; Crago, Aimee M.; Rosenberg, Mara; O'Connor, Rachael; Walker, Sarah R.; Ambrogio, Lauren; Auclair, Daniel; McKenna, Aaron; Heinrich, Michael C.; Frank, David A.; Meyerson, Matthew			Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors	NATURE GENETICS			English	Article							EXPRESSION; NAB2; COREPRESSOR; ACTIVATION; MUTATIONS	Solitary fibrous tumors (SFTs) are rare mesenchymal tumors. Here, we describe the identification of a NAB2-STAT6 fusion from whole-exome sequencing of 17 SFTs. Analysis in 53 tumors confirmed the presence of 7 variants of this fusion transcript in 29 tumors (55%), representing a lower bound for fusion frequency at this locus and suggesting that the NAB2-STAT6 fusion is a distinct molecular feature of SFTs.	[Chmielecki, Juliann; Walker, Sarah R.; Frank, David A.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chmielecki, Juliann; Rosenberg, Mara; Ambrogio, Lauren; Auclair, Daniel; McKenna, Aaron; Meyerson, Matthew] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA USA; [Crago, Aimee M.; O'Connor, Rachael] Mem Sloan Kettering Canc Ctr, Dept Surg, Sarcoma Biol Lab, New York, NY 10021 USA; [Walker, Sarah R.; Frank, David A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Walker, Sarah R.; Frank, David A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Heinrich, Michael C.] Portland Vet Affairs VA Med Ctr, Div Hematol & Med Oncol, Portland, OR USA; [Heinrich, Michael C.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Oregon Health & Science University; Harvard University; Harvard Medical School	Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	Heinrich, Michael/AAC-6745-2019	Heinrich, Michael/0000-0003-3790-0478; Meyerson, Matthew/0000-0002-9133-8108; Rosenberg, Mara/0000-0001-6400-3161; O'Connor, Rachael/0000-0002-6869-7954; Crago, Aimee/0000-0002-2965-752X	Carlos Slim Health Institute in Mexico; Specialized Program of Research Excellence (SPORE) grant in Soft Tissue Sarcoma [P50 CA140146]; MSKCC [P01CA47179]; American Cancer Society AstraZeneca; Kristen Ann Carr Foundation; NATIONAL CANCER INSTITUTE [P50CA140146, P01CA047179] Funding Source: NIH RePORTER	Carlos Slim Health Institute in Mexico; Specialized Program of Research Excellence (SPORE) grant in Soft Tissue Sarcoma; MSKCC; American Cancer Society AstraZeneca; Kristen Ann Carr Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the individuals with SFT who contributed material for this study. We thank members of the Genomics Platform at the Broad Institute for their technical expertise and M. Abazeed and A. Dulak for critically reviewing the manuscript. This work was conducted as part of the Slim Initiative for Genomic Medicine in the Americas (SIGMA), a project funded by the Carlos Slim Health Institute in Mexico. This work was supported by a Specialized Program of Research Excellence (SPORE) grant in Soft Tissue Sarcoma (P50 CA140146) and a P01 grant (P01CA47179) to S. Singer (MSKCC). J.C. is supported by an American Cancer Society AstraZeneca Postdoctoral Fellowship. A.M.C. is supported by a grant from the Kristen Ann Carr Foundation. M.M. is supported by generous donations from M.B. Zuckerman and Team Dragonfly of the Pan-Mass Challenge. Material was collected under institutional review board (IRB)-approved protocols at the Memorial Sloan-Kettering Cancer Center and the Oregon Health & Science University Biolibrary. All patients provided informed consent.	Abdulkadir SA, 2001, HUM PATHOL, V32, P935, DOI 10.1053/hupa.2001.27102; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bhattacharyya S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007620; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; He HJ, 2006, J BIOL CHEM, V281, P31369, DOI 10.1074/jbc.M603762200; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Merk BC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-184; Mertens F, 2009, SEMIN ONCOL, V36, P312, DOI 10.1053/j.seminoncol.2009.06.004; Nelson EA, 2011, ONCOTARGET, V2, P518; Pal NR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-5; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Shimoyamada H, 2010, AM J PATHOL, V177, P70, DOI 10.2353/ajpath.2010.091164; Svaren J, 1996, MOL CELL BIOL, V16, P3545	15	356	379	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					131	132		10.1038/ng.2522	http://dx.doi.org/10.1038/ng.2522			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23313954	Green Accepted, Green Submitted			2022-12-17	WOS:000314333000006
J	You, MS; Yue, Z; He, WY; Yang, XH; Yang, G; Xie, M; Zhan, DL; Baxter, SW; Vasseur, L; Gurr, GM; Douglas, CJ; Bai, JL; Wang, P; Cui, K; Huang, SG; Li, XC; Zhou, Q; Wu, ZY; Chen, QL; Liu, CH; Wang, B; Li, XJ; Xu, XF; Lu, CX; Hu, M; Davey, JW; Smith, SM; Chen, MS; Xia, XF; Tang, WQ; Ke, FS; Zheng, DD; Hu, YL; Song, FQ; You, YC; Ma, XL; Peng, L; Zheng, YK; Liang, Y; Chen, YQ; Yu, LY; Zhang, YN; Liu, YY; Li, GQ; Fang, L; Li, JX; Zhou, X; Luo, YD; Gou, CY; Wang, JY; Wang, J; Yang, HM; Wang, J				You, Minsheng; Yue, Zhen; He, Weiyi; Yang, Xinhua; Yang, Guang; Xie, Miao; Zhan, Dongliang; Baxter, Simon W.; Vasseur, Liette; Gurr, Geoff M.; Douglas, Carl J.; Bai, Jianlin; Wang, Ping; Cui, Kai; Huang, Shiguo; Li, Xianchun; Zhou, Qing; Wu, Zhangyan; Chen, Qilin; Liu, Chunhui; Wang, Bo; Li, Xiaojing; Xu, Xiufeng; Lu, Changxin; Hu, Min; Davey, John W.; Smith, Sandy M.; Chen, Mingshun; Xia, Xiaofeng; Tang, Weiqi; Ke, Fushi; Zheng, Dandan; Hu, Yulan; Song, Fengqin; You, Yanchun; Ma, Xiaoli; Peng, Lu; Zheng, Yunkai; Liang, Yong; Chen, Yaqiong; Yu, Liying; Zhang, Younan; Liu, Yuanyuan; Li, Guoqing; Fang, Lin; Li, Jingxiang; Zhou, Xin; Luo, Yadan; Gou, Caiyun; Wang, Junyi; Wang, Jian; Yang, Huanming; Wang, Jun			A heterozygous moth genome provides insights into herbivory and detoxification	NATURE GENETICS			English	Article							DIAMONDBACK MOTH; PLUTELLA-XYLOSTELLA; GENE; SEQUENCE; RESISTANCE; LEPIDOPTERA; MECHANISMS; PREDICTION; EVOLUTION; ALIGNMENT	How an insect evolves to become a successful herbivore is of profound biological and practical importance. Herbivores are often adapted to feed on a specific group of evolutionarily and biochemically related host plants(1), but the genetic and molecular bases for adaptation to plant defense compounds remain poorly understood(2). We report the first whole-genome sequence of a basal lepidopteran species, Plutella xylostella, which contains 18,071 protein-coding and 1,412 unique genes with an expansion of gene families associated with perception and the detoxification of plant defense compounds. A recent expansion of retrotransposons near detoxification-related genes and a wider system used in the metabolism of plant defense compounds are shown to also be involved in the development of insecticide resistance. This work shows the genetic and molecular bases for the evolutionary success of this worldwide herbivore and offers wider insights into insect adaptation to plant feeding, as well as opening avenues for more sustainable pest management.	[You, Minsheng; He, Weiyi; Yang, Guang; Xie, Miao; Vasseur, Liette; Gurr, Geoff M.; Douglas, Carl J.; Bai, Jianlin; Cui, Kai; Huang, Shiguo; Liu, Chunhui; Li, Xiaojing; Xu, Xiufeng; Smith, Sandy M.; Xia, Xiaofeng; Tang, Weiqi; Ke, Fushi; Zheng, Dandan; Hu, Yulan; Song, Fengqin; You, Yanchun; Ma, Xiaoli; Peng, Lu; Zheng, Yunkai; Liang, Yong; Chen, Yaqiong; Yu, Liying; Zhang, Younan] Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou, Peoples R China; [You, Minsheng; He, Weiyi; Yang, Guang; Xie, Miao; Vasseur, Liette; Gurr, Geoff M.; Douglas, Carl J.; Bai, Jianlin; Cui, Kai; Huang, Shiguo; Liu, Chunhui; Li, Xiaojing; Xu, Xiufeng; Smith, Sandy M.; Xia, Xiaofeng; Tang, Weiqi; Ke, Fushi; Zheng, Dandan; Hu, Yulan; Song, Fengqin; You, Yanchun; Ma, Xiaoli; Peng, Lu; Zheng, Yunkai; Liang, Yong; Chen, Yaqiong; Yu, Liying; Zhang, Younan] Minist Agr, Key Lab Integrated Pest Management Fujian Taiwan, Fuzhou, Peoples R China; [Yue, Zhen; Yang, Xinhua; Zhan, Dongliang; Zhou, Qing; Wu, Zhangyan; Chen, Qilin; Wang, Bo; Lu, Changxin; Hu, Min; Li, Guoqing; Fang, Lin; Li, Jingxiang; Zhou, Xin; Luo, Yadan; Gou, Caiyun; Wang, Junyi; Wang, Jian; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Baxter, Simon W.] Univ Cambridge, Dept Zool, Cambridge, England; [Baxter, Simon W.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Vasseur, Liette] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Gurr, Geoff M.] Charles Sturt Univ, EH Graham Ctr, Orange, NSW, Australia; [Douglas, Carl J.; Liu, Yuanyuan] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Wang, Ping] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Li, Xianchun] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Davey, John W.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Smith, Sandy M.] Univ Toronto, Fac Forestry, Toronto, ON, Canada; [Chen, Mingshun] Kansas State Univ, USDA ARS, Manhattan, KS 66506 USA; [Chen, Mingshun] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Beijing Genomics Institute (BGI); University of Cambridge; University of Adelaide; Brock University; Charles Sturt University; University of British Columbia; Cornell University; University of Arizona; University of Edinburgh; University of Toronto; Kansas State University; United States Department of Agriculture (USDA); Kansas State University; University of Copenhagen	You, MS (corresponding author), Fujian Agr & Forestry Univ, Inst Appl Ecol, Fuzhou, Peoples R China.	msyou@iae.fjau.edu.cn; yxg@iae.fjau.edu.cn; wangj@genomics.cn	wang, junyi/GYA-3213-2022; Zhou, Xin/D-4025-2009; Huang, Shiguo/GLU-2694-2022; GURR, GEOFFREY M/F-3519-2011; Davey, John/B-5075-2013; Zhou, Xin/AAI-9326-2021; liu, yuanyuan/GWZ-5838-2022; Wang, Jun/A-7261-2013; He, Weiyi/N-6148-2017; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Zhou, Xin/0000-0002-1407-7952; Huang, Shiguo/0000-0002-6402-0858; Zhou, Xin/0000-0002-1407-7952; He, Weiyi/0000-0001-8659-3123; Wang, Jun/0000-0002-8540-8931; Gurr, Geoff/0000-0001-5008-7966; Davey, John/0000-0002-1017-9775; Wang, Jun/0000-0002-2113-5874; Baxter, Simon/0000-0001-5773-6578	Educational Department of Fujian Province [JB09315]; National Natural Science Foundation of China [31230061]; BBSRC [BBS/E/D/20310000] Funding Source: UKRI	Educational Department of Fujian Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported through a special project of Research on Diamondback Moth Genomics (grant JB09315) to M.Y. and a Minjiang Scholar Program to L.V., G.M.G., C.J.D. and S.M.S. by the Educational Department of Fujian Province and through a key project (grant 31230061) to M.Y. from the National Natural Science Foundation of China. Insect rearing and sampling, as well as some of the DNA extractions, were conducted at the Fujian Provincial Key Laboratory of Biodiversity and Eco-safety and the Key Laboratory of Integrated Pest Management for Fujian-Taiwan Crops, the Ministry of Agriculture, China. We are grateful to AD. Briscoe (University of California Irvine) for her help in organizing and for providing ORs, OBPs and CSPs from Danaus plexippus and Heliconius melpomene and to G.L. Lovei (Aarhus University) for his comments and suggestions on the manuscript. We appreciate J. Liao and M. Zou (Fujian Agriculture and Forestry University) for providing the Bt-treated P. xylostella larvae used for quantitative gene expression analysis. We thank H. Wang, J. Luo, Y. Hong, S. Pan, L. Yang, Y. Weng, Y. Hong and Y. Liu for their technical assistance in rearing insects and preparing samples.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; ANKERSMIT GW, 1953, B ENTOMOL RES, V44, P421, DOI 10.1017/S0007485300025530; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000802; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Buono M, 2010, CELL MOL LIFE SCI, V67, P769, DOI 10.1007/s00018-009-0203-3; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-46; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Cui F, 2011, INSECT BIOCHEM MOLEC, V41, P1, DOI 10.1016/j.ibmb.2010.09.004; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; He WY, 2012, GENOMICS, V99, P169, DOI 10.1016/j.ygeno.2011.12.009; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; Henniges-Janssen K, 2011, HEREDITY, V107, P421, DOI 10.1038/hdy.2011.27; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kvist J., 2012, MOL ECOL, DOI [10.1111/j.1365-294X.2012.05521.x, DOI 10.1111/1.1365-294X.2012.05521.X]; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Li AG, 2006, J ECON ENTOMOL, V99, P914, DOI 10.1603/0022-0493-99.3.914; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; Pillai S, 2005, NUCLEIC ACIDS RES, V33, pW25, DOI 10.1093/nar/gki491; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tao XY, 2012, MOL ECOL, V21, P4371, DOI 10.1111/j.1365-294X.2012.05548.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Whiteman NK, 2010, PLANT PHYSIOL, V154, P475, DOI 10.1104/pp.110.161117; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zalucki MP, 2012, J ECON ENTOMOL, V105, P1115, DOI 10.1603/EC12107; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zimmer A, 2007, MOL GENET GENOMICS, V278, P393, DOI 10.1007/s00438-007-0257-6	85	356	417	17	279	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					220	225		10.1038/ng.2524	http://dx.doi.org/10.1038/ng.2524			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23313953	Green Published, hybrid			2022-12-17	WOS:000314333000020
J	Tsurusaki, Y; Okamoto, N; Ohashi, H; Kosho, T; Imai, Y; Hibi-Ko, Y; Kaname, T; Naritomi, K; Kawame, H; Wakui, K; Fukushima, Y; Homma, T; Kato, M; Hiraki, Y; Yamagata, T; Yano, S; Mizuno, S; Sakazume, S; Ishii, T; Nagai, T; Shiina, M; Ogata, K; Ohta, T; Niikawa, N; Miyatake, S; Okada, I; Mizuguchi, T; Doi, H; Saitsu, H; Miyake, N; Matsumoto, N				Tsurusaki, Yoshinori; Okamoto, Nobuhiko; Ohashi, Hirofumi; Kosho, Tomoki; Imai, Yoko; Hibi-Ko, Yumiko; Kaname, Tadashi; Naritomi, Kenji; Kawame, Hiroshi; Wakui, Keiko; Fukushima, Yoshimitsu; Homma, Tomomi; Kato, Mitsuhiro; Hiraki, Yoko; Yamagata, Takanori; Yano, Shoji; Mizuno, Seiji; Sakazume, Satoru; Ishii, Takuma; Nagai, Toshiro; Shiina, Masaaki; Ogata, Kazuhiro; Ohta, Tohru; Niikawa, Norio; Miyatake, Satoko; Okada, Ippei; Mizuguchi, Takeshi; Doi, Hiroshi; Saitsu, Hirotomo; Miyake, Noriko; Matsumoto, Naomichi			Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome	NATURE GENETICS			English	Article							GENE; SCHWANNOMATOSIS; SMARCB1; CANCER	By exome sequencing, we found de novo SMARCB1 mutations in two of five individuals with typical Coffin-Siris syndrome (CSS), a rare autosomal dominant anomaly syndrome. As SMARCB1 encodes a subunit of the SWItch/Sucrose NonFermenting (SWI/SNF) complex, we screened 15 other genes encoding subunits of this complex in 23 individuals with CSS. Twenty affected individuals (87%) each had a germline mutation in one of six SWI/SNF subunit genes, including SMARCB1, SMARCA4, SMARCA2, SMARCE1, ARID1A and ARID1B.	[Tsurusaki, Yoshinori; Miyatake, Satoko; Okada, Ippei; Mizuguchi, Takeshi; Doi, Hiroshi; Saitsu, Hirotomo; Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Div Med Genet, Izumi, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Izumi, Japan; [Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Iwatsuki, Saitama, Japan; [Kosho, Tomoki; Wakui, Keiko; Fukushima, Yoshimitsu] Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano, Japan; [Imai, Yoko; Hibi-Ko, Yumiko] Japanese Red Cross Med Ctr, Div Pediat, Tokyo, Japan; [Kaname, Tadashi; Naritomi, Kenji] Univ Ryukyus, Fac Med, Dept Med Genet, Okinawa, Japan; [Kawame, Hiroshi] Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Genet Counseling, Tokyo 112, Japan; [Kawame, Hiroshi] Nagano Childrens Hosp, Div Med Genet, Azumino, Japan; [Homma, Tomomi] Nihonkai Gen Hosp, Yamagata Prefectural & Sakata Municipal Hosp Org, Div Pediat, Sakata, Yamagata, Japan; [Kato, Mitsuhiro] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 990, Japan; [Hiraki, Yoko] Hiroshima Municipal Ctr Child Hlth & Dev, Hiroshima, Japan; [Yamagata, Takanori] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; [Yano, Shoji] Univ So Calif, Dept Pediat, Div Genet, Los Angeles Cty & Univ So Calif Med Ctr,Keck Sch, Los Angeles, CA 90089 USA; [Mizuno, Seiji] Cent Hosp Kasugai, Aichi Human Serv Ctr, Dept Pediat, Kasugai, Aichi, Japan; [Sakazume, Satoru; Ishii, Takuma; Nagai, Toshiro] Dokkyo Univ, Koshigaya Hosp, Dept Pediat, Sch Med, Koshigaya, Japan; [Ishii, Takuma] Hosp Disabled, Saitama, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 232, Japan; [Ohta, Tohru; Niikawa, Norio] Hlth Sci Univ Hokkaido, Res Inst Personalized Hlth Sci, Ishikari, Hokkaido 06102, Japan	Yokohama City University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Saitama Children's Medical Center; Shinshu University; Japanese Red Cross Medical Center; University of Tokyo; University of the Ryukyus; Ochanomizu University; Yamagata University; Jichi Medical University; University of Southern California; Dokkyo Medical University; Yokohama City University; Health Sciences University of Hokkaido	Matsumoto, N (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan.	nmiyake@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp	Yano, Shoji/AAG-2771-2021; Saitsu, Hirotomo/AAM-7131-2021	Yano, Shoji/0000-0001-5565-9572; Kato, Mitsuhiro/0000-0003-1485-8553; Tsurusaki, Yoshinori/0000-0002-7240-6355; Saitsu, Hirotomo/0000-0003-0723-0960	Ministry of Health, Labour and Welfare; Japan Science and Technology Agency; Strategic Research Program for Brain Sciences; Japan Epilepsy Research Foundation; Takeda Science Foundation; (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Yokohama City University; Grants-in-Aid for Scientific Research [21390104, 22790823] Funding Source: KAKEN	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Epilepsy Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yokohama City University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all the family members for participating in this study. This work was supported by research grants from the Ministry of Health, Labour and Welfare (to N. Miyake, H.S. and N. Matsumoto), the Japan Science and Technology Agency (to N. Matsumoto), the Strategic Research Program for Brain Sciences (to N. Matsumoto), the Japan Epilepsy Research Foundation (to H.S.) and the Takeda Science Foundation (to N. Matsumoto and N. Miyake). This study was also funded by a Grant-in-Aid for Scientific Research on Innovative Areas (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N. Matsumoto), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to N. Matsumoto), a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (to N. Miyake and H.S.) and a Grant for 2011 Strategic Research Promotion of Yokohama City University (to N. Matsumoto). This study was performed at the Advanced Medical Research Center at Yokohama City University. Informed consent was obtained from all the families of affected individuals. The Institutional Review Board of Yokohama City University approved this study.	Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Boyd C, 2008, CLIN GENET, V74, P358, DOI 10.1111/j.1399-0004.2008.01060.x; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; COFFIN GS, 1970, AM J DIS CHILD, V119, P433, DOI 10.1001/archpedi.1970.02100050435009; Hadfield KD, 2008, J MED GENET, V45, P332, DOI 10.1136/jmg.2007.056499; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Schneppenheim R, 2010, AM J HUM GENET, V86, P279, DOI 10.1016/j.ajhg.2010.01.013; Taylor MD, 2000, AM J HUM GENET, V66, P1403, DOI 10.1086/302833; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597	14	356	376	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2012	44	4					376	378		10.1038/ng.2219	http://dx.doi.org/10.1038/ng.2219			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	916VF	22426308				2022-12-17	WOS:000302130600009
J	Nguyen, DK; Disteche, CM				Nguyen, DK; Disteche, CM			Dosage compensation of the active X chromosome in mammals	NATURE GENETICS			English	Article							LINKED GENE-EXPRESSION; EARLY MOUSE EMBRYOS; DIFFERENTIAL EXPRESSION; TRANSCRIPTOME ANALYSIS; DOWN-SYNDROME; MUS MUSCULUS; MALE MEIOSIS; GENOME-WIDE; INACTIVATION; SPERMATOGENESIS	Monosomy of the X chromosome owing to divergence between the sex chromosomes leads to dosage compensation mechanisms to restore balanced expression between the X and the autosomes. In Drosophila melanogaster, upregulation of the male X leads to dosage compensation. It has been hypothesized that mammals likewise upregulate their active X chromosome. Together with X inactivation, this mechanism would maintain balanced expression between the X chromosome and autosomes and between the sexes. Here, we show that doubling of the global expression level of the X chromosome leads to dosage compensation in somatic tissues from several mammalian species. X-linked genes are highly expressed in brain tissues, consistent with a role in cognitive functions. Furthermore, the X chromosome is expressed but not upregulated in spermatids and secondary oocytes, preserving balanced expression of the genome in these haploid cells. Upon fertilization, upregulation of the active X must occur to achieve the observed dosage compensation in early embryos.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Disteche, CM (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	cdistech@u.washington.edu						Adler DA, 1997, P NATL ACAD SCI USA, V94, P9244, DOI 10.1073/pnas.94.17.9244; Akhtar A, 2003, CURR OPIN GENET DEV, V13, P161, DOI 10.1016/S0959-437X(03)00016-9; Amano K, 2004, HUM MOL GENET, V13, P1333, DOI 10.1093/hmg/ddh154; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; Birchler JA, 2003, GENETICA, V117, P179, DOI 10.1023/A:1022935927763; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Cheng MK, 2004, BIOESSAYS, V26, P821, DOI 10.1002/bies.20082; Disteche CM, 2002, CYTOGENET GENOME RES, V99, P36, DOI 10.1159/000071572; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Gartler S M, 1976, Adv Hum Genet, V7, P99; Gartler S M, 1972, Cell Differ, V1, P215, DOI 10.1016/0045-6039(72)90039-5; GUPTA V, IN PRESS J BIOL; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hamra FK, 2004, DEV BIOL, V269, P393, DOI 10.1016/j.ydbio.2004.01.027; HENDRIKSEN PJM, 1995, DEV BIOL, V170, P730, DOI 10.1006/dbio.1995.1252; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Malkov M, 1998, BIOL REPROD, V59, P84, DOI 10.1095/biolreprod59.1.84; MCCARREY JR, 1992, GENET ANAL-BIOMOL E, V9, P117, DOI 10.1016/1050-3862(92)90051-6; MCMAHON A, 1981, J EMBRYOL EXP MORPH, V64, P251; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; MONESI V, 1965, CHROMOSOMA, V17, P11, DOI 10.1007/BF00285153; Odorisio T, 1996, DEV BIOL, V180, P336, DOI 10.1006/dbio.1996.0305; Ohno S., 1967, SEX CHROMOSOMES SEX; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Saran NG, 2003, HUM MOL GENET, V12, P2013, DOI 10.1093/hmg/ddg217; Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Straub T, 2005, FEBS LETT, V579, P3258, DOI 10.1016/j.febslet.2005.03.050; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zheng P, 2004, BIOL REPROD, V70, P1419, DOI 10.1095/biolreprod.103.023796; Zhou X, 2005, J MED GENET, V42, P416, DOI 10.1136/jmg.2004.025353	49	356	361	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					47	53		10.1038/ng1705	http://dx.doi.org/10.1038/ng1705			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16341221				2022-12-17	WOS:000234227200016
J	Saze, H; Scheid, OM; Paszkowski, J				Saze, H; Scheid, OM; Paszkowski, J			Maintenance of CpG methylation is essential for epigenetic inheritance during plant gametogenesis	NATURE GENETICS			English	Article							HISTONE H3 METHYLTRANSFERASE; DNA METHYLATION; ARABIDOPSIS-THALIANA; GENE; MUTANTS; CHROMOMETHYLASE3; IDENTIFICATION; FERTILIZATION; EXPRESSION; MUTATIONS	In mammals, the DNA methyltransferase 1 (Dnmt1) faithfully copies the pattern of cytosine methylation at CpG sites to the newly synthesized strand, and this is essential for epigenetic inheritance(1). In Arabidopsis thaliana, several DNA methyltransferases or chromatin modifiers coupled to methylation changes have been characterized, and mutations that cause loss of their function are recessive(2-7). This is surprising because plant gametogenesis includes postmeiotic DNA replication in haploid nuclei before fertilization. Therefore, the recessive character of the mutations excludes the affected components from a regulatory role in postmeiotic maintenance or modification of epigenetic states. Here we show, however, that depletion of A. thaliana MET1, a homolog of mammalian Dnmt1 (ref. 8), results in immense epigenetic diversification of gametes. This diversity seems to be a consequence of passive postmeiotic demethylation, leading to gametes with fully demethylated and hemidemethylated DNA, followed by remethylation of hemimethylated templates once. MET1 is again-supplied in a zygote.	Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Saze, H (corresponding author), Friedrich Miescher Inst Biomed Res, POB 2543, CH-4002 Basel, Switzerland.	saze@fmi.ch	Saze, Hidetoshi/B-5922-2015	Saze, Hidetoshi/0000-0002-8647-1430; Mittelsten Scheid, Ortrun/0000-0002-7757-4809				Adams S, 2000, DEVELOPMENT, V127, P2493; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Friedman WE, 1999, DEVELOPMENT, V126, P1065; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Genger RK, 1999, PLANT MOL BIOL, V41, P269, DOI 10.1023/A:1006347010369; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kakutani T, 1999, GENETICS, V151, P831; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; KANKEL MW, IN PRESS GENETICS; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lord EM, 2002, ANNU REV CELL DEV BI, V18, P81, DOI 10.1146/annurev.cellbio.18.012502.083438; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Murfett J, 2001, PLANT CELL, V13, P1047, DOI 10.1105/tpc.13.5.1047; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Scheid OM, 1998, P NATL ACAD SCI USA, V95, P632, DOI 10.1073/pnas.95.2.632; Scheid OM, 2002, P NATL ACAD SCI USA, V99, P13659, DOI 10.1073/pnas.202380499; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832	30	356	390	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2003	34	1					65	69		10.1038/ng1138	http://dx.doi.org/10.1038/ng1138			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12669067				2022-12-17	WOS:000182667900018
J	Primig, M; Williams, RM; Winzeler, EA; Tevzadze, GG; Conway, AR; Hwang, SY; Davis, RW; Esposito, RE				Primig, M; Williams, RM; Winzeler, EA; Tevzadze, GG; Conway, AR; Hwang, SY; Davis, RW; Esposito, RE			The core meiotic transcriptome in budding yeasts	NATURE GENETICS			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; MEIOSIS-SPECIFIC GENE; SACCHAROMYCES-CEREVISIAE; NEGATIVE REGULATOR; DNA-SEQUENCE; CELL-CYCLE; EXPRESSION; RECOMBINATION; SPORULATION; GENOME	We used high-density oligonucleotide microarrays to analyse the genomes and meiotic expression patterns of two yeast strains, SK1 and W303, that display distinct kinetics and efficiencies of sporulation. Hybridization of genomic DNA to arrays revealed numerous gene deletions and polymorphisms in both backgrounds. The expression analysis yielded approximately 1,600 meiotically regulated genes in each strain, with a core set of approximately 60% displaying similar patterns in both strains. Most of these (95%) are MATa/MAT alpha -dependent and are not similarly expressed in near-isogenic meiosis-deficient controls. The transcript profiles correlate with the distribution of defined meiotic promoter elements and with the time of known gene function.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Silicon Genet, San Carlos, CA USA	University of Chicago; Stanford University	Esposito, RE (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA.		Winzeler, Elizabeth/AAP-6752-2020; Primig, Michael/G-3175-2013	Winzeler, Elizabeth/0000-0002-4049-2113; Primig, Michael/0000-0002-2061-0119; Williams, Roy/0000-0002-5442-9166	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029182] Funding Source: NIH RePORTER; NHGRI NIH HHS [1RO1HG01633] Funding Source: Medline; NIGMS NIH HHS [1R01GM29182] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON SF, 1995, PROTEIN SCI, V4, P1832, DOI 10.1002/pro.5560040918; ATCHESON CL, 1987, P NATL ACAD SCI USA, V84, P8035, DOI 10.1073/pnas.84.22.8035; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; BOWDISH KS, 1995, MOL CELL BIOL, V15, P2955; BRIZA P, 1990, GENE DEV, V4, P1775, DOI 10.1101/gad.4.10.1775; BUCKINGHAM LE, 1990, P NATL ACAD SCI USA, V87, P9406, DOI 10.1073/pnas.87.23.9406; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; COVITZ PA, 1993, GENE DEV, V7, P1598, DOI 10.1101/gad.7.8.1598; DELLASETA F, 1990, J BIOL CHEM, V265, P15168; DORSMAN JC, 1989, NUCLEIC ACIDS RES, V17, P4917, DOI 10.1093/nar/17.13.4917; Dujon B, 1998, ELECTROPHORESIS, V19, P617, DOI 10.1002/elps.1150190427; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ESPOSITO MS, 1969, GENETICS, V61, P79; Esposito R. E., 1981, MOL BIOL YEAST SACCH, V11, P211; Freire R, 1998, GENE DEV, V12, P2560, DOI 10.1101/gad.12.16.2560; GailusDurner V, 1996, MOL CELL BIOL, V16, P2777; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; HEPWORTH SR, 1995, MOL CELL BIOL, V15, P3934; KABACK DB, 1985, MOL CELL BIOL, V5, P751, DOI 10.1128/MCB.5.4.751; KLAPHOLZ S, 1985, GENETICS, V110, P187; KUPIEC M, 1997, SACCHAROMYCES CEREVI, P889; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Ozsarac N, 1997, MOL CELL BIOL, V17, P1152, DOI 10.1128/MCB.17.3.1152; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pierce M, 1998, MOL CELL BIOL, V18, P5970, DOI 10.1128/MCB.18.10.5970; Planta RJ, 1995, BIOCHEM CELL BIOL, V73, P825, DOI 10.1139/o95-090; Rolfes RJ, 1997, J BIOL CHEM, V272, P13343, DOI 10.1074/jbc.272.20.13343; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Steber CM, 1995, P NATL ACAD SCI USA, V92, P12490, DOI 10.1073/pnas.92.26.12490; Striano S, 1986, Acta Neurol (Napoli), V8, P1; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; SUMRADA RA, 1987, P NATL ACAD SCI USA, V84, P3997, DOI 10.1073/pnas.84.12.3997; SUROSKY RT, 1992, MOL CELL BIOL, V12, P3948, DOI 10.1128/MCB.12.9.3948; Sweet DH, 1997, MOL CELL BIOL, V17, P6223, DOI 10.1128/MCB.17.11.6223; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Zalevsky J, 1999, GENETICS, V153, P1271	43	356	369	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					415	423		10.1038/82539	http://dx.doi.org/10.1038/82539			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101837				2022-12-17	WOS:000165671700012
J	Danforth, E				Danforth, E			Failure of adipocyte differentiation causes type II diabetes mellitus?	NATURE GENETICS			English	Letter							FATTY-ACIDS		Univ Vermont, Underhill, VT USA	University of Vermont	Danforth, E (corresponding author), Univ Vermont, Underhill, VT USA.	edanforth@att.net						Anand A, 2000, NAT GENET, V24, P377, DOI 10.1038/74207; KASHIWAGI A, 1985, METABOLISM, V34, P364, DOI 10.1016/0026-0495(85)90226-4; KNITTLE JL, 1968, J CLIN INVEST, V47, P2091, DOI 10.1172/JCI105894; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; RANDLE PJ, 1963, LANCET, V1, P785; ROBBINS DC, 1979, METABOLISM, V28, P908, DOI 10.1016/0026-0495(79)90090-8; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327	9	356	368	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2000	26	1					13	13		10.1038/79111	http://dx.doi.org/10.1038/79111			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973236	Bronze			2022-12-17	WOS:000089078000006
J	Bolino, A; Muglia, M; Conforti, FL; LeGuern, E; Salih, MAM; Georgiou, DM; Christodoulou, K; Hausmanowa-Petrusewicz, I; Mandich, P; Schenone, A; Gambardella, A; Bono, F; Quattrone, A; Devoto, M; Monaco, AP				Bolino, A; Muglia, M; Conforti, FL; LeGuern, E; Salih, MAM; Georgiou, DM; Christodoulou, K; Hausmanowa-Petrusewicz, I; Mandich, P; Schenone, A; Gambardella, A; Bono, F; Quattrone, A; Devoto, M; Monaco, AP			Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2	NATURE GENETICS			English	Article							FOLDED MYELIN SHEATHS; DEMYELINATING NEUROPATHY; FAMILY; YEAST		Wellcome Trust Ctr Human Genet, Oxford, England; Natl Res Council, Inst Expt Med & Biotechnol, Cosenza, Italy; Hop La Pitie Salpetriere, Paris, France; King Saud Univ, Dept Pediat, Riyadh, Saudi Arabia; Cyprus Inst Neurol & Genet, Mol Genet Unit D, Nicosia, Cyprus; Polish Acad Sci, MRC, Neuromuscular Unit, Warsaw, Poland; Univ Genoa, Dipartimento Sci Neurol & Riabilitaz, Genoa, Italy; Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy; Univ Catanzaro, Inst Neurol, Catanzaro, Italy	University of Oxford; Wellcome Centre for Human Genetics; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; King Saud University; Polish Academy of Sciences; University of Genoa; University of Genoa; Magna Graecia University of Catanzaro	Monaco, AP (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.		Conforti, Francesca Luisa/AAT-2428-2020; schenone, angelo/I-3194-2012; QUATTRONE, Aldo/A-6734-2016; Devoto, Marcella/AAP-7595-2021; Salih, Mustafa/C-1222-2014; Gambardella, Antonio/F-5295-2012; Bolino, Alessandra/O-2933-2013; Mandich, Paola/CAG-1105-2022; Bolino, Alessandra/AAN-5442-2020; Monaco, Anthony P/A-4495-2010; Conforti, Francesca Luisa/K-8877-2016	schenone, angelo/0000-0002-2604-7830; QUATTRONE, Aldo/0000-0003-2001-957X; Salih, Mustafa/0000-0002-4379-2111; Gambardella, Antonio/0000-0001-7384-3074; Mandich, Paola/0000-0003-3123-3512; Bolino, Alessandra/0000-0002-8980-4878; Monaco, Anthony P/0000-0001-7480-3197; Christodoulou, Kyproula/0000-0002-0622-7594; Conforti, Francesca Luisa/0000-0001-8364-1783; MUGLIA, MARIA/0000-0001-6413-3935; DEVOTO, MARCELLA/0000-0002-4431-5114	Telethon [293/B] Funding Source: Medline	Telethon(Fondazione Telethon)		Ben Othmane K, 1999, GENOMICS, V62, P344, DOI 10.1006/geno.1999.6028; Bolino A, 2000, GENOMICS, V63, P271, DOI 10.1006/geno.1999.6088; Bolino A, 1996, HUM MOL GENET, V5, P1051, DOI 10.1093/hmg/5.7.1051; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; Gambardella A, 1997, BRAIN, V120, P2113, DOI 10.1093/brain/120.11.2113; Gambardella A, 1998, NEUROLOGY, V50, P799, DOI 10.1212/WNL.50.3.799; Hunter T, 1998, NAT GENET, V18, P303; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Laporte J, 1998, HUM MOL GENET, V7, P1703, DOI 10.1093/hmg/7.11.1703; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Nakagawa M, 1999, NEUROLOGY, V52, P1271, DOI 10.1212/WNL.52.6.1271; Nelis E, 1999, HUM MUTAT, V13, P11, DOI 10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.0.CO;2-A	12	356	376	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2000	25	1					17	19		10.1038/75542	http://dx.doi.org/10.1038/75542			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	311KU	10802647				2022-12-17	WOS:000086884000009
J	Minassian, BA; Lee, JR; Herbrick, JA; Huizenga, J; Soder, S; Mungall, AJ; Dunham, I; Gardner, R; Fong, CG; Carpenter, S; Jardim, L; Satishchandra, P; Andermann, E; Snead, OC; Lopes-Cendes, I; Tsui, LC; Delgado-Escueta, AV; Rouleau, GA; Scherer, SW				Minassian, BA; Lee, JR; Herbrick, JA; Huizenga, J; Soder, S; Mungall, AJ; Dunham, I; Gardner, R; Fong, CG; Carpenter, S; Jardim, L; Satishchandra, P; Andermann, E; Snead, OC; Lopes-Cendes, I; Tsui, LC; Delgado-Escueta, AV; Rouleau, GA; Scherer, SW			Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy	NATURE GENETICS			English	Article							LAFORAS-DISEASE; FORM; DIAGNOSIS	Lafora's disease (LD; OMIM 254780) is an autosomal recessive form of progressive myoclonus epilepsy characterized by seizures and cumulative neurological deterioration. Onset occurs during late childhood and usually results in death within ten years of the first symptoms(1,2). With few exceptions, patients follow a homogeneous clinical course despite the existence of genetic heterogeneity(3). Biopsy of various tissues, including brain, revealed characteristic polyglucosan inclusions called Lafora bodies(4-8), which suggested LD might be a generalized storage disease(6,9). Using a positional cloning approach, we have identified at chromosome 6q24 a novel gene, EPM2A. that encodes a protein with consensus amino acid sequence indicative of a protein tyrosine phosphatase (PTP). mRNA transcripts representing alternatively spliced forms of EPM2A were found in every tissue examined, including brain. Six distinct DNA sequence variations in EPM2A in nine families, and one homozygous microdeletion in another family have been found to cosegregate with LD. These mutations are predicted to cause deleterious effects in the putative protein product, named laforin, resulting in LD.	Univ Toronto, Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON M5G 1X8, Canada; Sanger Ctr, Hinxton CB10 1SA, Cambs, England; Salisbury Dist Hosp, Salisbury Hlth Care NHS Trust, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; Univ Calif Los Angeles, Sch Med, Calif Comprehens Epilepsy Program, Los Angeles, CA USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA; Univ Toronto, Toronto Hosp, Dept Pathol, Toronto, ON M5T 2S8, Canada; Hosp Clin Porto Alegre, Med Genet Serv, BR-90035003 Porto Alegre, RS, Brazil; Deemed Univ, Natl Inst Mental Hlth & Neurosci, Bangalore 560029, Karnataka, India; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; Montreal Gen Hosp, Res Inst, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Wellcome Trust Sanger Institute; Salisbury District Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; National Institute of Mental Health & Neurosciences - India; McGill University; McGill University; University of Toronto	Scherer, SW (corresponding author), Univ Toronto, Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada.		Jardim, Laura B/B-6149-2013; Tsui, Lap-chee/A-1081-2010; Mungall, Andrew J./U-7067-2018; Lopes-Cendes, Iscia/B-9416-2013; Scherer, Stephen W./B-3785-2013	Mungall, Andrew J./0000-0002-0905-2742; Lopes-Cendes, Iscia/0000-0002-6221-6822; Scherer, Stephen W./0000-0002-8326-1999; Dunham, Ian/0000-0003-2525-5598; Delgado-Escueta, Antonio V./0000-0002-1581-6999	NINDS NIH HHS [5P01-NS21908] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS021908] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHARYA JN, 1993, EPILEPSIA, V34, P476, DOI 10.1111/j.1528-1157.1993.tb02588.x; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; CARPENTER S, 1981, NEUROLOGY, V31, P1564, DOI 10.1212/WNL.31.12.1564; CARPENTER S, 1974, NEUROLOGY, V24, P531, DOI 10.1212/WNL.24.6.531; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; FONG CG, 1998, EPILEPSIA, V39, P4; Gurd JW, 1997, J NEUROCHEM, V69, P623; HARRIMAN DGF, 1955, BRAIN, V78, P325, DOI 10.1093/brain/78.3.325; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Lafora GR, 1911, VIRCHOWS ARCH A, V205, P295, DOI 10.1007/BF01989438; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Llinas R, 1997, P NATL ACAD SCI USA, V94, P1990, DOI 10.1073/pnas.94.5.1990; LOPESCENDES I, 1995, EPILEPSIA, V36, P6; MCLAUGHLIN S, 1993, J BIOL CHEM, V268, P6839; Minassian Berge A., 1996, Epilepsia, V37, P126; Sainz J, 1997, AM J HUM GENET, V61, P1205, DOI 10.1086/301596; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; SCHWARZ GA, 1965, ARCH NEUROL-CHICAGO, V12, P172, DOI 10.1001/archneur.1965.00460260062008; SERRATOSA JM, 1995, HUM MOL GENET, V9, P1657; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Van Heycop Ten Ham MW., 1974, HDB CLIN NEUROLOGY, V15, P382; WANG QM, 1994, J BIOL CHEM, V269, P14566; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328	24	356	369	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					171	174		10.1038/2470	http://dx.doi.org/10.1038/2470			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771710				2022-12-17	WOS:000076231300019
J	SOONG, NW; HINTON, DR; CORTOPASSI, G; ARNHEIM, N				SOONG, NW; HINTON, DR; CORTOPASSI, G; ARNHEIM, N			MOSAICISM FOR A SPECIFIC SOMATIC MITOCHONDRIAL-DNA MUTATION IN ADULT HUMAN BRAIN	NATURE GENETICS			English	Article							DELETIONS; DISEASE; INCREASE; TISSUES; MUSCLE; DAMAGE; GENE	The levels of a specific mitochondrial DNA deletion (mtDNA4977 measured in 12 brain regions of 6 normal adults 39 to 82 years old exhibited striking variation among anatomical locations. Comparisons of the same region among individuals showed an increase of mtDNA4977 With age. The three regions with the highest levels, caudate, putamen and substantia nigra, are characterized by a high dopamine metabolism. The breakdown of dopamine by mitochondrial MAO produces H2O2 which can lead to oxygen radical formation. We suggest that mtDNA4977 may be the "tip of the iceberg" of the spectrum of somatic mutations produced by oxidative damage.	USC, SCH MED, DEPT PATHOL, LOS ANGELES, CA 90033 USA; UNIV SO CALIF, INST TOXICOL, LOS ANGELES, CA 90033 USA	University of Southern California; University of Southern California	SOONG, NW (corresponding author), UNIV SO CALIF, MOLEC BIOL SECT, LOS ANGELES, CA 90089 USA.			Arnheim, Norman/0000-0003-1247-1347				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9; Bjorklund A, 1984, HDB CHEM NEUROANAT 1, V2, P55; BULPITT KJ, 1984, BRAIN RES, V300, P41, DOI 10.1016/0006-8993(84)91339-8; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; COLEMAN PD, 1987, NEUROBIOL AGING, V8, P521, DOI 10.1016/0197-4580(87)90127-8; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; CORTOPASSI GA, 1992, PROGR PARKINSONS DIS, V2; DEKEYSER J, 1990, ANN NEUROL, V27, P157, DOI 10.1002/ana.410270210; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GOLDSTEIN M, 1992, NEUROLOGY, V42, P8; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; GUPTA KP, 1990, MUTAT RES, V237, P17, DOI 10.1016/0921-8734(90)90028-P; HARDING AE, 1991, TRENDS NEUROSCI, V14, P132, DOI 10.1016/0166-2236(91)90081-5; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465; IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B; JENNER P, 1992, NEUROL CLIN, V10, P387, DOI 10.1016/S0733-8619(18)30217-2; JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; LUBIN MB, 1991, MOL CELL PROBE, V5, P307, DOI 10.1016/0890-8508(91)90054-N; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MORAES CT, 1991, CURRENT NEUROLOGY, V11, P83; MULLERHOCKER, 1992, J BRAIN PATHOLOGY, V2, P149; OZAWA T, 1990, BIOCHEM BIOPH RES CO, V170, P830, DOI 10.1016/0006-291X(90)92166-W; PHELPS ME, 1982, J CEREBR BLOOD F MET, V2, P113, DOI 10.1038/jcbfm.1982.14; PRZEDBORSKI S, 1992, J NEUROSCI, V12, P1658; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; RIEDERER P, 1992, ANN NEUROL, V32, pS101, DOI 10.1002/ana.410320717; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SHOFFNER JM, 1990, ADV HUM GENET, V19, P267; Sokal R.R., 1981, BIOMETRY, V2nd ed.; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WESTLUND KN, 1988, NEUROSCIENCE, V25, P439, DOI 10.1016/0306-4522(88)90250-3	44	356	361	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1992	2	4					318	323						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303287				2022-12-17	WOS:A1992KB49500018
J	Miotto, O; Amato, R; Ashley, EA; MacInnis, B; Almagro-Garcia, J; Amaratunga, C; Lim, P; Mead, D; Oyolal, SO; Dhorda, M; Imwong, M; Woodrow, C; Manske, M; Stalker, J; Drury, E; Campino, S; Amenga-Etego, L; Thanh, TNN; Tran, HT; Ringwald, P; Bethellm, D; Nosten, F; Phyo, AP; Pukrittayakamee, S; Chotivanich, K; Chuor, CM; Nguon, C; Suon, S; Sreng, S; Newton, PN; Mayxay, M; Khanthavong, M; Hongvanthong, B; Htut, Y; Han, KT; Kyaw, MP; Faiz, MA; Fanello, CI; Onyamboko, M; Mokuolu, OA; Jacob, CG; Takala-Harrison, S; Plowe, CV; Day, NP; Dondorp, AM; Spencer, CCA; McVean, G; Fairhurst, RM; White, NJ; Kwiatkowski, DP				Miotto, Olivo; Amato, Roberto; Ashley, Elizabeth A.; MacInnis, Bronwyn; Almagro-Garcia, Jacob; Amaratunga, Chanaki; Lim, Pharath; Mead, Daniel; Oyolal, Samuel O.; Dhorda, Mehul; Imwong, Mallika; Woodrow, Charles; Manske, Magnus; Stalker, Jim; Drury, Eleanor; Campino, Susana; Amenga-Etego, Lucas; Thuy-Nhien Nguyen Thanh; Hien Tinh Tran; Ringwald, Pascal; Bethellm, Delia; Nosten, Francois; Phyo, Aung Pyae; Pukrittayakamee, Sasithon; Chotivanich, Kesinee; Chuor, Char Meng; Nguon, Chea; Suon, Seila; Sreng, Sokunthea; Newton, Paul N.; Mayxay, Mayfong; Khanthavong, Maniphone; Hongvanthong, Bouasy; Htut, Ye; Han, Kay Thwe; Kyaw, Myat Phone; Faiz, Md Abul; Fanello, Caterina I.; Onyamboko, Marie; Mokuolu, Olugbenga A.; Jacob, Christopher G.; Takala-Harrison, Shannon; Plowe, Christopher V.; Day, Nicholas P.; Dondorp, Arjen M.; Spencer, Chris C. A.; McVean, Gilean; Fairhurst, Rick M.; White, Nicholas J.; Kwiatkowski, Dominic P.			Genetic architecture of artemisinin-resistant Plasmodium falciparum	NATURE GENETICS			English	Article							CHLOROQUINE RESISTANCE; PARASITE CLEARANCE; PFMDR2 GENE; MALARIA; SPREAD; EPIDEMIOLOGY; MUTATIONS; PROVINCE; WORLD	We report a large multicenter genome-wide association study of Plasmodium falciparum resistance to artemisinin, the frontline antimalarial drug. Across 15 locations in Southeast Asia, we identified at least 20 mutations in kelch13 (PF3D7_1343700) affecting the encoded propeller and BTB/POZ domains, which were associated with a slow parasite clearance rate after treatment with artemisinin derivatives. Nonsynonymous polymorphisms in fd (ferredoxin), arps10 (apicoplast ribosomal protein S10), mdr2 (multidrug resistance protein 2) and crt (chloroquine resistance transporter) also showed strong associations with artemisinin resistance. Analysis of the fine structure of the parasite population showed that the fd, arps10, mdr2 and crt polymorphisms are markers of a genetic background on which kelch13 mutations are particularly likely to arise and that they correlate with the contemporary geographical boundaries and population frequencies of artemisinin resistance. These findings indicate that the risk of new resistance-causing mutations emerging is determined by specific predisposing genetic factors in the underlying parasite population.	[Miotto, Olivo; Amato, Roberto; MacInnis, Bronwyn; Almagro-Garcia, Jacob; Mead, Daniel; Oyolal, Samuel O.; Manske, Magnus; Stalker, Jim; Drury, Eleanor; Campino, Susana; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Miotto, Olivo; Amato, Roberto; MacInnis, Bronwyn; Almagro-Garcia, Jacob; Manske, Magnus; Stalker, Jim; Campino, Susana; Amenga-Etego, Lucas; Spencer, Chris C. A.; McVean, Gilean; Kwiatkowski, Dominic P.] Univ Oxford, Ctr Genom & Global Hlth, MRC, Oxford, England; [Miotto, Olivo; Ashley, Elizabeth A.; Woodrow, Charles; Nosten, Francois; Phyo, Aung Pyae; Fanello, Caterina I.; Day, Nicholas P.; Dondorp, Arjen M.; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Matlidol Oxtord Trop Med Res Unit, Bangkok 10700, Thailand; [Amato, Roberto; Almagro-Garcia, Jacob; Spencer, Chris C. A.; McVean, Gilean; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ashley, Elizabeth A.; Dhorda, Mehul; Woodrow, Charles; Hien Tinh Tran; Nosten, Francois; Phyo, Aung Pyae; Newton, Paul N.; Mayxay, Mayfong; Fanello, Caterina I.; Onyamboko, Marie; Day, Nicholas P.; Dondorp, Arjen M.; White, Nicholas J.] Univ Oxford, Ctr Trop Med, Nuffield Dept Med, Oxford, England; [Amaratunga, Chanaki; Lim, Pharath; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, US NIH, Bethesda, MD 20892 USA; [Lim, Pharath; Chuor, Char Meng; Nguon, Chea; Suon, Seila; Sreng, Sokunthea] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Dhorda, Mehul; Jacob, Christopher G.; Takala-Harrison, Shannon; Plowe, Christopher V.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Dhorda, Mehul] Mahidol Univ, Asia Reg Ctr, WWARN, Bangkok 10700, Thailand; [Imwong, Mallika; Pukrittayakamee, Sasithon; Chotivanich, Kesinee] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [Amenga-Etego, Lucas] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Thuy-Nhien Nguyen Thanh; Hien Tinh Tran] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Ringwald, Pascal] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Bethellm, Delia] USAMC AFRIMS, Dept Immunol & Med, Bangkok, Thailand; [Nosten, Francois; Phyo, Aung Pyae] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Newton, Paul N.; Mayxay, Mayfong] Mahosot Hosp, Lao Oxford Mahosot Wellcome Trust Res Unit LOMWRU, Viangchan, Laos; [Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos; [Khanthavong, Maniphone; Hongvanthong, Bouasy] Minist Hlth, Ctr Mahariol Parasitol & Entomol, Viangchan, Laos; [Htut, Ye; Han, Kay Thwe; Kyaw, Myat Phone] Dept Med Res, Yarigon, Myanmar; [Faiz, Md Abul] Malaria Res Grp & Dev Care Fdn, Dhaka, Bangladesh; [Onyamboko, Marie] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Mokuolu, Olugbenga A.] Univ Ilorin, Dept Paediat & Child Hlth, Ilorin, Nigeria; [Plowe, Christopher V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21201 USA; [McVean, Gilean] Univ Oxford, Dept Stat, Oxford, England	Wellcome Trust Sanger Institute; University of Oxford; Mahidol University; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Center Parasitology, Entomology & Malaria Control; University System of Maryland; University of Maryland Baltimore; Mahidol University; Worldwide Antimalarial Resistance Network (WWARN); Mahidol University; Navrongo Health Research Center; University of Oxford; World Health Organization; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Ilorin; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; University of Oxford	Kwiatkowski, DP (corresponding author), Wellcome Trust Sanger Inst, Hinxton, Cambs, England.	dominic@sanger.ac.uk	Mead, Daniel/AAE-6629-2019; White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019; Mokuolu, Olugbenga/G-4334-2016; Fanello, Caterina/AAT-9679-2021; , Myat-Phone-Kyaw/P-1750-2019; Miotto, Olivo/AAE-7124-2019; Phyo, Aung Pyae/K-2413-2019; Imwong, Mallika/ABE-6493-2020; Lim, Pharath/AAF-6699-2020; Phyo, Aung Pyae/GYU-6181-2022; Campino, Susana/AAM-2577-2020	Mead, Daniel/0000-0001-7717-4330; White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Mokuolu, Olugbenga/0000-0001-8273-5876; Fanello, Caterina/0000-0003-1932-9562; Miotto, Olivo/0000-0001-8060-6771; Phyo, Aung Pyae/0000-0002-0383-9624; Phyo, Aung Pyae/0000-0002-0383-9624; Campino, Susana/0000-0003-1403-6138; Manske, Magnus/0000-0001-5916-0947; Newton, Paul/0000-0002-4608-6431; Amato, Roberto/0000-0001-8633-9221; Thuy-Nhien, Nguyen/0000-0002-4101-5706; Lim, Pharath/0000-0002-1012-2461; Kwiatkowski, Dominic/0000-0002-5023-0176; Takala-Harrison, Shannon/0000-0003-4674-8500; Ashley, Elizabeth/0000-0002-7620-4822; Oyola, Samuel O./0000-0002-6425-7345; Woodrow, Charles/0000-0002-5134-7165; Spencer, Christopher/0000-0002-8508-456X	Wellcome Trust; Wellcome Trust Sanger Institute [098051]; Wellcome Trust Centre for Human Genetics [090532/Z/09/Z]; Resource Centre for Genomic Epidemiology of Malaria [090770/Z/09/Z]; Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme; UK Medical Research Council [G0600718]; Bill and Melinda Gates Foundation [OPP1040463]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases; US National Institutes of Health; Department for International Development [PO5408]; MRC [G0600718, MR/M006212/1] Funding Source: UKRI; Medical Research Council [G0600718, MR/M006212/1, 1252410] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001000, ZIAAI001066, R01AI101713] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Sanger Institute(Wellcome Trust); Wellcome Trust Centre for Human Genetics(Wellcome Trust); Resource Centre for Genomic Epidemiology of Malaria; Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department for International Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the following colleagues for their efforts in support of this work: P. Vauterin, G. Band and Q.S. Le; J. Anderson, D. Dek, S. Duong, R. Gwadz, S. Mao, V. Ou, B. Sam, C. Sopha, V. Try and T. Wellems; the personnel at Phuoc Long Hospital, Bu Gia Map Health Station, Malaria Control Center of Binh Phuoc Province, Vietnam; M. Phommasansack, B. Phimphalat and C. Vilayhong; and A.K. Tshefu. Special thanks are given to V. Cornelius and K. Johnson for their continual support of the analysis group. The sequencing for this study was funded by the Wellcome Trust through core funding of the Wellcome Trust Sanger Institute (098051). The Wellcome Trust also supports the Wellcome Trust Centre for Human Genetics (090532/Z/09/Z), the Resource Centre for Genomic Epidemiology of Malaria (090770/Z/09/Z) and the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme. The Centre for Genomics and Global Health is supported by the UK Medical Research Council (G0600718). This work was funded in part by the Bill and Melinda Gates Foundation (OPP1040463), the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, US National Institutes of Health and the Department for International Development (PO5408). P.R. is a staff member of the World Health Organization. The views expressed in this publication are those of the authors and do not necessarily reflect the positions, decisions, policies or views of their employers or of the funding organizations.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Auburn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022213; Beez D, 2011, ANTIMICROB AGENTS CH, V55, P50, DOI 10.1128/AAC.00916-10; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Briolant S, 2012, ANTIMICROB AGENTS CH, V56, P2750, DOI 10.1128/AAC.05618-11; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Dahl EL, 2008, TRENDS PARASITOL, V24, P279, DOI 10.1016/j.pt.2008.03.007; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; Kimata-Ariga Y, 2007, J BIOCHEM, V142, P715, DOI 10.1093/jb/mvm184; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Manske HM, 2009, BIOINFORMATICS, V25, P2434, DOI 10.1093/bioinformatics/btp403; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Martinelli A, 2011, INT J PARASITOL, V41, P165, DOI 10.1016/j.ijpara.2010.08.008; Millet J, 2004, ANTIMICROB AGENTS CH, V48, P4869, DOI 10.1128/AAC.48.12.4869-4872.2004; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; PAYNE D, 1988, PARASITOL TODAY, V4, P112, DOI 10.1016/0169-4758(88)90042-7; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Rosenberg E, 2006, J BIOL CHEM, V281, P27039, DOI 10.1074/jbc.M601686200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sen Saunak, 2004, Current Drug Targets - Infectious Disorders, V4, P53, DOI 10.2174/1568005043480916; Tabernero P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-139; Takala-Harrison S, 2015, J INFECT DIS, V211, P670, DOI 10.1093/infdis/jiu491; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; Van Tyne D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001383; VASQUEZVIVAR J, 1992, J BIOL CHEM, V267, P6848; Venkatesan M, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-41; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; ZALIS MG, 1993, MOL BIOCHEM PARASIT, V62, P83, DOI 10.1016/0166-6851(93)90180-6	42	355	366	2	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					226	+		10.1038/ng.3189	http://dx.doi.org/10.1038/ng.3189			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25599401	Bronze, Green Submitted, Green Accepted			2022-12-17	WOS:000350327900012
J	Ong, CK; Subimerb, C; Pairojkul, C; Wongkham, S; Cutcutache, I; Yu, W; McPherson, JR; Allen, GE; Ng, CCY; Wong, BH; Myint, SS; Rajasegaran, V; Heng, HL; Gan, A; Zang, ZJ; Wu, YT; Wu, J; Lee, MH; Huang, DC; Ong, P; Chan-on, W; Cao, Y; Qian, CN; Lim, KH; Ooi, A; Dykema, K; Furge, K; Kukongviriyapan, V; Sripa, B; Wongkham, C; Yongvanit, P; Futreal, PA; Bhudhisawasdi, V; Rozen, S; Tan, P; Teh, BT				Ong, Choon Kiat; Subimerb, Chutima; Pairojkul, Chawalit; Wongkham, Sopit; Cutcutache, Ioana; Yu, Willie; McPherson, John R.; Allen, George E.; Ng, Cedric Chuan Young; Wong, Bernice Huimin; Myint, Swe Swe; Rajasegaran, Vikneswari; Heng, Hong Lee; Gan, Anna; Zang, Zhi Jiang; Wu, Yingting; Wu, Jeanie; Lee, Ming Hui; Huang, DaChuan; Ong, Pauline; Chan-on, Waraporn; Cao, Yun; Qian, Chao-Nan; Lim, Kiat Hon; Ooi, Aikseng; Dykema, Karl; Furge, Kyle; Kukongviriyapan, Veerapol; Sripa, Banchob; Wongkham, Chaisiri; Yongvanit, Puangrat; Futreal, P. Andrew; Bhudhisawasdi, Vajarabhongsa; Rozen, Steve; Tan, Patrick; Teh, Bin Tean			Exome sequencing of liver fluke-associated cholangiocarcinoma	NATURE GENETICS			English	Article							BILIARY-TRACT; GENOMIC ANALYSES; COPY NUMBERS; CANCER; MUTATIONS; CARCINOMA; INSTABILITY; INDUCTION; GROWTH; CELLS	Opisthorchis viverrini-related cholangiocarcinoma (CCA), a fatal bile duct cancer, is a major public health concern in areas endemic for this parasite. We report here whole-exome sequencing of eight O. viverrini-related tumors and matched normal tissue. We identified and validated 206 somatic mutations in 187 genes using Sanger sequencing and selected 15 genes for mutation prevalence screening in an additional 46 individuals with CCA (cases). In addition to the known cancer-related genes TP53 (mutated in 44.4% of cases), KRAS (16.7%) and SMAD4 (16.7%), we identified somatic mutations in 10 newly implicated genes in 14.8-3.7% of cases. These included inactivating mutations in MLL3 (in 14.8% of cases), ROBO2 (9.3%), RNF43 (9.3%) and PEG3 (5.6%), and activating mutations in the GNAS oncogene (9.3%). These genes have functions that can be broadly grouped into three biological classes: (i) deactivation of histone modifiers, (ii) activation of G protein signaling and (iii) loss of genome stability. This study provides insight into the mutational landscape contributing to O. viverrini-related CCA.	[Subimerb, Chutima; Pairojkul, Chawalit; Wongkham, Sopit; Chan-on, Waraporn; Kukongviriyapan, Veerapol; Sripa, Banchob; Wongkham, Chaisiri; Yongvanit, Puangrat; Bhudhisawasdi, Vajarabhongsa] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Ong, Choon Kiat; Subimerb, Chutima; Yu, Willie; Allen, George E.; Ng, Cedric Chuan Young; Wong, Bernice Huimin; Myint, Swe Swe; Rajasegaran, Vikneswari; Heng, Hong Lee; Gan, Anna; Huang, DaChuan; Ong, Pauline; Chan-on, Waraporn; Teh, Bin Tean] Natl Canc Ctr, Div Med Sci, Nat Canc Ctr Singapore Van Andel Res Inst Transla, Singapore, Singapore; [Ong, Choon Kiat; Subimerb, Chutima; Yu, Willie; Allen, George E.; Ng, Cedric Chuan Young; Wong, Bernice Huimin; Myint, Swe Swe; Rajasegaran, Vikneswari; Heng, Hong Lee; Gan, Anna; Zang, Zhi Jiang; Wu, Jeanie; Lee, Ming Hui; Huang, DaChuan; Ong, Pauline; Chan-on, Waraporn; Tan, Patrick; Teh, Bin Tean] Duke Natl Univ Singapore NUS Grad Med Sch, Div Canc & Stem Cell Biol, Singapore, Singapore; [Cutcutache, Ioana; McPherson, John R.; Wu, Yingting; Rozen, Steve] Duke NUS Grad Med Sch, Div Neurosci & Behav Disorders, Singapore, Singapore; [Yu, Willie] NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Zang, Zhi Jiang] Natl Canc Ctr, Div Cellular & Mol Res, Singapore, Singapore; [Wu, Yingting] Singapore MIT Alliance, Singapore, Singapore; [Cao, Yun; Qian, Chao-Nan] Sun Yat Sen Univ Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Lim, Kiat Hon] Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; [Ooi, Aikseng; Dykema, Karl; Furge, Kyle] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI USA; [Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Tan, Patrick] NUS, Canc Sci Inst Singapore, Singapore, Singapore; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore	Khon Kaen University; National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore; National Cancer Centre Singapore (NCCS); Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); Sun Yat Sen University; Singapore General Hospital; Van Andel Institute; Wellcome Trust Sanger Institute; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Bhudhisawasdi, V (corresponding author), Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand.	joevajare@gmail.com; steve.rozen@duke-nus.edu.sg; gmstanp@duke-nus.edu.sg; teh.bin.tean@singhealth.com.sg	Wongkham, Sopit/ABB-6966-2021; Xiao, Yang/B-5668-2012; Ooi, Aikseng/B-8776-2012; Rozen, Steven G./J-5939-2013	Ooi, Aikseng/0000-0003-3853-7156; Ong, Choon Kiat/0000-0001-6402-4288; Sripa, Banchob/0000-0001-8899-5919; HUANG, DACHUAN/0000-0002-7518-4081; Myint, Swe Swe/0000-0002-2430-088X; Wong, Bernice/0000-0001-8981-1376; Rozen, Steven G./0000-0002-4288-0056; Teh, Bin Tean/0000-0003-1514-1124	Singapore National Medical Research Council [NMRC/STAR/0006/2009]; Singapore Millennium Foundation; Lee Foundation; Singapore National Cancer Centre; Duke-NUS Graduate Medical School; Cancer Science Institute, Singapore; Research Team Strengthening Grant; National Genetic Engineering and Biotechnology Center; National Science and Technology Development Agency, Thailand; NUS Graduate School for Integrative Sciences and Engineering, Singapore	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Millennium Foundation(Singapore Millennium Foundation); Lee Foundation; Singapore National Cancer Centre; Duke-NUS Graduate Medical School(National University of Singapore); Cancer Science Institute, Singapore; Research Team Strengthening Grant; National Genetic Engineering and Biotechnology Center; National Science and Technology Development Agency, Thailand; NUS Graduate School for Integrative Sciences and Engineering, Singapore(National University of Singapore)	We thank L. Farber for editing the manuscript. This work is supported in part by funding from the Singapore National Medical Research Council (NMRC/STAR/0006/2009), The Singapore Millennium Foundation, The Lee Foundation, the Singapore National Cancer Centre Research Fund, the Duke-NUS Graduate Medical School, the Cancer Science Institute, Singapore, the Research Team Strengthening Grant, the National Genetic Engineering and Biotechnology Center and the National Science and Technology Development Agency, Thailand. W.Y. is the recipient of the NUS Graduate School for Integrative Sciences and Engineering Scholarship, Singapore.	Aoki K, 2007, ONCOGENE, V26, P3511, DOI 10.1038/sj.onc.1210141; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bengtsson H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-245; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Cardinale Vincenzo, 2010, Italian Journal of Anatomy and Embryology, V115, P85; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Gilbert SF, 2000, DEV BIOL, P494; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Homayounfar K, 2009, HUM PATHOL, V40, P834, DOI 10.1016/j.humpath.2008.11.005; Idziaszczyk S, 2010, CANCER GENET CYTOGEN, V202, P67, DOI 10.1016/j.cancergencyto.2010.04.023; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Low SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011824; McLean L, 2006, LIVER INT, V26, P1047, DOI 10.1111/j.1478-3231.2006.01350.x; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nakanuma Y, 2010, PATHOL INT, V60, P419, DOI 10.1111/j.1440-1827.2010.02543.x; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Rashid A, 2002, CLIN CANCER RES, V8, P3156; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Shinada K, 2011, BIOCHEM BIOPH RES CO, V404, P143, DOI 10.1016/j.bbrc.2010.11.082; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; van Oijen MGCT, 2000, CLIN CANCER RES, V6, P2138; VATANASAPT V, 1995, CANCER EPIDEM BIOMAR, V4, P475; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wong N, 2002, J HEPATOL, V37, P633, DOI 10.1016/S0168-8278(02)00269-6; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Xu XL, 2006, J CLIN INVEST, V116, P1843, DOI 10.1172/JCI27282	31	355	365	3	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2012	44	6					690	U113		10.1038/ng.2273	http://dx.doi.org/10.1038/ng.2273			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	949BT	22561520				2022-12-17	WOS:000304551100017
J	Wei, XM; Walia, V; Lin, JC; Teer, JK; Prickett, TD; Gartner, J; Davis, S; Stemke-Hale, K; Davies, MA; Gershenwald, JE; Robinson, W; Robinson, S; Rosenberg, SA; Samuels, Y				Wei, Xiaomu; Walia, Vijay; Lin, Jimmy C.; Teer, Jamie K.; Prickett, Todd D.; Gartner, Jared; Davis, Sean; Stemke-Hale, Katherine; Davies, Michael A.; Gershenwald, Jeffrey E.; Robinson, William; Robinson, Steven; Rosenberg, Steven A.; Samuels, Yardena		NISC Comparative Sequencing Progra	Exome sequencing identifies GRIN2A as frequently mutated in melanoma	NATURE GENETICS			English	Article							MUTATIONS; GENE; EXPRESSION; RECEPTORS; REVEALS; TRRAP	The incidence of melanoma is increasing more than any other cancer, and knowledge of its genetic alterations is limited. To systematically analyze such alterations, we performed whole-exome sequencing of 14 matched normal and metastatic tumor DNAs. Using stringent criteria, we identified 68 genes that appeared to be somatically mutated at elevated frequency, many of which are not known to be genetically altered in tumors. Most importantly, we discovered that TRRAP harbored a recurrent mutation that clustered in one position (p. Ser722Phe) in 6 out of 167 affected individuals (similar to 4%), as well as a previously unidentified gene, GRIN2A, which was mutated in 33% of melanoma samples. The nature, pattern and functional evaluation of the TRRAP recurrent mutation suggest that TRRAP functions as an oncogene. Our study provides, to our knowledge, the most comprehensive map of genetic alterations in melanoma to date and suggests that the glutamate signaling pathway is involved in this disease.	[Wei, Xiaomu; Walia, Vijay; Prickett, Todd D.; Gartner, Jared; Samuels, Yardena] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Lin, Jimmy C.] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD USA; [Lin, Jimmy C.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD USA; [Teer, Jamie K.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Davis, Sean] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [NISC Comparative Sequencing Progra] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Stemke-Hale, Katherine; Davies, Michael A.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Davies, Michael A.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Gershenwald, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Gershenwald, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Robinson, William; Robinson, Steven] Univ Colorado, Denver Sch Med, Div Med Oncol, Aurora, CO USA; [Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Samuels, Y (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	samuelsy@mail.nih.gov	Stemke-Hale, Katherine/K-9113-2013; Davies, Michael/GWV-2527-2022; Walia, Vijay/F-1647-2013; Davis, Sean/AAD-1801-2021; Gershenwald, Jeff/AAX-4367-2020	Stemke-Hale, Katherine/0000-0002-1231-4192; Davis, Sean/0000-0002-8991-6458; Gershenwald, Jeff/0000-0003-4519-5369; Robinson, William/0000-0003-1875-9691; Samuels, Yardena/0000-0002-3349-7266	National Human Genome Research Institute; National Cancer Institute, National Institutes of Health, USA; University of Texas MD Anderson Cancer Center [P50 CA93459]; NATIONAL CANCER INSTITUTE [ZIABC010984, P50CA093459, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIAHG200337, ZIBHG000196] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank V. Maduro, H. Abaan, P. Cruz and J. Mullikin for generating the sequence data analyzed here. We thank V.G. Prieto for pathologic review of the biospecimens from MelCore at MD Anderson. We thank T. Wolfsberg for bioinformatics help and J. Fekecs and D. Leja for graphical assistance. This work was supported by the Intramural Research Programs of the National Human Genome Research Institute, the National Cancer Institute, National Institutes of Health, USA and The University of Texas MD Anderson Cancer Center Melanoma SPORE (P50 CA93459).	Anton ES, 2004, NAT NEUROSCI, V7, P1319, DOI 10.1038/nn1345; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davies MA, 2009, CLIN CANCER RES, V15, P7538, DOI 10.1158/1078-0432.CCR-09-1985; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20073, 10.3322/caac.20105]; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Morente MM, 2006, EUR J CANCER, V42, P2684, DOI 10.1016/j.ejca.2006.04.029; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; PIN JP, 1995, BIOCHEM SOC T, V23, P91, DOI 10.1042/bst0230091; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shin SS, 2008, PIGM CELL MELANOMA R, V21, P368, DOI 10.1111/j.1755-148X.2008.00452.x; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087	30	355	381	0	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2011	43	5					442	+		10.1038/ng.810	http://dx.doi.org/10.1038/ng.810			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21499247	Green Accepted			2022-12-17	WOS:000289972600013
J	Novembre, J; Stephens, M				Novembre, John; Stephens, Matthew			Interpreting principal component analyses of spatial population genetic variation	NATURE GENETICS			English	Article							SYNTHETIC MAPS; DEMIC EXPANSIONS; ASSOCIATION; STRATIFICATION; EUROPE; ORIGIN	Nearly 30 years ago, Cavalli-Sforza et al. pioneered the use of principal component analysis (PCA) in population genetics and used PCA to produce maps summarizing human genetic variation across continental regions(1). They interpreted gradient and wave patterns in these maps as signatures of specific migration events(1-3). These interpretations have been controversial(4-7), but influential(8), and the use of PCA has become widespread in analysis of population genetics data(9-13). However, the behavior of PCA for genetic data showing continuous spatial variation, such as might exist within human continental groups, has been less well characterized. Here, we find that gradients and waves observed in Cavalli-Sforza et al.'s maps resemble sinusoidal mathematical artifacts that arise generally when PCA is applied to spatial data, implying that the patterns do not necessarily reflect specific migration events. Our findings aid interpretation of PCA results and suggest how PCA can help correct for continuous population structure in association studies.	[Novembre, John; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Stephens, M (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 5th Floor, Chicago, IL 60637 USA.	stephens@galton.uchicago.edu	Novembre, John/G-1339-2011		NHGRI NIH HHS [R01 HG02585-01, R01 HG002585] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; [Anonymous], 1975, TIME SERIES DATA ANA; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; DIACONIS P, IN PRESS ANN APPL ST; FREIBERGER WF, 1960, INT DICT APPL MATH; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Heidemann G, 2006, IEEE T PATTERN ANAL, V28, P822, DOI 10.1109/TPAMI.2006.107; INWIN DE, 2005, SCIENCE, V307, P414; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Podani J, 2002, ECOLOGY, V83, P3331; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; RENDINE S, 1986, AM NAT, V128, P681, DOI 10.1086/284597; Rendine S, 1999, HUM BIOL, V71, P15; RICHMAN MB, 1986, J CLIMATOL, V6, P293, DOI 10.1002/joc.3370060305; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Sokal RR, 1999, HUM BIOL, V71, P1; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	30	355	357	2	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					646	649		10.1038/ng.139	http://dx.doi.org/10.1038/ng.139			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18425127	Green Accepted			2022-12-17	WOS:000255366700034
J	Loveday, C; Turnbull, C; Ramsay, E; Hughes, D; Ruark, E; Frankum, JR; Bowden, G; Kalmyrzaev, B; Warren-Perry, M; Snape, K; Adlard, JW; Barwell, J; Berg, J; Brady, AF; Brewer, C; Brice, G; Chapman, C; Cook, J; Davidson, R; Donaldson, A; Douglas, F; Greenhalgh, L; Henderson, A; Izatt, L; Kumar, A; Lalloo, F; Miedzybrodzka, Z; Morrison, PJ; Paterson, J; Porteous, M; Rogers, MT; Shanley, S; Walker, L; Eccles, D; Evans, DG; Renwick, A; Seal, S; Lord, CJ; Ashworth, A; Reis-Filho, JS; Antoniou, AC; Rahman, N				Loveday, Chey; Turnbull, Clare; Ramsay, Emma; Hughes, Deborah; Ruark, Elise; Frankum, Jessica R.; Bowden, Georgina; Kalmyrzaev, Bolot; Warren-Perry, Margaret; Snape, Katie; Adlard, Julian W.; Barwell, Julian; Berg, Jonathan; Brady, Angela F.; Brewer, Carole; Brice, Glen; Chapman, Cyril; Cook, Jackie; Davidson, Rosemarie; Donaldson, Alan; Douglas, Fiona; Greenhalgh, Lynn; Henderson, Alex; Izatt, Louise; Kumar, Ajith; Lalloo, Fiona; Miedzybrodzka, Zosia; Morrison, Patrick J.; Paterson, Joan; Porteous, Mary; Rogers, Mark T.; Shanley, Susan; Walker, Lisa; Eccles, Diana; Evans, D. Gareth; Renwick, Anthony; Seal, Sheila; Lord, Christopher J.; Ashworth, Alan; Reis-Filho, Jorge S.; Antoniou, Antonis C.; Rahman, Nazneen		Breast Canc Susceptibility	Germline mutations in RAD51D confer susceptibility to ovarian cancer	NATURE GENETICS			English	Article							BREAST-CANCER; FANCONI-ANEMIA; BRCA2 MUTATIONS; HOMOLOGOUS RECOMBINATION; FAMILIAL OVARIAN; SPLICING SIGNALS; GENE; DNA; PREDICTION; SEQUENCE	Recently, RAD51C mutations were identified in families with breast and ovarian cancer(1). This observation prompted us to investigate the role of RAD51D in cancer susceptibility. We identified eight inactivating RAD51D mutations in unrelated individuals from 911 breast-ovarian cancer families compared with one inactivating mutation identified in 1,060 controls (P = 0.01). The association found here was principally with ovarian cancer, with three mutations identified in the 59 pedigrees with three or more individuals with ovarian cancer (P = 0.0005). The relative risk of ovarian cancer for RAD51D mutation carriers was estimated to be 6.30 (95% CI 2.86-13.85, P = 4.8 x 10(-6)). By contrast, we estimated the relative risk of breast cancer to be 1.32 (95% CI 0.59-2.96, P = 0.50). These data indicate that RAD51D mutation testing may have clinical utility in individuals with ovarian cancer and their families. Moreover, we show that cells deficient in RAD51D are sensitive to treatment with a PARP inhibitor, suggesting a possible therapeutic approach for cancers arising in RAD51D mutation carriers.	[Loveday, Chey; Turnbull, Clare; Ramsay, Emma; Hughes, Deborah; Ruark, Elise; Bowden, Georgina; Kalmyrzaev, Bolot; Warren-Perry, Margaret; Snape, Katie; Renwick, Anthony; Seal, Sheila; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Frankum, Jessica R.; Lord, Christopher J.; Ashworth, Alan; Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Adlard, Julian W.] Cookridge Hosp, Yorkshire Reg Ctr Canc Treatment, Leeds LS16 6QB, W Yorkshire, England; [Barwell, Julian] Univ Hosp Leicester Natl Hlth Serv NHS Trust, Leicestershire Genet Ctr, Leicester, Leics, England; [Berg, Jonathan] Univ Dundee, Div Med Sci, Dundee, Scotland; [Brady, Angela F.] Kennedy Galton Ctr, NW Thames Reg Genet Serv, London, England; [Brewer, Carole] Royal Devon & Exeter Hosp, Peninsula Reg Genet Serv, Exeter EX2 5DW, Devon, England; [Brice, Glen] St George Hosp, SW Thames Reg Genet Serv, London, England; [Chapman, Cyril] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; [Cook, Jackie] Sheffield Childrens NHS Fdn Trust, Sheffield Reg Genet Serv, Sheffield, S Yorkshire, England; [Davidson, Rosemarie] FergusonSmith Ctr Clin Genet, W Scotland Reg Genet Serv, Glasgow, Lanark, Scotland; [Donaldson, Alan] Univ Hosp Bristol NHS Fdn Trust, S Western Reg Genet Serv, Bristol, Avon, England; [Douglas, Fiona] Newcastle Upon Tyne Hosp NHS Fdn Trust, No Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England; [Greenhalgh, Lynn] Alder Hey Childrens NHS Fdn Trust, Cheshire & Merseyside Clin Genet Serv, Liverpool, Merseyside, England; [Henderson, Alex] Newcastle Upon Tyne Hosp NHS Trust, No Genet Serv Cumbria, Newcastle Upon Tyne, Tyne & Wear, England; [Izatt, Louise] Guys & St Thomas NHS Fdn Trust, SE Thames Reg Genet Serv, London, England; [Kumar, Ajith] Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London, England; [Lalloo, Fiona; Evans, D. Gareth] St Marys Hosp, Univ Dept Med Genet, Manchester M13 0JH, Lancs, England; [Lalloo, Fiona; Evans, D. Gareth] St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; [Miedzybrodzka, Zosia] Univ Aberdeen, Aberdeen, Scotland; [Miedzybrodzka, Zosia] Aberdeen Royal Infirm, N Scotland Clin Genet Serv, Aberdeen, Scotland; [Morrison, Patrick J.] Queens Univ Belfast, Dept Med Genet, Belfast, Antrim, North Ireland; [Morrison, Patrick J.] Belfast Hlth & Social Care HSC Trust, No Ireland Reg Genet Serv, Belfast, Antrim, North Ireland; [Paterson, Joan] Cambridge Univ Hosp NHS Fdn Trust, E Anglian Reg Genet Serv, Cambridge, England; [Porteous, Mary] Western Gen Hosp, SE Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Rogers, Mark T.] Univ Wales Hosp, All Wales Med Genet Serv, Cardiff CF4 4XW, S Glam, Wales; [Shanley, Susan] Royal Marsden NHS Fdn Trust, London, England; [Walker, Lisa] Oxford Radcliffe Hosp NHS Trust, Oxford Reg Genet Serv, Oxford, England; [Eccles, Diana] Univ Southampton, Fac Med, Southampton Univ Hosp NHS Trust, Southampton SO9 5NH, Hants, England; [Antoniou, Antonis C.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cookridge Hospital; University Hospitals of Leicester NHS Trust; University of Dundee; University of Exeter; St Georges University London; Birmingham Women's Hospital; Sheffield Children's NHS Foundation Trust; University of Bristol; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester; University of Manchester; University of Aberdeen; University of Aberdeen; Queens University Belfast; University of Cambridge; University of Edinburgh; Cardiff University; Royal Marsden NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Cambridge	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	nazneen.rahman@icr.ac.uk	Lord, Christopher/AAX-7130-2021; Turnbull, Clare/AAA-6596-2019; Lord, Christopher J/B-3295-2012; Eccles, Diana/K-6327-2019; Rahman, Nazneen/B-8890-2012; Evans, D Gareth/AAB-4308-2022; Snape, Katie/AAA-8101-2022; Lucassen, Anneke/D-7764-2017; Rahman, Nazneen/D-2802-2013	Lord, Christopher J/0000-0002-3226-0515; Eccles, Diana/0000-0002-9935-3169; Evans, D Gareth/0000-0002-8482-5784; Campbell, James/0000-0001-6756-8766; Lucassen, Anneke/0000-0003-3324-4338; Rahman, Nazneen/0000-0003-4376-0440; Eeles, Rosalind/0000-0002-3698-6241; Jacobs, Chris/0000-0002-9557-9080; Turnbull, Clare/0000-0002-1734-5772; Adlard, Julian/0000-0002-1693-0435; Kalmyrzaev, Bolot/0000-0001-5207-9492	Cancer Research UK [C8620/A8372, C8620/A8857, C12292/A11174]; US Military Acquisition (ACQ) Activity; Era of Hope Award [W81XWH-05-1-0204]; Breakthrough Breast Cancer; Institute of Cancer Research (UK); NHS; Medical Research Council (MRC) [G0000934]; Wellcome Trust [068545/Z/02]; MRC [G0000934, G0700491] Funding Source: UKRI; Cancer Research UK [11174] Funding Source: researchfish; Medical Research Council [G0000934, G0700491] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); US Military Acquisition (ACQ) Activity; Era of Hope Award; Breakthrough Breast Cancer; Institute of Cancer Research (UK)(Cancer Research UK); NHS; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank all the subjects and families that participated in the research. We thank A. Hall, D. Dudakia, J. Bull, R. Linger and A. Zachariou for their assistance in recruitment, B. Ebbs for assistance in DNA extraction and running the ABI sequencers, L. Thompson for the provision of cell lines and A. Strydom for assistance in preparing the manuscript. We are very grateful to all the clinicians and counselors in the Breast Cancer Susceptibility Collaboration UK (BCSC) that have contributed to the recruitment and collection of the Familial Breast Cancer Study (FBCS) samples. The full list of BCSC contributors is provided in the Supplementary Note. This work was funded by Cancer Research UK (C8620/A8372 and C8620/A8857), US Military Acquisition (ACQ) Activity, Era of Hope Award (W81XWH-05-1-0204), Breakthrough Breast Cancer and the Institute of Cancer Research (UK). We acknowledge NHS funding to the Royal Marsden/Institute of Cancer Research National Institute for Health Research NIHR) Specialist Cancer Biomedical Research Centre. C. T. is a Medical Research Council (MRC)-funded Clinical Research Fellow. A. C. A. is a Cancer Research UK Senior Cancer Research Fellow (C12292/A11174). We acknowledge the use of DNA from the British 1958 Birth Cohort collection funded by the MRC grant G0000934 and the Wellcome Trust grant 068545/Z/02.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2000, GENET EPIDEMIOL, V18, P173; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; EASTON DF, 1993, AM J HUM GENET, V52, P678; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gayther SA, 1999, AM J HUM GENET, V65, P1021, DOI 10.1086/302583; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hinz JM, 2006, NUCLEIC ACIDS RES, V34, P1358, DOI 10.1093/nar/gkl020; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; International Organization for Accreditation Bodies ILAC, 2002, IBS REAL WORLD SURV, P1; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ramus SJ, 2007, HUM MUTAT, V28, P1207, DOI 10.1002/humu.20599; Rebbeck TR, 2009, JNCI-J NATL CANCER I, V101, P80, DOI 10.1093/jnci/djn442; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	35	354	368	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2011	43	9					879	U90		10.1038/ng.893	http://dx.doi.org/10.1038/ng.893			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21822267	Green Accepted			2022-12-17	WOS:000294325800015
J	Mells, GF; Floyd, JAB; Morley, KI; Cordell, HJ; Franklin, CS; Shin, SY; Heneghan, MA; Neuberger, JM; Donaldson, PT; Day, DB; Ducker, SJ; Muriithi, AW; Wheater, EF; Hammond, CJ; Dawwas, MF; Jones, DE; Peltonen, L; Alexander, GJ; Sandford, RN; Anderson, CA				Mells, George F.; Floyd, James A. B.; Morley, Katherine I.; Cordell, Heather J.; Franklin, Christopher S.; Shin, So-Youn; Heneghan, Michael A.; Neuberger, James M.; Donaldson, Peter T.; Day, Darren B.; Ducker, Samantha J.; Muriithi, Agnes W.; Wheater, Elizabeth F.; Hammond, Christopher J.; Dawwas, Muhammad F.; Jones, David E.; Peltonen, Leena; Alexander, Graeme J.; Sandford, Richard N.; Anderson, Carl A.		The UK PBC Consortium; The Wellcome Trust Case Control Co	Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis	NATURE GENETICS			English	Article							VARIANTS; PATHOGENESIS; GENE; TOOL; HLA	In addition to the HLA locus, six genetic risk factors for primary biliary cirrhosis (PBC) have been identified in recent genome-wide association studies (GWAS). To identify additional loci, we carried out a GWAS using 1,840 cases from the UK PBC Consortium and 5,163 UK population controls as part of the Wellcome Trust Case Control Consortium 3 (WTCCC3). We followed up 28 loci in an additional UK cohort of 620 PBC cases and 2,514 population controls. We identified 12 new susceptibility loci (at a genome-wide significance level of P < 5 x 10(-8)) and replicated all previously associated loci. We identified three further new loci in a meta-analysis of data from our study and previously published GWAS results. New candidate genes include STAT4, DENND1B, CD80, IL7R, CXCR5, TNFRSF1A, CLEC16A and NFKB1. This study has considerably expanded our knowledge of the genetic architecture of PBC.	[Mells, George F.; Day, Darren B.; Muriithi, Agnes W.; Wheater, Elizabeth F.; Sandford, Richard N.] Univ Cambridge, Acad Dept Med Genet, Cambridge, England; [Mells, George F.; Alexander, Graeme J.] Univ Cambridge, Hosp Natl Hlth Serv NHS Fdn Trust, Dept Hepatol, Cambridge, England; [Floyd, James A. B.; Morley, Katherine I.; Franklin, Christopher S.; Shin, So-Youn; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Morley, Katherine I.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Sch Populat Hlth, Melbourne, Vic, Australia; [Cordell, Heather J.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Heneghan, Michael A.] Kings Coll London, Inst Liver Studies, Hosp NHS Fdn Trust, London WC2R 2LS, England; [Neuberger, James M.] Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England; [Donaldson, Peter T.; Ducker, Samantha J.; Jones, David E.] Univ Newcastle, Sch Med, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Hammond, Christopher J.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; University of Melbourne; Newcastle University - UK; University of London; King's College London; University of Birmingham; Newcastle University - UK; University of London; King's College London	Sandford, RN (corresponding author), Univ Cambridge, Acad Dept Med Genet, Cambridge, England.	rns13@cam.ac.uk; carl.anderson@sanger.ac.uk	Neuberger, James/ABG-3010-2020; Ramage, John/ABG-4603-2020; Morley, Katherine I/A-2986-2011; Anderson, Carl A/B-8327-2013; Dolwani, Sunil/M-4241-2016; Collier, David A/D-1649-2011; Burroughs, Andrew K/C-5645-2009; Dolwani, Sunil/C-9187-2013; Dominiczak, Anna F/P-9390-2017	Ramage, John/0000-0003-4824-6600; Morley, Katherine I/0000-0002-2725-5535; Anderson, Carl A/0000-0003-1719-7009; Collier, David A/0000-0003-4087-1559; Burroughs, Andrew K/0000-0001-6527-457X; Dominiczak, Anna F/0000-0003-4913-3608; Hammond, Christopher/0000-0002-3227-2620; Edkins, Sarah/0000-0003-0717-1972; Bulik, Cynthia/0000-0001-7772-3264; Ouwehand, Willem/0000-0002-7744-1790; Maxwell, Alexander P./0000-0002-6110-7253; Hunt, Sarah/0000-0002-8350-1235; Ch'ng, Chin Lye/0000-0003-3179-9313; Barrett, Jeffrey/0000-0002-1152-370X; Gillman, Matthew S./0000-0002-2340-6930; Cordell, Heather/0000-0002-1879-5572; Zeggini, Eleftheria/0000-0003-4238-659X; Aspinall, Richard/0000-0002-5208-8185; Lord, Graham/0000-0003-2069-4743; Das, Debasish/0000-0003-2340-1301; Hoeroldt, Barbara/0000-0001-8154-8155	Isaac Newton Trust; PBC Foundation; Wellcome Trust [085925/Z/08/Z, WT090355/A/09/Z, WT090355/B/09/Z, WT91745/Z/10/Z]; Raymond and Beverly Sackler Studentship; US National Institutes of Health National Eye Institute [1RO1EY018246]; NIHR comprehensive Biomedical Research Centre; MRC [G0802068, G0800460, G0500020] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY018246] Funding Source: NIH RePORTER; Medical Research Council [G0802068, G0500020, G0800460] Funding Source: researchfish	Isaac Newton Trust; PBC Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Raymond and Beverly Sackler Studentship; US National Institutes of Health National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIHR comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The PBC sample collection was funded by the Isaac Newton Trust, the PBC Foundation and the Wellcome Trust (085925/Z/08/Z). The PBC Genetics Study is a portfolio study of the National Institute for Health Research Comprehensive Clinical Research Network (NIHR CRN, portfolio reference 5630). The WTCCC3 project is also supported by the Wellcome Trust (WT090355/A/09/Z, WT090355/B/09/Z). G.F.M. is a Clinical Research Training Fellow of the Medical Research Council (G0800460). G.F.M. is also supported by a Raymond and Beverly Sackler Studentship. C.J.H. is an NIHR Senior Research Fellow. C.A.A. is funded by the Wellcome Trust (WT91745/Z/10/Z).; We are grateful to the PBC Foundation for helping us to establish the PBC Genetics Study, for endorsing it, and for encouraging members of the Foundation to contribute samples. We thank all of the research nurses who assisted with participant recruitment in collaborating centers. We thank the staff in the NIHR CRN and Clinical Research Collaboration (CRC) Cymru for providing invaluable support. We are grateful to K. Chittock and his colleagues at Source Bioscience for their efforts. We thank O. Burren for designing the participant database and for providing information technology support. We acknowledge the Department of Twin Research and Genetic Epidemiology, King's College London for additional control genotype data, which was part-funded by a US National Institutes of Health National Eye Institute grant 1RO1EY018246 (PI, T. Young) and genotyping by the NIH Center for Inherited Disease Research (CIDR), with additional genotyping performed at the Wellcome Trust Sanger Institute. The study also received support from the NIHR comprehensive Biomedical Research Centre award to Guy's & St. Thomas' NHS Foundation Trust partnering King's College London. Finally, we thank the individuals who contributed samples used in this study.	Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Donaldson PT, 2006, HEPATOLOGY, V44, P667, DOI 10.1002/hep.21316; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; Hirschfield GM, 2010, NAT GENET, V42, P655, DOI 10.1038/ng.631; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; James OFW, 1999, HEPATOLOGY, V30, P390, DOI 10.1002/hep.510300213; Jones DEJ, 2007, GUT, V56, P1615, DOI 10.1136/gut.2007.122150; Jones DEJ, 1999, J HEPATOL, V30, P402, DOI 10.1016/S0168-8278(99)80097-X; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Kitamura K, 2002, LAB INVEST, V82, P571, DOI 10.1038/labinvest.3780452; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Mao TK, 2005, HEPATOLOGY, V42, P802, DOI 10.1002/hep.20859; Morris JA, 2010, BIOINFORMATICS, V26, P1786, DOI 10.1093/bioinformatics/btq280; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2006, R LANG ENV STAT COMP, P14; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; SARMA V, 1992, J IMMUNOL, V148, P3302; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	28	354	365	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2011	43	4					329	U151		10.1038/ng.789	http://dx.doi.org/10.1038/ng.789			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21399635	Green Accepted, Green Submitted			2022-12-17	WOS:000288903700012
J	Ori, N; Cohen, AR; Etzioni, A; Brand, A; Yanai, O; Shleizer, S; Menda, N; Amsellem, Z; Efroni, I; Pekker, I; Alvarez, JP; Blum, E; Zamir, D; Eshed, Y				Ori, Naomi; Cohen, Aya Refael; Etzioni, Adi; Brand, Arnon; Yanai, Osnat; Shleizer, Sharona; Menda, Naama; Amsellem, Ziva; Efroni, Idan; Pekker, Irena; Alvarez, John Paul; Blum, Eyal; Zamir, Dani; Eshed, Yuval			Regulation of LANCEOLATE by miR319 is required for compound-leaf development in tomato	NATURE GENETICS			English	Article							MICRORNAS; GROWTH; MUTANT; LOCUS; GENE; MORPHOGENESIS; SHAPE; FORM	Plant leaves show pronounced plasticity of size and form. In the classical, partially dominant mutation Lanceolate ( La) 1, the large compound leaves of tomato (Solanum lycopersicum) are converted into small simple ones. We show that LA encodes a transcription factor from the TCP family(2,3) containing an miR319-binding site(4). Five independent La isolates are gain-offunction alleles that result from point mutations within the miR319-binding site and confer partial resistance of the La transcripts to microRNA (miRNA)-directed inhibition. The reduced sensitivity to miRNA regulation leads to elevated LA expression in very young La leaf primordia and to precocious differentiation of leaf margins. In contrast, downregulation of several LA-like genes using ectopic expression of miR319 resulted in larger leaflets and continuous growth of leaf margins. Our results imply that regulation of LA by miR319 defines a flexible window of morphogenetic competence along the developing leaf margin that is required for leaf elaboration.	Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Fac Agr, Otto Warburg Minerva Ctr Agr Biotechnol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science	Ori, N (corresponding author), Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, POB 12, IL-76100 Rehovot, Israel.	ori@agri.huji.ac.il; yuval.eshed@weizmann.ac.il	Menda, Naama/G-2915-2012	Eshed, Yuval/0000-0001-8290-0018; Efroni, Idan/0000-0002-0219-8685				Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; BOYNTON JE, 1965, TOMATO GENET COOP RE, V15, P24; CARUSO JL, 1968, AM J BOT, V55, P1169, DOI 10.2307/2440737; Chen JJ, 1997, PLANT CELL, V9, P1289, DOI 10.1105/tpc.9.8.1289; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; DENGLER NG, 1984, BOT GAZ, V145, P66, DOI 10.1086/337428; Dengler NG, 2001, INT J PLANT SCI, V162, P459, DOI 10.1086/320145; Hagemann W, 1996, PLANT SYST EVOL, V199, P121, DOI 10.1007/BF00984901; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Holtan HEE, 2003, GENETICS, V165, P1541; Kessler S, 2001, INT J PLANT SCI, V162, P475, DOI 10.1086/320136; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li CX, 2005, P NATL ACAD SCI USA, V102, P12978, DOI 10.1073/pnas.0504039102; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; LIFSCHYTZ E, 1969, GENETICS, V62, P353; MATHAN DS, 1960, SCIENCE, V131, P36, DOI 10.1126/science.131.3392.36; MATHAN DS, 1962, AM J BOT, V49, P504, DOI 10.2307/2439421; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Parnis A, 1997, PLANT CELL, V9, P2143, DOI 10.1105/tpc.9.12.2143; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Stadler LJ, 1930, J HERED, V21, P3, DOI 10.1093/oxfordjournals.jhered.a103249; STETTLER RF, 1964, AM J BOT, V51, P253, DOI 10.2307/2440294; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x	30	354	396	7	120	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					787	791		10.1038/ng2036	http://dx.doi.org/10.1038/ng2036			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17486095				2022-12-17	WOS:000246859100024
J	Ioannidis, JPA; Ntzani, EE; Trikalinos, TA				Ioannidis, JPA; Ntzani, EE; Trikalinos, TA			'Racial' differences in genetic effects for complex diseases	NATURE GENETICS			English	Article							POPULATION STRATIFICATION; CANCER; ASSOCIATIONS; VALIDITY; RACE	'Racial' differences are frequently debated in clinical, epidemiological and molecular research and beyond(1,2). In particular, there is considerable controversy regarding the existence and importance of 'racial' differences in genetic effects for complex diseases(3-6) influenced by a large number of genes(7). An important question is whether ancestry influences the impact of each gene variant on the disease risk. Here, we addressed this question by examining the genetic effects for 43 validated gene-disease associations across 697 study populations of various descents. The frequencies of the genetic marker of interest in the control populations often (58%) showed large heterogeneity (statistical variability) between 'races'. Conversely, we saw large heterogeneity in the genetic effects (odds ratios) between 'races' in only 14% of cases. Genetic markers for proposed gene-disease associations vary in frequency across populations, but their biological impact on the risk for common diseases may usually be consistent across traditional 'racial' boundaries.	Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina 45110, Greece; Tufts Univ, Sch Med, Tufts New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts Medical Center; Tufts University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ntzani, Evangelina E./K-1565-2019; Trikalinos, Thomas A/A-1217-2009; Ioannidis, John P. A./G-9836-2011	Ntzani, Evangelia/0000-0003-3712-4181				Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Feldman MW, 2003, NATURE, V424, P374, DOI 10.1038/424374a; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kaufman JS, 2001, AM J EPIDEMIOL, V154, P291, DOI 10.1093/aje/154.4.291; King MC, 2002, SCIENCE, V298, P2342, DOI 10.1126/science.1080373; Kressin NR, 2003, AM J PUBLIC HEALTH, V93, P1734, DOI 10.2105/AJPH.93.10.1734; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; PETTITI D, 1999, META ANAL DECISION A; Risch N, 2002, GENOME BIOL, V3, DOI [10.1186/GB-2002-3-7-COMMENT2007, DOI 10.1186/GB-2002-3-7-C0MMENT2007, 10.1186/gb-2002-3-7-comment2007]; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513	20	354	361	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1312	1318		10.1038/ng1474	http://dx.doi.org/10.1038/ng1474			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15543147				2022-12-17	WOS:000225354100020
J	Zaslaver, A; Mayo, AE; Rosenberg, R; Bashkin, P; Sberro, H; Tsalyuk, M; Surette, MG; Alon, U				Zaslaver, A; Mayo, AE; Rosenberg, R; Bashkin, P; Sberro, H; Tsalyuk, M; Surette, MG; Alon, U			Just-in-time transcription program in metabolic pathways	NATURE GENETICS			English	Article							RESPONSIVE REGULATORY PROTEIN; BACTERIAL-CELL-CYCLE; ESCHERICHIA-COLI; GENE-EXPRESSION; REGULATION NETWORK; OPTIMIZATION; KINETICS; SYSTEMS; ENZYMES	A primary goal of systems biology is to understand the design principles of the transcription networks that govern the timing of gene expression(1-5). Here we measured promoter activity for similar to100 genes in parallel from living cells at a resolution of minutes and accuracy of 10%, based on GFP and Lux reporter libraries(3). Focusing on the amino-acid biosynthesis systems of Escherichia coli 4, we identified a previously unknown temporal expression program and expression hierarchy that matches the enzyme order in unbranched pathways. We identified two design principles: the closer the enzyme is to the beginning of the pathway, the shorter the response time of the activation of its promoter and the higher its maximal promoter activity. Mathematical analysis suggests that this 'just-in-time' (ref. 5) transcription program is optimal under constraints of rapidly reaching a production goal with minimal total enzyme production(6,7). Our findings suggest that metabolic regulation networks are designed to generate precision promoter timing and activity programs that can be understood using the engineering principles of production pipelines.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada	Weizmann Institute of Science; Weizmann Institute of Science; University of Calgary	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	uri.alon@weizmann.ac.il	Surette, Michael G/AAE-8825-2020; MAYO, AVI E/K-1736-2012; mayo, avi/N-3756-2019	mayo, avi/0000-0002-4479-3423				Aizawa S, 1998, GENES CELLS, V3, P625, DOI 10.1046/j.1365-2443.1998.00219.x; CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994; CHARLIER D, 1992, J MOL BIOL, V226, P367, DOI 10.1016/0022-2836(92)90953-H; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; GILMAN A, 1995, BIOPHYS J, V69, P1321, DOI 10.1016/S0006-3495(95)79999-4; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HEINRICH R, 1991, EUR J BIOCHEM, V201, P1, DOI 10.1111/j.1432-1033.1991.tb16251.x; Heinrich R, 1996, J THEOR BIOL, V182, P243, DOI 10.1006/jtbi.1996.0161; Heinrich R., 1996, REGULATION CELLULAR; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Hung SP, 2002, J BIOL CHEM, V277, P40309, DOI 10.1074/jbc.M204044200; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Klipp E, 2002, EUR J BIOCHEM, V269, P5406, DOI 10.1046/j.1432-1033.2002.03223.x; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; LEGRAIN C, 1972, EUR J BIOCHEM, V27, P93, DOI 10.1111/j.1432-1033.1972.tb01814.x; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Oh MK, 2000, BIOTECHNOL PROGR, V16, P278, DOI 10.1021/bp000002n; PETTERSSON G, 1993, BIOCHIM BIOPHYS ACTA, V1164, P1, DOI 10.1016/0167-4838(93)90104-Y; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Savageau M, 1976, BIOCH SYSTEMS ANAL S; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881	30	354	358	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					486	491		10.1038/ng1348	http://dx.doi.org/10.1038/ng1348			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107854	Bronze			2022-12-17	WOS:000221183000021
J	Wasserman, WW; Palumbo, M; Thompson, W; Fickett, JW; Lawrence, CE				Wasserman, WW; Palumbo, M; Thompson, W; Fickett, JW; Lawrence, CE			Human-mouse genome comparisons to locate regulatory sites	NATURE GENETICS			English	Letter							SEQUENCE ALIGNMENT; GENE-EXPRESSION; REGIONS; MODELS; IDENTIFICATION; TRANSCRIPTION; RECOGNITION; EVOLUTION; NETWORK	Elucidating the human transcriptional regulatory network(1) is a challenge of the post-genomic era. Technical progress so far is impressive, including detailed understanding of regulatory mechanisms for at least a few genes in multicellular organisms(2-4), rapid and precise localization of regulatory regions within extensive regions of DNA by means of cross-species comparison(5-7), and de novo determination of transcription-factor binding specificities from large-scale yeast expression datas. Here we address two problems involved in extending these results to the human genome: first, it has been unclear how many model organism genomes will be needed to delineate most regulatory regions: and second, the discovery of transcription-factor binding sites (response elements) from expression data has not yet been generalized from single-celled organisms to multicellular organisms. We found that 98% (74/75) of experimentally defined sequence-specific binding sites of skeletal-muscle-specific transcription factors are confined to the 19% of human sequences that are most conserved in the orthologous rodent sequences. Also we found that in using this restriction, the binding specificities of all three major muscle-specific transcription factors (MYF. SRF and MEF2) can be computationally identified.	New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA; SmithKline Beecham Pharmaceut, Bioinformat Grp, King Of Prussia, PA 19406 USA	State University of New York (SUNY) System; Wadsworth Center; GlaxoSmithKline	Lawrence, CE (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Empire State Plaza,POB 509, Albany, NY 12237 USA.		Wasserman, Wyeth/I-4866-2015	Wasserman, Wyeth/0000-0001-6098-6412	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000981, R01HG001257] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG01257, R01 HG00981-03] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Agarwal P, 1996, J COMPUT BIOL, V3, P1, DOI 10.1089/cmb.1996.3.1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aparicio S, 1997, NAT GENET, V16, P79, DOI 10.1038/ng0597-79; Battey J, 1999, NAT GENET, V21, P73, DOI 10.1038/5012; Brickner AG, 1999, MAMM GENOME, V10, P95, DOI 10.1007/s003359900951; Duret L, 1997, CURR OPIN STRUC BIOL, V7, P399, DOI 10.1016/S0959-440X(97)80058-9; Fickett JW, 1997, GENOME RES, V7, P861, DOI 10.1101/gr.7.9.861; Fickett JW, 2000, CURR OPIN BIOTECH, V11, P19, DOI 10.1016/S0958-1669(99)00049-X; Harding K, 1997, AGRO FOOD IND HI TEC, V8, P8; HUANG XQ, 1990, COMPUT APPL BIOSCI, V6, P373; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KOOP BF, 1995, TRENDS GENET, V11, P367, DOI 10.1016/S0168-9525(00)89108-8; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liu JS, 1995, J AM STAT ASSOC, V90, P1156, DOI 10.2307/2291508; Liu JS, 1999, BIOINFORMATICS, V15, P38, DOI 10.1093/bioinformatics/15.1.38; ORKIN SH, 1995, EUR J BIOCHEM, V231, P271, DOI 10.1111/j.1432-1033.1995.tb20697.x; Qin WN, 1998, MOL CELL BIOCHEM, V184, P153, DOI 10.1023/A:1006807515892; Sankoff D, 1973, J Mol Biol, V77, P169; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tronche F, 1997, J MOL BIOL, V266, P231, DOI 10.1006/jmbi.1996.0760; Wasserman WW, 1998, J MOL BIOL, V278, P167, DOI 10.1006/jmbi.1998.1700; Werner T, 1999, MAMM GENOME, V10, P168, DOI 10.1007/s003359900963; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Zhu J, 1998, BIOINFORMATICS, V14, P25, DOI 10.1093/bioinformatics/14.1.25	30	354	373	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					225	228		10.1038/79965	http://dx.doi.org/10.1038/79965			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017083				2022-12-17	WOS:000089638800024
J	Weiss, KM; Terwilliger, JD				Weiss, KM; Terwilliger, JD			How many diseases does it take to map a gene with SNPs?	NATURE GENETICS			English	Editorial Material							SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN LIPOPROTEIN-LIPASE; TRANSCRIPTIONAL ACTIVITY; DROSOPHILA-MELANOGASTER; FUNCTIONAL GENOMICS; ALZHEIMER-DISEASE; CANDIDATE GENES; SEQUENCE; IDENTIFICATION; POPULATION		Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Columbia Univ, Dept Psychiat, Columbia Genome Ctr, New York, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Columbia University	Weiss, KM (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	kmw4@psu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058239] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 58239] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Artiga MJ, 1998, HUM MOL GENET, V7, P1887, DOI 10.1093/hmg/7.12.1887; Beckwith J. R., 1970, LACTOSE OPERON; BJERREGARD P, 1998, CIRCUMPOLAR INUIT HL; Bojko E R, 1997, Int J Circumpolar Health, V56, P134; Bojko E R, 1999, Int J Circumpolar Health, V58, P170; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Brent R, 1999, CURR BIOL, V9, pR338, DOI 10.1016/S0960-9822(99)80208-5; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Cole KA, 1999, NAT GENET, V21, P38, DOI 10.1038/4466; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Collins FS, 1999, ANN NY ACAD SCI, V882, P42, DOI 10.1111/j.1749-6632.1999.tb08532.x; Collins FS, 1999, GERIATRICS, V54, P41; Eaves IA, 2000, NAT GENET, V25, P320; EWENS WJ, 1978, AM J HUM GENET, V30, P328; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Garg K, 1999, GENOME RES, V9, P1087, DOI 10.1101/gr.9.11.1087; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Gragnoli C, 1997, DIABETES, V46, P1648, DOI 10.2337/diabetes.46.10.1648; Hall S, 1997, ARTERIOSCL THROM VAS, V17, P1969, DOI 10.1161/01.ATV.17.10.1969; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hatfield Frederick., 1993, HARDCORE BODYBUILDIN; HECKENLIVELY JR, 1996, EMORY RIMOINS PRINCI, P2555; HENDRICH BD, 1995, HUM MOL GENET, V4, P1765, DOI 10.1093/hmg/4.suppl_1.1765; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Irizarry K, 2000, NAT GENET, V26, P233, DOI 10.1038/79981; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Long AD, 1998, GENETICS, V149, P999; Mackay TFC, 1996, BIOESSAYS, V18, P113, DOI 10.1002/bies.950180207; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Martin ER, 2000, GENOMICS, V63, P7, DOI 10.1006/geno.1999.6057; McKusick V.A., 1998, MENDELIAN INHERITANC; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; NIKALI K, 1995, AM J HUM GENET, V56, P1088; Ott J, 2000, P NATL ACAD SCI USA, V97, P2, DOI 10.1073/pnas.97.1.2; Pastinen T, 1998, HUM MOL GENET, V7, P1453, DOI 10.1093/hmg/7.9.1453; Picoult-Newberg L, 1999, GENOME RES, V9, P167; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roberts L, 2000, SCIENCE, V287, P1898, DOI 10.1126/science.287.5460.1898; Rowell L, 1993, HUMAN CARDIOVASCULAR; RUSSO E, 2000, SCIENTIST, V14, P1; Sander C, 2000, SCIENCE, V287, P1977, DOI 10.1126/science.287.5460.1977; Sarkar S., 1998, GENETICS REDUCTIONIS; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; Schlichting CD., 1998, PHENOTYPIC EVOLUTION, DOI 10.1038/sj.hdy.688535; SCHLIEF R, 1986, GENETICS MOL BIOL; Scholtz CL, 1999, HUM MOL GENET, V8, P2025, DOI 10.1093/hmg/8.11.2025; Schork NJ, 1998, TRENDS GENET, V14, P266, DOI 10.1016/S0168-9525(98)01497-8; Shephard R.J., 1996, HLTH CONSEQUENCES MO, DOI [10.1017/CBO9780511983726, DOI 10.1017/CBO9780511983726]; Sing C, 1999, AM J HUM GENET, V65, pA14; Stam LF, 1996, GENETICS, V144, P1559; STEEL CM, 1996, EMORY RIMOINS PRINCI, P1501; TANG M, 1998, JAMA-J AM MED ASSOC, V2789, P751; Tang MX, 1996, AM J HUM GENET, V58, P574; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Terwilliger JD, 2000, HUM BIOL, V72, P63; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Terwilliger JD, 1998, HUM HERED, V48, P138, DOI 10.1159/000022794; TERWILLIGER JD, 2000, GENETIC DISSECTION C; TERWILLIGER JD, IN PRESS EUR J HUM G; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Trowell H. C., 1981, W DIS THEIR EMERGENC; Varilo T, 2000, EUR J HUM GENET, V8, P604, DOI 10.1038/sj.ejhg.5200482; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; WEISS K, IN PRESS THEOR POPUL; Weiss KM, 1996, MOL PHYLOGENET EVOL, V5, P259, DOI 10.1006/mpev.1996.0019; Weiss KM, 1998, GENOME RES, V8, P691, DOI 10.1101/gr.8.7.691; WEISS KM, 1999, GENETIC VARIATION HU; Woychik RP, 1998, MUTAT RES-FUND MOL M, V400, P3, DOI 10.1016/S0027-5107(98)00023-2; Zollner S, 2000, AM J HUM GENET, V66, P615, DOI 10.1086/302766	76	354	372	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2000	26	2					151	157		10.1038/79866	http://dx.doi.org/10.1038/79866			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017069				2022-12-17	WOS:000089638800010
J	Sauer, CG; Gehrig, A; WarnekeWittstock, R; Marquardt, A; Ewing, CC; Gibson, A; Lorenz, B; Jurklies, B; Weber, BHF				Sauer, CG; Gehrig, A; WarnekeWittstock, R; Marquardt, A; Ewing, CC; Gibson, A; Lorenz, B; Jurklies, B; Weber, BHF			Positional cloning of the gene associated with X-linked juvenile retinoschisis	NATURE GENETICS			English	Article							CELL-SURFACE PROTEIN; COAGULATION FACTOR-V; FACTOR-VIII; DICTYOSTELIUM-DISCOIDEUM; NERVOUS-SYSTEM; YAC CONTIG; SEQUENCE; CDNA; EXPRESSION; CHROMOSOME	X-linked juvenile retinoschisis (RS) is a recessively inherited vitreo-retinal degeneration characterized by macular pathology and intraretinal splitting of the retina. The RS gene has been localized to Xp22.2 to an approximately 1 Mb interval between DXS418 and DXS999/DXS7161. Mapping and expression analysis of expressed sequence tags have identified a novel transcript, designated XLRS1, within the centromeric RS locus that is exclusively expressed in retina. The predicted XLRS1 protein contains a highly conserved motif implicated in cell-cell interaction and thus may be active in cell adhesion processes during retinal development. Mutational analyses of XLRS1 in affected individuals from nine unrelated RS families revealed one nonsense, one frameshift, one splice acceptor and six missense mutations segregating with the disease phenotype in the respective families. These data provide strong evidence that the XLRS1 gene, when mutated, causes RS.	UNIV WURZBURG,INST HUMANGENET,D-97074 WURZBURG,GERMANY; UNIV SASKATCHEWAN,SASKATOON,SK S7K 0M7,CANADA; UNIV ESSEN GESAMTHSCH,AUGENKLIN,D-45147 ESSEN,GERMANY; UNIV REGENSBURG,AUGENKLIN,D-93042 REGENSBURG,GERMANY	University of Wurzburg; University of Saskatchewan; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg				Weber, Bernhard H.F./0000-0002-8808-7723				ALITALO T, 1987, CLIN GENET, V32, P192; ALITALO T, 1995, GENOMICS, V25, P691, DOI 10.1016/0888-7543(95)80012-B; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; ARAI M, 1989, J CLIN INVEST, V83, P1978, DOI 10.1172/JCI114107; ARDEN GB, 1988, AM J OPHTHALMOL, V105, P590; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P1256; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CONDON GP, 1986, ARCH OPHTHALMOL-CHIC, V104, P576, DOI 10.1001/archopht.1986.01050160132029; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CRIPE LD, 1992, BIOCHEMISTRY-US, V31, P3777, DOI 10.1021/bi00130a007; DEUTMAN AF, 1977, HEREDITARY RETINAL C, P1043; ELDER B, 1993, GENOMICS, V16, P374, DOI 10.1006/geno.1993.1200; Ewing C C, 1970, Trans Ophthalmol Soc U K, V89, P29; FELBOR U, IN PRESS HUM MUTAT; FERRERO GB, 1995, HUM MOL GENET, V4, P1821, DOI 10.1093/hmg/4.10.1821; FORSIUS H, 1973, CAN J OPHTHALMOL, V8, P385; Fukuzawa M, 1996, PLANT CELL PHYSIOL, V37, P505, DOI 10.1093/oxfordjournals.pcp.a028973; *GEN COMP GROUP, 1996, PROGR MAN WISC PACK; George NDL, 1996, ARCH OPHTHALMOL-CHIC, V114, P274, DOI 10.1001/archopht.1996.01100130270007; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; Haas J., 1898, ARCH AUGENHEILKD, V37, P343; Huopaniemi L, 1997, AM J HUM GENET, V60, P1139; IVES E J, 1970, American Journal of Human Genetics, V22, p17A; KANE WH, 1988, BLOOD, V71, P539; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; KAWANO K, 1981, GRAEFES ARCH CLIN EX, V217, P315; KELLNER U, 1990, GRAEF ARCH CLIN EXP, V228, P432, DOI 10.1007/BF00927256; KLJAVIN IJ, 1991, J NEUROSCI, V11, P2985; KOTANI E, 1995, BBA-GENE STRUCT EXPR, V1260, P245, DOI 10.1016/0167-4781(94)00202-E; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; LAROCCA D, 1991, CANCER RES, V51, P4994; MANSCHOT WA, 1972, ARCH OPHTHALMOL-CHIC, V88, P131; MILLER RF, 1970, J NEUROPHYSIOL, V33, P323, DOI 10.1152/jn.1970.33.3.323; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; NEHLS M, 1994, ONCOGENE, V9, P2169; PENOTTI FE, 1991, J THEOR BIOL, V150, P385, DOI 10.1016/S0022-5193(05)80436-9; PEREZ JL, 1994, ONCOGENE, V9, P211; Reichenbach Andreas, 1995, P395; ROMMENS JM, 1993, HUM MOL GENET, V2, P901, DOI 10.1093/hmg/2.7.901; ROSEN SD, 1973, P NATL ACAD SCI USA, V70, P2554, DOI 10.1073/pnas.70.9.2554; SHEFFIELD JB, 1987, AM ZOOL, V27, P145; SPRINGER WR, 1984, CELL, V39, P557, DOI 10.1016/0092-8674(84)90462-8; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; TAKAGI S, 1991, NEURON, V7, P295, DOI 10.1016/0896-6273(91)90268-5; TAKAGI S, 1995, DEV BIOL, V170, P207, DOI 10.1006/dbio.1995.1208; TRUETT MA, 1985, DNA-J MOLEC CELL BIO, V4, P333, DOI 10.1089/dna.1985.4.333; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; van de Vosse E, 1996, EUR J HUM GENET, V4, P101; WEBER BHF, 1995, CYTOGENET CELL GENET, V69, P35, DOI 10.1159/000133932; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WIEACKER P, 1983, HUM GENET, V64, P143, DOI 10.1007/BF00327111; YANOFF M, 1968, ARCH OPHTHALMOL-CHIC, V79, P49	52	354	379	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1997	17	2					164	170		10.1038/ng1097-164	http://dx.doi.org/10.1038/ng1097-164			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XZ555	9326935				2022-12-17	WOS:A1997XZ55500021
J	Nelson, CP; Goel, A; Butterworth, AS; Kanoni, S; Webb, TR; Marouli, E; Zeng, LY; Ntalla, I; Lai, FY; Hopewell, JC; Giannakopoulou, O; Jiang, T; Hamby, SE; Di Angelantonio, E; Assimes, TL; Bottinger, EP; Chambers, JC; Clarke, R; Palmer, CNA; Cubbon, RM; Ellinor, P; Ermel, R; Evangelou, E; Franks-, PW; Grace, C; Gu, DF; Hingorani, AD; Howson, JMM; Ingelsson, E; Kastrati, A; Kessler, T; Kyriakou, T; Lehtimaki, T; Lu, XF; Lu, YC; Marz, W; McPherson, R; Metspalu, A; Pujades-Rodriguez, M; Ruusalepp, A; Schadt, EE; Schmidt, AF; Sweeting, MJ; Zalloua, PA; AlGhalayini, K; Keavney, BD; Kooner, JS; Loos, RJF; Patel, RS; Rutter, MK; Tomaszewski, M; Tzoulaki, I; Zeggini, E; Erdmann-, J; Dedoussis, G; Bjorkegren, JLM; Schunkert, H; Farrall, M; Danesh, J; Samani, NJ; Watkins, H; Deloukas, P				Nelson, Christopher P.; Goel, Anuj; Butterworth, Adam S.; Kanoni, Stavroula; Webb, Tom R.; Marouli, Eirini; Zeng, Lingyao; Ntalla, Ioanna; Lai, Florence Y.; Hopewell, Jemma C.; Giannakopoulou, Olga; Jiang, Tao; Hamby, Stephen E.; Di Angelantonio, Emanuele; Assimes, Themistocles L.; Bottinger, Erwin P.; Chambers, John C.; Clarke, Robert; Palmer, Colin N. A.; Cubbon, Richard M.; Ellinor, Patrick; Ermel, Raili; Evangelou, Evangelos; Franks, Paul W.; Grace, Christopher; Gu, Dongfeng; Hingorani, Aroon D.; Howson, Joanna M. M.; Ingelsson, Erik; Kastrati, Adnan; Kessler, Thorsten; Kyriakou, Theodosios; Lehtimaki, Terho; Lu, Xiangfeng; Lu, Yingchang; Maerz, Winfried; McPherson, Ruth; Metspalu, Andres; Pujades-Rodriguez, Mar; Ruusalepp, Arno; Schadt, Eric E.; Schmidt, Amand F.; Sweeting, Michael J.; Zalloua, Pierre A.; AlGhalayini, Kamal; Keavney, Bernard D.; Kooner, Jaspal S.; Loos, Ruth J. F.; Patel, Riyaz S.; Rutter, Martin K.; Tomaszewski, Maciej; Tzoulaki, Ioanna; Zeggini, Eleftheria; Erdmann, Jeanette; Dedoussis, George; Bjorkegren, Johan L. M.; Schunkert, Heribert; Farrall, Martin; Danesh, John; Samani, Nilesh J.; Watkins, Hugh; Deloukas, Panos		EPIC-CVD Consortium; CardiogramplusC4D; Uk Biobank CardioMetab	Association analyses based on false discovery rate implicate new loci for coronary artery disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LOW-FREQUENCY; RISK LOCI; VARIANTS; ATHEROSCLEROSIS; ANNOTATION; DATABASE; RARE	Genome-wide association studies (GWAS) in coronary artery disease (CAD) had identified 66 loci at 'genome-wide significance' (P < 5 x 10(-8)) at the time of this analysis, but a much larger number of putative loci at a false discovery rate (FDR) of 5% (refs. 1-4). Here we leverage an interim release of UK Biobank (UKBB) data to evaluate the validity of the FDR approach. We tested a CAD phenotype inclusive of angina (SOFT; n(cases) = 10,801) as well as a stricter definition without angina (HARD; n(cases) = 6,482) and selected cases with the former phenotype to conduct a meta-analysis using the two most recent CAD GWAS(2,3). This approach identified 13 new loci at genome-wide significance, 12 of which were on our previous list of loci meeting the 5% FDR threshold(2), thus providing strong support that the remaining loci identified by FDR represent genuine signals. The 304 independent variants associated at 5% FDR in this study explain 21.2% of CAD heritability and identify 243 loci that implicate pathways in blood vessel morphogenesis as well as lipid metabolism, nitric oxide signaling and inflammation.	[Nelson, Christopher P.; Webb, Tom R.; Lai, Florence Y.; Hamby, Stephen E.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Nelson, Christopher P.; Webb, Tom R.; Lai, Florence Y.; Hamby, Stephen E.; Samani, Nilesh J.] Res Leicester Biomed Res Ctr, NIH, Leicester, Leics, England; [Goel, Anuj; Grace, Christopher; Kyriakou, Theodosios; Farrall, Martin; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Goel, Anuj; Butterworth, Adam S.; Grace, Christopher; Kyriakou, Theodosios; Farrall, Martin; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Butterworth, Adam S.; Jiang, Tao; Di Angelantonio, Emanuele; Howson, Joanna M. M.; Sweeting, Michael J.; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, MRC BHF, Cambridge, England; [Butterworth, Adam S.; Di Angelantonio, Emanuele; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England; [Kanoni, Stavroula; Marouli, Eirini; Ntalla, Ioanna; Giannakopoulou, Olga; Deloukas, Panos] Queen Mary Univ London, Barts & London Med Sch, William Harvey Res Inst, London, England; [Kanoni, Stavroula; Marouli, Eirini; Ntalla, Ioanna; Giannakopoulou, Olga; Deloukas, Panos] Queen Mary Univ London, Ctr Genom Hlth, London, England; [Zeng, Lingyao; Kastrati, Adnan; Kessler, Thorsten; Schunkert, Heribert] Clin Tech Univ Munchen, German Heart Ctr Munich, Partner Site Munich Heart Alliance, Munich, Germany; [Zeng, Lingyao; Kastrati, Adnan; Kessler, Thorsten; Schunkert, Heribert] DZHK, Partner Site Munich Heart Alliance, Munich, Germany; [Hopewell, Jemma C.; Clarke, Robert] Univ Oxford, Nuffield Dept Populat Hlth, CTSU, Oxford, England; [Assimes, Themistocles L.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Bottinger, Erwin P.; Lu, Yingchang; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Chambers, John C.; Evangelou, Evangelos; Tzoulaki, Ioanna] Imperial Coll London, Dept Epidemiol & Biostatist, London, England; [Chambers, John C.; Kooner, Jaspal S.] London North West Healthcare NHS Trust, Dept Cardiol, Southall, Middx, England; [Chambers, John C.; Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, London, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp, Biomed Res Inst, Mol & Clin Med, Dundee, Scotland; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp, Biomed Res Inst, Pharmacogen Ctr, Dundee, Scotland; [Cubbon, Richard M.] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England; [Ellinor, Patrick] Broad Inst Harvard & MIT, Cardiac Arrhythmia Serv, Boston, MA USA; [Ellinor, Patrick] Broad Inst Harvard & MIT, Cardiovasc Res Ctr, Boston, MA USA; [Ermel, Raili; Ruusalepp, Arno] Tartu Univ Hosp, Dept Cardiac Surg, Tartu, Estonia; [Evangelou, Evangelos; Tzoulaki, Ioanna] Univ Ioannina, Med Sch, Dept Hyg & Epidemiol, Ioannina, Greece; [Franks, Paul W.] Lund Univ, Skane Univ Hosp, Lund Univ Diabet Ctr, Dept Clin Sci,Genet & Mol Epidemiol Unit, Malmo, Sweden; [Franks, Paul W.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Franks, Paul W.] Umea Univ, Unit Med, Dept Publ Hlth & Clin Med, Umea, Sweden; [Gu, Dongfeng] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing, Peoples R China; [Hingorani, Aroon D.; Schmidt, Amand F.] UCL, Inst Cardiovasc Sci, London, England; [Ingelsson, Erik; Lu, Xiangfeng] Stanford Univ, Sch Med, Div Cardiovasc Med, Dept Med, Stanford, CA 94305 USA; [Lehtimaki, Terho] Univ Tampere, Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Lu, Yingchang] Vanderbilt Univ, Sch Med, Dept Med,Vanderbilt Ingram Canc Ctr, Divs Epidemiol,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Maerz, Winfried] Med Univ Graz, Clin Inst Med, Graz, Austria; [Maerz, Winfried] Med Univ Graz, Chem Lab Diagnost, Graz, Austria; [Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Med Clin Nephrol Rheumatol Hypertensiol Endocrino, Mannheim, Germany; [Maerz, Winfried] Academy Synlab Holding Deutschland GmbH, Mannheim, Germany; [McPherson, Ruth] Univ Ottawa, Heart Inst, Ruddy Canadian Cardiovasc Genet Ctr, Ottawa, ON, Canada; [Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Pujades-Rodriguez, Mar] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Ruusalepp, Arno; Bjorkegren, Johan L. M.] Clin Gene Networks AB, Stockholm, Sweden; [Schadt, Eric E.; Bjorkegren, Johan L. M.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Zalloua, Pierre A.] Lebanese Amer Univ, Sch Med, Beirut, Lebanon; [Zalloua, Pierre A.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [AlGhalayini, Kamal] King Abdulaziz Univ, Dept Med, Jeddah, Saudi Arabia; [Keavney, Bernard D.] Univ Manchester, Fac Biol Med & Hlth, Div Cardiovasc Sci, Manchester, Lancs, England; [Keavney, Bernard D.; Tomaszewski, Maciej] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Kooner, Jaspal S.] Imperial Coll London, Natl Heart & Lung Inst, Cardiovasc Sci, London, England; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth Dev Inst, New York, NY 10029 USA; [Patel, Riyaz S.] UCL, Farr Inst Hlth Informat, London, England; [Patel, Riyaz S.] St Bartholomews Hosp, Barts Heart Ctr, London, England; [Rutter, Martin K.] Univ Manchester, Fac Biol Med & Hlth, Div Diabet Endocrinol & Gastroenterol, Manchester, Lancs, England; [Rutter, Martin K.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Diabet Ctr, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Tomaszewski, Maciej] Manchester Acad Hlth Sci Ctr, Cent Manchester NHS Fdn Trust, Div Med, Manchester, Lancs, England; [Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Hinxton, England; [Erdmann, Jeanette] Univ Lubeck, Inst Cardiogenet, Lubeck, Germany; [Erdmann, Jeanette] DZHK, German Res Ctr Cardiovasc Res, Partner Site Hamburg Lubeck Kiel, Lubeck, Germany; [Erdmann, Jeanette] Univ Heart Ctr Lubeck, Lubeck, Germany; [Dedoussis, George] Harokopio Univ, Dept Nutr Dietet, Athens, Greece; [Bjorkegren, Johan L. M.] Karolinska Univ Sjukhuset, Karolinska Inst, Dept Med, Integrated Cardio Metab Ctr, Huddinge, Sweden; [Danesh, John] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia	University of Leicester; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; University of Cambridge; University of London; Queen Mary University London; University of London; Queen Mary University London; German Heart Centre Munich; Munich Heart Alliance; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Oxford; Stanford University; Icahn School of Medicine at Mount Sinai; Imperial College London; Imperial College London; University of Dundee; University of Dundee; University of Leeds; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Ioannina; Lund University; Skane University Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Umea University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of London; University College London; Stanford University; Tampere University; Tampere University; Vanderbilt University; Medical University of Graz; Medical University of Graz; Ruprecht Karls University Heidelberg; SYNLAB Group; University of Ottawa; University of Ottawa Heart Institute; University of Tartu; University of Leeds; Icahn School of Medicine at Mount Sinai; Lebanese American University; Harvard University; Harvard T.H. Chan School of Public Health; King Abdulaziz University; University of Manchester; University of Manchester; Imperial College London; Icahn School of Medicine at Mount Sinai; University of London; University College London; University of London; Queen Mary University London; University of Manchester; University of Manchester; University of Manchester; Wellcome Trust Sanger Institute; University of Lubeck; German Centre for Cardiovascular Research; Harokopio University Athens; Karolinska Institutet; Wellcome Trust Sanger Institute; King Abdulaziz University	Watkins, H (corresponding author), Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England.; Watkins, H (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	hugh.watkins@rdm.ox.ac.uk	DiAngelantonio, Emanuele/ABE-6852-2020; Webb, Tom/GMW-5311-2022; Webb, Tom/C-6237-2011; Loos, Ruth/GON-5877-2022; Erdmann, Jeanette/P-7513-2014; , Kastrati/Y-2389-2019; Tzoulaki, Ioanna/ABE-6269-2020; Lehtimäki, Terho/AAD-1094-2022; Evangelou, Evangelos/C-3033-2013; Franks, Paul/AAA-3300-2020; Study, GoDARTS/K-9448-2016; Kessler, Thorsten/AAI-7292-2021; Palmer, Colin NA/C-7053-2008; Kessler, Thorsten/O-7426-2015; Loos, Ruth J F/Q-2862-2016; Pujades-Rodriguez, Mar/T-1129-2018; Sweeting, Michael John/U-3917-2019; Kanoni, Stavroula/AAN-7161-2021; Assimes, Themistocles Leonard/D-9696-2015; Dedoussis, George/AAN-7252-2021; Schmidt, Amand Floriaan/G-6602-2017	Erdmann, Jeanette/0000-0002-4486-6231; Tzoulaki, Ioanna/0000-0002-4275-9328; Lehtimäki, Terho/0000-0002-2555-4427; Evangelou, Evangelos/0000-0002-5488-2999; Kessler, Thorsten/0000-0003-3326-1621; Palmer, Colin NA/0000-0002-6415-6560; Loos, Ruth J F/0000-0002-8532-5087; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Sweeting, Michael John/0000-0003-0980-8965; Kanoni, Stavroula/0000-0002-1691-9615; Assimes, Themistocles Leonard/0000-0003-2349-0009; Dedoussis, George/0000-0002-7798-6221; Schmidt, Amand Floriaan/0000-0003-1327-0424; Marouli, Eirini/0000-0001-6179-1609; Kyriakou, Theodosios/0000-0001-7794-8789; Franks, Paul/0000-0002-0520-7604; Howson, Joanna/0000-0001-7618-0050; Di Angelantonio, Emanuele/0000-0001-8776-6719; Goel, Anuj/0000-0003-2307-4021; Webb, Tom/0000-0001-5998-8226; Hingorani, Aroon/0000-0001-8365-0081; Rutter, Martin/0000-0001-6380-539X; Ruusalepp, Arno/0000-0001-5816-8613; Butterworth, Adam/0000-0002-6915-9015; Hopewell, Jemma/0000-0002-3870-8018; Deloukas, Panos/0000-0001-9251-070X; Nelson, Christopher/0000-0001-8025-2897; Tomaszewski, Maciej/0000-0001-8215-6567; Giannakopoulou, Olga/0000-0001-8611-2094; Keavney, Bernard/0000-0001-9573-0812	British Heart Foundation (BHF) [RG/14/5/30893, FS/14/66/31293]; UK National Institute for Health Research (NIHR); NIHR; BHF; Transatlantic Networks of Excellence Award from the Leducq Foundation [12CVD02]; EU-FP7 [HEALTH-F2-2013-601456, 201668, 305739, HEALTH-F2-2012-279233]; EU-FP6 [LSHM-CT-2007-037273]; AstraZeneca; Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Heart-Lung Foundation; Torsten and Ragnar Soderberg Foundation; Karolinska Institutet; Foundation Strategic Research; Stockholm County Council [560283]; Wellcome Trust [090532/Z/09/Z, 084723/Z/08/Z, 098051]; Deutsche Forschungsgemeinschaft Centre of Research Excellence [Sonderforschungsbereich CRC 1123 (B02)]; FP7 [HEALTH-F2-2013-601456]; Wellcome Trust; TriPartite Immunometabolism Consortium-Novo Nordisk Foundation [NNF15CC0018486]; Medical Research Council (MRC); Merck and Co; Roche Vitamins, Ltd.; BHF [FS/14/55/30806, SP/04/002, PG/16/49/32176, FS/12/80/29821, SP/09/002]; Andrea and Charles Bronfman Philanthropies; European Commission [CoG-2015_681742_NASCENT]; Swedish Research Council (Distinguished Young Researchers Award); Heart-Lung Foundation; Novo Nordisk Foundation; Canadian Institutes of Health Research; Canada Foundation for Innovation; Heart AMP; Stroke Foundation of Canada; European Regional Development Fund (ERDF); Wissenschaftsoffensive TMO; German Ministry for Education and Research [01ZX1313A-K]; NIHR-BRC Imperial College Healthcare NHS Trust; MRC [G0601966, G0700931, G0800270]; NIHR [RP-PG-0407-10371]; EU-FP7 (EpiMigrant) [279143]; Action on Hearing Loss [G51]; EU-FP7 (AtheroRemo) [201668]; Tampere University Foundation; Tampere University Hospital Medical Funds [9M048, 9N035]; Emil Aaltonen Foundation; Finnish Foundation of Cardiovascular Research; Pirkanmaa Regional Fund of the Finnish Cultural Foundation; Yrjo Jahnsson Foundation; Tampere Tuberculosis Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of the Finnish Diabetes Association; NIHR-BRC Cambridge; European Research Council (ERC) [268834]; Pfizer; Merck; Biogen; University of Cambridge; ERC [268834]; Estonian Research Council; EPIC-CVD Coordinating Centre team; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER; British Heart Foundation [RG/10/12/28456, RG/08/014/24067, FS/12/80/29821, FS/14/76/30933, RG/14/5/30893, RG/15/12/31616, PG/12/32/29544] Funding Source: researchfish; Medical Research Council [G0800270, MR/L003120/1, G0601966, G0700931, MC_qA137853] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10091, NF-SI-0512-10165, CL-2011-11-003, NF-SI-0611-10170] Funding Source: researchfish; Novo Nordisk Fonden [NNF15SA0018486] Funding Source: researchfish; MRC [MR/N011775/1, MR/L003120/1] Funding Source: UKRI	British Heart Foundation (BHF)(British Heart Foundation); UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); BHF(British Heart Foundation); Transatlantic Networks of Excellence Award from the Leducq Foundation; EU-FP7(European Commission); EU-FP6(European Commission); AstraZeneca(AstraZeneca); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Torsten and Ragnar Soderberg Foundation; Karolinska Institutet(Karolinska Institutet); Foundation Strategic Research; Stockholm County Council(Stockholm County Council); Wellcome Trust(Wellcome Trust); Deutsche Forschungsgemeinschaft Centre of Research Excellence(German Research Foundation (DFG)); FP7; Wellcome Trust(Wellcome Trust); TriPartite Immunometabolism Consortium-Novo Nordisk Foundation; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Merck and Co(Merck & Company); Roche Vitamins, Ltd.; BHF(British Heart Foundation); Andrea and Charles Bronfman Philanthropies; European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council (Distinguished Young Researchers Award)(Swedish Research Council); Heart-Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart AMP; Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); European Regional Development Fund (ERDF)(European Commission); Wissenschaftsoffensive TMO; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); NIHR-BRC Imperial College Healthcare NHS Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); EU-FP7 (EpiMigrant); Action on Hearing Loss; EU-FP7 (AtheroRemo); Tampere University Foundation; Tampere University Hospital Medical Funds; Emil Aaltonen Foundation; Finnish Foundation of Cardiovascular Research; Pirkanmaa Regional Fund of the Finnish Cultural Foundation; Yrjo Jahnsson Foundation; Tampere Tuberculosis Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of the Finnish Diabetes Association; NIHR-BRC Cambridge; European Research Council (ERC)(European Research Council (ERC)European Commission); Pfizer(Pfizer); Merck(Merck & Company); Biogen(Biogen); University of Cambridge(University of Cambridge); ERC(European Research Council (ERC)European Commission); Estonian Research Council(Estonian Research Council); EPIC-CVD Coordinating Centre team; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by British Heart Foundation (BHF) grants RG/14/5/30893 to P.D. and FS/14/66/31293 to O.G. The work of P.D. forms part of the research themes contributing to the translational research portfolios of the Barts Biomedical Research Centre and Leicester Biomedical Research Centre funded by the UK National Institute for Health Research (NIHR). F.Y.L. and S.E.H. are funded by NIHR. C.P.N., T.R.W. and N.J.S. are funded from BHF, the Transatlantic Networks of Excellence Award (12CVD02) from the Leducq Foundation and EU-FP7/2007-2013 grant HEALTH-F2-2013-601456. N.J.S. is an NIHR Senior Investigator. PROCARDIS was supported by EU-FP6 (LSHM-CT-2007-037273), AstraZeneca, BHF, the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Swedish Heart-Lung Foundation, the Torsten and Ragnar Soderberg Foundation, Karolinska Institutet, Foundation Strategic Research and the Stockholm County Council (560283). M.F. and H.W. are supported by Wellcome Trust award 090532/Z/09/Z, and M.F., H.W. and T.K. are supported by the BHF Centre of Research Excellence. A.G., H.W. and T.K. are supported by FP7/2007-2013 (HEALTH-F2-2013-601456 (CVGenes@Target)), and A.G. is supported by the Wellcome Trust and the TriPartite Immunometabolism Consortium-Novo Nordisk Foundation (NNF15CC0018486). HPS (ISRCTN48489393) was supported by the Medical Research Council (MRC), BHF, Merck and Co, and Roche Vitamins, Ltd. HPS acknowledges National Blood Service donor and UK-Twin Study controls (Wellcome Trust 07611, FP7/2007-2013). J.C.H. is funded by BHF (FS/14/55/30806). The Mount Sinai BioMe Biobank is supported by the Andrea and Charles Bronfman Philanthropies. The GLACIER Study and P.W.F. are funded by the European Commission (CoG-2015_681742_NASCENT), the Swedish Research Council (Distinguished Young Researchers Award), the Heart-Lung Foundation and the Novo Nordisk Foundation. OHGS studies were funded by the Canadian Institutes of Health Research, the Canada Foundation for Innovation and the Heart & Stroke Foundation of Canada. LURIC was funded from the EU-FP7 (Atheroremo (201668), RiskyCAD (305739), INTERREG IV Oberrhein Program), the European Regional Development Fund (ERDF), Wissenschaftsoffensive TMO and from the German Ministry for Education and Research, project e: AtheroSysMed (01ZX1313A-K). LOLIPOP is supported by the NIHR-BRC Imperial College Healthcare NHS Trust, BHF (SP/04/002), MRC (G0601966, G0700931), the Wellcome Trust (084723/Z/08/Z), NIHR (RP-PG-0407-10371), EU-FP7 (EpiMigrant, 279143) and Action on Hearing Loss (G51). The Helsinki Sudden Death Study was funded by EU-FP7 (201668, AtheroRemo), the Tampere University Foundation, Tampere University Hospital Medical Funds (grants 9M048 and 9N035 for T.L.), the Emil Aaltonen Foundation (T.L.), the Finnish Foundation of Cardiovascular Research (T.L., P.K.), the Pirkanmaa Regional Fund of the Finnish Cultural Foundation, the Yrjo Jahnsson Foundation, the Tampere Tuberculosis Foundation (T. L.), the Signe and Ane Gyllenberg Foundation (T. L.) and the Diabetes Research Foundation of the Finnish Diabetes Association (T. L.). M.T. (PG/16/49/32176) and R.C. (FS/12/80/29821) are supported by BHF. E.Z. acknowledges Wellcome Trust funding (098051). H.S. was supported by Deutsche Forschungsgemeinschaft (Sonderforschungsbereich CRC 1123 (B02)). The MRC/BHF Cardiovascular Epidemiology Unit was funded by MRC (G0800270), BHF (SP/09/002), NIHR-BRC Cambridge, the European Research Council (ERC; 268834), EU-FP7 (HEALTH-F2-2012-279233), Pfizer, Merck and Biogen.; r EPIC-CVD was supported by the University of Cambridge, EU-FP7 (HEALTH-F2-2012-279233), MRC (G0800270), BHF (SP/09/002) and ERC (268834). We thank all EPIC participants and staff and S. Spackman. EGCUT was funded by the Estonian Research Council grant for data management and the EPIC-CVD Coordinating Centre team. (IUT20-60), the Centre of Excellence in Genomics and Translational Medicine (GENTRANSMED), EU structural fund (Archimedes Foundation; 3.2.1001.11-0033), PerMed I and EU2020 (692145 ePerMed). This research was supported by BHF (SP/13/2/30111) and conducted using the UK Biobank Resource (application number 9922).	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Babaev VR, 2008, ATHEROSCLEROSIS, V197, P534, DOI 10.1016/j.atherosclerosis.2007.08.015; Bigdeli TB, 2016, BIOINFORMATICS, V32, P2598, DOI 10.1093/bioinformatics/btw303; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Danesh J, 2007, EUR J EPIDEMIOL, V22, P129, DOI 10.1007/s10654-006-9096-8; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Franzen O, 2016, SCIENCE, V353, P827, DOI 10.1126/science.aad6970; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Howson JMM, 2017, NAT GENET, V49, P1113, DOI 10.1038/ng.3874; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kukreja RC, 2012, J AM COLL CARDIOL, V59, P1921, DOI 10.1016/j.jacc.2011.09.086; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Munoz M, 2016, NAT GENET, V48, P980, DOI 10.1038/ng.3618; Nanda V, 2016, CIRC RES, V118, P230, DOI 10.1161/CIRCRESAHA.115.307906; Newson R., 2013, QQVALUE STATA MODULE; Newson R, 2003, STATA J, V3, P109, DOI 10.1177/1536867X0300300202; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pirinen M, 2012, NAT GENET, V44, P848, DOI 10.1038/ng.2346; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Rohwedder I, 2012, EMBO MOL MED, V4, P564, DOI 10.1002/emmm.201200237; Samson T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055202; Skipper M, 2015, NATURE, V518, P313, DOI 10.1038/518313a; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Stitziel NO., 2016, NEW ENGL J MED, V374, P1134; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Townsend N, 2015, CARDIOVASCULAR DIS S; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Webb TR., 2017, J AM COLL CARDIOL, V69, P823; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213	39	353	358	3	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2017	49	9					1385	+		10.1038/ng.3913	http://dx.doi.org/10.1038/ng.3913			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FF1PS	28714975	Green Accepted, Green Submitted			2022-12-17	WOS:000408672000017
J	Le, WD; Xu, PY; Jankovic, J; Jiang, H; Appel, SH; Smith, RG; Vassilatis, DK				Le, WD; Xu, PY; Jankovic, J; Jiang, H; Appel, SH; Smith, RG; Vassilatis, DK			Mutations in NR4A2 associated with familial Parkinson disease	NATURE GENETICS			English	Article							RECEPTOR NURR1 GENE; NURR1-DEFICIENT MICE; NEURONS; IDENTIFICATION; TRANSCRIPTION; ORGANIZATION; LOCALIZATION; EXPRESSION; PROMOTER; AGENESIS	NR4A2, encoding a member of nuclear receptor superfamily 1, is essential for the differentiation of the nigral dopaminergic neurons(2-4). To determine whether NR4A2 is a susceptibility gene for Parkinson disease, we carried out genetic analyses in 201 individuals affected with Parkinson disease and 221 age-matched unaffected controls. We identified two mutations in NR4A2 associated with Parkinson disease (-291Tdel and -245T-->G), which map to the first exon of NR4A2 and affect one allele in 10 of 107 individuals with familial Parkinson disease but not in any individuals with sporadic Parkinson disease (n = 94) or in unaffected controls (n = 221). The age at onset of disease and clinical features of these ten individuals were not different from those of individuals with typical Parkinson disease. The mutations resulted in a marked decrease in NR4A2 mRNA levels in transfected cell lines and in lymphocytes of affected individuals. Additionally, mutations in NR4A2 affect transcription of the gene encoding tyrosine hydroxylase. These data suggest that mutations in NR4A2 can cause dopaminergic dysfunction, associated with Parkinson disease.	Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Le, WD (corresponding author), Baylor Coll Med, Dept Neurol, 1 Baylor Plaza, Houston, TX 77030 USA.	Weidongl@bcm.tmc.edu						Buervenich S, 2000, AM J MED GENET, V96, P808, DOI 10.1002/1096-8628(20001204)96:6<808::AID-AJMG23>3.0.CO;2-E; Castillo SO, 1997, GENOMICS, V41, P250, DOI 10.1006/geno.1997.4677; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Chen YH, 2001, AM J MED GENET, V105, P753, DOI 10.1002/ajmg.10036; Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; Healy DG, 2002, MOVEMENT DISORD, V17, pS34; Hicks AA, 2002, ANN NEUROL, V52, P549, DOI 10.1002/ana.10324; Ichinose H, 1999, GENE, V230, P233, DOI 10.1016/S0378-1119(99)00065-7; Iwawaki T, 2000, BIOCHEM BIOPH RES CO, V274, P590, DOI 10.1006/bbrc.2000.3204; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Langston JW, 1998, ANN NEUROL, V44, pS45, DOI 10.1002/ana.410440707; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Le W, 1999, J NEUROCHEM, V73, P2218; Le WD, 1999, EXP NEUROL, V159, P451, DOI 10.1006/exnr.1999.7191; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; MAGES HW, 1994, MOL ENDOCRINOL, V8, P1583, DOI 10.1210/me.8.11.1583; MARTIN ED, 2001, JAMA-J AM MED ASSOC, V286, P2239; Nataraj AJ, 1999, ELECTROPHORESIS, V20, P1177, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1177::AID-ELPS1177>3.0.CO;2-2; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sacchetti P, 2001, J NEUROCHEM, V76, P1565, DOI 10.1046/j.1471-4159.2001.00181.x; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; SaucedoCardenas O, 1996, J MOL NEUROSCI, V7, P51, DOI 10.1007/BF02736848; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; Torii T, 1999, GENE, V230, P225, DOI 10.1016/S0378-1119(99)00064-5; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Van Duijn CM, 2001, AM J HUM GENET, V69, P505; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	30	353	381	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2003	33	1					85	89		10.1038/ng1066	http://dx.doi.org/10.1038/ng1066			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12496759				2022-12-17	WOS:000180136100023
J	Cho, RJ; Huang, MX; Campbell, MJ; Dong, HL; Steinmetz, L; Sapinoso, L; Hampton, G; Elledge, SJ; Davis, RW; Lockhart, DJ				Cho, RJ; Huang, MX; Campbell, MJ; Dong, HL; Steinmetz, L; Sapinoso, L; Hampton, G; Elledge, SJ; Davis, RW; Lockhart, DJ			Transcriptional regulation and function during the human cell cycle	NATURE GENETICS			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; THYMOCYTE APOPTOSIS; BINDING; EXPRESSION; PROTEIN; GENE; FAMILY; KINASE; DEATH; RHO	We report here the transcriptional profiling of the cell cycle on a genome-wide scale in human fibroblasts. We identified approximately 700 genes that display transcriptional fluctuation with a periodicity consistent with that of the cell cycle. Systematic analysis of these genes revealed functional organization within groups of coregulated transcripts. A diverse set of cytoskeletal reorganization genes exhibit cell-cycle-dependent regulation, indicating that biological pathways are redirected for the execution of cell division. Many genes involved in cell motility and remodeling of the extracellular matrix are expressed predominantly in M phase, indicating a mechanism for balancing proliferative and invasive cellular behavior. Transcripts upregulated during S phase displayed extensive overlap with genes induced by DNA damage; cell-cycle-regulated transcripts may therefore constitute coherent programs used in response to external stimuli. Our data also provide clues to biological function for hundreds of previously uncharacterized human genes.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Biochem & Mol Biol, Dept Mol & Human Genet, Houston, TX 77030 USA; Affymetrix Inc, Santa Clara, CA USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA USA; Mol Applicat Grp, Palo Alto, CA USA; Novartis Res Fdn, Genomics Inst, San Diego, CA USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Stanford University; Baylor College of Medicine; Howard Hughes Medical Institute; Affymetrix; Stanford University; Novartis; Salk Institute	Campbell, MJ (corresponding author), Celera Genomics, Foster City, CA USA.	michael.campbell@fc.celera.com	Cho, Raymond/AAO-8125-2020	Cho, Raymond/0000-0001-6090-6603; Steinmetz, Lars/0000-0002-3962-2865				Arai M, 1999, DEV DYNAM, V215, P297, DOI 10.1002/(SICI)1097-0177(199908)215:4<297::AID-AJA2>3.3.CO;2-9; Assmann V, 1999, J CELL SCI, V112, P3943; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P1421; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B; Farrance IKG, 1996, J BIOL CHEM, V271, P8266, DOI 10.1074/jbc.271.14.8266; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gil-Gomez G, 1998, EMBO J, V17, P7209, DOI 10.1093/emboj/17.24.7209; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Hakem A, 1999, J EXP MED, V189, P957, DOI 10.1084/jem.189.6.957; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; Kosaki R, 1999, CANCER RES, V59, P1141; Law SF, 2000, MOL CELL BIOL, V20, P5184, DOI 10.1128/MCB.20.14.5184-5195.2000; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Lind EF, 1999, J IMMUNOL, V162, P5374; Liu KY, 1999, MOL CELL BIOL, V19, P3696; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Martin LG, 1998, J VIROL, V72, P975, DOI 10.1128/JVI.72.2.975-985.1998; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; Moorman JP, 1996, J IMMUNOL, V156, P4146; Nasmyth K, 1996, SCIENCE, V274, P1643, DOI 10.1126/science.274.5293.1643; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; North AJ, 1999, J CELL SCI, V112, P4325; O'Connell CB, 1999, J CELL BIOL, V144, P305, DOI 10.1083/jcb.144.2.305; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Radhakrishna H, 1999, J CELL SCI, V112, P855; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Sanchez I, 1996, CURR OPIN CELL BIOL, V8, P318, DOI 10.1016/S0955-0674(96)80004-4; SATO N, 1992, J CELL SCI, V103, P131; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wei MC, 2000, GENE DEV, V14, P2060; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469	51	353	365	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					48	54		10.1038/83751	http://dx.doi.org/10.1038/83751			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11137997				2022-12-17	WOS:000166187900014
J	Wilson, CA; Ramos, L; Villasenor, MR; Anders, KH; Press, MF; Clarke, K; Karlan, B; Chen, JJ; Scully, R; Livingston, D; Zuch, RH; Kanter, MH; Cohen, S; Calzone, FJ; Slamon, DJ				Wilson, CA; Ramos, L; Villasenor, MR; Anders, KH; Press, MF; Clarke, K; Karlan, B; Chen, JJ; Scully, R; Livingston, D; Zuch, RH; Kanter, MH; Cohen, S; Calzone, FJ; Slamon, DJ			Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas	NATURE GENETICS			English	Article							CANCER SUSCEPTIBILITY GENE; EARLY-ONSET BREAST; OVARIAN-CANCER; SUBCELLULAR-LOCALIZATION; NUCLEAR PHOSPHOPROTEIN; MUTATIONS; EXPRESSION; POLYMORPHISMS; FAMILIES; LOCATION	Although the link between the BRCA1 tumour-suppressor gene and hereditary breast and ovarian cancer is established(1-5), the role, if any, of BRCA1 in non-familial cancers is unclear. BRCA1 mutations are rare in sporadic cancers(6-8), but loss of BRCA1 resulting from reduced expression or incorrect subcellular localization(9,10) is postulated to be important in non-familial breast and ovarian cancers. Epigenetic loss, however, has not received general acceptance due to controversy regarding the subcellular localization of BRCA1 proteins, reports of which have ranged from exclusively nuclear(11-15), to conditionally nuclear(10), to the ER/golgi(16), to cytoplasmic invaginations into the nucleus(17). In an attempt to resolve this issue, we have comprehensively characterized 19 anti-BRCA1. antibodies. These reagents detect a 220-kD protein localized in discrete nuclear foci in all epithelial cell lines, including those derived from breast malignancies. Immunohistochemical staining of human breast specimens also revealed BRCA1 nuclear foci in benign breast, invasive lobular cancers and low-grade ductal carcinomas. Conversely, BRCA1 expression was reduced or undetectable in the majority of high-grade, ductal carcinomas, suggesting that absence of BRCA1 may contribute to the pathogenesis of a significant percentage of sporadic breast cancers.	Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; So Calif Permanente Med Grp, Dept Pathol, Woodland Hills, CA 91365 USA; Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA; Dana Farber Canc Inst, Charles A Dana Div Human Canc Genet, Boston, MA 02115 USA; Amgen Inc, Amgen Ctr, Thousand Oaks, CA 91320 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups; University of Southern California; Harvard University; Dana-Farber Cancer Institute; Amgen	Slamon, DJ (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA.	dslamon@med1.medsch.ucla.edu	Scully, Ralph/F-5008-2013		NATIONAL CANCER INSTITUTE [R01CA036827] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA36827] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Chen YM, 1996, CANCER RES, V56, P3168; CHEN YM, 1995, SCIENCE, V270, P789, DOI 10.1126/science.270.5237.789; Coene E, 1997, NAT GENET, V16, P122, DOI 10.1038/ng0697-122; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; Dobrovic A, 1997, CANCER RES, V57, P3347; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1992, CANCER RES, V52, P2624; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; Jensen RA, 1996, NAT GENET, V12, P303, DOI 10.1038/ng0396-303; Mancini DN, 1998, ONCOGENE, V16, P1161, DOI 10.1038/sj.onc.1201630; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Ruffner H, 1997, P NATL ACAD SCI USA, V94, P7138, DOI 10.1073/pnas.94.14.7138; RUSSELL SEH, 1990, ONCOGENE, V5, P1581; Schmutzler RK, 1997, INT J CANCER, V74, P322, DOI 10.1002/(SICI)1097-0215(19970620)74:3<322::AID-IJC15>3.3.CO;2-J; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1996, SCIENCE, V272, P123, DOI 10.1126/science.272.5258.123; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SLAMON DJ, 1986, SCIENCE, V232, P768, DOI 10.1126/science.3008339; Thakur S, 1997, MOL CELL BIOL, V17, P444, DOI 10.1128/MCB.17.1.444; Thomas JE, 1996, J BIOL CHEM, V271, P28630, DOI 10.1074/jbc.271.45.28630; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Wilson CA, 1996, NAT GENET, V13, P264, DOI 10.1038/ng0796-264; Wilson CA, 1997, ONCOGENE, V14, P1, DOI 10.1038/sj.onc.1200924	27	353	364	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1999	21	2					236	240		10.1038/6029	http://dx.doi.org/10.1038/6029			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	9988281				2022-12-17	WOS:000078399500031
J	Huang, SR; Li, BM; Gray, MD; Oshima, J; Mian, SI; Campisi, J				Huang, SR; Li, BM; Gray, MD; Oshima, J; Mian, SI; Campisi, J			The premature ageing syndrome protein, WRN, is a 3 '-> 5 ' exonuclease	NATURE GENETICS			English	Letter							WERNER-SYNDROME; CELLS; HELICASE; INVITRO; DISEASE		Univ Calif Berkeley, Lawrence Berkeley Lab, Div Cell & Mol Biol, Berkeley, CA 94720 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Radiat Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Campisi, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Cell & Mol Biol, Berkeley, CA 94720 USA.				NIA NIH HHS [AG05776, AG11658, R01 AG011658, AG14446, F32 AG005776] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG014446, F32AG005776, R01AG011658] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CHENG RZ, 1990, MUTAT RES, V237, P259, DOI 10.1016/0921-8734(90)90008-F; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Goto M, 1997, MECH AGEING DEV, V98, P239, DOI 10.1016/S0047-6374(97)00111-5; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; MAIN IS, 1997, NUCLEIC ACIDS RES, V25, P3187; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; MARTIN GM, 1970, LAB INVEST, V23, P86; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; Ogburn CE, 1997, HUM GENET, V101, P121, DOI 10.1007/s004390050599; SALK D, 1985, ADV EXP MED BIOL, V190, P305; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	14	353	358	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					114	116		10.1038/2410	http://dx.doi.org/10.1038/2410			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771700	Green Accepted			2022-12-17	WOS:000076231300009
J	Macchia, PE; Lapi, P; Krude, H; Pirro, MT; Missero, C; Chiovato, L; Souabni, A; Baserga, M; Tassi, V; Pinchera, A; Fenzi, G; Gruters, A; Busslinger, M; Di Lauro, R				Macchia, PE; Lapi, P; Krude, H; Pirro, MT; Missero, C; Chiovato, L; Souabni, A; Baserga, M; Tassi, V; Pinchera, A; Fenzi, G; Gruters, A; Busslinger, M; Di Lauro, R			PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis	NATURE GENETICS			English	Article							PAIRED DOMAIN; GENES; TRANSCRIPTION; RECOGNITION; ISOFORMS; PROTEINS; SITE	Permanent congenital hypothyroidism (CH) is a common disease that occurs in 1 of 3,000-4,000 newborns. Except in rare cases due to hypothalamic or pituitary defects, CH is characterized by elevated levels of thyroid-stimulating hormone (TSH) resulting from reduced thyroid function. When thyroid hormone therapy is not initiated within the first two months of life, CH can cause severe neurological, mental and motor damage(1,2). In 80-85% of cases, CH is associated with and presumably is a consequence of thyroid dysgenesis (TD). In these cases, the thyroid gland can be absent (agenesis, 35-40%), ectopically located (30-45%) and/or severely reduced in size (hypoplasia, 5%), Familial cases of TD are rare, even though ectopic or absent thyroid has been occasionally observed in siblings(3). The pathogenesis of TD is still largely unknown. Although a genetic component has been suggested, mutations in the gene encoding the receptor for the thyroid-stimulating hormone (TSHR) have been identified in only two cases of TD with hypoplasia(4,5). We report mutations in the coding region of PAX8 in two sporadic patients and one familial case of TD. All three point mutations are located in the paired domain of PAX8 and result in severe reduction of the DNA-binding activity of this transcription factor. These genetic alterations implicate PAX8 in the pathogenesis of TD and in normal thyroid development.	Staz Zool A Dohrn, Naples, Italy; Univ Pisa, Ist Endocrinol, Pisa, Italy; Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Reggio Calabria, Fac Med & Chirurg Catanzaro, Cattedra Pediat, Calabria, Italy; Ist Sci Casa Sollievo Sofferenza, Div Unita Ric Endocrinol, San Giovanni Rotondo, Italy; Univ Naples Federico II, Cattedra Endocrinol, Naples, Italy; Humboldt Univ, Virchow Klinikum, Klin & Poliklin Kinderheilkunde, Berlin, Germany	Stazione Zoologica Anton Dohrn di Napoli; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Pisa; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Universita Mediterranea di Reggio Calabria; IRCCS Casa Sollievo Della Sofferenza; University of Naples Federico II; Humboldt University of Berlin	Di Lauro, R (corresponding author), Staz Zool A Dohrn, Naples, Italy.	rdilauro@unina.it	Macchia, Paolo Emidio/B-7391-2012; Chiovato, Luca/K-6617-2016; Di Lauro, Roberto/A-2746-2012; Busslinger, Meinrad J./J-1249-2016; Macchia, Paolo Emidio/AGZ-2839-2022; chiovato, luca/AAC-9003-2019	Macchia, Paolo Emidio/0000-0001-6503-6942; Chiovato, Luca/0000-0001-7457-7353; Di Lauro, Roberto/0000-0001-9493-3036; Busslinger, Meinrad J./0000-0002-9111-9351; Macchia, Paolo Emidio/0000-0001-6503-6942; Tassi, Vittorio/0000-0003-3536-4480; Missero, Caterina/0000-0003-0905-5123	Telethon [D.067, E.0254] Funding Source: Medline	Telethon(Fondazione Telethon)		Abramowicz MJ, 1997, J CLIN INVEST, V99, P3018, DOI 10.1172/JCI119497; ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Biebermann H, 1997, J CLIN ENDOCR METAB, V82, P3471, DOI 10.1210/jc.82.10.3471; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; DUSSAULT JH, 1975, J PEDIATR-US, V86, P670, DOI 10.1016/S0022-3476(75)80349-0; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P576, DOI 10.1128/MCB.12.2.576; GLORIEUX J, 1985, J PEDIATR-US, V107, P913, DOI 10.1016/S0022-3476(85)80187-6; GRUTERS A, 1996, BAILLIERE CLIN PAEDI, V4, P1; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Mckusick V.A., 1994, MENDELIAN INHERITANC; PLACHOV D, 1990, DEVELOPMENT, V110, P643; POLEEV A, 1995, EUR J BIOCHEM, V228, P899, DOI 10.1111/j.1432-1033.1995.tb20338.x; ROSSI DL, 1995, J BIOL CHEM, V270, P23139, DOI 10.1074/jbc.270.39.23139; ROVET JF, 1995, J PEDIATR-US, V126, P380, DOI 10.1016/S0022-3476(95)70452-3; STAPLETON P, 1993, NAT GENET, V3, P292, DOI 10.1038/ng0493-292; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; STUART ET, 1995, HUM MOL GENET, V4, P1717, DOI 10.1093/hmg/4.suppl_1.1717; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230	20	353	369	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1998	19	1					83	86		10.1038/ng0598-83	http://dx.doi.org/10.1038/ng0598-83			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZK651	9590296				2022-12-17	WOS:000073346700024
J	Connor, F; Bertwistle, D; Mee, PJ; Ross, GM; Swift, S; Grigorieva, E; Tybulewicz, VLJ; Ashworth, A				Connor, F; Bertwistle, D; Mee, PJ; Ross, GM; Swift, S; Grigorieva, E; Tybulewicz, VLJ; Ashworth, A			Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation	NATURE GENETICS			English	Article							CANCER SUSCEPTIBILITY GENE; EARLY EMBRYONIC LETHALITY; BREAST-CANCER; ATAXIA-TELANGIECTASIA; MDM2-DEFICIENT MICE; TARGETED DISRUPTION; OVARIAN-CANCER; DEFICIENT MICE; P53; DIFFERENTIATION	Germline mutation of the BRCA2 gene carries a high risk of developing breast cancer. To study the function of this gene, we generated a mutation in Brca2 in mice, Unlike other mutations in the Brca2 gene, which are lethal early in embryogenesis when homozygous, some of our homozygous mutant mice survive to adulthood. These animals have a wide range of defects, including small size, improper differentiation of tissues, absence of germ cells and the development of lethal thymic lymphomas. Fibroblasts cultured from Brca2(-/-)embryos have a defect in proliferation that may be mediated by over-expression of p53 and p21(Waf1/CIP1). We show that BrcaZ is required for efficient DNA repair, and our results suggest that loss of the p53 checkpoint may be essential for tumour progression triggered by mutations in BRCA2.	INST CANC RES,CHESTER BEATTY LABS,CRC,CTR CELL & MOL BIOL,LONDON SW3 6JB,ENGLAND; INST CANC RES,CHESTER BEATTY LABS,SECT GENE FUNCT & REGULAT,LONDON SW3 6JB,ENGLAND; NATL INST MED RES,DIV CELLULAR IMMUNOL,LONDON NW7 1AA,ENGLAND; NATL INST MED RES,DIV DEV NEUROBIOL,LONDON NW7 1AA,ENGLAND; INST CANC RES,ACAD UNIT RADIOTHERAPY & ONCOL,SUTTON SM2 5NG,SURREY,ENGLAND; ROYAL MARSDEN HOSP,SUTTON SM2 5NG,SURREY,ENGLAND	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust				Tybulewicz, Victor/0000-0003-2439-0798				Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Bishop DT, 1997, NAT GENET, V15, P226, DOI 10.1038/ng0397-226; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P113; Brugarolas J, 1997, NAT MED, V3, P721, DOI 10.1038/nm0797-721; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Connor F, 1997, HUM MOL GENET, V6, P291, DOI 10.1093/hmg/6.2.291; Crook T, 1997, LANCET, V350, P638, DOI 10.1016/S0140-6736(05)63327-2; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Easton D, 1997, NAT GENET, V16, P210, DOI 10.1038/ng0797-210; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; Godley LA, 1996, GENE DEV, V10, P836, DOI 10.1101/gad.10.7.836; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; IVANOV EL, 1997, CURR BIOL, V7, P492; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; LUNA RMD, 1995, NATURE, V378, P203; MEYN MS, 1995, CANCER RES, V55, P5991; Miki Y, 1996, NAT GENET, V13, P245, DOI 10.1038/ng0696-245; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; ROSS GM, 1995, CANCER RES, V55, P1235; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Sharan SK, 1997, GENOMICS, V40, P234, DOI 10.1006/geno.1996.4573; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Stratton MR, 1996, CURR OPIN GENET DEV, V6, P93, DOI 10.1016/S0959-437X(96)90017-9; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teng DHF, 1996, NAT GENET, V13, P241, DOI 10.1038/ng0696-241; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vaughn JP, 1996, CANCER RES, V56, P4590; Westphal CH, 1997, CANCER RES, V57, P1664; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	54	353	356	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1997	17	4					423	430		10.1038/ng1297-423	http://dx.doi.org/10.1038/ng1297-423			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YJ924	9398843				2022-12-17	WOS:A1997YJ92400022
J	Ioannidis, JPA; Allison, DB; Ball, CA; Coulibaly, I; Cui, XQ; Culhane, AC; Falchi, M; Furlanello, C; Game, L; Jurman, G; Mangion, J; Mehta, T; Nitzberg, M; Page, GP; Petretto, E; van Noort, V				Ioannidis, John P. A.; Allison, David B.; Ball, Catherine A.; Coulibaly, Issa; Cui, Xiangqin; Culhane, Aedin C.; Falchi, Mario; Furlanello, Cesare; Game, Laurence; Jurman, Giuseppe; Mangion, Jon; Mehta, Tapan; Nitzberg, Michael; Page, Grier P.; Petretto, Enrico; van Noort, Vera			Repeatability of published microarray gene expression analyses	NATURE GENETICS			English	Article							GENOME-WIDE ANALYSIS; REPRODUCIBILITY; ASSOCIATIONS; ARRAYEXPRESS; INFORMATION; REPOSITORY; SIGNATURE; MIAME; CELLS	Given the complexity of microarray-based gene expression studies, guidelines encourage transparent design and public data availability. Several journals require public data deposition and several public databases exist. However, not all data are publicly available, and even when available, it is unknown whether the published results are reproducible by independent scientists. Here we evaluated the replication of data analyses in 18 articles on microarray-based gene expression profiling published in Nature Genetics in 2005-2006. One table or figure from each article was independently evaluated by two teams of analysts. We reproduced two analyses in principle and six partially or with some discrepancies; ten could not be reproduced. The main reason for failure to reproduce was data unavailability, and discrepancies were mostly due to incomplete data annotation or specification of data processing and analysis. Repeatability of published microarray studies is apparently limited. More strict publication rules enforcing public data availability and explicit description of data processing and analysis should be considered.	[Ioannidis, John P. A.] Univ Ioannina, Sch Med, Clin & Mol Epidemiol Unit, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina 45110, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Ctr Genet Epidemiol & Modeling, Tufts Med Ctr, Boston, MA 02111 USA; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Allison, David B.; Coulibaly, Issa; Cui, Xiangqin; Mehta, Tapan; Page, Grier P.] Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Ball, Catherine A.; Nitzberg, Michael] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Culhane, Aedin C.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Culhane, Aedin C.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Falchi, Mario] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, London W12 0NN, England; [Falchi, Mario] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Furlanello, Cesare; Jurman, Giuseppe] Fdn Bruno Kessler, I-38100 Trento, Italy; [Game, Laurence; Mangion, Jon; Petretto, Enrico] Hammersmith Hosp, MRC, Ctr Clin Sci, Microarray Ctr, London W12 0NN, England; [Page, Grier P.] RTI Int, Stat & Epidemiol Unit, Atlanta, GA 30341 USA; [Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol Publ Hlth & Primary Care, London W2 1PG, England; [van Noort, Vera] European Mol Biol Lab, D-69117 Heidelberg, Germany	University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts Medical Center; Tufts University; Tufts University; University of Alabama System; University of Alabama Birmingham; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; University of London; King's College London; Fondazione Bruno Kessler; Imperial College London; Research Triangle Institute; Imperial College London; European Molecular Biology Laboratory (EMBL)	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Clin & Mol Epidemiol Unit, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Culhane, Aedin/AAG-8490-2019; Jurman, Giuseppe/GRS-8221-2022; van Noort, Vera/E-1053-2011; Falchi, Mario/F-5956-2013; Ioannidis, John P. A./G-9836-2011; van Noort, Vera/GWZ-9038-2022	Culhane, Aedin/0000-0002-1395-9734; van Noort, Vera/0000-0002-8436-6602; Cui, Xiangqin/0000-0003-0621-9313; Allison, David/0000-0003-3566-9399; Furlanello, Cesare/0000-0002-5384-3605; Jurman, Giuseppe/0000-0002-2705-5728; Falchi, Mario/0000-0002-5646-1004	NATIONAL CANCER INSTITUTE [R01CA098522] Funding Source: NIH RePORTER; MRC [MC_U120097112] Funding Source: UKRI; Medical Research Council [MC_U120097112] Funding Source: Medline; NCI NIH HHS [R01 CA098522] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Ball CA, 2004, PLOS BIOL, V2, P1276, DOI 10.1371/journal.pbio.0020317; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Brazma A, 2006, NAT BIOTECHNOL, V24, P1321, DOI 10.1038/nbt1106-1321; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen JJ, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-412; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Frey BJ, 2005, NAT GENET, V37, P991, DOI 10.1038/ng1630; Gentleman R, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1034; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; International Committee of Medical Journal Editors, 2008, UN REQ MAN UNPUB; Ioannidis JPA, 2007, EUR J CLIN INVEST, V37, P340, DOI 10.1111/j.1365-2362.2007.01794.x; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2007, EUR J CANCER, V43, P1999, DOI 10.1016/j.ejca.2007.05.019; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Larsson O, 2006, NAT BIOTECHNOL, V24, P1322, DOI 10.1038/nbt1106-1322; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Malek RL, 2006, NAT GENET, V38, P234, DOI 10.1038/ng1693; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Miron M, 2006, TRENDS GENET, V22, P84, DOI 10.1016/j.tig.2005.12.001; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schena M., 2003, MICROARRAY ANAL; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shields R, 2006, TRENDS GENET, V22, P65, DOI 10.1016/j.tig.2005.12.006; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tanaka H, 2005, NAT GENET, V37, P320, DOI 10.1038/ng1515; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; 2006, NAT GENET, V38, P1089	42	352	360	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					149	155		10.1038/ng.295	http://dx.doi.org/10.1038/ng.295			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19174838				2022-12-17	WOS:000263091300011
J	Lewis, A; Mitsuya, K; Umlauf, D; Smith, P; Dean, W; Walter, J; Higgins, M; Feil, R; Reik, W				Lewis, A; Mitsuya, K; Umlauf, D; Smith, P; Dean, W; Walter, J; Higgins, M; Feil, R; Reik, W			Imprinting on distal chromosome 7 in the placenta involves repressive histone methylation independent of DNA methylation	NATURE GENETICS			English	Article							BECKWITH-WIEDEMANN-SYNDROME; GENE-CLUSTER; X INACTIVATION; CONTROL REGION; MOUSE; EXPRESSION; GENOME; ESTABLISHMENT; SEQUENCE; MAMMALS	Imprinted genes are expressed from only one of the parental chromosomes and are marked epigenetically by DNA methylation and histone modifications(1-9). The imprinting center 2 (IC2) on mouse distal chromosome 7 is flanked by several paternally repressed genes, with the more distant ones imprinted exclusively in the placenta. We found that most of these genes lack parent-specific DNA methylation, and genetic ablation of methylation does not lead to loss of their imprinting in the trophoblast (placenta). The silent paternal alleles of the genes are marked in the trophoblast by repressive histone modifications (dimethylation at Lys9 of histone H3 and trimethylation at Lys27 of histone H3), which are disrupted when IC2 is deleted, leading to reactivation of the paternal alleles. Thus, repressive histone methylation is recruited by IC2 (potentially through a noncoding antisense RNA) to the paternal chromosome in a region of at least 700 kb and maintains imprinting in this cluster in the placenta, independently of DNA methylation. We propose that an evolutionarily older imprinting mechanism limited to extraembryonic tissues was based on histone modifications, and that this mechanism was subsequently made more stable for use in embryonic lineages by the recruitment of DNA methylation.	Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England; Tohoku Univ, Biomed Engn Res Org, Aoba Ku, Sendai, Miyagi 9808575, Japan; Inst Mol Genet, CNRS, UMR 5535, F-34293 Montpellier, France; Univ Montpellier 2, F-34293 Montpellier, France; Univ Saarland, D-66041 Saarbrucken, Germany; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Tohoku University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Saarland University; Roswell Park Cancer Institute	Reik, W (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England.	wolf.reik@bbsrc.ac.uk	Reik, Wolf/I-6794-2012; Mitsuya, Kohzoh/F-4437-2010; Feil, Robert P/D-2087-2013	Feil, Robert P/0000-0002-5671-5860; Reik, Wolf/0000-0003-0216-9881; Dean, Wendy/0000-0001-9441-5044; Lewis, Annabelle/0000-0003-1876-1927; Mitsuya, Kohzoh/0000-0002-0950-5406				Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Caspary T, 1998, MOL CELL BIOL, V18, P3466, DOI 10.1128/MCB.18.6.3466; Cleary MA, 2001, NAT GENET, V29, P78, DOI 10.1038/ng715; Dao D, 1999, HUM MOL GENET, V8, P1337, DOI 10.1093/hmg/8.7.1337; Engemann S, 2000, HUM MOL GENET, V9, P2691, DOI 10.1093/hmg/9.18.2691; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Grandjean V, 2001, FEBS LETT, V488, P165, DOI 10.1016/S0014-5793(00)02349-8; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Kanduri C, 2002, J BIOL CHEM, V277, P18106, DOI 10.1074/jbc.M200031200; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Sleutels F, 2002, ADV GENET, V46, P119; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Tanaka M, 1999, MECH DEVELOP, V87, P129, DOI 10.1016/S0925-4773(99)00158-6; UMLAUF D, 2004, NAT GENET       1031; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yatsuki H, 2002, GENOME RES, V12, P1860, DOI 10.1101/gr.110702; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	30	352	362	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1291	1295		10.1038/ng1468	http://dx.doi.org/10.1038/ng1468			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15516931				2022-12-17	WOS:000225354100016
J	Stromme, P; Mangelsdorf, ME; Shaw, MA; Lower, KM; Lewis, SME; Bruyere, H; Lutcherath, V; Gedeon, AK; Wallace, RH; Scheffer, IE; Turner, G; Partington, M; Frints, SGM; Fryns, JP; Sutherland, GR; Mulley, JC; Gecz, J				Stromme, P; Mangelsdorf, ME; Shaw, MA; Lower, KM; Lewis, SME; Bruyere, H; Lutcherath, V; Gedeon, AK; Wallace, RH; Scheffer, IE; Turner, G; Partington, M; Frints, SGM; Fryns, JP; Sutherland, GR; Mulley, JC; Gecz, J			Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy	NATURE GENETICS			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; INFANTILE SPASMS; WEST-SYNDROME; SPECTRUM; LINKAGE; DISEASE	Mental retardation and epilepsy often occur together. They are both heterogeneous conditions with acquired and genetic causes. Where causes are primarily genetic, major advances have been made in unraveling their molecular basis. The human X chromosome alone is estimated to harbor more than 100 genes that, when mutated, cause mental retardation(1). At least eight autosomal genes involved in idiopathic epilepsy have been identified(2), and many more have been implicated in conditions where epilepsy is a feature. We have identified mutations in an X chromosome-linked, Aristaless-related, homeobox gene (ARX), in nine families with mental retardation (syndromic and nonspecific), various forms of epilepsy, including infantile spasms and myoclonic seizures, and dystonia. Two recurrent mutations, present in seven families, result in expansion of polyalanine tracts of the ARX protein. These probably cause protein aggregation, similar to other polyalanine(3) and polyglutamine(4) disorders. In addition, we have identified a missense mutation within the ARX homeodomain and a truncation mutation. Thus, it would seem that mutation of ARX is a major contributor to X-linked mental retardation and epilepsy.	Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA 5006, Australia; Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; Childrens & Womens Hlth Ctr British Columbia, Dept Med Genet, Vancouver, BC, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Cent Hosp Rogaland, Dept Paediat, Stavanger, Norway; Univ Melbourne, Austin & Repatriat Med Ctr, Monash Med Ctr, Dept Med Neurol, Melbourne, Vic, Australia; Royal Childrens Hosp, Melbourne, Vic, Australia; Hunter Genet, Waratah, NSW, Australia; Univ Newcastle, Waratah, NSW, Australia; Univ Louvain Hosp VIB, Human Genome Lab, Louvain, Belgium; Univ Hosp, Dept Human Genet, B-3000 Louvain, Belgium; Univ Hosp, Dept Clin Genet, B-3000 Louvain, Belgium; Univ Adelaide, Dept Mol Biosci, Adelaide, SA, Australia	Womens & Childrens Hospital Australia; University of Adelaide; BC Women's Hospital & Health Centre; University of British Columbia; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; Royal Children's Hospital Melbourne; University of Newcastle; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain; Universite Catholique Louvain Hospital; University of Adelaide	Gecz, J (corresponding author), Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA 5006, Australia.	jozef.gecz@adelaide.edu.au	Sutherland, Grant Robert/D-2606-2012; Gedeon, Agi/G-7890-2011; Mangelsdorf, Marie E/A-2318-2013; Scheffer, Ingrid E/G-1668-2013; Gecz, Jozef/X-3469-2019	Mangelsdorf, Marie E/0000-0002-7855-7701; Scheffer, Ingrid E/0000-0002-2311-2174; Gecz, Jozef/0000-0002-7884-6861; Wallace, Robyn/0000-0001-6141-3317; Lower, Karen/0000-0003-2196-5234; Lewis, Suzanne/0000-0002-6300-5381; Frints, Suzanna G.M./0000-0002-5027-8364				Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Berkovic SF, 2001, EPILEPSIA, V42, P16, DOI 10.1046/j.1528-1157.2001.0420s5016.x; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Brown LY, 2001, HUM MOL GENET, V10, P791, DOI 10.1093/hmg/10.8.791; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Bruyere H, 1999, CLIN GENET, V55, P173, DOI 10.1034/j.1399-0004.1999.550305.x; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Claes S, 1997, ANN NEUROL, V42, P360, DOI 10.1002/ana.410420313; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; FEINBERG AP, 1977, DEV MED CHILD NEUROL, V19, P524; FRINTS SGM, IN PRESS AM J MED GE; Gall H, 1999, HAUTARZT, V50, P186, DOI 10.1007/s001050050887; Galliot B, 2000, TRENDS GENET, V16, P1, DOI 10.1016/S0168-9525(99)01888-0; Goodman FR, 2000, AM J HUM GENET, V67, P197, DOI 10.1086/302961; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Hill ME, 2001, BRAIN, V124, P522, DOI 10.1093/brain/124.3.522; Meijlink F, 1999, INT J DEV BIOL, V43, P651; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Ohira R, 2000, AM J HUM GENET, V67, P169; PARTINGTON MW, 1988, AM J MED GENET, V30, P251, DOI 10.1002/ajmg.1320300127; SCHEFFER IE, IN PRESS NEUROLOGY; Stromme P, 1999, J MED GENET, V36, P374; VIGEVANO F, 1993, EPILEPSIA, V34, P743, DOI 10.1111/j.1528-1157.1993.tb00456.x; Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886; Wong M, 2001, PEDIATR NEUROL, V24, P89, DOI 10.1016/S0887-8994(00)00238-1	29	352	361	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2002	30	4					441	445		10.1038/ng862	http://dx.doi.org/10.1038/ng862			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536BZ	11889467				2022-12-17	WOS:000174682000025
J	Matikainen, T; Perez, GI; Jurisicova, A; Pru, JK; Schlezinger, JJ; Ryu, HY; Laine, J; Sakai, T; Korsmeyer, SJ; Casper, RF; Sherr, DH; Tilly, JL				Matikainen, T; Perez, GI; Jurisicova, A; Pru, JK; Schlezinger, JJ; Ryu, HY; Laine, J; Sakai, T; Korsmeyer, SJ; Casper, RF; Sherr, DH; Tilly, JL			Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals	NATURE GENETICS			English	Article							DIOXIN-RESPONSIVE ENHANCER; PROTEIN-DNA INTERACTIONS; LIGANDED AH RECEPTOR; OOCYTE APOPTOSIS; CELL-DEATH; MOUSE OOCYTES; IN-VITRO; BCL-2; DESTRUCTION; FOLLICLES	Polycyclic aromatic hydrocarbons (PAHs) are toxic chemicals released into the environment by fossil fuel combustion. Moreover, a primary route of human exposure to PAHs is tobacco smoke(1,2). Oocyte destruction and ovarian failure occur in PAH-treated mice(1,2), and cigarette smoking causes early menopause in women(1,3). In many cells, PAHs activate the aromatic hydrocarbon receptor (Ahr), a member of the Per-Arnt-Sim family of transcription factors(4,5). The Ahr is also activated by dioxin, one of the most intensively studied environmental contaminants. Here we show that an exposure of mice to PAHs induces the expression of Bax in oocytes(6), followed by apoptosis. Ovarian damage caused by PAHs is prevented by Ahr or Bax inactivation. Oocytes microinjected with a Bax promoter-reporter construct show Ahr-dependent transcriptional activation after PAH, but not dioxin, treatment, consistent with findings that dioxin is not cytotoxic to oocytes. This difference in the action of PAHs versus dioxin is conveyed by a single base pair flanking each Ahr response element in the Bax promoter. Oocytes in human ovarian biopsies grafted into immunodeficient mice also accumulate Bax and undergo apoptosis after PAH exposure in vivo. Thus, Ahr-driven Bax transcription is a novel and evolutionarily conserved cell-death signaling pathway responsible for environmental toxicant-induced ovarian failure.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol,Vincent Ctr Reprod Biol, Boston, MA 02114 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Boston Univ, Sch Med, Dept Environm Hlth, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Publ Hlth, Boston, MA 02118 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02115 USA; Kyoto Prefectural Univ, Sch Med, Dept Prevent Med, Kyoto 6028566, Japan; Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst,Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst,Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyoto Prefectural University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Tilly, JL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol,Vincent Ctr Reprod Biol, Boston, MA 02114 USA.	jtilly@partners.org	Jurisicova, Andrea/E-4580-2013; Perez, Gloria I/GMX-1286-2022; Casper, Robert F./E-3775-2013	Casper, Robert F./0000-0002-6249-462X; Sherr, David/0000-0003-3353-0553; Schlezinger, Jennifer/0000-0001-6834-4369	NIEHS NIH HHS [R01-ES08430] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008430] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BLANK JA, 1987, MOL PHARMACOL, V32, P168; Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pa.35.040195.001515; Heidel SM, 1998, MOL PHARMACOL, V54, P1000, DOI 10.1124/mol.54.6.1000; Igata E, 1999, GENE, V238, P407, DOI 10.1016/S0378-1119(99)00348-0; JICK H, 1977, LANCET, V1, P1354; Jurisicova A, 1998, MOL REPROD DEV, V51, P243, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;243::AID-MRD3&gt;3.0.CO;2-P; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; LUSSKA A, 1993, J BIOL CHEM, V268, P6575; Mann KK, 1999, TOXICOL APPL PHARM, V161, P10, DOI 10.1006/taap.1999.8778; MATTISON DR, 1980, TOXICOL APPL PHARM, V56, P399, DOI 10.1016/0041-008X(80)90074-5; MATTISON DR, 1989, SEMIN REPROD ENDOCR, V7, P291, DOI 10.1055/s-2007-1021411; MATTISON DR, 1979, CANCER RES, V39, P3471; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Morita Y, 1999, MOL ENDOCRINOL, V13, P841, DOI 10.1210/me.13.6.841; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Pru JK, 2001, BIOL REPROD, V64, P965, DOI 10.1095/biolreprod64.3.965; Pru JK, 2001, MOL ENDOCRINOL, V15, P845, DOI 10.1210/me.15.6.845; QVIST R, 1990, J REPROD FERTIL, V89, P169, DOI 10.1530/jrf.0.0890169; Robles R, 2000, ENDOCRINOLOGY, V141, P450, DOI 10.1210/en.141.1.450; SHEN ES, 1992, J BIOL CHEM, V267, P6815; Shi SR, 1997, J HISTOCHEM CYTOCHEM, V45, P327, DOI 10.1177/002215549704500301; SILBERGELD EK, 1987, AM J IND MED, V11, P131, DOI 10.1002/ajim.4700110203; Sussman NB, 1999, J WOMENS HEALTH, V8, P217, DOI 10.1089/jwh.1999.8.217; TILLY JL, 1995, ENDOCRINOLOGY, V136, P232, DOI 10.1210/en.136.1.232; Weissman A, 1999, BIOL REPROD, V60, P1462, DOI 10.1095/biolreprod60.6.1462; Wilson CL, 1998, TOXICOL PATHOL, V26, P657, DOI 10.1177/019262339802600510	30	352	368	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2001	28	4					355	360		10.1038/ng575	http://dx.doi.org/10.1038/ng575			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458CC	11455387				2022-12-17	WOS:000170174800016
J	Matsuura, T; Yamagata, T; Burgess', DL; Rasmussen, A; Grewal, RP; Watase, K; Khajavi, M; McCall, AE; Davis, CF; Zu, L; Achari, M; Pulst, SM; Alonso, E; Noebels, JL; Nelson, DL; Zoghbi, HY; Ashizawa, T				Matsuura, T; Yamagata, T; Burgess', DL; Rasmussen, A; Grewal, RP; Watase, K; Khajavi, M; McCall, AE; Davis, CF; Zu, L; Achari, M; Pulst, SM; Alonso, E; Noebels, JL; Nelson, DL; Zoghbi, HY; Ashizawa, T			Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10	NATURE GENETICS			English	Article							TRINUCLEOTIDE REPEAT; POLYGLUTAMINE EXPANSION; CAG REPEAT; GENE; CLONING; DNA; REVEALS; DISEASE	Spinocerebellar ataxia type 10 (SCA10; MIM 603516; refs 1.2) is an autosomal dominant disorder characterized by cerebellar ataxia and seizures. The gene SCA10 maps to a 3.8-cM interval on human chromosome 22q13-qter (refs 1.2). Because several other SCA subtypes show trinucleotide repeat expansions, we examined microsatellites in this region. We found an expansion of a pentanucleotide (ATTCT) repeat in intron 9 of SCA10 in all patients in five Mexican SCA10 families. There was an inverse correlation between the expansion size, up to 22.5 kb larger than the normal allele, and the age of onset (r(2)=0.34, P=0.018). Analysis of 562 chromosomes from unaffected individuals of various ethnic origins (including 242 chromosomes from Mexican persons) showed a range of 10 to 22 ATTCT repeats with no evidence of expansions. Our data indicate that the new SCA10 intronic ATTCT pentanucleotide repeat in SCA10 patients is unstable and represents the largest microsatellite expansion found so far in the human genome.	Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Vet Affairs Med Ctr, Neurol Serv, Houston, TX 77030 USA; Inst Nacl Neurol & Neurocirugia, Mexico City, DF, Mexico; New Jersey Neurosci Inst, JKF Med Ctr, Edison, NJ USA; Univ Calif Los Angeles, Cedars Sinai Med Ctr, Rose Moss Lab Parkinson & Neurodgenerat Dis, Burns & Allen Res Inst,Div Neurol,Sch Med, Los Angeles, CA 90048 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ashizawa, T (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.		Rasmussen, Astrid/A-4878-2013	Rasmussen, Astrid/0000-0001-7744-2948; Davis, Caleb/0000-0002-5125-0494; Zoghbi, Huda/0000-0002-0700-3349; Noebels, Jeffrey/0000-0002-2887-0839	NICHD NIH HHS [HD24064, HD29256] Funding Source: Medline; NINDS NIH HHS [NS27699] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Breschel TS, 1997, HUM MOL GENET, V6, P1855, DOI 10.1093/hmg/6.11.1855; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Ikeuchi T, 1998, GENOMICS, V49, P321, DOI 10.1006/geno.1998.5266; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; Matsuura T, 1999, ANN NEUROL, V46, P480; Matsuura T, 1999, ANN NEUROL, V45, P407, DOI 10.1002/1531-8249(199903)45:3<407::AID-ANA21>3.0.CO;2-D; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; WELLS RD, 1998, GENETIC INSTABILITY; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zu L, 1999, AM J HUM GENET, V64, P594, DOI 10.1086/302247	20	352	374	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2000	26	2					191	194		10.1038/79911	http://dx.doi.org/10.1038/79911			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	359YC	11017075	Bronze			2022-12-17	WOS:000089638800016
J	Parsons, TJ; Muniec, DS; Sullivan, K; Woodyatt, N; AllistonGreiner, R; Wilson, MR; Berry, DL; Holland, KA; Weedn, VW; Gill, P; Holland, MM				Parsons, TJ; Muniec, DS; Sullivan, K; Woodyatt, N; AllistonGreiner, R; Wilson, MR; Berry, DL; Holland, KA; Weedn, VW; Gill, P; Holland, MM			A high observed substitution rate in the human mitochondrial DNA control region	NATURE GENETICS			English	Article							RECENT AFRICAN ORIGIN; MTDNA; EVOLUTION; SEQUENCE; IDENTIFICATION; POPULATIONS; REMAINS; POLYMORPHISM; BOTTLENECK; DIVERSITY	The rate and pattern of sequence substitutions in the mitochondrial DNA (mtDNA) control region (CR) is of central importance to studies of human evolution and to forensic identity testing. Here, we report a direct measurement of the intergenerational substitution rate in the human CR. We compared DNA sequences of two CR hypervariable segments from close maternal relatives, from 134 independent mtDNA lineages spanning 327 generational events. Ten substitutions were observed, resulting in an empirical rate of 1/33 generations, or 2.5/site/Myr. This is roughly twenty-fold higher than estimates derived from phylogenetic analyses. This disparity cannot be accounted for simply by substitutions at mutational hot spots, suggesting additional factors that produce the discrepancy between very near-term and long-term apparent rates of sequence divergence. The data also indicate that extremely rapid segregation of CR sequence variants between generations is common in humans, with a very small mtDNA bottleneck. These results have implications for forensic applications and studies of human evolution.	FORENS SCI SERV INC, BIRMINGHAM, W MIDLANDS, ENGLAND; FBI LAB, WASHINGTON, DC 20535 USA; GETTYSBURG COLL, DEPT CHEM, GETTYSBURG, PA 17325 USA	Forensic Science Service UK; Gettysburg College	Parsons, TJ (corresponding author), ARMED FORCES INST PATHOL, OFF ARMED FORCES MED EXAMINER, ARMED FORCES DNA IDENTIFICAT LAB, ROCKVILLE, MD 20850 USA.		Gill, Peter/C-3056-2009					Adachi J, 1996, MOL BIOL EVOL, V13, P200, DOI 10.1093/oxfordjournals.molbev.a025556; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; AYALA FJ, 1995, SCIENCE, V270, P1930, DOI 10.1126/science.270.5244.1930; Bendall KE, 1996, AM J HUM GENET, V59, P1276; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHEN YS, 1995, AM J HUM GENET, V57, P133; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; EXCOFFIER L, 1990, J MOL EVOL, V30, P125, DOI 10.1007/BF02099939; Gemmell NJ, 1996, MOL BIOL EVOL, V13, P798, DOI 10.1093/oxfordjournals.molbev.a025640; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; GINTHER C, 1992, NAT GENET, V2, P135, DOI 10.1038/ng1092-135; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; HASEGAWA M, 1991, J MOL EVOL, V32, P37, DOI 10.1007/BF02099927; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; HOLLAND MM, 1993, J FORENSIC SCI, V38, P542; HOLLAND MM, 1994, ADV FORENSIC HAEMOGE, P399; HOLLINGUM J, 1995, IND ROBOT, V22, P3; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HORAI S, 1990, AM J HUM GENET, V46, P828; Howell N, 1996, AM J HUM GENET, V59, P501; HOWELL N, 1992, HUM GENET, V90, P117; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; Miller KWP, 1996, INT J LEGAL MED, V109, P107, DOI 10.1007/BF01369668; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Nachman MW, 1996, GENETICS, V142, P953; NEI M, 1992, MOL BIOL EVOL, V9, P1176; PENNY D, 1995, MOL BIOL EVOL, V12, P863; PESOLE G, 1992, MOL BIOL EVOL, V9, P587; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; POULTON J, 1995, AM J HUM GENET, V57, P224; RUVOLO M, 1993, MOL BIOL EVOL, V10, P1115; Ruvolo M, 1996, MOL PHYLOGENET EVOL, V5, P202, DOI 10.1006/mpev.1996.0014; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; *SAS I, 1991, SAS PROC GUID REL 6; SOLIGNAC M, 1984, MOL GEN GENET, V197, P183, DOI 10.1007/BF00330961; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; SULLIVAN KM, 1992, INT J LEGAL MED, V105, P83, DOI 10.1007/BF02340829; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Templeton AR, 1996, GENETICS, V144, P1263; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAKELEY J, 1993, J MOL EVOL, V37, P613; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; WILLS C, 1995, EVOLUTION, V49, P593, DOI 10.1111/j.1558-5646.1995.tb02296.x; WILSON MR, 1993, CRIME LAB DIGEST, V20, P68; WILSON MR, 1995, INT J LEGAL MED, V108, P68, DOI 10.1007/BF01369907	54	352	360	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1997	15	4					363	368		10.1038/ng0497-363	http://dx.doi.org/10.1038/ng0497-363			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090380				2022-12-17	WOS:A1997WQ38900013
J	Gayther, SA; Mangion, J; Russell, P; Seal, S; Barfoot, R; Ponder, BAJ; Stratton, MR; Easton, D				Gayther, SA; Mangion, J; Russell, P; Seal, S; Barfoot, R; Ponder, BAJ; Stratton, MR; Easton, D			Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene	NATURE GENETICS			English	Article							SUSCEPTIBILITY GENE; APC GENE; POLYPOSIS; PHENOTYPE	The breast cancer susceptibility gene BRCA2 on chromosome 13q12-13 has recently been identified(1). Germline mutations of BRCA2 are predicted to account for approximately 35% of families with multiple case, early onset female breast cancer, and they are also associated with an increased risk of male breast cancer, ovarian cancer, prostate cancer and pancreatic cancer(2-4). Germline mutations of a second cancer susceptibility gene BRCA1 (ref. 5), are associated with a strong predisposition to ovarian cancer as well as female breast cancer(6). Recent studies have suggested that the phenotype in BRCA1 families with respect to the ratio of breast to ovarian cancer varies with the location of the BRCA1 mutation(7,8). To determine whether germline mutations in BRCA2 are associated with a similar variation in phenotypic risk, we have analysed the distribution of mutations in 25 families with multiple cases of breast and/or ovarian cancer ascertained in the United Kingdom and fire. These mutations all lead to premature truncation of BRCA2 as a result of frameshift deletions/insertions or nonsense mutations. Analysis of the mutation distribution along the length of the gene indicates a significant genotype-phenotype correlation. Truncating mutations in families with the highest risk of ovarian cancer relative to breast cancer are clustered in a region of approximately 3.3 kb in exon 11 (P=0.0004). Published data on mutations in 45 other BRCA2-linked families provide support for this correlation.	INST CANC RES,HADDOW LABS,SECT MOL CARCINOGENESIS,SUTTON SM2 5NG,SURREY,ENGLAND; UNIV FORVIE SITE,INST PUBL HLTH,CRC,GENET EPIDEMIOL GRP,CAMBRIDGE CB2 2SR,ENGLAND	University of London; Institute of Cancer Research - UK; University of Cambridge	Gayther, SA (corresponding author), ADDENBROOKES HOSP,CRC,HUMAN CANC GENET RES GRP,HILLS RD,BOX 238,CAMBRIDGE CB2 2QQ,ENGLAND.							Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; EASTON DF, 1993, AM J HUM GENET, V52, P718; GAYTHER SA, 1994, HUM MOL GENET, V3, P53, DOI 10.1093/hmg/3.1.53; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gayther SA, 1996, AM J HUM GENET, V58, P451; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAGASE H, 1992, CANCER RES, V52, P4055; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	16	352	358	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					103	105		10.1038/ng0197-103	http://dx.doi.org/10.1038/ng0197-103			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988179				2022-12-17	WOS:A1997WA37300031
J	Riggins, GJ; Thiagalingam, S; Rozenblum, E; Weinstein, CL; Kern, SE; Hamilton, SR; Willson, JKV; Markowitz, SD; Kinzler, KW; Vogelstein, B				Riggins, GJ; Thiagalingam, S; Rozenblum, E; Weinstein, CL; Kern, SE; Hamilton, SR; Willson, JKV; Markowitz, SD; Kinzler, KW; Vogelstein, B			Mad-related genes in the human	NATURE GENETICS			English	Letter							GROWTH-FACTOR-BETA		JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD 21231; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; CASE WESTERN RESERVE UNIV HOSP,DEPT MED,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV HOSP,IRELAND CANC CTR,CLEVELAND,OH 44106; JOHNS HOPKINS ONCOL CTR,HOWARD HUGHES MED INST,BALTIMORE,MD 21231	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine				Thiagalingam, Sam/0000-0001-5211-266X	NATIONAL CANCER INSTITUTE [R37CA043460, T32CA009243, R01CA043460, R37CA035494, R01CA035494] Funding Source: NIH RePORTER; NCI NIH HHS [CA 43460, CA 09243, CA35494] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brattain Michael G., 1994, Current Opinion in Oncology, V6, P77, DOI 10.1097/00001622-199401000-00011; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FYNAN TM, 1993, CRIT REV ONCOGENESIS, V4, P493; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HILLIER L, IN PRESS NATURE; HOULGATTE R, 1995, GENOME RES, V5, P272, DOI 10.1101/gr.5.3.272; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; HURSH DA, 1993, DEVELOPMENT, V117, P1211; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KORENBERG JR, 1995, GENOMICS, V29, P364, DOI 10.1006/geno.1995.9993; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; MASSAGUE J, 1995, CURR OPIN GENET DEV, V5, P91, DOI 10.1016/S0959-437X(95)90059-4; Ogasawara S, 1996, GASTROENTEROLOGY, V110, P52, DOI 10.1053/gast.1996.v110.pm8536888; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; ROBERTS AB, 1993, GROWTH FACTORS, V8, P1; ROJAS K, 1995, GENOMICS, V25, P329, DOI 10.1016/0888-7543(95)80153-D; SATTERWHITE DJ, 1994, INVAS METAST, V14, P309; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Schutte M, 1996, CANCER RES, V56, P2527; SEKELSKY JJ, 1995, GENETICS, V139, P1347; TNIAGALINGAM S, 1996, NAT GENET, V13, P343; Wick W, 1996, ONCOGENE, V12, P973; Wieland I, 1996, ONCOGENE, V12, P97	26	352	371	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					347	349		10.1038/ng0796-347	http://dx.doi.org/10.1038/ng0796-347			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673135				2022-12-17	WOS:A1996UU28300024
J	SHIRAKAWA, T; LI, AR; DUBOWITZ, M; DEKKER, JW; SHAW, AE; FAUX, JA; RA, CS; COOKSON, WOCM; HOPKIN, JM				SHIRAKAWA, T; LI, AR; DUBOWITZ, M; DEKKER, JW; SHAW, AE; FAUX, JA; RA, CS; COOKSON, WOCM; HOPKIN, JM			ASSOCIATION BETWEEN ATOPY AND VARIANTS OF THE BETA-SUBUNIT OF THE HIGH-AFFINITY IMMUNOGLOBULIN-E RECEPTOR	NATURE GENETICS			English	Article							FC-EPSILON-RI; MAST-CELL RECEPTOR; SINGLE AMINO-ACID; SERUM IGE LEVELS; BRONCHIAL HYPERRESPONSIVENESS; SURFACE EXPRESSION; TRANSFECTED CELLS; GENETIC-ANALYSIS; LINKAGE; CHROMOSOME-11Q	The beta-subunit of the high-affinity IgE receptor (Fc epsilon RI-beta) on chromosome 11 is maternally linked to atopy, the state of enhanced IgE responsiveness underlying allergic asthma and rhinitis. We have identified a common variant of Fc epsilon RI-beta, lle181Leu within the 4th transmembrane domain. Leu181 shows significant association with positive IgE responses in a random patient sample. Amongst 60 unrelated nuclear families with allergic asthmatic probands, Leu181 is identified in 10 (17%), is maternally inherited in each, and shows a strong association with atopy. Our data indicate that Fc epsilon RI-beta, subject to maternal modification, may be the atopy-causing locus on chromosome 11q.	JOHN RADCLIFFE HOSP,NUFFIELD DEPT MED,OXFORD OX3 9DU,ENGLAND; JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,TOKYO 113,JAPAN; CHURCHILL HOSP,OSLER CHEST UNIT,OXFORD OX3 7LJ,ENGLAND	University of Oxford; Juntendo University; University of Oxford			Cookson, William/HHC-1790-2022		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMELUNG PJ, 1992, CLIN EXP ALLERGY, V22, P1077, DOI 10.1111/j.1365-2222.1992.tb00133.x; ARSHAD SH, 1992, LANCET, V339, P1493, DOI 10.1016/0140-6736(92)91260-F; BACKER V, 1992, ALLERGY, V47, P484, DOI 10.1111/j.1398-9995.1992.tb00669.x; BEINBORN M, 1993, NATURE, V362, P348, DOI 10.1038/362348a0; BENSASSON SZ, 1990, P NATL ACAD SCI USA, V87, P1421, DOI 10.1073/pnas.87.4.1421; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; CHARMLEY P, 1990, NUCLEIC ACIDS RES, V18, P207, DOI 10.1093/nar/18.1.207; CLINE MG, 1989, THORAX, V44, P425, DOI 10.1136/thx.44.5.425; COLLEE JM, 1993, LANCET, V342, P936, DOI 10.1016/0140-6736(93)91988-X; COOKSON WOCM, 1988, LANCET, V1, P86; COOKSON WOCM, 1992, LANCET, V340, P381, DOI 10.1016/0140-6736(92)91468-N; COOKSON WOCM, 1989, LANCET, V1, P1292; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; ECCLESTON E, 1973, NATURE-NEW BIOL, V244, P73, DOI 10.1038/newbio244073b0; FERRIE RM, 1992, AM J HUM GENET, V51, P251; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; GASCAN H, 1991, J EXP MED, V173, P747, DOI 10.1084/jem.173.3.747; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; HALONEN M, 1992, AM REV RESPIR DIS, V146, P866, DOI 10.1164/ajrccm/146.4.866; HELM B, 1988, NATURE, V331, P180, DOI 10.1038/331180a0; HIZAWA N, 1992, CLIN EXP ALLERGY, V22, P1065, DOI 10.1111/j.1365-2222.1992.tb00131.x; HOLFORDSTREVENS V, 1984, J ALLERGY CLIN IMMUN, V73, P516, DOI 10.1016/0091-6749(84)90363-4; ISHIZAKA K, 1971, Clinical Allergy, V1, P9, DOI 10.1111/j.1365-2222.1971.tb02444.x; KINET JP, 1988, P NATL ACAD SCI USA, V85, P6483, DOI 10.1073/pnas.85.17.6483; KINET JP, 1985, BIOCHEMISTRY-US, V24, P7342, DOI 10.1021/bi00346a048; KUSTER H, 1992, J BIOL CHEM, V267, P12782; LYMPANY P, 1992, CLIN EXP ALLERGY, V22, P1085, DOI 10.1111/j.1365-2222.1992.tb00134.x; MAGNUSSON CGM, 1988, ALLERGY, V43, P241, DOI 10.1111/j.1398-9995.1988.tb00896.x; MARSH DG, 1982, J EXP MED, V155, P1439, DOI 10.1084/jem.155.5.1439; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; METZGER H, 1991, CLIN EXP ALLERGY, V21, P269, DOI 10.1111/j.1365-2222.1991.tb01658.x; MOFFATT MF, 1992, CLIN EXP ALLERGY, V22, P1046, DOI 10.1111/j.1365-2222.1992.tb00128.x; MOFFATT MF, IN PRESS LANCET; OKSENBERG D, 1992, NATURE, V360, P161, DOI 10.1038/360161a0; OLIVER JM, 1988, PROG ALLERGY, V42, P185; PAUL WE, 1992, ADV IMMUNOL, V53, P1; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; RA C, 1989, J BIOL CHEM, V264, P15323; REES DC, 1989, SCIENCE, V245, P510, DOI 10.1126/science.2667138; RICH SS, 1992, CLIN EXP ALLERGY, V22, P1070, DOI 10.1111/j.1365-2222.1992.tb00132.x; SANDFORD AJ, 1993, LANCET, V341, P332, DOI 10.1016/0140-6736(93)90136-5; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; SHIRAKAWA T, IN PRESS CLIN GENET; SPORIK R, 1992, CLIN EXP ALLERGY, V22, P897, DOI 10.1111/j.1365-2222.1992.tb02062.x; STENIUS B, 1971, Clinical Allergy, V1, P37, DOI 10.1111/j.1365-2222.1971.tb02446.x; TEDDER TF, 1988, P NATL ACAD SCI USA, V85, P208, DOI 10.1073/pnas.85.1.208; THOMPSON HL, 1990, J CLIN INVEST, V85, P1227, DOI 10.1172/JCI114557; TOLLERUD DJ, 1991, AM REV RESPIR DIS, V144, P776, DOI 10.1164/ajrccm/144.4.776; VARINBLANK N, 1990, J BIOL CHEM, V265, P15685; WODNARFILIPOWICZ A, 1989, NATURE, V339, P150, DOI 10.1038/339150a0; WOOLCOCK AJ, 1987, THORAX, V42, P361, DOI 10.1136/thx.42.5.361; YOUNG RP, 1992, CLIN EXP ALLERGY, V22, P205, DOI 10.1111/j.1365-2222.1992.tb03074.x; YOUNG RP, 1992, J MED GENET, V29, P236, DOI 10.1136/jmg.29.4.236; YOUNG RP, IN PRESS CLIN ALLERG	56	352	370	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					125	130		10.1038/ng0694-125	http://dx.doi.org/10.1038/ng0694-125			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920628				2022-12-17	WOS:A1994NQ03700009
J	WALTER, MA; SPILLETT, DJ; THOMAS, P; WEISSENBACH, J; GOODFELLOW, PN				WALTER, MA; SPILLETT, DJ; THOMAS, P; WEISSENBACH, J; GOODFELLOW, PN			A METHOD FOR CONSTRUCTING RADIATION HYBRID MAPS OF WHOLE GENOMES	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; SOMATIC-CELL HYBRIDS; HUMAN X-CHROMOSOME; DNA-SEQUENCE; GENE; IRRADIATION; REGION; FUSION; LOCUS; LOCALIZATION	In radiation hybrid mapping, chromosomes in human-rodent hybrid cells are fragmented by X-rays and fragments rescued by fusion of the donor cell to a recipient rodent cell. The co-retention frequencies of markers in 100-200 hybrids are used to map individual chromosomes, but mapping the whole genome in this way is impractical. We have reverted to the original protocols of Goss and Harris and have produced a panel of 44 hybrids using irradiated human fibroblasts as donors. This panel has been used to make a map of human chromosome 14 containing 40 ordered markers. The map integrates previously published maps and localizes nine new markers. We suggest that the construction of a high resolution map of the whole human genome is feasible with a single panel of 100-200 hybrids.	UNIV CAMBRIDGE,DEPT GENET,CAMBRIDGE CB2 3EH,ENGLAND; SOC LAB GENETHON,F-91000 EVRY,FRANCE	University of Cambridge					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARRETT JH, 1992, GENOMICS, V13, P95, DOI 10.1016/0888-7543(92)90207-9; BENHAM F, 1989, GENOMICS, V4, P509, DOI 10.1016/0888-7543(89)90274-7; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; BYTH BC, 1993, HUM MOL GENET, V2, P1752, DOI 10.1093/hmg/2.10.1752-a; CECCHERINI I, 1992, P NATL ACAD SCI USA, V89, P104, DOI 10.1073/pnas.89.1.104; COTTER FE, 1990, GENOMICS, V7, P257, DOI 10.1016/0888-7543(90)90548-9; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; COX DW, 1994, CYTOGENET CELL GENET, V66, P2; GOODFELLOW PJ, 1990, SOMAT CELL MOLEC GEN, V16, P163, DOI 10.1007/BF01233046; GORSKI JL, 1992, GENOMICS, V14, P657, DOI 10.1016/S0888-7543(05)80165-X; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HUGSON TJ, 1992, GENOMICS, V13, P622; JORDAN SA, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171; LAWRENCE S, 1991, P NATL ACAD SCI USA, V88, P7477, DOI 10.1073/pnas.88.17.7477; LUTY JA, 1991, NUCLEIC ACIDS RES, V19, P4308, DOI 10.1093/nar/19.15.4308; ORITA M, 1990, GENOMICS, V8, P271, DOI 10.1016/0888-7543(90)90282-Y; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4019, DOI 10.1093/nar/19.14.4019-a; POLYMEROPOULOS MH, 1993, HUM MOL GENET, V2, P490, DOI 10.1093/hmg/2.4.490; POWELL SJ, 1993, GENOMICS, V15, P435, DOI 10.1006/geno.1993.1084; SEFTON L, 1992, MAMM GENOME, V2, P21, DOI 10.1007/BF00570437; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; SIDEN TS, 1992, SOMAT CELL MOLEC GEN, V18, P33, DOI 10.1007/BF01233447; WALTER MA, 1993, TRENDS GENET, V9, P352, DOI 10.1016/0168-9525(93)90040-O; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WARRINGTON JA, 1992, GENOMICS, V13, P803, DOI 10.1016/0888-7543(92)90156-M; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4638, DOI 10.1093/nar/18.15.4638-a; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WESTERVELD A, 1971, NATURE-NEW BIOL, V234, P20, DOI 10.1038/newbio234020a0; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WILLARD HF, 1985, HUM GENET, V71, P138; YAMADA Y, 1993, GENOMICS, V15, P449, DOI 10.1006/geno.1993.1088; ZHAO B, 1992, NUCLEIC ACIDS RES, V20, P4097, DOI 10.1093/nar/20.15.4097	33	352	370	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					22	28		10.1038/ng0594-22	http://dx.doi.org/10.1038/ng0594-22			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075634				2022-12-17	WOS:A1994NJ84200008
J	Zhang, Y; Liu, JS				Zhang, Yu; Liu, Jun S.			Bayesian inference of epistatic interactions in case-control studies	NATURE GENETICS			English	Article							ASSOCIATION; STRATEGIES	Epistatic interactions among multiple genetic variants in the human genome may be important in determining individual susceptibility to common diseases. Although some existing computational methods for identifying genetic interactions have been effective for small- scale studies, we here propose a method, denoted ' bayesian epistasis association mapping' ( BEAM), for genome- wide case- control studies. BEAM treats the disease- associated markers and their interactions via a bayesian partitioning model and computes, via Markov chain Monte Carlo, the posterior probability that each marker set is associated with the disease. Testing this on an age- related macular degeneration genome- wide association data set, we demonstrate that the method is significantly more powerful than existing approaches and that genome- wide case- control epistasis mapping with many thousands of markers is both computationally and statistically feasible.	Harvard Univ, Dept Stat, Sci Ctr 715, Cambridge, MA 02138 USA; Penn State Univ, Dept Stat, University Pk, PA 16802 USA	Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Liu, JS (corresponding author), Harvard Univ, Dept Stat, Sci Ctr 715, 1 Oxford St, Cambridge, MA 02138 USA.	jliu@stat.harvard.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002518] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01HG002518-06] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ccok NR, 2004, STAT MED, V23, P1439, DOI 10.1002/sim.1749; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Liu JS., 2001, MONTE CARLO STRATEGI, DOI DOI 10.1007/978-0-387-76371-2; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Williams SM, 2004, HUM HERED, V57, P28, DOI 10.1159/000077387; Zee R. Y. L., 2002, Pharmacogenomics Journal, V2, P197, DOI 10.1038/sj.tpj.6500101; Zheng T, 2006, HUM HERED, V62, P196, DOI 10.1159/000096995; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	19	351	368	1	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1167	1173		10.1038/ng2110	http://dx.doi.org/10.1038/ng2110			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17721534				2022-12-17	WOS:000249122400030
J	Xia, B; Dorsman, JC; Ameziane, N; de Vries, Y; Rooimans, MA; Sheng, Q; Pals, G; Errami, A; Gluckman, E; Llera, J; Wang, W; Livingston, DM; Joenje, H; de Winter, JP				Xia, Bing; Dorsman, Josephine C.; Ameziane, Najim; de Vries, Yne; Rooimans, Martin A.; Sheng, Qing; Pals, Gerard; Errami, Abdellatif; Gluckman, Eliane; Llera, Julian; Wang, Weidong; Livingston, David M.; Joenje, Hans; de Winter, Johan P.			Fanconi anemia is associated with a defect in the BRCA2 partner PALB2	NATURE GENETICS			English	Article								The Fanconi anemia and BRCA networks are considered interconnected, as BRCA2 gene defects have been discovered in individuals with Fanconi anemia subtype D1. Here we show that a defect in the BRCA2- interacting protein PALB2 is associated with Fanconi anemia in an individual with a new subtype. PALB2- deficient cells showed hypersensitivity to cross- linking agents and lacked chromatin- bound BRCA2; these defects were corrected upon ectopic expression of PALB2 or by spontaneous reversion.	Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; MRC Holland BV, NL-1057 SN Amsterdam, Netherlands; Hop St Louis, Bone Marrow Transplant Unit, F-75475 Paris 10, France; Hosp Italiano Buenos Aires, Dept Pediat, Buenos Aires, DF, Argentina; NIA, Genet Lab, US Natl Inst Hlth, Baltimore, MD 21224 USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Italiano de Buenos Aires; University of Buenos Aires; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	de Winter, JP (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Van Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	David_Livingston@dfci.harvard.edu; j.dewinter@vumc.nl	Wang, Weidong/AAV-2446-2021; Pals, Gerard/A-5198-2011; eliane, Gluckman/AAA-5024-2021	Wang, Weidong/0000-0002-0658-7928; Pals, Gerard/0000-0003-4091-7115	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON AGING [ZIAAG000688, Z01AG000688] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alter BP, 2007, J MED GENET, V44, P1, DOI 10.1136/jmg.2006.043257; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bermejo JL, 2004, ANN ONCOL, V15, P1834, DOI [10.1093/annone/mdh474, 10.1093/annonc/mdh474]; Chang Mary Wu, 2003, Lymphat Res Biol, V1, P259; Friedenson Bernard, 2005, MedGenMed, V7, P60; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levitus M, 2006, CELL ONCOL, V28, P3; Mueller BU, 1999, SEMIN PERINATOL, V23, P332, DOI 10.1016/S0146-0005(99)80041-X; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Waisfisz Q, 1999, NAT GENET, V22, P379, DOI 10.1038/11956; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	13	351	357	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					159	161		10.1038/ng1942	http://dx.doi.org/10.1038/ng1942			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200672				2022-12-17	WOS:000244063900011
J	Pal, C; Papp, B; Lercher, MJ				Pal, C; Papp, B; Lercher, MJ			Adaptive evolution of bacterial metabolic networks by horizontal gene transfer	NATURE GENETICS			English	Article							ESCHERICHIA-COLI K-12; SACCHAROMYCES-CEREVISIAE; GENOME EVOLUTION; YEAST; ORGANIZATION; DUPLICATION; SCENARIOS; ENZYMES; MODELS; FLUX	Numerous studies have considered the emergence of metabolic pathways(1), but the modes of recent evolution of metabolic networks are poorly understood. Here, we integrate comparative genomics with flux balance analysis to examine (i) the contribution of different genetic mechanisms to network growth in bacteria, (ii) the selective forces driving network evolution and (iii) the integration of new nodes into the network. Most changes to the metabolic network of Escherichia coli in the past 100 million years are due to horizontal gene transfer, with little contribution from gene duplicates. Networks grow by acquiring genes involved in the transport and catalysis of external nutrients, driven by adaptations to changing environments. Accordingly, horizontally transferred genes are integrated at the periphery of the network, whereas central parts remain evolutionarily stable. Genes encoding physiologically coupled reactions are often transferred together, frequently in operons. Thus, bacterial metabolic networks evolve by direct uptake of peripheral reactions in response to changed environments.	European Mol Biol Lab, D-69012 Heidelberg, Germany; Eotvos Lorand Univ, MTA, Theoret Biol & Ecol Res Grp, H-1117 Budapest, Hungary; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	European Molecular Biology Laboratory (EMBL); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand University; University of Manchester; University of Bath	Lercher, MJ (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69012 Heidelberg, Germany.	lercher@embl.de	asif, huma/C-1441-2012; Lercher, Martin/K-7939-2013	Lercher, Martin/0000-0003-3940-1621; Papp, Balazs/0000-0003-3093-8852				Almaas E, 2004, NATURE, V427, P839, DOI 10.1038/nature02289; Alves R, 2002, J MOL BIOL, V320, P751, DOI 10.1016/S0022-2836(02)00546-6; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Hooper SD, 2003, MOL BIOL EVOL, V20, P945, DOI 10.1093/molbev/msg101; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Lawrence JG, 2003, MOL MICROBIOL, V50, P739, DOI 10.1046/j.1365-2958.2003.03778.x; LAWRENCE JG, 1991, J MOL EVOL, V33, P241, DOI 10.1007/BF02100675; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2; Ochman H, 1994, EXS, V69, P479; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reed JL, 2004, GENOME RES, V14, P1797, DOI 10.1101/gr.2546004; Rison SCG, 2002, J MOL BIOL, V318, P911, DOI 10.1016/S0022-2836(02)00140-7; Salgado H, 2004, NUCLEIC ACIDS RES, V32, pD303, DOI 10.1093/nar/gkh140; Schmidt S, 2003, TRENDS BIOCHEM SCI, V28, P336, DOI 10.1016/S0968-0004(03)00114-2; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Snel B, 2004, GENOME RES, V14, P391, DOI 10.1101/gr.1969504; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Taoka M, 2004, MOL CELL PROTEOMICS, V3, P780, DOI 10.1074/mcp.M400030-MCP200; Teichmann SA, 2001, J MOL BIOL, V311, P693, DOI 10.1006/jmbi.2001.4912; Thatcher JW, 1998, P NATL ACAD SCI USA, V95, P253, DOI 10.1073/pnas.95.1.253; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005	30	351	361	2	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2005	37	12					1372	1375		10.1038/ng1686	http://dx.doi.org/10.1038/ng1686			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16311593				2022-12-17	WOS:000233657300019
J	Haider, NB; Jacobson, SG; Cideciyan, AV; Swiderski, R; Streb, LM; Searby, C; Beck, G; Hockey, R; Hanna, DB; Gorman, S; Duhl, D; Carmi, R; Bennett, J; Weleber, RG; Fishman, GA; Wright, AF; Stone, EM; Sheffield, VC				Haider, NB; Jacobson, SG; Cideciyan, AV; Swiderski, R; Streb, LM; Searby, C; Beck, G; Hockey, R; Hanna, DB; Gorman, S; Duhl, D; Carmi, R; Bennett, J; Weleber, RG; Fishman, GA; Wright, AF; Stone, EM; Sheffield, VC			Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate	NATURE GENETICS			English	Article							SENSITIVITY	Hereditary human retinal degenerative diseases usually affect the mature photoreceptor topography by reducing the number of cells through apoptosis, resulting in loss of visual function(1). Only one inherited retinal disease, the enhanced S-cone syndrome (ESCS), manifests a gain in function of photoreceptors. ESCS is an autosomal recessive retinopathy in which patients have an increased sensitivity to blue light; perception of blue light is mediated by what is normally the least populous cone photoreceptor subtype, the S (short wavelength, blue) cones(2-8). People with ESCS also suffer visual loss, with night blindness occurring from early in life, varying degrees of L (long, red)- and M (middle, green)-cone vision, and retinal degeneration. The altered ratio of S- to L/M-cone photoreceptor sensitivity in ESCS may be due to abnormal cone cell fate determination during retinal development(7). In 94% of a cohort of ESCS probands we found mutations in NR2E3 (also known as PNR), which encodes a retinal nuclear receptor recently discovered to be a ligand-dependent transcription factor(9). Expression of NR2E3 was limited to the outer nuclear layer of the human retina. Our results suggest that NR2E3 has a role in determining photoreceptor phenotype during human retinogenesis.	Univ Iowa, Howard Hughes Med Inst, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Dept Ophthalmol, Iowa City, IA 52242 USA; Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA; Chiron Corp, Emeryville, CA 94608 USA; Ben Gurion Univ Negev, Inst Genet, Soroka Med Ctr, IL-84105 Beer Sheva, Israel; Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; Univ Illinois, Coll Med, Dept Ophthalmol, Chicago, IL USA; Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Pennsylvania; Pennsylvania Medicine; Novartis; Ben Gurion University; Soroka Medical Center; Oregon Health & Science University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Edinburgh	Sheffield, VC (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Pediat, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Searby, Charles/0000-0002-8108-8782; Jacobson, Samuel/0000-0003-2122-169X; Stone, Edwin M./0000-0003-3343-4414; Sheffield, Val/0000-0002-6282-0835	NATIONAL EYE INSTITUTE [R01EY010539, R01EY011298] Funding Source: NIH RePORTER; NEI NIH HHS [EY11298, EY10539, EY05627] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER R, 1993, INVEST OPHTH VIS SCI, V34, P1677; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; Bumsted K, 1999, J COMP NEUROL, V403, P502; CARMI R, 1995, AM J MED GENET, V59, P199, DOI 10.1002/ajmg.1320590216; CEPKO CL, 1993, PROG RETIN RES, V12, P1, DOI 10.1016/0278-4327(93)90002-B; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chen F, 1999, P NATL ACAD SCI USA, V96, P15149, DOI 10.1073/pnas.96.26.15149; Daniel A, 1999, DEVELOPMENT, V126, P2945; FAVRE M, 1958, Ophthalmologica, V135, P604; FISHMAN GA, 1976, BRIT J OPHTHALMOL, V60, P345, DOI 10.1136/bjo.60.5.345; FISHMAN GA, 1989, OPHTHALMOLOGY, V96, P913; Freund C, 1996, HUM MOL GENET, V5, P1471, DOI 10.1093/hmg/5.Supplement_1.1471; Greenstein VC, 1996, VISION RES, V36, P3711, DOI 10.1016/0042-6989(96)00073-9; HENDRICKSON A, 1996, GREAT BAS VIS SCI S, P42; HOOD DC, 1995, VISION RES, V35, P1473, DOI 10.1016/0042-6989(95)98727-Q; JACOB JB, 1991, 6TH P WORLD TEL FOR, V1, P111; JACOBSON SG, 1990, INVEST OPHTH VIS SCI, V31, P827; Jacobson SG, 1998, INVEST OPHTH VIS SCI, V39, P2417; KELLNER U, 1993, CLIN VISION SCI, V8, P425; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; MARMOR MF, 1990, AM J OPHTHALMOL, V110, P124, DOI 10.1016/S0002-9394(14)76980-6; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; ROMAN AJ, 1991, EXP EYE RES, V53, P685, DOI 10.1016/0014-4835(91)90230-C; Swiderski RE, 1999, MOL BRAIN RES, V68, P64, DOI 10.1016/S0169-328X(99)00085-6; SZEL A, 1994, DEV BRAIN RES, V81, P1, DOI 10.1016/0165-3806(94)90062-0; SZEL A, 1994, NATURE, V370, P336, DOI 10.1038/370336a0; WIKLER KC, 1994, P NATL ACAD SCI USA, V91, P6534, DOI 10.1073/pnas.91.14.6534; Wikler KC, 1996, PERSPECT DEV NEUROBI, V3, P161; WILLY PJ, 1998, HORMONES SIGNALING, V1, P307	30	351	366	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2000	24	2					127	131		10.1038/72777	http://dx.doi.org/10.1038/72777			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	280LQ	10655056				2022-12-17	WOS:000085104600011
J	Kolquist, KA; Ellisen, LW; Counter, CM; Meyerson, M; Tan, LK; Weinberg, RA; Haber, DA; Gerald, WL				Kolquist, KA; Ellisen, LW; Counter, CM; Meyerson, M; Tan, LK; Weinberg, RA; Haber, DA; Gerald, WL			Expression of TERT in early premalignant lesions and a subset of cells in normal tissues	NATURE GENETICS			English	Article							TELOMERASE ACTIVITY; HUMAN BREAST; CANCER; RNA	Activation of telomerase, the enzyme that synthesizes the telomere ends of linear chromosomes, has been implicated in human cell immortalization and cancer cell pathogenesis. Enzyme activity is undetectable in most normal cells and tissues, but present in immortal cells and cancer tissues(1-3). While expression of TERC, the RNA component of telomerase, is widespread(4-6), the restricted expression pattern of TERT, the telomerase catalytic subunit gene, is correlated with telomerase activity(7-9), and its ectopic expression in telomerase-negative cells is sufficient to reconstitute telomerase activity(10-12) and extend cellular lifespan(13). We have used in situ hybridization to study TERT expression at the single-cell level in normal tissues and in various stages of tumour progression. In normal tissues, including some that are known to be telomerase-negative, TERT mRNA was present in specific subsets of cells thought to have long-term proliferative capacity. This included mitotically inactive breast lobular epithelium in addition to some actively regenerating cells such as the stratum basale of the skin. TERT expression appeared early during tumorigenesis in vivo, beginning with early pre-invasive changes in human breast and colon tissues and increasing mRNA present within individual cells and in the number of expressing cells within a neoplastic lesion. The physiological expression of TERT within normal epithelial cells that retain of tumorigenesis have implications for the regulation of telomerase expression and for the identification of cells that may be targets for malignant transformation.	Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute	Gerald, WL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	geraldw@mskcc.org	Meyerson, Matthew L/E-7123-2012; Ellisen, Leif W/AAA-6572-2022	Ellisen, Leif W/0000-0003-0444-7910; Counter, Christopher M/0000-0003-0748-3079	NCI NIH HHS [CA 58596, CA 68273, CA 39826] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068273, R35CA039826, R01CA058596, R37CA058596] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Avilion AA, 1996, CANCER RES, V56, P645; BELAIR CD, 1997, P NATL ACAD SCI USA, V94, P13667; BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; CHADENEAU C, 1995, CANCER RES, V55, P2533; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Greaves M, 1996, TRENDS GENET, V12, P127, DOI 10.1016/0168-9525(96)30016-4; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; Harrington L, 1997, GENE DEV, V11, P3109, DOI 10.1101/gad.11.23.3109; Hiyama E, 1996, INT J ONCOL, V9, P453; Hiyama E, 1996, J NATL CANCER I, V88, P116, DOI 10.1093/jnci/88.2.116; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kyo S, 1997, CANCER RES, V57, P610; Lee SB, 1997, NAT GENET, V17, P309, DOI 10.1038/ng1197-309; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Ramakrishnan S, 1998, CANCER RES, V58, P622; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Takubo K, 1997, J SURG ONCOL, V66, P88, DOI 10.1002/(SICI)1096-9098(199710)66:2<88::AID-JSO3>3.0.CO;2-H; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; WELLINGS SR, 1975, J NATL CANCER I, V55, P231; Yashima K, 1998, CLIN CANCER RES, V4, P229; Yasumoto S, 1996, ONCOGENE, V13, P433	30	351	382	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					182	186		10.1038/554	http://dx.doi.org/10.1038/554			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620778				2022-12-17	WOS:000073865100029
J	Jouanolle, AM; Gandon, G; Jezequel, P; Blayau, M; Campion, ML; Yaouanq, J; Mosser, J; Fergelot, P; Chauvel, B; Bouric, P; Carn, G; Andrieux, N; Gicquel, I; LeGall, JY; David, V				Jouanolle, AM; Gandon, G; Jezequel, P; Blayau, M; Campion, ML; Yaouanq, J; Mosser, J; Fergelot, P; Chauvel, B; Bouric, P; Carn, G; Andrieux, N; Gicquel, I; LeGall, JY; David, V			Haemochromatosis and HLA-H	NATURE GENETICS			English	Letter							HEMOCHROMATOSIS GENE; D6S105		FAC MED,UPR 41 CNRS,F-35043 RENNES,FRANCE; CHU PONTCHAILLOU,SERV GENET MOL & HORMONOL,F-35033 RENNES,FRANCE; CHU PONTCHAILLOU,SERV EPIDEMIOL & HYG HOSP,F-35033 RENNES,FRANCE	CHU Rennes; CHU Rennes								BORETTO J, 1992, HUM GENET, V89, P33, DOI 10.1007/BF00207038; DAVID V, 1989, HUM GENET, V81, P123, DOI 10.1007/BF00293887; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gandon G, 1996, HUM GENET, V97, P103, DOI 10.1007/BF00218843; JAZWINSKA EC, 1993, AM J HUM GENET, V53, P347; RAHACHOWDHURY R, 1995, HUM MOL GENET, V4, P1869, DOI 10.1093/hmg/4.10.1869; SIMON M, 1987, AM J HUM GENET, V41, P89; SIMON M, 1990, PRINCIPLE PRACTICE M, P1783; YAOUANQ J, 1994, AM J HUM GENET, V54, P252	9	351	354	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					251	252		10.1038/ng1196-251	http://dx.doi.org/10.1038/ng1196-251			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896550				2022-12-17	WOS:A1996VQ14600014
J	RUDOLPH, U; FINEGOLD, MJ; RICH, SS; HARRIMAN, GR; SRINIVASAN, Y; BRABET, P; BOULAY, G; BRADLEY, A; BIRNBAUMER, L				RUDOLPH, U; FINEGOLD, MJ; RICH, SS; HARRIMAN, GR; SRINIVASAN, Y; BRABET, P; BOULAY, G; BRADLEY, A; BIRNBAUMER, L			ULCERATIVE-COLITIS AND ADENOCARCINOMA OF THE COLON IN G-ALPHA(I2)-DEFICIENT MICE	NATURE GENETICS			English	Article							INFLAMMATORY BOWEL-DISEASE; G-PROTEINS; ALPHA-SUBUNITS; ADENYLYL-CYCLASE; K+ CHANNELS; CELLS; MEMBRANES; TRANSFORMATION; INHIBITION; ONCOGENES	G proteins are involved in cellular signalling and regulate a variety of biological processes including differentiation and development. We have generated mice deficient for the G protein subunit alpha(i2) (G alpha(i2)) by homologous recombination in embryonic stem cells. G alpha(i2)-deficient mice display growth retardation and develop a lethal diffuse colitis with clinical and histopathological features closely resembling ulcerative colitis in humans, including the development of adenocarcinoma of the colon. Prior to clinical symptoms, the mice show profound alterations in thymocyte maturation and function. The study of these animals should provide important insights into the pathogenesis of ulcerative colitis as well as carcinogenesis.	BAYLOR COLL MED, DEPT CELL BIOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT PHARMACOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT PATHOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MICROBIOL & IMMUNOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MED, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MOLEC PHYSIOL & BIOPHYS, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DIV NEUROSCI, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MOLEC & HUMAN GENET, HOUSTON, TX 77030 USA; BAYLOR COLL MED, HOWARD HUGHES MED INST, HOUSTON, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute			Boulay, Guylain/D-9773-2010; Brabet, Philippe/AAO-8522-2020	Brabet, Philippe/0000-0003-2739-1622; Bradley, Allan/0000-0002-2349-8839				BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; CODINA J, 1991, J RECEPTOR RES, V11, P587, DOI 10.3109/10799899109066429; ELSON CO, 1984, J IMMUNOL METHODS, V67, P101, DOI 10.1016/0022-1759(84)90089-9; FISCHER M, 1991, J IMMUNOL, V146, P3452; GUPTA SK, 1992, MOL CELL BIOL, V12, P190, DOI 10.1128/MCB.12.1.190; GUPTA SK, 1992, J BIOL CHEM, V267, P7987; HERMOUET S, 1991, P NATL ACAD SCI USA, V88, P10455, DOI 10.1073/pnas.88.23.10455; HSU WH, 1990, J BIOL CHEM, V265, P11220; KIRSCH GE, 1990, AM J PHYSIOL, V259, pH820, DOI 10.1152/ajpheart.1990.259.3.H820; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; MONTMAYEUR JP, 1994, SCIENCE, V263, P95, DOI 10.1126/science.8272874; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; MOXHAM CM, 1993, SCIENCE, V260, P991, DOI 10.1126/science.8493537; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; PACE AM, 1991, P NATL ACAD SCI USA, V88, P7031, DOI 10.1073/pnas.88.16.7031; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; RUDOLPH U, 1993, TRANSGENIC RES, V2, P345, DOI 10.1007/BF01976176; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SCHERER NM, 1987, ARCH BIOCHEM BIOPHYS, V259, P431, DOI 10.1016/0003-9861(87)90509-1; SCHREIBER S, 1992, GASTROENTEROL CLIN N, V21, P451; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0; YATANI A, 1987, MOL ENDOCRINOL, V1, P283, DOI 10.1210/mend-1-4-283; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0	31	351	362	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1995	10	2					143	150		10.1038/ng0695-143	http://dx.doi.org/10.1038/ng0695-143			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663509				2022-12-17	WOS:A1995RA85700010
J	RISCH, N; DELEON, D; OZELIUS, L; KRAMER, P; ALMASY, L; SINGER, B; FAHN, S; BREAKEFIELD, X; BRESSMAN, S				RISCH, N; DELEON, D; OZELIUS, L; KRAMER, P; ALMASY, L; SINGER, B; FAHN, S; BREAKEFIELD, X; BRESSMAN, S			GENETIC-ANALYSIS OF IDIOPATHIC TORSION DYSTONIA IN ASHKENAZI JEWS AND THEIR RECENT DESCENT FROM A SMALL FOUNDER POPULATION	NATURE GENETICS			English	Article							AUTOSOMAL DOMINANT INHERITANCE; TAY-SACHS DISEASE; LINKAGE ANALYSIS; MAP; ASSOCIATIONS; DRIFT; HLA	We have examined data on six closely linked microsatellite loci on chromosome 9q34 from 59 Ashkenazi Jewish families with idiopathic torsion dystonia (ITD). Our data show that the vast majority (>90%) of early-onset ITD cases in the Ashkenazi population are due to a single founder mutation, which we estimate first appeared approximately 350 years ago. We also show that carriers preferentially originate from the northern part of the historic Jewish Pale of settlement (Lithuania and Byelorussia). The recent origin of this dominant mutation and its current high frequency (between 1/6,000 and 1/2,000) suggest that the Ashkenazi population descends from a limited group of founders, and emphasize the importance of genetic drift in determining disease allele frequencies in this population.	YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06520; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06520; COLUMBIA PRESBYTERIAN MED CTR,INST NEUROL,DYSTONIA CLIN RES CTR,NEW YORK,NY 10032; MASSACHUSETTS GEN HOSP E,NEUROSCI CTR NEUROL,MOLEC NEUROGENET UNIT,BOSTON,MA 02129; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; PRINCETON UNIV,OFF POPULAT RES,PRINCETON,NJ 08544	Yale University; Yale University; Columbia University; NewYork-Presbyterian Hospital; Harvard University; Harvard Medical School; Oregon Health & Science University; Harvard University; Harvard Medical School; Princeton University			Peng, Bo/A-6920-2009; Almasy, Laura/V-3156-2019	Peng, Bo/0000-0001-8225-2284; 	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026656, R01NS028384] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00348] Funding Source: Medline; NINDS NIH HHS [NS26656, NS28384] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO, V29, P856; [Anonymous], 1992, AM JEWISH YB; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; BREAKEFIELD XO, 1986, J NEUROGENET, V3, P159, DOI 10.3109/01677068609106846; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; BRESSMAN SB, 1994, ANN NEUROL, V36, P771, DOI 10.1002/ana.410360514; CHAKRAVARTI A, 1978, AM J HUM GENET, V30, P256; CHASE GA, 1972, AM J HUM GENET, V24, P339; COX T K, 1989, American Journal of Human Genetics, V45, pA136; DIAMOND JM, 1994, NATURE, V368, P291, DOI 10.1038/368291a0; Eldridge R, 1976, Adv Neurol, V14, P457; ELDRIDGE R, 1970, NEUROLOGY, V20, P1; ELLIS NA, 1994, AM J HUM GENET, V55, P453; FAHN S, 1986, CLIN NEUROPHARMAC S2, V9, P537; FLETCHER NA, 1990, BRAIN, V113, P379, DOI 10.1093/brain/113.2.379; FRAIKOR AL, 1977, SOC BIOL, V24, P117, DOI 10.1080/19485565.1977.9988272; GOODMAN RM, 1978, GENETIC DISORDERS JE; HAINES JL, 1990, GENOMICS, V8, P1, DOI 10.1016/0888-7543(90)90218-J; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HENSKE EP, 1993, GENOMICS, V17, P587, DOI 10.1006/geno.1993.1376; JORDE LB, 1992, GENETIC DIVERSITY AMONG JEWS, P305; KORCZYN AD, 1980, ANN NEUROL, V8, P387, DOI 10.1002/ana.410080409; KRAMER PL, 1990, ANN NEUROL, V27, P114, DOI 10.1002/ana.410270203; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; MOTULSKY AG, 1979, GENETIC DIS ASHKENAZ, P301; OTT J, 1976, AM J HUM GENET, V28, P528; OTT J, 1985, ANAL HUMAN GENETIC L; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; RISCH NJ, 1990, AM J HUM GENET, V46, P533; ROTTER JI, 1987, NATURE, V329, P289, DOI 10.1038/329289a0; SCHWALBE W, 1908, THESIS U BUCHDRUKERE; SERRE JL, 1990, HUM GENET, V84, P449; THOMSON G, 1981, THEOR POPUL BIOL, V20, P168, DOI 10.1016/0040-5809(81)90009-5; WAGENER D, 1978, AM J HUM GENET, V30, P262; Weinryb Bernard, 1972, JEWS POLAND SOCIAL E; YOKOYAMA S, 1979, ANN HUM GENET, V43, P133, DOI 10.1111/j.1469-1809.1979.tb02005.x; Zeman W, 1967, Psychiatr Neurol Neurochir, V70, P77; ZILBER N, 1984, J MED GENET, V218, P13; 1993, STAT ABSTR US 1993	41	351	362	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					152	159		10.1038/ng0295-152	http://dx.doi.org/10.1038/ng0295-152			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719342				2022-12-17	WOS:A1995QE67200016
J	SHEFFIELD, VC; STONE, EM; ALWARD, WLM; DRACK, AV; JOHNSON, AT; STREB, LM; NICHOLS, BE				SHEFFIELD, VC; STONE, EM; ALWARD, WLM; DRACK, AV; JOHNSON, AT; STREB, LM; NICHOLS, BE			GENETIC-LINKAGE OF FAMILIAL OPEN-ANGLE GLAUCOMA TO CHROMOSOME-1Q21-Q31	NATURE GENETICS			English	Article							ATRIAL-NATRIURETIC-FACTOR; DINUCLEOTIDE REPEAT POLYMORPHISM; INTRAOCULAR-PRESSURE; CILIARY PROCESSES; GENOMIC DNA; RECEPTOR; EXPRESSION; SEQUENCE; CYCLASE; BLOOD	Glaucoma is a significant cause of blindness world wide. There is evidence to suggest that at least a subset of the disease is determined genetically. We studied 37 members of a family affected with an autosomal dominant form of juvenile open angle glaucoma and 22 were found to be affected. Linkage analysis using short tandem repeat markers mapped the disease-causing gene to chromosome 1q21-q31. Eight markers were significantly linked (Z(max) > 3.0) to the disease, with the highest lod score 6.5 (theta=0), provided by D1S212. The atrial natriuretic peptide (ANP)/receptor system has been proposed to have a role in glaucoma and one of the ANP receptor genes maps to chromosome 1q.	UNIV IOWA HOSP & CLIN,DEPT OPHTHALMOL,IOWA CITY,IA 52242; UNIV IOWA HOSP & CLIN,DEPT PEDIAT,IOWA CITY,IA 52242	University of Iowa; University of Iowa			Alward, Wallace/AAY-4149-2020	Drack, Arlene/0000-0002-8195-8426; Alward, Wallace/0000-0001-6368-9018; Johnson, Arlan/0000-0002-9519-2943; Stone, Edwin M./0000-0003-3343-4414	NEI NIH HHS [EY08426] Funding Source: Medline; NHGRI NIH HHS [HG00457, P50HG00835] Funding Source: Medline; NATIONAL EYE INSTITUTE [R29EY008426] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000835, R01HG000457] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ARMALY MF, 1968, ARCH OPHTHALMOL-CHIC, V80, P354; ARMALY MF, 1967, ARCH OPHTHALMOL-CHIC, V78, P187; ARMALY MF, 1966, ARCH OPHTHALMOL-CHIC, V75, P32; ARMALY MF, 1967, ARCH OPHTHALMOL-CHIC, V78, P5; BIANCHI C, 1986, CURR EYE RES, V5, P283, DOI 10.3109/02713688609020054; BIRO I, 1951, OPHTHALMOLOGICA, V122, P228, DOI 10.1159/000301064; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; DEBOLD AJ, 1985, SCIENCE, V230, P767, DOI 10.1126/science.2932797; DIESTELHORST M, 1989, INT OPHTHALMOL, V13, P99, DOI 10.1007/BF02028647; FERNANDEZDURANGO R, 1990, VISION RES, V30, P1305, DOI 10.1016/0042-6989(90)90004-5; FERNANDEZDURANGO R, 1991, EXP EYE RES, V53, P591, DOI 10.1016/0014-4835(91)90217-3; FRANCOIS J, 1966, AM J OPHTHALMOL, V61, P652, DOI 10.1016/0002-9394(66)91201-3; FULLER F, 1988, J BIOL CHEM, V263, P9395; GARBERS DL, 1989, J BIOL CHEM, V264, P9103; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; GUTKOWSKA J, 1989, ENDOCR REV, V10, P519, DOI 10.1210/edrv-10-4-519; HARRIS D, 1965, AM J OPHTHALMOL, V60, P91, DOI 10.1016/0002-9394(65)92398-6; HOSKINS HD, 1989, BECKER SHAFFERS DIAG, V678; INAGAMI T, 1989, J BIOL CHEM, V264, P3043; JOHNSON AT, 1993, OPHTHALMOLOGY, V100, P524; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEIGHTON DA, 1976, T OPHTHAL SOC UK, V96, P28; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; LOWE DG, 1990, GENOMICS, V8, P304, DOI 10.1016/0888-7543(90)90286-4; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; Miller S J, 1962, Br J Ophthalmol, V46, P513, DOI 10.1136/bjo.46.9.513; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; NEEDLEMAN P, 1986, NEW ENGL J MED, V314, P828; Nichols B. E., 1992, American Journal of Human Genetics, V51, pA369; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PHELPS CD, 1974, GENETIC METABOLIC EY, P237; QUIRION R, 1984, PEPTIDES, V5, P1167, DOI 10.1016/0196-9781(84)90183-9; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1168, DOI 10.1093/nar/19.5.1168-a; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; WAARDENBURG P. J., 1950, GENETICA, V25, P79; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2835; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	37	351	401	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					47	50		10.1038/ng0593-47	http://dx.doi.org/10.1038/ng0593-47			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8513321				2022-12-17	WOS:A1993LA33700011
J	King, JC; Xu, J; Wongvipat, J; Hieronymus, H; Carver, BS; Leung, DH; Taylor, BS; Sander, C; Cardiff, RD; Couto, SS; Gerald, WL; Sawyers, CL				King, Jennifer C.; Xu, Jin; Wongvipat, John; Hieronymus, Haley; Carver, Brett S.; Leung, David H.; Taylor, Barry S.; Sander, Chris; Cardiff, Robert D.; Couto, Suzana S.; Gerald, William L.; Sawyers, Charles L.			Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis	NATURE GENETICS			English	Article							CANCER; FUSION; EXPRESSION; PTEN; ERG; MYC	The TMPRSS2-ERG fusion, present in approximately 50% of prostate cancers, is less common in prostatic intraepithelial neoplasia (PIN), raising questions about whether TMPRSS2-ERG contributes to disease initiation. We identified the translational start site of a common TMPRSS2-ERG fusion and showed that transgenic TMPRSS2-ERG mice develop PIN, but only in the context of PI3-kinase pathway activation. TMPRSS2-ERG positive human tumors are also enriched for PTEN loss, suggesting cooperation in prostate tumorigenesis.	[King, Jennifer C.; Xu, Jin; Wongvipat, John; Hieronymus, Haley; Carver, Brett S.; Leung, David H.; Gerald, William L.; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Taylor, Barry S.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Ctr, New York, NY USA; [Taylor, Barry S.] Cornell Univ, Weill Med Coll, Dept Phys & Biophys, New York, NY USA; [Cardiff, Robert D.] Univ Calif Davis, Dept Pathol & Lab Med, Ctr Comparat Med, Davis, CA 95616 USA; [Couto, Suzana S.] Mem Sloan Kettering Canc Ctr, Lab Comparat Pathol, New York, NY 10021 USA; [Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California Davis; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	sawyersc@mskcc.org	King, Jennifer C./G-1866-2017; King, Jennifer/F-8318-2010; Sawyers, Charles/G-5327-2016; King, Jennifer/ABN-3578-2022; Sander, Chris/H-1452-2011	King, Jennifer C./0000-0002-4394-4103; King, Jennifer/0000-0002-4394-4103; Sander, Chris/0000-0001-6059-6270	NIH/NCI Ruth L. Kirschstein NRSA [7F32CA113132]; Howard Hughes Medical Institute; Doris Duke Foundation; MSKCC Geoffrey Beene Cancer Research Center fellowship; NATIONAL CANCER INSTITUTE [F32CA113132] Funding Source: NIH RePORTER	NIH/NCI Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); MSKCC Geoffrey Beene Cancer Research Center fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J. C. K. is supported by a NIH/NCI Ruth L. Kirschstein NRSA (7F32CA113132). C. L. S. is supported by the Howard Hughes Medical Institute and the Doris Duke Foundation. B. S. T. is supported by a MSKCC Geoffrey Beene Cancer Research Center fellowship. We thank K. Yen, N. Clegg, Y. Chen, T. Shamu and the MSKCC CMG, Proteomics, and Molecular Cytology Core Facilities for technical help and/or discussions. We also thank P. P. Pandolfi (Beth Israel Deaconess Medical Center, Harvard University) for sharing unpublished results and V. Vasioukhin (Fred Hutchinson Cancer Research Center) for providing transgenic prostate lobes.	Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Jhavar S, 2008, J MOL DIAGN, V10, P50, DOI 10.2353/jmoldx.2008.070085; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Xu Q, 2007, P NATL ACAD SCI USA, V104, P17771, DOI 10.1073/pnas.0708476104; Yoshimoto M, 2008, MODERN PATHOL, V21, P1451, DOI 10.1038/modpathol.2008.96; Zhang JF, 2000, ENDOCRINOLOGY, V141, P4698, DOI 10.1210/en.141.12.4698	15	350	355	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					524	526		10.1038/ng.371	http://dx.doi.org/10.1038/ng.371			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19396167	Green Accepted			2022-12-17	WOS:000265575600012
J	Delous, M; Baala, L; Salomon, R; Laclef, C; Vierkotten, J; Tory, K; Golzio, C; Lacoste, T; Besse, L; Ozilou, C; Moutkine, I; Hellman, NE; Anselme, I; Silbermann, F; Vesque, C; Gerhardt, C; Rattenberry, E; Wolf, MTF; Gubler, MC; Martinovic, J; Encha-Razavi, F; Boddaert, N; Gonzales, M; Macher, MA; Nivet, H; Champion, G; Bertheleme, JP; Niaudet, P; McDonald, F; Hildebrandt, F; Johnson, CA; Vekemans, M; Antignac, C; Ruther, U; Schneider-Maunoury, S; Attie-Bitach, T; Saunier, S				Delous, Marion; Baala, Lekbir; Salomon, Remi; Laclef, Christine; Vierkotten, Jeanette; Tory, Kalman; Golzio, Christelle; Lacoste, Tiphanie; Besse, Laurianne; Ozilou, Catherine; Moutkine, Imane; Hellman, Nathan E.; Anselme, Isabelle; Silbermann, Flora; Vesque, Christine; Gerhardt, Christoph; Rattenberry, Eleanor; Wolf, Matthias T. F.; Gubler, Marie Claire; Martinovic, Jelena; Encha-Razavi, Ferechte; Boddaert, Nathalie; Gonzales, Marie; Macher, Marie Alice; Nivet, Hubert; Champion, Gerard; Bertheleme, Jean Pierre; Niaudet, Patrick; McDonald, Fiona; Hildebrandt, Friedhelm; Johnson, Colin A.; Vekemans, Michel; Antignac, Corinne; Ruether, Ulrich; Schneider-Maunoury, Sylvie; Attie-Bitach, Tania; Saunier, Sophie			The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome	NATURE GENETICS			English	Article							LEBER CONGENITAL AMAUROSIS; MUTANT FUSED-TOES; JUVENILE NEPHRONOPHTHISIS; CENTROSOMAL PROTEIN; MUTATIONS; MOUSE; NPHP1; NEPHROCYSTIN-4; ENCODES; CILIUM	Cerebello- oculo- renal syndrome ( CORS), also called Joubert syndrome type B, and Meckel ( MKS) syndrome belong to the group of developmental autosomal recessive disorders that are associated with primary cilium dysfunction. Using SNP mapping, we identified missense and truncating mutations in RPGRIP1L ( KIAA1005) in both CORS and MKS, and we show that inactivation of the mouse ortholog Rpgrip1l ( Ftm) recapitulates the cerebral, renal and hepatic defects of CORS and MKS. In addition, we show that RPGRIP1L colocalizes at the basal body and centrosomes with the protein products of both NPHP6 and NPHP4, known genes associated with MKS, CORS and nephronophthisis ( a related renal disorder and ciliopathy). In addition, the RPGRIP1L missense mutations found in CORS individuals diminishes the interaction between RPGRIP1L and nephrocystin- 4. Our findings show that mutations in RPGRIP1L can cause the multiorgan phenotypic abnormalities found in CORS or MKS, which therefore represent a continuum of the same underlying disorder.	INSERM, Hop Necker Enfants Malad, U574, F-75015 Paris, France; Univ Paris 05, F-75006 Paris, France; Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; Hop Necker Enfants Malad, APHP, F-75015 Paris, France; CNRS, UMR7622, Dev Biol Lab, F-75005 Paris, France; Univ Paris 06, F-75005 Paris, France; Univ Dusseldorf, Inst Entwicklungs & Mol Biol Tiere, EMT, D-40225 Dusseldorf, Germany; Hop Necker Enfants Malad, APHP, Dept Genet, F-75015 Paris, France; Womens Hosp Med Ctr, W Midlands Reg Genet, Birmingham B15 2TG, W Midlands, England; Univ Michigan, Dept Pediat & Human Genet, Ann Arbor, MI 48109 USA; Hop Necker Enfants Malad, F-75015 Paris, France; Hop Trousseau, Dept Foetopathol, F-75012 Paris, France; Hop Robert Debre, APHP, Dept Pediat, F-75019 Paris, France; CHU Bretonneau, Dept Nephrol & Clin Immunol, F-37000 Tours, France; CHU Angers, Dept Pediat Nephrol, F-49100 Angers, France; Ctr Perharidy, F-29680 Roscoff, France; St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Heinrich Heine University Dusseldorf; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Birmingham Women's Hospital; University of Michigan System; University of Michigan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Saint James's University Hospital; University of Leeds	Saunier, S (corresponding author), INSERM, Hop Necker Enfants Malad, U574, F-75015 Paris, France.	saunier@necker.fr	Saunier, Sophie/G-6044-2015; Schneider-Maunoury, Sylvie/K-6795-2017; Gerhardt, Christoph/AAO-4596-2020; ANTIGNAC, Corinne/H-8945-2017; Delous, Marion/H-3850-2017; Delous, Marion/Q-1835-2019; ATTIE-BITACH, Tania/K-1453-2017; Vesque, Christine/Q-8461-2019; Vesque, Christine/L-9839-2017; boddaert, nathalie/GWV-2865-2022	Saunier, Sophie/0000-0002-1069-0047; Schneider-Maunoury, Sylvie/0000-0002-0797-4735; Gerhardt, Christoph/0000-0002-6340-549X; ANTIGNAC, Corinne/0000-0002-9934-4940; Delous, Marion/0000-0003-2666-4457; Delous, Marion/0000-0003-2666-4457; ATTIE-BITACH, Tania/0000-0002-1155-3626; Vesque, Christine/0000-0001-7983-4953; Gubler, Marie-Claire/0000-0002-3526-5661; legendre, flora/0000-0002-4149-1913; Golzio, Christelle/0000-0002-4420-3921; boddaert, nathalie/0000-0003-0991-7774	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK068306] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anselme I, 2007, DEV BIOL, V304, P208, DOI 10.1016/j.ydbio.2006.12.025; BAALA L, IN PRESS AM J HUM GE; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Betz R, 2000, J PEDIATR-US, V136, P828, DOI 10.1067/mpd.2000.106225; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Caridi G, 2006, KIDNEY INT, V70, P1342, DOI 10.1038/sj.ki.5001768; Chen DH, 2001, BIOCHEM BIOPH RES CO, V280, P99, DOI 10.1006/bbrc.2000.4087; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Espinosa-Parrilla Y, 2002, MECH DEVELOP, V114, P187, DOI 10.1016/S0925-4773(02)00062-X; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Patel S, 2002, AM J NEURORADIOL, V23, P1074; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; Saunier S, 2005, CURR OPIN GENET DEV, V15, P324, DOI 10.1016/j.gde.2005.04.012; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Smith A., 1996, Managing Information, V3, P38; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; VANDERHOEVEN F, 1994, DEVELOPMENT, V120, P2601; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355	30	350	355	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					875	881		10.1038/ng2039	http://dx.doi.org/10.1038/ng2039			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17558409				2022-12-17	WOS:000247619800018
J	Chen, K; Rajewsky, N				Chen, Kevin; Rajewsky, Nikolaus			Natural selection on human microRNA binding sites inferred from SNP data	NATURE GENETICS			English	Article							POLYMORPHISM; RNA; IMPACT	A fundamental problem in biology is understanding how natural selection has shaped the evolution of gene regulation. Here we use SNP genotype data and techniques from population genetics to study an entire layer of short, cis-regulatory sites in the human genome. MicroRNAs (miRNAs) are a class of small noncoding RNAs that post-transcriptionally repress mRNA through cis-regulatory sites in 3 ' UTRs. We show that negative selection in humans is stronger on computationally predicted conserved miRNA binding sites than on other conserved sequence motifs in 3 ' UTRs, thus providing independent support for the target prediction model and explicitly demonstrating the contribution of miRNAs to darwinian fitness. Our techniques extend to nonconserved miRNA binding sites, and we estimate that 30%-50% of these are functional when the mRNA and miRNA are endogenously coexpressed. As we show that polymorphisms in predicted miRNA binding sites are likely to be deleterious, they are candidates for causal variants of human disease. We believe that our approach can be extended to studying other classes of cis-regulatory sites.	NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA; Max Delbruck Ctr Mol Med, Berlin, Germany	New York University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rajewsky, N (corresponding author), NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA.	rajewsky@mdc-berlin.de		Rajewsky, Nikolaus/0000-0002-4785-4332				Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Akashi H, 1999, GENETICS, V151, P221; Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hartl :D. L, 2000, PRIMER POPULATION GE; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; SAWYER SA, 1992, GENETICS, V132, P1161; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	30	350	378	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1452	1456		10.1038/ng1910	http://dx.doi.org/10.1038/ng1910			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17072316				2022-12-17	WOS:000242404200025
J	Conrad, DF; Jakobsson, M; Coop, G; Wen, XQ; Wall, JD; Rosenberg, NA; Pritchard, JK				Conrad, Donald F.; Jakobsson, Mattias; Coop, Graham; Wen, Xiaoquan; Wall, Jeffrey D.; Rosenberg, Noah A.; Pritchard, Jonathan K.			A worldwide survey of haplotype variation and linkage disequilibrium in the human genome	NATURE GENETICS			English	Article							HUMAN-POPULATIONS; HIGH-RESOLUTION; POLYMORPHISM DATA; WIDE ASSOCIATION; WHOLE-GENOME; DIVERSITY; PATTERNS; MAP; PORTABILITY; CHIMPANZEES	Recent genomic surveys have produced high-resolution haplotype information, but only in a small number of human populations. We report haplotype structure across 12 Mb of DNA sequence in 927 individuals representing 52 populations. The geographic distribution of haplotypes reflects human history, with a loss of haplotype diversity as distance increases from Africa. Although the extent of linkage disequilibrium (LD) varies markedly across populations, considerable sharing of haplotype structure exists, and inferred recombination hotspot locations generally match across groups. The four samples in the International HapMap Project contain the majority of common haplotypes found in most populations: averaging across populations, 83% of common 20-kb haplotypes in a population are also common in the most similar HapMap sample. Consequently, although the portability of tag SNPs based on the HapMap is reduced in low-LD Africans, the HapMap will be helpful for the design of genome-wide association mapping studies in nearly all human populations.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Michigan System; University of Michigan; University of Southern California; University of Chicago	Rosenberg, NA (corresponding author), Univ Michigan, Dept Human Genet, 100 Washtenaw Ave, Ann Arbor, MI 48109 USA.	rnoah@umich.edu	Jakobsson, Mattias/A-6116-2011	Jakobsson, Mattias/0000-0001-7840-7853; Coop, Graham/0000-0001-8431-0302; Rosenberg, Noah/0000-0002-1829-8664; Wen, Xiaoquan/0000-0001-8990-2737				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Bonnen PE, 2006, NAT GENET, V38, P214, DOI 10.1038/ng1712; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; DEBAKKER PI, 2006, PAC S BIOCOMPUT, V11, P478; Fearnhead P, 2005, AM J HUM GENET, V77, P781, DOI 10.1086/497579; Gonzalez-Neira A, 2006, GENOME RES, V16, P323, DOI 10.1101/gr.4138406; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Huang W, 2006, P NATL ACAD SCI USA, V103, P1418, DOI 10.1073/pnas.0510360103; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Montpetit A, 2006, PLOS GENET, V2, P282, DOI 10.1371/journal.pgen.0020027; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Pritchard JK, 2000, GENETICS, V155, P945; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rogers AR, 1996, AM J HUM GENET, V58, P1033; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sawyer SL, 2005, EUR J HUM GENET, V13, P677, DOI 10.1038/sj.ejhg.5201368; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Willer CJ, 2006, GENET EPIDEMIOL, V30, P180, DOI 10.1002/gepi.20131; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Yoo YK, 2006, GENETICS, V174, P491, DOI 10.1534/genetics.105.052225; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	35	350	362	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1251	1260		10.1038/ng1911	http://dx.doi.org/10.1038/ng1911			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17057719				2022-12-17	WOS:000241592700013
J	Chang, S; Multani, AS; Cabrera, NG; Naylor, ML; Laud, P; Lombard, D; Pathak, S; Guarente, L; DePinho, RA				Chang, S; Multani, AS; Cabrera, NG; Naylor, ML; Laud, P; Lombard, D; Pathak, S; Guarente, L; DePinho, RA			Essential role of limiting telomeres in the pathogenesis of Werner syndrome	NATURE GENETICS			English	Article							SYNDROME GENE-PRODUCT; IONIZING-RADIATION; WRN; TOPOISOMERASE; DYSFUNCTION; SENSITIVITY; FIBROBLASTS; HELICASES; HOMOLOG; GENOME	Mutational inactivation of the gene WRN causes Werner syndrome, an autosomal recessive disease characterized by premature aging, elevated genomic instability and increased cancer incidence(1,2). The capacity of enforced telomerase expression to rescue premature senescence of cultured cells from individuals with Werner syndrome(3) and the lack of a disease phenotype in Wrn-deficient mice with long telomeres(4) implicate telomere attrition in the pathogenesis of Werner syndrome. Here, we show that the varied and complex cellular phenotypes of Werner syndrome are precipitated by exhaustion of telomere reserves in mice. In late-generation mice null with respect to both Wrn and Terc ( encoding the telomerase RNA component), telomere dysfunction elicits a classical Werner-like premature aging syndrome typified by premature death, hair graying, alopecia, osteoporosis, type II diabetes and cataracts. This mouse model also showed accelerated replicative senescence and accumulation of DNA-damage foci in cultured cells, as well as increased chromosomal instability and cancer, particularly nonepithelial malignancies typical of Werner syndrome. These genetic data indicate that the delayed manifestation of the complex pleiotropic of Wrn deficiency relates to telomere shortening.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT)	Chang, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Box 11,1515 Holcombe Blvd, Houston, TX 77030 USA.	schang@mdanderson.org; ron_depinho@dfci.harvard.edu		Lombard, David/0000-0002-4292-0185; DePinho, Ronald/0000-0002-5625-577X	NATIONAL INSTITUTE ON AGING [K08AG001019, K08AG024873] Funding Source: NIH RePORTER; NIA NIH HHS [K08 AG024873, K08 AG001019] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; EPSTEIN CJ, 1966, MEDICINE, V45, P5893; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Kaneko H, 1999, CLIN EXP IMMUNOL, V118, P285; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; Melcher R, 2000, CYTOGENET CELL GENET, V91, P180, DOI 10.1159/000056841; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Orren DK, 2002, BIOCHEMISTRY-US, V41, P13483, DOI 10.1021/bi0266986; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; SALK D, 1981, CYTOGENET CELL GENET, V30, P92, DOI 10.1159/000131596; Schulz VP, 1996, HUM GENET, V97, P750; Suzuki N, 1997, NUCLEIC ACIDS RES, V25, P2973, DOI 10.1093/nar/25.15.2973; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	24	350	365	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					877	882		10.1038/ng1389	http://dx.doi.org/10.1038/ng1389			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15235603				2022-12-17	WOS:000222974000022
J	Hoffmann, R; Valencia, A				Hoffmann, R; Valencia, A			A gene network for navigating the literature	NATURE GENETICS			English	Letter							MAP		CSIC, CNB, Natl Biotechnol Ctr, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Hoffmann, R (corresponding author), CSIC, CNB, Natl Biotechnol Ctr, Madrid 28049, Spain.	hoffmann@cnb.uam.es; valencia@cnb.uam.es	Valencia, Alfonso/AAN-9230-2020; Valencia, Alfonso/I-3127-2015	Valencia, Alfonso/0000-0002-8937-6789; Valencia, Alfonso/0000-0002-8937-6789				Blaschke C, 2001, Genome Inform, V12, P123; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hoffmann R, 2003, TRENDS GENET, V19, P79, DOI 10.1016/S0168-9525(02)00014-8; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/ng0501-21; Kim W, 2001, J AM MED INFORM ASSN, P319; Koch C, 1999, SCIENCE, V284, P96, DOI 10.1126/science.284.5411.96; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Motter AE, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.065102	8	350	368	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					664	664		10.1038/ng0704-664	http://dx.doi.org/10.1038/ng0704-664			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15226743	Bronze			2022-12-17	WOS:000222354100004
J	St John, MAR; Tao, WF; Fei, XL; Fukumoto, R; Carcangiu, ML; Brownstein, DG; Parlow, AF; McGrath, J; Xu, TA				St John, MAR; Tao, WF; Fei, XL; Fukumoto, R; Carcangiu, ML; Brownstein, DG; Parlow, AF; McGrath, J; Xu, TA			Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction	NATURE GENETICS			English	Article							CYCLINS; PROLIFERATION; HYPERPLASIA; ENCODES; LACKING; CANCER; KINASE; MOUSE; CELLS	The lats gene has been identified as a tumour suppressor in Drosophila melanogaster using mosaic screens(1). Mosaic flies carrying somatic cells that are mutant for lats develop large tumours in many organs(1,2). The human LATS1 homologue res cues embryonic lethality and inhibits tumour growth in lats mutant flies, demonstrating the functional conservation of this gene(3). Biochemical and genetic analyses have revealed that LATS1 functions as a negative regulator of CDC2 (ref. 3). These data suggest that mammalian LATS1 may have a role in tumorigenesis. To elucidate the function of mammalian LATS1, we have generated Lats1(-/-) mice. Lats1(-/-) animals exhibit a lack of mammary grand development, infertility and growth retardation. Accompanying these defects are hyperplastic changes in the pituitary and decreased serum hormone levels. The reproductive hormone defects of Lats1(-/-) mice are reminiscent of isolated LH-hypogonadotropic hypogonadism and corpus luteum insufficiency in humans. Furthermore, Lats1(-/-) mice develop soft-tissue sarcomas and ovarian stromal cell tumours and are highly sensitive to carcinogenic treatments. Our data demonstrate a role for Lats1 in mammalian tumorigenesis and specific endocrine dysfunction.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Genet, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cell Biol, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pathol, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Comparat Med Sect, New Haven, CT 06536 USA; Univ Calif Los Angeles, Harbor Med Ctr, Natl Hormone & Pituitary Program, Torrance, CA 90509 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Yale University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Xu, TA (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.	Tian.Xu@yale.edu			NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA69408] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CLEMENT PB, 1997, HISTOLOGY PATHOLOGIS, P934; DIGIOVANNI J, 1992, PHARMACOL THERAPEUT, V54, P63, DOI 10.1016/0163-7258(92)90051-Z; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; GOSSLER A, 1986, P NATL ACAD SCI USA, V83, P9065, DOI 10.1073/pnas.83.23.9065; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Sprenger F, 1997, CURR BIOL, V7, P488, DOI 10.1016/S0960-9822(06)00220-X; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Thomas BJ, 1997, GENE DEV, V11, P1289, DOI 10.1101/gad.11.10.1289; WHEATER PR, 1987, FUNCTIONAL HISTOLOGY, P290; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; XU TA, 1995, DEVELOPMENT, V121, P1053	22	350	358	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1999	21	2					182	186		10.1038/5965	http://dx.doi.org/10.1038/5965			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	9988269				2022-12-17	WOS:000078399500019
J	Yu, RN; Ito, M; Saunders, TL; Camper, SA; Jameson, JL				Yu, RN; Ito, M; Saunders, TL; Camper, SA; Jameson, JL			Role of Ahch in gonadal development and gametogenesis	NATURE GENETICS			English	Article							ADRENAL HYPOPLASIA CONGENITA; HYPOGONADOTROPIC HYPOGONADISM; ENDOCRINE DEVELOPMENT; DAX-1; RECEPTOR; MICE; EXPRESSION; MUTATIONS; DOMAIN; CELLS	Ahch (also known as Dax1) encodes a transcription factor that has been implicated in sex determination and gonadal differentiation(1-3). Mutations in human AHC cause X-linked, adrenal hypoplasia congenita (AHC) and hypogonadotropic hypogonadism(4,5) (HH). Duplication of the Xp21 dosage-sensitive sex reversal (DSS) region, which contains the Ahch locus(1), and transgenic overexpression of Ahch (ref. 6) cause male-to-female sex reversal. Using Cre-mediated disruption of Ahch, we have generated a mouse model of AHC-HH that allows the function of Ahch to be examined in both males and females. Although Ahch has been postulated to function as an ovarian determination gene(2,6), the loss of Ahch function in females does not affect ovarian development or fertility. Ahch is instead essential for the maintenance of spermatogenesis. Lack of Ahch causes progressive degeneration of the testicular germinal epithelium independent of abnormalities in gonadotropin and testosterone production and results in male sterility. Ahch is thus not an ovarian determining gene, but rather has a critical role in spermatogenesis.	Northwestern Univ, Sch Med, Div Endocrinol Metab & Internal Med, Chicago, IL 60611 USA; Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA	Northwestern University; University of Michigan System; University of Michigan	Jameson, JL (corresponding author), Northwestern Univ, Sch Med, Div Endocrinol Metab & Internal Med, 303 E Super St, Chicago, IL 60611 USA.	ljameson@nwu.edu		Saunders, Thom/0000-0003-2015-101X; Jameson, James/0000-0001-9538-4059; Camper, Sally/0000-0001-8556-3379	NICHD NIH HHS [U54-HD-29164, P30-HD-28048, P01-HD-21921] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD021921] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028048, U54HD029164] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; DUNN TB, 1970, JNCI-J NATL CANCER I, V44, P1323; Habiby RL, 1996, J CLIN INVEST, V98, P1055, DOI 10.1172/JCI118866; Ikeda Y, 1996, MOL ENDOCRINOL, V10, P1261, DOI 10.1210/me.10.10.1261; Ito M, 1997, MOL CELL BIOL, V17, P1476, DOI 10.1128/MCB.17.3.1476; Lalli E, 1997, MOL ENDOCRINOL, V11, P1950, DOI 10.1210/me.11.13.1950; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; ROSSANT J, 1995, NAT MED, V1, P592, DOI 10.1038/nm0695-592; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Swain A, 1997, ACTA PAEDIATR, V86, P46; Tamai KT, 1996, MOL ENDOCRINOL, V10, P1561, DOI 10.1210/me.10.12.1561; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wurst W., 1993, Gene targeting: a practical approach., P33; Yu RN, 1998, TRENDS ENDOCRIN MET, V9, P169, DOI 10.1016/S1043-2760(98)00048-4; Yu RN, 1998, MOL ENDOCRINOL, V12, P1010, DOI 10.1210/me.12.7.1010; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0	23	350	363	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1998	20	4					353	357		10.1038/3822	http://dx.doi.org/10.1038/3822			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843206				2022-12-17	WOS:000077199600021
J	PetrijBosch, A; Peelen, T; vanVliet, M; vanEijk, R; Olmer, R; Drusedau, M; Hogervorst, FBL; Hageman, S; Arts, PJW; Ligtenberg, MJL; MeijersHeijboer, H; Klijn, JGM; Vasen, HFA; Cornelisse, CJ; vantVeer, LJ; Bakker, E; vanOmmen, GJB; Devilee, P				PetrijBosch, A; Peelen, T; vanVliet, M; vanEijk, R; Olmer, R; Drusedau, M; Hogervorst, FBL; Hageman, S; Arts, PJW; Ligtenberg, MJL; MeijersHeijboer, H; Klijn, JGM; Vasen, HFA; Cornelisse, CJ; vantVeer, LJ; Bakker, E; vanOmmen, GJB; Devilee, P			BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients	NATURE GENETICS			English	Article							EARLY-ONSET BREAST; OVARIAN-CANCER; FAMILIES; GENE	To date, more than 300 distinct small deletions, insertions and point mutations, mostly leading to premature termination of translation(1), have been reported in the breast/ovarian-cancer susceptibility gene BRCA1. The elevated frequencies of some mutations in certain ethnic subpopulations(2-4) are caused by founder effects(5,6), rather than by mutation hotspots. Here we report that the currently available mutation spectrum of BRCA1 has been biased by PCR-based mutation-screening methods, such as SSCP, the protein truncation test (PTT) and direct sequencing, using genomic DNA as template. Three large genomic deletions that are not detected by these approaches comprise 36% of all BRCA1 mutations found in Dutch breast-cancer families to date. A 510-bp Alu-mediated deletion comprising exon 22 was found in 8 of 170 breast-cancer families recruited for research purposes and in 6 of 49 probands referred to the Amsterdam Family Cancer Clinic for genetic counselling. In addition, a 3,835-bp Alu-mediated deletion encompassing exon 13 was detected in 6 of the 170 research families, while an deletion of approximately 14 kb was detected in a single family. Haplotype analyses indicated that each recurrent deletion had a single common ancestor.	LEIDEN UNIV,MED CTR,DEPT HUMAN GENET,NL-2300 RA LEIDEN,NETHERLANDS; LEIDEN UNIV,MED CTR,DEPT PATHOL,NL-2300 RA LEIDEN,NETHERLANDS; NETHERLANDS CANC INST,DEPT PATHOL,NL-1066 CX AMSTERDAM,NETHERLANDS; NETHERLANDS CANC INST,FAMILY CANC CTR,NL-1066 CX AMSTERDAM,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,NL-6500 HB NIJMEGEN,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,NL-3000 DR ROTTERDAM,NETHERLANDS; DR DANIEL DEN HOED CANC CTR,NL-3008 AE ROTTERDAM,NETHERLANDS; FAMILY CANC CTR,ROTTERDAM,NETHERLANDS; FDN DETECT HEREDITARY TUMOURS,LEIDEN,NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Netherlands Cancer Institute; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute			Ligtenberg, Marjolijn/N-9666-2013; Bakker, Egbert/D-3525-2009; DEVILEE, PETER/ABR-2140-2022	Ligtenberg, Marjolijn/0000-0003-1290-1474; Bakker, Egbert/0000-0002-2843-7357; Vasen, Hans/0000-0003-2682-2603				Caligo MA, 1996, ONCOGENE, V13, P1483; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; Durocher F, 1996, J MED GENET, V33, P814, DOI 10.1136/jmg.33.10.814; EASTON DF, 1993, AM J HUM GENET, V52, P678; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Hamann U, 1997, GENE CHROMOSOME CANC, V18, P126, DOI 10.1002/(SICI)1098-2264(199702)18:2<126::AID-GCC7>3.3.CO;2-O; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; INOUE R, 1995, CANCER RES, V55, P3521; Katagiri T, 1996, HUM MUTAT, V7, P334, DOI 10.1002/(SICI)1098-1004(1996)7:4<334::AID-HUMU7>3.0.CO;2-8; NAROD SA, 1995, AM J HUM GENET, V56, P254; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Peelen T, 1997, AM J HUM GENET, V60, P1041; Peelen T, 1996, EUR J HUM GENET, V4, P225; Puget N, 1997, CANCER RES, V57, P828; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; Szabo CI, 1997, AM J HUM GENET, V60, P1013; Xu CF, 1997, GENE CHROMOSOME CANC, V18, P102, DOI 10.1002/(SICI)1098-2264(199702)18:2<102::AID-GCC4>3.3.CO;2-A	25	350	360	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					341	345		10.1038/ng1197-341	http://dx.doi.org/10.1038/ng1197-341			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354803	Green Published			2022-12-17	WOS:A1997YD66700033
J	Kruglyak, L				Kruglyak, L			The use of a genetic map of biallelic markers in linkage studies	NATURE GENETICS			English	Article							HUMAN GENOME; HUMAN DNA; POLYMORPHISMS; HETEROZYGOSITY; TRAITS; ASSAY; SETS	Improvements in genetic mapping techniques have driven recent progress in human genetics. The use of single nucleotide polymorphisms (SNPs) as biallelic genetic markers offers the promise of rapid, highly automated genotyping. As maps of SNPs and the techniques for genotyping them are being developed, it is important to consider what properties such maps must have in order for them to be useful for linkage studies. I examine how polymorphic and densely spaced biallelic markers need to be for extraction of most of the inheritance information from human pedigrees, and compare maps of biallelics with today's genome-scanning sets of microsatellite markers. I conclude that a map of 700-900 moderately polymorphic biallelic markers is equivalent-and a map of 1,500-3,000 superior-to the current 300-400 microsatellite marker sets.			Kruglyak, L (corresponding author), WHITEHEAD INST BIOMED RES, 1 KENDALL SQ, BLDG 300, CAMBRIDGE, MA 02139 USA.				NHGRI NIH HHS [HG00017] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BROWN DL, 1994, AM J HUM GENET, V54, P544; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; ELSTON RC, 1992, 16TH P INT BIOM C HA, P39; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HOFKER MH, 1986, AM J HUM GENET, V39, P438; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NICKERSON DA, 1990, P NATL ACAD SCI USA, V87, P8923, DOI 10.1073/pnas.87.22.8923; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; TERWILLIGER JD, 1992, GENOMICS, V13, P951, DOI 10.1016/0888-7543(92)90006-E; Wang D., 1996, American Journal of Human Genetics, V59, pA3; WEBER JL, 1989, AM J HUM GENET, V44, P388; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	28	350	394	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1997	17	1					21	24		10.1038/ng0997-21	http://dx.doi.org/10.1038/ng0997-21			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU724	9288093				2022-12-17	WOS:A1997XU72400013
J	Liu, XZ; Walsh, J; Mburu, P; KendrickJones, J; Cope, MJTV; Steel, KP; Brown, SDM				Liu, XZ; Walsh, J; Mburu, P; KendrickJones, J; Cope, MJTV; Steel, KP; Brown, SDM			Mutations in the myosin VIIA gene cause non-syndromic recessive deafness	NATURE GENETICS			English	Article								Genetic hearing impairment affects around 1 in every 2,000 births(1). The bulk (approximately 70%) of genetic deafness is non-syndromic, in which hearing impairment is not associated with any other abnormalities. Over 25 loci involved in nonsyndromic deafness have been mapped and mutations in connexin 26 have been identified as a cause of non-sydromic deafness(2). One locus for non-syndromic recessive deafness, DFNB2 (ref. 4), has been localized to the same chromosomal region, 11q14, as one of the loci, USH1B, underlying the recessive deaf-blind syndrome, Usher syndrome type 1b, which is characterized by profound congenital sensorineural deafness, constant vestibular dysfunction and prepubertal onset of retinitis pigmentosa. Recently, it has been shown that a gene encoding an unconventional myosin, myosin VIIA, underlies the mouse recessive deafness mutation, shaker-1 (ref. 5) as well as Usher syndrome type 1b(6). Mice with shaker-1 demonstrate typical neuroepithelial defects manifested by hearing loss and vestibular dysfunction but no retinal pathology. Differences in retinal patterns of expression may account for the variance in phenotype between shaker-1 mice and Usher type 1 syndrome(7). Nevertheless, the expression of MYO7A in the neuroepithelium suggests that it should be considered a candidate for non-syndromic deafness in the human population. By screening families with non-syndromic deafness from China. we have identified two families carrying MYO7A mutations.	MRC, MOUSE GENOME CTR, HARWELL OX11 0RD, BERKS, ENGLAND; MRC, MAMMALIAN GENET UNIT, HARWELL OX11 0RD, BERKS, ENGLAND; MRC, MOL BIOL LAB, CAMBRIDGE CB2 2QH, ENGLAND; UNIV CALIF BERKELEY, DEPT CELL & MOL BIOL, BERKELEY, CA 94720 USA; MRC, INST HEARING RES, NOTTINGHAM NG7 2RD, ENGLAND	MRC Laboratory Molecular Biology; University of California System; University of California Berkeley				Cope, Jamie/0000-0002-6960-8271				Anderson H, 1968, Acta Otolaryngol, V65, P535; Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; Cope MJTV, 1996, STRUCTURE, V4, P969, DOI 10.1016/S0969-2126(96)00103-7; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Fraser G. R, 1976, BIG 4 CAUSES POVERTY; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; LIU XZ, 1994, AM J MED GENET, V53, P192, DOI 10.1002/ajmg.1320530214; LIU XZ, 1994, ANN OTO RHINOL LARYN, V103, P428, DOI 10.1177/000348949410300602; LIU XZ, IN PRESS HUM MUTAT; MEREDITH R, 1992, J AUDIOL MED, V1, P11; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Solc CK, 1994, AUDIT NEUROSCI, V1, P63; Steel KP, 1996, CURR OPIN NEUROBIOL, V6, P520, DOI 10.1016/S0959-4388(96)80059-6; STEPHENS D, 1996, GENETICS HEARING IMP, P100; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 1996, AM J HUM GENET, V59, P1074	19	350	368	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1997	16	2					188	190		10.1038/ng0697-188	http://dx.doi.org/10.1038/ng0697-188			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XB543	9171832				2022-12-17	WOS:A1997XB54300021
J	Nigro, V; Moreira, ED; Piluso, G; Vainzof, M; Belsito, A; Politano, L; Puca, AA; PassosBueno, MR; Zatz, M				Nigro, V; Moreira, ED; Piluso, G; Vainzof, M; Belsito, A; Politano, L; Puca, AA; PassosBueno, MR; Zatz, M			Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene	NATURE GENETICS			English	Letter							BETA-SARCOGLYCAN; LINKAGE; ADHALIN; PROTEINS; COMPLEX; MAPS		UNIV SAO PAULO,IBUSP,DEPT BIOL,BR-05508900 SAO PAULO,BRAZIL; UNIV NAPLES 2,FAC MED,IST PATOL GEN & ONCOL,I-80138 NAPLES,ITALY; UNIV NAPLES,DIPARTIMENTO INTERNIST CLIN & SPERIMENTALE,NAPLES,ITALY; TELETHON INST GENET & MED,MILAN,ITALY	Universidade de Sao Paulo; Universita della Campania Vanvitelli; University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)			Zatz, Mayana/M-5338-2015; Piluso, Giulio/AAA-3661-2019; Vainzof, Mariz/Q-4787-2019; Moreira, Eloisa/K-9155-2014; PILUSO, Giulio/AAA-3400-2019; Passos-Bueno, Maria Rita/I-6796-2016; Puca, Annibale Alessandro/K-2099-2018; Vainzof, Mariz/J-7150-2012; Nigro, Vincenzo/AAB-2274-2022; POLITANO, LUISA/AAK-6885-2020	Zatz, Mayana/0000-0003-3970-8025; Vainzof, Mariz/0000-0002-2797-0782; PILUSO, Giulio/0000-0001-9418-125X; Passos-Bueno, Maria Rita/0000-0002-9248-3008; Vainzof, Mariz/0000-0002-2797-0782; Nigro, Vincenzo/0000-0002-3378-5006	Telethon [899] Funding Source: Medline	Telethon(Fondazione Telethon)		Argov Z, 1988, DISORDERS VOLUNTARY, Vfifth, P981, DOI [10.1093/med/9780199698073.001.0001/med-9780199698073-chapter-33, DOI 10.1093/MED/9780199698073.001.0001/MED-9780199698073-CHAPTER-33]; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P337, DOI 10.1016/0960-8966(95)00005-8; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; MCNALLY EM, 1994, P NATL ACAD SCI USA, V91, P9690, DOI 10.1073/pnas.91.21.9690; Nigro V, 1996, HUM MOL GENET, V5, P1179, DOI 10.1093/hmg/5.8.1179; NIGRO V, 1992, HUM MOL GENET, V1, P517, DOI 10.1093/hmg/1.7.517; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; OTHMANE KB, 1992, NAT GENET, V2, P316; OWRTON R, 1995, SCIENCE, V270, P755; OZAWA E, 1995, HUM MOL GENET, V4, P1711, DOI 10.1093/hmg/4.suppl_1.1711; PassosBueno MR, 1996, HUM MOL GENET, V5, P815, DOI 10.1093/hmg/5.6.815; PassosBueno MR, 1996, J MED GENET, V33, P97, DOI 10.1136/jmg.33.2.97; PASSOSBUENO MR, 1995, HUM MOL GENET, V4, P1163; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; SPEER MC, 1992, AM J HUM GENET, V50, P1211; VAINZOF M, 1991, J NEUROL SCI, V101, P141, DOI 10.1016/0022-510X(91)90038-9; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x	24	350	360	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					195	198		10.1038/ng1096-195	http://dx.doi.org/10.1038/ng1096-195			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841194				2022-12-17	WOS:A1996VL44600028
J	DUHL, DMJ; VRIELING, H; MILLER, KA; WOLFF, GL; BARSH, GS				DUHL, DMJ; VRIELING, H; MILLER, KA; WOLFF, GL; BARSH, GS			NEOMORPHIC AGOUTI MUTATIONS IN OBESE YELLOW MICE	NATURE GENETICS			English	Article							A-PARTICLE GENES; COAT COLOR; MOUSE; SEQUENCES; ELEMENTS; PROTEIN	Several dominant mutations of the mouse agouti coat colour gene have pleiotropic effects that include obesity and a yellow coat. The A(y) allele is caused by a large deletion that affects the expression of several contiguous genes. We show that three other obesity-associated agouti mutations, A(iy), A(sy) and A(vy), are due to different molecular alterations that result in ubiquitous expression of a chimaeric RNA that encodes a normal agouti protein. The A(iy) and A(vy) alleles are caused by insertion of an intracisternal A particle element 1 kb or 100 kb, respectively, upstream of agouti coding sequences. These results provide a model for other genes that show allele-specific imprinting, and demonstrate that molecular mechanisms typically responsible for activation of proto-oncogenes can also lead to other disease phenotypes.	STANFORD UNIV,SCH MED,DEPT PEDIAT,STANFORD,CA 94305; STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305; US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079	Stanford University; Howard Hughes Medical Institute; Stanford University; US Food & Drug Administration (FDA)			Vrieling, Harry/ABC-8068-2020	Vrieling, Harry/0000-0002-3034-2664	NHGRI NIH HHS [HG-00377] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000377] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALGATE PA, 1993, ONCOGENE, V8, P1221; BARSH GS, 1990, DEVELOPMENT, V109, P683; BUITMAN SJ, 1992, CELL, V71, P1195; CHRISTY RJ, 1985, NUCLEIC ACIDS RES, V13, P289, DOI 10.1093/nar/13.1.289; CHRISTY RJ, 1988, MOL CELL BIOL, V8, P1093, DOI 10.1128/MCB.8.3.1093; CONKLIN BR, 1993, NATURE, V364, P110, DOI 10.1038/364110b0; Danforth C, 1927, J HERED, V18, P153, DOI 10.1093/oxfordjournals.jhered.a102826; DICKERSON GE, 1947, SCIENCE, V105, P496, DOI 10.1126/science.105.2732.496-a; DICKIE MM, 1969, J HERED, V60, P20, DOI 10.1093/oxfordjournals.jhered.a107920; DICKIES MM, 1962, J HERED, V53, P84, DOI 10.1093/oxfordjournals.jhered.a107129; DUHL DMJ, 1994, DEVELOPMENT, V120, P1695; FRIGERI LG, 1988, INT J OBESITY, V12, P305; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Green M. C., 1989, GENETIC VARIANTS STR, P17; HELLERSTROM C, 1963, METABOLISM, V12, P527; HESTON WE, 1961, J NATL CANCER I, V26, P969; HESTON WE, 1971, INT J CANCER, V7, P141, DOI 10.1002/ijc.2910070116; HESTON WE, 1968, J NATL CANCER I, V40, P1161; HESTON WE, 1947, J NATL CANCER I, V7, P463; HOLLIFIELD G, 1957, AM J PHYSIOL, V189, P36, DOI 10.1152/ajplegacy.1957.189.1.36; HOROWITZ M, 1984, EMBO J, V3, P2937, DOI 10.1002/j.1460-2075.1984.tb02235.x; JACKSON IJ, 1993, NATURE, V362, P587, DOI 10.1038/362587a0; JOHNSON PR, 1972, J LIPID RES, V13, P2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; KUFF EL, 1983, P NATL ACAD SCI-BIOL, V80, P1992, DOI 10.1073/pnas.80.7.1992; LUEDERS KK, 1993, MAMM GENOME, V4, P69, DOI 10.1007/BF00290429; MICHAUD EJ, 1993, GENE DEV, V7, P1203, DOI 10.1101/gad.7.7a.1203; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; PORTER S, 1991, DEV GENET, V12, P393, DOI 10.1002/dvg.1020120604; POZNANSKI AA, 1991, DEV BIOL, V143, P271, DOI 10.1016/0012-1606(91)90077-G; SHIMIZU H, 1989, LIFE SCI, V45, P543, DOI 10.1016/0024-3205(89)90105-7; Silvers W. K., 1979, COAT COLORS MICE, P6; VLAHAKIS G, 1963, J NATL CANCER I, V31, P189; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; WOLFF GL, 1987, CARCINOGENESIS, V8, P1889, DOI 10.1093/carcin/8.12.1889; WOLFF GL, 1986, J HERED, V77, P151, DOI 10.1093/oxfordjournals.jhered.a110206; WOLFF GL, 1978, GENETICS, V88, P529; WOLFF GL, 1963, GENETICS, V48, P1041; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666; YEN TT, 1984, INT J OBES S8, V1, P65	42	350	360	1	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					59	65		10.1038/ng0994-59	http://dx.doi.org/10.1038/ng0994-59			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987393				2022-12-17	WOS:A1994PE15700016
J	HAYASAKA, K; HIMORO, M; SATO, W; TAKADA, G; UYEMURA, K; SHIMIZU, N; BIRD, TD; CONNEALLY, PM; CHANCE, PF				HAYASAKA, K; HIMORO, M; SATO, W; TAKADA, G; UYEMURA, K; SHIMIZU, N; BIRD, TD; CONNEALLY, PM; CHANCE, PF			CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-1B IS ASSOCIATED WITH MUTATIONS OF THE MYELIN-P(0) GENE	NATURE GENETICS			English	Article							MAJOR STRUCTURAL PROTEIN; PERIPHERAL MYELIN; DISEASE TYPE-1A; HEREDITARY MOTOR; DUFFY LOCUS; LINKAGE; DNA; CHROMOSOME-1; SEQUENCE; DUPLICATION	P0, a major structural protein of peripheral myelin, is a homophilic adhesion molecule and maps to chromosome 1q22-q23, in the region of the locus for Charcot-Marie-Tooth neuropathy type 1B (CMT1B). We have investigated P0 as a candidate gene in two pedigrees with CMT1B and found point mutations which are completely linked with the disease (Z=5.5, theta=0). The mutations, glutamate substitution for lysine 96 or aspartate 90, are located in the extracellular domain, which plays a significant role in myelin membrane adhesion. Individuals with CMT1B are heterozygous for the normal allele and the mutant allele. Our results indicate that P0 is a gene responsible for CMT1B.	UNIV WASHINGTON,SCH MED,DIV MED GENET & NEUROL,SEATTLE,WA 98195; AKITA UNIV,SCH MED,DEPT DENT,AKITA 010,JAPAN; KEIO UNIV,SCH MED,DEPT PHYSIOL,TOKYO 160,JAPAN; KEIO UNIV,SCH MED,DEPT MOLEC BIOL,TOKYO 160,JAPAN; INDIANA UNIV,DEPT MED GENET,INDIANAPOLIS,IN 46202; CHILDRENS HOSP PHILADELPHIA,DIV NEUROL RES,PHILADELPHIA,PA 19104	University of Washington; University of Washington Seattle; Akita University; Keio University; Keio University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	HAYASAKA, K (corresponding author), AKITA UNIV,SCH MED,DEPT PEDIAT,AKITA 010,JAPAN.		Chance, Phillip/AAX-5826-2020; Hayasaka, Kiyoshi/H-5340-2012	Hayasaka, Kiyoshi/0000-0003-3621-8901				BARBU M, 1990, J NEUROSCI RES, V25, P143, DOI 10.1002/jnr.490250119; BIRD TD, 1982, AM J HUM GENET, V34, P388; CHANCE PF, 1990, AM J HUM GENET, V47, P915; CHANCE PF, 1992, NEUROLOGY, V42, P2037, DOI 10.1212/WNL.42.10.2037; DEFESCHE JC, 1990, NEUROLOGY, V40, P1450, DOI 10.1212/WNL.40.9.1450; Dyck P.J, 1993, PNP, P1094; ESPELUND M, 1990, NUCLEIC ACIDS RES, V18, P6157, DOI 10.1093/nar/18.20.6157; FISCHBECK KH, 1986, ANN NEUROL, V20, P527, DOI 10.1002/ana.410200414; GAL A, 1985, HUM GENET, V70, P38, DOI 10.1007/BF00389456; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HAYASAKA K, 1991, BIOCHEM BIOPH RES CO, V180, P515, DOI 10.1016/S0006-291X(05)81094-0; HAYASAKA K, IN PRESS GENOMICS; IONASESCU VV, 1992, AM J MED GENET, V42, P728, DOI 10.1002/ajmg.1320420521; KULKENS, IN PRESS NATURE GENE; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEBO RV, 1991, HUM GENET, V88, P1, DOI 10.1007/BF00204921; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MISIURA K, 1990, NUCLEIC ACIDS RES, V18, P4345, DOI 10.1093/nar/18.15.4345; OAKEY RJ, 1992, HUM MOL GENET, V1, P613, DOI 10.1093/hmg/1.8.613; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; SAKAMOTO Y, 1987, J BIOL CHEM, V262, P4208; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STEBBINS NB, 1982, AM J HUM GENET, V34, pA195; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; Uyemura Keiichi, 1992, P481; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5	33	350	359	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					31	34		10.1038/ng0993-31	http://dx.doi.org/10.1038/ng0993-31			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	7693129				2022-12-17	WOS:A1993LV56500011
J	Braasch, I; Gehrke, AR; Smith, JJ; Kawasaki, K; Manousaki, T; Pasquier, J; Amores, A; Desvignes, T; Batzel, P; Catchen, J; Berlin, AM; Campbell, MS; Barrell, D; Martin, KJ; Mulley, JF; Ravi, V; Lee, AP; Nakamura, T; Chalopin, D; Fan, S; Wcisel, D; Canestro, C; Sydes, J; Beaudry, FEG; Sun, Y; Hertel, J; Beam, MJ; Fasold, M; Ishiyama, M; Johnson, J; Kehr, S; Lara, M; Letaw, JH; Litman, GW; Litman, RT; Mikami, M; Ota, T; Saha, NR; Williams, L; Stadler, PF; Wang, H; Taylor, JS; Fontenot, Q; Ferrara, A; Searle, SMJ; Aken, B; Yandell, M; Schneider, I; Yoder, JA; Volff, JN; Meyer, A; Amemiya, CT; Venkatesh, B; Holland, PWH; Guiguen, Y; Bobe, J; Shubin, NH; Di Palma, F; Alfoldi, J; Lindblad-Toh, K; Postlethwait, JH				Braasch, Ingo; Gehrke, Andrew R.; Smith, Jeramiah J.; Kawasaki, Kazuhiko; Manousaki, Tereza; Pasquier, Jeremy; Amores, Angel; Desvignes, Thomas; Batzel, Peter; Catchen, Julian; Berlin, Aaron M.; Campbell, Michael S.; Barrell, Daniel; Martin, Kyle J.; Mulley, John F.; Ravi, Vydianathan; Lee, Alison P.; Nakamura, Tetsuya; Chalopin, Domitille; Fan, Shaohua; Wcisel, Dustin; Canestro, Cristian; Sydes, Jason; Beaudry, Felix E. G.; Sun, Yi; Hertel, Jana; Beam, Michael J.; Fasold, Mario; Ishiyama, Mikio; Johnson, Jeremy; Kehr, Steffi; Lara, Marcia; Letaw, John H.; Litman, Gary W.; Litman, Ronda T.; Mikami, Masato; Ota, Tatsuya; Saha, Nil Ratan; Williams, Louise; Stadler, Peter F.; Wang, Han; Taylor, John S.; Fontenot, Quenton; Ferrara, Allyse; Searle, Stephen M. J.; Aken, Bronwen; Yandell, Mark; Schneider, Igor; Yoder, Jeffrey A.; Volff, Jean-Nicolas; Meyer, Axel; Amemiya, Chris T.; Venkatesh, Byrappa; Holland, Peter W. H.; Guiguen, Yann; Bobe, Julien; Shubin, Neil H.; Di Palma, Federica; Alfoeldi, Jessica; Lindblad-Toh, Kerstin; Postlethwait, John H.			The spotted gar genome illuminates vertebrate evolution and facilitates human-teleost comparisons	NATURE GENETICS			English	Article							RAY-FINNED FISH; MHC CLASS-I; COMPLEX-CLASS-I; COMPREHENSIVE ANALYSIS; PROVIDES INSIGHTS; GENE DUPLICATION; HOX GENES; 2 ROUNDS; ZEBRAFISH; COELACANTH	To connect human biology to fish biomedical models, we sequenced the genome of spotted gar (Lepisosteus oculatus), whose lineage diverged from teleosts before teleost genome duplication (TGD). The slowly evolving gar genome has conserved in content and size many entire chromosomes from bony vertebrate ancestors. Gar bridges teleosts to tetrapods by illuminating the evolution of immunity, mineralization and development (mediated, for example, by Hox, ParaHox and microRNA genes). Numerous conserved noncoding elements (CNEs; often cis regulatory) undetectable in direct human-teleost comparisons become apparent using gar: functional studies uncovered conserved roles for such cryptic CNEs, facilitating annotation of sequences identified in human genome-wide association studies. Transcriptomic analyses showed that the sums of expression domains and expression levels for duplicated teleost genes often approximate the patterns and levels of expression for gar genes, consistent with subfunctionalization. The gar genome provides a resource for understanding evolution after genome duplication, the origin of vertebrate genomes and the function of human regulatory sequences.	[Braasch, Ingo; Amores, Angel; Desvignes, Thomas; Batzel, Peter; Sydes, Jason; Beam, Michael J.; Letaw, John H.; Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Gehrke, Andrew R.; Nakamura, Tetsuya; Shubin, Neil H.] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA; [Smith, Jeramiah J.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Kawasaki, Kazuhiko] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Manousaki, Tereza] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion, Greece; [Pasquier, Jeremy; Guiguen, Yann; Bobe, Julien] INRA, LPGP, UR1037, Campus Beaulieu, F-35042 Rennes, France; [Catchen, Julian] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Berlin, Aaron M.; Johnson, Jeremy; Lara, Marcia; Williams, Louise; Di Palma, Federica; Alfoeldi, Jessica; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge, MA USA; [Campbell, Michael S.; Yandell, Mark] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA; [Barrell, Daniel; Searle, Stephen M. J.; Aken, Bronwen] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Barrell, Daniel; Aken, Bronwen] European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton, England; [Martin, Kyle J.; Holland, Peter W. H.] Univ Oxford, Dept Zool, Oxford, England; [Mulley, John F.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Ravi, Vydianathan; Lee, Alison P.; Venkatesh, Byrappa] ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore, Singapore; [Chalopin, Domitille; Volff, Jean-Nicolas] Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69364 Lyon, France; [Fan, Shaohua; Meyer, Axel] Univ Konstanz, Dept Biol, Constance, Germany; [Wcisel, Dustin; Yoder, Jeffrey A.] N Carolina State Univ, Dept Mol Biomed Sci, Raleigh, NC 27695 USA; [Wcisel, Dustin; Yoder, Jeffrey A.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Canestro, Cristian] Univ Barcelona, Dept Genet, Barcelona, Spain; [Canestro, Cristian] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain; [Beaudry, Felix E. G.; Taylor, John S.] Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada; [Sun, Yi; Wang, Han] Soochow Univ, Ctr Circadian Clocks, Suzhou, Peoples R China; [Sun, Yi; Wang, Han] Soochow Univ, Coll Med, Sch Biol & Basic Med Sci, Suzhou, Peoples R China; [Hertel, Jana; Fasold, Mario; Kehr, Steffi; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Ishiyama, Mikio] Nippon Dent Univ Coll Niigata, Dept Dent Hyg, Niigata, Japan; [Litman, Gary W.; Litman, Ronda T.] Univ S Florida, Morsani Coll Med, Dept Pediat, St Petersburg, FL 33701 USA; [Mikami, Masato] Nippon Dent Univ, Sch Life Dent Niigata, Dept Microbiol, Niigata, Japan; [Ota, Tatsuya] SOKENDAI Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Japan; [Saha, Nil Ratan; Amemiya, Chris T.] Benaroya Res Inst, Mol Genet Program, Seattle, WA USA; [Fontenot, Quenton; Ferrara, Allyse] Nicholls State Univ, Dept Biol Sci, Thibodaux, LA 70310 USA; [Schneider, Igor] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Meyer, Axel] Univ Konstanz, Int Max Planck Res Sch Organismal Biol, Constance, Germany; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Braasch, Ingo] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Campbell, Michael S.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Martin, Kyle J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Chalopin, Domitille] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Fan, Shaohua] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Hertel, Jana] UFZ Helmholtz Ctr Environm Res, Young Investigators Grp Bioinformat & Transcript, Leipzig, Germany; [Fasold, Mario] ecSeq Bioinformat, Leipzig, Germany; [Di Palma, Federica] Genome Anal Ctr, Vertebrate & Hlth Genom, Norwich, Norfolk, England	University of Oregon; University of Chicago; University of Kentucky; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Hellenic Centre for Marine Research; INRAE; University of Illinois System; University of Illinois Urbana-Champaign; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Utah System of Higher Education; University of Utah; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of Oxford; Bangor University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Konstanz; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Barcelona; University of Barcelona; University of Victoria; Soochow University - China; Soochow University - China; Leipzig University; State University System of Florida; University of South Florida; Nippon Dental University; Graduate University for Advanced Studies - Japan; Benaroya Research Institute; University of Louisiana System; Nicholls State University; Universidade Federal do Para; Max Planck Society; University of Konstanz; Uppsala University; Michigan State University; Cold Spring Harbor Laboratory; University of Sheffield; University System of Georgia; University of Georgia; University of Pennsylvania; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); The Genome Analysis Centre (TGAC)	Braasch, I; Postlethwait, JH (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	braasch@msu.edu; jpostle@uoneuro.uoregon.edu	Ravi, Vydianathan/B-2759-2009; Schneider, Igor/K-6164-2012; Lee, Alison/HCH-1286-2022; Cañestro, Cristian/L-9661-2014; Bobe, Julien/I-6851-2017; Braasch, Ingo/A-6948-2010; Yoder, Jeffrey A./I-5329-2019; Meyer, Axel/C-9826-2009; Schor, Jana/F-8503-2017; Wang, Han/A-9774-2008; Beaudry, Felix/AAL-9802-2020; Thomas, Desvignes/AAX-3526-2020; Stadler, Peter F./L-7857-2015	Ravi, Vydianathan/0000-0003-0807-7697; Schneider, Igor/0000-0002-9046-7338; Lee, Alison/0000-0002-3773-1021; Cañestro, Cristian/0000-0003-4623-8105; Bobe, Julien/0000-0002-9355-8227; Braasch, Ingo/0000-0003-4766-611X; Yoder, Jeffrey A./0000-0002-6083-1311; Meyer, Axel/0000-0002-0888-8193; Schor, Jana/0000-0003-1200-6234; Wang, Han/0000-0003-2420-3147; Thomas, Desvignes/0000-0001-5126-8785; Nakamura, Tetsuya/0000-0003-0183-1685; Barrell, Daniel/0000-0002-0977-0963; Di-Palma, Federica/0000-0002-4394-0102; Smith, Jeramiah/0000-0001-5333-5531; Kehr, Stephanie/0000-0001-8461-5763; Ota, Tatsuya/0000-0002-1115-5169; Guiguen, Yann/0000-0001-5464-6219; Stadler, Peter F./0000-0002-5016-5191; Mulley, John/0000-0002-1537-7316; Amores, Angel/0000-0002-9307-3609; Martin, Kyle/0000-0002-4081-6835; Venkatesh, Byrappa/0000-0003-3620-0277	US National Institutes of Health (NIH)/National Human Genome Research Institute [U54 HG03067]; US NIH [R01 OD011116, R24 OD01119004, T32 HD055164, R01 AI057559, R24 OD010922, R01 GM079492]; Feodor Lynen Fellowship from the Alexander von Humboldt Foundation; Volkswagen Foundation Initiative Evolutionary Biology [I/84 815]; National Science Foundation (NSF) [1311436]; Uehara Memorial Foundation Research Fellowship; Japan Society for the Promotion of Science Postdoctoral Research Fellowship; Marine Biological Laboratory Research Award; Brazilian National Council for Scientific and Technological Development (CNPq) [402754/2012-3, 477658/2012-1]; Brinson Foundation; University of Chicago Biological Sciences Division; NSF [BCS0725227]; National Strategic Reference Framework [SPARCOMP, 36]; Ministry of Education and Religious Affairs of Greece; Agence Nationale de la Recherche (ANR) [ANR-10-GENM-017]; Wellcome Trust [WT095908, WT098051]; European Molecular Biology Laboratory; Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR), Singapore; European Research Council [268513]; Ministerio de Ciencia e Innovacion [BFU2010-14875, BFU2015-71340]; Generalitat de Catalunya, AGAUR [SGR2014-290]; National Basic Research Program of China (973 Program) [2012CB947600]; National Natural Science Foundation of China (NSFC) [31030062]; BBSRC [BBS/E/T/000PR5885] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055164] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020833] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM079492] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010922, R24OD011199, R01OD011116] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)/National Human Genome Research Institute; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feodor Lynen Fellowship from the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Volkswagen Foundation Initiative Evolutionary Biology; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Uehara Memorial Foundation Research Fellowship(Uehara Memorial Foundation); Japan Society for the Promotion of Science Postdoctoral Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Marine Biological Laboratory Research Award; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brinson Foundation; University of Chicago Biological Sciences Division(University of Chicago); NSF(National Science Foundation (NSF)); National Strategic Reference Framework; Ministry of Education and Religious Affairs of Greece; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Wellcome Trust(Wellcome Trust); European Molecular Biology Laboratory; Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); European Research Council(European Research Council (ERC)European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya, AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Broad Institute Genomics Platform for constructing and sequencing gar DNA and RNA libraries and J. Turner-Maier for the gar transcriptome assembly. We thank the teams of the Bayousphere Research Laboratory (Nicholls State University) and the University of Oregon Fish Facility for gar work and husbandry. We thank J. Westlund for the design of the species illustrations. The generation of gar sequences and assemblies by the Broad Institute of MIT and Harvard University was supported by US National Institutes of Health (NIH)/National Human Genome Research Institute grant U54 HG03067. This work was further supported by US NIH grants R01 OD011116 (alias R01 RR020833) and R24 OD01119004 (J.H.P.); a Feodor Lynen Fellowship from the Alexander von Humboldt Foundation and the Volkswagen Foundation Initiative Evolutionary Biology, grant I/84 815 (I.B.); US NIH grant T32 HD055164 and National Science Foundation (NSF) Doctoral Dissertation Improvement Grant 1311436 (A.R.G.); Uehara Memorial Foundation Research Fellowship 2013, Japan Society for the Promotion of Science Postdoctoral Research Fellowship 2012-127 and Marine Biological Laboratory Research Award 2014 (T.N.); Brazilian National Council for Scientific and Technological Development (CNPq) grants 402754/2012-3 and 477658/2012-1 (I.S.); the Brinson Foundation and the University of Chicago Biological Sciences Division (N.H.S.); NSF grant BCS0725227 (K.K.); call 'ARISTEIA I' of the National Strategic Reference Framework 2007-2013 (SPARCOMP, 36), Ministry of Education and Religious Affairs of Greece (T.M.); Agence Nationale de la Recherche (ANR) grant ANR-10-GENM-017 (PhyloFish; J.B.); the Wellcome Trust (grants WT095908 and WT098051) and the European Molecular Biology Laboratory (D.B., S.M.J.S. and B.A.); the Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR), Singapore (B.V.); European Research Council grant 268513 (P.W.H.H. and K.J.M.); the Ministerio de Ciencia e Innovacion (BFU2010-14875 and BFU2015-71340) and the Generalitat de Catalunya, AGAUR (SGR2014-290) (C. C.); US NIH grant R01 AI057559 (G.W.L. and J.A.Y.); US NIH grants R24 OD010922 and R01 GM079492 (C. T. A.); and the National Basic Research Program of China (973 Program) (2012CB947600) and the National Natural Science Foundation of China (NSFC) (31030062) (H.W.).	Albertson RC, 2009, TRENDS GENET, V25, P74, DOI 10.1016/j.tig.2008.11.006; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amores A, 1999, METHOD CELL BIOL, V60, P323; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Auguie B., 2017, GRIDEXTRA MISCELLANE; Batzel P., 2015, ZENODO, DOI [10.5281/zenodo.35461, DOI 10.5281/ZENODO.35461]; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Berlivet S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004018; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; BingulacPopovic J, 1997, IMMUNOGENETICS, V46, P129, DOI 10.1007/s002510050251; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; BOGART JP, 1994, J HERED, V85, P322, DOI 10.1093/oxfordjournals.jhered.a111470; Braasch I., 2012, POLYPLOIDY GENOME EV, V1, P341, DOI [10.1007/978-3-642-31442-1_17, DOI 10.1007/978-3-642-31442-1_17, 10.1007/978-3-642-31442-1_17/FIGURES/7, DOI 10.1007/978]; Braasch I, 2015, J EXP ZOOL PART B, V324, P316, DOI 10.1002/jez.b.22589; Braasch I, 2014, COMP BIOCHEM PHYS C, V163, P24, DOI 10.1016/j.cbpc.2014.01.005; Broughton RE, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.2ca8041495ffafd0c92756e75247483e; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; Canestro C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000496; Cannon JP, 2008, IMMUNITY, V29, P228, DOI 10.1016/j.immuni.2008.05.018; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chalopin D, 2015, GENOME BIOL EVOL, V7, P567, DOI 10.1093/gbe/evv005; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Crow KD, 2012, GENOME BIOL EVOL, V4, P937, DOI 10.1093/gbe/evs067; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Darwin C., 1859, ORIGINS SPECIES MEAN, DOI DOI 10.4324/9780203509104; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Desvignes T, 2015, TRENDS GENET, V31, P613, DOI 10.1016/j.tig.2015.09.002; Desvignes T, 2014, GENE, V546, P386, DOI 10.1016/j.gene.2014.05.036; Dijkstra JM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-260; Dirscherl H, 2014, DEV COMP IMMUNOL, V46, P11, DOI 10.1016/j.dci.2014.02.018; Dirscherl H, 2014, IMMUNOGENETICS, V66, P185, DOI 10.1007/s00251-013-0748-z; Duboule D, 1998, CURR OPIN GENET DEV, V8, P514, DOI 10.1016/S0959-437X(98)80004-X; Duester G, 2013, SEMIN CELL DEV BIOL, V24, P694, DOI 10.1016/j.semcdb.2013.08.001; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Force A, 1999, GENETICS, V151, P1531; Frankenberg SR, 2014, DEVELOPMENT, V141, P2921, DOI 10.1242/dev.108407; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gehrke AR, 2015, P NATL ACAD SCI USA, V112, P803, DOI 10.1073/pnas.1420208112; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grande L, 2010, COPEIA, P1; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimholt U, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0309-1; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hagedorn EJ, 2014, EXP CELL RES, V329, P220, DOI 10.1016/j.yexcr.2014.07.030; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI [10.5555/1414852, DOI 10.5555/1414852]; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hertel Jana, 2015, Life-Basel, V5, P905, DOI 10.3390/life5010905; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kawasaki K, 2005, P NATL ACAD SCI USA, V102, P18063, DOI 10.1073/pnas.0509263102; Kawasaki K, 2014, J EXP ZOOL PART B, V322, P390, DOI 10.1002/jez.b.22546; Kawasaki K, 2009, DEV GENES EVOL, V219, P147, DOI 10.1007/s00427-009-0276-x; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurosawa G, 2006, GENE, V370, P75, DOI 10.1016/j.gene.2005.11.015; Lagman D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-238; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Lee O, 2015, CRIT REV TOXICOL, V45, P124, DOI 10.3109/10408444.2014.965805; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Loh YHE, 2011, GENOME BIOL EVOL, V3, P55, DOI 10.1093/gbe/evq085; Long W L, 2001, BMC Dev Biol, V1, P6, DOI 10.1186/1471-213X-1-6; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Mulley JF, 2010, MOL BIOL EVOL, V27, P2386, DOI 10.1093/molbev/msq121; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nikaido M, 2013, GENOME RES, V23, P1740, DOI 10.1101/gr.158105.113; OHNO S, 1969, CHROMOSOMA, V26, P35, DOI 10.1007/BF00319498; Ohno S., 1970, P1; Pagan AJ, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a018499; Parra ZE, 2010, EUR J IMMUNOL, V40, P2319, DOI 10.1002/eji.201040515; Patton EE, 2011, METHOD CELL BIOL, V105, P339, DOI 10.1016/B978-0-12-381320-6.00014-X; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Rabosky DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2958; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Reitzel AM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-6; Rennison DJ, 2012, MOL PHYLOGENET EVOL, V62, P986, DOI 10.1016/j.ympev.2011.11.030; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Ryll B, 2014, EVOL DEV, V16, P123, DOI 10.1111/ede.12071; Sallan LC, 2014, BIOL REV, V89, P950, DOI 10.1111/brv.12086; Sasagawa I., 2008, FRONT MAT SCI CHINA, V2, P134; Sato A, 2000, IMMUNOGENETICS, V51, P108, DOI 10.1007/s002510050019; Scannell DR, 2008, GENOME RES, V18, P137, DOI 10.1101/gr.6341207; Schneider I, 2013, TRENDS GENET, V29, P419, DOI 10.1016/j.tig.2013.01.012; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SIRE JY, 1994, ANAT REC, V240, P189, DOI 10.1002/ar.1092400206; Smith JJ, 2015, GENOME RES, V25, P1081, DOI 10.1101/gr.184135.114; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; TAJIMA F, 1993, GENETICS, V135, P599; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Toloza-Villalobos J, 2015, J MOL EVOL, V80, P57, DOI 10.1007/s00239-014-9660-x; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wang H, 2008, J MOL EVOL, V67, P29, DOI 10.1007/s00239-008-9121-5; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yoder JA, 2009, DEV COMP IMMUNOL, V33, P135, DOI 10.1016/j.dci.2008.09.004; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	132	349	364	13	134	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					427	+		10.1038/ng.3526	http://dx.doi.org/10.1038/ng.3526			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26950095	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-17	WOS:000372908800014
J	Maury, MM; Tsai, YH; Charlier, C; Touchon, M; Chenal-Francisque, V; Leclercq, A; Criscuolo, A; Gaultier, C; Roussel, S; Brisabois, A; Disson, O; Rocha, EPC; Brisse, S; Lecuit, M				Maury, Mylene M.; Tsai, Yu-Huan; Charlier, Caroline; Touchon, Marie; Chenal-Francisque, Viviane; Leclercq, Alexandre; Criscuolo, Alexis; Gaultier, Charlotte; Roussel, Sophie; Brisabois, Anne; Disson, Olivier; Rocha, Eduardo P. C.; Brisse, Sylvain; Lecuit, Marc			Uncovering Listeria monocytogenes hypervirulence by harnessing its biodiversity	NATURE GENETICS			English	Article							COMPARATIVE GENOMICS; VIRULENCE; EVOLUTION; SEQUENCE; DISTINCT; CLONES; IDENTIFICATION; INTERNALIN; LINEAGES; SEROVARS	Microbial pathogenesis studies are typically performed with reference strains, thereby overlooking within-species heterogeneity in microbial virulence. Here we integrated human epidemiological and clinical data with bacterial population genomics to harness the biodiversity of the model foodborne pathogen Listeria monocytogenes and decipher the basis of its neural and placental tropisms. Taking advantage of the clonal structure of this bacterial species, we identify clones epidemiologically associated either with food or with human central nervous system (CNS) or maternal-neonatal (MN) listeriosis. The latter clones are also most prevalent in patients without immunosuppressive comorbidities. Strikingly, CNS- and MN-associated clones are hypervirulent in a humanized mouse model of listeriosis. By integrating epidemiological data and comparative genomics, we have uncovered multiple new putative virulence factors and demonstrate experimentally the contribution of the first gene cluster mediating L. monocytogenes neural and placental tropisms. This study illustrates the exceptional power in harnessing microbial biodiversity to identify clinically relevant microbial virulence attributes.	[Maury, Mylene M.; Touchon, Marie; Rocha, Eduardo P. C.; Brisse, Sylvain] Inst Pasteur, Microbial Evolutionary Genom Unit, Paris, France; [Maury, Mylene M.; Touchon, Marie; Rocha, Eduardo P. C.; Brisse, Sylvain] CNRS, UMR 3525, Paris, France; [Maury, Mylene M.] Paris Diderot Univ, Sorbonne Paris Cite, Cellule Pasteur, Paris, France; [Tsai, Yu-Huan; Charlier, Caroline; Chenal-Francisque, Viviane; Leclercq, Alexandre; Gaultier, Charlotte; Disson, Olivier; Lecuit, Marc] Inst Pasteur, Biol Infect Unit, Paris, France; [Tsai, Yu-Huan; Gaultier, Charlotte; Disson, Olivier; Lecuit, Marc] INSERM, Unit 1117, Paris, France; [Chenal-Francisque, Viviane; Leclercq, Alexandre; Lecuit, Marc] Natl Reference Ctr Listeria, Paris, France; [Leclercq, Alexandre; Lecuit, Marc] WHO, Collaborating Ctr Listeria, Paris, France; [Charlier, Caroline; Lecuit, Marc] Paris Descartes Univ, Necker Enfants Malades Univ Hosp, AP HP,Sorborne Paris Cite, Inst Imagine,Div Infect Dis & Trop Med, Paris, France; [Criscuolo, Alexis] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France; [Roussel, Sophie] Paris Est Univ, ANSES Agence Natl Secur Sanitaire Alimentat Envir, Food Safety Lab, Maisons Alfort, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); World Health Organization; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ecole Nationale Veterinaire d'Alfort (ENVA)	Brisse, S (corresponding author), Inst Pasteur, Microbial Evolutionary Genom Unit, Paris, France.; Brisse, S (corresponding author), CNRS, UMR 3525, Paris, France.; Lecuit, M (corresponding author), Inst Pasteur, Biol Infect Unit, Paris, France.; Lecuit, M (corresponding author), INSERM, Unit 1117, Paris, France.; Lecuit, M (corresponding author), Natl Reference Ctr Listeria, Paris, France.; Lecuit, M (corresponding author), WHO, Collaborating Ctr Listeria, Paris, France.; Lecuit, M (corresponding author), Paris Descartes Univ, Necker Enfants Malades Univ Hosp, AP HP,Sorborne Paris Cite, Inst Imagine,Div Infect Dis & Trop Med, Paris, France.	sylvain.brisse@pasteur.fr; marc.lecuit@pasteur.fr	Charlier, Caroline/AAH-8547-2020; Lecuit, Marc/J-4073-2013; Disson, Olivier/P-9935-2019; Lecuit, Marc/M-4126-2019; Brisse, Sylvain/M-8723-2013; Disson, Olivier/H-6359-2016; Alexandre, Leclercq Jean-Louis/H-2140-2018; Rocha, Eduardo/B-7009-2009	Charlier, Caroline/0000-0002-9375-3620; Lecuit, Marc/0000-0002-4491-1063; Disson, Olivier/0000-0002-7791-9782; Lecuit, Marc/0000-0002-4491-1063; Brisse, Sylvain/0000-0002-2516-2108; Alexandre, Leclercq Jean-Louis/0000-0003-3778-7313; Rocha, Eduardo/0000-0001-7704-822X; Roussel, Sophie/0000-0003-1830-5526; Maury, Mylene/0000-0002-6816-9182; Criscuolo, Alexis/0000-0002-8212-5215; Touchon, marie/0000-0001-7389-447X	Institut Pasteur; INSERM; French government's Investissement d'Avenir program; Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' [ANR-10-LABX-62-IBEID]; European Research Council (ERC); ERANET Proantilis; Programme Hospitalier de Recherche Clinique MONALISA; Programme de Recherche Translationnelle (PTR) ANSES-Institut Pasteur; Institut de Veille Sanitaire (InVS)	Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French government's Investissement d'Avenir program(French National Research Agency (ANR)); Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases'; European Research Council (ERC)(European Research Council (ERC)European Commission); ERANET Proantilis; Programme Hospitalier de Recherche Clinique MONALISA; Programme de Recherche Translationnelle (PTR) ANSES-Institut Pasteur; Institut de Veille Sanitaire (InVS)	We thank C. Soto Alvarez, G. Pontdeme, T. Cantinelli and L. Diancourt for their contributions to MLST data production and analysis, and S. Roche for providing low-virulence strains for genome sequencing. We also thank D. Mornico (Center of Bioinformatics, Biostatistics and Integrative Biology of the Institut Pasteur) for his help with the submission of genome reads and assemblies. This study was funded by the Institut Pasteur, INSERM, from the French government's Investissement d'Avenir program, Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' (grant ANR-10-LABX-62-IBEID), the European Research Council (ERC), ERANET Proantilis, the Programme Hospitalier de Recherche Clinique MONALISA and the Programme de Recherche Translationnelle (PTR) ANSES-Institut Pasteur. Listeriosis surveillance in France is funded by the Institut de Veille Sanitaire (InVS) and the Institut Pasteur.	Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Chenal-Francisque V, 2013, J CLIN MICROBIOL, V51, P1868, DOI 10.1128/JCM.00606-13; Chenal-Francisque V, 2011, EMERG INFECT DIS, V17, P1110, DOI [10.3201/eid/1706.101778, 10.3201/eid1706.101778]; Cossart P, 1996, SCIENCE, V271, P315, DOI 10.1126/science.271.5247.315; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Cotter PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000144; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Faith N, 2009, FOODBORNE PATHOG DIS, V6, P39, DOI 10.1089/fpd.2008.0154; FALKOW S, 1992, ANNU REV CELL BIOL, V8, P333, DOI 10.1146/annurev.cb.08.110192.002001; Glaser P, 2001, SCIENCE, V294, P849; Gray MJ, 2004, APPL ENVIRON MICROB, V70, P5833, DOI 10.1128/AEM.70.10.5833-5841.2004; Haase JK, 2014, ENVIRON MICROBIOL, V16, P405, DOI 10.1111/1462-2920.12342; Hain T, 2007, INT J MED MICROBIOL, V297, P541, DOI 10.1016/j.ijmm.2007.03.016; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Jacquet C, 2004, J INFECT DIS, V189, P2094, DOI 10.1086/420853; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 2007, MICROBES INFECT, V9, P1216, DOI 10.1016/j.micinf.2007.05.009; MCLAUCHLIN J, 1990, EUR J CLIN MICROBIOL, V9, P210, DOI 10.1007/BF01963840; Nightingale KK, 2005, APPL ENVIRON MICROB, V71, P8764, DOI 10.1128/AEM.71.12.8764-8772.2005; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Paradis E, 2002, J THEOR BIOL, V218, P175, DOI 10.1006/jtbi.2002.3066; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PIFFARETTI JC, 1989, P NATL ACAD SCI USA, V86, P3818, DOI 10.1073/pnas.86.10.3818; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Seeliger H.P.R., 1986, BERGEYS MANUAL SYSTE, P1235; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Ward TJ, 2008, APPL ENVIRON MICROB, V74, P7629, DOI 10.1128/AEM.01127-08; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wiedmann M, 1997, INFECT IMMUN, V65, P2707, DOI 10.1128/IAI.65.7.2707-2716.1997	34	349	363	2	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					308	313		10.1038/ng.3501	http://dx.doi.org/10.1038/ng.3501			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26829754	Green Accepted			2022-12-17	WOS:000370902600015
J	Krumm, N; Turner, TN; Baker, C; Vives, L; Mohajeri, K; Witherspoon, K; Raja, A; Coe, BP; Stessman, HA; He, ZX; Leal, SM; Bernier, R; Eichler, EE				Krumm, Niklas; Turner, Tychele N.; Baker, Carl; Vives, Laura; Mohajeri, Kiana; Witherspoon, Kali; Raja, Archana; Coe, Bradley P.; Stessman, Holly A.; He, Zong-Xiao; Leal, Suzanne M.; Bernier, Raphael; Eichler, Evan E.			Excess of rare, inherited truncating mutations in autism	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; TRANSMISSION DISEQUILIBRIUM; GROWTH-FACTOR; GENES; MODEL; DELETIONS; SUPPORTS; CHD8; RISK; CNVS	To assess the relative impact of inherited and de novo variants on autism risk, we generated a comprehensive set of exonic single-nucleotide variants (SNVs) and copy number variants (CNVs) from 2,377 families with autism. We find that private, inherited truncating SNVs in conserved genes are enriched in probands (odds ratio = 1.14, P = 0.0002) in comparison to unaffected siblings, an effect involving significant maternal transmission bias to sons. We also observe a bias for inherited CNVs, specifically for small (<100 kb), maternally inherited events (P = 0.01) that are enriched in CHD8 target genes (P = 7.4 x 10(-3)). Using a logistic regression model, we show that private truncating SNVs and rare, inherited CNVs are statistically independent risk factors for autism, with odds ratios of 1.11 (P = 0.0002) and 1.23 (P = 0.01), respectively. This analysis identifies a second class of candidate genes (for example, RIMS 1, CUL7 and LZTR1) where transmitted mutations may create a sensitized background but are unlikely to be completely penetrant.	[Krumm, Niklas; Turner, Tychele N.; Baker, Carl; Vives, Laura; Mohajeri, Kiana; Witherspoon, Kali; Raja, Archana; Coe, Bradley P.; Stessman, Holly A.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98104 USA; [Raja, Archana; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [He, Zong-Xiao; Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Baylor College of Medicine; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98104 USA.	eee@gs.washington.edu	Coe, Bradley/A-2878-2009	Coe, Bradley/0000-0001-8471-4016; Turner, Tychele/0000-0001-8246-6477; Stessman, Holly/0000-0002-0764-3493	US National Institutes of Health [1U01MH100233]; National Institute for Mental Health [R01MH101221, R01MH100047]; Simons Foundation [SFARI 89368, SFARI 137578]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100047, U01MH100233, R01MH101221] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Obenshain, D. Hall, B. Koser and S. Novikova for providing support for usage of the Amazon Cloud and for assistance in the deposition of SNV and CNV call sets into the National Database for Autism Research (NDAR). We are grateful to the laboratories of M. Wigler and M. State for providing early access to exome sequencing data as well as access to SNP microarray data. We also thank T. Brown for assistance in editing this manuscript. Funding for this study was provided, in part, by the US National Institutes of Health (1U01MH100233 to E.E.E.), by the National Institute for Mental Health (R01MH101221 to E.E.E. and R01MH100047 to R.B.) and by the Simons Foundation (SFARI 89368 to R.B. and SFARI 137578 to E.E.E.). E.E.E. is an investigator of the Howard Hughes Medical Institute. We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R. Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren and E. Wijsman). We appreciate obtaining access to phenotypic data on Simons Foundation Autism Research Initiative (SFARI) Base. Approved researchers can obtain the SSC population data set described in this study by applying at https://base.sfari.org/.	Baio J., 2012, MORBIDITY MORTALITY, V61; Bena F, 2013, AM J MED GENET B, V162B, P388, DOI 10.1002/ajmg.b.32148; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Bozdagi O, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-9; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Cukier HN, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-1; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dong S, 2014, CELL REP, V9, P16, DOI 10.1016/j.celrep.2014.08.068; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; He ZX, 2014, AM J HUM GENET, V94, P33, DOI 10.1016/j.ajhg.2013.11.021; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Kaindl AM, 2010, PROG NEUROBIOL, V90, P363, DOI 10.1016/j.pneurobio.2009.11.002; Krumm N, 2013, AM J HUM GENET, V93, P595, DOI 10.1016/j.ajhg.2013.07.024; KURAHASHI H, 1995, HUM MOL GENET, V4, P541, DOI 10.1093/hmg/4.4.541; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; Lupski JR, 2012, NAT GENET, V44, P1291, DOI 10.1038/ng.2479; Morita M, 2012, MOL CELL BIOL, V32, P3585, DOI 10.1128/MCB.00455-12; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Petrovski S., 2013, PLOS GENET, V9; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Poultney CS, 2013, AM J HUM GENET, V93, P607, DOI 10.1016/j.ajhg.2013.09.001; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Subtil-Rodriguez A, 2014, NUCLEIC ACIDS RES, V42, P2185, DOI 10.1093/nar/gkt1161; TAYLOR JW, 1977, AM J EPIDEMIOL, V106, P260, DOI 10.1093/oxfordjournals.aje.a112461; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	38	349	354	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					582	588		10.1038/ng.3303	http://dx.doi.org/10.1038/ng.3303			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ3LW	25961944	Green Accepted			2022-12-17	WOS:000355386500008
J	Kakiuchi, M; Nishizawa, T; Ueda, H; Gotoh, K; Tanaka, A; Hayashi, A; Yamamoto, S; Tatsuno, K; Katoh, H; Watanabe, Y; Ichimura, T; Ushiku, T; Funahashi, S; Tateishi, K; Wada, I; Shimizu, N; Nomura, S; Koike, K; Seto, Y; Fukayama, M; Aburatani, H; Ishikawa, S				Kakiuchi, Miwako; Nishizawa, Takashi; Ueda, Hiroki; Gotoh, Kengo; Tanaka, Atsushi; Hayashi, Akimasa; Yamamoto, Shogo; Tatsuno, Kenji; Katoh, Hiroto; Watanabe, Yoshiaki; Ichimura, Takashi; Ushiku, Tetsuo; Funahashi, Shinichi; Tateishi, Keisuke; Wada, Ikuo; Shimizu, Nobuyuki; Nomura, Sachiyo; Koike, Kazuhiko; Seto, Yasuyuki; Fukayama, Masashi; Aburatani, Hiroyuki; Ishikawa, Shumpei			Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma	NATURE GENETICS			English	Article							TNM CLASSIFICATION; 7TH EDITION; CANCER; GTPASES; EXPRESSION; ADHESION; PATHWAY; COHORT; RAS	Diffuse-type gastric carcinoma (DGC) is characterized by a highly malignant phenotype with prominent infiltration and stromal induction. We performed whole-exome sequencing on 30 DGC cases and found recurrent RHOA nonsynonymous mutations. With validation sequencing of an additional 57 cases, RHOA mutation was observed in 25.3% (22/87) of DGCs, with mutational hotspots affecting the Tyr42, Arg5 and Gly17 residues in RHOA protein. These positions are highly conserved among RHO family members, and Tyr42 and Arg5 are located outside the guanine nucleotide binding pocket. Several lines of functional evidence indicated that mutant RHOA works in a gain-of-function manner. Comparison of mutational profiles for the major gastric cancer subtypes showed that RHOA mutations occur specifically in DGCs, the majority of which were histopathologically characterized by the presence of poorly differentiated adenocarcinomas together with more differentiated components in the gastric mucosa. Our findings identify a potential therapeutic target for this poor-prognosis subtype of gastric cancer with no available molecularly targeted drugs.	[Kakiuchi, Miwako; Ueda, Hiroki; Gotoh, Kengo; Yamamoto, Shogo; Tatsuno, Kenji; Aburatani, Hiroyuki; Ishikawa, Shumpei] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan; [Kakiuchi, Miwako; Tateishi, Keisuke; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Nishizawa, Takashi; Funahashi, Shinichi] Forerunner Pharma Res Co Ltd, Tokyo, Japan; [Tanaka, Atsushi; Hayashi, Akimasa; Ichimura, Takashi; Ushiku, Tetsuo; Fukayama, Masashi; Ishikawa, Shumpei] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan; [Yamamoto, Shogo; Tatsuno, Kenji; Aburatani, Hiroyuki] Univ Tokyo, Translat Syst Biol & Med Initiat, Tokyo, Japan; [Katoh, Hiroto; Ishikawa, Shumpei] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Pathol, Tokyo, Japan; [Watanabe, Yoshiaki] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Kamakura, Kanagawa, Japan; [Wada, Ikuo; Shimizu, Nobuyuki; Nomura, Sachiyo; Seto, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Gastrointestinal Surg, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Chugai Pharmaceutical Co., Ltd.; Roche Holding; University of Tokyo	Ishikawa, S (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan.	sish.gpat@mri.tmd.ac.jp	Katoh, Hiroto/ADO-8117-2022; Tatsuno, Kenji/B-1765-2008; Tanaka, Atsushi/AAY-1154-2020	Nomura, Sachiyo/0000-0003-4293-6205; Tanaka, Atsushi/0000-0003-1229-4539; Kakiuchi, Miwako/0000-0002-6300-6771	Ministry of Education, Culture, Sports, Science and Technology of Japan [22134003]; JSPS (Japan Society for the Promotion of Science) KAKENHI grant [24221011]; Health Labor Sciences Research Grant; grant for the Translational Systems Biology and Medicine Initiative (TSBMI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS (Japan Society for the Promotion of Science) KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labor Sciences Research Grant; grant for the Translational Systems Biology and Medicine Initiative (TSBMI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan	We would like to thank K. Shiina, K. Sakuma, K. Nakano, A. Nishimoto and R. Sato for technical assistance. This study was supported by Grants-in-Aid for Scientific Research in Innovative Areas to the "Systems Cancer Project" (grant 22134003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.I.), by JSPS (Japan Society for the Promotion of Science) KAKENHI grant 24221011 (HA.), by a Health Labor Sciences Research Grant (HA.) and by a grant for the Translational Systems Biology and Medicine Initiative (TSBMI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.Y., K. Tatsuno and HA.). The supercomputing resource was provided by the Human Genome Center (University of Tokyo).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Bang Y, 2009, J CLIN ONCOL, V27; Borrmann R, 1926, HDB SPEZIELLEN PATHO, P812, DOI [DOI 10.1007/978-3-7091-5436-6_7, 10.1007/978-3-7091-5436-6_7]; Carothers AM, 2006, EXP CELL RES, V312, P387, DOI 10.1016/j.yexcr.2005.11.019; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Chiaravalli AM, 2012, WORLD J GASTROENTERO, V18, P896, DOI 10.3748/wjg.v18.i9.896; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hayashi T, 2013, CANCER-AM CANCER SOC, V119, P1330, DOI 10.1002/cncr.27928; Henson DE, 2004, ARCH PATHOL LAB MED, V128, P765; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Kaneko S, 2001, BRIT J CANCER, V84, P400, DOI 10.1054/bjoc.2000.1602; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kawazu M, 2013, P NATL ACAD SCI USA, V110, P3029, DOI 10.1073/pnas.1216141110; Kong X, 2012, J SURG ONCOL, V106, P346, DOI 10.1002/jso.23004; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Saito A, 2001, PATHOL INT, V51, P165, DOI 10.1046/j.1440-1827.2001.01179.x; Salinas PC, 2007, TRENDS CELL BIOL, V17, P333, DOI 10.1016/j.tcb.2007.07.003; Shang X, 2013, P NATL ACAD SCI USA, V110, P3155, DOI 10.1073/pnas.1212324110; Shang X, 2012, CHEM BIOL, V19, P699, DOI 10.1016/j.chembiol.2012.05.009; Stiekema J, 2013, EJSO-EUR J SURG ONC, V39, P686, DOI 10.1016/j.ejso.2013.02.026; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Warneke VS, 2011, J CLIN ONCOL, V29, P2364, DOI 10.1200/JCO.2010.34.4358; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	31	349	359	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2014	46	6					583	587		10.1038/ng.2984	http://dx.doi.org/10.1038/ng.2984			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AI4XU	24816255				2022-12-17	WOS:000336870700014
J	Rademakers, R; Baker, M; Nicholson, AM; Rutherford, NJ; Finch, N; Soto-Ortolaza, A; Lash, J; Wider, C; Wojtas, A; DeJesus-Hernandez, M; Adamson, J; Kouri, N; Sundal, C; Shuster, EA; Aasly, J; MacKenzie, J; Roeber, S; Kretzschmar, HA; Boeve, BF; Knopman, DS; Petersen, RC; Cairns, NJ; Ghetti, B; Spina, S; Garbern, J; Tselis, AC; Uitti, R; Das, P; Van Gerpen, JA; Meschia, JF; Levy, S; Broderick, DF; Graff-Radford, N; Ross, OA; Miller, BB; Swerdlow, RH; Dickson, DW; Wszolek, ZK				Rademakers, Rosa; Baker, Matt; Nicholson, Alexandra M.; Rutherford, Nicola J.; Finch, NiCole; Soto-Ortolaza, Alexandra; Lash, Jennifer; Wider, Christian; Wojtas, Aleksandra; DeJesus-Hernandez, Mariely; Adamson, Jennifer; Kouri, Naomi; Sundal, Christina; Shuster, Elizabeth A.; Aasly, Jan; MacKenzie, James; Roeber, Sigrun; Kretzschmar, Hans A.; Boeve, Bradley F.; Knopman, David S.; Petersen, Ronald C.; Cairns, Nigel J.; Ghetti, Bernardino; Spina, Salvatore; Garbern, James; Tselis, Alexandros C.; Uitti, Ryan; Das, Pritam; Van Gerpen, Jay A.; Meschia, James F.; Levy, Shawn; Broderick, Daniel F.; Graff-Radford, Neill; Ross, Owen A.; Miller, Bradley B.; Swerdlow, Russell H.; Dickson, Dennis W.; Wszolek, Zbigniew K.			Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids	NATURE GENETICS			English	Article							ADULT-ONSET LEUKODYSTROPHY; NASU-HAKOLA-DISEASE; NEUROAXONAL SPHEROIDS; PIGMENTED GLIA; MACROPHAGE; DEMENTIA; DAP12; EXPRESSION; MICROGLIA; SYSTEM	Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is an autosomal-dominant central nervous system white-matter disease with variable clinical presentations, including personality and behavioral changes, dementia, depression, parkinsonism, seizures and other phenotypes(1,2). We combined genome-wide linkage analysis with exome sequencing and identified 14 different mutations affecting the tyrosine kinase domain of the colony stimulating factor 1 receptor (encoded by CSF1R) in 14 families with HDLS. In one kindred, we confirmed the de novo occurrence of the mutation. Followup sequencing identified an additional CSF1R mutation in an individual diagnosed with corticobasal syndrome. In vitro, CSF-1 stimulation resulted in rapid autophosphorylation of selected tyrosine residues in the kinase domain of wild-type but not mutant CSF1R, suggesting that HDLS may result from partial loss of CSF1R function. As CSF1R is a crucial mediator of microglial proliferation and differentiation in the brain, our findings suggest an important role for microglial dysfunction in HDLS pathogenesis.	[Rademakers, Rosa; Baker, Matt; Nicholson, Alexandra M.; Rutherford, Nicola J.; Finch, NiCole; Soto-Ortolaza, Alexandra; Wider, Christian; Wojtas, Aleksandra; DeJesus-Hernandez, Mariely; Adamson, Jennifer; Kouri, Naomi; Sundal, Christina; Das, Pritam; Ross, Owen A.; Dickson, Dennis W.] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA; [Lash, Jennifer; Shuster, Elizabeth A.; Uitti, Ryan; Van Gerpen, Jay A.; Meschia, James F.; Graff-Radford, Neill; Wszolek, Zbigniew K.] Mayo Clin Florida, Dept Neurol, Jacksonville, FL USA; [Wider, Christian] Ctr Hosp Univ Vaudois CHUV UNIL, Dept Clin Neurosci, Lausanne, Switzerland; [Sundal, Christina] Gothenburg Univ, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Sahlgrenska Acad, Gothenburg, Sweden; [Aasly, Jan] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [MacKenzie, James] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland; [Roeber, Sigrun; Kretzschmar, Hans A.] Univ Munich, Ctr Neuropathol & Prion Res, Munich, Germany; [Boeve, Bradley F.; Knopman, David S.; Petersen, Ronald C.] Mayo Clin Minnesota, Dept Neurol, Rochester, MN USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Neurol, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Ghetti, Bernardino; Spina, Salvatore] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Dept Pathol & Lab Med, Indianapolis, IN USA; [Garbern, James] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Tselis, Alexandros C.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Broderick, Daniel F.] Mayo Clin Florida, Dept Radiol, Jacksonville, FL USA; [Miller, Bradley B.] Texas Tech Univ, Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79430 USA; [Swerdlow, Russell H.] Univ Kansas, Sch Med, Dept Neurol, Kansas City, KS USA	Mayo Clinic; Mayo Clinic; University of Gothenburg; Norwegian University of Science & Technology (NTNU); University of Aberdeen; University of Munich; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; University of Rochester; Wayne State University; HudsonAlpha Institute for Biotechnology; Mayo Clinic; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Kansas; University of Kansas Medical Center	Rademakers, R (corresponding author), Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA.	rademakers.rosa@mayo.edu	Ross, Owen/D-7573-2013; Wszolek, Zbigniew K./AAB-1431-2019; Kouri, Naomi/G-6695-2013; Spina, Salvatore/M-4463-2019; Meschia, James/GPP-1636-2022; Cairns, Nigel/AAB-9713-2020	Meschia, James/0000-0002-4475-8142; Cairns, Nigel/0000-0001-9858-3344; Ross, Owen/0000-0003-4813-756X; Levy, Shawn/0000-0002-1369-5740; Kouri, N/0000-0002-6841-9882; Dickson, Dennis W/0000-0001-7189-7917	Mayo Benefactor and the Mayo Foundation; US National Institute of Neurological Disorders and Stroke [P50 NS072187]; US National Institutes of Health (NIH) [R01 NS057567, IRC2NS070276]; Mayo Clinic Florida CR [MCF 90052018, MCF 90052030]; Dystonia Medical Research Foundation; NIH [R01 NS065782, R01 AG026251, P50 AGO 16574, PHS P30 AG 10133, U24 AG 21886-0151]; Peebler PSP Research Foundation; American Heart Association; James & Esther King Biomedical Research Program; Florida Department of Health; Myron and Jane Hanley Award in Stroke research; Leenaards Foundation; Swiss Parkinson Foundation; Mayo Clinic Florida Cerebrovascular Diseases Registry [08-003878]; Mayo Foundation for Medical Education and Research; Sven and Dagmar Salens, Stiftelse, Sweden; Swedish and Gothenburg Societies for the Neurologically Disabled; Swedish Society of Medicine Gothenburg; Gothenburg Foundation for Neurological Research; Bjornsson Foundation, Gothenburg, Sweden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070276, R01NS065782, R01NS057567, P50NS072187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, P30AG010133, P50AG016574, R01AG026251] Funding Source: NIH RePORTER	Mayo Benefactor and the Mayo Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Florida CR; Dystonia Medical Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peebler PSP Research Foundation; American Heart Association(American Heart Association); James & Esther King Biomedical Research Program; Florida Department of Health; Myron and Jane Hanley Award in Stroke research; Leenaards Foundation; Swiss Parkinson Foundation; Mayo Clinic Florida Cerebrovascular Diseases Registry; Mayo Foundation for Medical Education and Research; Sven and Dagmar Salens, Stiftelse, Sweden; Swedish and Gothenburg Societies for the Neurologically Disabled; Swedish Society of Medicine Gothenburg; Gothenburg Foundation for Neurological Research; Bjornsson Foundation, Gothenburg, Sweden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank all family members who participated in this study, D. Gamble for help in coordinating sample and data collection from subjects with ischemic stroke, and R. Ossi for review of brain MRI scans from subjects with ischemic stroke. This work is funded by a Mayo Benefactor and the Mayo Foundation. Mayo Clinic Jacksonville is a Morris K. Udall Parkinson's Disease Research Center of Excellence supported by the US National Institute of Neurological Disorders and Stroke (P50 NS072187). Z.K.W. is partially funded by the US National Institutes of Health (NIH; R01 NS057567 and IRC2NS070276) and by Mayo Clinic Florida CR programs (MCF 90052018 and MCF 90052030). Z.K.W. is further supported by the family of Carl Edward Botch Jr. and Susan Bass Botch, and by Dystonia Medical Research Foundation. R.R. is funded by NIH grants R01 NS065782, R01 AG026251 and P50 AGO 16574 and by the Peebler PSP Research Foundation. OAR. is supported by the American Heart Association, the James & Esther King Biomedical Research Program, the Florida Department of Health and the Myron and Jane Hanley Award in Stroke research. C.W. is supported by the Leenaards Foundation and the Swiss Parkinson Foundation. The Mayo Clinic Florida Cerebrovascular Diseases Registry (IRB no. 08-003878; J.F.M., Principal Investigator) is supported by the Mayo Foundation for Medical Education and Research. C.S. is supported by grants from Sven and Dagmar Salens, Stiftelse, Sweden; the Swedish and Gothenburg Societies for the Neurologically Disabled; The Swedish Society of Medicine Gothenburg; the Gothenburg Foundation for Neurological Research; and the Bjornsson Foundation, Gothenburg, Sweden. This work is further funded by NIH PHS P30 AG 10133 (Indiana Alzheimer Disease Center, to B.G.) and NIH U24 AG 21886-0151 (National Cell Repository for Alzheimer's disease, to B.G.).	Akiguchi I, 1997, STROKE, V28, P1423, DOI 10.1161/01.STR.28.7.1423; AKIYAMA H, 1994, BRAIN RES, V639, P171, DOI 10.1016/0006-8993(94)91779-5; AXELSSON R, 1984, ACTA PSYCHIAT SCAND, V69, P1; Baba Y, 2006, ACTA NEUROPATHOL, V111, P300, DOI 10.1007/s00401-006-0046-z; Bianchin M.M., 2010, NAT REV NEUROL, V6, DOI [10.1038/nrneuro1.2010.17-cl, DOI 10.1038/NRNEUROL.2010.17-CL]; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Browne L, 2003, EUR NEUROL, V50, P85, DOI 10.1159/000072504; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Freeman SH, 2009, BRAIN PATHOL, V19, P39, DOI 10.1111/j.1750-3639.2008.00163.x; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Hancock N, 2003, J NEUROL NEUROSUR PS, V74, P1345, DOI 10.1136/jnnp.74.9.1345; Itoh K, 2006, ACTA NEUROPATHOL, V111, P39, DOI 10.1007/s00401-005-1113-6; Keegan BM, 2008, NEUROLOGY, V70, P1128, DOI 10.1212/01.wnl.0000304045.99153.8f; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; Levin N, 2008, ISR MED ASSOC J, V10, P386; Marotti JD, 2004, ACTA NEUROPATHOL, V107, P481, DOI 10.1007/s00401-004-0847-x; Mascalchi M, 2006, AM J NEURORADIOL, V27, P1037; Mateen FJ, 2010, J NEUROL NEUROSUR PS, V81, P619, DOI 10.1136/jnnp.2008.169243; Moro-de-Casillas ML, 2004, J NEUROL NEUROSUR PS, V75, P1070, DOI 10.1136/jnnp.2003.028431; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Paloneva J, 2001, NEUROLOGY, V56, P1552, DOI 10.1212/WNL.56.11.1552; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Raivich G, 1998, J COMP NEUROL, V395, P342, DOI 10.1002/(SICI)1096-9861(19980808)395:3<342::AID-CNE6>3.0.CO;2-2; RIDGE SA, 1990, P NATL ACAD SCI USA, V87, P1377, DOI 10.1073/pnas.87.4.1377; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; SENGUPTA A, 1988, P NATL ACAD SCI USA, V85, P8062, DOI 10.1073/pnas.85.21.8062; SMITH TW, 1990, J NEUROPATH EXP NEUR, V49, P357, DOI 10.1097/00005072-199007000-00001; Soares MJ, 2009, MODERN PATHOL, V22, P744, DOI 10.1038/modpathol.2009.43; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Swerdlow RH, 2009, NEUROLOGY, V72, P260, DOI 10.1212/01.wnl.0000339484.61490.a4; Tanaka J, 2000, NEUROPATHOLOGY, V20, pS25; van der Knaap MS, 2000, NEUROLOGY, V54, P463, DOI 10.1212/WNL.54.2.463; Van Gerpen JA, 2008, NEUROLOGY, V71, P925, DOI 10.1212/01.wnl.0000325916.30701.21; Wang YQ, 1999, J NEUROSCI RES, V57, P616, DOI 10.1002/(SICI)1097-4547(19990901)57:5<616::AID-JNR4>3.0.CO;2-E; Wider C, 2009, NEUROLOGY, V72, P1953, DOI 10.1212/WNL.0b013e3181a826c0; Yamashita M, 2002, EUR NEUROL, V48, P20, DOI 10.1159/000064952; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200	40	349	361	3	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					200	205		10.1038/ng.1027	http://dx.doi.org/10.1038/ng.1027			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22197934	Green Accepted			2022-12-17	WOS:000299664400020
J	Wang, LD; Zhou, FY; Li, XM; Sun, LD; Song, X; Jin, Y; Li, JM; Kong, GQ; Qi, H; Cui, JA; Zhang, LQ; Yang, JZ; Li, JL; Li, XC; Ren, JL; Liu, ZC; Gao, WJ; Yuan, L; Wei, W; Zhang, YR; Wang, WP; Sheyhidin, I; Li, F; Chen, BP; Ren, SW; Liu, B; Li, D; Ku, JW; Fan, ZM; Zhou, SL; Guo, ZG; Zhao, XK; Liu, N; Ai, YH; Shen, FF; Cui, WY; Song, SA; Guo, T; Huang, J; Yuan, C; Huang, J; Wu, Y; Yue, WB; Feng, CW; Li, HL; Wang, Y; Tian, JY; Lu, Y; Yuan, Y; Zhu, WL; Liu, M; Fu, WJ; Yang, X; Wang, HJ; Han, SL; Chen, J; Han, M; Wang, HY; Zhang, P; Li, XM; Dong, JC; Xing, GL; Wang, R; Guo, M; Chang, ZW; Liu, HL; Guo, L; Yuan, ZQ; Liu, H; Lu, Q; Yang, LQ; Zhu, FG; Yang, XF; Feng, XS; Wang, Z; Li, Y; Gao, SG; Qige, QRW; Bai, LT; Yang, WJ; Lei, GY; Shen, ZY; Chen, LQ; Li, EM; Xu, LY; Wu, ZY; Cao, WK; Wang, JP; Bao, ZQ; Chen, JL; Ding, GC; Zhuang, XA; Zhou, YF; Zheng, HF; Zhang, Z; Zuo, XB; Dong, ZM; Fan, DM; He, X; Wang, J; Zhou, Q; Zhang, QX; Jiao, XY; Lian, SY; Ji, AF; Lu, XM; Wang, JS; Chang, FB; Lu, CD; Chen, ZG; Miao, JJ; Fan, ZL; Lin, RB; Liu, TJ; Wei, JC; Kong, QP; Lan, Y; Fan, YJ; Gao, FS; Wang, TY; Xie, D; Chen, SQ; Yang, WC; Hong, JY; Wang, LA; Qiu, SL; Cai, ZM; Zhang, XJ				Wang, Li-Dong; Zhou, Fu-You; Li, Xue-Min; Sun, Liang-Dan; Song, Xin; Jin, Yan; Li, Jiang-Man; Kong, Guo-Qiang; Qi, Hong; Cui, Juan; Zhang, Lian-Qun; Yang, Jie-Zhi; Li, Ji-Lin; Li, Xing-Chuan; Ren, Jing-Li; Liu, Zhi-Cai; Gao, Wen-Jun; Yuan, Ling; Wei, Wu; Zhang, Yan-Rui; Wang, Wei-Peng; Sheyhidin, Ilyar; Li, Feng; Chen, Bao-Ping; Ren, Shu-Wei; Liu, Bin; Li, Dan; Ku, Jian-Wei; Fan, Zong-Min; Zhou, Sheng-Li; Guo, Zhi-Gang; Zhao, Xue-Ke; Liu, Na; Ai, Yong-Hong; Shen, Fang-Fang; Cui, Wen-Yan; Song, Shuang; Guo, Tao; Huang, Jing; Yuan, Chao; Huang, Jia; Wu, Yue; Yue, Wen-Bin; Feng, Chang-Wei; Li, Hong-Lei; Wang, Yan; Tian, Jin-Ya; Lu, Yue; Yuan, Yi; Zhu, Wen-Liang; Liu, Min; Fu, Wen-Jing; Yang, Xia; Wang, Han-Jing; Han, Suo-Li; Chen, Jie; Han, Min; Wang, Hai-Yan; Zhang, Peng; Li, Xiu-Min; Dong, Jin-Cheng; Xing, Guo-Lan; Wang, Ran; Guo, Ming; Chang, Zhi-Wei; Liu, Hai-Lin; Guo, Li; Yuan, Zhi-Qing; Liu, Hai; Lu, Qin; Yang, Liu-Qin; Zhu, Fu-Guo; Yang, Xiu-Feng; Feng, Xiao-Shan; Wang, Zhou; Li, Yin; Gao, She-Gan; Qige, Qirenwang; Bai, Long-Tang; Yang, Wen-Jun; Lei, Guang-Yan; Shen, Zhong-Ying; Chen, Long-Qi; Li, En-Min; Xu, Li-Yan; Wu, Zhi-Yong; Cao, Wei-Ke; Wang, Jian-Po; Bao, Zhi-Qin; Chen, Ji-Li; Ding, Guang-Cheng; Zhuang, Xiang; Zhou, Ying-Fa; Zheng, Hou-Feng; Zhang, Zheng; Zuo, Xian-Bo; Dong, Zi-Ming; Fan, Dong-Mei; He, Xin; Wang, Jin; Zhou, Qi; Zhang, Qin-Xian; Jiao, Xin-Ying; Lian, Shi-Yong; Ji, Ai-Fang; Lu, Xiao-Mei; Wang, Jin-Sheng; Chang, Fu-Bao; Lu, Chang-Dong; Chen, Zhi-Guo; Miao, Jian-Jun; Fan, Zeng-Lin; Lin, Ruo-Bai; Liu, Tai-Jiang; Wei, Jin-Chang; Kong, Qing-Peng; Lan, Yu; Fan, Yu-Jing; Gao, Fu-Sheng; Wang, Tian-Yun; Xie, Dong; Chen, Shu-Qing; Yang, Wan-Cai; Hong, Jun-Yan; Wang, Liang; Qiu, Song-Liang; Cai, Zhi-Ming; Zhang, Xue-Jun			Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54	NATURE GENETICS			English	Article							PHOSPHOLIPASE-C-EPSILON; HIGH-INCIDENCE AREA; FUNCTIONAL-CHARACTERIZATION; NORTHERN CHINA; RISK-FACTORS; HAN CHINESE; CANCER	We performed a genome-wide association study of esophageal squamous cell carcinoma (ESCC) by genotyping 1,077 individuals with ESCC and 1,733 control subjects of Chinese Han descent. We selected 18 promising SNPs for replication in an additional 7,673 cases of ESCC and 11,013 control subjects of Chinese Han descent and 303 cases of ESCC and 537 control subjects of Chinese Uygur-Kazakh descent. We identified two previously unknown susceptibility loci for ESCC: PLCE1 at 10q23 (P-Han combined (for ESCC) = 7.46 x 10(-56), odds ratio (OR) = 1.43; PUygur-Kazakh for ESCC = 5.70 x 10(-4), OR = 1.53) and C20orf54 at 20p13 (P-Han combined (for ESCC) = 1.21 x 10(-11), OR = 0.86; PUygur-Kazakh for ESCC = 7.88 x 10(-3), OR = 0.66). We also confirmed association in 2,766 cases of gastric cardia adenocarcinoma cases and the same 11,013 control subjects (PLCE1, P-Han for GCA = 1.74 x 10(-39), OR = 1.55 and C20orf54, P-Han for GCA = 3.02 x 10(-3), OR = 0.91). PLCE1 and C20orf54 have important biological implications for both ESCC and GCA. PLCE1 might regulate cell growth, differentiation, apoptosis and angiogenesis. C20orf54 is responsible for transporting riboflavin, and deficiency of riboflavin has been documented as a risk factor for ESCC and GCA.	[Wang, Li-Dong; Song, Xin; Jin, Yan; Li, Jiang-Man; Zhang, Lian-Qun; Li, Dan; Zhou, Sheng-Li; Guo, Zhi-Gang; Zhao, Xue-Ke; Liu, Na; Ai, Yong-Hong; Shen, Fang-Fang; Cui, Wen-Yan; Yuan, Yi; Wang, Hai-Yan; Zhang, Peng; Li, Xiu-Min; Liu, Hai-Lin; Yuan, Zhi-Qing; Chen, Zhi-Guo; Wang, Tian-Yun; Yang, Wan-Cai; Wang, Liang] Xinxiang Med Univ, Canc Res Ctr, Xinxiang, Henan, Peoples R China; [Wang, Li-Dong; Zhou, Fu-You; Li, Xue-Min; Song, Xin; Li, Jiang-Man; Kong, Guo-Qiang; Qi, Hong; Cui, Juan; Yang, Jie-Zhi; Li, Xing-Chuan; Ren, Jing-Li; Yuan, Ling; Wang, Wei-Peng; Li, Dan; Fan, Zong-Min; Song, Shuang; Guo, Tao; Huang, Jing; Yuan, Chao; Huang, Jia; Wu, Yue; Feng, Chang-Wei; Li, Hong-Lei; Wang, Yan; Tian, Jin-Ya; Lu, Yue; Zhu, Wen-Liang; Liu, Min; Fu, Wen-Jing; Yang, Xia; Wang, Han-Jing; Han, Suo-Li; Chen, Jie; Dong, Jin-Cheng; Xing, Guo-Lan; Wang, Ran; Guo, Ming; Chang, Zhi-Wei; Guo, Li; Lu, Qin; Wang, Jian-Po; Ding, Guang-Cheng; Zhuang, Xiang; Zhou, Ying-Fa; Dong, Zi-Ming; Fan, Dong-Mei; He, Xin; Wang, Jin; Zhou, Qi; Zhang, Qin-Xian; Qiu, Song-Liang] Zhengzhou Univ, Henan Key Lab Esophageal Canc Res, Dept Basic Oncol & Pathol, Coll Med,Affiliated Hosp 1& 2, Zhengzhou, Henan, Peoples R China; [Zhou, Fu-You; Wang, Jian-Po; Lu, Chang-Dong] Anyang Tumor Hosp, Dept Thorac Surg & Tumor Prevent Treatment, Anyang, Henan, Peoples R China; [Li, Xue-Min; Wang, Wei-Peng; Bao, Zhi-Qin; Chen, Ji-Li; Miao, Jian-Jun; Fan, Zeng-Lin] Cixian Hosp, Dept Pathol & Thorac Surg, Ctr Hlth Screening & Endoscopy, Cixian, Hebei, Peoples R China; [Sun, Liang-Dan; Zheng, Hou-Feng; Zhang, Zheng; Zuo, Xian-Bo; Zhang, Xue-Jun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Li, Ji-Lin; Jiao, Xin-Ying; Wei, Jin-Chang] Linzhou Esophageal Canc Hosp, Dept Pathol & Thorac Surg, Linzhou, Henan, Peoples R China; [Liu, Zhi-Cai; Lian, Shi-Yong] Tumor Hosp Linzhou, Dept Thorac Surg, Linzhou, Henan, Peoples R China; [Gao, Wen-Jun; Chang, Fu-Bao] Peoples Hosp & Chinese Med Hosp Linzhou, Dept Thorac Surg, Linzhou, Henan, Peoples R China; [Yuan, Ling; Li, Yin] Canc Hosp Henan Prov, Dept Thorac Surg & Radiotherapy, Zhengzhou, Henan, Peoples R China; [Wei, Wu; Ji, Ai-Fang; Wang, Jin-Sheng] Changzhi Med Univ, Inst Hematol Dis, Changzhi, Shanxi, Peoples R China; [Wei, Wu; Ji, Ai-Fang; Wang, Jin-Sheng] Changzhi Med Univ, Dept Pathol, Changzhi, Shanxi, Peoples R China; [Zhang, Yan-Rui] Henan Prov Peoples Hosp, Dept Gastroenterol, Zhengzhou, Henan, Peoples R China; [Sheyhidin, Ilyar; Lu, Xiao-Mei] Xinjiang Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Urumqi, Xinjiang, Peoples R China; [Sheyhidin, Ilyar; Lu, Xiao-Mei] Xinjiang Med Univ, Affiliated Hosp 1, Med Res Ctr, Urumqi, Xinjiang, Peoples R China; [Li, Feng] Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Chen, Bao-Ping] Henan Univ, Huaihe Hosp, Dept Nephrol, Kaifeng, Henan, Peoples R China; [Ren, Shu-Wei] Xinyang Cent Hosp, Dept Oncol, Xinyang, Henan, Peoples R China; [Liu, Bin; Gao, Fu-Sheng] Capital Med Univ, Beijing Tongren Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Ku, Jian-Wei] Nanyang Med Coll, Affiliated Hosp 1, Dept Oncol, Nanyang, Henan, Peoples R China; [Yue, Wen-Bin] Peoples Hosp Puyang, Dept Oncol, Puyang, Henan, Peoples R China; [Han, Min; Zhu, Fu-Guo] First Peoples Hosp Shangqiu, Dept Gastroenterol & Thorac Surg, Shangqiu, Henan, Peoples R China; [Liu, Hai] Third Peoples Hosp Yunnan Prov, Dept Gastroenterol, Kunming, Yunnan, Peoples R China; [Yang, Liu-Qin] Cent Hosp Xinxiang, Dept Radiotherapy, Xinxiang, Henan, Peoples R China; [Yang, Xiu-Feng] Hebi Dahejian Hosp, Dept Surg, Hebi, Henan, Peoples R China; [Feng, Xiao-Shan; Gao, She-Gan] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Oncol, Luoyang, Henan, Peoples R China; [Wang, Zhou] Shandong Univ, Dept Thorac Surg, Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Qige, Qirenwang; Bai, Long-Tang] Inner Mongolia Med Coll, Affiliated Hosp, Dept Internal Mongolia Med, Hohhot, Inner Mongolia, Peoples R China; [Yang, Wen-Jun] Ningxia Med Univ, Dept Biotechnol, Ningxia, Peoples R China; [Lei, Guang-Yan] Tumor Hosp Shaanxi Prov, Dept Thorac Surg, Xian, Shaanxi, Peoples R China; [Shen, Zhong-Ying; Li, En-Min; Xu, Li-Yan; Wu, Zhi-Yong] Shantou Univ, Coll Med, Dept Oncol Pathol, Shantou, Guangdong, Peoples R China; [Shen, Zhong-Ying; Li, En-Min; Xu, Li-Yan; Wu, Zhi-Yong] Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Shantou, Guangdong, Peoples R China; [Chen, Long-Qi] Sichuan Univ, W China Hosp, Dept Thorac & Cardiovasc Surg, Chengdu 610064, Sichuan, Peoples R China; [Cao, Wei-Ke] Nanjing Med Univ, Huaian Hosp 1, Cent Lab, Huaian, Jiangsu, Peoples R China; [Lin, Ruo-Bai] Fujian Med Univ, Dept Thorac Surg, Union Hosp, Fuzhou, Fujian, Peoples R China; [Liu, Tai-Jiang] Red Cross Hosp Huojia, Dept Surg, Xinxiang, Henan, Peoples R China; [Kong, Qing-Peng] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resource & Evolut, Kunming, Yunnan, Peoples R China; [Lan, Yu; Fan, Yu-Jing] Peking Univ, Med Coll 4, Beijing Jishuitan Hosp, Dept Gastroenterol, Beijing 100871, Peoples R China; [Xie, Dong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Chen, Shu-Qing; Hong, Jun-Yan] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Cai, Zhi-Ming] Peking Univ, Shenzhen Hosp, Guangdong Key Lab Male Reprod Med & Genet, Shenzhen, Guangdong, Peoples R China	Xinxiang Medical University; Zhengzhou University; Anhui Medical University; Changzhi Medical College; Changzhi Medical College; Zhengzhou University; Xinjiang Medical University; Xinjiang Medical University; Shihezi University; Henan University; Capital Medical University; Nanyang Medical College; Henan University of Science & Technology; Shandong University; Inner Mongolia Medical University; Ningxia Medical University; Shantou University; Shantou University; Sichuan University; Nanjing Medical University; Fujian Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology; Peking University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang University; Peking University	Wang, LD (corresponding author), Xinxiang Med Univ, Canc Res Ctr, Xinxiang, Henan, Peoples R China.	ldwang@xxmu.edu.cn	zhou, sheng/GYJ-6012-2022; zhang, lianqun/HGF-1713-2022; xu, li/GNH-3667-2022; Yang, Wancai/O-7655-2019; Chen, Shu/Z-2943-2019; Chen, Gang/G-2722-2010; Zheng, Houfeng/K-4424-2012; li, xiu/GXV-1745-2022; Pillay, Nischalan/F-9536-2012; Yang, Wancai/G-3750-2010	Yang, Wancai/0000-0001-7437-9197; Zheng, Houfeng/0000-0001-5681-8598; ren, jingli/0000-0001-9891-0579; Zhou, Fu-You/0000-0002-6548-4099; Wang, Li Dong/0000-0002-7933-0410; Xie, Dong/0000-0002-1150-8657; Yang, Wenjun/0000-0001-5671-1344	Xinxiang Medical University [2009-5]; National Natural Science Foundations [30670956, 30971133]; 863 HighTech Key Projects [2006AA02A403, 2007AA02Z161]; China Key Program on Basic Research [2007CB516812]; Science and Technology Department of Henan Province [2009-8]; Health Department of Henan Province [2009-10]; Education Department of Henan Province [2008-7]; Anhui Provincial Special Scientific Program [2007-7]	Xinxiang Medical University; National Natural Science Foundations(National Natural Science Foundation of China (NSFC)); 863 HighTech Key Projects(National High Technology Research and Development Program of China); China Key Program on Basic Research; Science and Technology Department of Henan Province; Health Department of Henan Province; Education Department of Henan Province; Anhui Provincial Special Scientific Program	We thank all the patients and their family members whose contributions made this work possible; medical students from Xinxiang Medical University for sample and data collections; Y. Xing (Xinxiang Medical University) for organizing field work for sample collections and finding financial support for this study; the genotyping at Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, China, Hefei, Anhui for genotyping and statistical and bioinformatic analyses; B. G. Ma (Henan Provincial People's Hospital), W. Huang (Health Department of Henan Province), S. Y. Lian (Tumor Hospital of Linzhou), Z. Wang (Anyang Tumor Hospital), W. Zhang and J.T. Zhao (both People's Hospital of Heibi) for field work organization; J.H. Bian (Shantou University), J.J. Liu (Human Genetics, Genome Institute of Singapore) and I. Ding (National Cancer Institute, NIH) for discussions about the manuscript. Supported by Xinxiang Medical University Key Scientific Program (2009-5), the National Natural Science Foundations (30670956, 30971133), 863 HighTech Key Projects (2006AA02A403, 2007AA02Z161), China Key Program on Basic Research (2007CB516812), Special Scientific Programs from Science and Technology Department (2009-8), Health Department (2009-10) and Education Department (2008-7) of Henan Province and Anhui Provincial Special Scientific Program (2007-7).	Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2009, ADV ENZYME REGUL, V49, P54, DOI 10.1016/j.advenzreg.2009.01.004; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Cheung WY, 2009, GASTROENTEROL CLIN N, V38, P75, DOI 10.1016/j.gtc.2009.01.009; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; He YT, 2009, ASIAN PAC J CANCER P, V10, P619; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Hu N, 2005, CANCER RES, V65, P2542, DOI 10.1158/0008-5472.CAN-04-3247; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; Li K, 2002, INT J CANCER, V102, P271, DOI [10.1002/ijc.10706, 10.1002/jhc.10706]; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Messmann H, 2001, BEST PRACT RES CL GA, V15, P249, DOI 10.1053/bega.2000.0172; Morita M, 2010, INT J CLIN ONCOL, V15, P126, DOI 10.1007/s10147-010-0056-7; Munoz N, 1996, CANC EPIDEMIOLOGY PR, P681; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Siassi F, 2005, CANCER DETECT PREV, V29, P464, DOI 10.1016/j.cdp.2005.08.001; Sun G, 2007, FOOD ADDIT CONTAM A, V24, P181, DOI 10.1080/02652030601013471; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; WANG LD, 1993, CANCER RES, V53, P1783; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yamamoto S, 2009, J BIOCHEM, V145, P437, DOI 10.1093/jb/mvn181; Yang Chun-xia, 2005, Asian Pac J Cancer Prev, V6, P48; Yonezawa A, 2008, AM J PHYSIOL-CELL PH, V295, pC632, DOI 10.1152/ajpcell.00019.2008; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009668; Zhang WH, 2000, AM J HUM GENET, V67, P110, DOI 10.1086/302970	32	349	392	4	595	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					759	U46		10.1038/ng.648	http://dx.doi.org/10.1038/ng.648			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20729853				2022-12-17	WOS:000281388400010
J	Khor, CC; Chapman, SJ; Vannberg, FO; Dunne, A; Murphy, C; Ling, EY; Frodsham, AJ; Walley, AJ; Kyrieleis, O; Khan, A; Aucan, C; Segal, S; Moore, CE; Knox, K; Campbell, SJ; Lienhardt, C; Scott, A; Aaby, P; Sow, OY; Grignani, RT; Sillah, J; Sirugo, G; Peshu, N; Williams, TN; Maitland, K; Davies, RJO; Kwiatkowski, DP; Day, NP; Yala, D; Crook, DW; Marsh, K; Berkley, JA; O'Neill, LAJ; Hill, AVS				Khor, Chiea C.; Chapman, Stephen J.; Vannberg, Fredrik O.; Dunne, Aisling; Murphy, Caroline; Ling, Edmund Y.; Frodsham, Angela J.; Walley, Andrew J.; Kyrieleis, Otto; Khan, Amir; Aucan, Christophe; Segal, Shelley; Moore, Catrin E.; Knox, Kyle; Campbell, Sarah J.; Lienhardt, Christian; Scott, Anthony; Aaby, Peter; Sow, Oumou Y.; Grignani, Robert T.; Sillah, Jackson; Sirugo, Giorgio; Peshu, Nobert; Williams, Thomas N.; Maitland, Kathryn; Davies, Robert J. O.; Kwiatkowski, Dominic P.; Day, Nicholas P.; Yala, Djamel; Crook, Derrick W.; Marsh, Kevin; Berkley, James A.; O'Neill, Luke A. J.; Hill, Adrian V. S.			A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis	NATURE GENETICS			English	Article							TOLL-LIKE RECEPTORS; TLR4; GENE; LIPOPOLYSACCHARIDE; POLYMORPHISM; INDUCTION; MOLECULE; TIRAP; MICE; CD36	Toll-like receptors (TLRs) and members of their signaling pathway are important in the initiation of the innate immune response to a wide variety of pathogens(1-3). The adaptor protein Mal (also known as TIRAP), encoded by TIRAP (MIM 606252), mediates downstream signaling of TLR2 and TLR4 (refs. 4-6). We report a case-control study of 6,106 individuals from the UK, Vietnam and several African countries with invasive pneumococcal disease, bacteremia, malaria and tuberculosis. We genotyped 33 SNPs, including rs8177374, which encodes a leucine substitution at Ser180 of Mal. We found that heterozygous carriage of this variant associated independently with all four infectious diseases in the different study populations. Combining the study groups, we found substantial support for a protective effect of S180L heterozygosity against these infectious diseases (N = 6,106; overall P = 9.6 x 10(-8)). We found that the Mal S180L variant attenuated TLR2 signal transduction.	Churchill Hosp, Osler Chest Unit, Oxford, England; Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; John Radcliffe Hosp, Dept Microbiol, Oxford OX3 9DU, England; Inst Rech Dev, Dakar, Senegal; Kilifi District Hosp, Ctr Geog Med Res, Kenya Med Res Inst, Wellcome Trust Programme, Kilifi, Kenya; Bandim Hlth Project, Bissau, Guinea Bissau; Univ Ignace Deen, Serv Pneumophtisol, Conarky 634, Guinea; MRC Labs, Fajara, Gambia; Cho Quan Hosp, Ctr Trop Dis, Ho Chi Minh City, Vietnam; Inst Pasteur, Serv TB, Algiers, Algeria; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England	University of Oxford; Trinity College Dublin; University of Oxford; University of Oxford; Institut de Recherche pour le Developpement (IRD); Kenya Medical Research Institute; MRC Laboratory Molecular Biology; University of Oxford; Wellcome Centre for Human Genetics	Hill, AVS (corresponding author), Hammersmith Hosp, Imperial Coll London, Sect Genom Med, Du Cane Rd, London W12 0NN, England.	laoneill@tcd.ie; adrian.hill@well.ox.ac.uk	Lienhardt, Christian/AAU-4969-2021; Moore, Catrin/K-1980-2017; Walley, Andrew J/D-2573-2009; Sirugo, Giorgio/N-9056-2019; HILL, Adrian V>S>/C-1306-2008; Ling, Edmund/B-7923-2010; Sirugo, Giorgio/L-1628-2016	Lienhardt, Christian/0000-0003-0233-893X; Moore, Catrin/0000-0002-8639-9846; Walley, Andrew J/0000-0001-7707-7549; Pickett, Sarah/0000-0002-1242-2927; Aaby, Peter/0000-0001-8331-1389; Talbot, Angela/0000-0002-0386-8070; Khan, Amir/0000-0003-1176-6952; Berkley, James/0000-0002-1236-849X; Maitland, Kathryn/0000-0002-0007-0645; Kwiatkowski, Dominic/0000-0002-5023-0176; Khor, Chiea Chuen/0000-0002-1128-4729; dunne, aisling/0000-0002-2342-9518; O'Neill, Luke/0000-0002-4333-2748	Medical Research Council [G0200454, G19/9, MC_U122888468] Funding Source: Medline; Wellcome Trust [081835, 077092, 076934, 061089] Funding Source: Medline; MRC [G19/9, G0200454, MC_U122888468] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Clatworthy MR, 2004, J EXP MED, V199, P717, DOI 10.1084/jem.20032197; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Dean M, 2002, ANNU REV GENOM HUM G, V3, P263, DOI 10.1146/annurev.genom.3.022502.103149; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	28	349	365	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					523	528		10.1038/ng1976	http://dx.doi.org/10.1038/ng1976			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17322885	Green Accepted, Green Submitted			2022-12-17	WOS:000245271200023
J	Gandhi, TKB; Zhong, J; Mathivanan, S; Karthick, L; Chandrika, KN; Mohan, SS; Sharma, S; Pinkert, S; Nagaraju, S; Periaswamy, B; Mishra, G; Nandakumar, K; Shen, BY; Deshpande, N; Nayak, R; Sarker, M; Boeke, JD; Parmigiani, G; Schultz, J; Bader, JS; Pandey, A				Gandhi, TKB; Zhong, J; Mathivanan, S; Karthick, L; Chandrika, KN; Mohan, SS; Sharma, S; Pinkert, S; Nagaraju, S; Periaswamy, B; Mishra, G; Nandakumar, K; Shen, BY; Deshpande, N; Nayak, R; Sarker, M; Boeke, JD; Parmigiani, G; Schultz, J; Bader, JS; Pandey, A			Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets	NATURE GENETICS			English	Article							INTERACTION MAPS; ATPASE SUBUNITS; IDENTIFICATION; DATABASE; NETWORK; COMPLEX; GENES; PROTEASOME; CLONING; MEMBER	We present the first analysis of the human proteome with regard to interactions between proteins. We also compare the human interactome with the available interaction datasets from yeast (Saccharomyces cerevisiae), worm (Caenorhabditis elegans) and fly (Drosophila melanogaster). Of > 70,000 binary interactions, only 42 were common to human, worm and fly, and only 16 were common to all four datasets. An additional 36 interactions were common to fly and worm but were not observed in humans, although a coimmunoprecipitation assay showed that 9 of the interactions do occur in humans. A re-examination of the connectivity of essential genes in yeast and humans indicated that the available data do not support the presumption that the number of interaction partners can accurately predict whether a gene is essential. Finally, we found that proteins encoded by genes mutated in inherited genetic disorders are likely to interact with proteins known to cause similar disorders, suggesting the existence of disease subnetworks. The human interaction map constructed from our analysis should facilitate an integrative systems biology approach to elucidating the cellular networks that contribute to health and disease states.	Inst Bioinformat, Bangalore 560066, Karnataka, India; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA; Univ Wurzburg, Biozentrum, Dept Bioinformat, D-97074 Wurzburg, Germany; Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; Johns Hopkins Univ, High Throughput Biol Ctr, Baltimore, MD USA; Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD USA; Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Wurzburg; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Pandey, A (corresponding author), Inst Bioinformat, Int Technol Pk, Bangalore 560066, Karnataka, India.	pandey@jhmi.edu	Bader, Joel/A-1818-2009; Zhong, Jun/D-1662-2010; Pinkert, Stefan/A-5534-2009; Mathivanan, Suresh/D-2045-2009; Schultz, Joerg/B-9346-2008; Pandey, Akhilesh/B-4127-2009	Bader, Joel/0000-0002-6020-4625; Zhong, Jun/0000-0003-3148-4143; Mathivanan, Suresh/0000-0002-7290-5795; Pandey, Akhilesh/0000-0001-9943-6127; T. K. Boopathy, Gandhi/0000-0002-1821-9540; Deshpande, Chandrika/0000-0002-5557-519X; Nandakumar, Kannabiran/0000-0001-7185-8483; Boeke, Jef/0000-0001-5322-4946	NCRR NIH HHS [U54RR020839] Funding Source: Medline; NIGMS NIH HHS [R41 GM073492, R01 GM067761] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R41GM073492, R01GM067761] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arking DE, 2004, CIRC RES, V94, P712, DOI 10.1161/01.RES.0000123861.16082.95; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Coulomb S, 2005, P ROY SOC B-BIOL SCI, V272, P1721, DOI 10.1098/rspb.2005.3128; Cox D. R., 2018, ANAL BINARY DATA; Egan J.P., 1975, SIGNAL DETECTION THE; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fujiwara T, 1996, FEBS LETT, V387, P184, DOI 10.1016/0014-5793(96)00489-9; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; HAFT CR, 1994, J BIOL CHEM, V269, P26286; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hazbun TR, 2001, P NATL ACAD SCI USA, V98, P4277, DOI 10.1073/pnas.091096398; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hollander M, 1973, NONPARAMETRIC STAT M, P27; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ishizuka T, 2001, MOL ENDOCRINOL, V15, P1329, DOI 10.1210/me.15.8.1329; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mrowka R, 2001, GENOME RES, V11, P1971, DOI 10.1101/gr.206701; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; STAYON CA, 2004, GENOME BIOL, V5, pR96; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wojcik J, 2002, J MOL BIOL, V323, P763, DOI 10.1016/S0022-2836(02)01009-4; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zaza G, 2004, BLOOD, V104, P1435, DOI 10.1182/blood-2003-12-4306	48	349	362	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					285	293		10.1038/ng1747	http://dx.doi.org/10.1038/ng1747			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16501559				2022-12-17	WOS:000235589600007
J	MacDonald, TJ; Brown, KM; LaFleur, B; Peterson, K; Lawlor, C; Chen, YD; Packer, RJ; Cogen, P; Stephan, DA				MacDonald, TJ; Brown, KM; LaFleur, B; Peterson, K; Lawlor, C; Chen, YD; Packer, RJ; Cogen, P; Stephan, DA			Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease	NATURE GENETICS			English	Article							CHROMOSOME 17P DELETIONS; DNA-POLYMERASE-DELTA; GENE-EXPRESSION; GROWTH-FACTOR; CHILDHOOD MEDULLOBLASTOMA; MOLECULAR CLASSIFICATION; PROGNOSTIC-SIGNIFICANCE; BRAIN-TUMORS; RECEPTOR; CANCER	Little is known about the genetic regulation of medulloblastoma dissemination, but metastatic medulloblastoma is highly associated with poor outcome. We obtained expression profiles of 23 primary medulloblastomas clinically designated as either metastatic (M+) or non-metastatic (M0) and identified 85 genes whose expression differed significantly between classes. Using a class prediction algorithm based on these genes and a leave-one-out approach, we assigned sample class to these tumors (M+ or M0) with 72% accuracy and to four additional independent tumors with 100% accuracy. We also assigned the metastatic medulloblastoma cell line Daoy to the metastatic class. Notably, platelet-derived growth factor receptor alpha (PDGFRA) and members of the downstream RAS/mitogen-activated protein kinase (MAPK) signal transduction pathway are upregulated in M+ tumors. Immunohistochemical validation on an independent set of tumors shows significant overexpression of PDGFRA in M+ tumors compared to MO tumors. Using in vitro assays, we show that platelet-derived growth factor alpha (PDGFA) enhances medulloblastoma migration and increases downstream MAP2K1 (MEK1), MAP2K2 (MEK2), MAPK1 (p42 MAPK) and MAPK3 (p44 MAPK) phosphorylation in a dose-dependent manner. Neutralizing antibodies to PDGFRA blocks MAP2K1, MAP2K2 and MAPK1/3 phosphorylation, whereas U0126, a highly specific inhibitor of MAP2K1 and MAP2K2, also blocks MAPK1/3. Both inhibit migration and prevent PDGFA-stimulated migration. These results provide the first insight into the genetic regulation of medulloblastoma metastasis and are the first to suggest a role for PDGFRA and the RAS/MAPK signaling pathway in medulloblastoma metastasis. Inhibitors of PDGFRA and RAS proteins should therefore be considered for investigation as possible novel therapeutic strategies against medulloblastoma.	Childrens Natl Med Ctr, Res Ctr Genet Med, Washington, DC 20010 USA; Childrens Natl Med Ctr, Ctr Canc & Transplantat Biol, Washington, DC 20010 USA; George Washington Univ, Dept Genet, Washington, DC USA; Vanderbilt Univ, Dept Prevent Med, Div Biostat, Nashville, TN USA; NHGRI, NIH, Bethesda, MD 20892 USA; Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; Childrens Natl Med Ctr, Dept Neurosurg, Washington, DC 20010 USA; Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA	Children's National Health System; Children's National Health System; George Washington University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Children's National Health System; Children's National Health System; Children's National Health System	MacDonald, TJ (corresponding author), Childrens Natl Med Ctr, Res Ctr Genet Med, 111 Michigan Ave NW, Washington, DC 20010 USA.		MacDonald, Tobey/D-4554-2013; LaFleur, Bonnie J/GPJ-9592-2022	LaFleur, Bonnie J/0000-0002-4939-9337				Adesina AM, 1999, J CHILD NEUROL, V14, P411, DOI 10.1177/088307389901400701; BATRA SK, 1995, J NEURO-ONCOL, V24, P39, DOI 10.1007/BF01052657; BENDOR A, 2000, AGL200012 AG LABS; Biegel JA, 1997, CLIN CANCER RES, V3, P473; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Brown HG, 2000, J NEUROPATH EXP NEUR, V59, P857, DOI 10.1093/jnen/59.10.857; Cillo C, 1996, INT J CANCER, V66, P692, DOI 10.1002/(SICI)1097-0215(19960529)66:5<692::AID-IJC18>3.0.CO;2-6; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELLISON JA, 1994, J NEUROSCI RES, V37, P116, DOI 10.1002/jnr.490370116; Emadian SM, 1996, CLIN CANCER RES, V2, P1559; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; GARSON JA, 1989, BRIT J CANCER, V59, P889, DOI 10.1038/bjc.1989.188; Genda T, 2000, LAB INVEST, V80, P387, DOI 10.1038/labinvest.3780043; GILBERTSON RJ, 1995, BRIT J CANCER, V71, P473, DOI 10.1038/bjc.1995.96; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grotzer MA, 2000, J CLIN ONCOL, V18, P1027, DOI 10.1200/JCO.2000.18.5.1027; Herms J, 2000, INT J CANCER, V89, P395; Huang HT, 2000, CANCER RES, V60, P6868; Khan J, 1999, BIOCHIM BIOPHYS ACTA, V1423, P17; Kim JYH, 1999, CANCER RES, V59, P711; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Markert JM, 2001, PHYSIOL GENOMICS, V5, P21, DOI 10.1152/physiolgenomics.2001.5.1.21; McCarthy MJ, 1998, FEBS LETT, V423, P334, DOI 10.1016/S0014-5793(98)00122-7; Packer RJ, 1999, J CLIN ONCOL, V17, P2127, DOI 10.1200/JCO.1999.17.7.2127; Packer RJ, 1999, ARCH NEUROL-CHICAGO, V56, P421, DOI 10.1001/archneur.56.4.421; Packer RJ, 1999, BRAIN DEV-JPN, V21, P75, DOI 10.1016/S0387-7604(98)00085-0; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; Remacle A, 2000, INT J CANCER, V89, P118, DOI 10.1002/(SICI)1097-0215(20000320)89:2<118::AID-IJC3>3.0.CO;2-8; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sunshine C, 2000, EXP CELL RES, V257, P1, DOI 10.1006/excr.2000.4855; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Yao RJ, 1997, J BIOL CHEM, V272, P18261, DOI 10.1074/jbc.272.29.18261; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620; Yu JH, 2000, J BIOL CHEM, V275, P19076, DOI 10.1074/jbc.M910329199; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; ZEITZER PM, 1999, J CLIN ONCOL, V17, P832; Zurawel RH, 2000, GENE CHROMOSOME CANC, V27, P44, DOI 10.1002/(SICI)1098-2264(200001)27:1<44::AID-GCC6>3.0.CO;2-V	38	349	370	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					143	152		10.1038/ng731	http://dx.doi.org/10.1038/ng731			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11544480				2022-12-17	WOS:000171374100019
J	Verpy, E; Leibovici, M; Zwaenepoel, I; Liu, XZ; Gal, A; Salem, N; Mansour, A; Blanchard, S; Kobayashi, I; Keats, BJB; Slim, R; Petit, C				Verpy, E; Leibovici, M; Zwaenepoel, I; Liu, XZ; Gal, A; Salem, N; Mansour, A; Blanchard, S; Kobayashi, I; Keats, BJB; Slim, R; Petit, C			A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C	NATURE GENETICS			English	Article							MYOSIN-VIIA; DEAFNESS; REGION; GENE; IDENTIFICATION; TRANSCRIPTION; LOCALIZATION; MODULES; SYSTEM; SITES	Usher syndrome type 1 (USH1) is an autosomal recessive sensory defect involving congenital profound sensorineural deafness, vestibular dysfunction and blindness (due to progressive retinitis pigmentosa)(1). Six different USH1 loci have been reported. So far, only MYO7A (USH1B), encoding myosin VIIA (ref. 2), has been identified as a gene whose mutation causes the disease. Here, we report a gene underlying USH1C (MIM 276904), a USH1 subtype described in a population of Acadian descendants from Louisiana(3) and in a Lebanese family(4). We identified this gene (USH1C), encoding a PDZ-domain-containing protein, harmonin, in a subtracted mouse cDNA library derived from inner ear sensory areas. In patients we found a splice-site mutation, a frameshift mutation and the expansion of an intronic variable number of tandem repeat (VNTR). We showed that, in the mouse inner ear, only the sensory hair cells express harmonin. The inner ear Ush1c transcripts predicted several harmonin isoforms, some containing an additional coiled-coil domain and a proline- and serine-rich region. As several of these transcripts were absent from the eye, we propose that USH1C also underlies the DFNB18 form of isolated deafness.	Inst Pasteur, CNRS URA 1968, Unite Genet Deficits Sensoriels, Paris 15, France; Virginia Commonwealth Univ, Coll Med, Dept Human Genet, Richmond, VA USA; Virginia Commonwealth Univ, Coll Med, Dept Otolaryngol, Richmond, VA USA; Univ Hamburg, Krankenhaus Eppendorf, Inst Humangenet, D-2000 Hamburg, Germany; Univ St Joseph, Fac Med, Unite Genet Med, Beirut, Lebanon; Amer Univ Beirut, Dept Ophthalmol, Beirut, Lebanon; Amer Univ Beirut, Dept Biochem, Beirut, Lebanon; Hokkaido Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido 060, Japan; Louisiana State Univ, Hlth Sci Ctr, Dept Biometry & Genet, New Orleans, LA USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Virginia Commonwealth University; Virginia Commonwealth University; University of Hamburg; Saint Joseph University Beirut; American University of Beirut; American University of Beirut; Hokkaido University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Petit, C (corresponding author), Inst Pasteur, CNRS URA 1968, Unite Genet Deficits Sensoriels, Paris 15, France.	cpetit@pasteur.fr	Kobayashi, Ichiro/G-8638-2012; Slim, Rima/J-4104-2019; Leibovici, Michel/ABB-6745-2020	Slim, Rima/0000-0002-4060-2159; Petit, Christine/0000-0002-9069-002X	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC004530, R01DC002530] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC02530, R03 DC04530] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; DeAngelis MM, 1998, BBA-MOL BASIS DIS, V1407, P84, DOI 10.1016/S0925-4439(98)00025-8; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Higgins MJ, 1998, GENOME RES, V8, P57, DOI 10.1101/gr.8.1.57; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Jain PK, 1998, GENOMICS, V50, P290, DOI 10.1006/geno.1998.5320; Kimberling W J, 1995, J Am Acad Audiol, V6, P63; Kobayashi I, 1999, GASTROENTEROLOGY, V117, P823, DOI 10.1016/S0016-5085(99)70340-9; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Sahly I, 1997, ANAT EMBRYOL, V196, P159, DOI 10.1007/s004290050088; Saouda M, 1998, HUM GENET, V103, P193, DOI 10.1007/s004390050806; Scanlan MJ, 1999, BBA-GENE STRUCT EXPR, V1445, P39, DOI 10.1016/S0167-4781(99)00033-0; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.3.CO;2-9; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; Steel KP, 1995, ANNU REV GENET, V29, P675; Sudol M, 1998, ONCOGENE, V17, P1469, DOI 10.1038/sj.onc.1202182; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wolfrum U, 1998, CELL MOTIL CYTOSKEL, V40, P261, DOI 10.1002/(SICI)1097-0169(1998)40:3<261::AID-CM5>3.3.CO;2-#; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	31	349	361	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2000	26	1					51	55		10.1038/79171	http://dx.doi.org/10.1038/79171			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973247				2022-12-17	WOS:000089078000016
J	REITMAIR, AH; SCHMITS, R; EWEL, A; BAPAT, B; REDSTON, M; MITRI, A; WATERHOUSE, P; MITTRUCKER, HW; WAKEHAM, A; LIU, B; THOMASON, A; GRIESSER, H; GALLINGER, S; BALLHAUSEN, WG; FISHEL, R; MAK, TW				REITMAIR, AH; SCHMITS, R; EWEL, A; BAPAT, B; REDSTON, M; MITRI, A; WATERHOUSE, P; MITTRUCKER, HW; WAKEHAM, A; LIU, B; THOMASON, A; GRIESSER, H; GALLINGER, S; BALLHAUSEN, WG; FISHEL, R; MAK, TW			MSH2 DEFICIENT MICE ARE VIABLE AND SUSCEPTIBLE TO LYMPHOID TUMORS	NATURE GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH-REPAIR; ESCHERICHIA-COLI; MICROSATELLITE INSTABILITY; STEM-CELLS; GENETIC INSTABILITY; MUTATIONS; CARCINOGENESIS; RECOMBINATION; CARCINOMA	Alterations of the human MSH2 gene, a homologue of the bacterial MutS mismatch repair gene, co-segregate with the majority of hereditary non-polyposis colon cancer (HNPCC) cases. We have generated homozygous MSH2(+) mice. Surprisingly, these mice were found to be viable, produced offspring in a mendelian ratio and bred through at least two generations. Starting at two months of age homozygous -/- mice began, with high frequency, to develop lymphoid tumours that contained microsatellite instabilities. These data establish a direct link between MSH2 deficiency and the pathogenesis of cancer, These mutant mice should be good models to study the progression of tumours and also to screen carcinogenic and anti-cancer agents.	ONTARIO CANC INST,AMGEN INST,DEPT MED BIOPHYS,TORONTO,ON M4X 1K9,CANADA; ONTARIO CANC INST,AMGEN INST,DEPT IMMUNOL,TORONTO,ON M4X 1K9,CANADA; UNIV VERMONT,SCH MED,MARKEY CTR MOLEC GENET,DEPT MOLEC GENET & MICROBIOL,BURLINGTON,VT 05405; UNIV TORONTO,MT SINAI HOSP,SAMUEL LUNENFELD RES INST,DEPT PATHOL & LAB MED,TORONTO,ON M5G 1X5,CANADA; UNIV TORONTO,MT SINAI HOSP,SAMUEL LUNENFELD RES INST,DEPT SURG,TORONTO,ON M5G 1X5,CANADA; AMGEN INC,DEPT BIOL MOLEC,THOUSAND OAKS,CA 91320; UNIV TORONTO,ONTARIO CANC INST,DEPT PATHOL,TORONTO,ON M4X 1K9,CANADA; UNIV ERLANGEN NURNBERG,INST HUMANGENET,D-91054 ERLANGEN,GERMANY	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Vermont; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Amgen; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Erlangen Nuremberg			Gallinger, Steven/E-4575-2013; Bapat, Bharati/B-5839-2014	Waterhouse, Paul/0000-0001-8745-5224	NCI NIH HHS [CA56542, CA67007] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA056542, R01CA067007] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; ALANI E, 1994, GENETICS, V137, P19; ALBRIGHT LAC, 1988, NEW ENGL J MED, V319, P533; BAKER SM, 1995, CELL, V82, P302; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; BISHOP DT, 1990, CANCER SURV, V9, P585; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BRADLEY A, 1986, CURR TOP DEV BIOL, V20, P357, DOI 10.1016/S0070-2153(08)60675-4; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BURKS RT, 1994, ONCOGENE, V9, P1163; COHEN PR, 1992, AM J HEMATOL, V40, P64, DOI 10.1002/ajh.2830400114; CROCE CM, 1987, CELL, V49, P155, DOI 10.1016/0092-8674(87)90552-6; DELEON MP, 1993, CANCER, V71, P3493, DOI 10.1002/1097-0142(19930601)71:11<3493::AID-CNCR2820711106>3.0.CO;2-H; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; FEINSTEIN SI, 1986, GENETICS, V113, P13; FISHEL R, 1994, CANCER RES, V54, P5539; FISHEL R, 1994, SCIENCE, V266, P1403, DOI 10.1126/science.7973733; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHEL RA, 1986, J MOL BIOL, V188, P147, DOI 10.1016/0022-2836(86)90300-1; GONZALEZZULUETA M, 1993, CANCER RES, V53, P5620; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; HAN HJ, 1993, CANCER RES, V53, P5087; HONCHEL R, 1994, CANCER RES, V54, P1159; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JONES M, 1987, CELL, V50, P621, DOI 10.1016/0092-8674(87)90035-3; KEE F, 1991, GUT, V32, P509, DOI 10.1136/gut.32.5.509; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEUNG WPF, 1991, CELL, V65, P443; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LOEB LA, 1991, CANCER RES, V51, P3075; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; LYNCH HT, 1991, SEMIN ONCOL, V18, P337; Maniatis T., 1982, MOL CLONING; MERLO A, 1994, CANCER RES, V54, P2098; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NYSTROMLAHTI M, 1994, AM J HUM GENET, V55, P659; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; PARSONS R, 1995, SCIENCE, V268, P738, DOI 10.1126/science.7632227; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; PELTOMAKI P, 1993, CANCER RES, V53, P5853; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; RHYU MG, 1994, ONCOGENE, V9, P29; RISINGER JI, 1993, CANCER RES, V53, P5100; SCHOENBERG MP, 1994, BIOCHEM BIOPH RES CO, V198, P74, DOI 10.1006/bbrc.1994.1011; SELVA EM, 1995, GENETICS, V139; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; SHRIDHAR V, 1994, CANCER RES, V54, P2084; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; TEICH N, 1984, PATHOGENESIS RETROVI, P785; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WADA C, 1994, BLOOD, V83, P3449, DOI 10.1182/blood.V83.12.3449.bloodjournal83123449; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152; YEE CJ, 1994, CANCER RES, V54, P1641; YOUNG J, 1993, HUM MUTAT, V2, P351, DOI 10.1002/humu.1380020505	65	349	358	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					64	70		10.1038/ng0995-64	http://dx.doi.org/10.1038/ng0995-64			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550317				2022-12-17	WOS:A1995RR72800017
J	Gudbjartsson, DF; Holm, H; Gretarsdottir, S; Thorleifsson, G; Walters, GB; Thorgeirsson, G; Gulcher, J; Mathiesen, EB; Njolstad, I; Nyrnes, A; Wilsgaard, T; Hald, EM; Hveem, K; Stoltenberg, C; Kucera, G; Stubblefield, T; Carter, S; Roden, D; Ng, MCY; Baum, L; So, WY; Wong, KS; Chan, JCN; Gieger, C; Wichmann, HE; Gschwendtner, A; Dichgans, M; Kuhlenbaumer, G; Berger, K; Ringelstein, EB; Bevan, S; Markus, HS; Kostulas, K; Hillert, J; Sveinbjornsdottir, S; Valdimarsson, EM; Lochen, ML; Ma, RCW; Darbar, D; Kong, A; Arnar, DO; Thorsteinsdottir, U; Stefansson, K				Gudbjartsson, Daniel F.; Holm, Hilma; Gretarsdottir, Solveig; Thorleifsson, Gudmar; Walters, G. Bragi; Thorgeirsson, Gudmundur; Gulcher, Jeffrey; Mathiesen, Ellisiv B.; Njolstad, Inger; Nyrnes, Audhild; Wilsgaard, Tom; Hald, Erin M.; Hveem, Kristian; Stoltenberg, Camilla; Kucera, Gayle; Stubblefield, Tanya; Carter, Shannon; Roden, Dan; Ng, Maggie C. Y.; Baum, Larry; So, Wing Yee; Wong, Ka Sing; Chan, Juliana C. N.; Gieger, Christian; Wichmann, H-Erich; Gschwendtner, Andreas; Dichgans, Martin; Kuhlenbaeumer, Gregor; Berger, Klaus; Ringelstein, E. Bernd; Bevan, Steve; Markus, Hugh S.; Kostulas, Konstantinos; Hillert, Jan; Sveinbjornsdottir, Sigurlaug; Valdimarsson, Einar M.; Lochen, Maja-Lisa; Ma, Ronald C. W.; Darbar, Dawood; Kong, Augustine; Arnar, David O.; Thorsteinsdottir, Unnur; Stefansson, Kari			A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke	NATURE GENETICS			English	Article							CHROMOSOME 4Q25; ATBF1; RISK; METAANALYSIS; PROTEIN	We expanded our genome-wide association study on atrial fibrillation (AF) in Iceland, which previously identified risk variants on 4q25, and tested the most significant associations in samples from Iceland, Norway and the United States. A variant in the ZFHX3 gene on chromosome 16q22, rs7193343-T, associated significantly with AF (odds ratio OR = 1.21, P = 1.4 x 10(-10)). This variant also associated with ischemic stroke (OR = 1.11, P = 0.00054) and cardioembolic stroke (OR = 1.22, P = 0.00021) in a combined analysis of five stroke samples.	[Gudbjartsson, Daniel F.; Holm, Hilma; Gretarsdottir, Solveig; Thorleifsson, Gudmar; Walters, G. Bragi; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCode Genet, Reykjavik, Iceland; [Holm, Hilma] Emory Univ, Sch Med, Div Cardiol, Dept Internal Med, Atlanta, GA 30322 USA; [Thorleifsson, Gudmar; Arnar, David O.] Landspitali Univ Hosp, Div Cardiol, Dept Internal Med, Reykjavik, Iceland; [Thorleifsson, Gudmar; Arnar, David O.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Mathiesen, Ellisiv B.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Mathiesen, Ellisiv B.] Univ Hosp N Norway, Dept Neurol, Tromso, Norway; [Njolstad, Inger; Nyrnes, Audhild; Wilsgaard, Tom; Lochen, Maja-Lisa] Univ Tromso, Inst Community Med, Tromso, Norway; [Nyrnes, Audhild] Univ Hosp N Norway, Dept Geriatr, Tromso, Norway; [Hald, Erin M.; Lochen, Maja-Lisa] Univ Hosp N Norway, Dept Cardiol, Tromso, Norway; [Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Stoltenberg, Camilla] Norwegian Inst Publ Hlth, Oslo, Norway; [Kucera, Gayle; Stubblefield, Tanya; Carter, Shannon; Roden, Dan; Darbar, Dawood] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Ng, Maggie C. Y.; Baum, Larry; So, Wing Yee; Wong, Ka Sing; Chan, Juliana C. N.; Ma, Ronald C. W.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Gieger, Christian; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Epidemiol, Neuherberg, Germany; [Gschwendtner, Andreas; Dichgans, Martin] Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany; [Kuhlenbaeumer, Gregor] Univ Kiel, Inst Expt Med, Kiel, Germany; [Berger, Klaus] Inst Epidemiol & Social Med, Munster, Germany; [Ringelstein, E. Bernd] Univ Munster, Dept Neurol, Munster, Germany; [Ringelstein, E. Bernd] Univ Munster, Leibniz Inst Atherosclerosis Res, Munster, Germany; [Bevan, Steve; Markus, Hugh S.] St Georges Univ London, London, England; [Kostulas, Konstantinos; Hillert, Jan] Karolinska Univ Hosp Huddinge, Dept Neurol, Stockholm, Sweden; [Sveinbjornsdottir, Sigurlaug; Valdimarsson, Einar M.] Landspitali Univ Hosp, Dept Neurol, Reykjavik, Iceland	Emory University; Landspitali National University Hospital; University of Iceland; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU); Norwegian Institute of Public Health (NIPH); Vanderbilt University; Chinese University of Hong Kong; Prince of Wales Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Kiel; University of Munster; University of Munster; St Georges University London; Karolinska Institutet; Karolinska University Hospital; Landspitali National University Hospital	Gudbjartsson, DF (corresponding author), DeCode Genet, Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Stoltenberg, Camilla/G-5090-2017; Chan, Juliana/B-7918-2016; Darbar, Dawood/C-9079-2015; Roden, Dan/ABD-5412-2021; Wichmann, Heinz Erich/AAA-5695-2022; Wong, Ka Sing Lawrence/N-3434-2015; Dichgans, Martin/HCH-3247-2022; Njolstad, Inger/X-3784-2019; Ma, Ronald/C-2788-2009; Kuhlenbäumer, Gregor/A-5110-2009; Stefansson, Kari/AAE-7187-2019; Baum, Lawrence/B-1005-2013; Walters, G. Bragi/L-4215-2013; Hveem, Kristian/AFV-4683-2022	Chan, Juliana/0000-0003-1325-1194; Darbar, Dawood/0000-0002-4103-5977; Wong, Ka Sing Lawrence/0000-0002-2031-9866; Dichgans, Martin/0000-0002-0654-387X; Ma, Ronald/0000-0002-1227-803X; Baum, Lawrence/0000-0002-5345-9355; Walters, G. Bragi/0000-0002-5415-6487; Kong, Augustine/0000-0001-8193-5438; Lochen, Maja-Lisa/0000-0002-8532-6573; Gudbjartsson, Daniel/0000-0002-5222-9857; Bevan, Steve/0000-0003-0490-6830; Gieger, Christian/0000-0001-6986-9554	US National Institutes of Health [HL075266, U01 HL65962]; American Heart Association [0940116N]; German Federal Ministry of Education and Research [01GI9909/3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL075266, U01HL065962] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by US National Institutes of Health grants HL075266 and U01 HL65962 and American Heart Association grant 0940116N. Case ascertainment in the West Germany region (Westphalia) was part of the German Competence Net Stroke, which was supported by the German Federal Ministry of Education and Research (01GI9909/3). In the Dortmund Health Study (controls, West Germany) blood collection was done through funds of the Institute of Epidemiology and Social Medicine University of Muenster, the collection of sociodemographic and clinical variables was supported by the German Migraine & Headache Society (DMKG) and by unrestricted grants of equal share from Astra Zeneca, Berlin Chemie, Boots Healthcare, Glaxo-Smith-Kline, McNeil Pharma, MSD Sharp & Dohme and Pfizer to the University of Muenster.	Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Gretarsdottir S, 2008, ANN NEUROL, V64, P402, DOI 10.1002/ana.21480; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; Lip GYH, 2006, HEART, V92, P155, DOI 10.1136/hrt.2005.066944; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Qi Y, 2008, P NATL ACAD SCI USA, V105, P2481, DOI 10.1073/pnas.0712196105	11	348	360	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					876	878		10.1038/ng.417	http://dx.doi.org/10.1038/ng.417			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19597491	Green Accepted			2022-12-17	WOS:000268432900007
J	Musone, SL; Taylor, KE; Lu, TT; Nititham, J; Ferreira, RC; Ortmann, W; Shifrin, N; Petri, MA; Kamboh, MI; Manzi, S; Seldin, MF; Gregersen, PK; Behrens, TW; Ma, A; Kwok, PY; Criswell, LA				Musone, Stacy L.; Taylor, Kimberly E.; Lu, Timothy T.; Nititham, Joanne; Ferreira, Ricardo C.; Ortmann, Ward; Shifrin, Nataliya; Petri, Michelle A.; Kamboh, M. Ilyas; Manzi, Susan; Seldin, Michael F.; Gregersen, Peter K.; Behrens, Timothy W.; Ma, Averil; Kwok, Pui-Yan; Criswell, Lindsey A.			Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus	NATURE GENETICS			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; ENZYME A20; RESPONSES; 6Q23	The TNFAIP3 (tumor necrosis factor alpha-induced protein 3) gene encodes a ubiquitin editing enzyme, A20, that restricts NF-kappa B-dependent signaling and prevents inflammation. We show that three independent SNPs in the TNFAIP3 region (rs13192841, rs2230926 and rs6922466) are associated with systemic lupus erythematosus (SLE) among individuals of European ancestry. These findings provide critical links between A20 and the etiology of SLE.	[Taylor, Kimberly E.; Nititham, Joanne; Criswell, Lindsey A.] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Musone, Stacy L.; Kwok, Pui-Yan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Lu, Timothy T.; Shifrin, Nataliya; Ma, Averil] Univ Calif San Francisco, Colitis & Crohns Dis Ctr, Dept Med, San Francisco, CA 94143 USA; [Ferreira, Ricardo C.; Ortmann, Ward; Behrens, Timothy W.] Genentech Inc, San Francisco, CA 94080 USA; [Petri, Michelle A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 20205 USA; [Kamboh, M. Ilyas; Manzi, Susan] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15261 USA; [Seldin, Michael F.] Univ Calif Davis, Rowe Program Mol Med & Human Genet, Davis, CA 95616 USA; [Gregersen, Peter K.] Feinstein Inst Med Res, N Shore Long Isl Jewish Hlth Syst, Manhasset, NY 11030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; Northwell Health	Criswell, LA (corresponding author), Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA.	lindsey.criswell@ucsf.edu	Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059; Ferreira, Ricardo C./0000-0001-5733-3285; Kamboh, M. Ilyas/0000-0002-3453-1438	ABCoN contract [NO1-AR-1-2256]; Mary Kirkland Center for Lupus Research; Rainin Foundation; National Center for Research Resources [5 M01 RR-00079]; US Public Health Service;  [R01 AR44804];  [K24 AR02175];  [AI95386];  [AR050267];  [T32 DK07007];  [U19 AI063603];  [2R01 AR4658805];  [K24 AR02213];  [R01 HL 54900];  [R01 HL 74165]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054900, R01HL074165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095386, U19AI063603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR053308, N01AR012256, K24AR002175, R01AR050267, R01AR046588, R01AR044804, K24AR002213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007007] Funding Source: NIH RePORTER	ABCoN contract; Mary Kirkland Center for Lupus Research; Rainin Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); ; ; ; ; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01 AR44804 (L. A. C.), K24 AR02175 (L. A. C.), N01 AI95386 (P. K. G.), ABCoN contract NO1-AR-1-2256 (P. K. G.), AR050267 (M. F. S.), the Mary Kirkland Center for Lupus Research (L. A. C.), the Rainin Foundation (A. M.), T32 DK07007 (T. T. L.), U19 AI063603 (P.-Y. K.), 2R01 AR4658805 (S. M.), K24 AR02213 (S. M.), R01 HL 54900 (M. I. K.) and R01 HL 74165 (M. I. K.). These studies were performed in part in the General Clinical Research Center, Moffitt Hospital, University of California, San Francisco, with funds provided by the National Center for Research Resources, 5 M01 RR-00079, US Public Health Service. We also thank the individuals and physicians who contributed DNA samples and clinical data for this study.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Crow MK, 2008, NEW ENGL J MED, V358, P956, DOI 10.1056/NEJMe0800096; GRAHAM RR, 2008, NAT GENET       0801; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	10	348	360	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1062	1064		10.1038/ng.202	http://dx.doi.org/10.1038/ng.202			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165919	Green Accepted			2022-12-17	WOS:000258761200017
J	Suter, CM; Martin, DIK; Ward, RL				Suter, CM; Martin, DIK; Ward, RL			Germline epimutation of MLH1 in individuals with multiple cancers	NATURE GENETICS			English	Article							MICROSATELLITE INSTABILITY; EPIGENETIC INHERITANCE; METHYLATION; GENETICS; CPG; HYPERMETHYLATION; ALLELE	Epigenetic silencing can mimic genetic mutation by abolishing expression of a gene. We hypothesized that an epimutation could occur in any gene as a germline event that predisposes to disease and looked for examples in tumor suppressor genes in individuals with cancer. Here we report two individuals with soma-wide, allele-specific and mosaic hypermethylation of the DNA mismatch repair gene MLH1. Both individuals lack evidence of genetic mutation in any mismatch repair gene but have had multiple primary tumors that show mismatch repair deficiency, and both meet clinical criteria for hereditary nonpolyposis colorectal cancer. The epimutation was also present in spermatozoa of one of the individuals, indicating a germline defect and the potential for transmission to offspring. Germline epimutation provides a mechanism for phenocopying of genetic disease. The mosaicism and nonmendelian inheritance that are characteristic of epigenetic states could produce patterns of disease risk that resemble those of polygenic or complex traits.	Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; St Vincents Hosp, Dept Med Oncol, Sydney, NSW 2010, Australia; Univ New S Wales, Sch Med, Sydney, NSW, Australia; Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Martin, DIK (corresponding author), Victor Chang Cardiac Res Inst, Sydney, NSW, Australia.	d.martin@victorchang.unsw.edu.au	Ward, Robyn L/I-2313-2013	Ward, Robyn L/0000-0002-6877-8906				Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Chandler VL, 2000, PLANT MOL BIOL, V43, P121, DOI 10.1023/A:1006499808317; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; DAS OP, 1994, GENETICS, V136, P1121; Deng GR, 1999, CANCER RES, V59, P2029; Gazzoli I, 2002, CANCER RES, V62, P3925; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jass JR, 2000, ANN NY ACAD SCI, V910, P62; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Kuismanen SA, 1999, P NATL ACAD SCI USA, V96, P12661, DOI 10.1073/pnas.96.22.12661; Lynch HT, 1998, DIGESTION, V59, P481, DOI 10.1159/000007525; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nakagawa H, 2001, CANCER RES, V61, P6991; Rashid A, 2000, GASTROENTEROLOGY, V119, P323, DOI 10.1053/gast.2000.9361; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Renkonen E, 2003, J CLIN ONCOL, V21, P3629, DOI 10.1200/JCO.2003.03.181; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Roemer I, 1997, CURR BIOL, V7, P277, DOI 10.1016/S0960-9822(06)00124-2; Schoell WMJ, 1999, OBSTET GYNECOL, V94, P623, DOI 10.1016/S0029-7844(99)00373-7; Schofield PN, 2001, TOXICOL LETT, V120, P151, DOI 10.1016/S0378-4274(01)00294-6; Stoger R, 1997, HUM MOL GENET, V6, P1791, DOI 10.1093/hmg/6.11.1791; Suter CM, 2003, BRIT J CANCER, V88, P413, DOI 10.1038/sj.bjc.6600699; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Ward R, 2001, GUT, V48, P821, DOI 10.1136/gut.48.6.821; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532	30	348	367	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					497	501		10.1038/ng1342	http://dx.doi.org/10.1038/ng1342			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15064764	Bronze			2022-12-17	WOS:000221183000023
J	Futscher, BW; Oshiro, MM; Wozniak, RJ; Holtan, N; Hanigan, CL; Duan, H; Domann, FE				Futscher, BW; Oshiro, MM; Wozniak, RJ; Holtan, N; Hanigan, CL; Duan, H; Domann, FE			Role for DNA methylation in the control of cell type-specific maspin expression	NATURE GENETICS			English	Article							SUPPRESSOR GENE MASPIN; CPG ISLANDS; CYTOSINE METHYLATION; PROMOTER; DIFFERENTIATION; INACTIVATION; SITE; ETS	The nucleotide 5-methylcytosine is involved in processes crucial in mammalian development, such as X-chromosome inactivation and gene imprinting(1-5). In addition, cytosine methylation has long been speculated to be involved in the establishment and maintenance of cell type specific expression of developmentally regulated genes 6,7; however, it has been difficult to identify clear examples of such genes, particularly in humans(8). Here we provide evidence that cytosine methylation of the maspin gene (SERPINB5) promoter controls, in part, normal cell type specific SERPINB5 expression. In normal cells expressing SERPINB5, the SERPINB5 promoter is unmethylated and the promoter region has acetylated histones and an accessible chromatin structure. By contrast, normal cells that do not express SERPINB5 have a completely methylated SERPINB5 promoter with hypoacetylated histones, an inaccessible chromatin structure and a transcriptional repression that is relieved by inhibition of DNA methylation. These findings indicate that cytosine methylation is important in the establishment and maintenance of cell type restricted gene expression.	Univ Arizona, Arizona Canc Ctr, Bone Marrow Transplant Program, Dept Pharmacol & Toxicol, Tucson, AZ 85724 USA; Univ Iowa, Holden Comprehens Canc Ctr, Free Rad & Radiat Biol, Dept Radiat Oncol, Iowa City, IA 52242 USA	Arizona Center Cancer Care; University of Arizona; University of Iowa	Futscher, BW (corresponding author), Univ Arizona, Arizona Canc Ctr, Bone Marrow Transplant Program, Dept Pharmacol & Toxicol, Tucson, AZ 85724 USA.			Domann, Frederick/0000-0002-0489-2179				ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Baylin SB, 1998, ADV CANCER RES, V72, P141; BEARD C, 1995, GENE DEV, V9, P2325, DOI 10.1101/gad.9.19.2325; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cody DT, 1999, ORAL ONCOL, V35, P516, DOI 10.1016/S1368-8375(99)00026-3; Czerwenka KF, 2001, CANCER DETECT PREV, V25, P268; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Huang YH, 1999, ARCH BIOCHEM BIOPHYS, V364, P241, DOI 10.1006/abbi.1999.1142; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Johnson GK, 1997, J PERIODONTAL RES, V32, P447, DOI 10.1111/j.1600-0765.1997.tb00557.x; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; KONDO M, 1991, AM J PHYSIOL, V261, pL106, DOI 10.1152/ajplung.1991.261.2.L106; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Maass N, 2001, CLIN BIOCHEM, V34, P303, DOI 10.1016/S0009-9120(01)00220-X; Rice JC, 2000, NUCLEIC ACIDS RES, V28, P3233, DOI 10.1093/nar/28.17.3233; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; VENOLIA L, 1982, P NATL ACAD SCI-BIOL, V79, P2352, DOI 10.1073/pnas.79.7.2352; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Watts GS, 1997, MOL CELL BIOL, V17, P5612, DOI 10.1128/MCB.17.9.5612; Zabner J, 1996, J VIROL, V70, P6994, DOI 10.1128/JVI.70.10.6994-7003.1996; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; Zhang M, 1997, CELL GROWTH DIFFER, V8, P179; Zou ZQ, 2000, J BIOL CHEM, V275, P6051, DOI 10.1074/jbc.275.9.6051; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	31	348	372	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					175	179		10.1038/ng886	http://dx.doi.org/10.1038/ng886			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12021783				2022-12-17	WOS:000175903500014
J	Laberge-le Couteulx, S; Jung, HH; Labauge, P; Houtteville, JP; Lescoat, C; Cecillon, M; Marechal, E; Joutel, A; Bach, JF; Tournier-Lasserve, E				Laberge-le Couteulx, S; Jung, HH; Labauge, P; Houtteville, JP; Lescoat, C; Cecillon, M; Marechal, E; Joutel, A; Bach, JF; Tournier-Lasserve, E			Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas	NATURE GENETICS			English	Article							CHROMOSOME 7Q; GENE; MALFORMATION; PROTEINS; RAS; LOCALIZATION; APOPTOSIS; MICE; RAP1	Cavernous angiomas are vascular malformations mostly located in the central nervous system and characterized by enlarged capillary cavities without intervening brain parenchyma(1). Clinical symptoms include seizures, haemorrhage and focal neurological deficits. Cavernous angiomas prevalence is close to 0.5% in the general population(2). They may be inherited as an autosomal dominant condition in as much as 50% of cases(3). Cerebral cavernous malformations (CCM) loci were previously identified on 7q, 7p and 3q (refs 4,5). A strong founder effect was observed in the Hispano-American population, all families being linked to CCM1 on 7q (refs 4,6,7). CCM1 locus assignment was refined to a 4-cM interval bracketed by D7S2410 and D7S689 (ref. 8). Here we report a physical and transcriptional map of this interval and that CCM1, a gene whose protein product, KRIT1, interacts with RAP1A (also known as KREV1; ref. 9), a member of the RAS family of GTPases, is mutated in CCM1 families. Our data suggest the involvement of the RAP1A signal transduction pathway in vasculogenesis or angiogenesis(10).	Fac Med Necker, INSERM, U25, F-75730 Paris 15, France; CHR Cote Nacre, Serv Neurochirurg, Caen, France; Hop Lariboisiere, Lab Cytogenet, F-75010 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Tournier-Lasserve, E (corresponding author), Fac Med Necker, INSERM, U25, 156 Rue Vaugirard, F-75730 Paris 15, France.		Joutel, Anne/K-5601-2017; Laberge, Sophie/ABD-7353-2020; Tournier-Lasserve, Elisabeth/N-7134-2017	Joutel, Anne/0000-0003-3963-3860; Laberge, Sophie/0000-0003-4722-0361; Tournier-Lasserve, Elisabeth/0000-0002-3039-1677				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ASHA H, EMBO J, V18, P60599; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; DUBOVSKY J, 1995, HUM MOL GENET, V4, P453, DOI 10.1093/hmg/4.3.453; Gunel M, 1996, NEW ENGL J MED, V334, P946, DOI 10.1056/NEJM199604113341503; Gunel M, 1996, NEUROSURGERY, V38, P1265; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; JOHNSON EW, 1995, GENOME RES, V5, P368, DOI 10.1101/gr.5.4.368; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Labauge P, 1998, LANCET, V352, P1892, DOI 10.1016/S0140-6736(98)03011-6; Laberge S, 1999, EUR J HUM GENET, V7, P499, DOI 10.1038/sj.ejhg.5200324; OTTEN P, 1989, NEUROCHIRURGIE, V35, P82; PIZON V, 1988, ONCOGENE, V3, P201; Pizon V, 1996, EUR J CELL BIOL, V69, P224; Quarck R, 1996, EUR J CELL BIOL, V70, P269; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Russell DS, 1989, PATHOLOGY TUMOURS NE, P730; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293	22	348	353	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1999	23	2					189	193		10.1038/13815	http://dx.doi.org/10.1038/13815			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	10508515				2022-12-17	WOS:000082827500018
J	AHN, J; JOSEFLUDECKE, H; LINDOW, S; HORTON, WA; LEE, B; WAGNER, MJ; HORSTHEMKE, B; WELLS, DE				AHN, J; JOSEFLUDECKE, H; LINDOW, S; HORTON, WA; LEE, B; WAGNER, MJ; HORSTHEMKE, B; WELLS, DE			CLONING OF THE PUTATIVE TUMOR-SUPPRESSOR GENE FOR HEREDITARY MULTIPLE EXOSTOSES (EXT1)	NATURE GENETICS			English	Article							LANGER-GIEDION SYNDROME; SHORTEST REGION; SEQUENCES; DELETION; OVERLAP	Hereditary multiple exostoses is an autosomal dominant disorder that is characterized by short stature and multiple, benign bone tumours. In a majority of families, the genetic defect (EXT1) is linked to the Langer-Giedion syndrome chromosomal region in 8q24.1. From this region we have cloned and characterized a cDNA which spans chromosomal breakpoints previously identified in two multiple exostoses patients. Furthermore, the gene harbours frameshift mutations in affected members of two EXT1 families. The cDNA has a coding region of 2,238 bp with no apparent homology to other known gene sequences and thus its function remains elusive. However, recent studies in sporadic and exostosis-derived chondrosarcomas suggest that the 8q24.1-encoded EXT1 gene may have tumour suppressor function.	UNIV ESSEN GESAMTHSCH KLINIKUM, INST HUMANGENET, D-45122 ESSEN, GERMANY; UNIV HOUSTON, DEPT BIOL, HOUSTON, TX 77204 USA; UNIV HOUSTON, INST MOLEC BIOL, HOUSTON, TX 77204 USA; SHRINERS HOSP CRIPPLED CHILDRENS, PORTLAND, OR 97201 USA	University of Duisburg Essen; University of Houston System; University of Houston; University of Houston System; University of Houston			/AAD-2181-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027981, R01HD020691] Funding Source: NIH RePORTER; NICHD NIH HHS [HD27981, HD20691] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BUHLER EM, 1984, AM J MED GENET, V19, P113, DOI 10.1002/ajmg.1320190111; COOK A, 1993, AM J HUM GENET, V53, P71; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Frydman M., 1992, American Journal of Human Genetics, V51, pA79; GUO WW, 1993, NAT GENET, V4, P367, DOI 10.1038/ng0893-367; HECHT JT, 1995, AM J HUM GENET, V56, P1125; HENNEKAM RCM, 1991, J MED GENET, V28, P262, DOI 10.1136/jmg.28.4.262; HOU J, IN PRESS GENOMICS; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; LEMERRER M, 1992, J MED GENET, V29, P713, DOI 10.1136/jmg.29.10.713; LEONE NC, 1987, J HERED, V78, P171, DOI 10.1093/oxfordjournals.jhered.a110351; LOHMANN DR, 1994, HUM MOL GENET, V3, P2187, DOI 10.1093/hmg/3.12.2187; LUDECKE HJ, 1995, HUM MOL GENET, V4, P31, DOI 10.1093/hmg/4.1.31; LUDECKE HJ, 1991, AM J HUM GENET, V49, P1197; MERTENS F, 1994, GENE CHROMOSOME CANC, V9, P8, DOI 10.1002/gcc.2870090103; OGLE RF, 1991, J MED GENET, V28, P881, DOI 10.1136/jmg.28.12.881; PARRISH JE, 1991, GENOMICS, V11, P54, DOI 10.1016/0888-7543(91)90101-J; PARRISH JE, 1994, SOMAT CELL MOLEC GEN, V20, P143, DOI 10.1007/BF02290684; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; Sambrook J., 1989, MOL CLONING LAB MANU; SOLOMON L, 1964, AM J HUM GENET, V16, P351; SOLOMON L, 1963, J BONE JOINT SURG BR, V45, P292, DOI 10.1302/0301-620X.45B2.292; SUGIURA Y, 1976, JPN J HUM GENET, V21, P149; VOUTSINAS S, 1983, J MED GENET, V20, P345, DOI 10.1136/jmg.20.5.345; WOOD S, 1992, CYTOGENET CELL GENET, V59, P243, DOI 10.1159/000133260; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; YOSHIURA K, 1994, GENE CHROMOSOME CANC, V9, P57, DOI 10.1002/gcc.2870090110	29	348	376	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1995	11	2					137	143		10.1038/ng1095-137	http://dx.doi.org/10.1038/ng1095-137			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550340				2022-12-17	WOS:A1995RX80600014
J	WATERSTON, R; MARTIN, C; CRAXTON, M; HUYNH, C; COULSON, A; HILLIER, L; DURBIN, R; GREEN, P; SHOWNKEEN, R; HALLORAN, N; METZSTEIN, M; HAWKINS, T; WILSON, R; BERKS, M; DU, Z; THOMAS, K; THIERRYMIEG, J; SULSTON, J				WATERSTON, R; MARTIN, C; CRAXTON, M; HUYNH, C; COULSON, A; HILLIER, L; DURBIN, R; GREEN, P; SHOWNKEEN, R; HALLORAN, N; METZSTEIN, M; HAWKINS, T; WILSON, R; BERKS, M; DU, Z; THOMAS, K; THIERRYMIEG, J; SULSTON, J			A SURVEY OF EXPRESSED GENES IN CAENORHABDITIS-ELEGANS	NATURE GENETICS			English	Article							CHROMOSOME; DNA; MUTATIONS; SEQUENCE; GENOME	As an adjunct to the genomic sequencing of Caenorhabditis elegans, we have investigated a representative cDNA library of 1,517 clones. A single sequence read has been obtained from the 5' end of each clone, allowing its characterization with respect to the public databases, and the clones are being localized on the genome map. The result is the identification of about 1,200 of the estimated 15,000 genes of C. elegans. More than 30% of the inferred protein sequences have significant similarity to existing sequences in the databases, providing a route towards in vivo analysis of known genes in the nematode. These clones also provide material for assessing the accuracy of predicted exons and splicing patterns and will lead to a more accurate estimate of the total number of genes in the organism than has hitherto been available.	LAWRENCE LIVERMORE NATL LAB, CTR HUMAN GENOME, LIVERMORE, CA 94550 USA; MRC, MOLEC BIOL LAB, CAMBRIDGE CB2 2QH, ENGLAND; CTR RECH BIOL MOLEC & PHYS MATH, CNRS, F-34044 MONTPELLIER, FRANCE	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; MRC Laboratory Molecular Biology; Centre National de la Recherche Scientifique (CNRS)	WATERSTON, R (corresponding author), WASHINGTON UNIV, SCH MED, DEPT GENET, BOX 8232, 4566 SCOTT AVE, ST LOUIS, MO 63110 USA.		Wilson, Richard K./AAF-4139-2019; Durbin, Richard/AAE-7178-2019; THIERRY-MIEG, Jean/F-1975-2017	Wilson, Richard K./0000-0002-1992-1358; Durbin, Richard/0000-0002-9130-1006; THIERRY-MIEG, Jean/0000-0002-0396-6789				ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOSSY B, 1984, EMBO J, V3, P2537, DOI 10.1002/j.1460-2075.1984.tb02169.x; BRENNER S, 1974, GENETICS, V77, P71; CLARK DV, 1988, GENETICS, V119, P345; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; COULSON A, 1991, BIOESSAYS, V13, P413, DOI 10.1002/bies.950130809; Coulson Alan, 1988, P19; CRAXTON M, 1991, Methods (Orlando), V3, P20, DOI 10.1016/S1046-2023(05)80159-8; DEAR S, 1991, NUCLEIC ACIDS RES, V19, P3907, DOI 10.1093/nar/19.14.3907; EDGLEY ML, 1990, GENETIC MAPS, V5, P3; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GIBSON TJ, 1987, GENE ANAL TECH, V4, P41, DOI 10.1016/0735-0651(87)90016-1; GLEESON T, 1991, NUCLEIC ACIDS RES, V19, P6481, DOI 10.1093/nar/19.23.6481; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HALL LMC, 1983, J MOL BIOL, V169, P83, DOI 10.1016/S0022-2836(83)80176-4; HALLORAN N, IN PRESS METHODS MOL, V10; HERMAN RK, 1988, NEMATODE CAENORHABDI, P17; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LEESMILLER JP, 1992, P NATL ACAD SCI USA, V89, P80, DOI 10.1073/pnas.89.1.80; MCCOMBIE WR, 1992, NATRUE GENET, V1; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; OLSON M, 1991, GENOME DYNAMICS PROT, P1; PALAZZOLO MJ, 1990, GENE, V88, P25, DOI 10.1016/0378-1119(90)90056-W; PARK EC, 1986, GENETICS, V113, P821; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SCHWOB E, 1992, NATURE, V355, P179, DOI 10.1038/355179a0; STADEN R, 1990, METHOD ENZYMOL, V183, P163; STATES DJ, 1991, P NATL ACAD SCI USA, V88, P5518, DOI 10.1073/pnas.88.13.5518; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0	32	348	358	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1992	1	2					114	123		10.1038/ng0592-114	http://dx.doi.org/10.1038/ng0592-114			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC980	1302004				2022-12-17	WOS:A1992JC98000010
J	Cree, LM; Samuels, DC; Lopes, SCDS; Rajasimha, HK; Wonnapinij, P; Mann, JR; Dahl, HHM; Chinnery, PF				Cree, Lynsey M.; Samuels, David C.; Lopes, Susana Chuva de Sousa; Rajasimha, Harsha Karur; Wonnapinij, Passorn; Mann, Jeffrey R.; Dahl, Hans-Henrik M.; Chinnery, Patrick F.			A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes	NATURE GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; PRIMORDIAL GERM-CELLS; RANDOM GENETIC DRIFT; MOUSE EMBRYOS; D-LOOP; MTDNA; OOCYTES; MICE; PROLIFERATION; HETEROPLASMY	Mammalian mitochondrial DNA (mtDNA) is inherited principally down the maternal line, but the mechanisms involved are not fully understood. Females harboring a mixture of mutant and wild-type mtDNA (heteroplasmy) transmit a varying proportion of mutant mtDNA to their offspring. In humans with mtDNA disorders, the proportion of mutated mtDNA inherited from the mother correlates with disease severity(1-4). Rapid changes in allele frequency can occur in a single generation(5,6). This could be due to a marked reduction in the number of mtDNA molecules being transmitted from mother to offspring (the mitochondrial genetic bottleneck), to the partitioning of mtDNA into homoplasmic segregating units, or to the selection of a group of mtDNA molecules to re-populate the next generation. Here we show that the partitioning of mtDNA molecules into different cells before and after implantation, followed by the segregation of replicating mtDNA between proliferating primordial germ cells, is responsible for the different levels of heteroplasmy seen in the offspring of heteroplasmic female mice.	[Cree, Lynsey M.; Chinnery, Patrick F.] Univ Newcastle, Mitrochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Samuels, David C.; Rajasimha, Harsha Karur; Wonnapinij, Passorn] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Lopes, Susana Chuva de Sousa] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Mann, Jeffrey R.] City Hope Natl Med Ctr, Div Biol, Duarte, CA 91010 USA; [Dahl, Hans-Henrik M.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Dahl, Hans-Henrik M.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; [Chinnery, Patrick F.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Virginia Polytechnic Institute & State University; University of Cambridge; City of Hope; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Newcastle University - UK	Chinnery, PF (corresponding author), Univ Newcastle, Mitrochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	p.f.chinnery@ncl.ac.uk	Samuels, David/AHC-8381-2022; Samuels, David/C-1365-2012; Samuels, David C/A-5393-2008	Samuels, David/0000-0003-3529-7791; Samuels, David C/0000-0003-3529-7791; Cree, Lynsey/0000-0003-2090-1589; Chinnery, Patrick/0000-0002-7065-6617	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bendall KE, 1996, AM J HUM GENET, V59, P1276; Bergstrom CT, 1998, GENETICS, V149, P2135; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; GINSBURG M, 1990, DEVELOPMENT, V110, P521; HOGAN B, 1994, MANIPULATING MOUSE E; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1992, HUM GENET, V90, P117; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; Spiropoulos J, 2002, MOL HUM REPROD, V8, P719, DOI 10.1093/molehr/8.8.719; Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003; STREFFER C, 1980, CELL TISSUE KINET, V13, P135, DOI 10.1111/j.1365-2184.1980.tb00456.x; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; VILKKI J, 1990, AM J HUM GENET, V47, P95; Wright S., 1969, EVOLUTION GENETICS P	30	347	354	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2008	40	2					249	254		10.1038/ng.2007.63	http://dx.doi.org/10.1038/ng.2007.63			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18223651				2022-12-17	WOS:000252732900026
J	Cho, E; Feng, Y; Rauskolb, C; Maitra, S; Fehon, R; Irvine, KD				Cho, Eunjoo; Feng, Yongqiang; Rauskolb, Cordelia; Maitra, Sushmita; Fehon, Rick; Irvine, Kenneth D.			Delineation of a Fat tumor suppressor pathway	NATURE GENETICS			English	Article							PLANAR CELL POLARITY; PROMOTES APOPTOSIS; DROSOPHILA-MELANOGASTER; PROLIFERATION CONTROL; CUBITUS INTERRUPTUS; EXPANDED FUNCTION; PROTEIN-KINASE; DOUBLE-TIME; CYCLE EXIT; GROWTH	Recent studies in Drosophila melanogaster of the protocadherins Dachsous and Fat suggest that they act as ligand and receptor, respectively, for an intercellular signaling pathway that influences tissue polarity, growth and gene expression, but the basis for signaling downstream of Fat has remained unclear. Here, we characterize functional relationships among D. melanogaster tumor suppressors and identify the kinases Discs overgrown and Warts as components of a Fat signaling pathway. fat, discs overgrown and warts regulate a common set of downstream genes in multiple tissues. Genetic experiments position the action of discs overgrown upstream of the Fat pathway component dachs, whereas warts acts downstream of dachs. Warts protein coprecipitates with Dachs, and Warts protein levels are influenced by fat, dachs and discs overgrown in vivo, consistent with its placement as a downstream component of the pathway. The tumor suppressors Merlin, expanded, hippo, salvador and mob as tumor suppressor also share multiple Fat pathway phenotypes but regulate Warts activity independently. Our results functionally link what had been four disparate groups of D. melanogaster tumor suppressors, establish a basic framework for Fat signaling from receptor to transcription factor and implicate Warts as an integrator of multiple growth control signals.	Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Chicago	Irvine, KD (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu	Feng, Yongqiang/AAR-7719-2021; Feng, Yongqiang/N-2731-2018	Feng, Yongqiang/0000-0002-2320-5063; Feng, Yongqiang/0000-0002-2320-5063	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM63057] Funding Source: Medline; NINDS NIH HHS [NS034783] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034783, R01NS034783] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blaumueller CM, 2000, MECH DEVELOP, V92, P251, DOI 10.1016/S0925-4773(00)00246-X; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Buckles GR, 2001, DEVELOPMENT, V128, P3533; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Cho E, 2004, DEVELOPMENT, V131, P4489, DOI 10.1242/dev.01315; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Edwards KM, 2004, ONCOGENE, V23, P5263, DOI 10.1038/sj.onc.1207686; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Garoia F, 2005, MECH DEVELOP, V122, P175, DOI 10.1016/j.mod.2004.10.007; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jaiswal M, 2006, DEVELOPMENT, V133, P925, DOI 10.1242/dev.02243; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; McCartney BM, 2000, DEVELOPMENT, V127, P1315; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Rauskolb C, 1999, DEV BIOL, V210, P339, DOI 10.1006/dbio.1999.9273; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Strutt H, 2004, DEVELOPMENT, V131, P881, DOI 10.1242/dev.00996; Strutt H, 2002, DEV CELL, V3, P851, DOI 10.1016/S1534-5807(02)00363-5; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; WATSON KL, 1994, J CELL SCI, P19; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zilian O, 1999, DEVELOPMENT, V126, P5409	49	347	354	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1142	1150		10.1038/ng1887	http://dx.doi.org/10.1038/ng1887			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16980976				2022-12-17	WOS:000241251100013
J	Zhou, W; Nielsen, JB; Fritsche, LG; Dey, R; Gabrielsen, ME; Wolford, BN; LeFaive, J; VandeHaar, P; Gagliano, SA; Gifford, A; Bastarache, LA; Wei, WQ; Denny, JC; Lin, MX; Hveem, K; Kang, HM; Abecasis, GR; Willer, CJ; Lee, S				Zhou, Wei; Nielsen, Jonas B.; Fritsche, Lars G.; Dey, Rounak; Gabrielsen, Maiken E.; Wolford, Brooke N.; LeFaive, Jonathon; VandeHaar, Peter; Gagliano, Sarah A.; Gifford, Aliya; Bastarache, Lisa A.; Wei, Wei-Qi; Denny, Joshua C.; Lin, Maoxuan; Hveem, Kristian; Kang, Hyun Min; Abecasis, Goncalo R.; Willer, Cristen J.; Lee, Seunggeun			Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LINEAR MIXED MODELS; CONJUGATE GRADIENTS; ALGORITHM; INFERENCE; SYSTEMS	In genome-wide association studies (GWAS) for thousands of phenotypes in large biobanks, most binary traits have substantially fewer cases than controls. Both of the widely used approaches, the linear mixed model and the recently proposed logistic mixed model, perform poorly; they produce large type I error rates when used to analyze unbalanced case-control phenotypes. Here we propose a scalable and accurate generalized mixed model association test that uses the saddlepoint approximation to calibrate the distribution of score test statistics. This method, SAIGE (Scalable and Accurate Implementation of GEneralized mixed model), provides accurate P values even when case-control ratios are extremely unbalanced. SAIGE uses state-of-art optimization strategies to reduce computational costs; hence, it is applicable to GWAS for thousands of phenotypes by large biobanks. Through the analysis of UK Biobank data of 408,961 samples from white British participants with European ancestry for > 1,400 binary phenotypes, we show that SAIGE can efficiently analyze large sample data, controlling for unbalanced case-control ratios and sample relatedness.	[Zhou, Wei; Wolford, Brooke N.; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Zhou, Wei; Fritsche, Lars G.; Dey, Rounak; Wolford, Brooke N.; LeFaive, Jonathon; VandeHaar, Peter; Gagliano, Sarah A.; Kang, Hyun Min; Abecasis, Goncalo R.; Lee, Seunggeun] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Nielsen, Jonas B.; Lin, Maoxuan; Willer, Cristen J.] Univ Michigan, Sch Med, Dept Internal Med, Div Cardiol, Ann Arbor, MI 48109 USA; [Fritsche, Lars G.; Gabrielsen, Maiken E.; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway; [Fritsche, Lars G.; Dey, Rounak; LeFaive, Jonathon; VandeHaar, Peter; Gagliano, Sarah A.; Kang, Hyun Min; Abecasis, Goncalo R.; Lee, Seunggeun] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Gifford, Aliya; Bastarache, Lisa A.; Wei, Wei-Qi; Denny, Joshua C.] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Denny, Joshua C.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Hveem, Kristian] Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, Levanger, Norway; [Willer, Cristen J.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Norwegian University of Science & Technology (NTNU); University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Norwegian University of Science & Technology (NTNU); University of Michigan System; University of Michigan	Willer, CJ (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.; Lee, S (corresponding author), Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA.; Willer, CJ (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Cardiol, Ann Arbor, MI 48109 USA.; Lee, S (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA.; Willer, CJ (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.	cristen@umich.edu; leeshawn@umich.edu	Wolford, Brooke/GQZ-2025-2022; Wolford, Brooke/Y-3162-2019; Hveem, Kristian/AFV-4683-2022; Fritsche, Lars G/AAF-9387-2019; Denny, Josh/AAL-3359-2021; Dey, Rounak/AAQ-9662-2021	Wolford, Brooke/0000-0003-3153-1552; Fritsche, Lars G/0000-0002-2110-1690; Denny, Josh/0000-0002-3049-7332; Dey, Rounak/0000-0002-6540-8280; Nielsen, Jonas Bille/0000-0002-6654-2852; Lin, Maoxuan/0000-0001-5191-1857; LeFaive, Jonathon/0000-0003-3668-6086	NIH [R01 HG008773, R35 HL135824, R01 LM010685, U2C OD023196]; University of Michigan Rackham Predoctoral Fellowship; Danish Heart Foundation; Lundbeck Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133786, R35HL135824] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008773, T32HG000040] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U2COD023196] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Rackham Predoctoral Fellowship(University of Michigan System); Danish Heart Foundation; Lundbeck Foundation(Lundbeckfonden); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research has been conducted using the UK Biobank Resource under application number 24460. S.L. and R.D. were supported by NIH R01 HG008773. C.J.W. was supported by NIH R35 HL135824. W.Z. was supported by the University of Michigan Rackham Predoctoral Fellowship. J.B.N. was supported by the Danish Heart Foundation and the Lundbeck Foundation. J.C.D., A.G., L.A.B., and W.-Q.W. were supported by NIH R01 LM010685 and U2C OD023196.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Chen H, 2016, AM J HUM GENET, V98, P653, DOI 10.1016/j.ajhg.2016.02.012; de Villemereuil P, 2016, GENETICS, V204, P1281, DOI 10.1534/genetics.115.186536; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Dey R, 2017, AM J HUM GENET, V101, P37, DOI 10.1016/j.ajhg.2017.05.014; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; HESTENES MR, 1952, J RES NAT BUR STAND, V49, P409, DOI 10.6028/jres.049.044; IMHOF JP, 1961, BIOMETRIKA, V48, P419, DOI 10.2307/2332763; KAASSCHIETER EF, 1988, J COMPUT APPL MATH, V24, P265, DOI 10.1016/0377-0427(88)90358-5; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kuonen D, 1999, BIOMETRIKA, V86, P929, DOI 10.1093/biomet/86.4.929; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Shameer K, 2014, HUM GENET, V133, P95, DOI 10.1007/s00439-013-1355-7; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	29	346	353	12	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2018	50	9					1335	+		10.1038/s41588-018-0184-y	http://dx.doi.org/10.1038/s41588-018-0184-y			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS0CH	30104761	Green Accepted, Green Submitted			2022-12-17	WOS:000443151300026
J	Hu, B; Wang, W; Ou, SJ; Tang, JY; Li, H; Che, RH; Zhang, ZH; Chai, XY; Wang, HR; Wang, YQ; Liang, CZ; Liu, LC; Piao, ZZ; Deng, QY; Deng, K; Xu, C; Liang, Y; Zhang, LH; Li, LG; Chu, CC				Hu, Bin; Wang, Wei; Ou, Shujun; Tang, Jiuyou; Li, Hua; Che, Ronghui; Zhang, Zhihua; Chai, Xuyang; Wang, Hongru; Wang, Yiqin; Liang, Chengzhen; Liu, Linchuan; Piao, Zhongze; Deng, Qiyun; Deng, Kun; Xu, Chi; Liang, Yan; Zhang, Lianhe; Li, Legong; Chu, Chengcai			Variation in NRT1.1B contributes to nitrate-use divergence between rice subspecies	NATURE GENETICS			English	Article							CHLORATE-RESISTANT MUTANTS; ARABIDOPSIS-THALIANA; JAPONICA RICE; TRANSPORTER; AMMONIUM; INDICA; CHL1; SEQUENCE; REVEALS; PLANTS	Asian cultivated rice (Oryza sativa L.) consists of two main subspecies, indica and japonica. Indica has higher nitrate-absorption activity than japonica, but the molecular mechanisms underlying that activity remain elusive. Here we show that variation in a nitrate-transporter gene, NRT1.1B (OsNPF6.5), may contribute to this divergence in nitrate use. Phylogenetic analysis revealed that NRT1.1B diverges between indica and japonica. NRT1.1B-indica variation was associated with enhanced nitrate uptake and root-to-shoot transport and upregulated expression of nitrate-responsive genes. The selection signature of NRT1.1B-indica suggests that nitrate-use divergence occurred during rice domestication. Notably, field tests with near-isogenic and transgenic lines confirmed that the japonica variety carrying the NRT1.1B-indica allele had significantly improved grain yield and nitrogen-use efficiency (NUE) compared to the variety without that allele. Our results show that variation in NRT1.1B largely explains nitrate-use divergence between indica and japonica and that NRT1.1Bindica can potentially improve the NUE of japonica.	[Hu, Bin; Wang, Wei; Ou, Shujun; Tang, Jiuyou; Li, Hua; Che, Ronghui; Zhang, Zhihua; Wang, Hongru; Wang, Yiqin; Liang, Chengzhen; Xu, Chi; Liang, Yan; Chu, Chengcai] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, State Key Lab Plant Gen, Beijing, Peoples R China; [Wang, Wei; Li, Hua; Zhang, Zhihua; Wang, Hongru; Liang, Yan] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Ou, Shujun] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Chai, Xuyang] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Liu, Linchuan] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai, Peoples R China; [Piao, Zhongze] Shanghai Acad Agr Sci, Crop Breeding & Cultivat Res Inst, Shanghai, Peoples R China; [Deng, Qiyun] China Natl Hybrid Rice Res, Changsha, Peoples R China; [Deng, Qiyun] Dev Ctr, Changsha, Peoples R China; [Deng, Kun; Zhang, Lianhe] Henan Univ Sci & Technol, Sch Agr, Luoyang, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Michigan State University; Capital Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Academy of Agricultural Sciences; Henan University of Science & Technology	Chu, CC (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, State Key Lab Plant Gen, Beijing, Peoples R China.	ccchu@genetics.ac.cn	Tang, Jiuyou/J-7224-2015; Hu, Bin/HCI-1705-2022; Wang, Yiqin/AAJ-8144-2020; Zhang, Zhihua/GQZ-1360-2022; Zhang, Zhihua/AAJ-4229-2021; Chu, Chengcai/AAF-6083-2019; Ou, Shujun/N-5263-2019	Tang, Jiuyou/0000-0002-9059-2139; Hu, Bin/0000-0002-2696-4348; Chu, Chengcai/0000-0001-8097-6115; Ou, Shujun/0000-0001-5938-7180; Wang, Hongru/0000-0001-8305-5231; Liu, Linchuan/0000-0002-8669-7202	Ministry of Science and Technology of China [2014AA10A602-5, 2015CB755702]; Chinese Academy of Sciences [XDA08010400]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank H. Xue (Shanghai Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai, China) for providing the nrt1.1b mutant and M. Schlqappi (Marquette University, Milwaukee, Wisconsin, USA) and X. Wang (China Agricultural University, Beijing, China) for language editing. This work was supported by grants from the Ministry of Science and Technology of China (2014AA10A602-5, 2015CB755702) and the Chinese Academy of Sciences (XDA08010400).	Alachiotis N, 2012, BIOINFORMATICS, V28, P2274, DOI 10.1093/bioinformatics/bts419; Almagro A, 2008, PLANT CELL, V20, P3289, DOI 10.1105/tpc.107.056788; Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao LZ, 2008, GENETICS, V179, P965, DOI 10.1534/genetics.106.068072; Gojon A, 2011, J EXP BOT, V62, P2299, DOI 10.1093/jxb/erq419; Goudet J., 2001, CLADISTICS; Ho CH, 2010, CURR OPIN PLANT BIOL, V13, P604, DOI 10.1016/j.pbi.2010.08.005; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Jensen JD, 2007, GENETICS, V176, P2371, DOI 10.1534/genetics.106.069450; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kirk GJD, 2005, ANN BOT-LONDON, V96, P639, DOI 10.1093/aob/mci216; Koutroubas SD, 2003, FIELD CROP RES, V83, P251, DOI 10.1016/S0378-4290(03)00067-4; Kronzucker HJ, 2000, NEW PHYTOL, V145, P471, DOI 10.1046/j.1469-8137.2000.00606.x; Li CCY, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001380, 10.1371/journal.pgen.1002196]; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Mandal A, 2012, BIOCHEM J, V445, P313, DOI 10.1042/BJ20120190; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; MOLL RH, 1987, CROP SCI, V27, P181, DOI 10.2135/cropsci1987.0011183X002700020007x; Monden I, 2001, BIOL CHEM, V382, P1551, DOI 10.1515/BC.2001.189; Oka H.I., 1983, ORIGIN CULTIVATED RI; OOSTINDI.FJ, 1973, MUTAT RES, V19, P175, DOI 10.1016/0027-5107(73)90076-6; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015289; SCHOLTEN HJ, 1986, J PLANT PHYSIOL, V123, P45, DOI 10.1016/S0176-1617(86)80065-7; TA TC, 1981, SOIL SCI PLANT NUTR, V27, P347, DOI 10.1080/00380768.1981.10431289; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teng S, 2006, EUPHYTICA, V152, P141, DOI 10.1007/s10681-006-9189-1; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; WANG XM, 1986, THEOR APPL GENET, V72, P328, DOI 10.1007/BF00288569; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhao Y, 2014, STRUCTURE, V22, P1152, DOI 10.1016/j.str.2014.06.008	34	346	426	35	442	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					834	+		10.1038/ng.3337	http://dx.doi.org/10.1038/ng.3337			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26053497				2022-12-17	WOS:000357090300025
J	He, HSHS; Meyer, CA; Shin, HJ; Bailey, ST; Wei, G; Wang, QB; Zhang, Y; Xu, KX; Ni, M; Lupien, M; Mieczkowski, P; Lieb, JD; Zhao, KJ; Brown, M; Liu, XS				He, Housheng Hansen; Meyer, Clifford A.; Shin, Hyunjin; Bailey, Shannon T.; Wei, Gang; Wang, Qianben; Zhang, Yong; Xu, Kexin; Ni, Min; Lupien, Mathieu; Mieczkowski, Piotr; Lieb, Jason D.; Zhao, Keji; Brown, Myles; Liu, X. Shirley			Nucleosome dynamics define transcriptional enhancers	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR; PROSTATE-CANCER; HIGH-RESOLUTION; HUMAN GENOME; CHROMATIN-STRUCTURE; CHIP-SEQ; PROMOTERS; GENE; NKX3.1; MODEL	Chromatin plays a central role in eukaryotic gene regulation. We performed genome-wide mapping of epigenetically marked nucleosomes to determine their position both near transcription start sites and at distal regulatory elements, including enhancers. In prostate cancer cells, where androgen receptor binds primarily to enhancers, we found that androgen treatment dismisses a central nucleosome present at androgen receptor binding sites that is flanked by a pair of marked nucleosomes. A new quantitative model built on the behavior of such nucleosome pairs correctly identified regions bound by the regulators of the immediate androgen response, including androgen receptor and FOXA1. More importantly, this model also correctly predicted previously unidentified binding sites for other transcription factors present after prolonged androgen stimulation, including OCT1 and NKX3-1. Therefore, quantitative modeling of enhancer structure provides a powerful predictive method to infer the identity of transcription factors involved in cellular responses to specific stimuli.	[He, Housheng Hansen; Meyer, Clifford A.; Shin, Hyunjin; Zhang, Yong; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [He, Housheng Hansen; Meyer, Clifford A.; Shin, Hyunjin; Zhang, Yong; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [He, Housheng Hansen; Bailey, Shannon T.; Wang, Qianben; Xu, Kexin; Ni, Min; Lupien, Mathieu; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [He, Housheng Hansen; Bailey, Shannon T.; Wang, Qianben; Xu, Kexin; Ni, Min; Lupien, Mathieu; Brown, Myles] Harvard Univ, Sch Med, Boston, MA USA; [Wei, Gang; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Mieczkowski, Piotr; Lieb, Jason D.] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Mieczkowski, Piotr; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Liu, XS (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	myles_brown@dfci.harvard.edu; xsliu@jimmy.harvard.edu	He, Housheng/G-9614-2011; Bailey, Shannon/B-8045-2014; Brown, Myles/B-6906-2008; Brown, Myles/AAX-5332-2021; Wei, Gang/A-3291-2011; Wang, Qianben/E-4267-2011; Zhang, Yong/B-4838-2011; He, Hansen/ABD-8439-2020	Brown, Myles/0000-0002-8213-1658; Zhang, Yong/0000-0001-6316-2734; He, Hansen/0000-0003-2898-3363; Liu, Xiaole/0000-0003-4736-7339; Mieczkowski, Piotr/0000-0003-2418-0096; Lupien, Mathieu/0000-0003-0929-9478; Lieb, Jason/0000-0001-7601-8061	US National Institutes of Health [1R01 HG004069-02, 2P50 CA090381-06]; Department of Defense [W81XWH-07-1-0037]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA090381] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZIAHL006030, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants from US National Institutes of Health (1R01 HG004069-02 to X. S. L., and 2P50 CA090381-06 to X. S. L. and M. B.), the Department of Defense (W81XWH-07-1-0037 to X. S. L.) and the Prostate Cancer Foundation (to M. B.).	Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Korkmaz CG, 2004, J UROLOGY, V172, P1134, DOI 10.1097/01.ju.0000136526.78535.b8; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Liu WW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-45; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Narlikar L, 2007, PLOS COMPUT BIOL, V3, P2199, DOI 10.1371/journal.pcbi.0030215; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537	32	346	355	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					343	U101		10.1038/ng.545	http://dx.doi.org/10.1038/ng.545			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20208536	Green Submitted, Green Accepted			2022-12-17	WOS:000276150500015
J	Papaemmanuil, E; Hosking, FJ; Vijayakrishnan, J; Price, A; Olver, B; Sheridan, E; Kinsey, SE; Lightfoot, T; Roman, E; Irving, JAE; Allan, JM; Tomlinson, IP; Taylor, M; Greaves, M; Houlston, RS				Papaemmanuil, Elli; Hosking, Fay J.; Vijayakrishnan, Jayaram; Price, Amy; Olver, Bianca; Sheridan, Eammon; Kinsey, Sally E.; Lightfoot, Tracy; Roman, Eve; Irving, Julie A. E.; Allan, James M.; Tomlinson, Ian P.; Taylor, Malcolm; Greaves, Mel; Houlston, Richard S.			Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FAMILY; CANCER; IKAROS; GENE; DIFFERENTIATION; PROTEINS; DELETION; MEMBERS; GROWTH	To identify risk variants for childhood acute lymphoblastic leukemia (ALL), we conducted a genome-wide association study of two case-control series, analyzing the genotypes with respect to 291,423 tagging SNPs in a total of 907 ALL cases and 2,398 controls. We identified risk loci for ALL at 7p12.2 (IKZF1, rs4132601, odds ratio (OR) = 1.69, P = 1.20 x 10(-19)), 10q21.2 (ARID5B, rs7089424, OR = 1.65, P = 6.69 x 10(-19)) and 14q11.2 (CEBPE, rs2239633, OR = 1.34, P = 2.88 x 10(-7)). The 10q21.2 (ARID5B) risk association appears to be selective for the subset of B-cell precursor ALL with hyperdiploidy. These data show that common low-penetrance susceptibility alleles contribute to the risk of developing childhood ALL and provide new insight into disease causation of this specific hematological cancer. Notably, all three risk variants map to genes involved in transcriptional regulation and differentiation of B-cell progenitors.	[Papaemmanuil, Elli; Hosking, Fay J.; Vijayakrishnan, Jayaram; Price, Amy; Olver, Bianca; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Sheridan, Eammon] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England; [Kinsey, Sally E.] St James Hosp, Dept Paediat & Adolescent Oncol & Haematol, Leeds LS9 7TF, W Yorkshire, England; [Lightfoot, Tracy; Roman, Eve] Univ York, Epidemiol & Genet Unit, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Irving, Julie A. E.; Allan, James M.] Univ Newcastle, No Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England; [Tomlinson, Ian P.] Wellcome Trust Ctr Human Genet, Oxford, England; [Taylor, Malcolm] Univ Manchester, St Marys Hosp, Canc Immunogenet Grp, Sch Canc Sci, Manchester M13 0JH, Lancs, England; [Greaves, Mel] Inst Canc Res, Sect Haematooncol, Surrey, England	University of London; Institute of Cancer Research - UK; Saint James's University Hospital; Saint James's University Hospital; University of York - UK; Newcastle University - UK; University of Oxford; Wellcome Centre for Human Genetics; University of Manchester; University of London; Institute of Cancer Research - UK	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	richard.houlston@icr.ac.uk	Allan, James/B-4448-2009	Houlston, Richard/0000-0002-5268-0242; Allan, James/0000-0002-7580-5087; Roman, Eve/0000-0001-7603-3704; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Hosking, Fay/0000-0002-1101-039X	Cancer Research UK [C1298/A8362] Funding Source: Medline; Medical Research Council [G0000934] Funding Source: Medline; Blood Cancer UK [13027] Funding Source: Medline; MRC [G0000934] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Blood Cancer UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akasaka T, 2007, BLOOD, V109, P3451, DOI 10.1182/blood-2006-08-041012; Boulton A, 2000, BRIT J CANCER, V82, P1073; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang LW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r38; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Couto E, 2005, BRIT J CANCER, V93, P1307, DOI 10.1038/sj.bjc.6602867; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Harker N, 2002, MOL CELL, V10, P1403, DOI 10.1016/S1097-2765(02)00711-6; Hemminki K, 2002, LEUKEMIA, V16, P297, DOI 10.1038/sj.leu.2402351; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hodgson S.V., 2007, PRACTICAL GUIDE HUMA, V3rd; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Lahoud MH, 2001, GENOME RES, V11, P1327, DOI 10.1101/gr.168801; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Pettiti D, 1994, METAANALYSIS DECISIO; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Stiller CA, 1996, BRIT MED BULL, V52, P682; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95	25	346	360	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					1006	U73		10.1038/ng.430	http://dx.doi.org/10.1038/ng.430			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19684604	Green Accepted			2022-12-17	WOS:000269382100013
J	Stratton, MR; Rahman, N				Stratton, Michael R.; Rahman, Nazneen			The emerging landscape of breast cancer susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; ATAXIA-TELANGIECTASIA; PROSTATE-CANCER; BRCA2; MUTATIONS; GENE; VARIANT; PROTEIN; RISK	The genetic basis of inherited predisposition to breast cancer has been assiduously investigated for the past two decades and has been the subject of several recent discoveries. Three reasonably well-defined classes of breast cancer susceptibility alleles with different levels of risk and prevalence in the population have become apparent: rare high-penetrance alleles, rare moderate-penetrance alleles and common low-penetrance alleles. The contribution of each component to breast cancer predisposition is still to be fully explored, as are the phenotypic characteristics of the cancers associated with them, the ways in which they interact, much of their biology and their clinical utility. These recent advances herald a new chapter in the exploration of susceptibility to breast cancer and are likely to provide insights relevant to other common, heterogeneous diseases.	[Stratton, Michael R.] Wellcome Trust Genome Campus, Wellcome Trust Sange Inst, Canc Genom Project, Cambridge CB10 1SA, England; [Stratton, Michael R.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England	Wellcome Trust Sanger Institute; University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Wellcome Trust Genome Campus, Wellcome Trust Sange Inst, Canc Genom Project, 15 Cotswold Rd, Cambridge CB10 1SA, England.	nazneen.rahman@icr.ac.uk	Rahman, Nazneen/B-8890-2012; Rahman, Nazneen/D-2802-2013	Rahman, Nazneen/0000-0003-4376-0440				Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Antoniou AC, 2006, ONCOGENE, V25, P5898, DOI 10.1038/sj.onc.1209879; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Domchek SM, 2006, ONCOGENE, V25, P5825, DOI 10.1038/sj.onc.1209881; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Heikkinen K, 2006, CARCINOGENESIS, V27, P1593, DOI 10.1093/carcin/bgi360; Honrado E, 2006, CRIT REV ONCOL HEMAT, V59, P27, DOI 10.1016/j.critrevonc.2006.01.006; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Peto J, 2000, NAT GENET, V26, P411, DOI 10.1038/82533; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2005, J MED GENET, V42, P147, DOI 10.1136/jmg.2004.022673; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Seal S, 2003, CANCER RES, V63, P8596; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Smith P, 2006, GENE CHROMOSOME CANC, V45, P646, DOI 10.1002/gcc.20330; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Thompson D, 2004, J MAMMARY GLAND BIOL, V9, P221, DOI 10.1023/B:JOMG.0000048770.90334.3b; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tommiska J, 2006, INT J CANCER, V118, P2911, DOI 10.1002/ijc.21738; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; van Puijenbroek M, 2005, J PATHOL, V206, P198, DOI 10.1002/path.1764; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	55	346	358	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					17	22		10.1038/ng.2007.53	http://dx.doi.org/10.1038/ng.2007.53			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18163131				2022-12-17	WOS:000252118600011
J	Lehner, B; Crombie, C; Tischler, J; Fortunato, A; Fraser, AG				Lehner, Ben; Crombie, Catriona; Tischler, Julia; Fortunato, Angelo; Fraser, Andrew G.			Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways	NATURE GENETICS			English	Article							ENHANCED RNA INTERFERENCE; C-ELEGANS; SPLIT-ENDS; MORPHOLOGICAL EVOLUTION; COMPLEX; COMPONENT; PROTEIN; SCREEN; RAS; CAPACITOR	Most heritable traits, including disease susceptibility, are affected by interactions between multiple genes. However, we understand little about how genes interact because very few possible genetic interactions have been explored experimentally. We have used RNA interference in Caenorhabditis elegans to systematically test similar to 65,000 pairs of genes for their ability to interact genetically. We identify similar to 350 genetic interactions between genes functioning in signaling pathways that are mutated in human diseases, including components of the EGF/Ras, Notch and Wnt pathways. Most notably, we identify a class of highly connected 'hub' genes: inactivation of these genes can enhance the phenotypic consequences of mutation of many different genes. These hub genes all encode chromatin regulators, and their activity as genetic hubs seems to be conserved across animals. We propose that these genes function as general buffers of genetic variation and that these hub genes may act as modifier genes in multiple, mechanistically unrelated genetic diseases in humans.	Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England	Wellcome Trust Sanger Institute	Fraser, AG (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England.	agf@sanger.ac.uk	Lehner, Ben/ABH-6562-2020; Fortunato, Angelo/AAI-1120-2019; Lehner, Ben/L-3413-2014	Lehner, Ben/0000-0002-8817-1124; Fortunato, Angelo/0000-0001-7363-0423; Lehner, Ben/0000-0002-8817-1124; Fraser, Andrew/0000-0001-9939-6014	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bach EA, 2003, GENETICS, V165, P1149; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Baugh LR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r45; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; CARRERA I, 2003, DROS RES C, V44, pA346; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Ch'ng Q, 1999, DEVELOPMENT, V126, P3303; Chen FL, 2000, CURR BIOL, V10, P943, DOI 10.1016/S0960-9822(00)00625-4; CLARK DV, 1995, MOL GEN GENET, V247, P367, DOI 10.1007/BF00293205; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feng Y, 2003, CANCER RES, V63, P8726; Gause M, 2006, MOL CELL BIOL, V26, P2347, DOI 10.1128/MCB.26.6.2347-2359.2006; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Herman MA, 1999, DEVELOPMENT, V126, P1055; Howard RM, 2002, GENE DEV, V16, P1815, DOI 10.1101/gad.998402; Inoue T, 2002, MECH DEVELOP, V119, pS203, DOI 10.1016/S0925-4773(03)00117-5; JANODY F, 2002, DROS RES C, V43, P90; Jiang LI, 1999, GENE DEV, V13, P877, DOI 10.1101/gad.13.7.877; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; Kuang B, 2000, DEVELOPMENT, V127, P1517; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lehner B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r4; Lin HV, 2003, DEVELOPMENT, V130, P3125, DOI 10.1242/dev.00527; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Moghal N, 2003, DEVELOPMENT, V130, P57, DOI 10.1242/dev.00189; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rebay I, 2000, GENETICS, V154, P695; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Staehling-Hampton K, 1999, GENETICS, V153, P275; SUNDARAM MV, WORMBOOK; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Haaften G, 2004, P NATL ACAD SCI USA, V101, P12992, DOI 10.1073/pnas.0403131101; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Zhang H, 2001, DEVELOPMENT, V128, P767	48	346	361	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					896	903		10.1038/ng1844	http://dx.doi.org/10.1038/ng1844			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16845399				2022-12-17	WOS:000239325700018
J	Valentonyte, R; Hampe, J; Huse, K; Rosenstiel, P; Albrecht, M; Stenzel, A; Nagy, M; Gaede, KI; Franke, A; Haesler, R; Koch, A; Lengauer, T; Seegert, D; Reiling, N; Ehlers, S; Schwinger, E; Platzer, M; Krawczak, M; Muller-Quernheim, J; Schurmann, M; Schreiber, S				Valentonyte, R; Hampe, J; Huse, K; Rosenstiel, P; Albrecht, M; Stenzel, A; Nagy, M; Gaede, KI; Franke, A; Haesler, R; Koch, A; Lengauer, T; Seegert, D; Reiling, N; Ehlers, S; Schwinger, E; Platzer, M; Krawczak, M; Muller-Quernheim, J; Schurmann, M; Schreiber, S			Sarcoidosis is associated with a truncating splice site mutation in BTNL2	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; EPITHELIAL-CELLS; ALLELIC ASSOCIATION; CRYSTAL-STRUCTURE; DUTCH PATIENTS; TNF-ALPHA; GENE; SUSCEPTIBILITY; DISEASE; MARKER	Sarcoidosis is a polygenic immune disorder with predominant manifestation in the lung. Genome-wide linkage analysis previously indicated that the extended major histocompatibility locus on chromosome 6p was linked to susceptibility to sarcoidosis. Here, we carried out a systematic three-stage SNP scan of 16.4 Mb on chromosome 6p21 in as many as 947 independent cases of familial and sporadic sarcoidosis and found that a 15-kb segment of the gene butyrophilin-like 2 (BTNL2) was associated with the disease. The primary disease-associated variant (rs2076530; P-TDT = 3 x 10(-6), Pcase-control = 1.1 x 10(-8); replication P-TDT = 0.0018, Pcase-control = 1.8 x 10(-6)) represents a risk factor that is independent of variation in HLA-DRB1. BTNL2 is a member of the immunoglobulin superfamily and has been implicated as a costimulatory molecule involved in T-cell activation on the basis of its homology to B7-1. The G --> A transition constituting rs2076530 leads to the use of a cryptic splice site located 4 bp upstream of the affected wild-type donor site. Transcripts of the risk-associated allele have a premature stop in the spliced mRNA. The resulting protein lacks the C-terminal IgC domain and transmembrane helix, thereby disrupting the membrane localization of the protein, as shown in experiments using green fluorescent protein and V5 fusion proteins.	Univ Kiel, Univ Klinikum Schleswig Holstein, Inst Clin Mol Biol, D-24105 Kiel, Germany; Univ Kiel, Univ Klinikum Schleswig Holstein, Kiel Ctr German Natl Genotyping Platform, D-24105 Kiel, Germany; Inst Mol Biotechnol, D-07745 Jena, Germany; Max Planck Inst Informat, D-66123 Saarbrucken, Germany; Charite Univ Hosp, Inst Forens Med, D-10115 Berlin, Germany; Res Ctr Borstel, D-23845 Borstel, Germany; Univ Freiburg, Dept Pneumol, D-79106 Freiburg, Germany; Conaris Res Inst AG, D-24118 Kiel, Germany; Univ Lubeck, Inst Human Genet, D-23538 Lubeck, Germany; Univ Kiel, Univ Klinikum Schleswig Holstein, Inst Med Stat & Informat, D-24105 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Forschungszentrum Borstel; University of Freiburg; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital	Hampe, J (corresponding author), Univ Kiel, Univ Klinikum Schleswig Holstein, Inst Clin Mol Biol, Campus Kiel,Schittenhelmstr 12, D-24105 Kiel, Germany.	j.hampe@mucosa.de	Seegert, Dirk/B-8826-2011; Häsler, Robert/A-4908-2009; Krawczak, Michael/A-8964-2010; Franke, Andre/B-2151-2010; Müller-Quernheim, Joachim/H-1983-2011; Albrecht, Mario/B-6694-2008; Reiling, Norbert/D-6796-2013; Hampe, Jochen/A-2555-2010; Ehlers, Stefan/B-4075-2010; Rosenstiel, Philip/A-5137-2009	Häsler, Robert/0000-0003-4174-8229; Krawczak, Michael/0000-0003-2603-1502; Franke, Andre/0000-0003-1530-5811; Albrecht, Mario/0000-0002-3103-9624; Reiling, Norbert/0000-0001-6673-4291; Hampe, Jochen/0000-0002-2421-6127; Rosenstiel, Philip/0000-0002-9692-8828; Huse, Klaus/0000-0003-3854-1884				Abdallah A, 2003, GENES IMMUN, V4, P450, DOI 10.1038/sj.gene.6364001; Agadjanyan MG, 2003, J IMMUNOL, V171, P4311, DOI 10.4049/jimmunol.171.8.4311; Albrecht M, 2003, FEBS LETT, V538, P173, DOI 10.1016/S0014-5793(03)00161-3; Bajorath J, 2001, J MOL GRAPH MODEL, V19, P619; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Costabel U, 1999, EUR RESPIR J, V14, P735, DOI 10.1034/j.1399-3003.1999.14d02.x; Foley PJ, 2001, AM J RESP CELL MOL, V25, P272, DOI 10.1165/ajrcmb.25.3.4261; Grutters JC, 2002, AM J RESP CRIT CARE, V165, P1119, DOI 10.1164/ajrccm.165.8.200110-0320; Hampe J, 2004, BIOTECHNIQUES, V36, P148, DOI 10.2144/04361DD01; Hampe J, 2001, BIOINFORMATICS, V17, P654, DOI 10.1093/bioinformatics/17.7.654; Hampe J, 2002, P NATL ACAD SCI USA, V99, P321, DOI 10.1073/pnas.261567999; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; HUNNINGHAKE GW, 1979, AM J PATHOL, V97, P149; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; KRAWCZAK M, 1992, HUM GENET, V90, P41; KRAWCZAK M, 1988, HUM GENET, V80, P78, DOI 10.1007/BF00451461; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Legouis R, 2003, EMBO REP, V4, P1096, DOI 10.1038/sj.embor.7400006; Long MY, 1999, MOL BIOL EVOL, V16, P1528, DOI 10.1093/oxfordjournals.molbev.a026065; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Reiling N, 2001, J IMMUNOL, V167, P3339, DOI 10.4049/jimmunol.167.6.3339; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; Rybicki BA, 2003, AM J RESP CRIT CARE, V167, P444, DOI 10.1164/rccm.2112060; Rybicki BA, 2001, AM J RESP CRIT CARE, V164, P2085, DOI 10.1164/ajrccm.164.11.2106001; Sato H, 2002, AM J RESP CELL MOL, V27, P406, DOI 10.1165/rcmb.4782; Schurmann M, 2001, AM J RESP CRIT CARE, V164, P840, DOI 10.1164/ajrccm.164.5.2007056; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Stammers M, 2000, IMMUNOGENETICS, V51, P373, DOI 10.1007/s002510050633; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Stenzel A, 2004, HUM GENET, V114, P377, DOI 10.1007/s00439-003-1075-5; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; Zhang XW, 2003, P NATL ACAD SCI USA, V100, P2586, DOI 10.1073/pnas.252771499; Ziegenhagen MW, 2003, J INTERN MED, V253, P18, DOI 10.1046/j.1365-2796.2003.01074.x; Zissel G, 2000, J INVEST MED, V48, P66	42	346	362	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					357	364		10.1038/ng1519	http://dx.doi.org/10.1038/ng1519			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15735647				2022-12-17	WOS:000228040000018
J	SANGO, K; YAMANAKA, S; HOFFMANN, A; OKUDA, Y; GRINBERG, A; WESTPHAL, H; MCDONALD, MP; CRAWLEY, JN; SANDHOFF, K; SUZUKI, K; PROIA, RL				SANGO, K; YAMANAKA, S; HOFFMANN, A; OKUDA, Y; GRINBERG, A; WESTPHAL, H; MCDONALD, MP; CRAWLEY, JN; SANDHOFF, K; SUZUKI, K; PROIA, RL			MOUSE MODELS OF TAY-SACHS AND SANDHOFF DISEASES DIFFER IN NEUROLOGIC PHENOTYPE AND GANGLIOSIDE METABOLISM	NATURE GENETICS			English	Article							HEXOSAMINIDASE-A; DEGRADATION; STORAGE; PROTEIN; GM2	Tay-Sachs and Sandhoff diseases are clinically similar neurodegenerative disorders. These two sphingolipidoses are characterized by a heritable absence of beta-hexosaminidase A resulting in defective G(M2) ganglioside degradation. Through disruption of the Hexa and Herb genes in embryonic stem cells, we have established mouse models corresponding to each disease, Unlike the two human disorders, the two mouse models show very different neurologic phenotypes. Although exhibiting biochemical and pathologic features of the disease, the Tay-Sachs model showed no neurological abnormalities. In contrast, the Sandhoff model was severely affected. The phenotypic difference between the two mouse models is the result of differences in the ganglioside degradation pathway between mice and humans.	NIDDKD,GENET & BIOCHEM BRANCH,BIOCHEM GENET SECT,BETHESDA,MD 20892; UNIV BONN,INST ORGAN CHEM & BIOCHEM,D-53121 BONN,GERMANY; NICHHD,MAMMALIAN GENES & DEV LAB,BETHESDA,MD 20892; NIMH,EXPTL THERAPEUT BRANCH,BEHAV NEUROPHARMACOL SECT,BETHESDA,MD 20892; UNIV N CAROLINA,DEPT PATHOL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,BRAIN & DEV RES CTR,CHAPEL HILL,NC 27599	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Bonn; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill			Proia, Richard L/A-7908-2012	Proia, Richard/0000-0003-0456-1270; McDonald, Michael P./0000-0002-9642-964X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024453] Funding Source: NIH RePORTER; NICHD NIH HHS [HD03110] Funding Source: Medline; NINDS NIH HHS [NS24453] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BURG J, 1983, H-S Z PHYSIOL CHEM, V364, P821, DOI 10.1515/bchm2.1983.364.2.821; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CONZELMANN E, 1991, DEV NEUROSCI-BASEL, V13, P197, DOI 10.1159/000112160; CONZELMANN E, 1979, H-S Z PHYSIOL CHEM, V360, P1837, DOI 10.1515/bchm2.1979.360.2.1837; GRAVEL RA, 1995, METABOLIC MOL BASES, P2839; KLIMA H, 1993, BIOCHEM J, V292, P571, DOI 10.1042/bj2920571; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEINEKUGEL P, 1992, HUM GENET, V88, P513, DOI 10.1007/BF00219337; RIBONI L, 1995, J NEUROCHEM, V64, P451; Robertson E. J., 1987, TERATOCARCINOMAS EMB; SANDHOFF K, 1977, ANGEW CHEM INT EDIT, V16, P273, DOI 10.1002/anie.197702733; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SANDHOFF K, 1967, BIOCHIM BIOPHYS ACTA, V141, P442, DOI 10.1016/0304-4165(67)90124-9; SCHWARZMANN G, 1978, BIOCHIM BIOPHYS ACTA, V529, P106, DOI 10.1016/0005-2760(78)90108-X; SONDERFELD S, 1985, EUR J BIOCHEM, V149, P247, DOI 10.1111/j.1432-1033.1985.tb08919.x; SUZUKI K, 1991, DEV NEUROSCI-BASEL, V13, P205, DOI 10.1159/000112161; SUZUKI Y, 1971, NEUROLOGY, V21, P313, DOI 10.1212/WNL.21.4.313; TANLIKE M, 1995, ACTA NEUROPATHOL, V89, P296; VANDENEIJNDEN DH, 1971, Z PHYSIOL CHEM, V352, P1601; YAMANAKA S, 1994, GENOMICS, V21, P588, DOI 10.1006/geno.1994.1318; YAMANAKA S, 1994, P NATL ACAD SCI USA, V91, P9975, DOI 10.1073/pnas.91.21.9975	21	346	358	1	25	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					170	176		10.1038/ng1095-170	http://dx.doi.org/10.1038/ng1095-170			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550345				2022-12-17	WOS:A1995RX80600019
J	WU, JS; FORBES, JR; CHEN, HS; COX, DW				WU, JS; FORBES, JR; CHEN, HS; COX, DW			THE LEC RAT HAS A DELETION IN THE COPPER TRANSPORTING ATPASE GENE HOMOLOGOUS TO THE WILSON DISEASE GENE	NATURE GENETICS			English	Article							MENKES DISEASE; CANDIDATE GENE; HEREDITARY HEPATITIS; DNA; ACCUMULATION; ENCODES	The Long-Evans Cinnamon (LEC) rat shows similarity to Wilson disease in many clinical and biochemical features. We have cloned cDNAs for the rat gene (Afp7b) homologous to the human Wilson disease gene (ATP7B) and have used them to identify a partial deletion in the Atp7b gene in the LEC rat. The deletion removes at least 900 bp of the coding region at the 3' end, includes the crucial ATP binding domain and extends downstream of the gene. Our results provide convincing evidence for defining the LEC rat as an animal model for Wilson disease. This model will be important for studying liver pathophysiology, for developing therapy for Wilson disease and for studying the pathway of copper transport and its possible interaction with other heavy metals.	HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ON,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PAEDIAT,TORONTO M5S 1A1,ON,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto								BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; BULL PC, IN PRESS TRENDS GENE; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Danks DM, 1989, METABOLIC BASIS INHE, P1411; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GELLER SA, 1994, HEPATOLOGY, V19, P389; LI Y, 1991, J CLIN INVEST, V87, P1858, DOI 10.1172/JCI115208; LI Y, 1991, LEC RAT NEW MODEL HE, P122; LOEB LA, 1988, P NATL ACAD SCI USA, V85, P3918, DOI 10.1073/pnas.85.11.3918; MASUDA R, 1988, LAB ANIM, V22, P166, DOI 10.1258/002367788780864402; MASUDA R, 1988, JPN J CANC RES, V79, P825; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; ONO T, 1991, JPN J CANCER RES, V82, P486, DOI 10.1111/j.1349-7006.1991.tb01875.x; PREDKI PF, 1992, J BIOL CHEM, V267, P5842; SASAKI M, 1985, RAT NEWS LETT, V14, P4; SAWAKI M, 1990, CARCINOGENESIS, V11, P1875; SONE H, 1992, MOL CARCINOGEN, V5, P199, DOI 10.1002/mc.2940050306; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; TKESHELASHVILI LK, 1991, J BIOL CHEM, V266, P6401; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WALSHE JM, 1989, Q J MED, V70, P253; WILSON JM, 1988, P NATL ACAD SCI USA, V85, P4421, DOI 10.1073/pnas.85.12.4421; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471; YOSHIDA MC, 1987, J HERED, V78, P361, DOI 10.1093/oxfordjournals.jhered.a110416	25	346	354	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1994	7	4					541	545		10.1038/ng0894-541	http://dx.doi.org/10.1038/ng0894-541			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951327				2022-12-17	WOS:A1994PA83200024
J	Klein, C; Grudzien, M; Appaswamy, G; Germeshausen, M; Sandrock, I; Schaffer, AA; Rathinam, C; Boztug, K; Schwinzer, B; Rezaei, N; Bohn, G; Melin, M; Carlsson, G; Fadeel, B; Dahl, N; Palmblad, J; Henter, JI; Zeidler, C; Grimbacher, B; Welte, K				Klein, Christoph; Grudzien, Magda; Appaswamy, Giridharan; Germeshausen, Manuela; Sandrock, Inga; Schaffer, Alejandro A.; Rathinam, Chozhavendan; Boztug, Kaan; Schwinzer, Beate; Rezaei, Nima; Bohn, Georg; Melin, Malin; Carlsson, Goran; Fadeel, Bengt; Dahl, Niklas; Palmblad, Jan; Henter, Jan-Inge; Zeidler, Cornelia; Grimbacher, Bodo; Welte, Karl			HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)	NATURE GENETICS			English	Article							COLONY-STIMULATING-FACTOR; MYELOID PROGENITOR CELLS; PROTEIN HAX-1; MITOCHONDRIA; APOPTOSIS; DEATH; NEUTROPHILS; MUTATIONS; INTERACTS; LEUKEMIA	Autosomal recessive severe congenital neutropenia (SCN)(1) constitutes a primary immunodeficiency syndrome associated with increased apoptosis in myeloid cells(2,3), yet the underlying genetic defect remains unknown. Using a positional cloning approach and candidate gene evaluation, we identified a recurrent homozygous germline mutation in HAX1 in three pedigrees. After further molecular screening of individuals with SCN, we identified 19 additional affected individuals with homozygous HAX1 mutations, including three belonging to the original pedigree described by Kostmann(1). HAX1 encodes the mitochondrial protein HAX1, which has been assigned functions in signal transduction(4) and cytoskeletal control(5,6). Here, we show that HAX1 is critical for maintaining the inner mitochondrial membrane potential and protecting against apoptosis in myeloid cells. Our findings suggest that HAX1 is a major regulator of myeloid homeostasis and underline the significance of genetic control of apoptosis in neutrophil development.	Hannover Med Sch, Dept Pediat Hematol Oncol, D-30625 Hannover, Germany; Freiburg Univ Hosp, Med Ctr, Div Rheumatol & Clin Immunol, D-79106 Freiburg, Germany; NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Dept Hlth & Human Serv, Bethesda, MD 20894 USA; Univ Tehran Med Sci, Immunol Asthma & Allergy Res Inst, Tehran, Iran; Univ Childrens Hosp, Dept Genet & Pathol, S-75185 Uppsala, Sweden; Karolinska Univ Hosp, Karolinska Inst, Dept Woman & Child Hlth, Childhood Canc Res Unit, S-17176 Stockholm, Sweden; Karolinska Inst, Inst Environm Med, Div Biochem & Toxicol, S-17177 Stockholm, Sweden; Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Med, S-14186 Stockholm, Sweden	Hannover Medical School; University of Freiburg; National Institutes of Health (NIH) - USA; Immunology Asthma & Allergy Research Institute - Iran; Tehran University of Medical Sciences; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Klein, C (corresponding author), Hannover Med Sch, Dept Pediat Hematol Oncol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	klein.christoph@mh-hannover.de	Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012; Rezaei, Nima/B-4245-2008; Boztug, Kaan/AAM-4161-2021	Rezaei, Nima/0000-0002-3836-1827; Boztug, Kaan/0000-0001-8387-9185; Henter, Jan-Inge/0000-0002-0629-2126	Intramural NIH HHS Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [ZIALM000097, Z01LM000097] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Cario G, 2005, BRIT J HAEMATOL, V129, P275, DOI 10.1111/j.1365-2141.2005.05428.x; Carlsson G, 2004, BLOOD, V103, P3355, DOI 10.1182/blood-2003-04-1011; Carlsson G, 2001, ACTA PAEDIATR, V90, P757, DOI 10.1080/080352501750315663; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; Dufva M, 2001, J GEN VIROL, V82, P1581, DOI 10.1099/0022-1317-82-7-1581; ELSNER J, 1993, EXP HEMATOL, V21, P38; Gallagher AR, 2000, P NATL ACAD SCI USA, V97, P4017, DOI 10.1073/pnas.97.8.4017; GILMAN PA, 1970, BLOOD-J HEMATOL, V36, P576, DOI 10.1182/blood.V36.5.576.576; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Kawaguchi Y, 2000, J VIROL, V74, P10104, DOI 10.1128/JVI.74.21.10104-10111.2000; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; KOSTMANN R, 1956, Acta Paediatr Suppl, V45, P1; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; Maianski NA, 2002, BLOOD, V99, P672, DOI 10.1182/blood.V99.2.672; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Radhika V, 2004, J BIOL CHEM, V279, P49406, DOI 10.1074/jbc.M408836200; Rosenberg PS, 2006, BLOOD, V107, P4628, DOI 10.1182/blood-2005-11-4370; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; Suzuki Y, 1997, J IMMUNOL, V158, P2736; WETTE K, 2006, SEMIN HEMATOL, V43, P189; Yedavalli VSRK, 2005, J VIROL, V79, P13735, DOI 10.1128/JVI.79.21.13735-13746.2005	30	345	361	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					86	92		10.1038/ng1940	http://dx.doi.org/10.1038/ng1940			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17187068				2022-12-17	WOS:000243136500022
J	Mansfield, JH; Harfe, BD; Nissen, R; Obenauer, J; Srineel, J; Chaudhuri, A; Farzan-Kashani, R; Zuker, M; Pasquinelli, AE; Ruvkun, G; Sharp, PA; Tabin, CJ; McManus, MT				Mansfield, JH; Harfe, BD; Nissen, R; Obenauer, J; Srineel, J; Chaudhuri, A; Farzan-Kashani, R; Zuker, M; Pasquinelli, AE; Ruvkun, G; Sharp, PA; Tabin, CJ; McManus, MT			MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; MESSENGER-RNA; GENES; IDENTIFICATION; DROSOPHILA; CLEAVAGE; ELEMENT; DOMAIN; MOUSE; MIRNA	MicroRNAs (miRNAs) are a class of short (similar to22-nt) noncoding RNA molecules that downregulate expression of their mRNA targets. Since their discovery as regulators of developmental timing in Caenorhabditis elegans, hundreds of miRNAs have been identified in both animals and plants(1). Here, we report a technique for visualizing detailed miRNA expression patterns in mouse embryos. We elucidate the tissue-specific expression of several miRNAs during embryogenesis, including two encoded by genes embedded in homeobox (Hox) clusters, miR-10a and miR-196a. These two miRNAs are expressed in patterns that are markedly reminiscent of those of Hox genes. Furthermore, miR-196a negatively regulates Hoxb8, indicating that its restricted expression pattern probably reflects a role in the patterning function of the Hox complex.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; Rensselaer Polytech Inst, Dept Math Sci, Troy, NY 12180 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; MIT, NcGovern Inst, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; State University System of Florida; University of Florida; Massachusetts Institute of Technology (MIT); St Jude Children's Research Hospital; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu; mmcmanus@diabetes.ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Nissen, Robert/0000-0002-0591-1167	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD041826] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dietrich S, 1997, DEVELOPMENT, V124, P3895; ERSELIUS JR, 1990, DEVELOPMENT, V110, P629; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; van den Akker E, 2001, DEVELOPMENT, V128, P1911; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	27	345	393	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2004	36	10					1079	1083		10.1038/ng1421	http://dx.doi.org/10.1038/ng1421			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15361871	Bronze			2022-12-17	WOS:000224156500016
J	Lewandoski, M; Sun, X; Martin, GR				Lewandoski, M; Sun, X; Martin, GR			Fgf8 signalling from the AER is essential for normal limb development	NATURE GENETICS			English	Article							APICAL ECTODERMAL RIDGE; VERTEBRATE LIMB; MOUSE; OUTGROWTH; INITIATION; ROLES; GENE; MORPHOGENESIS; GASTRULATION; MAINTENANCE	Vertebrate limb development depends on signals from the apical ectodermal ridge (AER), which rims the distal tip of the limb bud(1). Removal of the AER in chick results in limbs lacking distal skeletal elements(2,3). Fibroblast growth factor (FGF) proteins can substitute for the AER (refs 4-7), suggesting that FGF signalling mediates AER activity. Of the four mouse Fgf genes (Fgf4, Fgf8, Fgf9, Fgf17) known to display AER-specific expression domains within the limb bud (AER-Fgfs), only Fgf8 is expressed throughout the AER. Moreover, Fgf8 expression precedes that of other AER-Fgfs (refs 8-13), suggesting that Fgf8 may perform unique functions early in limb development(6,7). In mice, loss of function of Fgf4 (refs 13,14), Fgf9 (D. Ornitz, pers. comm.) or Fgf17 (ref. 15) has no effect on limb formation. We report here that inactivating Fgf8 in early limb ectoderm causes a substantial reduction in limb-bud size, a delay in Shh expression, misregulation of Fgf4 expression, and hypoplasia or aplasia of specific skeletal elements. Our data identify Fgf8 as the only known AER-Fgf individually necessary for normal limb development, and provide insight into the function of Fgf signalling from the AER in the normal outgrowth and patterning of the limb.	Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Program Dev Biol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Martin, GR (corresponding author), Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94143 USA.			Lewandoski, Mark/0000-0002-1066-3735	NICHD NIH HHS [R01 HD34380] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034380] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1; MAHMOOD R, 1995, CURR BIOL, V5, P797, DOI 10.1016/S0960-9822(95)00157-6; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Merino R, 1999, DEVELOPMENT, V126, P5515; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Moon AM, 2000, DEVELOPMENT, V127, P989; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1992, DEVELOPMENT, V114, P755; OHUCHI H, 1994, BIOCHEM BIOPH RES CO, V204, P882, DOI 10.1006/bbrc.1994.2542; Pizette S, 1999, DEVELOPMENT, V126, P883; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tabin CJ, 1998, NATURE, V396, P322, DOI 10.1038/24516; TICKLE C, 1994, ANNU REV CELL BIOL, V10, P121; Vogel A, 1996, DEVELOPMENT, V122, P1737; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu JS, 2000, DEVELOPMENT, V127, P1833; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	30	345	357	1	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					460	463		10.1038/82609	http://dx.doi.org/10.1038/82609			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101846				2022-12-17	WOS:000165671700021
J	Xia, JH; Liu, CY; Tang, BS; Pan, Q; Huang, L; Dai, HP; Zhang, BR; Xie, W; Hu, DX; Zheng, D; Shi, XL; Wang, DA; Xia, K; Yu, KP; Liao, XD; Feng, Y; Yang, YF; Xiao, JY; Xie, DH; Huang, JZ				Xia, JH; Liu, CY; Tang, BS; Pan, Q; Huang, L; Dai, HP; Zhang, BR; Xie, W; Hu, DX; Zheng, D; Shi, XL; Wang, DA; Xia, K; Yu, KP; Liao, XD; Feng, Y; Yang, YF; Xiao, JY; Xie, DH; Huang, JZ			Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant healing impairment	NATURE GENETICS			English	Article							MARIE-TOOTH DISEASE; HEARING IMPAIRMENT; DEAFNESS; HETEROGENEITY; FAMILIES; LINKAGE; REGION; MAPS	Hearing impairment is the most commonly occurring condition that affects the ability of humans to communicate(1). More than 50% of the cases of profound early-onset deafness are caused by genetic factors(2,3). Over 40 loci for non-syndromic deafness have been genetically mapped, and mutations in several genes have been shown to cause hearing loss(4). Mutations in the gene encoding connexin 26 (GJB2) cause both autosomal recessive and dominant forms of hearing impairment(5,6). To study the possible involvement of other members of the connexin family in hereditary hearing impairment, we cloned the gene (GJB3) encoding human gap junction protein beta-3 using homologous EST searching and nested PCR. GJB3 was mapped to human chromosome 1p33-p35. Mutation analysis revealed that a missense mutation and a nonsense mutation of GJB3 were associated with high-frequency hearing loss in two families. Moreover. expression of Gjb3 was identified in rat inner ear tissue by RT-PCR. These findings suggest that mutations in GJB3 may be responsible for bilateral high-frequency hearing impairment.	Affiliated Xiangya Hosp, Natl Lab Med Genet China, Changsha 410078, Hunan, Peoples R China; Affiliated Xiangya Hosp, Dept Neurol, Changsha 410078, Hunan, Peoples R China; Affiliated Xiangya Hosp, Dept Otorhinol, Changsha 410078, Hunan, Peoples R China; Hunan Med Univ, Affiliated Hosp 2, Dept Otorhinol, Changsha 410078, Hunan, Peoples R China; Hunan Med Univ, Affiliated Hosp 2, Dept Cardiothorac Surg, Changsha 410078, Hunan, Peoples R China; Zhejiang Med Univ, Affiliated Hosp 2, Dept Neurol, Hangzhou 310009, Zhejiang, Peoples R China	Central South University; Central South University; Zhejiang University	Xia, JH (corresponding author), Affiliated Xiangya Hosp, Natl Lab Med Genet China, Changsha 410078, Hunan, Peoples R China.	nlmglcy@public.cs.hn.cn	XIA, KUN/AAO-3525-2020; Liu, Chunyu/G-7561-2012; Liu, chunyu/Q-3901-2017	Liu, Chunyu/0000-0002-5986-4415; Shi, Xiaoliu/0000-0002-9759-2254				AYIMU D, 1997, J AUDIOL SPEECH PATH, V5, P144; BENOTHMANE K, 1993, GENOMICS, V17, P370; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; COUCKE P, 1994, NEW ENGL J MED, V331, P425, DOI 10.1056/NEJM199408183310702; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Engle EC, 1997, AM J HUM GENET, V60, P1150; FAIN PR, 1994, AM J HUM GENET, V54, P229; HULL R, 1978, HDB CLIN AUDIOLOGY, P426; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; REARDON W, 1992, J MED GENET, V29, P521, DOI 10.1136/jmg.29.8.521; Scott DA, 1998, NATURE, V391, P32, DOI 10.1038/34079; VanCamp G, 1997, AM J HUM GENET, V60, P758; VanCamp G, 1997, GENOMICS, V41, P70, DOI 10.1006/geno.1997.4624; VANDERSCHROEFF JG, 1988, HUM GENET, V80, P97, DOI 10.1007/BF00451466; White TW, 1998, NATURE, V394, P630, DOI 10.1038/29202	19	345	428	0	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1998	20	4					370	373		10.1038/3845	http://dx.doi.org/10.1038/3845			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	142KM	9843210				2022-12-17	WOS:000077199600025
J	Adler, CJ; Dobney, K; Weyrich, LS; Kaidonis, J; Walker, AW; Haak, W; Bradshaw, CJA; Townsend, G; Soltysiak, A; Alt, KW; Parkhill, J; Cooper, A				Adler, Christina J.; Dobney, Keith; Weyrich, Laura S.; Kaidonis, John; Walker, Alan W.; Haak, Wolfgang; Bradshaw, Corey J. A.; Townsend, Grant; Soltysiak, Arkadiusz; Alt, Kurt W.; Parkhill, Julian; Cooper, Alan			Sequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and Industrial revolutions	NATURE GENETICS			English	Article							16S RIBOSOMAL-RNA; BACTERIAL COMMUNITY COMPOSITION; PERIODONTAL-DISEASE; DIVERSITY; CALCULUS; TRANSMISSION; RESILIENCE; CARIES; DNA	The importance of commensal microbes for human health is increasingly recognized(1-5), yet the impacts of evolutionary changes in human diet and culture on commensal microbiota remain almost unknown. Two of the greatest dietary shifts in human evolution involved the adoption of carbohydrate-rich Neolithic (farming) diets(6,7) (beginning similar to 10,000 years before the present(6,8)) and the more recent advent of industrially processed flour and sugar (in similar to 1850)(9). Here, we show that calcified dental plaque (dental calculus) on ancient teeth preserves a detailed genetic record throughout this period. Data from 34 early European skeletons indicate that the transition from hunter-gatherer to farming shifted the oral microbial community to a disease-associated configuration. The composition of oral microbiota remained unexpectedly constant between Neolithic and medieval times, after which (the now ubiquitous) cariogenic bacteria became dominant, apparently during the Industrial Revolution. Modern oral microbiotic ecosystems are markedly less diverse than historic populations, which might be contributing to chronic oral (and other) disease in postindustrial lifestyles.	[Adler, Christina J.; Weyrich, Laura S.; Haak, Wolfgang; Cooper, Alan] Univ Adelaide, Australian Ctr Ancient DNA, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Adler, Christina J.; Weyrich, Laura S.; Haak, Wolfgang; Bradshaw, Corey J. A.; Cooper, Alan] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Adler, Christina J.] Univ Sydney, Inst Dent Res, Westmead Millennium Inst, Fac Dent, Sydney, NSW 2006, Australia; [Dobney, Keith] Univ Aberdeen, Dept Archaeol, Sch Geosci, Aberdeen, Scotland; [Kaidonis, John; Townsend, Grant] Univ Adelaide, Sch Dent, Adelaide, SA, Australia; [Walker, Alan W.; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Bradshaw, Corey J. A.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Bradshaw, Corey J. A.] South Australian Res & Dev Inst, Henley Beach, SA, Australia; [Soltysiak, Arkadiusz] Univ Warsaw, Dept Bioarchaeol, Inst Archaeol, Warsaw, Poland; [Alt, Kurt W.] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55122 Mainz, Germany	University of Adelaide; University of Adelaide; University of Sydney; Westmead Institute for Medical Research; University of Aberdeen; University of Adelaide; Wellcome Trust Sanger Institute; University of Adelaide; South Australian Research & Development Institute (SARDI); University of Warsaw; Johannes Gutenberg University of Mainz	Cooper, A (corresponding author), Univ Adelaide, Australian Ctr Ancient DNA, Sch Earth & Environm Sci, Adelaide, SA, Australia.	alan.cooper@adelaide.edu.au	Haak, Wolfgang/C-2362-2014; Parkhill, Julian/G-4703-2011; Cooper, Alan/E-8171-2012; Haak, Wolfgang/Z-4947-2019; Bradshaw, Corey J.A./A-1311-2008; Walker, Alan W./AAE-8102-2019	Haak, Wolfgang/0000-0003-2475-2007; Parkhill, Julian/0000-0002-7069-5958; Cooper, Alan/0000-0002-7738-7851; Haak, Wolfgang/0000-0003-2475-2007; Bradshaw, Corey J.A./0000-0002-5328-7741; Walker, Alan W./0000-0001-5099-8495; Soltysiak, Arkadiusz/0000-0002-9040-5022; Weyrich, Laura/0000-0001-5243-4634; Dobney, Keith/0000-0001-9036-4681; Adler, Christina/0000-0002-4731-5291	Australian Research Council; Wellcome Trust [WT092799/Z/10/Z, WT098051]; Sir Mark Mitchell Foundation	Australian Research Council(Australian Research Council); Wellcome Trust(Wellcome TrustEuropean Commission); Sir Mark Mitchell Foundation	We thank the Australian Research Council, the Wellcome Trust (WT092799/Z/10/Z and WT098051) and the Sir Mark Mitchell Foundation for funding support.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Asikainen S, 1996, ORAL MICROBIOL IMMUN, V11, P387, DOI 10.1111/j.1399-302X.1996.tb00200.x; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; BRAIDWOOD R, 1961, SCIENCE, V133, P2008, DOI 10.1126/science.133.3469.2008; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Childe V.G., 1925, DAWN EUROPEAN CIVILI; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Dave S, 2008, ORAL DIS, V14, P95, DOI 10.1111/j.1601-0825.2007.01438.x; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Ellis RJ, 2003, APPL ENVIRON MICROB, V69, P3223, DOI 10.1128/AEM.69.6.3223-3230.2003; Elshahed MS, 2008, APPL ENVIRON MICROB, V74, P5422, DOI 10.1128/AEM.00410-08; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faveri M, 2008, ORAL MICROBIOL IMMUN, V23, P112, DOI 10.1111/j.1399-302X.2007.00397.x; GRINE FE, 1990, ARCH ORAL BIOL, V35, P381, DOI 10.1016/0003-9969(90)90185-D; Grossi S G, 1998, Ann Periodontol, V3, P51, DOI 10.1902/annals.1998.3.1.51; Hujoel P, 2009, J DENT RES, V88, P490, DOI 10.1177/0022034509337700; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jin Y, 2002, CRIT REV ORAL BIOL M, V13, P426, DOI 10.1177/154411130201300506; Kerr NW, 1998, J PERIODONTAL RES, V33, P131; La Duc MT, 2004, MICROB ECOL, V47, P150, DOI 10.1007/s00248-003-1012-0; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Lieverse AR, 1999, INT J OSTEOARCHAEOL, V9, P219, DOI 10.1002/(SICI)1099-1212(199907/08)9:4<219::AID-OA475>3.0.CO;2-V; Lilley J., 1994, ARCHAEOLOGY YORK, V12, P291; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MARSH P D, 1991, Proceedings of the Finnish Dental Society, V87, P515; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Marsh Philip D, 2010, Dent Clin North Am, V54, P441, DOI 10.1016/j.cden.2010.03.002; Mercado FB, 2001, J PERIODONTOL, V72, P779, DOI 10.1902/jop.2001.72.6.779; Nogales B, 2001, APPL ENVIRON MICROB, V67, P1874, DOI 10.1128/AEM.67.4.1874-1884.2001; Oelze VM, 2011, J ARCHAEOL SCI, V38, P270, DOI 10.1016/j.jas.2010.08.027; Petchey OL, 2009, THEOR ECOL-NETH, V2, P177, DOI 10.1007/s12080-009-0041-9; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Preus HR, 2011, J ARCHAEOL SCI, V38, P1827, DOI 10.1016/j.jas.2011.03.020; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/nmeth.1361, 10.1038/NMETH.1361]; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Scott GR, 2012, J ARCHAEOL SCI, V39, P1388, DOI 10.1016/j.jas.2011.09.029; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; VANDERMEERSCH B, 1994, CR ACAD SCI II, V319, P727; VANSTEENBERGEN TJM, 1993, J MED MICROBIOL, V39, P416, DOI 10.1099/00222615-39-6-416; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Zhang Y, 2012, J ECOL, V100, P742, DOI 10.1111/j.1365-2745.2011.01944.x	50	344	356	4	181	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					450	455		10.1038/ng.2536	http://dx.doi.org/10.1038/ng.2536			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	115VS	23416520	Green Accepted, Green Submitted			2022-12-17	WOS:000316840600018
J	Endele, S; Rosenberger, G; Geider, K; Popp, B; Tamer, C; Stefanova, I; Milh, M; Kortum, F; Fritsch, A; Pientka, FK; Hellenbroich, Y; Kalscheuer, VM; Kohlhase, J; Moog, U; Rappold, G; Rauch, A; Ropers, HH; von Spiczak, S; Tonnies, H; Villeneuve, N; Villard, L; Zabel, B; Zenker, M; Laube, B; Reis, A; Wieczorek, D; Van Maldergem, L; Kutsche, K				Endele, Sabine; Rosenberger, Georg; Geider, Kirsten; Popp, Bernt; Tamer, Ceyhun; Stefanova, Irina; Milh, Mathieu; Kortuem, Fanny; Fritsch, Angela; Pientka, Friederike K.; Hellenbroich, Yorck; Kalscheuer, Vera M.; Kohlhase, Juergen; Moog, Ute; Rappold, Gudrun; Rauch, Anita; Ropers, Hans-Hilger; von Spiczak, Sarah; Toennies, Holger; Villeneuve, Nathalie; Villard, Laurent; Zabel, Bernhard; Zenker, Martin; Laube, Bodo; Reis, Andre; Wieczorek, Dagmar; Van Maldergem, Lionel; Kutsche, Kerstin			Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes	NATURE GENETICS			English	Article							LONG-TERM POTENTIATION; MOLECULAR DETERMINANTS; GENETIC ENHANCEMENT; EPSILON-1 SUBUNIT; MICE LACKING; SITE; DISCRIMINATION; REFINEMENT; DISEASE; PATTERN	N-methyl-D-aspartate (NMDA) receptors mediate excitatory neurotransmission in the mammalian brain. Two glycine-binding NR1 subunits and two glutamate-binding NR2 subunits each form highly Ca2+-permeable cation channels which are blocked by extracellular Mg2+ in a voltage-dependent manner(1). Either GRIN2B or GRIN2A, encoding the NMDA receptor subunits NR2B and NR2A, was found to be disrupted by chromosome translocation breakpoints in individuals with mental retardation and/or epilepsy. Sequencing of GRIN2B in 468 individuals with mental retardation revealed four de novo mutations: a frameshift, a missense and two splice-site mutations. In another cohort of 127 individuals with idiopathic epilepsy and/or mental retardation, we discovered a GRIN2A nonsense mutation in a three-generation family. In a girl with early-onset epileptic encephalopathy, we identified the de novo GRIN2A mutation c.1845C>A predicting the amino acid substitution p.N615K. Analysis of NR1-NR2A(N615K) (NR2A subunit with the p.N615K alteration) receptor currents revealed a loss of the Mg2+ block and a decrease in Ca2+ permeability. Our findings suggest that disturbances in the neuronal electrophysiological balance during development result in variable neurological phenotypes depending on which NR2 subunit of NMDA receptors is affected.	[Rosenberger, Georg; Kortuem, Fanny; Fritsch, Angela; Pientka, Friederike K.; Kutsche, Kerstin] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Endele, Sabine; Popp, Bernt; Rauch, Anita; Zenker, Martin; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Geider, Kirsten; Tamer, Ceyhun; Laube, Bodo] Tech Univ Darmstadt, Abt Mol & Zellulare Neurophysiol, Darmstadt, Germany; [Stefanova, Irina; Hellenbroich, Yorck] Univ Lubeck, Inst Humangenet, Lubeck, Germany; [Milh, Mathieu; Villard, Laurent] Fac Med Timone, U910, INSERM, Marseille, France; [Milh, Mathieu] Hop Enfants La Timone, Dept Paediat Neurol, Marseille, France; [Kalscheuer, Vera M.; Ropers, Hans-Hilger] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany; [Kohlhase, Juergen] Ctr Human Genet, Freiburg, Germany; [Moog, Ute] Univ Heidelberg, Inst Human Genet, Heidelberg, Germany; [Rappold, Gudrun] Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany; [von Spiczak, Sarah] Univ Med Ctr Schleswig Holstein, Dept Neuropaediat, Kiel, Germany; [Toennies, Holger] Univ Med Ctr Schleswig Holstein, Inst Human Genet, Kiel, Germany; [Villeneuve, Nathalie] Hop Henri Gastaut, Ctr St Paul, Marseille, France; [Villard, Laurent] Univ Aix Marseille 2, Marseille, France; [Zabel, Bernhard] Univ Hosp Freiburg, Ctr Pediat & Adolescent Med, Freiburg, Germany; [Zabel, Bernhard] Inst Human Genet, Freiburg, Germany; [Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Van Maldergem, Lionel] Univ Liege, Ctr Genet Humaine, Liege, Belgium	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; Technical University of Darmstadt; University of Lubeck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Max Planck Society; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; UDICE-French Research Universities; Aix-Marseille Universite; University of Freiburg; University of Duisburg Essen; University of Liege	Kutsche, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany.	kkutsche@uke.de	Reis, André/D-2309-2009; Villard, Laurent/E-3941-2016; Rauch, Anita/C-5568-2014; Wieczorek, Dagmar/AAU-6008-2021; Van Maldergem, Lionel/O-3242-2019; Popp, Bernt/M-2157-2019; milh, mathieu/F-9165-2013; Van Maldergem, Lionel/G-9849-2017	Reis, André/0000-0002-6301-6363; Villard, Laurent/0000-0001-6657-5008; Rauch, Anita/0000-0003-2930-3163; Wieczorek, Dagmar/0000-0003-2812-6492; Van Maldergem, Lionel/0000-0001-8880-5214; Popp, Bernt/0000-0002-3679-1081; Van Maldergem, Lionel/0000-0001-8880-5214; Kalscheuer, Vera/0000-0001-6898-3259	German Ministry of Research and Education [01GS08160, 01GS08168- 9, 01GS08161, 01GS08164]; Fondation Fran aise pour la Recherche sur l'Epilepsie; Gemeinnutzige HertieStiftung; Deutsche Forschungsgemeinschaft [FOR 885/IRP5]	German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF)); Fondation Fran aise pour la Recherche sur l'Epilepsie; Gemeinnutzige HertieStiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank all subjects and healthy (control) individuals for their participation in this study; P. De Jonghe for providing DNA samples of individuals with idiopathic epilepsy; A. Gal and B. Horsthemke for continuous support; H.-H. Richardt and H. Petri for clinical evaluation of subjects 3 and 1; A. Tzschach and M. Hoeltzenbein for initial help with collecting clinical data of subject 2; S. Fuchs for chromosome analysis; B. Lubker and C. Menzel for FISH analysis; R. Ullmann and A. Ahmed for array comparative genomic hybridization (CGH) on subject 2, O. Riess and M. Bonin for copy number variation analysis on subjects 8 and 9, and I. Gohring and A. B. Ekici for microarray analysis of the Erlanger cohort; S. Berkel, J. Hoyer and K. Cremer for support with data maintenance; and A. Diem, S. Freier, I. Jantke, S. Meien and K. Ziegler for skillfull technical assistance. This work was part of the German Mental Retardation Network (MRNET) funded through a grant from the German Ministry of Research and Education to A. Rauch and A. Reis (01GS08160), G. Rappold (01GS08168- 9), H.- H. R. (01GS08161) and D. W. (01GS08164). M. M. was supported by the Fondation Fran aise pour la Recherche sur l'Epilepsie, B. L. was supported by the Gemeinnutzige HertieStiftung, and G. Rosenberger and K. K. were supported by a grant from the Deutsche Forschungsgemeinschaft (FOR 885/IRP5).	Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Chen W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-85; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Ding YX, 2010, DEV MED CHILD NEUROL, V52, P1028, DOI 10.1111/j.1469-8749.2010.03746.x; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Laube B, 2004, NEUROPHARMACOLOGY, V47, P994, DOI 10.1016/j.neuropharm.2004.07.041; Madry C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00006; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; REUTLINGER C, 2010, EPILEPSIA       0402, DOI DOI 10.1111/J.1528-1167.2010.02555.X; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Spitz R, 2006, GENE CHROMOSOME CANC, V45, P1130, DOI 10.1002/gcc.20376; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P13, DOI 10.1111/j.1469-7793.1998.013bx.x; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	38	344	354	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					1021	U153		10.1038/ng.677	http://dx.doi.org/10.1038/ng.677			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20890276				2022-12-17	WOS:000283540500023
J	Blazquez, MA; Ahn, JH; Weigel, D				Blazquez, MA; Ahn, JH; Weigel, D			A thermosensory pathway controlling flowering time in Arabidopsis thaliana	NATURE GENETICS			English	Article							MADS DOMAIN PROTEIN; CIRCADIAN CLOCK; PHYTOCHROME-B; MUTANTS; GENE; VERNALIZATION; ENCODES; LIGHT; PHENOTYPE; REPRESSOR	Onset of flowering is controlled by environmental signals such as light and temperature. Molecular-genetic studies in Arabidopsis thaliana have focused on daily light duration, or photoperiod, and transient exposure to winter-like temperatures, or vernalizationl. Yet ambient growth temperature, which is strongly affected by current changes in global climate(2), has been largely ignored. Here, we show that genes of the autonomous pathway, previously thought only to act independently of the environment as regulators of the floral repressor FLC (ref. 1), are centrally involved in mediating the effects of ambient temperature. In contrast to wild-type plants and those mutant in other pathways, autonomous-pathway mutants flower at the same time regardless of ambient temperature. In contrast, the exaggerated temperature response of cryptochrome-2 mutants is caused by temperature-dependent redundancy with the phytochrome A photoreceptor. As with vernalization and photoperiod, ambient temperature ultimately affects expression of the floral pathway integrator FT.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain; Korea Univ, Grad Sch Biotechnol, Seoul 136701, South Korea; Max Planck Inst Dev Biol, Dept Biol Mol, D-72076 Tubingen, Germany	Salk Institute; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Korea University; Max Planck Society	Weigel, D (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	weigel@weigelworld.org	Weigel, Detlef/GSJ-0799-2022; Blazquez, Miguel A/B-1495-2008; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008; Ahn, Ji Hoon/A-4141-2011	Weigel, Detlef/0000-0002-2114-7963; Blazquez, Miguel A/0000-0001-5743-0448; Weigel, Detlef/0000-0002-2114-7963; Ahn, Ji Hoon/0000-0003-0347-3922				AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Bagnall DJ, 1996, PLANTA, V200, P278, DOI 10.1007/BF00208319; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Halevy H., 1985, CRC HDB FLOWERING; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; *INT PAN CLIM CHAN, 2002, CLIM CHANG 2001 SYNT; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Long S. P., 1988, PLANTS TEMPERATURE; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Menzel A, 2001, GLOBAL CHANGE BIOL, V7, P657, DOI 10.1046/j.1365-2486.2001.00430.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mockler TC, 1999, DEVELOPMENT, V126, P2073; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596	30	344	388	7	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2003	33	2					168	171		10.1038/ng1085	http://dx.doi.org/10.1038/ng1085			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12548286				2022-12-17	WOS:000180773700014
J	Rouault, JP; Falette, N; Guehenneux, F; Guillot, C; Rimokh, R; Wang, Q; Berthet, C; MoyretLalle, C; Savatier, P; Pain, B; Shaw, P; Berger, R; Samarut, J; Magaud, JP; Ozturk, M; Samarut, C; Puisieux, A				Rouault, JP; Falette, N; Guehenneux, F; Guillot, C; Rimokh, R; Wang, Q; Berthet, C; MoyretLalle, C; Savatier, P; Pain, B; Shaw, P; Berger, R; Samarut, J; Magaud, JP; Ozturk, M; Samarut, C; Puisieux, A			Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway	NATURE GENETICS			English	Article							WILD-TYPE P53; HUMAN-BREAST-CANCER; TRANSCRIPTIONAL ACTIVATION; GENE; EXPRESSION; PROTEIN; GROWTH; CELLS; ARREST; LINE	Cell cycle regulation is critical for maintenance of genome integrity. A prominent factor that guarantees genomic stability of cells is p53 (ref. 1). The P53 gene encodes a transcription factor that has a role as a tumour suppressor(2). identification of p53-target genes should provide greater insight into the molecular mechanisms that mediate the tumour suppressor activities of p53. The rodent Pc3/Tis21 gene was initially described as an immediate early gene induced by tumour promoters and growth factors in PC12 and Swiss 3T3 cells(3,4). It is expressed in a variety of cell and tissue types and encodes a remarkably labile protein(4,5). Pc3/Tis21 has a strong sequence similarity to the human antiproliferative BTG1 gene cloned from a chromosomal translocation of a B-cell chronic lymphocytic leukaemia(6). This similarity led us to speculate that BTG1 and the putative human homologue of Pc3/Tis21 (named BTG2) were members of a new family of genes involved in growth control and/or differentiation. This hypothesis was recently strengthened by the identification of a new antiproliferative protein, named TOE, which shares sequence similarity with BTG1 and PC3/TIS21 (ref. 7). Here, we cloned and localized the human BTG2 gene. We show that BTG2 expression is induced through a p53-dependent mechanism and that BTG2 function may be relevant to cell cycle control and cellular response to DNA damage.	CTR LEON BERARD,INSERM U453,CNRS,F-69373 LYON 08,FRANCE; HOP EDOUARD HERRIOT,LAB CYTOGENET MOL,F-69437 LYON 03,FRANCE; ECOLE NORMALE SUPER LYON,LAB BIOL MOL & CELLULAIRE,CNRS UMR49,INRA,F-69373 LYON 08,FRANCE; INST PATHOL,DIV EXPT ONCOL,CH-1011 LAUSANNE,SWITZERLAND; INST GENET MOL,INSERM,U301,F-75010 PARIS,FRANCE; BILKENT UNIV,DEPT MOL BIOL & GENET,TR-06533 BILKENT,ANKARA,TURKEY	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Ihsan Dogramaci Bilkent University			Rimokh, Ruth/G-7506-2014; SAVATIER, Pierre/J-4663-2014; Moyret-Lalle, Caroline/G-2742-2013; Samarut, Jacques/AAD-2587-2019; berthet, cyril/T-4842-2017; OZTURK, MEHMET/AAS-7241-2021; ozturk, mehmet/G-3330-2014; Pain, Bertrand/A-7686-2015	Moyret-Lalle, Caroline/0000-0002-8359-2018; berthet, cyril/0000-0003-3166-3141; OZTURK, MEHMET/0000-0002-6092-9706; PUISIEUX, Alain/0000-0002-9938-3798; Pain, Bertrand/0000-0002-1210-8444				AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; ALONIGRINSTEIN R, 1995, EMBO J, V14, P1392, DOI 10.1002/j.1460-2075.1995.tb07125.x; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BARTEK J, 1990, ONCOGENE, V5, P893; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; CASEY G, 1991, ONCOGENE, V6, P1791; CHEN LC, 1989, P NATL ACAD SCI USA, V86, P7204, DOI 10.1073/pnas.86.18.7204; CHERIFF D, 1990, P NATL ACAD SCI USA, V87, P8639; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; FREBOURG T, 1992, CANCER RES, V52, P6976; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HENSLER PJ, 1994, MOL CELL BIOL, V14, P2291, DOI 10.1128/MCB.14.4.2291; KASTAN MB, 1991, CANCER RES, V51, P6304; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; MATHEWS CG, 1987, NATURE, V325, P524; MATSUDA A, 1996, ONCOGENE, V12, P705; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MIYASHITA T, 1994, CANCER RES, V54, P3131; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; PARASKEVA C, 1988, INT J CANCER, V41, P908; POWELL SN, 1995, CANCER RES, V55, P1643; PUISIEUX A, 1993, FASEB J, V7, P1407, DOI 10.1096/fasebj.7.14.8224613; RAO PN, 1979, EFFECTS DRUGS CELL N, P475; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; SAVATIER P, 1994, ONCOGENE, V9, P809; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; STEWART N, 1995, ONCOGENE, V10, P109; TAKAHASHI K, 1993, MOL CARCINOGEN, V8, P58, DOI 10.1002/mc.2940080112; VARNUM BC, 1994, J CELL PHYSIOL, V158, P205, DOI 10.1002/jcp.1041580125; VIKHANSKAYA F, 1994, NUCLEIC ACIDS RES, V22, P1012, DOI 10.1093/nar/22.6.1012; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WALDMAN T, 1995, CANCER RES, V55, P5187; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120	44	344	359	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1996	14	4					482	486		10.1038/ng1296-482	http://dx.doi.org/10.1038/ng1296-482			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VV730	8944033	Green Published			2022-12-17	WOS:A1996VV73000029
J	KENNEDY, GC; GERMAN, MS; RUTTER, WJ				KENNEDY, GC; GERMAN, MS; RUTTER, WJ			THE MINISATELLITE IN THE DIABETES SUSCEPTIBILITY LOCUS IDDM2 REGULATES INSULIN TRANSCRIPTION	NATURE GENETICS			English	Article							POLYMORPHIC REGION ADOPTS; HLA-DR; GENETIC-ANALYSIS; BINDING-PROTEIN; DNA; MELLITUS; EXPRESSION; SEQUENCES; CELLS; INDIVIDUALS	Genetic susceptibility to insulin-dependent diabetes mellitus (IDDM) is inherited as a polygenic trait. One of the loci implicated in IDDM is a polymorphic minisatellite 5' of the human insulin (INS) gene on chromosome 11. This insulin-linked polymorphic region (ILPR) is composed of tandemly repeated sequences, which fall into three size classes: IDDM is strongly associated with short ILPR alleles. We now show that the ILPR is capable of transducing a transcriptional signal in pancreatic beta-cells, with a long ILPR possessing greater activity than a short ILPR. The ILPR contains numerous high-affinity binding sites for the transcription factor Pur-1, and transcriptional activation by Pur-1 is modulated by naturally occurring sequences in the ILPR. Our results demonstrate a possible function for this unique minisatellite, which may have implications for type 1 diabetes.	UNIV CALIF SAN FRANCISCO,HORMONE RES INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021344] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK021344] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; COLLICK A, 1991, NUCLEIC ACIDS RES, V19, P6399, DOI 10.1093/nar/19.23.6399; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DAVIES K, 1993, NATURE, V364, P88, DOI 10.1038/364088a0; GERMAN MS, 1990, J BIOL CHEM, V265, P22063; HAMMONDKOSACK MCU, 1993, J MOL ENDOCRINOL, V10, P121, DOI 10.1677/jme.0.0100121; HAMMONDKOSACK MCU, 1992, FEBS LETT, V301, P79, DOI 10.1016/0014-5793(92)80214-2; HAMMONDKOSACK MCU, 1992, NUCLEIC ACIDS RES, V20, P231, DOI 10.1093/nar/20.2.231; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KENNEDY GC, 1993, BIOCHEM SOC T, V21, P178, DOI 10.1042/bst0210178; KENNEDY GC, 1992, P NATL ACAD SCI USA, V89, P11498, DOI 10.1073/pnas.89.23.11498; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; MADDOX J, 1994, NATURE, V368, P685, DOI 10.1038/368685a0; MADSEN OD, 1991, MOL ENDOCRINOL, V5, P143, DOI 10.1210/mend-5-1-143; OWERBACH D, 1993, DIABETES, V42, P1708, DOI 10.2337/diabetes.42.12.1708; OWERBACH D, 1989, DIABETES, V38, P942, DOI 10.2337/diabetes.38.7.942; OWERBACH D, 1983, NATURE, V303, P815, DOI 10.1038/303815a0; OWERBACH D, 1984, GENE, V32, P475, DOI 10.1016/0378-1119(84)90021-0; OWERBACH D, 1988, DIABETOLOGIA, V31, P751, DOI 10.1007/BF00274778; PLATZ P, 1981, DIABETOLOGIA, V21, P108; ROTWEIN P, 1986, AM J HUM GENET, V39, P291; SEINO S, 1992, MOL BIOL EVOL, V9, P193; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; TAUTZ D, 1993, EXS, V67, P21; THOMSON G, 1988, AM J HUM GENET, V43, P799; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TREPICCHIO WL, 1992, NUCLEIC ACIDS RES, V20, P2427, DOI 10.1093/nar/20.10.2427; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U; WAHLS WP, 1991, NUCLEIC ACIDS RES, V19, P3269, DOI 10.1093/nar/19.12.3269; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; YAMAZAKI H, 1992, J BIOL CHEM, V267, P12311	37	344	350	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					293	298		10.1038/ng0395-293	http://dx.doi.org/10.1038/ng0395-293			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773292				2022-12-17	WOS:A1995QL23200020
J	Moore, JW; Herrera-Foessel, S; Lan, CX; Schnippenkoetter, W; Ayliffe, M; Huerta-Espino, J; Lillemo, M; Viccars, L; Milne, R; Periyannan, S; Kong, XY; Spielmeyer, W; Talbot, M; Bariana, H; Patrick, JW; Dodds, P; Singh, R; Lagudah, E				Moore, John W.; Herrera-Foessel, Sybil; Lan, Caixia; Schnippenkoetter, Wendelin; Ayliffe, Michael; Huerta-Espino, Julio; Lillemo, Morten; Viccars, Libby; Milne, Ricky; Periyannan, Sambasivam; Kong, Xiuying; Spielmeyer, Wolfgang; Talbot, Mark; Bariana, Harbans; Patrick, John W.; Dodds, Peter; Singh, Ravi; Lagudah, Evans			A recently evolved hexose transporter variant confers resistance to multiple pathogens in wheat	NATURE GENETICS			English	Article							ADULT-PLANT RESISTANCE; LEAF RUST RESISTANCE; STRIPE RUST; POWDERY MILDEW; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; DURABLE RESISTANCE; FUNGAL PATHOGENS; AESTIVUM L.; STEM RUST	As there are numerous pathogen species that cause disease and limit yields of crops, such as wheat (Triticum aestivum), single genes that provide resistance to multiple pathogens are valuable in crop improvement(1,2). The mechanistic basis of multi-pathogen resistance is largely unknown. Here we use comparative genomics, mutagenesis and transformation to isolate the wheat Lr67 gene, which confers partial resistance to all three wheat rust pathogen species and powdery mildew. The Lr67 resistance gene encodes a predicted hexose transporter (LR67res) that differs from the susceptible form of the same protein (LR67sus) by two amino acids that are conserved in orthologous hexose transporters. Sugar uptake assays show that LR67sus, and related proteins encoded by homeoalleles, function as high-affinity glucose transporters. LR67res exerts a dominant-negative effect through heterodimerization with these functional transporters to reduce glucose uptake. Alterations in hexose transport in infected leaves may explain its ability to reduce the growth of multiple biotrophic pathogen species.	[Moore, John W.; Schnippenkoetter, Wendelin; Ayliffe, Michael; Viccars, Libby; Milne, Ricky; Periyannan, Sambasivam; Spielmeyer, Wolfgang; Talbot, Mark; Dodds, Peter; Lagudah, Evans] Commonwealth Sci & Ind Res Org CSIRO Agr, Canberra, ACT, Australia; [Herrera-Foessel, Sybil; Lan, Caixia; Singh, Ravi] Int Maize & Wheat Improvement Ctr CIMMYT, Mexico City, DF, Mexico; [Huerta-Espino, Julio] Campo Expt Valle Mexico INIFAP, Chapingo, Edo De Mexico, Mexico; [Lillemo, Morten] Norwegian Univ Life Sci, Dept Plant Sci, As, Norway; [Kong, Xiuying] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Bariana, Harbans] Univ Sydney, Plant Breeding Inst Cobbitty, Narellan, Australia; [Patrick, John W.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Norwegian University of Life Sciences; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; University of Sydney; University of Newcastle	Lagudah, E (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Agr, Canberra, ACT, Australia.	evans.lagudah@csiro.au	Spielmeyer, Wolfgang/M-3254-2018; Milne, Ricky J/C-3386-2016; Periyannan, Sambasivam/C-1722-2014; Ayliffe, Michael A/A-2089-2010; Huerta-Espino, Julio JH/N-9840-2018; Lagudah, Evans/A-2007-2010; Huerta-Espino, Julio/E-7345-2010; Lillemo, Morten/H-9406-2019; Singh, Ravi Prakash/I-5575-2019; Dodds, Peter/D-1181-2009	Spielmeyer, Wolfgang/0000-0002-5115-7820; Milne, Ricky J/0000-0002-9792-4175; Periyannan, Sambasivam/0000-0002-5421-2872; Huerta-Espino, Julio JH/0000-0001-8334-9862; Lagudah, Evans/0000-0002-6234-1789; Huerta-Espino, Julio/0000-0001-8334-9862; Lillemo, Morten/0000-0002-8594-8794; Patrick, John/0000-0003-0964-9327; Schnippenkoetter, Wendelin/0000-0003-4120-4379; Dodds, Peter/0000-0003-0620-5923	Grains Research and Development Corporation, Australia [CSP00161, CSP00164]; Office of the Chief Executive (OCE) Post Doctoral Fellowship of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia	Grains Research and Development Corporation, Australia(Grains R&D Corp); Office of the Chief Executive (OCE) Post Doctoral Fellowship of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia	This work was supported by funds provided through Grains Research and Development Corporation (CSP00161, CSP00164), Australia, and the Office of the Chief Executive (OCE) Post Doctoral Fellowship of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia. We are grateful to S. Chandramohan, V. Calvo-Salazar, T. Richardson, H. Miah and X. Xia for technical assistance. We thank A. Ashton, I. Dry, P. Ryan and A. Rae for helpful discussions.	Ayliffe M, 2013, MOL PLANT MICROBE IN, V26, P658, DOI 10.1094/MPMI-12-12-0291-R; Buttner M, 2010, PLANT BIOLOGY, V12, P35, DOI 10.1111/j.1438-8677.2010.00383.x; CGIAR Research Program on Wheat, 2014, WHEAT CRP ANN REP 20; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; DYCK PL, 1979, CAN J PLANT SCI, V59, P329, DOI 10.4141/cjps79-053; DYCK PL, 1994, GENOME, V37, P556, DOI 10.1139/g94-079; Ellis JG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00641; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gou JY, 2015, PLANT CELL, V27, P1755, DOI 10.1105/tpc.114.134296; Hayes MA, 2007, J EXP BOT, V58, P1985, DOI 10.1093/jxb/erm061; Hayes MA, 2010, PLANT PHYSIOL, V153, P211, DOI 10.1104/pp.110.154765; Herrera-Foessel SA, 2014, THEOR APPL GENET, V127, P781, DOI 10.1007/s00122-013-2256-9; Herrera-Foessel SA, 2011, THEOR APPL GENET, V122, P239, DOI 10.1007/s00122-010-1439-x; Hiebert CW, 2010, THEOR APPL GENET, V121, P1083, DOI 10.1007/s00122-010-1373-y; Hulbert S, 2014, MOL PLANT MICROBE IN, V27, P207, DOI 10.1094/MPMI-09-13-0295-FI; Ishida Y, 2015, METHODS MOL BIOL, V1223, P189, DOI 10.1007/978-1-4939-1695-5_15; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Kolmer JA, 2008, CROP SCI, V48, P1841, DOI 10.2135/cropsci2007.08.0474; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lagudah ES, 2009, THEOR APPL GENET, V119, P889, DOI 10.1007/s00122-009-1097-z; LEMOINE R, 1987, PHYSIOL PLANTARUM, V69, P639, DOI 10.1111/j.1399-3054.1987.tb01978.x; Lemonnier P, 2014, PLANT MOL BIOL, V85, P473, DOI 10.1007/s11103-014-0198-5; Liesche J, 2011, J PLANT PHYSIOL, V168, P1426, DOI 10.1016/j.jplph.2011.02.005; McCurdy DW, 2010, MOL PLANT, V3, P1049, DOI 10.1093/mp/ssq050; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Norholm MHH, 2006, FEBS LETT, V580, P2381, DOI 10.1016/j.febslet.2006.03.064; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Panstruga R, 2005, BIOCHEM SOC T, V33, P389, DOI 10.1042/BST0330389; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Proels RK, 2014, MOL PLANT PATHOL, V15, P858, DOI 10.1111/mpp.12139; Richardson T, 2014, PLANT CELL TISS ORG, V119, P647, DOI 10.1007/s11240-014-0564-7; Risk JM, 2012, PLANT BIOTECHNOL J, V10, P477, DOI 10.1111/j.1467-7652.2012.00683.x; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sonnewald S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051763; Spielmeyer W, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-96; Stodart BJ, 2007, GENET RESOUR CROP EV, V54, P759, DOI 10.1007/s10722-006-9150-0; Tingay S, 1997, PLANT J, V11, P1369, DOI 10.1046/j.1365-313X.1997.11061369.x; Wang MB, 1998, ACTA HORTIC, P401, DOI 10.17660/ActaHortic.1998.461.46; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110	45	343	363	15	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1494	1498		10.1038/ng.3439	http://dx.doi.org/10.1038/ng.3439			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26551671				2022-12-17	WOS:000365813200024
J	Levitus, M; Waisfisz, Q; Godthelp, BC; de Vries, Y; Hussain, S; Wiegant, WW; Elghalbzouri-Maghrani, E; Steltenpool, J; Rooimans, MA; Pals, G; Arwert, F; Mathew, CG; Zdzienicka, MZ; Hiom, K; De Winter, JP; Joenje, H				Levitus, M; Waisfisz, Q; Godthelp, BC; de Vries, Y; Hussain, S; Wiegant, WW; Elghalbzouri-Maghrani, E; Steltenpool, J; Rooimans, MA; Pals, G; Arwert, F; Mathew, CG; Zdzienicka, MZ; Hiom, K; De Winter, JP; Joenje, H			The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J	NATURE GENETICS			English	Article							PROTEIN; BACH1	The protein predicted to be defective in individuals with Fanconi anemia complementation group J ( FA- J), FANCJ, is a missing component in the Fanconi anemia pathway of genome maintenance. Here we identify pathogenic mutations in eight individuals with FA- J in the gene encoding the DEAH- box DNA helicase BRIP1, also called FANCJ. This finding is compelling evidence that the Fanconi anemia pathway functions through a direct physical interaction with DNA.	Vrije Univ Amsterdam Med Ctr, Dept Clin Genet & Human Genet, NL-1081 BT Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Toxicogenet, NL-2333 AL Leiden, Netherlands; Kings Coll London, Guys Hosp, Div Med & Mol Genet, London, England; Nicholas Copernicus Univ, Coll Med L Rydygier, Dept Mol Cell Genet, Bydgoszcz, Poland; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Nicolaus Copernicus University; MRC Laboratory Molecular Biology	Joenje, H (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet & Human Genet, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	joenje@vumc.nl	Hiom, Kevin/B-4374-2009; Mathew, Christopher G/G-3434-2015	Mathew, Christopher G/0000-0003-4178-1838; Pals, Gerard/0000-0003-4091-7115; Waisfisz, Quinten/0000-0002-7384-9182				Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Doherty AMO, 2003, MAMM GENOME, V14, P583, DOI 10.1007/s00335-003-4002-0; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Risinger MA, 2004, CANCER CELL, V6, P539, DOI 10.1016/j.ccr.2004.12.001; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	10	343	353	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					934	935		10.1038/ng1625	http://dx.doi.org/10.1038/ng1625			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16116423				2022-12-17	WOS:000231591900016
J	Bulavin, DV; Phillips, C; Nannenga, B; Timofeev, O; Donehower, LA; Anderson, CW; Appella, E; Fornace, AJ				Bulavin, DV; Phillips, C; Nannenga, B; Timofeev, O; Donehower, LA; Anderson, CW; Appella, E; Fornace, AJ			Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway	NATURE GENETICS			English	Article							CYCLIN D1; TRANSGENIC MICE; GENE PROMOTER; AMPLIFICATION; EXPRESSION; PPM1D; PHOSPHORYLATION; METHYLATION; APOPTOSIS; P53	Modulation of tumor suppressor activities may provide new opportunities for cancer therapy. Here we show that disruption of the gene Ppm1d encoding Wip1 phosphatase activated the p53 and p16 ( also called Ink4a) p19 ( also called ARF) pathways through p38 MAPK signaling and suppressed in vitro transformation of mouse embryo fibroblasts ( MEFs) by oncogenes. Disruption of the gene Cdkn2a ( encoding p16 and p19), but not of Trp53 ( encoding p53), reconstituted cell transformation in Ppm1d - null MEFs. In vivo, deletion of Ppm1d in mice bearing mouse mammary tumor virus ( MMTV) promoter driven oncogenes Erbb2 ( also called c - neu) or Hras1 impaired mammary carcinogenesis, whereas reduced expression of p16 and p19 by methylation-induced silencing or inactivation of p38 MAPK correlated with tumor appearance. We conclude that inactivation or depletion of the Wip1 phosphatase with resultant p38 MAPK activation suppresses tumor appearance by modulating the Cdkn2a tumor-suppressor locus.	NCI, Gene Response Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine; Baylor College of Medicine; United States Department of Energy (DOE); Brookhaven National Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bulavin, DV (corresponding author), NCI, Gene Response Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	bulavin@nih.gov	Fornace, Albert J/A-7407-2008	Fornace, Albert J/0000-0001-9695-085X; Timofeev, Oleg/0000-0002-3114-6403; Dudgeon, Crissy/0000-0001-9010-2569	DIVISION OF BASIC SCIENCES - NCI [Z01BC007184] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC005599, Z01BC005599] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; Bowe DB, 2002, ONCOGENE, V21, P291, DOI 10.1038/sj/onc/1205025; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Bulavin DV, 1999, ONCOGENE, V18, P5611, DOI 10.1038/sj.onc.1202945; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Choi J, 2000, GENOMICS, V64, P298, DOI 10.1006/geno.2000.6134; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; DICKINSON AJ, 1990, OPHTHALMIC PAED GEN, V11, P1, DOI 10.3109/13816819009012942; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; GILLETT C, 1994, CANCER RES, V54, P1812; Goloudina A, 2003, CELL CYCLE, V2, P473, DOI 10.4161/cc.2.5.482; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Koch-Paiz CA, 2000, BIOTECHNIQUES, V29, P706, DOI 10.2144/00294bm07; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nielsen NH, 2001, CANCER LETT, V163, P59, DOI 10.1016/S0304-3835(00)00674-1; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zhang SL, 2003, ONCOGENE, V22, P2285, DOI 10.1038/sj.onc.1206257	38	343	360	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					343	350		10.1038/ng1317	http://dx.doi.org/10.1038/ng1317			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	14991053	Bronze			2022-12-17	WOS:000220647200017
J	Moreira, MC; Klur, S; Watanabe, M; Nemeth, AH; Le Ber, I; Moniz, JC; Tranchant, C; Aubourg, P; Tazir, M; Schols, L; Pandolfo, M; Schulz, JB; Pouget, J; Calvas, P; Shizuka-Ikeda, M; Shoji, M; Tanaka, M; Izatt, L; Shaw, CE; M'Zahem, A; Dunne, E; Bomont, P; Benhassine, T; Bouslam, N; Stevanin, G; Brice, A; Guimaraes, J; Mendonca, P; Barbot, C; Coutinho, P; Sequeiros, J; Durr, A; Warter, JM; Koenig, M				Moreira, MC; Klur, S; Watanabe, M; Nemeth, AH; Le Ber, I; Moniz, JC; Tranchant, C; Aubourg, P; Tazir, M; Schols, L; Pandolfo, M; Schulz, JB; Pouget, J; Calvas, P; Shizuka-Ikeda, M; Shoji, M; Tanaka, M; Izatt, L; Shaw, CE; M'Zahem, A; Dunne, E; Bomont, P; Benhassine, T; Bouslam, N; Stevanin, G; Brice, A; Guimaraes, J; Mendonca, P; Barbot, C; Coutinho, P; Sequeiros, J; Durr, A; Warter, JM; Koenig, M			Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2	NATURE GENETICS			English	Article							SPINOCEREBELLAR ATAXIA; PERIPHERAL NEUROPATHY; CEREBELLAR ATROPHY; GENE; DNA; ENCODES; SEN1	Ataxia-ocular apraxia 2 (AOA2) was recently identified as a new autosomal recessive ataxia. We have now identified causative mutations in 15 families, which allows us to clinically define this entity by onset between 10 and 22 years, cerebellar atrophy, axonal sensorimotor neuropathy, oculomotor apraxia and elevated alpha-fetoprotein (AFP). Ten of the fifteen mutations cause premature termination of a large DEAxQ-box helicase, the human ortholog of yeast Sen1p, involved in RNA maturation and termination.	ULP, CNRS, INSERM, IGBMC, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France; Gunma Univ, Sch Med, Maebashi, Gumma 3718511, Japan; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Hop La Pitie Salpetriere, APHP, INSERM, U289, F-75651 Paris, France; Hop La Pitie Salpetriere, APHP, Dept Genet Cytogenet & Embryol, F-75651 Paris, France; Hosp Sto Antonio dos Capuchos, Lisbon, Portugal; Hop Univ Strasbourg, F-67091 Strasbourg, France; Hop St Vincent de Paul, INSERM, U342, F-75675 Paris, France; Ctr Hosp Univ Algier, Algiers, Algeria; Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany; Free Univ Brussels, Hop Erasme, B-1070 Brussels, Belgium; Univ Tubingen, Ctr Neurol, Dept Gen Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; Hop Timone Adults, F-13385 Marseille, France; Hop Purpan, F-31059 Toulouse, France; Guys Hosp, Dept Clin Genet, London SE1 9RT, England; Univ London Kings Coll, Inst Psychiat, London SE5 8AF, England; Guys Kings & St Thomas Sch Med, London SE5 8AF, England; Ctr Hosp Univ Ben Badis, Constantine, Algeria; Inst Pasteur Alger, Algiers, Algeria; Hosp Egas Moniz, Lisbon, Portugal; Hosp Divino Espirito Santo, Dept Hematol, Azores, Portugal; Univ Porto, UnIGENe, IBMC, ICBAS, P-4150180 Oporto, Portugal; Hosp Maria Pia, Dept Neuropediat, P-4050 Oporto, Portugal; Hosp Sao Sebastiao, Dept Neurol, P-4520 Sta Maria Da Feira, Portugal	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Gunma University; University of Oxford; Wellcome Centre for Human Genetics; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ruhr University Bochum; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de Toulouse; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Egas Moniz Hospital; Universidade do Porto	Koenig, M (corresponding author), ULP, CNRS, INSERM, IGBMC, F-67404 Illkirch Graffenstaden, Cu Strasbourg, France.	mkoenig@igbmc.u-strasbg.fr	Dunne, Eimear/AGX-1949-2022; Brice, Alexis/A-2170-2009; Pandolfo, Massimo/B-2853-2010; Coutinho, Paula/K-6053-2013; Schöls, Ludger/ABB-2482-2021; Lima, Marta T/C-7042-2009; brice, alexis/AAE-8275-2019; Stevanin, Giovanni/E-5038-2016; Bomont, Pascale/GLS-8721-2022; Schulz, Jörg B/D-9786-2012; Barbot, Clara/K-6378-2013; Dunne, Eimear/C-6785-2012; Bomont, Pascale L/Y-5517-2018	Dunne, Eimear/0000-0001-9862-1398; Schöls, Ludger/0000-0001-7774-5025; brice, alexis/0000-0002-0941-3990; Stevanin, Giovanni/0000-0001-9368-8657; Bomont, Pascale/0000-0001-7216-3261; Schulz, Jörg B/0000-0002-8903-0593; Barbot, Clara/0000-0002-5597-107X; Dunne, Eimear/0000-0001-9862-1398; Bomont, Pascale L/0000-0001-7216-3261; Sequeiros, Jorge/0000-0002-9846-1037; Shoji, Mikio/0000-0003-1027-1712; tranchant, christine/0000-0002-2895-1292; Franco Mendonca, Pedro/0000-0002-3850-2909; Coutinho, Paula/0000-0002-3461-230X; Nemeth, Andrea/0000-0002-2941-7657				Bomont P, 2000, EUR J HUM GENET, V8, P986, DOI 10.1038/sj.ejhg.5200586; Cox GA, 1998, NEURON, V21, P1327, DOI 10.1016/S0896-6273(00)80652-2; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; MIZUTA TR, 1993, NUCLEIC ACIDS RES, V21, P1761, DOI 10.1093/nar/21.8.1761; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Nemeth AH, 2000, AM J HUM GENET, V67, P1320, DOI 10.1016/S0002-9297(07)62962-0; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Watanabe M, 1998, ANN NEUROL, V44, P265, DOI 10.1002/ana.410440220	15	343	355	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					225	227		10.1038/ng1303	http://dx.doi.org/10.1038/ng1303			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14770181	Green Published, Bronze			2022-12-17	WOS:000189250400008
J	Nishimura, DY; Swiderski, RE; Alward, WLM; Searby, CC; Patil, SR; Bennet, SR; Kanis, AB; Gastier, JM; Stone, EM; Sheffield, VC				Nishimura, DY; Swiderski, RE; Alward, WLM; Searby, CC; Patil, SR; Bennet, SR; Kanis, AB; Gastier, JM; Stone, EM; Sheffield, VC			The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25	NATURE GENETICS			English	Article							OPEN-ANGLE GLAUCOMA; PROTEIN-CODING REGIONS; HUMAN PAX6 GENE; RIEGER SYNDROME; 2ND LOCUS; DNA; ANIRIDIA; POLYSACCHARIDE; LOCALIZATION; TRANSLATION	A number of different eye disorders with the presence of early-onset glaucoma as a component of the phenotype have been mapped to human chromosome 6p25. These disorders have been postulated to be either allelic to each other or associated with a cluster of tightly linked genes. We have identified two primary congenital glaucoma (PCC) patients with chromosomal anomalies involving 6p25. In order to identify a gene involved in PCG, the chromosomal breakpoints in a patient with a balanced translocation between 6p25 and 13q22 were cloned. Cloning of the 6p25 breakpoint led to the identification of two candidate genes based on proximity to the breakpoint. One of these, FKHL7, encoding a forkhead transcription factor, is in close proximity to the breakpoint in the balanced translocation patient and is deleted in a second PCC patient with partial 6p monosomy. Furthermore, FKHL7 was found to harbour mutations in patients diagnosed with Rieger anomaly (RA), Axenfeld anomaly (AA) and iris hypoplasia (IH). This study demonstrates that mutations in FKHL7 cause a spectrum of glaucoma phenotypes.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Dept Ophthalmol, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Stanford Univ, Med Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA; VitreoRetinal Surg, Minneapolis, MN 55435 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; Stanford University	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu	Alward, Wallace/AAY-4149-2020	Alward, Wallace/0000-0001-6368-9018; Stone, Edwin M./0000-0003-3343-4414; Sheffield, Val/0000-0002-6282-0835	NEI NIH HHS [R01-EY-10564] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010564] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akarsu AN, 1996, HUM MOL GENET, V5, P1199, DOI 10.1093/hmg/5.8.1199; ALTSCHUL SF, 1990, J MOL BIOL, V215, P40; Alward WLM, 1998, AM J OPHTHALMOL, V125, P98, DOI 10.1016/S0002-9394(99)80242-6; Alward WLM, 1996, J GLAUCOMA, V5, P276; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; CURRIE HL, 1995, CLIN DIAGN LAB IMMUN, V2, P554, DOI 10.1128/CDLI.2.5.554-562.1995; DORIN JR, 1992, HUM MOL GENET, V1, P53, DOI 10.1093/hmg/1.1.53; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Gould DB, 1997, AM J HUM GENET, V61, P765; Graff C, 1997, HUM GENET, V101, P130, DOI 10.1007/s004390050601; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Jordan T, 1997, AM J HUM GENET, V61, P882, DOI 10.1086/514874; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; LAITINEN J, 1994, BIOTECHNIQUES, V17, P316; Larsson C, 1995, GENOMICS, V30, P464, DOI 10.1006/geno.1995.1266; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; LI Y, 1995, VIROLOGY, V212, P134, DOI 10.1006/viro.1995.1462; Mears AJ, 1996, AM J HUM GENET, V59, P1321; Milot E, 1996, TRENDS GENET, V12, P123, DOI 10.1016/0168-9525(96)30019-X; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; NUSSBAUM RL, 1983, HUM GENET, V64, P148, DOI 10.1007/BF00327113; Phillips JC, 1996, AM J HUM GENET, V59, P613; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; PUCK JM, 1987, J CLIN INVEST, V79, P1395, DOI 10.1172/JCI112967; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stoilova D, 1996, GENOMICS, V36, P142, DOI 10.1006/geno.1996.0434; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Wirtz MK, 1997, AM J HUM GENET, V60, P296; Xu Y, 1994, Genet Eng (N Y), V16, P241	43	343	363	1	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1998	19	2					140	147		10.1038/493	http://dx.doi.org/10.1038/493			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620769				2022-12-17	WOS:000073865100020
J	JOUET, M; ROSENTHAL, A; ARMSTRONG, G; MACFARLANE, J; STEVENSON, R; PATERSON, J; METZENBERG, A; IONASESCU, V; TEMPLE, K; KENWRICK, S				JOUET, M; ROSENTHAL, A; ARMSTRONG, G; MACFARLANE, J; STEVENSON, R; PATERSON, J; METZENBERG, A; IONASESCU, V; TEMPLE, K; KENWRICK, S			X-LINKED SPASTIC PARAPLEGIA (SPG1), MASA SYNDROME AND X-LINKED HYDROCEPHALUS RESULT FROM MUTATIONS IN THE L1 GENE	NATURE GENETICS			English	Article							ADHESION MOLECULE L1; MENTAL-RETARDATION; NEURITE OUTGROWTH; LINKAGE ANALYSIS; IMMUNOGLOBULIN SUPERFAMILY; DNA PROBES; XQ28; LOCALIZATION; DOMAINS; GROWTH	X-linked hydrocephalus, spastic paraplegia type I and MASA syndrome are related disorders with loci in subchromosomal region Xq28. We have previously shown that X-linked hydrocephalus is caused by mutations in the gene for neural cell adhesion molecule L1 (L1CAM), an axonal glycoprotein involved in neuronal migration and differentiation. Here we report mutations of the L1 gene in MASA syndrome and SPG1, in addition to HSAS families. Two of the HSAS mutations would abolish cell surface expression of L1 and represent the first functional null mutations in this disorder. Our results indicate that these three syndromes form part of a clinical spectrum resulting from a heterogeneous group of mutations in the L1 gene.	UNIV CAMBRIDGE,ADDENBROOKES HOSP,DEPT MED,CAMBRIDGE CB2 2QQ,CAMBS,ENGLAND; INST MOLEK BIOTECHNOL,JENA,GERMANY; GREENWOOD GENET CTR,GREENWOOD,SC 29646; DUNCAN GUTHRIE INST MED GENET,GLASGOW G3 8SJ,SCOTLAND; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV IOWA HOSP & CLIN,DEPT PEDIAT,IOWA CITY,IA 52242; PRINCESS ANNE HOSP,SOUTHAMPTON,HANTS,ENGLAND	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Greenwood Genetic Center; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Iowa								APPEL F, 1993, J NEUROSCI, V13, P4764; ATASHI JR, 1992, NEURON, V8, P831, DOI 10.1016/0896-6273(92)90197-L; BATCH JA, 1992, HUM MOL GENET, V1, P497, DOI 10.1093/hmg/1.7.497; BIANCHINE JW, 1974, CLIN GENET, V5, P298; BICKERS DS, 1949, BRAIN, V72, P246, DOI 10.1093/brain/72.2.246; Boyd E, 1993, Clin Dysmorphol, V2, P332; EDWARDS JH, 1961, ARCH DIS CHILD, V36, P481, DOI 10.1136/adc.36.189.481; FRYNS JP, 1991, J MED GENET, V28, P429, DOI 10.1136/jmg.28.6.429-a; GAREIS FJ, 1984, AM J MED GENET, V17, P333, DOI 10.1002/ajmg.1320170126; Grumet M, 1991, Curr Opin Neurobiol, V1, P370, DOI 10.1016/0959-4388(91)90055-C; GUTMANN DH, 1990, AM J HUM GENET, V365, P251; HALLIDAY J, 1986, J MED GENET, V23, P23, DOI 10.1136/jmg.23.1.23; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; JOOSTEN EAJ, 1989, NEUROSCI LETT, V100, P94, DOI 10.1016/0304-3940(89)90666-6; JOUET M, 1993, J MED GENET, V30, P214, DOI 10.1136/jmg.30.3.214; JOUET M, 1993, NAT GENET, V4, P331, DOI 10.1038/ng0893-331; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; Krook Anna, 1992, Human Molecular Genetics, V1, P391, DOI 10.1093/hmg/1.6.391; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LYONNET S, 1992, GENOMICS, V14, P508, DOI 10.1016/S0888-7543(05)80254-X; MACIAS VR, 1992, AM J MED GENET, V43, P408, DOI 10.1002/ajmg.1320430162; MIURA M, 1991, FEBS LETT, V289, P91, DOI 10.1016/0014-5793(91)80915-P; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; REID RA, 1992, J MOL NEUROSCI, V3, P127, DOI 10.1007/BF02919404; RIETSCHEL M, 1991, AM J MED GENET, V41, P10, DOI 10.1002/ajmg.1320410104; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; Rutishauser U, 1989, CURR OPIN CELL BIOL, V1, P898, DOI 10.1016/0955-0674(89)90056-2; SADOUL R, 1989, J NEUROCHEM, V53, P1471, DOI 10.1111/j.1471-4159.1989.tb08540.x; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; SCHRANDERSTUMPEL C, 1990, J MED GENET, V27, P688, DOI 10.1136/jmg.27.11.688; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SONDEREGGER P, 1992, J CELL BIOL, V119, P1387, DOI 10.1083/jcb.119.6.1387; STRAIN L, 1994, AM J HUM GENET, V54, P236; VANCAMP G, 1993, NAT GENET, V4, P421; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5; WILLEMS PJ, 1987, AM J MED GENET, V27, P921, DOI 10.1002/ajmg.1320270419; WILLEMS PJ, 1992, AM J HUM GENET, V51, P307; WILLEMS PJ, 1990, GENOMICS, V8, P367, DOI 10.1016/0888-7543(90)90294-5; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; WINTER RM, 1989, HUM GENET, V82, P367; YEATMAN GW, 1984, AM J MED GENET, V17, P339, DOI 10.1002/ajmg.1320170127	43	343	354	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					402	407		10.1038/ng0794-402	http://dx.doi.org/10.1038/ng0794-402			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920659				2022-12-17	WOS:A1994NU30600015
J	Pasquali, L; Gaulton, KJ; Rodriguez-Segui, SA; Mularoni, L; Miguel-Escalada, I; Akerman, I; Tena, JJ; Moran, I; Gomez-Marin, C; van de Bunt, M; Ponsa-Cobas, J; Castro, N; Nammo, T; Cebola, I; Garcia-Hurtado, J; Maestro, MA; Pattou, F; Piemonti, L; Berney, T; Gloyn, AL; Ravassard, P; Gomez-Skarmeta, JL; Muller, F; McCarthy, MI; Ferrer, J				Pasquali, Lorenzo; Gaulton, Kyle J.; Rodriguez-Segui, Santiago A.; Mularoni, Loris; Miguel-Escalada, Irene; Akerman, Ildem; Tena, Juan J.; Moran, Ignasi; Gomez-Marin, Carlos; van de Bunt, Martijn; Ponsa-Cobas, Joan; Castro, Natalia; Nammo, Takao; Cebola, Ines; Garcia-Hurtado, Javier; Angel Maestro, Miguel; Pattou, Francois; Piemonti, Lorenzo; Berney, Thierry; Gloyn, Anna L.; Ravassard, Philippe; Luis Gomez-Skarmeta, Jose; Mueller, Ferenc; McCarthy, Mark I.; Ferrer, Jorge			Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants	NATURE GENETICS			English	Article							BETA-CELL; TRANSCRIPTION FACTORS; HISTONE MODIFICATIONS; PROVIDES INSIGHTS; GENE; CHROMATIN; GENOME; EXPRESSION; GLUCOSE; LIVER	Type 2 diabetes affects over 300 million people, causing severe complications and premature death, yet the underlying molecular mechanisms are largely unknown. Pancreatic islet dysfunction is central in type 2 diabetes pathogenesis, and understanding islet genome regulation could therefore provide valuable mechanistic insights. We have now mapped and examined the function of human islet cis-regulatory networks. We identify genomic sequences that are targeted by islet transcription factors to drive islet-specific gene activity and show that most such sequences reside in clusters of enhancers that form physical three-dimensional chromatin domains. We find that sequence variants associated with type 2 diabetes and fasting glycemia are enriched in these clustered islet enhancers and identify trait-associated variants that disrupt DNA binding and islet enhancer activity. Our studies illustrate how islet transcription factors interact functionally with the epigenome and provide systematic evidence that the dysregulation of islet enhancers is relevant to the mechanisms underlying type 2 diabetes.	[Pasquali, Lorenzo; Rodriguez-Segui, Santiago A.; Mularoni, Loris; Akerman, Ildem; Castro, Natalia; Nammo, Takao; Garcia-Hurtado, Javier; Angel Maestro, Miguel; Ferrer, Jorge] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Genom Programming Beta Cells Lab, Barcelona, Spain; [Pasquali, Lorenzo; Mularoni, Loris; Akerman, Ildem; Castro, Natalia; Garcia-Hurtado, Javier; Angel Maestro, Miguel; Ferrer, Jorge] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain; [Gaulton, Kyle J.; van de Bunt, Martijn; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Gaulton, Kyle J.; van de Bunt, Martijn; Gloyn, Anna L.; McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Gaulton, Kyle J.; van de Bunt, Martijn; Gloyn, Anna L.; McCarthy, Mark I.] Churchill Hosp, Biomed Res Ctr, Oxford Natl Inst Hlth Res NIHR, Oxford OX3 7LJ, England; [Miguel-Escalada, Irene; Mueller, Ferenc] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Tena, Juan J.; Gomez-Marin, Carlos; Luis Gomez-Skarmeta, Jose] Univ Pablo Olavide Junta Andalucia, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain; [Moran, Ignasi; Ponsa-Cobas, Joan; Cebola, Ines; Ferrer, Jorge] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Pattou, Francois] Univ Lille 2, INSERM Biotherapies Diabet U859, Lille, France; [Piemonti, Lorenzo] Ist Sci San Raffaele, Diabet Res Inst, I-20132 Milan, Italy; [Berney, Thierry] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Berney, Thierry] Univ Geneva, Geneva, Switzerland; [Ravassard, Philippe] Univ Paris 06, INSERM U975, CNRS UMR 7225, Biotechnol & Biotherapy Team,Ctr Rech,Inst Cervea, Paris, France	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Birmingham; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Geneva; University of Geneva; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Ferrer, J (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Genom Programming Beta Cells Lab, Barcelona, Spain.	j.ferrer@imperial.ac.uk	Gómez-Marín, Carlos/AAX-2173-2021; Cebola, Inês/AAG-9652-2020; Berney, Thierry/ABE-9450-2021; Moran, Ignasi/AAA-6417-2020; Mularoni, Loris/B-3777-2017; Gomez-Skarmeta, Jose Luis/B-5268-2014; Pattou, Francois/O-6151-2017; Tena, Juan J./Q-5995-2019; Tena, Juan J/M-2265-2014; Pasquali, Lorenzo/B-6239-2008; Miguel-Escalada, Irene/J-6535-2014; Ferrer, Jorge/A-3176-2012; Piemonti, Lorenzo/P-7605-2017; McCarthy, Mark/M-3763-2015	Cebola, Inês/0000-0003-3528-4982; Berney, Thierry/0000-0002-4230-9378; Moran, Ignasi/0000-0002-3307-7106; Mularoni, Loris/0000-0001-7053-7717; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Pattou, Francois/0000-0001-8388-3766; Tena, Juan J./0000-0001-8165-7984; Tena, Juan J/0000-0001-8165-7984; Pasquali, Lorenzo/0000-0003-2423-1826; Miguel-Escalada, Irene/0000-0003-3461-6404; Ferrer, Jorge/0000-0002-5959-5729; Piemonti, Lorenzo/0000-0002-2172-2198; Gomez-Marin, Carlos/0000-0001-9724-2919; ravassard, philippe/0000-0002-0393-9262; McCarthy, Mark/0000-0002-4393-0510; Akerman, Ildem/0000-0002-9875-1421; mueller, ferenc/0000-0002-0996-774X; Garcia-Hurtado, Javier/0000-0001-5271-3107; Rodriguez-Segui, Santiago A./0000-0003-2952-8485; Gloyn, Anna/0000-0003-1205-1844; Gaulton, Kyle/0000-0003-1318-7161; van de Bunt, Martijn/0000-0002-6744-6125	National Medical Research Council of Singapore, Singapore Translational Researcher Award schemes; Biomedical Research Council of Singapore; National Research Foundation (NRF); European Foundation for the Study of Diabetes Lilly fellowship; Ministerio de Econom a y Competitividad [SAF2011-27086, BFU2010-14839, CSD2007-00008]; Innovative Medicines Initiative; Andalusian Government [CVI-3488]; Biology of Liver and Pancreatic Development and Disease Marie Curie Initial Training Network; Wellcome Trust [090532, 098381, 090367, 095101, 101033]; Juvenile Diabetes Research Foundation [31-2012-783]; Framework Programme 7 [HEALTH-F4-2007-201413]; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish	National Medical Research Council of Singapore, Singapore Translational Researcher Award schemes; Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Research Foundation (NRF); European Foundation for the Study of Diabetes Lilly fellowship; Ministerio de Econom a y Competitividad(Spanish Government); Innovative Medicines Initiative; Andalusian Government; Biology of Liver and Pancreatic Development and Disease Marie Curie Initial Training Network; Wellcome Trust(Wellcome Trust); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Framework Programme 7; National Institute for Health Research(National Institute for Health Research (NIHR))	We thank J.Rios (IDIBAPS) for expert statistical advice, M. Parsons (Johns Hopkins University) for Tg(ins: mCherry)jh2 transgenics and R. Stein (Vanderbilt University), J. Habener (Harvard University) and G. Gradwohl (Institute of Genetics and Molecular and Cellular Biology) for MAFA, IDX1, and NGN3 DNA constructs.We thank the DIAGRAM and MAGIC consortia, the Singapore Prospective Study Program, the Singapore Consortium of Cohort Studies, the Singapore Indian Eye Study, the Singapore Malay Eye Study and Y.Y.Teo, E.S.Tai, T.Y. Wong, W.Y. Lim and X.Wang (National University of Singapore; funded by the National Medical Research Council of Singapore, Singapore Translational Researcher Award schemes, the Biomedical Research Council of Singapore and the National Research Foundation (NRF) Fellowship scheme).This work was carried out in part at the Centre Esther Koplowitz. This work was funded by grants from a European Foundation for the Study of Diabetes Lilly fellowship (L.Pasquali), the Ministerio de Econom a y Competitividad (SAF2011-27086 to J.F., BFU2010-14839 and CSD2007-00008 to J.L.G.S.), the Innovative Medicines Initiative (DIRECT to M.I.M. and J.F.), the Andalusian Government (CVI-3488 to J.L.G.S.), the Biology of Liver and Pancreatic Development and Disease Marie Curie Initial Training Network (F.M.and J.F.), the Wellcome Trust (090532, 098381 and 090367 to M.I.M., 095101 to A.L.G., 101033 to J.F.), Juvenile Diabetes Research Foundation (31-2012-783 to T.B., F.P. and L. Piemonti) and Framework Programme 7 (HEALTH-F4-2007-201413 to M.I.M.).	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Bucher P, 2005, TRANSPLANTATION, V79, P91, DOI 10.1097/01.TP.0000147344.73915.C8; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hindorff LA, CATALOG PUBLISHED GE; Hu LP, 2005, AM J PHYSIOL-ENDOC M, V289, pE1085, DOI 10.1152/ajpendo.00210.2005; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Khoo C, 2012, MOL ENDOCRINOL, V26, P521, DOI 10.1210/me.2011-1231; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCulloch LJ, 2011, MOL GENET METAB, V104, P648, DOI 10.1016/j.ymgme.2011.08.026; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meng AM, 1997, P NATL ACAD SCI USA, V94, P6267, DOI 10.1073/pnas.94.12.6267; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Rozen S, 2000, Methods Mol Biol, V132, P365; Sander M, 2000, DEVELOPMENT, V127, P5533; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Splinter E, 2012, METHODS, V58, P221, DOI 10.1016/j.ymeth.2012.04.009; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; Tennant BR, 2013, DIABETOLOGIA, V56, P542, DOI 10.1007/s00125-012-2797-5; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	71	342	346	3	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					136	+		10.1038/ng.2870	http://dx.doi.org/10.1038/ng.2870			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24413736	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000331208300009
J	Chan-on, W; Nairismagi, ML; Ong, CK; Lim, WK; Dima, S; Pairojkul, C; Lim, KH; McPherson, JR; Cutcutache, I; Heng, HL; Ooi, L; Chung, A; Chow, P; Cheow, PC; Lee, SY; Choo, SP; Tan, IBH; Duda, D; Nastase, A; Myint, SS; Wong, BH; Gan, AN; Rajasegaran, V; Ng, CCY; Nagarajan, S; Jusakul, A; Zhang, SL; Vohra, P; Yu, W; Huang, DC; Sithithaworn, P; Yongvanit, P; Wongkham, S; Khuntikeo, N; Bhudhisawasdi, V; Popescu, I; Rozen, SG; Tan, P; Teh, B				Chan-on, Waraporn; Nairismaegi, Maarja-Liisa; Ong, Choon Kiat; Lim, Weng Khong; Dima, Simona; Pairojkul, Chawalit; Lim, Kiat Hon; McPherson, John R.; Cutcutache, Ioana; Heng, Hong Lee; Ooi, London; Chung, Alexander; Chow, Pierce; Cheow, Peng Chung; Lee, Ser Yee; Choo, Su Pin; Tan, Iain Bee Huat; Duda, Dan; Nastase, Anca; Myint, Swe Swe; Wong, Bernice Huimin; Gan, Anna; Rajasegaran, Vikneswari; Ng, Cedric Chuan Young; Nagarajan, Sanjanaa; Jusakul, Apinya; Zhang, Shenli; Vohra, Priya; Yu, Willie; Huang, DaChuan; Sithithaworn, Paiboon; Yongvanit, Puangrat; Wongkham, Sopit; Khuntikeo, Narong; Bhudhisawasdi, Vajaraphongsa; Popescu, Irinel; Rozen, Steven G.; Tan, Patrick; Teh, Bin Tean			Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers	NATURE GENETICS			English	Article							OPISTHORCHIS-VIVERRINI; FREQUENT MUTATION; TUMOR-SUPPRESSOR; COPY NUMBERS; CHOLANGIOCARCINOMA; PATHOGENESIS; PHENOTYPE; PATHWAYS; PATIENT; ARID1A	The impact of different carcinogenic exposures on the specific patterns of somatic mutation in human tumors remains unclear. To address this issue, we profiled 209 cholangiocarcinomas (CCAs) from Asia and Europe, including 108 cases caused by infection with the liver fluke Opisthorchis viverrini and 101 cases caused by non-O. viverrini-related etiologies. Whole-exome sequencing (n = 15) and prevalence screening (n = 194) identified recurrent somatic mutations in BAP1 and ARID1A, neither of which, to our knowledge, has previously been reported to be mutated in CCA. Comparisons between intrahepatic O. viverrini-related and non-O. viverrini-related CCAs demonstrated statistically significant differences in mutation patterns: BAP1, IDH1 and IDH2 were more frequently mutated in non-O. viverrini CCAs, whereas TP53 mutations showed the reciprocal pattern. Functional studies demonstrated tumor suppressive functions for BAP1 and ARID1A, establishing the role of chromatin modulators in CCA pathogenesis. These findings indicate that different causative etiologies may induce distinct somatic alterations, even within the same tumor type.	[Chan-on, Waraporn; Nairismaegi, Maarja-Liisa; Ong, Choon Kiat; Lim, Weng Khong; Heng, Hong Lee; Myint, Swe Swe; Wong, Bernice Huimin; Gan, Anna; Rajasegaran, Vikneswari; Ng, Cedric Chuan Young; Nagarajan, Sanjanaa; Jusakul, Apinya; Yu, Willie; Huang, DaChuan; Teh, Bin Tean] Natl Canc Ctr Singapore, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore; [Chan-on, Waraporn; Nairismaegi, Maarja-Liisa; Ong, Choon Kiat; Lim, Weng Khong; Heng, Hong Lee; Myint, Swe Swe; Wong, Bernice Huimin; Gan, Anna; Rajasegaran, Vikneswari; Ng, Cedric Chuan Young; Nagarajan, Sanjanaa; Jusakul, Apinya; Zhang, Shenli; Vohra, Priya; Yu, Willie; Huang, DaChuan; Tan, Patrick; Teh, Bin Tean] Duke Natl Univ Singapore, Grad Sch Med, Div Canc & Stem Cell Biol, Singapore, Singapore; [Chan-on, Waraporn; Pairojkul, Chawalit; Sithithaworn, Paiboon; Yongvanit, Puangrat; Wongkham, Sopit; Khuntikeo, Narong; Bhudhisawasdi, Vajaraphongsa] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Dima, Simona; Nastase, Anca; Popescu, Irinel] Fundeni Clin Inst, Ctr Digest Dis & Liver Transplantat, Bucharest, Romania; [Lim, Kiat Hon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [McPherson, John R.; Cutcutache, Ioana; Rozen, Steven G.] Duke Natl Univ Singapore, Grad Sch Med, Div Neurosci & Behav Disorders, Singapore, Singapore; [Ooi, London; Chung, Alexander; Chow, Pierce; Cheow, Peng Chung; Lee, Ser Yee] Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore; [Choo, Su Pin; Tan, Iain Bee Huat] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Duda, Dan] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA; [Duda, Dan] Harvard Univ, Sch Med, Boston, MA USA; [Yu, Willie] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Tan, Patrick] Genome Inst Singapore, Singapore, Singapore; [Tan, Patrick; Teh, Bin Tean] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; Khon Kaen University; Institutul Clinic Fundeni; Singapore General Hospital; National University of Singapore; Singapore General Hospital; National Cancer Centre Singapore (NCCS); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Teh, B (corresponding author), Natl Canc Ctr Singapore, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore.	vajara_b@kku.ac.th; irinel.popescu@icfundeni.ro; steve.rozen@duke-nus.edu.sg; gmstanp@duke-nus.edu.sg; teh.bin.tean@singhealth.com.sg	Dima, Simona Olimpia/B-8822-2017; Ooi, London Lucien/AGK-1395-2022; Lim, Weng Khong/Q-8661-2019; Popescu, Irinel/S-9228-2019; Lee, Ser Yee/H-3116-2013; Dima, Simona/P-5582-2019; POPESCU, IRINEL/B-3048-2008; Wongkham, Sopit/ABB-6966-2021; CHOO, Su Pin/ABB-3892-2020; Sithithaworn, Paiboon/E-4378-2019; Duda, Dan G/H-8523-2014; Rozen, Steven G./J-5939-2013	Lim, Weng Khong/0000-0003-4391-1130; Lee, Ser Yee/0000-0001-9119-7408; Dima, Simona/0000-0001-5275-8938; Sithithaworn, Paiboon/0000-0002-9480-1778; Duda, Dan G/0000-0001-7065-8797; Myint, Swe Swe/0000-0002-2430-088X; Jusakul, Apinya/0000-0001-7652-7771; Dukes, Priya/0000-0002-8801-4671; Wong, Bernice/0000-0001-8981-1376; Ong, Choon Kiat/0000-0001-6402-4288; Chow, Pierce/0000-0003-0584-2584; Tan, Iain/0000-0003-4951-0354; HUANG, DACHUAN/0000-0002-7518-4081; Teh, Bin Tean/0000-0003-1514-1124; Rozen, Steven G./0000-0002-4288-0056	Singapore National Medical Research Council [NMRC/STAR/0006/2009]; Singapore Millennium Foundation; Lee Foundation; Singapore National Cancer Centre Research Fund; Duke-National University of Singapore Graduate Medical School; Cancer Science Institute, Singapore; Verdant Foundation, Hong Kong; Executive Agency for Higher Education, Research and Development, Romania; National Genetic Engineering and Biotechnology Center; National Science and Technology Development Agency, Thailand; National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Millennium Foundation(Singapore Millennium Foundation); Lee Foundation; Singapore National Cancer Centre Research Fund; Duke-National University of Singapore Graduate Medical School(National University of Singapore); Cancer Science Institute, Singapore; Verdant Foundation, Hong Kong; Executive Agency for Higher Education, Research and Development, Romania; National Genetic Engineering and Biotechnology Center; National Science and Technology Development Agency, Thailand; National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship(National University of Singapore)	We thank B. Haaland for reviewing all statistical tests performed in this study and the Duke-National University of Singapore Genome Biology Facility for performing whole-exome sequencing and methylation assays. We thank D. Jefferson (New England Medical Center, Tufts University) for the H69 cell line. We thank B. Sripa (Khon Kean University) for the M139 cell line. This work was supported in part by funding from the Singapore National Medical Research Council (NMRC/STAR/0006/2009), the Singapore Millennium Foundation, the Lee Foundation, the Singapore National Cancer Centre Research Fund, the Duke-National University of Singapore Graduate Medical School, the Cancer Science Institute, Singapore, the Verdant Foundation, Hong Kong, Innovation Funding from the Executive Agency for Higher Education, Research and Development, Romania, a Research Team Strengthening Grant, the National Genetic Engineering and Biotechnology Center and the National Science and Technology Development Agency, Thailand. W.Y. is the recipient of a National University of Singapore Graduate School for Integrative Sciences and Engineering scholarship.	Bengtsson H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-245; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060, DOI 10.1152/ajpgi.1994.266.6.G1060; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; IARC, 1994, IARC MONOGR EVAL CAR, V61, P121; Inoue H, 2002, J BIOL CHEM, V277, P41674, DOI 10.1074/jbc.M205961200; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Neubert G, 2013, GENE, V512, P453, DOI 10.1016/j.gene.2012.10.061; Olsson L, 2014, LEUKEMIA, V28, P302, DOI 10.1038/leu.2013.206; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Saichua P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002228; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Sia D, 2013, ONCOGENE, V32, P4861, DOI 10.1038/onc.2012.617; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	39	342	348	1	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1474	U100		10.1038/ng.2806	http://dx.doi.org/10.1038/ng.2806			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24185513				2022-12-17	WOS:000327715800014
J	Johansen, CT; Wang, JA; Lanktree, MB; Cao, HN; McIntyre, AD; Ban, MR; Martins, RA; Kennedy, BA; Hassell, RG; Visser, ME; Schwartz, SM; Voight, BF; Elosua, R; Salomaa, V; O'Donnell, CJ; Dallinga-Thie, GM; Anand, SS; Yusuf, S; Huff, MW; Kathiresan, S; Hegele, RA				Johansen, Christopher T.; Wang, Jian; Lanktree, Matthew B.; Cao, Henian; McIntyre, Adam D.; Ban, Matthew R.; Martins, Rebecca A.; Kennedy, Brooke A.; Hassell, Reina G.; Visser, Maartje E.; Schwartz, Stephen M.; Voight, Benjamin F.; Elosua, Roberto; Salomaa, Veikko; O'Donnell, Christopher J.; Dallinga-Thie, Geesje M.; Anand, Sonia S.; Yusuf, Salim; Huff, Murray W.; Kathiresan, Sekar; Hegele, Robert A.			Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia	NATURE GENETICS			English	Article							HYPERLIPOPROTEINEMIA PHENOTYPES; LOCI; DISEASE; RISK; TRIGLYCERIDES; CONTRIBUTE; MUTATIONS; ALLELES	Genome-wide association studies (GWAS) have identified multiple loci associated with plasma lipid concentrations(1-5). Common variants at these loci together explain <10% of variation in each lipid trait(4,5). Rare variants with large individual effects may also contribute to the heritability of lipid traits(6,7); however, the extent to which rare variants affect lipid phenotypes remains to be determined. Here we show an accumulation of rare variants, or a mutation skew, in GWAS-identified genes in individuals with hypertriglyceridemia (HTG). Through GWAS, we identified common variants in APOA5, GCKR, LPL and APOB associated with HTG. Resequencing of these genes revealed a significant burden of 154 rare missense or nonsense variants in 438 individuals with HTG, compared to 53 variants in 327 controls (P = 6.2 x 10(-8)), corresponding to a carrier frequency of 28.1% of affected individuals and 15.3% of controls (P = 2.6 x 10(-5)). Considering rare variants in these genes incrementally increased the proportion of genetic variation contributing to HTG.	[Johansen, Christopher T.; Wang, Jian; Lanktree, Matthew B.; Cao, Henian; McIntyre, Adam D.; Ban, Matthew R.; Martins, Rebecca A.; Kennedy, Brooke A.; Hassell, Reina G.; Huff, Murray W.; Hegele, Robert A.] Univ Western Ontario, Dept Biochem, Robarts Res Inst, London, ON, Canada; [Visser, Maartje E.; Dallinga-Thie, Geesje M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Visser, Maartje E.; Dallinga-Thie, Geesje M.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Schwartz, Stephen M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Voight, Benjamin F.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Voight, Benjamin F.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Voight, Benjamin F.; Kathiresan, Sekar] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Elosua, Roberto] Inst Municipal Invest Med, E-08003 Barcelona, Spain; [Salomaa, Veikko] Natl Inst Hlth & Welf, Chron Dis Epidemiol Unit, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland; [O'Donnell, Christopher J.] Harvard Univ, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [O'Donnell, Christopher J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [O'Donnell, Christopher J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Anand, Sonia S.; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON, Canada; [Huff, Murray W.; Hegele, Robert A.] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Finland National Institute for Health & Welfare; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); McMaster University; Population Health Research Institute; Western University (University of Western Ontario)	Hegele, RA (corresponding author), Univ Western Ontario, Dept Biochem, Robarts Res Inst, London, ON, Canada.	hegele@robarts.ca	Hegele, Robert/AAF-6482-2020; Hegele, Robert/G-3301-2011; Voight, Benjamin/F-1775-2011; Huff, Murray/G-3307-2011; wang, jian/GVS-0711-2022; Lanktree, Matthew Bruce/I-9790-2019	Hegele, Robert/0000-0003-2861-5325; Lanktree, Matthew Bruce/0000-0002-5750-6286; dallinga-thie, geesje/0000-0001-5412-5923; Yusuf, Salim/0000-0003-4776-5601; Voight, Benjamin/0000-0002-6205-9994	US National Institutes of Health through the National Heart, Lung, and Blood Institute [R01 HL087676]; National Center for Research Resources [U54 RR020278]; Canadian Institutes of Health Research (CIHR) [MOP-13430, MOP-79523, CTP-79853]; Heart and Stroke Foundation of Ontario; Sigrid Juselius Foundation; Finnish Academy [129494]; Michael G. DeGroote Heart and Stroke Foundation of Ontario Chair; Eli Lilly May Cohen Chair in Women's Health Research at McMaster University; Jacob J. Wolfe Distinguished Medical Research Chair; Edith Schulich Vinet Canada Research Chair in Human Genetics (Tier I); Heart and Stroke Foundation of Ontario [NA-6059, T-6018, PRG-4854]; Pfizer Jean Davignon Distinguished Cardiovascular and Metabolic; Genome Canada through the Ontario Genomics Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087676] Funding Source: NIH RePORTER	US National Institutes of Health through the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Academy(Academy of Finland); Michael G. DeGroote Heart and Stroke Foundation of Ontario Chair; Eli Lilly May Cohen Chair in Women's Health Research at McMaster University; Jacob J. Wolfe Distinguished Medical Research Chair; Edith Schulich Vinet Canada Research Chair in Human Genetics (Tier I); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Pfizer Jean Davignon Distinguished Cardiovascular and Metabolic; Genome Canada through the Ontario Genomics Institute(Genome Canada); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the London Regional Genomics Centre (D. Carter, G. Barbe and K. Kang) for their dedication to this project, and the Myocardial Infarction Genetics Consortium (MIGen) study for the use of their genotype data as control data in our study. The MIGen study was funded by the US National Institutes of Health through the National Heart, Lung, and Blood Institute's STAMPEED genomics research program (R01 HL087676) and the National Center for Research Resources (U54 RR020278). This work was made possible by the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET). C.T.J. is supported by a Canadian Institutes of Health Research (CIHR) Banting and Best Canada Graduate Scholarship, a Heart and Stroke Foundation of Ontario Program Grant and a CIHR Vascular Research Fellowship. V. S. was supported by the Sigrid Juselius Foundation and by the Finnish Academy (grant 129494). S. S. A. is supported by the Michael G. DeGroote Heart and Stroke Foundation of Ontario Chair and the Eli Lilly May Cohen Chair in Women's Health Research at McMaster University. R. A. H. is supported by the Jacob J. Wolfe Distinguished Medical Research Chair, the Edith Schulich Vinet Canada Research Chair in Human Genetics (Tier I), the Martha G. Blackburn Chair in Cardiovascular Research and operating grants from the CIHR (MOP-13430, MOP-79523, CTP-79853), the Heart and Stroke Foundation of Ontario (NA-6059, T-6018, PRG-4854), the Pfizer Jean Davignon Distinguished Cardiovascular and Metabolic Research Award and Genome Canada through the Ontario Genomics Institute.	Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; GAFFNEY D, 1995, ARTERIOSCL THROM VAS, V15, P1025, DOI 10.1161/01.ATV.15.8.1025; Hegele RA, 2009, HUM MOL GENET, V18, P4189, DOI 10.1093/hmg/ddp361; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mittlbock M, 1999, COMPUT METH PROG BIO, V58, P17, DOI 10.1016/S0169-2607(98)00061-3; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peterfy M, 2007, NAT GENET, V39, P1483, DOI 10.1038/ng.2007.24; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Wang J, 2008, NAT CLIN PRACT CARD, V5, P730, DOI 10.1038/ncpcardio1326; Wang J, 2008, HUM MOL GENET, V17, P2894, DOI 10.1093/hmg/ddn188; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P2450, DOI 10.1161/ATVBAHA.107.150680; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yuan G, 2007, CAN MED ASSOC J, V176, P1113, DOI 10.1503/cmaj.060963	27	342	353	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2010	42	8					684	+		10.1038/ng.628	http://dx.doi.org/10.1038/ng.628			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	633RZ	20657596	Green Accepted			2022-12-17	WOS:000280524000012
J	Bulavin, DV; Demidov, ON; Saito, S; Kauraniemi, P; Phillips, C; Amundson, SA; Ambrosino, C; Sauter, G; Nebreda, AR; Anderson, CW; Kallioniemi, A; Fornace, AJ; Appella, E				Bulavin, DV; Demidov, ON; Saito, S; Kauraniemi, P; Phillips, C; Amundson, SA; Ambrosino, C; Sauter, G; Nebreda, AR; Anderson, CW; Kallioniemi, A; Fornace, AJ; Appella, E			Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity	NATURE GENETICS			English	Article							POSTTRANSLATIONAL MODIFICATIONS; PREMATURE SENESCENCE; GENETIC ALTERATIONS; HUMAN FIBROBLASTS; BREAST-CANCER; UV-RADIATION; P38 KINASE; PATHWAY; PROTEIN; PHOSPHATASE	Expression of oncogenic Ras in primary human cells activates p53, thereby protecting cells from transformation. We show that in Ras-expressing IMR-90 cells, p53 is phosphorylated at Ser33 and Ser46 by the p38 mitogen-activated protein kinase (MAPK). Activity of p38 MAPK is regulated by the p53-inducible phosphatase PPM1D, creating a potential feedback loop. Expression of oncogenic Ras suppresses PPM1D mRNA induction, leaving p53 phosphorylated at Ser33 and Ser46 and in an active state. Retrovirus-mediated overexpression of PPM1D reduced p53 phosphorylation at these sites, abrogated Ras-induced apoptosis and partially rescued cells from cell-cycle arrest. Inactivation of p38 MAPK (the product of Mapk14) in vivo by gene targeting or by PPM1D overexpression expedited tumor formation after injection of mouse embryo fibroblasts (MEFs) expressing E1A+Ras into nude mice. The gene encoding PPM1D (PPM1D, at 17q22/q23) is amplified in human breast-tumor cell lines and in approximately 11% of primary breast tumors, most of which harbor wildtype p53. These findings suggest that inactivation of the p38 MAPK through PPM1D overexpression resulting from PPM1D amplification contributes to the development of human cancers by suppressing p53 activation.	NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NIH, Gene Response Sect, Bethesda, MD 20892 USA; NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; Tampere Univ, Inst Med Technol, Canc Genet Lab, Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; European Mol Biol Lab, Heidelberg, Germany; Univ Basel, Inst Pathol, Basel, Switzerland; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Tampere University; Tampere University; Tampere University Hospital; European Molecular Biology Laboratory (EMBL); University of Basel; United States Department of Energy (DOE); Brookhaven National Laboratory	Appella, E (corresponding author), NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.		Nebreda, Angel Rodriguez/R-9594-2019; ambrosino, concetta/AAB-3452-2019; Fornace, Albert J/A-7407-2008; Demidov, Oleg/U-2050-2017; Demidov, Oleg/AAC-4462-2021	Fornace, Albert J/0000-0001-9695-085X; Demidov, Oleg/0000-0003-4323-7174; Demidov, Oleg/0000-0003-4323-7174; Kallioniemi, Anne/0000-0003-3552-8158; Dudgeon, Crissy/0000-0001-9010-2569				Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; Bulavin DV, 1999, ONCOGENE, V18, P5611, DOI 10.1038/sj.onc.1202945; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Esteller M, 2000, CANCER RES, V60, P129; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Ho GH, 2001, BREAST CANCER RES TR, V65, P225, DOI 10.1023/A:1010686518990; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LI J, 2002, NATURE GENET, V31; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; OConnor PM, 1997, CANCER RES, V57, P4285; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Oster SK, 2000, MOL CELL BIOL, V20, P6768, DOI 10.1128/MCB.20.18.6768-6778.2000; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Tirkkonen M, 1998, GENE CHROMOSOME CANC, V21, P177, DOI 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.3.CO;2-C; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	31	342	364	1	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					210	215		10.1038/ng894	http://dx.doi.org/10.1038/ng894			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12021785				2022-12-17	WOS:000175903500021
J	Kwon, CH; Zhu, XY; Zhang, JY; Knoop, LL; Tharp, R; Smeyne, RJ; Eberhart, CG; Burger, PC; Baker, SJ				Kwon, CH; Zhu, XY; Zhang, JY; Knoop, LL; Tharp, R; Smeyne, RJ; Eberhart, CG; Burger, PC; Baker, SJ			Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease	NATURE GENETICS			English	Article							CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; SIGNALING PATHWAY; PROSTATE-CANCER; COWDEN-SYNDROME; PTEN(+/-) MICE; GLIOMA-CELLS; GENE; EXPRESSION; PTEN/MMAC1	Somatic inactivation of PTEN occurs in different human tumors including glioblastoma, endometrial carcinoma and prostate carcinoma. Germline mutations in PTEN result in a range of phenotypic abnormalities that occur with variable penetrance, including neurological features such as macrocephaly, seizures, ataxia and Lhermitte-Duclos disease (also described as dysplastic gangliocytoma of the cerebellum). Homozygous deletion of Pten causes embryonic lethality in mice. To investigate function in the brain, we used Cre-loxP technology to selectively inactivate Pten in specific mouse neuronal populations. Loss of Pten resulted in progressive macrocephaly and seizures. Neurons lacking Pten expressed high levels of phosphorylated Akt and showed a progressive increase in soma size without evidence of abnormal proliferation. Cerebellar abnormalities closely resembled the histopathology of human Lhermitte-Duclos disease. These results indicate that Pten regulates neuronal size in vivo in a cell-autonomous manner and provide new insights into the etiology of Lhermitte-Duclos disease.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Tennessee, Dept Pathol, Memphis, TN 38163 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Johns Hopkins University	Baker, SJ (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale, Memphis, TN 38105 USA.	suzanne.baker@stjude.org	Kwon, Chang-hyuk/E-3450-2011; Baker, Suzanne J/N-8167-2018		NATIONAL CANCER INSTITUTE [P01CA071907, P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [CA71907, CA21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Bruni P, 2000, ONCOGENE, V19, P3146, DOI 10.1038/sj.onc.1203633; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cheyney IW, 1999, CANCER RES, V59, P2318; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies MA, 1998, CANCER RES, V58, P5285; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Furnari FB, 1998, CANCER RES, V58, P5002; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goldowitz D, 2000, J NEUROSCI, V20, P4129; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Huang H, 1999, DEVELOPMENT, V126, P5365; Iida S, 1998, INT J MOL MED, V1, P925; KUHAR SG, 1993, DEVELOPMENT, V117, P97; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li J, 1998, CANCER RES, V58, P5667; Li Y, 2001, BMC Mol Biol, V2, P2, DOI 10.1186/1471-2199-2-2; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Marcus CD, 1996, NEURORADIOLOGY, V38, P529; Marino S, 2000, GENE DEV, V14, P994; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Miyazawa K, 2000, J NEUROSCI, V20, P5756, DOI 10.1523/JNEUROSCI.20-15-05756.2000; MUCKE L, 1991, NEW BIOL, V3, P465; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; RAINOV NG, 1995, CLIN NEUROL NEUROSUR, V97, P175, DOI 10.1016/0303-8467(95)00017-E; Robinson S, 2000, NEUROSURGERY, V46, P371, DOI 10.1097/00006123-200002000-00021; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Tuli S, 1997, CAN J NEUROL SCI, V24, P155, DOI 10.1017/S031716710002151X; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; VINCHON M, 1994, J NEUROL NEUROSUR PS, V57, P699, DOI 10.1136/jnnp.57.6.699; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Zhu XY, 2001, CANCER RES, V61, P4569; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	50	342	356	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2001	29	4					404	411		10.1038/ng781	http://dx.doi.org/10.1038/ng781			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	498JZ	11726927				2022-12-17	WOS:000172507500015
J	Nadeau, JH; Singer, JB; Matin, A; Lander, ES				Nadeau, JH; Singer, JB; Matin, A; Lander, ES			Analysing complex genetic traits with chromosome substitution strains	NATURE GENETICS			English	Editorial Material							HUMAN-DISEASE; MOUSE MODELS; MICE; POPULATION; GENOME	Many valuable animal models of human disease are known and new models are continually being generated in existing inbred strains(1,2). Some disease models are simple mendelian traits, but most have a polygenic basis. The current approach to identifying quantitative trait loci (QTLs) that underlie such traits is to localize them in crosses, construct congenic strains carrying individual QTLs, and finally map and clone the genes. This process is time-consuming and expensive, requiring the genotyping of large crosses and many generations of breeding. Here we describe a different approach in which a panel of chromosome substitution strains (CSSs) is used for QTL mapping. Each of these strains has a single chromosome from the donor strain substituting for the corresponding chromosome in the host strain. We discuss the construction, applications and advantages of CSSs compared with conventional crosses for detecting and analysing QTLs, including those that have weak phenotypic effects.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA USA	Case Western Reserve University; University Hospitals of Cleveland; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Nadeau, JH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	jhn4@po.cwru.edu			NATIONAL CANCER INSTITUTE [R01CA075056] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012305] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG000195] Funding Source: NIH RePORTER; NCI NIH HHS [CA75056] Funding Source: Medline; NCRR NIH HHS [RR12305] Funding Source: Medline; NHGRI NIH HHS [F32 HG00195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; Bedell MA, 1997, GENE DEV, V11, P1, DOI 10.1101/gad.11.1.1; Collin GB, 1996, MAMM GENOME, V7, P68, DOI 10.1007/s003359900017; DARVASI A, 1995, GENETICS, V141, P1199; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Gould KA, 1996, GENETICS, V144, P1769; HUDGINS CC, 1985, J IMMUNOL, V134, P3849; LANDER ES, 1989, GENETICS, V121, P185; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Matin A, 1999, NAT GENET, V23, P237, DOI 10.1038/13874; SCRIBNER CL, 1988, CLIN IMMUNOL IMMUNOP, V49, P133, DOI 10.1016/0090-1229(88)90102-X; SNELL GD, 1948, J GENET, V49, P87, DOI 10.1007/BF02986826; Steen RG, 1999, GENOME RES, V9, pAP1; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WATERS NS, 1994, BEHAV BRAIN RES, V63, P195, DOI 10.1016/0166-4328(94)90091-4	18	342	361	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2000	24	3					221	225		10.1038/73427	http://dx.doi.org/10.1038/73427			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	288XW	10700173				2022-12-17	WOS:000085590600010
J	Wakayama, T; Yanagimachi, R				Wakayama, T; Yanagimachi, R			Cloning of male mice from adult tail-tip cells	NATURE GENETICS			English	Letter							OOCYTES		Univ Hawaii, Dept Anat & Reprod Biol, Sch Med, Honolulu, HI 96822 USA	University of Hawaii System	Wakayama, T (corresponding author), Univ Hawaii, Dept Anat & Reprod Biol, Sch Med, Honolulu, HI 96822 USA.							Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; CHATOT CL, 1990, BIOL REPROD, V42, P432, DOI 10.1095/biolreprod42.3.432; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; HOGAN B, 1994, MANIPULATING MOUSE E, P173; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Spindle A, 1996, DEV BIOL, V173, P447, DOI 10.1006/dbio.1996.0039; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	11	342	372	1	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					127	128		10.1038/9632	http://dx.doi.org/10.1038/9632			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369248				2022-12-17	WOS:000080680900011
J	Bowtell, DDL				Bowtell, DDL			Options available - from start to finish - for obtaining expression data by microarray	NATURE GENETICS			English	Review							3 ABUNDANCE CLASSES; GENE-EXPRESSION; DNA MICROARRAY; MESSENGER-RNA; HYBRIDIZATION; GENOME; CANCER; SCALE; PATTERNS; PROTEOME	The excitement surrounding microarray technology has been tempered by the limited ability of the general biomedical research community to gain access to it. Given that the hardware required for exploitation of the technology is becoming increasingly available, it is an appropriate moment to review options, be they commercially or publically available. Here, we provide a snapshot of the rapidly changing field of microarray-based RNA expression analysis and consider the components and procedures for putting together a complete system.	Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia	Peter Maccallum Cancer Center	Bowtell, DDL (corresponding author), Peter MacCallum Canc Inst, Locked Bag 1,A Beckett St, Melbourne, Vic 3000, Australia.		Bowtell, David/H-1007-2016	Bowtell, David/0000-0001-9089-7525				ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Bassett DE, 1999, NAT GENET, V21, P51, DOI 10.1038/4478; BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; CALE KA, 1999, NAT GENET, V21, P38; Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; DeRisi J, 1996, NAT GENET, V14, P457; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DRMANAC R, 1993, SCIENCE, V260, P1649, DOI 10.1126/science.8503011; DRMANAC R, 1994, SCIENCE, V163, P596; Drmanac S, 1998, NAT BIOTECHNOL, V16, P54, DOI 10.1038/nbt0198-54; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Ermolaeva O, 1998, NAT GENET, V20, P19, DOI 10.1038/1670; FRIEMERT C, 1989, Methods in Molecular and Cellular Biology, V1, P143; GRESS TM, 1992, MAMM GENOME, V3, P609, DOI 10.1007/BF00352477; HASTIE ND, 1976, CELL, V9, P761, DOI 10.1016/0092-8674(76)90139-2; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; KAHN P, 1995, SCIENCE, V270, P369, DOI 10.1126/science.270.5235.369; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Lashkari DA, 1997, P NATL ACAD SCI USA, V94, P13057, DOI 10.1073/pnas.94.24.13057; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Pietu G, 1996, GENOME RES, V6, P492, DOI 10.1101/gr.6.6.492; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; Schutze K, 1998, NAT BIOTECHNOL, V16, P737, DOI 10.1038/nbt0898-737; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Simone NL, 1998, TRENDS GENET, V14, P272, DOI 10.1016/S0168-9525(98)01489-9; STREZOSKA Z, 1991, P NATL ACAD SCI USA, V88, P10089, DOI 10.1073/pnas.88.22.10089; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Welford SM, 1998, NUCLEIC ACIDS RES, V26, P3059, DOI 10.1093/nar/26.12.3059; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	36	342	471	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1999	21			S			25	32		10.1038/4455	http://dx.doi.org/10.1038/4455			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	156NU	9915497				2022-12-17	WOS:000078008200008
J	Hemminki, A; Tomlinson, I; Markie, D; Jarvinen, H; Sistonen, P; Bjorkqvist, AM; Knuutila, S; Salovaara, R; Bodmer, W; Shibata, D; delaChapelle, A; Aaltonen, LA				Hemminki, A; Tomlinson, I; Markie, D; Jarvinen, H; Sistonen, P; Bjorkqvist, AM; Knuutila, S; Salovaara, R; Bodmer, W; Shibata, D; delaChapelle, A; Aaltonen, LA			Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis	NATURE GENETICS			English	Article							SOLID TUMORS; CANCER	Many human cancer susceptibility genes have been successfully mapped by genetic linkage studies(1). One that has so far eluded researchers is that for Peutz-Jeghers (P-J) syndrome, a condition characterized by intestinal hamartomatous polyposis and melanin spots of the lips, buccal mucosa and digits(2,3). A dramatically elevated risk of malignancy has also been documented(4). Gastrointestinal tumours as well as cancers of the breast, ovary, testis and uterine cervix appear to be overrepresented in families with this syndrome(4,5). The nature of hamartomatous polyps is equivicol. Hamartomas are usually considered histologically benign(6), but in the case of Peutz-Jeghers patients, there are reports of adenomatous and malignant changes in the polyps, and the possibility of a hamartoma-carcinoma sequence has been discussed(5,7,8). A search for a putative tumour suppressor locus was made using comparative genomic hybridization (CGH) of Peutz-Jeghers polyps, combined with loss of heterozygosity (LOH) study. Genetic linkage analysis in 12 families using markers from a deletion site demonstrated the presence of a high-penetrance locus in distal 19p with a multipoint lod score of 7.00 at marker D19S886 without evidence of genetic heterogeneity. The study demonstrates the power of CCH combined with LOH analysis in identifying putative tumour suppressor loci, and provides molecular evidence of malignant potential in hamartomas.	UNIV HELSINKI,DEPT MED GENET,HAARTMAN INST,FIN-00014 HELSINKI,FINLAND; UNIV HELSINKI,DEPT PATHOL,HAARTMAN INST,FIN-00014 HELSINKI,FINLAND; IMPERIAL CANC RES FUND,CANC GENET LAB,LONDON WC2A 3PX,ENGLAND; DUNEDIN SCH MED,DEPT PATHOL,DUNEDIN,NEW ZEALAND; UNIV HELSINKI,CENT HOSP,DEPT SURG 2,FIN-00290 HELSINKI,FINLAND; FINNISH RED CROSS & BLOOD TRANSFUS SERV,SF-00310 HELSINKI,FINLAND; UNIV SO CALIF,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90033	University of Helsinki; University of Helsinki; Cancer Research UK; University of Otago; University of Helsinki; Helsinki University Central Hospital; University of Southern California			Aaltonen, Lauri/A-5375-2010; Markie, David/I-7893-2019	Aaltonen, Lauri/0000-0001-6839-4286; Bodmer, Walter/0000-0001-6244-9792; Markie, David/0000-0001-5452-9194				COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Defago MR, 1996, ENDOSCOPY, V28, P267, DOI 10.1055/s-2007-1005447; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; HIZAWA K, 1993, DIS COLON RECTUM, V36, P953, DOI 10.1007/BF02050632; JEGHERS H, 1949, NEW ENGL J MED, V241, P992; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; KNUDSON AG, 1993, NAT GENET, V5, P103, DOI 10.1038/ng1093-103; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1991, ANAL HUMAN GENETIC L; Peutz JL, 1921, NEDERL MAANDSCHR GEN, V10, P134; PHILLIPS RK, 1994, FAMILIAL ADENOMATOUS; ROSAI J, 1996, ACKERMANS SURGICAL P; SHIBATA D, 1992, AM J PATHOL, V141, P539; Shibata D, 1996, NAT MED, V2, P676, DOI 10.1038/nm0696-676	15	342	364	1	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					87	90		10.1038/ng0197-87	http://dx.doi.org/10.1038/ng0197-87			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988175				2022-12-17	WOS:A1997WA37300027
J	BROOKCARTER, PT; PERAL, B; WARD, CJ; THOMPSON, P; HUGHES, J; MAHESHWAR, MM; NELLIST, M; GAMBLE, V; HARRIS, PC; SAMPSON, JR				BROOKCARTER, PT; PERAL, B; WARD, CJ; THOMPSON, P; HUGHES, J; MAHESHWAR, MM; NELLIST, M; GAMBLE, V; HARRIS, PC; SAMPSON, JR			DELETION OF THE TSC2 AND PKD1 GENES ASSOCIATED WITH SEVERE INFANTILE POLYCYSTIC KIDNEY-DISEASE - A CONTIGUOUS GENE SYNDROME	NATURE GENETICS			English	Article							TUBEROUS SCLEROSIS; INSITU HYBRIDIZATION	Major genes which cause tuberous sclerosis (TSC) and autosomal dominant polycystic kidney disease (ADPKD), known as TSC2 and PKD1 respectively, lie immediately adjacent to each other on chomosome 16p. Renal cysts are often found in TSC, but a specific renal phenotype, distinguished by the severity and infantile presentation of the cystic changes, is seen in a small proportion of cases. We have identified large deletions disrupting TSC2 and PKD1 in each of six such cases studied. Analysis of the deletions indicates that they inactivate PKD1, in contrast to the mutations reported in ADPKD patients, where in each case abnormal transcripts have been detected.	UNIV WALES COLL MED, INST MED GENET, CARDIFF CF4 4XN, S GLAM, WALES; JOHN RADCLIFFE HOSP, INST MOLEC MED, MRC, MOLEC HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND	Cardiff University; University of Oxford			Peral, Belén/F-4562-2015	Peral, Belén/0000-0003-4984-4020	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BERNSTEIN J, 1991, ANN NY ACAD SCI, V615, P36; COLE BR, 1987, J PEDIATR-US, V111, P693, DOI 10.1016/S0022-3476(87)80244-5; CREE JE, 1969, P ROY SOC MED, V62, P327, DOI 10.1177/003591576906200410; FINK GM, 1993, J AM SOC NEPHROL, V3, P1863; FINK GM, 1994, KIDNEY INT, V40, P1153; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gomez MR, 1988, TUBEROUS SCLEROSIS; GREEN AJ, 1994, HUM MOL GENET, V3, P1833, DOI 10.1093/hmg/3.10.1833; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Hermann B. G., 1987, Cell, USA, V48, P813; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MANDEL JL, 1993, NAT GENET, V4, P8, DOI 10.1038/ng0593-8; NELLIST M, 1993, J MED GENET, V30, P224, DOI 10.1136/jmg.30.3.224; NELLIST M, 1993, CELL, V75, P1305; OCALLAGHAN TJ, 1975, ARCH INTERN MED, V135, P1082, DOI 10.1001/archinte.135.8.1082; PERAL B, 1994, AM J HUM GENET, V54, P899; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Sambrook J., 1989, MOL CLONING LAB MANU; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; STAPLETON FB, 1980, J PEDIATR-US, V97, P574, DOI 10.1016/S0022-3476(80)80011-4; STILLWELL TJ, 1987, J UROLOGY, V138, P477, DOI 10.1016/S0022-5347(17)43234-4; VANBAAL JG, 1989, CLIN GENET, V35, P167; WARD CJ, 1994, CELL, V77, P881; WEBB DW, 1993, BMJ-BRIT MED J, V306, P1258, DOI 10.1136/bmj.306.6887.1258; WENZL JE, 1970, J PEDIATR-US, V77, P673, DOI 10.1016/S0022-3476(70)80211-6; ZERRES K, 1993, J MED GENET, V30, P583, DOI 10.1136/jmg.30.7.583; ZIMMERHACKL LB, IN PRESS PEDIAT NEPH	28	342	350	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1994	8	4					328	332		10.1038/ng1294-328	http://dx.doi.org/10.1038/ng1294-328			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894481				2022-12-17	WOS:A1994PV68200011
J	Bishop, DT; Demenais, F; Iles, MM; Harland, M; Taylor, JC; Corda, E; Randerson-Moor, J; Aitken, JF; Avril, MF; Azizi, E; Bakker, B; Bianchi-Scarra, G; Bressac-de Paillerets, B; Calista, D; Cannon-Albright, LA; Chin-A-Woeng, T; Debniak, T; Galore-Haskel, G; Ghiorzo, P; Gut, I; Hansson, J; Hocevar, M; Hoiom, V; Hopper, JL; Ingvar, C; Kanetsky, PA; Kefford, RF; Landi, MT; Lang, J; Lubinski, J; Mackie, R; Malvehy, J; Mann, GJ; Martin, NG; Montgomery, GW; van Nieuwpoort, FA; Novakovic, S; Olsson, H; Puig, S; Weiss, M; van Workum, W; Zelenika, D; Brown, KM; Goldstein, AM; Gillanders, EM; Boland, A; Galan, P; Elder, DE; Gruis, NA; Hayward, NK; Lathrop, GM; Barrett, JH; Bishop, JAN				Bishop, D. Timothy; Demenais, Florence; Iles, Mark M.; Harland, Mark; Taylor, John C.; Corda, Eve; Randerson-Moor, Juliette; Aitken, Joanne F.; Avril, Marie-Francoise; Azizi, Esther; Bakker, Bert; Bianchi-Scarra, Giovanna; Bressac-de Paillerets, Brigitte; Calista, Donato; Cannon-Albright, Lisa A.; Chin-A-Woeng, Thomas; Debniak, Tadeusz; Galore-Haskel, Gilli; Ghiorzo, Paola; Gut, Ivo; Hansson, Johan; Hocevar, Marko; Hoiom, Veronica; Hopper, John L.; Ingvar, Christian; Kanetsky, Peter A.; Kefford, Richard F.; Landi, Maria Teresa; Lang, Julie; Lubinski, Jan; Mackie, Rona; Malvehy, Josep; Mann, Graham J.; Martin, Nicholas G.; Montgomery, Grant W.; van Nieuwpoort, Frans A.; Novakovic, Srdjan; Olsson, Hakan; Puig, Susana; Weiss, Marjan; van Workum, Wilbert; Zelenika, Diana; Brown, Kevin M.; Goldstein, Alisa M.; Gillanders, Elizabeth M.; Boland, Anne; Galan, Pilar; Elder, David E.; Gruis, Nelleke A.; Hayward, Nicholas K.; Lathrop, G. Mark; Barrett, Jennifer H.; Bishop, Julia A. Newton			Genome-wide association study identifies three loci associated with melanoma risk	NATURE GENETICS			English	Article							CUTANEOUS MALIGNANT-MELANOMA; SUN EXPOSURE; PHENOTYPIC CHARACTERISTICS; FAMILY-HISTORY; MC1R VARIANTS; CDKN2A; GENES; MUTATIONS; WOMEN; SUSCEPTIBILITY	We report a genome-wide association study of melanoma conducted by the GenoMEL consortium based on 317K tagging SNPs for 1,650 selected cases and 4,336 controls, with replication in an additional two cohorts (1,149 selected cases and 964 controls from GenoMEL, and a population-based case-control study in Leeds of 1,163 cases and 903 controls). The genome-wide screen identified five loci with genotyped or imputed SNPs reaching P < 5 x 10(-7). Three of these loci were replicated: 16q24 encompassing MC1R (combined P = 2.54 x 10(-27) for rs258322), 11q14-q21 encompassing TYR (P = 2.41 x 10(-14) for rs1393350) and 9p21 adjacent to MTAP and flanking CDKN2A (P = 4.03 x 10(-7) for rs7023329). MC1R and TYR are associated with pigmentation, freckling and cutaneous sun sensitivity, well-recognized melanoma risk factors. Common variants within the 9p21 locus have not previously been associated with melanoma. Despite wide variation in allele frequency, these genetic variants show notable homogeneity of effect across populations of European ancestry living at different latitudes and show independent association to disease risk.	[Bishop, D. Timothy; Iles, Mark M.; Harland, Mark; Taylor, John C.; Randerson-Moor, Juliette; Barrett, Jennifer H.; Bishop, Julia A. Newton] St James Univ Hosp, Epidemiol & Biostat Sect, Leeds Inst Mol Med, Canc Res UK Clin Ctr Leeds, Leeds LS9 7TF, W Yorkshire, England; [Demenais, Florence; Corda, Eve] Fdn Jean Dausset CEPH, INSERM, U946, F-75010 Paris, France; [Aitken, Joanne F.] Canc Council, Viertel Ctr Res Canc Control, Brisbane, Qld, Australia; [Avril, Marie-Francoise] Hop Cochin, AP HP, Fac Paris 5, Serv Dermatol, F-75674 Paris, France; [Azizi, Esther; Galore-Haskel, Gilli] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Dept Dermatol, IL-52621 Tel Hashomer, Israel; [Bakker, Bert; Weiss, Marjan] Leiden Univ, Dept Clin Genet, Ctr Human & Clin Genet, Med Ctr, Leiden, Netherlands; [Bianchi-Scarra, Giovanna; Ghiorzo, Paola] Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy; [Bressac-de Paillerets, Brigitte] CNRS, Inst Canc Gustave Roussy, Serv Genet, FRE 2939, Villejuif, France; [Calista, Donato] Maurizio Bufalini Hosp, Dermatol Unit, Cesena, Italy; [Cannon-Albright, Lisa A.] Univ Utah, Salt Lake City, UT USA; [Chin-A-Woeng, Thomas; van Workum, Wilbert] ServiceXS, NL-2333 BZ Leiden, Netherlands; [Debniak, Tadeusz; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Szczecin, Poland; [Gut, Ivo; Zelenika, Diana; Boland, Anne; Lathrop, G. Mark] Ctr Natl Genotypage, Inst Genom, Commissariat Energie Atorn, Evry, France; [Hansson, Johan; Hoiom, Veronica] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Hocevar, Marko; Novakovic, Srdjan] Inst Oncol Ljubljana, Ljubljana, Slovenia; [Hopper, John L.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt MEGA Epidemiol, Melbourne, Vic 3010, Australia; [Ingvar, Christian; Olsson, Hakan] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden; [Kanetsky, Peter A.] Univ Penn, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kefford, Richard F.; Mann, Graham J.] Univ Sydney, Westmead Inst Canc Res, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Kefford, Richard F.; Mann, Graham J.] Melanoma Inst Australia, Westmead, NSW, Australia; [Landi, Maria Teresa; Goldstein, Alisa M.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Lang, Julie; Mackie, Rona] Univ Glasgow, Dept Med Genet, Glasgow G12 8QQ, Lanark, Scotland; [Mackie, Rona] Univ Glasgow, Dept Publ Hlth & Hlth Policy, Glasgow G12 8QQ, Lanark, Scotland; [Malvehy, Josep; Puig, Susana] Hosp Clin Barcelona, Melanoma Unit, Dept Dermatol, IDIBAPS, E-08036 Barcelona, Spain; [Malvehy, Josep; Puig, Susana] CIBER Enfermedades Raras, Barcelona, Spain; [Martin, Nicholas G.; Montgomery, Grant W.; Hayward, Nicholas K.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [van Nieuwpoort, Frans A.; Gruis, Nelleke A.] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands; [Brown, Kevin M.] Translat Genom Res Inst, Melanoma Genom Lab, Phoenix, AZ USA; [Gillanders, Elizabeth M.] NHGRI, Inherited Dis Res Branch, NIH, Baltimore, MD USA; [Galan, Pilar] CRNH Idf, INSERM, INRA, CNAM,UMR U557,U1125, Bobigny, France; [Elder, David E.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Cancer Research UK; Saint James's University Hospital; University of Leeds; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Genoa; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Ospedale Maurizio Bufalini; Utah System of Higher Education; University of Utah; Pomeranian Medical University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Institute of Oncology - Slovenia; University of Melbourne; Lund University; Skane University Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Sydney; Westmead Institute for Medical Research; Melanoma Institute Australia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Glasgow; University of Glasgow; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; QIMR Berghofer Medical Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Translational Genomics Research Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Pennsylvania	Bishop, DT (corresponding author), St James Univ Hosp, Epidemiol & Biostat Sect, Leeds Inst Mol Med, Canc Res UK Clin Ctr Leeds, Leeds LS9 7TF, W Yorkshire, England.	d.t.bishop@leeds.ac.uk	Gut, Ivo/ABF-3188-2020; Ghiorzo, Paola/CAG-0673-2022; Scarrà, Giovanna Bianchi/G-8933-2014; Calista, Donato/AAM-1567-2020; hayward, nicholas k/C-1367-2015; Montgomery, Grant W/B-7148-2008; Bakker, Egbert/D-3525-2009; Weiss, Marjan M/AAN-4979-2020; Paillerets, Brigitte Bressac-de/D-8954-2018; Puig, Susana/AAB-2091-2020; Ingvar, Christian/AAE-9841-2019; Höiom, Veronica/F-4153-2012; hayward, nick/AAV-8802-2020; Pilar, Galan/F-2908-2017; Aitken, Joanne F/C-5289-2009; Mann, Graham J/G-4758-2014; Demenais, Florence/G-3298-2013	Gut, Ivo/0000-0001-7219-632X; Ghiorzo, Paola/0000-0002-3651-8173; Scarrà, Giovanna Bianchi/0000-0002-6127-1192; hayward, nicholas k/0000-0003-4760-1033; Montgomery, Grant W/0000-0002-4140-8139; Bakker, Egbert/0000-0002-2843-7357; Weiss, Marjan M/0000-0002-0936-1406; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Puig, Susana/0000-0003-1337-9745; Pilar, Galan/0000-0003-1706-3107; Mann, Graham J/0000-0003-1301-405X; Demenais, Florence/0000-0001-8361-0936; Newton-Bishop, Julia/0000-0001-9147-6802; Gruis, Nelleke/0000-0002-5210-9150; Iles, Mark/0000-0002-2603-6509; Randerson-Moor, Juliette/0000-0003-0303-0072; Novakovic, Srdjan/0000-0002-8888-4810; Olsson, Hakan/0000-0002-8794-9635; Kefford, Richard/0000-0001-9251-9229; Aitken, Joanne Frances/0000-0001-6859-2186; Bishop, Tim/0000-0002-8752-8785; Martin, Nicholas/0000-0003-4069-8020; Barrett, Jenny/0000-0002-1720-7724; malvehy, josep/0000-0002-6998-914X; albright, lisa/0000-0003-2602-3668	NATIONAL CANCER INSTITUTE [R01CA083115, R01CA102422, R01CA088363] Funding Source: NIH RePORTER; Cancer Research UK [10589, C588/A4994, A4994] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R01 CA5558, R01 CA083115-08, R01 CA102422, R01 ROI CA83115, R0-1 CA 83115, R01 CA083115, CA88363] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bataille V, 1996, BRIT J CANCER, V73, P1605, DOI 10.1038/bjc.1996.302; Baxter AJ, 2008, TWIN RES HUM GENET, V11, P183, DOI 10.1375/twin.11.2.183; Berwick M, 2006, CANCER EPIDEM BIOMAR, V15, P1520, DOI 10.1158/1055-9965.EPI-06-0270; Bishop JAN, 2000, J INVEST DERMATOL, V114, P28, DOI 10.1046/j.1523-1747.2000.00823.x; Borg A, 2000, J NATL CANCER I, V92, P1260, DOI 10.1093/jnci/92.15.1260; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cannon-Albright L A, 1991, Important Adv Oncol, P39; Chang YM, 2009, INT J CANCER, V124, P420, DOI 10.1002/ijc.23869; Chaudru V, 2004, JNCI-J NATL CANCER I, V96, P785, DOI 10.1093/jnci/djh136; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Debniak T, 2008, EUR J CANCER, V44, P110, DOI 10.1016/j.ejca.2007.10.006; Elwood JM, 1997, INT J CANCER, V73, P198, DOI 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Holland EA, 1995, ONCOGENE, V11, P2289; Holland EA, 1999, GENE CHROMOSOME CANC, V25, P339, DOI 10.1002/(SICI)1098-2264(199908)25:4<339::AID-GCC5>3.0.CO;2-H; Hollenbeak CS, 2005, CANCER, V104, P1962, DOI 10.1002/cncr.21404; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P934, DOI 10.1093/oxfordjournals.aje.a117360; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; Kanetsky PA, 2006, CANCER RES, V66, P9330, DOI 10.1158/0008-5472.CAN-06-1634; Landi MT, 2004, J MED GENET, V41, P557, DOI 10.1136/jmg.2003.016907; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Naldi L, 2005, ANN EPIDEMIOL, V15, P545, DOI 10.1016/j.annepidem.2004.10.005; Newton-Bishop JA, 1999, BRIT J CANCER, V80, P295, DOI 10.1038/sj.bjc.6690354; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pastorino L, 2008, PIGM CELL MELANOMA R, V21, P700, DOI 10.1111/j.1755-148X.2008.00512.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peric B, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-86; Platz A, 1997, J NATL CANCER I, V89, P697, DOI 10.1093/jnci/89.10.697; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Puig S, 2005, J CLIN ONCOL, V23, P3043, DOI 10.1200/JCO.2005.08.034; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Titus-Ernstoff L, 2005, INT J CANCER, V116, P144, DOI 10.1002/ijc.21001; Whiteman DC, 2008, GUT, V57, P173, DOI 10.1136/gut.2007.131375	42	341	346	4	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					920	U85		10.1038/ng.411	http://dx.doi.org/10.1038/ng.411			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19578364	Green Accepted			2022-12-17	WOS:000268432900018
J	Suzuki, H; Forrest, ARR; van Nimwegen, E; Daub, CO; Balwierz, PJ; Irvine, KM; Lassmann, T; Ravasi, T; Hasegawa, Y; de Hoon, MJL; Katayama, S; Schroder, K; Carninci, P; Tomaru, Y; Kanamori-Katayama, M; Kubosaki, A; Akalin, A; Ando, Y; Arner, E; Asada, M; Asahara, H; Bailey, T; Bajic, VB; Bauer, D; Beckhouse, AG; Bertin, N; Bjorkegren, J; Brombacher, F; Bulger, E; Chalk, AM; Chiba, J; Cloonan, N; Dawe, A; Dostie, J; Engstrom, PG; Essack, M; Faulkner, GJ; Fink, JL; Fredman, D; Fujimori, K; Furuno, M; Gojobori, T; Gough, J; Grimmond, SM; Gustafsson, M; Hashimoto, M; Hashimoto, T; Hatakeyama, M; Heinzel, S; Hide, W; Hofmann, O; Hornquist, M; Huminiecki, L; Ikeo, K; Imamoto, N; Inoue, S; Inoue, Y; Ishihara, R; Iwayanagi, T; Jacobsen, A; Kaur, M; Kawaji, H; Kerr, MC; Kimura, R; Kimura, S; Kimura, Y; Kitano, H; Koga, H; Kojima, T; Kondo, S; Konno, T; Krogh, A; Kruger, A; Kumar, A; Lenhard, B; Lennartsson, A; Lindow, M; Lizio, M; MacPherson, C; Maeda, N; Maher, CA; Maqungo, M; Mar, J; Matigian, NA; Matsuda, H; Mattick, JS; Meier, S; Miyamoto, S; Miyamoto-Sato, E; Nakabayashi, K; Nakachi, Y; Nakano, M; Nygaard, S; Okayama, T; Okazaki, Y; Okuda-Yabukami, H; Orlando, V; Otomo, J; Pachkov, M; Petrovsky, N; Plessy, C; Quackenbush, J; Radovanovic, A; Rehli, M; Saito, R; Sandelin, A; Schmeier, S; Schonbach, C; Schwartz, AS; Semple, CA; Sera, M; Severin, J; Shirahige, K; Simons, C; Laurent, GS; Suzuki, M; Suzuki, T; Sweet, MJ; Taft, RJ; Takeda, S; Takenaka, Y; Tan, K; Taylor, MS; Teasdale, RD; Tegner, J; Teichmann, S; Valen, E; Wahlestedt, C; Waki, K; Waterhouse, A; AWells, C; Winther, O; Wu, L; Yamaguchi, K; Yanagawa, H; Yasuda, J; Zavolan, M; Hume, DA; Arakawa, T; Fukuda, S; Imamura, K; Kai, C; Kaiho, A; Kawashima, T; Kawazu, C; Kitazume, Y; Kojima, M; Miura, H; Murakami, K; Murata, M; Ninomiya, N; Nishiyori, H; Noma, S; Ogawa, C; Sano, T; Simon, C; Tagami, M; Takahashi, Y; Kawai, J; Hayashizaki, Y				Suzuki, Harukazu; Forrest, Alistair R. R.; van Nimwegen, Erik; Daub, Carsten O.; Balwierz, Piotr J.; Irvine, Katharine M.; Lassmann, Timo; Ravasi, Timothy; Hasegawa, Yuki; de Hoon, Michiel J. L.; Katayama, Shintaro; Schroder, Kate; Carninci, Piero; Tomaru, Yasuhiro; Kanamori-Katayama, Mutsumi; Kubosaki, Atsutaka; Akalin, Altuna; Ando, Yoshinari; Arner, Erik; Asada, Maki; Asahara, Hiroshi; Bailey, Timothy; Bajic, Vladimir B.; Bauer, Denis; Beckhouse, Anthony G.; Bertin, Nicolas; Bjorkegren, Johan; Brombacher, Frank; Bulger, Erika; Chalk, Alistair M.; Chiba, Joe; Cloonan, Nicole; Dawe, Adam; Dostie, Josee; Engstrom, Par G.; Essack, Magbubah; Faulkner, Geoffrey J.; Fink, J. Lynn; Fredman, David; Fujimori, Ko; Furuno, Masaaki; Gojobori, Takashi; Gough, Julian; Grimmond, Sean M.; Gustafsson, Mika; Hashimoto, Megumi; Hashimoto, Takehiro; Hatakeyama, Mariko; Heinzel, Susanne; Hide, Winston; Hofmann, Oliver; Hornquist, Michael; Huminiecki, Lukasz; Ikeo, Kazuho; Imamoto, Naoko; Inoue, Satoshi; Inoue, Yusuke; Ishihara, Ryoko; Iwayanagi, Takao; Jacobsen, Anders; Kaur, Mandeep; Kawaji, Hideya; Kerr, Markus C.; Kimura, Ryuichiro; Kimura, Syuhei; Kimura, Yasumasa; Kitano, Hiroaki; Koga, Hisashi; Kojima, Toshio; Kondo, Shinji; Konno, Takeshi; Krogh, Anders; Kruger, Adele; Kumar, Ajit; Lenhard, Boris; Lennartsson, Andreas; Lindow, Morten; Lizio, Marina; MacPherson, Cameron; Maeda, Norihiro; Maher, Christopher A.; Maqungo, Monique; Mar, Jessica; Matigian, Nicholas A.; Matsuda, Hideo; Mattick, John S.; Meier, Stuart; Miyamoto, Sei; Miyamoto-Sato, Etsuko; Nakabayashi, Kazuhiko; Nakachi, Yutaka; Nakano, Mika; Nygaard, Sanne; Okayama, Toshitsugu; Okazaki, Yasushi; Okuda-Yabukami, Haruka; Orlando, Valerio; Otomo, Jun; Pachkov, Mikhail; Petrovsky, Nikolai; Plessy, Charles; Quackenbush, John; Radovanovic, Aleksandar; Rehli, Michael; Saito, Rintaro; Sandelin, Albin; Schmeier, Sebastian; Schonbach, Christian; Schwartz, Ariel S.; Semple, Colin A.; Sera, Miho; Severin, Jessica; Shirahige, Katsuhiko; Simons, Cas; Laurent, George St.; Suzuki, Masanori; Suzuki, Takahiro; Sweet, Matthew J.; Taft, Ryan J.; Takeda, Shizu; Takenaka, Yoichi; Tan, Kai; Taylor, Martin S.; Teasdale, Rohan D.; Tegner, Jesper; Teichmann, Sarah; Valen, Eivind; Wahlestedt, Claes; Waki, Kazunori; Waterhouse, Andrew; AWells, Christine; Winther, Ole; Wu, Linda; Yamaguchi, Kazumi; Yanagawa, Hiroshi; Yasuda, Jun; Zavolan, Mihaela; Hume, David A.; Arakawa, Takahiro; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Kaiho, Ai; Kawashima, Tsugumi; Kawazu, Chika; Kitazume, Yayoi; Kojima, Miki; Miura, Hisashi; Murakami, Kayoko; Murata, Mitsuyoshi; Ninomiya, Noriko; Nishiyori, Hiromi; Noma, Shohei; Ogawa, Chihiro; Sano, Takuma; Simon, Christophe; Tagami, Michihira; Takahashi, Yukari; Kawai, Jun; Hayashizaki, Yoshihide		FANTOM Consortium; Riken Omics Sci Ctr	The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line	NATURE GENETICS			English	Article							SERUM RESPONSE FACTOR; MONOCYTE-MACROPHAGE MATURATION; MESSENGER-RNA EXPRESSION; FACTOR-BINDING-SITES; GENE-EXPRESSION; SIGNALING PATHWAYS; STEM-CELLS; GENOME; PHOSPHORYLATION; PROLIFERATION	Using deep sequencing (deepCAGE), the FANTOM4 study measured the genome-wide dynamics of transcription-start-site usage in the human monocytic cell line THP-1 throughout a time course of growth arrest and differentiation. Modeling the expression dynamics in terms of predicted cis-regulatory sites, we identified the key transcription regulators, their time-dependent activities and target genes. Systematic siRNA knockdown of 52 transcription factors confirmed the roles of individual factors in the regulatory network. Our results indicate that cellular states are constrained by complex networks involving both positive and negative regulatory interactions among substantial numbers of transcription factors and that no single transcription factor is both necessary and sufficient to drive the differentiation process.	[Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Suzuki, Harukazu; Forrest, Alistair R. R.; Daub, Carsten O.; Lassmann, Timo; Hasegawa, Yuki; de Hoon, Michiel J. L.; Katayama, Shintaro; Carninci, Piero; Tomaru, Yasuhiro; Kanamori-Katayama, Mutsumi; Kubosaki, Atsutaka; Ando, Yoshinari; Arner, Erik; Bertin, Nicolas; Bulger, Erika; Furuno, Masaaki; Hashimoto, Takehiro; Ishihara, Ryoko; Kawaji, Hideya; Kimura, Yasumasa; Kondo, Shinji; Lennartsson, Andreas; Lizio, Marina; Maeda, Norihiro; Nakano, Mika; Okuda-Yabukami, Haruka; Plessy, Charles; Severin, Jessica; Suzuki, Masanori; Suzuki, Takahiro; Waki, Kazunori; Waterhouse, Andrew; Yamaguchi, Kazumi; Yasuda, Jun] RIKEN, Yokohama Inst, Omics Sci Ctr, Kanagawa, Japan; [Forrest, Alistair R. R.; Beckhouse, Anthony G.; Chalk, Alistair M.; Matigian, Nicholas A.; AWells, Christine] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [van Nimwegen, Erik; Balwierz, Piotr J.; Pachkov, Mikhail; Zavolan, Mihaela] Univ Basel, Bioctr, CH-4056 Basel, Switzerland; [van Nimwegen, Erik; Balwierz, Piotr J.; Pachkov, Mikhail; Zavolan, Mihaela] Swiss Inst Bioinformat, Basel, Switzerland; [Irvine, Katharine M.; Schroder, Kate; Bailey, Timothy; Bauer, Denis] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Ravasi, Timothy; Schwartz, Ariel S.; Tan, Kai] Univ Calif San Diego, Jacobs Sch Engn, Dept Bioengn, La Jolla, CA 92093 USA; [Akalin, Altuna; Engstrom, Par G.; Fredman, David; Lenhard, Boris] Bergen Ctr Computat Sci, Bergen, Norway; [Asada, Maki; Asahara, Hiroshi; Hashimoto, Megumi] Natl Res Inst Child Hlth & Dev, Tokyo, Japan; [Bajic, Vladimir B.; Dawe, Adam; Essack, Magbubah; Hide, Winston; Hofmann, Oliver; Kaur, Mandeep; Kruger, Adele; MacPherson, Cameron; Maqungo, Monique; Meier, Stuart; Radovanovic, Aleksandar; Schmeier, Sebastian; AWells, Christine] Univ Western Cape, S African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa; [Bjorkegren, Johan; Tegner, Jesper] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Computat Med Grp,Atherosclerosis Res Unit,Ctr Mol, Stockholm, Sweden; [Brombacher, Frank] Univ Cape Town, Fac Hlth Sci, IIDMM, Observatory, South Africa; [Chiba, Joe; Kimura, Ryuichiro; Nakabayashi, Kazuhiko] Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo 162, Japan; [Cloonan, Nicole; Faulkner, Geoffrey J.; Grimmond, Sean M.; Mattick, John S.; Simons, Cas; Taft, Ryan J.] Univ Queensland, Inst Mol Biosci, Special Res Ctr Funct & Appl Genom, ARC, St Lucia, Qld, Australia; [Dostie, Josee] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Fink, J. Lynn; Kerr, Markus C.; Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, Ctr Excellence Bioinformat, ARC, St Lucia, Qld, Australia; [Fujimori, Ko] Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Osaka 580, Japan; [Gojobori, Takashi; Ikeo, Kazuho; Konno, Takeshi; Miyamoto, Sei; Okayama, Toshitsugu; Sera, Miho] Natl Inst Genet, Res Org Informat & Syst, Ctr Informat Biol, Shizuoka, Japan; [Gojobori, Takashi; Ikeo, Kazuho; Konno, Takeshi; Miyamoto, Sei; Okayama, Toshitsugu; Sera, Miho] Natl Inst Genet, DDBJ, Shizuoka, Japan; [Gough, Julian] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Gustafsson, Mika; Hornquist, Michael] Linkoping Univ, Dept Sci & Technol, Norrkoping, Sweden; [Hatakeyama, Mariko; Kojima, Toshio] RIKEN, Yokohama Inst, Genom Sci Ctr, Computat & Expt Syst Biol Grp, Kanagawa, Japan; [Heinzel, Susanne; Petrovsky, Nikolai] Flinders Univ & Med Ctr, Dept Endocrinol & Diabet, Adelaide, SA, Australia; [Hide, Winston; Hofmann, Oliver] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Huminiecki, Lukasz] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Imamoto, Naoko] RIKEN, Wako Inst, Discovery & Res Inst, Cellular Dynam Lab, Saitama, Japan; [Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Inoue, Satoshi] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Inoue, Yusuke] Gunma Univ, Fac Engn, Dept Biol & Chem Engn, Gunma, Japan; [Iwayanagi, Takao] Hitachi Ltd, Res & Dev Grp, R&D Solut Ctr, Tokyo, Japan; [Jacobsen, Anders; Krogh, Anders; Lindow, Morten; Nygaard, Sanne; Sandelin, Albin; Valen, Eivind; Winther, Ole] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Jacobsen, Anders; Krogh, Anders; Lindow, Morten; Nygaard, Sanne; Sandelin, Albin; Valen, Eivind; Winther, Ole] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Kimura, Syuhei] Tottori Univ, Fac Engn, Dept Informat & Knowledge Engn, Tottori 680, Japan; [Kitano, Hiroaki] Syst Biol Inst, Shibuya Ku, Tokyo, Japan; [Koga, Hisashi] Kazusa DNA Res Inst, Dept Human Gene Res, Chiba, Japan; [Kumar, Ajit; Laurent, George St.] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Mar, Jessica; Quackenbush, John] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA; [Matsuda, Hideo; Takenaka, Yoichi] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka, Japan; [Miyamoto-Sato, Etsuko; Yanagawa, Hiroshi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan; [Nakachi, Yutaka; Okazaki, Yasushi] Saitama Med Sch, Res Ctr Genom Med, Div Funct Genom & Syst Med, Saitama, Japan; [Orlando, Valerio] IRCCS Fdn Santa Lucia EBRI, Dulbecco Telethon Inst, Rome, Italy; [Orlando, Valerio] IGB CNR, Naples, Italy; [Otomo, Jun; Takeda, Shizu] Hitachi Ltd, Cent Res Labs, Tokyo, Japan; [Rehli, Michael] Univ Regensburg, Dept Hematol & Oncol, Regensburg, Germany; [Saito, Rintaro] Keio Univ, Fac Environm & Informat Studies, Kanagawa, Japan; [Schonbach, Christian] Nanyang Technol Univ, Div Genom & Genet, Sch Biol Sci, Singapore, Singapore; [Semple, Colin A.] Western Gen Hosp, Human Genet Unit, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [Shirahige, Katsuhiko] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Comp Sci, Tokyo 152, Japan; [Sweet, Matthew J.] Univ Queensland, CRC Chron Inflammatory Dis, Sch Mol & Microbial Sci, Inst Mol Biosci, St Lucia, Qld, Australia; [Taylor, Martin S.] EMBL European Bioinformat Inst, Cambridge, England; [Tegner, Jesper] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Teichmann, Sarah] MRC, Mol Biol Lab, Struct Studies Div, Cambridge CB2 2QH, England; [Wahlestedt, Claes] Scripps Res Inst, Jupiter, FL USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; RIKEN; Griffith University; University of Basel; Swiss Institute of Bioinformatics; University of Queensland; University of California System; University of California San Diego; National Center for Child Health & Development - Japan; South African National Biodiversity Institute; University of the Western Cape; Karolinska Institutet; Karolinska University Hospital; University of Cape Town; Tokyo University of Science; University of Queensland; McGill University; University of Queensland; Osaka University of Pharmaceutical Sciences; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Bristol; Linkoping University; RIKEN; Flinders University South Australia; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; RIKEN; University of Tokyo; University of Tokyo; Gunma University; Hitachi Limited; University of Copenhagen; University of Copenhagen; Tottori University; Kazusa DNA Research Institute; George Washington University; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Osaka University; Keio University; Saitama Medical University; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Hitachi Limited; University of Regensburg; Keio University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Edinburgh; Tokyo Institute of Technology; University of Queensland; European Molecular Biology Laboratory (EMBL); Linkoping University; MRC Laboratory Molecular Biology; Scripps Research Institute	Hume, DA (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	david.hume@roslin.ed.ac.uk; yosihide@gsc.riken.jp	Lassmann, Timo/A-8271-2008; Faulkner, Geoffrey J/M-3168-2014; Lassmann, Timo/HCH-4313-2022; Katayama, Shintaro/F-2958-2010; Semple, Colin A M/A-5613-2009; Teasdale, Rohan D/B-2538-2009; Hide, Winston Hide/C-7217-2009; Daub, Carsten O/A-7436-2010; Kimura, Yasumasa/M-9720-2013; Chalk, Alistair/O-3522-2019; Zavolan, Mihaela/S-3888-2016; Mattick, John S/I-7789-2012; Valen, Eivind/A-8617-2011; Petrovsky, Nikolai/P-1912-2017; Skanderup, Anders Jacobsen/K-1081-2013; Sweet, Matthew J/F-2229-2011; Nygaard, Sanne/M-2569-2014; Wells, Christine A/A-5071-2010; Matigian, Nicholas A/A-4935-2009; Hayashizaki, Yoshihide/N-6590-2015; Arner, Erik/A-1895-2010; Dawe, Adam/C-5295-2009; Inoue, Yusuke/O-6207-2018; Teasdale, Rohan/AAD-6698-2019; Imamoto, Naoko/A-7458-2015; Radovanovic, Aleksandar/M-3687-2019; Ando, Yoshinari/AAK-5668-2020; Kawai, Jun/A-6451-2016; tegner, jesper N/R-5095-2017; Okada, Mariko/N-6933-2015; Schroder, Kate/C-6132-2008; Hide, Winston/R-3815-2019; AKALIN, ALTUNA/A-4424-2012; Irvine, Katharine M/A-5559-2011; Fredman, David J/H-3566-2013; de Hoon, Michiel/A-6443-2013; Tomic, Nevena/AAA-2135-2021; Beckhouse, Anthony G/A-2601-2010; Suzuki, Harukazu/N-9553-2015; Grimmond, Sean M/J-5304-2016; Hide, Winston A/V-2727-2017; Hume, David A/C-7695-2013; Taft, Ryan/B-2945-2010; Bertin, Nicolas/O-9602-2019; Bauer, Denis/C-3903-2009; Simons, Cas/A-7905-2011; Kaur, Mandeep/N-4550-2015; Essack, Magbubah/G-5008-2013; Schmeier, Sebastian/D-4731-2011; Fink, Lynn/C-2031-2008; Mattick, John/ABH-6130-2020; Matigian, Nicholas/AAF-9390-2020; Carninci, Piero/K-1568-2014; Kawaji, Hideya/N-5116-2015; Taylor, Martin S/C-3825-2009; Ravasi, Timothy/B-8777-2008; Kerr, Markus C/A-9864-2014; Plessy, Charles/N-5054-2015; Lennartsson, Andreas/E-7823-2011; Severin, Jessica/AAQ-2723-2020; Suzuki, Takahiro/AAW-8509-2020; Fujimori, Ko/AAD-5428-2021; Grimmond, Sean/K-3246-2019; Rehli, Michael/E-9093-2011; Radovanovic, Aleksandar/D-1313-2012; Nakachi, Yutaka/M-2446-2013; Schönbach, Christian/B-1998-2009; Essack, Magbubah/R-2773-2019; Forrest, Alistair/A-6597-2008; van Nimwegen, Erik/ABF-1085-2021; Sandelin, Albin/G-2881-2011; Cloonan, Nicole/B-5272-2008; Hofmann, Oliver M/F-1800-2013; Krogh, Anders/M-1541-2014; Bertin, Nicolas/C-3025-2008; Waki, Kazunori/T-6444-2019; Bajic, Vladimir/D-2810-2009	Lassmann, Timo/0000-0002-0138-2691; Faulkner, Geoffrey J/0000-0001-5769-4494; Lassmann, Timo/0000-0002-0138-2691; Katayama, Shintaro/0000-0001-7581-5157; Semple, Colin A M/0000-0003-1765-4118; Teasdale, Rohan D/0000-0001-7455-5269; Hide, Winston Hide/0000-0002-8621-3271; Daub, Carsten O/0000-0002-3295-8729; Chalk, Alistair/0000-0002-9630-6236; Mattick, John S/0000-0002-7680-7527; Petrovsky, Nikolai/0000-0002-1580-5245; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Sweet, Matthew J/0000-0002-0406-8139; Nygaard, Sanne/0000-0002-3002-6047; Wells, Christine A/0000-0003-3133-3628; Matigian, Nicholas A/0000-0001-7735-9415; Arner, Erik/0000-0003-1225-4908; Inoue, Yusuke/0000-0002-9710-7482; Teasdale, Rohan/0000-0001-7455-5269; Imamoto, Naoko/0000-0002-2886-3022; Radovanovic, Aleksandar/0000-0002-8749-7608; Ando, Yoshinari/0000-0002-8128-6201; tegner, jesper N/0000-0002-9568-5588; Schroder, Kate/0000-0001-9261-3805; Hide, Winston/0000-0002-8621-3271; AKALIN, ALTUNA/0000-0002-0468-0117; Irvine, Katharine M/0000-0002-6716-1605; Fredman, David J/0000-0003-3507-0554; Beckhouse, Anthony G/0000-0002-5141-8250; Suzuki, Harukazu/0000-0002-8087-0836; Grimmond, Sean M/0000-0002-8102-7998; Hide, Winston A/0000-0002-8621-3271; Bauer, Denis/0000-0001-8033-9810; Simons, Cas/0000-0003-3147-8042; Kaur, Mandeep/0000-0002-9757-4048; Essack, Magbubah/0000-0003-2709-5356; Schmeier, Sebastian/0000-0002-3947-8226; Fink, Lynn/0000-0003-2912-6048; Mattick, John/0000-0002-7680-7527; Matigian, Nicholas/0000-0001-7735-9415; Carninci, Piero/0000-0001-7202-7243; Kawaji, Hideya/0000-0002-0575-0308; Taylor, Martin S/0000-0001-7656-330X; Plessy, Charles/0000-0001-7410-6295; Severin, Jessica/0000-0003-1274-208X; Suzuki, Takahiro/0000-0002-0972-6911; Fujimori, Ko/0000-0002-2506-0769; Grimmond, Sean/0000-0002-8102-7998; Rehli, Michael/0000-0003-3992-932X; Radovanovic, Aleksandar/0000-0002-8749-7608; Nakachi, Yutaka/0000-0003-1964-2495; Schönbach, Christian/0000-0002-0693-7617; Forrest, Alistair/0000-0003-4543-1675; van Nimwegen, Erik/0000-0001-6338-1312; Sandelin, Albin/0000-0002-7109-7378; Cloonan, Nicole/0000-0001-7802-6647; Hofmann, Oliver M/0000-0002-7738-1513; Mar, Jessica/0000-0002-5147-9299; Quackenbush, John/0000-0002-2702-5879; Ravasi, Timothy/0000-0002-9950-465X; Krogh, Anders/0000-0002-5147-6282; Bertin, Nicolas/0000-0002-9835-9606; Huminiecki, Lukasz/0000-0003-1943-4450; Ando, Yukio/0000-0001-7115-9105; Teichmann, Sarah/0000-0002-6294-6366; Zavolan, Mihaela/0000-0002-8832-2041; de Hoon, Michiel/0000-0003-0489-2352; Tan, Kai/0000-0002-9104-5567; Lennartsson, Andreas/0000-0002-3272-2505; MacPherson, Cameron/0000-0002-8945-9736; Winther, Ole/0000-0002-1966-3205; Heinzel, Susanne/0000-0001-9524-2835; Okazaki, Yasushi/0000-0003-3241-5502; Hume, David/0000-0002-2615-1478; Valen, Eivind/0000-0003-1840-6108; Engstrom, Par/0000-0001-5265-2121; Waki, Kazunori/0000-0001-7311-7208; Bajic, Vladimir/0000-0001-5435-4750; Yasuda, Jun/0000-0002-3887-6871; Lenhard, Boris/0000-0002-1114-1509; Matsuda, Hideo/0000-0002-4701-3779	Ministry of Education, Culture, Sports, Science and Technology, Japan; RIKEN Frontier Research System, Functional RNA research program; Australian National Health and Medical Research Council [ID 428261]; SNF [SNF 3100A0-118318]; MRC [MC_U105161047] Funding Source: UKRI; Grants-in-Aid for Scientific Research [21570151] Funding Source: KAKEN; Medical Research Council [G9900991B, MC_U105161047] Funding Source: researchfish; Fondazione Telethon Funding Source: Custom	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Frontier Research System, Functional RNA research program; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); SNF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fondazione Telethon(Fondazione Telethon)	We thank A. Ambesi, H. Atsui, M. Bansal, V. Belcastro, H. Daub, D. di Bernardo, M. Furuya, A. Hasegawa, K. Hayashida, A. Hirakiyama, F. Hori, K. Koseki, S. Kuhara, N. Miyamoto, S. Miyano, M. Nishikawa, C. Ohinata, M. Persson, S. Saihara, C. Sakaba, H. Sano, E. Shibazaki, T. Takagi, K. Toyoda, Y. Tsujimura and M. Yamamoto for discussion, encouragement and technical assistance. We thank M. Muramatsu, T. Ogawa, Y. Sakaki and A. Wada for support and encouragement. This work was mainly supported by grants for the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Y. H.), Research Grant for the RIKEN Genome Exploration Research Project from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (Y. H.) and the RIKEN Frontier Research System, Functional RNA research program (Y. H.). A. R. R. F. is supported by a CJ Martin Fellowship from the Australian National Health and Medical Research Council (ID 428261). E. v. N. acknowledges support from SNF grant SNF # 3100A0-118318.	ABRINK M, 1994, LEUKEMIA, V8, P1579; ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Biggs JR, 1998, CELL GROWTH DIFFER, V9, P667; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bussemaker HJ, 2007, ANNU REV BIOPH BIOM, V36, P329, DOI 10.1146/annurev.biophys.36.040306.132725; Carey JO, 1996, BLOOD, V87, P4316, DOI 10.1182/blood.V87.10.4316.bloodjournal87104316; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carter JH, 2007, J IMMUNOL, V178, P3038, DOI 10.4049/jimmunol.178.5.3038; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cooper SJ, 2007, GENOME RES, V17, P136, DOI 10.1101/gr.5875007; Das D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100067; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Fleige A, 2007, J BIOL CHEM, V282, P24320, DOI 10.1074/jbc.M703119200; Foster N, 2007, J LEUKOCYTE BIOL, V81, P893, DOI 10.1189/jlb.0206086; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044; Iyer D, 2006, P NATL ACAD SCI USA, V103, P4516, DOI 10.1073/pnas.0505338103; KAUFFMAN SA, 1993, ORIGINS ORDER SELF O; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Krishnaraju K, 1998, BLOOD, V92, P1957, DOI 10.1182/blood.V92.6.1957.418k24_1957_1966; Martino V, 2006, ONCOL REP, V15, P207; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Morton S, 2004, FEBS LETT, V572, P177, DOI 10.1016/j.febslet.2004.07.031; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Nguyen DH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100054; Odero MD, 2000, GENE CHROMOSOME CANC, V29, P333, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1040>3.3.CO;2-Q; Pession A, 2003, ONCOGENE, V22, P8671, DOI 10.1038/sj.onc.1207125; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; REDDY MA, 1994, J EXP MED, V180, P2309, DOI 10.1084/jem.180.6.2309; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Schmitz G, 2008, REV PHYSIOL BIOCH P, V160, P93, DOI 10.1007/112_2008_802; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TREJO J, 1994, J BIOL CHEM, V269, P21682; TSUCHIYA S, 1982, CANCER RES, V42, P1530; van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507	49	341	347	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					553	562		10.1038/ng.375	http://dx.doi.org/10.1038/ng.375			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19377474	Green Accepted			2022-12-17	WOS:000265575600016
J	Tregouet, DA; Konig, IR; Erdmann, J; Munteanu, A; Braund, PS; Hall, AS; Grosshennig, A; Linsel-Nitschke, P; Perret, C; DeSuremain, M; Meitinger, T; Wright, BJ; Preuss, M; Balmforth, AJ; Ball, SG; Meisinger, C; Germain, C; Evans, A; Arveiler, D; Luc, G; Ruidavets, JB; Morrison, C; van der Harst, P; Schreiber, S; Neureuther, K; Schafer, A; Bugert, P; El Mokhtari, NE; Schrezenmeir, J; Stark, K; Rubin, D; Wichmann, HE; Hengstenberg, C; Ouwehand, W; Ziegler, A; Tiret, L; Thompson, JR; Cambien, F; Schunkert, H; Samani, NJ				Tregouet, David-Alexandre; Koenig, Inke R.; Erdmann, Jeanette; Munteanu, Alexandru; Braund, Peter S.; Hall, Alistair S.; Grosshennig, Anika; Linsel-Nitschke, Patrick; Perret, Claire; DeSuremain, Maylis; Meitinger, Thomas; Wright, Ben J.; Preuss, Michael; Balmforth, Anthony J.; Ball, Stephen G.; Meisinger, Christa; Germain, Cecile; Evans, Alun; Arveiler, Dominique; Luc, Gerald; Ruidavets, Jean-Bernard; Morrison, Caroline; van der Harst, Pim; Schreiber, Stefan; Neureuther, Katharina; Schaefer, Arne; Bugert, Peter; El Mokhtari, Nour E.; Schrezenmeir, Juergen; Stark, Klaus; Rubin, Diana; Wichmann, H-Erich; Hengstenberg, Christian; Ouwehand, Willem; Ziegler, Andreas; Tiret, Laurence; Thompson, John R.; Cambien, Francois; Schunkert, Heribert; Samani, Nilesh J.		Wellcome Trust Case Control Consor; Cardiogenics Consortium	Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease	NATURE GENETICS			English	Article							APOLIPOPROTEIN(A) GENE; MYOCARDIAL-INFARCTION; LIPOPROTEIN(A) LEVELS; HEART-DISEASE; POLYMORPHISMS; ECTIM	We identify the SLC22A3-LPAL2-LPA gene cluster as a strong susceptibility locus for coronary artery disease (CAD) through a genome-wide haplotype association (GWHA) study. This locus was not identified from previous genome-wide association (GWA) studies focused on univariate analyses of SNPs. The proposed approach may have wide utility for analyzing GWA data for other complex traits.	[Tregouet, David-Alexandre; Munteanu, Alexandru; Perret, Claire; DeSuremain, Maylis; Tiret, Laurence; Cambien, Francois] Univ Paris 06, INSERM, UMR S 525, F-75013 Paris, France; [Koenig, Inke R.; Grosshennig, Anika; Preuss, Michael; Ziegler, Andreas] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Erdmann, Jeanette; Grosshennig, Anika; Linsel-Nitschke, Patrick; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Braund, Peter S.; van der Harst, Pim; Samani, Nilesh J.] Univ Leicester, Clin Sci Wing, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Hall, Alistair S.; Balmforth, Anthony J.; Ball, Stephen G.] Univ Leeds, LIGHT, Leeds LS1 3EX, W Yorkshire, England; [Meitinger, Thomas; Meisinger, Christa; Wichmann, H-Erich] Deutsch Forschungszentrum Umwelt & Gesundheit, Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Neuherberg, Germany; [Wright, Ben J.; Thompson, John R.] Univ Leicester, Dept Hlth Sci & Genet, Leicester LE1 7RH, Leics, England; [Germain, Cecile] Univ Paris 11, CNRS, UMR S 8623, Rech Informat Lab, F-91403 Orsay, France; [Evans, Alun] Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT7 1NN, Antrim, North Ireland; [Arveiler, Dominique] Multinat MONItoring Trends & Determinants CArdiov, Fac Med, Lab Epidemiol & Sante Publ EA1801, F-67085 Strasbourg, France; [Luc, Gerald] Univ Lille 2, Pasteur Inst Lille, INSERM, U545, F-59019 Lille, France; [Ruidavets, Jean-Bernard] MONICA Toulouse, Fac Med, INSERM, U518, F-31073 Toulouse, France; [Morrison, Caroline] Glasgow Royal Infirm, MONICA Project, Glasgow G4 0SF, Lanark, Scotland; [Schreiber, Stefan; Schaefer, Arne; El Mokhtari, Nour E.] Univ Kiel, Inst Klin Mol Biol, D-24105 Kiel, Germany; [Neureuther, Katharina; Stark, Klaus; Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93042 Regensburg, Germany; [Bugert, Peter] Univ Heidelberg, Med Fac Mannheim, Inst Transfus Med & Immunol, Mol Biol Lab, D-69117 Heidelberg, Germany; [Schrezenmeir, Juergen; Rubin, Diana] Inst Physiol & Biochem Ernahrung, Bundesforsch Sanstalt Ernahrung & Lebensmittel, D-24121 Kiel, Germany; [Ouwehand, Willem] Univ Cambridge, Dept Haematol, Cambridge CB2 2PT, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Leeds; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Leicester; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Queens University Belfast; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Glasgow; University of Kiel; University of Regensburg; Ruprecht Karls University Heidelberg; University of Cambridge	Tregouet, DA (corresponding author), Univ Paris 06, INSERM, UMR S 525, F-75013 Paris, France.	david.tregouet@upmc.fr	Stark, Klaus/L-7367-2013; Wichmann, Heinz Erich/AAA-5695-2022; König, Inke R/A-4544-2009; Hall, Alistair/K-1953-2019; Meitinger, Thomas/O-1318-2015; Stark, Klaus/D-3813-2009; Hengstenberg, Christian/U-5485-2019; Erdmann, Jeanette/A-4417-2009; Erdmann, Jeanette/P-7513-2014; Meisinger, Christine/B-5358-2014; Cambien, Francois/AAP-9751-2020; Trégouët, David-Alexandre/P-9210-2019; Tregouet, David-Alexandre/E-3961-2016; Ziegler, Andreas/G-4246-2012	Stark, Klaus/0000-0002-7832-1942; König, Inke R/0000-0003-0504-6465; Stark, Klaus/0000-0002-7832-1942; Erdmann, Jeanette/0000-0002-4486-6231; Trégouët, David-Alexandre/0000-0001-9084-7800; Preuss, Michael/0000-0001-5266-8465; Ziegler, Andreas/0000-0002-8386-5397; Schaefer, Arne/0000-0001-5816-6765; Meisinger, Christa/0000-0002-9026-6544; Meitinger, Thomas/0000-0002-8838-8403; Hall, Alistair/0000-0003-0306-7887	Wellcome Trust; Deutsche Forschungsgemeinschaft; German National Genome Research Network; German Federal Ministry of Education and Research; State of Bavaria; European Union [INFSO-RI-031688]; BHF; Cardiogenics [LSHM-CT-2006-037593]; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German National Genome Research Network; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; European Union(European Commission); BHF(British Heart Foundation); Cardiogenics(European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The WTCCC Study was funded by the Wellcome Trust. Recruitment of cases for the WTCCC Study was carried out by the British Heart Foundation (BHF) Family Heart Study Research Group and supported by the BHF and the UK Medical Research Council. We also acknowledge support of the Wellcome Trust Functional Genomics Initiative in Cardiovascular Genetics. The German Study was supported by the Deutsche Forschungsgemeinschaft, the German Federal Ministry of Education and Research in the context of the German National Genome Research Network (NGFN-2 and NGFN-plus). The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the GSF-National Research Centre for Environment and Health, which is funded by the German Federal Ministry of Education and Research and of the State of Bavaria. This work has also been partially supported by the EGEEII project funded by the European Union INFSO-RI-031688. N. J. S. is supported by a Chair funded by the BHF. The main sponsor of the current analysis is the EU funded integrated project 'Cardiogenics' (LSHM-CT-2006-037593).	BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Brazier L, 1999, ATHEROSCLEROSIS, V144, P323, DOI 10.1016/S0021-9150(98)00333-5; Browning BL, 2008, HUM GENET, V123, P273, DOI 10.1007/s00439-008-0472-1; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Fischer M, 2005, CIRCULATION, V111, P855, DOI 10.1161/01.CIR.0000155611.41961.BB; Gagliardi F, 2005, PHILOS T R SOC A, V363, P1729, DOI 10.1098/rsta.2005.1603; Holmer SR, 2003, CIRCULATION, V107, P696, DOI 10.1161/01.CIR.0000048125.79640.77; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Li Y, 2006, AM J HUM GENET S, VS79, P2290; PARRA HJ, 1992, ARTERIOSCLER THROMB, V12, P701, DOI 10.1161/01.ATV.12.6.701; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226	13	341	349	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2009	41	3					283	285		10.1038/ng.314	http://dx.doi.org/10.1038/ng.314			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19198611	Green Published			2022-12-17	WOS:000263640200007
J	Suzuki, T; Shen, HF; Akagi, K; Morse, HC; Malley, JD; Naiman, DQ; Jenkins, NA; Copeland, NG				Suzuki, T; Shen, HF; Akagi, K; Morse, HC; Malley, JD; Naiman, DQ; Jenkins, NA; Copeland, NG			New genes involved in cancer identified by retroviral tagging	NATURE GENETICS			English	Article							TRANSPOSITION; LYMPHOMA; MAP; PROTOONCOGENE; ACTIVATION; EXPRESSION; INSERTION; DISTANCE; CLONING; REGION	Retroviral insertional mutagenesis in BXH2 and AKXD mice induces a high incidence of myeloid leukemia and B- and T-cell lymphoma, respectively. The retroviral integration sites (RISs) in these tumors thus provide powerful genetic tags for the discovery of genes involved in cancer(1,2). Here we report the first large-scale use of retroviral tagging for cancer gene discovery in the post-genome era. Using high throughput inverse PCR1, we cloned and analyzed the sequences of 884 RISs from a tumor panel composed primarily of B- cell lymphomas. We then compared these sequences, and another 415 RIS sequences previously cloned from BXH2 myeloid leukemias and from a few AKXD lymphomas, against the recently assembled mouse genome sequence. These studies identified 152 loci that are targets of retroviral integration in more than one tumor (common retroviral integration sites, CISs) and therefore likely to encode a cancer gene. Thirty-six CISs encode genes that are known or predicted to be genes involved in human cancer or their homologs, whereas others encode candidate genes that have not yet been examined for a role in human cancer. Our studies demonstrate the power of retroviral tagging for cancer gene discovery in the post-genome era and indicate a largely unrecognized complexity in mouse and presumably human cancer.	NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; NIAID, Immunopathol Lab, Bethesda, MD 20892 USA; NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; Johns Hopkins Univ, Dept Math Sci, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Johns Hopkins University	Copeland, NG (corresponding author), NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA.	copeland@ncifcrf.gov	Naiman, Daniel Q/A-3304-2010	Naiman, Daniel Q/0000-0001-6504-9081; Morse, Herbert/0000-0002-9331-3705	CENTER FOR INFORMATION TECHNOLOGY [Z01CT000268, ZIACT000268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000858, ZIAAI000858] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEN-DAVID Y, 1990, New Biologist, V2, P1015; Cao JN, 1997, J CANCER RES CLIN, V123, P447, DOI 10.1007/s004320050085; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; GILBERT DJ, 1993, J VIROL, V67, P2083, DOI 10.1128/JVI.67.4.2083-2090.1993; Hansen GM, 2000, GENOME RES, V10, P237, DOI 10.1101/gr.10.2.237; Hartley JW, 2000, LAB INVEST, V80, P159, DOI 10.1038/labinvest.3780020; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; JENKINS NA, 1982, J VIROL, V42, P379, DOI 10.1128/JVI.42.2.379-388.1982; LARGAESPADA DA, 1995, J VIROL, V69, P5095, DOI 10.1128/JVI.69.8.5095-5102.1995; LAZO PA, 1990, P NATL ACAD SCI USA, V87, P170, DOI 10.1073/pnas.87.1.170; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; LUND AH, 2002, NAT GENET, V32, P80, DOI DOI 10.1038/NG956; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Mock BA, 1996, GENOMICS, V37, P24, DOI 10.1006/geno.1996.0516; Morse HC, 2001, LEUKEMIA RES, V25, P719, DOI 10.1016/S0145-2126(01)00022-4; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Neri A, 1996, LEUKEMIA LYMPHOMA, V23, P43, DOI 10.3109/10428199609054800; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; TOMASETTO C, 1995, GENOMICS, V28, P367, DOI 10.1006/geno.1995.1163; ZEIDLER R, 1994, GENE CHROMOSOME CANC, V9, P282, DOI 10.1002/gcc.2870090408; Zeng WR, 1997, ONCOGENE, V14, P2355, DOI 10.1038/sj.onc.1201076	27	341	354	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2002	32	1					166	174		10.1038/ng949	http://dx.doi.org/10.1038/ng949			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	588RR	12185365				2022-12-17	WOS:000177714900017
J	Holmes, SE; O'Hearn, EE; McInnis, MG; Gorelick-Feldman, DA; Kleiderlein, JJ; Callahan, C; Kwak, NG; Ingersoll-Ashworth, RG; Sherr, M; Sumner, AJ; Sharp, AH; Ananth, U; Seltzer, WK; Boss, MA; Vieria-Saecker, AM; Epplen, JT; Riess, O; Ross, CA; Margolis, RL				Holmes, SE; O'Hearn, EE; McInnis, MG; Gorelick-Feldman, DA; Kleiderlein, JJ; Callahan, C; Kwak, NG; Ingersoll-Ashworth, RG; Sherr, M; Sumner, AJ; Sharp, AH; Ananth, U; Seltzer, WK; Boss, MA; Vieria-Saecker, AM; Epplen, JT; Riess, O; Ross, CA; Margolis, RL			Expansion of a novel CAG trinucleotide repeat in the 5 ' region of PPP2R2B is associated with SCA12	NATURE GENETICS			English	Article							PROTEIN PHOSPHATASE 2A; REGULATORY SUBUNIT		Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Psychiat Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21205 USA; Louisiana State Univ, Sch Med, Dept Neurol, New Orleans, LA 70112 USA; Athena Diagnost Inc, Worcester, MA USA; Ruhr Univ Bochum, Dept Human Mol Genet, D-4630 Bochum, Germany; Univ Rostock, Dept Med Genet, D-2500 Rostock, Germany	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Louisiana State University System; Ruhr University Bochum; University of Rostock	Margolis, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA.		McInnis, Melvin G/F-6963-2012	McInnis, Melvin G/0000-0002-0375-6247; , Roxann/0000-0002-4266-613X; Epplen, Joerg T./0000-0002-6087-3327	NIMH NIH HHS [MH50763, MH01275] Funding Source: Medline; NINDS NIH HHS [NS16375] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050763, K21MH001275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016375, P50NS016375] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Burke TW, 1998, COLD SPRING HARB SYM, V63, P75, DOI 10.1101/sqb.1998.63.75; Deng XM, 1998, J BIOL CHEM, V273, P34157, DOI 10.1074/jbc.273.51.34157; Ince TA, 1995, J BIOL CHEM, V270, P30249, DOI 10.1074/jbc.270.51.30249; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; Margolis RL, 1999, ARCH GEN PSYCHIAT, V56, P1019, DOI 10.1001/archpsyc.56.11.1019; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; MAYERJAEKEL RE, 1993, CELL, V72, P621, DOI 10.1016/0092-8674(93)90080-A; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Ott J., 1991, ANAL HUMAN GENETIC L; Santoro MF, 1998, J BIOL CHEM, V273, P13119, DOI 10.1074/jbc.273.21.13119; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; Schols L, 1997, ANN NEUROL, V42, P924, DOI 10.1002/ana.410420615; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Strack S, 1998, J COMP NEUROL, V392, P515; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0	15	341	368	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					391	392		10.1038/70493	http://dx.doi.org/10.1038/70493			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581021				2022-12-17	WOS:000084023900011
J	Toomes, C; James, J; Wood, AJ; Wu, CL; McCormick, D; Lench, N; Hewitt, C; Moynihan, L; Roberts, E; Woods, CG; Markham, A; Wong, M; Widmer, R; Ghaffar, KA; Pemberton, M; Hussein, IR; Temtamy, SA; Davies, R; Read, AP; Sloan, P; Dixon, MJ; Thakker, NS				Toomes, C; James, J; Wood, AJ; Wu, CL; McCormick, D; Lench, N; Hewitt, C; Moynihan, L; Roberts, E; Woods, CG; Markham, A; Wong, M; Widmer, R; Ghaffar, KA; Pemberton, M; Hussein, IR; Temtamy, SA; Davies, R; Read, AP; Sloan, P; Dixon, MJ; Thakker, NS			Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis	NATURE GENETICS			English	Article							PAPILLON-LEFEVRE-SYNDROME; DIPEPTIDYL-PEPTIDASE-I; MOLECULAR-CLONING; LINKAGE ANALYSIS; EXPRESSION; LOCALIZATION; 11Q14-Q21	Papillon-Lefevre syndrome, or keratosis palmoplantaris with periodontopathia (PLS, MIM 245000), is an autosomal recessive disorder that is mainly ascertained by dentists because of the severe periodontitis that afflicts patients(1,2). Both the deciduous and permanent dentitions are affected, resulting in premature tooth loss. Palmoplantar keratosis, varying from mild psoriasiform scaly skin to overt hyperkeratosis, typically develops within the first three years of life. Keratosis also affects other sites such as elbows and knees. Most PLS patients display both periodontitis and hyperkeratosis. some patients have only palmoplantar keratosis or periodontitis, and in rare individuals the periodontitis is mild and of late onset(3-6). The PLS locus has been mapped to chromosome 11q14-q21 (refs 7-9). Using homozygosity mapping in eight small consanguineous families, we have narrowed the candidate region to a 1.2-cM interval between D11S4082 and D11S931. The gene (CTSC) encoding the lysosomal protease cathepsin C (or dipeptidyl aminopeptidase I) lies within this interval. We defined the genomic structure of CTSC and found mutations in all eight families. In two of these families we used a functional assay to demonstrate an almost total loss of cathepsin C activity in PLS patients and reduced activity in obligate carriers.	Univ Manchester, St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Univ Manchester, Sch Biol Sci, Manchester, Lancs, England; Univ Manchester, Turner Dent Sch, Dept Dent Med & Surg, Manchester, Lancs, England; Queens Univ Belfast, Dept Oncol, Belfast City Hosp Tower, Belfast, Antrim, North Ireland; St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; New Childrens Hosp, Dept Immunol & Infect Dis, Westmead, NSW, Australia; Westmead Hosp, Dept Paediat Dent, Dent Clin Sch, Westmead, NSW 2145, Australia; Eins Shams Univ, Dept Oral Diagnosis & Periodontol, Cairo, Egypt; Natl Res Ctr, Dept Human Genet, Cairo, Egypt; Dent Hlth Unit, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; Belfast City Hospital; Queens University Belfast; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Sydney; University of Sydney; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Manchester	Thakker, NS (corresponding author), Univ Manchester, St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England.		hussein, ibtessam M.R/H-9489-2012; Lench, Nicholas/AAB-1791-2021; Hussein, ibtessam R/L-4020-2014; woods, christopher g/A-1361-2010	Thakker, Nalin/0000-0002-8664-1508; Toomes, Carmel/0000-0001-8373-9545; Lench, Nicholas/0000-0002-6108-0759; Hussein, ibtessam/0000-0001-9909-9888; temtamy, samia/0000-0002-6452-823X; Ghaffar, khaled/0000-0001-5340-789X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BROWN J, 1993, SIGHT SOUND, V3, P64; BULLON P, 1993, J CLIN PERIODONTOL, V20, P662, DOI 10.1111/j.1600-051X.1993.tb00712.x; Cigic B, 1999, BIOCHEM BIOPH RES CO, V258, P6, DOI 10.1006/bbrc.1999.0570; Fardal O, 1998, J CLIN PERIODONTOL, V25, P181, DOI 10.1111/j.1600-051X.1998.tb02425.x; FISHER J, 1997, EUR J HUM GENET, V51, P56; GORLIN RJ, 1964, J PEDIATR-US, V65, P895, DOI 10.1016/S0022-3476(64)80014-7; HAMILTON RE, 1974, ORAL SURG ORAL MED O, V37, P754, DOI 10.1016/0030-4220(74)90141-8; Hart T C, 1994, Periodontol 2000, V6, P88, DOI 10.1111/j.1600-0757.1994.tb00029.x; Hart TC, 1998, AM J MED GENET, V79, P134, DOI 10.1002/(SICI)1096-8628(19980901)79:2<134::AID-AJMG9>3.0.CO;2-Q; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; KURIBAYASHI M, 1993, J BIOCHEM-TOKYO, V113, P441, DOI 10.1093/oxfordjournals.jbchem.a124064; Laass MW, 1997, HUM GENET, V101, P376, DOI 10.1007/s004390050645; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; Oguzkurt P, 1996, J PEDIATR SURG, V31, P955; PARIS A, 1995, FEBS LETT, V369, P326, DOI 10.1016/0014-5793(95)00777-7; Pham CTN, 1997, J BIOL CHEM, V272, P10695, DOI 10.1074/jbc.272.16.10695; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Rao NV, 1997, J BIOL CHEM, V272, P10260; SMYTH M, 1994, J NEUROCHEM, V63, P1439; Soskolne WA, 1996, J CLIN PERIODONTOL, V23, P764, DOI 10.1111/j.1600-051X.1996.tb00607.x; TEMPEL TR, 1972, J PERIODONTAL RE S10, V7, P26; WALLACE IJC, 1990, IRISH J MED SCI, V159, P203, DOI 10.1007/BF02937266	25	341	363	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					421	424		10.1038/70525	http://dx.doi.org/10.1038/70525			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581027	Green Published			2022-12-17	WOS:000084023900016
J	vanderNeut, R; Krimpenfort, P; Calafat, J; Niessen, CM; Sonnenberg, A				vanderNeut, R; Krimpenfort, P; Calafat, J; Niessen, CM; Sonnenberg, A			Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice	NATURE GENETICS			English	Letter							BASEMENT-MEMBRANE ADHESION; CELL-ADHESION; COMPONENT; SEQUENCE; GENE; ALPHA-6-BETA-4; IDENTIFICATION; AUTOANTIGEN; EXPRESSION; RECEPTORS		NETHERLANDS CANC INST, DIV CELL BIOL, 1066 CX AMSTERDAM, NETHERLANDS; NETHERLANDS CANC INST, DIV MOLEC GENET, 1066 CX AMSTERDAM, NETHERLANDS	Netherlands Cancer Institute; Netherlands Cancer Institute				Niessen, Carien M./0000-0002-4892-9391				ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; BAUDOIN C, IN PRESS CELL ADH CO; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CHAN YM, 1994, GENE DEV, V8, P2574, DOI 10.1101/gad.8.21.2574; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; GIUDICE GJ, 1991, J CLIN INVEST, V87, P734, DOI 10.1172/JCI115054; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HASHIMOTO T, 1993, J INVEST DERMATOL, V100, P310, DOI 10.1111/1523-1747.ep12469916; HIEDA Y, 1992, J CELL BIOL, V116, P1497, DOI 10.1083/jcb.116.6.1497; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HOPKINSON SB, 1992, J INVEST DERMATOL, V99, P264, DOI 10.1111/1523-1747.ep12616615; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JONES JCR, 1994, EXP CELL RES, V213, P1, DOI 10.1006/excr.1994.1166; KAJIJI S, 1989, EMBO J, V8, P673, DOI 10.1002/j.1460-2075.1989.tb03425.x; KENNEL SJ, 1992, J CELL SCI, V101, P145; KENNEL SJ, 1989, J BIOL CHEM, V264, P15515; KENNEL SJ, 1993, GENE, V130, P209, DOI 10.1016/0378-1119(93)90421-X; LANGHOFER M, 1993, CELL SCI, P753; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; NIESSEN CM, 1994, J CELL SCI, V107, P543; NIESSEN CM, 1994, EXP CELL RES, V211, P360, DOI 10.1006/excr.1994.1099; NIESSEN CM, IN PRESS J CELL SCI; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SONNENBERG A, 1993, J CELL SCI, V106, P1083; SONNENBERG A, 1987, J BIOL CHEM, V262, P10376; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; WATT SM, 1992, EXP HEMATOL, V20, P1101	35	341	345	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1996	13	3					366	369		10.1038/ng0796-366	http://dx.doi.org/10.1038/ng0796-366			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673140				2022-12-17	WOS:A1996UU28300029
J	BAJOCCHI, G; FELDMAN, SH; CRYSTAL, RG; MASTRANGELI, A				BAJOCCHI, G; FELDMAN, SH; CRYSTAL, RG; MASTRANGELI, A			DIRECT INVIVO GENE-TRANSFER TO EPENDYMAL CELLS IN THE CENTRAL-NERVOUS-SYSTEM USING RECOMBINANT ADENOVIRUS VECTORS	NATURE GENETICS			English	Article							GENETICALLY MODIFIED CELLS; BLOOD-BRAIN-BARRIER; BETA-GALACTOSIDASE; DRUG DELIVERY; RAT	To evaluate the potential for adenovirus-mediated central nervous system (CNS) gene transfer, the replication deficient recombinant adenovirus vectors Ad.RSVbetagal (coding for beta-galactosidase) and Ad-alpha1AT (coding for human alpha1-antitrypsin) were administered to the lateral ventricle of rats. Ad.RSVbetagal transferred beta-galactosidase to ependymal cells lining the ventricles whereas Ad-alpha1AT mediated alpha1-antitrypsin secretion into the cerebral spinal fluid for 1 week. These observations, together with beta-galactosidase activity in the globus pallidus and substantia nigra following stereotactic administration of Ad.RSVbetagal to the globus pallidus, suggest that adenovirus vectors will be useful for CNS gene therapy.	NHLBI, PULM BRANCH, BETHESDA, MD 20892 USA; NHLBI, LAB ANIM MED & SURG SECT, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)			BAJOCCHI, GIANLUIGI/AAA-6565-2020; Feldman, Sanford/AAH-7070-2021	bajocchi, gianluigi/0000-0002-6430-800X				ANDERSEN JK, 1992, HUM GENE THER, V3, P487, DOI 10.1089/hum.1992.3.5-487; BALERCIA G, 1991, J NEUROCYTOL, V21, P105; BASS NH, 1973, BRAIN RES, V52, P323, DOI 10.1016/0006-8993(73)90668-9; BOWSHER D, 1957, ANAT RECORD, V128, P23, DOI 10.1002/ar.1091280104; Brumback R.A., 1989, CEREBROSPINAL FLUID, P15; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; DANNENBERG AM, 1981, METHODS STUDYING MON, P375; DOBSON AT, 1990, NEURON, V5, P353, DOI 10.1016/0896-6273(90)90171-B; FEDEROFF HJ, 1992, P NATL ACAD SCI USA, V89, P1636, DOI 10.1073/pnas.89.5.1636; GAGE FH, 1990, PROG BRAIN RES, V82, P1; HARBAUGH RE, 1989, NEUROBIOL AGING, V10, P623, DOI 10.1016/0197-4580(89)90155-3; HORWITZ MS, 1991, FUNDAMENTAL VIROLOGY, P1679; HUANG Q, 1992, EXP NEUROL, V115, P303, DOI 10.1016/0014-4886(92)90196-W; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; Kasper M, 1992, Adv Anat Embryol Cell Biol, V126, P1; KAWAJA MD, 1992, J NEUROSCI, V12, P2849; KRIEGER DT, 1981, NEW ENGL J MED, V304, P944, DOI 10.1056/NEJM198104163041605; LEMARCHAND P, 1992, P NATL ACAD SCI USA, V89, P6482, DOI 10.1073/pnas.89.14.6482; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; MIETTINEN M, 1986, AM J PATHOL, V123, P231; ONO T, 1990, NEUROSCI LETT, V117, P259, DOI 10.1016/0304-3940(90)90673-W; PARDRIDGE WM, 1988, ANNU REV PHARMACOL, V28, P25; PARDRIDGE WM, 1989, NEUROBIOL AGING, V10, P636, DOI 10.1016/0197-4580(89)90160-7; Paxinos G., 2004, J CHEM INF MODEL, V5th; ROSEMBERG MB, 1988, SCIENCE, V2, P1575; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; ROTMAN B, 1961, P NATL ACAD SCI USA, V47, P1981, DOI 10.1073/pnas.47.12.1981; SHIMOHAMA S, 1989, MOL BRAIN RES, V5, P271, DOI 10.1016/0169-328X(89)90061-2; WOLFE JH, 1992, NAT GENET, V1, P379, DOI 10.1038/ng0892-379; [No title captured]	31	341	362	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1993	3	3					229	234		10.1038/ng0393-229	http://dx.doi.org/10.1038/ng0393-229			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KP790	8485578				2022-12-17	WOS:A1993KP79000012
J	Wang, YX; Xiong, GS; Hu, J; Jiang, L; Yu, H; Xu, J; Fang, YX; Zeng, LJ; Xu, EB; Xu, J; Ye, WJ; Meng, XB; Liu, RF; Chen, HQ; Jing, YH; Wang, YH; Zhu, XD; Li, JY; Qian, Q				Wang, Yuexing; Xiong, Guosheng; Hu, Jiang; Jiang, Liang; Yu, Hong; Xu, Jie; Fang, Yunxia; Zeng, Longjun; Xu, Erbo; Xu, Jing; Ye, Weijun; Meng, Xiangbing; Liu, Ruifang; Chen, Hongqi; Jing, Yanhui; Wang, Yonghong; Zhu, Xudong; Li, Jiayang; Qian, Qian			Copy number variation at the GL7 locus contributes to grain size diversity in rice	NATURE GENETICS			English	Article							GENE; ENCODES; WEIGHT; LENGTH; YIELD; WIDTH; IMPACT; SHAPE; QTL	Copy number variants (CNVs) are associated with changes in gene expression levels and contribute to various adaptive traits(1,2). Here we show that a CNV at the Grain Length on Chromosome 7 (GL7) locus contributes to grain size diversity in rice (Oryza sativa L.). GL7 encodes a protein homologous to Arabidopsis thaliana LONGIFOLIA proteins, which regulate longitudinal cell elongation. Tandem duplication of a 17.1-kb segment at the GL7 locus leads to upregulation of GL7 and downregulation of its nearby negative regulator, resulting in an increase in grain length and improvement of grain appearance quality. Sequence analysis indicates that allelic variants of GL7 and its negative regulator are associated with grain size diversity and that the CNV at the GL7 locus was selected for and used in breeding. Our work suggests that pyramiding beneficial alleles of GL7 and other yield- and quality-related genes may improve the breeding of elite rice varieties.	[Wang, Yuexing; Hu, Jiang; Xu, Jie; Fang, Yunxia; Xu, Erbo; Xu, Jing; Ye, Weijun; Liu, Ruifang; Chen, Hongqi; Zhu, Xudong; Qian, Qian] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Wang, Yuexing; Xiong, Guosheng; Jiang, Liang; Yu, Hong; Meng, Xiangbing; Jing, Yanhui; Wang, Yonghong; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Wang, Yuexing; Xiong, Guosheng; Jiang, Liang; Yu, Hong; Meng, Xiangbing; Jing, Yanhui; Wang, Yonghong; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, Beijing, Peoples R China; [Xiong, Guosheng; Zeng, Longjun; Liu, Ruifang; Qian, Qian] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS	Qian, Q (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	ricezxd@126.com; jyli@genetics.ac.cn; qianqian188@hotmail.com	Yu, Hong/H-2770-2012; qian, qian/AAH-8708-2021; Li, Jiayang/AAG-4377-2020	Yu, Hong/0000-0002-1748-8693; meng, xiangbing/0000-0001-7040-7138	Ministry of Science and Technology of China [2013CBA01400]; National Natural Science Foundation of China [31221004, 31201004, 31201194]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the National Medium Rice Genebank at the China National Rice Research Institute for providing rice accessions. This work was supported by grants from the Ministry of Science and Technology of China (2013CBA01400) and the National Natural Science Foundation of China (31221004, 31201004 and 31201194).	[程俊彪 Cheng Junbiao], 2002, [广东农业科学, Guangdong Agricultural Sciences], V0, P5; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Drevensek S, 2012, PLANT CELL, V24, P178, DOI 10.1105/tpc.111.089748; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Imbe T., 2004, Bulletin of the National Institute of Crop Science, P35; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Lee YK, 2006, DEVELOPMENT, V133, P4305, DOI 10.1242/dev.02604; Li YB, 2014, NAT GENET, V46, P398, DOI 10.1038/ng.2923; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; McHale LK, 2012, PLANT PHYSIOL, V159, P1295, DOI 10.1104/pp.112.194605; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; Qiu XJ, 2012, THEOR APPL GENET, V125, P1717, DOI 10.1007/s00122-012-1948-x; Shao GN, 2012, THEOR APPL GENET, V125, P1303, DOI 10.1007/s00122-012-1914-7; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Yu P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-649; Yu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-372; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zuo JR, 2014, ANNU REV GENET, V48, P99, DOI 10.1146/annurev-genet-120213-092138	27	340	412	15	264	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					944	+		10.1038/ng.3346	http://dx.doi.org/10.1038/ng.3346			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26147619				2022-12-17	WOS:000358674100022
J	Bonn, S; Zinzen, RP; Girardot, C; Gustafson, EH; Perez-Gonzalez, A; Delhomme, N; Ghavi-Helm, Y; Wilczynski, B; Riddell, A; Furlong, EEM				Bonn, Stefan; Zinzen, Robert P.; Girardot, Charles; Gustafson, E. Hilary; Perez-Gonzalez, Alexis; Delhomme, Nicolas; Ghavi-Helm, Yad; Wilczynski, Bartek; Riddell, Andrew; Furlong, Eileen E. M.			Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development	NATURE GENETICS			English	Article							GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; HUMAN GENOME; TRANSCRIPTIONAL NETWORK; HISTONE MODIFICATIONS; MUSCLE DEVELOPMENT; CELL-TYPES; PROMOTERS; MAP; METHYLATIONS	Chromatin modifications are associated with many aspects of gene expression, yet their role in cellular transitions during development remains elusive. Here, we use a new approach to obtain cell type specific information on chromatin state and RNA polymerase II (Pol II) occupancy within the multicellular Drosophila melanogaster embryo. We directly assessed the relationship between chromatin modifications and the spatio-temporal activity of enhancers. Rather than having a unique chromatin state, active developmental enhancers show heterogeneous histone modifications and Pol II occupancy. Despite this complexity, combined chromatin signatures and Pol II presence are sufficient to predict enhancer activity de novo. Pol II recruitment is highly predictive of the timing of enhancer activity and seems dependent on the timing and location of transcription factor binding. Chromatin modifications typically demarcate large regulatory regions encompassing multiple enhancers, whereas local changes in nucleosome positioning and Pol II occupancy delineate single active enhancers. This cell type specific view identifies dynamic enhancer usage, an essential step in deciphering developmental networks.	[Bonn, Stefan; Zinzen, Robert P.; Girardot, Charles; Gustafson, E. Hilary; Perez-Gonzalez, Alexis; Delhomme, Nicolas; Ghavi-Helm, Yad; Wilczynski, Bartek; Riddell, Andrew; Furlong, Eileen E. M.] EMBL, Genome Biol Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Furlong, EEM (corresponding author), EMBL, Genome Biol Unit, Heidelberg, Germany.	eileen.furlong@embl.de	Wilczynski, Bartek/A-5710-2009; Delhomme, Nicolas/B-9187-2015; Gonzalez, Alexis/O-9802-2016; Zinzen, Robert P/A-3130-2015; Zinzen, Robert/AAG-2784-2020; Girardot, Charles/AAF-2417-2020	Wilczynski, Bartek/0000-0002-8134-0589; Delhomme, Nicolas/0000-0002-3053-0796; Gonzalez, Alexis/0000-0002-8674-2034; Zinzen, Robert P/0000-0002-8638-5102; Girardot, Charles/0000-0003-4301-3920; Ghavi-Helm, Yad/0000-0003-2397-9576; Gustafson, Eleanor Hilary/0000-0003-3978-8088; Furlong, Eileen/0000-0002-9544-8339; Bonn, Stefan/0000-0003-4366-5662	ERASysBio (Mod Heart); Human Frontiers Science Program Organization; International Human Frontiers Science Program Organization; EMBL	ERASysBio (Mod Heart); Human Frontiers Science Program Organization(Human Frontier Science Program); International Human Frontiers Science Program Organization(Human Frontier Science Program); EMBL	This work was technically supported by the EMBL Genomics Core facility for Solexa sequencing and by the IT service unit. We thank S. Muller for performing Drosophila injections and all members of the Furlong laboratory for discussions and comments on the manuscript. We thank J. Lis (Cornell University) for the Rpb3 (Pol II) antibody. This work was supported by grants to E.E.M.F. from ERASysBio (Mod Heart) and the Human Frontiers Science Program Organization and by a long-term fellowship to R.P.Z. from the International Human Frontiers Science Program Organization. S.B. was funded by the EMBL Interdisciplinary Postdoc (EIPOD) programme.	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Cunha PMF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001014; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Deal RB, 2010, DEV CELL, V18, P1030, DOI 10.1016/j.devcel.2010.05.013; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Jakobsen JS, 2007, GENE DEV, V21, P2448, DOI 10.1101/gad.437607; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shankaranarayanan P, 2011, NAT METHODS, V8, P565, DOI [10.1038/nmeth.1626, 10.1038/NMETH.1626]; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Wilczynski B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.35; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	48	340	348	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					148	156		10.1038/ng.1064	http://dx.doi.org/10.1038/ng.1064			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22231485				2022-12-17	WOS:000299664400011
J	Razzaque, MA; Nishizawa, T; Komoike, Y; Yagi, H; Furutani, M; Amo, R; Kamisago, M; Momma, K; Katayama, H; Nakagawa, M; Fujiwara, Y; Matsushima, M; Mizuno, K; Tokuyama, M; Hirota, H; Muneuchi, J; Higashinakagawa, T; Matsuoka, R				Razzaque, M. Abdur; Nishizawa, Tsutomu; Komoike, Yuta; Yagi, Hisato; Furutani, Michiko; Amo, Ryunosuke; Kamisago, Mitsuhiro; Momma, Kazuo; Katayama, Hiroshi; Nakagawa, Masao; Fujiwara, Yuko; Matsushima, Masaki; Mizuno, Katsumi; Tokuyama, Mika; Hirota, Hamao; Muneuchi, Jun; Higashinakagawa, Toru; Matsuoka, Rumiko			Germline gain-of-function mutations in RAF1 cause Noonan syndrome	NATURE GENETICS			English	Article							FACIO-CUTANEOUS SYNDROME; PROTEIN-KINASE-A; CARDIAC-HYPERTROPHY; SIGNALING PATHWAY; C-RAF; B-RAF; DISORDERS; PHENOTYPE; KRAS; ACTIVATION	Noonan syndrome is characterized by short stature, facial dysmorphia and a wide spectrum of congenital heart defects1,2. Mutations of PTPN11, KRAS and SOS1 in the RAS- MAPK pathway cause similar to 60% of cases of Noonan syndrome3-9. However, the gene(s) responsible for the remainder are unknown. We have identified five different mutations in RAF1 in ten individuals with Noonan syndrome; those with any of four mutations causing changes in the CR2 domain of RAF1 had hypertrophic cardiomyopathy (HCM), whereas affected individuals with mutations leading to changes in the CR3 domain did not. Cells transfected with constructs containing Noonan syndrome - associated RAF1 mutations showed increased in vitro kinase and ERK activation, and zebrafish embryos with morpholino knockdown of raf1 demonstrated the need for raf1 for the development of normal myocardial structure and function. Thus, our findings implicate RAF1 gain-of-function mutations as a causative agent of a human developmental disorder, representing a new genetic mechanism for the activation of the MAPK pathway.	Tokyo Womens Med Univ, IREIIMS, Tokyo 1628666, Japan; Waseda Univ, Sch Educ, Dept Biol, Tokyo, Japan; Tokyo Womens Med Univ, Grad Sch Med, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Div Pediat Cardiol, Tokyo 1628666, Japan; Osaka Med Coll, Dept Pediat, Osaka, Japan; Shiga Univ Med Sci, Dept Pediat, Shiga, Japan; Jikei Univ, Dept Pediat, Tokyo, Japan; Social Insurance Chukyo Hosp, Dept Pediat Cardiol, Aichi, Japan; Chiba Childrens Hosp, Dept Neonatol, Chiba, Japan; Toho Univ, Dept Pediat, Tokyo, Japan; Kitasato Univ, Dept Pediat, Kanagawa, Japan; Kyushu Univ, Dept Pediat, Fukuoka 812, Japan	Tokyo Women's Medical University; Waseda University; Tokyo Women's Medical University; Tokyo Women's Medical University; Osaka Medical College; Shiga University of Medical Science; Jikei University; Chiba Children's Hospital; Toho University; Kitasato University; Kyushu University	Matsuoka, R (corresponding author), Tokyo Womens Med Univ, IREIIMS, Tokyo 1628666, Japan.	rumiko@imcir.twmu.ac.jp		Amo, Ryunosuke/0000-0001-8644-2296; Razzaque, Md Abdur/0000-0002-5932-3432; Yagi, Hisato/0000-0003-1460-4043				ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Chan EYW, 2002, MOL CARCINOGEN, V33, P189, DOI 10.1002/mc.10031; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komoike Y, 2005, BIOCHEM BIOPH RES CO, V328, P858, DOI 10.1016/j.bbrc.2005.01.031; Kratz CP, 2006, CELL CYCLE, V5, P1607, DOI 10.4161/cc.5.15.3128; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Yamazaki T, 1997, J MOL CELL CARDIOL, V29, P2491, DOI 10.1006/jmcc.1997.0488; Zebisch A, 2006, CANCER RES, V66, P3401, DOI 10.1158/0008-5472.CAN-05-0115	28	340	357	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					1013	1017		10.1038/ng2078	http://dx.doi.org/10.1038/ng2078			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17603482				2022-12-17	WOS:000248446900020
J	He, XC; Yin, T; Grindley, JC; Tian, Q; Sato, T; Tao, WA; Dirisina, R; Porter-Westpfahl, KS; Hembree, M; Johnson, T; Wiedemann, LM; Barrett, TA; Hood, L; Wu, H; Li, LH				He, Xi C.; Yin, Tong; Grindley, Justin C.; Tian, Qiang; Sato, Toshiro; Tao, W. Andy; Dirisina, Raminarao; Porter-Westpfahl, Kimberly S.; Hembree, Mark; Johnson, Teri; Wiedemann, Leanne M.; Barrett, Terrence A.; Hood, Leroy; Wu, Hong; Li, Linheng			PTEN-deficient intestinal stem cells initiate intestinal polyposis	NATURE GENETICS			English	Article							BETA-CATENIN; GERMLINE MUTATIONS; JUVENILE POLYPOSIS; CRYPT FISSION; SELF-RENEWAL; PROTEIN-KINASE; CANCER CELLS; CYCLIN D1; PHOSPHORYLATION; EXPRESSION	Intestinal polyposis, a precancerous neoplasia, results primarily from an abnormal increase in the number of crypts, which contain intestinal stem cells ( ISCs). In mice, widespread deletion of the tumor suppressor Phosphatase and tensin homolog ( PTEN) generates hamartomatous intestinal polyps with epithelial and stromal involvement. Using this model, we have established the relationship between stem cells and polyp and tumor formation. PTEN helps govern the proliferation rate and number of ISCs and loss of PTEN results in an excess of ISCs. In PTEN-deficient mice, excess ISCs initiate de novo crypt formation and crypt fission, recapitulating crypt production in fetal and neonatal intestine. The PTEN-Akt pathway probably governs stem cell activation by helping control nuclear localization of the Wnt pathway effector beta-catenin. Akt phosphorylates beta-catenin at Ser552, resulting in a nuclear- localized form in ISCs. Our observations show that intestinal polyposis is initiated by PTEN- deficient ISCs that undergo excessive proliferation driven by Akt activation and nuclear localization of beta- catenin.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Inst Syst Biol, Seattle, WA 98103 USA; Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Northwestern Univ, Sch Med, Div Gastroenterol, Dept Med Microbiol & Immunol, Chicago, IL 60611 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Stowers Institute for Medical Research; Institute for Systems Biology (ISB); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Northwestern University; University of Kansas; University of Kansas Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Li, LH (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	lil@stowers-institute.org	Wiedemann, Leanne/E-3316-2010; Tao, Andy/N-1290-2019; Sato, Toshiro/J-3522-2014; Tao, Weiguo/AAL-2777-2020	Sato, Toshiro/0000-0001-8353-8137; Tao, Weiguo/0000-0002-5535-5517; Wiedemann, Leanne/0000-0002-0964-4676; Barrett, Terrence/0000-0001-6428-3271; Li, Linheng/0000-0001-9963-430X	NIAID NIH HHS [R01 AI061701, R01 AI061701-02] Funding Source: Medline; NIDDK NIH HHS [R01 DK070001] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070001] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asai R, 2005, DEV GROWTH DIFFER, V47, P501, DOI 10.1111/j.1440-169X.2005.00825.x; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Brittan M, 2002, J PATHOL, V197, P492, DOI 10.1002/path.1155; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Koike M, 2004, J BIOL CHEM, V279, P34038, DOI 10.1074/jbc.M405821200; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Megy S, 2005, PEPTIDES, V26, P227, DOI 10.1016/j.peptides.2004.09.021; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Preston SL, 2003, CANCER RES, V63, P3819; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Wasan HS, 1998, J PATHOL, V185, P246; Wirtzfeld DA, 2001, ANN SURG ONCOL, V8, P319, DOI 10.1245/aso.2001.8.4.319; Wong WM, 2002, GUT, V50, P212, DOI 10.1136/gut.50.2.212; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	50	340	357	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					189	198		10.1038/ng1928	http://dx.doi.org/10.1038/ng1928			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17237784	Green Accepted			2022-12-17	WOS:000244063900016
J	Consonni, C; Humphry, ME; Hartmann, HA; Livaja, M; Durner, J; Westphal, L; Vogel, J; Lipka, V; Kemmerling, B; Schulze-Lefert, P; Somerville, SC; Panstruga, R				Consonni, Chiara; Humphry, Matthew E.; Hartmann, H. Andreas; Livaja, Maren; Durner, Jorg; Westphal, Lore; Vogel, John; Lipka, Volker; Kemmerling, Birgit; Schulze-Lefert, Paul; Somerville, Shauna C.; Panstruga, Ralph			Conserved requirement for a plant host cell protein in powdery mildew pathogenesis	NATURE GENETICS			English	Article							NONHOST RESISTANCE; DISEASE RESISTANCE; MLO RESISTANCE; SALICYLIC-ACID; BARLEY; ARABIDOPSIS; DEFENSE; GENE; SUSCEPTIBILITY; PENETRATION	In the fungal phylum Ascomycota, the ability to cause disease in plants and animals has been gained and lost repeatedly during phylogenesis(1). In monocotyledonous barley, loss-of-function mlo alleles result in effective immunity against the Ascomycete Blumeria graminis f. sp. hordei, the causal agent of powdery mildew disease(2,3). However, mlo-based disease resistance has been considered a barley-specific phenomenon to date. Here, we demonstrate a conserved requirement for MLO proteins in powdery mildew pathogenesis in the dicotyledonous plant species Arabidopsis thaliana. Epistasis analysis showed that mlo resistance in A. thaliana does not involve the signaling molecules ethylene, jasmonic acid or salicylic acid, but requires a syntaxin, glycosyl hydrolase and ABC transporter(4-6). These findings imply that a common host cell entry mechanism of powdery mildew fungi evolved once and at least 200 million years ago, suggesting that within the Erysiphales ( powdery mildews) the ability to cause disease has been a stable trait throughout phylogenesis.	Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; GSF, Natl Res Ctr Environm & Hlth, Inst Biochem Plant Pathol, Dept Plant Immun, D-85754 Oberschleissheim, Germany; Inst Plant Biochem, Dept Stress & Dev Biol, D-06120 Halle, Germany; USDA, Genom & Gene Discovery Unit, Albany, CA 94710 USA; Univ Tubingen, Dept Plant Biochem, D-72076 Tubingen, Germany	Max Planck Society; Carnegie Institution for Science; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leibniz Institut fur Pflanzenbiochemie; United States Department of Agriculture (USDA); Eberhard Karls University of Tubingen	Panstruga, R (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	panstrug@mpiz-koeln.mpg.de	Vogel, John P/B-3176-2009; Panstruga, Ralph/F-3340-2011; Bruening, Stefan/B-8505-2011; Humphry, Matthew/A-8136-2008; Lipka, Volker/C-5874-2009; Schulze-Lefert, Paul/B-6707-2011; Schulze-Lefert, Paul/A-7746-2008; Humphry, Matt/E-8072-2010	Panstruga, Ralph/0000-0002-3756-8957; Vogel, John/0000-0003-1786-2689; Kemmerling, Birgit/0000-0003-1174-0189	PHS HHS [FG32 GN19499-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Berbee ML, 2001, PHYSIOL MOL PLANT P, V59, P165, DOI 10.1006/pmpp.2001.0355; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Devoto A, 2003, J MOL EVOL, V56, P77, DOI 10.1007/s00239-002-2382-5; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Freialdenhoven A, 1996, PLANT CELL, V8, P5, DOI 10.1105/tpc.8.1.5; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Jarosch B, 1999, MOL PLANT MICROBE IN, V12, P508, DOI 10.1094/MPMI.1999.12.6.508; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Kumar J, 2001, PHYTOPATHOLOGY, V91, P127, DOI 10.1094/PHYTO.2001.91.2.127; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Mori Yasuhiro, 2000, Mycoscience, V41, P437, DOI 10.1007/BF02461662; Morris K, 2000, PLANT J, V23, P677, DOI 10.1046/j.1365-313x.2000.00836.x; Panstruga R, 2005, PLANT MOL BIOL, V59, P485, DOI 10.1007/s11103-005-0353-0; Panstruga R, 2005, BIOCHEM SOC T, V33, P389, DOI 10.1042/BST0330389; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Piffanelli P, 2002, PLANT PHYSIOL, V129, P1076, DOI 10.1104/pp.010954; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; van Wees SCM, 2003, PLANT J, V33, P733, DOI 10.1046/j.1365-313X.2003.01665.x; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Vogel JP, 2004, PLANT J, V40, P968, DOI 10.1111/j.1365-313X.2004.02264.x; Vogel JP, 2002, PLANT CELL, V14, P2095, DOI 10.1105/tpc.003509; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; WOLTER M, 1993, MOL GEN GENET, V239, P122, DOI 10.1007/BF00281610; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1	28	340	379	8	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					716	720		10.1038/ng1806	http://dx.doi.org/10.1038/ng1806			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16732289	Green Published			2022-12-17	WOS:000237954800029
J	Wienholds, E; Koudijs, MJ; van Eeden, FJM; Cuppen, E; Plasterk, RHA				Wienholds, E; Koudijs, MJ; van Eeden, FJM; Cuppen, E; Plasterk, RHA			The microRNA-producing enzyme Dicer1 is essential for zebrafish development	NATURE GENETICS			English	Article							RNA-INTERFERENCE; GENES; ELEGANS	MicroRNAs (miRNAs) are produced by the Dicer1 enzyme; the role of Dicer1 in vertebrate development is unknown. Here we report target-selected inactivation of the dicer1 gene in zebrafish. We observed an initial build-up of miRNA levels, produced by maternal Dicer1, in homozygous dicer1 mutants, but miRNA accumulation stopped after a few days. This resulted in developmental arrest around day 10. These results indicate that miRNA-producing Dicer1 is essential for vertebrate development.	Netherlands Inst Dev Biol, Hubrecht Lab, Dept Funct Genom, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Dept Funct Genom, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		Van Eeden, Freek/E-6198-2010; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542				Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762	10	340	371	0	37	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2003	35	3					217	218		10.1038/ng1251	http://dx.doi.org/10.1038/ng1251			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14528306				2022-12-17	WOS:000186273300015
J	Silva, JP; Kohler, M; Graff, C; Oldfors, A; Magnuson, MA; Berggren, PO; Larsson, NG				Silva, JP; Kohler, M; Graff, C; Oldfors, A; Magnuson, MA; Berggren, PO; Larsson, NG			Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes	NATURE GENETICS			English	Article							GENE MUTATION; DNA; MEDICINE; MOUSE	Mitochondrial dysfunction is an important contributor to human pathology(1-4) and it is estimated that mutations of mitochondrial DNA (mtDNA) cause approximately 0.5-1% of all types of diabetes mellitus(5,6). We have generated a mouse model for mitochondrial diabetes by tissue-specific disruption of the nuclear gene encoding mitochondrial transcription factor A (Tfam, previously mtTFA; ref, 7) in pancreatic beta -cells. This transcriptional activator is imported to mitochondria, where it is essential for mtDNA expression and maintenance(8,9). The Tfam-mutant mice developed diabetes from the age of approximately 5 weeks and displayed severe mtDNA depletion, deficient oxidative phosphorylation and abnormal appearing mitochondria in islets at the ages of 7-9 weeks, We performed physiological studies of beta -cell stimulus-secretion coupling in islets isolated from 7-9-week-old mutant mice and found reduced hyperpolarization of the mitochondrial membrane potential, impaired Ca2+-signalling and lowered insulin release in response to glucose stimulation. We observed reduced beta -cell mass in older mutants. Our findings identity two phases in the pathogenesis of mitochondrial diabetes; mutant beta -cells initially display reduced stimulus-secretion coupling, later followed by beta -cell loss, This animal model reproduces the beta -cell pathology of human mitochondrial diabetes and provides genetic evidence for a critical role of the respiratory chain in insulin secretion.	Karolinska Inst, Karolinska Hosp, Dept Mol Med, Rolf Luft Ctr Diabet Res, S-10401 Stockholm, Sweden; Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden; Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Vanderbilt University	Larsson, NG (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Mol Med, Rolf Luft Ctr Diabet Res, S-10401 Stockholm, Sweden.			Berggren, Per-Olof/0000-0001-8991-413X; Magnuson, Mark/0000-0002-8824-6499; Larsson, Nils-Goran/0000-0001-5100-996X; Oldfors, Anders/0000-0002-5758-7397; Graff, Caroline/0000-0002-9949-2951; Kohler, Martin/0000-0001-6487-4303				BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Graff C, 1999, J INTERN MED, V246, P11, DOI 10.1046/j.1365-2796.1999.00514.x; GUENETTE DR, 1995, CD-ROM PROF, V8, P10; KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403; KANATSUNA T, 1981, DIABETES, V30, P231, DOI 10.2337/diabetes.30.3.231; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Kobayashi T, 1997, DIABETES, V46, P1567, DOI 10.2337/diabetes.46.10.1567; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; Larsson NG, 1999, FEBS LETT, V455, P199, DOI 10.1016/S0014-5793(99)00854-6; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; Otabe S, 1999, BIOCHEM BIOPH RES CO, V259, P149, DOI 10.1006/bbrc.1999.0650; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089	21	340	345	1	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					336	340		10.1038/81649	http://dx.doi.org/10.1038/81649			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062475				2022-12-17	WOS:000165176500024
J	Finucane, HK; Reshef, YA; Anttila, V; Slowikowski, K; Gusev, A; Byrnes, A; Gazal, S; Loh, PR; Lareau, C; Shoresh, N; Genovese, G; Saunders, A; Macosko, E; Pollack, S; Perry, JRB; Buenrostro, JD; Bernstein, BE; Raychaudhuri, S; McCarroll, S; Neale, BM; Price, AL				Finucane, Hilary K.; Reshef, Yakir A.; Anttila, Verneri; Slowikowski, Kamil; Gusev, Alexander; Byrnes, Andrea; Gazal, Steven; Loh, Po-Ru; Lareau, Caleb; Shoresh, Noam; Genovese, Giulio; Saunders, Arpiar; Macosko, Evan; Pollack, Samuela; Perry, John R. B.; Buenrostro, Jason D.; Bernstein, Bradley E.; Raychaudhuri, Soumya; McCarroll, Steven; Neale, Benjamin M.; Price, Alkes L.		Brainstorm Consortium	Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; SUSCEPTIBILITY LOCI; COMPLEX TRAITS; RISK LOCI; PARTITIONING HERITABILITY; PREFRONTAL CORTEX; BIPOLAR DISORDER; METAANALYSIS; SCHIZOPHRENIA	We introduce an approach to identify disease-relevant tissues and cell types by analyzing gene expression data together with genome-wide association study (GWAS) summary statistics. Our approach uses stratified linkage disequilibrium (LD) score regression to test whether disease heritability is enriched in regions surrounding genes with the highest specific expression in a given tissue. We applied our approach to gene expression data from several sources together with GWAS summary statistics for 48 diseases and traits (average N = 169,331) and found significant tissue-specific enrichments (false discovery rate (FDR) < 5%) for 34 traits. In our analysis of multiple tissues, we detected a broad range of enrichments that recapitulated known biology. In our brain-specific analysis, significant enrichments included an enrichment of inhibitory over excitatory neurons for bipolar disorder, and excitatory over inhibitory neurons for schizophrenia and body mass index. Our results demonstrate that our polygenic approach is a powerful way to leverage gene expression data for interpreting GWAS signals.	[Finucane, Hilary K.; Anttila, Verneri; Slowikowski, Kamil; Byrnes, Andrea; Lareau, Caleb; Shoresh, Noam; Genovese, Giulio; Buenrostro, Jason D.; Bernstein, Bradley E.; Raychaudhuri, Soumya; McCarroll, Steven; Neale, Benjamin M.; Price, Alkes L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Finucane, Hilary K.] MIT, Dept Math, Cambridge, MA 02139 USA; [Finucane, Hilary K.; Gusev, Alexander; Gazal, Steven; Loh, Po-Ru; Pollack, Samuela; Price, Alkes L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Reshef, Yakir A.] Harvard Univ, Dept Comp Sci, Cambridge, MA 02138 USA; [Anttila, Verneri; Byrnes, Andrea; Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Anttila, Verneri; Byrnes, Andrea; Bernstein, Bradley E.; Neale, Benjamin M.] Harvard Med Sch, Boston, MA USA; [Slowikowski, Kamil] Harvard Univ, Bioinformat & Integrat Genom, Cambridge, MA 02138 USA; [Slowikowski, Kamil; Raychaudhuri, Soumya] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA USA; [Lareau, Caleb] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Saunders, Arpiar; Macosko, Evan; McCarroll, Steven] Harvard Med Sch, Dept Genet, Boston, MA USA; [Perry, John R. B.] Univ Cambridge, Sch Clin Med, MRC, Epidemiol Unit,Inst Metab Sci, Cambridge Biomed Campus, Cambridge, England; [Buenrostro, Jason D.] Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Raychaudhuri, Soumya] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol, Boston, MA USA; [Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA USA; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of Cambridge; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Manchester	Finucane, HK; Price, AL (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Finucane, HK (corresponding author), MIT, Dept Math, Cambridge, MA 02139 USA.; Finucane, HK; Price, AL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	finucane@broadinstitute.org; aprice@hsph.harvard.edu	Slowikowski, Kamil/K-3728-2016; Macosko, Evan/X-4664-2019; Gazal, Steven/AAK-3764-2020; Hansen, Thomas Folkmann/O-5965-2014; Lareau, Caleb/ABF-9490-2020	Slowikowski, Kamil/0000-0002-2843-6370; Hansen, Thomas Folkmann/0000-0001-6703-7762; Lareau, Caleb/0000-0003-4179-4807; Reshef, Yakir/0000-0001-6463-4203; Gazal, Steven/0000-0003-4510-5730; Raychaudhuri, Soumya/0000-0002-1901-8265	NIH [R01 MH107649, R01 MH109978, U01 CA194393, U01 HG009379]; Fannie and John Hertz Foundation; Eric and Wendy Schmidt; NATIONAL CANCER INSTITUTE [U01CA194393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG009379, T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR067677, R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH103877, U01MH103339, R01MH105472, R21MH105881, R01MH094714, U01MH103392, R01MH109978, U01MH103365, U01MH103346, R01MH107649, R01MH105898, P50MH106934, U01MH103340, R21MH102791] Funding Source: NIH RePORTER; MRC [MC_UU_12015/2] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fannie and John Hertz Foundation; Eric and Wendy Schmidt; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are thankful to R. Herbst, E. Hodis, F. Hormozdiari, M. Kanai, T. Pers, S. Riesenfeld, J. Ulirsch and A. Veres for helpful comments. This research was conducted using the UK Biobank Resource (application number: 16549). This research was funded by NIH grants R01 MH107649 (H.K.F., S.G., B.M.N., A.L.P.), R01 MH109978 (A.G., A.L.P.), U01 CA194393 (H.K.F., A.L.P.) and U01 HG009379 (S.R., A.L.P.). H.K. F. was also supported by the Fannie and John Hertz Foundation and by Eric and Wendy Schmidt. Data on neuron types were generated as part of the PsychENCODE Consortium, P. Sklar, Icahn School of Medicine at Mount Sinai), U01MH103365 (F. Vaccarino, Yale University; M. Gerstein, Yale University; S. Weissman, Yale University), U01MH103346 (P. Farnham, University of Southern California; J. A. Knowles, University of Southern California), U01MH103340 (C. Liu, SUNY Upstate Medical University; K. White, University of Chicago), U01MH103339 (N. Sestan, Yale University; M. State, University of California, San Francisco), R21MH109956 (A. Jaffe, Lieber Institute for Brain Development), R21MH105881 (D. Pinto, Icahn School of Medicine at Mount Sinai), R21MH105853 (A. Jaffe, Lieber Institute for Brain Development; D. Weinberger, Lieber Institute for Brain Development), R21MH103877 (S. Dracheva, Icahn School of Medicine at Mount Sinai; S. Akbarian, Icahn School of Medicine at Mount Sinai), R21MH102791 (A. Jaffe, Lieber Institute for Brain Development), R01MH111721 (F. Goes, Johns Hopkins University; T. Hyde, Lieber Institute for Brain Development), R01MH110928 (M. State, University of California, San Francisco; S. Sanders, University of California, San Francisco; J. Willsey, University of California, San Francisco), R01MH110927 (D. Geschwind, University of California, Los Angeles), R01MH110926 (N. Sestan, Yale University), R01MH110921 (P. Sklar, Icahn School of Medicine at Mount Sinai), R01MH110920 (C. Liu, SUNY Upstate Medical University), R01MH110905 (K. White, University of Chicago), R01MH109715 (D. Pinto, Icahn School of Medicine at Mount Sinai), R01MH109677 (P. Roussos, Icahn School of Medicine at Mount Sinai), R01MH105898, (P. Zandi, Johns Hopkins University; T. M. Hyde, Lieber Institute for Brain Development), R01MH094714, (D. Geschwind, University of California, Los Angeles), P50MH106934, (N. Sestan, Yale University), R01MH105472 (G. Crawford, Duke University; P. Sullivan, University of North Carolina).	Akbarian S, 2015, NAT NEUROSCI, V18, P1707, DOI 10.1038/nn.4156; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; Anttila V, 2016, BIORXIV, DOI [10.1101/048991, DOI 10.1101/048991]; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Backenroth D., 2016, TISSUE SPECIFIC FUNC, DOI [10.1101/069229, DOI 10.1101/069229]; Barbosa IG, 2014, NEUROIMMUNOMODULAT, V21, P117, DOI 10.1159/000356539; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Broedl UC, 2004, CIRC RES, V94, P1554, DOI 10.1161/01.RES.0000130657.00222.39; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cordell HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9019; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Dhirapong A, 2011, HEPATOLOGY, V53, P527, DOI 10.1002/hep.24044; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elamin I, 2013, BEHAV NEUROL, V27, P23, DOI [10.3233/BEN-120295, 10.1155/2013/329375]; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Feingold KR, 2011, J LIPID RES, V52, P1, DOI 10.1194/jlr.E012138; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gagliano SA, 2016, ANN CLIN TRANSL NEUR, V3, P924, DOI 10.1002/acn3.369; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hanford LC, 2016, BIPOLAR DISORD, V18, P4, DOI 10.1111/bdi.12362; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Huang KL, 2017, NAT NEUROSCI, V20, P1052, DOI 10.1038/nn.4587; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Li Y, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw627; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Loh P-R, 2017, MIXED MODEL ASS BIOB, DOI [10.1101/194944, DOI 10.1101/194944]; Maleki N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-71; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Medic N, 2016, INT J OBESITY, V40, P1177, DOI 10.1038/ijo.2016.42; Muller-Ladner U, 2005, NAT CLIN PRACT RHEUM, V1, P102, DOI 10.1038/ncprheum0047; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Ongen H, 2017, NAT GENET, V49, P1676, DOI 10.1038/ng.3981; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Rege S, 2013, AUST NZ J PSYCHIAT, V47, P1136, DOI 10.1177/0004867413499077; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sakai T, 2008, NEUROPATHOLOGY, V28, P143, DOI 10.1111/j.1440-1789.2007.00867.x; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Slowikowski K, 2014, BIOINFORMATICS, V30, P2496, DOI 10.1093/bioinformatics/btu326; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steiner J, 2010, EUR ARCH PSY CLIN N, V260, P509, DOI 10.1007/s00406-010-0098-x; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tfelt-Hansen PC, 2011, HEADACHE, V51, P752, DOI 10.1111/j.1526-4610.2011.01892.x; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Trott DW, 2014, ADV PHYSIOL EDUC, V38, P20, DOI 10.1152/advan.00063.2013; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wilens TE, 2002, ANNU REV MED, V53, P113, DOI 10.1146/annurev.med.53.082901.103945; Woo D, 2014, AM J HUM GENET, V94, P511, DOI 10.1016/j.ajhg.2014.02.012; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang J, 2014, HEPATOLOGY, V60, P1708, DOI 10.1002/hep.27313; Zlotnikov-Klionsky Y, 2015, IMMUNITY, V43, P776, DOI 10.1016/j.immuni.2015.08.015	87	339	340	6	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2018	50	4					621	+		10.1038/s41588-018-0081-4	http://dx.doi.org/10.1038/s41588-018-0081-4			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GC1GR	29632380	Green Accepted, Green Submitted			2022-12-17	WOS:000429529300022
J	Ostergaard, P; Simpson, MA; Connell, FC; Steward, CG; Brice, G; Woollard, WJ; Dafou, D; Kilo, T; Smithson, S; Lunt, P; Murday, VA; Hodgson, S; Keenan, R; Pilz, DT; Martinez-Corral, I; Makinen, T; Mortimer, PS; Jeffery, S; Trembath, RC; Mansour, S				Ostergaard, Pia; Simpson, Michael A.; Connell, Fiona C.; Steward, Colin G.; Brice, Glen; Woollard, Wesley J.; Dafou, Dimitra; Kilo, Tatjana; Smithson, Sarah; Lunt, Peter; Murday, Victoria A.; Hodgson, Shirley; Keenan, Russell; Pilz, Daniela T.; Martinez-Corral, Ines; Makinen, Taija; Mortimer, Peter S.; Jeffery, Steve; Trembath, Richard C.; Mansour, Sahar			Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)	NATURE GENETICS			English	Article							MYELODYSPLASIA; CEBPA	We report an allelic series of eight mutations in GATA2 underlying Emberger syndrome, an autosomal dominant primary lymphedema associated with a predisposition to acute myeloid leukemia. GATA2 is a transcription factor that plays an essential role in gene regulation during vascular development and hematopoietic differentiation. Our findings indicate that haploinsufficiency of GATA2 underlies primary lymphedema and predisposes to acute myeloid leukemia in this syndrome.	[Brice, Glen; Hodgson, Shirley; Mansour, Sahar] St Georges Univ London, SW Thames Reg Genet Serv, London, England; [Ostergaard, Pia; Jeffery, Steve] St Georges Univ London, Med Genet Unit, London, England; [Simpson, Michael A.; Woollard, Wesley J.; Dafou, Dimitra; Trembath, Richard C.] Kings Coll London, Sch Med, Div Genet & Mol Med, Guys Hosp, London WC2R 2LS, England; [Connell, Fiona C.] Guys Hosp, Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, London SE1 9RT, England; [Steward, Colin G.] Royal Hosp Children, Bone Marrow Transplant Unit, Bristol, Avon, England; [Kilo, Tatjana] Childrens Hosp Westmead, Haematol Unit, Sydney, NSW, Australia; [Smithson, Sarah; Lunt, Peter] St Michaels Hosp, Dept Clin Genet, Bristol, Avon, England; [Murday, Victoria A.] Yorkhill Hosp, Dept Clin Genet, Glasgow, Lanark, Scotland; [Keenan, Russell] Alder Hey Childrens Hosp, Dept Paediat Haematol, Liverpool L12 2AP, Merseyside, England; [Pilz, Daniela T.] Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; [Martinez-Corral, Ines; Makinen, Taija] Canc Res UK London Res Inst, Lymphat Dev Lab, London, England; [Mortimer, Peter S.] St Georges Univ London, Dept Cardiac & Vasc Sci, London, England	St Georges University London; St Georges University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Bristol Royal Hospital For Children; University of Sydney; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Cardiff University; Cancer Research UK; St Georges University London	Mansour, S (corresponding author), St Georges Univ London, SW Thames Reg Genet Serv, London, England.	smansour@sgul.ac.uk	Ostergaard, Pia/H-8522-2019; Simpson, Michael/F-4737-2011; Makinen, Taija/CAI-2233-2022; Makinen, Taija/C-5765-2014; Dafou, Dimitra/N-6094-2015; Martinez-Corral, Ines/F-1799-2016; Lunt, Peter/AAF-8265-2020	Ostergaard, Pia/0000-0002-2190-1356; Simpson, Michael/0000-0002-8539-8753; Makinen, Taija/0000-0002-9338-1257; Makinen, Taija/0000-0002-9338-1257; Dafou, Dimitra/0000-0003-4170-0612; Martinez-Corral, Ines/0000-0001-9194-2412; Steward, Colin/0000-0001-6291-0710; Trembath, Richard/0000-0003-0550-3400	British Heart Foundation (BHF) [RG/08/006/25302, PG/10/58/28477, FS/06/063/21445]; Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; British Heart Foundation [PG/10/58/28477, RG/08/006/25302] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This study has been made possible by the commitment and courage of the families concerned, and we are indebted to them. This work was supported by the British Heart Foundation (BHF) grants RG/08/006/25302, PG/10/58/28477 and FS/06/063/21445. The authors also acknowledge support from the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. This research utilized the resources of the Biomics Unit at St George's University of London. We also thank T. Enver, University College London Cancer Institute, London for kindly providing the GATA2 reporter constructs.	Callier P, 2009, AM J MED GENET A, V149A, P1323, DOI 10.1002/ajmg.a.32857; DICKINSON RE, 2011, BLOOD           0715, DOI DOI 10.1182/BLOOD-2011-06-360313; Haugas M, 2010, DEV DYNAM, V239, P2452, DOI 10.1002/dvdy.22373; HSU AP, 2011, BLOOD           0613, DOI DOI 10.1182/BLOOD-2011-05-356352; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; Mansour S, 2010, AM J MED GENET A, V152A, P2287, DOI 10.1002/ajmg.a.33445; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Preudhomme C, 2000, BLOOD, V96, P2862, DOI 10.1182/blood.V96.8.2862.h8002862_2862_2869; Rodrigues NP, 2008, BLOOD, V112, P4862, DOI 10.1182/blood-2008-01-136564; Smith ML, 2004, NEW ENGL J MED, V351, P2403, DOI 10.1056/NEJMoa041331; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Zhang SJ, 2008, P NATL ACAD SCI USA, V105, P2076, DOI 10.1073/pnas.0711824105; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	15	339	347	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2011	43	10					929	931		10.1038/ng.923	http://dx.doi.org/10.1038/ng.923			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21892158	Green Submitted			2022-12-17	WOS:000295316200005
J	Broske, AM; Vockentanz, L; Kharazi, S; Huska, MR; Mancini, E; Scheller, M; Kuhl, C; Enns, A; Prinz, M; Jaenisch, R; Nerlov, C; Leutz, A; Andrade-Navarro, MA; Jacobsen, SEW; Rosenbauer, F				Broeske, Ann-Marie; Vockentanz, Lena; Kharazi, Shabnam; Huska, Matthew R.; Mancini, Elena; Scheller, Marina; Kuhl, Christiane; Enns, Andreas; Prinz, Marco; Jaenisch, Rudolf; Nerlov, Claus; Leutz, Achim; Andrade-Navarro, Miguel A.; Jacobsen, Sten Eirik W.; Rosenbauer, Frank			DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; EPIGENETIC REGULATION; TRANSCRIPTION FACTORS; B-CELLS; PROGENITOR; MICE; DIFFERENTIATION; IDENTIFICATION; EXPRESSION; CANCER	DNA methylation is a dynamic epigenetic mark that undergoes extensive changes during differentiation of self-renewing stem cells. However, whether these changes are the cause or consequence of stem cell fate remains unknown. Here, we show that alternative functional programs of hematopoietic stem cells (HSCs) are governed by gradual differences in methylation levels. Constitutive methylation is essential for HSC self-renewal but dispensable for homing, cell cycle control and suppression of apoptosis. Notably, HSCs from mice with reduced DNA methyltransferase 1 activity cannot suppress key myeloerythroid regulators and thus can differentiate into myeloerythroid, but not lymphoid, progeny. A similar methylation dosage effect controls stem cell function in leukemia. These data identify DNA methylation as an essential epigenetic mechanism to protect stem cells from premature activation of predominant differentiation programs and suggest that methylation dynamics determine stem cell functions in tissue homeostasis and cancer.	[Broeske, Ann-Marie; Vockentanz, Lena; Huska, Matthew R.; Scheller, Marina; Kuhl, Christiane; Enns, Andreas; Leutz, Achim; Andrade-Navarro, Miguel A.; Rosenbauer, Frank] Max Delbruck Ctr Mol Med, Berlin, Germany; [Kharazi, Shabnam; Jacobsen, Sten Eirik W.] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Hematopoiet Stem Cell Lab, Lund, Sweden; [Mancini, Elena; Nerlov, Claus] Mouse Biol Unit, European Mol Biol Lab, Monterotondo, Italy; [Prinz, Marco] Univ Freiburg, Dept Neuropathol, Freiburg, Germany; [Jaenisch, Rudolf] Whitehead Inst, Cambridge, MA 02142 USA; [Jacobsen, Sten Eirik W.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab, Oxford OX3 9DU, England	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Lund University; European Molecular Biology Laboratory (EMBL); University of Freiburg; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Oxford	Rosenbauer, F (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	f.rosenbauer@mdc-berlin.de	Leutz, Achim/K-9643-2013; Andrade, Miguel A/B-6565-2008; Jacobsen, Sten Eirik W/D-3974-2018	Leutz, Achim/0000-0001-8259-927X; Andrade, Miguel A/0000-0001-6650-1711; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Broske, Ann-Marie/0000-0002-2529-6317; Huska, Matthew/0000-0002-0912-745X; Scheller, Marina/0000-0001-6108-0831; Rosenbauer, Frank/0000-0001-7977-9421	German Research Foundation; German Cancer Aid (Mildred Scheel); Helmholtz Association of German Research Centers; UK Medical Research Council; Medical Research Council [G0801073, G0701761, G0501838] Funding Source: researchfish; MRC [G0801073, G0501838, G0701761] Funding Source: UKRI	German Research Foundation(German Research Foundation (DFG)); German Cancer Aid (Mildred Scheel)(Deutsche Krebshilfe); Helmholtz Association of German Research Centers(Helmholtz Association); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank V. Malchin, C. Graubmann and J. F. Zinke for their excellent technical assistance; J. Schoenheit for his help with real-time PCR; H. P. Rahn and Z. Ma for assistance with high-speed cell sorting; M. L. Cleary (Stanford University School of Medicine), S. Fillatreau (Deutsches Rheuma-Forschungszentrum), A. Muller (University of Wurzburg), K. Rajewsky (Harvard Medical School), M. Rehli (University of Regensburg), M. Tomasson (Washington University School of Medicine), B. L. Kee (University of Chicago) and T. Somervaille (Stanford University School of Medicine) for reagents; members of the Rosenbauer lab for discussions; D. G. Tenen for support during the initial phase of this study; and C. Plass, C. Muller-Tidow, C. Bonifer and D. G. Tenen for advice on the manuscript. This work was supported by grants from the German Research Foundation, the German Cancer Aid (Mildred Scheel) and the Helmholtz Association of German Research Centers to F. R. S. E. W. J. is the recipient of a strategic appointment grant from the UK Medical Research Council.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Bottardi S, 2007, CELL CYCLE, V6, P1035, DOI 10.4161/cc.6.9.4208; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Domen Jos, 1998, Blood, V91, P2272; Ehlers A, 2008, LEUKEMIA, V22, P835, DOI 10.1038/leu.2008.12; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; FIOTHO C, 2009, LEUKEMIA, V23, P1019; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KAIHO SI, 1985, ANAL BIOCHEM, V149, P117, DOI 10.1016/0003-2697(85)90483-X; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Landgrebe J, 2002, GENOME BIOL, V3; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; NICOLIS S, 1991, NUCLEIC ACIDS RES, V19, P5285, DOI 10.1093/nar/19.19.5285; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Seet CS, 2004, J EXP MED, V199, P1689, DOI 10.1084/jem.20032202; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Ushijima T, 1997, P NATL ACAD SCI USA, V94, P2284, DOI 10.1073/pnas.94.6.2284; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	49	339	346	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2009	41	11					1207	1215		10.1038/ng.463	http://dx.doi.org/10.1038/ng.463			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	512KM	19801979				2022-12-17	WOS:000271247600013
J	Meetei, AR; Medhurst, AL; Ling, C; Xue, YT; Singh, TR; Bier, P; Steltenpool, J; Stone, S; Dokal, I; Mathew, CG; Hoatlin, M; Joenje, H; de Winter, JP; Wang, WD				Meetei, AR; Medhurst, AL; Ling, C; Xue, YT; Singh, TR; Bier, P; Steltenpool, J; Stone, S; Dokal, I; Mathew, CG; Hoatlin, M; Joenje, H; de Winter, JP; Wang, WD			A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M	NATURE GENETICS			English	Article							HOMOLOGOUS RECOMBINATION; ENDONUCLEASE; HELICASE; GENE; DEFICIENT; MUTATION; COMPLEX; GENOME; ATPASE; BRCA2	Fanconi anemia is a genetic disease characterized by genomic instability and cancer predisposition(1). Nine genes involved in Fanconi anemia have been identified; their products participate in a DNA damage - response network involving BRCA1 and BRCA2 ( refs. 2,3). We previously purified a Fanconi anemia core complex containing the FANCL ubiquitin ligase and six other Fanconi anemia associated proteins(4 - 6). Each protein in this complex is essential for monoubiquitination of FANCD2, a key reaction in the Fanconi anemia DNA damage - response pathway(2,7). Here we show that another component of this complex, FAAP250, is mutant in individuals with Fanconi anemia of a new complementation group ( FA- M). FAAP250 or FANCM has sequence similarity to known DNA- repair proteins, including archaeal Hef, yeast MPH1 and human ERCC4 or XPF. FANCM can dissociate DNA triplex, possibly owing to its ability to translocate on duplex DNA. FANCM is essential for monoubiquitination of FANCD2 and becomes hyperphosphorylated in response to DNA damage. Our data suggest an evolutionary link between Fanconi anemia associated proteins and DNA repair; FANCM may act as an engine that translocates the Fanconi anemia core complex along DNA.	Vrije Univ Amsterdam Med Ctr, Dept Clin Genet & Human Genet, NL-1081 BT Amsterdam, Netherlands; Cincinnati Childrens Hosp, Div Expt Hematol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; Oregon Hlth & Sci Univ, Div Mol Med & Mol & Med Genet NRC3, Portland, OR 97239 USA; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London, England; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Oregon Health & Science University; Imperial College London; University of London; King's College London	de Winter, JP (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet & Human Genet, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	j.dewinter@vumc.nl; wangw@grc.nia.nih.gov	Ittershagen, Stacie/X-7658-2019; Mathew, Christopher G/G-3434-2015; Wang, Weidong/AAV-2446-2021	Mathew, Christopher G/0000-0003-4178-1838; Ittershagen, Stacie (Stone)/0000-0003-3834-176X; Dokal, Inderjeet/0000-0003-4462-4782; singh, thiyam/0000-0002-0441-6818; Wang, Weidong/0000-0002-0658-7928	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R01 CA112775] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA112775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000688] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Demuth I, 2004, ONCOGENE, V23, P8611, DOI 10.1038/sj.onc.1207895; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Garcia-Cabeza I, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-7; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Komori K, 2004, J BIOL CHEM, V279, P53175, DOI 10.1074/jbc.M409243200; Komori K, 2002, GENES GENET SYST, V77, P227, DOI 10.1266/ggs.77.227; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; LEVITUS M, 2005, J NAT GENET, V37, P934, DOI DOI 10.1038/NG1625; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Prakash R, 2005, J BIOL CHEM, V280, P7854, DOI 10.1074/jbc.M413898200; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Scheller J, 2000, GENETICS, V155, P1069; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; Sgouros J, 1999, TRENDS BIOCHEM SCI, V24, P95, DOI 10.1016/S0968-0004(99)01355-9; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Taniguchi T, 2002, BLOOD, V100, P2457, DOI 10.1182/blood-2002-03-0860; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933	30	339	360	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					958	963		10.1038/ng1626	http://dx.doi.org/10.1038/ng1626			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16116422	Green Accepted			2022-12-17	WOS:000231591900020
J	Kizawa, H; Kou, I; Iida, A; Sudo, A; Miyamoto, Y; Fukuda, A; Mabuchi, A; Kotani, A; Kawakami, A; Yamamoto, S; Uchida, A; Nakamura, K; Notoya, K; Nakamura, Y; Ikegawa, S				Kizawa, H; Kou, I; Iida, A; Sudo, A; Miyamoto, Y; Fukuda, A; Mabuchi, A; Kotani, A; Kawakami, A; Yamamoto, S; Uchida, A; Nakamura, K; Notoya, K; Nakamura, Y; Ikegawa, S			An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis	NATURE GENETICS			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; TGF-BETA; SEQUENCE POLYMORPHISMS; OSTEOPHYTE FORMATION; GENE-CLUSTER; KNEE; ASSOCIATION; EXPRESSION; DECORIN; DIFFERENTIATION	Osteoarthritis is the most common form of human arthritis. We investigated the potential role of asporin, an extracellular matrix component expressed abundantly in the articular cartilage of individuals with osteoarthritis, in the pathogenesis of osteoarthritis. Here we report a significant association between a polymorphism in the aspartic acid (D) repeat of the gene encoding asporin (ASPN) and osteoarthritis. In two independent populations of individuals with knee osteoarthritis, the D14 allele of ASPN is overrepresented relative to the common D13 allele, and its frequency increases with disease severity. The D14 allele is also overrepresented in individuals with hip osteoarthritis. Asporin suppresses TGF-beta-mediated expression of the genes aggrecan (AGC1) and type II collagen (COL2A1) and reduced proteoglycan accumulation in an in vitro model of chondrogenesis. The effect on TGF-beta activity is allele-specific, with the D14 allele resulting in greater inhibition than other alleles. In vitro binding assays showed a direct interaction between asporin and TGF-beta. Taken together, these findings provide another functional link between extracellular matrix proteins, TGF-beta activity and disease, suggesting new therapeutic strategies for osteoarthritis.	RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Bone & Joint Dis,Minato Ku, Tokyo 1088639, Japan; Takeda Chem Ind Ltd, Div Pharmaceut Res, Pharmaceut Res Labs 1, Yodogawa Ku, Osaka 5328686, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Genotyping,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Mie Univ, Fac Med, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan; Univ Tokyo, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138655, Japan; Kyorin Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1818611, Japan; Tokyo Teishin Hosp, Dept Orthoped Surg, Chiyoda Ku, Tokyo 1028798, Japan; Tokyo Metropolitan Geriatr Hosp, Dept Orthoped Surg, Itabashi Ku, Tokyo 1730015, Japan	RIKEN; Takeda Chemical Industries; RIKEN; Mie University; University of Tokyo; Kyorin University	Ikegawa, S (corresponding author), RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Bone & Joint Dis,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Iida, Aritoshi/CAA-1373-2022; Ikegawa, Shiro/N-6895-2015	Iida, Aritoshi/0000-0001-7538-1651; Ikegawa, Shiro/0000-0003-0316-2147				Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Dugan TA, 2003, J BIOL CHEM, V278, P13655, DOI 10.1074/jbc.M300171200; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Gill MR, 2002, OSTEOARTHR CARTILAGE, V10, P751, DOI 10.1053/joca.2002.0527; Grimaud E, 2002, CYTOKINE GROWTH F R, V13, P241, DOI 10.1016/S1359-6101(02)00004-7; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Ikeda T, 2001, J HUM GENET, V46, P538, DOI 10.1007/s100380170036; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; KELLGREN JH, 1963, ANN RHEUM DIS, V22, P237, DOI 10.1136/ard.22.4.237; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Loughlin J, 2002, ARTHRITIS RHEUM, V46, P1519, DOI 10.1002/art.10260; Loughlin J, 2001, CURR OPIN RHEUMATOL, V13, P111, DOI 10.1097/00002281-200103000-00004; Mabuchi A, 2001, J HUM GENET, V46, P456, DOI 10.1007/s100380170045; Meulenbelt I, 1997, ARTHRITIS RHEUM, V40, P1760, DOI 10.1002/art.1780401006; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Scharstuhl A, 2002, J IMMUNOL, V169, P507, DOI 10.4049/jimmunol.169.1.507; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; SINGH K, 1993, J BIOCHEM-TOKYO, V114, P702, DOI 10.1093/oxfordjournals.jbchem.a124240; Smith AJP, 2004, GENES IMMUN, V5, P451, DOI 10.1038/sj.gene.6364107; Spector TD, 1996, BRIT MED J, V312, P940; Spector Tim D, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS39; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Uitterlinden AG, 2000, ARTHRITIS RHEUM-US, V43, P1456, DOI 10.1002/1529-0131(200007)43:7<1456::AID-ANR7>3.0.CO;2-M; VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Yamada R, 2001, AM J HUM GENET, V68, P674, DOI 10.1086/318789; Yang VWC, 1999, J BIOL CHEM, V274, P12454, DOI 10.1074/jbc.274.18.12454; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35	37	339	354	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					138	144		10.1038/ng1496	http://dx.doi.org/10.1038/ng1496			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15640800				2022-12-17	WOS:000226690100019
J	Umlauf, D; Goto, Y; Cao, R; Cerqueira, F; Wagschal, A; Zhang, Y; Feil, R				Umlauf, D; Goto, Y; Cao, R; Cerqueira, F; Wagschal, A; Zhang, Y; Feil, R			Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes	NATURE GENETICS			English	Article							H3 LYSINE-27 METHYLATION; DNA METHYLATION; X-INACTIVATION; GENE; CHROMOSOME; REGION; EXPRESSION; SEQUENCE; CLUSTER	Imprinted genes are clustered in domains, and their allelic repression is mediated by imprinting control regions(1-3). These imprinting control regions are marked by DNA methylation, which is essential to maintain imprinting in the embryo(4). To explore how imprinting is regulated in placenta, we studied the Kcnq1 domain on mouse distal chromosome 7. This large domain is controlled by an intronic imprinting control region(5,6) and comprises multiple genes that are imprinted in placenta, without the involvement of promoter DNA methylation(7-10). We found that the paternal repression along the domain involves acquisition of trimethylation at Lys27 and dimethylation at Lys9 of histone H3. Eed-Ezh2 Polycomb complexes are recruited to the paternal chromosome and potentially regulate its repressive histone methylation. Studies on embryonic stem cells and early embryos support our proposal that chromatin repression is established early in development and is maintained in the placenta. In the embryo, however, imprinting is stably maintained only at genes that have promoter DNA methylation. These data underscore the importance of histone methylation in placental imprinting and identify mechanistic similarities with X-chromosome inactivation in extraembryonic tissues, suggesting that the two epigenetic mechanisms are evolutionarily linked.	Inst Mol Genet, CNRS, UMR 5535, F-34090 Montpellier, France; Univ Montpellier 2, F-34090 Montpellier, France; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; University of North Carolina; University of North Carolina Chapel Hill	Feil, R (corresponding author), Inst Mol Genet, CNRS, UMR 5535, 1919 Route de Mende, F-34090 Montpellier, France.	robert.feil@igmm.cnrs.fr	Feil, Robert P/D-2087-2013	Feil, Robert P/0000-0002-5671-5860; Zhang, Yi/0000-0002-2789-0811				Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caspary T, 1998, MOL CELL BIOL, V18, P3466, DOI 10.1128/MCB.18.6.3466; Dean W, 1998, DEVELOPMENT, V125, P2273; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Engemann S, 2000, HUM MOL GENET, V9, P2691, DOI 10.1093/hmg/9.18.2691; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Higashimoto K, 2002, GENOMICS, V80, P575, DOI 10.1006/geno.2002.7006; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mancini-DiNardo D, 2003, HUM MOL GENET, V12, P283, DOI 10.1093/hmg/ddg024; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Sleutels F, 2000, CURR OPIN GENET DEV, V10, P229, DOI 10.1016/S0959-437X(00)00062-9; Tanaka M, 1999, MECH DEVELOP, V87, P129, DOI 10.1016/S0925-4773(99)00158-6; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Yatsuki H, 2002, GENOME RES, V12, P1860, DOI 10.1101/gr.110702; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	30	339	357	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1296	1300		10.1038/ng1467	http://dx.doi.org/10.1038/ng1467			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15516932				2022-12-17	WOS:000225354100017
J	Kurose, K; Gilley, K; Matsumoto, S; Watson, PH; Zhou, XP; Eng, C				Kurose, K; Gilley, K; Matsumoto, S; Watson, PH; Zhou, XP; Eng, C			Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas	NATURE GENETICS			English	Article							EXPRESSION; CANCERS	We have recently shown that loss of heterozygosity of specific markers, including those at 10q23, 17p13-p15 and 16q24, can occur in the stromal and epithelial compartments of primary invasive breast carcinomas. Here, we demonstrate high frequencies of somatic mutations in TP53 (encoding tumor protein p53) and PTEN (encoding phosphate and tensin homolog) in breast neoplastic epithelium and stroma. Mutations in TP53 and PTEN are mutually exclusive in either compartment. In contrast, mutations in WFDC1 (16q24, encoding WAP four-disulfide core domain 1) occur with low frequency in the stroma.	Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Div Human Genet, Dept Internal Med, Columbus, OH 43210 USA; Univ Manitoba, Dept Pathol, Winnipeg, MB R3T 2N2, Canada; Univ Cambridge, Human Canc Genet Res Grp, Canc Res UK, Cambridge CB2 2XZ, England	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Manitoba; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Eng, C (corresponding author), Ohio State Univ, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA.			Eng, Charis/0000-0002-3693-5145; Watson, Peter/0000-0002-1642-0638				ENG C, 2001, METABOLIC MOL BASES, V1, P979; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Larsen M, 2000, MAMM GENOME, V11, P767, DOI 10.1007/s003350010135; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Tomlinson IPM, 2002, GENE CHROMOSOME CANC, V34, P349, DOI 10.1002/gcc.10085; Wernert N, 2001, ANTICANCER RES, V21, P2259	8	339	358	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					355	357		10.1038/ng1013	http://dx.doi.org/10.1038/ng1013			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12379854				2022-12-17	WOS:000179034800009
J	Robitaille, J; MacDonald, MLE; Kaykas, A; Sheldahl, LC; Zeisler, J; Dube, MP; Zhang, LH; Singaraja, RR; Guernsey, DL; Zheng, BY; Siebert, LF; Hoskin-Mott, A; Trese, MT; Pimstone, SN; Shastry, BS; Moon, RT; Hayden, MR; Goldberg, YP; Samuels, ME				Robitaille, J; MacDonald, MLE; Kaykas, A; Sheldahl, LC; Zeisler, J; Dube, MP; Zhang, LH; Singaraja, RR; Guernsey, DL; Zheng, BY; Siebert, LF; Hoskin-Mott, A; Trese, MT; Pimstone, SN; Shastry, BS; Moon, RT; Hayden, MR; Goldberg, YP; Samuels, ME			Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy	NATURE GENETICS			English	Article							CANDIDATE GENE ANALYSIS; TARGETED DISRUPTION; LINKAGE ANALYSIS; WNT; RECEPTOR; WINGLESS; COMPLEX; PROTEIN; MUTATIONS; CARCINOMA	Familial exudative vitreoretinopathy (FEVR) is a hereditary ocular disorder characterized by a failure of peripheral retinal vascularization. Loci associated with FEVR map to 11q13-q23 (EVR1; OMIM 133780, ref. 1), Xp11.4 (EVR2; OMIM 305390, ref. 2) and 11p13-12 (EVR3; OMIM 605750, ref. 3). Here we have confirmed linkage to the 11q13-23 locus for autosomal dominant FEVR in one large multigenerational family and refined the disease locus to a genomic region spanning 1.55 Mb. Mutations in FZD4, encoding the putative Wnt receptor frizzled-4, segregated completely with affected individuals in the family and were detected in affected individuals from an additional unrelated family, but not in normal controls. FZD genes encode Wnt receptors, which are implicated in development and carcinogenesis. Injection of wildtype and mutated FZD4 into Xenopus laevis embryos revealed that wildtype, but not mutant, frizzled-4 activated calcium/calmodulin-dependent protein kinase II (CAMKII) and protein kinase C (PKC), components of the Wnt/Ca2+ signaling pathway. In one of the mutants, altered subcellular trafficking led to defective signaling. These findings support a function for frizzled-4 in retinal angiogenesis and establish the first association between a Wnt receptor and human disease.	Xenon Genet Inc, Burnaby, BC V5G 4W8, Canada; Dalhousie Univ, Dept Ophthalmol, Izaak Walton Killam Hlth Ctr, Halifax, NS B3H 2Y9, Canada; Dalhousie Univ, Dept Pathol, Div Mol Pathol & Mol Genet, Halifax, NS B3H 4H7, Canada; Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Western Ontario, Dept Ophthalmol, London, ON, Canada; Dalhousie Univ, QEII Sci Ctr, Dept Ophthalmol, Halifax, NS, Canada; William Beaumont Hosp, Royal Oak, MI 48072 USA; Oakland Univ, Dept Biol Sci, Rochester, MI USA; Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada	Dalhousie University; Dalhousie University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Western University (University of Western Ontario); Dalhousie University; Beaumont Health; Oakland University; University of British Columbia	Hayden, MR (corresponding author), Xenon Genet Inc, Burnaby, BC V5G 4W8, Canada.		Moon, Randall/M-5605-2019; Dubé, Marie-Pierre/B-9364-2008; Moon, Randall T/B-1743-2014; Hayden, Michael R/D-8581-2011	Moon, Randall/0000-0002-9352-1408; Dubé, Marie-Pierre/0000-0001-8442-4393; Moon, Randall T/0000-0002-9352-1408; Hayden, Michael R/0000-0001-5159-1419; Sheldahl, Laird/0000-0002-3298-5436; MacDonald, Marcia/0000-0001-7946-0023; Singaraja, Roshni/0000-0002-3418-3867				Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CANNY CLB, 1976, ARCH OPHTHALMOL-CHIC, V94, P1114; de Crecchio G, 1998, CLIN GENET, V54, P315, DOI 10.1034/j.1399-0004.1998.5440409.x; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Downey LM, 2001, AM J HUM GENET, V68, P778, DOI 10.1086/318790; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Kondo H, 2001, HUM GENET, V108, P368, DOI 10.1007/s004390100503; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; LI Y, 1992, AM J OPHTHALMOL, V113, P712, DOI 10.1016/S0002-9394(14)74800-7; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; MULLER B, 1994, GENOMICS, V20, P317, DOI 10.1006/geno.1994.1176; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; Shastry BS, 2000, CLIN GENET, V58, P329, DOI 10.1034/j.1399-0004.2000.580412.x; SHASTRY BS, 1995, GENOMICS, V27, P341, DOI 10.1006/geno.1995.1052; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	27	339	425	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2002	32	2					326	330		10.1038/ng957	http://dx.doi.org/10.1038/ng957			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	599AP	12172548				2022-12-17	WOS:000178311100026
J	Stone, EM; Lotery, AJ; Munier, FL; Heon, E; Piguet, B; Guymer, RH; Vandenburgh, K; Cousin, P; Nishimura, D; Swiderski, RE; Silvestri, G; Mackey, DA; Hageman, GS; Bird, AC; Sheffield, VC; Schorderet, DF				Stone, EM; Lotery, AJ; Munier, FL; Heon, E; Piguet, B; Guymer, RH; Vandenburgh, K; Cousin, P; Nishimura, D; Swiderski, RE; Silvestri, G; Mackey, DA; Hageman, GS; Bird, AC; Sheffield, VC; Schorderet, DF			A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy	NATURE GENETICS			English	Article							AGE-RELATED MACULOPATHY; BEAVER DAM EYE; MACULAR DEGENERATION; GENE; FIBRILLIN; PROTEIN; DRUSEN; PREVALENCE; FAMILY; DNA	Malattia Leventinese (ML) and Doyne honeycomb retinal dystrophy (DHRD) refer to two autosomal dominant diseases characterized by yellow-white deposits known as drusen that accumulate beneath the retinal pigment epithelium(1-4) (RPE). Both loci were mapped to chromosome 2p16-21 (refs 5,6) and this genetic interval has been subsequently narrowed(6) (7). The importance of these diseases is due in large part to their close phenotypic similarity to age-related macular degeneration (AMD), a disorder with a strong genetic: components(8-10) that accounts for approximately 50% of registered blindness in the Western world(11-14). Just as in ML and DHRD, the early hallmark of AMD is the presence of drusen(15) (16). Here we use a combination of positional and candidate gene methods to identify a single non-conservative mutation (Arg345Trp) in the gene EFEMP1 (for EGF-containing fibrillin-like extracellular matrix protein 1) in all families studied. This change was not present in 477 control individuals or in 494 patients with age-related macular degeneration. Identification of this mutation may aid in the development of an animal model for drusen, as well as in the identification of other genes involved in human macular degeneration.	Univ Iowa, Coll Med, Dept Ophthalmol, Iowa City, IA 52242 USA; CHU Vaudois, Div Med Genet, CH-1011 Lausanne, Switzerland; Hop Jules Gonin, Lausanne, Switzerland; Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada; Eye Res Inst Canada, Toronto, ON, Canada; Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Parkville, Vic 3052, Australia; Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA; Royal Victoria Hosp, Dept Ophthalmol, Belfast BT12 6BA, Antrim, North Ireland; Univ Tasmania, Menzies Ctr Populat Hlth Res, Hobart, Tas 7001, Australia; Moorfields Eye Hosp, Inst Ophthalmol, London, England; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA USA	University of Iowa; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Toronto; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Iowa; University of Tasmania; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Howard Hughes Medical Institute; University of Iowa	Stone, EM (corresponding author), Univ Iowa, Coll Med, Dept Ophthalmol, Iowa City, IA 52242 USA.		Mackey, David A/H-5340-2014	Mackey, David A/0000-0001-7914-4709; Lotery, Andrew/0000-0001-5541-4305; Silvestri, Giuliana/0000-0001-5662-5374; Guymer, Robyn/0000-0002-9441-4356; Stone, Edwin M./0000-0003-3343-4414; Sheffield, Val/0000-0002-6282-0835	NEI NIH HHS [EY11515, EY10539] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011515, R01EY010539] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; Collins T., 1913, OPHTHALMOSCOPE, V11, P537; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Doyne R., 1899, T OPHTHAL SOC UK, V19, P71; Edwards AO, 1998, AM J OPHTHALMOL, V126, P417, DOI 10.1016/S0002-9394(98)00097-X; Evans J, 1996, BRIT J OPHTHALMOL, V80, P9, DOI 10.1136/bjo.80.1.9; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; FORNI S, 1962, Ophthalmologica, V143, P313; Gregory CY, 1996, HUM MOL GENET, V5, P1055, DOI 10.1093/hmg/5.7.1055; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Heon E, 1996, ARCH OPHTHALMOL-CHIC, V114, P193, DOI 10.1001/archopht.1996.01100130187014; Ikegawa S, 1996, GENOMICS, V35, P590, DOI 10.1006/geno.1996.0402; Jay M, 1996, EYE, V10, P469, DOI 10.1038/eye.1996.103; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; LECKACZERNIK B, 1995, MOL CELL BIOL, V15, P120, DOI 10.1128/MCB.15.1.120; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Meyers S M, 1994, Trans Am Ophthalmol Soc, V92, P775; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Saemisch T, 1925, HDB GESAMMTEN AUGENH, P1; SARKS JP, 1994, EYE, V8, P269, DOI 10.1038/eye.1994.57; SILVESTRI G, 1994, EYE, V8, P564, DOI 10.1038/eye.1994.138; Tran H, 1997, MATRIX BIOL, V15, P479, DOI 10.1016/S0945-053X(97)90021-4; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WELLISZ T, 1993, J LONG-TERM EFF MED, V3, P223	30	339	352	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					199	202		10.1038/9722	http://dx.doi.org/10.1038/9722			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369267				2022-12-17	WOS:000080680900030
J	WASCO, W; GURUBHAGAVATULA, S; DPARADIS, M; ROMANO, DM; SISODIA, SS; HYMAN, BT; NEVE, RL; TANZI, RE				WASCO, W; GURUBHAGAVATULA, S; DPARADIS, M; ROMANO, DM; SISODIA, SS; HYMAN, BT; NEVE, RL; TANZI, RE			ISOLATION AND CHARACTERIZATION OF APLP2 ENCODING A HOMOLOG OF THE ALZHEIMERS ASSOCIATED AMYLOID BETA-PROTEIN PRECURSOR	NATURE GENETICS			English	Article							MESSENGER-RNA; GENETIC-LINKAGE; DISEASE LOCUS; CDNA; LOCALIZATION; PEPTIDE; CHROMOSOME-14; RECEPTOR; MUTATION; MAPS	Familial Alzheimer's disease (FAD) is a genetically heterogeneous disorder that includes a rare early-onset form linked to mutations in the amyloid b protein precursor (APP) gene. Clues to the function of APP derive from the recent finding that it is a member of a highly conserved protein family that includes the mammalian amyloid precursor-like protein (APLP1) gene which maps to the same general region of human chromosome 19 linked to late-onset FAD. Here we report the isolation of the human APLP2 gene. We show that APLP2 is a close relative of APP and exhibits a very similar pattern of expression in the brain and throughout the body. Like APP, APLP2 contains a cytoplasmic domain predicted to couple with the GTP-binding protein G(o) indicating that it may be an additional cell surface activator of this G protein.	MASSACHUSETTS GEN HOSP, DEPT NEUROL, BOSTON, MA 02115 USA; MCLEAN HOSP, MAILMAN RES CTR, BELMONT, MA 02178 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA	Harvard University; Massachusetts General Hospital; Harvard University; McLean Hospital; Johns Hopkins University; Johns Hopkins University	WASCO, W (corresponding author), MASSACHUSETTS GEN HOSP, CTR NEUROSCI, GENET & AGING LAB, BOSTON, MA 02129 USA.		Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Paradis, Marc d./0000-0003-2387-3157	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG008487, R01AG008487] Funding Source: NIH RePORTER; NIA NIH HHS [AG08487] Funding Source: Medline; NINDS NIH HHS [NS30428] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BUSH AI, IN PRESS J BIOL CHEM; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; GEISSLER EN, 1991, SOMAT CELL MOLEC GEN, V17, P207, DOI 10.1007/BF01232978; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GUILLEN A, 1990, EMBO J, V9, P1449, DOI 10.1002/j.1460-2075.1990.tb08261.x; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HYMAN BT, 1993, MOL BRAIN RES, V18, P253, DOI 10.1016/0169-328X(93)90197-W; JACOBSEN JS, 1991, NEUROBIOL AGING, V12, P575, DOI 10.1016/0197-4580(91)90089-3; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KONIG G, 1992, J BIOL CHEM, V267, P19804; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; PALACIOS G, 1992, MOL BRAIN RES, V15, P195, DOI 10.1016/0169-328X(92)90109-O; PELLETIER J, 1991, GENOMICS, V10, P1079, DOI 10.1016/0888-7543(91)90203-Q; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STGEORGEHYSLOP PH, 1989, NEUROBIOL AGING, V10, P417, DOI 10.1016/0197-4580(89)90082-1; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STRITMATTER SM, NATURE, V344, P836; TANZI RE, 1993, MOL BRAIN RES, V18, P246, DOI 10.1016/0169-328X(93)90196-V; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TANZI RE, 1991, ANN NY ACAD SCI, V640, P149; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; TANZI RE, 1992, AM J HUM GENET, V51, P273; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; WASCO W, 1992, GENOMICS, V15, P238; WASCO W, IN PRESS ALZHEIMERS; YAN YC, 1990, P NATL ACAD SCI USA, V87, P2405, DOI 10.1073/pnas.87.7.2405; ZIMMERMANN K, 1988, EMBO J, V7, P367, DOI 10.1002/j.1460-2075.1988.tb02822.x; 1991, PROGRAM MANUAL GCG P	51	339	349	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					95	100		10.1038/ng0993-95	http://dx.doi.org/10.1038/ng0993-95			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220435				2022-12-17	WOS:A1993LV56500025
J	KARTNER, N; AUGUSTINAS, O; JENSEN, TJ; NAISMITH, AL; RIORDAN, JR				KARTNER, N; AUGUSTINAS, O; JENSEN, TJ; NAISMITH, AL; RIORDAN, JR			MISLOCALIZATION OF DELTA-F508 CFTR IN CYSTIC-FIBROSIS SWEAT GLAND	NATURE GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE; IDENTIFICATION; LOCALIZATION; EXPRESSION; ANTIBODIES; MUTATIONS; CHLORIDE; TRANSPORT; PANCREAS	Misprocessing and mislocalization of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) has been described for the major CF-causing mutation (DELTA-F508) in heterologous expression systems in vitro. We have generated monoclonal antibodies (mAbs) to CFTR with the aim of localizing the protein and its CF variants in vivo. Of the tissues where CFTR was observed, only the sweat gland is readily available and does not undergo secondary changes due to CF disease pathology. Sweat ducts from CF patients homozygous for DELTA-F508 did not show the typical apical membrane staining seen in control biopsies. This demonstrates that the biosynthetic arrest and intracellular retention of DELTA-F508 CFTR initially observed in vitro does occur in vivo and emphasizes the need to focus efforts on understanding the mislocalization.	HOSP SICK CHILDREN,CYST FIBROSIS RES DEV PROGRAM,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT BIOCHEM,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO M5S 1A8,ONTARIO,CANADA; UNIV TORONTO,DEPT CLIN BIOCHEM,TORONTO M5S 1A8,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	KARTNER, N (corresponding author), HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA.							ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BARON DA, 1984, LAB INVEST, V51, P233; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BEAR CE, 1992, FASEB J, V6, pA127; BEHM JK, 1987, PEDIATR RES, V22, P271, DOI 10.1203/00006450-198709000-00007; BLOMFIEL.J, 1973, GUT, V14, P558, DOI 10.1136/gut.14.7.558; BLOMFIELD J, 1973, ARCH DIS CHILD, V48, P267, DOI 10.1136/adc.48.4.267; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; COHN JA, 1991, BIOCHEM BIOPH RES CO, V181, P36, DOI 10.1016/S0006-291X(05)81378-6; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DISANTAGNESE PA, 1958, PEDIATRICS, V22, P507; DONOWITZ M, 1986, ANNU REV PHYSIOL, V48, P135, DOI 10.1146/annurev.ph.48.030186.001031; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; FORSTNER GG, 1987, GENETICS EPITHELIAL; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; GUILLERMIT H, 1990, HUM GENET, V85, P450, DOI 10.1007/BF02428306; JOHNSTON WH, 1956, ARCH DIS CHILD, V31, P477, DOI 10.1136/adc.31.160.477; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOPELMAN H, 1989, CLIN INVEST MED, V12, P207; LUCKOW VA, 1989, VIROLOGY, V170, P31, DOI 10.1016/0042-6822(89)90348-6; MARINO CR, 1991, J CLIN INVEST, V88, P712, DOI 10.1172/JCI115358; MCGRADY K, 1955, AMA AM J DIS CHILD, V90, P610; MUNGER BL, 1961, J PEDIATR-US, V59, P497, DOI 10.1016/S0022-3476(61)80233-3; REDDY MM, 1989, AM J PHYSIOL, V257, pC727, DOI 10.1152/ajpcell.1989.257.4.C727; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; SARKADI B, 1992, J BIOL CHEM, V267, P2087; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0	38	339	348	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1992	1	5					321	327		10.1038/ng0892-321	http://dx.doi.org/10.1038/ng0892-321			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ121	1284548				2022-12-17	WOS:A1992JJ12100007
J	Fallon, PG; Sasaki, T; Sandilands, A; Campbell, LE; Saunders, SP; Mangan, NE; Callanan, JJ; Kawasaki, H; Shiohama, A; Kubo, A; Sundberg, JP; Presland, RB; Fleckman, P; Shimizu, N; Kudoh, J; Irvine, AD; Amagai, M; McLean, WHI				Fallon, Padraic G.; Sasaki, Takashi; Sandilands, Aileen; Campbell, Linda E.; Saunders, Sean P.; Mangan, Niamh E.; Callanan, John J.; Kawasaki, Hiroshi; Shiohama, Aiko; Kubo, Akiharu; Sundberg, John P.; Presland, Richard B.; Fleckman, Philip; Shimizu, Nobuyoshi; Kudoh, Jun; Irvine, Alan D.; Amagai, Masayuki; McLean, W. H. Irwin			A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming	NATURE GENETICS			English	Article							OF-FUNCTION MUTATIONS; ATOPIC-DERMATITIS; ICHTHYOSIS VULGARIS; FILAGGRIN MUTATIONS; HUMAN PROFILAGGRIN; MICE; EXPRESSION; DISEASE; ASTHMA; ECZEMA	Loss-of-function mutations in the FLG (filaggrin) gene cause the semidominant keratinizing disorder ichthyosis vulgaris(1) and convey major genetic risk for atopic dermatitis (eczema)(2-4), eczema-associated asthma(2,3) and other allergic phenotypes(5). Several low-frequency FLG null alleles occur in Europeans and Asians, with a cumulative frequency of similar to 9% in Europe(4). Here we report a 1-bp deletion mutation, 5303delA, analogous to common human FLG mutations, within the murine Flg gene in the spontaneous mouse mutant flaky tail (ft). We demonstrate that topical application of allergen to mice homozygous for this mutation results in cutaneous inflammatory infiltrates and enhanced cutaneous allergen priming with development of allergen-specific antibody responses. These data validate flaky tail as a useful model of filaggrin deficiency and provide experimental evidence for the hypothesis that antigen transfer through a defective epidermal barrier is a key mechanism underlying elevated IgE sensitization and initiation of cutaneous inflammation in humans with filaggrin-related atopic disease.	[Sandilands, Aileen; Campbell, Linda E.; McLean, W. H. Irwin] Univ Dundee, Coll Life Sci, Div Mol Med, Epithelial Genet Grp, Dundee, Scotland; [Sandilands, Aileen; Campbell, Linda E.; McLean, W. H. Irwin] Univ Dundee, Coll Med Dent & Nursing, Div Mol Med, Epithelial Genet Grp, Dundee, Scotland; [Fallon, Padraic G.; Saunders, Sean P.; Mangan, Niamh E.; Irvine, Alan D.] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [Sasaki, Takashi; Shiohama, Aiko; Kudoh, Jun] Keio Univ, Sch Med, Dept Mol Biol, Tokyo, Japan; [Sasaki, Takashi; Shiohama, Aiko; Shimizu, Nobuyoshi; Kudoh, Jun] Keio Univ, Adv Res Ctr Genome Super Power, Ibaraki, Japan; [Callanan, John J.] Univ Coll Dublin, Coll Life Sci, Conway Inst Biomol & Biomed Res, Vet Sci Ctr, Dublin 2, Ireland; [Kawasaki, Hiroshi; Kubo, Akiharu; Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA; [Presland, Richard B.] Univ Washington, Sch Dent, Dept Oral Biol, Seattle, WA 98195 USA; [Presland, Richard B.; Fleckman, Philip] Univ Washington, Dept Med, Div Dermatol, Seattle, WA USA; [Irvine, Alan D.] Our Ladys Childrens Hosp, Dept Paediat Dermatol, Dublin, Ireland	University of Dundee; University of Dundee; Trinity College Dublin; Keio University; Keio University; University College Dublin; Keio University; Jackson Laboratory; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin	McLean, WHI (corresponding author), Univ Dundee, Coll Life Sci, Div Mol Med, Epithelial Genet Grp, Dundee, Scotland.	w.h.i.mclean@dundee.ac.uk	Sasaki, Takashi/AAD-1461-2019; Kubo, Akiharu/I-2711-2014; Irvine, Alan D/A-3982-2008; McLean, William HI/C-6352-2009; Fallon, Padraic/Y-2711-2019; Amagai, Masayuki/K-5325-2013	Kubo, Akiharu/0000-0003-0902-3586; Irvine, Alan D/0000-0002-9048-2044; Fallon, Padraic/0000-0002-8401-7293; Amagai, Masayuki/0000-0003-3314-7052; Callanan, John/0000-0003-4356-1783; Sasaki, Takashi/0000-0002-6275-046X; Saunders, Sean/0000-0003-1689-3598; Mangan, Niamh/0000-0003-3844-0709; Presland, Richard/0000-0003-1440-7402; McLean, William Henry Irwin/0000-0001-5539-5757	Ministry of Health, Labour, and Welfare of Japan; National Institute of Health [P01 AM21557, R01 AR49183]; Odland Endowed Research Fund; Science Foundation Ireland; Children's Medical and Research Foundation, OLCHC; British Skin Foundation; National Eczema Society; Medical Research Council [G0700314]; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P01AM021557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049183] Funding Source: NIH RePORTER; MRC [G0700314] Funding Source: UKRI	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Odland Endowed Research Fund; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation, OLCHC; British Skin Foundation; National Eczema Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. Mistry, A. Smyth, T. Adachi and M. Furuhashi for their technical assistance and T. Yoshida for his cooperation. We are grateful for the assistance of B. Cloak with photomicrography and S. Worrell with histopathology. This work was supported by the Labour Sciences Research Grants for Research on Allergic Disease and Immunology from the Ministry of Health, Labour, and Welfare of Japan (M. A.), National Institute of Health grants P01 AM21557 (P. F.), R01 AR49183 (R. B. P.) and the Odland Endowed Research Fund (P. F.). P. G. F. was supported by Science Foundation Ireland. A. D. I. is supported by the Children's Medical and Research Foundation, OLCHC. Filaggrin research in the McLean laboratory is supported by grants from The British Skin Foundation, The National Eczema Society, The Medical Research Council (Reference number G0700314) and donations from anonymous families affected by eczema in the Tayside Region of Scotland.	Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Chen L, 2008, CLIN EXP ALLERGY, V38, P1367, DOI 10.1111/j.1365-2222.2008.02987.x; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Kim BE, 2008, CLIN IMMUNOL, V126, P332, DOI 10.1016/j.clim.2007.11.006; Mangan NE, 2006, J IMMUNOL, V176, P138, DOI 10.4049/jimmunol.176.1.138; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; McLean WHI, 2008, J ALLERGY CLIN IMMUN, V121, P1294, DOI 10.1016/j.jaci.2008.02.039; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pearton DJ, 2002, J INVEST DERMATOL, V119, P661, DOI 10.1046/j.1523-1747.2002.01831.x; PRESLAND RB, 1995, J INVEST DERMATOL, V104, P218, DOI 10.1111/1523-1747.ep12612770; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; ROTHNAGEL JA, 1987, J BIOL CHEM, V262, P15643; ROTHNAGEL JA, 1990, J BIOL CHEM, V265, P1862; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sasaki T, 2008, J DERMATOL SCI, V51, P113, DOI 10.1016/j.jdermsci.2008.02.009; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Sundberg JP., 1984, HDB MOUSE MUTATIONS, V2, P269; Terada M, 2006, P NATL ACAD SCI USA, V103, P8816, DOI 10.1073/pnas.0602900103; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Williams H, 2006, J ALLERGY CLIN IMMUN, V118, P209, DOI 10.1016/j.jaci.2006.04.043; Zhang D, 2002, J INVEST DERMATOL, V119, P905, DOI 10.1046/j.1523-1747.2002.00133.x	30	338	348	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					602	608		10.1038/ng.358	http://dx.doi.org/10.1038/ng.358			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19349982	Green Accepted			2022-12-17	WOS:000265575600023
J	Miyamoto, Y; Mabuchi, A; Shi, DQ; Kubo, T; Takatori, Y; Saito, S; Fujioka, M; Sudo, A; Uchida, A; Yamamoto, S; Ozaki, K; Takigawa, M; Tanaka, T; Nakamura, Y; Jiang, Q; Ikegawa, S				Miyamoto, Yoshinari; Mabuchi, Akihiko; Shi, Dongquan; Kubo, Toshikazu; Takatori, Yoshio; Saito, Susumu; Fujioka, Mikihiro; Sudo, Akihiro; Uchida, Atsumasa; Yamamoto, Seizo; Ozaki, Koichi; Takigawa, Masaharu; Tanaka, Toshihiro; Nakamura, Yusuke; Jiang, Qing; Ikegawa, Shiro			A functional polymorphism in the 5 ' UTR of GDF5 is associated with susceptibility to osteoarthritis	NATURE GENETICS			English	Article							CHONDROSARCOMA CELL-LINE; ACID REPEAT POLYMORPHISM; SEQUENCE POLYMORPHISMS; MORPHOGENETIC PROTEINS; KNEE-OSTEOARTHRITIS; HIP OSTEOARTHRITIS; GENE; MUTATION; CHONDRODYSPLASIA; CHONDROGENESIS	Osteoarthritis (MIM 165720), characterized by degeneration of articular cartilage, is the most common form of human arthritis and a major concern for aging societies worldwide(1-3). Epidemiological and genetic studies have shown that osteoarthritis is a polygenic disease(1,4,5). Here, we report that the gene encoding growth differentiation factor 5 (GDF5) is associated with osteoarthritis in Asian populations. A SNP in the 5' UTR of GDF5 (+104T/ C; rs143383) showed significant association (P = 1.8 x 10(-13)) with hip osteoarthritis in two independent Japanese populations. This association was replicated for knee osteoarthritis in Japanese (P = 0.0021) and Han Chinese (P = 0.00028) populations. This SNP, located in the GDF5 core promoter, exerts allelic differences on transcriptional activity in chondrogenic cells, with the susceptibility allele showing reduced activity. Our findings implicate GDF5 as a susceptibility gene for osteoarthritis and suggest that decreased GDF5 expression is involved in the pathogenesis of osteoarthritis.	RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Tokyo 1088639, Japan; Nanjing Univ, Sch Med, Drum Tower hosp, Ctr Diagnosis Treatment Joint Dis, Nanjing 210008, Jiangsu, Peoples R China; Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto 6028566, Japan; Univ Tokyo, Dept Orthopaed Surg, Tokyo 1138655, Japan; Sumitorno Hosp, Dept Orthopaed Surg, Kita Ku, Osaka 5300005, Japan; Mie Univ, Fac Med, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan; Tokyo Metropolitan Geriatr Hosp, Dept Orthopaed Surg, Itabashi Ku, Tokyo 1730015, Japan; RIKEN, Lab Cardiovasc Dis, SNP Res Ctr, Minato Ku, Tokyo 1088639, Japan; Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama 7008525, Japan; RIKEN, Lab Genotyping, SNP Res Ctr, Minato Ku, Tokyo 1088639, Japan	RIKEN; Nanjing University; Kyoto Prefectural University of Medicine; University of Tokyo; Sumitomo Hospital; Mie University; RIKEN; Okayama University; RIKEN	Ikegawa, S (corresponding author), Osaka Rosai Hosp, Dept Orthopaed Surg, 1179-3 Nagasone Cho, Osaka 5918025, Japan.	sikegawa@ims.u-tokyo.ac.jp	shi, dongquan/ABH-3078-2021; Shi, Dongquan/ABG-6949-2021; Tanaka, Toshihiro/J-9310-2014; shi, dongquan/AAE-9956-2020; Ikegawa, Shiro/N-6895-2015	shi, dongquan/0000-0002-4769-7816; Tanaka, Toshihiro/0000-0001-6201-9784; Ikegawa, Shiro/0000-0003-0316-2147; Ozaki, Kouichi/0000-0003-0028-1570				Bobacz K, 2002, OSTEOARTHR CARTILAGE, V10, P394, DOI 10.1053/joca.2002.0522; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Chano T, 1998, VIRCHOWS ARCH, V432, P529, DOI 10.1007/s004280050201; Erlacher L, 1998, J BONE MINER RES, V13, P383, DOI 10.1359/jbmr.1998.13.3.383; Faiyaz-Ul-Haque M, 2002, AM J MED GENET, V111, P31, DOI 10.1002/ajmg.10501; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hotten GC, 1996, GROWTH FACTORS, V13, P65, DOI 10.3109/08977199609034567; Ikeda T, 2001, J HUM GENET, V46, P538, DOI 10.1007/s100380170036; Jiang Q, 2006, J HUM GENET, V51, P1068, DOI 10.1007/s10038-006-0065-6; KELLGREN JH, 1952, BRIT MED J, V1, P181, DOI 10.1136/bmj.1.4751.181; KELLGREN JH, 1963, ANN RHEUM DIS, V22, P237, DOI 10.1136/ard.22.4.237; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kunisada T, 1998, INT J CANCER, V77, P854, DOI 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1; Mabuchi A, 2001, J HUM GENET, V46, P456, DOI 10.1007/s100380170045; Merino R, 1999, DEV BIOL, V206, P33, DOI 10.1006/dbio.1998.9129; Mototani H, 2005, HUM MOL GENET, V14, P1009, DOI 10.1093/hmg/ddi093; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb02031.x; Savarirayan R, 2003, AM J MED GENET A, V117A, P136, DOI 10.1002/ajmg.a.10924; Stecher RM, 1941, AM J MED SCI, V201, P801, DOI 10.1097/00000441-194106000-00004; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Sugiura T, 1999, BIOCHEM BIOPH RES CO, V263, P707, DOI 10.1006/bbrc.1999.1445; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537	30	338	365	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					529	533		10.1038/2005	http://dx.doi.org/10.1038/2005			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17384641				2022-12-17	WOS:000245271200024
J	Shih, DQ; Bussen, M; Sehayek, E; Ananthanarayanan, M; Shneider, BL; Suchy, FJ; Shefer, S; Bollileni, JS; Gonzalez, FJ; Breslow, JL; Stoffel, M				Shih, DQ; Bussen, M; Sehayek, E; Ananthanarayanan, M; Shneider, BL; Suchy, FJ; Shefer, S; Bollileni, JS; Gonzalez, FJ; Breslow, JL; Stoffel, M			Hepatocyte nuclear factor-1 alpha is an essential regulator of bile acid and plasma cholesterol metabolism	NATURE GENETICS			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR LXR-ALPHA; TRANSCRIPTION FACTOR; TRANSGENIC MICE; GENE; EXPRESSION; ATHEROSCLEROSIS; LIVER; PROTEIN; PATHWAY	Maturity-onset diabetes of the young type 3 (MODY3) is caused by haploinsufficiency of hepatocyte nuclear factor-let (encoded by TCF1). Tcf1(-/-) mice have type 2 diabetes, dwarfism, renal Fanconi syndrome, hepatic dysfunction and hypercholestrolemia. Here we explore the molecular basis for the hypercholesterolemia using oligonucleotide microchip expression analysis. We demonstrate that Tcf1(-/-) mice have a defect in bile acid transport, increased bile acid and liver cholesterol synthesis, and impaired HDL metabolism. Tcf1(-/-) liver has decreased expression of the basolateral membrane bile acid transporters Slc10a1, Slc21a3 and Slc21a5, leading to impaired portal bile acid uptake and elevated plasma bile acid concentrations. In intestine and kidneys, Tcf1(-/-) mice lack expression of the ileal bile acid transporter (Slc10a2), resulting in increased fecal and urinary bile acid excretion. The Tcf1 protein (also known as HNF-1 alpha) also regulates transcription of the gene ((Nr1h4) encoding the farnesoid X receptor-1 (Fxr-1), thereby leading to reduced expression of small heterodimer partner-1 (Shp-1) and repression of Cyp7a1, the rate-limiting enzyme in the classic bile acid biosynthesis pathway. In addition, hepatocyte bile acid storage protein is absent from Tcf1(-/-) mice. Increased plasma cholesterol of Tcf1(-/-) mice resides predominantly in large, buoyant, high-density lipoprotein (HDL) particles. This is most likely due to reduced activity of the HDL-catabolic enzyme hepatic lipase (Lipc) and increased expression of HDL-cholesterol esterifying enzyme lecithin:cholesterol acyl transferase (Lcat). Our studies demonstrate that Tcf1, in addition to being an important regulator of insulin secretion, is an essential transcriptional regulator of bile acid and HDL-cholesterol metabolism.	Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA; Rockefeller Univ, Biochem Genet & Metab Lab, New York, NY 10021 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY USA; Univ Med & Dent New Jersey, Dept Med, Piscataway, NJ 08854 USA; NCI, Bethesda, MD 20892 USA	Rockefeller University; Rockefeller University; Icahn School of Medicine at Mount Sinai; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stoffel, M (corresponding author), Rockefeller Univ, Lab Metab Dis, 1230 York Ave, New York, NY 10021 USA.		Breslow, Jan L/B-7544-2008	Stoffel, Markus/0000-0003-1304-5817	NICHD NIH HHS [HD20632] Funding Source: Medline; NIDDK NIH HHS [R01DK55033-01, DK26756, DK02076] Funding Source: Medline; NIGMS NIH HHS [GM07739] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020632, R37HD020632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055033, R37DK026756, K11DK002076, R01DK026756] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AALTOSETALA K, 1994, J CLIN INVEST, V93, P1776, DOI 10.1172/JCI117163; ANANTHANARAYANAN M, 1991, AM J PHYSIOL, V261, pG810, DOI 10.1152/ajpgi.1991.261.5.G810; Austin MA, 1996, CURR OPIN LIPIDOL, V7, P167, DOI 10.1097/00041433-199606000-00010; Bergwerk AJ, 1996, AM J PHYSIOL-GASTR L, V271, pG231, DOI 10.1152/ajpgi.1996.271.2.G231; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chawla A, 2000, CELL, V103, P1, DOI 10.1016/S0092-8674(00)00097-0; Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Christie DM, 1996, AM J PHYSIOL-GASTR L, V271, pG377, DOI 10.1152/ajpgi.1996.271.2.G377; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; FELKER TE, 1978, P NATL ACAD SCI USA, V75, P3459, DOI 10.1073/pnas.75.7.3459; Foger B, 1999, J BIOL CHEM, V274, P36912, DOI 10.1074/jbc.274.52.36912; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; HOMANICS GE, 1995, J BIOL CHEM, V270, P2974, DOI 10.1074/jbc.270.7.2974; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; LAGGNER P, 1977, EUR J BIOCHEM, V77, P165, DOI 10.1111/j.1432-1033.1977.tb11654.x; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Levine DM, 1997, CLIN CHEM, V43, P669; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; MAHLEY RW, 1975, BIOCHEMISTRY-US, V14, P2817, DOI 10.1021/bi00684a005; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MANZATO E, 1976, J CLIN INVEST, V57, P1248, DOI 10.1172/JCI108393; Meier PJ, 1997, HEPATOLOGY, V26, P1667, DOI 10.1002/hep.510260641; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285, DOI 10.1152/ajpgi.1997.272.6.G1285; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; NORUM KR, 1971, J CLIN INVEST, V50, P1131, DOI 10.1172/JCI106585; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; POWELL DR, 1993, DNA CELL BIOL, V12, P283, DOI 10.1089/dna.1993.12.283; Sehayek E, 1998, P NATL ACAD SCI USA, V95, P10194, DOI 10.1073/pnas.95.17.10194; SETCHELL KDR, 1983, J LIPID RES, V24, P1085; SETCHELL KDR, 1995, BIOCHEMISTRY-US, V34, P4169, DOI 10.1021/bi00013a004; Shneider BL, 1997, J BIOL CHEM, V272, P31006, DOI 10.1074/jbc.272.49.31006; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stieger B, 1998, CURR OPIN CELL BIOL, V10, P462, DOI 10.1016/S0955-0674(98)80059-8; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; STOLZ A, 1993, J BIOL CHEM, V268, P10448; TRANCHE T, 1994, LIVER GENE EXPRESSIO, P155; vanAntwerpen R, 1997, J LIPID RES, V38, P659; WONG MH, 1994, J BIOL CHEM, V269, P1340; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	43	338	352	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2001	27	4					375	382		10.1038/86871	http://dx.doi.org/10.1038/86871			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	416ZU	11279518				2022-12-17	WOS:000167811200011
J	McPherron, AC; Lawler, AM; Lee, SJ				McPherron, AC; Lawler, AM; Lee, SJ			Regulation of anterior posterior patterning of the axial skeleton by growth differentiation factor 11	NATURE GENETICS			English	Article							BETA SUPERFAMILY; NEURAL TISSUE; MOUSE EMBRYO; HOX GENES; CELLS; EMBRYOGENESIS; EXPRESSION; MEMBER	The bones that comprise the axial skeleton have distinct morphological features characteristic of their positions along the anterior/posterior axis. We previously described a novel TGF-beta family member, myostatin (encoded by the gene Mstn, formerly Gdf8), that has an essential role in regulating skeletal muscle mass(1). We also identified a gene related to Mstn by low-stringency screening(1). While the work described here was being completed, the cloning of this gene, designated Gdf11 (also called Bmp11), was also reported by other groups(2,3). Here we show that Gdf11, a new transforming growth factor beta (TGF beta) superfamily member, has an important role in establishing this skeletal pattern. During early mouse embryogenesis, Gdf11 is expressed in the primitive streak and tail bud regions, which are sites where new mesodermal cells are generated. Homozygous mutant mice carrying a targeted deletion of Cdf11 exhibit anteriorly directed homeotic transformations throughout the axial skeleton and posterior displacement of the hindlimbs. The effect of the mutation is dose dependent, as Cdf11(+/-) mice have a milder phenotype than Gdf11(-/-) mice. Mutant embryos show alterations in patterns of Hox gene expression, suggesting that Gdf11 acts upstream of the Hox genes. Our findings suggest that Gdf11 is a secreted signal that acts globally to specify positional identity along the anterior/posterior axis.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Lee, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 725 N Wolfe St, Baltimore, MD 21205 USA.							Capecchi MR, 1997, COLD SPRING HARB SYM, V62, P273, DOI 10.1101/SQB.1997.062.01.034; Durston AJ, 1997, CELL MOL LIFE SCI, V53, P339, DOI 10.1007/PL00000610; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; KNECHT AK, 1995, DEVELOPMENT, V121, P1927; LEE SJ, 1990, MOL ENDOCRINOL, V4, P1034, DOI 10.1210/mend-4-7-1034; Mark M, 1997, PEDIATR RES, V42, P421, DOI 10.1203/00006450-199710000-00001; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC., 1996, GROWTH FACTORS CYTOK, P357, DOI [10.1016/s1874-5687(96)80016-4, DOI 10.1016/S1874-5687(96)80016-4]; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Oh SP, 1997, GENE DEV, V11, P1812, DOI 10.1101/gad.11.14.1812; PETERSON RL, 1992, MECH DEVELOP, V37, P151, DOI 10.1016/0925-4773(92)90077-W; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; TAM PPL, 1992, DEVELOPMENT, V115, P703; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75	16	338	390	0	41	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1999	22	3					260	264		10.1038/10320	http://dx.doi.org/10.1038/10320			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	210VT	10391213				2022-12-17	WOS:000081125900018
J	Heppner, C; Kester, MB; Agarwal, SK; Debelenko, LV; EmmertBuck, MR; Guru, SC; Manickam, P; Olufemi, SE; Skarulis, MC; Doppman, JL; Alexander, RH; Kim, YS; Saggar, SK; Lubensky, IA; Zhuang, ZP; Liotta, LA; Chandrasekharappa, SC; Collins, FS; Spiegel, AM; Burns, AL; Marx, SJ				Heppner, C; Kester, MB; Agarwal, SK; Debelenko, LV; EmmertBuck, MR; Guru, SC; Manickam, P; Olufemi, SE; Skarulis, MC; Doppman, JL; Alexander, RH; Kim, YS; Saggar, SK; Lubensky, IA; Zhuang, ZP; Liotta, LA; Chandrasekharappa, SC; Collins, FS; Spiegel, AM; Burns, AL; Marx, SJ			Somatic mutation of the MEN1 gene in parathyroid tumours	NATURE GENETICS			English	Article							ENDOCRINE NEOPLASIA TYPE-1; SUPPRESSOR GENE; TUMORS; CHROMOSOME-11; CARCINOMA; RETINOBLASTOMA; METHYLATION	Primary hyperparathyroidism is a common disorder with an annual incidence of approximately 0.5 in 1,000 (ref. 1), In more than 95% of cases, the disease is caused by sporadic parathyroid adenoma or sporadic hyperplasia. Some cases are caused by inherited syndromes, such as multiple endocrine neoplasia type 1 (MEN1; ref. 2), In most cases, the molecular basis of parathyroid neoplasia is unknown. Parathyroid adenomas are usually monoclonal(3,4), suggesting that one important step in tumour development is a mutation in a progenitor cell, Approximately 30% of sporadic parathyroid tumours show loss of heterozygosity (LOH) for polymorphic markers on 11q13, the site of the MEN1 tumour suppressor gene(4-8). This raises the question of whether such sporadic parathyroid tumours are caused by sequential inactivation of both alleles of the MEN1 gene(9). We recently cloned the MEN1 gene and identified MEN1 germline mutations in fourteen of fifteen kindreds with familial MEN1 (ref. 10). We have studied parathyroid tumours not associated with MEN1 to determine whether somatic mutations in the MEN1 gene are present, Among 33 tumours we found somatic MEN1 gene mutation in 7, while the corresponding MEN1 germline sequence was normal in each patient. All tumours with MEN1 gene mutation showed LOH on 11q13, making the tumour cells hemi- or homozygous for the mutant allele. Thus, somatic MEN1 gene mutation contributes to tumorigenesis in a substantial number of parathyroid tumours not associated with the MEN1 syndrome.	NIDDKD, METAB DIS BRANCH, NIH, BETHESDA, MD 20892 USA; NCI, PATHOL LAB, NIH, BETHESDA, MD 20892 USA; NHGRI, LAB GENE TRANSFER, NIH, BETHESDA, MD 20892 USA; NIH, CTR CLIN, DEPT DIAGNOST RADIOL, BETHESDA, MD 20892 USA; NCI, SURG BRANCH, NIH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Agarwal, Sunita K/D-1428-2016	Agarwal, Sunita K/0000-0002-7557-3191				Agarwal SK, 1997, HUM MOL GENET, V6, P1169, DOI 10.1093/hmg/6.7.1169; ARNOLD A, 1994, ENDOCRIN METAB CLIN, V23, P93, DOI 10.1016/S0889-8529(18)30118-X; Bates AS, 1997, J CLIN ENDOCR METAB, V82, P818, DOI 10.1210/jc.82.3.818; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; Bright RK, 1997, CANCER RES, V57, P995; BYSTROM C, 1990, P NATL ACAD SCI USA, V87, P1968, DOI 10.1073/pnas.87.5.1968; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; CHOMCZYNSKI P, 1995, ANAL BIOCHEM, V225, P163, DOI 10.1006/abio.1995.1126; CRYNS VL, 1994, NEW ENGL J MED, V330, P757, DOI 10.1056/NEJM199403173301105; CRYNS VL, 1994, J CLIN ENDOCR METAB, V78, P1320, DOI 10.1210/jc.78.6.1320; Debelenko LV, 1997, CANCER RES, V57, P2238; Dotzenrath C, 1996, J CLIN ENDOCR METAB, V81, P3194, DOI 10.1210/jc.81.9.3194; EmmertBuck MR, 1997, CANCER RES, V57, P1855; Fain PR, 1996, HUM MOL GENET, V5, P1631, DOI 10.1093/hmg/5.10.1631; FRIEDMAN E, 1989, NEW ENGL J MED, V321, P213, DOI 10.1056/NEJM198907273210402; FRIEDMAN E, 1992, CANCER RES, V52, P6804; HALIASSOS A, 1989, NUCLEIC ACIDS RES, V17, P8093, DOI 10.1093/nar/17.20.8093; HEATH H, 1980, NEW ENGL J MED, V302, P189, DOI 10.1056/NEJM198001243020402; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hsi ED, 1996, J CLIN ENDOCR METAB, V81, P1736, DOI 10.1210/jc.81.5.1736; Jakobovitz G, 1996, J CLIN ENDOCR METAB, V81, P3164; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LIDA A, 1995, GENE CHROMOSOME CANC, V12, P73, DOI 10.1002/gcc.2870120114; Lubensky IA, 1996, CANCER RES, V56, P5272; MANICKAM P, IN PRESS HUM GENET; MATSUO K, 1991, MOL ENDOCRINOL, V5, P1873, DOI 10.1210/mend-5-12-1873; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Metz David C., 1994, P591; Pausova Z, 1996, J CLIN ENDOCR METAB, V81, P2711, DOI 10.1210/jc.81.7.2711; Pearce SHS, 1996, CLIN ENDOCRINOL, V45, P195, DOI 10.1046/j.1365-2265.1996.d01-1561.x; SARKAR G, 1992, GENOMICS, V13, P441, DOI 10.1016/0888-7543(92)90266-U; Tahara H, 1996, J CLIN ENDOCR METAB, V81, P3663, DOI 10.1210/jc.81.10.3663; Tahara H, 1996, CANCER RES, V56, P599; THAKKER RV, 1989, NEW ENGL J MED, V321, P218, DOI 10.1056/NEJM198907273210403	35	338	341	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1997	16	4					375	378		10.1038/ng0897-375	http://dx.doi.org/10.1038/ng0897-375			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241276				2022-12-17	WOS:A1997XM90900021
J	UEDA, H; ULLRICH, SJ; GANGEMI, JD; KAPPEL, CA; NGO, L; FEITELSON, MA; JAY, G				UEDA, H; ULLRICH, SJ; GANGEMI, JD; KAPPEL, CA; NGO, L; FEITELSON, MA; JAY, G			FUNCTIONAL INACTIVATION BUT NOT STRUCTURAL MUTATION OF P53 CAUSES LIVER-CANCER	NATURE GENETICS			English	Article							HEPATITIS-B VIRUS; PRIMARY HEPATOCELLULAR CARCINOMAS; TRANSFORMATION-RELATED PROTEIN; TUMOR-SUPPRESSOR GENE; ALPHA-B/D HYBRID; X-PROTEIN; SV40-TRANSFORMED CELLS; MONOCLONAL-ANTIBODY; TRANS-ACTIVATION; HOST PROTEIN	Structural mutations in the p53 gene are seen in virtually every form of human cancer. To determine whether such mutations are important for initiating tumorigenesis, we have been studying hepatocellular carcinoma, in which most cases are associated with chronic hepatitis B virus infections. Using a transgenic mouse model where expression of a single HBV gene product, the HBx protein, induces progressive changes in the liver, we show that tumour development correlates precisely with p53 binding to HBx in the cytoplasm and complete blockage of p53 entry into the nucleus. Analysis of tumour cell DNA shows no evidence for p53 mutation, except in advanced tumours where a small proportion of cells may have acquired specific base substitutions. Our results suggest that genetic changes in p53 are late events which may contribute to tumour progression.	AMER RED CROSS,JEROME H HOLLAND LAB,DEPT VIROL,ROCKVILLE,MD 20855; CLEMSON UNIV,GREENVILLE HOSP SYST,CLEMSON,SC 29634; THOMAS JEFFERSON UNIV,DEPT PATHOL & CELL BIOL,PHILADELPHIA,PA 19107	American Red Cross; Clemson University; Jefferson University			Jay, Gregory/C-6346-2013	Jay, Gregory/0000-0003-1517-8488				BARAK Y, 1992, EMBO J, V11, P2115, DOI 10.1002/j.1460-2075.1992.tb05270.x; Beasley R.P., 1984, VIRAL HEPATITIS LIVE, P209; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; BUETOW KH, 1992, P NATL ACAD SCI USA, V89, P9622, DOI 10.1073/pnas.89.20.9622; COLGROVE R, 1989, J VIROL, V63, P4019, DOI 10.1128/JVI.63.9.4019-4026.1989; CRAWFORD LV, 1981, P NATL ACAD SCI-BIOL, V78, P41, DOI 10.1073/pnas.78.1.41; CROSS JC, 1993, P NATL ACAD SCI USA, V90, P8078, DOI 10.1073/pnas.90.17.8078; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DIPPOLD WG, 1981, P NATL ACAD SCI-BIOL, V78, P1695, DOI 10.1073/pnas.78.3.1695; FEITELSON MA, 1993, ONCOGENE, V8, P1109; FELTELSON MA, 1990, VIROLOGY, V177, P367; FUJIYAMA A, 1983, NUCLEIC ACIDS RES, V11, P4601, DOI 10.1093/nar/11.13.4601; GANGEMI JD, 1989, J INTERFERON RES, V9, P227, DOI 10.1089/jir.1989.9.227; GREENBLATT MS, 1994, CANCER RES, V54, P4855; GUTIERREZ MI, 1992, CANCER RES, V52, P1032; HALEVY O, 1991, ONCOGENE, V6, P1593; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HORISBERGER MA, 1987, J GEN VIROL, V68, P945, DOI 10.1099/0022-1317-68-3-945; HOSONO S, 1991, ONCOGENE, V6, P237; HSU HC, 1993, CANCER RES, V53, P4691; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; JAY G, 1979, COLD SPRING HARB SYM, V44, P659; JAY G, 1981, P NATL ACAD SCI USA, V78, P2931; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEE TH, 1990, J VIROL, V64, P5939, DOI 10.1128/JVI.64.12.5939-5947.1990; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; NISHIDA N, 1993, CANCER RES, V53, P358; ODA T, 1992, CANCER RES, V52, P6358; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PERRILLO RP, 1993, DIGEST DIS SCI, V38, P577, DOI 10.1007/BF01316785; PIETENPOL JA, 1993, NATURE, V365, P17, DOI 10.1038/365017a0; POPPER H, 1987, HEPATOLOGY, V7, P764, DOI 10.1002/hep.1840070425; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SCHEK N, 1991, ONCOGENE, V6, P1735; SETO E, 1988, P NATL ACAD SCI USA, V85, P8286, DOI 10.1073/pnas.85.21.8286; SHEU JC, 1992, CANCER RES, V52, P6098; SPANDAU DF, 1988, J VIROL, V62, P427, DOI 10.1128/JVI.62.2.427-434.1988; SZEKELY L, 1993, P NATL ACAD SCI USA, V90, P5455, DOI 10.1073/pnas.90.12.5455; TANAKA S, 1993, CANCER RES, V53, P2884; TERAMOTO T, 1994, CANCER RES, V54, P231; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; TURKASPA R, 1990, J VIROL, V64, P1821, DOI 10.1128/JVI.64.4.1821-1824.1990; TWU JS, 1987, J VIROL, V61, P3448, DOI 10.1128/JVI.61.11.3448-3453.1987; ULLRICH SJ, 1992, J BIOL CHEM, V267, P15259; ULLRICH SJ, 1993, P NATL ACAD SCI USA, V90, P5954, DOI 10.1073/pnas.90.13.5954; UNSAL H, 1994, P NATL ACAD SCI USA, V91, P822, DOI 10.1073/pnas.91.2.822; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286	53	338	343	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					41	47		10.1038/ng0195-41	http://dx.doi.org/10.1038/ng0195-41			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704023				2022-12-17	WOS:A1995PZ91300013
J	Watanabe, K; Stringer, S; Frei, O; Mirkov, MU; de Leeuw, C; Polderman, TJC; van der Sluis, S; Andreassen, OA; Neale, BM; Posthuma, D				Watanabe, Kyoko; Stringer, Sven; Frei, Oleksandr; Mirkov, Masa Umicevic; de Leeuw, Christiaan; Polderman, Tinca J. C.; van der Sluis, Sophie; Andreassen, Ole A.; Neale, Benjamin M.; Posthuma, Danielle			A global overview of pleiotropy and genetic architecture in complex traits	NATURE GENETICS			English	Article							LD SCORE REGRESSION; SNP HERITABILITY; GWAS; ASSOCIATION; RESOURCE; DATABASE; DISEASE	After a decade of genome-wide association studies (GWASs), fundamental questions in human genetics, such as the extent of pleiotropy across the genome and variation in genetic architecture across traits, are still unanswered. The current availability of hundreds of GWASs provides a unique opportunity to address these questions. We systematically analyzed 4,155 publicly available GWASs. For a subset of well-powered GWASs on 558 traits, we provide an extensive overview of pleiotropy and genetic architecture. We show that trait-associated loci cover more than half of the genome, and 90% of these overlap with loci from multiple traits. We find that potential causal variants are enriched in coding and flanking regions, as well as in regulatory elements, and show variation in polygenicity and discoverability of traits. Our results provide insights into how genetic variation contributes to trait variation. All GWAS results can be queried and visualized at the GWAS ATLAS resource (https://atlas.ctglab.nl).	[Watanabe, Kyoko; Stringer, Sven; Mirkov, Masa Umicevic; de Leeuw, Christiaan; Polderman, Tinca J. C.; van der Sluis, Sophie; Posthuma, Danielle] Vrije Univ Amsterdam, Dept Complex Trait Genet, Ctr Neurogen & Cognit Res, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Frei, Oleksandr; Andreassen, Ole A.] Univ Oslo, KG Jebsen Ctr Psychosis Res, Inst Clin Med, NORMENT, Oslo, Norway; [van der Sluis, Sophie; Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Complex Trait Genet, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Neale, Benjamin M.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Neale, Benjamin M.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Neale, Benjamin M.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Vrije Universiteit Amsterdam; University of Oslo; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Oslo; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Posthuma, D (corresponding author), Vrije Univ Amsterdam, Dept Complex Trait Genet, Ctr Neurogen & Cognit Res, Neurosci Campus Amsterdam, Amsterdam, Netherlands.; Posthuma, D (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Complex Trait Genet, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	d.posthuma@vu.nl	Andreassen, Ole A./AAY-7531-2020	de Leeuw, Christiaan/0000-0003-1076-9828; Andreassen, Ole A./0000-0002-4461-3568; Polderman, Tinca/0000-0001-5564-301X; Frei, Oleksandr/0000-0002-6427-2625; van der Sluis, Sophie/0000-0001-9958-7216; Watanabe, Kyoko/0000-0002-3303-8860; Posthuma, Danielle/0000-0001-7582-2365	Netherlands Organization for Scientific Research [NWO VICI 453-14-005, NWO VIDI 452-12-014]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank all consortiums and all other individual laboratories for making GWAS summary statistics publicly available. We also thank P. Visscher and N. Wray for their thoughtful suggestions and discussions. We additionally thank A. Dale for his suggestions. This work was funded by the Netherlands Organization for Scientific Research (grant nos. NWO VICI 453-14-005 and NWO VIDI 452-12-014).	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Benner C, 2017, AM J HUM GENET, V101, P539, DOI 10.1016/j.ajhg.2017.08.012; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Canela-Xandri O, 2018, NAT GENET, V50, P1593, DOI 10.1038/s41588-018-0248-z; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Frei O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10310-0; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Henderson Paul, 2012, Cells, V1, P492, DOI 10.3390/cells1030492; Holland D., 2018, SNP HERITABILITY POL, DOI [10.1101/133132, DOI 10.1101/133132]; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Speed D, 2019, NAT GENET, V51, P277, DOI 10.1038/s41588-018-0279-5; Speed D, 2017, NAT GENET, V49, P986, DOI 10.1038/ng.3865; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Timpson NJ, 2018, NAT REV GENET, V19, P110, DOI 10.1038/nrg.2017.101; van de Bunt M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005535; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wray NR, 2018, CELL, V173, P1573, DOI 10.1016/j.cell.2018.05.051; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	41	337	340	9	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2019	51	9					1339	+		10.1038/s41588-019-0481-0	http://dx.doi.org/10.1038/s41588-019-0481-0			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IV1AX	31427789	Green Submitted			2022-12-17	WOS:000484010800010
J	Kiryluk, K; Li, YF; Scolari, F; Sanna-Cherchi, S; Choi, M; Verbitsky, M; Fasel, D; Lata, S; Prakash, S; Shapiro, S; Fischman, C; Snyder, HJ; Appel, G; Izzi, C; Viola, BF; Dallera, N; Del Vecchio, L; Barlassina, C; Salvi, E; Bertinetto, FE; Amoroso, A; Savoldi, S; Rocchietti, M; Amore, A; Peruzzi, L; Coppo, R; Salvadori, M; Ravani, P; Magistroni, R; Ghiggeri, GM; Caridi, G; Bodria, M; Lugani, F; Allegri, L; Delsante, M; Maiorana, M; Magnano, A; Frasca, G; Boer, E; Boscutti, G; Ponticelli, C; Mignani, R; Marcantoni, C; Di Landro, D; Santoro, D; Pani, A; Polci, R; Feriozzi, S; Chicca, S; Galliani, M; Gigante, M; Gesualdo, L; Zamboli, P; Battaglia, GG; Garozzo, M; Maixnerova, D; Tesar, V; Eitner, F; Rauen, T; Floege, J; Kovacs, T; Nagy, J; Mucha, K; Paczek, L; Zaniew, M; Mizerska-Wasiak, M; Roszkowska-Blaim, M; Pawlaczyk, K; Gale, D; Barratt, J; Thibaudin, L; Berthoux, F; Canaud, G; Boland, A; Metzger, M; Panzer, U; Suzuki, H; Goto, S; Narita, I; Caliskan, Y; Xie, JY; Hou, P; Chen, N; Zhang, H; Wyatt, RJ; Novak, J; Julian, BA; Feehally, J; Stengel, B; Cusi, D; Lifton, RP; Gharavi, AG				Kiryluk, Krzysztof; Li, Yifu; Scolari, Francesco; Sanna-Cherchi, Simone; Choi, Murim; Verbitsky, Miguel; Fasel, David; Lata, Sneh; Prakash, Sindhuri; Shapiro, Samantha; Fischman, Clara; Snyder, Holly J.; Appel, Gerald; Izzi, Claudia; Viola, Battista Fabio; Dallera, Nadia; Del Vecchio, Lucia; Barlassina, Cristina; Salvi, Erika; Bertinetto, Francesca Eleonora; Amoroso, Antonio; Savoldi, Silvana; Rocchietti, Marcella; Amore, Alessandro; Peruzzi, Licia; Coppo, Rosanna; Salvadori, Maurizio; Ravani, Pietro; Magistroni, Riccardo; Ghiggeri, Gian Marco; Caridi, Gianluca; Bodria, Monica; Lugani, Francesca; Allegri, Landino; Delsante, Marco; Maiorana, Mariarosa; Magnano, Andrea; Frasca, Giovanni; Boer, Emanuela; Boscutti, Giuliano; Ponticelli, Claudio; Mignani, Renzo; Marcantoni, Carmelita; Di Landro, Domenico; Santoro, Domenico; Pani, Antonello; Polci, Rosaria; Feriozzi, Sandro; Chicca, Silvana; Galliani, Marco; Gigante, Maddalena; Gesualdo, Loreto; Zamboli, Pasquale; Battaglia, Giovanni Giorgio; Garozzo, Maurizio; Maixnerova, Dita; Tesar, Vladimir; Eitner, Frank; Rauen, Thomas; Floege, Juergen; Kovacs, Tibor; Nagy, Judit; Mucha, Krzysztof; Paczek, Leszek; Zaniew, Marcin; Mizerska-Wasiak, Malgorzata; Roszkowska-Blaim, Maria; Pawlaczyk, Krzysztof; Gale, Daniel; Barratt, Jonathan; Thibaudin, Lise; Berthoux, Francois; Canaud, Guillaume; Boland, Anne; Metzger, Marie; Panzer, Ulf; Suzuki, Hitoshi; Goto, Shin; Narita, Ichiei; Caliskan, Yasar; Xie, Jingyuan; Hou, Ping; Chen, Nan; Zhang, Hong; Wyatt, Robert J.; Novak, Jan; Julian, Bruce A.; Feehally, John; Stengel, Benedicte; Cusi, Daniele; Lifton, Richard P.; Gharavi, Ali G.			Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LEUKEMIA INHIBITORY FACTOR; ULCERATIVE-COLITIS; COMMON VARIANTS; DENDRITIC CELLS; CROHNS-DISEASE; VAV PROTEINS; SUSCEPTIBILITY; ALPHA; EXPRESSION	We performed a genome-wide association study (GWAS) of IgA nephropathy (IgAN), the most common form of glomerulonephritis, with discovery and follow-up in 20,612 individuals of European and East Asian ancestry. We identified six new genome-wide significant associations, four in ITGAM-ITGAX, VAV3 and CARD9 and two new independent signals at HLA-DQB1 and DEFA. We replicated the nine previously reported signals, including known SNPs in the HLA-DQB1 and DEFA loci. The cumulative burden of risk alleles is strongly associated with age at disease onset. Most loci are either directly associated with risk of inflammatory bowel disease (IBD) or maintenance of the intestinal epithelial barrier and response to mucosal pathogens. The geospatial distribution of risk alleles is highly suggestive of multi-locus adaptation, and genetic risk correlates strongly with variation in local pathogens, particularly helminth diversity, suggesting a possible role for host-intestinal pathogen interactions in shaping the genetic landscape of IgAN.	[Kiryluk, Krzysztof; Li, Yifu; Sanna-Cherchi, Simone; Verbitsky, Miguel; Fasel, David; Lata, Sneh; Prakash, Sindhuri; Shapiro, Samantha; Fischman, Clara; Snyder, Holly J.; Appel, Gerald; Gharavi, Ali G.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10027 USA; [Scolari, Francesco; Izzi, Claudia; Dallera, Nadia] Univ Brescia, Div Nephrol, Azienda Osped Spedali Civili Brescia, Montichiari Hosp, Brescia, Italy; [Scolari, Francesco; Dallera, Nadia] Univ Brescia, Dept Med & Surg Specialties, Brescia, Italy; [Choi, Murim; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Choi, Murim] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Izzi, Claudia] Univ Brescia, Dept Obstet & Gynecol, Prenatal Diag Unit, Brescia, Italy; [Viola, Battista Fabio] Univ Brescia, Div Nephrol, Azienda Osped Spedali Civili Brescia, Spedali Civili Hosp, Brescia, Italy; [Del Vecchio, Lucia; Barlassina, Cristina; Salvi, Erika; Cusi, Daniele] Univ Milan, Div Renal, Dipartimento Med Chirurg & Odontoiatria, San Paolo Hosp,Sch Med, Milan, Italy; [Bertinetto, Francesca Eleonora; Amoroso, Antonio] Univ Hosp Turin, Citta Salute & Sci, Turin, Italy; [Bertinetto, Francesca Eleonora; Amoroso, Antonio] Univ Turin, Dept Med Sci, Turin, Italy; [Savoldi, Silvana; Rocchietti, Marcella] Osped Cirie, Nephrol & Dialysis Unit, Turin, Italy; [Savoldi, Silvana; Rocchietti, Marcella] Osped Chivasso, Turin, Italy; [Amore, Alessandro; Peruzzi, Licia; Coppo, Rosanna] Regina Margheritra Hosp, Nephrol Dialysis & Transplantat Unit, Turin, Italy; [Salvadori, Maurizio] Careggi Hosp, Div Nephrol & Renal Transplantat, Florence, Italy; [Ravani, Pietro] Univ Calgary, Dept Med, Calgary, AB, Canada; [Ravani, Pietro] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Magistroni, Riccardo] Univ Modena & Reggio Emilia, Azienda Osped Univ Policlin Modena, Div Nephrol Dialysis & Transplantat, Modena, Italy; [Ghiggeri, Gian Marco; Caridi, Gianluca; Bodria, Monica; Lugani, Francesca] Giannina Gaslini Inst, Div Nephrol Dialysis & Transplantat, Genoa, Italy; [Allegri, Landino; Delsante, Marco; Maiorana, Mariarosa; Magnano, Andrea] Azienda Osped Univ, Div Nephrol, Parma, Italy; [Allegri, Landino; Delsante, Marco; Maiorana, Mariarosa; Magnano, Andrea] Univ Parma, Chair Nephrol, I-43100 Parma, Italy; [Frasca, Giovanni] Riuniti Hosp, Div Nephrol Dialysis & Renal Transplantat, Ancona, Italy; [Boer, Emanuela] Gorizia Hosp, Div Nephrol & Dialysis, Gorizia, Italy; [Boscutti, Giuliano] Azienda Osped Univ Osped Riuniti Trieste, Div Nephrol, Trieste, Italy; [Ponticelli, Claudio] Humanitas Clin & Res Ctr, Nephrol & Dialysis Unit, Milan, Italy; [Mignani, Renzo] Infermi Hosp, Div Nephrol & Dialysis, Rimini, Italy; [Marcantoni, Carmelita; Di Landro, Domenico] Cannizzaro Hosp, Div Nephrol, Catania, Italy; [Santoro, Domenico] Univ Messina, Chair Nephrol, Div Nephol & Dialysis, Azienda Osped Univ Policlin, Messina, Italy; [Pani, Antonello] G Brotzu Hosp, Dept Nephrol & Dialysis, Cagliari, Italy; [Polci, Rosaria; Feriozzi, Sandro] Hosp Viterbo, Viterbo, Italy; [Chicca, Silvana; Galliani, Marco] Sandro Pertini Hosp, Div Nephrol & Dialysis, Rome, Italy; [Gigante, Maddalena] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy; [Gesualdo, Loreto] Univ Bari, Dept Emergency & Organ Transplantat, Nephrol Sect, Bari, Italy; [Zamboli, Pasquale] Univ Naples 2, Dept Nephrol, Naples, Italy; [Battaglia, Giovanni Giorgio; Garozzo, Maurizio] Osped Acireale, Unita Operat Nefrol & Dialisi, Acireale, Italy; [Maixnerova, Dita; Tesar, Vladimir] Charles Univ Prague, Fac Med 1, Dept Nephrol, Prague, Czech Republic; [Maixnerova, Dita; Tesar, Vladimir] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic; [Eitner, Frank; Rauen, Thomas; Floege, Juergen] Univ Aachen, Dept Nephrol, Rhein Westfal Tech Hsch, Aachen, Germany; [Eitner, Frank] Bayer Pharma, Kidney Dis Res, Wuppertal, Germany; [Kovacs, Tibor; Nagy, Judit] Univ Pecs, Fac Med, Nephrol Ctr, Pecs, Hungary; [Kovacs, Tibor; Nagy, Judit] Univ Pecs, Fac Med, Dept Internal Med 2, Pecs, Hungary; [Mucha, Krzysztof; Paczek, Leszek] Med Univ Warsaw, Dept Immunol Transplantol & Internal Med, Warsaw, Poland; [Zaniew, Marcin] Krysiewicza Childrens Hosp, Poznan, Poland; [Mizerska-Wasiak, Malgorzata; Roszkowska-Blaim, Maria] Med Univ Warsaw, Dept Pediat & Nephrol, Warsaw, Poland; [Pawlaczyk, Krzysztof] Poznan Med Univ, Dept Nephrol Transplantol & Internal Med, Poznan, Poland; [Gale, Daniel] UCL, Ctr Nephrol, London, England; [Barratt, Jonathan; Feehally, John] Univ Hosp Leicester, John Walls Renal Unit, Leicester, Leics, England; [Barratt, Jonathan; Feehally, John] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Thibaudin, Lise; Berthoux, Francois] Univ North Hosp, Dept Nephrol Dialysis & Renal Transplantat, St Etienne, France; [Canaud, Guillaume] Hop Necker Enfants Malad, Serv Nephrol Transplantat Adultes, Paris, France; [Boland, Anne] Univ Paris 05, INSERM, Inst Necker Enfants Malades, Sorbonne Paris Cite, Paris, France; [Boland, Anne] CEA, Ctr Natl Genotypage, Inst Genom, Evry, France; [Metzger, Marie; Stengel, Benedicte] INSERM, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Metzger, Marie; Stengel, Benedicte] Univ Paris 11, Villejuif, France; [Panzer, Ulf] Univ Klinikum Hamburg Eppendorf, Med Klin 3, Hamburg, Germany; [Suzuki, Hitoshi] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan; [Goto, Shin; Narita, Ichiei] Niigata Univ, Div Clin Nephrol & Rheumatol, Niigata, Japan; [Caliskan, Yasar] Istanbul Univ, Istanbul Fac Med, Div Nephrol, Istanbul, Turkey; [Xie, Jingyuan; Chen, Nan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nephrol, Shanghai 200030, Peoples R China; [Hou, Ping; Zhang, Hong] Peking Univ, Inst Nephrol, Peking Univ Hosp 1, Div Renal, Beijing 100871, Peoples R China; [Wyatt, Robert J.] Univ Tennessee, Hlth Sci Ctr, Div Pediat Nephrol, Memphis, TN USA; [Wyatt, Robert J.] Le Bonheur Childrens Hosp, Childrens Fdn Res Ctr, Memphis, TN USA; [Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Julian, Bruce A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Columbia University; Hospital Spedali Civili Brescia; University of Brescia; University of Brescia; Yale University; Seoul National University (SNU); University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; San Paolo-Polo Universitaria Hospital; University of Milan; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Ospedale Infantile Regina Margherita; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Calgary; University of Calgary; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Parma; University Hospital of Parma; University of Parma; University of Trieste; Hospital of Rimini; University of Messina; Ospedale Sandro Pertini; University of Foggia; Universita degli Studi di Bari Aldo Moro; Universita della Campania Vanvitelli; Charles University Prague; Charles University Prague; General University Hospital Prague; RWTH Aachen University; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Pecs; University of Pecs; Medical University of Warsaw; Medical University of Warsaw; Poznan University of Medical Sciences; University of London; University College London; University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester; CHU de St Etienne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Hamburg; University Medical Center Hamburg-Eppendorf; Juntendo University; Niigata University; Istanbul University; Shanghai Jiao Tong University; Peking University; University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; Yale University	Gharavi, AG (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10027 USA.	richard.lifton@yale.edu; ag2239@columbia.edu	Stengel, Benedicte/G-5730-2015; Salvi, Erika/C-1033-2015; santoro, domenico/L-2482-2013; Maiorana, Mariarosa/AGI-3423-2022; Gesualdo, Loreto/K-7751-2016; , yasar/P-3321-2019; Del Vecchio, Lucia/AAH-3140-2019; Caridi, Gianluca/F-7052-2010; Mucha, Krzysztof/AAC-4853-2020; Izzi, Claudia/GZG-8769-2022; Izzi, Claudia/AAB-7004-2022; scolari, francesco/AAC-5957-2022; Choi, Murim/AAP-9120-2021; Boscutti, Giuliano/AAH-8559-2021; Caliskan, Yasar/ABG-4334-2021; PERUZZI, LICIA/I-1873-2012; santoro, domenico/P-7902-2014; bodria, monica/K-2115-2016; amoroso, antonio/AAL-1475-2020; Rauen, Thomas/GLR-8682-2022; Xie, Jingyuan/AAX-2708-2021; Pawlaczyk, Krzysztof/HHC-4586-2022; Ghiggeri, Gian Marco/N-4712-2015; Gigante, Maddalena/R-4369-2016; Feriozzi, Sandro/AAP-6209-2020; Narita, Ichiei/G-5204-2017; del vecchio, lucia/AAG-7073-2019; Pani, Antonello/HDN-3366-2022; chang, guoqing/GNP-4110-2022; Ravani, Pietro/J-3050-2015; Pawlaczyk, Krzysztof/T-2827-2019; AMOROSO, ANTONIO/AAN-3884-2020; xie, jing/GRY-1689-2022; Magistroni, Riccardo/AAL-8753-2020; Salvi, Erika/AAA-1415-2019; Gale, Daniel/D-5594-2013; Lugani, Francesca/J-7183-2016; Metzger, Marie/K-9772-2018	Stengel, Benedicte/0000-0001-9469-0804; Salvi, Erika/0000-0002-2724-2291; santoro, domenico/0000-0002-4279-6559; Maiorana, Mariarosa/0000-0003-2426-3262; Gesualdo, Loreto/0000-0002-4861-0911; Caridi, Gianluca/0000-0001-6700-3001; Mucha, Krzysztof/0000-0002-6613-7638; santoro, domenico/0000-0002-4279-6559; bodria, monica/0000-0001-9690-9945; amoroso, antonio/0000-0002-9437-9407; Pawlaczyk, Krzysztof/0000-0001-6237-0814; Ghiggeri, Gian Marco/0000-0003-3659-9062; Gigante, Maddalena/0000-0001-8228-7639; Narita, Ichiei/0000-0001-7692-3096; Ravani, Pietro/0000-0001-6973-8570; Pawlaczyk, Krzysztof/0000-0001-6237-0814; Magistroni, Riccardo/0000-0002-3319-0248; Salvi, Erika/0000-0002-2724-2291; Gale, Daniel/0000-0002-9170-1579; Nagy, Judit/0000-0003-1702-5071; Barlassina, Cristina/0000-0001-7407-2697; Peruzzi, Licia/0000-0002-5704-3867; Tesar, Vladimir/0000-0001-6982-0689; Izzi, Claudia/0000-0001-6253-3185; Maixnerova, Dita/0000-0002-6733-2857; Barratt, Jonathan/0000-0002-9063-7229; Lugani, Francesca/0000-0002-4189-8561; Metzger, Marie/0000-0003-3597-5409; Galliani, Marco/0000-0001-5813-9177; LI, YIFU/0000-0002-7077-7689; Wyatt, Robert/0000-0001-6077-0259; Paczek, Leszek/0000-0003-0160-3009; Delsante, Marco/0000-0003-0715-6764; Scolari, Francesco/0000-0003-0233-9705	US National Institutes of Health (NIH) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK082753, R01DK095510]; Center for Glomerular Diseases at Columbia University; NIH/NIDDK [K23DK090207, R03DK099564, R21DK098531]; Carl W Gottschalk Research Scholar Grant from the American Society of Nephrology (ASN); American Heart Association (AHA) [13GRNT14680075]; Italian Ministry of Health and NIH Ricerca Finalizzata; Fondazione Malattie Renali nel Bambino; InterOmics (PB05 MIUR-CNR Italian Flagship Project);  [SROP-4.2.2/B-10/1/2010-0029]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK090207, R03DK099564, R01DK095510, R01DK082753, R01DK103184, P30DK079310] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26670429] Funding Source: KAKEN	US National Institutes of Health (NIH) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Center for Glomerular Diseases at Columbia University; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Carl W Gottschalk Research Scholar Grant from the American Society of Nephrology (ASN); American Heart Association (AHA)(American Heart Association); Italian Ministry of Health and NIH Ricerca Finalizzata; Fondazione Malattie Renali nel Bambino; InterOmics (PB05 MIUR-CNR Italian Flagship Project); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to all the study participants for their contribution to this work. This study was supported by US National Institutes of Health (NIH) grants R01DK082753 (A.G.G. and J. Novak) and R01DK095510 (A.G.G. and R.P.L.) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and by the Center for Glomerular Diseases at Columbia University. R.P.L. is an investigator of the Howard Hughes Medical Institute. K.K. is supported by NIH/NIDDK grants K23DK090207 and R03DK099564 and by a Carl W Gottschalk Research Scholar Grant from the American Society of Nephrology (ASN). S.S.-C. is supported by NIH/NIDDK grant R21DK098531 and by American Heart Association (AHA) grant 13GRNT14680075. G.M.G. is supported by the Joint Italian Ministry of Health and NIH Ricerca Finalizzata and by the Fondazione Malattie Renali nel Bambino. D.C. and the HYPERGENES Consortium are supported by InterOmics (PB05 MIUR-CNR Italian Flagship Project). Additionally, we would like to acknowledge individuals from the following organizations: the IgA Nephropathy Foundation of America for facilitating recruitment of individuals in the United States; the Columbia University Glomerular Center (New York), including). Radhalcrishnan, D. Cohen, C. Kunis, A. Bomback and P. Canetta, for referrals of IgAN cases; the Polish Registry of Congenital Malformations (PRCM; Poznan, Poland), including A. Materna-Kiryluk and A. Latos-Bielenska (supported by the Polish Ministry of Health), for facilitating the recruitment of the Polish IgAN cohort; J. Nagy at the University of Pecs, Hungary (supported by SROP-4.2.2/B-10/1/2010-0029); the GN-PROGRESS study, including F. Martinez, E Vrtovsnik and D. Droz, for adjudicating all IgAN cases as well as individual center investigators, including X. Belenfant (Hopital A Gregoire, Montreuil, France); B. Charpentier and A. Durrbach (Assistance Publique-Hopitaux de Paris (AP-HP) Hopital Bicetre, Kremlin-Bicetre, France); G. Rostoker (Hopital C Galien, Quincy/Senart, France); J. Rossert and C. facquot (AP-HP, Hopital Europeen G Pompidou, Paris); P. Lang and P. Remy (AP-HP HOpital H. Mondor, Creteil, France); O. Kourilsky (Hopital L. Michel, Evry, France); J.-P. Grunfeld and D. Chauveau (AP-HP Hopital Necker, Paris); G. Deray and H. Izzedine (AP-HP Hopital Pitie Salpetriere, Paris); C. Legendre and F. Martinez (AP-HP Hopital Saint-Louis, Paris); and P. Ronco and E. Rondeau (AP-HP Hopital Tenon, Paris). We would also like to thank L. Sturg from the Dalla Lana School of Public Health at the University of Toronto (Toronto) for contributing the R code for HD-GWAS analysis.	Ambruzs JM, 2014, CLIN J AM SOC NEPHRO, V9, P265, DOI 10.2215/CJN.04660513; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Barry MA, 2013, ARCH DIS CHILD, V98, P635, DOI 10.1136/archdischild-2012-302338; Barsoum R S, 1987, Nephrol Dial Transplant, V2, P488; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; CORBI AL, 1988, J EXP MED, V167, P1597, DOI 10.1084/jem.167.5.1597; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Ernst M, 2001, J EXP MED, V194, P189, DOI 10.1084/jem.194.2.189; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Feehally J, 2010, J AM SOC NEPHROL, V21, P1791, DOI 10.1681/ASN.2010010076; Ferragine CE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002136; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Freudenberg J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/art.30235; Fritz DK, 2011, J IMMUNOL, V186, P1107, DOI 10.4049/jimmunol.0903476; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Fujimoto K, 2011, J IMMUNOL, V186, P6287, DOI 10.4049/jimmunol.1004036; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kalabis J, 2003, FASEB J, V17, P1115, DOI 10.1096/fj.02-0852fje; Kiryluk K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002765; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Kunisawa J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2718; Lanternier F, 2013, NEW ENGL J MED, V369, P1704, DOI 10.1056/NEJMoa1208487; Levison SE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-127; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu JY, 2009, J CELL SCI, V122, P324, DOI 10.1242/jcs.033720; Liu ZH, 2013, NAT REV NEPHROL, V9, P523, DOI 10.1038/nrneph.2013.146; McCarthy DD, 2011, J CLIN INVEST, V121, P3991, DOI 10.1172/JCI45563; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Osman W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032683; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Prunotto M, 2010, J AM SOC NEPHROL, V21, P507, DOI 10.1681/ASN.2008121259; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rockman SP, 2001, J GASTROEN HEPATOL, V16, P991, DOI 10.1046/j.1440-1746.2001.02588.x; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; Sokol H, 2013, GASTROENTEROLOGY, V145, P591, DOI 10.1053/j.gastro.2013.05.047; Swat W, 2005, IMMUNOL RES, V32, P259, DOI 10.1385/IR:32:1-3:259; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; van Egmond M, 1999, BLOOD, V93, P4387, DOI 10.1182/blood.V93.12.4387.412k08_4387_4394; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; van Spriel AB, 2002, J IMMUNOL, V169, P3831, DOI 10.4049/jimmunol.169.7.3831; Vigorito E, 2005, BLOOD, V106, P2391, DOI 10.1182/blood-2004-12-4894; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Yang SK, 2013, INFLAMM BOWEL DIS, V19, P954, DOI 10.1097/MIB.0b013e3182802ab6; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Yu XQ, 2012, NAT GENET, V44, P178, DOI 10.1038/ng.1047; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079	73	337	355	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1187	1196		10.1038/ng.3118	http://dx.doi.org/10.1038/ng.3118			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25305756	Green Submitted, Green Accepted			2022-12-17	WOS:000344131900009
J	Bezzina, CR; Barc, J; Mizusawa, Y; Remme, CA; Gourraud, JB; Simonet, F; Verkerk, AO; Schwartz, PJ; Crotti, L; Dagradi, F; Guicheney, P; Fressart, V; Leenhardt, A; Antzelevitch, C; Bartkowiak, S; Schulze-Bahr, E; Zumhagen, S; Behr, ER; Bastiaenen, R; Tfelt-Hansen, J; Olesen, MS; Kaab, S; Beckmann, BM; Weeke, P; Watanabe, H; Endo, N; Minamino, T; Horie, M; Ohno, S; Hasegawa, K; Makita, N; Nogami, A; Shimizu, W; Aiba, T; Froguel, P; Balkau, B; Lantieri, O; Torchio, M; Wiese, C; Weber, D; Wolswinkel, R; Coronel, R; Boukens, BJ; Bezieau, S; Charpentier, E; Chatel, S; Despres, A; Gros, F; Kyndt, F; Lecointe, S; Lindenbaum, P; Portero, V; Violleau, J; Gessler, M; Tan, HL; Roden, DM; Christoffels, VM; Le Marec, H; Wilde, AA; Probst, V; Schott, JJ; Dina, C; Redon, R				Bezzina, Connie R.; Barc, Julien; Mizusawa, Yuka; Remme, Carol Ann; Gourraud, Jean-Baptiste; Simonet, Floriane; Verkerk, Arie O.; Schwartz, Peter J.; Crotti, Lia; Dagradi, Federica; Guicheney, Pascale; Fressart, Veronique; Leenhardt, Antoine; Antzelevitch, Charles; Bartkowiak, Susan; Schulze-Bahr, Eric; Zumhagen, Sven; Behr, Elijah R.; Bastiaenen, Rachel; Tfelt-Hansen, Jacob; Olesen, Morten Salling; Kaeaeb, Stefan; Beckmann, Britt M.; Weeke, Peter; Watanabe, Hiroshi; Endo, Naoto; Minamino, Tohru; Horie, Minoru; Ohno, Seiko; Hasegawa, Kanae; Makita, Naomasa; Nogami, Akihiko; Shimizu, Wataru; Aiba, Takeshi; Froguel, Philippe; Balkau, Beverley; Lantieri, Olivier; Torchio, Margherita; Wiese, Cornelia; Weber, David; Wolswinkel, Rianne; Coronel, Ruben; Boukens, Bas J.; Bezieau, Stephane; Charpentier, Eric; Chatel, Stephanie; Despres, Aurore; Gros, Francoise; Kyndt, Florence; Lecointe, Simon; Lindenbaum, Pierre; Portero, Vincent; Violleau, Jade; Gessler, Manfred; Tan, Hanno L.; Roden, Dan M.; Christoffels, Vincent M.; Le Marec, Herve; Wilde, Arthur A.; Probst, Vincent; Schott, Jean-Jacques; Dina, Christian; Redon, Richard			Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; QT INTERVAL DURATION; ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; GENETIC-VARIATION; CONDUCTION SYSTEM; LOCI; EXPRESSION; HETEROGENEITY; SCN10A	Brugada syndrome is a rare cardiac arrhythmia disorder, causally related to SCN5A mutations in around 20% of cases(1-3). Through a genome-wide association study of 312 individuals with Brugada syndrome and 1,115 controls, we detected 2 significant association signals at the SCN10A locus (rs10428132) and near the HEY2 gene (rs9388451). Independent replication confirmed both signals (meta-analyses: rs10428132, P = 1.0 x 10(-68); rs9388451, P = 5.1 x 10(-17)) and identified one additional signal in SCN5A (at 3p21; rs11708996, P = 1.0 x 10(-14)). The cumulative effect of the three loci on disease susceptibility was unexpectedly large (P-trend = 6.1 x 10(-81)). The association signals at SCN5A-SCN10A demonstrate that genetic polymorphisms modulating cardiac conduction(4-7) can also influence susceptibility to cardiac arrhythmia. The implication of association with HEY2, supported by new evidence that Hey2 regulates cardiac electrical activity, shows that Brugada syndrome may originate from altered transcriptional programming during cardiac development(8). Altogether, our findings indicate that common genetic variation can have a strong impact on the predisposition to rare diseases.	[Bezzina, Connie R.; Barc, Julien; Mizusawa, Yuka; Remme, Carol Ann; Wolswinkel, Rianne; Coronel, Ruben; Boukens, Bas J.; Tan, Hanno L.; Wilde, Arthur A.] Univ Amsterdam, Acad Med Ctr, Dept Clin & Expt Cardiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Barc, Julien] ICIN Netherlands Heart Inst, Utrecht, Netherlands; [Gourraud, Jean-Baptiste; Simonet, Floriane; Charpentier, Eric; Chatel, Stephanie; Despres, Aurore; Gros, Francoise; Kyndt, Florence; Lecointe, Simon; Lindenbaum, Pierre; Portero, Vincent; Violleau, Jade; Le Marec, Herve; Probst, Vincent; Schott, Jean-Jacques; Dina, Christian; Redon, Richard] INSERM, UMR 1087, Inst Thorax, Nantes, France; [Gourraud, Jean-Baptiste; Simonet, Floriane; Charpentier, Eric; Chatel, Stephanie; Despres, Aurore; Gros, Francoise; Kyndt, Florence; Lecointe, Simon; Lindenbaum, Pierre; Portero, Vincent; Violleau, Jade; Le Marec, Herve; Probst, Vincent; Schott, Jean-Jacques; Dina, Christian; Redon, Richard] CNRS, UMR 6291, Nantes, France; [Gourraud, Jean-Baptiste; Simonet, Floriane; Charpentier, Eric; Chatel, Stephanie; Despres, Aurore; Gros, Francoise; Kyndt, Florence; Lecointe, Simon; Lindenbaum, Pierre; Portero, Vincent; Violleau, Jade; Le Marec, Herve; Probst, Vincent; Schott, Jean-Jacques; Dina, Christian; Redon, Richard] Univ Nantes, Nantes, France; [Gourraud, Jean-Baptiste; Chatel, Stephanie; Despres, Aurore; Kyndt, Florence; Lecointe, Simon; Lindenbaum, Pierre; Violleau, Jade; Le Marec, Herve; Probst, Vincent; Schott, Jean-Jacques; Dina, Christian; Redon, Richard] Ctr Hosp Univ CHU Nantes, Inst Thorax, Serv Cardiol, Nantes, France; [Verkerk, Arie O.; Boukens, Bas J.; Christoffels, Vincent M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Schwartz, Peter J.; Crotti, Lia; Dagradi, Federica; Torchio, Margherita] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Schwartz, Peter J.; Crotti, Lia; Dagradi, Federica; Torchio, Margherita] Ist Auxol Italiano, IRCCS, Ctr Cardiac Arrhythmias Genet Origin, Milan, Italy; [Schwartz, Peter J.] Hatter Inst Cardiovasc Res Africa, Cardiovasc Genet Lab, Cape Town, South Africa; [Schwartz, Peter J.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Schwartz, Peter J.] Univ Stellenbosch, Dept Med, ZA-7600 Stellenbosch, South Africa; [Schwartz, Peter J.] King Saud Univ, Coll Med, Dept Family & Community Med, Chair Sudden Death, Riyadh 11461, Saudi Arabia; [Crotti, Lia] Helmholtz Ctr Munich, Inst Human Genet, Neuherberg, Germany; [Guicheney, Pascale; Fressart, Veronique] Fac Med Pierre & Marie Curie, INSERM, U956, Paris, France; [Guicheney, Pascale; Fressart, Veronique] Univ Paris 06, Inst Federatif Rech 14, UMRS 956, Paris, France; [Fressart, Veronique] Grp Hosp Pitie Salpetriere, AP HP, Serv Biochim Metab, Unite Fonct Cardiogenet & Myogenet Mol & Cellulai, F-75634 Paris, France; [Leenhardt, Antoine] Hop Bichat Claude Bernard, AP HP, Serv Cardiol, Ctr Reference Malad Cardiaques Hereditaires, F-75877 Paris, France; [Leenhardt, Antoine] INSERM, U698, Paris, France; [Leenhardt, Antoine] Univ Paris Diderot, Paris, France; [Antzelevitch, Charles; Bartkowiak, Susan] Masonic Med Res Lab, Dept Expt Cardiol, Utica, NY USA; [Schulze-Bahr, Eric; Zumhagen, Sven] Univ Hosp, Inst Genet Heart Dis IfGH, Dept Cardiovasc Med, Munster, Germany; [Behr, Elijah R.; Bastiaenen, Rachel] St Georges Univ London, Cardiovasc Sci Res Ctr, London, England; [Tfelt-Hansen, Jacob; Olesen, Morten Salling] Univ Copenhagen, Mol Cardiol Lab, Danish Natl Res Fdn Ctr Cardiac Arrhythmia DARC, Copenhagen, Denmark; [Tfelt-Hansen, Jacob; Olesen, Morten Salling] Rigshosp, Copenhagen Univ Hosp, Dept Cardiol, Ctr Heart, DK-2100 Copenhagen, Denmark; [Kaeaeb, Stefan; Beckmann, Britt M.] Univ Munich, Univ Hosp Munich, Dept Med 1, Munich, Germany; [Kaeaeb, Stefan] Deutsch Forschungszentrum Herz Kreislauferkrankun, Partner Site Munich Heart Alliance, Munich, Germany; [Weeke, Peter; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Med & Pharmacol, Nashville, TN 37212 USA; [Watanabe, Hiroshi; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Endo, Naoto] Niigata Univ, Grad Sch Med & Dent Sci, Dept Regenerat & Transplant Med, Div Orthopaed Surg, Niigata, Japan; [Horie, Minoru; Ohno, Seiko; Hasegawa, Kanae] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga 52021, Japan; [Makita, Naomasa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Physiol, Nagasaki 852, Japan; [Nogami, Akihiko] Yokohama Rosai Hosp, Div Heart Rhythm Management, Yokohama, Kanagawa, Japan; [Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 113, Japan; [Shimizu, Wataru; Aiba, Takeshi] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Div Arrhythmia & Electrophysiol, Suita, Osaka, Japan; [Froguel, Philippe] Lille Pasteur Inst, CNRS, UMR 8199, Lille, France; [Froguel, Philippe] Lille Nord France Univ, Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Balkau, Beverley] Ctr Rech Epidemiol & Sante Populat CESP, INSERM, U1018, Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Lantieri, Olivier] Inst Inter Reg Sante IRSA, La Riche, France; [Wiese, Cornelia; Weber, David; Gessler, Manfred] Univ Wurzburg, Theodor Boveri Inst, Bioctr, D-97070 Wurzburg, Germany; [Bezieau, Stephane; Kyndt, Florence] CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France	University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Nantes Universite; Nantes Universite; CHU de Nantes; University of Amsterdam; Academic Medical Center Amsterdam; University of Pavia; IRCCS Istituto Auxologico Italiano; University of Cape Town; Stellenbosch University; King Saud University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Masonic Medical Research Laboratory; University of Munster; St Georges University London; Danmarks Grundforskningsfond; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Munich; Munich Heart Alliance; Vanderbilt University; Niigata University; Niigata University; Shiga University of Medical Science; Nagasaki University; Yokohama Rosai Hospital; Nippon Medical School; National Cerebral & Cardiovascular Center - Japan; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Wurzburg; Nantes Universite; CHU de Nantes	Bezzina, CR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin & Expt Cardiol, Heart Failure Res Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.r.bezzina@amc.uva.nl; richard.redon@inserm.fr	torchio, margherita/AAA-7061-2020; Crotti, Lia/AAB-3914-2019; Schott, jean-Jacques/F-8842-2013; LECOINTE, Simon/D-3565-2015; Gourraud, Jean baptiste/D-6421-2015; Guicheney, Pascale/D-1034-2017; Horie, Minoru/ABG-7128-2020; Gourraud, Jean baptiste/GSI-4249-2022; Coronel, Ruben/AAZ-8948-2020; olesen, morten/AAC-5752-2021; Schwartz, Peter J/J-4267-2016; probst, vincent/D-4996-2015; Roden, Dan/ABD-5412-2021; Charpentier, Eric/D-5277-2015; Le Marec, Hervé/D-2718-2015; Violleau, Jade/D-4810-2015; CHATEL, Stephanie/D-2536-2015; Simonet, Floriane/D-3538-2015; Ohno, Seiko/Q-3969-2019; Tfelt-Hansen, Jacob/AAU-8691-2020; Minamino, Tohru/P-8145-2018; Dina, Christian R/D-3535-2015; Redon, Richard/F-3303-2014; Ohno, Seiko/AEL-3289-2022; Lindenbaum, Pierre/A-7154-2008; barc, julien/K-5495-2014; Kaab, Stefan/H-3915-2012; KYNDT, Florence/D-6370-2015; FROGUEL, Philippe/O-6799-2017; Dagradi, Federica/J-9610-2016; Bézieau, stéphane/G-5621-2015	Schott, jean-Jacques/0000-0002-9578-9475; Guicheney, Pascale/0000-0002-7663-2050; Gourraud, Jean baptiste/0000-0002-6961-2131; Coronel, Ruben/0000-0001-9433-6119; Schwartz, Peter J/0000-0003-0367-1048; probst, vincent/0000-0002-5492-8619; Le Marec, Hervé/0000-0002-8288-8693; CHATEL, Stephanie/0000-0003-0677-5627; Ohno, Seiko/0000-0003-1209-8896; Tfelt-Hansen, Jacob/0000-0003-3895-9316; Minamino, Tohru/0000-0003-1627-6151; Dina, Christian R/0000-0002-7722-7348; Redon, Richard/0000-0001-7751-2280; Ohno, Seiko/0000-0003-1209-8896; Lindenbaum, Pierre/0000-0003-0148-9787; barc, julien/0000-0003-4106-5946; KYNDT, Florence/0000-0001-6651-1696; FROGUEL, Philippe/0000-0003-2972-0784; Dagradi, Federica/0000-0002-1090-3292; Bézieau, stéphane/0000-0003-0095-1319; Portero, Vincent/0000-0002-7221-859X; crotti, lia/0000-0001-8739-6527; Simonet, Floriane/0000-0002-6366-7211; Charpentier, Eric/0000-0002-8571-7603; Gessler, Manfred/0000-0002-7915-6045; Antzelevitch, Charles/0000-0001-7349-1582; Bezzina, Connie/0000-0002-0633-3514; Torchio, Margherita/0000-0003-3887-6772; Leenhardt, Antoine/0000-0001-7368-4528; Verkerk, Arie/0000-0003-2140-834X; Behr, Elijah/0000-0002-8731-2853; Antzelevitch, Charles/0000-0001-5215-4667; Olesen, Morten Salling/0000-0001-9477-5322; Boukens, Bastiaan J/0000-0001-6449-145X; Bastiaenen, Rachel/0000-0002-5018-8035	Leducq Foundation [CVD-05]; Ministry of Education, Culture, Sports, Science and Technology of Japan; French Ministry of Health [PHRC AOR04070, P040411, PHRCI DGS2001/0248]; INSERM (ATIP-Avenir program); French Regional Council of Pays-de-la-Loire; Netherlands Heart Institute [061.02]; Division for Earth and Life Sciences (ALW) [836.09.003]; Netherlands Organization for Scientific Research (NWO); Netherlands Heart Foundation [NHS 2007B202, 2009B066]; European Society of Cardiology; Netherlands Heart Institute (ICIN); French-Dutch Academy through the Van Gogh program; Interdisziplin ren Zentrums fur Klinische Forschung (IZKF) of the University of Munster; Collaborative Research Center [SFB656]; German Research Foundation [DFG-SFB 688, TP A16]; Medical Research Council [G1002084] Funding Source: researchfish; Grants-in-Aid for Scientific Research [24591038, 23390209] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL065962, R01HL047678, R01HL049989] Funding Source: NIH RePORTER; MRC [G1002084] Funding Source: UKRI	Leducq Foundation(Leducq Foundation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); French Ministry of Health; INSERM (ATIP-Avenir program); French Regional Council of Pays-de-la-Loire(Region Pays de la Loire); Netherlands Heart Institute; Division for Earth and Life Sciences (ALW); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation); European Society of Cardiology; Netherlands Heart Institute (ICIN); French-Dutch Academy through the Van Gogh program; Interdisziplin ren Zentrums fur Klinische Forschung (IZKF) of the University of Munster; Collaborative Research Center; German Research Foundation(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Beekman, C. de Gier-de Vries, B. de Jonge and the Genomic Platform of Nantes (Biogenouest Genomics) for technical support. We are also grateful to the French Clinical Network against Inherited Cardiac Arrhythmias, which includes the University Hospitals of Nantes, Bordeaux, Rennes, Tours, Brest, Strasbourg, La Reunion, Angers and Montpellier. This study was funded by research grants from the Leducq Foundation (CVD-05; Alliance Against Sudden Cardiac Death), the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant-in-aid for the Project in Sado for Total Health, PROST), the French Ministry of Health (PHRC AOR04070, P040411 and PHRCI DGS2001/0248), INSERM (ATIP-Avenir program to R. R.) and the French Regional Council of Pays-de-la-Loire. This research was also supported by the Netherlands Heart Institute (grant 061.02 to C. A. R. and C. R. B.) and the Division for Earth and Life Sciences (ALW; project 836.09.003 to C. A. R.) with financial aid from the Netherlands Organization for Scientific Research (NWO). C. R. B. acknowledges support from the Netherlands Heart Foundation (NHS 2007B202 and 2009B066). J.B. was supported by a research grant from the European Society of Cardiology and the Netherlands Heart Institute (ICIN) and by the French-Dutch Academy through the Van Gogh program. E.S.-B. was supported by the Interdisziplin ren Zentrums fur Klinische Forschung (IZKF) of the University of Munster and the Collaborative Research Center SFB656. M. G. acknowledges support from the German Research Foundation (DFG-SFB 688 and TP A16). This manuscript is dedicated to the memory of Denis Escande, who founded the Leducq Foundation Network Alliance Against Sudden Cardiac Death.	Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Arnolds DE, 2012, J CLIN INVEST, V122, P2509, DOI 10.1172/JCI62617; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Byers S, 1998, J AM STAT ASSOC, V93, P577, DOI 10.2307/2670109; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Crotti L, 2012, J AM COLL CARDIOL, V60, P1410, DOI 10.1016/j.jacc.2012.04.037; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Fischer A, 2003, TRENDS CARDIOVAS MED, V13, P221, DOI 10.1016/S1050-1738(03)00082-3; Frayley C., 2006, MCLUST VERSION 3 R N; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Hermida JS, 2010, AM J CARDIOL, V106, P1758, DOI 10.1016/j.amjcard.2010.07.049; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; Kokubo H, 2004, CIRC RES, V95, P540, DOI 10.1161/01.RES.0000141136.85194.f0; Kolder ICRM, 2012, J MOL CELL CARDIOL, V52, P620, DOI 10.1016/j.yjmcc.2011.12.014; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Little RJ, 1987, STAT ANAL MISSING DA; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marroni F, 2009, CIRC-CARDIOVASC GENE, V2, P322, DOI 10.1161/CIRCGENETICS.108.833806; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Nademanee K, 2011, CIRCULATION, V123, P1270, DOI 10.1161/CIRCULATIONAHA.110.972612; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Pallante BA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P186, DOI 10.1161/CIRCEP.109.928820; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pirinen M, 2012, NAT GENET, V44, P848, DOI 10.1038/ng.2346; Postel-Vinay S, 2012, NAT GENET, V44, P323, DOI 10.1038/ng.1085; Priori SG, 2000, CIRCULATION, V102, P2509, DOI 10.1161/01.CIR.102.20.2509; Priori SG, 2002, EUROPACE, V4, P3, DOI 10.1053/eupc.2001.0214; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Remme CA, 2009, BASIC RES CARDIOL, V104, P511, DOI 10.1007/s00395-009-0012-8; Remme CA, 2006, CIRCULATION, V114, P2584, DOI 10.1161/CIRCULATIONAHA.106.653949; Rubin DB, 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Sakata Y, 2002, P NATL ACAD SCI USA, V99, P16197, DOI 10.1073/pnas.252648999; Sakuma M, 2008, J BONE MINER METAB, V26, P373, DOI 10.1007/s00774-007-0841-1; Schulze-Bahr Eric, 2003, Hum Mutat, V21, P651, DOI 10.1002/humu.9144; Shao WL, 2002, MOL CELL BIOL, V22, P3358, DOI 10.1128/MCB.22.10.3358-3372.2002; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Stouffer S, 1949, STUDIES SOCIAL PSYCH, V1; Straus SMJM, 2004, J CLIN EPIDEMIOL, V57, P98, DOI 10.1016/S0895-4356(03)00210-5; van den Boogaard M, 2012, J CLIN INVEST, V122, P2519, DOI 10.1172/JCI62613; Verkerk AO, 2012, CIRC RES, V111, P333, DOI 10.1161/CIRCRESAHA.112.274035; Wilde AAM, 2010, J MOL CELL CARDIOL, V49, P543, DOI 10.1016/j.yjmcc.2010.07.012; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Yang T, 2012, CIRC RES, V111, P322, DOI 10.1161/CIRCRESAHA.112.265173	60	337	340	3	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2013	45	9					1044	+		10.1038/ng.2712	http://dx.doi.org/10.1038/ng.2712			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	209ID	23872634	Green Accepted			2022-12-17	WOS:000323748200014
J	Li, W; Zhang, Q; Oiso, N; Novak, EK; Gautam, R; O'Brien, EP; Tinsley, CL; Blake, DJ; Spritz, RA; Copeland, NG; Jenkins, NA; Amato, D; Roe, BA; Starcevic, M; Dell'Angelica, EC; Elliott, RW; Mishra, V; Kingsmore, SF; Paylor, RE; Swank, RT				Li, W; Zhang, Q; Oiso, N; Novak, EK; Gautam, R; O'Brien, EP; Tinsley, CL; Blake, DJ; Spritz, RA; Copeland, NG; Jenkins, NA; Amato, D; Roe, BA; Starcevic, M; Dell'Angelica, EC; Elliott, RW; Mishra, V; Kingsmore, SF; Paylor, RE; Swank, RT			Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)	NATURE GENETICS			English	Article							HERMANSKY-PUDLAK-SYNDROME; STORAGE POOL DEFICIENCY; PLATELET-DENSE GRANULES; GENETIC-VARIATION; MOUSE MODEL; 6P22.3 GENE; MUTATION; PROTEIN; HOMOLOG; TRAFFICKING	Hermansky-Pudlak syndrome (HPS; MIM 203300) is a genetically heterogeneous disorder characterized by oculocutaneous albinism, prolonged bleeding and pulmonary fibrosis due to abnormal vesicle trafficking to lysosomes and related organelles, such as melanosomes and platelet dense granules(1-3). In mice, at least 16 loci are associated with HPS4-6, including sandy (sdy; ref. 7). Here we show that the sdy mutant mouse expresses no dysbindin protein owing to a deletion in the gene Dtnbp1 (encoding dysbindin) and that mutation of the human ortholog DTNBP1 causes a novel form of HPS called HPS-7. Dysbindin is a ubiquitously expressed protein that binds to alpha- and beta-dystrobrevins, components of the dystrophin-associated protein complex (DPC) in both muscle and nonmuscle cells(8). We also show that dysbindin is a component of the biogenesis of lysosome-related organelles complex 1 (BLOC-1; refs. 9-11), which regulates trafficking to lysosome-related organelles and includes the proteins pallidin, muted and cappuccino, which are associated with HPS in mice. These findings show that BLOC-1 is important in producing the HPS phenotype in humans, indicate that dysbindin has a role in the biogenesis of lysosome-related organelles and identify unexpected interactions between components of DPC and BLOC-1.	Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; Univ Toronto, Dept Med, Div Hematol & Med Oncol, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Florida, Dept Med, Gainesville, FL 32610 USA; Mol Staging, New Haven, CT 06511 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Roswell Park Cancer Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Oklahoma System; University of Oklahoma - Norman; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; State University System of Florida; University of Florida; Baylor College of Medicine	Swank, RT (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA.		Oiso, Naoki/H-6540-2019	Oiso, Naoki/0000-0001-5593-6496; Kingsmore, Stephen/0000-0001-7180-2527; kingsmore, stephen/0000-0002-3758-4631	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039824] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL068117] Funding Source: Medline; NIAID NIH HHS [P01 AI039824-050002, P01 AI039824] Funding Source: Medline; NICHD NIH HHS [U19 HD077693] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Detter JC, 2000, P NATL ACAD SCI USA, V97, P4144, DOI 10.1073/pnas.080517697; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; Huang LP, 1999, NAT GENET, V23, P329, DOI 10.1038/15507; Huizing M, 2001, THROMB HAEMOSTASIS, V86, P233, DOI 10.1055/s-0037-1616221; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Lee ST, 1995, MOL CELLS, V5, P668; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Nguyen T, 2002, J INVEST DERMATOL, V119, P1156, DOI 10.1046/j.1523-1747.2002.19535.x; Novak EK, 2002, BLOOD, V100, P128, DOI 10.1182/blood.V100.1.128; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; REDDINGTON M, 1987, BLOOD, V69, P1300; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Spritz RA, 1999, TRENDS GENET, V15, P337, DOI 10.1016/S0168-9525(99)01785-0; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Suzuki T, 2003, P NATL ACAD SCI USA, V100, P1146, DOI 10.1073/pnas.0237292100; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; Suzuki T, 2001, GENOMICS, V78, P30, DOI 10.1006/geno.2001.6644; SWANK RT, 1991, GENET RES, V58, P51, DOI 10.1017/S0016672300029608; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087; Zhang Q, 2002, HUM MOL GENET, V11, P697, DOI 10.1093/hmg/11.6.697; [No title captured]	30	337	351	0	12	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					84	89		10.1038/ng1229	http://dx.doi.org/10.1038/ng1229			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12923531	Green Accepted			2022-12-17	WOS:000185018500015
J	Koonin, EV; Altschul, SF; Bork, P				Koonin, EV; Altschul, SF; Bork, P			Functional motifs	NATURE GENETICS			English	Letter							ALIGNMENT		MAX DELBRUCK CTR MOLEC MED, BERLIN, GERMANY; EUROPEAN MOLEC BIOL LAB, D-690012 HEIDELBERG, GERMANY	Helmholtz Association; Max Delbruck Center for Molecular Medicine; European Molecular Biology Laboratory (EMBL)	Koonin, EV (corresponding author), NIH, NATL CTR BIOTECHNOL INFORMAT, NATL LIB MED, BETHESDA, MD 20894 USA.		Altschul, Stephen/R-4000-2019; Bork, Peer/F-1813-2013	Bork, Peer/0000-0002-2627-833X				ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALROCH A, 1996, NUCLEIC ACIDS RES, V24, P189; Chen YM, 1996, SCIENCE, V272, P125, DOI 10.1126/science.272.5258.125; CHEN YM, 1995, SCIENCE, V270, P789, DOI 10.1126/science.270.5237.789; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jensen RA, 1996, NAT GENET, V12, P303, DOI 10.1038/ng0396-303; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Prives C, 1993, CURR OPIN CELL BIOL, V5, P214, DOI 10.1016/0955-0674(93)90105-Y; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Scully R, 1996, SCIENCE, V272, P123, DOI 10.1126/science.272.5258.123; SIEDE W, 1994, GENETICS, V138, P271; TAKAHASHI H, 1995, CANCER RES, V55, P2998; TATUSOV RL, 1994, P NATL ACAD SCI USA, V91, P12091, DOI 10.1073/pnas.91.25.12091; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2	27	337	343	2	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1996	13	3					266	268		10.1038/ng0796-266	http://dx.doi.org/10.1038/ng0796-266			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673121				2022-12-17	WOS:A1996UU28300009
J	Edery, P; Attie, T; Amiel, J; Pelet, A; Eng, C; Hofstra, RMW; Martelli, H; Bidaud, C; Munnich, A; Lyonnet, S				Edery, P; Attie, T; Amiel, J; Pelet, A; Eng, C; Hofstra, RMW; Martelli, H; Bidaud, C; Munnich, A; Lyonnet, S			Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome)	NATURE GENETICS			English	Letter							CHROMOSOME-10		HOP NECKER ENFANTS MALAD,INST NECKER,INSERM,U393,SERV GENET MED,F-75743 PARIS,FRANCE; HOP NECKER ENFANTS MALAD,INST NECKER,INSERM,U393,UNITE RECH HANDICAPS GENET,F-75743 PARIS,FRANCE; HARVARD UNIV,SCH MED,DEPT MED,DANA FARBER CANC INST,DIV CANC EPIDEMIOL & CONTROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,DANA FARBER CANC INST,DIV MED ONCOL,BOSTON,MA 02115; UNIV GRONINGEN,DEPT MED GENET,9713 AW GRONINGEN,NETHERLANDS	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Groningen			Edery, Patrick/B-6407-2012; amiel, jeanne/AGX-1124-2022; Lyonnet, Stanislas/H-5483-2017; ATTIE-BITACH, Tania/K-1453-2017; amiel, jeanne/H-3501-2017	Lyonnet, Stanislas/0000-0001-5426-9417; ATTIE-BITACH, Tania/0000-0002-1155-3626; amiel, jeanne/0000-0001-5973-4728; Eng, Charis/0000-0002-3693-5145; PELET, Anastella/0000-0002-8353-1725; Hofstra, Robert/0000-0001-7498-3829				AMBANI LM, 1983, J PEDIATR-US, V102, P802, DOI 10.1016/S0022-3476(83)80267-4; ANGRIST M, 1993, NAT GENET, V4, P351, DOI 10.1038/ng0893-351; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; BADNER JA, 1990, AM J MED GENET, V35, P100, DOI 10.1002/ajmg.1320350119; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; BOLANDE RP, 1974, HUM PATHOL, V5, P409, DOI 10.1016/S0046-8177(74)80021-3; CURRIE ABM, 1986, J PEDIATR SURG, V21, P248, DOI 10.1016/S0022-3468(86)80846-6; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Hirschsprung H., 1888, JAHRBUCHF RKINDERHEI, V27, P1; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033; LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346; Mallory S B, 1986, Pediatr Dermatol, V3, P119, DOI 10.1111/j.1525-1470.1986.tb00501.x; Okamoto E, 1967, J PEDIATR SURG, V2, P437; OMMEN GS, 1979, AM J MED GENET, V3, P217; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; SAKURAI T, 1992, TRENDS PHARMACOL SCI, V13, P103; SHAH KN, 1981, J PEDIATR-US, V99, P432, DOI 10.1016/S0022-3476(81)80339-3; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; VANCAMP G, 1995, J MED GENET, V32, P531, DOI 10.1136/jmg.32.7.531; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; YANAGISAWA M, 1994, CIRCULATION, V89, P1320, DOI 10.1161/01.CIR.89.3.1320	28	337	347	1	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					442	444		10.1038/ng0496-442	http://dx.doi.org/10.1038/ng0496-442			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630502				2022-12-17	WOS:A1996UC55300027
J	LEGIUS, E; MARCHUK, DA; COLLINS, FS; GLOVER, TW				LEGIUS, E; MARCHUK, DA; COLLINS, FS; GLOVER, TW			SOMATIC DELETION OF THE NEUROFIBROMATOSIS TYPE-1 GENE IN A NEUROFIBROSARCOMA SUPPORTS A TUMOR SUPPRESSOR GENE HYPOTHESIS	NATURE GENETICS			English	Article							VONRECKLINGHAUSEN NEUROFIBROMATOSIS; GENOMIC STRUCTURE; CDNA SEQUENCE; MUTATIONS; PRODUCT; IDENTIFICATION; CLONING; DOMAIN; LOCUS; GAP	Individuals with neurofibromatosis type 1 (NF1) have an increased risk of developing benign and malignant tumours. The NF1 gene is thought to be a tumour suppressor gene, yet no direct proof at the molecular level exists to support this hypothesis. Here we describe a neurofibrosarcoma from a patient with NF1 with loss of heterozygosity for all chromosome 17 polymorphisms tested. On the remaining chromosome 17 homologue, a 200 kilobase (kb) tumour specific deletion of NF1 was demonstrated. This is the first example of a homozygous inactivation of NF1 at the molecular level in a malignant tumour from an NF1 patient and the results strongly support the tumour suppressor gene hypothesis for this disease.	UNIV MICHIGAN,DEPT PEDIAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Legius, Eric/H-1735-2011	Marchuk, Douglas/0000-0002-3110-6671	NATIONAL CANCER INSTITUTE [R01CA043222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023410] Funding Source: NIH RePORTER; NCI NIH HHS [CA43222] Funding Source: Medline; NHGRI NIH HHS [HG00018] Funding Source: Medline; NINDS NIH HHS [NS23410] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CAWTHON RM, 1991, GENOMICS, V9, P446, DOI 10.1016/0888-7543(91)90410-G; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; EDWARDS A, 1991, AM J HUM GENET, V49, P746; GLOVER TW, 1991, GENE CHROMOSOME CANC, V3, P62, DOI 10.1002/gcc.2870030111; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; LEE B, 1991, AM J HUM GENET, V48, P511; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEGIUS E, 1992, GENOMICS, V13, P1316, DOI 10.1016/0888-7543(92)90055-W; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MARCHUK DA, 1992, GENOMICS, V13, P672, DOI 10.1016/0888-7543(92)90140-N; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MARTINGALLARDO A, IN PRESS DNA SEQUENC; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OCONNELL P, 1990, GENOMICS, V7, P547, DOI 10.1016/0888-7543(90)90198-4; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SKUSE GR, 1989, GENE CHROMOSOME CANC, V1, P36, DOI 10.1002/gcc.2870010107; STEPHENS K, 1992, HUM GENET, V88, P279; VISKOCHIL D, 1991, MOL CELL BIOL, V11, P906, DOI 10.1128/MCB.11.2.906; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU W, 1992, GENE CHROMOSOME CANC, V4, P337, DOI 10.1002/gcc.2870040411	30	337	348	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					122	126		10.1038/ng0293-122	http://dx.doi.org/10.1038/ng0293-122			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499945				2022-12-17	WOS:A1993KL01000008
J	MATSUDA, F; SHIN, EK; NAGAOKA, H; MATSUMURA, R; HAINO, M; FUKITA, Y; TAKAISHI, S; IMAI, T; RILEY, JH; ANAND, R; SOEDA, E; HONJO, T				MATSUDA, F; SHIN, EK; NAGAOKA, H; MATSUMURA, R; HAINO, M; FUKITA, Y; TAKAISHI, S; IMAI, T; RILEY, JH; ANAND, R; SOEDA, E; HONJO, T			STRUCTURE AND PHYSICAL MAP OF 64 VARIABLE SEGMENTS IN THE 3(I)0.8-MEGABASE REGION OF THE HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN LOCUS	NATURE GENETICS			English	Article							ARTIFICIAL-CHROMOSOME LIBRARIES; HUMAN MONOCLONAL-ANTIBODY; VH GENE SUBGROUPS; GERM-LINE GENES; B-CELL LINES; NUCLEOTIDE-SEQUENCES; PREFERENTIAL UTILIZATION; RHEUMATOID-ARTHRITIS; GEL-ELECTROPHORESIS; DNA AUTOANTIBODIES	We have constructed the physical map of the 0.8 megabase DNA fragment which contains the 3' 64 variable region (V) gene segments of the human immunoglobulin heavy chain (H) locus. The organization of the V(H) locus showed several features that indicate dynamic reshuffling of this locus. The sequenced 64 V(H) segments include 31 pseudogenes, of which 24 are highly conserved except for a few point mutations. Comparison of the 64 germline V(H) sequences shows that each V(H) family has conserved sequences, suggesting that there might be some genetic or selection mechanisms involved in maintenance of each family. The total number of the human V(H) segments was estimated to be about 120, including at least 7 orphons.	KYOTO UNIV,FAC MED,CTR MOLEC BIOL,SAKYO KU,KYOTO 606,JAPAN; KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN; INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,GENE BANK,TSUKUBA,IBARAKI 305,JAPAN; ICI PHARMACEUT PLC,DEPT BIOTECHNOL,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND	Kyoto University; Kyoto University; RIKEN			Takaishi, Shigeo/AAS-3319-2021; Matsuda, Fumihiko/B-9893-2009; Honjo, Tasuku/N-4470-2016					ADDERSON EE, 1991, J IMMUNOL, V147, P1667; AKAHORI Y, 1990, J CLIN INVEST, V85, P1722, DOI 10.1172/JCI114627; ALEXANDER A, 1988, J CLIN INVEST, V82, P1244, DOI 10.1172/JCI113722; ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; BERMAN JE, 1988, EMBO J, V7, P723; BRODEUR PH, 1988, J EXP MED, V168, P2261, DOI 10.1084/jem.168.6.2261; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CAIRNS E, 1989, J IMMUNOL, V143, P685; CHEN PP, 1990, SCAND J IMMUNOL, V31, P257, DOI 10.1111/j.1365-3083.1990.tb02767.x; CHERIF D, 1990, GENE CHROMOSOME CANC, V2, P103, DOI 10.1002/gcc.2870020205; CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416; DERSIMONIAN H, 1989, J IMMUNOL, V142, P4027; DERSIMONIAN H, 1987, J IMMUNOL, V139, P2496; EBELING SB, 1992, INT IMMUNOL, V4, P313, DOI 10.1093/intimm/4.3.313; FELGENHAUER M, 1990, NUCLEIC ACIDS RES, V18, P4927, DOI 10.1093/nar/18.16.4927; FRIEDMAN DF, 1991, J EXP MED, V174, P525, DOI 10.1084/jem.174.3.525; GIBSON TJ, 1987, GENE, V53, P275, DOI 10.1016/0378-1119(87)90016-3; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HARINDRANATH N, 1991, INT IMMUNOL, V3, P865, DOI 10.1093/intimm/3.9.865; HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.bi.54.070185.004103; HUGHESJONES NC, 1990, BIOCHEM J, V268, P135, DOI 10.1042/bj2680135; HUMPHRIES CG, 1988, NATURE, V331, P446, DOI 10.1038/331446a0; IMAI T, 1990, GENOMICS, V8, P297, DOI 10.1016/0888-7543(90)90285-3; Kabat EA, 1991, SEQUENCES PROTEINS I; KISHIMOTO T, 1989, NUCLEIC ACIDS RES, V17, P4385, DOI 10.1093/nar/17.11.4385; KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1; LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7; LORENZ W, 1987, NUCLEIC ACIDS RES, V15, P9667, DOI 10.1093/nar/15.23.9667; MATSUDA F, 1990, EMBO J, V9, P2501, DOI 10.1002/j.1460-2075.1990.tb07429.x; MATSUDA F, 1988, EMBO J, V7, P1047, DOI 10.1002/j.1460-2075.1988.tb02912.x; MATTHYSSENS G, 1980, P NATL ACAD SCI-BIOL, V77, P6561, DOI 10.1073/pnas.77.11.6561; MILLI M, 1991, MOL IMMUNOL, V28, P753; MORTARI F, 1992, EUR J IMMUNOL, V22, P241, DOI 10.1002/eji.1830220135; NICKERSON KG, 1989, J EXP MED, V169, P1391, DOI 10.1084/jem.169.4.1391; NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833; PASCUAL V, 1990, J CLIN INVEST, V86, P1320, DOI 10.1172/JCI114841; RECHAVI G, 1982, P NATL ACAD SCI-BIOL, V79, P4405, DOI 10.1073/pnas.79.14.4405; RECHAVI G, 1983, P NATL ACAD SCI-BIOL, V80, P855, DOI 10.1073/pnas.80.3.855; Sambrook J., 1989, MOL CLONING LAB MANU; SANZ I, 1989, J IMMUNOL, V142, P4054; SANZ I, 1989, J IMMUNOL, V142, P883; SANZ I, 1989, EMBO J, V8, P3471; SCHROEDER HW, 1990, P NATL ACAD SCI USA, V87, P6146, DOI 10.1073/pnas.87.16.6146; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; SHEN A, 1987, P NATL ACAD SCI USA, V84, P8563, DOI 10.1073/pnas.84.23.8563; SHIN EK, 1991, EMBO J, V10, P3641, DOI 10.1002/j.1460-2075.1991.tb04930.x; SILVERSTEIN LE, 1989, J EXP MED, V169, P1631; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; WALTER MA, 1991, J CLIN INVEST, V87, P1266, DOI 10.1172/JCI115128; WALTER MA, 1990, EMBO J, V9, P3303, DOI 10.1002/j.1460-2075.1990.tb07530.x; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; YANG PH, 1990, P NATL ACAD SCI USA, V88, P7907	54	337	412	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					88	94		10.1038/ng0193-88	http://dx.doi.org/10.1038/ng0193-88			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490662				2022-12-17	WOS:A1993KF37200019
J	Carter, NP				Carter, Nigel P.			Methods and strategies for analyzing copy number variation using DNA microarrays	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; CDNA MICROARRAYS; ARRAY CGH; STRUCTURAL VARIATION; BREAST-CANCER; RESOLUTION; SEQUENCE; OLIGONUCLEOTIDES; IDENTIFICATION	The association of DNA copy-number variation (CNV) with specific gene function and human disease has been long known, but the wide scope and prevalence of this form of variation has only recently been fully appreciated. The latest studies using microarray technology have demonstrated that as much as 12% of the human genome and thousands of genes are variable in copy number, and this diversity is likely to be responsible for a significant proportion of normal phenotypic variation. Current challenges involve developing methods not only for detecting and cataloging CNVs in human populations at increasingly higher resolution but also for determining the association of CNVs with biological function, recent human evolution, and common and complex human disease.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Carter, NP (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	npc@sanger.ac.uk			Wellcome Trust [077008] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Carvalho B, 2004, J CLIN PATHOL, V57, P644, DOI 10.1136/jcp.2003.013029; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Dhami P, 2005, AM J HUM GENET, V76, P750, DOI 10.1086/429588; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gribble SM, 2007, J MED GENET, V44, P51, DOI 10.1136/jmg.2006.044909; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; JACOBS PA, 1959, LANCET, V1, P710; Kallioniemi Anne, 1996, Methods (Orlando), V9, P113, DOI 10.1006/meth.1996.0015; KALLIONIEMI OP, 1993, SEMIN CANCER BIOL, V4, P41; Kauraniemi P, 2001, CANCER RES, V61, P8235; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; KUNZE J, 1980, NEUROPEDIATRICS, V11, P203, DOI 10.1055/s-2008-1071392; Kwok PY, 1996, GENOMICS, V31, P123, DOI 10.1006/geno.1996.0019; Lejeune J, 1965, Ann Genet, V8, P11; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Mantripragada KK, 2003, J MOL MED-JMM, V81, P443, DOI 10.1007/s00109-003-0458-3; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mir KU, 2000, ANNU REV GENOM HUM G, V1, P329, DOI 10.1146/annurev.genom.1.1.329; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; MORTON CC, 1981, ACTA GENET MED GEMEL, V30, P39, DOI 10.1017/S0001566000006607; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Porkka K, 2002, LAB INVEST, V82, P629, DOI 10.1038/labinvest.3780457; Price TS, 2005, NUCLEIC ACIDS RES, V33, P3455, DOI 10.1093/nar/gki643; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; SEDANO H O, 1971, Birth Defects Original Article Series, V7, P89; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273; Taillon-Miller P, 1998, GENOME RES, V8, P748, DOI 10.1101/gr.8.7.748; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; VERMA RS, 1977, HUM GENET, V38, P231, DOI 10.1007/BF00527408; Vermeesch JR, 2005, J HISTOCHEM CYTOCHEM, V53, P413, DOI 10.1369/jhc.4A6436.2005; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456	52	336	384	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S16	S21		10.1038/ng2028	http://dx.doi.org/10.1038/ng2028			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597776	Green Accepted			2022-12-17	WOS:000253974400004
J	Nakamura, Y; Itoh, T; Matsuda, H; Gojobori, T				Nakamura, Y; Itoh, T; Matsuda, H; Gojobori, T			Biased biological functions of horizontally transferred genes in prokaryotic genomes	NATURE GENETICS			English	Article							PATHOGENICITY ISLANDS; EVOLUTION; BACTERIA; NEISSERIA; SEQUENCE; EXCHANGE	Horizontal gene transfer is one of the main mechanisms contributing to microbial genome diversification(1-3). To clarify the overall picture of interspecific gene flow among prokaryotes, we developed a new method for detecting horizontally transferred genes and their possible donors by Bayesian inference with training models for nucleotide composition. Our method gives the average posterior probability ( horizontal transfer index) for each gene sequence, with a low horizontal transfer index indicating recent horizontal transfer. We found that 14% of open reading frames in 116 prokaryotic complete genomes were subjected to recent horizontal transfer. Based on this data set, we quantitatively determined that the biological functions of horizontally transferred genes, except mobile element genes, are biased to three categories: cell surface, DNA binding and pathogenicity-related functions. Thus, the transferability of genes seems to depend heavily on their functions.	Res Org Informat & Syst, Natl Inst Genet, Ctr Informat Biol, Shizuoka 4118540, Japan; Res Org Informat & Syst, Natl Inst Genet, DNA Data Bank Japan, Shizuoka 4118540, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; Natl Inst Agrobiol Sci, Genome Res Dept, Tsukuba, Ibaraki 3058602, Japan; Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Osaka 5608531, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Agrobiological Sciences - Japan; Osaka University	Gojobori, T (corresponding author), Res Org Informat & Syst, Natl Inst Genet, Ctr Informat Biol, 1111 Yata, Shizuoka 4118540, Japan.	tgojobor@genes.nig.ac.jp	asif, huma/C-1441-2012	Itoh, Takeshi/0000-0002-6291-4233; Matsuda, Hideo/0000-0002-4701-3779				AMABILECUEVAS CF, 1992, CELL, V70, P189, DOI 10.1016/0092-8674(92)90095-T; BORODOVSKY M, 1995, NUCLEIC ACIDS RES, V23, P3554, DOI 10.1093/nar/23.17.3554; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Charlebois RL, 2003, NATURE, V421, P217, DOI 10.1038/421217a; Davis J, 2001, J BACTERIOL, V183, P4626, DOI 10.1128/JB.183.15.000-000.2001; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Genereux DP, 2003, TRENDS GENET, V19, P191, DOI 10.1016/S0168-9525(03)00055-6; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Kroll JS, 1998, P NATL ACAD SCI USA, V95, P12381, DOI 10.1073/pnas.95.21.12381; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauer FG, 2000, CURR OPIN MICROBIOL, V3, P65, DOI 10.1016/S1369-5274(99)00053-3; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang B, 2001, J MOL EVOL, V53, P244, DOI 10.1007/s002390010214; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999	27	336	356	4	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					760	766		10.1038/ng1381	http://dx.doi.org/10.1038/ng1381			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15208628	Bronze			2022-12-17	WOS:000222354100029
J	Cai, ST; Han, HJ; Kohwi-Shigematsu, T				Cai, ST; Han, HJ; Kohwi-Shigematsu, T			Tissue-specific nuclear architecture and gene expession regulated by SATB1	NATURE GENETICS			English	Article							MATRIX-ATTACHMENT REGION; BINDING PROTEIN SATB1; BETA-GLOBIN LOCUS; CELL-SPECIFIC DEMETHYLATION; HISTONE H3 METHYLATION; C-MYC; CHAIN ENHANCER; IN-VIVO; CHROMATIN; DNA	Eukaryotic chromosomes are packaged in nuclei by many orders of folding. Little is known about how higher-order chromatin packaging might affect gene expression. SATB1 is a cell-type specific nuclear protein that recruits chromatin-remodeling factors and regulates numerous genes during thymocyte differentiation. Here we show that in thymocyte nuclei, SATB1 has a cage-like 'network' distribution circumscribing heterochromatin and selectively tethers specialized DNA sequences onto its network. This was shown by fluorescence in situ hybridization on wild-type and Satb1-null thymocytes using in vivo SATB1-bound sequences as probes. Many gene loci, including that of Myc and a brain-specific gene, are anchored by the SATB1 network at specific genomic sites, and this phenomenon is precisely correlated with proper regulation of distant genes. Histone-modification analyses across a gene-enriched genomic region of 70 kb showed that acetylation of histone H3 at Lys9 and Lys14 peaks at the SATB1-binding site and extends over a region of roughly 10 kb covering genes regulated by SATB1. By contrast, in Satb1-null thymocytes, this site is marked by methylation at H3 Lys9. We propose SATB1 as a new type of gene regulator with a novel nuclear architecture, providing sites for tissue-specific organization of DNA sequences and regulating region-specific histone modification.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kohwi-Shigematsu, T (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd 84-171, Berkeley, CA 94720 USA.							Alvarez JD, 2000, GENE DEV, V14, P521; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Bulger M, 2002, CURR OPIN GENET DEV, V12, P170, DOI 10.1016/S0959-437X(02)00283-6; Cai ST, 1999, METHODS, V19, P394, DOI 10.1006/meth.1999.0875; Chan HM, 2001, J CELL SCI, V114, P2363; COCKERILL PN, 1987, J BIOL CHEM, V262, P5394; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Douglas NC, 2001, NAT IMMUNOL, V2, P307, DOI 10.1038/86308; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Fernandez LA, 2001, MOL CELL BIOL, V21, P196, DOI 10.1128/MCB.21.1.196-208.2001; FORRESTER WC, 1994, SCIENCE, V265, P1221, DOI 10.1126/science.8066460; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Galande S, 1999, J BIOL CHEM, V274, P20521, DOI 10.1074/jbc.274.29.20521; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Hawkins SM, 2001, J BIOL CHEM, V276, P44472, DOI 10.1074/jbc.M104193200; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; KOHWI Y, 1993, GENE DEV, V7, P1766, DOI 10.1101/gad.7.9.1766; Kohwi-Shigematsu T, 1998, METHOD CELL BIOL, V53, P323; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; KohwiShigematsu T, 1997, BIOCHEMISTRY-US, V36, P12005, DOI 10.1021/bi971444j; KOHWISHIGEMATSU T, 1992, METHOD ENZYMOL, V212, P155; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Liu JQ, 1997, MOL CELL BIOL, V17, P5275, DOI 10.1128/MCB.17.9.5275; Liu WM, 1999, CANCER RES, V59, P5695; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; RIEGEL JS, 1990, J IMMUNOL, V144, P3611; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; SANDERS J, 1992, NUCLEIC ACIDS RES, V20, P5907, DOI 10.1093/nar/20.22.5907; Schubeler D, 2000, GENE DEV, V14, P940; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; WREGGETT KA, 1994, CYTOGENET CELL GENET, V66, P99, DOI 10.1159/000133676; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	50	336	364	0	10	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					42	51		10.1038/ng1146	http://dx.doi.org/10.1038/ng1146			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12692553	Green Published			2022-12-17	WOS:000182667900015
J	Paloneva, J; Kestila, M; Wu, J; Salminen, A; Bohling, T; Ruotsalainen, V; Hakola, P; Bakker, ABH; Phillips, JH; Pekkarinen, P; Lanier, LL; Timonen, T; Peltonen, L				Paloneva, J; Kestila, M; Wu, J; Salminen, A; Bohling, T; Ruotsalainen, V; Hakola, P; Bakker, ABH; Phillips, JH; Pekkarinen, P; Lanier, LL; Timonen, T; Peltonen, L			Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts	NATURE GENETICS			English	Article							POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA; NATURAL-KILLER-CELLS; SCLEROSING LEUKOENCEPHALOPATHY; MEMBRANOUS LIPODYSTROPHY; CUTTING EDGE; PLO-SL; PROTEIN; GENE; RECEPTORS; ACTIVATION	Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL; MIM 221770), also known as Nasu-Hakola disease, is a recessively inherited disease characterized by a combination of psychotic symptoms rapidly progressing to presenile dementia and bone cysts restricted to wrists and ankles(1-3). PLOSL has a global distribution, although most of the patients have been diagnosed in Finland(4) and Japan. with an estimated population prevalence of 2x10(-6) (ref. 2) in the Finns. We have previously identified a shared 153-kb ancestor haplotype in all Finnish disease alleles between markers D1951175 and D195608 on chromosome 19q13.1 (refs 5,6). Here we characterize the molecular defect in PLOSL by identifying one large deletion in all Finnish PLOSL alleles and another mutation in a Japanese patient, both representing loss-of-function mutations, in the gene encoding TYRO protein tyrosine kinase binding protein(7) (TYROBP; formerly DAP12). TYROBP is a transmembrane protein that has been recognized as a key activating signal transduction element in natural killer (NK) cells(8). On the plasma membrane of NK cells, TYROBP associates with activating receptors recognizing major histocompatibility complex (MHC) class I molecules(7,9). No abnormalities in NK cell function were detected in PLOSL patients homozygous for a null allele of TYROBP.	Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Gonda Ctr, Los Angeles, CA USA; Univ Helsinki, Haartman Inst, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Haartman Inst, Dept Pathol, Helsinki, Finland; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Ctr, San Francisco, CA 94143 USA; Dept Biochem, Oulu, Finland; Bioctr Oulu, Oulu, Finland; Univ Kuopio, Dept Forens Psychiat, FIN-70211 Kuopio, Finland; DNAX Res Inst Molec & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA USA	Finland National Institute for Health & Welfare; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Helsinki; University of Helsinki; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Finland National Institute for Health & Welfare; University of Oulu; University of Eastern Finland; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Human Mol Genet, Mannerheimintie 166, Helsinki, Finland.	lpeltonen@mednet.ucla.edu	Bakker, Arnold B./F-8494-2010; Lanier, Lewis L/E-2139-2014; Ijäs, Petra/F-8280-2015; Paloneva, Juha/K-2419-2019	Bakker, Arnold B./0000-0003-1489-1847; Lanier, Lewis L/0000-0003-1308-3952; Ijäs, Petra/0000-0002-7292-1971; Paloneva, Juha/0000-0003-3340-9390				ABRAMSKY O, 1989, DISSECTION TISSUE CU, P1; Bakker ABH, 1999, P NATL ACAD SCI USA, V96, P9792, DOI 10.1073/pnas.96.17.9792; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Campbell KS, 1999, INT J BIOCHEM CELL B, V31, P631, DOI 10.1016/S1357-2725(99)00022-9; Chang CW, 1999, J IMMUNOL, V163, P4651; Colonna M, 1998, NATURE, V391, P642, DOI 10.1038/35515; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Dietrich J, 2000, J IMMUNOL, V164, P9, DOI 10.4049/jimmunol.164.1.9; EDVARDSEN P, 1983, INT ORTHOP, V7, P99; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Hakola P., 1990, MONOGRAPHS PSYCHIAT, V17, P1; Harris NL, 1997, GENOME RES, V7, P754, DOI 10.1101/gr.7.7.754; Heymann D, 1998, CYTOKINE, V10, P155, DOI 10.1006/cyto.1997.0277; KALIMO H, 1994, ACTA NEUROL SCAND, V89, P353; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lenkkeri U, 1998, HUM GENET, V102, P192, DOI 10.1007/s004390050676; MAKELA P, 1982, SKELETAL RADIOL, V8, P51; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; Nylander PO, 1996, CLIN GENET, V50, P353; Pekkarinen P, 1998, AM J HUM GENET, V62, P362, DOI 10.1086/301722; Pekkarinen P, 1998, GENOMICS, V54, P307, DOI 10.1006/geno.1998.5591; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Rolstad B, 1998, SCAND J IMMUNOL, V47, P412; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Smith KM, 1998, J IMMUNOL, V161, P7; Verloes A, 1997, J MED GENET, V34, P753, DOI 10.1136/jmg.34.9.753; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	30	336	348	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2000	25	3					357	361		10.1038/77153	http://dx.doi.org/10.1038/77153			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	10888890				2022-12-17	WOS:000087920900030
J	Wigle, JT; Chowdhury, K; Gruss, P; Oliver, G				Wigle, JT; Chowdhury, K; Gruss, P; Oliver, G			Prox1 function is crucial for mouse lens-fibre elongation	NATURE GENETICS			English	Article							MORPHOGENESIS; GENE	Although insights have emerged regarding genes controlling the early stages of eye formation, little is known about lens-fibre differentiation and elongation, The expression pattern of the Prox1 homeobox gene suggests it has a role in a variety of embryonic tissues, including lens'. To analyse the requirement far Prox1 during mammalian development, we inactivated the locus in mice, Homozygous Prox1-null mice die at mid-gestation from multiple developmental defects; here we describe the specific effect an lens development Prox1 inactivation causes abnormal cellular proliferation, downregulated expression of the cell-cycle inhibitors Cdkn Ib (also known as p27(KIP1)) and Cdkn1b (also known as p57(KIP2)), misexpression of E-cadherin and inappropriate apoptosis. Consequently, mutant lens cells fail to polarize and elongate properly, resulting in a hollow lens, Our data provide evidence that the progression of terminal fibre differentiation and elongation is dependent on Prox1 activity during lens development.	St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	St Jude Children's Research Hospital; Max Planck Society	Oliver, G (corresponding author), St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA.		Wigle, J.t./G-2005-2014	Wigle, J.t./0000-0002-4985-7684	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058462] Funding Source: NIH RePORTER; NCI NIH HHS [CA 21765] Funding Source: Medline; NIGMS NIH HHS [GM58462] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOBER E, 1994, DEVELOPMENT, V120, P603; CARTIER M, 1992, NAT GENET, V2, P42, DOI 10.1038/ng0992-42; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GORING DR, 1992, EXP EYE RES, V54, P785, DOI 10.1016/0014-4835(92)90034-P; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Lang RA, 1997, CELL DEATH DIFFER, V4, P12, DOI 10.1038/sj.cdd.4400211; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; SANDILANDS A, 1995, J CELL SCI, V108, P1397; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	12	336	343	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	1999	21	3					318	322		10.1038/6844	http://dx.doi.org/10.1038/6844			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173JR	10080188				2022-12-17	WOS:000078977900029
J	Paternoster, L; Standl, M; Waage, J; Baurecht, H; Hotze, M; Strachan, DP; Curtin, JA; Bonnelykke, K; Tian, C; Takahashi, A; Esparza-Gordillo, J; Alves, AC; Thyssen, JP; den Dekker, HT; Ferreira, MA; Altmaier, E; Sleiman, PMA; Xiao, FL; Gonzalez, JR; Marenholz, I; Kalb, B; Pino-Yanes, M; Xu, CJ; Carstensen, L; Groen-Blokhuis, MM; Venturini, C; Pennell, CE; Barton, SJ; Levin, AM; Curjuric, I; Bustamante, M; Kreiner-Moller, E; Lockett, GA; Bacelis, J; Bunyavanich, S; Myers, RA; Matanovic, A; Kumar, A; Tung, JY; Hirota, T; Kubo, M; McArdle, WL; Henderson, AJ; Kemp, JP; Zheng, J; Smith, GD; Rueschendorf, F; Bauerfeind, A; Lee-Kirsch, MA; Arnold, A; Homuth, G; Schmidt, CO; Mangold, E; Cichon, S; Keil, T; Rodriguez, E; Peters, A; Franke, A; Lieb, W; Novak, N; Foelster-Holst, R; Horikoshi, M; Pekkanen, J; Sebert, S; Husemoen, LL; Grarup, N; De Jongste, JC; Rivadeneira, F; Hofman, A; Jaddoe, VWV; Pasmans, SGMA; Elbert, NJ; Uitterlinden, AG; Marks, GB; Thompson, PJ; Matheson, MC; Robertson, CF; Ried, JS; Li, J; Zuo, XB; Zheng, XD; Yin, XY; Sun, LD; McAleer, MA; O'Regan, GM; Fahy, CMR; Campbell, LE; Macek, M; Kurek, M; Hu, D; Eng, C; Postma, DS; Feenstra, B; Geller, F; Hottenga, JJ; Middeldorp, CM; Hysi, P; Bataille, V; Spector, T; Tiesler, CMT; Thiering, E; Pahukasahasram, B; Yang, JJ; Imboden, M; Huntsman, S; Vilor-Tejedor, N; Relton, CL; Myhre, R; Nystad, W; Custovic, A; Weiss, ST; Meyers, DA; Soederhaell, C; Melen, E; Ober, C; Raby, BA; Simpson, A; Jacobsson, B; Holloway, JW; Bisgaard, H; Sunyer, J; Probst-Hensch, NM; Williams, LK; Godfrey, KM; Wang, CA; Boomsma, DI; Melbye, M; Koppelman, GH; Jarvis, D; McLean, WHI; Irvine, AD; Zhang, XJ; Hakonarson, H; Gieger-, C; Burchard, EG; Martin, NG; Duijts, L; Linneberg, A; Jarvelin, MR; Noethen, MM; Lau, S; Huebner, N; Lee, YA; Tamari, M; Hinds, DA; Glass, D; Brown, SJ; Heinrich, J; Evans, DM; Weidinger, S				Paternoster, Lavinia; Standl, Marie; Waage, Johannes; Baurecht, Hansjoerg; Hotze, Melanie; Strachan, David P.; Curtin, John A.; Bonnelykke, Klaus; Tian, Chao; Takahashi, Atsushi; Esparza-Gordillo, Jorge; Alves, Alexessander Couto; Thyssen, Jacob P.; den Dekker, Herman T.; Ferreira, Manuel A.; Altmaier, Elisabeth; Sleiman, Patrick M. A.; Xiao, Feng Li; Gonzalez, Juan R.; Marenholz, Ingo; Kalb, Birgit; Pino-Yanes, Maria; Xu, Cheng-Jian; Carstensen, Lisbeth; Groen-Blokhuis, Maria M.; Venturini, Cristina; Pennell, Craig E.; Barton, Sheila J.; Levin, Albert M.; Curjuric, Ivan; Bustamante, Mariona; Kreiner-Moller, Eskil; Lockett, Gabrielle A.; Bacelis, Jonas; Bunyavanich, Supinda; Myers, Rachel A.; Matanovic, Anja; Kumar, Ashish; Tung, Joyce Y.; Hirota, Tomomitsu; Kubo, Michiaki; McArdle, Wendy L.; Henderson, A. John; Kemp, John P.; Zheng, Jie; Smith, George Davey; Rueschendorf, Franz; Bauerfeind, Anja; Lee-Kirsch, Min Ae; Arnold, Andreas; Homuth, Georg; Schmidt, Carsten O.; Mangold, Elisabeth; Cichon, Sven; Keil, Thomas; Rodriguez, Elke; Peters, Annette; Franke, Andre; Lieb, Wolfgang; Novak, Natalija; Foelster-Holst, Regina; Horikoshi, Momoko; Pekkanen, Juha; Sebert, Sylvain; Husemoen, Lise L.; Grarup, Niels; De Jongste, Johan C.; Rivadeneira, Fernando; Hofman, Albert; Jaddoe, Vincent W. V.; Pasmans, Suzanne G. M. A.; Elbert, Niels J.; Uitterlinden, Andre G.; Marks, Guy B.; Thompson, Philip J.; Matheson, Melanie C.; Robertson, Colin F.; Ried, Janina S.; Li, Jin; Zuo, Xian Bo; Zheng, Xiao Dong; Yin, Xian Yong; Sun, Liang Dan; McAleer, Maeve A.; O'Regan, Grainne M.; Fahy, Caoimhe M. R.; Campbell, Linda E.; Macek, Milan; Kurek, Michael; Hu, Donglei; Eng, Celeste; Postma, Dirkje S.; Feenstra, Bjarke; Geller, Frank; Hottenga, Jouke Jan; Middeldorp, Christel M.; Hysi, Pirro; Bataille, Veronique; Spector, Tim; Tiesler, Carla M. T.; Thiering, Elisabeth; Pahukasahasram, Badri; Yang, James J.; Imboden, Medea; Huntsman, Scott; Vilor-Tejedor, Natalia; Relton, Caroline L.; Myhre, Ronny; Nystad, Wenche; Custovic, Adnan; Weiss, Scott T.; Meyers, Deborah A.; Soederhaell, Cilla; Melen, Erik; Ober, Carole; Raby, Benjamin A.; Simpson, Angela; Jacobsson, Bo; Holloway, John W.; Bisgaard, Hans; Sunyer, Jordi; Probst-Hensch, Nicole M.; Williams, L. Keoki; Godfrey, Keith M.; Wang, Carol A.; Boomsma, Dorret I.; Melbye, Mads; Koppelman, Gerard H.; Jarvis, Deborah; McLean, W. H. Irwin; Irvine, Alan D.; Zhang, Xue Jun; Hakonarson, Hakon; Gieger-, Christian; Burchard, Esteban G.; Martin, Nicholas G.; Duijts, Liesbeth; Linneberg, Allan; Jarvelin, Marjo-Riitta; Noethen, Markus M.; Lau, Susanne; Huebner, Norbert; Lee, Young-Ae; Tamari, Mayumi; Hinds, David A.; Glass, Daniel; Brown, Sara J.; Heinrich, Joachim; Evans, David M.; Weidinger, Stephan		AAGC; EArly Genetics Lifecourse Epidemio	Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCI; INTERLEUKIN-7 RECEPTOR; VARIANTS; METAANALYSIS; DISEASE; ASTHMA; FILAGGRIN; CELLS; IL-7; SKIN	Genetic association studies have identified 21 loci associated with atopic dermatitis risk predominantly in populations of European ancestry. To identify further susceptibility loci for this common, complex skin disease, we performed a meta-analysis of >15 million genetic variants in 21,399 cases and 95,464 controls from populations of European, African, Japanese and Latino ancestry, followed by replication in 32,059 cases and 228,628 controls from 18 studies. We identified ten new risk loci, bringing the total number of known atopic dermatitis risk loci to 31 (with new secondary signals at four of these loci). Notably, the new loci include candidate genes with roles in the regulation of innate host defenses and T cell function, underscoring the important contribution of (auto) immune mechanisms to atopic dermatitis pathogenesis.	[Paternoster, Lavinia] Univ Bristol, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Paternoster, Lavinia; Kemp, John P.; Zheng, Jie; Smith, George Davey; Relton, Caroline L.; Evans, David M.] Univ Bristol, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Paternoster, Lavinia; McArdle, Wendy L.; Henderson, A. John; Kemp, John P.; Zheng, Jie; Smith, George Davey; Evans, David M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Standl, Marie; Tiesler, Carla M. T.; Thiering, Elisabeth; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Waage, Johannes; Bonnelykke, Klaus; Kreiner-Moller, Eskil; Bisgaard, Hans] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood COPS, Copenhagen, Denmark; [Baurecht, Hansjoerg; Hotze, Melanie; Rodriguez, Elke; Foelster-Holst, Regina; Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol Allergol & Venereol, Kiel, Germany; [Strachan, David P.] Univ London, Populat Hlth Res Inst, St Georges, London, England; [Curtin, John A.; Custovic, Adnan; Simpson, Angela] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Ctr Resp Med & Allergy, Manchester, Lancs, England; [Curtin, John A.; Custovic, Adnan; Simpson, Angela] Univ Hosp South Manchester Natl Hlth Serv NHS Fdn, Manchester, Lancs, England; [Tian, Chao; Tung, Joyce Y.; Hinds, David A.] 23andMe Inc, Mountain View, CA USA; [Takahashi, Atsushi] Inst Phys & Chem Res RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Esparza-Gordillo, Jorge; Marenholz, Ingo; Kalb, Birgit; Rueschendorf, Franz; Bauerfeind, Anja; Huebner, Norbert; Lee, Young-Ae] Max Delbruck Ctr Mol Med, Berlin, Germany; [Esparza-Gordillo, Jorge; Marenholz, Ingo; Matanovic, Anja; Lee, Young-Ae] Charite, Expt & Clin Res Ctr, Clin Pediat Allergy, D-13353 Berlin, Germany; [Alves, Alexessander Couto] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Thyssen, Jacob P.] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergol, Natl Allergy Res Ctr, Copenhagen, Denmark; [den Dekker, Herman T.; De Jongste, Johan C.; Jaddoe, Vincent W. V.; Duijts, Liesbeth] Erasmus Univ, Med Ctr, Dept Pediat, Rotterdam, Netherlands; [den Dekker, Herman T.; Rivadeneira, Fernando; Hofman, Albert; Jaddoe, Vincent W. V.; Uitterlinden, Andre G.; Duijts, Liesbeth] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [den Dekker, Herman T.; Rivadeneira, Fernando; Jaddoe, Vincent W. V.; Elbert, Niels J.; Duijts, Liesbeth] Erasmus Univ, Med Ctr, Generat Study Grp R, Rotterdam, Netherlands; [Ferreira, Manuel A.; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Altmaier, Elisabeth; Gieger-, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Altmaier, Elisabeth; Peters, Annette; Gieger-, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Altmaier, Elisabeth; Ried, Janina S.; Gieger-, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Sleiman, Patrick M. A.; Li, Jin; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Sleiman, Patrick M. A.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xiao, Feng Li; Zuo, Xian Bo; Zheng, Xiao Dong; Yin, Xian Yong; Sun, Liang Dan; Zhang, Xue Jun] Anhui Med Univ, Inst Dermatol, Hefei, Peoples R China; [Gonzalez, Juan R.; Bustamante, Mariona; Vilor-Tejedor, Natalia; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Gonzalez, Juan R.; Bustamante, Mariona; Vilor-Tejedor, Natalia; Sunyer, Jordi] UPF, Barcelona, Spain; [Gonzalez, Juan R.; Bustamante, Mariona; Vilor-Tejedor, Natalia; Sunyer, Jordi] CIBERESP, Barcelona, Spain; [Kalb, Birgit; Lau, Susanne] Charite, Pediat Pneumol & Immunol, D-13353 Berlin, Germany; [Pino-Yanes, Maria; Hu, Donglei; Eng, Celeste; Huntsman, Scott; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Pino-Yanes, Maria] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Madrid, Spain; [Pino-Yanes, Maria] Hosp Univ Nuestra Senora de Candelaria, Res Unit, Santa Cruz De Tenerife, Spain; [Xu, Cheng-Jian; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen Res Inst Asthma & COPD GRIAC, NL-9700 AB Groningen, Netherlands; [Xu, Cheng-Jian] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen Res Inst Asthma & COPD GRIAC, NL-9700 AB Groningen, Netherlands; [Carstensen, Lisbeth; Feenstra, Bjarke; Geller, Frank; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Groen-Blokhuis, Maria M.; Hottenga, Jouke Jan; Middeldorp, Christel M.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Netherlands Twin Register, Dept Biol Psychol, Amsterdam, Netherlands; [Venturini, Cristina; Hysi, Pirro; Bataille, Veronique; Spector, Tim; Glass, Daniel] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Pennell, Craig E.; Wang, Carol A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Barton, Sheila J.; Godfrey, Keith M.] Univ Southampton, Lifecourse Epidemiol Unit, MRC, Southampton, Hants, England; [Levin, Albert M.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Curjuric, Ivan; Kumar, Ashish; Imboden, Medea; Probst-Hensch, Nicole M.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Curjuric, Ivan; Kumar, Ashish; Imboden, Medea; Probst-Hensch, Nicole M.] Univ Basel, Basel, Switzerland; [Bustamante, Mariona] CRG, Barcelona, Spain; [Lockett, Gabrielle A.; Holloway, John W.] Univ Southampton, Fac Med, Human Dev & Hlth, Southampton SO9 5NH, Hants, England; [Bacelis, Jonas; Jacobsson, Bo] Sahlgrens Univ Hosp, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Bunyavanich, Supinda] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Myers, Rachel A.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Kumar, Ashish; Melen, Erik] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Kumar, Ashish; Horikoshi, Momoko] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Hirota, Tomomitsu; Tamari, Mayumi] Inst Phys & Chem Res RIKEN, Ctr Integrat Med Sci, Lab Resp & Allerg Dis, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] Inst Phys & Chem Res RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Kemp, John P.; Evans, David M.] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia; [Lee-Kirsch, Min Ae] Tech Univ Dresden, Klin Kinder & Jugendmed, D-01062 Dresden, Germany; [Arnold, Andreas] Univ Med Greifswald, Clin & Polyclin Dermatol, Greifswald, Germany; [Homuth, Georg] Med Univ Med, Interfac Inst Genet & Funct Genom, Dept Funct Genom, Greifswald, Germany; [Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Schmidt, Carsten O.] Univ Med Greifswald, Study Hlth Pomerania KEF Klin Epidemiol Forsch, Inst Community Med, Greifswald, Germany; [Mangold, Elisabeth; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Cichon, Sven] Univ Basel Hosp, Div Med Genet, CH-4031 Basel, Switzerland; [Cichon, Sven] Univ Basel, Dept Biomed, Basel, Switzerland; [Cichon, Sven] Res Ctr Julich, Struct & Funct Org Brain Genom Imaging, Inst Neurosci & Med INM 1, Julich, Germany; [Keil, Thomas] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Keil, Thomas] Univ Wurzburg, Inst Clin Epidemiol & Biometry, D-97070 Wurzburg, Germany; [Peters, Annette] Munich Heart Alliance, DZHK German Res Ctr Cardiovasc Res, Munich, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Lieb, Wolfgang] Univ Kiel, Inst Epidemiol, Kiel, Germany; [Novak, Natalija] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Pekkanen, Juha] Natl Inst Hlth & Welf, Unit Living Environm & Hlth, Kuopio, Finland; [Pekkanen, Juha] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Fac Med, Ctr Life Course Epidemiol & Syst Med, Oulu, Finland; [Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Husemoen, Lise L.; Linneberg, Allan] Capital Region Denmark, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Grarup, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Pasmans, Suzanne G. M. A.; Elbert, Niels J.] Erasmus Univ, Med Ctr, Dept Dermatol, Rotterdam, Netherlands; [Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Thompson, Philip J.] Queen Elizabeth II Med Ctr, Lung Inst Western Australia, Nedlands, WA, Australia; [Thompson, Philip J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Matheson, Melanie C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Robertson, Colin F.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [McAleer, Maeve A.; Irvine, Alan D.] Natl Childrens Res Ctr, Dublin, Ireland; [McAleer, Maeve A.; O'Regan, Grainne M.; Irvine, Alan D.] Our Ladys Childrens Hosp, Dept Pediat Dermatol, Dublin, Ireland; [Fahy, Caoimhe M. R.; Irvine, Alan D.] Univ Dublin Trinity Coll, Clin Med, Dublin 2, Ireland; [Campbell, Linda E.; McLean, W. H. Irwin; Brown, Sara J.] Univ Dundee, Ctr Dermatol & Genet Med, Dundee, Scotland; [Macek, Milan] Univ Hosp Motol, Dept Biol & Med Genet, Prague, Czech Republic; [Macek, Milan] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Kurek, Michael] Pomeranian Med Univ, Dept Clin Allergol, Szczecin, Poland; [Tiesler, Carla M. T.; Thiering, Elisabeth] Univ Munich, Dr von Hauner Childrens Hosp, Div Metab Dis & Nutr Med, Munich, Germany; [Pahukasahasram, Badri; Williams, L. Keoki] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA; [Yang, James J.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Relton, Caroline L.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Myhre, Ronny; Nystad, Wenche; Jacobsson, Bo] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Raby, Benjamin A.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Weiss, Scott T.; Raby, Benjamin A.] Harvard Univ, Sch Med, Boston, MA USA; [Meyers, Deborah A.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Soederhaell, Cilla] Karolinska Inst, Ctr Innovat Med CIMED, Stockholm, Sweden; [Melen, Erik] Sachs Childrens Hosp, Stockholm, Sweden; [Holloway, John W.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Sunyer, Jordi] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain; [Williams, L. Keoki] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Godfrey, Keith M.] Univ Southampton, Southampton Biomed Res Ctr, Natl Inst Hlth Res, Southampton, Hants, England; [Godfrey, Keith M.] Univ Hosp Southampton Natl Hlth Serv NHS Fdn Trus, Southampton, Hants, England; [Boomsma, Dorret I.] Vrije Univ Amsterdam, Inst Hlth & Care Res EMGO, Amsterdam, Netherlands; [Melbye, Mads; Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Melbye, Mads] Stanford Sch Med, Dept Med, Stanford, CA USA; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp,Groningen Res Inst Asthma, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, COPD GRIAC, Groningen, Netherlands; [Jarvis, Deborah] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol Occupat Med & Publ Hlth, London, England; [Jarvis, Deborah] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Med Res Council Publ Hlth England Ctr Environm &, Dept Epidemiol & Biostat, London, England; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Glostrup, Denmark; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Med Res Council Publ Hlth England Ctr Environm &, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Brown, Sara J.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Dermatol, Dundee DD1 9SY, Scotland	University of Bristol; University of Bristol; University of Bristol; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Copenhagen; University of Kiel; Schleswig Holstein University Hospital; University of London; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; RIKEN; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; QIMR Berghofer Medical Research Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Anhui Medical University; Pompeu Fabra University; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California San Francisco; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Groningen; University of Groningen; Statens Serum Institut; Vrije Universiteit Amsterdam; University of London; King's College London; University of Western Australia; University of Southampton; Henry Ford Health System; Henry Ford Hospital; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Southampton; Sahlgrenska University Hospital; University of Gothenburg; Icahn School of Medicine at Mount Sinai; University of Chicago; Karolinska Institutet; University of Oxford; Wellcome Centre for Human Genetics; RIKEN; RIKEN; University of Queensland; Technische Universitat Dresden; Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; University of Bonn; University of Bonn; University of Basel; University of Basel; Helmholtz Association; Research Center Julich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Kiel; University of Kiel; University of Bonn; Finland National Institute for Health & Welfare; University of Helsinki; University of Oulu; University of Oulu; Novo Nordisk Foundation; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Sydney; Woolcock Institute of Medical Research; University of Western Australia; University of Western Australia; University of Melbourne; Murdoch Children's Research Institute; National Children's Research Centre (NCRC); Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University of Dundee; Motol University Hospital; Charles University Prague; Pomeranian Medical University; University of Munich; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; Newcastle University - UK; Norwegian Institute of Public Health (NIPH); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Wake Forest University; Karolinska Institutet; Karolinska Institutet; University of Southampton; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Henry Ford Health System; Henry Ford Hospital; University of Southampton; Vrije Universiteit Amsterdam; University of Copenhagen; Stanford University; University of Groningen; University of Groningen; Imperial College London; Imperial College London; University of California System; University of California San Francisco; Rigshospitalet; Imperial College London; University of Oulu; University of Dundee	Paternoster, L (corresponding author), Univ Bristol, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England.	l.paternoster@bristol.ac.uk	Irvine, Alan D/A-3982-2008; Tamari, Mayumi/N-5378-2015; Davey Smith, George/A-7407-2013; Kubo, Michiaki/N-7947-2015; Lee-Kirsch, Min Ae/C-5769-2018; Rodríguez, Elke/C-4259-2013; Holloway, John W/B-5424-2009; Boomsma, Dorret I/AAX-4470-2020; Weidinger, Stephan/C-8461-2011; Pasmans, Suzanne/AAI-6016-2021; Kemp, John P./R-3091-2018; Custovic, Adnan/A-2435-2012; Koppelman, Gerard/AAG-9187-2020; Heinrich, Joachim/N-1720-2013; Thyssen, Jacob/ABD-8517-2020; Marks, Guy B./F-5058-2013; Grarup, Niels/K-2807-2015; Bisgaard, Hans/N-4761-2016; Bustamante, Mariona/ABB-9142-2021; Relton, Caroline/AAC-5904-2019; Sunyer, Jordi/G-6909-2014; Schmidt, Carsten Oliver/AAH-2778-2019; Middeldorp, Christel M/L-7728-2017; Pennell, Craig/ABD-6902-2020; Evans, David M/H-6325-2013; Raby, Benjamin/AAK-3866-2021; Franke, Andre/B-2151-2010; Horikoshi, Momoko/AAF-9034-2019; Gonzalez, Juan R/B-7860-2018; Krause, Lutz/G-6283-2013; tian, chao/GYD-3462-2022; Peters, Annette/A-6117-2011; Rivadeneira, Fernando/O-5385-2015; Matheson, Melanie C/O-4721-2015; Xu, Cheng-Jian/G-9144-2018; Pino-Yanes, Maria/C-8498-2017; Lieb, Wolfgang/AAC-7650-2022; Jacobsson, Bo/O-8007-2014; Cichon, Sven/B-9618-2014; Baurecht, Hansjorg/C-4035-2013; Paternoster, Lavinia/C-1292-2015	Irvine, Alan D/0000-0002-9048-2044; Davey Smith, George/0000-0002-1407-8314; Rodríguez, Elke/0000-0003-3692-3950; Holloway, John W/0000-0001-9998-0464; Weidinger, Stephan/0000-0003-3944-252X; Pasmans, Suzanne/0000-0003-1018-4475; Kemp, John P./0000-0002-9105-2249; Custovic, Adnan/0000-0001-5218-7071; Heinrich, Joachim/0000-0002-9620-1629; Marks, Guy B./0000-0002-8976-8053; Grarup, Niels/0000-0001-5526-1070; Bisgaard, Hans/0000-0003-4131-7592; Bustamante, Mariona/0000-0003-0127-2860; Sunyer, Jordi/0000-0002-2602-4110; Schmidt, Carsten Oliver/0000-0001-5266-9396; Middeldorp, Christel M/0000-0002-6218-0428; Pennell, Craig/0000-0002-0937-6165; Evans, David M/0000-0003-0663-4621; Franke, Andre/0000-0003-1530-5811; Gonzalez, Juan R/0000-0003-3267-2146; Krause, Lutz/0000-0003-3806-0845; Peters, Annette/0000-0001-6645-0985; Rivadeneira, Fernando/0000-0001-9435-9441; Matheson, Melanie C/0000-0002-5822-3499; Xu, Cheng-Jian/0000-0003-1586-4672; Pino-Yanes, Maria/0000-0003-0332-437X; Jacobsson, Bo/0000-0001-5079-2374; Wang, Carol/0000-0002-4301-3974; Cichon, Sven/0000-0002-9475-086X; Dharmage, Shyamali/0000-0001-6063-1937; Godfrey, Keith/0000-0002-4643-0618; Zheng, Jie/0000-0002-6623-6839; Bonnelykke, Klaus/0000-0003-2003-1018; Kreiner, Eskil/0000-0003-1204-2438; Nothen, Markus/0000-0002-8770-2464; Hysi, Pirro/0000-0001-5752-2510; Thyssen, Jacob Pontoppidan/0000-0003-3770-1743; Thiering, Elisabeth/0000-0002-5429-9584; Koppelman, Gerard/0000-0001-8567-3252; Kumar, Ashish/0000-0002-7075-5930; Ober, Carole/0000-0003-4626-9809; Baurecht, Hansjorg/0000-0002-9265-5594; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Vilor-Tejedor, Natalia/0000-0003-4935-6721; Geller, Frank/0000-0002-9238-3269; Kalb, Birgit/0000-0002-3104-6736; Sebert, Sylvain/0000-0001-6681-6983; Bacelis, Jonas/0000-0002-2450-732X; Hinds, David/0000-0002-4911-803X; Strachan, David/0000-0001-7854-1366; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Paternoster, Lavinia/0000-0003-2514-0889; Relton, Caroline/0000-0003-2052-4840; melbye, mads/0000-0001-8264-6785; Lau, Susanne/0000-0002-5189-4265; Couto Alves, Alex/0000-0001-8519-7356; Standl, Marie/0000-0002-5345-2049; Simpson, Angela/0000-0003-2733-6666; Venturini, Cristina/0000-0002-4769-7912; Linneberg, Allan/0000-0002-0994-0184; Jarvis, Deborah/0000-0002-1753-3896; Gieger, Christian/0000-0001-6986-9554; Pekkanen, Juha/0000-0002-1083-8777; Barton, Sheila/0000-0003-4963-4242	MRC Population Health Scientist Fellowship [MR/J012165/1]; Australian Research Council Future Fellowship [FT130101709]; Medical Research Council program grant [MC_UU_12013/4]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118833] Funding Source: NIH RePORTER; MRC [MR/J012165/1, MR/N01104X/1, G0601361, MC_UU_12013/4, MR/K002449/2, MC_UU_12013/2, G0700314, MC_UU_12011/4, MR/K002449/1, G0802780, G1001799, MC_UU_12013/1] Funding Source: UKRI; Lundbeck Foundation [R139-2012-12679, R163-2013-16235] Funding Source: researchfish; Medical Research Council [MR/J012165/1, MC_UU_12013/1, G9815508, MC_UU_12011/4, MR/K002449/1, G0700314, MC_UU_12013/2, MR/K002449/2, G0802780, G1001799, MC_UU_12013/4, G0601361, MC_PC_15018, MR/N01104X/1] Funding Source: researchfish	MRC Population Health Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Research Council Future Fellowship(Australian Research Council); Medical Research Council program grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This publication is the work of the authors, and L.P. will serve as guarantor for the contents of this paper. This research was specifically funded by an MRC Population Health Scientist Fellowship awarded to L.P. (MR/J012165/1). D.M.E. is supported by an Australian Research Council Future Fellowship (FT130101709) and a Medical Research Council program grant (MC_UU_12013/4). Individual study acknowledgment and funding statements can be found in the Supplementary Note.	Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Baker BS, 2006, CLIN EXP IMMUNOL, V144, P1, DOI 10.1111/j.1365-2249.2005.02980.x; Baron S, 2005, GUT, V54, P357, DOI 10.1136/gut.2004.054353; Bataille V, 2012, J EUR ACAD DERMATOL, V26, P1067, DOI 10.1111/j.1468-3083.2011.04444.x; Baurecht H, 2015, AM J HUM GENET, V96, P104, DOI 10.1016/j.ajhg.2014.12.004; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Blair DR, 2013, CELL, V155, P70, DOI 10.1016/j.cell.2013.08.030; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Cole C, 2014, J ALLERGY CLIN IMMUN, V134, P82, DOI 10.1016/j.jaci.2014.04.021; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; de Jong MAWP, 2010, TRENDS IMMUNOL, V31, P452, DOI 10.1016/j.it.2010.08.002; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Esparza-Gordillo J, 2013, J ALLERGY CLIN IMMUN, V132, P371, DOI 10.1016/j.jaci.2013.01.057; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Giarnbartolomei C., 2014, PLOS GENET, V10; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jakobsen C, 2013, J CROHNS COLITIS, V7, P79, DOI 10.1016/j.crohns.2012.05.024; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kitabatake M, 2012, J IMMUNOL, V189, P1193, DOI 10.4049/jimmunol.1102774; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; Lundstrom W, 2013, P NATL ACAD SCI USA, V110, pE1761, DOI 10.1073/pnas.1222303110; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Nagarajan P, 2010, J CELL SCI, V123, P3566, DOI 10.1242/jcs.062240; Niwa Y, 2004, J INVEST DERMATOL, V123, P999, DOI 10.1111/j.0022-202X.2004.23462.x; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; So HC, 2011, GENET EPIDEMIOL, V35, P447, DOI 10.1002/gepi.20593; Steward-Tharp SM, 2014, BLOOD, V123, P2978, DOI 10.1182/blood-2013-09-523167; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Tang TS, 2012, J ALLERGY CLIN IMMUN, V129, P1209, DOI 10.1016/j.jaci.2012.02.002; Tintle S, 2011, J ALLERGY CLIN IMMUN, V128, P583, DOI 10.1016/j.jaci.2011.05.042; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Uehira M, 1998, J INVEST DERMATOL, V110, P740, DOI 10.1046/j.1523-1747.1998.00179.x; Wang X, 2013, HUM MOL GENET, V22, P2303, DOI 10.1093/hmg/ddt064; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213	69	335	343	4	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1449	+		10.1038/ng.3424	http://dx.doi.org/10.1038/ng.3424			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26482879	Green Submitted, Green Accepted			2022-12-17	WOS:000365813200017
J	Reincke, M; Sbiera, S; Hayakawa, A; Theodoropoulou, M; Osswald, A; Beuschlein, F; Meitinger, T; Mizuno-Yamasaki, E; Kawaguchi, K; Saeki, Y; Tanaka, K; Wieland, T; Graf, E; Saeger, W; Ronchi, CL; Allolio, B; Buchfelder, M; Strom, TM; Fassnacht, M; Komada, M				Reincke, Martin; Sbiera, Silviu; Hayakawa, Akira; Theodoropoulou, Marily; Osswald, Andrea; Beuschlein, Felix; Meitinger, Thomas; Mizuno-Yamasaki, Emi; Kawaguchi, Kohei; Saeki, Yasushi; Tanaka, Keiji; Wieland, Thomas; Graf, Elisabeth; Saeger, Wolfgang; Ronchi, Cristina L.; Allolio, Bruno; Buchfelder, Michael; Strom, Tim M.; Fassnacht, Martin; Komada, Masayuki			Mutations in the deubiquitinase gene USP8 cause Cushing's disease	NATURE GENETICS			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; ENDOCYTIC TRAFFICKING; UBPY; UBIQUITYLATION; PROTEIN; HRS; UBIQUITINATION; PATHOGENESIS; DEGRADATION	Cushing's disease is caused by corticotroph adenomas of the pituitary. To explore the molecular mechanisms of endocrine autonomy in these tumors, we performed exome sequencing of 10 corticotroph adenomas. We found somatic mutations in the USP8 deubiquitinase gene in 4 of 10 adenomas. The mutations clustered in the 14-3-3 protein binding motif and enhanced the proteolytic cleavage and catalytic activity of USP8. Cleavage of USP8 led to increased deubiqutination of the EGF receptor, impairing its downregulation and sustaining EGF signaling. USP8 mutants enhanced promoter activity of the gene encoding proopiomelanocortin. In summary, our data show that dominant mutations in USP8 cause Cushing's disease via activation of EGF receptor signaling.	[Reincke, Martin; Osswald, Andrea; Beuschlein, Felix] Univ Munich, Med Klin & Poliklin 4, Munich, Germany; [Sbiera, Silviu] Univ Wurzburg, D-97070 Wurzburg, Germany; [Hayakawa, Akira; Mizuno-Yamasaki, Emi; Kawaguchi, Kohei; Komada, Masayuki] Tokyo Inst Technol, Dept Biol Sci, Yokohama, Kanagawa 227, Japan; [Theodoropoulou, Marily] Max Planck Inst Psychiat, Dept Endocrinol, D-80804 Munich, Germany; [Meitinger, Thomas; Wieland, Thomas; Graf, Elisabeth; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Meitinger, Thomas] DZHK, German Ctr Cardiovasc Res, Munich, Germany; [Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Tokyo 113, Japan; [Saeger, Wolfgang] Univ Hamburg, Inst Neuropathol, Hamburg, Germany; [Ronchi, Cristina L.; Fassnacht, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany; [Allolio, Bruno] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany; [Buchfelder, Michael] Klinikum Univ Erlangen, Neurochirurg Klin, Erlangen, Germany	University of Munich; University of Wurzburg; Tokyo Institute of Technology; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; German Centre for Cardiovascular Research; Tokyo Metropolitan Institute of Medical Science; University of Hamburg; University of Wurzburg; University of Wurzburg; University of Erlangen Nuremberg	Fassnacht, M (corresponding author), Univ Munich, Med Klin & Poliklin 4, Munich, Germany.	martin.reincke@med.uni-muenchen.de; fassnacht_m@ukw.de	Meitinger, Thomas/O-1318-2015; Sbiera, Silviu/E-8128-2019; Saeki, Yasushi/AAR-8198-2021; Fassnacht, Martin/N-9614-2019; Theodoropoulou, Marily/S-9546-2017	Sbiera, Silviu/0000-0002-6271-5533; Saeki, Yasushi/0000-0002-9202-5453; Fassnacht, Martin/0000-0001-6170-6398; Theodoropoulou, Marily/0000-0002-7378-4374; Ronchi, Cristina/0000-0001-5020-2071; Meitinger, Thomas/0000-0002-8838-8403; Beuschlein, Felix/0000-0001-7826-3984; Kawaguchi, Kohei/0000-0003-2665-7708	Else Kroner-Fresenius-Stiftung [2012_A103]; Bundesministerium fur Bildung und Forschung [BMBF 01EO1004-D2]; Wilhelm Sander-Stiftung [2012.095.1]; Ministry of Education, Culture, Science and Technology of Japan [24112003, 24112008]; Novartis AG; Pfizer; Ipsen for the Hypophysenregister der Arbeitsgemeinschaft Hypophyse of the German Society of Endocrinology; NovoNordisk; German Federal Ministry of Education and Research [01EX1021B]; Verbund Personalisierte Medizin, Teilprojekt NeoExNET [PM1]; Grants-in-Aid for Scientific Research [26000014] Funding Source: KAKEN	Else Kroner-Fresenius-Stiftung; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Wilhelm Sander-Stiftung; Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Novartis AG; Pfizer(Pfizer); Ipsen for the Hypophysenregister der Arbeitsgemeinschaft Hypophyse of the German Society of Endocrinology(Ipsen); NovoNordisk(Novo Nordisk); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Verbund Personalisierte Medizin, Teilprojekt NeoExNET; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Minoru Fukuda and Mitsunori Fukuda for the LAMP2 antibody and EGFP-Rab11A<SUP>S25A</SUP> expression vector, respectively. The study was supported in by the Else Kroner-Fresenius-Stiftung (grant 2012_A103 to M.R.), Bundesministerium fur Bildung und Forschung (grant BMBF 01EO1004-D2 to M.F. and B.A.), the Wilhelm Sander-Stiftung (grant 2012.095.1 to B.A.), and Grants-in-aid from the Ministry of Education, Culture, Science and Technology of Japan (grant 24112003 to M.K. and 24112008 to Y.S.). W.S. is supported by funds from Novartis AG, Pfizer and NovoNordisk and Ipsen for the Hypophysenregister der Arbeitsgemeinschaft Hypophyse of the German Society of Endocrinology. M.T. is supported by a grant from the German Federal Ministry of Education and Research (01EX1021B, Spitzencluster M4, Verbund Personalisierte Medizin, Teilprojekt NeoExNET (PM1)). We thank B. Mauracher, P. Rank, J. Stalla and J.L. Monteserin-Garcia for excellent technical assistance.	Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Cao YN, 2014, SCIENCE, V344, P913, DOI 10.1126/science.1249480; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Cushing H, 1932, B JOHNS HOPKINS HOSP, V50, P137; Dworakowska D, 2012, EUR J CLIN INVEST, V42, P665, DOI 10.1111/j.1365-2362.2011.02621.x; Fukuoka H, 2011, J CLIN INVEST, V121, P4712, DOI 10.1172/JCI60417; Goh G, 2014, NAT GENET, V46, P613, DOI 10.1038/ng.2956; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Ishida M, 2012, J CELL SCI, V125, P5177, DOI 10.1242/jcs.109314; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; LIU B, 1992, MOL CELL BIOL, V12, P3978, DOI 10.1128/MCB.12.9.3978; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2007, EXP CELL RES, V313, P3624, DOI 10.1016/j.yexcr.2007.07.028; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Morino C, 2004, EXP CELL RES, V297, P380, DOI 10.1016/j.yexcr.2004.03.038; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Nomura N, 1994, DNA Res, V1, P223, DOI 10.1093/dnares/1.5.223; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Paez-Pereda M, 2001, J CLIN INVEST, V108, P1123, DOI 10.1172/JCI11098; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Sato Y, 2014, SCIENCE, V344, P917, DOI 10.1126/science.1252328; STALLA GK, 1988, ENDOCRINOLOGY, V122, P618; Stratakis CA, 2010, CLIN GENET, V78, P457, DOI 10.1111/j.1399-0004.2010.01406.x; Tanno H, 2013, J BIOCHEM, V153, P497, DOI 10.1093/jb/mvt028; Theodoropoulou M, 2004, J ENDOCRINOL, V183, P385, DOI 10.1677/joe.1.05616; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004	39	335	347	3	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					31	+		10.1038/ng.3166	http://dx.doi.org/10.1038/ng.3166			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX5TM	25485838				2022-12-17	WOS:000346990400008
J	Weinhold, N; Jacobsen, A; Schultz, N; Sander, C; Lee, W				Weinhold, Nils; Jacobsen, Anders; Schultz, Nikolaus; Sander, Chris; Lee, William			Genome-wide analysis of noncoding regulatory mutations in cancer	NATURE GENETICS			English	Article							TERT PROMOTER MUTATIONS; LUNG-CANCER; DNA; GENES; ADENOCARCINOMA; PARAGANGLIOMA; DISCOVERY; PROTEINS; MELANOMA; TUMORS	Cancer primarily develops because of somatic alterations in the genome. Advances in sequencing have enabled large-scale sequencing studies across many tumor types, emphasizing the discovery of alterations in protein-coding genes. However, the protein-coding exome comprises less than 2% of the human genome. Here we analyze the complete genome sequences of 863 human tumors from The Cancer Genome Atlas and other sources to systematically identify noncoding regions that are recurrently mutated in cancer. We use new frequency- and sequence-based approaches to comprehensively scan the genome for noncoding mutations with potential regulatory impact. These methods identify recurrent mutations in regulatory elements upstream of PLEKHS1, WDR74 and SDHD, as well as previously identified mutations in the TERT promoter. SDHD promoter mutations are frequent in melanoma and are associated with reduced gene expression and poor prognosis. The non-protein-coding cancer genome remains widely unexplored, and our findings represent a step toward targeting the entire genome for clinical purposes.	[Weinhold, Nils; Jacobsen, Anders; Schultz, Nikolaus; Sander, Chris; Lee, William] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Jacobsen, Anders] Univ Copenhagen, Dept Biol, Sect Computat & RNA Biol, Copenhagen, Denmark; [Lee, William] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; University of Copenhagen; Memorial Sloan Kettering Cancer Center	Lee, W (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA.	leew1@mskcc.org	Schultz, Nikolaus/ABE-6347-2020; Skanderup, Anders Jacobsen/K-1081-2013	Skanderup, Anders Jacobsen/0000-0001-6847-4980; Schultz, Nikolaus/0000-0002-0131-4904	TCGA GDAC grant from the US National Institutes of Health [NCI U24-CA143840]; Danish Research Council; Carlsberg Foundation; NATIONAL CANCER INSTITUTE [U24CA143840] Funding Source: NIH RePORTER	TCGA GDAC grant from the US National Institutes of Health; Danish Research Council(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank TCGA as well as numerous other groups who have made their data available for public analysis. The authors additionally thank the CGHub team, members of the Memorial Sloan Kettering Cancer Center Bioinformatics Core, G. Ratsch and J. Chodera for the setup and administration of high-performance computing resources. This work was supported in part by a TCGA GDAC grant from the US National Institutes of Health for N.W., N.S., CS. and W.L. (NCI U24-CA143840) and grants from the Danish Research Council and the Carlsberg Foundation for A.J.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krol M, 2010, J APPL GENET, V51, P37, DOI 10.1007/BF03195709; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lehmann KV, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks800; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Schneider C, 2011, SEMIN DIAGN PATHOL, V28, P167, DOI 10.1053/j.semdp.2011.04.001; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; THUKRAL SK, 1991, MOL CELL BIOL, V11, P1566, DOI 10.1128/MCB.11.3.1566; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; VIRGILIO L, 1994, P NATL ACAD SCI USA, V91, P12530, DOI 10.1073/pnas.91.26.12530; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670	34	335	337	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1160	1165		10.1038/ng.3101	http://dx.doi.org/10.1038/ng.3101			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25261935	Green Accepted			2022-12-17	WOS:000344131900005
J	Comadran, J; Kilian, B; Russell, J; Ramsay, L; Stein, N; Ganal, M; Shaw, P; Bayer, M; Thomas, W; Marshall, D; Hedley, P; Tondelli, A; Pecchioni, N; Francia, E; Korzun, V; Walther, A; Waugh, R				Comadran, Jordi; Kilian, Benjamin; Russell, Joanne; Ramsay, Luke; Stein, Nils; Ganal, Martin; Shaw, Paul; Bayer, Micha; Thomas, William; Marshall, David; Hedley, Pete; Tondelli, Alessandro; Pecchioni, Nicola; Francia, Enrico; Korzun, Viktor; Walther, Alexander; Waugh, Robbie			Natural variation in a homolog of Antirrhinum CENTRORADIALIS contributed to spring growth habit and environmental adaptation in cultivated barley	NATURE GENETICS			English	Article							FLOWERING-LOCUS-T; GENOME-WIDE ASSOCIATION; GENE; TIME; DOMESTICATION; WHEAT; PHOTOPERIOD; ORTHOLOG; QTL; FT	As early farming spread from the Fertile Crescent in the Near East around 10,000 years before the present(1), domesticated crops encountered considerable ecological and environmental change. Spring-sown crops that flowered without the need for an extended period of cold to promote flowering and day length insensitive crops able to exploit the longer, cooler days of higher latitudes emerged and became established. To investigate the genetic consequences of adaptation to these new environments, we identified signatures of divergent selection in the highly differentiated modern-day spring and winter barleys. In one genetically divergent region, we identify a natural variant of the barley homolog of Antirrhinum CENTRORADIALIS(2) (HvCEN) as a contributor to successful environmental adaptation. The distribution of HvCEN alleles in a large collection of wild and landrace accessions indicates that this involved selection and enrichment of preexisting genetic variants rather than the acquisition of mutations after domestication.	[Comadran, Jordi; Russell, Joanne; Ramsay, Luke; Shaw, Paul; Bayer, Micha; Thomas, William; Marshall, David; Hedley, Pete; Waugh, Robbie] James Hutton Inst, Cell & Mol Sci Grp, Dundee, Scotland; [Kilian, Benjamin; Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genebank Dept Genome Divers Grp, Gatersleben, Germany; [Ganal, Martin] TraitGenetics, Gatersleben, Germany; [Tondelli, Alessandro] Genom Res Ctr, Consiglio Ric Sperimentaz Agr CRA, Fiorenzuola Darda, Italy; [Pecchioni, Nicola; Francia, Enrico] Univ Modena & Reggio Emilia, Dept Life Sci, Reggio Emilia, Italy; [Korzun, Viktor] KWS LOCHOW, KWS Cereals Biotechnol, Bergen, Germany; [Walther, Alexander] Univ Gothenburg, Reg Climate Grp, Dept Earth Sci, Gothenburg, Sweden	James Hutton Institute; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Universita di Modena e Reggio Emilia; KWS Saat AG; University of Gothenburg	Waugh, R (corresponding author), James Hutton Inst, Cell & Mol Sci Grp, Dundee, Scotland.	robbie.waugh@hutton.ac.uk	Tondelli, Alessandro/I-7433-2015; Shaw, Paul D/E-9718-2011; Francia, Enrico/N-7931-2019; Hedley, Peter/F-1149-2011; Bayer, Micha/F-2255-2013; Pecchioni, Nicola/E-5389-2015; Tondelli, Alessandro/AAJ-1720-2020; Francia, Enrico/C-8444-2015; Korzun, Viktor/U-6352-2019; Stein, Nils/F-7507-2017	Tondelli, Alessandro/0000-0001-9299-7773; Shaw, Paul D/0000-0002-0202-1150; Francia, Enrico/0000-0001-8709-1002; Hedley, Peter/0000-0003-0866-324X; Pecchioni, Nicola/0000-0003-1704-2541; Tondelli, Alessandro/0000-0001-9299-7773; Francia, Enrico/0000-0001-8709-1002; Korzun, Viktor/0000-0003-0760-8249; Stein, Nils/0000-0003-3011-8731; Kilian, Benjamin/0000-0002-9145-6980; Marshall, David/0000-0001-9309-2570; Bayer, Micha/0000-0003-0041-3115	Scottish Government Rural and Environment Science and Analytical Services Division Research Programme [WP 5.2]; European Union International Research Cooperation with Mediterranean Partner Countries program [ICA3-CT2002-10026, FP7-212019]; German Science Foundation [SPP1530]; BBSRC [BB/D522003/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D522003/1] Funding Source: researchfish	Scottish Government Rural and Environment Science and Analytical Services Division Research Programme; European Union International Research Cooperation with Mediterranean Partner Countries program; German Science Foundation(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Graner, S. Friedel, F. Blattner, R. Sharma, R.K. Pasam, R. Neef and G. Willcox for discussions, K. Mayer and M. Pfeifer for searches for conservation of synteny in sequenced model grass genomes, J. Plieske and G. Durstewitz for their assistance in mapping and development of the cluster file and C. Trautewig, M. Ziems, K. Wolf, N. Uzrek and J. Morris for excellent technical assistance. We thank H. Ozkan, E. Fridman and the IPK Genebank for providing seeds and/or DNA for barley accessions. The authors would like to acknowledge the support given by the Scottish Government Rural and Environment Science and Analytical Services Division Research Programme (WP 5.2), the European Union International Research Cooperation with Mediterranean Partner Countries program ICA3-CT2002-10026 (Mapping Adaptation of Barley to Drought Environments) and Framework Programme 7 (FP7) TriticeaeGenome grant (FP7-212019), and the German Science Foundation Priority Programme SPP1530 to B.K.	Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Bradley D, 1996, NATURE, V379, P791, DOI 10.1038/379791a0; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Comadran J, 2011, THEOR APPL GENET, V122, P1363, DOI 10.1007/s00122-011-1537-4; Comadran J, 2011, THEOR APPL GENET, V122, P523, DOI 10.1007/s00122-010-1466-7; Coventry SJ, 2003, AUST J AGR RES, V54, P1103, DOI 10.1071/AR02194; Diamond J., 1997, RUZHYA MIKROBY STALI; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; Kikuchi R, 2009, PLANT PHYSIOL, V149, P1341, DOI 10.1104/pp.108.132134; Kilian B, 2009, PLANT GENET GENOMICS, V7, P81, DOI 10.1007/978-0-387-77489-3_3; Koti K, 2006, EUPHYTICA, V152, P17, DOI 10.1007/s10681-006-9170-z; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; Laurie DA, 1997, PLANT MOL BIOL, V35, P167, DOI 10.1023/A:1005726329248; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Morrell PL, 2005, P NATL ACAD SCI USA, V102, P2442, DOI 10.1073/pnas.0409804102; Nilan RA, 1971, P388; Oliver SN, 2009, P NATL ACAD SCI USA, V106, P8386, DOI 10.1073/pnas.0903566106; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Pnueli L, 1998, DEVELOPMENT, V125, P1979; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Reinheimer JL, 2004, THEOR APPL GENET, V109, P1267, DOI 10.1007/s00122-004-1736-3; Sameri M, 2011, BREEDING SCI, V61, P183, DOI 10.1270/jsbbs.61.183; SHANNON S, 1991, PLANT CELL, V3, P877, DOI 10.1105/tpc.3.9.877; Snape JW, 2001, EUPHYTICA, V119, P185, DOI 10.1023/A:1017594422176; Stockinger EJ, 2007, PLANT J, V51, P308, DOI 10.1111/j.1365-313X.2007.0141.x; Stracke S, 2009, THEOR APPL GENET, V118, P259, DOI 10.1007/s00122-008-0896-y; Szucs P, 2007, MOL GENET GENOMICS, V277, P249, DOI 10.1007/s00438-006-0195-8; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; von Bothmer R, 2003, DEV PL GEN, V7, P9; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	40	335	341	0	165	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1388	1392		10.1038/ng.2447	http://dx.doi.org/10.1038/ng.2447			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23160098				2022-12-17	WOS:000311713200021
J	Fairfax, BP; Makino, S; Radhakrishnan, J; Plant, K; Leslie, S; Dilthey, A; Ellis, P; Langford, C; Vannberg, FO; Knight, JC				Fairfax, Benjamin P.; Makino, Seiko; Radhakrishnan, Jayachandran; Plant, Katharine; Leslie, Stephen; Dilthey, Alexander; Ellis, Peter; Langford, Cordelia; Vannberg, Fredrik O.; Knight, Julian C.			Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DETERMINANTS; PSORIASIS; SNP; VISUALIZATION; APOPTOSIS; COMPLEX	Trans-acting genetic variants have a substantial, albeit poorly characterized, role in the heritable determination of gene expression. Using paired purified primary monocytes and B cells, we identify new predominantly cell type-specific cis and trans expression quantitative trait loci (eQTLs), including multi-locus trans associations to LYZ and KLF4 in monocytes and B cells, respectively. Additionally, we observe a B cell-specific trans association of rs11171739 at 12q13.2, a known autoimmune disease locus, with IP6K2 (P = 5.8 x 10(-15)), PRIC285 (P = 3.0 x 10(-10)) and an upstream region of CDKN1A (P = 2 x 10(-52)), suggesting roles for cell cycle regulation and peroxisome proliferator-activated receptor gamma (PPAR gamma) signaling in autoimmune pathogenesis. We also find that specific human leukocyte antigen (HLA) alleles form trans associations with the expression of AOAH and ARHGAP24 in monocytes but not in B cells. In summary, we show that mapping gene expression in defined primary cell populations identifies new cell type-specific trans-regulated networks and provides insights into the genetic basis of disease susceptibility.	[Fairfax, Benjamin P.; Makino, Seiko; Radhakrishnan, Jayachandran; Plant, Katharine; Vannberg, Fredrik O.; Knight, Julian C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Leslie, Stephen] Univ Oxford, Dept Oncol, Oxford, England; [Dilthey, Alexander] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Ellis, Peter; Langford, Cordelia] Univ Cambridge, Wellcome Trust Sanger Inst, Cambridge, England; [Vannberg, Fredrik O.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Cambridge; Wellcome Trust Sanger Institute; University System of Georgia; Georgia Institute of Technology	Fairfax, BP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	bfairfax@well.ox.ac.uk; julian@well.ox.ac.uk	Knight, Julian Charles/W-2399-2019; Knight, Julian/C-7242-2009	Knight, Julian Charles/0000-0002-0377-5536; Knight, Julian/0000-0002-0377-5536; Radhakrishnan, Jayachandran/0000-0001-6009-1862; Fairfax, Benjamin/0000-0001-7413-5002	Wellcome Trust [074318, 088891, 075491/Z/04]; European Research Council under the European Union [FP7/2007-2013, 281824]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; National Institute for Health Research [ACF-2008-13-017] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council under the European Union(European Research Council (ERC)); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	We are very grateful to all the volunteers who participated in this study, together with members of the Knight laboratory and A. Hill for their support. We thank A. Auton for his assistance in the identification of probes containing SNPs with European MAF of >0.01% using the 1000 Genomes Project data set and to J. Broxholme for bioinformatic support and mapping of all probes to the reference sequence. We thank G. Gibson, A. Hill and colleagues for critical reading of the manuscript and helpful suggestions. This work was supported by the Wellcome Trust (074318 to J. C. K., 088891 to B. P. F. and 075491/Z/04 to the core facilities at the Wellcome Trust Centre for Human Genetics), the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) (281824 to J. C. K.) and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre.	Akino K, 2007, CANCER SCI, V98, P88, DOI 10.1111/j.1349-7006.2006.00351.x; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Benson V, 2010, INT IMMUNOL, V22, P167, DOI 10.1093/intimm/dxp123; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Elstak ED, 2011, BLOOD, V118, P1570, DOI 10.1182/blood-2011-02-339523; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fischer U, 1997, HUM MOL GENET, V6, P1817, DOI 10.1093/hmg/6.11.1817; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; HAGEN FS, 1991, BIOCHEMISTRY-US, V30, P8415, DOI 10.1021/bi00098a020; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Ho PYPC, 2008, ANN RHEUM DIS, V67, P677, DOI 10.1136/ard.2007.071399; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Kim K, 2009, GENES IMMUN, V10, P482, DOI 10.1038/gene.2009.5; KNOWLES RW, 1986, J IMMUNOL, V137, P2618; Koldobskiy MA, 2010, P NATL ACAD SCI USA, V107, P20947, DOI 10.1073/pnas.1015671107; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; Lavelin I, 2005, J BIOL CHEM, V280, P7178, DOI 10.1074/jbc.M411990200; Lawson BR, 2004, J EXP MED, V199, P547, DOI 10.1084/jem.20031685; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; MUKAI R, 1984, J IMMUNOL, V133, P3211; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Neznanov N, 2005, DNA CELL BIOL, V24, P777, DOI 10.1089/dna.2005.24.777; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; TEDDER TF, 1989, J IMMUNOL, V143, P712; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomaru T, 2006, ENDOCRINOLOGY, V147, P377, DOI 10.1210/en.2005-0450; Van Laer L, 1998, NAT GENET, V20, P194; Vandiedonck C, 2011, GENOME RES, V21, P1042, DOI 10.1101/gr.116681.110; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu HP, 2008, BLOOD, V112, P1166, DOI 10.1182/blood-2007-06-098327; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	67	335	338	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2012	44	5					502	+		10.1038/ng.2205	http://dx.doi.org/10.1038/ng.2205			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	934BW	22446964	Green Accepted			2022-12-17	WOS:000303416300008
J	Maller, JB; Fagerness, JA; Reynolds, RC; Neale, BM; Daly, MJ; Seddon, JM				Maller, Julian B.; Fagerness, Jesen A.; Reynolds, Robyn C.; Neale, Benjamin M.; Daly, Mark J.; Seddon, Johanna M.			Variation in complement factor 3 is associated with risk of age-related macular degeneration	NATURE GENETICS			English	Article							FACTOR-H POLYMORPHISM; VARIANT; CFH; GENES; Y402H	The association of variants in complement factors H and B with age-related macular degeneration has led to more intense genetic and functional analysis of the complement pathway. We identify a nonsynonymous coding change in complement factor 3 that is strongly associated with risk of age-related macular degeneration in a large case-control sample.	Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; MIT, Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; Tufts Univ New England Med Ctr, New England Eye Ctr, Ophthal Epidemiol & Genet Serv, Boston, MA 02111 USA; Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AP, England; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tufts Medical Center; University of London; King's College London; Harvard University; Harvard Medical School	Seddon, JM (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	mjdaly@chgr.mgh.harvard.edu; jseddon@tufts-nemc.org	maller, julian B/A-9323-2009; Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Maller, Julian/0000-0002-1565-9559	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [N01EY002127, R01EY011309] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR020278] Funding Source: Medline; NEI NIH HHS [EY11309, R01 EY011309, N01-EY-0-2127] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abrera-Abeleda MA, 2006, J MED GENET, V43, P582, DOI 10.1136/jmg.2005.038315; BOTTO M, 1990, J EXP MED, V172, P1011, DOI 10.1084/jem.172.4.1011; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; WYATT RJ, 1987, RECENT DEV MUCOSAL I; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	14	335	364	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1200	1201		10.1038/ng2131	http://dx.doi.org/10.1038/ng2131			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17767156				2022-12-17	WOS:000249737400014
J	Vulliamy, T; Marrone, A; Szydlo, R; Walne, A; Mason, PJ; Dokal, I				Vulliamy, T; Marrone, A; Szydlo, R; Walne, A; Mason, PJ; Dokal, I			Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC	NATURE GENETICS			English	Article							SMALL NUCLEOLAR RNAS; APLASTIC-ANEMIA; CELLS; COMPONENT; LENGTH	Telomerase is a ribonucleoprotein complex that is required to synthesize DNA repeats at the ends of each chromosome. The RNA component of this reverse transcriptase is mutated in the bone marrow failure syndrome autosomal dominant dyskeratosis congenita. Here we show that disease anticipation is observed in families with this disease and that this is associated with progressive telomere shortening.	Hammersmith Hosp, Imperial Coll London, Dept Haematol, Div Invest Sci, London W12 0NN, England	Imperial College London	Mason, PJ (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Hematol, Campus Box 8125,660 S Euclid Ave, St Louis, MO 63110 USA.	PMason@im.wustl.edu	Mason, Philip J/B-1087-2008; Szydlo, Richard/C-6678-2012	Szydlo, Richard/0000-0003-1102-8298; Dokal, Inderjeet/0000-0003-4462-4782				Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; Brummendorf TH, 2001, BLOOD, V97, P895, DOI 10.1182/blood.V97.4.895; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Lindblad K, 1999, SEMIN NEUROL, V19, P289, DOI 10.1055/s-2008-1040845; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Notaro R, 1997, P NATL ACAD SCI USA, V94, P13782, DOI 10.1073/pnas.94.25.13782; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6	15	335	347	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					447	449		10.1038/ng1346	http://dx.doi.org/10.1038/ng1346			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15098033	Bronze			2022-12-17	WOS:000221183000014
J	Fluck, CE; Tajima, T; Pandey, AV; Arlt, W; Okuhara, K; Verge, CF; Jabs, EW; Mendonca, BB; Fujieda, K; Miller, WL				Fluck, CE; Tajima, T; Pandey, AV; Arlt, W; Okuhara, K; Verge, CF; Jabs, EW; Mendonca, BB; Fujieda, K; Miller, WL			Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome	NATURE GENETICS			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; PATIENT; 17-ALPHA-HYDROXYLASE/17,20-LYASE; DEFICIENCY; MUTATIONS; PREGNANCY; DEFECTS	Deficient activities of multiple steroidogenic enzymes have been reported without and with Antley-Bixler syndrome (ABS), but mutations of corresponding cytochrome P450 enzymes have not been found. We identified mutations in POR, encoding P450 oxidoreductase, the obligate electron donor for these enzymes, in a woman with amenorrhea and three children with ABS, even though knock-out of POR is embryonically lethal in mice. Mutations of POR also affect drug-metabolizing P450 enzymes, explaining the association of ABS with maternal fluconazole ingestion.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Hokkaido Univ, Dept Pediat, Sapporo, Hokkaido, Japan; Sydney Childrens Hosp, Dept Endocrinol, Randwick, NSW, Australia; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; Univ Sao Paulo, Hosp Clin, Dept Med, Sao Paulo, Brazil; Asahikawa Med Coll, Dept Pediat, Asahikawa, Hokkaido 078, Japan	University of California System; University of California San Francisco; Hokkaido University; Johns Hopkins University; Universidade de Sao Paulo; Asahikawa Medical College	Miller, WL (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	wlmlab@itsa.ucsf.edu	Arlt, Wiebke/B-6310-2009; Toshihiro, Tajima/A-5720-2012; Mendonca, Berenice B/C-2827-2012; Miller, Walter L/J-3696-2012; Mendonca, Berenice/AAS-3742-2021; Mendonca, Berenice B/J-6917-2015; Pandey, Amit V/AAO-6442-2020; Pandey, Amit V/A-7223-2008	Arlt, Wiebke/0000-0001-5106-9719; Mendonca, Berenice/0000-0003-1762-1084; Mendonca, Berenice B/0000-0003-1762-1084; Pandey, Amit V/0000-0001-8331-5902; Pandey, Amit V/0000-0001-8331-5902; Jabs, Ethylin/0000-0001-8983-5466; Flueck, Christa/0000-0002-4568-5504				Adachi M, 1999, ENDOCR J, V46, P285, DOI 10.1507/endocrj.46.285; Aleck KA, 1997, AM J MED GENET, V72, P253, DOI 10.1002/(SICI)1096-8628(19971031)72:3&lt;253::AID-AJMG1&gt;3.0.CO;2-S; Auchus RJ, 1999, MOL ENDOCRINOL, V13, P1169, DOI 10.1210/me.13.7.1169; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Chun K, 1998, AM J MED GENET, V77, P219, DOI 10.1002/(SICI)1096-8628(19980518)77:3<219::AID-AJMG6>3.0.CO;2-K; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Kelley RI, 2002, AM J MED GENET, V110, P95, DOI 10.1002/ajmg.10510; MILLER WL, 1986, NEW ENGL J MED, V314, P1321; Otto DME, 2003, MOL CELL BIOL, V23, P6103, DOI 10.1128/MCB.23.17.6103-6116.2003; PETERSON RE, 1985, NEW ENGL J MED, V313, P1182, DOI 10.1056/NEJM198511073131903; Reardon W, 2000, J MED GENET, V37, P26, DOI 10.1136/jmg.37.1.26; Roth C, 2000, EUR J PEDIATR, V159, P189, DOI 10.1007/s004310050048; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411	15	335	354	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2004	36	3					228	230		10.1038/ng1300	http://dx.doi.org/10.1038/ng1300			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	778PR	14758361	Bronze			2022-12-17	WOS:000189250400009
J	Suka, N; Luo, KH; Grunstein, M				Suka, N; Luo, KH; Grunstein, M			Sir2p and Sas2p opposingly regulate acetylation of yeast histone H4 lysine16 and spreading of heterochromatin	NATURE GENETICS			English	Article							SILENT MATING LOCI; TELOMERIC HETEROCHROMATIN; SACCHAROMYCES-CEREVISIAE; DOSAGE COMPENSATION; MOLECULAR-MODEL; MSL COMPLEX; H3; METHYLATION; DROSOPHILA; PROTEINS	The Sir3 protein helps form telomeric heterochromatin by interacting with hypoacetylated histone H4 lysine 16 (H4-Lys16). The molecular nature of the heterochromatin boundary is still unknown. Here we show that the MYST-like acetyltransferase Sas2p is required for the acetylation (Ac) of H4-Lys16 in euchromatin. In a sas2Delta strain or a phenocopy Lys16Arg mutant, Sir3p spreads from roughly 3 kb to roughly 15 kb, causing hypoacetylation and repression of adjacent chromatin. We also found that disruption of Sir3p binding in a deacetylase-deficient sir2Delta strain can be suppressed by sas2Delta. These data indicate that opposing effects of Sir2p and Sas2p on acetylation of H4-Lys16 maintain the boundary at telomeric heterochromatin.	Univ Calif Los Angeles, Dept Biol Chem, Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Grunstein, M (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Sch Med, Boyer Hall, Los Angeles, CA 90095 USA.							Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brown AJP, 1998, METHOD MICROBIOL, V26, P119; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Gu WG, 2000, EMBO J, V19, P5202, DOI 10.1093/emboj/19.19.5202; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KIMURA A, 2002, NAT GENET, V32; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wach A, 1998, METHOD MICROBIOL, V26, P67	33	335	345	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2002	32	3					378	383		10.1038/ng1017	http://dx.doi.org/10.1038/ng1017			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12379856				2022-12-17	WOS:000179034800012
J	Knudson, CM; Korsmeyer, SJ				Knudson, CM; Korsmeyer, SJ			Bcl-2 and Bax function independently to regulate cell death	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY; DEFICIENT MICE; APOPTOSIS; SURVIVAL; PROTEIN; THYMOCYTES; HAIR; SELECTION; BCL-X(L); BH1	The BCL-2 family has Various pairs of antagonist and agonist proteins that regulate apoptosis, Whether their function is interdependent is uncertain. Using a genetic approach to address this question, we utilized gain- and loss-of-function models of Bcl-2 and Bax and found that apoptosis and thymic hypoplasia characteristic of Bcl-2-deficient mice are largely absent in mice also deficient in Bax. A single copy of Bax promoted apoptosis in the absence of Bcl-2. In contrast, overexpression of Bcl-2 still repressed apoptosis in the absence of Bax. While an in vivo competition exists between Bax and Bcl-2, each is able to regulate apoptosis independently.	WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT MED, DIV MOL ONCOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT PATHOL, DIV MOL ONCOL, ST LOUIS, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)				Knudson, Charles Michael/0000-0003-3964-5466	NATIONAL CANCER INSTITUTE [P01CA049712] Funding Source: NIH RePORTER; NCI NIH HHS [CA49712] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armstrong RC, 1996, J BIOL CHEM, V271, P16850, DOI 10.1074/jbc.271.28.16850; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Boulakia CA, 1996, ONCOGENE, V12, P529; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4573; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Farrow SN, 1996, CURR OPIN GENET DEV, V6, P45, DOI 10.1016/S0959-437X(96)90009-X; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; KAMADA S, 1995, CANCER RES, V55, P354; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Shaham S, 1996, CELL, V86, P201, DOI 10.1016/S0092-8674(00)80092-6; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; Shimizu S, 1996, ONCOGENE, V12, P2251; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; Uhlmann EJ, 1996, CANCER RES, V56, P2506; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; VEIS DJ, 1993, J IMMUNOL, V151, P2546; VEISNOVACK D, 1994, AM J PATHOL, V145, P61; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	40	335	342	3	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1997	16	4					358	363		10.1038/ng0897-358	http://dx.doi.org/10.1038/ng0897-358			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM909	9241272				2022-12-17	WOS:A1997XM90900017
J	PENTAO, L; WISE, CA; CHINAULT, AC; PATEL, PI; LUPSKI, JR				PENTAO, L; WISE, CA; CHINAULT, AC; PATEL, PI; LUPSKI, JR			CHARCOT-MARIE-TOOTH TYPE-1A DUPLICATION APPEARS TO ARISE FROM RECOMBINATION AT REPEAT SEQUENCES FLANKING THE 1.5 MB MONOMER UNIT	NATURE GENETICS			English	Article							HEREDITARY HYPERTROPHIC NEUROPATHY; ARTIFICIAL CHROMOSOME CLONES; TREMBLER MOUSE; MUSCULAR-DYSTROPHY; ALU-PCR; DISEASE; YEAST; DNA; DELETIONS; IDENTIFICATION	We have constructed a 3.1 megabase (Mb) physical map of chromosome 17p11.2-p12, which contains a submicroscopic duplication in patients with Charcot-Marie-Tooth disease type 1A (CMT1A). We find that the CMT1A duplication is a tandem repeat of 1.5 Mb of DNA. A YAC contig encompassing the CMT1A duplication and spanning the endpoints was also developed. Several low copy repeats in 17p11.2-p12 were identified including the large (> 17 kb) CMT1A-REP unit which may be part of a mosaic repeat. CMT1A-REP flanks the 1.5 Mb CMT1A monomer unit on normal chromosome 17 and is present in an additional copy on the CMT1A duplicated chromosome. We propose that the de novo CMT1A duplication arises from unequal crossing over due to misalignment these CMT1A-REP repeat sequences during meiosis.	BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT BIOCHEM,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine			Patel, Pragna/H-9129-2017	Patel, Pragna/0000-0003-3584-1072; Wise, Carol/0000-0002-6790-2194				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; BIRD A, 1987, TRENDS GENET, V3, P341; BREUKEL C, 1990, NUCLEIC ACIDS RES, V18, P3097, DOI 10.1093/nar/18.10.3097; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; Charcot JM, 1886, REV MED-PARIS, V6, P97; DARRAS BT, 1988, AM J HUM GENET, V43, P620; EDWARDS A, 1991, AM J HUM GENET, V49, P746; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; GUZZETTA V, 1992, GENOMICS, V13, P551, DOI 10.1016/0888-7543(92)90124-B; HALLAM PJ, 1992, ANN NEUROL, V31, P570, DOI 10.1002/ana.410310518; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; Hu Xiuyuan, 1992, Human Mutation, V1, P3, DOI 10.1002/humu.1380010103; HU XY, 1990, AM J HUM GENET, V46, P682; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; LOW PA, 1977, NEUROPATH APPL NEURO, V3, P81, DOI 10.1111/j.1365-2990.1977.tb00572.x; LOW PA, 1976, J NEUROL SCI, V30, P343, DOI 10.1016/0022-510X(76)90139-8; LOW PA, 1976, J NEUROL SCI, V30, P327, DOI 10.1016/0022-510X(76)90138-6; LOW PA, 1975, J NEUROL SCI, V26, P565, DOI 10.1016/0022-510X(75)90057-X; LOW PA, 1978, J NEUROL SCI, V35, P93, DOI 10.1016/0022-510X(78)90104-1; LOW PA, 1977, J NEUROL NEUROSUR PS, V40, P434, DOI 10.1136/jnnp.40.5.434; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, AM J MED GENET, V40, P354, DOI 10.1002/ajmg.1320400323; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1900, IN PRESS AM J MED GE; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; MACMILLAN JC, 1992, J MED GENET, V29, P12, DOI 10.1136/jmg.29.1.12; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; PATEL PI, 1990, AM J HUM GENET, V47, P926; PATEL PI, 1990, AM J HUM GENET, V46, P801; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SKRE H, 1974, CLIN GENET, V6, P98; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TIMEMRMAN V, 1992, NATUER GENET, V1, P171; Tooth HH, 1886, PERONEAL TYPE PROGRE; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	51	335	339	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					292	300		10.1038/ng1292-292	http://dx.doi.org/10.1038/ng1292-292			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303282				2022-12-17	WOS:A1992KB49500013
J	Turner, TL; Bourne, EC; Von Wettberg, EJ; Hu, TT; Nuzhdin, SV				Turner, Thomas L.; Bourne, Elizabeth C.; Von Wettberg, Eric J.; Hu, Tina T.; Nuzhdin, Sergey V.			Population resequencing reveals local adaptation of Arabidopsis lyrata to serpentine soils	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; MICROSATELLITE MARKERS; GENOMIC ANALYSIS; CANDIDATE GENES; DIFFERENTIATION	A powerful way to map functional genomic variation and reveal the genetic basis of local adaptation is to associate allele frequency across the genome with environmental conditions(1-5). Serpentine soils, characterized by high heavy-metal content and low calcium-to-magnesium ratios, are a classic context for studying adaptation of plants to local soil conditions(6,7). To investigate whether Arabidopsis lyrata is locally adapted to serpentine soil, and to map the polymorphisms responsible for such adaptation, we pooled DNA from individuals from serpentine and nonserpentine soils and sequenced each 'gene pool' with the Illumina Genome Analyzer. The polymorphisms that are most strongly associated with soil type are enriched at heavy-metal detoxification and calcium and magnesium transport loci, providing numerous candidate mutations for serpentine adaptation. Sequencing of three candidate loci in the European subspecies of A. lyrata indicates parallel differentiation of the same polymorphism at one locus, confirming ecological adaptation, and different polymorphisms at two other loci, which may indicate convergent evolution.	[Turner, Thomas L.] Austrian Acad Sci, Gregor Mendel Inst, A-1010 Vienna, Austria; [Bourne, Elizabeth C.] Macaulay Land Use Res Inst, Aberdeen AB9 2QJ, Scotland; [Turner, Thomas L.; Hu, Tina T.; Nuzhdin, Sergey V.] Univ So Calif, Los Angeles, CA USA; [Von Wettberg, Eric J.] Univ Calif Davis, Davis, CA 95616 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); James Hutton Institute; University of Southern California; University of California System; University of California Davis	Turner, TL (corresponding author), Univ Calif Santa Barbara, Evolut Ecol & Marine Biol Dept, Santa Barbara, CA 93106 USA.	tturner@lifesci.ucsb.edu	von Wettberg, Eric/C-1115-2016	von Wettberg, Eric/0000-0002-2724-0317; Bourne, Elizabeth/0000-0002-6369-9133	US National Science Foundation (NSF) [DEB-0548991, RGM-076643, DEB-0723935]; University of Southern California; Macaulay Development Fund; Gregor Mendel Institute; NIH NRSA	US National Science Foundation (NSF)(National Science Foundation (NSF)); University of Southern California; Macaulay Development Fund; Gregor Mendel Institute; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to M. Nordborg, R. Pakeman and R. Brooker for their advice and support, and to M. Woodhead, J. Russell and C. Booth for assistance with microsatellite analysis. This work was supported by the US National Science Foundation (NSF) grant DEB-0548991 and US National Institutes of Health (NIH) grant RGM-076643 (S. V. N.), NSF DEB-0723935 (to M. Nordborg), the University of Southern California (S. V. N., T. L. T. and T. T. H.), an NSF predoctoral fellowship (T. L. T.), the Macaulay Development Fund (E. C. B.), the Gregor Mendel Institute (T. L. T.) and an NIH NRSA fellowship (E. J. V. W.).	Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clauss MJ, 2002, MOL ECOL, V11, P591, DOI 10.1046/j.0962-1083.2002.01465.x; Diener AC, 2001, PLANT CELL, V13, P1625, DOI 10.1105/tpc.13.7.1625; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Kruckeberg A.R., 1984, CALIFORNIA SERPENTIN; KRUCKEBERG AR, 1951, AM J BOT, V38, P408, DOI 10.2307/2438248; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; OAKESHOTT JG, 1982, EVOLUTION, V36, P86, DOI 10.1111/j.1558-5646.1982.tb05013.x; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Ross-Ibarra J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002411; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Turner TL, 2008, GENETICS, V179, P455, DOI 10.1534/genetics.107.083659; Turner TL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003183; Woodhead M, 2007, MOL ECOL NOTES, V7, P631, DOI 10.1111/j.1471-8286.2006.01656.x; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; ZHOU JM, 1994, PLANT CELL, V6, P875, DOI 10.1105/tpc.6.6.875	18	334	345	1	264	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2010	42	3					260	U42		10.1038/ng.515	http://dx.doi.org/10.1038/ng.515			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	560OQ	20101244				2022-12-17	WOS:000274912400017
J	Eeles, RA; Kote-Jarai, Z; Al Olama, AA; Giles, GG; Guy, M; Severi, G; Muir, K; Hopper, JL; Henderson, BE; Haiman, CA; Schleutker, J; Hamdy, FC; Neal, DE; Donovan, JL; Stanford, JL; Ostrander, EA; Ingles, SA; John, EM; Thibodeau, SN; Schaid, D; Park, JY; Spurdle, A; Clements, J; Dickinson, JL; Maier, C; Vogel, W; Dork, T; Rebbeck, TR; Cooney, KA; Cannon-Albright, L; Chappuis, PO; Hutter, P; Zeegers, M; Kaneva, R; Zhang, HW; Lu, YJ; Foulkes, WD; English, DR; Leongamornlert, DA; Tymrakiewicz, M; Morrison, J; Ardern-Jones, AT; Hall, AL; O'Brien, LT; Wilkinson, RA; Saunders, EJ; Page, EC; Sawyer, EJ; Edwards, SM; Dearnaley, DP; Horwich, A; Huddart, RA; Khoo, VS; Parker, CC; Van As, N; Woodhouse, CJ; Thompson, A; Christmas, T; Ogden, C; Cooper, CS; Southey, MC; Lophatananon, A; Liu, JF; Kolonel, LN; Le Marchand, L; Wahlfors, T; Tammela, TL; Auvinen, A; Lewis, SJ; Cox, A; FitzGerald, LM; Koopmeiners, JS; Karyadi, DM; Kwon, EM; Stern, MC; Corral, R; Joshi, AD; Shahabi, A; McDonnell, SK; Sellers, TA; Pow-Sang, J; Chambers, S; Aitken, J; Gardiner, RA; Batra, J; Kedda, MA; Lose, F; Polanowski, A; Patterson, B; Serth, J; Meyer, A; Luedeke, M; Stefflova, K; Ray, AM; Lange, EM; Farnham, J; Khan, H; Slavov, C; Mitkova, A; Cao, GW; Easton, DF				Eeles, Rosalind A.; Kote-Jarai, Zsofia; Al Olama, Ali Amin; Giles, Graham G.; Guy, Michelle; Severi, Gianluca; Muir, Kenneth; Hopper, John L.; Henderson, Brian E.; Haiman, Christopher A.; Schleutker, Johanna; Hamdy, Freddie C.; Neal, David E.; Donovan, Jenny L.; Stanford, Janet L.; Ostrander, Elaine A.; Ingles, Sue A.; John, Esther M.; Thibodeau, Stephen N.; Schaid, Daniel; Park, Jong Y.; Spurdle, Amanda; Clements, Judith; Dickinson, Joanne L.; Maier, Christiane; Vogel, Walther; Doerk, Thilo; Rebbeck, Timothy R.; Cooney, Kathleen A.; Cannon-Albright, Lisa; Chappuis, Pierre O.; Hutter, Pierre; Zeegers, Maurice; Kaneva, Radka; Zhang, Hong-Wei; Lu, Yong-Jie; Foulkes, William D.; English, Dallas R.; Leongamornlert, Daniel A.; Tymrakiewicz, Malgorzata; Morrison, Jonathan; Ardern-Jones, Audrey T.; Hall, Amanda L.; O'Brien, Lynne T.; Wilkinson, Rosemary A.; Saunders, Edward J.; Page, Elizabeth C.; Sawyer, Emma J.; Edwards, Stephen M.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Van As, Nicholas; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Cooper, Colin S.; Southey, Melissa C.; Lophatananon, Artitaya; Liu, Jo-Fen; Kolonel, Laurence N.; Le Marchand, Loic; Wahlfors, Tiina; Tammela, Teuvo L.; Auvinen, Anssi; Lewis, Sarah J.; Cox, Angela; FitzGerald, Liesel M.; Koopmeiners, Joseph S.; Karyadi, Danielle M.; Kwon, Erika M.; Stern, Mariana C.; Corral, Roman; Joshi, Amit D.; Shahabi, Ahva; McDonnell, Shannon K.; Sellers, Thomas A.; Pow-Sang, Julio; Chambers, Suzanne; Aitken, Joanne; Gardiner, R. A. (Frank); Batra, Jyotsna; Kedda, Mary Anne; Lose, Felicity; Polanowski, Andrea; Patterson, Briony; Serth, Juergen; Meyer, Andreas; Luedeke, Manuel; Stefflova, Klara; Ray, Anna M.; Lange, Ethan M.; Farnham, Jim; Khan, Humera; Slavov, Chavdar; Mitkova, Atanaska; Cao, Guangwen; Easton, Douglas F.		British Assoc Urological Surg; UK ProtecT Study Collaborators; PRACTICAL Consortium	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study	NATURE GENETICS			English	Article							AUSTRALIAN CASE-CONTROL; MULTIPLE; RISK; VARIANTS; ANTIGEN	Prostate cancer (PrCa) is the most frequently diagnosed cancer in males in developed countries. To identify common PrCa susceptibility alleles, we previously conducted a genome-wide association study in which 541,129 SNPs were genotyped in 1,854 PrCa cases with clinically detected disease and in 1,894 controls. We have now extended the study to evaluate promising associations in a second stage in which we genotyped 43,671 SNPs in 3,650 PrCa cases and 3,940 controls and in a third stage involving an additional 16,229 cases and 14,821 controls from 21 studies. In addition to replicating previous associations, we identified seven new prostate cancer susceptibility loci on chromosomes 2, 4, 8, 11 and 22 (with P = 1.6 x 10(-8) to P = 2.7 x 10(-33)).	[Eeles, Rosalind A.; Kote-Jarai, Zsofia; Guy, Michelle; Leongamornlert, Daniel A.; Tymrakiewicz, Malgorzata; Hall, Amanda L.; O'Brien, Lynne T.; Wilkinson, Rosemary A.; Saunders, Edward J.; Page, Elizabeth C.; Sawyer, Emma J.; Edwards, Stephen M.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Cooper, Colin S.] Inst Canc Res, Surrey, England; [Eeles, Rosalind A.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Page, Elizabeth C.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Van As, Nicholas; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris] Royal Marsden Natl Hlth Serv Fdn Trust, Surrey, England; [Eeles, Rosalind A.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Page, Elizabeth C.; Dearnaley, David P.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Van As, Nicholas; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris] Royal Marsden Natl Hlth Serv Fdn Trust, London, England; [Al Olama, Ali Amin; Morrison, Jonathan; Easton, Douglas F.] Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Dept Publ Hlth & Primary Care, Strangeways Lab, Cambridge, England; [Giles, Graham G.; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; [Giles, Graham G.; Severi, Gianluca; Hopper, John L.; English, Dallas R.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Carlton, Vic 3053, Australia; [Muir, Kenneth; Lophatananon, Artitaya; Liu, Jo-Fen] Univ Nottingham, Sch Med, Queens Med Ctr, Nottingham, England; [Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Schleutker, Johanna; Wahlfors, Tiina] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg, Oxford, England; [Neal, David E.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England; [Donovan, Jenny L.; Lewis, Sarah J.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Stanford, Janet L.; FitzGerald, Liesel M.; Koopmeiners, Joseph S.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Stanford, Janet L.] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; [Ostrander, Elaine A.; Karyadi, Danielle M.; Kwon, Erika M.] NHGRI, NIH, Bethesda, MD 20892 USA; [John, Esther M.] No Calif Canc Ctr, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Thibodeau, Stephen N.; Schaid, Daniel; McDonnell, Shannon K.] Mayo Clin, Rochester, MN USA; [Park, Jong Y.; Sellers, Thomas A.; Pow-Sang, Julio] Univ S Florida, H Lee Moffitt Canc Ctr, Div Canc Prevent & Control, Tampa, FL 33682 USA; [Spurdle, Amanda; Lose, Felicity] Queensland Inst Med Res, Mol Canc Epidemiol Lab, Brisbane, Qld 4006, Australia; [Clements, Judith; Batra, Jyotsna; Kedda, Mary Anne; Lose, Felicity] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Clements, Judith; Batra, Jyotsna; Kedda, Mary Anne; Lose, Felicity] Queensland Univ Technol, Sch Life Sci, Brisbane, Qld 4001, Australia; [Clements, Judith; Batra, Jyotsna; Kedda, Mary Anne; Lose, Felicity] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia; [Dickinson, Joanne L.; Polanowski, Andrea; Patterson, Briony] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia; [Maier, Christiane; Vogel, Walther; Luedeke, Manuel] Inst Human Genet & Anthropol, Ulm, Germany; [Doerk, Thilo] Hannover Med Sch, Clin Obstet, D-3000 Hannover, Germany; [Doerk, Thilo] Hannover Med Sch, Clin Gynaecol, D-3000 Hannover, Germany; [Rebbeck, Timothy R.; Stefflova, Klara] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.; Stefflova, Klara] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Cooney, Kathleen A.; Ray, Anna M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Cooney, Kathleen A.; Ray, Anna M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Cannon-Albright, Lisa; Farnham, Jim] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA; [Chappuis, Pierre O.] Univ Hosp Geneva, Div Med Genet, Geneva, Switzerland; [Chappuis, Pierre O.] Univ Hosp Geneva, Div Oncol, Geneva, Switzerland; [Hutter, Pierre] Inst Cent Hop Valaisans, Div Med Genet, Sion, Switzerland; [Zeegers, Maurice; Khan, Humera] Univ Birmingham, Unit Genet Epidemiol, Dept Publ Hlth Epidemiol & Biostat, Sch Med, Birmingham B15 2TT, W Midlands, England; [Zeegers, Maurice] Maastricht Univ, Dept Complex Genet, Cluster Genet & Cell Biol, Nutr & Toxicol Res Inst,Med Ctr, Maastricht, Netherlands; [Kaneva, Radka; Mitkova, Atanaska] Med Univ Sofia, Mol Med Ctr, Sofia, Bulgaria; [Kaneva, Radka; Mitkova, Atanaska] Med Univ Sofia, Dept Chem & Biochem, Sofia, Bulgaria; [Zhang, Hong-Wei; Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China; [Lu, Yong-Jie] Univ London, Inst Canc, Barts & London Sch Med & Dent, London, England; [Foulkes, William D.] McGill Univ, Program Canc Genet, Montreal, PQ, Canada; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Lophatananon, Artitaya] Chulabhorn Canc Res Ctr, Bangkok, Thailand; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; [Tammela, Teuvo L.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Tammela, Teuvo L.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Auvinen, Anssi] Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland; [Cox, Angela] Univ Sheffield, Inst Canc Studies, Sheffield, S Yorkshire, England; [Koopmeiners, Joseph S.] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; [Chambers, Suzanne; Aitken, Joanne] Canc Council Queensland, Viertel Ctr Res Canc Control, Brisbane, Qld, Australia; [Aitken, Joanne] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Gardiner, R. A. (Frank)] Univ Queensland, Dept Surg, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Serth, Juergen] Hannover Med Sch, Urol Clin, D-3000 Hannover, Germany; [Serth, Juergen] Hannover Med Sch, Clin Urol Oncol, D-3000 Hannover, Germany; [Meyer, Andreas] Hannover Med Sch, Dept Radiat Oncol, D-3000 Hannover, Germany; [Lange, Ethan M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Slavov, Chavdar] Med Univ Sofia, Dept Urol, Alexandrovska Univ Hosp, Sofia, Bulgaria	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Cancer Research UK; University of Cambridge; Cancer Council Victoria; University of Melbourne; University of Nottingham; University of Southern California; Tampere University; University of Oxford; Cancer Research UK; CRUK Cambridge Institute; University of Bristol; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Stanford University; Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; QIMR Berghofer Medical Research Institute; Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Tasmania; Menzies Institute for Medical Research; Hannover Medical School; Hannover Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of Geneva; University of Geneva; University of Birmingham; Maastricht University; Medical University Sofia; Medical University Sofia; Naval Medical University; University of London; Queen Mary University London; McGill University; University of Melbourne; Chulabhorn Research Institute; Chulabhorn Royal Academy; Chulabhorn Hospital; Cancer Research Center of Hawaii; University of Hawaii System; Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Sheffield; University of Washington; University of Washington Seattle; Cancer Council Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; Hannover Medical School; Hannover Medical School; Hannover Medical School; University of North Carolina; University of North Carolina Chapel Hill; Medical University Sofia	Eeles, RA (corresponding author), Inst Canc Res, Surrey, England.	rosalind.eeles@icr.ac.uk	Severi, Gianluca/H-3774-2018; Aitken, Joanne F/C-5289-2009; O'Mara, Tracy/M-7508-2016; Dearnaley, David P/J-2318-2014; Kaneva, Radka P/V-6535-2017; Chambers, Suzanne K/C-5508-2009; Kaneva, Radka/AAT-5322-2021; Foulkes, William D./AAR-9586-2021; Batra, Jyotsna/B-4130-2011; Dörk, Thilo/J-8620-2012; Auvinen, Anssi/AAL-2111-2020; Spurdle, Amanda B/A-4978-2011; Auvinen, Anssi/AAD-9311-2020; Severi, Gianluca/Q-1824-2019; Dickinson, Joanne/J-7728-2014; Chambers, Suzanne K/H-5957-2012; English, Dallas/AAH-5005-2019; Griffiths, TR Leyshon/K-7433-2019; Gardiner, Robert/G-2096-2010; Thomson, Russell J/H-5653-2012; Rebbeck, Timothy/GLU-8348-2022; Kaneva, Radka P/AGS-5076-2022; Wahlfors, Tiina/U-7635-2018	Severi, Gianluca/0000-0001-7157-419X; O'Mara, Tracy/0000-0002-5436-3232; Dearnaley, David P/0000-0002-3954-2806; Kaneva, Radka P/0000-0002-1437-1393; Foulkes, William D./0000-0001-7427-4651; Dörk, Thilo/0000-0002-9458-0282; Auvinen, Anssi/0000-0003-1125-4818; Spurdle, Amanda B/0000-0003-1337-7897; Severi, Gianluca/0000-0001-7157-419X; Chambers, Suzanne K/0000-0003-2369-6111; English, Dallas/0000-0001-7828-8188; Griffiths, TR Leyshon/0000-0002-3879-0664; Thomson, Russell J/0000-0003-4949-4120; Rebbeck, Timothy/0000-0002-4799-1900; Kaneva, Radka P/0000-0002-1437-1393; Leongamornlert, Daniel/0000-0002-3486-3168; Cornford, Philip/0000-0002-7146-9258; Southey, Melissa/0000-0002-6313-9005; Schleutker, Johanna/0000-0002-1863-0305; Surowy, Harald/0000-0002-3595-9188; Farnham, James/0000-0002-8213-949X; Giles, Graham/0000-0003-4946-9099; FitzGerald, Liesel/0000-0002-6882-2698; Rogers, Paul/0000-0003-2593-2595; Barsi, Klara/0000-0001-9338-0468; Cox, Angela/0000-0002-5138-1099; Saunders, Ed/0000-0003-4343-3570; albright, lisa/0000-0003-2602-3668; Alexander, Kimberly/0000-0003-3906-2412; huddart, robert/0000-0003-3604-1990; Cooney, Kathleen/0000-0003-3831-6943; McLaren, Duncan/0000-0002-9862-4158; Aitken, Joanne Frances/0000-0001-6859-2186; Wahlfors, Tiina/0000-0002-3910-796X; Lose, Felicity/0000-0001-8337-3547; Eeles, Rosalind/0000-0002-3698-6241; Bancroft, Elizabeth/0000-0002-5482-5660; Karyadi, Danielle/0000-0003-4164-5625; Mitev, Vanyo/0000-0001-7528-590X; Clements, Judith/0000-0001-6026-1964; McDonnell, Shannon/0000-0001-6201-369X; Clarke, Noel/0000-0001-7776-8059; Adeyoju, Adebanji/0000-0003-4010-5985; Hickish, Tamas/0000-0001-6770-7279; Ostrander, Elaine/0000-0001-6075-9738; Dickinson, Joanne/0000-0003-4621-1703; Evans, Gareth/0000-0002-8482-5784; Lewis, Sarah/0000-0003-4311-6890; Lu, Yong-Jie/0000-0001-6174-6621; Polanowski, Andrea/0000-0002-9612-220X; van As, Nicholas/0000-0001-6829-8788; batra, Jyotsna/0000-0003-4646-6247; Hamdy, Freddie/0000-0003-2627-2154; Neal, David/0000-0002-6033-5086	Cancer Research UK [11022, C5047/A10692, 10588, C1287/A10118, C5047/A3354, C16913/A6135, C5047/A7357, C16913/A6835, 10118, C522/A8649] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; Medical Research Council [G0500966, G0501019] Funding Source: Medline; NCI NIH HHS [R01CA84979, R01 CA056678-05, U01 CA089600-04, U01 CA089600, N01 PC035141, CA56678, P50 CA105641, R01 CA092579-05, R01CA128813, R01 CA063464-10, N01-PC-35141, P50 CA105641-05, R01 CA092579, CA92579, R01 CA072818, P50 CA069568-12, R01 CA128813, CA54281, R37 CA054281-17, CA97186, R01 CA063464, R01 CA072818-09, R01 CA084979, R01 CA084979-05, CA63464, P50 CA097186-08, P50 CA097186, R01 CA128813-02, R37 CA054281, P50 CA069568] Funding Source: Medline; NCRR NIH HHS [M01 RR000064-41, M01 RR00064] Funding Source: Medline; NIGMS NIH HHS [T32 GM007814] Funding Source: Medline; Department of Health Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA069568, R01CA128813, R37CA054281, R01CA092579, R01CA063464, R01CA056678, P50CA097186, U01CA089600, U01CA063464, R01CA054281, R01CA084979, P50CA105641, R01CA072818] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; MRC [G0501019, G0500966] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahn J, 2008, NAT GENET, V40, P1032, DOI 10.1038/ng0908-1032; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Donovan J, 2003, Health Technol Assess, V7, P1; Eeles R, 2008, NAT GENET, V40, P1035, DOI 10.1038/ng0908-1035; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Giles GG, 2002, CANCER EPIDEM BIOMAR, V11, P549; Giles GG, 2001, ANN ONCOL, V12, P761, DOI 10.1023/A:1011131105617; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Severi G, 2003, J NATL CANCER I, V95, P818, DOI 10.1093/jnci/95.11.818; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Witte JS, 2009, NAT REV GENET, V10, P77, DOI 10.1038/nrg2507; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	17	334	345	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1116	U97		10.1038/ng.450	http://dx.doi.org/10.1038/ng.450			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19767753	Green Accepted, Green Submitted			2022-12-17	WOS:000270330400016
J	Kerkel, K; Spadola, A; Yuan, E; Kosek, J; Jiang, L; Hod, E; Li, K; Murty, VV; Schupf, N; Vilain, E; Morris, M; Haghighi, F; Tycko, B				Kerkel, Kristi; Spadola, Alexandra; Yuan, Eric; Kosek, Jolanta; Jiang, Le; Hod, Eldad; Li, Kerry; Murty, Vundavalli V.; Schupf, Nicole; Vilain, Eric; Morris, Mitzi; Haghighi, Fatemeh; Tycko, Benjamin			Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation	NATURE GENETICS			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; PRADER-WILLI-SYNDROME; MONOALLELIC EXPRESSION; PROMOTER ACTIVITY; GENE; CYP2A6; IDENTIFICATION; EPIMUTATION	Allele-specific DNA methylation (ASM) is a hallmark of imprinted genes, but ASM in the larger nonimprinted fraction of the genome is less well characterized. Using methylation-sensitive SNP analysis (MSNP), we surveyed the human genome at 50K and 250K resolution, identifying ASM as recurrent genotype call conversions from heterozygosity to homozygosity when genomic DNAs were predigested with the methylation-sensitive restriction enzyme HpaII. Using independent assays, we confirmed ASM at 16 SNP-tagged loci distributed across various chromosomes. At 12 of these loci (75%), the ASM tracked strongly with the sequence of adjacent SNPs. Further analysis showed allele-specific mRNA expression at two loci from this methylation-based screen -the vanin and CYP2A6-CYP2A7 gene clusters -both implicated in traits of medical importance. This recurrent phenomenon of sequence-dependent ASM has practical implications for mapping and interpreting associations of noncoding SNPs and haplotypes with human phenotypes.	[Kerkel, Kristi; Yuan, Eric; Kosek, Jolanta; Jiang, Le; Li, Kerry; Murty, Vundavalli V.; Tycko, Benjamin] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Spadola, Alexandra] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY 10032 USA; [Hod, Eldad; Murty, Vundavalli V.; Tycko, Benjamin] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Schupf, Nicole] Columbia Univ, Med Ctr, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; [Schupf, Nicole] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY 10032 USA; [Vilain, Eric] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA; [Vilain, Eric] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Morris, Mitzi; Haghighi, Fatemeh] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University	Tycko, B (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA.	bt12@columbia.edu			NCI NIH HHS [R21 CA125461, R21 CA128556] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA128556, R21CA125461] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; CHANDLER LA, 1987, CELL, V50, P711, DOI 10.1016/0092-8674(87)90329-1; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Ohlsson R, 1998, TRENDS GENET, V14, P435, DOI 10.1016/S0168-9525(98)01583-2; Pitarque M, 2004, HUM MUTAT, V23, P258, DOI 10.1002/humu.20002; Pitarque M, 2001, BIOCHEM BIOPH RES CO, V284, P455, DOI 10.1006/bbrc.2001.4990; Saitoh S, 1997, AM J MED GENET, V68, P195, DOI 10.1002/(SICI)1096-8628(19970120)68:2<195::AID-AJMG15>3.3.CO;2-T; SILVA AJ, 1988, CELL, V54, P145, DOI 10.1016/0092-8674(88)90546-6; Suter CM, 2007, NAT GENET, V39, P573, DOI 10.1038/ng0507-573a; SUTER CM, 2007, NAT GENET, V39, P576; Tyndale RF, 2003, ANN MED, V35, P94, DOI 10.1080/07853890310010014; von Richter O, 2004, PHARMACOGENETICS, V14, P369, DOI 10.1097/00008571-200406000-00006; Wang JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001293; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739; Zogel C, 2006, EUR J HUM GENET, V14, P752, DOI 10.1038/sj.ejhg.5201602	22	334	342	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					904	908		10.1038/ng.174	http://dx.doi.org/10.1038/ng.174			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18568024	Green Published			2022-12-17	WOS:000257166500027
J	Park, TJ; Mitchell, BJ; Abitua, PB; Kintner, C; Wallingford, JB				Park, Tae Joo; Mitchell, Brian J.; Abitua, Philip B.; Kintner, Chris; Wallingford, John B.			Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells	NATURE GENETICS			English	Article							NEURAL-TUBE DEFECTS; SUBCELLULAR-LOCALIZATION; INTRAFLAGELLAR TRANSPORT; CENTRIOLE FORMATION; SIGNALING PATHWAYS; QUAIL OVIDUCT; POLARITY; CILIOGENESIS; WNT; EMBRYOS	The planar cell polarity (PCP) signaling system governs many aspects of polarized cell behavior. Here, we use an in vivo model of vertebrate mucociliary epithelial development to show that Dishevelled (Dvl) is essential for the apical positioning of basal bodies. We find that Dvl and Inturned mediate the activation of the Rho GTPase specifically at basal bodies, and that these three proteins together mediate the docking of basal bodies to the apical plasma membrane. Moreover, we find that this docking involves a Dvl-dependent association of basal bodies with membrane-bound vesicles and the vesicle-trafficking protein, Sec8. Once docked, basal bodies again require Dvl and Rho for the planar polarization that underlies directional beating of cilia. These results demonstrate previously undescribed functions for PCP signaling components and suggest that a common signaling apparatus governs both apical docking and planar polarization of basal bodies.	[Park, Tae Joo; Abitua, Philip B.; Wallingford, John B.] Univ Texas, Dept Mol Cell & Dev Biol, Austin, TX 78712 USA; [Park, Tae Joo; Abitua, Philip B.; Wallingford, John B.] Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Mitchell, Brian J.; Kintner, Chris] Salk Inst Biol Studies, La Jolla, CA 92186 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Salk Institute	Wallingford, JB (corresponding author), Univ Texas, Dept Mol Cell & Dev Biol, Austin, TX 78712 USA.	wallingford@mail.utexas.edu	Park, Tae Joo/G-1460-2011	Park, Tae Joo/0000-0003-3176-177X; Mitchell, Brian/0000-0001-6281-1536; Abitua, Philip/0000-0002-8264-0807	NIGMS NIH HHS [R01 GM074104, R01 GM074104-04, R01 GM076507, R01 GM074104-04S1, R01 GM076507-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104, R01GM076507] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 2004, CURR BIOL, V14, P2046, DOI 10.1016/j.cub.2004.11.007; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; ASSHETON R, 1896, Q J MICROSC SCI, V38, P465; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; BOISVIEUXULRICH E, 1985, BIOL CELL, V55, P147, DOI 10.1111/j.1768-322X.1985.tb00417.x; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Chilvers M A, 2000, Paediatr Respir Rev, V1, P27, DOI 10.1053/prrv.2000.0009; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; COHEN E, 1988, BIOL CELL, V62, P165, DOI 10.1016/0248-4900(88)90033-0; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; FRISCH D, 1968, ANAT REC, V162, P221, DOI 10.1002/ar.1091620209; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Huang T, 2003, J CELL SCI, V116, P4935, DOI 10.1242/jcs.00830; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kishida S, 2007, GENES CELLS, V12, P49, DOI 10.1111/j.1365-2443.2006.01030.x; KONIG G, 1993, DEV BIOL, V160, P355, DOI 10.1006/dbio.1993.1312; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nokhbatolfoghahai M, 2005, J NAT HIST, V39, P887, DOI 10.1080/00222930400002937; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Panizzi JR, 2007, DEVELOPMENT, V134, P921, DOI 10.1242/dev.02776; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Raji AR, 2007, ANAT HISTOL EMBRYOL, V36, P10, DOI 10.1111/j.1439-0264.2006.00709.x; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; SIVE HL, 2000, EARLY DEV XENOPUS IA; SOROKIN SP, 1968, J CELL SCI, V3, P207; STEINMAN RM, 1968, AM J ANAT, V122, P19, DOI 10.1002/aja.1001220103; Toskala E, 2005, AM J PHYSIOL-LUNG C, V289, pL454, DOI 10.1152/ajplung.00036.2005; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015	50	334	341	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2008	40	7					871	879		10.1038/ng.104	http://dx.doi.org/10.1038/ng.104			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18552847	Green Accepted			2022-12-17	WOS:000257166500022
J	Scheper, GC; van der Klok, T; van Andel, RJ; van Berkel, CGM; Sissler, M; Smet, J; Muravina, TI; Serkov, SV; Uziel, G; Bugiani, M; Schiffmann, R; Krageloh-Mann, I; Smeitink, JAM; Florentz, C; Van Coster, R; Pronk, JC; van der Knaap, MS				Scheper, Gert C.; van der Klok, Thom; van Andel, Rob J.; van Berkel, Carola G. M.; Sissler, Marie; Smet, Joel; Muravina, Tatjana I.; Serkov, Sergey V.; Uziel, Graziella; Bugiani, Marianna; Schiffmann, Raphael; Kraegeloh-Mann, Ingeborg; Smeitink, Jan A. M.; Florentz, Catherine; Van Coster, Rudy; Pronk, Jan C.; van der Knaap, Marjo S.			Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	NATURE GENETICS			English	Article							VANISHING WHITE-MATTER; DISEASE; FIBROBLASTS; TRANSLATION; MUTATIONS; DEFECTS; GENE	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (LBSL) has recently been defined based on a highly characteristic constellation of abnormalities observed by magnetic resonance imaging and spectroscopy(1). LBSL is an autosomal recessive disease, most often manifesting in early childhood. Affected individuals develop slowly progressive cerebellar ataxia, spasticity and dorsal column dysfunction, sometimes with a mild cognitive deficit or decline. We performed linkage mapping with microsatellite markers in LBSL families and found a candidate region on chromosome 1, which we narrowed by means of shared haplotypes. Sequencing of genes in this candidate region uncovered mutations in DARS2, which encodes mitochondrial aspartyl-tRNA synthetase, in affected individuals from all 30 families. Enzyme activities of mutant proteins were decreased. We were surprised to find that activities of mitochondrial complexes from fibroblasts and lymphoblasts derived from affected individuals were normal, as determined by different assays.	Vrije Univ Amsterdam, Dept Pediat & Child Neurol, NL-1081 HV Amsterdam, Netherlands; Univ Strasbourg 1, CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; Univ Hosp, Dept Pediat, Div Neurol & Metab, B-9000 Ghent, Belgium; Ist Nazl Neurol, Child Neurol Dept, I-20133 Milan, Italy; Russian Acad Med Sci, Burdenko Neurosurg Inst, Dept Neuroimaging, Moscow, Russia; NINDS, Dev & Metab Neurol BRanch, NIH, Bethesda, MD 20892 USA; Univ Tubingen, Childrens Hosp, Dept Pediat Neurol, D-72076 Tubingen, Germany; Radboud Univ Nijmegen, Nijmegen Ctr Mitochondrial Disorders, Ctr Med, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Vrije Univ Amsterdam, Ctr Med, Dept Human Genet, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ghent University; Ghent University Hospital; Burnazyan Federal Medical Biophysical Center; Russian Academy of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Radboud University Nijmegen; Vrije Universiteit Amsterdam	Scheper, GC (corresponding author), Vrije Univ Amsterdam, Dept Pediat & Child Neurol, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	gc.scheper@vumc.nl	Smeitink, Jan A.M./D-6064-2011; Scheper, Gert C/D-7001-2014; Smeitink, Jan/C-1351-2013; Smet, Joel/B-7428-2013	SISSLER, Marie/0000-0001-8594-5238; Smet, Joel/0000-0002-9551-6282	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002984] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; De Paepe B, 2006, PEDIATR RES, V59, P2, DOI 10.1203/01.pdr.0000191294.34122.ab; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Forshew T, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.023663; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Jacobs EH, 2002, FASEB J, V16, P1961, DOI 10.1096/fj.02-0272fje; Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Leegwater PAJ, 1999, AM J HUM GENET, V65, P728, DOI 10.1086/302548; Linnankivi T, 2004, NEUROLOGY, V63, P688, DOI 10.1212/01.WNL.0000134658.35601.41; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Petzold GC, 2006, J NEUROL NEUROSUR PS, V77, P889, DOI 10.1136/jnnp.2005.078568; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; SCHOLTE HR, 1992, J INHERIT METAB DIS, V15, P347, DOI 10.1007/BF02435973; Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854; Serkov SV, 2004, NEUROPEDIATRICS, V35, P1, DOI 10.1055/s-2003-43548; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; SMET J, 2005, CELL BIOL LAB HDB, P259; t Hart LM, 2005, DIABETES, V54, P1892, DOI 10.2337/diabetes.54.6.1892; Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020; van der Knaap MS, 2003, ANN NEUROL, V53, P252, DOI 10.1002/ana.10456; Van der Knaap MS., 2005, MAGNETIC RESONANCE M; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50	30	334	354	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					534	539		10.1038/ng2013	http://dx.doi.org/10.1038/ng2013			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17384640				2022-12-17	WOS:000245271200025
J	Berezikov, E; Cuppen, E; Plasterk, RHA				Berezikov, Eugene; Cuppen, Edwin; Plasterk, Ronald H. A.			Approaches to microRNA discovery	NATURE GENETICS			English	Article							NONCODING RNAS; COMPUTATIONAL IDENTIFICATION; MAMMALIAN MICRORNAS; GENE-EXPRESSION; PREDICTION; ZEBRAFISH; SEQUENCE; CONSERVATION; PRECURSORS; MIRNAS	MicroRNAs (miRNAs) are noncoding RNAs that can regulate gene expression. Several hundred genes encoding miRNAs have been experimentally identified in animals, and many more are predicted by computational methods. How can new miRNAs be discovered and distinguished from other types of small RNA? Here we summarize current methods for identifying and validating miRNAs and discuss criteria used to define an miRNA.	[Berezikov, Eugene; Cuppen, Edwin; Plasterk, Ronald H. A.] Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Berezikov, E (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl	Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016; Berezikov, Eugene/D-3363-2013	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Berezikov, Eugene/0000-0002-1145-2884				Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Devor EJ, 2006, J HERED, V97, P186, DOI 10.1093/jhered/esj022; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Huttenhofer A, 2006, NUCLEIC ACIDS RES, V34, P635, DOI 10.1093/nar/gkj469; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Legendre M, 2005, BIOINFORMATICS, V21, P841, DOI 10.1093/bioinformatics/bti073; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyers BC, 2006, CURR OPIN BIOTECH, V17, P139, DOI 10.1016/j.copbio.2006.01.008; Missal K, 2005, BIOINFORMATICS, V21, P77, DOI 10.1093/bioinformatics/bti1113; Missal K, 2006, J EXP ZOOL PART B, V306B, P379, DOI 10.1002/jez.b.21086; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Nelson JM, 2006, J CORP FINANC, V12, P187, DOI 10.1016/j.jcorpfin.2005.07.002; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; PFEFFER S, 2003, CURRENT PROTOCOLS MO; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474	76	334	398	3	52	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38			6			S2	S7		10.1038/ng1794	http://dx.doi.org/10.1038/ng1794			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V44DK	16736019				2022-12-17	WOS:000202983200002
J	SMITH, TAG; MEHAFFEY, MG; KAYDA, DB; SAUNDERS, JM; YEI, S; TRAPNELL, BC; MCCLELLAND, A; KALEKO, M				SMITH, TAG; MEHAFFEY, MG; KAYDA, DB; SAUNDERS, JM; YEI, S; TRAPNELL, BC; MCCLELLAND, A; KALEKO, M			ADENOVIRUS-MEDIATED EXPRESSION OF THERAPEUTIC PLASMA-LEVELS OF HUMAN FACTOR-IX IN MICE	NATURE GENETICS			English	Article							GENE-TRANSFER; HEMOPHILIA-B; INVIVO; EPITHELIUM; KINETICS; ANIMALS; PROTEIN; CELLS; LIVER	Gene therapy strategies designed to combat haemophilia B, caused by defects in clotting factor IX, have so far concentrated on ex vivo approaches. We have now evaluated adenoviral vector-mediated expression of human factor IX in vivo. Injection of the vector Av1H9B, which encodes human factor IX cDNA, into the tail veins of mice resulted in efficient liver transduction and plasma levels of human factor IX that would be therapeutic for haemophilia B patients. However, levels slowly declined to baseline by nine weeks and were not re-established by a second vector injection. These results address both the advantages and obstacles to the use of adenoviral vectors for treatment of haemophilia B.	GENET THERAPY INC,GAITHERSBURG,MD 20878	Novartis				McClelland, Alan/0000-0003-2949-3542				AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; BRIET E, 1991, BLOOD COAGUL FIBRIN, V2, P47; DAI Y, 1992, P NATL ACAD SCI USA, V89, P10892, DOI 10.1073/pnas.89.22.10892; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; DIPERSIO CM, 1991, MOL CELL BIOL, V11, P4405, DOI 10.1128/MCB.11.9.4405; EVANS JP, 1989, BLOOD, V74, P207; GERRARD AJ, 1993, NAT GENET, V3, P180, DOI 10.1038/ng0293-180; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HEDNER U, 1989, METABOLIC BASIS INHE, V2, P2116; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; HORWITZ MS, 1990, VIROLOGY, V2, P1723; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; JALLAT S, 1990, EMBO J, V9, P3295, DOI 10.1002/j.1460-2075.1990.tb07529.x; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; MITTAL SK, 1993, VIRUS RES, V28, P67, DOI 10.1016/0168-1702(93)90090-A; PALMER TD, 1989, BLOOD, V73, P438; RAGOT T, 1993, NATURE, V361, P647, DOI 10.1038/361647a0; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626; SHENK T, 1984, CURR TOP MICROBIOL, V111, P1; SMITH KJ, 1981, BLOOD, V58, P625; STRATFORDPERRICAUDET LD, 1990, HUM GENE THER, V1, P241, DOI 10.1089/hum.1990.1.3-241; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; STROBER S, 1984, ANNU REV IMMUNOL, V2, P219, DOI 10.1146/annurev.iy.02.040184.001251; THOMPSON AR, 1980, BRIT J HAEMATOL, V45, P329, DOI 10.1111/j.1365-2141.1980.tb07152.x; THOMPSON AR, 1986, BLOOD, V67, P565; THOMPSON AR, 1991, CURR STUD HEMATOL BL, V58, P59; YAO SN, 1991, P NATL ACAD SCI USA, V88, P8101, DOI 10.1073/pnas.88.18.8101; 1991, B WORLD HEALTH ORGAN, V69, P17; 1993, HUM GENE THER, V4, P391	34	334	356	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					397	402		10.1038/ng1293-397	http://dx.doi.org/10.1038/ng1293-397			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298650				2022-12-17	WOS:A1993ML14500018
J	Williams, MJ; Werner, B; Barnes, CP; Graham, TA; Sottoriva, A				Williams, Marc J.; Werner, Benjamin; Barnes, Chris P.; Graham, Trevor A.; Sottoriva, Andrea			Identification of neutral tumor evolution across cancer types	NATURE GENETICS			English	Article							INTRATUMOR HETEROGENEITY; COLORECTAL-CANCER; CLONAL EVOLUTION; MUTATIONS; PROGRESSION; GROWTH; MODEL; DIVERSITY; DYNAMICS; DRIVER	Despite extraordinary efforts to profile cancer genomes, interpreting the vast amount of genomic data in the light of cancer evolution remains challenging. Here we demonstrate that neutral tumor evolution results in a power-law distribution of the mutant allele frequencies reported by next-generation sequencing of tumor bulk samples. We find that the neutral power law fits with high precision 323 of 904 cancers from 14 types and from different cohorts. In malignancies identified as evolving neutrally, all clonal selection seemingly occurred before the onset of cancer growth and not in later-arising subclones, resulting in numerous passenger mutations that are responsible for intratumoral heterogeneity. Reanalyzing cancer sequencing data within the neutral framework allowed the measurement, in each patient, of both the in vivo mutation rate and the order and timing of mutations. This result provides a new way to interpret existing cancer genomic data and to discriminate between functional and non-functional intratumoral heterogeneity.	[Williams, Marc J.; Graham, Trevor A.] Queen Mary Univ London, Evolut & Canc Lab, Barts Canc Inst, London, England; [Williams, Marc J.; Barnes, Chris P.] UCL, Dept Cell & Dev Biol, London, England; [Williams, Marc J.] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London, England; [Werner, Benjamin; Sottoriva, Andrea] Inst Canc Res, Ctr Evolut & Canc, London SW3 6JB, England; [Barnes, Chris P.] UCL, Dept Genet Evolut & Environm, London, England	University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London	Graham, TA (corresponding author), Queen Mary Univ London, Evolut & Canc Lab, Barts Canc Inst, London, England.; Sottoriva, A (corresponding author), Inst Canc Res, Ctr Evolut & Canc, London SW3 6JB, England.	t.graham@qmul.ac.uk; andrea.sottoriva@icr.ac.uk		Barnes, Chris/0000-0002-9459-1395; Werner, Benjamin/0000-0002-6857-8699; Graham, Trevor/0000-0001-9582-1597; Williams, Marc/0000-0001-5524-4174; Sottoriva, Andrea/0000-0001-6709-9533	Chris Rokos Fellowship in Evolution and Cancer; Geoffrey W Lewis Post-Doctoral Training fellowship; Wellcome Trust [105104/Z/14/Z]; Wellcome Trust through a Research Career Development Fellowship [097319/Z/11/Z]; Cancer Research UK Career Development Award; UK Medical Research Council student fellowship; Cancer Research UK [19771] Funding Source: researchfish; Medical Research Council [1503539] Funding Source: researchfish	Chris Rokos Fellowship in Evolution and Cancer; Geoffrey W Lewis Post-Doctoral Training fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust through a Research Career Development Fellowship(Wellcome Trust); Cancer Research UK Career Development Award(Cancer Research UK); UK Medical Research Council student fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A.S. is supported by The Chris Rokos Fellowship in Evolution and Cancer. B.W. is supported by the Geoffrey W Lewis Post-Doctoral Training fellowship. This work was supported by the Wellcome Trust (105104/Z/14/Z). C.P.B. acknowledges funding from the Wellcome Trust through a Research Career Development Fellowship (097319/Z/11/Z). This work was supported by a Cancer Research UK Career Development Award to T.A.G. M.J.W. is supported by a UK Medical Research Council student fellowship.	Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Attolini CSO, 2010, P NATL ACAD SCI USA, V107, P17604, DOI 10.1073/pnas.1009117107; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Basanta D, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0020; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Durrett R, 2004, THEOR POPUL BIOL, V66, P129, DOI 10.1016/j.tpb.2004.04.002; Durrett R, 2013, ANN APPL PROBAB, V23, P230, DOI 10.1214/11-AAP824; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerstung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027136; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Griffiths R.C., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; Guo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089244; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Heng HHQ, 2006, J CELL PHYSIOL, V208, P461, DOI 10.1002/jcp.20685; Jesinghaus M, 2015, AM J SURG PATHOL, V39, P1140, DOI 10.1097/PAS.0000000000000423; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kessler DA, 2013, P NATL ACAD SCI USA, V110, P11682, DOI 10.1073/pnas.1309667110; Luria SE, 1943, GENETICS, V28, P491; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Maruvka YE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026480; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Ohta T, 1996, THEOR POPUL BIOL, V49, P128, DOI 10.1006/tpbi.1996.0007; Polyak K, 2014, NAT MED, V20, P344, DOI 10.1038/nm.3518; Shou WY, 2015, ELIFE, V4, DOI 10.7554/eLife.07158; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sprouffske K, 2011, CANCER PREV RES, V4, P1135, DOI 10.1158/1940-6207.CAPR-10-0374; Sun SH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S3-S2; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	42	333	338	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					238	244		10.1038/ng.3489	http://dx.doi.org/10.1038/ng.3489			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26780609	Green Submitted, Green Accepted			2022-12-17	WOS:000370902600007
J	Marvig, RL; Sommer, LM; Molin, S; Johansen, HK				Marvig, Rasmus Lykke; Sommer, Lea Mette; Molin, Soren; Johansen, Helle Krogh			Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis	NATURE GENETICS			English	Article							REGULATES BIOFILM FORMATION; DI-GMP PHOSPHODIESTERASE; RESISTANCE MECHANISMS; CARBAPENEM RESISTANCE; MULTIDRUG-RESISTANCE; FUNCTIONAL-ANALYSIS; EFFLUX PUMP; EPIDEMIOLOGY; POPULATIONS; MUTATIONS	Little is known about how within-host evolution compares between genotypically different strains of the same pathogenic species. We sequenced the whole genomes of 474 longitudinally collected clinical isolates of Pseudomonas aeruginosa sampled from 34 children and young individuals with cystic fibrosis. Our analysis of 36 P. aeruginosa lineages identified convergent molecular evolution in 52 genes. This list of genes suggests a role in host adaptation for remodeling of regulatory networks and central metabolism, acquisition of antibiotic resistance and loss of extracellular virulence factors. Furthermore, we find an ordered succession of mutations in key regulatory networks. Accordingly, mutations in downstream transcriptional regulators were contingent upon mutations in upstream regulators, suggesting that remodeling of regulatory networks might be important in adaptation. The characterization of genes involved in host adaptation may help in predicting bacterial evolution in patients with cystic fibrosis and in the design of future intervention strategies.	[Marvig, Rasmus Lykke; Johansen, Helle Krogh] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Marvig, Rasmus Lykke; Sommer, Lea Mette; Molin, Soren] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Sommer, Lea Mette; Molin, Soren; Johansen, Helle Krogh] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark	Rigshospitalet; University of Copenhagen; Technical University of Denmark; Technical University of Denmark	Marvig, RL (corresponding author), Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark.	rmarvig@gmail.com		Marvig, Rasmus L./0000-0002-5267-3173; Molin, Soren/0000-0002-7973-2639; Madsen Sommer, Lea Mette/0000-0002-1622-6691	Lundbeck Foundation; Novo Nordisk Foundation; Lundbeck Foundation [R167-2013-15229] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517, NNF12OC1015920] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank U.R. Johansen, P. Poss, H. Nordbjerg, N. Kirkby, K. Bloksted and B.H. Erichsen for excellent technical assistance and T. Pressler and M. Skov for information about the patients' visits to the hospital. This work was supported by the Lundbeck Foundation, and H.K.J. was supported by a clinical research stipend from the Novo Nordisk Foundation.	Aires JR, 1999, ANTIMICROB AGENTS CH, V43, P2624, DOI 10.1128/AAC.43.11.2624; An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10; Ballestero S, 1996, J ANTIMICROB CHEMOTH, V38, P39, DOI 10.1093/jac/38.1.39; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Behrends V, 2013, J BIOL CHEM, V288, P15098, DOI 10.1074/jbc.M112.442814; Cabot G, 2012, ANTIMICROB AGENTS CH, V56, P6349, DOI 10.1128/AAC.01388-12; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Chewapreecha C, 2014, NAT GENET, V46, P305, DOI 10.1038/ng.2895; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Cramer N, 2011, ENVIRON MICROBIOL, V13, P1690, DOI 10.1111/j.1462-2920.2011.02483.x; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Damkiaer S, 2013, P NATL ACAD SCI USA, V110, P7766, DOI 10.1073/pnas.1221466110; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DEVRIES CA, 1994, J BACTERIOL, V176, P6677, DOI 10.1128/JB.176.21.6677-6687.1994; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Grad YH, 2014, LANCET INFECT DIS, V14, P220, DOI 10.1016/S1473-3099(13)70693-5; Hancock REW, 1998, CLIN INFECT DIS, V27, pS93, DOI 10.1086/514909; Heeb S, 2006, J MOL BIOL, V355, P1026, DOI 10.1016/j.jmb.2005.11.045; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hoiby N., 2000, CYSTIC FIBROSIS, V2nd, P83; Holt KE, 2013, P NATL ACAD SCI USA, V110, P17522, DOI 10.1073/pnas.1308632110; Huse HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082621; Islam S, 2004, CLIN MICROBIOL INFEC, V10, P877, DOI 10.1111/j.1469-0691.2004.00991.x; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Johansen HK, 2008, J CYST FIBROS, V7, P391, DOI 10.1016/j.jcf.2008.02.003; Juan C, 2005, ANTIMICROB AGENTS CH, V49, P4733, DOI 10.1128/AAC.49.11.4733-4738.2005; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; LUZAR MA, 1985, INFECT IMMUN, V50, P572, DOI 10.1128/IAI.50.2.572-576.1985; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Marvig RL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003741; Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Pai H, 2001, ANTIMICROB AGENTS CH, V45, P480, DOI 10.1128/AAC.45.2.480-484.2001; Pasca MR, 2012, MICROB DRUG RESIST, V18, P23, DOI 10.1089/mdr.2011.0019; Schurek KN, 2009, ANTIMICROB AGENTS CH, V53, P4345, DOI 10.1128/AAC.01267-08; SCHURR MJ, 1994, J BACTERIOL, V176, P3375, DOI 10.1128/jb.176.11.3375-3382.1994; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sobel ML, 2005, ANTIMICROB AGENTS CH, V49, P1782, DOI 10.1128/AAC.49.5.1782-1786.2005; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Sokurenko EV, 1999, TRENDS MICROBIOL, V7, P191, DOI 10.1016/S0966-842X(99)01493-6; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Swofford D.L., 2003, PAUP PHYLOGENETIC AN; Waine DJ, 2008, J CLIN MICROBIOL, V46, P3491, DOI 10.1128/JCM.00357-08; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975, DOI 10.1128/AAC.43.12.2975; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Worby CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003549; Yang L, 2008, J BACTERIOL, V190, P2767, DOI 10.1128/JB.01581-07; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; YU H, 1995, J BACTERIOL, V177, P3259, DOI 10.1128/jb.177.11.3259-3268.1995; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; ZIMAKOFF J, 1983, J HOSP INFECT, V4, P31, DOI 10.1016/0195-6701(83)90062-2	64	333	333	3	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2015	47	1					57	+		10.1038/ng.3148	http://dx.doi.org/10.1038/ng.3148			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX5TM	25401299				2022-12-17	WOS:000346990400012
J	Rothman, N; Garcia-Closas, M; Chatterjee, N; Malats, N; Wu, XF; Figueroa, JD; Real, FX; Van den Berg, D; Matullo, G; Baris, D; Thun, M; Kiemeney, LA; Vineis, P; De Vivo, I; Albanes, D; Purdue, MP; Rafnar, T; Hildebrandt, MAT; Kiltie, AE; Cussenot, O; Golka, K; Kumar, R; Taylor, JA; Mayordomo, JI; Jacobs, KB; Kogevinas, M; Hutchinson, A; Wang, ZW; Fu, YP; Prokunina-Olsson, L; Burdett, L; Yeager, M; Wheeler, W; Tardon, A; Serra, C; Carrato, A; Garcia-Closas, R; Lloreta, J; Johnson, A; Schwenn, M; Karagas, MR; Schned, A; Andriole, G; Grubb, R; Black, A; Jacobs, EJ; Diver, WR; Gapstur, SM; Weinstein, SJ; Virtamo, J; Cortessis, VK; Gago-Dominguez, M; Pike, MC; Stern, MC; Yuan, JM; Hunter, DJ; McGrath, M; Dinney, CP; Czerniak, B; Chen, M; Yang, HS; Vermeulen, SH; Aben, KK; Witjes, JA; Makkinje, RR; Sulem, P; Besenbacher, S; Stefansson, K; Riboli, E; Brennan, P; Panico, S; Navarro, C; Allen, NE; Bueno-De-Mesquita, HB; Trichopoulos, D; Caporaso, N; Landi, MT; Canzian, F; Ljungberg, B; Tjonneland, A; Clavel-Chapelon, F; Bishop, DT; Teo, MTW; Knowles, MA; Guarrera, S; Polidoro, S; Ricceri, F; Sacerdote, C; Allione, A; Cancel-Tassin, G; Selinski, S; Hengstler, JG; Dietrich, H; Fletcher, T; Rudnai, P; Gurzau, E; Koppova, K; Bolick, SCE; Godfrey, A; Xu, ZL; Sanz-Velez, JI; Garcia-Prats, MD; Sanchez, M; Valdivia, G; Porru, S; Benhamou, S; Hoover, RN; Fraumeni, JF; Silverman, DT; Chanock, SJ				Rothman, Nathaniel; Garcia-Closas, Montserrat; Chatterjee, Nilanjan; Malats, Nuria; Wu, Xifeng; Figueroa, Jonine D.; Real, Francisco X.; Van den Berg, David; Matullo, Giuseppe; Baris, Dalsu; Thun, Michael; Kiemeney, Lambertus A.; Vineis, Paolo; De Vivo, Immaculata; Albanes, Demetrius; Purdue, Mark P.; Rafnar, Thorunn; Hildebrandt, Michelle A. T.; Kiltie, Anne E.; Cussenot, Olivier; Golka, Klaus; Kumar, Rajiv; Taylor, Jack A.; Mayordomo, Jose I.; Jacobs, Kevin B.; Kogevinas, Manolis; Hutchinson, Amy; Wang, Zhaoming; Fu, Yi-Ping; Prokunina-Olsson, Ludmila; Burdett, Laurie; Yeager, Meredith; Wheeler, William; Tardon, Adonina; Serra, Consol; Carrato, Alfredo; Garcia-Closas, Reina; Lloreta, Josep; Johnson, Alison; Schwenn, Molly; Karagas, Margaret R.; Schned, Alan; Andriole, Gerald, Jr.; Grubb, Robert, III; Black, Amanda; Jacobs, Eric J.; Diver, W. Ryan; Gapstur, Susan M.; Weinstein, Stephanie J.; Virtamo, Jarmo; Cortessis, Victoria K.; Gago-Dominguez, Manuela; Pike, Malcolm C.; Stern, Mariana C.; Yuan, Jian-Min; Hunter, David J.; McGrath, Monica; Dinney, Colin P.; Czerniak, Bogdan; Chen, Meng; Yang, Hushan; Vermeulen, Sita H.; Aben, Katja K.; Witjes, J. Alfred; Makkinje, Remco R.; Sulem, Patrick; Besenbacher, Soren; Stefansson, Kari; Riboli, Elio; Brennan, Paul; Panico, Salvatore; Navarro, Carmen; Allen, Naomi E.; Bueno-de-Mesquita, H. Bas; Trichopoulos, Dimitrios; Caporaso, Neil; Landi, Maria Teresa; Canzian, Federico; Ljungberg, Borje; Tjonneland, Anne; Clavel-Chapelon, Francoise; Bishop, David T.; Teo, Mark T. W.; Knowles, Margaret A.; Guarrera, Simonetta; Polidoro, Silvia; Ricceri, Fulvio; Sacerdote, Carlotta; Allione, Alessandra; Cancel-Tassin, Geraldine; Selinski, Silvia; Hengstler, Jan G.; Dietrich, Holger; Fletcher, Tony; Rudnai, Peter; Gurzau, Eugen; Koppova, Kvetoslava; Bolick, Sophia C. E.; Godfrey, Ashley; Xu, Zongli; Sanz-Velez, Jose I.; Garcia-Prats, Maria D.; Sanchez, Manuel; Valdivia, Gabriel; Porru, Stefano; Benhamou, Simone; Hoover, Robert N.; Fraumeni, Joseph F., Jr.; Silverman, Debra T.; Chanock, Stephen J.			A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci	NATURE GENETICS			English	Article							CONFERS SUSCEPTIBILITY; UDP-GLUCURONOSYLTRANSFERASES; TELOMERASE MUTATIONS; SEQUENCE VARIANT; COMMON VARIANTS; DOWN-REGULATION; RISK; GENE; STRATIFICATION; POLYMORPHISMS	We conducted a multi-stage, genome-wide association study of bladder cancer with a primary scan of 591,637 SNPs in 3,532 affected individuals (cases) and 5,120 controls of European descent from five studies followed by a replication strategy, which included 8,382 cases and 48,275 controls from 16 studies. In a combined analysis, we identified three new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1: rs1014971, (P = 8 x 10(-12)) maps to a non-genic region of chromosome 22q13.1, rs8102137 (P = 2 x 10(-11)) on 19q12 maps to CCNE1 and rs11892031 (P = 1 x 10(-7)) maps to the UGT1A cluster on 2q37.1. We confirmed four previously identified genome-wide associations on chromosomes 3q28, 4p16.3, 8q24.21 and 8q24.3, validated previous candidate associations for the GSTM1 deletion (P = 4 x 10(-11)) and a tag SNP for NAT2 acetylation status (P = 4 x 10(-11)), and found interactions with smoking in both regions. Our findings on common variants associated with bladder cancer risk should provide new insights into the mechanisms of carcinogenesis.	[Rothman, Nathaniel; Garcia-Closas, Montserrat; Chatterjee, Nilanjan; Figueroa, Jonine D.; Baris, Dalsu; Albanes, Demetrius; Purdue, Mark P.; Fu, Yi-Ping; Prokunina-Olsson, Ludmila; Black, Amanda; Weinstein, Stephanie J.; Caporaso, Neil; Landi, Maria Teresa; Hoover, Robert N.; Fraumeni, Joseph F., Jr.; Silverman, Debra T.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Malats, Nuria; Real, Francisco X.] Spanish Natl Canc Res Ctr, Madrid, Spain; [Wu, Xifeng; Hildebrandt, Michelle A. T.; Chen, Meng; Yang, Hushan] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Van den Berg, David; Cortessis, Victoria K.; Gago-Dominguez, Manuela; Pike, Malcolm C.; Stern, Mariana C.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Matullo, Giuseppe; Vineis, Paolo; Guarrera, Simonetta; Polidoro, Silvia; Ricceri, Fulvio; Sacerdote, Carlotta; Allione, Alessandra] Human Genet Fdn HuGeF, Turin, Italy; [Thun, Michael; Jacobs, Eric J.; Diver, W. Ryan; Gapstur, Susan M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Kiemeney, Lambertus A.; Vermeulen, Sita H.; Aben, Katja K.] Radboud Univ Nijmegen Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Witjes, J. Alfred] Radboud Univ Nijmegen Med Ctr, Dept Urol, Nijmegen, Netherlands; [Vineis, Paolo; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, London, England; [De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Rafnar, Thorunn; Sulem, Patrick; Besenbacher, Soren; Stefansson, Kari] DeCODE Genet, Reykjavik, Iceland; [Kiltie, Anne E.] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England; [Cussenot, Olivier] Tenon Hosp, AP HP, Dept Urol, Paris, France; [Cussenot, Olivier; Cancel-Tassin, Geraldine] Ctr Rech Pathol Prostat, Paris, France; [Golka, Klaus; Selinski, Silvia; Hengstler, Jan G.] Leibniz Res Ctr Working Environm & Human Factor, Dortmund, Germany; [Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Taylor, Jack A.; Bolick, Sophia C. E.; Godfrey, Ashley; Xu, Zongli] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA; [Mayordomo, Jose I.; Sanchez, Manuel; Valdivia, Gabriel] Univ Zaragoza, Zaragoza, Spain; [Jacobs, Kevin B.; Hutchinson, Amy; Wang, Zhaoming; Burdett, Laurie; Yeager, Meredith] SAIC Frederick Inc, Natl Canc Inst Frederick, Core Genotype Facil, Frederick, MD USA; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis] Municipal Inst Med Res, Barcelona, Spain; [Kogevinas, Manolis; Tardon, Adonina; Navarro, Carmen] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece; [Wheeler, William] Informat Management Serv Inc, Rockville, MD USA; [Tardon, Adonina] Univ Oviedo, Inst Univ Oncol, Oviedo, Spain; [Carrato, Alfredo] Ramon & Cajal Univ Hosp, Madrid, Spain; [Garcia-Closas, Reina] Hosp Univ Canarias, Unidad Invest, San Cristobal la Laguna, Spain; [Lloreta, Josep] Univ Pompeu Fabra, Hosp Mar Inst Municipal Invest Med IMIM, Barcelona, Spain; [Johnson, Alison] Vermont Canc Registry, Burlington, VT USA; [Schwenn, Molly] Maine Canc Registry, Augusta, ME USA; [Karagas, Margaret R.; Schned, Alan] Dartmouth Med Sch, Hanover, NH USA; [Andriole, Gerald, Jr.; Grubb, Robert, III] Washington Univ, Sch Med, Dept Urol, St Louis, MO USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Helsinki, Finland; [Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Yuan, Jian-Min] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Hunter, David J.; McGrath, Monica] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Dinney, Colin P.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Czerniak, Bogdan] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Vermeulen, Sita H.; Makkinje, Remco R.] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Brennan, Paul] Int Agcy Res Canc, Lyon, France; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Navarro, Carmen] Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Allen, Naomi E.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Ljungberg, Borje] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Tjonneland, Anne] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Clavel-Chapelon, Francoise] Paris S Univ, Inst Gustave Roussy, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Bishop, David T.; Teo, Mark T. W.; Knowles, Margaret A.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, Turin, Italy; [Dietrich, Holger] Paul Gerhardt Fdn, Dept Urol, Wittenberg, Germany; [Fletcher, Tony] Inst Hyg & Trop Med, London, England; [Rudnai, Peter] Natl Inst Environm Hlth, Budapest, Hungary; [Gurzau, Eugen] Univ Babes Bolyai, Ctr Environm Hlth, R-3400 Cluj Napoca, Romania; [Koppova, Kvetoslava] State Hlth Inst, Banska Bystrica, Slovakia; [Sanz-Velez, Jose I.; Garcia-Prats, Maria D.] San Jorge Univ Hosp, Huesca, Spain; [Porru, Stefano] Univ Brescia, Sect Occupat Med & Ind Hyg, Dept Expt & Appl Med, Brescia, Italy; [Benhamou, Simone] CEPH, Fdn Jean Dausset, U946, INSERM, Paris, France; [Benhamou, Simone] Inst Gustave Roussy, UMR8200, CNRS, Villejuif, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Texas System; UTMD Anderson Cancer Center; Pompeu Fabra University; University of Southern California; University of Turin; American Cancer Society; Radboud University Nijmegen; Radboud University Nijmegen; Imperial College London; Harvard University; Brigham & Women's Hospital; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Zaragoza; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; National & Kapodistrian University of Athens; Information Management Services, Inc.; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Hospital Universitario Ramon y Cajal; Universidad de la Laguna; Pompeu Fabra University; Dartmouth College; Washington University (WUSTL); Finland National Institute for Health & Welfare; Memorial Sloan Kettering Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Radboud University Nijmegen; University of Iceland; World Health Organization; International Agency for Research on Cancer (IARC); University of Naples Federico II; Murcia Regional Health Council; University of Oxford; Netherlands National Institute for Public Health & the Environment; Academy of Athens; Helmholtz Association; German Cancer Research Center (DKFZ); Umea University; Danish Cancer Society; UNICANCER; Gustave Roussy; Saint James's University Hospital; University of Leeds; University of Turin; University of London; London School of Hygiene & Tropical Medicine; Babes Bolyai University from Cluj; Hospital Universidad San Jorge; University of Brescia; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Gustave Roussy	Garcia-Closas, M (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	montse.garciaclosas@icr.ac.uk	taylor, jack a/C-7154-2019; Kiemeney, Lambertus A./D-3357-2009; Figueroa, Jonine/GWD-1322-2022; Kogevinas, Manolis/C-3918-2017; Clavel-Chapelon, Francoise/G-6733-2014; Lloreta, J/I-2112-2014; Lloreta-Trull, Josep/GRR-9682-2022; Wang, Zhaoming/R-5527-2018; Yeager, Meredith/AAA-5322-2020; Guarrera, Simonetta/AAB-8482-2022; Makkinje, Remco/Q-2406-2015; Figueroa, Jonine/AFK-2752-2022; Stefansson, Kari/AAE-7187-2019; Van Den Berg, David J/G-8598-2017; Figueroa, Jonine/AAG-1065-2022; Panico, Salvatore/K-6506-2016; Malats, Nuria/H-7041-2015; Ricceri, Fulvio/I-9910-2018; Mayordomo, Jose/K-3453-2013; Aben, Katja KH/G-9686-2016; Polidoro, Silvia/GYJ-3517-2022; Kumar, Rajiv/H-6431-2019; Lloreta-Trull, Josep/AAZ-1229-2020; Albanes, Demetrius/B-9749-2015; Diver, Ryan/AAG-3469-2019; Garcia-Closas, Montserrat/AAZ-6930-2021; Vermeulen, Sita H./L-4716-2015; Serra, C/E-6879-2014; Weinstein, Stephanie J/P-1627-2017; TARDON, ADONINA/B-6563-2014; Witjes, Fred/N-9665-2013; Hengstler, Jan G./O-1415-2013; Benhamou, Simone/K-6554-2015; Purdue, Mark P/C-9228-2016; Garcia-Closas, Montserrat/F-3871-2015; Arribas, Francisco X Real/H-5275-2015; Prokunina-Olsson, Ludmila/A-8240-2019; Prokunina-Olsson, Ludmila/V-7960-2019; Canzian, Federico/I-2804-2014; Benhamou, Simone/ABD-2590-2020; Gago-Dominguez, Manuela/AAP-6611-2021; Matullo, Giuseppe/K-6383-2016; Fletcher, Tony/D-2394-2011	taylor, jack a/0000-0001-5303-6398; Kiemeney, Lambertus A./0000-0002-2368-1326; Figueroa, Jonine/0000-0002-5100-623X; Kogevinas, Manolis/0000-0002-9605-0461; Lloreta, J/0000-0003-1644-9470; Wang, Zhaoming/0000-0001-7556-3869; Figueroa, Jonine/0000-0002-5100-623X; Van Den Berg, David J/0000-0002-5404-5218; Figueroa, Jonine/0000-0002-5100-623X; Panico, Salvatore/0000-0002-5498-8312; Malats, Nuria/0000-0003-2538-3784; Ricceri, Fulvio/0000-0001-8749-9737; Aben, Katja KH/0000-0002-0214-2147; Kumar, Rajiv/0000-0002-6093-0395; Diver, Ryan/0000-0002-5418-9000; Garcia-Closas, Montserrat/0000-0003-1033-2650; Vermeulen, Sita H./0000-0003-4913-8601; Serra, C/0000-0001-8337-8356; Weinstein, Stephanie J/0000-0002-3834-1535; TARDON, ADONINA/0000-0001-5150-1209; Purdue, Mark P/0000-0003-1177-3108; Garcia-Closas, Montserrat/0000-0003-1033-2650; Arribas, Francisco X Real/0000-0001-9501-498X; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Matullo, Giuseppe/0000-0003-0674-7757; Ljungberg, Borje/0000-0002-4121-3753; Fletcher, Tony/0000-0003-3385-200X; Tjonneland, Anne/0000-0003-4385-2097; BENHAMOU, Simone/0000-0001-5853-8047; Riboli, Elio/0000-0001-6795-6080; xu, zongli/0000-0002-9034-8902; Gurzau, Eugen/0000-0002-8688-6118; Bishop, Tim/0000-0002-8752-8785; Kiltie, Anne/0000-0001-7208-2912; Polidoro, Silvia/0000-0003-2968-0575; Hengstler, Jan/0000-0002-1427-5246; Cortessis, Victoria/0000-0002-2339-1089; Knowles, Margaret/0000-0002-9363-8657; cussenot, olivier/0000-0002-9912-0533; CARRATO, ALFREDO/0000-0001-7749-8140; Navarro, Carmen/0000-0001-8896-7483; Allione, Alessandra/0000-0001-9599-309X; Canzian, Federico/0000-0002-4261-4583; Besenbacher, Soren/0000-0003-1455-1738; Jacobs, Kevin/0000-0002-4657-6473; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Gago, Manuela/0000-0001-6713-4351; Dinney, Colin/0000-0002-8969-711X; Yuan, Jian-Min/0000-0002-4620-3108; Sacerdote, Carlotta/0000-0002-8008-5096	National Cancer Institute, US National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049033] Funding Source: NIH RePORTER; Cancer Research UK [12933, 10589] Funding Source: researchfish; Medical Research Council [G0801056B] Funding Source: researchfish; National Institute for Health Research [ACF-2006-02-005] Funding Source: researchfish	National Cancer Institute, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project has been funded in part with federal funds from the National Cancer Institute, US National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	Aben KKH, 2006, EUR J CANCER, V42, P1428, DOI 10.1016/j.ejca.2005.07.039; Ando Y, 2000, CANCER RES, V60, P6921; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; BELL DA, 1993, J NATL CANCER I, V85, P1159, DOI 10.1093/jnci/85.14.1159; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Fearnhead P, 2004, GENETICS, V167, P2067, DOI 10.1534/genetics.103.021584; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Garcia-Closas M, 2011, PHARMACOGENET GENOM, V21, P231, DOI 10.1097/FPC.0b013e32833e1b54; Giuliani L, 2001, INT J CANCER, V91, P141, DOI 10.1002/1097-0215(20010101)91:1<141::AID-IJC1005>3.0.CO;2-H; Hein DW, 2006, ONCOGENE, V25, P1649, DOI 10.1038/sj.onc.1209374; Iida K, 2010, J BIOCHEM, V147, P353, DOI 10.1093/jb/mvp169; KANTOR AF, 1985, INT J CANCER, V35, P703, DOI 10.1002/ijc.2910350602; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; LOWER GM, 1979, ENVIRON HEALTH PERSP, V29, P71, DOI 10.2307/3429048; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Murta-Nascimento C, 2007, CANCER EPIDEM BIOMAR, V16, P1595, DOI 10.1158/1055-9965.EPI-06-0743; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Richter J, 2000, AM J PATHOL, V157, P787, DOI 10.1016/S0002-9440(10)64592-0; Rothwell A, 2007, PERS REV, V36, P23, DOI 10.1108/00483480710716704; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Silverman DT, 2006, CANC EPIDEMIOLOGY PR, V3, P1101; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Strassburg CP, 2008, ARCH TOXICOL, V82, P415, DOI 10.1007/s00204-008-0314-x; Strassburg CP, 1998, MOL PHARMACOL, V54, P647; Strassburg CP, 1997, CANCER RES, V57, P2979; Sun L, 2002, HUM HERED, V54, P99, DOI 10.1159/000067666; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	52	333	342	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					978	U98		10.1038/ng.687	http://dx.doi.org/10.1038/ng.687			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20972438	Green Accepted			2022-12-17	WOS:000283540500015
J	Hoischen, A; van Bon, BWM; Gilissen, C; Arts, P; van Lier, B; Steehouwer, M; de Vries, P; de Reuver, R; Wieskamp, N; Mortier, G; Devriendt, K; Amorim, MZ; Revencu, N; Kidd, A; Barbosa, M; Turner, A; Smith, J; Oley, C; Henderson, A; Hayes, IM; Thompson, EM; Brunner, HG; de Vries, BBA; Veltman, JA				Hoischen, Alexander; van Bon, Bregje W. M.; Gilissen, Christian; Arts, Peer; van Lier, Bart; Steehouwer, Marloes; de Vries, Petra; de Reuver, Rick; Wieskamp, Nienke; Mortier, Geert; Devriendt, Koen; Amorim, Marta Z.; Revencu, Nicole; Kidd, Alexa; Barbosa, Mafalda; Turner, Anne; Smith, Janine; Oley, Christina; Henderson, Alex; Hayes, Ian M.; Thompson, Elizabeth M.; Brunner, Han G.; de Vries, Bert B. A.; Veltman, Joris A.			De novo mutations of SETBP1 cause Schinzel-Giedion syndrome	NATURE GENETICS			English	Article							PROTEIN; GENE; DELINEATION; LEUKEMIA; FUSION	Schinzel-Giedion syndrome is characterized by severe mental retardation, distinctive facial features and multiple congenital malformations; most affected individuals die before the age of ten. We sequenced the exomes of four affected individuals (cases) and found heterozygous de novo variants in SETBP1 in all four. We also identified SETBP1 mutations in eight additional cases using Sanger sequencing. All mutations clustered to a highly conserved 11-bp exonic region, suggesting a dominant-negative or gain-of-function effect.	[Hoischen, Alexander; van Bon, Bregje W. M.; Gilissen, Christian; Arts, Peer; van Lier, Bart; Steehouwer, Marloes; de Vries, Petra; de Reuver, Rick; Wieskamp, Nienke; Brunner, Han G.; de Vries, Bert B. A.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Mortier, Geert] Univ Antwerp Hosp, Ctr Med Genet, Antwerp, Belgium; [Devriendt, Koen] Leuven Univ Hosp, Ctr Human Genet, Katholieke Univ Leuven, Louvain, Belgium; [Amorim, Marta Z.] Hosp Pediat Coimbra, Serv Genet Coimbra, Coimbra, Portugal; [Revencu, Nicole] Catholic Univ Louvain, Clin Univ St Luc, Ctr Human Genet, B-1200 Brussels, Belgium; [Kidd, Alexa] Christchurch Hosp, Canterbury Hlth Labs, Christchurch, New Zealand; [Barbosa, Mafalda] Inst Nacl Saude Doutor Ricardo, Ctr Genet Med Doutor Jacinto Magalhaes, Porto, Portugal; [Turner, Anne] Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW, Australia; [Smith, Janine] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW, Australia; [Oley, Christina] Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; [Henderson, Alex] Newcastle Upon Tyne Hosp Natl Hlth Serv Fdn Trust, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Hayes, Ian M.] No Reg Genet Serv, Auckland, New Zealand; [Thompson, Elizabeth M.] Womens & Childrens Hosp, S Australian Clin Genet Serv, Adelaide, SA, Australia	Radboud University Nijmegen; University of Antwerp; KU Leuven; University Hospital Leuven; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Canterbury Health Laboratories; Christchurch Hospital New Zealand; University of Sydney; University of Sydney; Birmingham Women's Hospital; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Womens & Childrens Hospital Australia	Veltman, JA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	j.veltman@antrg.umcn.nl	van Bon, Bregje/Q-2445-2015; Hoischen, Alexander/D-1282-2013; Gilissen, Christian/E-5246-2012; van Bon, Bregje/D-3720-2013; Veltman, Joris A/F-5128-2010; Mortier, Geert/D-2542-2012; Hoischen, Alexander/AGF-7293-2022; Arts, Peer/Q-4139-2019; Brunner, Han/C-9928-2013	van Bon, Bregje/0000-0003-2234-0105; Hoischen, Alexander/0000-0002-8072-4476; Gilissen, Christian/0000-0003-1693-9699; Veltman, Joris A/0000-0002-3218-8250; Mortier, Geert/0000-0001-9871-4578; Hoischen, Alexander/0000-0002-8072-4476; Arts, Peer/0000-0002-6742-6239; 	Netherlands Organization for Health Research and Development [917-66-36, 911-08-025, 917-86-319]; EU [Health-F5-2009-223143, LSHG-CT-2006-37627]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); EU(European Commission)	We thank the subjects and their parents for participation in this study. We thank S. Keijzers-Vloet, J. de Ligt, N. Leijsten and personnel from the Sequencing Facility Nijmegen for technical assistance and I. Saleem for referring patient 3 to us. This study was financially supported by the Netherlands Organization for Health Research and Development (ZonMW grants 917-66-36 and 911-08-025 to J. A. V. and to B.B.A.d.V.), the EU-funded TECHGENE project (Health-F5-2009-223143 to P.A. and J.A.V.) and the AnEUploidy project (LSHG-CT-2006-37627 to A.Hoischen, B.W.M.v.B., H.G.B., B.B.A.d.V. and J.A.V.).	Buysse K, 2008, AM J MED GENET A, V146A, P1330, DOI 10.1002/ajmg.a.32267; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; KRUEGER RC, 1990, J BIOL CHEM, V265, P12075; Lehman AM, 2008, AM J MED GENET A, V146A, P1299, DOI 10.1002/ajmg.a.32277; Minakuchi M, 2001, EUR J BIOCHEM, V268, P1340, DOI 10.1046/j.1432-1327.2001.02000.x; Minn D, 2002, AM J MED GENET, V109, P211, DOI 10.1002/ajmg.10348; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; NIEDUSZYNSKI IA, 1990, BIOCHEM J, V271, P243, DOI 10.1042/bj2710243; Panagopoulos I, 2007, BRIT J HAEMATOL, V136, P294, DOI 10.1111/j.1365-2141.2006.06410.x; SCHINZEL A, 1978, AM J MED GENET, V1, P361, DOI 10.1002/ajmg.1320010402; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; VAREZVENEGAS R, 2002, GENE, V285, P25; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407	15	333	344	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2010	42	6					483	485		10.1038/ng.581	http://dx.doi.org/10.1038/ng.581			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601RN	20436468				2022-12-17	WOS:000278081500009
J	Hallmayer, J; Faraco, J; Lin, L; Hesselson, S; Winkelmann, J; Kawashima, M; Mayer, G; Plazzi, G; Nevsimalova, S; Bourgin, P; Hong, SSC; Honda, Y; Honda, M; Hogl, B; Longstreth, WT; Montplaisir, J; Kemlink, D; Einen, M; Chen, J; Musone, SL; Akana, M; Miyagawa, T; Duan, J; Desautels, A; Erhardt, C; Hesla, PE; Poli, F; Frauscher, B; Jeong, JH; Lee, SP; Ton, TGN; Kvale, M; Kolesar, L; Dobrovolna, M; Nepom, GT; Salomon, D; Wichmann, HE; Rouleau, GA; Gieger, C; Levinson, DF; Gejman, PV; Meitinger, T; Young, T; Peppard, P; Tokunaga, K; Kwok, PY; Risch, N; Mignot, E				Hallmayer, Joachim; Faraco, Juliette; Lin, Ling; Hesselson, Stephanie; Winkelmann, Juliane; Kawashima, Minae; Mayer, Geert; Plazzi, Giuseppe; Nevsimalova, Sona; Bourgin, Patrice; Hong, Sheng Seung-Chul; Honda, Yutaka; Honda, Makoto; Hoegl, Birgit; Longstreth, William T., Jr.; Montplaisir, Jacques; Kemlink, David; Einen, Mali; Chen, Justin; Musone, Stacy L.; Akana, Matthew; Miyagawa, Taku; Duan, Jubao; Desautels, Alex; Erhardt, Christine; Hesla, Per Egil; Poli, Francesca; Frauscher, Birgit; Jeong, Jong-Hyun; Lee, Sung-Pil; Ton, Thanh G. N.; Kvale, Mark; Kolesar, Libor; Dobrovolna, Marie; Nepom, Gerald T.; Salomon, Dan; Wichmann, H-Erich; Rouleau, Guy A.; Gieger, Christian; Levinson, Douglas F.; Gejman, Pablo V.; Meitinger, Thomas; Young, Terry; Peppard, Paul; Tokunaga, Katsushi; Kwok, Pui-Yan; Risch, Neil; Mignot, Emmanuel			Narcolepsy is strongly associated with the T-cell receptor alpha locus	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFORMATION; EVOLUTION; MUTATION; REGION; GENE	Narcolepsy with cataplexy, characterized by sleepiness and rapid onset into REM sleep, affects 1 in 2,000 individuals(1,2). Narcolepsy was first shown to be tightly associated with HLA-DR2 (ref. 3) and later sublocalized to DQB1*0602 (ref. 4). Following studies in dogs(5) and mice(6), a 95% loss of hypocretin-producing cells in postmortem hypothalami from narcoleptic individuals was reported(7,8). Using genome-wide association (GWA) in Caucasians with replication in three ethnic groups, we found association between narcolepsy and polymorphisms in the TRA@ (T-cell receptor alpha) locus, with highest significance at rs1154155 (average allelic odds ratio 1.69, genotypic odds ratios 1.94 and 2.55, P < 10(-21), 1,830 cases, 2,164 controls). This is the first documented genetic involvement of the TRA@ locus, encoding the major receptor for HLA-peptide presentation, in any disease. It is still unclear how specific HLA alleles confer susceptibility to over 100 HLA-associated disorders(9); thus, narcolepsy will provide new insights on how HLA-TCR interactions contribute to organ-specific autoimmune targeting and may serve as a model for over 100 other HLA-associated disorders(9).	[Hallmayer, Joachim; Faraco, Juliette; Lin, Ling; Kawashima, Minae; Einen, Mali; Mignot, Emmanuel] Stanford Univ, Sch Med, Ctr Sleep Sci, Palo Alto, CA 94304 USA; [Hallmayer, Joachim; Faraco, Juliette; Lin, Ling; Kawashima, Minae; Einen, Mali; Levinson, Douglas F.; Mignot, Emmanuel] Stanford Univ, Sch Med, Dept Psychiat, Palo Alto, CA 94304 USA; [Hesselson, Stephanie; Chen, Justin; Musone, Stacy L.; Akana, Matthew; Kvale, Mark; Kwok, Pui-Yan; Risch, Neil] Univ Calif San Francisco, Sch Med, Inst Human Genet, San Francisco, CA USA; [Winkelmann, Juliane; Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Winkelmann, Juliane] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkelmann, Juliane; Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, Munich, Germany; [Kawashima, Minae; Miyagawa, Taku; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Tokyo, Japan; [Mayer, Geert] Hephata Klin, Schwalmstadt, Germany; [Mayer, Geert] Univ Marburg, Dept Neurol, Marburg, Germany; [Plazzi, Giuseppe; Poli, Francesca] Univ Bologna, Bologna, Italy; [Nevsimalova, Sona; Kemlink, David] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Nevsimalova, Sona; Kemlink, David] Gen Teaching Hosp, Prague, Czech Republic; [Bourgin, Patrice; Erhardt, Christine] Univ Strasbourg, Hop Civil, Sleep Clin, Strasbourg, France; [Hong, Sheng Seung-Chul; Jeong, Jong-Hyun; Lee, Sung-Pil] Catholic Univ Korea, St Vincents Hosp, Dept Neuropsychiat, Suwon, South Korea; [Honda, Yutaka; Honda, Makoto] Tokyo Inst Psychiat, Tokyo, Japan; [Hoegl, Birgit; Frauscher, Birgit] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Longstreth, William T., Jr.; Ton, Thanh G. N.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Longstreth, William T., Jr.; Ton, Thanh G. N.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Montplaisir, Jacques; Desautels, Alex] Univ Montreal, Sleep Disorders Ctr, Montreal, PQ, Canada; [Duan, Jubao; Gejman, Pablo V.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat, Evanston, IL USA; [Hesla, Per Egil] Coliseum Majorstua Clin, Oslo, Norway; [Kolesar, Libor] Inst Clin & Expt Med, Dept Immunogenet, Prague, Czech Republic; [Dobrovolna, Marie] Inst Hematol & Blood Transfus, Natl Reference Lab DNA Diagnost, HLA Typing Lab, CR-12820 Prague, Czech Republic; [Nepom, Gerald T.] Benaroya Res Inst Virginia Mason, Seattle, WA USA; [Salomon, Dan] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Wichmann, H-Erich; Gieger, Christian] Helmholtz Zentrum Munchen, Inst Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neur, Montreal, PQ, Canada; [Gejman, Pablo V.] N Shore Univ HlthSyts, Evanston, IL USA; [Young, Terry; Peppard, Paul] Univ Wisconsin, Sch Med, Dept Populat Hlth Sci, Madison, WI USA; [Risch, Neil] Kaiser Permanente No Calif Div Res, Oakland, CA USA; [Mignot, Emmanuel] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; University of California System; University of California San Francisco; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Tokyo; Philipps University Marburg; University of Bologna; Charles University Prague; General University Hospital Prague; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Catholic University of Korea; Tokyo Institute of Psychiatry; Medical University of Innsbruck; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universite de Montreal; Northwestern University; Feinberg School of Medicine; Institute for Clinical & Experimental Medicine (IKEM); Institute of Hematology Prague; Benaroya Research Institute; Virginia Mason Medical Center; Scripps Research Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Universite de Montreal; University of Wisconsin System; University of Wisconsin Madison; Kaiser Permanente; Howard Hughes Medical Institute; Stanford University	Mignot, E (corresponding author), Stanford Univ, Sch Med, Ctr Sleep Sci, Palo Alto, CA 94304 USA.	mignot@stanford.edu	Nevšímalová, Soňa/H-3533-2017; Wichmann, Heinz Erich/AAA-5695-2022; Kemlink, David/Q-3019-2019; Meitinger, Thomas/O-1318-2015; Kemlink, David/F-9567-2017; Kwok, Pui-Yan/F-7725-2014; Plazzi, Giuseppe/AAB-9627-2020; Salomon, Daniel/E-9380-2012	Nevšímalová, Soňa/0000-0003-0083-3742; Kemlink, David/0000-0003-1398-5796; Kwok, Pui-Yan/0000-0002-5087-3059; Meitinger, Thomas/0000-0002-8838-8403; Nepom, Gerald/0000-0002-8063-1464; Winkelmann, Juliane/0000-0003-2667-9691; Gieger, Christian/0000-0001-6986-9554; Hogl, Birgit/0000-0003-1894-7641; Jeong, Jong-Hyun/0000-0003-3570-7607; Plazzi, Giuseppe/0000-0002-1051-0472; Chen, Justin/0000-0002-1661-4547	US National Institutes of Neurological Disease and Stroke [P50 NS2372]; National Institutes of Mental Health [R01 MH080957]; Czech Ministry of Education [MSM0021620849, MZO 0002373601]; National institutes of Allergic and Infectious diseases [5U19 AI063603]; National Institute of Neurological Disorders and Stroke [R01 NS38523]; MIUR PRIN [2005065029]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI063603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH079470, R01MH080957, U01MH079469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038523, R37NS033797, P50NS023724] Funding Source: NIH RePORTER	US National Institutes of Neurological Disease and Stroke; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); National institutes of Allergic and Infectious diseases; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MIUR PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are most indebted to all the participants of the study, most notably the subjects with narcolepsy. This study was supported primarily by the US National Institutes of Neurological Disease and Stroke grant P50 NS2372. Additional funding included National Institutes of Mental Health R01 MH080957 to E. M., 5U01 MH079470 to D. F. L., 5U01 MH079469-02 to P. V. G., R01 HL62252 to T. Y. Czech Ministry of Education MSM0021620849 and MZO 0002373601 to S. N., National institutes of Allergic and Infectious diseases 5U19 AI063603 to D. S., National Institute of Neurological Disorders and Stroke R01 NS38523 to W. T. L., MIUR PRIN Grant 2005065029 to G. P. and a grant from Grants-in-Aid for Scientific Research on Comprehensive Genomics from the Ministry of Education, Culture, Sports, Science and Technology of Japan to K. T. G. A. R. is supported by the Canadian Institutes of Health Research. Grant MGC 77493 to J. Montplaisir. E. M. is an HHMI supported investigator. We are also grateful to GAIN (the Genetic Association Information Network, NIH) and KORA (Kooperative Gesundheitsforschung in der Region Augsburg, Germany). The KORA research platform was initiated and financed by the German Federal Ministry of Education and Research and by the State of Bavaria. The authors extend their thanks to E. Wan, C. Chu, C. Ha, J. Zhang and A. Voros for technical assistance, and C. Grumet for brainstorming and constant support.	Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fuschiotti P, 2007, MOL IMMUNOL, V44, P3380, DOI 10.1016/j.molimm.2007.02.017; Garcia KC, 1998, CURR OPIN BIOTECH, V9, P338, DOI 10.1016/S0958-1669(98)80004-9; Haynes MR, 2004, IMMUNOGENETICS, V56, P470, DOI 10.1007/s00251-004-0706-x; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; KOOP BF, 1994, GENOMICS, V19, P478, DOI 10.1006/geno.1994.1097; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Longstreth WT, 2007, SLEEP, V30, P13, DOI 10.1093/sleep/30.1.13; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Ng MCY, 2007, J CLIN ENDOCR METAB, V92, P3733, DOI 10.1210/jc.2007-0849; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Overeem S, 2008, SLEEP MED REV, V12, P95, DOI 10.1016/j.smrv.2007.07.010; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scammell TE, 2006, SLEEP, V29, P601, DOI 10.1093/sleep/29.5.601; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Shiina T, 2004, TISSUE ANTIGENS, V64, P631, DOI 10.1111/j.1399-0039.2004.00327.x; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1	25	333	340	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2009	41	6					708	711		10.1038/ng.372	http://dx.doi.org/10.1038/ng.372			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	450OW	19412176	Green Accepted			2022-12-17	WOS:000266411700020
J	Fisher, SA; Tremelling, M; Anderson, CA; Gwilliam, R; Bumpstead, S; Prescott, NJ; Nimmo, ER; Massey, D; Berzuini, C; Johnson, C; Barrett, JC; Cummings, FR; Drummond, H; Lees, CW; Onnie, CM; Hanson, CE; Blaszczyk, K; Inouye, M; Ewels, P; Ravindrarajah, R; Keniry, A; Hunt, S; Carter, M; Watkins, N; Ouwehand, W; Lewis, CM; Cardon, L; Lobo, A; Forbes, A; Sanderson, J; Jewell, DP; Mansfield, JC; Deloukas, P; Mathew, CG; Parkes, M; Satsangi, J				Fisher, Sheila A.; Tremelling, Mark; Anderson, Carl A.; Gwilliam, Rhian; Bumpstead, Suzannah; Prescott, Natalie J.; Nimmo, Elaine R.; Massey, Dunecan; Berzuini, Carlo; Johnson, Christopher; Barrett, Jeffrey C.; Cummings, Fraser R.; Drummond, Hazel; Lees, Charlie W.; Onnie, Clive M.; Hanson, Catherine E.; Blaszczyk, Katarzyna; Inouye, Mike; Ewels, Philip; Ravindrarajah, Radhi; Keniry, Andrew; Hunt, Sarah; Carter, Martyn; Watkins, Nick; Ouwehand, Willem; Lewis, Cathryn M.; Cardon, Lon; Lobo, Alan; Forbes, Alastair; Sanderson, Jeremy; Jewell, Derek P.; Mansfield, John C.; Deloukas, Panos; Mathew, Christopher G.; Parkes, Miles; Satsangi, Jack		Wellcome Trust Case Control Consor	Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; IL23R; IDENTIFICATION; PHENOTYPE; VARIANTS	We report results of a nonsynonymous SNP scan for ulcerative colitis and identify a previously unknown susceptibility locus at ECM1. We also show that several risk loci are common to ulcerative colitis and Crohn's disease (IL23R, IL12B, HLA, NKX2-3 and MST1), whereas autophagy genes ATG16L1 and IRGM, along with NOD2 (also known as CARD15), are specific for Crohn's disease. These data provide the first detailed illustration of the genetic relationship between these common inflammatory bowel diseases.	[Nimmo, Elaine R.; Lees, Charlie W.; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Gastrointestinal Unit, Div Med Sci,Sch Mol & Clin Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Fisher, Sheila A.; Prescott, Natalie J.; Onnie, Clive M.; Blaszczyk, Katarzyna; Lewis, Cathryn M.; Mathew, Christopher G.] Guys Hosp, Dept Med & Mol Genet, Univ London Kings Coll, Sch Med, London SE1 9RT, England; [Tremelling, Mark; Massey, Dunecan; Berzuini, Carlo; Johnson, Christopher; Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge CB2 2QQ, England; [Anderson, Carl A.; Barrett, Jeffrey C.; Cardon, Lon] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Gwilliam, Rhian; Bumpstead, Suzannah; Inouye, Mike; Ewels, Philip; Ravindrarajah, Radhi; Keniry, Andrew; Hunt, Sarah; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Cummings, Fraser R.; Jewell, Derek P.] Univ Oxford, Radcliffe Infirm, Gastroenterol Unit, Oxford OX2 6HE, England; [Hanson, Catherine E.; Mansfield, John C.] Newcastle Univ, Royal Victoria Infirm, Dept Gastroenterol & Hepatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Carter, Martyn] Univ Sheffield, Sch Med, Royal Hallamshire Hosp, Div Mol & Genet Med, Sheffield S10 2JF, S Yorkshire, England; [Watkins, Nick; Ouwehand, Willem] Univ Cambridge, Dept Haematol, Natl Blood Serv Ctr, Cambridge CB2 2PT, England; [Forbes, Alastair] UCL Hosp Trust, Inst Digest Dis, London NW1 2BU, England; [Sanderson, Jeremy] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London SE1 7EH, England	University of Edinburgh; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; Radcliffe Infirmary; University of Oxford; Newcastle University - UK; University of Sheffield; University of Cambridge; University College London Hospitals NHS Foundation Trust; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust	Satsangi, J (corresponding author), Univ Edinburgh, Western Gen Hosp, Gastrointestinal Unit, Div Med Sci,Sch Mol & Clin Med, Edinburgh EH4 2XU, Midlothian, Scotland.	j.satsangi@ed.ac.uk	Berzuini, Carlo/AAA-7023-2019; Lewis, Cathryn/M-8766-2019; Ewels, Philip/J-7771-2013; Deloukas, Panos/B-2922-2013; Dominiczak, Anna F/P-9390-2017; Mathew, Christopher G/G-3434-2015; Lewis, Cathryn M/A-5225-2010; HILL, Adrian V>S>/C-1306-2008; Prescott, Natalie J/F-6490-2011; Breen, Gerome/Y-2706-2019; eyre, stephen/K-3776-2017; Anderson, Carl A/B-8327-2013; Yuldasheva, Nadira Yusupovna/GXM-9013-2022	Berzuini, Carlo/0000-0001-6056-0489; Lewis, Cathryn/0000-0002-8249-8476; Ewels, Philip/0000-0003-4101-2502; Deloukas, Panos/0000-0001-9251-070X; Dominiczak, Anna F/0000-0003-4913-3608; Mathew, Christopher G/0000-0003-4178-1838; Lewis, Cathryn M/0000-0002-8249-8476; Prescott, Natalie J/0000-0002-5901-7371; Breen, Gerome/0000-0003-2053-1792; eyre, stephen/0000-0002-1251-6974; Anderson, Carl A/0000-0003-1719-7009; Inouye, Michael/0000-0001-9413-6520; Munroe, Patricia/0000-0002-4176-2947; Zeggini, Eleftheria/0000-0003-4238-659X; Lees, Charlie/0000-0002-0732-8215; Parkes, Miles/0000-0002-6467-0631; Hunt, Sarah/0000-0002-8350-1235; Lango Allen, Hana/0000-0002-7803-8688; Hattersley, Andrew/0000-0001-5620-473X; Massey, Dunecan/0000-0002-7144-4579; Weedon, Michael/0000-0002-6174-6135; Dunger, Professor David/0000-0002-2566-9304; Cummings, Fraser/0000-0002-9659-3247; Forbes, Alastair/0000-0001-7416-9843; Lindgren, Cecilia/0000-0002-4903-9374; Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Barrett, Jeffrey/0000-0002-1152-370X	Medical Research Council [G0400874, MC_U105260799, G0800383, MC_QA137934, G0800759, G0600329, G0000934, G0802320] Funding Source: Medline; Wellcome Trust [077011, 076113, 089120, 090532] Funding Source: Medline; Chief Scientist Office [CZB/4/540] Funding Source: Medline; MRC [G0400874, G0600329, G0000934, G0800383, MC_qA137934, MC_U105260799] Funding Source: UKRI; Medical Research Council [MC_qA137934] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chan I, 2007, EXP DERMATOL, V16, P881, DOI 10.1111/j.1600-0625.2007.00608.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mochida A, 2007, TISSUE ANTIGENS, V70, P128, DOI 10.1111/j.1399-0039.2007.00866.x; Morrison AC, 2004, J IMMUNOL, V172, P1825, DOI 10.4049/jimmunol.172.3.1825; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Silverberg MS, 2003, INFLAMM BOWEL DIS, V9, P1, DOI 10.1097/00054725-200301000-00001; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051	15	333	338	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					710	712		10.1038/ng.145	http://dx.doi.org/10.1038/ng.145			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18438406	Green Accepted			2022-12-17	WOS:000256212000010
J	De Fusco, M; Becchetti, A; Patrignani, A; Annesi, G; Gambardella, A; Quattrone, A; Ballabio, A; Wanke, E; Casari, G				De Fusco, M; Becchetti, A; Patrignani, A; Annesi, G; Gambardella, A; Quattrone, A; Ballabio, A; Wanke, E; Casari, G			The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy	NATURE GENETICS			English	Article							ACETYLCHOLINE-RECEPTOR; CHRNA4 GENE; MUTATION; BETA-2-SUBUNIT; MOUSE		TIGEM, Telethon Inst Genet & Med, Milan, Italy; Univ Milan, Dept Biosci & Biotechnol, Milan, Italy; Natl Res Council, Inst Expt Med & Biotechnol, Cosenza, Italy; Sch Med, Inst Neurol, Catanzaro, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Milan	Casari, G (corresponding author), TIGEM, Telethon Inst Genet & Med, San Raffaele Biomed Sci Pk, Milan, Italy.		Gambardella, Antonio/F-5295-2012; Annesi, Grazia/AAX-5732-2020; Becchetti, Andrea/AAF-7821-2020; De Fusco, Maurizio/AAN-7358-2020; CASARI, Giorgio/J-3070-2018; QUATTRONE, Aldo/A-6734-2016	Gambardella, Antonio/0000-0001-7384-3074; Becchetti, Andrea/0000-0002-9297-0527; BALLABIO, Andrea/0000-0003-1381-4604; CASARI, Giorgio/0000-0002-0115-8980; QUATTRONE, Aldo/0000-0003-2001-957X; Partigiani, Andrea/0000-0001-8019-3911	Telethon [1046, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Buisson B, 1996, J NEUROSCI, V16, P7880; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; FLORES CM, 1992, MOL PHARMACOL, V41, P31; GAMBARDELLA A, IN PRESS NEUROLOGY; Hirose S, 1999, NEUROLOGY, V53, P1749, DOI 10.1212/WNL.53.8.1749; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; Phillips HA, 1998, AM J HUM GENET, V63, P1108, DOI 10.1086/302047; Rempel N, 1998, HUM GENET, V103, P645, DOI 10.1007/s004390050885; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Tenchini ML, 1999, SLEEP, V22, P637, DOI 10.1093/sleep/22.5.637	15	333	341	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2000	26	3					275	276						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062464				2022-12-17	WOS:000165176500013
J	WILLIAMS, BO; REMINGTON, L; ALBERT, DM; MUKAI, S; BRONSON, RT; JACKS, T				WILLIAMS, BO; REMINGTON, L; ALBERT, DM; MUKAI, S; BRONSON, RT; JACKS, T			COOPERATIVE TUMORIGENIC EFFECTS OF GERMLINE MUTATIONS IN RB AND P53	NATURE GENETICS			English	Article							WILD-TYPE P53; CELL LUNG-CANCER; RETINOBLASTOMA SUSCEPTIBILITY GENE; TUMOR-SUPPRESSOR GENE; LARGE T-ANTIGEN; TRANSGENIC MICE; BREAST-CANCER; CYCLE CONTROL; PINEAL ORGAN; APOPTOSIS	The tumour suppressor genes Rb and p53 are mutated in several types of human cancer, and many tumour types carry mutations in both genes. To study how these genes normally function, we and others have created mouse strains with Rb and p53 mutations. Here we describe the phenotypic effects of combined germline mutations in these two tumour suppressor genes. Mice mutant for both genes have reduced viability and exhibit novel pathology including pinealoblastomas, islet cell tumours, bronchial epithelial hyperplasia and retinal dysplasia. These data indicate that mutations in Rb and p53 can cooperate in the transformation of certain cell types in the mouse.	MIT,CTR CANC RES,DEPT BIOL,CAMBRIDGE,MA 02139; UNIV WISCONSIN,DEPT OPHTHALMOL,MADISON,WI 53792; HARVARD UNIV,SCH MED,MASSACHUSETTS EYE & EAR INFIRM,DEPT OPHTHALMOL,BOSTON,MA 02114; TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111; TUFTS UNIV,SCH VET MED,DEPT PATHOL,BOSTON,MA 02111	Massachusetts Institute of Technology (MIT); University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Tufts University; Tufts University			Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301				AGUAYO SM, 1992, NEW ENGL J MED, V327, P1285, DOI 10.1056/NEJM199210293271806; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; CROOK T, 1991, ONCOGENE, V6, P873; DAVIDOFF AM, 1991, P NATL ACAD SCI USA, V88, P5006, DOI 10.1073/pnas.88.11.5006; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DYSON N, 1989, CELL, V58, P249, DOI 10.1016/0092-8674(89)90839-8; EWEN ME, 1989, CELL, V58, P257, DOI 10.1016/0092-8674(89)90840-4; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HENSEL CH, 1991, ONCOGENE, V6, P1067; HENSEL CH, 1990, CANCER RES, V50, P3067; HOLLINGSWORTH J, 1993, CURR OPIN CELL BIOL, V5, P194; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JAKOBIEC FA, 1977, CANCER-AM CANCER SOC, V39, P2048, DOI 10.1002/1097-0142(197705)39:5<2048::AID-CNCR2820390522>3.0.CO;2-9; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MALKIN D, 1993, CANCER GENET CYTOGEN, V66, P83, DOI 10.1016/0165-4608(93)90233-C; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; MERCER WE, 1990, P NATL ACAD SCI USA, V87, P6166, DOI 10.1073/pnas.87.16.6166; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; PESIN SR, 1989, AM J OPHTHALMOL, V107, P121, DOI 10.1016/0002-9394(89)90209-2; PROSSER J, 1990, ONCOGENE, V5, P1573; RUGGERI B, 1992, ONCOGENE, V7, P1503; RYGAARD K, 1990, CANCER RES, V50, P5312; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; Shew J.-Y., 1989, ONCOGENE RES, V1, P205; STANNARD C, 1985, BRIT J OPHTHALMOL, V69, P749, DOI 10.1136/bjo.69.10.749; STRATTON MR, 1990, ONCOGENE, V5, P1297; TANG A, 1988, SCIENCE, V241, P1797; VANDYKE TA, 1994, SEMIN CANCER BIOL, V5, P47; VARLEY JM, 1989, ONCOGENE, V4, P725; VARLEY JM, 1991, ONCOGENE, V6, P413; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; WEINBERG RA, 1992, CANCER SURV, V12, P43; WINDLE JJ, 1990, NATURE, V343, P665, DOI 10.1038/343665a0; WURTMAN RJ, 1977, NEW ENGL J MED, V296, P1383, DOI 10.1056/NEJM197706162962405; WURTMAN RJ, 1977, NEW ENGL J MED, V296, P1329, DOI 10.1056/NEJM197706092962307; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0	58	333	340	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1994	7	4					480	484		10.1038/ng0894-480	http://dx.doi.org/10.1038/ng0894-480			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951317				2022-12-17	WOS:A1994PA83200013
J	Gormley, P; Anttila, V; Winsvold, BS; Palta, P; Esko, T; Pers, TH; Farh, KH; Cuenca-Leon, E; Muona, M; Furlotte, NA; Kurth, T; Ingason, A; McMahon, G; Ligthart, L; Terwindt, GM; Kallela, M; Freilinger, TM; Ran, C; Gordon, SG; Stam, AH; Steinberg, S; Borck, G; Koiranen, M; Quaye, L; Adams, HHH; Lehtimaki, T; Sarin, AP; Wedenoja, J; Hinds, DA; Buring, JE; Schurks, M; Ridker, PM; Hrafnsdottir, MG; Stefansson, H; Ring, SM; Hottenga, JJ; Penninx, BWJH; Farkkila, M; Artto, V; Kaunisto, M; Vepsalainen, S; Malik, R; Heath, AC; Madden, PAF; Martin, NG; Montgomery, GW; Kurki, MI; Kals, M; Magi, R; Parn, K; Hamalainen, E; Huang, HL; Byrnes, AE; Franke, L; Huang, J; Stergiakouli, E; Lee, PH; Sandor, C; Webber, C; Cader, Z; Muller-Myhsok, B; Schreiber, S; Meitinger, T; Eriksson, JG; Salomaa, V; Heikkila, K; Loehrer, E; Uitterlinden, AG; Hofman, A; van Duijn, CM; Cherkas, L; Pedersen, LM; Stubhaug, A; Nielsen, CS; Mannikko, M; Mihailov, E; Milani, L; Gobel, H; Esserlind, AL; Christensen, AF; Hansen, TF; Werge, T; Kaprio, J; Aromaa, AJ; Raitakari, O; Ikram, MA; Spector, T; Jarvelin, MR; Metspalu, A; Kubisch, C; Strachan, DP; Ferrari, MD; Belin, AC; Dichgans, M; Wessman, M; van den Maagdenberg, AMJM; Zwart, JA; Boomsma, DI; Smith, GD; Stefansson, K; Eriksson, N; Daly, MJ; Neale, BM; Olesen, J; Chasman, DI; Nyholt, DR; Palotie, A				Gormley, Padhraig; Anttila, Verneri; Winsvold, Bendik S.; Palta, Priit; Esko, Tonu; Pers, Tune H.; Farh, Kai-How; Cuenca-Leon, Ester; Muona, Mikko; Furlotte, Nicholas A.; Kurth, Tobias; Ingason, Andres; McMahon, George; Ligthart, Lannie; Terwindt, Gisela M.; Kallela, Mikko; Freilinger, Tobias M.; Ran, Caroline; Gordon, Scott G.; Stam, Anine H.; Steinberg, Stacy; Borck, Guntram; Koiranen, Markku; Quaye, Lydia; Adams, Hieab H. H.; Lehtimaki, Terho; Sarin, Antti-Pekka; Wedenoja, Juho; Hinds, David A.; Buring, Julie E.; Schurks, Markus; Ridker, Paul M.; Hrafnsdottir, Maria Gudlaug; Stefansson, Hreinn; Ring, Susan M.; Hottenga, Jouke-Jan; Penninx, Brenda W. J. H.; Farkkila, Markus; Artto, Ville; Kaunisto, Mari; Vepsalainen, Salli; Malik, Rainer; Heath, Andrew C.; Madden, Pamela A. F.; Martin, Nicholas G.; Montgomery, Grant W.; Kurki, Mitja I.; Kals, Mart; Magi, Reedik; Parn, Kalle; Hamalainen, Eija; Huang, Hailiang; Byrnes, Andrea E.; Franke, Lude; Huang, Jie; Stergiakouli, Evie; Lee, Phil H.; Sandor, Cynthia; Webber, Caleb; Cader, Zameel; Muller-Myhsok, Bertram; Schreiber, Stefan; Meitinger, Thomas; Eriksson, Johan G.; Salomaa, Veikko; Heikkila, Kauko; Loehrer, Elizabeth; Uitterlinden, Andre G.; Hofman, Albert; van Duijn, Cornelia M.; Cherkas, Lynn; Pedersen, Linda M.; Stubhaug, Audun; Nielsen, Christopher S.; Mannikko, Minna; Mihailov, Evelin; Milani, Lili; Gobel, Hartmut; Esserlind, Ann-Louise; Christensen, Anne Francke; Hansen, Thomas Folkmann; Werge, Thomas; Kaprio, Jaakko; Aromaa, Arpo J.; Raitakari, Olli; Ikram, M. Arfan; Spector, Tim; Jarvelin, Marjo-Riitta; Metspalu, Andres; Kubisch, Christian; Strachan, David P.; Ferrari, Michel D.; Belin, Andrea C.; Dichgans, Martin; Wessman, Maija; van den Maagdenberg, Arn M. J. M.; Zwart, John-Anker; Boomsma, Dorret I.; Smith, George Davey; Stefansson, Kari; Eriksson, Nicholas; Daly, Mark J.; Neale, Benjamin M.; Olesen, Jes; Chasman, Daniel I.; Nyholt, Dale R.; Palotie, Aarno		Int Headache Genetics Consortium	Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; FAMILIAL HEMIPLEGIC MIGRAINE; GENE-EXPRESSION; SPREADING DEPRESSION; SYSTEMATIC ANALYSIS; QUALITY-CONTROL; GLOBAL BURDEN; MOUSE MODELS; NITRIC-OXIDE	Migraine is a debilitating neurological disorder affecting around one in seven people worldwide, but its molecular mechanisms remain poorly understood. There is some debate about whether migraine is a disease of vascular dysfunction or a result of neuronal dysfunction with secondary vascular changes. Genome-wide association ( GWA) studies have thus far identified 13 independent loci associated with migraine. To identify new susceptibility loci, we carried out a genetic study of migraine on 59,674 affected subjects and 316,078 controls from 22 GWA studies. We identified 44 independent single-nucleotide polymorphisms ( SNPs) significantly associated with migraine risk ( P < 5 x 10(-8)) that mapped to 38 distinct genomic loci, including 28 loci not previously reported and a locus that to our knowledge is the first to be identified on chromosome X. In subsequent computational analyses, the identified loci showed enrichment for genes expressed in vascular and smooth muscle tissues, consistent with a predominant theory of migraine that highlights vascular etiologies.	[Gormley, Padhraig; Cuenca-Leon, Ester; Kurki, Mitja I.; Lee, Phil H.; Palotie, Aarno] Massachusetts Gen Hosp, Psychiat & Neurodevelopmental Genet Unit, Boston, MA 02114 USA; [Gormley, Padhraig; Anttila, Verneri; Farh, Kai-How; Cuenca-Leon, Ester; Kurki, Mitja I.; Huang, Hailiang; Byrnes, Andrea E.; Lee, Phil H.; Daly, Mark J.; Neale, Benjamin M.; Palotie, Aarno] Harvard Univ, Sch Med, Boston, MA 02138 USA; [Gormley, Padhraig; Anttila, Verneri; Esko, Tonu; Pers, Tune H.; Farh, Kai-How; Cuenca-Leon, Ester; Kurki, Mitja I.; Huang, Hailiang; Byrnes, Andrea E.; Lee, Phil H.; Daly, Mark J.; Neale, Benjamin M.; Palotie, Aarno] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02139 USA; [Gormley, Padhraig; Anttila, Verneri; Cuenca-Leon, Ester; Kurki, Mitja I.; Huang, Hailiang; Byrnes, Andrea E.; Lee, Phil H.; Daly, Mark J.; Neale, Benjamin M.; Palotie, Aarno] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA; [Gormley, Padhraig; Huang, Jie; Palotie, Aarno] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, Cambs, England; [Anttila, Verneri; Farh, Kai-How; Huang, Hailiang; Byrnes, Andrea E.; Daly, Mark J.; Neale, Benjamin M.; Palotie, Aarno] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Winsvold, Bendik S.; Pedersen, Linda M.; Zwart, John-Anker] Oslo Univ Hosp, FORMI, Oslo, Norway; [Winsvold, Bendik S.; Zwart, John-Anker] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Winsvold, Bendik S.; Zwart, John-Anker] Univ Oslo, Inst Clin Med, Oslo, Norway; [Palta, Priit; Muona, Mikko; Sarin, Antti-Pekka; Kaunisto, Mari; Kurki, Mitja I.; Hamalainen, Eija; Kaprio, Jaakko; Wessman, Maija; Palotie, Aarno] Univ Helsinki, FIMM, Helsinki, Finland; [Esko, Tonu; Kals, Mart; Magi, Reedik; Parn, Kalle; Mihailov, Evelin; Milani, Lili; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Esko, Tonu; Pers, Tune H.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Pers, Tune H.] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Pers, Tune H.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Farh, Kai-How] Illumina, San Diego, CA USA; [Cuenca-Leon, Ester] Vall dHebron Res Inst, Pediat Neurol, Barcelona, Spain; [Muona, Mikko; Wessman, Maija] Folkhalsan Inst Genet, Helsinki, Finland; [Muona, Mikko] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Muona, Mikko] Univ Helsinki, Res Programs Unit, Mol Neurol Res Program, Helsinki, Finland; [Furlotte, Nicholas A.; Hinds, David A.; Eriksson, Nicholas] 23andMe Inc, Mountain View, CA USA; [Kurth, Tobias] Charite, Inst Publ Hlth, D-13353 Berlin, Germany; [Kurth, Tobias; Buring, Julie E.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Ingason, Andres; Steinberg, Stacy; Stefansson, Hreinn; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [McMahon, George; Ring, Susan M.; Stergiakouli, Evie; Smith, George Davey] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Ligthart, Lannie; Hottenga, Jouke-Jan; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Terwindt, Gisela M.; Stam, Anine H.; Ferrari, Michel D.; van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Kallela, Mikko; Farkkila, Markus; Artto, Ville; Vepsalainen, Salli] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Freilinger, Tobias M.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany; [Freilinger, Tobias M.; Malik, Rainer; Dichgans, Martin] Univ Munich, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Ran, Caroline; Belin, Andrea C.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Gordon, Scott G.; Martin, Nicholas G.; Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia; [Borck, Guntram] Univ Ulm, Inst Human Genet, D-89069 Ulm, Germany; [Koiranen, Markku; Mannikko, Minna; Jarvelin, Marjo-Riitta] Univ Oulu, Ctr Life Course Epidemiol & Syst Med, Oulu, Finland; [Quaye, Lydia; Cherkas, Lynn; Spector, Tim] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Loehrer, Elizabeth; Hofman, Albert; van Duijn, Cornelia M.; Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands; Univ Tampere, Sch Med, Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Wedenoja, Juho; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Buring, Julie E.; Ridker, Paul M.; Chasman, Daniel I.] Harvard Med Sch, Boston, MA USA; [Schurks, Markus] Univ Duisburg Essen, Dept Neurol, Essen, Germany; [Hrafnsdottir, Maria Gudlaug] Landspitali Univ Hosp, Reykjavik, Iceland; [Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Heath, Andrew C.; Madden, Pamela A. F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Kurki, Mitja I.] Kuopio Univ Hosp, Dept Neurosurg, SF-70210 Kuopio, Finland; [Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Sandor, Cynthia; Webber, Caleb] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford, England; [Cader, Zameel] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Cader, Zameel] John Radcliffe Hosp, Oxford Headache Ctr, Oxford, England; [Muller-Myhsok, Bertram] Max Planck Inst Psychiat, Munich, Germany; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Hosp, Helsinki, Finland; [Eriksson, Johan G.; Salomaa, Veikko; Aromaa, Arpo J.] Natl Inst Hlth & Welf, Helsinki, Finland; [Heikkila, Kauko] Univ Helsinki, Inst Clin Med, Helsinki, Finland; [Loehrer, Elizabeth] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Stubhaug, Audun; Nielsen, Christopher S.] Oslo Univ Hosp, Dept Pain Management & Res, Oslo, Norway; [Stubhaug, Audun] Univ Oslo, Fac Med, Oslo, Norway; [Nielsen, Christopher S.] Norwegian Inst Publ Hlth, Dept Ageing & Hlth, Oslo, Norway; [Gobel, Hartmut] Kiel Pain & Headache Ctr, Kiel, Germany; [Esserlind, Ann-Louise; Christensen, Anne Francke; Olesen, Jes] Univ Copenhagen, Glostrup Hosp, Rigshosp, Dept Neurol,Danish Headache Ctr, Copenhagen, Denmark; [Hansen, Thomas Folkmann] Univ Copenhagen, Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, iPSYCH, Roskilde, Denmark; [Werge, Thomas] Mental Hlth Serv Copenhagen, MHC Sct Hans, Inst Biol Psychiat, Copenhagen, Denmark; [Werge, Thomas] Univ Copenhagen, Fac Med & Hlth Sci, Inst Clin Sci, Copenhagen, Denmark; [Werge, Thomas] iPSYCH, Copenhagen, Denmark; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Hlth, Helsinki, Finland; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland; [Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC Hlth Protect Agcy HPE Ctr Environm & Hlth, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Kubisch, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Strachan, David P.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Muller-Myhsok, Bertram; Dichgans, Martin] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [van den Maagdenberg, Arn M. J. M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Nyholt, Dale R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Stat & Genom Epidemiol Lab, Kelvin Grove, Qld, Australia; [Palotie, Aarno] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute; Harvard University; Massachusetts General Hospital; University of Oslo; University of Oslo; University of Oslo; University of Helsinki; University of Tartu; Harvard University; Boston Children's Hospital; Statens Serum Institut; Novo Nordisk Foundation; University of Copenhagen; Illumina; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Helsinki; University of Helsinki; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Brigham & Women's Hospital; University of Bristol; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Helsinki; Helsinki University Central Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Karolinska Institutet; QIMR Berghofer Medical Research Institute; Ulm University; University of Oulu; University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Tampere University; University of Helsinki; Harvard University; Harvard Medical School; University of Duisburg Essen; Landspitali National University Hospital; Vrije Universiteit Amsterdam; Washington University (WUSTL); Kuopio University Hospital; University of Eastern Finland; University of Groningen; University of Oxford; University of Oxford; University of Oxford; Max Planck Society; University of Kiel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); Rigshospitalet; University of Copenhagen; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; University of Copenhagen; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Finland National Institute for Health & Welfare; University of Turku; University of Turku; Erasmus University Rotterdam; Erasmus MC; Imperial College London; University of Oulu; University of Oulu; University of Hamburg; University Medical Center Hamburg-Eppendorf; St Georges University London; University of Munich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Iceland; Queensland University of Technology (QUT); Harvard University; Massachusetts General Hospital	Palotie, A (corresponding author), Massachusetts Gen Hosp, Psychiat & Neurodevelopmental Genet Unit, Boston, MA 02114 USA.; Palotie, A (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.; Palotie, A (corresponding author), Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02139 USA.; Palotie, A (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02139 USA.; Palotie, A (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, Cambs, England.; Palotie, A (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; Palotie, A (corresponding author), Univ Helsinki, FIMM, Helsinki, Finland.; Palotie, A (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Boomsma, Dorret I/AAX-4470-2020; Loehrer, Elizabeth/ABF-2400-2020; Adams, Hieab/GLN-6421-2022; Ferrari, Michel D./ABE-3758-2021; Nyholt, Dale Robert/J-3174-2017; Winsvold, Bendik/ABF-7839-2021; Kurth, Tobias/A-9243-2012; Daly, Mark J/B-2453-2017; Penninx, Brenda WJH/S-7627-2017; Belin, Andrea Carmine/AAV-9933-2021; Göbel, Hartmut/AAE-4719-2020; Kurki, Mitja/GWM-5671-2022; Ikram, M. Arfan/AAM-5225-2021; Heikkilä, Kauko/E-5578-2019; Lehtimäki, Terho/AAD-1094-2022; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Gormley, Padhraig/L-1949-2018; Palta, Priit/W-2477-2019; Kubisch, Christian/F-1893-2011; Hansen, Thomas/GWZ-2858-2022; Mägi, Reedik/AAJ-9679-2021; Milani, Lili/N-1097-2019; Meitinger, Thomas/O-1318-2015; Vila-Pueyo, Marta/M-2530-2019; Stefansson, Kari/AAE-7187-2019; Vila-Pueyo, Marta/C-8415-2018; Hansen, Thomas Folkmann/O-5965-2014; Kaprio, Jaakko/A-1820-2008; Raitakari, Olli/AAQ-7389-2021; Montgomery, Grant W/B-7148-2008; Wedenoja, Juho/AAX-7008-2020; Dichgans, Martin/HCH-3247-2022; Franke, Lude/P-7036-2016; Cormand, Bru/H-5338-2015; Ran, Caroline/T-1088-2019; Davey Smith, George/A-7407-2013	Loehrer, Elizabeth/0000-0003-1249-4442; Ferrari, Michel D./0000-0001-9691-9449; Nyholt, Dale Robert/0000-0001-7159-3040; Winsvold, Bendik/0000-0003-4171-8919; Kurth, Tobias/0000-0001-7169-2620; Daly, Mark J/0000-0002-0949-8752; Penninx, Brenda WJH/0000-0001-7779-9672; Belin, Andrea Carmine/0000-0001-6668-3172; Heikkilä, Kauko/0000-0002-9256-8028; Lehtimäki, Terho/0000-0002-2555-4427; Gormley, Padhraig/0000-0002-8908-6968; Palta, Priit/0000-0001-9320-7008; Kubisch, Christian/0000-0003-4220-0978; Milani, Lili/0000-0002-5323-3102; Vila-Pueyo, Marta/0000-0003-0652-2988; Hansen, Thomas Folkmann/0000-0001-6703-7762; Kaprio, Jaakko/0000-0002-3716-2455; Montgomery, Grant W/0000-0002-4140-8139; Wedenoja, Juho/0000-0002-6155-0378; Dichgans, Martin/0000-0002-0654-387X; Franke, Lude/0000-0002-5159-8802; Cormand, Bru/0000-0001-5318-4382; Ran, Caroline/0000-0003-0239-9871; Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Ligthart, Lannie/0000-0002-6570-3319; Anttila, Verneri/0000-0002-0073-4675; Olesen, Jes/0000-0002-6712-2702; Muona, Mikko/0000-0002-0949-6650; Stergiakouli, Evangelia/0000-0003-3586-0927; Eriksson, Johan/0000-0002-2516-2060; Malik, Rainer/0000-0001-9212-2520; Esserlind, Ann-Louise/0000-0001-9561-3595; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hinds, David/0000-0002-4911-803X; Palotie, Aarno/0000-0002-2527-5874; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Posthuma, Danielle/0000-0001-7582-2365; Lessel, Davor/0000-0003-4496-244X; Van Duijn, Cornelia/0000-0002-2374-9204; Webber, Caleb/0000-0001-8063-7674; Magi, Reedik/0000-0002-2964-6011; Meitinger, Thomas/0000-0002-8838-8403; Cader, Zameel/0000-0002-6952-406X; Pers, Tune/0000-0003-0207-4831; Kaunisto, Mari/0000-0002-6946-9195; Pedersen, Linda/0000-0002-8448-983X; Pozo-Rosich, Patricia/0000-0003-0796-4702; Esko, Tonu/0000-0003-1982-6569	GTEx Consortium; MRC [MC_UU_12021/4, MC_UU_00002/10, G0600705, G1002319, G1001799, MC_UU_12013/1, MR/N01104X/1, MC_UP_A320_1004] Funding Source: UKRI; Lundbeck Foundation [R190-2014-3904, R155-2014-1724] Funding Source: researchfish; Medical Research Council [MC_UU_12021/4, MR/N01104X/1, G1002319, MC_UP_A320_1004, G1001799, MC_UU_12013/1, G0600705, MC_UU_00002/10] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042157] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [UM1CA182913, R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851, R01HL087679] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG006981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268, U24MH068457, RC2MH089951, R01MH081802, K99MH101367, RC2MH089995, R01MH063706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS092963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007535, R01AA014041, R01AA013321, P50AA011998, K05AA017688, R01AA010249, R01AA007728, R01AA013320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012854, R37DA018673, K08DA019951, R25DA027995] Funding Source: NIH RePORTER	GTEx Consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the numerous individuals who contributed to sample collection, storage, handling, phenotyping, and genotyping for each of the individual cohorts. We also acknowledge the important contribution to research made by the study participants. We are grateful to H. Zhao (QIMR Berghofer Medical Research Institute) for helpful correspondence on the pathway analyses. We acknowledge the GTEx Consortium for support and contribution of pilot data. A list of study-specific acknowledgments and funding information can be found in the Supplementary Note.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Anttila V, 2010, NAT GENET, V42, P869, DOI 10.1038/ng.652; Arndt AK, 2013, AM J HUM GENET, V93, P67, DOI 10.1016/j.ajhg.2013.05.015; Ashina M, 2013, CEPHALALGIA, V33, P540, DOI 10.1177/0333102412475234; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Bown MJ, 2011, AM J HUM GENET, V89, P619, DOI 10.1016/j.ajhg.2011.10.002; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Castellano J, 2011, ARTERIOSCL THROM VAS, V31, P1411, DOI 10.1161/ATVBAHA.111.225490; Chasman DI, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004366; Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856; Chi JT, 2007, PLOS GENET, V3, P1770, DOI 10.1371/journal.pgen.0030164; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; De Bock M, 2011, J CEREBR BLOOD F MET, V31, P1942, DOI 10.1038/jcbfm.2011.86; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Debette S, 2015, NAT GENET, V47, P78, DOI 10.1038/ng.3154; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Desch M, 2010, CARDIOVASC RES, V86, P496, DOI 10.1093/cvr/cvq008; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Dixit D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.179; Dong H, 2006, AM J PHYSIOL-HEART C, V291, pH1226, DOI 10.1152/ajpheart.00196.2006; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Ferrari MD, 2015, LANCET NEUROL, V14, P65, DOI 10.1016/S1474-4422(14)70220-0; Freilinger T, 2012, NAT GENET, V44, P777, DOI 10.1038/ng.2307; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Fujimura M, 2014, J STROKE, V16, P65, DOI 10.5853/jos.2014.16.2.65; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hager J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038663; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Hanna MG, 2006, NAT CLIN PRACT NEURO, V2, P252, DOI 10.1038/ncpneuro0178; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Ismailov II, 1996, P NATL ACAD SCI USA, V93, P10505, DOI 10.1073/pnas.93.19.10505; Kar R, 2013, J BONE MINER RES, V28, P1611, DOI 10.1002/jbmr.1917; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kraev A, 2001, J BIOL CHEM, V276, P23161, DOI 10.1074/jbc.M102314200; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lang NN, 2007, AM J PHYSIOL-HEART C, V292, pH1026, DOI 10.1152/ajpheart.00797.2006; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Law C, 2006, J MED GENET, V43, P908, DOI 10.1136/jmg.2006.042176; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Magi R, 2010, GENET EPIDEMIOL, V34, P846, DOI 10.1002/gepi.20540; Malik R, 2015, NEUROLOGY, V84, P2132, DOI 10.1212/WNL.0000000000001606; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McElhinney DB, 2002, CIRCULATION, V106, P2567, DOI 10.1161/01.CIR.0000037221.45902.69; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morton MJ, 2005, P NATL ACAD SCI USA, V102, P16102, DOI 10.1073/pnas.0506870102; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nyholt DR, 2008, HUM MOL GENET, V17, P3318, DOI 10.1093/hmg/ddn227; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Olesen J, 2009, LANCET NEUROL, V8, P679, DOI 10.1016/S1474-4422(09)70090-0; Olesen J, 2008, PHARMACOL THERAPEUT, V120, P157, DOI 10.1016/j.pharmthera.2008.08.003; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Porcu E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003266; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramachandran R, 2013, P NATL ACAD SCI USA, V110, P7476, DOI 10.1073/pnas.1217431110; Read SJ, 2000, BRAIN RES, V870, P44, DOI 10.1016/S0006-8993(00)02400-8; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sinner MF, 2014, CIRCULATION, V130, P1225, DOI 10.1161/CIRCULATIONAHA.114.009892; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Tfelt-Hansen PC, 2011, HEADACHE, V51, P752, DOI 10.1111/j.1526-4610.2011.01892.x; The GTFx Consortium, 2013, NAT GENET, V45, P580; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Winsvold BS, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000010; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yamaji M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115563; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39	91	332	335	5	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					856	+		10.1038/ng.3598	http://dx.doi.org/10.1038/ng.3598			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27322543	Green Accepted, Green Submitted			2022-12-17	WOS:000380755100008
J	Choudhury, AR; Ju, ZY; Djojosubroto, MW; Schienke, A; Lechel, A; Schaetzlein, S; Jiang, H; Stepczynska, A; Wang, CF; Buer, J; Lee, HW; von Zglinicki, T; Ganser, A; Schirmacher, P; Nakauchi, H; Rudolph, KL				Choudhury, Aaheli Roy; Ju, Zhenyu; Djojosubroto, Meta W.; Schienke, Andrea; Lechel, Andre; Schaetzlein, Sonja; Jiang, Hong; Stepczynska, Anna; Wang, Chunfang; Buer, Jan; Lee, Han-Woong; von Zglinicki, Thomas; Ganser, Arnold; Schirmacher, Peter; Nakauchi, Hiromitsu; Rudolph, K. Lenhard			Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation	NATURE GENETICS			English	Article							HUMAN FIBROBLASTS; MOUSE TELOMERASE; DNA-DAMAGE; SENESCENCE; LENGTH; P21(CIP1/WAF1); REGENERATION; CAPACITY; AGE; P53	Telomere shortening limits the proliferative lifespan of human cells by activation of DNA damage pathways, including upregulation of the cell cycle inhibitor p21 (encoded by Cdkn1a, also known as Cip1 and Waf1)) (refs. 1-5). Telomere shortening in response to mutation of the gene encoding telomerase is associated with impaired organ maintenance and shortened lifespan in humans(6) and in mice(7-9). The in vivo function of p21 in the context of telomere dysfunction is unknown. Here we show that deletion of p21 prolongs the lifespan of telomerase-deficient mice with dysfunctional telomeres. p21 deletion improved hematolymphopoiesis and the maintenance of intestinal epithelia without rescuing telomere function. Moreover, deletion of p21 rescued proliferation of intestinal progenitor cells and improved the repopulation capacity and self-renewal of hematopoietic stem cells from mice with dysfunctional telomeres. In these mice, apoptotic responses remained intact, and p21 deletion did not accelerate chromosomal instability or cancer formation. This study provides experimental evidence that telomere dysfunction induces p21-dependent checkpoints in vivo that can limit longevity at the organismal level.	Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; Helmholtz Ctr Infect Res, Dept Mucosal Immun, D-38124 Braunschweig, Germany; Univ Newcastle Upon Tyne, Inst Hlth & Aging, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Hannover Med Sch, Inst Med Microbiol, D-30625 Hannover, Germany; Yonsei Univ, Coll Sci, Seoul 120749, South Korea; Dept Hematol & Oncol, D-30625 Hannover, Germany; Univ Hosp, Inst Pathol, D-69120 Heidelberg, Germany; Univ Tokyo, Inst Med Sci, Lab Stem Cell Therapy, Tokyo 1088693, Japan	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Newcastle University - UK; Hannover Medical School; Yonsei University; Ruprecht Karls University Heidelberg; University of Tokyo	Rudolph, KL (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Rudolph.Lenhard@MH-Hannover.de	Lechel, André/AAQ-2041-2021	Lechel, André/0000-0003-0221-6959; Rudolph, Karl Lenhard/0000-0002-4839-2862; Buer, Jan/0000-0002-7602-1698; von Zglinicki, Thomas/0000-0002-5939-0248; Roy Choudhury, Aaheli/0000-0001-6907-0734				ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Carnero A, 2004, ONCOGENE, V23, P6006, DOI 10.1038/sj.onc.1207839; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Lechel A, 2005, EMBO REP, V6, P275, DOI 10.1038/sj.embor.7400352; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; LIPSCHITZ DA, 1984, BLOOD, V63, P502; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Min HY, 2005, IMMUNOL REV, V205, P7, DOI 10.1111/j.0105-2896.2005.00263.x; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Randall TD, 1998, STEM CELLS, V16, P38, DOI 10.1002/stem.160038; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C	30	332	349	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					99	105		10.1038/ng1937	http://dx.doi.org/10.1038/ng1937			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17143283				2022-12-17	WOS:000243136500024
J	Fischer, J; Lefevre, C; Morava, E; Mussini, JM; Laforet, P; Negre-Salvayre, A; Lathrop, M; Salvayre, R				Fischer, Judith; Lefevre, Caroline; Morava, Eva; Mussini, Jean-Marie; Laforet, Pascal; Negre-Salvayre, Anne; Lathrop, Mark; Salvayre, Robert			The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy	NATURE GENETICS			English	Article							CHANARIN-DORFMAN-SYNDROME; FAMILY-MEMBERS; LIPOLYSIS; METABOLISM; EXPRESSION; PROTEIN; CGI-58	Neutral lipid storage disease comprises a heterogeneous group of autosomal recessive disorders characterized by systemic accumulation of triglycerides in cytoplasmic droplets. Here we report a neutral lipid storage disease subgroup characterized by mild myopathy, absence of ichthyosis and mutations in both alleles of adipose triglyceride lipase (PNPLA2, also known as ATGL). Three of these mutations are predicted to lead to a truncated ATGL protein with an intact patatin domain containing the active site, but with defects in the hydrophobic domain. The block in triglyceride degradation was mimicked by short interfering RNA directed against ATGL. NLSDM is distinct from Chanarin-Dorfman syndrome, which is characterized by neutral lipid storage disease with ichthyosis, mild myopathy and hepatomegaly due to mutations in ABHD5 (also known as CGI-58).	Ctr Natl Genotypage, F-91057 Evry, France; Radboud Univ Nijmegen, Ctr Med, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Univ Nantes, Ctr Hosp, Dept Internal Med, F-44093 Nantes, France; Grp Hosp Pitie Salpetriere, AP HP, Inst Myol, Ctr Ref Pathol Neuromusc, F-75651 Paris 13, France; CHU Rangueil, IFR 31, F-31432 Toulouse 04, France; Univ Toulouse 3, INSERM, U446, F-31432 Toulouse 04, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Radboud University Nijmegen; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Fischer, J (corresponding author), Ctr Natl Genotypage, F-91057 Evry, France.	fischer@cng.fr; salvayre@toulouse.inserm.fr	Fischer, Judith/E-6327-2016; Morava, E./L-4529-2015	Fischer, Judith/0000-0002-8580-8118; Negre-Salvayre, Anne/0000-0003-2136-5706				CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; DORFMAN ML, 1974, ARCH DERMATOL, V110, P261, DOI 10.1001/archderm.110.2.261; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JORDANS GHW, 1953, ACTA MED SCAND, V145, P419; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; RADOM J, 1987, EUR J BIOCHEM, V164, P703, DOI 10.1111/j.1432-1033.1987.tb11183.x; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	15	332	353	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					28	30		10.1038/ng1951	http://dx.doi.org/10.1038/ng1951			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17187067				2022-12-17	WOS:000243136500014
J	Pastural, E; Barrat, FJ; DufourcqLagelouse, R; Certain, S; Sanal, O; Jabado, N; Seger, R; Griscelli, C; Fischer, A; DesaintBasile, G				Pastural, E; Barrat, FJ; DufourcqLagelouse, R; Certain, S; Sanal, O; Jabado, N; Seger, R; Griscelli, C; Fischer, A; DesaintBasile, G			Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene	NATURE GENETICS			English	Article							UNCONVENTIONAL MYOSIN; PARTIAL ALBINISM; IMMUNODEFICIENCY; INVOLVEMENT; LOCUS		HOP NECKER ENFANTS MALAD,INSERM U429,UNITE RECH DEV NORMAL & PATHOL SYST IMMUNITAIRE,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,UNITE IMMUNOL & HEMATOL PEDIAT,F-75743 PARIS 15,FRANCE; HACETTEPE CHILDRENS HOSP MED CTR,ANKARA,TURKEY; UNIV KINDERSPITAL ZURICH,ABT IMMUNOL HAMATOL,CH-8032 ZURICH,SWITZERLAND	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Hacettepe University; University Children's Hospital Zurich			Jabado, Nada/AAN-4026-2020; de Saint Basile, Genevieve/G-9731-2017	de Saint Basile, Genevieve/0000-0002-1913-5269; DOGNIAUX, Stephanie/0000-0003-3309-1204				Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Barrat FJ, 1996, AM J HUM GENET, V59, P625; BEJAOUI M, 1989, ARCH FR PEDIATR, V46, P733; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ELEJALDE BR, 1979, AM J MED GENET, V3, P65, DOI 10.1002/ajmg.1320030112; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Evans L. L., 1995, Molecular Biology of the Cell, V6, p145A; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; HARALDSSON A, 1991, EUR J PEDIATR, V150, P419, DOI 10.1007/BF02093723; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; HURVITZ H, 1993, EUR J PEDIATR, V152, P402, DOI 10.1007/BF01955897; JENKINS NA, 1981, NATURE, V293, P370, DOI 10.1038/293370a0; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; KLEIN C, 1994, J PEDIATR-US, V125, P886, DOI 10.1016/S0022-3476(05)82003-7; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; MANI F, 1994, BRAZ J MED BIOL RES, V27, P2639; Maniatis T., 1982, MOL CLONING; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MOORE KJ, 1995, CYTOGENET CELL GENET, V69, P53, DOI 10.1159/000133937; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; STROBEL MC, 1990, MOL CELL BIOL, V10, P501, DOI 10.1128/MCB.10.2.501; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693; WINDHORST DB, 1973, J INVEST DERMATOL, V60, P529, DOI 10.1111/1523-1747.ep12703609	26	332	339	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1997	16	3					289	292		10.1038/ng0797-289	http://dx.doi.org/10.1038/ng0797-289			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XG609	9207796				2022-12-17	WOS:A1997XG60900026
J	Harbour, JW; Roberson, EDO; Anbunathan, H; Onken, MD; Worley, LA; Bowcock, AM				Harbour, J. William; Roberson, Elisha D. O.; Anbunathan, Hima; Onken, Michael D.; Worley, Lori A.; Bowcock, Anne M.			Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma	NATURE GENETICS			English	Article							GENES; GNAQ	Uveal melanoma is the most common primary cancer of the eye and often results in fatal metastasis. Here, we describe mutations occurring exclusively at codon 625 of the SF3B1 gene, encoding splicing factor 3B subunit 1, in low-grade uveal melanomas with good prognosis. Thus, uveal melanoma is among a small group of cancers associated with SF3B1 mutations, and these mutations denote a distinct molecular subset of uveal melanomas.	[Harbour, J. William; Onken, Michael D.; Worley, Lori A.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Roberson, Elisha D. O.; Anbunathan, Hima; Bowcock, Anne M.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Harbour, JW (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	jwharbour@med.miami.edu; bowcock@genetics.wustl.edu	Harbour, J. William/B-1448-2015; Onken, Michael D/H-5620-2013; Roberson, Elisha/ABC-1810-2020; Anbunathan, Hima/AAU-9360-2021; Roberson, Elisha D.O./J-1747-2012	Harbour, J. William/0000-0002-1104-9809; Onken, Michael D/0000-0003-4082-1105; Roberson, Elisha/0000-0001-5921-2399; Anbunathan, Hima/0000-0002-8458-4845; Roberson, Elisha D.O./0000-0001-5921-2399; Bowcock, Anne/0000-0001-8691-9090	US National Institutes of Health (NIH) [R01 CA16187001, CA12597007]; Melanoma Research Alliance; Melanoma Research Foundation; Tumori Foundation; Research to Prevent Blindness, Inc.; US NIH Vision Core grant [P30 EY02687c]; US NIH training grant [5 T32 AR007279-32]; NATIONAL CANCER INSTITUTE [R01CA161870, R01CA125970] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Melanoma Research Foundation; Tumori Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); US NIH Vision Core grant; US NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by US National Institutes of Health (NIH) grants R01 CA16187001 (A.M.B. and J.W.H.) and CA12597007 (J.W.H.), the Melanoma Research Alliance (J.W.H.), the Melanoma Research Foundation (J.W.H.), the Tumori Foundation (J.W.H.), Research to Prevent Blindness, Inc. (J.W.H.) and awards to the Department of Ophthalmology and Visual Sciences at Washington University from a Research to Prevent Blindness, Inc., Unrestricted grant and the US NIH Vision Core grant P30 EY02687c. E.D.O.R. was supported under US NIH training grant 5 T32 AR007279-32. We thank L. Cao for technical assistance and C. Jordan for exome capture. We thank the patients who volunteered to participate in the study in order to make this work possible. This study was approved by the Human Studies Committee at Washington University in St. Louis, and informed consent was obtained from all subjects.	An M, 2012, INT J DEV BIOL, V56, P223, DOI 10.1387/ijdb.113383ma; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Harbour JW, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00979.x; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Onken MD, 2008, INVEST OPHTH VIS SCI, V49, P5230, DOI 10.1167/iovs.08-2145; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Visconte V, 2012, LEUKEMIA, V26, P2447, DOI 10.1038/leu.2012.130; Visconte V, 2012, BLOOD, V120, P3173, DOI 10.1182/blood-2012-05-430876; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016	13	331	337	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2013	45	2					133	135		10.1038/ng.2523	http://dx.doi.org/10.1038/ng.2523			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	081PB	23313955	Green Accepted			2022-12-17	WOS:000314333000007
J	Birnbaum, S; Ludwig, KU; Reutter, H; Herms, S; Steffens, M; Rubini, M; Baluardo, C; Ferrian, M; de Assis, NA; Alblas, MA; Barth, S; Freudenberg, J; Lauster, C; Schmidt, G; Scheer, M; Braumann, B; Berge, SJ; Reich, RH; Schiefke, F; Hemprich, A; Potzsch, S; Steegers-Theunissen, RP; Potzsch, B; Moebus, S; Horsthemke, B; Kramer, FJ; Wienker, TF; Mossey, PA; Propping, P; Cichon, S; Hoffmann, P; Knapp, M; Nothen, MM; Mangold, E				Birnbaum, Stefanie; Ludwig, Kerstin U.; Reutter, Heiko; Herms, Stefan; Steffens, Michael; Rubini, Michele; Baluardo, Carlotta; Ferrian, Melissa; de Assis, Nilma Almeida; Alblas, Margrieta A.; Barth, Sandra; Freudenberg, Jan; Lauster, Carola; Schmidt, Guel; Scheer, Martin; Braumann, Bert; Berge, Stefaan J.; Reich, Rudolf H.; Schiefke, Franziska; Hemprich, Alexander; Poetzsch, Simone; Steegers-Theunissen, Regine P.; Poetzsch, Bernd; Moebus, Susanne; Horsthemke, Bernhard; Kramer, Franz-Josef; Wienker, Thomas F.; Mossey, Peter A.; Propping, Peter; Cichon, Sven; Hoffmann, Per; Knapp, Michael; Noethen, Markus M.; Mangold, Elisabeth			Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; EXPRESSION; RISK; IRF6; METAANALYSIS; DISEASE; DESIGN; CANCER; SCAN	We conducted a genome-wide association study involving 224 cases and 383 controls of Central European origin to identify susceptibility loci for nonsyndromic cleft lip with or without cleft palate (NSCL/P). A 640-kb region at chromosome 8q24.21 was found to contain multiple markers with highly significant evidence for association with the cleft phenotype, including three markers that reached genome-wide significance. The 640-kb cleft-associated region was saturated with 146 SNP markers and then analyzed in our entire NSCL/P sample of 462 unrelated cases and 954 controls. In the entire sample, the most significant SNP (rs987525) had a P value of 3.34 x 10(-24). The odds ratio was 2.57 (95% CI = 2.02-3.26) for the heterozygous genotype and 6.05 (95% CI = 3.88-9.43) for the homozygous genotype. The calculated population attributable risk for this marker is 0.41, suggesting that this study has identified a major susceptibility locus for NSCL/P.	[Birnbaum, Stefanie; Reutter, Heiko; de Assis, Nilma Almeida; Cichon, Sven; Hoffmann, Per; Noethen, Markus M.; Mangold, Elisabeth] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Birnbaum, Stefanie; Kramer, Franz-Josef] Univ Gottingen, Dept Oral & Maxillofacial Surg, Gottingen, Germany; [Ludwig, Kerstin U.; Herms, Stefan; Alblas, Margrieta A.; Barth, Sandra; Cichon, Sven; Hoffmann, Per; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-5300 Bonn, Germany; [Steffens, Michael; Wienker, Thomas F.; Knapp, Michael] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; [Rubini, Michele; Baluardo, Carlotta; Ferrian, Melissa] Univ Ferrara, Dept Expt & Diagnost Med, Med Genet Unit, I-44100 Ferrara, Italy; [Freudenberg, Jan] Northshore LIJ Univ Hosp, Feinstein Inst Med Res, Ctr Genom & Human Genet, New York, NY USA; [Lauster, Carola; Schmidt, Guel] Humboldt Univ, Dept Cleft Lip & Cleft Palate Surg, Berlin, Germany; [Scheer, Martin] Univ Cologne, Dept Oral & Maxillofacial Surg, Cologne, Germany; [Braumann, Bert] Univ Cologne, Dept Orthodont, Cologne, Germany; [Berge, Stefaan J.] Radboud Univ Nijmegen, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands; [Reich, Rudolf H.] Univ Bonn, Dept Oral & Maxillofacial Plast Surg, D-5300 Bonn, Germany; [Schiefke, Franziska; Hemprich, Alexander] Univ Leipzig, Dept Oral & Maxillofacial Surg, Leipzig, Germany; [Poetzsch, Simone] Univ Magdeburg, D-39106 Magdeburg, Germany; [Steegers-Theunissen, Regine P.] Univ Med Ctr, Rotterdam, Netherlands; [Poetzsch, Bernd] Univ Bonn, Inst Expt Hematol & Transfus Med, D-5300 Bonn, Germany; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Duisburg, Germany; [Horsthemke, Bernhard] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Duisburg, Germany; [Mossey, Peter A.] Univ Dundee, Dent Hosp & Sch, Orthodont Unit, Dundee, Scotland	University of Bonn; University of Gottingen; University of Bonn; University of Bonn; University of Ferrara; Northwell Health; Humboldt University of Berlin; University of Cologne; University of Cologne; Radboud University Nijmegen; University of Bonn; Leipzig University; Otto von Guericke University; University of Bonn; University of Duisburg Essen; University of Duisburg Essen; University of Dundee	Mangold, E (corresponding author), Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany.	e.mangold@uni-bonn.de	Cichon, Sven/B-9618-2014; Rubini, Michele/AFF-8477-2022; Herms, Stefan/J-1949-2014; Berge, Stefaan/AAP-3708-2020; Cichon, Sven/H-8803-2013; Ludwig, Kerstin U/H-7828-2019; Hoffmann, Per/A-5149-2010; Bergé, S.J./H-8011-2014; Nöthen, Markus/B-2027-2009	Cichon, Sven/0000-0002-9475-086X; Rubini, Michele/0000-0003-1448-9516; Herms, Stefan/0000-0002-2786-8200; Cichon, Sven/0000-0002-9475-086X; Ludwig, Kerstin U/0000-0002-8541-2519; Hoffmann, Per/0000-0002-6573-983X; Nöthen, Markus/0000-0002-8770-2464; Ferrian, Melissa/0000-0002-3746-4576; Mossey, Peter/0000-0002-9914-6901; Moebus, Susanne/0000-0002-0072-5410; Steffens, Michael/0000-0002-6445-8593	Deutsche Forschungsgemeinschaft [MA 2546/3-1, KR 1912/7-1, NO 246/6-1, WI 1555/5-1]; Heinz Nixdorf Foundation, Germany; European Comission FP5 [QLG1-CT-2000-01019]; University of Ferrara; CNPq/Brazil	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heinz Nixdorf Foundation, Germany; European Comission FP5; University of Ferrara; CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank the subjects and their families for their participation in the study as well as the German support group for people with cleft lip and/or palate (Deutsche Selbsthilfevereinigung fur Lippen-Gaumen-Fehlbildungen e. V.). We acknowledge M. Saffar, H. Koch, C. Opitz, M. Krimmel, K. Gundlach, K. Lohrer and B. Blaumeiser for their kind support in contacting subjects. The EUROCRAN project included contributions from R. Brusati, G. Garattini, E. Calzolari, M. Accordi and A. Franchella (Italy), W. C. Shaw, P. Nelson and P. Houston (UK), S. de Weerd and I. Krapels (Netherlands), V. Kozelj and B. Peterlin (Slovenia), Y. Anastassov (Bulgaria), S. Hanstein (Estonia), A. Czeizel (Hungary), I. Klimova (Slovak Republic) and J. Little (Canada). We also thank S. Raeder, S. Uhlhaas, N. Kluck, A. Flosdorff and M. Arbustini for their laboratory work; H. Henschke and A. Diaz Lacava for their database management; and S. Boehringer for discussions. The study was supported by the Deutsche Forschungsgemeinschaft (FOR 423 and individual grants MA 2546/3-1, KR 1912/7-1, NO 246/6-1, WI 1555/5-1). The Heinz Nixdorf Recall cohort was established with the generous support of the Heinz Nixdorf Foundation, Germany (Chairman: Dr. jur. G. Schmidt). The EUROCRAN study was supported by the European Comission FP5 (contract no. QLG1-CT-2000-01019) and the ITALCLEFT study by a FAR-2008 grant from the University of Ferrara. N.A. is supported by the CNPq/Brazil.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker T, 2004, AM J HUM GENET, V75, P561, DOI 10.1086/424390; Cann HM, 2002, SCIENCE, V296, P261; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Hirano T, 2008, MUTAT RES-FUND MOL M, V640, P97, DOI 10.1016/j.mrfmmm.2007.12.008; Jackson MR, 2002, ANN HUM GENET, V66, P307, DOI 10.1017/S0003480002001203; Jugessur A, 2008, GENET EPIDEMIOL, V32, P413, DOI 10.1002/gepi.20314; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moskvina V, 2005, ANN HUM GENET, V69, P566, DOI 10.1111/j.1529-8817.2005.00175.x; Mossey P., 2002, CLEFT LIP PALATE, P127; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; RISCH N, 1996, SCIENCE, V273, P1517; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466	29	331	348	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					473	477		10.1038/ng.333	http://dx.doi.org/10.1038/ng.333			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19270707				2022-12-17	WOS:000264659000023
J	Zhang, XJ; Huang, W; Yang, S; Sun, LD; Zhang, FY; Zhu, QX; Zhang, FR; Zhang, C; Du, WH; Pu, XM; Li, H; Xiao, FL; Wang, ZX; Cui, Y; Hao, F; Zheng, J; Yang, XQ; Cheng, H; He, CD; Liu, XM; Xu, LM; Zheng, HF; Zhang, SM; Zhang, JZ; Wang, HY; Cheng, YL; Ji, BH; Fang, QY; Li, YZ; Zhou, FS; Han, JW; Quan, C; Chen, B; Liu, JL; Li, D; Fan, L; Zhang, AP; Liu, SX; Yang, CJ; Wang, PG; Zhou, WM; Lin, GS; Wu, WD; Fan, X; Gao, M; Yang, BQ; Lu, WS; Zhang, Z; Zhu, KJ; Shen, SK; Li, M; Zhang, XY; Cao, TT; Ren, W; Zhang, X; He, J; Tang, XF; Lu, S; Yang, JQ; Zhang, L; Wang, DN; Yuan, F; Yin, XY; Huang, HJ; Wang, HF; Lin, XY; Liu, JJ				Zhang, Xue-Jun; Huang, Wei; Yang, Sen; Sun, Liang-Dan; Zhang, Feng-Yu; Zhu, Qi-Xing; Zhang, Fu-Ren; Zhang, Chi; Du, Wen-Hui; Pu, Xiong-Ming; Li, Hui; Xiao, Feng-Li; Wang, Zai-Xing; Cui, Yong; Hao, Fei; Zheng, Jie; Yang, Xue-Qin; Cheng, Hui; He, Chun-Di; Liu, Xiao-Ming; Xu, Li-Min; Zheng, Hou-Feng; Zhang, Shu-Mei; Zhang, Jian-Zhong; Wang, Hong-Yan; Cheng, Yi-Lin; Ji, Bi-Hua; Fang, Qiao-Yun; Li, Yu-Zhen; Zhou, Fu-Sheng; Han, Jian-Wen; Quan, Cheng; Chen, Bin; Liu, Jun-Lin; Li, Da; Fan, Li; Zhang, An-Ping; Liu, Sheng-Xiu; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lin, Guo-Shu; Wu, Wei-Dong; Fan, Xing; Gao, Min; Yang, Bao-Qi; Lu, Wen-Sheng; Zhang, Zheng; Zhu, Kun-Ju; Shen, Song-Ke; Li, Min; Zhang, Xiao-Yan; Cao, Ting-Ting; Ren, Wei; Zhang, Xin; He, Jun; Tang, Xian-Fa; Lu, Shun; Yang, Jian-Qiang; Zhang, Lin; Wang, Dan-Ni; Yuan, Feng; Yin, Xian-Yong; Huang, Hong-Jie; Wang, Hai-Feng; Lin, Xin-Yi; Liu, Jian-Jun			Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21	NATURE GENETICS			English	Article							VULGARIS; IL12B; POLYMORPHISMS; POPULATION; PROTEINS; SEQUENCE; COMPLEX; IL23R; SKIN	We report the first large genome-wide association study (GWAS) in a Chinese population to identify susceptibility variants for psoriasis using a two-stage case-control design. In the first stage, we carried out a genome-wide association analysis in 1,139 cases and 1,132 controls of Chinese Han ancestry using Illumina Human 610-Quad BeadChips. In the second stage, we took top SNPs forward for replication in two independent samples of 5,182 cases and 6,516 controls of Chinese Han ancestry, and 539 cases and 824 controls of Chinese Uygur ancestry. In addition to the strong replication for two known susceptibility loci MHC (rs1265181, P 1.93 x 10(-208), OR = 22.62) and IL12B (rs3213094, P-combined = 2.58 x 10(-26), OR = 0.78), we identified a new susceptibility locus within the LCE gene cluster on 1q21 (rs4085613, P-combined = 6.69 x 10(-30), OR = 0.76).	[Zhang, Xue-Jun; Yang, Sen; Sun, Liang-Dan; Zhang, Feng-Yu; Zhu, Qi-Xing; Zhang, Chi; Du, Wen-Hui; Li, Hui; Xiao, Feng-Li; Wang, Zai-Xing; Cui, Yong; Cheng, Hui; Liu, Xiao-Ming; Zheng, Hou-Feng; Zhang, Shu-Mei; Wang, Hong-Yan; Cheng, Yi-Lin; Ji, Bi-Hua; Fang, Qiao-Yun; Li, Yu-Zhen; Zhou, Fu-Sheng; Han, Jian-Wen; Quan, Cheng; Chen, Bin; Liu, Jun-Lin; Li, Da; Fan, Li; Zhang, An-Ping; Liu, Sheng-Xiu; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lin, Guo-Shu; Fan, Xing; Gao, Min; Lu, Wen-Sheng; Zhang, Zheng; Zhu, Kun-Ju; Shen, Song-Ke; Li, Min; Zhang, Xiao-Yan; Cao, Ting-Ting; Ren, Wei; Zhang, Xin; He, Jun; Tang, Xian-Fa; Lu, Shun; Yang, Jian-Qiang; Zhang, Lin; Wang, Dan-Ni; Yuan, Feng; Yin, Xian-Yong; Liu, Jian-Jun] Anhui Med Univ, Inst Dermatol, Hosp 1, Hefei 230022, Anhui, Peoples R China; [Zhang, Xue-Jun; Yang, Sen; Sun, Liang-Dan; Zhang, Feng-Yu; Zhu, Qi-Xing; Zhang, Chi; Du, Wen-Hui; Li, Hui; Xiao, Feng-Li; Wang, Zai-Xing; Cui, Yong; Cheng, Hui; Zheng, Hou-Feng; Zhang, Shu-Mei; Wang, Hong-Yan; Cheng, Yi-Lin; Han, Jian-Wen; Quan, Cheng; Chen, Bin; Liu, Jun-Lin; Li, Da; Fan, Li; Zhang, An-Ping; Liu, Sheng-Xiu; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lin, Guo-Shu; Fan, Xing; Gao, Min; Lu, Wen-Sheng; Zhang, Zheng; Zhu, Kun-Ju; Shen, Song-Ke; Li, Min; Zhang, Xiao-Yan; Cao, Ting-Ting; Ren, Wei; Zhang, Xin; He, Jun; Tang, Xian-Fa; Lu, Shun; Yang, Jian-Qiang; Zhang, Lin; Wang, Dan-Ni; Yuan, Feng; Yin, Xian-Yong; Liu, Jian-Jun] Anhui Med Univ, Dept Dermatol, Hosp 1, Hefei 230022, Anhui, Peoples R China; [Zhang, Xue-Jun; Yang, Sen; Sun, Liang-Dan; Zhang, Feng-Yu; Zhu, Qi-Xing; Zhang, Chi; Du, Wen-Hui; Pu, Xiong-Ming; Li, Hui; Xiao, Feng-Li; Wang, Zai-Xing; Cui, Yong; Cheng, Hui; Zheng, Hou-Feng; Zhang, Shu-Mei; Wang, Hong-Yan; Cheng, Yi-Lin; Fang, Qiao-Yun; Zhou, Fu-Sheng; Han, Jian-Wen; Quan, Cheng; Chen, Bin; Liu, Jun-Lin; Li, Da; Fan, Li; Zhang, An-Ping; Liu, Sheng-Xiu; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lin, Guo-Shu; Fan, Xing; Gao, Min; Lu, Wen-Sheng; Zhang, Zheng; Zhu, Kun-Ju; Shen, Song-Ke; Li, Min; Zhang, Xiao-Yan; Cao, Ting-Ting; Ren, Wei; Zhang, Xin; He, Jun; Tang, Xian-Fa; Lu, Shun; Yang, Jian-Qiang; Zhang, Lin; Wang, Dan-Ni; Yuan, Feng; Yin, Xian-Yong; Liu, Jian-Jun] Minist Educ & Anhui Prov, Key Lab Gene Resource Utilizat Severe Dis, Hefei 230032, Anhui, Peoples R China; [Zhang, Xue-Jun; Yang, Sen; Sun, Liang-Dan; Zhang, Feng-Yu; Zhu, Qi-Xing; Zhang, Fu-Ren; Zhang, Chi; Du, Wen-Hui; Pu, Xiong-Ming; Li, Hui; Xiao, Feng-Li; Wang, Zai-Xing; Cui, Yong; Yang, Xue-Qin; Cheng, Hui; Zheng, Hou-Feng; Zhang, Shu-Mei; Wang, Hong-Yan; Cheng, Yi-Lin; Han, Jian-Wen; Quan, Cheng; Chen, Bin; Liu, Jun-Lin; Li, Da; Fan, Li; Zhang, An-Ping; Liu, Sheng-Xiu; Yang, Chun-Jun; Wang, Pei-Guang; Zhou, Wen-Ming; Lin, Guo-Shu; Wu, Wei-Dong; Fan, Xing; Gao, Min; Yang, Bao-Qi; Lu, Wen-Sheng; Zhang, Zheng; Zhu, Kun-Ju; Shen, Song-Ke; Li, Min; Zhang, Xiao-Yan; Cao, Ting-Ting; Ren, Wei; Zhang, Xin; He, Jun; Tang, Xian-Fa; Lu, Shun; Yang, Jian-Qiang; Zhang, Lin; Wang, Dan-Ni; Yuan, Feng; Yin, Xian-Yong] Anhui Med Univ, Dept Dermatol & Venerol, Hefei 230032, Anhui, Peoples R China; [Huang, Wei; Huang, Hong-Jie; Wang, Hai-Feng] Chinese Natl Human Genome Ctr, Shanghai 201203, Peoples R China; [Huang, Wei; Huang, Hong-Jie; Wang, Hai-Feng] Natl Engn Ctr Biochip Design & Engineer, Shanghai 201203, Peoples R China; [Zhang, Feng-Yu; Yang, Bao-Qi] Shandong Prov Inst Dermatol & Venereol, Jinan 250022, Shandong, Peoples R China; [Pu, Xiong-Ming; Wu, Wei-Dong] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Dermatol, Urumqi 830001, Xinjiang, Peoples R China; [Hao, Fei] Third Mil Med Univ, Dept Dermatol, Southwest Hosp, Chongqing 400038, Peoples R China; [Zheng, Jie] Shanghai Jiao Tong Univ, Sch Med, Dept Dermatol, Ruijin Hosp, Shanghai 200025, Peoples R China; [Yang, Xue-Qin] Gen Hosp AF, Dept Dermatol, PLA, Beijing 100036, Peoples R China; [He, Chun-Di] China Med Univ, Dept Dermatol, Hosp 1, Shenyang 110001, Liaoning, Peoples R China; [Liu, Xiao-Ming] Dalian Med Univ, Dept Dermatol, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China; [Xu, Li-Min] Changzheng Hosp, Dept Dermatol, Tianjin 300120, Peoples R China; [Zhang, Jian-Zhong] Peking Univ, Dept Dermatol, Peoples Hosp, Beijing 100044, Peoples R China; [Ji, Bi-Hua] Wannan Med Coll, Dept Dermatol, Yijishan Hosp, Wuhu 241000, Anhui, Peoples R China; [Li, Yu-Zhen] Harbin Med Coll, Dept Dermatol, Affiliated Hosp 2, Harbin 150086, Heilongjiang, Peoples R China; [Lin, Xin-Yi; Liu, Jian-Jun] Genome Inst Singapore, Singapore 138672, Singapore	Anhui Medical University; Anhui Medical University; Anhui Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Army Medical University; Shanghai Jiao Tong University; China Medical University; Dalian Medical University; Naval Medical University; Peking University; Wannan Medical College; Harbin Medical University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Zhang, XJ (corresponding author), Anhui Med Univ, Inst Dermatol, Hosp 1, Hefei 230022, Anhui, Peoples R China.	ayzxj@vip.sina.com	Zhu, Qixing/AAM-4214-2020; Chen, Gang/G-2722-2010; Lin, Xinyi Cindy/D-8130-2019; Zhang, Fengyu/M-1396-2019; Liu, Jianjun/AAK-4989-2020; Zhu, Kunju/AAN-5264-2020; Cui, Yong/AAF-9300-2020; Pillay, Nischalan/F-9536-2012; Zheng, Houfeng/K-4424-2012	Lin, Xinyi Cindy/0000-0002-7209-6588; Zhang, Fengyu/0000-0001-8504-0770; Liu, Jianjun/0000-0002-3255-3019; Zhu, Kunju/0000-0002-3649-209X; Zheng, Houfeng/0000-0001-5681-8598; Wang, Haifeng/0000-0001-5022-0720	Anhui Provincial Special Scientific [2007-7]; High-Tech Research and Development Program of China [2007AA02Z161]; Key Project of Natural Science Foundation of China [30530670]; National Basic Research Program of China [2007B516801]; General Program of National Natural Science Foundation of China [30671895, 30771196, 30771942]; Agency for Science & Technology and Research of Singapore (A*STAR)	Anhui Provincial Special Scientific; High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Key Project of Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agency for Science & Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR))	We thank G. P. Zhao, G. Y. Xu, L. Jin, X. Zhang, S. J. Xu and Z. G. Lin for assistance. And we would like to thank all the volunteers who took part in this work. We also want to thank L. Yi and E. Tantoso for their assistance in data analysis. This work was funded by the Anhui Provincial Special Scientific Program (2007-7), the High-Tech Research and Development Program of China (863 Plan) (2007AA02Z161), the Key Project of Natural Science Foundation of China (30530670), National Basic Research Program of China (973 Plan) (2007B516801), General Program of National Natural Science Foundation of China (30671895, 30771196, 30771942) and Agency for Science & Technology and Research of Singapore (A*STAR) (for J. J. L. and X. Y. L.).	BACKENDORF C, 1992, NAT GENET, V2, P91, DOI 10.1038/ng1092-91; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Bowcock AM, 2004, J INVEST DERMATOL, V122, pXV, DOI 10.1111/j.0022-202X.2004.22627.x; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chang YT, 2007, BRIT J DERMATOL, V156, P899, DOI 10.1111/j.1365-2133.2007.07820.x; ENGELKAMP D, 1993, P NATL ACAD SCI USA, V90, P6547, DOI 10.1073/pnas.90.14.6547; Fan X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000038; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Lesueur F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000906; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; SIMONS RDGP, 1949, J INVEST DERMATOL, V12, P285, DOI 10.1038/jid.1949.42; Tsunemi Y, 2002, J DERMATOL SCI, V30, P161, DOI 10.1016/S0923-1811(02)00072-5; Wang A, 2001, GENOMICS, V73, P284, DOI 10.1006/geno.2001.6518; YIP SY, 1984, J AM ACAD DERMATOL, V10, P965, DOI 10.1016/S0190-9622(84)80314-X; Zhang XJ, 2002, INT J DERMATOL, V41, P663, DOI 10.1046/j.1365-4362.2002.01596.x; Zhang XJ, 2007, J INVEST DERMATOL, V127, P2544, DOI 10.1038/sj.jid.5700896	27	331	367	5	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2009	41	2					205	210		10.1038/ng.310	http://dx.doi.org/10.1038/ng.310			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	403OG	19169255				2022-12-17	WOS:000263091300021
J	Zimprich, A; Grabowski, M; Asmus, F; Naumann, M; Berg, D; Bertram, M; Scheidtmann, K; Kern, P; Winkelmann, F; Muller-Myhsok, B; Riedel, L; Bauer, M; Muller, T; Castro, M; Meitinger, T; Strom, TM; Gasser, T				Zimprich, A; Grabowski, M; Asmus, F; Naumann, M; Berg, D; Bertram, M; Scheidtmann, K; Kern, P; Winkelmann, F; Muller-Myhsok, B; Riedel, L; Bauer, M; Muller, T; Castro, M; Meitinger, T; Strom, TM; Gasser, T			Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome	NATURE GENETICS			English	Article							GIRDLE MUSCULAR-DYSTROPHY; HEREDITARY ESSENTIAL MYOCLONUS; ONSET TORSION DYSTONIA; D2 DOPAMINE-RECEPTOR; ALPHA-SARCOGLYCAN; COMPLEX; FAMILY; 2D	The dystonias are a common clinically and genetically heterogeneous group of movement disorders. More than ten loci for inherited forms of dystonia have been mapped, but only three mutated genes have been identified so far. These are DYT1, encoding torsin A(1) and mutant in the early-onset generalized form, GCH1 (formerly known as DYT5), encoding GTP-cyclohydrolase I and mutant in dominant dopa-responsive dystonia(2), and TH, encoding tyrosine hydroxylase and mutant in the recessive form of the disease(3). Myoclonus-dystonia syndrome (MDS; DYT11) is an autosomal dominant disorder characterized by bilateral, alcohol-sensitive myoclonic jerks involving mainly the arms and axial muscles(4,5). Dystonia, usually torticollis and/or writer's cramp, occurs in most but not all affected patients and may occasionally be the only symptom of the disease(6,7). In addition, patients often show prominent psychiatric abnormalities, including panic attacks and obsessive-compulsive behavior(8-10). In most MDS families, the disease is linked to a locus on chromosome 7q21 (refs. 11-13). Using a positional cloning approach, we have identified five different heterozygous loss-of-function mutations in the gene for epsilon -sarcoglycan (SGCE), which we mapped to a refined critical region of about 3.2 Mb. SGCE is expressed in all brain regions examined. Pedigree analysis shows a marked difference in penetrance depending on the parental origin of the disease allele, This is indicative of a maternal imprinting mechanism, which has been demonstrated in the mouse epsilon -sarcoglycan gene(14).	Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany; GSF Munich, Natl Res Ctr, Inst Human Genet, Munich, Germany; Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; Heidelberg Univ, Dept Neurol, D-6900 Heidelberg, Germany; Neurol Hosp, Bad Aibling, Germany; Klinikum Buch, Dept Neurol, Berlin, Germany; Inst Psychiat, Dept Neurol, Munich, Germany; Bernhard Nocht Inst Trop Med, Hamburg, Germany; LionBiosci AG, Heidelberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Wurzburg; Ruprecht Karls University Heidelberg; Bernhard Nocht Institut fur Tropenmedizin	Gasser, T (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Neurol, Munich, Germany.	tgasser@brain.nefo.med.uni-muenchen.de	Müller-Myhsok, Bertram/A-3289-2013; Gasser, Thomas/GNH-5293-2022; Zimprich, Alexander/A-5232-2017; Berg, Daniela/A-8728-2019; Meitinger, Thomas/O-1318-2015	Gasser, Thomas/0000-0002-1069-1146; Zimprich, Alexander/0000-0002-1668-5177; Berg, Daniela/0000-0001-5796-5442; Meitinger, Thomas/0000-0002-8838-8403; Castro, Mirna/0000-0002-3452-9215; Winkelmann, Juliane/0000-0003-2667-9691; Bauer, Michaela/0000-0001-8717-3278				Asmus F, 2001, ANN NEUROL, V49, P121, DOI 10.1002/1531-8249(200101)49:1<121::AID-ANA20>3.0.CO;2-8; DOHENY D, 2000, MOVEMENT DISORD, V15, pS162; Durr A, 2000, ANN NEUROL, V48, P127; Ettinger AJ, 1997, J BIOL CHEM, V272, P32534, DOI 10.1074/jbc.272.51.32534; FAHN S, 1991, MOVEMENT DISORD, V6, P237, DOI 10.1002/mds.870060308; Gasser T, 1998, Adv Neurol, V78, P325; Gasser T, 1996, MOVEMENT DISORD, V11, P363, DOI 10.1002/mds.870110403; Grimes DA, 2001, MOVEMENT DISORD, V16, P106, DOI 10.1002/1531-8257(200101)16:1<106::AID-MDS1022>3.0.CO;2-7; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Imamura M, 2000, HUM MOL GENET, V9, P3091, DOI 10.1093/hmg/9.20.3091; Klein C, 2000, AM J HUM GENET, V67, P1314; Klein C, 1999, P NATL ACAD SCI USA, V96, P5173, DOI 10.1073/pnas.96.9.5173; Kurlan R, 1988, Adv Neurol, V50, P385; KURLAN R, 1987, MOVEMENT DISORD, V2, P301, DOI 10.1002/mds.870020407; KYLLERMAN M, 1990, MOVEMENT DISORD, V5, P270, DOI 10.1002/mds.870050403; Lim LE, 1998, CURR OPIN NEUROL, V11, P443, DOI 10.1097/00019052-199810000-00006; LUDECKE B, 1995, HUM GENET, V95, P123; LUNDEMO G, 1985, ACTA NEUROL SCAND, V72, P176; McNally EM, 1998, FEBS LETT, V422, P27, DOI 10.1016/S0014-5793(97)01593-7; Nygaard TG, 1999, ANN NEUROL, V46, P794, DOI 10.1002/1531-8249(199911)46:5<794::AID-ANA19>3.0.CO;2-2; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Quinn N P, 1988, Adv Neurol, V50, P391; Scheidtmann K, 2000, NERVENARZT, V71, P839, DOI 10.1007/s001150050673; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Straub V, 1999, J BIOL CHEM, V274, P27989, DOI 10.1074/jbc.274.39.27989	27	331	346	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2001	29	1					66	69		10.1038/ng709	http://dx.doi.org/10.1038/ng709			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	468WN	11528394				2022-12-17	WOS:000170781300019
J	Lee, SH; Girard, S; Macina, D; Busa, M; Zafer, A; Belouchi, A; Gros, P; Vidal, SM				Lee, SH; Girard, S; Macina, D; Busa, M; Zafer, A; Belouchi, A; Gros, P; Vidal, SM			Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily	NATURE GENETICS			English	Article							RESISTANCE LOCUS CMV1; GENE-COMPLEX; LY49; MHC; FAMILY; MAP; CHROMOSOME-6; SPECIFICITY; RECOGNITION; EXPRESSION	Cytomegalovirus is the leading cause of congenital viral disease and the most important opportunistic infection in immunocompromised patients(1,2). We have used a mouse experimental infection model (MCMV) to study the genetic parameters of host/virus interaction. Susceptibility to infection with MCMV is controlled by Cmv1, a chromosome 6 locus that regulates natural killer (NK) cell activity against virally infected targets(3-5). Here, we use a positional cloning strategy to isolate the gene mutated at the Cmv1 locus. Cmv1 maps within a 0.35-cM interval defined by markers D6Ott8 and D6Ott115, which corresponds to a physical distance of 1.6 Mb (refs. 6-8). A transcript map of the region identified 19 genes(8), including members of the killer cell lectin-like receptor family a (Klra, formerly Ly49; refs. 9-12), which encode inhibitory or activating NK cell receptors that interact with MHC class I molecules(13-15). Klra genes have different copy numbers and genomic organization, and are highly polymorphic among inbred strains, making it difficult to distinguish between normal allelic variants and distinct Klra genes(15-17), or possible mutations associated with Cmv1. The recombinant inbred strain BXD-8/Ty (BXD-8; ref. 18), derived from Cmv1(r) C57BL/6 (B6, resistant) and Cmv1(s) DBA/2 (susceptible), is of particular interest because it is highly susceptible to MCMV infection despite having a B6 haplotype at Cmv1, We determined that MCMV susceptibility in BXD-8 is associated with the deletion of Klra8 (formerly Ly49h).	Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; Galileo Genom Inc, Montreal, PQ, Canada; McGill Univ, Dept Biochem, Montreal, PQ, Canada	University of Ottawa; McGill University	Vidal, SM (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.							BRENNAN J, 1994, J EXP MED, V180, P2287, DOI 10.1084/jem.180.6.2287; Brown MG, 1997, IMMUNOL REV, V155, P53, DOI 10.1111/j.1600-065X.1997.tb00939.x; Brown MG, 1997, GENOMICS, V42, P16, DOI 10.1006/geno.1997.4721; DELAINE M, 1995, PHYS WORLD, V8, P6; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Depatie C, 1997, GENOMICS, V39, P154, DOI 10.1006/geno.1996.4498; Depatie C, 1999, INT IMMUNOL, V11, P1541, DOI 10.1093/intimm/11.9.1541; Depatie C, 2000, GENOMICS, V66, P161, DOI 10.1006/geno.2000.6186; Farrell H, 2000, MICROBES INFECT, V2, P521, DOI 10.1016/S1286-4579(00)00315-4; Gosselin P, 1999, J LEUKOCYTE BIOL, V66, P165, DOI 10.1002/jlb.66.1.165; HO M, 1994, TRANSPLANT P, V5, P7; Hoglund P, 1997, IMMUNOL REV, V155, P11, DOI 10.1111/j.1600-065X.1997.tb00936.x; Hurme M, 1998, SCAND J INFECT DIS, V30, P447, DOI 10.1080/00365549850161403; Idris AH, 1998, J EXP MED, V188, P2243, DOI 10.1084/jem.188.12.2243; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kuboto A, 1999, J IMMUNOL, V163, P212; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Makrigiannis AP, 2000, J LEUKOCYTE BIOL, V68, P765; Makrigiannis AP, 2000, IMMUNOL RES, V21, P39, DOI 10.1385/IR:21:1:39; McQueen KL, 1998, IMMUNOGENETICS, V48, P174, DOI 10.1007/s002510050421; Nakamura MC, 1999, J EXP MED, V189, P493, DOI 10.1084/jem.189.3.493; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; SCALZO AA, 1995, GENOMICS, V27, P435, DOI 10.1006/geno.1995.1074; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; SMITH HRC, 1994, J IMMUNOL, V153, P1068; Takei F, 1997, IMMUNOL REV, V155, P67, DOI 10.1111/j.1600-065X.1997.tb00940.x; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; Threlkeld MG, 1995, MANDELL DOUGLAS BENN, P1351	30	331	337	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2001	28	1					42	45		10.1038/88247	http://dx.doi.org/10.1038/88247			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	427NW	11326273				2022-12-17	WOS:000168413300013
J	Di Palma, F; Holme, RH; Bryda, EC; Belyantseva, IA; Pellegrino, R; Kachar, B; Steel, KP; Noben-Trauth, K				Di Palma, F; Holme, RH; Bryda, EC; Belyantseva, IA; Pellegrino, R; Kachar, B; Steel, KP; Noben-Trauth, K			Mutations in Cdh23, encoding a new type of cadherin, cause stereocilia disorganization in waltzer, the mouse model for Usher syndrome type 1D	NATURE GENETICS			English	Article							MYOSIN VIIA; GENE; MICE; IDENTIFICATION; DEAFNESS; CHROMOSOME-10; LOCALIZATION; ALLELE; ROLES; CA2+	Mouse chromosome 10 harbors several loci associated with hearing loss, including waltzer (v), modifier-of deaf waddler (mdfw) and Age-related hearing loss(1) (Ahl). The human region that is orthologous to the mouse 'waltzer' region is located at 10q21-q22 and contains the human deafness loci DFNB12 and USH1D (refs. 2,3). Numerous mutations at the waltzer locus have been documented causing erratic circling and hearing loss(4-7). Here we report the identification of a new gene mutated in v. The 10.5-kb Cdh23 cDNA encodes a very large, single-pass transmembrane protein, that we have called otocadherin. It has an extracellular domain that contains 27 repeats; these show significant homology to the cadherin ectodomain. In v(6J), a GT transversion creates a premature stop codon. In v(Alb), a Cr exchange generates an ectopic donor splice site, effecting deletion of 119 nucleotides of exonic sequence. In v(2J), a GA transition abolishes the donor splice site, leading to aberrant splice forms. All three alleles are predicted to cause loss of function. We demonstrate Cdh23 expression in the neurosensory epithelium and show that during early hair-cell differentiation, stereocilia organization is disrupted in v(2J) homozygotes. Our data indicate that otocadherin is a critical component of hair bundle formation. Mutations in human CDH23 cause Usher syndrome type 1D and thus, establish waltzer as the mouse model for USH1D.	Natl Inst Deafness & Other Commun Disorders, Sect Murine Genet, Genet Mol Lab, NIH, Rockville, MD USA; Natl Inst Deafness & Other Commun Disorders, Lab Cellular Biol, NIH, Rockville, MD USA; MRC, Inst Hearing Res, Nottingham, England; Marshall Univ, Sch Med, Dept Immunol & Mol Genet, Huntington, WV USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Marshall University	Noben-Trauth, K (corresponding author), Natl Inst Deafness & Other Commun Disorders, Sect Murine Genet, Genet Mol Lab, NIH, Rockville, MD USA.	nobentk@nidcd.nih.gov		Di-Palma, Federica/0000-0002-4394-0102	NIDCD NIH HHS [DC03771] Funding Source: Medline; PHS HHS [DZ 00036-04] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000002, ZIADC000002, Z01DC000036, R03DC003771] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; BOLZ H, 2000, NAT GENET, V27, P105; Bryda EC, 1997, MAMM GENOME, V8, P1, DOI 10.1007/s003359900336; Chaib H, 1996, HUM MOL GENET, V5, P1061, DOI 10.1093/hmg/5.7.1061; DEOL MS, 1956, J EMBRYOL EXP MORPH, V4, P190; DEOL MS, 1956, PROC R SOC SER B-BIO, V145, P206, DOI 10.1098/rspb.1956.0028; FLAHERTY L, 1992, P NATL ACAD SCI USA, V89, P2859, DOI 10.1073/pnas.89.7.2859; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HUNTERDUVAR IM, 1978, ACTA OTO-LARYNGOL, P3; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Liu XR, 1999, J NEUROSCI, V19, P6267; *MGD, 2000, MOUS GEN INF PROJ; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; Rost B, 1996, METHOD ENZYMOL, V266, P525; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Self T, 1998, DEVELOPMENT, V125, P557; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Suzuki ST, 1996, J CELL SCI, V109, P2609; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; Yagi T, 2000, GENE DEV, V14, P1169; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yonezawa S, 1999, HEARING RES, V134, P116, DOI 10.1016/S0378-5955(99)00080-5	29	331	339	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2001	27	1					103	107		10.1038/83660	http://dx.doi.org/10.1038/83660			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138008				2022-12-17	WOS:000166187900025
J	Zhang, K; Kniazeva, M; Han, M; Li, W; Yu, ZY; Yang, ZL; Li, Y; Metzker, ML; Allikmets, R; Zack, DJ; Kakuk, LE; Lagali, PS; Wong, PW; MacDonald, IM; Sieving, PA; Figueroa, DJ; Austin, CP; Gould, RJ; Ayyagari, R; Petrukhin, K				Zhang, K; Kniazeva, M; Han, M; Li, W; Yu, ZY; Yang, ZL; Li, Y; Metzker, ML; Allikmets, R; Zack, DJ; Kakuk, LE; Lagali, PS; Wong, PW; MacDonald, IM; Sieving, PA; Figueroa, DJ; Austin, CP; Gould, RJ; Ayyagari, R; Petrukhin, K			A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; DISEASE GENE; ABCR; IDENTIFICATION; MEMBRANE; ACID; BIOSYNTHESIS; ELONGATION; MUTATIONS	Stargardt-like macular dystrophy (STGD3, MIM 600110) and autosomal dominant macular dystrophy (adMD) are inherited forms of macular degeneration characterized by decreased visual acuity, macular atrophy and extensive fundus flecks(1-3). Genetic mapping data suggest that mutations in a single gene may be responsible for both conditions, already known to bear clinical resemblance(1-3). Here we limit the minimum genetic region for STGD3 and adMD to a 0.6-cM interval by recombination breakpoint mapping and identify a single 5-bp deletion within the protein-coding region of a new retinal photoreceptor-specific gene, ELOVL4, in all affected members of STGD3 and adMD families. Bioinformatic analysis of ELOVL4 revealed that it has homology to a group of yeast proteins that function in the biosynthesis of Very long chain fatty acids. Our results are therefore the first to implicate the biosynthesis of fatty acids in the pathogenesis of inherited macular degeneration.	Merck Res Labs, Dept Pharmacol, W Point, PA USA; Merck Res Labs, Dept Human Genet, W Point, PA USA; Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD USA; Univ Colorado, Howard Hughes Med Inst, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Columbia Univ, Dept Ophthalmol, New York, NY USA; Columbia Univ, Dept Pathol, New York, NY USA; Univ Michigan, WK Kellogg Eye Ctr, Ann Arbor, MI 48109 USA; Univ Alberta, Dept Sci Biol, Edmonton, AB, Canada; Univ Alberta, Dept Ophthalmol, Edmonton, AB, Canada; Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	Merck & Company; Merck & Company; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Columbia University; Columbia University; University of Michigan System; University of Michigan; University of Alberta; University of Alberta; University of Alberta	Petrukhin, K (corresponding author), Merck Res Labs, Dept Pharmacol, W Point, PA USA.		Allikmets, Rando/ABD-4533-2021; Kniazeva, Marina/D-4085-2012; Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697; Petrukhin, Konstantin/0000-0002-5545-6924; MacDonald, Ian/0000-0001-7472-8385; Zack, Don/0000-0002-7966-1973	NEI NIH HHS [EY00401] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; Allikmets R, 1999, HUM GENET, V104, P449, DOI 10.1007/s004390050986; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; CINTI DL, 1992, PROG LIPID RES, V31, P1, DOI 10.1016/0163-7827(92)90014-A; Edwards AO, 1999, AM J OPHTHALMOL, V127, P426, DOI 10.1016/S0002-9394(98)00331-6; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Griesinger IB, 2000, INVEST OPHTH VIS SCI, V41, P248; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lagali PS, 2000, CAN J OPHTHALMOL, V35, P315, DOI 10.1016/S0008-4182(00)80059-9; Luthria DL, 1996, J BIOL CHEM, V271, P16020, DOI 10.1074/jbc.271.27.16020; Molday LL, 2000, NAT GENET, V25, P257, DOI 10.1038/77004; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895; Shah AB, 1997, AM J HUM GENET, V61, P317, DOI 10.1086/514864; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sprecher H, 1995, J LIPID RES, V36, P2471; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; STONE EM, 1994, ARCH OPHTHALMOL-CHIC, V112, P765, DOI 10.1001/archopht.1994.01090180063036; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; Tvrdik P, 2000, J CELL BIOL, V149, P707, DOI 10.1083/jcb.149.3.707; Tvrdik P, 1997, J BIOL CHEM, V272, P31738, DOI 10.1074/jbc.272.50.31738; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; ZHANG K, 1994, ARCH OPHTHALMOL-CHIC, V112, P759, DOI 10.1001/archopht.1994.01090180057035	30	331	348	2	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					89	93		10.1038/83817	http://dx.doi.org/10.1038/83817			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138005				2022-12-17	WOS:000166187900022
J	Thomas, JT; Lin, KM; Nandedkar, M; Camargo, M; Cervenka, A; Luyten, FP				Thomas, JT; Lin, KM; Nandedkar, M; Camargo, M; Cervenka, A; Luyten, FP			A human chondrodysplasia due to a mutation in a TGF-beta superfamily member	NATURE GENETICS			English	Letter							BONE-INDUCTIVE PROTEIN; FAMILY; PURIFICATION; OSTEOGENIN; MOUSE; GENE		UNIV ANTIOQUIA,DEPT BIOL,MEDELLIN,COLOMBIA; UNIV MINNESOTA,SCH DENT,DEPT ORAL SCI,MINNEAPOLIS,MN 55455	Universidad de Antioquia; University of Minnesota System; University of Minnesota Twin Cities	Thomas, JT (corresponding author), NIDR,NIH,BONE RES BRANCH,BETHESDA,MD 20892, USA.		Luyten, Frank/GPS-7793-2022					AMATAYAKULCHANTLER S, 1994, J BIOL CHEM, V269, P27687; BRUNNER AM, 1992, MOL ENDOCRINOL, V6, P1691, DOI 10.1210/me.6.10.1691; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; CHANG SC, 1994, J BIOL CHEM, V269, P28227; GREULICH WW, 1983, RADIOGRAPHIC ATLAS S, P108; GRIFFITH DL, IN PRESS P NATL ACAD; GRUNEBERG H, 1973, J EMBRYOL EXP MORPH, V30, P119; HUNTER AGW, 1976, HUM GENET, V34, P107; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; LANGER LO, 1989, HUM GENET, V81, P323, DOI 10.1007/BF00283684; LUYTEN FP, 1989, J BIOL CHEM, V264, P13377; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Mckusick V.A., 1994, MENDELIAN INHERITANC; OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; SAMPATH TK, 1987, P NATL ACAD SCI USA, V84, P7109, DOI 10.1073/pnas.84.20.7109; SPANGER J, 1992, EUR J PADIATR, V151, P407; STENZEL P, 1994, DEV BIOL, V166, P149, DOI 10.1006/dbio.1994.1303; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; VENKATARAMAN G, 1995, P NATL ACAD SCI USA, V92, P5406, DOI 10.1073/pnas.92.12.5406; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484; WHARTON KA, 1991, P NATL ACAD SCI USA, V88, P9214, DOI 10.1073/pnas.88.20.9214; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241	26	331	351	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					315	317		10.1038/ng0396-315	http://dx.doi.org/10.1038/ng0396-315			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589725	Green Published			2022-12-17	WOS:A1996TY18300023
J	BELLUS, GA; MCINTOSH, I; SMITH, EA; AYLSWORTH, AS; KAITILA, I; HORTON, WA; GREENHAW, GA; HECHT, JT; FRANCOMANO, CA				BELLUS, GA; MCINTOSH, I; SMITH, EA; AYLSWORTH, AS; KAITILA, I; HORTON, WA; GREENHAW, GA; HECHT, JT; FRANCOMANO, CA			A RECURRENT MUTATION IN THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH-FACTOR RECEPTOR-3 CAUSES HYPOCHONDROPLASIA	NATURE GENETICS			English	Letter							DIVERSITY; FAMILY; GENE		JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21205; NIH,NATL CTR HUMAN GENOME RES,MED GENET BRANCH,BETHESDA,MD 20892; UNIV N CAROLINA,DEPT PEDIAT,CHAPEL HILL,NC 27599; UNIV N CAROLINA,BRAIN & DEV RES CTR,CHAPEL HILL,NC 27599; HELSINKI UNIV HOSP,DEPT CLIN GENET,SF-00290 HELSINKI,FINLAND; SHRINERS HOSP CRIPPLED CHILDREN,DEPT RES,PORTLAND,OR 97201; UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX 77225	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; Helsinki University Central Hospital; University of Texas System				Bellus, Gary/0000-0001-7492-3324	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010293] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR41135] Funding Source: Medline; NICHD NIH HHS [HD24061] Funding Source: Medline; NIDCR NIH HHS [DE10293] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; BELUS GA, 1995, AM J HUM GENET, V56, P368; FRANCOMANO CA, 1994, HUM MOL GENET, V3, P787, DOI 10.1093/hmg/3.5.787; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; HALL BD, 1979, RADIOLOGY, V133, P95, DOI 10.1148/133.1.95; HECHT JT, IN PRESS J MED GENET; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; JONES CT, 1992, HUM MOL GENET, V1, P11, DOI 10.1093/hmg/1.1.11; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; LEMERRER M, 1994, NAT GENET, V6, P318; MAROTEAUX P, 1988, ARCH FR PEDIATR, V45, P105; MCKUSICK VA, 1973, J MED GENET, V10, P11, DOI 10.1136/jmg.10.1.11; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; MULLIS PE, 1991, CLIN ENDOCRINOL, V34, P265, DOI 10.1111/j.1365-2265.1991.tb03765.x; PAULI RM, 1995, AM J HUM GENET, V56, P732; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; ROUSSEAU F, 1995, NAT GENET, V10, P11, DOI 10.1038/ng0595-11; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; STOILOV I, 1995, AM J MED GENET, V55, P127, DOI 10.1002/ajmg.1320550132; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; VELLNOV M, 1994, NAT GENET, V6, P314; WALKER BA, 1971, AM J DIS CHILD, V122, P95, DOI 10.1001/archpedi.1971.02110020029001; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; WYNNEDAVIES R, 1981, J BONE JOINT SURG BR, V63, P508, DOI 10.1302/0301-620X.63B4.7298674	28	331	344	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					357	359		10.1038/ng0795-357	http://dx.doi.org/10.1038/ng0795-357			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670477				2022-12-17	WOS:A1995RG38600023
J	MATSUNAMI, N; SMITH, B; BALLARD, L; LENSCH, MW; ROBERTSON, M; ALBERTSEN, H; HANEMANN, CO; MULLER, HW; BIRD, TD; WHITE, R; CHANCE, PF				MATSUNAMI, N; SMITH, B; BALLARD, L; LENSCH, MW; ROBERTSON, M; ALBERTSEN, H; HANEMANN, CO; MULLER, HW; BIRD, TD; WHITE, R; CHANCE, PF			PERIPHERAL MYELIN PROTEIN-22 GENE MAPS IN THE DUPLICATION IN CHROMOSOME-17P11.2 ASSOCIATED WITH CHARCOT-MARIE-TOOTH-1A	NATURE GENETICS			English	Article							MARIE-TOOTH NEUROPATHY; HEREDITARY MOTOR; LINKAGE; DISEASE	Charcot-Marie-Tooth disease 1A (CMT1A) is a hereditary demyelinating peripheral neuropathy, associated with a DNA duplication on chromosome 17p11.2. A related disorder in the mouse, trembler (Tr), maps to mouse chromosome 11 which has syntenic homology to human chromosome 17p. Recently, the peripheral myelin protein-22 (pmp-22) gene was identified as the likely Tr locus. We have constructed a partial yeast artificial chromosome contig spanning the CMT1A gene region and mapped the PMP-22 gene to the duplicated region. These observations further implicate PMP-22 as a candidate gene for CMT1A, and suggest that over-expression of this gene may be one mechanism that produces the CMT1A phenotype.	UNIV UTAH,MED CTR,DEPT PEDIAT,DIV MED GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,MED CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV DUSSELDORF,DEPT NEUROL,MOLEC NEUROBIOL LAB,W-4000 DUSSELDORF 1,GERMANY; UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; UNIV WASHINGTON,SCH MED,DIV NEUROL,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DIV PEDIAT,SEATTLE,WA 98195	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Heinrich Heine University Dusseldorf; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle			Chance, Phillip/AAX-5826-2020; Hanemann, C Oliver/AAV-6257-2020	Hanemann, C Oliver/0000-0002-1951-1025				AGUAYO AJ, 1977, NATURE, V265, P73, DOI 10.1038/265073a0; ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BIRD TD, 1982, AM J HUM GENET, V34, P388; CHANCE PF, 1990, AM J HUM GENET, V47, P915; CHANCE PF, IN PRESS NEUROLOGY; DAVISSON MT, 1978, CYTOGENET CELL GENET, V22, P552, DOI 10.1159/000131022; DYCK PJ, 1984, DISEASES PERIPHERAL, P1609; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; GAL A, 1985, HUM GENET, V70, P38, DOI 10.1007/BF00389456; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HENRY EW, 1988, SCIENCE, V241, P344, DOI 10.1126/science.3388045; LEBO RV, 1992, AM J HUM GENET, V50, P42; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; MUNKE M, 1987, J MOL EVOL, V25, P134, DOI 10.1007/BF02101755; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195	23	331	332	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					176	179		10.1038/ng0692-176	http://dx.doi.org/10.1038/ng0692-176			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303231				2022-12-17	WOS:A1992JC98200008
J	ROSENFELD, PJ; COWLEY, GS; MCGEE, TL; SANDBERG, MA; BERSON, EL; DRYJA, TP				ROSENFELD, PJ; COWLEY, GS; MCGEE, TL; SANDBERG, MA; BERSON, EL; DRYJA, TP			A NULL MUTATION IN THE RHODOPSIN GENE CAUSES ROD PHOTORECEPTOR DYSFUNCTION AND AUTOSOMAL RECESSIVE RETINITIS-PIGMENTOSA	NATURE GENETICS			English	Article							RETINAL DEGENERATION; SPLICING MUTATION; TRANSDUCIN; DROSOPHILA; DEFECTS; MUTANTS; DNA; IDENTIFICATION; TRANSCRIPTION; SEQUENCE	Mutations within the rhodopsin gene are known to give rise to autosomal dominant retinitis pigmentosa (RP), a common hereditary form of retinal degeneration. We now describe a patient with autosomal recessive RP who is homozygous for a nonsense mutation at codon 249 within exon 4 of the rhodopsin gene. This null mutation, the first gene defect identified in autosomal recessive retinitis pigmentosa, should result in a functionally inactive rhodopsin protein that is missing the sixth and seventh transmembrane domains including the 11-cis-retinal attachment site. We also found a different null mutation carried heterozygously by an unrelated unaffected individual. Heterozygous carriers of either mutation had normal ophthalmologic examinations but their electroretinograms revealed an abnormality in rod photoreceptor function.	HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,DEPT OPHTHALMOL,HOWE LAB,243 CHARLES ST,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,DEPT OPHTHALMOL,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary								Berson E L, 1990, Trans Am Ophthalmol Soc, V88, P355; BERSON EL, 1968, ARCH OPHTHALMOL-CHIC, V80, P58; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; BOUGHMAN JA, 1980, AM J HUM GENET, V32, P223; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; FARRAR GJ, 1991, GENOMICS, V11, P870, DOI 10.1016/0888-7543(91)90009-4; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FARRAR GJ, 1991, GENOMICS, V11, P1170; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; GAL A, 1991, GENOMICS, V11, P468, DOI 10.1016/0888-7543(91)90159-C; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; INGLEHEARN CF, 1991, AM J HUM GENET, V48, P26; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; JUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; KAZAZIAN HH, 1990, SEMIN HEMATOL, V27, P209; KEEN TJ, 1991, GENOMICS, V11, P199, DOI 10.1016/0888-7543(91)90119-Y; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MCWILLIAM P, 1989, GENOMICS, V5, P619, DOI 10.1016/0888-7543(89)90031-1; MOLLER DE, 1991, NEW ENGL J MED, V325, P938; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTOUSA JE, 1989, J NEUROGENET, V6, P41, DOI 10.3109/01677068909107099; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; REES DJG, 1985, NATURE, V316, P643, DOI 10.1038/316643a0; REICHEL E, 1989, AM J OPHTHALMOL, V108, P540, DOI 10.1016/0002-9394(89)90431-5; SANDBERG MA, 1990, INVEST OPHTH VIS SCI, V31, P2283; SHEFFIELD VC, 1991, AM J HUM GENET, V49, P699; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; TAKEMOTO DJ, 1986, BIOCHEM J, V235, P309, DOI 10.1042/bj2350309; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; WASHBURN T, 1989, J BIOL CHEM, V264, P15464; WEIL D, 1990, J BIOL CHEM, V265, P16007; WEIL D, 1988, J BIOL CHEM, V263, P8561; WEISS ER, 1988, J BIOL CHEM, V263, P6150; YANDELL DW, 1989, CANCER CEL, V7, P223	50	331	335	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					209	213		10.1038/ng0692-209	http://dx.doi.org/10.1038/ng0692-209			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303237				2022-12-17	WOS:A1992JC98200015
J	Koolen, DA; Vissers, LELM; Pfundt, R; de Leeuw, N; Knight, SJL; Regan, R; Kooy, RF; Reyniers, E; Romano, C; Fichera, M; Schinzel, A; Baumer, A; Anderlid, BM; Schoumans, J; Knoers, NV; van Kessel, AG; Sistermans, EA; Veltman, JA; Brunner, HG; de Vries, BBA				Koolen, David A.; Vissers, Lisenka E. L. M.; Pfundt, Rolph; de Leeuw, Nicole; Knight, Samantha J. L.; Regan, Regina; Kooy, R. Frank; Reyniers, Edwin; Romano, Corrado; Fichera, Marco; Schinzel, Albert; Baumer, Alessandra; Anderlid, Britt-Marie; Schoumans, Jacqueline; Knoers, Nine V.; van Kessel, Ad Geurts; Sistermans, Erik A.; Veltman, Joris A.; Brunner, Han G.; de Vries, Bert B. A.			A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; FRONTOTEMPORAL DEMENTIA; TAU; MAPT	Submicroscopic genomic copy number changes have been identified only recently as an important cause of mental retardation. We describe the detection of three interstitial, overlapping 17q21.31 microdeletions in a cohort of 1,200 mentally retarded individuals associated with a clearly recognizable clinical phenotype of mental retardation, hypotonia and a characteristic face. The deletions encompass the MAPT and CRHR1 genes and are associated with a common inversion polymorphism.	Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Churchill Hosp, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Antwerp VIB, Dept Med Genet, B-2610 Antwerp, Belgium; IRCCS, Oasi Inst Res Mental Retardat & Brain Aging, I-94018 Troina, Italy; Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; Karolinska Hosp, Dept Mol Med & Surg, S-17176 Stockholm, Sweden	Radboud University Nijmegen; University of Oxford; Wellcome Centre for Human Genetics; Flanders Institute for Biotechnology (VIB); University of Antwerp; IRCCS Oasi Maria SS; University of Zurich; Karolinska Institutet; Karolinska University Hospital	de Vries, BBA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	b.devries@antrg.umcn.nl	Brunner, Han/C-9928-2013; van Kessel, Ad Geurts/A-2810-2010; Vissers, Lisenka ELM/A-2598-2015; Sistermans, Erik/B-1109-2009; Fichera, Marco/K-9220-2016; de Leeuw, N./L-4480-2015; Koolen, D.A./L-4448-2015; Kooy, Frank/F-5276-2014; Romano, Corrado/B-9695-2008; Veltman, Joris A/F-5128-2010; Pfundt, Rolph/L-4576-2015	Vissers, Lisenka ELM/0000-0001-6470-5497; Sistermans, Erik/0000-0001-7187-4563; Fichera, Marco/0000-0002-8225-6880; Kooy, Frank/0000-0003-2024-0485; Romano, Corrado/0000-0003-1049-0683; Veltman, Joris A/0000-0002-3218-8250; Knight, Samantha/0000-0002-6047-3462				Cruts M, 2005, HUM MOL GENET, V14, P1753, DOI 10.1093/hmg/ddi182; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Donnai D, 2000, AM J MED GENET, V97, P164, DOI 10.1002/1096-8628(200022)97:2<164::AID-AJMG8>3.0.CO;2-F; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikegami S, 2000, NEUROSCI LETT, V279, P129, DOI 10.1016/S0304-3940(99)00964-7; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Varela MC, 2006, CYTOGENET GENOME RES, V114, P89, DOI 10.1159/000091934	15	330	339	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					999	1001		10.1038/ng1853	http://dx.doi.org/10.1038/ng1853			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16906164				2022-12-17	WOS:000240112100015
J	Sweet-Cordero, A; Mukherjee, S; Subramanian, A; You, H; Roix, JJ; Ladd-Acosta, C; Mesirov, J; Golub, TR; Jacks, T				Sweet-Cordero, A; Mukherjee, S; Subramanian, A; You, H; Roix, JJ; Ladd-Acosta, C; Mesirov, J; Golub, TR; Jacks, T			An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GROWTH-FACTOR; LUNG ADENOCARCINOMA; BREAST-CANCER; RAS; CLASSIFICATION; MUTATIONS; PATTERNS; PROTEIN; TUMORS	Using advanced gene targeting methods, generating mouse models of cancer that accurately reproduce the genetic alterations present in human tumors is now relatively straightforward. The challenge is to determine to what extent such models faithfully mimic human disease with respect to the underlying molecular mechanisms that accompany tumor progression. Here we describe a method for comparing mouse models of cancer with human tumors using gene-expression profiling. We applied this method to the analysis of a model of Kras2-mediated lung cancer and found a good relationship to human lung adenocarcinoma, thereby validating the model. Furthermore, we found that whereas a gene-expression signature of KRAS2 activation was not identifiable when analyzing human tumors with known KRAS2 mutation status alone, integrating mouse and human data uncovered a gene-expression signature of KRAS2 mutation in human lung cancer. We confirmed the importance of this signature by gene-expression analysis of short hairpin RNA-mediated inhibition of oncogenic Kras2. These experiments identified both a pattern of gene expression indicative of KRAS2 mutation and potential effectors of oncogenic KRAS2 activity in human cancer. This approach provides a strategy for using genomic analysis of animal models to probe human disease.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; MIT, Eli & Edyth L Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Eli & Edyth L Broad Inst, Cambridge, MA 02141 USA	Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Jacks, T (corresponding author), MIT, Ctr Canc Res, Bldg E17-517,40 Ames St, Cambridge, MA 02139 USA.	tjacks@mit.edu	Mesirov, Jill/AGF-7626-2022	Mukherjee, Sayan/0000-0002-6715-3920				Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bonner AE, 2004, ONCOGENE, V23, P1166, DOI 10.1038/sj.onc.1207234; Camps M, 1998, FEBS LETT, V425, P271, DOI 10.1016/S0014-5793(98)00250-6; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; KLIMSTRA DS, 1994, AM J PATHOL, V145, P1547; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; MANTEL N, 1967, CANCER RES, V27, P209; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Naoki K, 2002, CANCER RES, V62, P7001; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Tchernitsa OI, 2004, ONCOGENE, V23, P4536, DOI 10.1038/sj.onc.1207585; Toyoshima Y, 2004, J BIOL CHEM, V279, P25898, DOI 10.1074/jbc.M400661200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van 't Veer LJ, 2003, BREAST CANCER RES, V5, P57, DOI 10.1186/bcr562; Vapnik Y. N., 1998, STAT LEARNING THEORY; Zuber J, 2000, NAT GENET, V24, P144, DOI 10.1038/72799	36	330	346	1	12	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2005	37	1					48	55		10.1038/ng1490	http://dx.doi.org/10.1038/ng1490			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15608639				2022-12-17	WOS:000225997500020
J	Morrish, TA; Gilbert, N; Myers, JS; Vincent, BJ; Stamato, TD; Taccioli, GE; Batzer, MA; Moran, JV				Morrish, TA; Gilbert, N; Myers, JS; Vincent, BJ; Stamato, TD; Taccioli, GE; Batzer, MA; Moran, JV			DNA repair mediated by endonuclease-independent LINE-1 retrotransposition	NATURE GENETICS			English	Article							STRAND BREAK-REPAIR; HAMSTER OVARY CELL; REVERSE-TRANSCRIPTASE; V(D)J RECOMBINATION; MUSCULAR-DYSTROPHY; GENE; INSERTION; ELEMENT; ENCODES; RNA	Long interspersed elements (LINE-1s) are abundant retrotransposons in mammalian genomes that probably retrotranspose by target site-primed reverse transcription (TPRT)(1,2). During TPRT, the LINE-1 endonuclease cleaves genomic DNA 3, freeing a 3 hydroxyl that serves as a primer for reverse transcription of LINE-1 RNA by LINE-1 reverse transcriptase. The nascent LINE-1 cDNA joins to genomic DNA, generating LINE-1 structural hallmarks such as frequent 5' truncations, a 3' poly( A)(+) tail and variable-length target site duplications (TSDs)(2). Here we describe a pathway for LINE-1 retrotransposition in Chinese hamster ovary (CHO) cells that acts independently of endonuclease but is dependent upon reverse transcriptase. We show that endonuclease-independent LINE-1 retrotransposition occurs at near-wildtype levels in two mutant cell lines that are deficient in nonhomologous end-joining (NHEJ). Analysis of the pre- and post-integration sites revealed that endonuclease-independent retrotransposition results in unusual structures because the LINE-1s integrate at atypical target sequences, are truncated predominantly at their 3 ends and lack TSDs. Moreover, two of nine endonuclease-independent retrotranspositions contained cDNA fragments at their 3 ends that are probably derived from the reverse transcription of endogenous mRNA. Thus, our results suggest that LINE-1s can integrate into DNA lesions, resulting in retrotransposon-mediated DNA repair in mammalian cells.	Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48105 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48105 USA; Louisiana State Univ, Biol Computat & Visualizat Ctr, Dept Biol Sci, Baton Rouge, LA USA; Lankenau Inst Med Res, Wynnewood, PA USA; Boston Univ, Sch Med, Dept Microbiol, Boston, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Louisiana State University System; Louisiana State University; Lankenau Medical Center; Lankenau Institute for Medical Research; Boston University	Moran, JV (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, 1241 E Catherine St, Ann Arbor, MI 48105 USA.		Gilbert, Nicolas/M-9568-2018	Gilbert, Nicolas/0000-0003-3311-7494; Morrish, Tammy/0000-0002-6725-0253				BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Carroll ML, 2001, J MOL BIOL, V311, P17, DOI 10.1006/jmbi.2001.4847; CHAMBEYRON S, 2002, J BIOL CHEM     0306; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FULLER LF, 1988, MUTAT RES, V193, P109, DOI 10.1016/0167-8817(88)90041-7; GIACCIA AJ, 1990, AM J HUM GENET, V47, P459; Higashiyama T, 1997, EMBO J, V16, P3715, DOI 10.1093/emboj/16.12.3715; Kojima T, 2000, MOL BRAIN RES, V75, P121, DOI 10.1016/S0169-328X(99)00313-7; Kondo-Iida E, 1999, HUM MOL GENET, V8, P2303, DOI 10.1093/hmg/8.12.2303; Levin HL, 1997, CELL, V88, P5, DOI 10.1016/S0092-8674(00)81851-6; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; MAGER DL, 1985, NUCLEIC ACIDS RES, V13, P6559, DOI 10.1093/nar/13.18.6559; Moran J.V., 2002, MOBILE DNA, P836; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; Pardue ML, 1997, GENETICA, V100, P73, DOI 10.1023/A:1018352706024; Priestley A, 1998, NUCLEIC ACIDS RES, V26, P1965, DOI 10.1093/nar/26.8.1965; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; STAMATO TD, 1983, SOMAT CELL GENET, V9, P165, DOI 10.1007/BF01543175; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; VOLIVA CF, 1984, J MOL BIOL, V178, P795, DOI 10.1016/0022-2836(84)90312-7; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001	30	330	341	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2002	31	2					159	165		10.1038/ng898	http://dx.doi.org/10.1038/ng898			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	557HR	12006980				2022-12-17	WOS:000175903500011
J	Chen, C; Kolodner, RD				Chen, C; Kolodner, RD			Gross chromosomal rearrangements in Saccharomyces cerevisiae replication and recombination defective mutants	NATURE GENETICS			English	Article							NIJMEGEN BREAKAGE SYNDROME; INDUCED DNA-REPLICATION; PROTEIN-A; REPAIR; YEAST; TRANSLOCATIONS; GENE; METABOLISM; DELETIONS; LEUKEMIA	Cancer progression is often associated with the accumulation of gross chromosomal rearrangements (GCRs), such as translocations, deletion of a chromosome arm, interstitial deletions or inversions(1-3). In many instances, GCRs inactivate tumour-suppressor genes or generate novel fusion proteins that initiate carcinogenesis(3,4). The mechanism underlying GCR formation appears to involve interactions between DNA sequences of little or no homology(5-8). We previously demonstrated that mutations in the gene encoding the largest subunit of the Saccharomyces cerevisiae single-stranded DNA binding protein (RFA1) increase microhomology-medialed GCR formations. To further our understanding of GCR formation, we have developed a novel mutator assay in 5. cerevisiae that allows specific detection of such events. In this assay, the rate of GCR formation was increased 600-5,000-fold by mutations in RFA1, RAD27, MRE11, XRS2 and RAD50, but was minimally affected by mutations in RAD51, RAD54, RAD57, YKU70, YKU80, LIG4 and POL30. Genetic analysis of these mutants suggested that at least three distinct pathways can suppress GCRs: two that suppress microhomology-mediated GCRs (RFA1 and RAD27) and one that suppresses non-homology-mediated GCRs (RAD50/MRE11/XRS2).	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA.		Chen, Clark C/C-8714-2013	Chen, Clark C/0000-0001-6258-9277	NIGMS NIH HHS [GM26017, GM50006] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026017, R37GM026017, R01GM050006] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amin NS, 1996, GENETICS, V144, P479; Barr FG, 1998, NAT GENET, V19, P121, DOI 10.1038/475; Bosco G, 1998, GENETICS, V150, P1037; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen SH, 1998, J POLYM RES-TAIWAN, V5, P9, DOI 10.1007/s10965-006-0034-y; CHRZANOWSKA KH, 1995, AM J MED GENET, V57, P462, DOI 10.1002/ajmg.1320570321; GAUWERKY CE, 1993, SEMIN CANCER BIOL, V4, P333; GILMAN JG, 1987, BRIT J HAEMATOL, V67, P369, DOI 10.1111/j.1365-2141.1987.tb02360.x; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; LUZI P, 1995, HUM MOL GENET, V4, P2335, DOI 10.1093/hmg/4.12.2335; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Maniar HS, 1997, GENETICS, V145, P891; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; Merrill BJ, 1998, GENETICS, V148, P611; MITELMAN F, 1991, CATALOG CHROMOSOME A; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; NINIO J, 1991, GENETICS, V129, P957; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; SHIKANO T, 1993, CANCER GENET CYTOGEN, V71, P22, DOI 10.1016/0165-4608(93)90198-U; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tsukamoto Y, 1997, MOL GEN GENET, V255, P543, DOI 10.1007/s004380050527; Tsukamoto Y, 1996, GENETICS, V142, P383; Umezu K, 1998, GENETICS, V148, P989; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOODSSAMUELS P, 1991, GENOMICS, V10, P94, DOI 10.1016/0888-7543(91)90489-2	29	330	331	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1999	23	1					81	85		10.1038/12687	http://dx.doi.org/10.1038/12687			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	231XU	10471504				2022-12-17	WOS:000082337300021
J	Quignon, F; De Bels, F; Koken, M; Feunteun, J; Ameisen, JC; de The, H				Quignon, F; De Bels, F; Koken, M; Feunteun, J; Ameisen, JC; de The, H			PML induces a novel caspase-independent death process	NATURE GENETICS			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; CELL-DEATH; GROWTH-SUPPRESSOR; RAR-ALPHA; NUCLEAR-BODIES; DNA-DAMAGE; PROTEIN; APOPTOSIS; BAX; EXPRESSION	PML nuclear bodies (NBs) are nuclear matrix-associated structures altered by viruses and oncogenes. We show here that PML overexpression induces rapid cell death, independent of de novo transcription and cell cycling. PML death involves cytoplasmic features of apoptosis in the absence of caspase-3 activation, and caspase inhibitors such as zVAD accelerate PML death, zVAD also accelerates interferon (IFN)-induced death, suggesting that PML contributes to IFN-induced apoptosis. The death effector BAX and the cdk inhibitor p27KIP1 are novel NB-associated proteins recruited by PML to these nuclear domains, whereas the acute promyelocytic leukaemia (APL) PML/RAR alpha oncoprotein delocalizes them. Arsenic enhances targeting of PML BAX and p27KIP1 to NBs and synergizes with PML and IFN to induce cell death. Thus, cell death susceptibility correlates with NE recruitment of NE proteins. These findings reveal a novel cell death pathway that neither requires nor induces caspase-3 activation, and suggest that NBs participate in the control of cell survival.	Univ Paris 07, Hop St Louis, Inst Hematol,CNRS UPR 9051, Lab Associe Comite Paris Ligue Contre Canc, F-75475 Paris 10, France; Hop Bichat, INSERM CJF 9707, F-75877 Paris, France; Inst Gustave Roussy, CNRS URA 1967, F-94805 Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	de The, H (corresponding author), Univ Paris 07, Hop St Louis, Inst Hematol,CNRS UPR 9051, Lab Associe Comite Paris Ligue Contre Canc, 1 Av C Vellefaux, F-75475 Paris 10, France.	ameisen@caramail.com; dethe@chu-stlouis.fr	koken, marcel/J-8154-2012; koken, marcel/N-1349-2019; Feunteun, Jean/AAZ-1267-2020; Quignon, Frédérique/P-4249-2017	koken, marcel/0000-0002-0839-0125; Feunteun, Jean/0000-0003-1212-9189				Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; Ameisen JC, 1996, SCIENCE, V272, P1278, DOI 10.1126/science.272.5266.1278; BAZARBACHI A, IN PRESS BLOOD; Borden KLB, 1997, FEBS LETT, V418, P30, DOI 10.1016/S0014-5793(97)01344-6; Borden KLB, 1998, J VIROL, V72, P3819, DOI 10.1128/JVI.72.5.3819-3826.1998; Chan JYH, 1997, BIOCHEM BIOPH RES CO, V240, P640, DOI 10.1006/bbrc.1997.7692; CHELBIALIX M, IN PRESS ONCOGENE; Chen GQ, 1997, BLOOD, V89, P3345; DANIEL MT, 1993, BLOOD, V82, P1858; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Estaquier J, 1997, BLOOD, V90, P1618, DOI 10.1182/blood.V90.4.1618.1618_1618_1625; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Gianni M, 1998, BLOOD, V91, P4300, DOI 10.1182/blood.V91.11.4300.411k41_4300_4310; Gongora C, 1997, J BIOL CHEM, V272, P19457, DOI 10.1074/jbc.272.31.19457; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grotzinger T, 1996, J BIOL CHEM, V271, P25253, DOI 10.1074/jbc.271.41.25253; Han J., 1995, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Jiang WQ, 1997, CELL GROWTH DIFFER, V8, P513; KOKEN MHM, 1995, ONCOGENE, V10, P1315; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Koken MHM, 1997, P NATL ACAD SCI USA, V94, P10255, DOI 10.1073/pnas.94.19.10255; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Le XF, 1998, ONCOGENE, V16, P1839, DOI 10.1038/sj.onc.1201705; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; MADANI A, 1995, ONCOGENE, V10, P2259; Mandal M, 1998, ONCOGENE, V17, P999, DOI 10.1038/sj.onc.1202020; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Monney L, 1998, J BIOL CHEM, V273, P6121, DOI 10.1074/jbc.273.11.6121; MU ZM, 1994, MOL CELL BIOL, V14, P6858, DOI 10.1128/MCB.14.10.6858; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Okura T, 1996, J IMMUNOL, V157, P4277; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Quignon F, 1997, BBA-REV CANCER, V1333, pM53, DOI 10.1016/S0304-419X(97)00025-5; Stadler M, 1995, ONCOGENE, V11, P2565; STUURMAN N, 1997, CELL MOL BIOL LETT, V2, P137; Testa U, 1998, J CLIN INVEST, V101, P2278, DOI 10.1172/JCI1332; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wang ZG, 1998, BLOOD, V92, P1497, DOI 10.1182/blood.V92.5.1497.417k41_1497_1504; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	54	330	339	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1998	20	3					259	265		10.1038/3068	http://dx.doi.org/10.1038/3068			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806544				2022-12-17	WOS:000076698100019
J	Braverman, N; Steel, G; Obie, C; Moser, A; Moser, H; Gould, SJ; Valle, D				Braverman, N; Steel, G; Obie, C; Moser, A; Moser, H; Gould, SJ; Valle, D			Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata	NATURE GENETICS			English	Article							ORNITHINE-DELTA-AMINOTRANSFERASE; SIGNAL IMPORT RECEPTOR; TARGETING SIGNAL; PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; 3-KETOACYL-COA THIOLASE; BIOGENESIS DISORDERS; HANSENULA-POLYMORPHA; ZELLWEGER SYNDROME; GENE	Rhizomelic chondrodysplasia punctata (RCDP) is a rare autosomal recessive phenotype that comprises complementation group 11 of the peroxisome biogenesis disorders (PBD). PEX7, a candidate gene for RCDP identified in yeast, encodes the receptor for peroxisomal matrix proteins with the type-2 peroxisome targeting signal (PTS2). By homology probing we identified human and murine PEX7 genes and found that expression of either corrects the PTS2-import defect characteristic of RCDP cells. In a collection of 36 RCDP probands, we found two inactivating PEX7 mutations: one, L292ter, was present in 26 of the probands, all with a severe phenotype; the second, A218V, was present in three probands, including two with a milder phenotype. A third mutation, G217R, whose functional significance is yet to be determined, was present in five probands, all compound heterozygotes with L292ter. We conclude that PEX7 is responsible for RCDP (PBD CG11) and suggest a founder effect may explain the high frequency of L292ter.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT CELL BIOL & ANAT,BALTIMORE,MD 21205	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University					NCRR NIH HHS [RR00052, RR00722] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barth PG, 1996, AM J MED GENET, V62, P164, DOI 10.1002/(SICI)1096-8628(19960315)62:2<164::AID-AJMG9>3.0.CO;2-W; BRODY LC, 1992, J BIOL CHEM, V267, P3302; BRUL S, 1988, J CLIN INVEST, V81, P1710, DOI 10.1172/JCI113510; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cooper DN, 1995, METABOLIC MOL BASES, P259; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; DODT G, IN PRESS NEW YORK AC; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; ENGELHARDT JF, 1991, J BIOL CHEM, V266, P752; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FABER KN, 1995, FEBS LETT, V357, P115, DOI 10.1016/0014-5793(94)01317-T; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fukuda S, 1996, AM J HUM GENET, V59, P1210; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GIETL C, 1994, P NATL ACAD SCI USA, V91, P3151, DOI 10.1073/pnas.91.8.3151; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GRAY RGF, 1992, J INHERIT METAB DIS, V15, P931, DOI 10.1007/BF01800236; HEIKOOP JC, 1990, J CLIN INVEST, V86, P126, DOI 10.1172/JCI114674; HEIKOOP JC, 1991, BIOCHIM BIOPHYS ACTA, V1097, P69; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Hieter P, 1996, NAT GENET, V13, P253, DOI 10.1038/ng0796-253; HOEFLER G, 1988, J PEDIATR-US, V112, P726, DOI 10.1016/S0022-3476(88)80689-9; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; KUNAU WH, 1993, BIOCHIMIE, V75, P209, DOI 10.1016/0300-9084(93)90079-8; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; MAQUAT LE, 1995, RNA, V1, P453; MARYNEN P, 1995, GENOMICS, V30, P366, DOI 10.1006/geno.1995.0032; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MITCHELL GA, 1988, J BIOL CHEM, V263, P14288; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; Motley AM, 1996, BBA-MOL BASIS DIS, V1315, P153, DOI 10.1016/0925-4439(95)00114-X; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; NUOFFER JM, 1994, J INHERIT METAB DIS, V17, P60, DOI 10.1007/BF00735395; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; PIKE MG, 1990, J PEDIATR-US, V116, P88, DOI 10.1016/S0022-3476(05)81651-8; POLLTHE BT, 1991, J INHERIT METAB DIS, V14, P361, DOI 10.1007/BF01811703; POULOS A, 1995, J PEDIATR-US, V127, P596, DOI 10.1016/S0022-3476(95)70121-4; PURDUE PE, 1994, J BIOL CHEM, V269, P30065; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Sambrook J, 1989, MOL CLONING LAB MANU; SHIMOZAWA N, 1993, AM J HUM GENET, V52, P843; SHIMOZAWA N, 1992, SCIENCE, V255, P11325; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SMEITINK JAM, 1992, J INHERIT METAB DIS, V15, P377, DOI 10.1007/BF02435981; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P389, DOI 10.1007/BF02435984; WANDERS RJA, 1994, J INHERIT METAB DIS, V17, P315, DOI 10.1007/BF00711817; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI [10.1016/0307-4412(91), DOI 10.1016/0307-4412(91)]; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65; Zhang JW, 1996, J CELL BIOL, V132, P325, DOI 10.1083/jcb.132.3.325	69	330	335	0	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1997	15	4					369	376		10.1038/ng0497-369	http://dx.doi.org/10.1038/ng0497-369			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WQ389	9090381				2022-12-17	WOS:A1997WQ38900014
J	BOGUSKI, MS; SCHULER, GD				BOGUSKI, MS; SCHULER, GD			ESTABLISHING A HUMAN TRANSCRIPT MAP	NATURE GENETICS			English	Editorial Material							EXPRESSED SEQUENCE TAGS; HUMAN GENOME PROJECT; CHROMOSOMAL ASSIGNMENT; CDNAS				BOGUSKI, MS (corresponding author), NATL LIB MED,NATL CTR BIOTECHNOL INFORMAT,BETHESDA,MD 20894, USA.							ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; BENSON DA, 1994, NUCLEIC ACIDS RES, V22, P3441, DOI 10.1093/nar/22.17.3441; BERRY R, 1995, NAT GENET, V10, P415, DOI 10.1038/ng0895-415; BOGUSKI MS, 1995, TRENDS BIOCHEM SCI, V20, P295, DOI 10.1016/S0968-0004(00)89051-9; COLLINS F, 1993, SCIENCE, V262, P43, DOI 10.1126/science.8211127; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; DURKIN AS, 1992, GENOMICS, V14, P808; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NOWAK R, 1994, SCIENCE, V263, P608, DOI 10.1126/science.7508142; POLYMEROPOULOS MH, 1992, GENOMICS, V12, P492, DOI 10.1016/0888-7543(92)90439-Y; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; STEWART A, 1995, HUGO GENOME DIGEST, V2, P6; STEWART A, 1995, HUGO GENOME DIGEST, V2, P1; WILCOX AS, 1991, NUCLEIC ACIDS RES, V19, P1837, DOI 10.1093/nar/19.8.1837; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; ZHANG J, 1994, 27 HAW INT C SYST SC, P58	18	330	354	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					369	371		10.1038/ng0895-369	http://dx.doi.org/10.1038/ng0895-369			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670480				2022-12-17	WOS:A1995RM37500002
J	VALENTIJN, LJ; BOLHUIS, PA; ZORN, I; HOOGENDIJK, JE; VANDENBOSCH, N; HENSELS, GW; STANTON, VP; HOUSMAN, DE; FISCHBECK, KH; ROSS, DA; NICHOLSON, GA; MEERSHOEK, EJ; DAUWERSE, HG; VANOMMEN, GJB; BAAS, F				VALENTIJN, LJ; BOLHUIS, PA; ZORN, I; HOOGENDIJK, JE; VANDENBOSCH, N; HENSELS, GW; STANTON, VP; HOUSMAN, DE; FISCHBECK, KH; ROSS, DA; NICHOLSON, GA; MEERSHOEK, EJ; DAUWERSE, HG; VANOMMEN, GJB; BAAS, F			THE PERIPHERAL MYELIN GENE PMP-22/GAS-3 IS DUPLICATED IN CHARCOT-MARIE-TOOTH DISEASE TYPE-1A	NATURE GENETICS			English	Article							GROWTH ARREST; DNA-MOLECULES; SEPARATION; LINKAGE; LOCUS; YEAST	Charcot-Marie-Tooth disease type 1A (CMT1A) is associated with a DNA duplication at chromosome 17p11.2. In view of the point mutation in the gene for peripheral myelin protein pmp-22/gas-3 in Trembler mice, a murine model for CMT1A, we have analysed whether this gene is altered in CMT1A. Here we show that the human homologue of the murine pmp-22 gene is located within the CMT1A DNA duplication, which is a direct repeat and does not interrupt the coding region of PMP-22. Expression of PMP-22 in CMT1A fibroblasts is similar to expression in control fibroblasts. Increased gene dosage or altered PMP-22 expression in the peripheral nervous system are therefore possible mechanisms by which PMP-22 is involved in CMT1A.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139; UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104; UNIV SYDNEY,CONCORD HOSP,DEPT MED,SYDNEY,NSW 2006,AUSTRALIA; LEIDEN UNIV,SYLVIUS LABS,DEPT HUMAN GENET,2333 AL LEIDEN,NETHERLANDS	Massachusetts Institute of Technology (MIT); University of Pennsylvania; Concord Repatriation General Hospital; University of Sydney; Leiden University; Leiden University - Excl LUMC	VALENTIJN, LJ (corresponding author), UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL K2206,MEIBERGDREEF 9,1105 AZ AMSTERDAM,NETHERLANDS.		Baas, Frank/F-9574-2010	Baas, Frank/0000-0003-3912-5428; Stanton, Vincent/0000-0002-2205-6000				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BAAS F, 1984, HUM GENET, V67, P301, DOI 10.1007/BF00291357; BIRD TD, 1982, AM J HUM GENET, V34, P388; CARLE GF, 1984, NUCLEIC ACIDS RES, V12, P5647, DOI 10.1093/nar/12.14.5647; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; DAUWERSE JG, IN PRESS BLOOD, V79; DEFESCHE JC, 1990, NEUROLOGY, V40, P1450, DOI 10.1212/WNL.40.9.1450; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; HOOGENDIJK JE, 1991, HUM GENET, V88, P215, DOI 10.1007/BF00206075; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; HOOGENDIJK JE, 1991, HDB CLIN NEUROLOGY; HULSEBOS TJM, 1991, CYTOGENET CELL GENET, V56, P171, DOI 10.1159/000133080; LEBO RV, 1991, HUM GENET, V88, P1, DOI 10.1007/BF00204921; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1992, NATURE GENET, V1; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Sambrook J., 1989, MOL CLONING LAB MANU; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sherman F., 1986, METHODS YEAST GENETI; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195	26	330	332	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					166	170		10.1038/ng0692-166	http://dx.doi.org/10.1038/ng0692-166			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303229				2022-12-17	WOS:A1992JC98200006
J	Yano, K; Yamamoto, E; Aya, K; Takeuchi, H; Lo, PC; Hu, L; Yamasaki, M; Yoshida, S; Kitano, H; Hirano, K; Matsuoka, M				Yano, Kenji; Yamamoto, Eiji; Aya, Koichiro; Takeuchi, Hideyuki; Lo, Pei-ching; Hu, Li; Yamasaki, Masanori; Yoshida, Shinya; Kitano, Hidemi; Hirano, Ko; Matsuoka, Makoto			Genome-wide association study using whole-genome sequencing rapidly identifies new genes influencing agronomic traits in rice	NATURE GENETICS			English	Article							GRAIN-SIZE; PHOTOPERIOD SENSITIVITY; LINKAGE DISEQUILIBRIUM; NATURAL VARIATION; GREEN-REVOLUTION; COMPLEX TRAITS; MAGIC MAIZE; ARABIDOPSIS; REVEALS; SELECTION	A genome-wide association study ( GWAS) can be a powerful tool for the identification of genes associated with agronomic traits in crop species, but it is often hindered by population structure and the large extent of linkage disequilibrium. In this study, we identified agronomically important genes in rice using GWAS based on whole-genome sequencing, followed by the screening of candidate genes based on the estimated effect of nucleotide polymorphisms. Using this approach, we identified four new genes associated with agronomic traits. Some genes were undetectable by standard SNP analysis, but we detected them using gene-based association analysis. This study provides fundamental insights relevant to the rapid identification of genes associated with agronomic traits using GWAS and will accelerate future efforts aimed at crop improvement.	[Yano, Kenji; Aya, Koichiro; Takeuchi, Hideyuki; Lo, Pei-ching; Hu, Li; Kitano, Hidemi; Hirano, Ko; Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi, Japan; [Yamamoto, Eiji] NARO Inst Vegetable & Tea Sci, Tsu, Mie, Japan; [Yamasaki, Masanori] Kobe Univ, Grad Sch Agr Sci, Food Resources Educ & Res Ctr, Kasai, Hyogo, Japan; [Yoshida, Shinya] Hyogo Prefectural Res Ctr Agr Forestry & Fisherie, Kasai, Hyogo, Japan	Nagoya University; Kobe University	Matsuoka, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi, Japan.; Yamamoto, E (corresponding author), NARO Inst Vegetable & Tea Sci, Tsu, Mie, Japan.	yame@affrc.go.jp; makoto@agr.nagoya-u.ac.jp	Yamasaki, Masanori/C-5193-2018	Yamasaki, Masanori/0000-0001-7759-3965; Yamamoto, Eiji/0000-0002-3095-6455; Yano, Kenji/0000-0002-2428-9748	Japan Society for the Promotion of Science [26252001]; Council for Science, Technology and Innovation (CSTI); Cross-Ministerial Strategic Innovation Promotion Program (SIP); "Technologies for Creating Next-Generation Agriculture, Forestry and Fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO);  [16J08722]; Grants-in-Aid for Scientific Research [15H04436] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science, Technology and Innovation (CSTI); Cross-Ministerial Strategic Innovation Promotion Program (SIP); "Technologies for Creating Next-Generation Agriculture, Forestry and Fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science through a Grant in Aid for Scientific Research (A) (26252001), Council for Science, Technology and Innovation (CSTI), Cross-Ministerial Strategic Innovation Promotion Program (SIP), "Technologies for Creating Next-Generation Agriculture, Forestry and Fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO), and by Grant in Aid for JSPS Fellows Grant Number 16J08722.	Abrash EB, 2011, PLANT CELL, V23, P2864, DOI 10.1105/tpc.111.086637; Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Asano K, 2011, P NATL ACAD SCI USA, V108, P11034, DOI 10.1073/pnas.1019490108; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Cavanagh C, 2008, CURR OPIN PLANT BIOL, V11, P215, DOI 10.1016/j.pbi.2008.01.002; Chen XM, 2002, DEVELOPMENT, V129, P1085; Dell'Acqua M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0716-z; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Ebana K, 2008, BREEDING SCI, V58, P281, DOI 10.1270/jsbbs.58.281; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Ferrari R, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.06.005; Fujino K, 2010, MOL GENET GENOMICS, V284, P137, DOI 10.1007/s00438-010-0555-2; Fujita D, 2013, P NATL ACAD SCI USA, V110, P20431, DOI 10.1073/pnas.1310790110; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hashimoto Z, 2004, THEOR APPL GENET, V109, P1586, DOI 10.1007/s00122-004-1794-6; Hazzouri KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9824; Holland JB, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0713-2; Huang XH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7258; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2013, TRENDS GENET, V29, P225, DOI 10.1016/j.tig.2012.12.001; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ivanov DK, 2015, J GERONTOL A-BIOL, V70, P1470, DOI 10.1093/gerona/glv047; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jorgenson E, 2006, NAT REV GENET, V7, P885, DOI 10.1038/nrg1962; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Koo BH, 2013, MOL PLANT, V6, P1877, DOI 10.1093/mp/sst088; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Lipka AE, 2015, CURR OPIN PLANT BIOL, V24, P110, DOI 10.1016/j.pbi.2015.02.010; Ma XY, 2013, CANCER EPIDEM BIOMAR, V22, P467, DOI 10.1158/1055-9965.EPI-12-1365; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Matsubara K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00193; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayerle J, 2013, JAMA-J AM MED ASSOC, V309, P1912, DOI 10.1001/jama.2013.4350; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Ott J, 2015, NAT REV GENET, V16, P275, DOI 10.1038/nrg3908; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Ozawa K, 2012, METHODS MOL BIOL, V847, P51, DOI 10.1007/978-1-61779-558-9_5; Platt A, 2010, GENETICS, V186, P1045, DOI 10.1534/genetics.110.121665; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Ren GD, 2012, CURR BIOL, V22, P695, DOI 10.1016/j.cub.2012.02.052; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Shin J-H, 2006, J STAT SOFTW, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Takahashi Y, 2011, GENES GENET SYST, V86, P175, DOI 10.1266/ggs.86.175; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Vilhjalmsson BJ, 2013, NAT REV GENET, V14, P1, DOI 10.1038/nrg3382; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Woolston C, 2014, NATURE, V514, pS49, DOI 10.1038/514S49a; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096	73	329	349	32	331	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					927	+		10.1038/ng.3596	http://dx.doi.org/10.1038/ng.3596			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27322545				2022-12-17	WOS:000380755100017
J	Li, MZ; Tian, SL; Jin, L; Zhou, GY; Li, Y; Zhang, Y; Wang, T; Yeung, CKL; Chen, L; Ma, JD; Zhang, JB; Jiang, AA; Li, J; Zhou, CW; Zhang, J; Liu, YK; Sun, XQ; Zhao, HW; Niu, ZX; Lou, PE; Xian, LJ; Shen, XY; Liu, SQ; Zhang, SH; Zhang, MW; Zhu, L; Shuai, SR; Bai, L; Tang, GQ; Liu, HF; Jiang, YZ; Mai, MM; Xiao, J; Wang, X; Zhou, Q; Wang, ZQ; Stothard, P; Xue, M; Gao, XL; Luo, ZG; Gu, YR; Zhu, HM; Hu, XX; Zhao, YF; Plastow, GS; Wang, JY; Jiang, Z; Li, K; Li, N; Li, XW; Li, RQ				Li, Mingzhou; Tian, Shilin; Jin, Long; Zhou, Guangyu; Li, Ying; Zhang, Yuan; Wang, Tao; Yeung, Carol K. L.; Chen, Lei; Ma, Jideng; Zhang, Jinbo; Jiang, Anan; Li, Ji; Zhou, Chaowei; Zhang, Jie; Liu, Yingkai; Sun, Xiaoqing; Zhao, Hongwei; Niu, Zexiong; Lou, Pinger; Xian, Lingjin; Shen, Xiaoyong; Liu, Shaoqing; Zhang, Shunhua; Zhang, Mingwang; Zhu, Li; Shuai, Surong; Bai, Lin; Tang, Guoqing; Liu, Haifeng; Jiang, Yanzhi; Mai, Miaomiao; Xiao, Jian; Wang, Xun; Zhou, Qi; Wang, Zhiquan; Stothard, Paul; Xue, Ming; Gao, Xiaolian; Luo, Zonggang; Gu, Yiren; Zhu, Hongmei; Hu, Xiaoxiang; Zhao, Yaofeng; Plastow, Graham S.; Wang, Jinyong; Jiang, Zhi; Li, Kui; Li, Ning; Li, Xuewei; Li, Ruiqiang			Genomic analyses identify distinct patterns of selection in domesticated pigs and Tibetan wild boars	NATURE GENETICS			English	Article							HIGH-FIBER DIETS; HIGH-ALTITUDE; HUMAN-POPULATIONS; BEHAVIOR; HYPOXIA; ADAPTATION; EVOLUTION; SOWS; PHYLOGEOGRAPHY; HYPERTENSION	We report the sequencing at 131x coverage, de novo assembly and analyses of the genome of a female Tibetan wild boar. We also resequenced the whole genomes of 30 Tibetan wild boars from six major distributed locations and 18 geographically related pigs in China. We characterized genetic diversity, population structure and patterns of evolution. We searched for genomic regions under selection, which includes genes that are involved in hypoxia, olfaction, energy metabolism and drug response. Comparing the genome of Tibetan wild boar with those of neighboring Chinese domestic pigs further showed the impact of thousands of years of artificial selection and different signatures of selection in wild boar and domestic pig. We also report genetic adaptations in Tibetan wild boar that are associated with high altitudes and characterize the genetic basis of increased salivation in domestic pig.	[Li, Mingzhou; Jin, Long; Li, Ying; Wang, Tao; Ma, Jideng; Jiang, Anan; Zhou, Chaowei; Zhang, Jie; Liu, Yingkai; Lou, Pinger; Xian, Lingjin; Zhang, Shunhua; Zhang, Mingwang; Zhu, Li; Shuai, Surong; Bai, Lin; Tang, Guoqing; Liu, Haifeng; Jiang, Yanzhi; Mai, Miaomiao; Xiao, Jian; Wang, Xun; Li, Xuewei] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Peoples R China; [Li, Mingzhou; Li, Ruiqiang] Peking Univ, Peking Tsinghua Ctr Life Sci, Biodynam Opt Imaging Ctr BIOPIC, Beijing 100871, Peoples R China; [Li, Mingzhou; Li, Ruiqiang] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Tian, Shilin; Zhou, Guangyu; Zhang, Yuan; Yeung, Carol K. L.; Zhang, Jinbo; Li, Ji; Sun, Xiaoqing; Zhao, Hongwei; Niu, Zexiong; Shen, Xiaoyong; Liu, Shaoqing; Zhu, Hongmei; Jiang, Zhi; Li, Ruiqiang] Novogene Bioinformat Inst, Beijing, Peoples R China; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Zhou, Qi] Yaan Vocat Coll, Yaan, Peoples R China; [Wang, Zhiquan; Stothard, Paul; Plastow, Graham S.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Xue, Ming] Minist Agr China, Natl Anim Husb Serv, Beijing, Peoples R China; [Gao, Xiaolian] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Luo, Zonggang] Southwest Univ Rongchang, Dept Anim Sci, Chongqing, Peoples R China; [Gu, Yiren] Sichuan Anim Sci Acad, Chengdu, Sichuan, Peoples R China; [Hu, Xiaoxiang; Zhao, Yaofeng; Li, Ning] China Agr Univ, Natl Engn Lab Anim Breeding, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	Sichuan Agricultural University; Peking University; Peking University; University of Alberta; Ministry of Agriculture & Rural Affairs; University of Houston System; University of Houston; China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Li, XW (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Peoples R China.	xuewei.li@sicau.edu.cn; lirq@pku.edu.cn	zhang, jin/GXV-9154-2022; Tian, Shilin/AAP-9998-2020	Plastow, Graham/0000-0002-3774-3110; Tian, Shilin/0000-0001-8958-1806; Li, Mingzhou/0000-0001-8681-7684	National Special Foundation for Transgenic Species of China [2014ZX0800950B, 2009ZX08009-155B, 2011ZX08006-003]; Foundation for Discipline Construction of Sichuan Agricultural University; Ministry of Agriculture of China [NYCYTX-009]; Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province [2011YZGG15]; National High Technology Research and Development Program of China (863 Program) [2013AA102502]; Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences; China Postdoctoral Science Foundation [2012M520123]; Chongqing Fund for Distinguished Young Scientists [CSTC2010BA1007]; Peking University; Peking-Tsinghua Center for Life Sciences; National Basic Research Program of China [2011CB809201]	National Special Foundation for Transgenic Species of China; Foundation for Discipline Construction of Sichuan Agricultural University; Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chongqing Fund for Distinguished Young Scientists; Peking University(Peking University); Peking-Tsinghua Center for Life Sciences; National Basic Research Program of China(National Basic Research Program of China)	We thank J. Guan, Y. Liu, Y. Xie, H. Wang and L. Bai for help in preparing the pig tissues. We thank Q. Quan, F. Wang, Y. Tan, Y. Guo and G. Yu for the optimizing chart. We thank S. Zhao and L. Huang for critical review of the manuscript. This work was supported by grants from the National Special Foundation for Transgenic Species of China (2014ZX0800950B, 2009ZX08009-155B and 2011ZX08006-003), the Foundation for Discipline Construction of Sichuan Agricultural University, the Specialized Research Fund of Ministry of Agriculture of China (NYCYTX-009), the Project of Provincial Twelfth Five Years' Animal Breeding of Sichuan Province (2011YZGG15), the National High Technology Research and Development Program of China (863 Program) (2013AA102502), the Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences and the China Postdoctoral Science Foundation (2012M520123) to X. L. and M. L., the Chongqing Fund for Distinguished Young Scientists (CSTC2010BA1007) to J. W. and the Fund of Peking University to the Biodynamic Optical Imaging Center (BIOPIC), the Fund of Peking-Tsinghua Center for Life Sciences and the Fund of National Basic Research Program of China (2011CB809201) to R.L.	Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beall CM, 2004, P NATL ACAD SCI USA, V101, P14300, DOI 10.1073/pnas.0405949101; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; Chen JM, 2008, MOL PHYLOGENET EVOL, V48, P168, DOI 10.1016/j.ympev.2008.03.008; Chen KF, 2007, INT J BIOL SCI, V3, P153; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Nguyen DT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-584; Gerstein HC, 2006, CAN MED ASSOC J, V174, P25, DOI 10.1503/cmaj.050649; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Kanis E, 2004, ANIM SCI, V78, P315, DOI 10.1017/S1357729800054102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kuehn M, 2008, EUR ARCH OTO-RHINO-L, V265, P299, DOI 10.1007/s00405-007-0446-2; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li Y, 2012, J SYST EVOL, V50, P362, DOI 10.1111/j.1759-6831.2012.00209.x; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Marchese S, 1998, EUR J BIOCHEM, V252, P563, DOI 10.1046/j.1432-1327.1998.2520563.x; Meyer UA, 2013, ANNU REV PHARMACOL, V53, P475, DOI 10.1146/annurev-pharmtox-010510-100502; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Moore LG, 2001, AM J PHYS ANTHROPOL, V114, P42, DOI 10.1002/1096-8644(200101)114:1<42::AID-AJPA1004>3.0.CO;2-B; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Nasvall J, 2012, SCIENCE, V338, P384, DOI 10.1126/science.1226521; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Palomera-Sanchez Z, 2011, DNA REPAIR, V10, P119, DOI 10.1016/j.dnarep.2010.10.010; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Ramonet Y, 1999, J ANIM SCI, V77, P591; Ramonet Y, 2000, BRIT J NUTR, V84, P85; Romanenko V, 2006, J BIOL CHEM, V281, P27964, DOI 10.1074/jbc.M603871200; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Taylor BJ, 2013, J CARD FAIL, V19, P50, DOI 10.1016/j.cardfail.2012.11.005; Whittaker X, 1999, APPL ANIM BEHAV SCI, V63, P25, DOI 10.1016/S0168-1591(98)00243-3; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zhu L, 2009, HIGH ALT MED BIOL, V10, P45, DOI 10.1089/ham.2008.1042	56	329	368	14	282	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1431	U180		10.1038/ng.2811	http://dx.doi.org/10.1038/ng.2811			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24162736				2022-12-17	WOS:000327715800007
J	Peng, ZH; Lu, Y; Li, LB; Zhao, Q; Feng, Q; Gao, ZM; Lu, HY; Hu, T; Yao, N; Liu, KY; Li, Y; Fan, DL; Guo, YL; Li, WJ; Lu, YQ; Weng, QJ; Zhou, CC; Zhang, L; Huang, T; Zhao, Y; Zhu, CR; Liu, XG; Yang, XW; Wang, T; Miao, K; Zhuang, CY; Cao, XL; Tang, WL; Liu, GS; Liu, YL; Chen, J; Liu, ZJ; Yuan, LC; Liu, ZH; Huang, XH; Lu, TT; Fei, BH; Ning, ZM; Han, B; Jiang, ZH				Peng, Zhenhua; Lu, Ying; Li, Lubin; Zhao, Qiang; Feng, Qi; Gao, Zhimin; Lu, Hengyun; Hu, Tao; Yao, Na; Liu, Kunyan; Li, Yan; Fan, Danlin; Guo, Yunli; Li, Wenjun; Lu, Yiqi; Weng, Qijun; Zhou, CongCong; Zhang, Lei; Huang, Tao; Zhao, Yan; Zhu, Chuanrang; Liu, Xinge; Yang, Xuewen; Wang, Tao; Miao, Kun; Zhuang, Caiyun; Cao, Xiaolu; Tang, Wenli; Liu, Guanshui; Liu, Yingli; Chen, Jie; Liu, Zhenjing; Yuan, Licai; Liu, Zhenhua; Huang, Xuehui; Lu, Tingting; Fei, Benhua; Ning, Zemin; Han, Bin; Jiang, Zehui			The draft genome of the fast-growing non-timber forest species moso bamboo (Phyllostachys heterocycla)	NATURE GENETICS			English	Article							POPULUS-TRICHOCARPA; ORYZA-SATIVA; RICE; GENE; SEQUENCE; GRASSES; DIVERSIFICATION; EXPRESSION; DIVERSITY; POACEAE	Bamboo represents the only major lineage of grasses that is native to forests and is one of the most important non-timber forest products in the world. However, no species in the Bambusoideae subfamily has been sequenced. Here, we report a high-quality draft genome sequence of moso bamboo (P. heterocycla var. pubescens). The 2.05-Gb assembly covers 95% of the genomic region. Gene prediction modeling identified 31,987 genes, most of which are supported by cDNA and deep RNA sequencing data. Analyses of clustered gene families and gene collinearity show that bamboo underwent whole-genome duplication 7-12 million years ago. Identification of gene families that are key in cell wall biosynthesis suggests that the whole-genome duplication event generated more gene duplicates involved in bamboo shoot development. RNA sequencing analysis of bamboo flowering tissues suggests a potential connection between drought-responsive and flowering genes.	[Peng, Zhenhua; Li, Lubin; Yao, Na; Wang, Tao; Miao, Kun; Zhuang, Caiyun; Cao, Xiaolu; Chen, Jie; Liu, Zhenjing; Liu, Zhenhua; Jiang, Zehui] Chinese Acad Forestry, Res Inst Forestry, Key Lab Tree Breeding & Cultivat, State Forestry Adm, Beijing, Peoples R China; [Lu, Ying; Zhao, Qiang; Feng, Qi; Lu, Hengyun; Liu, Kunyan; Li, Yan; Fan, Danlin; Guo, Yunli; Li, Wenjun; Lu, Yiqi; Weng, Qijun; Zhou, CongCong; Zhang, Lei; Huang, Tao; Zhao, Yan; Zhu, Chuanrang; Huang, Xuehui; Lu, Tingting; Ning, Zemin; Han, Bin] Chinese Acad Sci, Natl Ctr Gene Res, Shanghai Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Gao, Zhimin; Hu, Tao; Liu, Xinge; Yang, Xuewen; Tang, Wenli; Liu, Guanshui; Liu, Yingli; Yuan, Licai; Fei, Benhua; Jiang, Zehui] Int Ctr Bamboo & Rattan, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; International Centre for Bamboo & Rattan	Han, B (corresponding author), Chinese Acad Sci, Natl Ctr Gene Res, Shanghai Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	bhan@ncgr.ac.cn; jiangzehui@icbr.ac.cn	liu, ying/GXF-4294-2022; yao, na/HDL-8772-2022; Ning, Zemin/D-2411-2013; LIU, YING/GZL-7252-2022	Ning, Zemin/0000-0003-4359-776X; Hu, Tao/0000-0002-1430-3112; Lu, Ying/0000-0002-2509-9209; Yao, Na/0000-0001-8394-4143; wang, tao/0000-0002-8592-9083	Forestry Project of the Ministry of Science and Technology of the People's Republic of China [200704001]; Chinese Academy of Sciences [KSCX2-YW-G-034]	Forestry Project of the Ministry of Science and Technology of the People's Republic of China; Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank C. Xu for her technological support in cytogenetic analysis. This work was supported by the Forestry Project of the Ministry of Science and Technology of the People's Republic of China (grant 200704001 to Z.J.) and the Chinese Academy of Sciences (KSCX2-YW-G-034 to B.H.).	Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Chen RY, 2003, 8 C ACAD C CHINESE S; Cui K, 2012, J PROTEOME RES, V11, P2492, DOI 10.1021/pr2011878; Das M, 2005, ANN BOT-LONDON, V95, P835, DOI 10.1093/aob/mci088; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; Fornara Fabio, 2010, Cell, V141, DOI 10.1016/j.cell.2010.04.024; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gui YJ, 2010, J INTEGR PLANT BIOL, V52, P1008, DOI 10.1111/j.1744-7909.2010.00965.x; Gui YJ, 2007, SCI CHINA SER C, V50, P700, DOI 10.1007/s11427-007-0081-6; Guyot R, 2004, GENOME, V47, P610, DOI 10.1139/G04-016; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Humphreys JM, 2002, CURR OPIN PLANT BIOL, V5, P224, DOI 10.1016/S1369-5266(02)00257-1; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kellogg EA, 1998, P NATL ACAD SCI USA, V95, P2005, DOI 10.1073/pnas.95.5.2005; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lobovikov M., 2007, WORLD BAMBOO RESOURC, VVolume 18; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Sanchez-Ken JG, 2007, SYST BOT, V32, P71, DOI 10.1600/036364407780360102; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sharma RK, 2008, GENOME, V51, P91, DOI [10.1139/G07-101, 10.1139/g07-101]; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Sungkaew S, 2009, J PLANT RES, V122, P95, DOI 10.1007/s10265-008-0192-6; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Yin YB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-99; Zhang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	37	329	431	12	147	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					456	461		10.1038/ng.2569	http://dx.doi.org/10.1038/ng.2569			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23435089	hybrid			2022-12-17	WOS:000316840600019
J	Horton, MW; Hancock, AM; Huang, YS; Toomajian, C; Atwell, S; Auton, A; Muliyati, NW; Platt, A; Sperone, FG; Vilhjalmsson, BJ; Nordborg, M; Borevitz, JO; Bergelson, J				Horton, Matthew W.; Hancock, Angela M.; Huang, Yu S.; Toomajian, Christopher; Atwell, Susanna; Auton, Adam; Muliyati, N. Wayan; Platt, Alexander; Sperone, F. Gianluca; Vilhjalmsson, Bjarni J.; Nordborg, Magnus; Borevitz, Justin O.; Bergelson, Joy			Genome-wide patterns of genetic variation in worldwide Arabidopsis thaliana accessions from the RegMap panel	NATURE GENETICS			English	Article							RECOMBINATION; SEQUENCE; ADAPTATION; POLYMORPHISMS; ASSOCIATION; EVOLUTION; SELECTION; HELITRON; CLIMATE; SWEEPS	Arabidopsis thaliana is native to Eurasia and is naturalized across the world. Its ability to be easily propagated and its high phenotypic variability make it an ideal model system for functional, ecological and evolutionary genetics. To date, analyses of the natural genetic variation of A. thaliana have involved small numbers of individual plants or genetic markers. Here we genotype 1,307 worldwide accessions, including several regional samples, using a 250K SNP chip. This allowed us to produce a high-resolution description of the global pattern of genetic variation. We applied three complementary selection tests and identified new targets of selection. Further, we characterized the pattern of historical recombination in A. thaliana and observed an enrichment of hotspots in its intergenic regions and repetitive DNA, which is consistent with the pattern that is observed for humans but which is strikingly different from that observed in other plant species. We have made the seeds we used to produce this Regional Mapping (RegMap) panel publicly available. This panel comprises one of the largest genomic mapping resources currently available for global natural isolates of a non-human species.	[Horton, Matthew W.; Hancock, Angela M.; Muliyati, N. Wayan; Sperone, F. Gianluca; Borevitz, Justin O.; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Huang, Yu S.; Atwell, Susanna; Platt, Alexander; Vilhjalmsson, Bjarni J.; Nordborg, Magnus] Univ So Calif, Los Angeles, CA USA; [Toomajian, Christopher] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Auton, Adam] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Nordborg, Magnus] Austrian Acad Sci, Gregor Mendel Inst, A-1010 Vienna, Austria	University of Chicago; University of Southern California; Kansas State University; University of Oxford; Wellcome Centre for Human Genetics; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	jbergels@uchicago.edu	Borevitz, Justin/B-5423-2012; Vilhjálmsson, Bjarni/ABC-1369-2020; Atwell, Susanna/H-8630-2016; Toomajian, Christopher/ABA-2615-2021; Vilhjalmsson, Bjarni/K-3971-2014	Borevitz, Justin/0000-0001-8408-3699; Vilhjálmsson, Bjarni/0000-0003-2277-9249; Atwell, Susanna/0000-0001-8680-9721; Toomajian, Christopher/0000-0002-6763-0678; Vilhjalmsson, Bjarni/0000-0003-2277-9249; Hancock, Angela/0000-0002-4768-3377; Platt, Alexander/0000-0003-3783-4781; Horton, Matthew/0000-0002-7537-0730; Bergelson, Joy/0000-0001-7893-7387; Nordborg, Magnus/0000-0001-7178-9748	National Science Foundation; Graduate Assistance in Areas of National Need (GAANN) training grant; Achievement Rewards for College Scientists (ARCS) Foundation; US National Institutes of Health [GM057994, GM083068]; Dropkin Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083068, R01GM057994] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Graduate Assistance in Areas of National Need (GAANN) training grant(US Department of Education); Achievement Rewards for College Scientists (ARCS) Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dropkin Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Hubisz for the code for the CLR statistic and for help in using the software. We also thank E. Leffler for helpful discussions regarding recombination hotspots. M.W.H. was supported by a National Science Foundation Predoctoral Fellowship, a Graduate Assistance in Areas of National Need (GAANN) training grant and an Achievement Rewards for College Scientists (ARCS) Foundation Scholarship. This research was supported by US National Institutes of Health grant GM057994 (J.B.), US National Institutes of Health grant GM083068 (J.B. and M.N.), National Science Foundation 2010 grants (M.N. and J.B.) and a Dropkin Foundation Fellowship (A.M.H.). This is contribution number 11-3634-J from the Kansas Agricultural Experiment Station (C.T.).	Alonso-Blanco C, 2003, GENETICS, V164, P711; Anastasio AE, 2011, PLANT J, V67, P554, DOI 10.1111/j.1365-313X.2011.04606.x; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2008, GENETICS, V178, P2031, DOI 10.1534/genetics.107.083279; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chiang GCK, 2011, MOL ECOL, V20, P3336, DOI 10.1111/j.1365-294X.2011.05181.x; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gill KS, 1996, GENETICS, V144, P1883; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; He LM, 2009, P NATL ACAD SCI USA, V106, P8410, DOI 10.1073/pnas.0902972106; Hollister JD, 2007, MOL BIOL EVOL, V24, P2515, DOI 10.1093/molbev/msm197; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Lewandowska-Sabat AM, 2010, MOL ECOL, V19, P4753, DOI 10.1111/j.1365-294X.2010.04840.x; LEWONTIN RC, 1973, GENETICS, V74, P175; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Yandeau-Nelson MD, 2005, GENETICS, V169, P917, DOI 10.1534/genetics.104.035089; Yang SA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040003	43	329	335	2	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2012	44	2					212	216		10.1038/ng.1042	http://dx.doi.org/10.1038/ng.1042			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22231484	Green Accepted			2022-12-17	WOS:000299664400022
J	Musio, A; Selicorni, A; Focarelli, ML; Gervasini, C; Milani, D; Russo, S; Vezzoni, P; Larizza, L				Musio, A; Selicorni, A; Focarelli, ML; Gervasini, C; Milani, D; Russo, S; Vezzoni, P; Larizza, L			X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations	NATURE GENETICS			English	Article							SISTER-CHROMATID COHESION; NIPPED-B; ROBERTS-SYNDROME; HUMAN HOMOLOG; CUT GENE; DROSOPHILA; PHENOTYPE; PROTEINS; NIPBL; EXPRESSION	Cornelia de Lange syndrome is a multisystem developmental disorder characterized by facial dysmorphisms, upper limb abnormalities, growth delay and cognitive retardation. Mutations in the NIPBL gene, a component of the cohesin complex, account for approximately half of the affected individuals. We report here that mutations in SMC1L1 (also known as SMC1), which encodes a different subunit of the cohesin complex, are responsible for CdLS in three male members of an affected family and in one sporadic case.	CNR, Inst Biomed Technol, Human Genome Dept, I-20090 Segrate, Italy; Univ Milan, Fdn Policlin, Clin Pediat 1, I-20122 Milan, Italy; Univ Milan, San Paolo Sch Med, Div Med Genet, I-20142 Milan, Italy; Ist Auxol Italiano, Mol Genet Lab, I-20095 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Istituto Auxologico Italiano	Musio, A (corresponding author), CNR, Inst Biomed Technol, Human Genome Dept, Via Fratelli Cervi,93, I-20090 Segrate, Italy.	antonio.musio@itb.cnr.it	Gervasini, Cristina/A-5728-2014; Musio, Antonio/GRO-1712-2022; Milani, Donatella/AAC-8430-2019; Vezzoni, Paolo/K-3197-2018; Vezzoni, Paolo/R-3416-2019	Gervasini, Cristina/0000-0002-1165-7935; Milani, Donatella/0000-0002-3087-8514; Vezzoni, Paolo/0000-0002-6382-3923; Russo, Silvia/0000-0002-5893-0193; MUSIO, ANTONIO/0000-0001-7701-6543				BROWN CJ, 1995, HUM MOL GENET, V4, P251, DOI 10.1093/hmg/4.2.251; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Egemen A, 2005, GENET COUNSEL, V16, P27; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Musio A, 2005, HUM MOL GENET, V14, P525, DOI 10.1093/hmg/ddi049; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; SELICORNI A, 1993, AM J MED GENET, V47, P977, DOI 10.1002/ajmg.1320470708; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548	14	329	344	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2006	38	5					528	530		10.1038/ng1779	http://dx.doi.org/10.1038/ng1779			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16604071				2022-12-17	WOS:000237147500013
J	Campbell, CD; Ogburn, EL; Lunetta, KL; Lyon, HN; Freedman, ML; Groop, LC; Altshuler, D; Ardlie, KG; Hirschhorn, JN				Campbell, CD; Ogburn, EL; Lunetta, KL; Lyon, HN; Freedman, ML; Groop, LC; Altshuler, D; Ardlie, KG; Hirschhorn, JN			Demonstrating stratification in a European American population	NATURE GENETICS			English	Article							GENETIC ASSOCIATION; STRUCTURED POPULATIONS; QUANTITATIVE TRAITS; GENOMIC CONTROL; DISEQUILIBRIUM; INFERENCE; VARIANTS; MARKERS; DISEASE; CANCER	Population stratification occurs in case-control association studies when allele frequencies differ between cases and controls because of ancestry. Stratification may lead to false positive associations, although this issue remains controversial(1-4). Empirical studies have found little evidence of stratification in European-derived populations, but potentially significant levels of stratification could not be ruled out(5-7). We studied a European American panel discordant for height, a heritable trait that varies widely across Europe(8). Genotyping 178 SNPs and applying standard analytical methods(6,9-11) yielded no evidence of stratification. But a SNP in the gene LCT that varies widely in frequency across Europe(12) was strongly associated with height (P < 10(-6)). This apparent association was largely or completely due to stratification; rematching individuals on the basis of European ancestry greatly reduced the apparent association, and no association was observed in Polish or Scandinavian individuals. The failure of standard methods to detect this stratification indicates that new methods may be required.	Childrens Hosp, Program Genom, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Genom Collaborat Inc, Cambridge, MA 02139 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; Lund Univ, Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Lund University; Skane University Hospital	Hirschhorn, JN (corresponding author), Childrens Hosp, Program Genom, 300 Longwood Ave, Boston, MA 02115 USA.	joelh@broad.mit.edu	Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; Lunetta, Kathryn/0000-0002-9268-810X				Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Allison DB, 1997, AM J HUM GENET, V60, P676; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pfaff CL, 2002, GENET EPIDEMIOL, V22, P196, DOI 10.1002/gepi.0126; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; THOMAS DC, 2002, BIOMARKERS PREV, V11, P505; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513	29	329	337	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					868	872		10.1038/ng1607	http://dx.doi.org/10.1038/ng1607			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16041375				2022-12-17	WOS:000230880400017
J	Irobi, J; Van Impe, K; Seeman, P; Jordanova, A; Dierick, I; Verpoorten, N; Michalik, A; De Vriendt, E; Jacobs, A; Van Gerwen, V; Vennekens, K; Mazanec, R; Tournev, I; Hilton-Jones, D; Talbot, K; Kremensky, N; Van Den Bosch, L; Robberecht, W; Vandekerckhove, J; Van Broeckhoven, C; Gettemans, J; De Jonghe, P; Timmerman, V				Irobi, J; Van Impe, K; Seeman, P; Jordanova, A; Dierick, I; Verpoorten, N; Michalik, A; De Vriendt, E; Jacobs, A; Van Gerwen, V; Vennekens, K; Mazanec, R; Tournev, I; Hilton-Jones, D; Talbot, K; Kremensky, N; Van Den Bosch, L; Robberecht, W; Vandekerckhove, J; Van Broeckhoven, C; Gettemans, J; De Jonghe, P; Timmerman, V			Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy	NATURE GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; ALPHA-A-CRYSTALLIN; HMN-II; MISSENSE MUTATION; CANDIDATE GENES; UP-REGULATION; PROTEIN; HSP27; MEMBER; SUPERFAMILY	Distal hereditary motor neuropathies are pure motor disorders of the peripheral nervous system resulting in severe atrophy and wasting of distal limb muscles'. In two pedigrees with distal hereditary motor neuropathy type II linked to chromosome 12q24.3, we identified the same mutation (K141N) in small heat-shock 22-kDa protein 8 (encoded by HSPB8; also called HSP22). We found a second mutation (K141E) in two smaller families. Both mutations target the same amino acid, which is essential to the structural and functional integrity of the small heat-shock protein alphaA-crystallin(2). This positively charged residue, when mutated in other small heat-shock proteins, results in various human disorders(.)(3,4) Coimmunoprecipitation experiments showed greater binding of both HSPB8 mutants to the interacting partner HSPB1. Expression of mutant HSPB8 in cultured cells promoted formation of intracellular aggregates. Our findings provide further evidence that mutations in heat-shock proteins have an important role in neurodegenerative disorders.	Univ Instelling Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; State Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; Charles Univ Prague, Sch Med 2, Dept Child Neurol, Prague, Czech Republic; Med Univ Sofia, Lab Mol Pathol, Sofia, Bulgaria; Charles Univ Prague, Sch Med 2, Dept Neurol, Prague, Czech Republic; Med Univ Sofia, Dept Neurol, Sofia, Bulgaria; Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 2JD, England; Katholieke Univ Leuven, Dept Expt Neurol, Neurobiol Lab, Louvain, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); Ghent University; Charles University Prague; Medical University Sofia; Charles University Prague; Medical University Sofia; Radcliffe Infirmary; University of Oxford; KU Leuven; University of Antwerp	Timmerman, V (corresponding author), Univ Instelling Antwerp VIB, Dept Mol Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	vincent.timmerman@ua.ac.be	Timmerman, Vincent/O-7283-2019; Talbot, Kevin/F-7361-2011; Jordanova, Albena/H-8323-2015; Van Broeckhoven, Christine/M-7853-2019; Van Broeckhoven, Christine/G-8362-2017; Van Den Bosch, Ludo/B-7258-2012	Timmerman, Vincent/0000-0002-2162-0933; Jordanova, Albena/0000-0002-3833-3754; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Den Bosch, Ludo/0000-0003-0104-4067; Talbot, Kevin/0000-0001-5490-1697				Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Benndorf R, 2001, J BIOL CHEM, V276, P26753, DOI 10.1074/jbc.M103001200; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bera S, 2002, BIOCHEMISTRY-US, V41, P297, DOI 10.1021/bi011010v; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARPER SW, 1990, NUCLEIC ACIDS RES, V18, P6457, DOI 10.1093/nar/18.21.6457; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Fontaine JM, 2003, CELL STRESS CHAPERON, V8, P62, DOI 10.1379/1466-1268(2003)8<62:TSODFP>2.0.CO;2; GETTEMANS J, 1995, J BIOL CHEM, V270, P2644, DOI 10.1074/jbc.270.6.2644; Grohmann K, 2001, NAT GENET, V29, P75, DOI 10.1038/ng703; HARDING AE, 1980, J NEUROL SCI, V45, P337, DOI 10.1016/0022-510X(80)90177-X; Irobi J, 2000, GENOMICS, V65, P34, DOI 10.1006/geno.2000.6149; Irobi J, 2002, J PERIPHER NERV SYST, V7, P87, DOI 10.1046/j.1529-8027.2002.02014.x; Irobi J, 2001, ANN HUM GENET, V65, P517, DOI 10.1017/S0003480001008910; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; MATSUDAIRA PT, 1978, ANAL BIOCHEM, V87, P386, DOI 10.1016/0003-2697(78)90688-7; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; TIMMERMAN V, 1992, J NEUROL SCI, V109, P41, DOI 10.1016/0022-510X(92)90091-X; Timmerman V, 1996, HUM MOL GENET, V5, P1065, DOI 10.1093/hmg/5.7.1065; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vleminckx V, 2002, J NEUROPATH EXP NEUR, V61, P968, DOI 10.1093/jnen/61.11.968; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	30	329	350	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2004	36	6					597	601		10.1038/ng1328	http://dx.doi.org/10.1038/ng1328			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825MX	15122253	Bronze			2022-12-17	WOS:000221763700016
J	Noben-Trauth, K; Zheng, QY; Johnson, KR				Noben-Trauth, K; Zheng, QY; Johnson, KR			Association of cadherin 23 with polygenic inheritance and genetic modification of sensorineural hearing loss	NATURE GENETICS			English	Article							SYNDROME TYPE 1D; INBRED STRAINS; MICE; LOCUS; SUSCEPTIBILITY; STEREOCILIA; MUTATIONS; HARMONIN; MODEL; MOUSE	Age-related hearing loss (AHL) in common inbred mouse strains is a genetically complex quantitative trait. We found a synonymous single-nucleotide polymorphism in exon 7 of Cdh23 that shows significant association with AHL and the deafness modifier mdfw (modifer of deafwaddler). The hypomorphic Cdh23(753A) allele causes in-frame skipping of exon 7. Altered adhesion or reduced stability of CDH23 may confer susceptibility to AHL. Homozygosity at Cdh23(753A) or in combination with heterogeneous secondary factors is a primary determinant of AHL in mice.	Natl Inst Deafness & Other Commun Disorders, Neurogenet Sect, NIH, Rockville, MD 20850 USA; Jackson Lab, Bar Harbor, ME 04609 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Jackson Laboratory	Noben-Trauth, K (corresponding author), Natl Inst Deafness & Other Commun Disorders, Neurogenet Sect, NIH, 5 Res Court, Rockville, MD 20850 USA.		Zheng, Qing/C-1731-2012		NIDCD NIH HHS [R01 DC005827, R01 DC004301, R01 DC004301-05, R21 DC005846, R01 DC009246, R21 DC005846-01A1, R01 DC005827-03, R03 DC004376-01A1] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009246, R21DC005846, R01DC004301, Z01DC000036, R03DC004376, R01DC005827] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Davis RR, 2001, HEARING RES, V155, P82, DOI 10.1016/S0378-5955(01)00250-7; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; ERWAY LC, 1993, HEARING RES, V65, P125, DOI 10.1016/0378-5955(93)90207-H; Johnson KR, 2002, GENOMICS, V80, P461, DOI 10.1016/S0888-7543(02)96858-8; Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831; Johnson KR, 2000, GENOMICS, V70, P171, DOI 10.1006/geno.2000.6377; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; von Brederlow B, 2002, HUM MUTAT, V19, P268, DOI 10.1002/humu.10049; Willott JF, 1998, HEARING RES, V115, P162, DOI 10.1016/S0378-5955(97)00189-5; Yamoah EN, 1998, J NEUROSCI, V18, P610; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zheng QY, 2001, HEARING RES, V154, P45, DOI 10.1016/S0378-5955(01)00215-5	15	329	345	0	12	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2003	35	1					21	23		10.1038/ng1226	http://dx.doi.org/10.1038/ng1226			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	716FQ	12910270	Green Accepted			2022-12-17	WOS:000185018500006
J	Mitchell, KJ; Pinson, KI; Kelly, OG; Brennan, J; Zupicich, L; Scherz, P; Leighton, PA; Goodrich, LV; Lu, XW; Avery, BJ; Tate, P; Dill, K; Pangilinan, E; Wakenight, P; Tessier-Lavigne, M; Skarnes, WC				Mitchell, KJ; Pinson, KI; Kelly, OG; Brennan, J; Zupicich, L; Scherz, P; Leighton, PA; Goodrich, LV; Lu, XW; Avery, BJ; Tate, P; Dill, K; Pangilinan, E; Wakenight, P; Tessier-Lavigne, M; Skarnes, WC			Functional analysis of secreted and transmembrane proteins critical to mouse development	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; GENE TRAP INTEGRATIONS; INSERTIONAL MUTATIONS; REGULATED GENES; GROWTH-FACTOR; MUTANT MICE; GENOME-WIDE; TOUT-VELU; DISRUPTION; IDENTIFICATION	We describe the successful application of a modified gene-trap approach, the secretory trap, to systematically analyze the functions in vivo of large numbers of genes encoding secreted and membrane proteins. Secretory-trap insertions in embryonic stem cells can be transmitted to the germ line of mice with high efficiency and effectively mutate the target gene. Of 60 insertions analyzed in mice, one-third cause recessive lethal phenotypes affecting various stages of embryonic and postnatal development. Thus, secretory-trap mutagenesis can be used for a genome-wide functional analysis of cell signaling pathways that are critical for normal mammalian development and physiology.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Skarnes, WC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	skarnes@socrates.berkeley.edu	Schick, Joel/ABA-3728-2021	Schick, Joel/0000-0002-8623-4910; Mitchell, Kevin/0000-0002-3433-4530; Brennan, Jane/0000-0003-3222-5485				AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Brennan J, 1999, METH MOL B, V97, P123, DOI 10.1385/1-59259-270-8:123; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41; Cal S, 2000, MOL BIOL CELL, V11, P1457, DOI 10.1091/mbc.11.4.1457; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; CHEN CC, 1993, ASIA PAC J PHARMACOL, V8, P1; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CORMICK C, 1998, NAT GENET, V19, P158; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; DEGREGORI J, 1994, GENE DEV, V8, P265, DOI 10.1101/gad.8.3.265; Forrester LM, 1996, P NATL ACAD SCI USA, V93, P1677, DOI 10.1073/pnas.93.4.1677; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Friedrich GA, 1997, DEV BIOL, V192, P364, DOI 10.1006/dbio.1997.8727; GASCA S, 1995, DEV GENET, V17, P141, DOI 10.1002/dvg.1020170206; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Hicks GG, 1997, NAT GENET, V16, P338, DOI 10.1038/ng0897-338; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; McClive P, 1998, DEV DYNAM, V212, P267, DOI 10.1002/(SICI)1097-0177(199806)212:2<267::AID-AJA11>3.0.CO;2-1; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Paine-Saunders S, 2000, DEV BIOL, V225, P179, DOI 10.1006/dbio.2000.9831; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Sagane K, 1999, GENE, V236, P79, DOI 10.1016/S0378-1119(99)00253-X; Sam M, 1998, DEV DYNAM, V212, P304, DOI 10.1002/(SICI)1097-0177(199806)212:2<304::AID-AJA15>3.0.CO;2-3; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Tate P, 1998, J CELL SCI, V111, P2575; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; VONMELCHNER H, 1992, GENE DEV, V6, P919, DOI 10.1101/gad.6.6.919; Voss AK, 1998, DEV DYNAM, V212, P258; WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WURST W, 1995, GENETICS, V139, P889; Yeo TT, 1997, J NEUROSCI RES, V47, P348, DOI 10.1002/(SICI)1097-4547(19970201)47:3<348::AID-JNR13>3.0.CO;2-Y; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	55	329	344	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2001	28	3					241	249		10.1038/90074	http://dx.doi.org/10.1038/90074			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431694				2022-12-17	WOS:000169656400016
J	Grady, WM; Willis, J; Guilford, PJ; Dunbier, AK; Toro, TT; Lynch, H; Wiesner, G; Ferguson, K; Eng, C; Park, JG; Kim, SJ; Markowitz, S				Grady, WM; Willis, J; Guilford, PJ; Dunbier, AK; Toro, TT; Lynch, H; Wiesner, G; Ferguson, K; Eng, C; Park, JG; Kim, SJ; Markowitz, S			Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer	NATURE GENETICS			English	Article							CADHERIN GERMLINE MUTATIONS; CPG ISLAND METHYLATION; DNA METHYLATION; COLORECTAL-CANCER; HYPERMETHYLATION; TUMORS; CELLS		Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Human Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ireland Canc Ctr, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Univ Otago, Dept Biochem, Canc Genet Lab, Dunedin, New Zealand; Creighton Univ, Sch Med, Dept Prevent Med, Omaha, NE 68178 USA; Ohio State Univ, Sch Med, Clin Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Sch Med, Human Canc Genet Program, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Sch Med, Div Human Genet, Dept Internal Med, Columbus, OH 43210 USA; Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea; NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA; Howard Hughes Med Inst, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of Otago; Creighton University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Seoul National University (SNU); Seoul National University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute	Markowitz, S (corresponding author), Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA.		Park, Jae-Gahb/J-5494-2012	Guilford, Parry/0000-0002-7256-9576; Eng, Charis/0000-0002-3693-5145; Dunbier, Anita/0000-0003-4621-7419	NATIONAL CANCER INSTITUTE [R01CA072160, K08CA077676, R01CA067409] Funding Source: NIH RePORTER; NCI NIH HHS [KO8 CA77676, R01 CA72160, R01 CA67409] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahuja N, 1998, CANCER RES, V58, P5489; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; GRAFF JR, 1995, CANCER RES, V55, P5195; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Guilford PJ, 1999, HUM MUTAT, V14, P249, DOI 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Myohanen SK, 1998, CANCER RES, V58, P591; Prowse AH, 1997, AM J HUM GENET, V60, P765; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Stirzaker C, 1997, CANCER RES, V57, P2229; Toyota M, 1999, CANCER RES, V59, P5438	15	329	347	0	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					16	17		10.1038/79120	http://dx.doi.org/10.1038/79120			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973239				2022-12-17	WOS:000089078000009
J	Martinez-Mir, A; Paloma, E; Allikmets, R; Ayuso, C; del Rio, T; Dean, M; Vilageliu, L; Gonzalez-Duarte, R; Balcells, S				Martinez-Mir, A; Paloma, E; Allikmets, R; Ayuso, C; del Rio, T; Dean, M; Vilageliu, L; Gonzalez-Duarte, R; Balcells, S			Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR	NATURE GENETICS			English	Letter									Univ Barcelona, Fac Biol, Dept Genet, E-08071 Barcelona, Spain; NCI, Intramural Res Support Program, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; Fdn Jimenez Diaz, Dept Genet, E-28040 Madrid, Spain; NCI, Lab Gen Divers, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA	University of Barcelona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Gonzalez-Duarte, R (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, E-08071 Barcelona, Spain.		Dean, Michael/R-7501-2019; Allikmets, Rando/ABD-4533-2021; Martinez-Mir, Amalia/K-7715-2018; Balcells, Susana/C-5222-2017; Dean, Michael C/G-8172-2012; IBIS, NEUROGENETICA/P-2947-2015	Martinez-Mir, Amalia/0000-0002-1628-8972; Balcells, Susana/0000-0003-1211-1907; Dean, Michael C/0000-0003-2234-0631; Ayuso, Carmen/0000-0002-9242-7065				Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; AZARIAN SM, 1997, FEBS LETT, V409, P347; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BAYES M, IN PRSS J MED GENET; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; KNOWLES JA, 1994, HUM MOL GENET, V3, P1401, DOI 10.1093/hmg/3.8.1401; MartinezMir A, 1997, GENOMICS, V40, P142, DOI 10.1006/geno.1996.4528; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; MAW S, 1997, NAT GENET, V17, P198; Osterberg G., 1935, ACTA OPHTHALMOL    S, V13, P1; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15	15	329	338	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					11	12		10.1038/ng0198-11	http://dx.doi.org/10.1038/ng0198-11			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425888	Green Submitted			2022-12-17	WOS:000071259600009
J	Flannick, J; Thorleifsson, G; Beer, NL; Jacobs, SBR; Grarup, N; Burtt, NP; Mahajan, A; Fuchsberger, C; Atzmon, G; Benediktsson, R; Blangero, J; Bowden, DW; Brandslund, I; Brosnan, J; Burslem, F; Chambers, J; Cho, YS; Cho, YS; Douglas, DA; Duggirala, R; Dymek, Z; Farjoun, Y; Fennell, T; Fontanillas, P; Forsen, T; Gabriel, S; Glaser, B; Gudbjartsson, DF; Hanis, C; Hansen, T; Hreidarsson, AB; Hveem, K; Ingelsson, E; Isomaa, B; Johansson, S; Jorgensen, T; Jorgensen, ME; Kathiresan, S; Kong, A; Kooner, J; Kravic, J; Laakso, M; Lee, JY; Lind, L; Lindgren, CM; Linneberg, A; Masson, G; Meitinger, T; Mohlke, KL; Molven, A; Morris, AP; Potluri, S; Rauramaa, R; Ribel-Madsen, R; Richard, AM; Rolph, T; Saloemaa, V; Segre, AV; Skarstrand, H; Steinthorsdottir, V; Stringham, HM; Sulem, P; Tai, ES; Teo, YY; Teslovich, T; Thorsteinsdottir, U; Trimmer, JK; Tuomi, T; Tuomilehto, J; Vaziri-Sani, F; Voight, BF; Voight, BF; Boehnke, M; McCarthy, MI; Njolstad, PR; Pedersen, O; Groop, L; Cox, DR; Stefansson, K; Altshuler, D				Flannick, Jason; Thorleifsson, Gudmar; Beer, Nicola L.; Jacobs, Suzanne B. R.; Grarup, Niels; Burtt, Noel P.; Mahajan, Anubha; Fuchsberger, Christian; Atzmon, Gil; Benediktsson, Rafn; Blangero, John; Bowden, Don W.; Brandslund, Ivan; Brosnan, Julia; Burslem, Frank; Chambers, John; Cho, Yoon Shin; Christensen, Cramer; Douglas, Desiree A.; Duggirala, Ravindranath; Dymek, Zachary; Farjoun, Yossi; Fennell, Timothy; Fontanillas, Pierre; Forsen, Tom; Gabriel, Stacey; Glaser, Benjamin; Gudbjartsson, Daniel F.; Hanis, Craig; Hansen, Torben; Hreidarsson, Astradur B.; Hveem, Kristian; Ingelsson, Erik; Isomaa, Bo; Johansson, Stefan; Jorgensen, Torben; Jorgensen, Marit Eika; Kathiresan, Sekar; Kong, Augustine; Kooner, Jaspal; Kravic, Jasmina; Laakso, Markku; Lee, Jong-Young; Lind, Lars; Lindgren, Cecilia M.; Linneberg, Allan; Masson, Gisli; Meitinger, Thomas; Mohlke, Karen L.; Molven, Anders; Morris, Andrew P.; Potluri, Shobha; Rauramaa, Rainer; Ribel-Madsen, Rasmus; Richard, Ann-Marie; Rolph, Tim; Salomaa, Veikko; Segre, Ayellet V.; Skaerstrand, Hanna; Steinthorsdottir, Valgerdur; Stringham, Heather M.; Sulem, Patrick; Tai, E. Shyong; Teo, Yik Ying; Teslovich, Tanya; Thorsteinsdottir, Unnur; Trimmer, Jeff K.; Tuomi, Tiinamaija; Tuomilehto, Jaakko; Vaziri-Sani, Fariba; Voight, Benjamin F.; Wilson, James G.; Boehnke, Michael; McCarthy, Mark I.; Njolstad, Pal R.; Pedersen, Oluf; Groop, Leif; Cox, David R.; Stefansson, Kari; Altshuler, David		Go-T2D Consortium; T2D-Genes Consortium	Loss-of-function mutations in SLC30A8 protect against type 2 diabetes	NATURE GENETICS			English	Article							ZINC TRANSPORTER ZNT8; GENOME-WIDE ASSOCIATION; GLUCOSE-HOMEOSTASIS; COMMON VARIANTS; BETA-CELL; INSULIN; RARE; PATHOPHYSIOLOGY; EXPRESSION; RESPONSES	Loss-of-function mutations protective against human disease provide in vivo validation of therapeutic targets1-3, but none have yet been described for type 2 diabetes (T2D). Through sequencing or genotyping of -150,000 individuals across 5 ancestry groups, we identified 12 rare protein-truncating variants in SLC30A8, which encodes an islet zinc transporter (ZnT8) 4 and harbors a common variant (p. Trp325Arg) associated with T2D risk and glucose and proinsulin levels5-7. Collectively, carriers of protein-truncating variants had 65% reduced T2D risk (P = 1.7 x 10(-6)), and non-diabetic Icelandic carriers of a frameshift variant (p. Lys34Serfs* 50) demonstrated reduced glucose levels (-0.17 s. d., P = 4.6 x 10(-4)). The two most common proteintruncating variants (p. Arg138* and p. Lys34Serfs* 50) individually associate with T2D protection and encode unstable ZnT8 proteins. Previous functional study of SLC30A8 suggested that reduced zinc transport increases T2D risk(8,9), and phenotypic heterogeneity was observed in mouse Slc30a8 knockouts(10-15). In contrast, loss-of-function mutations in humans provide strong evidence that SLC30A8 haploinsufficiency protects against T2D, suggesting ZnT8 inhibition as a therapeutic strategy in T2D prevention.	[Flannick, Jason; Beer, Nicola L.; Jacobs, Suzanne B. R.; Burtt, Noel P.; Dymek, Zachary; Farjoun, Yossi; Fennell, Timothy; Fontanillas, Pierre; Gabriel, Stacey; Kathiresan, Sekar; Lindgren, Cecilia M.; Segre, Ayellet V.; Voight, Benjamin F.; Njolstad, Pal R.; Altshuler, David] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02141 USA; [Flannick, Jason; Segre, Ayellet V.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Flannick, Jason; Altshuler, David] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Thorleifsson, Gudmar; Gudbjartsson, Daniel F.; Kong, Augustine; Masson, Gisli; Steinthorsdottir, Valgerdur; Sulem, Patrick; Thorsteinsdottir, Unnur; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Beer, Nicola L.; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Grarup, Niels; Hansen, Torben; Ribel-Madsen, Rasmus; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark; [Mahajan, Anubha; Ingelsson, Erik; Lindgren, Cecilia M.; Morris, Andrew P.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Fuchsberger, Christian; Stringham, Heather M.; Teslovich, Tanya; Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Atzmon, Gil] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Atzmon, Gil] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Benediktsson, Rafn; Hreidarsson, Astradur B.] Landspitali Univ Hosp, Dept Endocrinol & Metab, Reykjavik, Iceland; [Blangero, John; Duggirala, Ravindranath] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Bowden, Don W.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; [Bowden, Don W.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Diabet Res, Winston Salem, NC USA; [Bowden, Don W.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC USA; [Bowden, Don W.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC USA; [Brandslund, Ivan] Vejle Hosp, Dept Clin Biochem, Vejle, Denmark; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Brosnan, Julia; Richard, Ann-Marie; Rolph, Tim; Trimmer, Jeff K.] Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Cambridge, MA USA; [Burslem, Frank] Prescient Life Sci, Cardiovasc & Metab Dis Practice, London, England; [Chambers, John] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Chambers, John; Kooner, Jaspal] Univ London Imperial Coll Sci Technol & Med, Healthcare Natl Hlth Serv NHS Trust, London, England; [Chambers, John; Kooner, Jaspal] Ealing Hosp NHS Trust, Southall, Middx, England; [Cho, Yoon Shin] Hallym Univ, Dept Biomed Sci, Chunchon, South Korea; [Christensen, Cramer] Vejle Hosp, Dept Internal Med & Endocrinol, Vejle, Denmark; [Douglas, Desiree A.; Skaerstrand, Hanna; Vaziri-Sani, Fariba] Lund Univ, Dept Clin Sci, Unit Diabet & Celiac Dis, Malmo, Sweden; [Forsen, Tom; Tuomi, Tiinamaija] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Forsen, Tom] Vaasa Hlth Care Ctr, Diabetes Care Unit, Vaasa, Finland; [Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Endocrinol & Metab Serv, Jerusalem, Israel; [Glaser, Benjamin] IDRG, Holon, Israel; [Hanis, Craig] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Hveem, Kristian] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, Levanger, Norway; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Isomaa, Bo] Dept Social Serv & Hlth Care, Pietarsaari, Finland; [Johansson, Stefan; Molven, Anders; Njolstad, Pal R.] Univ Bergen, KG Jebsen Ctr Diabet Res, Dept Clin Sci, Bergen, Norway; [Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Johansson, Stefan] Univ Bergen, Dept Biomed, Bergen, Norway; [Jorgensen, Torben; Linneberg, Allan] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben; Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med, Copenhagen, Denmark; [Jorgensen, Torben; Linneberg, Allan] Aalborg Univ, Fac Med, Aalborg, Denmark; [Jorgensen, Marit Eika] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Kathiresan, Sekar; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kathiresan, Sekar; Altshuler, David] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kooner, Jaspal] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, NHLI, London, England; [Kravic, Jasmina; Groop, Leif] Lund Univ, Ctr Diabet, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Lee, Jong-Young] Korea Natl Inst Hlth, Osong Hlth Technol, Ctr Genome Sci, Seoul, Chungcheongbuk, South Korea; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Linneberg, Allan] Glostrup Univ Hosp, Dept Clin Expt Res, Glostrup, Denmark; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Molven, Anders] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Potluri, Shobha; Cox, David R.] Pfizer Inc, Appl Quantitat Genotherapeut, San Francisco, CA USA; [Rauramaa, Rainer] Kuopio Res Inst Exercise Med, Kuopio, Finland; [Rauramaa, Rainer] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, SF-70210 Kuopio, Finland; [Salomaa, Veikko] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Tai, E. Shyong; Teo, Yik Ying] Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Med, Singapore 117548, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Dept Med, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Ctr Mol Epidemiol, Singapore 117548, Singapore; [Teo, Yik Ying] Genome Inst Singapore, Agcy Sci Technol & Res, Singapore, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Teo, Yik Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabetes Prevent Unit, Helsinki, Finland; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21413, Saudi Arabia; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Phys & Biophys, Jackson, MS 39216 USA; [McCarthy, Mark I.] Churchill Hosp, Hlth Res NIHR Biomed Res Ctr, Oxford Natl Inst, Oxford, England; [Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Groop, Leif] Univ Helsinki, Finnish Inst Mol Med FIMM, Helsinki, Finland; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Oxford; Novo Nordisk Foundation; University of Copenhagen; University of Oxford; Wellcome Centre for Human Genetics; University of Michigan System; University of Michigan; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Landspitali National University Hospital; Texas Biomedical Research Institute; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Pfizer; Imperial College London; Imperial College London; Hallym University; University of Southern Denmark; Lillebaelt Hospital; Lund University; University of Helsinki; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Texas System; University of Texas Health Science Center Houston; University of Southern Denmark; Norwegian University of Science & Technology (NTNU); Uppsala University; Folkhalsan Research Center; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Copenhagen; Aalborg University; Steno Diabetes Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Imperial College London; Lund University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Uppsala University; University of Copenhagen; Technical University of Munich; University of North Carolina; University of North Carolina Chapel Hill; University of Bergen; University of Bergen; Haukeland University Hospital; University of Liverpool; Pfizer; Kuopio University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; University of Iceland; Danube University Krems; Finland National Institute for Health & Welfare; King Abdulaziz University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Mississippi; University of Mississippi Medical Center; University of Bergen; Haukeland University Hospital; University of Helsinki; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Altshuler, D (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02141 USA.	kstefans@decode.is; altshuler@molbio.mgh.harvard.edu	Benediktsson, Rafn/R-2457-2018; Chen, Peng/E-5546-2015; Lee, Jong-Young/M-6319-2013; Fuchsberger, Christian/ABD-7127-2021; Blangero, John/ABA-7175-2021; Grarup, Niels/K-2807-2015; Vaziri-Sani, Fariba/J-6390-2014; Johansson, Stefan/C-4394-2011; Hveem, Kristian/AFV-4683-2022; Glaser, Benjamin/F-8411-2017; Meitinger, Thomas/O-1318-2015; Pedersen, Oluf/Z-1731-2019; Stefansson, Kari/AAE-7187-2019; Pedersen, Oluf/AAG-8015-2020; Jørgensen, Torben/Z-1335-2018; Altshuler, David M/A-4476-2009; McCarthy, Mark/M-3763-2015	Benediktsson, Rafn/0000-0002-2954-9801; Chen, Peng/0000-0002-1422-4641; Lee, Jong-Young/0000-0002-0092-9958; Fuchsberger, Christian/0000-0002-5918-8947; Grarup, Niels/0000-0001-5526-1070; Vaziri-Sani, Fariba/0000-0002-9953-2829; Johansson, Stefan/0000-0002-2298-7008; Glaser, Benjamin/0000-0003-4711-5000; Pedersen, Oluf/0000-0002-3321-3972; Altshuler, David M/0000-0002-7250-4107; Kong, Augustine/0000-0001-8193-5438; Jorgensen, Marit Eika/0000-0001-8356-5565; Meitinger, Thomas/0000-0002-8838-8403; Jorgensen, Torben/0000-0001-9453-2830; Mahajan, Anubha/0000-0001-5585-3420; Lindgren, Cecilia/0000-0002-4903-9374; Linneberg, Allan/0000-0002-0994-0184; McCarthy, Mark/0000-0002-4393-0510; Brandslund, Ivan/0000-0002-4203-5442; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Voight, Benjamin/0000-0002-6205-9994; Yoon, Joon/0000-0002-9509-119X; Tuomi, Tiinamaija/0000-0002-8306-6202; Jacobs, Suzanne/0000-0002-8103-1700; Tai, E Shyong/0000-0003-2929-8966; Hansen, Torben/0000-0001-8748-3831	US National Institutes of Health (NIH) Training [5-T32-GM007748-33]; Doris Duke Charitable Foundation [2006087]; Fulbright Diabetes UK Fellowship [BDA 11/0004348]; Broad Institute from Pfizer, Inc.; NIH [U01 DK085501, U01 DK085524, U01 DK085545, U01 DK085584]; Swedish Research Council [Dnr 521-2010-3490, Dnr 349-2006-237]; European Research Council (ERC) [GENETARGET T2D, GA269045]; ENGAGE [2007-201413]; CEED3 [2008-223211]; Sigrid Juselius Foundation; Folkh lsan Research Foundation; ERC [AdG 293574]; Research Council of Norway [197064/V50]; KG Jebsen Foundation; University of Bergen; Western Norway Health Authority; Lundbeck Foundation; Novo Nordisk Foundation; Wellcome Trust [WT098017, WT064890, WT090532, WT090367, WT098381]; Uppsala University; Swedish Research Council and the Swedish Heart- Lung Foundation; Academy of Finland [124243, 102318, 123885, 139635]; Finnish Heart Foundation; Finnish Diabetes Foundation, Tekes [1510/31/06]; Commission of the European Community [HEALTH-F2-2007-201681]; Ministry of Education and Culture of Finland; European Commission Framework Programme 6 Integrated Project [LSHM-CT-2004-005272]; City of Kuopio and Social Insurance Institution of Finland; Finnish Foundation for Cardiovascular Disease; NIH/NIDDK [U01-DK085545]; National Heart, Lung, and Blood Institute (NHLBI); National Institute on Minority Health and Health Disparities [N01 HC-95170, N01 HC-95171, N01 HC-95172]; European Union Seventh Framework Programme, DIAPREPP; Swedish Child Diabetes Foundation (Barndiabetesfonden);  [5U01DK085526];  [DK088389];  [U54HG003067];  [R01DK072193];  [R01DK062370];  [Z01HG000024]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095170, N01HC095171, N01HC095172] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R13CA124293] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098032, U01DK085524, R01DK072193, R01DK062370, R01DK093757, RC2DK088389, U01DK062370, U01DK085584, U01DK085501, U01DK085526, U01DK085545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007748] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0005637] Funding Source: researchfish	US National Institutes of Health (NIH) Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Fulbright Diabetes UK Fellowship(Diabetes UK); Broad Institute from Pfizer, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); ENGAGE; CEED3; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Folkh lsan Research Foundation; ERC(European Research Council (ERC)European Commission); Research Council of Norway(Research Council of Norway); KG Jebsen Foundation; University of Bergen; Western Norway Health Authority; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Wellcome Trust(Wellcome TrustEuropean Commission); Uppsala University; Swedish Research Council and the Swedish Heart- Lung Foundation; Academy of Finland(Academy of Finland); Finnish Heart Foundation; Finnish Diabetes Foundation, Tekes; Commission of the European Community(European Commission); Ministry of Education and Culture of Finland; European Commission Framework Programme 6 Integrated Project; City of Kuopio and Social Insurance Institution of Finland; Finnish Foundation for Cardiovascular Disease; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); European Union Seventh Framework Programme, DIAPREPP; Swedish Child Diabetes Foundation (Barndiabetesfonden); ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This manuscript is dedicated to the memory of David R. Cox, our dear friend and colleague, who was relentlessly supportive of this work-and more generally, of the use of human genetics to improve human health. He is missed, but his legacy goes on. We gratefully acknowledge the contribution of all similar to 150,000 participants from the various population studies that contributed to this work. J.F. was supported in part by US National Institutes of Health (NIH) Training Grant 5-T32-GM007748-33. D. A. was supported by funding from the Doris Duke Charitable Foundation (2006087). N. L. B. was supported by a Fulbright Diabetes UK Fellowship (BDA 11/0004348). This work was supported in part by funding to the Broad Institute (principal investigator D. A.) from Pfizer, Inc. Funding for the GoT2D and T2D-GENES studies was provided by grants 5U01DK085526 (NIH/NIDDK; Multiethnic Study of Type 2 Diabetes Genes), DK088389 (NIH/NIDDK; Low-Pass Sequencing and High-Density SNP Genotyping for Type 2 Diabetes) and U54HG003067 (National Human Genome Research Institute (NHGRI); Large-Scale Sequencing and Analysis of Genomes), as well as by NIH grants U01 DK085501, U01 DK085524, U01 DK085545 and U01 DK085584. The Malm Preventive Project and the Scania Diabetes Registry were supported by grants from the Swedish Research Council (Dnr 521-2010-3490 to L. G. and Dnr 349-2006-237 to the Lund University Diabetes Centre), as well as by a European Research Council (ERC) grant (GENETARGET T2D, GA269045) and two European Union grants (ENGAGE (2007-201413) and CEED3 (2008-223211)) to L. G. The Botnia study was supported by funding from the Sigrid Juselius Foundation and the Folkh lsan Research Foundation. P. R. N. was funded by the ERC (AdG 293574), the Research Council of Norway (197064/V50), the KG Jebsen Foundation, the University of Bergen, the Western Norway Health Authority, the European Association for the Study of Diabetes Sabbatical Leave Programme and Innovest. The Danish studies were supported by the Lundbeck Foundation (Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care (LuCamp); http://www.lucamp.org/) and the Danish Council for Independent Research. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen, partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk/). The PIVUS/ ULSAM cohort was supported by Wellcome Trust grants WT098017, WT064890 and WT090532, Uppsala University, the Uppsala University Hospital, the Swedish Research Council and the Swedish Heart- Lung Foundation. The METSIM study was supported by the Academy of Finland (contract 124243), the Finnish Heart Foundation, the Finnish Diabetes Foundation, Tekes (contract 1510/31/06), the Commission of the European Community (HEALTH-F2-2007-201681) and grants R01DK062370 and R01DK072193 (NIH/NIDDK) and grant (NHGRI). The FUSION study was supported by grants R01DK062370 and R01DK072193 (NIH/NIDDK) and grant Z01HG000024 (NHGRI). The DR's EXTRA Study was supported by the Ministry of Education and Culture of Finland (627; 2004-2011), the Academy of Finland (102318; 123885), Kuopio University Hospital, the Finnish Diabetes Association, the Finnish Heart Association and the P ivikki and Sakari Sohlberg Foundation and by grants from the European Commission Framework Programme 6 Integrated Project (EXGENESIS); LSHM-CT-2004-005272, City of Kuopio and Social Insurance Institution of Finland (4/26/2010). V.; Salomaa is funded by the Academy of Finland, grant 139635, and by the Finnish Foundation for Cardiovascular Disease. Sequencing and genotyping of British individuals was supported by Wellcome Trust grants WT090367, WT090532 and WT098381 and by NIH/NIDDK grant U01-DK085545. Funding for the Jackson Heart Study (JHS) was provided by the National Heart, Lung, and Blood Institute (NHLBI) and by the National Institute on Minority Health and Health Disparities (N01 HC-95170, N01 HC-95171 and N01 HC-95172). A. P. M. acknowledges support from Wellcome Trust grants WT098017, WT090532 and WT064890. F.V.-S. and H. S. were supported by the European Union Seventh Framework Programme, DIAPREPP (Diabetes Type 1 Prediction, Early Pathogenesis and Prevention, grant agreement 202013), and by the Swedish Child Diabetes Foundation (Barndiabetesfonden).	Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Guey LT, 2011, GENET EPIDEMIOL, V35, P236, DOI 10.1002/gepi.20572; Hardy AB, 2012, AM J PHYSIOL-ENDOC M, V302, pE1084, DOI 10.1152/ajpendo.00448.2011; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Pound LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040972; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Rutter GA, 2010, ISLETS, V2, P49, DOI 10.4161/isl.2.1.10259; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Sullivan D, 2012, JAMA-J AM MED ASSOC, V308, P2497, DOI 10.1001/jama.2012.25790; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; van de Bunt M, 2010, CURR DIABETES REP, V10, P452, DOI 10.1007/s11892-010-0150-2; Waters P J, 2001, Curr Issues Mol Biol, V3, P57; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Xavier GD, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/906590	28	328	335	0	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					357	+		10.1038/ng.2915	http://dx.doi.org/10.1038/ng.2915			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24584071	Green Accepted			2022-12-17	WOS:000334510100011
J	Caussinus, E; Gonzalez, C				Caussinus, E; Gonzalez, C			Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster	NATURE GENETICS			English	Article							GENETIC INSTABILITY; FATE DETERMINANTS; SELF-RENEWAL; POLARITY; PROLIFERATION; NEUROBLAST; CANCER; DLG; LGL; NEUROGENESIS	Loss of cell polarity and cancer are tightly correlated(1), but proof for a causative relationship has remained elusive. In stem cells, loss of polarity and impairment of asymmetric cell division could alter cell fates and thereby render daughter cells unable to respond to the mechanisms that control proliferation(2). To test this hypothesis, we generated Drosophila melanogaster larval neuroblasts containing mutations in various genes that control asymmetric cell division and then assayed their proliferative potential after transplantation into adult hosts. We found that larval brain tissue carrying neuroblasts with mutations in raps (also called pins), mira, numb or pros grew to more than 100 times their initial size, invading other tissues and killing the hosts in 2 weeks. These tumors became immortal and could be retransplanted into new hosts for years. Six weeks after the first implantation, genome instability and centrosome alterations, two traits of malignant carcinomas(3,4), appeared in these tumors. Increasing evidence suggests that some tumors may be of stem cell origin(5,6). Our results show that loss of function of any of several genes that control the fate of a stem cell's daughters may result in hyperproliferation, triggering a chain of events that subverts cell homeostasis in a general sense and leads to cancer.	ICREA & IRBB, Cell Div Grp, Barcelona, Spain; European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany	ICREA; European Molecular Biology Laboratory (EMBL)	Gonzalez, C (corresponding author), ICREA & IRBB, Cell Div Grp, Parc Cient Barcelona,C Josep Samitier 1-5, Barcelona, Spain.	cgonzalez@pcb.ub.es	Gonzalez, Cayetano/K-3933-2019; Gonzalez, Cayetano/K-3055-2019	Gonzalez, Cayetano/0000-0002-5259-3608	ICREA Funding Source: Custom	ICREA(ICREA)		Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Bardin AJ, 2004, CURR OPIN NEUROBIOL, V14, P6, DOI 10.1016/j.conb.2003.12.002; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110; Chia W, 2002, CURR OPIN GENET DEV, V12, P459, DOI 10.1016/S0959-437X(02)00326-X; GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Gatewood WB, 1997, AFR AM REV, V31, P365, DOI 10.2307/3042495; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; GEHRING W, 1966, J EMBRYOL EXP MORPH, V15, P77; HADORN E, 1966, DEV BIOL, V13, P424, DOI 10.1016/0012-1606(66)90058-3; HADORN E, 1978, GENETICS BIOL DROS C, V2, P557; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Liu H, 2005, CELL CYCLE, V4, P646, DOI 10.4161/cc.4.5.1674; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Pihan GA, 2003, CANCER RES, V63, P1398; Pihan GA, 1998, CANCER RES, V58, P3974; Shih IM, 2001, CANCER RES, V61, P818; SUNKEL CE, 1995, EMBO J, V14, P28, DOI 10.1002/j.1460-2075.1995.tb06972.x; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; WATSON KL, 1994, J CELL SCI, P19; Wodarz A, 2000, CURR BIOL, V10, pR624, DOI 10.1016/S0960-9822(00)00658-8	30	328	341	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1125	1129		10.1038/ng1632	http://dx.doi.org/10.1038/ng1632			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16142234				2022-12-17	WOS:000232185600026
J	Bereshchenko, OR; Gu, W; Dalla-Favera, R				Bereshchenko, OR; Gu, W; Dalla-Favera, R			Acetylation inactivates the transcriptional repressor BCL6	NATURE GENETICS			English	Article							CENTER B-CELLS; GERMINAL-CENTER FORMATION; FINGER ENCODING GENE; SOMATIC HYPERMUTATION; HISTONE DEACETYLASES; POZ DOMAIN; P53; LYMPHOMA; PROTEIN; DIFFERENTIATION	The proto-oncogene BCL6 encodes a BTB/POZ-zinc finger transcriptional repressor that is necessary for germinal-center formation and has been implicated in the pathogenesis of B-cell lymphomas. Here we show that the coactivator p300 binds and acetylates BCL6 in vivo and inhibits its function. Acetylation disrupts the ability of BCL6 to recruit histone deacetylases (HDACs), thereby hindering its capacity to repress transcription and to induce cell transformation. BCL6 is acetylated under physiologic conditions in normal germinal-center B cells and in germinal center-derived B-cell tumors. Treatment with specific inhibitors shows that levels of acetylation of BCL6 are controlled by both HDAC-dependent and SIR2-dependent pathways. Pharmacological inhibition of these pathways leads to the accumulation of the inactive acetylated BCL6 and to cell-cycle arrest and apoptosis in B-cell lymphoma cells. These results identify a new mechanism of regulation of the proto-oncogene BCL6 with potential for therapeutic exploitation. Furthermore, these findings provide a new mechanism by which acetylation can promote transcription not only by modifying histones and activating transcriptional activators, but also by inhibiting transcriptional repressors.	Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.			Bereshchenko, Oxana/0000-0002-2772-6042				Albagli O, 1996, BIOCHEM BIOPH RES CO, V220, P911, DOI 10.1006/bbrc.1996.0505; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Artiga MJ, 2002, AM J PATHOL, V160, P1371, DOI 10.1016/S0002-9440(10)62564-3; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chan HM, 2001, NAT CELL BIOL, V3, P667, DOI 10.1038/35083062; Chan HM, 2001, J CELL SCI, V114, P2363; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2000, GENE DEV, V14, P1021; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Moller MB, 1999, CLIN CANCER RES, V5, P1085; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Ye BH, 1995, EMBO J, V14, P6209, DOI 10.1002/j.1460-2075.1995.tb00311.x; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Zhang H, 2001, BBA-MOL CELL RES, V1540, P188, DOI 10.1016/S0167-4889(01)00128-8; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	50	328	342	0	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2002	32	4					606	613		10.1038/ng1018	http://dx.doi.org/10.1038/ng1018			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621MH	12402037				2022-12-17	WOS:000179593000012
J	Tavernarakis, N; Wang, SL; Dorovkov, M; Ryazanov, A; Driscoll, M				Tavernarakis, N; Wang, SL; Dorovkov, M; Ryazanov, A; Driscoll, M			Heritable and inducible genetic interference by double-stranded RNA encoded by transgenes	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; EXPRESSION; SEQUENCE; IDENTIFICATION; DEGRADATION; MORPHOLOGY; PLANTS	Double-stranded RNA interference (RNAi) is an effective method for disrupting expression of specific genes in Caenorhabditis elegans and other organisms(1-5). Applications of this reverse-genetics tool, however, am somewhat restricted in nematodes because introduced dsRNA is not stably inherited(5). Another difficulty is that RNAi disruption of late-acting genes has been generally less consistent than that of embryonically expressed genes, perhaps because the concentration of dsRNA becomes lower as cellular division proceeds or as developmental time advances(1). In particular, some neuronally expressed genes appear refractory to dsRNA-mediated interference. We sought to extend the applicability of RNAi by in vivo expression of heritable inverted-repeat (IR) genes. We assayed the efficacy of in vivo-driven RNAi in three situations for which heritable, inducible RNAi would be advantageous: (i) production of large numbers of animals deficient for gene activities required for viability or reproduction; (ii) generation of large populations of phenocopy mutants for biochemical analysis; and (iii) effective gene inactivation in the nervous system. We report that heritable IR genes confer potent and specific gene inactivation for each of these applications. We suggest that a similar strategy might be used to test for dsRNA interference effects in higher organisms in which it is feasible to construct transgenic animals, but impossible to directly or transiently introduce high concentrations of dsRNA.	Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Driscoll, M (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA.		Tavernarakis, Nektarios/B-9684-2013; ryazanov, alexey/J-8081-2017	Tavernarakis, Nektarios/0000-0002-5253-1466; 	NIGMS NIH HHS [GM57300] Funding Source: Medline; NINDS NIH HHS [NS344435, NS37955] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037955] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; BRENNER S, 1974, GENETICS, V77, P71; DIBB NJ, 1989, J MOL BIOL, V205, P603, DOI 10.1016/0022-2836(89)90229-5; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; JONES D, 1986, J BIOL CHEM, V261, P2006; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; MADURO M, 1995, GENETICS, V141, P977; MELLO CC, 1994, METHODS CELL BIOL CA, P451; MITANI S, 1993, DEVELOPMENT, V119, P773; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Montgomery MK, 1998, TRENDS GENET, V14, P255, DOI 10.1016/S0168-9525(98)01510-8; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; PARK EC, 1986, GENETICS, V113, P821; Ren XC, 1999, J NEUROBIOL, V39, P107, DOI 10.1002/(SICI)1097-4695(199904)39:1&lt;107::AID-NEU9&gt;3.0.CO;2-7; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	25	328	445	1	35	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2000	24	2					180	183		10.1038/72850	http://dx.doi.org/10.1038/72850			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	280LQ	10655066				2022-12-17	WOS:000085104600021
J	Rozmahel, R; Wilschanski, M; Matin, A; Plyte, S; Oliver, M; Auerbach, W; Moore, A; Forstner, J; Durie, P; Nadeau, J; Bear, C; Tsui, LC				Rozmahel, R; Wilschanski, M; Matin, A; Plyte, S; Oliver, M; Auerbach, W; Moore, A; Forstner, J; Durie, P; Nadeau, J; Bear, C; Tsui, LC			Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor	NATURE GENETICS			English	Article							PANCREATIC FUNCTION; STEM-CELLS; MOUSE; CFTR; IDENTIFICATION; MUTAGENESIS; EPITHELIUM; MUTATIONS; PHENOTYPE; TRANSPORT	Mice that have been made deficient for the cystic fibrosis transmembrane conductance regulator (Cftr) usually die of intestinal obstruction, We have created Cftr-deficient mice and demonstrate prolonged survival among backcross and intercross progeny with different inbred strains, suggesting that modulation of disease severity is genetically determined. A genome scan showed that the major modifier locus maps near the centromere of mouse chromosome 7. Electrophysiological studies on mice with prolonged survival show that the partial rectification of Cl- and Na+ ion transport abnormalities can be explained in part by up-regulation of a calcium-activated Cl- conductance, Identification of modifier genes in our Cftr(m1HSC)/Cft(rm1HSC) mice should provide important insight into the heterogeneous disease presentation observed among CF patients.	UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PHYSIOL,TORONTO,ON,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PEDIAT,TORONTO,ON,CANADA; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M56 1X8,CANADA; HOSP SICK CHILDREN,DIV GASTROENTEROL,TORONTO,ON M56 1X8,CANADA; HOSP SICK CHILDREN,DIV CELL BIOL,TORONTO,ON M56 1X8,CANADA; HOSP SICK CHILDREN,DIV BIOCHEM RES,TORONTO,ON M56 1X8,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University			Tsui, Lap-chee/A-1081-2010					ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; ASADA Y, 1994, NAT GENET, V6, P363, DOI 10.1038/ng0494-363; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BJERKNES M, 1981, ANAT REC, V199, P565, DOI 10.1002/ar.1091990412; BRILLIANT MH, 1994, MAMM GENOME, V5, pS104; CHANG XB, 1993, J BIOL CHEM, V268, P11304; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; COREY M, 1989, J PEDIATR-US, V115, P274, DOI 10.1016/S0022-3476(89)80082-4; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; ECKMAN E, 1994, PEDIATR PULM, V10, pA62; EVANS GS, 1992, J CELL SCI, V101, P219; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; LISON L, 1954, STAIN TECHNOL, V29, P13; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 1993, Gene targeting: a practical approach., P147; ONEAL WK, 1993, HUM MOL GENET, V2, P1561, DOI 10.1093/hmg/2.10.1561; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; RATLIFF R, 1992, NAT GENET, V4, P35; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; ZHOU L, 1994, SCIENCE, V266, P1705, DOI 10.1126/science.7527588	35	328	334	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					280	287		10.1038/ng0396-280	http://dx.doi.org/10.1038/ng0396-280			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589719				2022-12-17	WOS:A1996TY18300017
J	CALONGE, MT; GASPARINI, P; CHILLARON, J; CHILLON, M; GALLUCCI, M; ROUSAUD, F; ZELANTE, L; TESTAR, X; DALLAPICCOLA, B; DISILVERIO, F; BARCELO, P; ESTIVILL, X; ZORZANO, A; NUNES, V; PALACIN, M				CALONGE, MT; GASPARINI, P; CHILLARON, J; CHILLON, M; GALLUCCI, M; ROUSAUD, F; ZELANTE, L; TESTAR, X; DALLAPICCOLA, B; DISILVERIO, F; BARCELO, P; ESTIVILL, X; ZORZANO, A; NUNES, V; PALACIN, M			CYSTINURIA CAUSED BY MUTATIONS IN RBAT, A GENE INVOLVED IN THE TRANSPORT OF CYSTINE	NATURE GENETICS			English	Article							BORDER MEMBRANE-VESICLES; AMINO-ACID-TRANSPORT; EXPRESSION CLONING; RAT-KIDNEY; SYSTEM; CHAIN; TUBULES; CDNA	Cystinuria is a classic heritable aminoaciduria that involves the defective transepithelial transport of cystine and dibasic amino acids in the kidney and intestine. Six missense mutations in the human rBAT gene, which is involved in high-affinity transport of cystine and dibasic amino acids in kidney and intestine, segregate with cystinuria. These mutations account for 30% of the cystinuria chromosomes studied. Homozygosity for the most common mutation (M467T) was detected in three cystinuric siblings. Mutation M467T nearly abolished the amino acid transport activity induced by rBAT in Xenopus oocytes. These results establish rBAT as a cystinuria gene.	HOSP DURAN I REYNALS, IRO, DEPT MOLEC GENET, E-80907 BARCELONA, SPAIN; UNIV BARCELONA, FAC BIOL, DEPT BIOQUIM & FISIOL, E-08028 BARCELONA, SPAIN; OSPED CSS, IRCCS, SERV GENET MED, FOGGIA, ITALY; UNIV ROMA LA SAPIENZA, DIPARTIMENTO UROL, ROME, ITALY; FDN PUIGVERT, SERV NEFROL IUNA, E-08025 BARCELONA, SPAIN	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome; Fundacio Puigvert			Chillaron, Josep/ABF-7663-2021; Nunes, Virginia/AAD-1014-2019; Zorzano, Antonio/R-5479-2018; Estivill, Xavier/A-3125-2013; Nunes, Virginia/D-4356-2014; Gasparini, Paolo/B-6173-2014; Palacín, Manuel/G-9786-2015; Wilson, Matthew H/K-3193-2013; Dallapiccola, Bruno/K-8692-2016; Chillon, Miguel/A-2466-2009; Gallucci, Michele/K-9600-2016	Chillaron, Josep/0000-0003-3068-7598; Nunes, Virginia/0000-0002-5747-9310; Estivill, Xavier/0000-0002-0723-2256; Nunes, Virginia/0000-0002-5747-9310; Dallapiccola, Bruno/0000-0002-5031-1013; Chillon, Miguel/0000-0003-0840-2111; Palacin, Manuel/0000-0002-8670-293X; Gallucci, Michele/0000-0002-3637-6531	Telethon [E.0083] Funding Source: Medline	Telethon(Fondazione Telethon)		BERTRAN J, 1993, J BIOL CHEM, V268, P14842; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5601, DOI 10.1073/pnas.89.12.5601; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5606, DOI 10.1073/pnas.89.12.5606; BIBER J, 1983, PFLUG ARCH EUR J PHY, V396, P335, DOI 10.1007/BF01063939; BROWN RR, 1967, SCIENCE, V157, P432, DOI 10.1126/science.157.3787.432; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; COLCADAN L, 1980, PEDIATR RES, V14, P109; FOREMAN JW, 1980, METABOLISM, V29, P53, DOI 10.1016/0026-0495(80)90098-0; FURLONG TJ, 1990, AM J PHYSIOL, V258, pF321, DOI 10.1152/ajprenal.1990.258.2.F321; FURRIOLS M, 1993, J BIOL CHEM, V268, P27060; Garrod AE, 1908, LANCET, V2, P214; Garrod AE, 1908, LANCET, V2, P142; Garrod AE, 1908, LANCET, V2, P1; Garrod AE, 1908, LANCET, V2, P73; HURWITZ R, 1979, INT J CANCER, V23, P174, DOI 10.1002/ijc.2910230206; KANAI Y, 1992, AM J PHYSIOL, V263, pF1087, DOI 10.1152/ajprenal.1992.263.6.F1087; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE WS, 1993, J CLIN INVEST, V91, P1959, DOI 10.1172/JCI116415; LEVY HL, 1973, ADV HUM GENET, P1; MARKOVICH D, 1993, J BIOL CHEM, V268, P1362; MCKUSICK VA, 1990, MENDELIAN INHERITANC, P1128; MCNAMARA PD, 1992, BIOCHIM BIOPHYS ACTA, V1103, P101, DOI 10.1016/0005-2736(92)90062-Q; MCNAMARA PD, 1981, BIOCHEM J, V194, P443, DOI 10.1042/bj1940443; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OZEGOVIC B, 1982, BIOSCIENCE REP, V2, P913, DOI 10.1007/BF01114898; PICKEL VM, 1993, P NATL ACAD SCI USA, V90, P7779, DOI 10.1073/pnas.90.16.7779; ROSENBERG LE, 1965, NEW ENGL J MED, V273, P1239, DOI 10.1056/NEJM196512022732303; ROSENBERG LE, 1966, J CLIN INVEST, V45, P365, DOI 10.1172/JCI105351; ROSENBERGLE, 1966, T ASSOC AM PHYSICIAN, V79, P284; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAFER JA, 1984, PFLUG ARCH EUR J PHY, V401, P143, DOI 10.1007/BF00583874; SEGAL S, 1977, SCIENCE, V197, P169, DOI 10.1126/science.877548; SEGAL S, 1989, METABOLIC BASIS INHE, P2479; SHARLAND M, 1992, J MED GENET, V29, P507; SILBERNAGL S, 1988, PHYSIOL REV, V68, P911, DOI 10.1152/physrev.1988.68.3.911; SINGER A, 1989, J UROLOGY, V142, P669, DOI 10.1016/S0022-5347(17)38849-3; SMITH A, 1977, MED J AUSTRALIA, V2, P153, DOI 10.5694/j.1326-5377.1977.tb99112.x; TATE SS, 1992, P NATL ACAD SCI USA, V89, P1, DOI 10.1073/pnas.89.1.1; THIER S, 1964, SCIENCE, V143, P482, DOI 10.1126/science.143.3605.482; TURK E, 1991, NATURE, V350, P354, DOI 10.1038/350354a0; TURNELL DC, 1982, CLIN CHEM, V28, P527; VANWINKLE LJ, 1988, J BIOL CHEM, V263, P3150; VOLKL H, 1982, PFLUG ARCH EUR J PHY, V395, P190, DOI 10.1007/BF00584808; WELLS RG, 1992, P NATL ACAD SCI USA, V89, P5596, DOI 10.1073/pnas.89.12.5596	44	328	331	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1994	6	4					420	425		10.1038/ng0494-420	http://dx.doi.org/10.1038/ng0494-420			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054986				2022-12-17	WOS:A1994ND87000025
J	Guo, GW; Sun, XJ; Chen, C; Wu, S; Huang, PD; Li, ZS; Dean, M; Huang, Y; Jia, WL; Zhou, Q; Tang, AF; Yang, ZQ; Li, XX; Song, PF; Zhao, XK; Ye, R; Zhang, SQ; Lin, Z; Qi, MF; Wan, SQ; Xie, LF; Fan, F; Nickerson, ML; Zou, XJ; Hu, XD; Xing, L; Lv, ZJ; Mei, HB; Gao, SJ; Liang, CZ; Gao, ZB; Lu, JX; Yu, Y; Liu, CX; Li, L; Fang, XD; Jiang, ZM; Yang, J; Li, CL; Zhao, X; Chen, J; Zhang, F; Lai, YQ; Lin, ZG; Zhou, FJ; Chen, H; Chan, HC; Tsang, S; Theodorescu, D; Li, YR; Zhang, XQ; Wang, J; Yang, HM; Gui, YT; Wang, J; Cai, ZM				Guo, Guangwu; Sun, Xiaojuan; Chen, Chao; Wu, Song; Huang, Peide; Li, Zesong; Dean, Michael; Huang, Yi; Jia, Wenlong; Zhou, Quan; Tang, Aifa; Yang, Zuoquan; Li, Xianxin; Song, Pengfei; Zhao, Xiaokun; Ye, Rui; Zhang, Shiqiang; Lin, Zhao; Qi, Mingfu; Wan, Shengqing; Xie, Liangfu; Fan, Fan; Nickerson, Michael L.; Zou, Xiangjun; Hu, Xueda; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Gao, Shengjie; Liang, Chaozhao; Gao, Zhibo; Lu, Jingxiao; Yu, Yuan; Liu, Chunxiao; Li, Lin; Fang, Xiaodong; Jiang, Zhimao; Yang, Jie; Li, Cailing; Zhao, Xin; Chen, Jing; Zhang, Fang; Lai, Yongqi; Lin, Zheguang; Zhou, Fangjian; Chen, Hao; Chan, Hsiao Chang; Tsang, Shirley; Theodorescu, Dan; Li, Yingrui; Zhang, Xiuqing; Wang, Jian; Yang, Huanming; Gui, Yaoting; Wang, Jun; Cai, Zhiming			Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation	NATURE GENETICS			English	Article							MUTATIONS; FGFR3; ANEUPLOIDY; CARCINOMA; FUSIONS; VARIANT	Bladder cancer is one of the most common cancers worldwide, with transitional cell carcinoma (TCC) being the predominant form. Here we report a genomic analysis of TCC by both whole-genome and whole-exome sequencing of 99 individuals with TCC. Beyond confirming recurrent mutations in genes previously identified as being mutated in TCC, we identified additional altered genes and pathways that were implicated in TCC. Notably, we discovered frequent alterations in STAG2 and ESPL1, two genes involved in the sister chromatid cohesion and segregation (SCCS) process. Furthermore, we also detected a recurrent fusion involving FGFR3 and TACC3, another component of SCCS, by transcriptome sequencing of 42 DNA-sequenced tumors. Overall, 32 of the 99 tumors (32%) harbored genetic alterations in the SCCS process. Our analysis provides evidence that genetic alterations affecting the SCCS process may be involved in bladder tumorigenesis and identifies a new therapeutic possibility for bladder cancer.	[Guo, Guangwu; Sun, Xiaojuan; Wu, Song; Li, Zesong; Huang, Yi; Tang, Aifa; Zhang, Shiqiang; Qi, Mingfu; Xie, Liangfu; Zou, Xiangjun; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Chen, Hao; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Urol Surg, Shenzhen, Peoples R China; [Guo, Guangwu; Chen, Chao; Huang, Peide; Jia, Wenlong; Zhou, Quan; Yang, Zuoquan; Song, Pengfei; Ye, Rui; Lin, Zhao; Wan, Shengqing; Fan, Fan; Hu, Xueda; Gao, Shengjie; Gao, Zhibo; Yu, Yuan; Li, Lin; Fang, Xiaodong; Yang, Jie; Zhao, Xin; Zhang, Fang; Li, Yingrui; Zhang, Xiuqing; Wang, Jian; Yang, Huanming; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Sun, Xiaojuan; Wu, Song; Li, Zesong; Huang, Yi; Tang, Aifa; Zhang, Shiqiang; Qi, Mingfu; Xie, Liangfu; Zou, Xiangjun; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Chen, Hao; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Natl Reg Key Technol Engn Lab Clin Applicat Canc, Shenzhen, Peoples R China; [Sun, Xiaojuan; Wu, Song; Li, Zesong; Huang, Yi; Tang, Aifa; Zhang, Shiqiang; Qi, Mingfu; Xie, Liangfu; Zou, Xiangjun; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Chen, Hao; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Engn Lab Tumor Clin Immune Gene Therapy, Shenzhen, Peoples R China; [Sun, Xiaojuan; Wu, Song; Li, Zesong; Huang, Yi; Tang, Aifa; Zhang, Shiqiang; Qi, Mingfu; Xie, Liangfu; Zou, Xiangjun; Xing, Li; Lv, Zhaojie; Mei, Hongbin; Chen, Hao; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Genitourinary Tumor, Shenzhen, Peoples R China; [Wu, Song] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Song; Zhou, Fangjian] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Dean, Michael; Nickerson, Michael L.] NCI, Canc & Inflammat Program, US Natl Inst Hlth NIH, Frederick, MD 21701 USA; [Li, Xianxin; Lu, Jingxiao; Jiang, Zhimao; Li, Cailing; Chen, Jing; Lai, Yongqi; Lin, Zheguang; Gui, Yaoting] Peking Univ Shenzhen Hosp, Shenzhen PKU HKUST Med Ctr, Inst Urol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen, Peoples R China; [Zhao, Xiaokun] Cent Southern Univ, Xiangya Hosp 2, Dept Urol, Changsha, Hunan, Peoples R China; [Liang, Chaozhao] Anhui Med Univ, Affiliated Hosp 1, Dept Urol, Hefei, Peoples R China; [Liu, Chunxiao] Southern Med Univ, Zhujiang Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Chan, Hsiao Chang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Tsang, Shirley] BioMatrix, Rockville, MD USA; [Theodorescu, Dan] Univ Colorado, Ctr Comprehens Canc, Dept Surg, Aurora, CO USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark	Shenzhen University; Beijing Genomics Institute (BGI); Shenzhen University; Shenzhen University; Shenzhen University; Sun Yat Sen University; Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Central South University; Anhui Medical University; Southern Medical University - China; Chinese University of Hong Kong; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Cai, ZM (corresponding author), Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Urol Surg, Shenzhen, Peoples R China.	guiyaoting@hotmail.com; wangj@genomics.org.cn; caizhiming2000@163.com	Chen, Hao/D-3425-2012; zou, xiangjun/ABG-6926-2021; Wang, Jun/A-7261-2013; Chan, Hsiao Chang/E-1507-2016; Dean, Michael/R-7501-2019; gui, yaoting/GLT-3684-2022; Li, Yingrui/K-1064-2015; Chen, Hao/AAH-4124-2020; Zhao, Xin/AFZ-4565-2022; Dean, Michael C/G-8172-2012; Jia, Justin/AAV-4349-2021; Fang, Xiaodong/K-6743-2018; Wang, Jun/B-9503-2016; Gao, Shengjie/S-4016-2017; Wang, Jun/C-8434-2016	Chen, Hao/0000-0001-8319-8101; zou, xiangjun/0000-0001-5146-599X; Chen, Hao/0000-0001-8319-8101; Dean, Michael C/0000-0003-2234-0631; Jia, Justin/0000-0002-7136-9919; Fang, Xiaodong/0000-0001-7061-3337; Wang, Jun/0000-0002-2113-5874; Ye, Rui/0000-0002-4866-088X; Gao, Shengjie/0000-0002-5221-8381; Wang, Jun/0000-0002-8540-8931; Peide, Huang/0000-0001-6108-5069	Chinese High-Tech (863) Program [2012AA02A201, 2012AA02A208]; Guangdong Innovative Research Team Program [2009010016]; State Key Development Program for Basic Research of China-973 Program [2011CB809203, 2014CB745200]; Shenzhen Municipal Government of China [JC201005260191A, CXB201108250096A, ZDSY20120615154448514, BGI20100001]; NATIONAL CANCER INSTITUTE [ZIABC011301, ZIABC011300] Funding Source: NIH RePORTER	Chinese High-Tech (863) Program(National High Technology Research and Development Program of China); Guangdong Innovative Research Team Program; State Key Development Program for Basic Research of China-973 Program(National Basic Research Program of ChinaState Key Development Program for Basic Research of China); Shenzhen Municipal Government of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Chinese High-Tech (863) Program (2012AA02A201 and 2012AA02A208), the Guangdong Innovative Research Team Program (2009010016), the State Key Development Program for Basic Research of China-973 Program (2011CB809203 and 2014CB745200) and the Shenzhen Municipal Government of China (JC201005260191A, CXB201108250096A, ZDSY20120615154448514 and BGI20100001).	Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bertino JR, 1996, STEM CELLS, V14, P5, DOI 10.1002/stem.140005; CAIRNS P, 1991, ONCOGENE, V6, P2305; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Charchar FJ, 2010, HYPERTENSION, V55, P1231, DOI 10.1161/HYPERTENSIONAHA.109.141663; Chiang DY, 2009, NAT METHODS, V6, P99, DOI 10.1038/NMETH.1276; CORDONCARDO C, 1994, INT J CANCER, V56, P347, DOI 10.1002/ijc.2910560309; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Hornigold N, 1999, ONCOGENE, V18, P2657, DOI 10.1038/sj.onc.1202854; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia WL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r12; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mhawech-Fauceglia P, 2006, CANCER-AM CANCER SOC, V106, P1205, DOI 10.1002/cncr.21743; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; WILLIAMSON MP, 1995, HUM MOL GENET, V4, P1569, DOI 10.1093/hmg/4.9.1569; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yamada NA, 2011, CYTOGENET GENOME RES, V132, P248, DOI 10.1159/000322717; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	39	327	338	3	128	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2013	45	12					1459	U213		10.1038/ng.2798	http://dx.doi.org/10.1038/ng.2798			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	262EA	24121792	Green Accepted			2022-12-17	WOS:000327715800011
J	Lai, JS; Li, RQ; Xu, X; Jin, WW; Xu, ML; Zhao, HN; Xiang, ZK; Song, WB; Ying, K; Zhang, M; Jiao, YP; Ni, PX; Zhang, JG; Li, D; Guo, XS; Ye, KX; Jian, M; Wang, B; Zheng, HS; Liang, HQ; Zhang, XQ; Wang, SC; Chen, SJ; Li, JS; Fu, Y; Springer, NM; Yang, HM; Wang, JA; Dai, JR; Schnable, PS; Wang, J				Lai, Jinsheng; Li, Ruiqiang; Xu, Xun; Jin, Weiwei; Xu, Mingliang; Zhao, Hainan; Xiang, Zhongkai; Song, Weibin; Ying, Kai; Zhang, Mei; Jiao, Yinping; Ni, Peixiang; Zhang, Jianguo; Li, Dong; Guo, Xiaosen; Ye, Kaixiong; Jian, Min; Wang, Bo; Zheng, Huisong; Liang, Huiqing; Zhang, Xiuqing; Wang, Shoucai; Chen, Shaojiang; Li, Jiansheng; Fu, Yan; Springer, Nathan M.; Yang, Huanming; Wang, Jian; Dai, Jingrui; Schnable, Patrick S.; Wang, Jun			Genome-wide patterns of genetic variation among elite maize inbred lines	NATURE GENETICS			English	Article							SSP MAYS L.; DIVERSITY; SEQUENCE; ARABIDOPSIS; RECOMBINATION; POLYMORPHISMS; CHROMOSOME-1; SELECTION; WHOLE	We have resequenced a group of six elite maize inbred lines, including the parents of the most productive commercial hybrid in China. This effort uncovered more than 1,000,000 SNPs, 30,000 indel polymorphisms and 101 low-sequence-diversity chromosomal intervals in the maize genome. We also identified several hundred complete genes that show presence/absence variation among these resequenced lines. We discuss the potential roles of complementation of presence/absence variations and other deleterious mutations in contributing to heterosis. High-density SNP and indel polymorphism markers reported here are expected to be a valuable resource for future genetic studies and the molecular breeding of this important crop.	[Lai, Jinsheng; Zhao, Hainan; Xiang, Zhongkai; Song, Weibin; Zhang, Mei; Jiao, Yinping] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Lai, Jinsheng; Jin, Weiwei; Xu, Mingliang; Zhao, Hainan; Xiang, Zhongkai; Song, Weibin; Zhang, Mei; Jiao, Yinping; Wang, Shoucai; Chen, Shaojiang; Li, Jiansheng; Dai, Jingrui] China Agr Univ, Natl Maize Improvement Ctr, Beijing 100094, Peoples R China; [Li, Ruiqiang; Xu, Xun; Ni, Peixiang; Zhang, Jianguo; Li, Dong; Guo, Xiaosen; Ye, Kaixiong; Jian, Min; Wang, Bo; Zheng, Huisong; Liang, Huiqing; Zhang, Xiuqing; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Ying, Kai; Fu, Yan; Schnable, Patrick S.] Iowa State Univ, Ctr Plant Genom, Ames, IA USA; [Springer, Nathan M.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	China Agricultural University; China Agricultural University; Beijing Genomics Institute (BGI); Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	jlai@cau.edu.cn; schnable@iastate.edu; wangj@genomics.cn	Springer, Nathan/F-2680-2013; wang, jian/GVS-0711-2022; Ye, Kaixiong/C-2297-2017; Xu, Xun/AAI-6763-2020; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Springer, Nathan/0000-0002-7301-4759; Ye, Kaixiong/0000-0003-4658-7292; Xu, Xun/0000-0002-5338-5173; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Zhang, Jianguo/0000-0003-0723-1701; Schnable, Patrick/0000-0001-9169-5204	973 program [2009CB118400, 2007CB815703, 2007CB815705, 2007CB109000]; 863 project [2010AA10A106]; National Natural Science Foundation of China [30725008]; Shenzhen Bureau of Science Technology AMP; Information, China [ZYC200903240077A, CXB200903110066A]; Chinese Academy of Science [GJHZ0701-6]; Danish Natural Science Research Council; US National Science Foundation [DBI-0527192]	973 program(National Basic Research Program of China); 863 project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Bureau of Science Technology AMP; Information, China; Chinese Academy of Science(Chinese Academy of Sciences); Danish Natural Science Research Council(Danish Natural Science Research Council); US National Science Foundation(National Science Foundation (NSF))	Supported by the 973 program (2009CB118400; 2007CB815703; 2007CB815705; 2007CB109000), the 863 project (2010AA10A106), the National Natural Science Foundation of China (30725008), the Shenzhen Bureau of Science Technology & Information, China (ZYC200903240077A; CXB200903110066A), the Chinese Academy of Science (GJHZ0701-6), the Ole Romer grant from the Danish Natural Science Research Council and the US National Science Foundation (DBI-0527192). We thank L. Goodman for editing the manuscript.	Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Everitt B S, 1996, Stat Methods Med Res, V5, P107, DOI 10.1177/096228029600500202; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Grant MR, 1998, P NATL ACAD SCI USA, V95, P15843, DOI 10.1073/pnas.95.26.15843; Lai JS, 2005, P NATL ACAD SCI USA, V102, P9068, DOI 10.1073/pnas.0502923102; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; TAJIMA F, 1983, GENETICS, V105, P437; Tenaillon MI, 2002, GENETICS, V162, P1401; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620	32	327	369	3	175	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					1027	+		10.1038/ng.684	http://dx.doi.org/10.1038/ng.684			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20972441				2022-12-17	WOS:000283540500024
J	Anderson, MG; Smith, RS; Hawes, NL; Zabaleta, A; Chang, B; Wiggs, JL; John, SWM				Anderson, MG; Smith, RS; Hawes, NL; Zabaleta, A; Chang, B; Wiggs, JL; John, SWM			Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice	NATURE GENETICS			English	Article							BROWN LOCUS PROTEIN; OCULOCUTANEOUS ALBINISM; DISPERSION SYNDROME; MOUSE MUTATION; IRIS ATROPHY; TYROSINASE; MELANOCYTES; MELANOMA; TYRP1; GP75	Pigmentary glaucoma is a significant cause of human blindness. Abnormally liberated iris pigment and cell debris enter the ocular drainage structures, leading to increased intraocular pressure (IOP) and glaucoma(1-3). DBA/2J (D2) mice develop a form of pigmentary glaucoma involving iris pigment dispersion (IPD) and iris stromal atrophy (ISA)(4,5). Using high-resolution mapping techniques, sequencing and functional genetic tests, we show that IPD and ISA result from mutations in related genes encoding melanosomal proteins. IPD is caused by a premature stop codon mutation in the Gpnmb (Gpnmb(R150X)) gene, as proved by the occurrence of IPD only in D2 mice that are homozygous with respect to Gpnmb(R150X). otherwise, similar D2 mice that are not homozygous for Gpnmb(R150X) do not develop IPD. ISA is caused by the recessive Tyrp1(b) mutant allele and rescued by the transgenic introduction of wildtype Tyrp1. We hypothesize that IPD and ISA alter melanosomes, allowing toxic intermediates of pigment production to leak from melanosomes, causing iris disease and subsequent pigmentary glaucoma. This is supported by the rescue of IPD and ISA in D2 eyes with substantially decreased pigment production. These data indicate that pigment production and mutant melanosomal protein genes may contribute to human pigmentary glaucoma. The fact that hypopigmentation profoundly alleviates the D2 disease indicates that therapeutic strategies designed to decrease pigment production may be beneficial in human pigmentary glaucoma.	Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Howard Hughes Medical Institute; Jackson Laboratory; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Tufts University	John, SWM (corresponding author), Howard Hughes Med Inst, Bar Harbor, ME 04609 USA.		Anderson, Michael/B-4580-2009	Anderson, Michael/0000-0001-5730-6105; Chang, Bo/0000-0001-8259-7290	NATIONAL EYE INSTITUTE [F32EY007015] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY007015] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andersen JS, 1997, ARCH OPHTHALMOL-CHIC, V115, P384, DOI 10.1001/archopht.1997.01100150386012; Anderson MG, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-1; Boissy RE, 1996, AM J HUM GENET, V58, P1145; Boissy RE, 1998, EXP DERMATOL, V7, P198, DOI 10.1111/j.1600-0625.1998.tb00324.x; CAMPBELL DG, 1996, GLAUCOMAS, V2, P975; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; EPSTEIN DL, 1997, CHANDLER GRANTS GLAU, P220; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; HALABAN R, 1990, P NATL ACAD SCI USA, V87, P4809, DOI 10.1073/pnas.87.12.4809; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; JOHNSON R, 1992, NAT GENET, V1, P226, DOI 10.1038/ng0692-226; KOBAYASHI T, 1994, EMBO J, V13, P5818, DOI 10.1002/j.1460-2075.1994.tb06925.x; KOBAYASHI T, 1994, J BIOL CHEM, V269, P29198; Kobayashi T, 1998, J BIOL CHEM, V273, P31801, DOI 10.1074/jbc.273.48.31801; Lalouette A, 1998, GENOMICS, V50, P9, DOI 10.1006/geno.1998.5314; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; MOYER FH, 1966, AM ZOOL, V6, P43; Nylander K, 2000, J PATHOL, V190, P39, DOI 10.1002/(SICI)1096-9896(200001)190:1<39::AID-PATH492>3.0.CO;2-V; RITCH R, 1993, AM J OPHTHALMOL, V115, P707, DOI 10.1016/S0002-9394(14)73635-9; Stjernschantz J, 2000, ACTA OPHTHALMOL SCAN, V78, P618, DOI 10.1034/j.1600-0420.2000.078006618.x; SUGAR HS, 1966, AM J OPHTHALMOL, V62, P499; SWANK RT, 1991, GENET RES, V58, P51, DOI 10.1017/S0016672300029608; TAI T, 1983, CANCER RES, V43, P2773; TAYLOR BA, 1996, GENETIC VARIANTS STR, V2, P1597; Turque N, 1996, EMBO J, V15, P3338, DOI 10.1002/j.1460-2075.1996.tb00699.x; VIJAYASARADHI S, 1995, J CELL BIOL, V130, P807, DOI 10.1083/jcb.130.4.807; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Wistrand PJ, 1997, SURV OPHTHALMOL, V41, pS129, DOI 10.1016/S0039-6257(97)80020-3; ZDARSKY E, 1990, GENETICS, V126, P443	30	327	343	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2002	30	1					81	85		10.1038/ng794	http://dx.doi.org/10.1038/ng794			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	508TL	11743578				2022-12-17	WOS:000173105600018
J	Urness, LD; Sorensen, LK; Li, DY				Urness, LD; Sorensen, LK; Li, DY			Arteriovenous malformations in mice lacking activin receptor-like kinase-1	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; CARDIOVASCULAR DEVELOPMENT; HEMATOPOIETIC-CELLS; ENDOTHELIAL-CELLS; VASCULOGENESIS; MORPHOGENESIS; ANGIOGENESIS; EPHRIN-B2; EMBRYO	The mature circulatory system is comprised of two parallel, yet distinct, vascular networks that carry blood to and from the heart. Studies have suggested that endothelial tubes are specified as arteries and veins at the earliest stages of angiogenesis, before the onset of circulation(1-4). To understand the molecular basis for arterial-venous identity, we have focused our studies on a human vascular dysplasia, hereditary haemorrhagic telangiectasia (HHT), wherein arterial and venous beds fail to remain distinct. Genetic studies have demonstrated that HHT can be caused by loss-of-function mutations in the gene encoding activin receptor-like kinase-1 (ACVRL1; ref. 5). ACVRL1 encodes a type I receptor for the TGF-P superfamily of growth factors(6-8). At the earliest stage of vascular development, mice lacking Acvrl1 develop large shunts between arteries and veins, downregulate arterial Efnb2 and fail to confine intravascular haematopoiesis to arteries. These mice die by mid-gestation with severe arteriovenous malformations resulting from fusion of major arteries and veins. The early loss of anatomical, molecular and functional distinctions between arteries and Veins indicates that Acvrl1 is required for developing distinct arterial and venous vascular beds.	Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Li, DY (corresponding author), Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA.	dean.li@hci.utah.edu						Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Attisano Liliana, 1996, Cytokine and Growth Factor Reviews, V7, P327, DOI 10.1016/S1359-6101(96)00042-1; DIETERLENLIEVRE F, 1981, DEV BIOL, V88, P180, DOI 10.1016/0012-1606(81)90228-1; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; FLAMME I, 1992, DEVELOPMENT, V116, P435; GADSON PF, 1993, IN VITRO CELL DEV-AN, V29A, P773; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Hogan B., 1986, MANIPULATING MOUSE E; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; JOHNSON I, 1989, J SOCIAL WORK PRACTI, V1, P13; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Manaia A, 2000, DEVELOPMENT, V127, P643; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pepper MS, 1996, CURR TOP MICROBIOL, V213, P31; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; STJACQUES S, 1994, ENDOCRINOLOGY, V134, P2645, DOI 10.1210/en.134.6.2645; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TENDIJKE P, 1993, ONCOGENE, V8, P2879; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wilkinson DG, 1992, SITU HYBRIDIZATION P	26	327	341	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					328	331		10.1038/81634	http://dx.doi.org/10.1038/81634			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062473				2022-12-17	WOS:000165176500022
J	ADACHI, M; SUEMATSU, S; KONDO, T; OGASAWARA, J; TANAKA, T; YOSHIDA, N; NAGATA, S				ADACHI, M; SUEMATSU, S; KONDO, T; OGASAWARA, J; TANAKA, T; YOSHIDA, N; NAGATA, S			TARGETED MUTATION IN THE FAS GENE CAUSES HYPERPLASIA IN PERIPHERAL LYMPHOID ORGANS AND LIVER	NATURE GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; CELL-SURFACE ANTIGEN; LPR MICE; MONOCLONAL-ANTIBODY; MOLECULAR-CLONING; APOPTOTIC BODIES; MESSENGER-RNA; STEM-CELLS; RAT-LIVER; EXPRESSION	Fas, a type I membrane protein that transduces an apoptotic signal, is expressed in lymphocytes as well as in various tissues such as the liver, lung and heart. The mouse lymphoproliferation (lpr) mutation is a leaky mutation in Fas. By means of gene targeting, we generated a mouse strain which is completely deficient in Fas. In addition to the massive production of lymphocytes, the Fas-null mice showed substantial liver hyperplasia, which was accompanied by the enlargement of nuclei in hepatocytes. The Fas system seems to play a role in the apoptotic process to maintain homeostasis of the liver as well as the peripheral lymphoid organs.	OSAKA BIOSCI INST,SUITA,OSAKA 565,JAPAN; OSAKA MED CTR MATERNAL & CHILD HLTH,IZUMI,OSAKA 59002,JAPAN				Kondo, Toru/F-9420-2012; Nagata, Shigekazu/AAG-3203-2019; Tanaka, Takashi/O-8254-2015	Nagata, Shigekazu/0000-0001-9758-8426; 				ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; Andrew W, 1943, AM J ANAT, V72, P199, DOI 10.1002/aja.1000720204; ARBER N, 1988, LIVER, V8, P80; BENEDETTI A, 1988, J HEPATOL, V7, P319, DOI 10.1016/S0168-8278(88)80004-7; BENEDETTI A, 1988, LIVER, V8, P172; CHU JL, 1993, J EXP MED, V178, P723, DOI 10.1084/jem.178.2.723; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cellbio.7.1.663; EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; ITOH N, 1993, J BIOL CHEM, V268, P10932; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; IZUI S, 1984, J IMMUNOL, V133, P227; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAGI D, 1994, SCIENCE, V265, P5287; KOBAYASHI S, 1993, BIOCHEM BIOPH RES CO, V191, P617, DOI 10.1006/bbrc.1993.1262; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; MACMAHON AP, 1990, CELL, V62, P1037; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARIANI SM, 1994, EUR J IMMUNOL, V24, P3119, DOI 10.1002/eji.1830241231; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; NI R, 1995, EXP CELL RES, V215, P332; OEHM A, 1992, J BIOL CHEM, V267, P10709; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SUDA T, 1995, J IMMUNOL, V154, P3806; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; TANAKA T, 1995, CELL, P353; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; VIGNAUX F, 1995, J EXP MED, V181, P781, DOI 10.1084/jem.181.2.781; Watanabe T., 1994, J TOXICOL PATHOL, V7, P353; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WU JG, 1993, J EXP MED, V178, P461, DOI 10.1084/jem.178.2.461; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747	50	327	329	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					294	300		10.1038/ng1195-294	http://dx.doi.org/10.1038/ng1195-294			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581453				2022-12-17	WOS:A1995TC63900018
J	STRONG, TV; TAGLE, DA; VALDES, JM; ELMER, LW; BOEHM, K; SWAROOP, M; KAATZ, KW; COLLINS, FS; ALBIN, RL				STRONG, TV; TAGLE, DA; VALDES, JM; ELMER, LW; BOEHM, K; SWAROOP, M; KAATZ, KW; COLLINS, FS; ALBIN, RL			WIDESPREAD EXPRESSION OF THE HUMAN AND RAT HUNTINGTONS-DISEASE GENE IN BRAIN AND NONNEURAL TISSUES	NATURE GENETICS			English	Article							STRIATAL PROJECTION NEURONS	We have used RNA in situ hybridization to study the regional expression of the Huntington's disease gene (HD) and its rat homologue in brain and selected nonneural tissues. The HD transcript was expressed throughout the brain in both rat and human, especially in the neurons of the dentate gyrus and pyramidal neurons of the hippocampal formation, cerebellar granule cell layer, cerebellar Purkinje cells and pontine nuclei. Other brain areas expressed lower levels of the HD transcript without pronounced regional differences. Neuronal expression predominated over glial expression in all regions. HD mRNA was also expressed in colon, liver, pancreas and testes. The regional specificity of neuropathology in HD, which is most prominent in the basal ganglia, thus cannot be accounted for by the pattern of expression of HD.	UNIV MICHIGAN, DEPT INTERNAL MED, DIV MOLEC MED & GENET, 4570 MSRB II, ANN ARBOR, MI 48109 USA; NIH, NATL CTR HUMAN GENOME RES, BETHESDA, MD 20892 USA; UNIV MICHIGAN, DEPT NEUROL, ANN ARBOR, MI 48104 USA; UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, CELL & MOLEC BIOL PROGRAM, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Strong, Theresa/GSM-6652-2022	Strong, Theresa/0000-0001-6783-8703; Kaatz, Kevin/0000-0002-7890-4865; Swaroop, Manju/0000-0002-0576-1664	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG000067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001300, P01NS019613] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG 00067-01] Funding Source: Medline; NINDS NIH HHS [NS 01300, NS 19613] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1990, NEW ENGL J MED, V322, P1293, DOI 10.1056/NEJM199005033221807; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; DAWBARN D, 1985, BRAIN RES, V340, P251, DOI 10.1016/0006-8993(85)90921-7; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIFIGLIA M, 1990, TRENDS NEUROSCI, V13, P286, DOI 10.1016/0166-2236(90)90111-M; FERRANTE RJ, 1987, BRAIN RES, V411, P162, DOI 10.1016/0006-8993(87)90694-9; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; FOLSTEIN SE, 1989, HUNTINGTONS DISEASE; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; HARRINGTON KM, 1991, J NEUROPATH EXP NEUR, V50, P309; HIRSCH EC, 1989, NEUROSCI LETT, V96, P145, DOI 10.1016/0304-3940(89)90048-7; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MORRIS M, 1991, HUNTINGTONS DIS, P81; MYERS RH, 1989, AM J HUM GENET, V45, P615; QUARREL O, 1991, HUNTINGTONS DISEASE, P37; QUARREL O, 1991, HUNTINGTONS DISEASE, P141; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; Sambrook J., 1989, MOL CLONING LAB MANU; STRONG TV, IN PRESS J CLIN INVE; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0	23	327	335	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1993	5	3					259	265		10.1038/ng1193-259	http://dx.doi.org/10.1038/ng1193-259			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275091				2022-12-17	WOS:A1993MF12200016
J	Hu, Y; Chen, JD; Fang, L; Zhang, ZY; Ma, W; Niu, YC; Ju, LZ; Deng, JQ; Zhao, T; Lian, JM; Baruch, K; Fang, D; Liu, X; Ruan, YL; Rahman, MU; Han, JL; Wang, K; Wang, Q; Wu, HT; Mei, GF; Zang, YH; Han, ZG; Xu, CY; Shen, WJ; Yang, DF; Si, ZF; Dai, F; Zou, LF; Huang, F; Bai, YL; Zhang, YG; Brodt, A; Ben-Hamo, H; Zhu, XF; Zhou, BL; Guan, XY; Zhu, SJ; Chen, XY; Zhang, TZ				Hu, Yan; Chen, Jiedan; Fang, Lei; Zhang, Zhiyuan; Ma, Wei; Niu, Yongchao; Ju, Longzhen; Deng, Jieqiong; Zhao, Ting; Lian, Jinmin; Baruch, Kobi; Fang, David; Liu, Xia; Ruan, Yong-ling; Rahman, Mehboob-ur; Han, Jinlei; Wang, Kai; Wang, Qiong; Wu, Huaitong; Mei, Gaofu; Zang, Yihao; Han, Zegang; Xu, Chenyu; Shen, Weijuan; Yang, Duofeng; Si, Zhanfeng; Dai, Fan; Zou, Liangfeng; Huang, Fei; Bai, Yulin; Zhang, Yugao; Brodt, Avital; Ben-Hamo, Hilla; Zhu, Xiefei; Zhou, Baoliang; Guan, Xueying; Zhu, Shuijin; Chen, Xiaoya; Zhang, Tianzhen			Gossypium barbadense and Gossypium hirsutum genomes provide insights into the origin and evolution of allotetraploid cotton	NATURE GENETICS			English	Article							VACUOLAR INVERTASE; FIBER ELONGATION; SEQUENCE; PROTEIN; GENES; DNA; CENTROMERES; ANNOTATION; PREDICTION; TRANSPORT	Allotetraploid cotton is an economically important natural-fiber-producing crop worldwide. After polyploidization, Gossypium hirsutum L. evolved to produce a higher fiber yield and to better survive harsh environments than Gossypium barbadense, which produces superior-quality fibers. The global genetic and molecular bases for these interspecies divergences were unknown. Here we report high-quality de novo-assembled genomes for these two cultivated allotetraploid species with pronounced improvement in repetitive-DNA-enriched centromeric regions. Whole-genome comparative analyses revealed that species-specific alterations in gene expression, structural variations and expanded gene families were responsible for speciation and the evolutionary history of these species. These findings help to elucidate the evolution of cotton genomes and their domestication history. The information generated not only should enable breeders to improve fiber quality and resilience to ever-changing environmental conditions but also can be translated to other crops for better understanding of their domestication history and use in improvement.	[Hu, Yan; Chen, Jiedan; Fang, Lei; Zhang, Zhiyuan; Ma, Wei; Zhao, Ting; Ruan, Yong-ling; Si, Zhanfeng; Dai, Fan; Guan, Xueying; Zhu, Shuijin; Zhang, Tianzhen] Zhejiang Univ, Plant Precis Breeding Acad, Coll Agr & Biotechnol, Inst Crop Sci,Zhejiang Prov Key Lab Crop Genet Re, Hangzhou, Zhejiang, Peoples R China; [Hu, Yan; Fang, Lei; Ju, Longzhen; Deng, Jieqiong; Zhao, Ting; Wang, Qiong; Wu, Huaitong; Mei, Gaofu; Zang, Yihao; Han, Zegang; Xu, Chenyu; Shen, Weijuan; Yang, Duofeng; Zhu, Xiefei; Zhou, Baoliang; Guan, Xueying; Zhang, Tianzhen] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Niu, Yongchao; Lian, Jinmin; Zou, Liangfeng; Huang, Fei] Genosys Inc, Shenzhen, Peoples R China; [Baruch, Kobi; Brodt, Avital; Ben-Hamo, Hilla] NRGene Ltd, Ness Ziona, Israel; [Fang, David] USDA ARS, Cotton Fiber Biosci Res Unit, Southern Reg Res Ctr, New Orleans, LA USA; [Liu, Xia; Bai, Yulin; Zhang, Yugao] Esquel Grp, Wanchai, Hong Kong, Peoples R China; [Ruan, Yong-ling] Univ Newcastle, Sch Environm & Life Sci, Newcastle, NSW, Australia; [Ruan, Yong-ling] Univ Newcastle, Australia China Res Ctr Crop Improvement, Newcastle, NSW, Australia; [Rahman, Mehboob-ur] NIBGE, Plant Genom & Mol Breeding Lab, Faisalabad, Pakistan; [Han, Jinlei; Wang, Kai] Fujian Agr & Forestry Univ, Ctr Genom & Biotechnol, Haixia Inst Sci & Technol, Fujian Prov Key Lab Haixia Appl Plant Syst Biol, Fuzhou, Fujian, Peoples R China; [Chen, Xiaoya] Chinese Acad Sci, Natl Ctr Gene Res, CAS Ctr Excellence Mol Plant Sci, Shanghai Inst Plant Physiol & Ecol,State Key Lab, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University; Nanjing Agricultural University; United States Department of Agriculture (USDA); University of Newcastle; University of Newcastle; Pakistan Institute of Engineering & Applied Science; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, TZ (corresponding author), Zhejiang Univ, Plant Precis Breeding Acad, Coll Agr & Biotechnol, Inst Crop Sci,Zhejiang Prov Key Lab Crop Genet Re, Hangzhou, Zhejiang, Peoples R China.; Zhang, TZ (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	cotton@zju.edu.cn	Ma, Wei/AAH-9556-2019; Mei, Gaofu/AAG-7632-2020; Ruan, Yong-Ling/AAU-7244-2021; FANG, DAVID/AAV-5774-2020; han, zegang/AAS-4882-2020; Han, Zegang/AEU-8445-2022; Wang, Kai/A-2143-2011	Ruan, Yong-Ling/0000-0002-8394-4474; FANG, DAVID/0000-0003-0036-5459; han, zegang/0000-0003-2244-5994; Wang, Kai/0000-0002-1074-0438; MA, WEI/0000-0001-5716-6106; Chen, Jiedan/0000-0002-5223-8243; Chen, Xiaoya/0000-0002-2909-8414; Wang, Qiong/0000-0001-8843-7060; Niu, Yongchao/0000-0002-9774-5417	National Key R&D Program for Crop Breeding [2016YFD0100505, 2016YFD0101001]; National Science Foundation of China [31661143016]; Distinguished Discipline Support Program of Zhejiang University; Esquel Group	National Key R&D Program for Crop Breeding; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Distinguished Discipline Support Program of Zhejiang University; Esquel Group	Research reported in this publication was supported by the National Key R&D Program for Crop Breeding (2016YFD0100505 to L.F., 2016YFD0101001 to J.C.), the National Science Foundation of China (31661143016 to T. Zhang), the Distinguished Discipline Support Program of Zhejiang University and the Esquel Group.	Akdemir KC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0767-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andres Z, 2014, P NATL ACAD SCI USA, V111, pE1806, DOI 10.1073/pnas.1320421111; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Avni R, 2017, SCIENCE, V357, P93, DOI 10.1126/science.aan0032; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Bassil E, 2011, PLANT CELL, V23, P3482, DOI 10.1105/tpc.111.089581; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Du XM, 2018, NAT GENET, V50, P796, DOI 10.1038/s41588-018-0116-x; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Fang L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1167-5; Fryxell P.A., 1979, NATURAL HIST COTTON, P37; GERSTEL DU, 1953, EVOLUTION, V7, P234, DOI 10.2307/2405734; Gong ZY, 2012, PLANT CELL, V24, P3559, DOI 10.1105/tpc.112.100511; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grover CE, 2004, GENOME RES, V14, P1474, DOI 10.1101/gr.2673204; Guigo R, 1998, J COMPUT BIOL, V5, P681, DOI 10.1089/cmb.1998.5.681; Guo L, 2018, SCIENCE, V362, P343, DOI 10.1126/science.aat4096; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Han JL, 2016, PLANT J, V88, P992, DOI 10.1111/tpj.13309; Han LB, 2013, PLANT CELL, V25, P4421, DOI 10.1105/tpc.113.116970; Hedrich R, 2015, CURR OPIN PLANT BIOL, V25, P63, DOI 10.1016/j.pbi.2015.04.008; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jiang J, 2013, PLANT CENTROMERE BIOLOGY, P1, DOI 10.1002/9781118525715; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KOHEL R J, 1970, Crop Science, V10, P670; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li XR, 2010, J EXP BOT, V61, P287, DOI 10.1093/jxb/erp299; Li Y, 2016, PLANT BIOTECHNOL J, V14, P951, DOI 10.1111/pbi.12450; Li YJ, 2018, PLANT J, V93, P1088, DOI 10.1111/tpj.13832; Liu X, 2015, SCI REP-UK, V5, DOI [10.1038/srep14139, 10.1038/srep10007]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo MC, 2017, NATURE, V551, P498, DOI 10.1038/nature24486; Luo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035261; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MENZEL MY, 1954, GENETICS, V39, P546; Meyer S, 2011, PLANT J, V67, P247, DOI 10.1111/j.1365-313X.2011.04587.x; Meyer S, 2010, TRENDS PLANT SCI, V15, P40, DOI 10.1016/j.tplants.2009.10.002; Mittler R, 2012, TRENDS BIOCHEM SCI, V37, P118, DOI 10.1016/j.tibs.2011.11.007; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Naramoto S, 2010, P NATL ACAD SCI USA, V107, P21890, DOI 10.1073/pnas.1016260107; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nei M., 2000, MOL EVOLUTION PHYLOG; Nussbaumer T, 2013, NUCLEIC ACIDS RES, V41, pD1144, DOI 10.1093/nar/gks1153; Ou S., 2017, PLANT PHYSIOL; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ruan YL, 2001, PLANT CELL, V13, P47, DOI 10.1105/tpc.13.1.47; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneider KL, 2016, P NATL ACAD SCI USA, V113, pE987, DOI 10.1073/pnas.1522008113; She R, 2009, GENOME RES, V19, P143, DOI 10.1101/gr.082081.108; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Springer NM, 2018, NAT GENET, V50, P1282, DOI 10.1038/s41588-018-0158-0; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Su HD, 2017, NEW PHYTOL, V214, P682, DOI 10.1111/nph.14415; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Voorrips, 2001, JOINMAP VERSION 3 0; Wang B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11708; Wang K, 2014, GENOME RES, V24, P107, DOI 10.1101/gr.160887.113; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang L, 2014, PLANT J, V78, P686, DOI 10.1111/tpj.12512; Wang L, 2010, PLANT SIGNAL BEHAV, V5, P1561, DOI 10.4161/psb.5.12.13568; Wang L, 2010, PLANT PHYSIOL, V154, P744, DOI 10.1104/pp.110.162487; Wang S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0678-1; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Westengen O, 2005, THEOR APPL GENET, V110, P392, DOI 10.1007/s00122-004-1850-2; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xie T, 2015, MOL PLANT, V8, P489, DOI 10.1016/j.molp.2014.12.015; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17662; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang MP, 2012, NAT PROTOC, V7, P467, DOI 10.1038/nprot.2011.455; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang ZY, 2017, PLANT CELL, V29, P2027, DOI 10.1105/tpc.17.00358; Zhao GY, 2017, NAT PLANTS, V3, P946, DOI 10.1038/s41477-017-0067-8; Zhu ZX, 2016, PLANT J, V87, P568, DOI 10.1111/tpj.13219	101	326	355	29	157	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2019	51	4					739	+		10.1038/s41588-019-0371-5	http://dx.doi.org/10.1038/s41588-019-0371-5			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HQ9SJ	30886425	hybrid			2022-12-17	WOS:000462767500020
J	Kanai, M; Akiyama, M; Takahashi, A; Matoba, N; Momozawa, Y; Ikeda, M; Iwata, N; Ikegawa, S; Hirata, M; Matsuda, K; Kubo, M; Okada, Y; Kamatani, Y				Kanai, Masahiro; Akiyama, Masato; Takahashi, Atsushi; Matoba, Nana; Momozawa, Yukihide; Ikeda, Masashi; Iwata, Nakao; Ikegawa, Shiro; Hirata, Makoto; Matsuda, Koichi; Kubo, Michiaki; Okada, Yukinori; Kamatani, Yoichiro			Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LD SCORE REGRESSION; BODY-MASS INDEX; BLOOD-PRESSURE; MENDELIAN RANDOMIZATION; SUSCEPTIBILITY LOCI; RARE VARIANTS; COMMON; RISK; AUTOIMMUNE	Clinical measurements can be viewed as useful intermediate phenotypes to promote understanding of complex human diseases. To acquire comprehensive insights into the underlying genetics, here we conducted a genome-wide association study (GWAS) of 58 quantitative traits in 162,255 Japanese individuals. Overall, we identified 1,407 trait-associated loci (P < 5.0 x 10(-8)), 679 of which were novel. By incorporating 32 additional GWAS results for complex diseases and traits in Japanese individuals, we further highlighted pleiotropy, genetic correlations, and cell-type specificity across quantitative traits and diseases, which substantially expands the current understanding of the associated genetics and biology. This study identified both shared polygenic effects and cell-type specificity, represented by the genetic links among clinical measurements, complex diseases, and relevant cell types. Our findings demonstrate that even without prior biological knowledge of cross-phenotype relationships, genetics corresponding to clinical measurements successfully recapture those measurements' relevance to diseases, and thus can contribute to the elucidation of unknown etiology and pathogenesis.	[Kanai, Masahiro; Okada, Yukinori] Osaka Univ, Grad Sch Med, Dept Stat Genet, Osaka, Japan; [Kanai, Masahiro; Akiyama, Masato; Takahashi, Atsushi; Matoba, Nana; Okada, Yukinori; Kamatani, Yoichiro] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Kanai, Masahiro] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA; [Takahashi, Atsushi] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Genom Med, Osaka, Japan; [Momozawa, Yukihide] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi, Japan; [Ikegawa, Shiro] RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo, Japan; [Hirata, Makoto] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Matsuda, Koichi] Univ Tokyo, Grad Sch Frontier Sci, Tokyo, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Okada, Yukinori] Osaka Univ, Immunol Frontier Res Ctr WPI IFReC, Lab Stat Immunol, Osaka, Japan; [Kamatani, Yoichiro] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan	Osaka University; RIKEN; Harvard University; Harvard Medical School; National Cerebral & Cardiovascular Center - Japan; RIKEN; Fujita Health University; RIKEN; University of Tokyo; University of Tokyo; RIKEN; Osaka University; Kyoto University	Okada, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Stat Genet, Osaka, Japan.; Okada, Y; Kamatani, Y (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan.; Okada, Y (corresponding author), Osaka Univ, Immunol Frontier Res Ctr WPI IFReC, Lab Stat Immunol, Osaka, Japan.; Kamatani, Y (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	yokada@sg.med.osaka-u.ac.jp; yoichiro.kamatani@riken.jp	Kanai, Masahiro/AAD-6726-2021; Ikegawa, Shiro/N-6895-2015; Akiyama, Masato/AHC-2589-2022; Matsuda, Koichi/D-4597-2011	Kanai, Masahiro/0000-0001-5165-4408; Ikegawa, Shiro/0000-0003-0316-2147; Matsuda, Koichi/0000-0001-7292-2686; Matoba, Nana/0000-0001-5329-0134; Ikeda, Masashi/0000-0001-6237-2449; Takahashi, Atsushi/0000-0001-7099-8767; IWATA, Nakao/0000-0003-3189-6076	Tailor-Made Medical Treatment Program (the BioBank Japan Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); Strategic Research Program for Brain Sciences (SRPBS) of AMED; Nakajima Foundation Fellowship; Japan Society for the Promotion of Science (JSPS) KAKENHI [15H05670, 15H05907, 15H05911, 15K14429, 16H03269, 16K15738]; AMED [16km0405206h0001, 16gm6010001h0001, 17ek0410041h0001]; Takeda Science Foundation; Uehara Memorial Foundation; Naito Foundation; Daiichi Sankyo Foundation of Life Science; Senri Life Science Foundation; Grants-in-Aid for Scientific Research [15H05670] Funding Source: KAKEN	Tailor-Made Medical Treatment Program (the BioBank Japan Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Strategic Research Program for Brain Sciences (SRPBS) of AMED; Nakajima Foundation Fellowship; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Daiichi Sankyo Foundation of Life Science; Senri Life Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge the staff of BBJ for their outstanding assistance in collecting samples and clinical information. We also thank the Tohoku Medical Megabank Project, the Japan Public Health Center-based Prospective (JPHC) Study, and the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study for their invaluable contributions to the case-control studies used in this study. We thank the staff of the Japan Scoliosis Clinical Research Group (JSCRG) for their support in recruiting patients to the AIS GWAS used in this study. We are grateful to H. Finucane for helpful discussions and assistance with LD score regression analysis. This research was supported by the Tailor-Made Medical Treatment Program (the BioBank Japan Project) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) and the Japan Agency for Medical Research and Development (AMED). The study of psychiatric disorders was supported by the Strategic Research Program for Brain Sciences (SRPBS) of AMED. M. Kanai was supported by a Nakajima Foundation Fellowship. Y.O. was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grants 15H05670, 15H05907, 15H05911, 15K14429, 16H03269, and 16K15738), AMED (grants 16km0405206h0001, 16gm6010001h0001, and 17ek0410041h0001), Takeda Science Foundation, the Uehara Memorial Foundation, the Naito Foundation, Daiichi Sankyo Foundation of Life Science, and Senri Life Science Foundation.	Akiyama M, 2017, NAT GENET, V49, P1458, DOI 10.1038/ng.3951; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Azab B, 2013, ANGIOLOGY, V64, P137, DOI 10.1177/0003319712436577; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; CLARK EA, 1991, ANNU REV IMMUNOL, V9, P97; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gadhoum SZ, 2008, NAT CHEM BIOL, V4, P751, DOI 10.1038/nchembio.116; Han B, 2016, NAT GENET, V48, P803, DOI 10.1038/ng.3572; Hirata J., 2017, J INVEST DERMATOL; Hirata M, 2017, J EPIDEMIOL, V27, pS9, DOI 10.1016/j.je.2016.12.003; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Ikeda M, 2017, MOL PSYCHIAT; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kanai M, 2016, J HUM GENET, V61, P861, DOI 10.1038/jhg.2016.72; Khankari NK, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002118; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu JX, 2016, SCI REP-UK, V6, DOI 10.1038/srep38813; Liu YR, 2008, J IMMUNOL, V181, P1887, DOI 10.4049/jimmunol.181.3.1887; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Low SK, 2017, NAT GENET, V49, P953, DOI 10.1038/ng.3842; Nagai A, 2017, J EPIDEMIOL, V27, pS2, DOI 10.1016/j.je.2016.12.005; Ogura Y, 2015, AM J HUM GENET, V97, P337, DOI 10.1016/j.ajhg.2015.06.012; Okada Y, 2015, NAT GENET, V47, P798, DOI 10.1038/ng.3310; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Perlstein TS, 2008, ARTERIOSCL THROM VAS, V28, P166, DOI 10.1161/ATVBAHA.107.153262; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rosenberg MA, 2014, AM J EPIDEMIOL, V180, P215, DOI 10.1093/aje/kwu126; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Timio F, 2003, BLOOD PRESSURE, V12, P122, DOI 10.1080/08037050310001084; Trynka G, 2015, AM J HUM GENET, V97, P139, DOI 10.1016/j.ajhg.2015.05.016; Tsai WN, 2015, ANN CLIN BIOCHEM, V52, P251, DOI 10.1177/0004563214541969; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wu AH, 2016, INT J CARDIOL, V213, P4, DOI 10.1016/j.ijcard.2015.08.110; Yavorska OO, 2017, INT J EPIDEMIOL, V46, P1734, DOI 10.1093/ije/dyx034; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4	57	326	328	7	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2018	50	3					390	+		10.1038/s41588-018-0047-6	http://dx.doi.org/10.1038/s41588-018-0047-6			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FZ9LR	29403010	hybrid			2022-12-17	WOS:000427933400015
J	Xu, B; Roos, JL; Dexheimer, P; Boone, B; Plummer, B; Levy, S; Gogos, JA; Karayiorgou, M				Xu, Bin; Roos, J. Louw; Dexheimer, Phillip; Boone, Braden; Plummer, Brooks; Levy, Shawn; Gogos, Joseph A.; Karayiorgou, Maria			Exome sequencing supports a de novo mutational paradigm for schizophrenia	NATURE GENETICS			English	Article							PROTEIN-COUPLED RECEPTORS; POPULATION; VARIANTS; DISEASE; FAMILIES; SPECTRUM; LINKAGE	Despite its high heritability, a large fraction of individuals with schizophrenia do not have a family history of the disease (sporadic cases). Here we examined the possibility that rare de novo protein-altering mutations contribute to the genetic component of schizophrenia by sequencing the exomes of 53 sporadic cases, 22 unaffected controls and their parents. We identified 40 de novo mutations in 27 cases affecting 40 genes, including a potentially disruptive mutation in DGCR2, a gene located in the schizophrenia-predisposing 22q11.2 microdeletion region. A comparison to rare inherited variants indicated that the identified de novo mutations show a large excess of non-synonymous changes in schizophrenia cases, as well as a greater potential to affect protein structure and function. Our analyses suggest a major role for de novo mutations in schizophrenia as well as a large mutational target, which together provide a plausible explanation for the high global incidence and persistence of the disease.	[Xu, Bin; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Xu, Bin; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Roos, J. Louw] Univ Pretoria, Weskoppies Hosp, ZA-0002 Pretoria, South Africa; [Roos, J. Louw] Univ Pretoria, Dept Psychiat, ZA-0002 Pretoria, South Africa; [Dexheimer, Phillip; Boone, Braden; Plummer, Brooks; Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY USA	Columbia University; Columbia University; University of Pretoria; University of Pretoria; HudsonAlpha Institute for Biotechnology; Columbia University	Karayiorgou, M (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	jag90@columbia.edu; mk2758@columbia.edu		Levy, Shawn/0000-0002-1369-5740; Roos, Johannes/0000-0002-0572-1072; Dexheimer, Phillip/0000-0003-3965-6894	National Institute of Mental Health (NIMH) [MH061399, MH077235]; Lieber Center for Schizophrenia Research at Columbia University; National Alliance for Research on Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077235, R01MH061399] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lieber Center for Schizophrenia Research at Columbia University; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank all the families who participated in this research. We also thank H. Pretorius and nursing sisters R. van Wyk, C. Botha and H. van den Berg for their assistance with subject recruitment, family history assessments and diagnostic evaluations. We thank Y. Sun for technical assistance with DNA extractions and sample preparations and J. Grun for information technology support. We also thank E. Fledderman and S. Thomas for support of the sequencing studies and M. Robinson for critical project support. This work was supported in part by National Institute of Mental Health (NIMH) grants MH061399 (to M. K.) and MH077235 (to J. A. G.) and the Lieber Center for Schizophrenia Research at Columbia University. B. X. was partially supported by a National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award.	Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Arguello PA, 2010, SCHIZOPHRENIA BULL, V36, P289, DOI 10.1093/schbul/sbp153; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cruz MT, 2011, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00207; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Gloriam DEI, 2005, BBA-GEN SUBJECTS, V1722, P235, DOI 10.1016/j.bbagen.2004.12.001; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Kajiwara K, 1996, BIOCHEM BIOPH RES CO, V222, P144, DOI 10.1006/bbrc.1996.0712; Karayiorgou M, 2004, AM J MED GENET B, V124B, P20, DOI 10.1002/ajmg.b.20090; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106	35	326	341	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					864	U72		10.1038/ng.902	http://dx.doi.org/10.1038/ng.902			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21822266	Green Accepted			2022-12-17	WOS:000294325800012
J	Wilson, JF; Weale, ME; Smith, AC; Gratrix, F; Fletcher, B; Thomas, MG; Bradman, N; Goldstein, DB				Wilson, JF; Weale, ME; Smith, AC; Gratrix, F; Fletcher, B; Thomas, MG; Bradman, N; Goldstein, DB			Population genetic structure of variable drug response	NATURE GENETICS			English	Article							FUNCTIONAL-SIGNIFICANCE; CYP1A2 GENE; METABOLISM; CYP2D6; POLYMORPHISMS; DEBRISOQUINE; MEPHENYTOIN; CYP2C19; HUMANS; DEFECT	Geographic patterns of genetic variation, including variation at drug metabolizing enzyme (DME) loci and drug targets, indicate that geographic structuring of inter-individual variation in drug response may occur frequently. This raises two questions: how to represent human population genetic structure in the evaluation of drug safety and efficacy, and how to relate this structure to drug response. We address these by (i) inferring the genetic structure present in a heterogeneous sample and (ii) comparing the distribution of DME variants across the inferred genetic clusters of individuals. We find that commonly used ethnic labels are both insufficient and inaccurate representations of the inferred genetic clusters, and that drug-metabolizing profiles, defined by the distribution of DME variants, differ significantly among the clusters. We note, however, that the complexity of human demographic history means that there is no obvious natural clustering scheme, nor an obvious appropriate degree of resolution. Our comparison of drug-metabolizing profiles across the inferred clusters establishes a framework for assessing the appropriate level of resolution in relating genetic structure to drug response.	UCL, Dept Biol, Galton Lab, London, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; UCL, Dept Biol, Ctr Genet Anthropol, London, England; Genost Ltd, London WC1A 2HN, England	University of London; University College London; University of Oxford; University of London; University College London	Wilson, JF (corresponding author), UCL, Dept Biol, Galton Lab, Mortimer St, London, England.	d.goldstein@ucl.ac.uk	Wilson, James F/A-5704-2009; Weale, Michael E/F-2587-2010; Goldstein, David/AAY-8125-2020; Thomas, Mark G/A-2219-2012	Wilson, James F/0000-0001-5751-9178; Weale, Michael E/0000-0003-4593-1186; Thomas, Mark G/0000-0002-2452-981X				Basile VS, 2000, MOL PSYCHIATR, V5, P410, DOI 10.1038/sj.mp.4000736; Bernal ML, 1999, PHARMACOGENETICS, V9, P657, DOI 10.1097/00008571-199910000-00013; BLUM M, 1991, P NATL ACAD SCI USA, V88, P5237, DOI 10.1073/pnas.88.12.5237; Daly D. A., 1993, AM J SPEECH-LANG PAT, V2, P6, DOI [10.1044/1058-0360.0202.06., DOI 10.1044/1058-0360.0202.06]; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Ferguson RJ, 1998, J PHARMACOL EXP THER, V284, P356; Gaedigk A, 1998, PHARMACOGENETICS, V8, P305, DOI 10.1097/00008571-199808000-00004; Gaedigk A, 1999, PHARMACOGENETICS, V9, P669, DOI 10.1097/01213011-199912000-00002; Goldstein JA, 1996, METHOD ENZYMOL, V272, P210, DOI 10.1016/S0076-6879(96)72025-6; GOUGH AC, 1990, NATURE, V347, P773, DOI 10.1038/347773a0; KAGIMOTO M, 1990, J BIOL CHEM, V265, P17209; KOHLMEIER L, 1997, DESIGN CONCEPTS NUTR, P312; Krajinovic M, 1999, BLOOD, V93, P1496, DOI 10.1182/blood.V93.5.1496.405a36_1496_1501; Meyer UA, 1997, ANNU REV PHARMACOL, V37, P269, DOI 10.1146/annurev.pharmtox.37.1.269; Pritchard JK, 2000, GENETICS, V155, P945; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; WEBER WW, 1997, PHARMACOGENETICS; Wilson JF, 2000, AM J HUM GENET, V67, P926, DOI 10.1086/303083; 1998, INT C HARM ETHN FACT	21	326	339	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2001	29	3					265	269		10.1038/ng761	http://dx.doi.org/10.1038/ng761			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488AC	11685208				2022-12-17	WOS:000171911000011
J	Shimohata, T; Nakajima, T; Yamada, M; Uchida, C; Onodera, O; Naruse, S; Kimura, T; Koide, R; Nozaki, K; Sano, Y; Ishiguro, H; Sakoe, K; Ooshima, T; Sato, A; Ikeuchi, T; Oyake, M; Sato, T; Aoyagi, Y; Hozumi, I; Nagatsu, T; Takiyama, Y; Nishizawa, M; Goto, J; Kanazawa, I; Davidson, I; Tanese, N; Takahashi, H; Tsuji, S				Shimohata, T; Nakajima, T; Yamada, M; Uchida, C; Onodera, O; Naruse, S; Kimura, T; Koide, R; Nozaki, K; Sano, Y; Ishiguro, H; Sakoe, K; Ooshima, T; Sato, A; Ikeuchi, T; Oyake, M; Sato, T; Aoyagi, Y; Hozumi, I; Nagatsu, T; Takiyama, Y; Nishizawa, M; Goto, J; Kanazawa, I; Davidson, I; Tanese, N; Takahashi, H; Tsuji, S			Expanded polyglutamine stretches interact with TAF(II)130, interfering with CREB-dependent transcription	NATURE GENETICS			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; NUCLEAR-LOCALIZATION; AGGREGATE FORMATION; MAMMALIAN-CELLS; ANDROGEN RECEPTOR; TRANSGENIC MICE; BINDING PROTEIN; DRPLA PROTEIN; PC12 CELLS; HUNTINGTIN	At least eight inherited neurodegenerative diseases are caused by expanded CAG repeats encoding polyglutamine (polyQ) stretches. Although cytotoxicities of expanded polyQ stretches are implicated, the molecular mechanisms of neurodegeneration remain unclear. We found that expanded! polyQ stretches preferentially bind to TAF(II)130, a coactivator involved in cAMP-responsive element binding protein (CREB)-dependent transcriptional activation, and strongly suppress CREB-dependent transcriptional activation. The suppression of CREB-dependent transcription and the cell death induced by polyQ stretches were restored by the co-expression of TAF(II)130. Our results indicate that interference of transcription by the binding of TAF(II)130 with expanded polyQ stretches is involved in the pathogenetic mechanisms underlying neurodegeneration.	Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 951, Japan; Univ Tsukuba, TARA Ctr, Inst Appl Biochem, Tsukuba, Ibaraki, Japan; St Marianna Univ, Inst Med Sci, PRESTO JST, Kawasaki, Kanagawa, Japan; Hamamatsu Univ Sch Med, Dept Biochem, Shizuoka, Japan; Fujita Hlth Univ, Inst Comprehens Med Sci, Aichi, Japan; Jichi Med Sch, Dept Neurol, Jichi, Tochigi, Japan; Univ Tokyo, Fac Med, Inst Brain Res, Dept Neurol, Tokyo 113, Japan; ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Strasbourg, France; NYU Med Ctr, Dept Microbiol, New York, NY 10016 USA; NYU Med Ctr, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA	Niigata University; Niigata University; University of Tsukuba; Japan Science & Technology Agency (JST); Saint Marianna University; Hamamatsu University School of Medicine; Fujita Health University; Jichi Medical University; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; New York University; New York University	Tsuji, S (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan.	tsuji@cc.niigaa-u.ac.jp	Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472; Sato, Toshiya/0000-0001-7844-9930; Tanese, Naoko/0000-0002-1946-3211; Hozumi, Isao/0000-0003-0984-6291; Davidson, Irwin/0000-0001-5533-1171; OHSHIMA, Takayuki/0000-0002-1501-6430				Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BRINDLE P, 1993, NATURE, V364, P821, DOI 10.1038/364821a0; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DESOUZA EB, 1987, BRAIN RES, V437, P355, DOI 10.1016/0006-8993(87)91651-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44; Kaytor MD, 1999, HUM MOL GENET, V8, P1657, DOI 10.1093/hmg/8.9.1657; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Koyano S, 1999, NEUROSCI LETT, V273, P117, DOI 10.1016/S0304-3940(99)00656-4; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Li SH, 1999, J NEUROSCI, V19, P5159; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Mengus G, 1997, GENE DEV, V11, P1381, DOI 10.1101/gad.11.11.1381; Miyashita T, 1998, BIOCHEM BIOPH RES CO, V249, P96, DOI 10.1006/bbrc.1998.9096; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moulder KL, 1999, J NEUROSCI, V19, P705; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; Parker D, 1996, MOL CELL BIOL, V16, P694; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; SAPP E, 1995, NEUROSCIENCE, V64, P397, DOI 10.1016/0306-4522(94)00427-7; Sato A, 1999, HUM MOL GENET, V8, P997, DOI 10.1093/hmg/8.6.997; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schilling G, 1999, NEURON, V24, P275, DOI 10.1016/S0896-6273(00)80839-9; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Tait D, 1998, HUM MOL GENET, V7, P991, DOI 10.1093/hmg/7.6.991; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Timmers HJLM, 1996, BRAIN RES, V728, P141, DOI 10.1016/S0006-8993(96)00080-7; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	48	326	334	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					29	36		10.1038/79139	http://dx.doi.org/10.1038/79139			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973244				2022-12-17	WOS:000089078000013
J	Terauchi, Y; Tsuji, Y; Satoh, S; Minoura, H; Murakami, K; Okuno, A; Inukai, K; Asano, T; Kaburagi, Y; Ueki, K; Nakajima, H; Hanafusa, T; Matsuzawa, Y; Sekihara, H; Yin, YX; Barrett, JC; Oda, H; Ishikawa, T; Akanuma, Y; Komuro, I; Suzuki, M; Yamamura, K; Kodama, T; Suzuki, H; Koyasu, S; Aizawa, S; Tobe, K; Fukui, Y; Yazaki, Y; Kadowaki, T				Terauchi, Y; Tsuji, Y; Satoh, S; Minoura, H; Murakami, K; Okuno, A; Inukai, K; Asano, T; Kaburagi, Y; Ueki, K; Nakajima, H; Hanafusa, T; Matsuzawa, Y; Sekihara, H; Yin, YX; Barrett, JC; Oda, H; Ishikawa, T; Akanuma, Y; Komuro, I; Suzuki, M; Yamamura, K; Kodama, T; Suzuki, H; Koyasu, S; Aizawa, S; Tobe, K; Fukui, Y; Yazaki, Y; Kadowaki, T			Increased insulin sensitivity and hypoglycaemia in mice lacking the P85 alpha subunit of phosphoinositide 3-kinase	NATURE GENETICS			English	Article							RECEPTOR TYROSINE KINASES; RAT ADIPOSE-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATORY SUBUNIT; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; GROWTH-FACTOR; PROTEIN; SUBSTRATE-1; TRANSLOCATION	The hallmark of type 2 diabetes, the most common metabolic disorder, is a defect in insulin-stimulated glucose transport in peripheral tissues. Although a role for phosphoinositide-3-kinase (PI3K) activity in insulin-stimulated glucose transport and glucose transporter isoform 4 (Glut4) translocation has been suggested in vitro(1,2), its role in vive and the molecular link between activation of PI3K and translocation has not yet been elucidated. To determine the role of PI3K in glucose homeostasis, we generated mice with a targeted disruption of the gene encoding the p85 alpha regulatory subunit of PI3K (Pik3r1; refs 3-5). Pik3r1(-/-) mice showed increased insulin sensitivity and hypoglycaemia due to increased glucose transport in skeletal muscle and adipocytes. Insulin-stimulated PI3K activity associated with insulin receptor substrates (IRSs) was mediated via full-length p85 alpha in wild-type mice, but via the p50 alpha alternative splicing isoform of the same gene(6,7) in Pik3r1(-/-) mice. This isoform switch was associated with an increase in insulin-induced generation of phosphatidylinositol(3, 4, 5)triphosphate (PtdIns(3, 4, 5)P-3) in Pik3r1(-/-) adipocytes and facilitation of Glut4 translocation from the law-density microsome (LDM) fraction to the plasma membrane (PM). This mechanism seems to be responsible for the phenotype of Pik3r1(-/-) mice, namely increased glucose transport and hypoglycaemia. Our work provides the first direct evidence that PI3K and its regulatory subunit have a role in glucose homeostasis in vive.	Univ Tokyo, Dept Internal Med, Tokyo 1138655, Japan; Univ Tokyo, Dept Pathol, Tokyo 1138655, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Dept Mol Biol & Med, Tokyo 1138655, Japan; Univ Tokyo, Dept Appl Biol Chem, Biol Chem Lab, Tokyo 1138655, Japan; Osaka Univ, Dept Internal Med 2, Suita, Osaka 565, Japan; Yokohama City Univ, Dept Internal Med, Yokohama, Kanagawa 236, Japan; NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; Asahi Life Fdn, Inst Diabet Care & Res, Tokyo 100, Japan; Kumamoto Univ, Sch Med, Lab Transgen Technol, Kumamoto 860, Japan; Kumamoto Univ, Sch Med, Dept Dev Genet, Kumamoto 860, Japan; Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Morphogenesis, Kumamoto 860, Japan; Keio Univ, Sch Med, Dept Immunol, Tokyo 160, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Osaka University; Yokohama City University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Asahi Life Foundation; Kumamoto University; Kumamoto University; Kumamoto University; Keio University	Kadowaki, T (corresponding author), Univ Tokyo, Dept Internal Med, Tokyo 1138655, Japan.		Koyasu, Shigeo/J-5583-2015; Suzuki, Harumi/L-1271-2013; Terauchi, Yasuo/AAO-4347-2020; Fukui, Yasuhisa/E-8806-2010	Koyasu, Shigeo/0000-0001-9585-3038; Suzuki, Harumi/0000-0003-3616-9361; 	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050142] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; HARANO Y, 1981, J CLIN ENDOCR METAB, V52, P982, DOI 10.1210/jcem-52-5-982; Holman GD, 1997, DIABETOLOGIA, V40, P991, DOI 10.1007/s001250050780; Inukai K, 1997, J BIOL CHEM, V272, P7873, DOI 10.1074/jbc.272.12.7873; Inukai K, 1996, J BIOL CHEM, V271, P5317, DOI 10.1074/jbc.271.10.5317; Kaburagi Y, 1997, J BIOL CHEM, V272, P25839, DOI 10.1074/jbc.272.41.25839; KADOWAKI T, 1996, ENDOCR J, V43, P533; KELLY KL, 1993, J BIOL CHEM, V268, P4391; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PONS S, 1995, MOL CELL BIOL, V15, P4453; Ricort JM, 1996, EUR J BIOCHEM, V239, P17, DOI 10.1111/j.1432-1033.1996.0017u.x; SATOH S, 1993, J BIOL CHEM, V268, P17820; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074	28	326	336	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					230	235		10.1038/6023	http://dx.doi.org/10.1038/6023			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	9988280				2022-12-17	WOS:000078399500030
J	GUILLEMOT, F; CASPARY, T; TILGHMAN, SM; COPELAND, NG; GILBERT, DJ; JENKINS, NA; ANDERSON, DJ; JOYNER, AL; ROSSANT, J; NAGY, A				GUILLEMOT, F; CASPARY, T; TILGHMAN, SM; COPELAND, NG; GILBERT, DJ; JENKINS, NA; ANDERSON, DJ; JOYNER, AL; ROSSANT, J; NAGY, A			GENOMIC IMPRINTING OF MASH2, A MOUSE GENE REQUIRED FOR TROPHOBLAST DEVELOPMENT	NATURE GENETICS			English	Article							GROWTH FACTOR-II; PATERNAL GENOMES; H19 GENE; EXPRESSION; CELLS; LINKAGE; ACHAETE; EMBRYOGENESIS; CHROMOSOME-7; DROSOPHILA	The mouse gene Mash2 encodes a transcription factor required for development of trophoblast progenitors. Mash2- homozygous mutant embryos die at 10 days post-coitum from placental failure. Here we show that Mash2 is genomically imprinted. First, Mash2+/- embryos inheriting a wild-type allele from their father die at the same stage as appears almost completely repressed by 8.5 days post-coitum. Finally, we have genetically and physically mapped Mash2 to the distal region of chromosome 7, within a The mouse gene Mash2 encodes a transcription factor required for development of cluster of imprinted genes, including insulin-2, insulin-like growth factor-2 and H19.	MT SINAI HOSP,SAMUEL LUNENFELD RES INST,TORONTO,ON M5G 1X5,CANADA; PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544; PRINCETON UNIV,HOWARD HUGHES MED INST,PRINCETON,NJ 08544; NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702; CALTECH,HOWARD HUGHES MED INST,DIV BIOL,PASADENA,CA 91106; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON M5S 1A8,CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Princeton University; Howard Hughes Medical Institute; Princeton University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; California Institute of Technology; Howard Hughes Medical Institute; University of Toronto	GUILLEMOT, F (corresponding author), UNIV LOUIS PASTEUR STRASBOURG 1,CU STRASBOURG,INST GENET & BIOL MOLEC & CELLULAIRE,CNRS,INSERM,F-67404 ILLKIRCH GRAFFENS,FRANCE.		Guillemot, Francois/AAV-1482-2021; Nagy, Andras/G-6465-2013; Caspary, Tamara/AAH-5625-2020	Nagy, Andras/0000-0003-4311-0413; Caspary, Tamara/0000-0002-6579-7589	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051460] Funding Source: NIH RePORTER; NCI NIH HHS [N0I-CO-46000] Funding Source: Medline; NIGMS NIH HHS [GM51460] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AVRAHAM KB, 1994, GENOMICS, V21, P656, DOI 10.1006/geno.1994.1330; BARLOW DP, 1994, TRENDS GENET, V10, P194, DOI 10.1016/0168-9525(94)90255-0; Bartolomei M.S., 1992, SEMIN DEV BIOL, V3, P107; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; BARTON SC, 1985, J EMBRYOL EXP MORPH, V90, P267; BEECHEY CV, 1993, MOUSE GENOME, V91, P310; BEECHEY CV, 1993, MOUSE GENOME, V92, P108; BEECHEY CV, 1993, MOUSE GENOME, V91, P857; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; CATTANACH BM, 1990, DEVELOPMENT, P63; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CLARKE HJ, 1988, DEVELOPMENT, V104, P175; CLINE TW, 1993, TRENDS GENET, V9, P385, DOI 10.1016/0168-9525(93)90138-8; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FORONI L, 1992, J MOL BIOL, V226, P747, DOI 10.1016/0022-2836(92)90630-3; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; Green EL, 1981, GENETICS PROBABILITY, P77; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HALL JG, 1990, AM J HUM GENET, V46, P857; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; JOHNSON JE, 1990, NATURE, V346, P868; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; LEE JE, 1990, DEVELOPMENT, V110, P151; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LESCISIN KR, 1989, GENE DEV, V2, P1639; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; MANN JR, 1984, NATURE, V310, P66, DOI 10.1038/310066a0; MARTINEZ C, 1991, SCIENCE, V251, P1485, DOI 10.1126/science.1900954; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MCLAUGHLIN KJ, IN PRESS GENES DEV; MOENS CB, 1993, DEVELOPMENT, V119, P485; NAGY A, 1987, DEVELOPMENT, V101, P67; POIRIER F, 1991, DEVELOPMENT, V113, P1105; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; SOLTER D, 1988, ANNU REV GENET, V22, P127; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; THOMSON JA, 1988, GENE DEV, V2, P1344, DOI 10.1101/gad.2.10.1344; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61	50	326	337	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					235	242		10.1038/ng0395-235	http://dx.doi.org/10.1038/ng0395-235			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773285				2022-12-17	WOS:A1995QL23200011
J	Turley, P; Walters, RK; Maghzian, O; Okbay, A; Lee, JJ; Fontana, MA; Nguyen-Viet, TA; Wedow, R; Zacher, M; Furlotte, NA; Magnusson, P; Oskarsson, S; Johannesson, M; Visscher, PM; Laibson, D; Cesarini, D; Neale, BM; Benjamin, DJ				Turley, Patrick; Walters, Raymond K.; Maghzian, Omeed; Okbay, Aysu; Lee, James J.; Fontana, Mark Alan; Tuan Anh Nguyen-Viet; Wedow, Robbee; Zacher, Meghan; Furlotte, Nicholas A.; Magnusson, Patrik; Oskarsson, Sven; Johannesson, Magnus; Visscher, Peter M.; Laibson, David; Cesarini, David; Neale, Benjamin M.; Benjamin, Daniel J.		23andMe Res Team; Social Sci Genetic Assoc Co	Multi-trait analysis of genome-wide association summary statistics using MTAG	NATURE GENETICS			English	Article							MAJOR DEPRESSIVE DISORDER; LD SCORE REGRESSION; INCREASES ACCURACY; COMPLEX TRAITS; NEUROTICISM; RISK; METAANALYSIS; INDIVIDUALS; LOCI	We introduce multi-trait analysis of GWAS (MTAG), a method for joint analysis of summary statistics from genome-wide association studies (GWAS) of different traits, possibly from overlapping samples. We apply MTAG to summary statistics for depressive symptoms (N-eff = 354,862), neuroticism (N = 168,105), and subjective well-being (N = 388,538). As compared to the 32, 9, and 13 genome-wide significant loci identified in the single-trait GWAS (most of which are themselves novel), MTAG increases the number of associated loci to 64, 37, and 49, respectively. Moreover, association statistics from MTAG yield more informative bioinformatics analyses and increase the variance explained by polygenic scores by approximately 25%, matching theoretical expectations.	[Turley, Patrick; Walters, Raymond K.; Neale, Benjamin M.] Broad Inst, Cambridge, MA 02142 USA; [Turley, Patrick; Walters, Raymond K.; Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Cambridge, MA 02114 USA; [Maghzian, Omeed; Laibson, David] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Okbay, Aysu] Vrije Univ Amsterdam, Dept Complex Trait Genet, Amsterdam, Netherlands; [Lee, James J.] Univ Minnesota, Dept Psychol, Minneapolis, MN USA; [Fontana, Mark Alan] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Tuan Anh Nguyen-Viet; Benjamin, Daniel J.] Univ Southern Calif, Ctr Econ & Social Res, Los Angeles, CA 90007 USA; [Wedow, Robbee] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Wedow, Robbee] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Wedow, Robbee] Univ Colorado, Dept Sociol, Boulder, CO 80309 USA; [Zacher, Meghan] Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; [Furlotte, Nicholas A.] 23&Me Inc, Mountain View, CA USA; [Magnusson, Patrik] Karolinska Inst, Inst Med Epidemiol & Biostat, Stockholm, Sweden; [Oskarsson, Sven] Uppsala Univ, Dept Govt, Uppsala, Sweden; [Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, Stockholm, Sweden; [Visscher, Peter M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Laibson, David; Cesarini, David; Benjamin, Daniel J.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Cesarini, David] NYU, Dept Econ, New York, NY 10003 USA; [Cesarini, David] NYU, Ctr Expt Social Sci, New York, NY 10003 USA; [Cesarini, David] Inst Naringslivsforskning, Stockholm, Sweden; [Benjamin, Daniel J.] Univ Southern Calif, Dept Econ, Los Angeles, CA 90089 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Vrije Universiteit Amsterdam; University of Minnesota System; University of Minnesota Twin Cities; University of Southern California; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Harvard University; Karolinska Institutet; Uppsala University; Stockholm School of Economics; University of Queensland; University of Queensland; National Bureau of Economic Research; New York University; New York University; Research Institute of Industrial Economics (IFN); University of Southern California	Turley, P; Neale, BM (corresponding author), Broad Inst, Cambridge, MA 02142 USA.; Turley, P; Neale, BM (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Cambridge, MA 02114 USA.; Benjamin, DJ (corresponding author), Univ Southern Calif, Ctr Econ & Social Res, Los Angeles, CA 90007 USA.; Cesarini, D; Benjamin, DJ (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.; Cesarini, D (corresponding author), NYU, Dept Econ, New York, NY 10003 USA.; Cesarini, D (corresponding author), NYU, Ctr Expt Social Sci, New York, NY 10003 USA.; Cesarini, D (corresponding author), Inst Naringslivsforskning, Stockholm, Sweden.; Benjamin, DJ (corresponding author), Univ Southern Calif, Dept Econ, Los Angeles, CA 90089 USA.	paturley@broadinstitute.org; dac12@nyu.edu; bneale@broadinstitute.org; daniel.benjamin@gmail.com	Visscher, Peter/ABB-6151-2020; Johannesson, Magnus/E-9680-2011; Magnusson, Patrik KE/C-4458-2017; Laibson, David/AAA-7362-2022	Visscher, Peter/0000-0002-2143-8760; Johannesson, Magnus/0000-0001-8759-6393; Magnusson, Patrik KE/0000-0002-7315-7899; Wedow, Robbee/0000-0002-3108-7087; Lee, James J/0000-0001-6547-5128; Alipanahi, Babak/0000-0001-8216-7178; Okbay, Aysu/0000-0002-5170-7781	Social Science Genetic Association Consortium (SSGAC); Ragnar Soderberg Foundation [E9/11, E42/15]; Swedish Research Council [421-2013-1061]; Jan Wallander and Tom Hedelius Foundation; ERC Consolidator Grant [647648 EdGe]; Pershing Square Fund of the Foundations of Human Behavior; National Science Foundation's Graduate Research Fellowship Program [DGE 1144083]; NIA/NIH [P01-AG005842, P01-AG005842-20S2, T32-AG000186-23, P30-AG012810, R01-AG042568-02, 1R01-MH107649-03, 1R01-MH101244-02, 5U01-MH109539-02]; ESRC [ES/S008349/1] Funding Source: UKRI; MRC [MR/N01104X/2, G1001799, MR/N01104X/1] Funding Source: UKRI; Economic and Social Research Council [ES/S008349/1] Funding Source: researchfish; Medical Research Council [MC_qA137853, MR/N01104X/1, G1001799, MR/N01104X/2] Funding Source: researchfish; Wellcome Trust [213422/Z/18/Z] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921, R01HD073342, R01HD060726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244, R01MH107649, U01MH109539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG005842, T32AG000186, P30AG034532, R01AG042568, P30AG012810] Funding Source: NIH RePORTER	Social Science Genetic Association Consortium (SSGAC); Ragnar Soderberg Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Jan Wallander and Tom Hedelius Foundation; ERC Consolidator Grant(European Research Council (ERC)); Pershing Square Fund of the Foundations of Human Behavior(Pershing Square Foundation); National Science Foundation's Graduate Research Fellowship Program(National Science Foundation (NSF)); NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Beauchamp, P. Koellinger, O. Sandewall, C. Shulman, and R. de Vlaming for helpful comments and P. Bowers, E. Kong, T. Kundu, S. Lee, H. Li, R. Li, and R. Royer for research assistance. This research was carried out under the auspices of the Social Science Genetic Association Consortium (SSGAC). The study was supported by the Ragnar Soderberg Foundation (E9/11, M.J.; E42/15, D.C.), the Swedish Research Council (421-2013-1061, M.J.), the Jan Wallander and Tom Hedelius Foundation (M.J.), an ERC Consolidator Grant (647648 EdGe, P. Koellinger), the Pershing Square Fund of the Foundations of Human Behavior (D.L.), the National Science Foundation's Graduate Research Fellowship Program (DGE 1144083, R.W.), and the NIA/NIH through grants P01-AG005842, P01-AG005842-20S2, and T32-AG000186-23 to D. Wise at NBER; P30-AG012810 (D.L.) to NBER; R01-AG042568-02 (D.J.B.) to the University of Southern California; and 1R01-MH107649-03 (B.M.N.), 1R01-MH101244-02 (B.M.N.), and 5U01-MH109539-02 (B.M.N.) to the Broad Institute at Harvard and MIT. This research has also been conducted using the UK Biobank Resource under application number 11425. We thank the research participants and employees of 23andMe for making this work possible. We also thank K. Mullan Harris and Add Health for early access to the data used in our replication and prediction analyses. A full list of acknowledgements is provided in the Supplementary Note.	Baselmans B. M. L., 2017, BIORXIV; Bolormaa S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004198; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de Moor MHM, 2015, JAMA PSYCHIAT, V72, P642, DOI 10.1001/jamapsychiatry.2015.0554; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Galesloot TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095923; Hu YM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006836; Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623; Lee S. H., 2017, BIORXIV; Lee SH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42091; Maier R, 2015, AM J HUM GENET, V96, P283, DOI 10.1016/j.ajhg.2014.12.006; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pin JP, 2016, NATURE, V540, P60, DOI 10.1038/nature20566; Porter HF, 2017, SCI REP-UK, V7, DOI 10.1038/srep38837; Smith DJ, 2016, MOL PSYCHIATR, V21, P749, DOI 10.1038/mp.2016.49; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Wientjes YCJ, 2016, GENETICS, V202, P799, DOI 10.1534/genetics.115.183269; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhu XF, 2015, AM J HUM GENET, V96, P21, DOI 10.1016/j.ajhg.2014.11.011	30	325	328	9	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2018	50	2					229	+		10.1038/s41588-017-0009-4	http://dx.doi.org/10.1038/s41588-017-0009-4			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV4BT	29292387	Green Submitted, Green Accepted			2022-12-17	WOS:000424519200014
J	Lin, LP; Sabnis, AJ; Chan, E; Olivas, V; Cade, L; Pazarentzos, E; Asthana, S; Neel, D; Yan, JJ; Lu, XY; Pham, L; Wang, MXM; Karachaliou, N; Cao, MG; Manzano, JL; Ramirez, JL; Torres, JMS; Buttitta, F; Rudin, CM; Collisson, EA; Algazi, A; Robinson, E; Osman, I; Munoz-Couselo, E; Cortes, J; Frederick, DT; Cooper, ZA; McMahon, M; Marchetti, A; Rosell, R; Flaherty, KT; Wargo, JA; Bivona, TG				Lin, Luping; Sabnis, Amit J.; Chan, Elton; Olivas, Victor; Cade, Lindsay; Pazarentzos, Evangelos; Asthana, Saurabh; Neel, Dana; Yan, Jenny Jiacheng; Lu, Xinyuan; Pham, Luu; Wang, Mingxue M.; Karachaliou, Niki; Gonzalez Cao, Maria; Luis Manzano, Jose; Luis Ramirez, Jose; Sanchez Torres, Jose Miguel; Buttitta, Fiamma; Rudin, Charles M.; Collisson, Eric A.; Algazi, Alain; Robinson, Eric; Osman, Iman; Munoz-Couselo, Eva; Cortes, Javier; Frederick, Dennie T.; Cooper, Zachary A.; McMahon, Martin; Marchetti, Antonio; Rosell, Rafael; Flaherty, Keith T.; Wargo, Jennifer A.; Bivona, Trever G.			The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies	NATURE GENETICS			English	Article							SIGNALING PATHWAY; COLON-CANCER; INHIBITION; BRAF; KRAS; LUNG; MELANOMA; TRANSCRIPTION; ACTIVATION; SURVIVAL	Resistance to RAF-and MEK-targeted therapy is a major clinical challenge(1-4). RAF and MEK inhibitors are initially but only transiently effective in some but not all patients with BRAF gene mutation and are largely ineffective in those with RAS gene mutation because of resistance(5-14). Through a genetic screen in BRAF-mutant tumor cells, we show that the Hippo pathway effector YAP (encoded by YAP1) acts as a parallel survival input to promote resistance to RAF and MEK inhibitor therapy. Combined YAP and RAF or MEK inhibition was synthetically lethal not only in several BRAF-mutant tumor types but also in RAS-mutant tumors. Increased YAP in tumors harboring BRAF V600E was a biomarker of worse initial response to RAF and MEK inhibition in patients, establishing the clinical relevance of our findings. Our data identify YAP as a new mechanism of resistance to RAF-and MEK-targeted therapy. The findings unveil the synthetic lethality of combined suppression of YAP and RAF or MEK as a promising strategy to enhance treatment response and patient survival.	[Lin, Luping; Sabnis, Amit J.; Chan, Elton; Olivas, Victor; Cade, Lindsay; Pazarentzos, Evangelos; Asthana, Saurabh; Neel, Dana; Yan, Jenny Jiacheng; Lu, Xinyuan; Pham, Luu; Wang, Mingxue M.; Collisson, Eric A.; Algazi, Alain; Bivona, Trever G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lin, Luping; Sabnis, Amit J.; Chan, Elton; Olivas, Victor; Cade, Lindsay; Pazarentzos, Evangelos; Asthana, Saurabh; Neel, Dana; Yan, Jenny Jiacheng; Lu, Xinyuan; Pham, Luu; Wang, Mingxue M.; Collisson, Eric A.; Algazi, Alain; McMahon, Martin; Bivona, Trever G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Sabnis, Amit J.] Univ Calif San Francisco, Dept Pediat, Div Pediat Hematol & Oncol, San Francisco, CA USA; [Karachaliou, Niki; Gonzalez Cao, Maria; Rosell, Rafael] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Canc Biol & Precis Med Program, Badalona, Spain; [Luis Manzano, Jose] Hosp Badalona Germans Trias & Pujol, Calalan Inst Oncol, Med Oncol Serv, Badalona, Spain; [Luis Ramirez, Jose] Hosp Badalona Germans Trias & Pujol, Fundacio Inst Recerca Germans Trias & Pujol IGTP, Translat Oncol Lab, Catalan Inst Oncol, Barcelona, Spain; [Sanchez Torres, Jose Miguel] Hosp Univ La Princess, Med Oncol Serv, Madrid, Spain; [Buttitta, Fiamma] Univ Fdn, Ctr Predict Mol Med, Chieti, Italy; [Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Mol Chem & Pharmacol Program, New York, NY 10021 USA; [Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, New York, NY 10021 USA; [Robinson, Eric; Osman, Iman] NYU, Inst Canc, Ronald O Perelman Dept Dermatol Med & Urol, New York, NY USA; [Munoz-Couselo, Eva; Cortes, Javier] Vall dHebron Inst Oncol, Barcelona, Spain; [Frederick, Dennie T.; Flaherty, Keith T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Frederick, Dennie T.; Flaherty, Keith T.] Massachusetts Gen Hosp, Ctr Comprehens Canc, Boston, MA 02114 USA; [Cooper, Zachary A.; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Cooper, Zachary A.; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Hospital Germans Trias i Pujol; Catalan Institute of Oncology; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Hospital Germans Trias i Pujol; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; New York University; Vall d'Hebron Institut d'Oncologia (VHIO); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Bivona, TG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	tbivona@medicine.ucsf.edu	Ramirez, Jose Luis/E-5161-2018; Rudin, Charles/R-2530-2019	Ramirez, Jose Luis/0000-0003-1447-2941; Rudin, Charles/0000-0001-5204-3465; Sabnis, Amit/0000-0002-2061-5139; Cooper, Zachary/0000-0003-1059-0940; Pazarentzos, Evangelos/0000-0002-5453-1646; Pham, Luu/0000-0002-2437-5590	US National Institutes of Health (NIH) Director's New Innovator Award [DP2CA174497]; Howard Hughes Medical Institute; Doris Duke Charitable Foundation; American Lung Association; National Lung Cancer Partnership; Addario Foundation; Van Auken Private Foundation; Sidney Kimmel Foundation for Cancer Research; Searle Scholars Program; La Caixa Foundation; US NIH [R01CA131261]; NATIONAL CANCER INSTITUTE [R01CA131261, P01CA163222, P30CA016672, P30CA008748, DP2CA174497] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Lung Association; National Lung Cancer Partnership; Addario Foundation; Van Auken Private Foundation; Sidney Kimmel Foundation for Cancer Research; Searle Scholars Program; La Caixa Foundation(La Caixa Foundation); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Bollag and P. Lin (Plexxikon) for providing PLX4720. We thank J. Weissman and members of the Bivona laboratory for critical review of the manuscript. The authors acknowledge funding support (to T.G.B.) from the following sources: US National Institutes of Health (NIH) Director's New Innovator Award (DP2CA174497), the Howard Hughes Medical Institute (Collaborative Innovation Award), the Doris Duke Charitable Foundation, the American Lung Association, the National Lung Cancer Partnership, the Addario and Van Auken Private Foundations, the Sidney Kimmel Foundation for Cancer Research and the Searle Scholars Program. The authors also acknowledge funding from La Caixa Foundation (to R.R.) and from US NIH grant R01CA131261 (to M.M.).	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fordyce SL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-116; Frederick DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101286; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin LP, 2014, P NATL ACAD SCI USA, V111, pE748, DOI 10.1073/pnas.1320956111; Migliardi G, 2012, CLIN CANCER RES, V18, P2515, DOI 10.1158/1078-0432.CCR-11-2683; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Tan N, 2013, MOL CANCER THER, V12, P853, DOI 10.1158/1535-7163.MCT-12-0949; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Riely GJ, 2012, J CLIN ONCOL, V30; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Rudin CM, 2013, J THORAC ONCOL, V8, pE41, DOI 10.1097/JTO.0b013e31828bb1b3; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	36	325	332	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					250	+		10.1038/ng.3218	http://dx.doi.org/10.1038/ng.3218			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25665005	Green Accepted, Green Submitted			2022-12-17	WOS:000350327900016
J	Saitsu, H; Nishimura, T; Muramatsu, K; Kodera, H; Kumada, S; Sugai, K; Kasai-Yoshida, E; Sawaura, N; Nishida, H; Hoshino, A; Ryujin, F; Yoshioka, S; Nishiyama, K; Kondo, Y; Tsurusaki, Y; Nakashima, M; Miyake, N; Arakawa, H; Kato, M; Mizushima, N; Matsumoto, N				Saitsu, Hirotomo; Nishimura, Taki; Muramatsu, Kazuhiro; Kodera, Hirofumi; Kumada, Satoko; Sugai, Kenji; Kasai-Yoshida, Emi; Sawaura, Noriko; Nishida, Hiroya; Hoshino, Ai; Ryujin, Fukiko; Yoshioka, Seiichiro; Nishiyama, Kiyomi; Kondo, Yukiko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Miyake, Noriko; Arakawa, Hirokazu; Kato, Mitsuhiro; Mizushima, Noboru; Matsumoto, Naomichi			De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood	NATURE GENETICS			English	Article							BRAIN IRON ACCUMULATION; PROTEIN FAMILY; BINDING-SITES; ATG PROTEINS; MICE; MECHANISMS; MITOPHAGY; PROPPINS; DISTINCT; DISEASE	Static encephalopathy of childhood with neurodegeneration in adulthood (SENDA) is a recently established subtype of neurodegeneration with brain iron accumulation (NBIA)(1-3). By exome sequencing, we found de novo heterozygous mutations in WDR45 at Xp11.23 in two individuals with SENDA, and three additional WDR45 mutations were identified in three other subjects by Sanger sequencing. Using lymphoblastoid cell lines (LCLs) derived from the subjects, aberrant splicing was confirmed in two, and protein expression was observed to be severely impaired in all five. WDR45 encodes WD-repeat domain 45 (WDR45). WDR45 (also known as WIP14) is one of the four mammalian homologs of yeast Atgl 8, which has an important role in autophagy(4,5). Lower autophagic activity and accumulation of aberrant early autophagic structures were demonstrated in the LCLs of the affected subjects. These findings provide direct evidence that an autophagy defect is indeed associated with a neurodegenerative disorder in humans.	[Saitsu, Hirotomo; Kodera, Hirofumi; Nishiyama, Kiyomi; Kondo, Yukiko; Tsurusaki, Yoshinori; Nakashima, Mitsuko; Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Nishimura, Taki; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Grad Sch, Tokyo, Japan; [Nishimura, Taki; Mizushima, Noboru] Tokyo Med & Dent Univ, Fac Med, Tokyo, Japan; [Nishimura, Taki; Mizushima, Noboru] Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Tokyo, Japan; [Nishimura, Taki; Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo 113, Japan; [Muramatsu, Kazuhiro; Sawaura, Noriko; Arakawa, Hirokazu] Gunma Univ, Dept Pediat, Grad Sch Med, Gunma, Japan; [Kumada, Satoko; Kasai-Yoshida, Emi] Tokyo Metropolitan Neurol Hosp, Dept Neuropediat, Tokyo, Japan; [Sugai, Kenji] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo, Japan; [Nishida, Hiroya; Hoshino, Ai] Natl Rehabil Ctr Children Disabil, Dept Pediat, Tokyo, Japan; [Ryujin, Fukiko; Yoshioka, Seiichiro] Shiga Univ Med Sci, Dept Pediat, Shiga, Japan; [Kato, Mitsuhiro] Yamagata Univ, Dept Pediat, Fac Med, Yamagata 990, Japan	Yokohama City University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; Gunma University; Tokyo Metropolitan Institute for Neuroscience; National Center for Neurology & Psychiatry - Japan; Shiga University of Medical Science; Yamagata University	Saitsu, H (corresponding author), Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 232, Japan.	hsaitsu@yokohama-cu.ac.jp; nmizu@m.u-tokyo.ac.jp; naomat@yokohama-cu.ac.jp	Muramatsu, Kazuhiro/AAA-6350-2021; Saitsu, Hirotomo/AAM-7131-2021; Mizushima, Noboru/C-3635-2009; NISHIMURA, TAKI/I-6616-2018	Muramatsu, Kazuhiro/0000-0001-9256-5591; Mizushima, Noboru/0000-0002-6258-6444; NISHIMURA, TAKI/0000-0003-4019-5984; Saitsu, Hirotomo/0000-0003-0723-0960; Kato, Mitsuhiro/0000-0003-1485-8553; Tsurusaki, Yoshinori/0000-0002-7240-6355				Baskaran S, 2012, MOL CELL, V47, P339, DOI 10.1016/j.molcel.2012.05.027; Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929; Gregory A, 2011, CURR NEUROL NEUROSCI, V11, P254, DOI 10.1007/s11910-011-0181-3; Haack TB, 2012, AM J HUM GENET, V91, P1144, DOI 10.1016/j.ajhg.2012.10.019; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Kasai-Yoshida E, 2013, MOVEMENT DISORD, V28, P397, DOI 10.1002/mds.25158; Kimura Y, 2013, BRAIN DEV-JPN, V35, P458, DOI 10.1016/j.braindev.2012.07.008; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Kruer MC, 2012, AM J NEURORADIOL, V33, P407, DOI 10.3174/ajnr.A2677; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lu Q, 2011, DEV CELL, V21, P343, DOI 10.1016/j.devcel.2011.06.024; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Schneider SA, 2012, SEMIN PEDIATR NEUROL, V19, P57, DOI 10.1016/j.spen.2012.03.005; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Watanabe Y, 2012, J BIOL CHEM, V287, P31681, DOI 10.1074/jbc.M112.397570; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	34	325	332	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2013	45	4					445	449		10.1038/ng.2562	http://dx.doi.org/10.1038/ng.2562			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23435086				2022-12-17	WOS:000316840600017
J	Tian, C; Stokowski, RP; Kershenobich, D; Ballinger, DG; Hinds, DA				Tian, Chao; Stokowski, Renee P.; Kershenobich, David; Ballinger, Dennis G.; Hinds, David A.			Variant in PNPLA3 is associated with alcoholic liver disease	NATURE GENETICS			English	Article							ADIPONUTRIN; AMERICANS; CIRRHOSIS; RISK	Two genome-wide association studies (GWAS) have described associations of variants in PNPLA3 with nonalcoholic fatty liver and plasma liver enzyme levels. We investigated the contributions of these variants to liver disease in Mestizo subjects with a history of alcohol dependence. We found that rs738409 in PNPLA3 is strongly associated with alcoholic liver disease and clinically evident alcoholic cirrhosis (unadjusted OR = 2.25, P = 1.7 x 10(-10); ancestry-adjusted OR = 1.79, P = 1.9 x 10(-5)).	[Tian, Chao; Stokowski, Renee P.; Ballinger, Dennis G.; Hinds, David A.] Perlegen Sci, Mountain View, CA USA; [Kershenobich, David] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico; [Ballinger, Dennis G.] Complete Genom, Mountain View, CA USA	Universidad Nacional Autonoma de Mexico	Hinds, DA (corresponding author), Perlegen Sci, Mountain View, CA USA.	david_hinds@perlegen.com						Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; Flores YN, 2008, AM J GASTROENTEROL, V103, P2231, DOI 10.1111/j.1572-0241.2008.02022.x; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hoyumpa A, 2005, HEPATOLOGY, V42, p442A; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kollerits B, 2010, J MED GENET, V47, P116, DOI 10.1136/jmg.2009.066597; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Mann RE, 2003, ALCOHOL RES HEALTH, V27, P209; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sozio M, 2008, AM J PHYSIOL-ENDOC M, V295, pE10, DOI 10.1152/ajpendo.00011.2008; Tian C, 2007, AM J HUM GENET, V80, P1014, DOI 10.1086/513522; Yoon Y.-H., 2008, 83 NAT I ALC AB ALC; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	15	325	329	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2010	42	1					21	23		10.1038/ng.488	http://dx.doi.org/10.1038/ng.488			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	536PA	19946271	Bronze			2022-12-17	WOS:000273055100010
J	Murdoch, S; Djuric, U; Mazhar, B; Seoud, M; Khan, R; Kuick, R; Bagga, R; Kircheisen, R; Ao, A; Ratti, B; Hanash, S; Rouleau, GA; Slim, R				Murdoch, S; Djuric, U; Mazhar, B; Seoud, M; Khan, R; Kuick, R; Bagga, R; Kircheisen, R; Ao, A; Ratti, B; Hanash, S; Rouleau, GA; Slim, R			Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans	NATURE GENETICS			English	Article							NITRIC-OXIDE; MICE; PREGNANCY; PROTEIN; LOCUS	Hydatidiform mole (HM) is an abnormal human pregnancy with no embryo and cystic degeneration of placental villi. We report five mutations in the maternal gene NALP7 in individuals with familial and recurrent HMs. NALP7 is a member of the CATERPILLER protein family involved in inflammation and apoptosis. NALP7 is the first maternal effect gene identified in humans and is also responsible for recurrent spontaneous abortions, stillbirths and intrauterine growth retardation.	McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; McGill Univ, Ctr Hlth, Dept Obstet & Gynecol, Montreal, PQ H3G 1A4, Canada; Pakistan Inst Med Sci, Dept Obstet & Gynecol, Maternal & Child Hlth Ctr Unit 11, Islamabad, Pakistan; Amer Univ Beirut, Dept Obstet & Gynecol, Beirut, Lebanon; Univ Michigan, Dept Pediat & Commun Dis, Ann Arbor, MI 48109 USA; Postgrad Inst Med Educ & Res, Dept Obstet & Gynecol, Chandigarh 160012, India; Inst Klin Genet, D-55131 Mainz, Germany; Notre Dame Hosp, Ctr Study Brain Dis, Montreal, PQ H2L 4M1, Canada	McGill University; McGill University; Pakistan Institute of Medical Sciences; American University of Beirut; University of Michigan System; University of Michigan; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Universite de Montreal	Slim, R (corresponding author), McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H3G 1A4, Canada.	rima.slim@muhc.mcgill.ca	ao, asangla/Q-5454-2019; Bagga, Rashmi/Y-1680-2019; Slim, Rima/J-4104-2019	Bagga, Rashmi/0000-0003-2693-2343; Slim, Rima/0000-0002-4060-2159; Djuric, Ugljesa/0000-0003-0027-3079				Agarwal P, 2004, ACTA OBSTET GYN SCAN, V83, P213, DOI 10.1111/j.0001-6349.2004.077b.x; Chiu PM, 2001, HISTOPATHOLOGY, V38, P243, DOI 10.1046/j.1365-2559.2001.01065.x; Deb Kaushik, 2004, Archives of Gynecology and Obstetrics, V270, P133, DOI 10.1007/s00404-004-0623-0; Harma M, 2004, EUR J GYNAECOL ONCOL, V25, P333; Hodges MD, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e95; Karmakar S, 2002, AM J REPROD IMMUNOL, V48, P210, DOI 10.1034/j.1600-0897.2002.01151.x; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Mazhar S, 1995, J PAKISTAN I MED SCI, V6, P383; Moglabey YB, 1999, HUM MOL GENET, V8, P667, DOI 10.1093/hmg/8.4.667; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; Okada K, 2004, CANCER SCI, V95, P949, DOI 10.1111/j.1349-7006.2004.tb03182.x; Savion S, 2002, AM J REPROD IMMUNOL, V47, P118, DOI 10.1034/j.1600-0897.2002.1o027.x; Strakova Z, 2002, J REPROD IMMUNOL, V55, P35, DOI 10.1016/S0165-0378(01)00141-3; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019	15	325	352	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					300	302		10.1038/ng1740	http://dx.doi.org/10.1038/ng1740			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16462743				2022-12-17	WOS:000235589600010
J	GODFREY, P; RAHAL, JO; BEAMER, WG; COPELAND, NG; JENKINS, NA; MAYO, KE				GODFREY, P; RAHAL, JO; BEAMER, WG; COPELAND, NG; JENKINS, NA; MAYO, KE			GHRH RECEPTOR OF LITTLE MICE CONTAINS A MISSENSE MUTATION IN THE EXTRACELLULAR DOMAIN THAT DISRUPTS RECEPTOR FUNCTION	NATURE GENETICS			English	Article							HORMONE-RELEASING HORMONE; MESSENGER-RIBONUCLEIC-ACID; PANCREATIC-ISLET TUMOR; MOUSE GENOME; RAT PLACENTA; GROWTH; GENE; EXPRESSION; SEQUENCES; DWARF	The growth hormone-releasing hormone receptor (GHRHR) is a member of the family of G protein-coupled receptors that is expressed on pituitary somatotrope cells and mediates the actions of GHRH in stimulating growth hormone (GH) synthesis and secretion. We report that the Ghrhr gene is located in the middle of mouse chromosome 6 in the same region as the little mutation. Mice homozygous for this mutation have reduced GH secretion and a dwarf phenotype. A missense mutation was identified in the extracellular domain of the little GHRHR that disrupts receptor function, suggesting that the growth deficit in these mice results from a defect in the GHRHR. Similar alterations in GHRHR might explain some isolated GH deficiencies in humans.	NORTHWESTERN UNIV, DEPT BIOCHEM, EVANSTON, IL 60208 USA; NORTHWESTERN UNIV, DEPT MOLEC BIOL, EVANSTON, IL 60208 USA; NORTHWESTERN UNIV, DEPT CELL BIOL, EVANSTON, IL 60208 USA; NCI, FREDERICK CANC RES & DEV CTR, MAMMALIAN GENET LAB, ABL BASIC RES PROGRAM, FREDERICK, MD 21702 USA; JACKSON LAB, BAR HARBOR, ME 04609 USA	Northwestern University; Northwestern University; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Jackson Laboratory					NATIONAL CANCER INSTITUTE [R03CA054889] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101, CA-54889] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARRUFO A, 1987, P NATL ACAD SCI USA, V84, P8573; ASA SL, 1992, ENDOCRINOLOGY, V131, P2083, DOI 10.1210/en.131.5.2083; BAGNATO A, 1992, ENDOCRINOLOGY, V130, P1097, DOI 10.1210/en.130.3.1097; BEAMER WG, 1976, J ENDOCRINOL, V71, P37, DOI 10.1677/joe.0.0710037; BERRY SA, 1990, ENDOCRINOLOGY, V127, P1404, DOI 10.1210/endo-127-3-1404; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; CAMP TA, 1991, MOL ENDOCRINOL, V5, P1405, DOI 10.1210/mend-5-10-1405; CHENG TC, 1983, ENDOCRINOLOGY, V113, P1669, DOI 10.1210/endo-113-5-1669; CHIAMPANI T, 1992, ENDOCRINOLOGY, V131, P2785; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DONAHUE LR, 1993, J ENDOCRINOL, V136, P91, DOI 10.1677/joe.0.1360091; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; EICHER EM, 1976, J HERED, V67, P87, DOI 10.1093/oxfordjournals.jhered.a108682; GAYLINN BD, 1993, MOL ENDOCRINOL, V7, P77, DOI 10.1210/me.7.1.77; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Green EL, 1981, GENETICS PROBABILITY, P77; GUILLEMIN R, 1982, SCIENCE, V218, P585, DOI 10.1126/science.6812220; HAMMER RE, 1984, NATURE, V311, P65, DOI 10.1038/311065a0; HARPOLD MM, 1979, CELL, V17, P1025, DOI 10.1016/0092-8674(79)90341-6; HELLER DL, 1988, MOL CELL BIOL, V8, P2797, DOI 10.1128/MCB.8.7.2797; HORVATH S, 1989, BRAIN RES, V481, P8, DOI 10.1016/0006-8993(89)90479-4; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; ISHAHARA T, 1991, EMBO J, V10, P1635; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; JANSSON JO, 1986, SCIENCE, V232, P511, DOI 10.1126/science.3008329; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; MACGILLIVRAY MH, 1987, ENDOCRINOL METAB, P1581; MARGIORIS AN, 1990, ENDOCRINOLOGY, V126, P151, DOI 10.1210/endo-126-1-151; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; MAYO KE, 1988, MOL ENDOCRINOL, V2, P606, DOI 10.1210/mend-2-7-606; MCCORMICK A, 1990, NATURE, V345, P829, DOI 10.1038/345829a0; MEIGAN G, 1988, ENDOCRINOLOGY, V123, P1098, DOI 10.1210/endo-123-2-1098; MORETTI C, 1990, ENDOCRINOLOGY, V127, P2117, DOI 10.1210/endo-127-5-2117; PAN Y, 1992, NAT GENET, V2, P103, DOI 10.1038/ng1092-103; PHELPS CJ, 1987, PEPTIDES, V8, P1127, DOI 10.1016/0196-9781(87)90146-X; RIVIER J, 1982, NATURE, V300, P276, DOI 10.1038/300276a0; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; SANO T, 1988, ENDOCR REV, V9, P357, DOI 10.1210/edrv-9-3-357; Schaible R., 1961, Genetics, V46, P896; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SIRACUSA LD, 1991, GENOMICS, V10, P313, DOI 10.1016/0888-7543(91)90314-5; Sneil GD, 1929, P NATL ACAD SCI USA, V15, P733, DOI 10.1073/pnas.15.9.733; SPATOLA E, 1991, ENDOCRINOLOGY, V129, P1193, DOI 10.1210/endo-129-3-1193; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; SUHR ST, 1989, MOL ENDOCRINOL, V3, P1693, DOI 10.1210/mend-3-11-1693; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; THORNER MO, 1982, J CLIN INVEST, V70, P965, DOI 10.1172/JCI110708; UNDERWOOD L E, 1985, P155; WILSON DB, 1988, ACTA ANAT, V131, P150	56	325	328	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1993	4	3					227	232		10.1038/ng0793-227	http://dx.doi.org/10.1038/ng0793-227			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8395283				2022-12-17	WOS:A1993LJ84200008
J	Lee, W; Teckie, S; Wiesner, T; Ran, LL; Granada, CNP; Lin, MY; Zhu, SN; Cao, Z; Liang, YP; Sboner, A; Tap, WD; Fletcher, JA; Huberman, KH; Qin, LX; Viale, A; Singer, S; Zheng, DY; Berger, MF; Chen, Y; Antonescu, CR; Chi, P				Lee, William; Teckie, Sewit; Wiesner, Thomas; Ran, Leili; Granada, Carlos N. Prieto; Lin, Mingyan; Zhu, Sinan; Cao, Zhen; Liang, Yupu; Sboner, Andrea; Tap, William D.; Fletcher, Jonathan A.; Huberman, Kety H.; Qin, Li-Xuan; Viale, Agnes; Singer, Samuel; Zheng, Deyou; Berger, Michael F.; Chen, Yu; Antonescu, Cristina R.; Chi, Ping			PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors	NATURE GENETICS			English	Article							METHYLTRANSFERASE GENE EZH2; REPRESSIVE COMPLEX 2; HISTONE METHYLTRANSFERASE; SOMATIC MUTATIONS; STEM; PLURIPOTENT; METHYLATION; DELETIONS; CHROMATIN; MAPS	Malignant peripheral nerve sheath tumors (MPNSTs) represent a group of highly aggressive soft-tissue sarcomas that may occur sporadically, in association with neurofibromatosis type I (NF1 associated) or after radiotherapy(1-3). Using comprehensive genomic approaches, we identified loss-of-function somatic alterations of the Polycomb repressive complex 2 (PRC2) components (EED or SUZ12) in 92% of sporadic, 70% of NF1-associated and 90% of radiotherapy-associated MPNSTs. MPNSTs with PRC2 loss showed complete loss of trimethylation at lysine 27 of histone H3 (H3K27me3) and aberrant transcriptional activation of multiple PRC2-repressed homeobox master regulators and their regulated developmental pathways. Introduction of the lost PRC2 component in a PRC2-deficient MPNST cell line restored H3K27me3 levels and decreased cell growth. Additionally, we identified frequent somatic alterations of CDKN2A (81% of all MPNSTs) and NF1 (72% of non-NF1-associated MPNSTs), both of which significantly co-occur with PRC2 alterations. The highly recurrent and specific inactivation of PRC2 components, NF1 and CDKN2A highlights their critical and potentially cooperative roles in MPNST pathogenesis.	[Lee, William] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10021 USA; [Lee, William; Teckie, Sewit] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Teckie, Sewit; Wiesner, Thomas; Ran, Leili; Zhu, Sinan; Cao, Zhen; Liang, Yupu; Berger, Michael F.; Chen, Yu; Chi, Ping] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Granada, Carlos N. Prieto; Berger, Michael F.; Antonescu, Cristina R.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Lin, Mingyan; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Sboner, Andrea] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Sboner, Andrea] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY USA; [Sboner, Andrea] Weill Cornell Med Coll, Inst Precis Med, New York, NY USA; [Tap, William D.; Chen, Yu; Chi, Ping] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Tap, William D.; Chen, Yu; Chi, Ping] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Huberman, Kety H.; Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA; [Qin, Li-Xuan] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Singer, Samuel] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Brigham & Women's Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chi, P (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	chip@mskcc.org	lin, mingyan/HDL-9420-2022; Prieto Granada, Carlos N./J-4665-2019	Prieto Granada, Carlos N./0000-0002-5025-7539; Wiesner, Thomas/0000-0001-5877-2992; Zheng, Deyou/0000-0003-4354-5337; Singer, Samuel/0000-0001-9713-8230	US National Institutes of Health (NIH) [NCI U24-CA143840]; Harry J. Lloyd Trust-Translational Research grant; Charles H. Revson Senior Fellowship; Jubilaeumsfonds of the Oesterreichische Nationalbank; US NIH [P50CA140146, DP2CA174499, K08CA151660, K08CA140946]; Sidney Kimmel Foundation; Cycle for Survival Fund; NATIONAL CANCER INSTITUTE [P50CA127003, P30CA008748, DP2CA174499, K08CA151660, P50CA140146, U24CA143840, K08CA140946] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry J. Lloyd Trust-Translational Research grant; Charles H. Revson Senior Fellowship; Jubilaeumsfonds of the Oesterreichische Nationalbank; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Foundation; Cycle for Survival Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Next-generation sequencing and SNP6.0 analysis were performed at the Memorial Sloan Kettering Cancer Center (MSKCC) Genomics Core Facility, Center for Molecular Oncology (CMO). The authors thank members of the cBioPortal team (J. Gao, B. Gross, N. Schultz and C. Sander) for assistance with data analysis and visualization. The authors also thank T. Chan (MSKCC) and HOPP informatics for assistance with data analysis. This work was supported in part by a grant from the US National Institutes of Health (NIH) to W.L. (NCI U24-CA143840), the Harry J. Lloyd Trust-Translational Research grant to T.W., the Charles H. Revson Senior Fellowship to T.W., Jubilaeumsfonds of the Oesterreichische Nationalbank to T.W., grants from the US NIH to P.C. (P50CA140146, Career Development Award and Developmental Research Project.; DP2CA174499; K08CA151660), Y.C. (K08CA140946), L.-X.Q. (P50CA140146), C.R.A. (P50CA140146) and S.S. (P50CA140146), an award from the Sidney Kimmel Foundation to P.C. (Kimmel Scholar Award) and funding from the Cycle for Survival Fund to P.C.	Andor N, 2014, BIOINFORMATICS, V30, P50, DOI 10.1093/bioinformatics/btt622; Antonescu C.R., 2013, TUMORS PERIPHERAL NE, V553; Brennan M.F., 2013, MANAGEMENT SOFT TISS, P149; Eilber FC, 2004, CANCER-AM CANCER SOC, V101, P2270, DOI 10.1002/cncr.20570; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kourea HP, 1999, AM J PATHOL, V155, P1855, DOI 10.1016/S0002-9440(10)65504-6; LaFemina J, 2013, ANN SURG ONCOL, V20, P66, DOI 10.1245/s10434-012-2573-2; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nielsen GP, 1999, AM J PATHOL, V155, P1879, DOI 10.1016/S0002-9440(10)65507-1; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Perrone F, 2003, CLIN CANCER RES, V9, P4132; Rodriguez FJ, 2012, ACTA NEUROPATHOL, V123, P293, DOI 10.1007/s00401-012-0955-y; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Stucky CCH, 2012, ANN SURG ONCOL, V19, P878, DOI 10.1245/s10434-011-1978-7; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Won HH, 2013, JOVE-J VIS EXP, DOI 10.3791/50710; Xie HF, 2014, CELL STEM CELL, V14, P68, DOI 10.1016/j.stem.2013.10.001; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	29	324	330	2	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2014	46	11					1227	1232		10.1038/ng.3095	http://dx.doi.org/10.1038/ng.3095			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AS2TI	25240281	Green Accepted			2022-12-17	WOS:000344131900014
J	Rung, J; Cauchi, S; Albrechtsen, A; Shen, LS; Rocheleau, G; Cavalcanti-Proenca, C; Bacot, F; Balkau, B; Belisle, A; Borch-Johnsen, K; Charpentier, G; Dina, C; Durand, E; Elliott, P; Hadjadj, S; Jarvelin, MR; Laitinen, J; Lauritzen, T; Marre, M; Mazur, A; Meyre, D; Montpetit, A; Pisinger, C; Posner, B; Poulsen, P; Pouta, A; Prentki, M; Ribel-Madsen, R; Ruokonen, A; Sandbaek, A; Serre, D; Tichet, J; Vaxillaire, M; Wojtaszewski, JFP; Vaag, A; Hansen, T; Polychronakos, C; Pedersen, O; Froguel, P; Sladek, R				Rung, Johan; Cauchi, Stephane; Albrechtsen, Anders; Shen, Lishuang; Rocheleau, Ghislain; Cavalcanti-Proenca, Christine; Bacot, Francois; Balkau, Beverley; Belisle, Alexandre; Borch-Johnsen, Knut; Charpentier, Guillaume; Dina, Christian; Durand, Emmanuelle; Elliott, Paul; Hadjadj, Samy; Jaervelin, Marjo-Riitta; Laitinen, Jaana; Lauritzen, Torsten; Marre, Michel; Mazur, Alexander; Meyre, David; Montpetit, Alexandre; Pisinger, Charlotta; Posner, Barry; Poulsen, Pernille; Pouta, Anneli; Prentki, Marc; Ribel-Madsen, Rasmus; Ruokonen, Aimo; Sandbaek, Anelli; Serre, David; Tichet, Jean; Vaxillaire, Martine; Wojtaszewski, Jorgen F. P.; Vaag, Allan; Hansen, Torben; Polychronakos, Constantin; Pedersen, Oluf; Froguel, Philippe; Sladek, Robert			Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RECEPTOR SUBSTRATE-1 GENE; MUSCLE GLYCOGEN-SYNTHASE; SUSCEPTIBILITY LOCI; BETA-CELL; RISK LOCI; DISRUPTION; MICE; POLYMORPHISM; METAANALYSIS	Genome-wide association studies have identified common variants that only partially explain the genetic risk for type 2 diabetes (T2D). Using genome-wide association data from 1,376 French individuals, we identified 16,360 SNPs nominally associated with T2D and studied these SNPs in an independent sample of 4,977 French individuals. We then selected the 28 best hits for replication in 7,698 Danish subjects and identified 4 SNPs showing strong association with T2D, one of which (rs2943641, P = 9.3 x 10(-12), OR = 1.19) was located adjacent to the insulin receptor substrate 1 gene (IRS1). Unlike previously reported T2D risk loci, which predominantly associate with impaired beta cell function, the C allele of rs2943641 was associated with insulin resistance and hyperinsulinemia in 14,358 French, Danish and Finnish participants from population-based cohorts; this allele was also associated with reduced basal levels of IRS1 protein and decreased insulin induction of IRS1-associated phosphatidylinositol-3-OH kinase activity in human skeletal muscle biopsies.	[Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Borch-Johnsen, Knut; Poulsen, Pernille; Ribel-Madsen, Rasmus; Vaag, Allan; Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Rung, Johan; Shen, Lishuang; Rocheleau, Ghislain; Bacot, Francois; Belisle, Alexandre; Mazur, Alexander; Montpetit, Alexandre; Serre, David; Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Cauchi, Stephane; Cavalcanti-Proenca, Christine; Dina, Christian; Durand, Emmanuelle; Meyre, David; Vaxillaire, Martine; Froguel, Philippe] CNRS, UMR 8090, Inst Biol, Lille, France; [Cauchi, Stephane; Cavalcanti-Proenca, Christine; Dina, Christian; Durand, Emmanuelle; Meyre, David; Vaxillaire, Martine; Froguel, Philippe] Univ Lille 2, Inst Pasteur, Lille, France; [Albrechtsen, Anders] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Rocheleau, Ghislain; Polychronakos, Constantin; Sladek, Robert] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada; [Balkau, Beverley] INSERM, U780, Villejuif, France; [Balkau, Beverley] Univ Paris Sud, Orsay, France; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, Corbeil Essonnes, France; [Elliott, Paul; Jaervelin, Marjo-Riitta; Pouta, Anneli] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Hadjadj, Samy] Univ Poitiers, Poitiers Hosp, Ctr Invest Clin INSERM 0801, Unite Format & Rech,INSERM U927, Poitiers, France; [Jaervelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jaervelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jaervelin, Marjo-Riitta] Natl Publ Hlth Inst, Dept Child & Adolescent Hlth, Helsinki, Finland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Helsinki, Finland; [Lauritzen, Torsten; Sandbaek, Anelli] Univ Aarhus, Dept Gen Practice, Aarhus C, Denmark; [Marre, Michel] Bichat Claude Bernard Univ Hosp, Dept Endocrinol Diabetol & Nutr, AP HP, Paris, France; [Marre, Michel] Univ Paris 07, INSERM, U695, Paris, France; [Marre, Michel] Diderot Univ, Paris, France; [Pisinger, Charlotta] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Posner, Barry] McGill Univ, Fac Med, Dept Med, Montreal, PQ, Canada; [Posner, Barry] McGill Univ, Polypeptide Hormone Lab, Montreal, PQ, Canada; [Posner, Barry] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Prentki, Marc] Montreal Diabet Res Ctr, Montreal, PQ, Canada; [Prentki, Marc] Univ Montreal, Mol Nutr Unit, Montreal, PQ, Canada; [Prentki, Marc] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Prentki, Marc] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Ruokonen, Aimo] Univ Oulu, Dept Clin Chem, Oulu, Finland; [Tichet, Jean] Inst Interreg Sante, La Riche, France; [Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Copenhagen Muscle Res Ctr, Inst Exercise & Sport Sci, Copenhagen NV, Denmark; [Vaag, Allan] Lund Univ, Unit Diabet & Endocrinol, Dept Clin Sci, Malmo Univ Hosp, Malmo, Sweden; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense M, Denmark; [Polychronakos, Constantin] McGill Univ, Dept Pediat, Fac Med, Montreal, PQ H3A 2T5, Canada; [Pedersen, Oluf] Univ Copenhagen, Dept Biomed Sci, Copenhagen N, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus C, Denmark; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Genom Med, London, England; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Genom Med, London, England	Novo Nordisk; Hagedorn Research Institute; Steno Diabetes Center; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Copenhagen; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier Sud Francilien; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; Finnish Institute of Occupational Health; Aarhus University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Oulu; University of Copenhagen; Lund University; Skane University Hospital; University of Southern Denmark; McGill University; University of Copenhagen; Aarhus University; Imperial College London; Imperial College London	Pedersen, O (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	oluf@hagedorn.dk; phillipe.froguel@good.ibl.fr; robert.sladek@mcgill.ca	Albrechtsen, Anders/K-4281-2013; Dina, Christian R/D-3535-2015; Pedersen, Oluf/Z-1731-2019; Shen, Lishuang/B-3040-2013; Wojtaszewski, Jørgen FP/P-6583-2014; FROGUEL, Philippe/O-6799-2017; Pedersen, Oluf/AAG-8015-2020; Sladek, Robert/R-2391-2019; Meyre, David/D-7315-2011	Albrechtsen, Anders/0000-0001-7306-031X; Dina, Christian R/0000-0002-7722-7348; Pedersen, Oluf/0000-0002-3321-3972; Wojtaszewski, Jørgen FP/0000-0001-9785-6830; FROGUEL, Philippe/0000-0003-2972-0784; Sladek, Robert/0000-0002-2730-1204; Meyre, David/0000-0003-4850-7444; wojtaszewski, jorgen/0000-0001-8185-3408; Marre, Michel/0000-0002-3071-1837; Rung, Johan/0000-0001-5875-8429; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Polychronakos, Constantin/0000-0002-7624-6635; Elliott, Paul/0000-0002-7511-5684; Vaag, Allan Arthur/0000-0002-3690-2191; Shen, Lishuang/0000-0002-0436-0199; Pisinger, Charlotta/0000-0002-7970-3168	Genome Canada; Genome Quebec; Canada Foundation for Innovation; French Government (Agence Nationale de la Recherche); French Region of Nord Pas De Calais (Contrat de Projets Etat-Region); Caisse Nationale d'Assurance Maladie des Travailleurs Salaries; Lilly; Novartis Pharma; Sanofi-Aventis; Institut National de la Sante et de la Recherche Medicale (INSERM); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; Fondation de France; Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques; Office National Interprofessionnel des Vins; Ardix Medical; Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk; Pierre Fabre; Roche and Topcon; Oulu University Hospital, Finland; Academy of Finland; European Commission [QLG1-CT-2000-01643]; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction; Prevention and Care (LUCAMP); European Union [LSHM-CT-2004-512013, LSHM-CT-2004-005272, LSHM-CT-2006-518153]; Danish Diabetes Association; Danish Agency for Science, Technology and Innovation [271-06-0539]; Canadian Chair in diabetes and metabolism; Fonds de la recherche en sante du Quebec; Montreal General Hospital Foundation; MRC [G0801056, G0600331] Funding Source: UKRI; Medical Research Council [G0801056, G0600331, G0801056B] Funding Source: researchfish	Genome Canada(Genome Canada); Genome Quebec; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); French Government (Agence Nationale de la Recherche)(French National Research Agency (ANR)); French Region of Nord Pas De Calais (Contrat de Projets Etat-Region)(Region Hauts-de-France); Caisse Nationale d'Assurance Maladie des Travailleurs Salaries; Lilly(Eli Lilly); Novartis Pharma; Sanofi-Aventis(Sanofi-Aventis); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; Fondation de France(Fondation de France); Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques; Office National Interprofessionnel des Vins; Ardix Medical; Bayer Diagnostics(Bayer AG); Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk(Novo Nordisk); Pierre Fabre; Roche and Topcon; Oulu University Hospital, Finland; Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction; Prevention and Care (LUCAMP); European Union(European Commission); Danish Diabetes Association; Danish Agency for Science, Technology and Innovation; Canadian Chair in diabetes and metabolism; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Montreal General Hospital Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Genome Canada, Genome Quebec and the Canada Foundation for Innovation. This work was also supported by the French Government (Agence Nationale de la Recherche), the French Region of Nord Pas De Calais (Contrat de Projets Etat-Region), and the following charities: Association Francaise des Diabetiques, Programme National de Recherche sur le Diabete and Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques. The D. E. S. I. R. study has been supported by the Caisse Nationale d'Assurance Maladie des Travailleurs Salaries, Lilly, Novartis Pharma and Sanofi-Aventis, Institut National de la Sante et de la Recherche Medicale (INSERM) (Reseaux en Sante Publique, Interactions entre les determinants de la sante), Association Diabete Risque Vasculaire, Federation Francaise de Cardiologie, Fondation de France, Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques, Office National Interprofessionnel des Vins, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche and Topcon. The D. E. S. I. R. Study Group: INSERM U780: B. Balkau, P. Ducimetiere, E. Eschwege; INSERM U367: F. Alhenc-Gelas; Centre Hospitalier Universitaire D'Angers: Y. Gallois, A. Girault; Bichat Hospital: F. Fumeron, M. Marre; Medical Examination Services: Alencon, Angers, Caen, Chateauroux, Cholet, Le Mans and Tours; Research Institute for General Medicine: J. Cogneau; General practitioners of the region; Cross-Regional Institute for Health: C. Born, E. Caces, M. Cailleau, J. G. Moreau, F. Rakotozafy, J. Tichet, S. Vol. The NFBC 1986 study has been supported by the Oulu University Hospital, Finland, the Academy of Finland and the European Commission (Framework 5 award QLG1-CT-2000-01643). The Danish study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP), the European Union (EUGENE2) grant LSHM-CT-2004-512013, EXGENESIS grant LSHM-CT-2004-005272, the Danish Diabetes Association and the Danish Agency for Science, Technology and Innovation, grant no. 271-06-0539. This study was supported in part by a grant from the European Union (Integrated Project EuroDia LSHM-CT-2006-518153 in the Framework Programme 6 [FP6] of the European Community). M. P. is the recipient of a Canadian Chair in diabetes and metabolism. R. S. is a Chercheur-boursier of the Fonds de la recherche en sante du Quebec and the recipient of an MGH One Hundred and Seventy-Fifth Anniversary Award from Research Institute of the Montreal General Hospital Foundation. We thank L. Peltonen-Palotie for her contribution in DNA extraction and distribution; M. Deweider and F. Allegaert for the DNA bank management; R. Frechette, V. Catudal, D. Vincent, A. Forman, I.-L. Wantzin, T. Lorentzen, M. Stendal, M. H. Kristensen, T. Brunt and A. L. Nielsen for their technical or management assistance. Large-scale computations were performed using the Consortium Laval, Universite du Quebec, McGill and Eastern Quebec supercomputer facility. We are sincerely indebted to all subjects who participated in this study.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Almind K, 1996, J CLIN INVEST, V97, P2569, DOI 10.1172/JCI118705; ALMIND K, 1993, LANCET, V342, P828, DOI 10.1016/0140-6736(93)92694-O; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Aston-Mourney K, 2008, DIABETOLOGIA, V51, P540, DOI 10.1007/s00125-008-0930-2; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; CLAUSEN JO, 1995, LANCET, V346, P397, DOI 10.1016/S0140-6736(95)92779-4; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Florez JC, 2007, DIABETOLOGIA, V50, P1209, DOI 10.1007/s00125-007-0657-5; Florez JC, 2004, DIABETES, V53, P3313, DOI 10.2337/diabetes.53.12.3313; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Jellema A, 2003, DIABETOLOGIA, V46, P990, DOI 10.1007/s00125-003-1126-4; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Poulsen P, 2005, DIABETES, V54, P1289, DOI 10.2337/diabetes.54.5.1289; Poulsen P, 2005, DIABETES, V54, P275, DOI 10.2337/diabetes.54.1.275; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Terauchi Y, 1997, J CLIN INVEST, V99, P861, DOI 10.1172/JCI119250; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2004, DIABETES, V53, P3319, DOI 10.2337/diabetes.53.12.3319; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	42	324	332	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2009	41	10					1110	U89		10.1038/ng.443	http://dx.doi.org/10.1038/ng.443			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	500UG	19734900				2022-12-17	WOS:000270330400015
J	Myers, S; Freeman, C; Auton, A; Donnelly, P; McVean, G				Myers, Simon; Freeman, Colin; Auton, Adam; Donnelly, Peter; McVean, Gil			A common sequence motif associated with recombination hot spots and genome instability in humans	NATURE GENETICS			English	Article							MEIOTIC RECOMBINATION; GERMLINE MUTATION; ALLELE DIVERSITY; MINISATELLITE; HOTSPOT; COMPLEX; CROSSOVERS; REARRANGEMENTS; MICRODELETION; GENERATION	In humans, most meiotic crossover events are clustered into short regions of the genome known as recombination hot spots. We have previously identified DNA motifs that are enriched in hot spots, particularly the 7-mer CCTCCCT. Here we use the increased hot-spot resolution afforded by the Phase 2 HapMap and novel search methods to identify an extended family of motifs based around the degenerate 13-mer CCNCCNTNNCCNC, which is critical in recruiting crossover events to at least 40% of all human hot spots and which operates on diverse genetic backgrounds in both sexes. Furthermore, these motifs are found in hypervariable minisatellites and are clustered in the breakpoint regions of both disease-causing nonallelic homologous recombination hot spots and common mitochondrial deletion hot spots, implicating the motif as a driver of genome instability.	[Myers, Simon] Massachusetts Inst Technol & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Myers, Simon; Freeman, Colin; Auton, Adam; Donnelly, Peter; McVean, Gil] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Auton, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Cornell University; University of Oxford; Wellcome Centre for Human Genetics	Myers, S (corresponding author), Massachusetts Inst Technol & Harvard, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	myers@stats.ox.ac.uk	Auton, Adam J/B-1159-2009; Myers, Simon R/A-6792-2015	Myers, Simon R/0000-0002-2585-9626; Donnelly, Peter/0000-0001-9495-3408	Engineering and Physical Sciences Research Council (EPSRC); Wolfson Foundation; EU; Wellcome Trust	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wolfson Foundation; EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank J. Lupski for help with compiling information on NAHR hot spots and G. Coop for discussion. We thank the Engineering and Physical Sciences Research Council (EPSRC), the Wolfson Foundation, the EU and the Wellcome Trust for financial support.	Andreassen R, 1998, HUM MOL GENET, V7, P2113, DOI 10.1093/hmg/7.13.2113; Baudat F, 2007, PLOS GENET, V3, P1029, DOI 10.1371/journal.pgen.0030100; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Berg I, 2003, AM J HUM GENET, V72, P1436, DOI 10.1086/375629; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Buard J, 2000, AM J HUM GENET, V67, P333, DOI 10.1086/303015; Buard J, 1998, EMBO J, V17, P3495, DOI 10.1093/emboj/17.12.3495; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; De Raedt T, 2006, NAT GENET, V38, P1419, DOI 10.1038/ng1920; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 1998, EMBO J, V17, P4147, DOI 10.1093/emboj/17.14.4147; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; LINNANE AW, 1990, BIOCHEM INT, V22, P1067; Lopes J, 2006, MOL CELL BIOL, V26, P6675, DOI 10.1128/MCB.00649-06; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; May CA, 1996, HUM MOL GENET, V5, P1823, DOI 10.1093/hmg/5.11.1823; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Neumann R, 2006, HUM MOL GENET, V15, P1401, DOI 10.1093/hmg/ddl063; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; Stead JDH, 2000, HUM MOL GENET, V9, P713, DOI 10.1093/hmg/9.5.713; Tamaki K, 1999, HUM MOL GENET, V8, P879, DOI 10.1093/hmg/8.5.879; Van Esch H, 2005, HUM MOL GENET, V14, P1795, DOI 10.1093/hmg/ddi186; Vergnaud G, 2000, GENOME RES, V10, P899, DOI 10.1101/gr.10.7.899; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950	30	324	328	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1124	1129		10.1038/ng.213	http://dx.doi.org/10.1038/ng.213			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165926				2022-12-17	WOS:000258761200028
J	Hu, YG; Liu, YH; Pelletier, S; Buchdunger, E; Warmuth, M; Fabbro, D; Hallek, M; Van Etten, RA; Li, SG				Hu, YG; Liu, YH; Pelletier, S; Buchdunger, E; Warmuth, M; Fabbro, D; Hallek, M; Van Etten, RA; Li, SG			Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia	NATURE GENETICS			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL ONCOGENE; TYROSINE KINASE; IMATINIB MESYLATE; BLAST CRISIS; MYELOPROLIFERATIVE DISEASE; PHILADELPHIA-CHROMOSOME; SIGNAL-TRANSDUCTION; CLINICAL RESISTANCE; STI571 RESISTANCE	The Abl kinase inhibitor imatinib mesylate is the preferred treatment for Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML) in chronic phase but is much less effective in CML blast crisis or Ph+ B-cell acute lymphoblastic leukemia (B-ALL). Here, we show that Bcr-Abl activated the Src kinases Lyn, Hck and Fgr in B-lymphoid cells. BCR-ABL1 retrovirus-transduced marrow from mice lacking all three Src kinases efficiently induced CML but not B-ALL in recipients. The kinase inhibitor CGP76030 impaired the proliferation of B-lymphoid cells expressing Bcr-Abl in vitro and prolonged survival of mice with B-ALL but not CML. The combination of CGP76030 and imatinib was superior to imatinib alone in this regard. The biochemical target of CGP76030 in leukemia cells was Src kinases, not Bcr-Abl. These results implicate Src family kinases as therapeutic targets in Ph+ B-ALL and suggest that simultaneous inhibition of Src and Bcr-Abl kinases may benefit individuals with Ph+ acute leukemia.	Jackson Lab, Bar Harbor, ME 04609 USA; Novartis Pharma AG, CH-4002 Basel, Switzerland; Univ Munich, Med Klin 3, Munich, Germany; Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Jackson Laboratory; Novartis; University of Munich; Tufts Medical Center; Tufts University	Li, SG (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	sli@jax.org	Hallek, Michael/Y-3191-2019	Hallek, Michael/0000-0002-7425-4455; Hu, Yiguo/0000-0002-3973-2140				Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Cuenco GM, 2001, ONCOGENE, V20, P8236, DOI 10.1038/sj.onc.1205095; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; FINER MH, 1994, BLOOD, V83, P43; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; He YP, 2002, BLOOD, V99, P2957, DOI 10.1182/blood.V99.8.2957; Hoover RR, 2002, BLOOD, V100, P1068, DOI 10.1182/blood.V100.3.1068; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Klejman A, 2002, ONCOGENE, V21, P5868, DOI 10.1038/sj.onc.1205724; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; La Rosee P, 2002, CANCER RES, V62, P7149; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; Li SG, 2001, BLOOD, V97, P1442, DOI 10.1182/blood.V97.5.1442; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Million RP, 2000, BLOOD, V96, P664; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Roumiantsev S, 2002, P NATL ACAD SCI USA, V99, P10700, DOI 10.1073/pnas.162140299; Roumiantsev S, 2001, BLOOD, V97, P4, DOI 10.1182/blood.V97.1.4; Sattler M, 2003, SEMIN HEMATOL, V40, P4, DOI 10.1053/shem.2003.50034; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Sexl V, 2000, BLOOD, V96, P2277, DOI 10.1182/blood.V96.6.2277; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Stanglmaier M, 2003, LEUKEMIA, V17, P283, DOI 10.1038/sj.leu.2402778; TAUCHI T, 1994, J BIOL CHEM, V269, P15381; Van Etten RA, 2002, ONCOGENE, V21, P8643, DOI 10.1038/sj.onc.1206091; Warmuth M, 2003, BLOOD, V101, P664, DOI 10.1182/blood-2002-01-0288; Warmuth M, 1997, J BIOL CHEM, V272, P33260, DOI 10.1074/jbc.272.52.33260; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Wolff NC, 2001, BLOOD, V98, P2808, DOI 10.1182/blood.V98.9.2808; Yang WT, 1998, EXP HEMATOL, V26, P1126	40	324	340	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					453	461		10.1038/ng1343	http://dx.doi.org/10.1038/ng1343			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15098032	Green Published, Bronze			2022-12-17	WOS:000221183000016
J	Chuaqui, RF; Bonner, RF; Best, CJM; Gillespie, JW; Flaig, MJ; Hewitt, SM; Phillips, JL; Krizman, DB; Tangrea, MA; Ahram, M; Linehan, WM; Knezevic, V; Emmert-Buck, MR				Chuaqui, RF; Bonner, RF; Best, CJM; Gillespie, JW; Flaig, MJ; Hewitt, SM; Phillips, JL; Krizman, DB; Tangrea, MA; Ahram, M; Linehan, WM; Knezevic, V; Emmert-Buck, MR			Post-analysis follow-up and validation of microarray experiments	NATURE GENETICS			English	Review							LASER CAPTURE MICRODISSECTION; DIFFERENTIALLY EXPRESSED GENES; HUMAN PROSTATE-CANCER; CDNA MICROARRAY; BREAST-CANCER; PROTEOMIC ANALYSIS; CELL-LINES; RNA; DNA; PROFILES	Measurement of gene-expression profiles using microarray technology is becoming increasingly popular among the biomedical research community. Although there has been great progress in this field, investigators are still confronted with a difficult question after completing their experiments: how to validate the large data sets that are generated? This review summarizes current approaches to verifying global expression results, discusses the caveats that must be considered, and describes some methods that are being developed to address outstanding problems.	NCI, Pathogenet Unit, Pathol Lab, Bethesda, MD 20892 USA; NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Emmert-Buck, MR (corresponding author), NCI, Pathogenet Unit, Pathol Lab, Bethesda, MD 20892 USA.	mbuck@helix.nih.gov	Bonner, Robert F/C-6783-2015; Bonner, Robert/GQO-9087-2022; Ahram, Mamoun/D-8497-2015; Best, Carolyn J.M./J-4009-2015	Ahram, Mamoun/0000-0003-4457-3604; Best, Carolyn J.M./0000-0002-3868-6816; Hewitt, Stephen/0000-0001-8283-1788				Ahram M, 2002, MOL CARCINOGEN, V33, P9, DOI 10.1002/mc.10019; Al Moustafa AE, 2002, ONCOGENE, V21, P2634, DOI 10.1038/sj.onc.1205351; Alevizos I, 2001, ONCOGENE, V20, P6196, DOI 10.1038/sj.onc.1204685; Amundson SA, 1999, ONCOGENE, V18, P3666, DOI 10.1038/sj.onc.1202676; Bangur CS, 2002, ONCOGENE, V21, P3814, DOI 10.1038/sj.onc.1205480; BATTIFORA H, 1986, LAB INVEST, V55, P244; Bonaventure P, 2002, BRAIN RES, V943, P38, DOI 10.1016/S0006-8993(02)02504-0; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Bubendorf L, 1999, J NATL CANCER I, V91, P1758, DOI 10.1093/jnci/91.20.1758; Burton GR, 2002, GENE, V293, P21, DOI 10.1016/S0378-1119(02)00726-6; Canada AT, 1996, BIOCHEM PHARMACOL, V51, P87, DOI 10.1016/0006-2952(95)02157-4; Carlisle AJ, 2000, MOL CARCINOGEN, V28, P12, DOI 10.1002/(SICI)1098-2744(200005)28:1<12::AID-MC3>3.0.CO;2-Q; Chaib H, 2001, NEOPLASIA, V3, P43, DOI 10.1038/sj.neo.7900126; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Clark J, 2002, GENE CHROMOSOME CANC, V34, P104, DOI 10.1002/gcc.10039; Cole KA, 1999, NAT GENET, V21, P38, DOI 10.1038/4466; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ellis M, 2002, CLIN CANCER RES, V8, P1155; Emmert-Buck MR, 2000, MOL CARCINOGEN, V27, P158, DOI 10.1002/(SICI)1098-2744(200003)27:3<158::AID-MC2>3.0.CO;2-2; Emmert-Buck MR, 2000, AM J PATHOL, V156, P1109, DOI 10.1016/S0002-9440(10)64979-6; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Englert CR, 2000, CANCER RES, V60, P1526; Fejzo MS, 2001, AM J PATHOL, V159, P1645, DOI 10.1016/S0002-9440(10)63011-8; Fend F, 1999, AM J PATHOL, V154, P61, DOI 10.1016/S0002-9440(10)65251-0; Hess KR, 2001, TRENDS BIOTECHNOL, V19, P463, DOI 10.1016/S0167-7799(01)01792-9; Hodge DL, 2002, J IMMUNOL, V168, P6090, DOI 10.4049/jimmunol.168.12.6090; Holloway AJ, 2002, NAT GENET, V32, P481, DOI 10.1038/ng1030; Hoos A, 2001, LAB INVEST, V81, P1331, DOI 10.1038/labinvest.3780347; Jiang YQ, 2002, ONCOGENE, V21, P2270, DOI 10.1038/sj.onc.1205278; JONES MB, IN PRESS CLIN CANC R; Kallioniemi OP, 2001, HUM MOL GENET, V10, P657, DOI 10.1093/hmg/10.7.657; Kang JS, 2002, CLIN CANCER RES, V8, P117; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LaTulippe E, 2002, CANCER RES, V62, P4499; Leethanakul C, 2000, ONCOGENE, V19, P3220, DOI 10.1038/sj.onc.1203703; Luo J, 2001, CANCER RES, V61, P4683; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Luzzi V, 2001, AM J PATHOL, V158, P2005, DOI 10.1016/S0002-9440(10)64672-X; Magee JA, 2001, CANCER RES, V61, P5692; Mills JC, 2001, NAT CELL BIOL, V3, pE175, DOI 10.1038/35087108; Mousses S, 2002, CANCER RES, V62, P1256; Mutch DM, 2001, GENOME BIOL, V2; Nacht M, 2001, P NATL ACAD SCI USA, V98, P15203, DOI 10.1073/pnas.261414598; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; Ornstein DK, 2000, ELECTROPHORESIS, V21, P2235, DOI 10.1002/1522-2683(20000601)21:11<2235::AID-ELPS2235>3.0.CO;2-A; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; Paweletz CP, 2000, CANCER RES, V60, P6293; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Petricoin EF, 2002, NAT GENET, V32, P474, DOI 10.1038/ng1029; Porkka K, 2002, LAB INVEST, V82, P629, DOI 10.1038/labinvest.3780457; Qi ZY, 2002, J NEURO-ONCOL, V56, P197, DOI 10.1023/A:1015079705841; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Rhodes DR, 2002, CANCER RES, V62, P4427; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Saban MR, 2001, PHYSIOL GENOMICS, V5, P147, DOI 10.1152/physiolgenomics.2001.5.3.147; Scheidl SJ, 2002, AM J PATHOL, V160, P801, DOI 10.1016/S0002-9440(10)64903-6; Sgroi DC, 1999, CANCER RES, V59, P5656; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Slonim DK, 2002, NAT GENET, V32, P502, DOI 10.1038/ng1033; Stamey TA, 2001, J UROLOGY, V166, P2171, DOI 10.1016/S0022-5347(05)65528-0; Stoeckert CJ, 2002, NAT GENET, V32, P469, DOI 10.1038/ng1028; Strausberg RL, 2000, TRENDS GENET, V16, P103, DOI 10.1016/S0168-9525(99)01937-X; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Taniguchi M, 2001, GENOMICS, V71, P34, DOI 10.1006/geno.2000.6427; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Vu H L, 2000, Nucleic Acids Res, V28, pE18, DOI 10.1093/nar/28.7.e18; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Welsh JB, 2001, CANCER RES, V61, P5974	70	324	350	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2002	32			S			509	514		10.1038/ng1034	http://dx.doi.org/10.1038/ng1034			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	624CN	12454646				2022-12-17	WOS:000179742900011
J	Anderson, SE; Schlegel, BP; Nakajima, T; Wolpin, ES; Parvin, JD				Anderson, SE; Schlegel, BP; Nakajima, T; Wolpin, ES; Parvin, JD			BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase a	NATURE GENETICS			English	Article							TRANSCRIPTIONAL ACTIVATION; OVARIAN-CANCER; BREAST; DROSOPHILA	The breast cancer specific tumour suppressor protein, BRCA1 (refs 1,2), activates transcription when linked with a DNA-binding domain(3,4) and is a component of the RNA polymerase II (Pol II) holoenzyme(5,6). We show here that RNA helicase A (RHA) protein(7,8) links BRCA1 to the holoenzyme complex. The region of BRCA1 which interacts with RHA and, thus, the holoenzyme complex, corresponds to subregions of the BRCT domain of BRCA1 (ref. 9). This interaction was shown to occur in yeast nuclei, and expression in human cells of a truncated RHA molecule which retains binding to BRCA1 inhibited transcriptional activation mediated by the BRCA1 carboxy terminus. These data are the first to identify a specific protein interaction with the BRCA1 C-terminal domain and are consistent with the model that BRCA1 functions as a transcriptional coactivator.	Brigham & Womens Hosp, Dept Pathol, Div Mol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Tsukuba, Inst Appl Biochem, Ibaraki, Osaka 3058572, Japan	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Tsukuba	Parvin, JD (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Mol Oncol, 75 Francis St, Boston, MA 02115 USA.		Parvin, Jeffrey D/C-8955-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053504] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM18829, GM53504] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASPENSTROM P, 1995, METHOD ENZYMOL, V256, P228; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; LEE CG, 1993, J BIOL CHEM, V268, P16822; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nakajima T, 1997, GENE DEV, V11, P738, DOI 10.1101/gad.11.6.738; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Zhang SS, 1997, J BIOL CHEM, V272, P11487	17	324	342	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1998	19	3					254	256		10.1038/930	http://dx.doi.org/10.1038/930			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662397				2022-12-17	WOS:000074565900020
J	DESOUZA, AT; HANKINS, GR; WASHINGTON, MK; ORTON, TC; JIRTLE, RL				DESOUZA, AT; HANKINS, GR; WASHINGTON, MK; ORTON, TC; JIRTLE, RL			M6P/IGF2R GENE IS MUTATED IN HUMAN HEPATOCELLULAR CARCINOMAS WITH LOSS OF HETEROZYGOSITY	NATURE GENETICS			English	Note							FACTOR-II RECEPTOR; MANNOSE 6-PHOSPHATE BINDING; FACTOR TYPE-2 RECEPTOR; GROWTH-FACTOR; IGF-II; MOUSE		DUKE UNIV,MED CTR,DEPT RADIAT ONCOL,DURHAM,NC 27710; ZENECA PHARMACEUT,DEPT SAFETY MED,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND; DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710	Duke University; Duke University								BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; CAUSIN C, 1988, BIOCHEM J, V252, P795, DOI 10.1042/bj2520795; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; DAHMS NM, 1993, J BIOL CHEM, V268, P5457; DAHMS NM, 1994, J BIOL CHEM, V269, P3802; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; DESOUZA AT, 1995, ONCOGENE, V10, P1725; HARTSHORN MA, 1988, J ENDOCRINOL, V121, P221; HOROWITZ DS, 1994, TRENDS GENET, V10, P100, DOI 10.1016/0168-9525(94)90233-X; JIRTLE RL, 1994, CARCINOGENESIS, V15, P1473, DOI 10.1093/carcin/15.8.1473; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; LAUREYS G, 1988, GENOMICS, V3, P224, DOI 10.1016/0888-7543(88)90083-3; OGAWA O, 1993, HUM MOL GENET, V2, P2163, DOI 10.1093/hmg/2.12.2163; OSBORNE CK, 1989, MOL ENDOCRINOL, V3, P1701, DOI 10.1210/mend-3-11-1701; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.biochem.55.1.1119; SINGER C, 1995, CANCER RES, V55, P2448; SZEBENYI G, 1994, GENOMICS, V19, P120, DOI 10.1006/geno.1994.1021; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; WESTLUND B, 1991, J BIOL CHEM, V266, P23233; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; YANG DY, 1991, CARCINOGENESIS, V12, P1893, DOI 10.1093/carcin/12.10.1893	22	324	330	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					447	449		10.1038/ng1295-447	http://dx.doi.org/10.1038/ng1295-447			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493029				2022-12-17	WOS:A1995TH62900026
J	Merker, M; Blin, C; Mona, S; Duforet-Frebourg, N; Lecher, S; Willery, E; Blum, MGB; Ruch-Gerdes, S; Mokrousov, I; Aleksic, E; Allix-Beguec, C; Antierens, A; Augustynowicz-Kopec, E; Banff', M; Barletta, F; Beckr, HP; Barry, CE; Bonnet, M; Borroni, E; Campos-Herrero, I; Cirillo, D; Cox, H; Crowe, S; Crudu, V; Die, R; Drobniewski, F; Fauville-Dufaux, M; Gagneuxr, S; Ghebremichael, S; Hanekom, M; Hoffner, S; Jiao, WW; Kalon, S; Kohl, TA; Kontsevaya, I; Lillebaek, T; Maeda, S; Nikolayevskyy, V; Rasmussen, M; Rastogi, N; Samper, S; Sanchez-Padilla, E; Savic, B; Shamputa, IC; Shen, A; Sng, LH; Stakenas, P; Toit, K; Varaine, F; Vukovic, D; Wahl, C; Warren, R; Supply, P; Niemann, S; Wirth, T				Merker, Matthias; Blin, Camille; Mona, Stefano; Duforet-Frebourg, Nicolas; Lecher, Sophie; Willery, Eve; Blum, Michael G. B.; Ruech-Gerdes, Sabine; Mokrousov, Igor; Aleksic, Eman; Allix-Beguec, Caroline; Antierens, Annick; Augustynowicz-Kopec, Ewa; Banff', Marie; Barletta, Francesca; Beckr, Hans Peter; Barry, Clifton E., III; Bonnet, Maryline; Borroni, Emanuele; Campos-Herrero, Isolina; Cirillo, Daniela; Cox, Helen; Crowe, Suzanne; Crudu, Valeriu; Die, Roland; Drobniewski, Francis; Fauville-Dufaux, Maryse; Gagneuxr, Sebastien; Ghebremichael, Solomon; Hanekom, Madeleine; Hoffner, Sven; Jiao, Wei-wei; Kalon, Stobdan; Kohl, Thomas A.; Kontsevaya, Irina; Lillebaek, Troels; Maeda, Shinji; Nikolayevskyy, Vladyslav; Rasmussen, Michael; Rastogi, Nalin; Samper, Sofia; Sanchez-Padilla, Elisabeth; Savic, Branislava; Shamputa, Isdore Chola; Shen, Adong; Sng, Li-Hwei; Stakenas, Petras; Toit, Kadri; Varaine, Francis; Vukovic, Dragana; Wahl, Celine; Warren, Robin; Supply, Philip; Niemann, Stefan; Wirth, Thierrv			Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage	NATURE GENETICS			English	Article							DRUG-RESISTANT TUBERCULOSIS; NEW-YORK-CITY; MUTATION-RATE; MAXIMUM-LIKELIHOOD; SOUTH-AFRICA; MCE OPERONS; STRAINS; POPULATION; EMERGENCE; TRANSMISSION	Mycobacterium tuberculosis strains of the Beijing lineage are globally distributed and are associated with the massive spread of multidrug-resistant (MDR) tuberculosis in Eurasia. Here we reconstructed the biogeographical structure and evolutionary history of this lineage by genetic analysis of 4,987 isolates from 99 countries and whole-genome sequencing of 110 representative isolates. We show that this lineage initially originated in the Far East, from where it radiated worldwide in several waves. We detected successive increases in population size for this pathogen over the last 200 years, practically coinciding with the Industrial Revolution, the First World War and HIV epidemics. Two MDR clones of this lineage started to spread throughout central Asia and Russia concomitantly with the collapse of the public health system in the former Soviet Union. Mutations identified in genes putatively under positive selection and associated with virulence might have favored the expansion of the most successful branches of the lineage.	[Merker, Matthias; Kohl, Thomas A.] Mol Mycobacteriol Res Ctr Borstel, Borstel, Germany; [Blin, Camille; Mona, Stefano] Ecole Prat Flautes Etud, Lab Biol Integrat Populat Evolut Mol, Paris, France; [Blin, Camille; Mona, Stefano; Wirth, Thierrv] Univ Paris 06, Sorbonne Univ, Ecole Prat Hautes Etud,UMR CNRS 7205, Inst Systemat Evolut Biodivers,Museum Natl Hist N, Paris, France; [Duforet-Frebourg, Nicolas; Blum, Michael G. B.] Univ Grenoble 1, CNRS, Lab Techn Ingn Med Complexite Informat Math & App, Grenoble, France; [Lecher, Sophie; Willery, Eve; Supply, Philip] Ctr Infect & Immun Lille, INSERM, U1019, Lille, France; [Lecher, Sophie; Willery, Eve; Supply, Philip] CNRS, UMR 8204, Lille, France; [Lecher, Sophie; Willery, Eve; Supply, Philip] Univ Lille Nord, Ctr Infect & Immun Lille, Lille, France; [Lecher, Sophie; Willery, Eve; Supply, Philip] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; Res Ctr Borstel, Natl Reference Ctr Mycobacteria, Borstel, Germany; [Mokrousov, Igor] St Petersburg Pasteur Inst, Lab Mol Microbiol, St Petersburg, Russia; [Aleksic, Eman] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Allix-Beguec, Caroline; Wahl, Celine; Supply, Philip] Genoscreen, Lille, France; [Antierens, Annick] Med Sans Frontieres Switzerland, Dept Med, Geneva, Switzerland; [Augustynowicz-Kopec, Ewa] Natl TB & Lung Dis Res Inst, Dept Microbiol, Warsaw, Poland; [Banff', Marie] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Barletta, Francesca] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Mol Epidemiol Unit TB, Lima, Peru; [Beckr, Hans Peter; Gagneuxr, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Barry, Clifton E., III; Shamputa, Isdore Chola] NIAID, TB Res Sect, US NIH, Bethesda, MD 20892 USA; [Bonnet, Maryline; Sanchez-Padilla, Elisabeth] Epictr, Clin Res Dept, Paris, France; [Borroni, Emanuele; Cirillo, Daniela] Ist Sci San Raffaele, Emerging Bacterial Pathogens Unit, I-20132 Milan, Italy; [Campos-Herrero, Isolina] Hosp Univ Gran Canaria Dr Negrin, Dept Microbiol, Las Palmas Gran Canaria, Spain; [Cox, Helen] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Crowe, Suzanne] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Crowe, Suzanne] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Crudu, Valeriu] Phthysiopneumol Inst, Natl TB Reference Lab, Kishinev, Moldova; [Die, Roland] Schleswig Holstein Univ Hosp, Inst Epidemiol, Kiel, Germany; [Drobniewski, Francis; Nikolayevskyy, Vladyslav] Barts & London Queen Marys Sch Med & Dent, Publ Hlth England Natl Mycobacterial Reference, London, England; Barts & London Queen Marys Sch Med & Dent, Publ Hlth England Natl Mycobacterial Reference &, London, England; [Drobniewski, Francis; Nikolayevskyy, Vladyslav] Barts & London Queen Marys Sch Med & Dent, Human Immunodeficiency Virus Grp, London, England; [Drobniewski, Francis; Nikolayevskyy, Vladyslav] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London, England; [Fauville-Dufaux, Maryse] TB & Mycobacteria Sci Inst Publ Hlth, Brussels, Belgium; [Ghebremichael, Solomon] Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden; [Hanekom, Madeleine; Warren, Robin] Univ Stellenbosch, Fac Med & Hlth Sci, Ctr TB Res,Div Mol Biol & Human Genet, Ctr Excellence Biomed TB Res,MRC,Natl Res Fdn,Dep, Cape Town, South Africa; [Hoffner, Sven] Swedish Inst Communicable Dis Control, Dept Diagnost & Vaccinol, Solna, Sweden; [Jiao, Wei-wei; Shen, Adong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children, Beijing, Peoples R China; [Jiao, Wei-wei; Shen, Adong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing, Peoples R China; [Kalon, Stobdan] US Agcy Int Dev Qual Hlth Care Project, Bishkek, Kyrgyzstan; [Kontsevaya, Irina] Sarnara Oblast TB Serv, Samara, Russia; [Lillebaek, Troels; Rasmussen, Michael] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark; [Maeda, Shinji] Japan Anti TB Assoc, Res Inst TB, Tokyo, Japan; [Rastogi, Nalin] WHO, Inst Paslieur Guadeloupe, Supranat TB Reference Lab, Abymes, France; [Samper, Sofia] Hosp Univ Miguel Servet, Inst Invest Sanit Aragon, Zaragoza, Spain; [Savic, Branislava; Vukovic, Dragana] Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Sng, Li-Hwei] Singapore Gen Hosp, Dept Pathol, Cent TB Lab, Singapore, Singapore; [Stakenas, Petras] Vilnius Univ, Inst Biotechnol, Dept Immunol & Cell Biol, Vilnius, Lithuania; [Toit, Kadri] Tartu Univ Hosp, United Labs, Tartu, Estonia; [Varaine, Francis] Med Sans Frontieres, Dept Med, Paris, France; [Niemann, Stefan] German Ctr Infect Res, Borstel Site, Borstel, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Forschungszentrum Borstel; Saint-Petersburg Pasteur Institute; Burnet Institute; Doctors Without Borders; University of Bern; Universidad Peruana Cayetano Heredia; University of Basel; Swiss Tropical & Public Health Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Cape Town; Florey Institute of Neuroscience & Mental Health; Monash University; University of Kiel; Schleswig Holstein University Hospital; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Imperial College London; Public Health Agency of Sweden; National Research Foundation - South Africa; Stellenbosch University; Swedish Institute for Infectious Disease Control; Capital Medical University; Capital Medical University; Statens Serum Institut; World Health Organization; Miguel Servet University Hospital; University of Belgrade; Singapore General Hospital; Vilnius University; Doctors Without Borders; Sanofi-Aventis; Sanofi France; German Center for Infection Research	Wirth, T (corresponding author), Ecole Prat Flautes Etud, Lab Biol Integrat Populat Evolut Mol, Paris, France.	philip.supply@ibl.cnrs.fr; sniemann@fz-borstel.de; wirth@rnram.fr	Blum, Michael/F-9978-2010; Merker, Matthias/P-7399-2015; RASTOGI, NALIN/AAP-1958-2020; Shamputa, Isdore Chola/AAR-3252-2020; Barry, Clifton E/ABE-7992-2020; Barry, Clifton E/H-3839-2012; Kontsevaya, Irina/AAJ-8173-2020; Allix-Béguec, Caroline/AAI-4645-2021; Cirillo, Daniela Maria/AAB-3646-2019; Wirth, Thierry/B-4915-2008; Shamputa, Isdore Chola/AAR-7683-2020; Mona, Stefano/AAF-5061-2019; Mokrousov, Igor/J-3640-2014; Niemann, Stefan/C-9327-2011; Kohl, Thomas Andreas/AAB-9782-2020; Nikolayevskyy, Vladyslav/HFZ-7738-2022; Mokrousov, Igor/Q-5941-2019; Gagneux, Sebastien/ABE-7909-2020; Augustynowicz-Kopeć, Ewa/AAL-1757-2020; Supply, Philip/A-9580-2019; Borroni, Emanuele/K-5179-2016	Blum, Michael/0000-0003-4174-7373; Merker, Matthias/0000-0003-1386-2331; RASTOGI, NALIN/0000-0002-7199-7747; Shamputa, Isdore Chola/0000-0003-1888-8936; Barry, Clifton E/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Allix-Béguec, Caroline/0000-0001-7642-4844; Cirillo, Daniela Maria/0000-0001-6415-1535; Wirth, Thierry/0000-0002-7371-0172; Shamputa, Isdore Chola/0000-0003-1888-8936; Mokrousov, Igor/0000-0001-5924-0576; Kohl, Thomas Andreas/0000-0002-1126-6803; Nikolayevskyy, Vladyslav/0000-0002-9502-0332; Mokrousov, Igor/0000-0001-5924-0576; Augustynowicz-Kopeć, Ewa/0000-0001-6162-8748; Mona, Stefano/0000-0001-9087-0656; Niemann, Stefan/0000-0002-6604-0684; Cox, Helen/0000-0002-6538-7192; Samper, Sofia/0000-0002-3011-2519; Kontsevaya, Irina/0000-0003-3421-7550; Warren, Robin/0000-0001-5741-7358; Beck, Hans-Peter/0000-0001-8326-4834; Klaos, Kadri/0000-0002-0055-755X; Supply, Philip/0000-0003-3690-3853; Vukovic, Dragana/0000-0002-4028-308X; Lillebaek, Troels/0000-0002-2601-2718; Gagneux, Sebastien/0000-0001-7783-9048; Borroni, Emanuele/0000-0001-6780-5119	European Community [278864]; European Union [223681]; Action Transversale du Museum National d'Histoire Naturelle 'Les Microorganismes; Acteurs Cles dans les Ecosystemes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783] Funding Source: NIH RePORTER	European Community(European Commission); European Union(European Commission); Action Transversale du Museum National d'Histoire Naturelle 'Les Microorganismes; Acteurs Cles dans les Ecosystemes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge L. Cowan and J. Posey (US Centers for Disease Control and Prevention) for pros ding us with significant amounts of genot)iping data for M. tuberculosis Beijing isolates. We thank T. Ubben, I. Radzio, F Struwe-Sonnenschein and). Zallet (Research Center Borstel) for excellent technical assistance. We acknowledge J. Peh for her assistance and support in the study and I. Comas for statistical advice. Parts of this work have been supported by grants from the European Community's Seventh ilramework Programme (FP7120072013) under grant agreement 278864 in the framework ot. the European Union PathoNGenTrace project and grant agreement 223681 in the framework of the TB-PAN-NET project. We also thank Action Transversale du Museum National d'Histoire Naturelle 'Les Microorganismes, Acteurs Cles dans les Ecosystemes' for financial support. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Ahmad S, 2004, SCAND J IMMUNOL, V60, P382, DOI 10.1111/j.0300-9475.2004.01490.x; Beaumont MA, 1999, GENETICS, V153, P2013; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Bifani PJ, 1996, JAMA-J AM MED ASSOC, V275, P452, DOI 10.1001/jama.275.6.452; Blom J, 2011, BIOINFORMATICS, V27, P1351, DOI 10.1093/bioinformatics/btr151; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Comas I, 2011, TRENDS MICROBIOL, V19, P492, DOI 10.1016/j.tim.2011.07.002; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; DROLET GJ, 1945, AM J PUBLIC HEALTH, V35, P689, DOI 10.2105/AJPH.35.7.689; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duforet-Frebourg N, 2014, MOL BIOL EVOL, V31, P2483, DOI 10.1093/molbev/msu182; Etienne G, 2009, J BACTERIOL, V191, P2613, DOI 10.1128/JB.01235-08; Fang J., 2013, ATLAS SUSTAINABILITY; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Gioffre A, 2005, MICROBES INFECT, V7, P325, DOI 10.1016/j.micinf.2004.11.007; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Holden C, 1999, SCIENCE, V286, P1670, DOI 10.1126/science.286.5445.1670; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kato-Maeda M, 2012, CLIN VACCINE IMMUNOL, V19, P1227, DOI 10.1128/CVI.00250-12; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201//EID1903.120246]; Laruelle M., 2009, CHINA EURASIA FORUM, V7, P93; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; Maloney E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000534; Meikle V, 2009, CLIN VACCINE IMMUNOL, V16, P1352, DOI 10.1128/CVI.00211-09; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mokrousov I, 2013, CLIN MICROBIOL REV, V26, P342, DOI 10.1128/CMR.00087-12; Munsiff SS, 2003, J INFECT DIS, V188, P356, DOI 10.1086/376837; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Nieselt-Struwe K, 2001, MOL BIOL EVOL, V18, P1204, DOI 10.1093/oxfordjournals.molbev.a003907; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Osorio NS, 2013, MOL BIOL EVOL, V30, P1326, DOI 10.1093/molbev/mst038; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; PLIKAYTIS BB, 1994, J CLIN MICROBIOL, V32, P1542, DOI 10.1128/JCM.32.6.1542-1546.1994; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Ragheb MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-145; Reyes JF, 2010, INFECT GENET EVOL, V10, P1046, DOI 10.1016/j.meegid.2010.06.016; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sirakova TD, 2002, J BACTERIOL, V184, P6796, DOI 10.1128/JB.184.24.6796-6802.2002; Stavrum R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026295; Stoffels K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063128; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Supply P, 2011, INFECT GENET EVOL, V11, P251, DOI 10.1016/j.meegid.2010.12.009; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2019, 10 HLTH ISS WHO WILL; Wilson IJ, 1998, GENETICS, V150, P499; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	78	323	343	2	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2015	47	3					242	249		10.1038/ng.3195	http://dx.doi.org/10.1038/ng.3195			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CC4MQ	25599400				2022-12-17	WOS:000350327900014
J	Kiemeney, LA; Thorlacius, S; Sulem, P; Geller, F; Aben, KKH; Stacey, SN; Gudmundsson, J; Jakobsdottir, M; Bergthorsson, JT; Sigurdsson, A; Blondal, T; Witjes, JA; Vermeulen, SH; Hulsbergen-van de Kaa, CA; Swinkels, DW; Ploeg, M; Cornel, EB; Vergunst, H; Thorgeirsson, TE; Gudbjartsson, D; Gudjonsson, SA; Thorleifsson, G; Kristinsson, KT; Mouy, M; Snorradottir, S; Placidi, D; Campagna, M; Arici, C; Koppova, K; Gurzau, E; Rudnai, P; Kellen, E; Polidoro, S; Guarrera, S; Sacerdote, C; Sanchez, M; Saez, B; Valdivia, G; Ryk, C; De Verdier, P; Lindblom, A; Golka, K; Bishop, DT; Knowles, MA; Nikulasson, S; Petursdottir, V; Jonsson, E; Geirsson, G; Kristjansson, B; Mayordomo, JI; Steineck, G; Porru, S; Buntinx, F; Zeegers, MP; Fletcher, T; Kumar, R; Matullo, G; Vineis, P; Kiltie, AE; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Rafnar, T; Stefansson, K				Kiemeney, Lambertus A.; Thorlacius, Steinunn; Sulem, Patrick; Geller, Frank; Aben, Katja K. H.; Stacey, Simon N.; Gudmundsson, Julius; Jakobsdottir, Margret; Bergthorsson, Jon T.; Sigurdsson, Asgeir; Blondal, Thorarinn; Witjes, J. Alfred; Vermeulen, Sita H.; Hulsbergen-van de Kaa, Christina A.; Swinkels, Dorine W.; Ploeg, Martine; Cornel, Erik B.; Vergunst, Henk; Thorgeirsson, Thorgeir E.; Gudbjartsson, Daniel; Gudjonsson, Sigurjon A.; Thorleifsson, Gudmar; Kristinsson, Kari T.; Mouy, Magali; Snorradottir, Steinunn; Placidi, Donatella; Campagna, Marcello; Arici, Cecilia; Koppova, Kvetoslava; Gurzau, Eugene; Rudnai, Peter; Kellen, Eliane; Polidoro, Silvia; Guarrera, Simonetta; Sacerdote, Carlotta; Sanchez, Manuel; Saez, Berta; Valdivia, Gabriel; Ryk, Charlotta; de Verdier, Petra; Lindblom, Annika; Golka, Klaus; Bishop, D. Timothy; Knowles, Margaret A.; Nikulasson, Sigfus; Petursdottir, Vigdis; Jonsson, Eirikur; Geirsson, Gudmundur; Kristjansson, Baldvin; Mayordomo, Jose I.; Steineck, Gunnar; Porru, Stefano; Buntinx, Frank; Zeegers, Maurice P.; Fletcher, Tony; Kumar, Rajiv; Matullo, Giuseppe; Vineis, Paolo; Kiltie, Anne E.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Stefansson, Kari			Sequence variant on 8q24 confers susceptibility to urinary bladder cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; UROTHELIAL CELL-CARCINOMA; PROSTATE-CANCER; LUNG-CANCER; NICOTINE DEPENDENCE; GENE-EXPRESSION; P63 EXPRESSION; BREAST-CANCER; RISK; DISEASE	We conducted a genome-wide SNP association study on 1,803 urinary bladder cancer (UBC) cases and 34,336 controls from Iceland and The Netherlands and follow up studies in seven additional case-control groups (2,165 cases and 3,800 controls). The strongest association was observed with allele T of rs9642880 on chromosome 8q24, 30 kb upstream of MYC (allele-specific odds ratio (OR) = 1.22; P = 9.34 x 10(-12)). Approximately 20% of individuals of European ancestry are homozygous for rs9642880[T], and their estimated risk of developing UBC is 1.49 times that of noncarriers. No association was observed between UBC and the four 8q24 variants previously associated with prostate, colorectal and breast cancers, nor did rs9642880 associate with any of these three cancers. A weaker signal, but nonetheless of genome-wide significance, was captured by rs710521[A] located near TP63 on chromosome 3q28 (allele-specific OR = 1.19; P = 1.15 x 10(-7)).	[Kiemeney, Lambertus A.; Aben, Katja K. H.; Vermeulen, Sita H.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Witjes, J. Alfred; Ploeg, Martine] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Aben, Katja K. H.] Ctr Comprehens Canc E, NL-6501 BG Nijmegen, Netherlands; [Thorlacius, Steinunn; Sulem, Patrick; Geller, Frank; Stacey, Simon N.; Gudmundsson, Julius; Jakobsdottir, Margret; Bergthorsson, Jon T.; Sigurdsson, Asgeir; Blondal, Thorarinn; Thorgeirsson, Thorgeir E.; Gudbjartsson, Daniel; Gudjonsson, Sigurjon A.; Thorleifsson, Gudmar; Kristinsson, Kari T.; Mouy, Magali; Snorradottir, Steinunn; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Stefansson, Kari] DeCode Genet, IS-101 Reykjavik, Iceland; [Hulsbergen-van de Kaa, Christina A.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem, NL-6500 HB Nijmegen, Netherlands; [Cornel, Erik B.] Streekziekenhuis Midden Twente, Dept Urol, NL-7550 AM Hengelo, Netherlands; [Vergunst, Henk] Canisius Wilhelmina Ziekenhuis, Dept Urol, NL-6500 GS Nijmegen, Netherlands; [Placidi, Donatella; Campagna, Marcello; Arici, Cecilia; Porru, Stefano] Univ Brescia, Dept Expt & Appl Med, Sect Occupat Med & Ind Hyg, I-25125 Brescia, Italy; [Koppova, Kvetoslava] State Hlth Inst, SK-97556 Banska Bystrica, Slovakia; [Gurzau, Eugene] Ctr Environm Hlth, Cluj Napoca 400166, Romania; [Rudnai, Peter] Natl Inst Environm Hlth, H-1450 Budapest, Hungary; [Kellen, Eliane; Buntinx, Frank] Catholic Univ Louvain, Dept Gen Practice, B-3000 Louvain, Belgium; [Kellen, Eliane] Catholic Univ Louvain, Ctr Canc Prevent LUCK, B-3000 Louvain, Belgium; [Polidoro, Silvia; Matullo, Giuseppe; Vineis, Paolo] ISI Fdn, Turin, Italy; [Polidoro, Silvia; Guarrera, Simonetta; Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; [Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, I-10123 Turin, Italy; Ctr Canc Epidemiol & Prevent CPO Piemonte, I-10123 Turin, Italy; [Sanchez, Manuel] Univ Hosp, Div Urol, Zaragoza 50009, Spain; [Valdivia, Gabriel] Univ Zaragoza, Sch Med, Dept Urol, E-50009 Zaragoza, Spain; [Ryk, Charlotta; de Verdier, Petra; Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Golka, Klaus] Univ Dortmund, Inst Occupat Physiol, Dortmund, Germany; [Bishop, D. Timothy] St James Univ Hosp, Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds LS9 7TF, W Yorkshire, England; [Knowles, Margaret A.; Kiltie, Anne E.] St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Oncol, Leeds LS9 7TF, W Yorkshire, England; [Nikulasson, Sigfus; Petursdottir, Vigdis] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Jonsson, Eirikur; Geirsson, Gudmundur; Kristjansson, Baldvin] Landspitali Univ Hosp, Dept Urol, IS-101 Reykjavik, Iceland; [Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza 50009, Spain; [Mayordomo, Jose I.] Hlth Sci Inst, Nanotechnol Inst Aragon, Zaragoza 50009, Spain; [Steineck, Gunnar] Karolinska Hosp, Dept Oncol & Pathol, S-17176 Stockholm, Sweden; [Steineck, Gunnar] Sahlgrens Univ Hosp, Dept Oncol, S-41345 Gothenburg, Sweden; [Buntinx, Frank] Maastricht Univ, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; [Zeegers, Maurice P.] Univ Birmingham, Dept Publ Hlth & Epidemiol, Unit Genet Epidemiol, Birmingham B15 2TT, W Midlands, England; [Zeegers, Maurice P.] Nutr & Toxicol Res Inst, Dept Complex Genet, NL-6200 MD Maastricht, Netherlands; [Fletcher, Tony] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; University of Brescia; Universite Catholique Louvain; Universite Catholique Louvain; University of Turin; University of Turin; Miguel Servet University Hospital; University of Zaragoza; Karolinska Institutet; Dortmund University of Technology; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Landspitali National University Hospital; Landspitali National University Hospital; Miguel Servet University Hospital; Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Maastricht University; University of Birmingham; Maastricht University; University of London; London School of Hygiene & Tropical Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); Imperial College London; University of Iceland	Stefansson, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands.	b.kiemeney@ebh.umcn.nl; kstefans@decode.is	Arici, Cecilia/AAO-7689-2020; Placidi, Donatella/A-6965-2011; Vermeulen, Sita H./L-4716-2015; Swinkels, Dorine W./H-8098-2014; Matullo, Giuseppe/K-6383-2016; Stefansson, Kari/AAE-7187-2019; Steineck, Gunnar/W-1515-2019; Campagna, Marcello/L-1011-2016; Guarrera, Simonetta/AAB-8482-2022; de Kaa, Christina A Hulsbergen-van/L-4399-2015; Mayordomo, Jose/K-3453-2013; Witjes, Fred/N-9665-2013; Polidoro, Silvia/GYJ-3517-2022; Kiemeney, Lambertus A./D-3357-2009; Kumar, Rajiv/H-6431-2019; Buntinx, Frank/E-4950-2011; Aben, Katja KH/G-9686-2016; Fletcher, Tony/D-2394-2011	Arici, Cecilia/0000-0003-1493-590X; Placidi, Donatella/0000-0003-1606-5397; Vermeulen, Sita H./0000-0003-4913-8601; Swinkels, Dorine W./0000-0002-1040-9446; Matullo, Giuseppe/0000-0003-0674-7757; Steineck, Gunnar/0000-0002-0787-3969; Campagna, Marcello/0000-0002-5277-8477; Kiemeney, Lambertus A./0000-0002-2368-1326; Kumar, Rajiv/0000-0002-6093-0395; Aben, Katja KH/0000-0002-0214-2147; Saez, Berta/0000-0003-0753-1165; Knowles, Margaret/0000-0002-9363-8657; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Kiltie, Anne/0000-0001-7208-2912; Sacerdote, Carlotta/0000-0002-8008-5096; Gudbjartsson, Daniel/0000-0002-5222-9857; Polidoro, Silvia/0000-0003-2968-0575; Bishop, Tim/0000-0002-8752-8785; Fletcher, Tony/0000-0003-3385-200X; Geller, Frank/0000-0002-9238-3269; Gurzau, Eugen/0000-0002-8688-6118; Kong, Augustine/0000-0001-8193-5438; Bergthorsson, Jon Thor/0000-0002-0560-2639; Zeegers, Maurice/0000-0002-2387-083X; Ryk, Charlotta/0000-0002-7881-7614; Gudjonsson, Sigurjon A./0000-0001-9314-7412	European Commission [LSHC-CT-2005-018827, LSHM-CT-2004-005166]; National Institute of Health [R01-DA017932]; Radboud University Nijmegen Medical Centre; Cancer Research UK; Yorkshire Cancer Research; ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility),; European Union [513943]; compagnia di San Paolo; Italian Association for Cancer Research, Italy; Piedmont Region Progetti di Ricerca Sanitaria Finalizzata; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017932] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radboud University Nijmegen Medical Centre; Cancer Research UK(Cancer Research UK); Yorkshire Cancer Research; ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility),; European Union(European Commission); compagnia di San Paolo(Compagnia di San Paolo); Italian Association for Cancer Research, Italy(Fondazione AIRC per la ricerca sul cancro); Piedmont Region Progetti di Ricerca Sanitaria Finalizzata; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the individuals that participated in the study and whose contribution made this work possible. We also thank the nurses at Noatun (deCODE's participant recruitment center) and the personnel at the deCODE core facilities. We acknowledge the Icelandic Cancer Registry for assistance in the ascertainment of the Icelandic UBC cases. Collection of samples and data in Iceland and The Netherlands was funded in part by the European Commission (POLYGENE: LSHC-CT-2005-018827 and GENADDICT: LSHM-CT-2004-005166), the National Institute of Health (R01-DA017932) and a research investment grant of the Radboud University Nijmegen Medical Centre. The Leeds Bladder Cancer Study was funded by Cancer Research UK and Yorkshire Cancer Research. Torino Bladder Cancer Case Control Study was supported by a grant to ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence operating within the European Union 6th Framework Program, Priority 5: "Food Quality and Safety'' (Contract No 513943); by a grant of the compagnia di San Paolo, the Italian Association for Cancer Research, Italy and the Piedmont Region Progetti di Ricerca Sanitaria Finalizzata.	Aben KKH, 2006, EUR J CANCER, V42, P1428, DOI 10.1016/j.ejca.2005.07.039; Aben KKH, 2002, INT J CANCER, V98, P274, DOI 10.1002/ijc.10191; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; DEPINHO RA, 1991, ADV CANCER RES, V57, P1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Koga F, 2003, CLIN CANCER RES, V9, P5501; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mhawech-Fauceglia P, 2006, CANCER-AM CANCER SOC, V106, P1205, DOI 10.1002/cncr.21743; Murta-Nascimento C, 2007, CANCER EPIDEM BIOMAR, V16, P1595, DOI 10.1158/1055-9965.EPI-06-0743; *NAT CANC I DIV CA, 2007, SURV EP END RES PROG; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	30	323	334	4	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1307	1312		10.1038/ng.229	http://dx.doi.org/10.1038/ng.229			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18794855	Green Accepted			2022-12-17	WOS:000260501500022
J	Cullen, BR				Cullen, Bryan R.			Viruses and microRNAs	NATURE GENETICS			English	Article							SMALL INTERFERING RNA; HERPES-SIMPLEX-VIRUS; NUCLEAR EXPORT; GENE-EXPRESSION; MESSENGER-RNAS; IDENTIFICATION; TRANSCRIPTS; INHIBIT; REQUIREMENTS; TRANSLATION	The discovery of RNA interference and cellular microRNAs (miRNAs) has not only affected how biological research is conducted but also revealed an entirely new level of post-transcriptional gene regulation. Here, I discuss the potential functions of the virally encoded miRNAs recently identified in several pathogenic human viruses and propose that cellular miRNAs may have had a substantial effect on viral evolution and may continue to influence the in vivo tissue tropism of viruses. Our increasing knowledge of the role and importance of virally encoded miRNAs will probably offer new insights into how viruses that establish latent infections, such as herpesviruses, avoid elimination by the host innate or adaptive immune system. Research into viral miRNA function might also suggest new approaches for treating some virally induced diseases.	[Cullen, Bryan R.] Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA; [Cullen, Bryan R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA.	culle002@mc.duke.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071408] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM071408] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Branco FJ, 2005, J VIROL, V79, P9019, DOI 10.1128/JVI.79.14.9019-9025.2005; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Cai XZ, 2006, J VIROL, V80, P2234, DOI 10.1128/JVI.80.5.2234-2242.2006; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; FRASER NW, 1992, VIROLOGY, V191, P1, DOI 10.1016/0042-6822(92)90160-Q; FURNARI FB, 1993, P NATL ACAD SCI USA, V90, P378, DOI 10.1073/pnas.90.2.378; Gitlin L, 2003, J VIROL, V77, P7159, DOI 10.1128/JVI.77.13.7159-7165.2003; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Gwizdek C, 2001, J BIOL CHEM, V276, P25910, DOI 10.1074/jbc.M100493200; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Linial ML, 1999, J VIROL, V73, P1747, DOI 10.1128/JVI.73.3.1747-1755.1999; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Macrae AI, 2001, J VIROL, V75, P5315, DOI 10.1128/JVI.75.11.5315-5327.2001; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Sano M, 2006, FEBS LETT, V580, P1553, DOI 10.1016/j.febslet.2006.01.085; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; THIMMAPPAYA B, 1982, CELL, V31, P543, DOI 10.1016/0092-8674(82)90310-5; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	54	323	348	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38			6			S25	S30		10.1038/ng1793	http://dx.doi.org/10.1038/ng1793			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V44DK	16736021				2022-12-17	WOS:000202983200006
J	Kim, JC; Badano, JL; Sibold, S; Esmail, MA; Hill, J; Hoskins, BE; Leitch, CC; Venner, K; Ansley, SJ; Ross, AJ; Leroux, MR; Katsanis, N; Beales, PL				Kim, JC; Badano, JL; Sibold, S; Esmail, MA; Hill, J; Hoskins, BE; Leitch, CC; Venner, K; Ansley, SJ; Ross, AJ; Leroux, MR; Katsanis, N; Beales, PL			The Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region and is required for microtubule anchoring and cell cycle progression	NATURE GENETICS			English	Article							GAMMA-TUBULIN; CENTROSOME; OBESITY; COMPLEX; GENE; IDENTIFICATION; MUTATIONS; DYNACTIN; BINDS	BBS4 is one of several proteins that cause Bardet-Biedl syndrome (BBS), a multisystemic disorder of genetic and clinical complexity. Here we show that BBS4 localizes to the centriolar satellites of centrosomes and basal bodies of primary cilia, where it functions as an adaptor of the p150(glued) subunit of the dynein transport machinery to recruit PCM1 (pericentriolar material 1 protein) and its associated cargo to the satellites. Silencing of BBS4 induces PCM1 mislocalization and concomitant deanchoring of centrosomal microtubules, arrest in cell division and apoptotic cell death. Expression of two truncated forms of BBS4 that are similar to those found in some individuals with BBS had a similar effect on PCM1 and microtubules. Our findings indicate that defective targeting or anchoring of pericentriolar proteins and microtubule disorganization contribute to the BBS phenotype and provide new insights into possible causes of familial obesity, diabetes and retinal degeneration.	Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21287 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Inst Neurol, Dept Electron Microscopy, London WC1N 3BG, England; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21287 USA	Simon Fraser University; Johns Hopkins University; University of London; University College London; University of London; University College London; Johns Hopkins University; Johns Hopkins Medicine	Leroux, MR (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	leroux@sfu.ca; katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012; Beales, Philip L/C-7367-2009	Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652				Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Balczon R, 1999, CELL MOTIL CYTOSKEL, V42, P60, DOI 10.1002/(SICI)1097-0169(1999)42:1<60::AID-CM6>3.3.CO;2-Z; BALCZON R, 1994, J CELL BIOL, V124, P783, DOI 10.1083/jcb.124.5.783; Beales PL, 1999, J MED GENET, V36, P437; Beisson J, 2003, CURR OPIN CELL BIOL, V15, P96, DOI 10.1016/S0955-0674(02)00017-0; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Moudjou M, 1996, J CELL SCI, V109, P875; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Ou YY, 2003, CELL MOTIL CYTOSKEL, V55, P125, DOI 10.1002/cm.10115; Rattner J. B., 1992, P45; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zimmerman W, 2000, TRAFFIC, V1, P927, DOI 10.1034/j.1600-0854.2000.011202.x; Zimmerman W, 1999, CURR OPIN CELL BIOL, V11, P122, DOI 10.1016/S0955-0674(99)80015-5	29	323	331	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2004	36	5					462	470		10.1038/ng1352	http://dx.doi.org/10.1038/ng1352			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	817NA	15107855	Bronze			2022-12-17	WOS:000221183000017
J	Santoro, R; Li, JW; Grummt, I				Santoro, R; Li, JW; Grummt, I			The nucleolar remodeling complex NoRC mediates heterochromatin formation and silencing of ribosomal gene transcription	NATURE GENETICS			English	Article							POLYMERASE I TRANSCRIPTION; HISTONE METHYLATION; DNA METHYLATION; CHROMATIN; ISWI; TEMPLATES; SUBUNIT; HDAC1; FORM	Epigenetic control mechanisms silence about half of the ribosomal RNA (rRNA) genes in metabolically active cells. In exploring the mechanism by which the active or silent state of rRNA genes is inherited, we found that NoRC, a nucleolar remodeling complex containing Snf2h (also called Smarca5, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin, subfamily a, member 5), represses rDNA transcription. NoRC mediates rDNA silencing by recruiting DNA methyltransferase and histone deacetylase activity to the rDNA promoter, thus establishing structural characteristics of heterochromatin such as DNA methylation, histone hypoacetylation and methylation of the Lys9 residue of histone H3. These results indicate that active and inactive rRNA genes can be demarcated by their associated proteins, and link chromatin remodeling to DNA methylation and specific histone modifications.	German Canc Res Ctr, Div Mol Biol Cell 2, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Grummt, I (corresponding author), German Canc Res Ctr, Div Mol Biol Cell 2, D-69120 Heidelberg, Germany.	I.Grummt@DKFZ-Heidelberg.de	Santoro, Raffaella/L-2637-2013					Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; GOODMARK JP, 2000, CELL, V103, P423; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Langst G, 1997, EMBO J, V16, P760, DOI 10.1093/emboj/16.4.760; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Varga-Weisz P, 2001, ONCOGENE, V20, P3076, DOI 10.1038/sj.onc.1204332; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	26	323	332	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					393	396		10.1038/ng1010	http://dx.doi.org/10.1038/ng1010			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12368916				2022-12-17	WOS:000179034800014
J	Lindblad-Toh, K; Winchester, E; Daly, MJ; Wang, DG; Hirschhorn, JN; Laviolette, JP; Ardlie, K; Reich, DE; Robinson, E; Sklar, P; Shah, N; Thomas, D; Fan, JB; Gingeras, T; Warrington, J; Patil, N; Hudson, TJ; Lander, ES				Lindblad-Toh, K; Winchester, E; Daly, MJ; Wang, DG; Hirschhorn, JN; Laviolette, JP; Ardlie, K; Reich, DE; Robinson, E; Sklar, P; Shah, N; Thomas, D; Fan, JB; Gingeras, T; Warrington, J; Patil, N; Hudson, TJ; Lander, ES			Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse	NATURE GENETICS			English	Article							GENOME	Single-nucleotide polymorphisms (SNPs) have been the focus of much attention in human genetics because they are extremely abundant and well-suited for automated large-scale genotyping, Human SNPs, however, are less informative than other types of genetic markers (such as simple-sequence length polymorphisms or microsatellites) and thus more loci are required for mapping traits. SNPs offer similar advantages for experimental genetic organisms such as the mouse, but they entail no loss of informativeness because bi-allelic markers are fully informative in analysing crosses between inbred strains. Here we report a large-scale analysis of SNPs in the mouse genome. We characterized the rate of nucleotide polymorphism in eight mouse strains and identified a collection of 2,848 SNPs located in 1,755 sequence-tagged sites (STSs) using high-density oligonucleotide arrays. Three-quarters of these SNPs have been mapped on the mouse genome, providing a first-generation SNP map of the mouse. We have also developed a multiplex genotyping procedure by which a genome scan can be performed with only six genotyping reactions per animal.	MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02139 USA; Bristol Myers Squibb, Princeton, NJ USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; Affymetrix Inc, Santa Clara, CA USA; McGill Univ, Ctr Hlth, Montreal Genome Ctr, Montreal, PQ H3A 2T5, Canada; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Bristol-Myers Squibb; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Affymetrix; McGill University; Massachusetts Institute of Technology (MIT)	Lindblad-Toh, K (corresponding author), MIT, Whitehead Inst Biomed Res, Ctr Genome Res, Cambridge, MA 02139 USA.		Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Gingeras, Thomas/0000-0001-9106-3573	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001806] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG01806] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ATCHLEY WR, 1993, MOL BIOL EVOL, V10, P1150; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; FERRIS SD, 1983, GENETICS, V105, P681; Nusbaum C, 1999, NAT GENET, V22, P388, DOI 10.1038/11967; SAGE RD, 1981, MOUSE BIOMEDICAL RES, P40; Syvanen AC, 1999, HUM MUTAT, V13, P1; Van Etten WJ, 1999, NAT GENET, V22, P384, DOI 10.1038/11962; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	11	323	360	0	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2000	24	4					381	386		10.1038/74215	http://dx.doi.org/10.1038/74215			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	299HK	10742102				2022-12-17	WOS:000086192800017
J	NOAKES, PG; MINER, JH; GAUTAM, M; CUNNINGHAM, JM; SANES, JR; MERLIE, JP				NOAKES, PG; MINER, JH; GAUTAM, M; CUNNINGHAM, JM; SANES, JR; MERLIE, JP			THE RENAL GLOMERULUS OF MICE LACKING S-LAMININ LAMININ BETA-2 - NEPHROSIS DESPITE MOLECULAR COMPENSATION BY LAMININ BETA-1	NATURE GENETICS			English	Article							BASEMENT-MEMBRANE; ALPORT SYNDROME; IV COLLAGEN; NEUROMUSCULAR-JUNCTION; MONOCLONAL-ANTIBODIES; SYNAPTIC CLEFT; KIDNEY; GENE; IDENTIFICATION; PATHOGENESIS	S-laminin/laminin beta 2, a homologue of the widely distributed laminin B1/beta 1 chain, is a major component of adult renal glomerular basement membrane (GEM). Immature GEM bears beta 1, which is replaced by beta 2 as development proceeds. In mutant mice that lack beta 2, the GEM remains rich in beta 1, suggesting that a feedback mechanism normally regulates GEM maturation. The beta 2-deficient GEM is structurally intact and contains normal complements of several collagenous acid noncollagenous glycoproteins. However, mutant mice develop massive proteinuria due to failure of the glomerular filtration barrier. These results support the idea that laminin beta chains are functionally distinct although they assemble to form similar structures. Laminin beta 2-deficient mice may provide a model for human congenital or idiopathic nephrotic syndromes.	WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)			Noakes, Peter/X-9825-2019	Noakes, Peter/0000-0001-9821-8478; Gautam, Medha/0000-0002-5418-4322				ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; ABRAHAMSON DR, 1992, J HISTOCHEM CYTOCHEM, V40, P1943, DOI 10.1177/40.12.1280666; ABRAHAMSON DR, 1989, J CELL BIOL, V109, P3477, DOI 10.1083/jcb.109.6.3477; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BENDER BL, 1981, AM J PATHOL, V103, P419; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; CARLSON JA, 1993, DISEASES KIDNEY, P383; COUSER WG, 1993, KIDNEY INT, V44, pS19; DANIELS BS, 1994, J LAB CLIN MED, V124, P224; DESJARDINS M, 1991, J CELL BIOL, V113, P689, DOI 10.1083/jcb.113.3.689; EDDY A, 1992, PEDIATRIC KIDNEY DIS, P329; EKBLOM P, 1992, KIDNEY PHYSL PATHOPH, P475; FALKON JR, 1994, TRENDS NEUROSCI, V17, P469; FRENK S, 1955, P SOC EXP BIOL MED, V89, P424; GREEN TL, 1992, J BIOL CHEM, V267, P2014; HONG X, 1994, NAT GENET, V8, P297; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUDSON BG, 1992, KIDNEY INT, V42, P179, DOI 10.1038/ki.1992.276; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; KASHTAN CE, 1992, KIDNEY INT, V42, P115, DOI 10.1038/ki.1992.269; Kashtan CE, 1994, RENAL PATHOLOGY, P1239; KATO M, 1988, J CELL BIOL, V106, P2203, DOI 10.1083/jcb.106.6.2203; KATZ A, 1991, KIDNEY INT, V40, P643, DOI 10.1038/ki.1991.256; KESTILA M, 1994, AM J HUM GENET, V54, P757; KLEPPEL MM, 1989, LAB INVEST, V61, P278; MARTIN PT, IN PRESS SCIENCE; MCCLUSKEY RT, 1992, PATHOLOGY KIDNEY, P169; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; NASH MA, 1992, PEDIAT KIDNEY DIS, P1247; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; OGURA A, 1994, NEPHRON, V68, P239, DOI 10.1159/000188264; OLSON JL, 1992, PATHOLOGY KIDNEY, P779; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; REEVES WH, 1980, J CELL BIOL, V85, P735, DOI 10.1083/jcb.85.3.735; Rohrbach DH, 1993, MOL CELLULAR ASPECTS; SANES JR, 1982, J CELL BIOL, V93, P442, DOI 10.1083/jcb.93.2.442; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SARIOLA H, 1984, DEV BIOL, V101, P86, DOI 10.1016/0012-1606(84)90119-2; SCHARER K, 1992, PEDIATRIC KIDNEY DIS, P593; Schnaper HW, 1993, DIS KIDNEY, P1731; SOROKIN L, 1992, KIDNEY INT, V41, P657, DOI 10.1038/ki.1992.101; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9; TIMPL R, 1993, EXPERIENTIA, V49, P417, DOI 10.1007/BF01923586; Vehaskari VM, 1992, PEDIAT KIDNEY DIS, P531; WEWER UM, 1994, GENOMICS, V24, P243, DOI 10.1006/geno.1994.1612; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449	51	323	332	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					400	406		10.1038/ng0895-400	http://dx.doi.org/10.1038/ng0895-400			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670489				2022-12-17	WOS:A1995RM37500012
J	KEMP, CJ; WHELDON, T; BALMAIN, A				KEMP, CJ; WHELDON, T; BALMAIN, A			P53-DEFICIENT MICE ARE EXTREMELY SUSCEPTIBLE TO RADIATION-INDUCED TUMORIGENESIS	NATURE GENETICS			English	Article							WILD-TYPE P53; CHROMOSOMAL INSTABILITY; IONIZING-RADIATION; SKIN TUMORS; DNA-DAMAGE; CANCER; APOPTOSIS; GENE; TRANSMISSION; DEFICIENT	Mice constitutively lacking alleles of the p53 tumour suppressor gene spontaneously develop lymphomas and sarcomas. We report here that a single dose of 4 Gy radiation dramatically decreases the latency for tumour development in p53 heterozygous mice. The pattern of genetic alterations at the remaining wild type allele in these tumours differs substantially from spontaneous tumours from similar mice indicating that p53 itself may have been a target for radiation-induced alterations. Lower dose irradiation (1 Gy) of preweanling p53 null mice also significantly decreases tumour latency, suggesting that there are additional genetic targets involved in radiation-induced malignancy. Thus p53-deficient mice provide a sensitive model system for studies of the consequences of radiation exposure.	BEATSON INST CANC RES,CRC,BEATSON LABS,GLASGOW G61 1BD,SCOTLAND; DEPT MED ONCOL,GLASGOW G61 1BD,LANARK,SCOTLAND; DEPT RADIAT ONCOL & CLIN PHYS,GLASGOW G61 1BD,LANARK,SCOTLAND	Beatson Institute								BREIMER LH, 1988, BRIT J CANCER, V57, P6, DOI 10.1038/bjc.1988.2; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, ONCOGENE, V8, P2457; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; KADHIM MA, 1992, NATURE, V355, P738, DOI 10.1038/355738a0; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; KEMP CJ, 1993, CANCER RES, V53, P6022; KENNEDY AR, 1980, P NATL ACAD SCI-BIOL, V77, P7262, DOI 10.1073/pnas.77.12.7262; KEURBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; LI FP, 1988, CANCER RES, V48, P5358; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARDER BA, 1993, MOL CELL BIOL, V13, P6667, DOI 10.1128/MCB.13.11.6667; MERRITT AJ, 1994, CANCER RES, V54, P614; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; PURDIE CA, 1994, ONCOGENE, V9, P603; SEARLE AG, 1989, LOW DOSE RAD BIOL BA, P123; SLICHENMYER WJ, 1993, CANCER RES, V53, P4164; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; WISEMAN RW, 1994, P NATL ACAD SCI USA, V91, P3759, DOI 10.1073/pnas.91.9.3759; YI CH, 1992, MOL CARCINOG, V5, P270; 1988, UNSCEAR UN SCI COMMI	28	323	331	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					66	69		10.1038/ng0994-66	http://dx.doi.org/10.1038/ng0994-66			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987394				2022-12-17	WOS:A1994PE15700017
J	TAKIYAMA, Y; NISHIZAWA, M; TANAKA, H; KAWASHIMA, S; SAKAMOTO, H; KARUBE, Y; SHIMAZAKI, H; SOUTOME, M; ENDO, K; OHTA, S; KAGAWA, Y; KANAZAWA, I; MIZUNO, Y; YOSHIDA, M; YUASA, T; HORIKAWA, Y; OYANAGI, K; NAGAI, H; KONDO, T; INUZUKA, T; ONODERA, O; TSUJI, S				TAKIYAMA, Y; NISHIZAWA, M; TANAKA, H; KAWASHIMA, S; SAKAMOTO, H; KARUBE, Y; SHIMAZAKI, H; SOUTOME, M; ENDO, K; OHTA, S; KAGAWA, Y; KANAZAWA, I; MIZUNO, Y; YOSHIDA, M; YUASA, T; HORIKAWA, Y; OYANAGI, K; NAGAI, H; KONDO, T; INUZUKA, T; ONODERA, O; TSUJI, S			THE GENE FOR MACHADO-JOSEPH DISEASE MAPS TO HUMAN CHROMOSOME-14Q	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; NON-PORTUGUESE FAMILY; SPINOCEREBELLAR ATAXIA; HEREDITARY ATAXIA; LINKAGE ANALYSIS; AZOREAN DISEASE; JAPANESE FAMILY; LOCUS; DEGENERATION; KINDREDS	Machado-Joseph disease (MJD) is an autosomal dominant, multisystem neurodegenerative disorder involving predominantly cerebellar, pyramidal, extrapyramidal, motor neuron and oculomotor systems. Although it was first reported in families of Portuguese-Azorean descent, MJD has also been described in non-Azorean families from various countries, being one of the most common hereditary spinocerebellar degenerations. With the use of highly polymorphic microsatellite DNA polymorphisms, we have assigned the gene for MJD to the long arm of chromosome 14 (14q24.3-q32) by genetic linkage to microsatellite loci D14S55 and D14S48 (multipoint lod score Z(max) = 9.719).	JICHI MED SCH,DEPT NEUROL,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; JICHI MED SCH,DEPT BIOCHEM,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; JUNTENDO UNIV,FAC MED,DEPT NEUROL,TOKYO 113,JAPAN; NIIGATA UNIV,DEPT NEUROL,NIIGATA 951,JAPAN; NIIGATA UNIV,CTR MAT BRAIN DIS,NIIGATA 951,JAPAN; UNIV TOKYO,INST BRAIN RES,DEPT NEUROL,TOKYO 113,JAPAN; TOKYO MED & DENT UNIV,FAC MED,DEPT NEUROL,TOKYO 113,JAPAN; SHINRAKUEN HOSP,DEPT NEUROL,NIIGATA 95021,JAPAN; SUIBARAGO HOSP,DEPT NEUROL,NIIGATA 95921,JAPAN; AGANO HOSP,DEPT NEUROL,YASUDA,NIIGATA 95922,JAPAN	Jichi Medical University; Jichi Medical University; Juntendo University; Niigata University; Niigata University; University of Tokyo; Tokyo Medical & Dental University (TMDU)			Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472; Shimazaki, Haruo/0000-0003-0628-7164				BARBEAU A, 1984, CAN J NEUROL SCI, V11, P510, DOI 10.1017/S0317167100034983; BHARUCHA NE, 1986, ARCH NEUROL-CHICAGO, V43, P142, DOI 10.1001/archneur.1986.00520020036014; BOWDEN DW, 1989, AM J HUM GENET, V44, P671; CARSON WJ, 1992, GENOMICS, V13, P852, DOI 10.1016/0888-7543(92)90168-R; FORSE RA, 1989, J NEUROGENET, V5, P155, DOI 10.3109/01677068909066204; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; HEALTON EB, 1980, NEUROLOGY, V30, P1084, DOI 10.1212/WNL.30.10.1084; HIRAYAM K, 1991, ANN REPORT RES COMMI, P29; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; JORDAN SA, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171; KITAMURA J, 1989, ARCH NEUROL-CHICAGO, V46, P425, DOI 10.1001/archneur.1989.00520400085024; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LIMA L, 1980, NEUROLOGY, V30, P319, DOI 10.1212/WNL.30.3.319; LUTY JA, 1991, NUCLEIC ACIDS RES, V19, P4308, DOI 10.1093/nar/19.15.4308; Maniatis T, 1989, DECONTAMINATION DILU; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; MYERS SM, 1986, CYTOGENET CELL GENET, V43, P226, DOI 10.1159/000132328; NAKANO KK, 1972, NEUROLOGY, V22, P49, DOI 10.1212/WNL.22.1.49; OTT J, 1991, ANAL HUMAN GENETIC L, P74; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RISCH N, 1991, AM J HUM GENET, V48, P1058; ROMANUL FCA, 1977, NEW ENGL J MED, V296, P1505, DOI 10.1056/NEJM197706302962606; ROSENBERG RN, 1976, NEUROLOGY, V26, P703, DOI 10.1212/WNL.26.8.703; ROSENBERG RN, 1992, MOVEMENT DISORD, V3, P193; SAKAI T, 1983, NEUROLOGY, V33, P74, DOI 10.1212/WNL.33.1.74; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; STEGEORGEHYSLOP P, 1992, NAT GENET, V2, P330; SUITE NDA, 1986, J NEUROGENET, V3, P177, DOI 10.3109/01677068609106847; TAKIYAMA Y, 1989, ACTA NEUROL SCAND, V79, P214, DOI 10.1111/j.1600-0404.1989.tb03741.x; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4638, DOI 10.1093/nar/18.15.4638-a; WEBER JL, 1989, AM J HUM GENET, V44, P388; WOODS BT, 1972, J NEUROL SCI, V17, P149, DOI 10.1016/0022-510X(72)90137-2; YAKURA H, 1974, NEW ENGL J MED, V291, P154; YUASA T, 1986, ANN NEUROL, V19, P152, DOI 10.1002/ana.410190207; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23; 1992, SCIENC E, V258, P67	39	323	329	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					300	304		10.1038/ng0793-300	http://dx.doi.org/10.1038/ng0793-300			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358439				2022-12-17	WOS:A1993LJ84200020
J	Pansuriya, TC; van Eijk, R; d'Adamo, P; van Ruler, MAJH; Kuijjer, ML; Oosting, J; Cleton-Jansen, AM; van Oosterwijk, JG; Verbeke, SLJ; Meijer, D; van Wezel, T; Nord, KH; Sangiorgi, L; Toker, B; Liegl-Atzwanger, B; San-Julian, M; Sciot, R; Limaye, N; Kindblom, LG; Daugaard, S; Godfraind, C; Boon, LM; Vikkula, M; Kurek, KC; Szuhai, K; French, PJ; Bovee, JVMG				Pansuriya, Twinkal C.; van Eijk, Ronald; d'Adamo, Pio; van Ruler, Maayke A. J. H.; Kuijjer, Marieke L.; Oosting, Jan; Cleton-Jansen, Anne-Marie; van Oosterwijk, Jolieke G.; Verbeke, Sofie L. J.; Meijer, Danielle; van Wezel, Tom; Nord, Karolin H.; Sangiorgi, Luca; Toker, Berkin; Liegl-Atzwanger, Bernadette; San-Julian, Mikel; Sciot, Raf; Limaye, Nisha; Kindblom, Lars-Gunnar; Daugaard, Soeren; Godfraind, Catherine; Boon, Laurence M.; Vikkula, Miikka; Kurek, Kyle C.; Szuhai, Karoly; French, Pim J.; Bovee, Judith V. M. G.			Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome	NATURE GENETICS			English	Article							GENOME-WIDE ANALYSIS; ACTIVATING MUTATIONS; OSTERIX EXPRESSION; FIBROUS DYSPLASIA; IN-VITRO; CHONDROSARCOMA; LINE; DLX5; DIFFERENTIATION; ESTABLISHMENT	Ollier disease and Maffucci syndrome are non-hereditary skeletal disorders characterized by multiple enchondromas (Ollier disease) combined with spindle cell hemangiomas (Maffucci syndrome). We report somatic heterozygous mutations in IDH1 (c.394C>T encoding an R132C substitution and c.395G>A encoding an R132H substitution) or IDH2 (c.516G>C encoding R172S) in 87% of enchondromas (benign cartilage tumors) and in 70% of spindle cell hemangiomas (benign vascular lesions). In total, 35 of 43 (81%) subjects with Ollier disease and 10 of 13 (77%) with Maffucci syndrome carried IDH1 (98%) or IDH2 (2%) mutations in their tumors. Fourteen of 16 subjects had identical mutations in separate lesions. Immunohistochemistry to detect mutant IDH1 R132H protein suggested intraneoplastic and somatic mosaicism. IDH1 mutations in cartilage tumors were associated with hypermethylation and downregulated expression of several genes. Mutations were also found in 40% of solitary central cartilaginous tumors and in four chondrosarcoma cell lines, which will enable functional studies to assess the role of IDH1 and IDH2 mutations in tumor formation.	[Pansuriya, Twinkal C.; van Eijk, Ronald; van Ruler, Maayke A. J. H.; Kuijjer, Marieke L.; Oosting, Jan; Cleton-Jansen, Anne-Marie; van Oosterwijk, Jolieke G.; Verbeke, Sofie L. J.; Meijer, Danielle; van Wezel, Tom; Bovee, Judith V. M. G.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [d'Adamo, Pio] Univ Trieste, Inst Maternal & Child Hlth, Inst Ricovero & Cura Carattere Sci, Trieste, Italy; [Verbeke, Sofie L. J.] Univ Antwerp Hosp, Dept Pathol, Antwerp, Belgium; [Nord, Karolin H.] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; [Sangiorgi, Luca] Rizzoli Orthoped Inst, Dept Med Genet, Bologna, Italy; [Toker, Berkin] Istanbul Univ, Sch Med, Istanbul, Turkey; [Liegl-Atzwanger, Bernadette] Med Univ, Inst Pathol, Graz, Austria; [San-Julian, Mikel] Univ Navarra Clin, Dept Orthopaed Surg & Traumatol, Pamplona, Spain; [Sciot, Raf; Boon, Laurence M.; Vikkula, Miikka] Katholieke Univ Leuven, Dept Pathol, Louvain, Belgium; [Limaye, Nisha] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Kindblom, Lars-Gunnar] Royal Orthopaed Hosp, Dept Musculoskeletal Pathol, Birmingham B31 2AP, W Midlands, England; [Daugaard, Soeren] Univ Copenhagen, Dept Pathol, Copenhagen, Denmark; [Godfraind, Catherine] Catholic Univ Louvain, Pathol Lab, Clin Univ St Luc, B-1200 Brussels, Belgium; [Boon, Laurence M.] Catholic Univ Louvain, Div Plast Surg, Clin Univ St Luc, Ctr Vasc Anomalies, B-1200 Brussels, Belgium; [Kurek, Kyle C.] Harvard Univ, Sch Med, Dept Pathol, Childrens Hosp Boston, Boston, MA 02115 USA; [Szuhai, Karoly] Leiden Univ, Dept Mol & Cell Biol, Med Ctr, Leiden, Netherlands; [French, Pim J.] Erasmus Univ, Dept Neurol, Med Ctr, Rotterdam, Netherlands; [Vikkula, Miikka] Catholic Univ Louvain, Walloon Excellence Lifesci & Biotechnol WELBIO, B-1200 Brussels, Belgium	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Trieste; University of Antwerp; Lund University; Skane University Hospital; IRCCS Istituto Ortopedico Rizzoli; Istanbul University; Medical University of Graz; University of Navarra; KU Leuven; Universite Catholique Louvain; Royal Orthopaedic Hospital; University of Copenhagen; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Harvard University; Boston Children's Hospital; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Universite Catholique Louvain; WELBIO	Bovee, JVMG (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	J.V.M.G.Bovee@lumc.nl	van Wezel, Tom/Z-3092-2019; kuijjer, marieke/AAG-5844-2019; van Wezel, Tom/AAL-5626-2021; Boon, Laurence/HCI-3629-2022; Szuhai, Karoly/A-1100-2008; Sangiorgi, Luca/AHI-1694-2022; Meijer, Danielle/AFL-5078-2022; van Wezel, Tom/A-9599-2008; d'Adamo, Adamo Pio/G-4064-2011; Vikkula, Miikka/Q-1038-2018	van Wezel, Tom/0000-0001-5773-7730; kuijjer, marieke/0000-0001-6280-3130; Szuhai, Karoly/0000-0002-1228-4245; van Wezel, Tom/0000-0001-5773-7730; d'Adamo, Adamo Pio/0000-0001-9367-4909; Vikkula, Miikka/0000-0002-6236-338X; Bovee, Judith/0000-0003-1155-0481; van Eijk, Ronald/0000-0001-7955-6295; Hansen Nord, Karolin/0000-0002-2397-2254; Sangiorgi, Luca/0000-0003-3658-1209; van Oosterwijk, Jolieke/0000-0003-2282-6121; French, Pim/0000-0002-0668-9529; sciot, raf/0000-0003-2244-5839	Netherlands Organization for Scientific Research [917-76-315]; Liddy Shriver Sarcoma Initiative; Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, network [6/05]; US National Institutes of Health [AR048564]; FNRS-Fonds de la Recherche Scientifique; Manton Center for Orphan Disease Research at Children's Hospital Boston [94824-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048564] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Liddy Shriver Sarcoma Initiative; Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, network(Belgian Federal Science Policy Office); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FNRS-Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Manton Center for Orphan Disease Research at Children's Hospital Boston; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to all of the participants and their families for taking part in this study. We would like to thank S. Romeo and C.M.A. Reijnders for providing DNA from cartilage tumors. We are grateful to A.B. Mohseny for help with statistics, to D. van der Geest and T. Krenacs for constructing TMAs and to P. Wijers-Koster, D. de Jong, B. van den Akker, R. Duim, M. Winter, I.H. Briaire-de Bruijn and M.E. Bowen for expert technical assistance. C.J.F. Waaijer, P.C.W. Hogendoorn and C.E. de Andrea are acknowledged for fruitful discussion. We would like to acknowledge F. Bertoni, E.L. Staals and P. Bacchini for kindly providing peripheral dedifferentiated chondrosarcomas and vascular tumors, T. Kalinski for the C3842 cell line, M. Namba for the OUMS27 cell line, T. Ariizumi for the NDCS1 cell line and A. Llombart Bosch for the CH2879 cell line. J. Mulliken, J. Upton and S. Fishman kindly provided spindle cell hemangiomas. S.H.M. Verdegaal, A.H.M. Taminiau and M.A.J. van de Sande are acknowledged for contributing patient data. We are thankful to S. Boeuf, R. Forsyth and P.P. Mainil-Varlet for providing single Ollier disease cases and to W. Wutys for providing a single metachondromatosis case. The continuous support of the Netherlands Committee on Bone Tumors is highly acknowledged. The study was funded by The Netherlands Organization for Scientific Research (917-76-315 to J.V.M.G.B. and T.C.P.), the Liddy Shriver Sarcoma Initiative (to J.V.M.G.B. and J.O.), the Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, network 6/05, the US National Institutes of Health (AR048564) and the FNRS-Fonds de la Recherche Scientifique (all to M.V.) and the Manton Center for Orphan Disease Research at Children's Hospital Boston (94824-01 to K.K.). The study was performed within the EuroBoNeT, a European Commission-granted Network of Excellence for studying the pathology and genetics of bone tumors (018814).	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361; Bovee JVMG, 2010, P NATL ACAD SCI USA, V107, P1813, DOI 10.1073/pnas.0914431107; Bowen ME, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002050; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Buddingh EP, 2011, CLIN CANCER RES, V17, P2110, DOI 10.1158/1078-0432.CCR-10-2047; Chin HJ, 2007, DEV GROWTH DIFFER, V49, P515, DOI 10.1111/j.1440-169x.2007.00940.x; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Cohen MM, 2001, AM J MED GENET, V98, P290, DOI 10.1002/1096-8628(20010201)98:4<290::AID-AJMG1112>3.0.CO;2-F; Collinson M, 2010, AM J MED GENET A, V152A, P3124, DOI 10.1002/ajmg.a.33567; Couvineau A, 2008, HUM MOL GENET, V17, P2766, DOI 10.1093/hmg/ddn176; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de Andrea C.E., 2011, ONCOGENE        0801, DOI [10.1038/onc.2011.311, DOI 10.1038/ONC.2011.311]; de Andrea CE, 2011, J PATHOL, V224, P160, DOI 10.1002/path.2886; EVANS HL, 1977, CANCER-AM CANCER SOC, V40, P818, DOI 10.1002/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gaal J, 2010, J CLIN ENDOCR METAB, V95, P1274, DOI 10.1210/jc.2009-2170; Gil-Benso R, 2003, LAB INVEST, V83, P877, DOI 10.1097/01.LAB.0000073131.34648.EA; Hallor KH, 2009, CLIN CANCER RES, V15, P2685, DOI 10.1158/1078-0432.CCR-08-2330; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hemerly JP, 2010, EUR J ENDOCRINOL, V163, P747, DOI 10.1530/EJE-10-0473; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Ikota H, 2011, BRAIN TUMOR PATHOL, V28, P107, DOI 10.1007/s10014-010-0016-y; Jones KB, 2010, P NATL ACAD SCI USA, V107, P2054, DOI 10.1073/pnas.0910875107; Kalfa N, 2006, J CLIN ENDOCR METAB, V91, P1842, DOI 10.1210/jc.2005-2710; Kalinski T, 2005, VIRCHOWS ARCH, V446, P287, DOI 10.1007/s00428-004-1194-y; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Kudo N, 2007, VIRCHOWS ARCH, V451, P691, DOI 10.1007/s00428-007-0426-3; Kunisada T, 1998, INT J CANCER, V77, P854, DOI 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Leyva-Carmona M, 2009, J PEDIAT HEMATOL ONC, V31, P304, DOI 10.1097/MPH.0b013e318196a70e; Lietman SA, 2005, J BONE JOINT SURG AM, V87A, P2489, DOI 10.2106/JBJS.E.00160; LUCAS DR, 2002, WHO CLASSIFICATION T, P237; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Meijer D, 2011, CLIN SARCOMA RES, V1, DOI 10.1186/2045-3329-1-5; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pansuriya TC, 2011, GENE CHROMOSOME CANC, V50, P673, DOI 10.1002/gcc.20889; Pansuriya TC, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-2; Pansuriya TC, 2010, INT J CLIN EXP PATHO, V3, P557; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Ranger A, 2009, NEUROSURGERY, V65, P1106, DOI 10.1227/01.NEU.0000356984.92242.D5; Reijnders CMA, 2010, AM J PATHOL, V177, P1946, DOI 10.2353/ajpath.2010.100296; Rietveld L, 2009, INT J GYNECOL PATHOL, V28, P464, DOI 10.1097/PGP.0b013e3181a05af4; Rozeman LB, 2004, HUM MUTAT, V24, P466, DOI 10.1002/humu.20095; Rozeman LB, 2009, MODERN PATHOL, V22, P1489, DOI 10.1038/modpathol.2009.120; SCHWARTZ HS, 1987, J BONE JOINT SURG AM, V69A, P269, DOI 10.2106/00004623-198769020-00016; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; SPRANGER J, 1978, PEDIATR RADIOL, V7, P215, DOI 10.1007/BF02386711; Szuhai K, 2011, HUM MUTAT, V32, pE2036, DOI 10.1002/humu.21423; Thomas DM, 2011, J PATHOL, V224, P306, DOI 10.1002/path.2928; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Verbeke SLJ, 2011, HISTOPATHOLOGY, V58, P254, DOI 10.1111/j.1365-2559.2011.03750.x; Verdegaal S.H.M., 1961, ONCOLOGIST IN PRESS; Wolff JN, 2008, BIOTECHNIQUES, V44, P193, DOI 10.2144/000112719; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Zhu H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008097	64	322	347	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2011	43	12					1256	U124		10.1038/ng.1004	http://dx.doi.org/10.1038/ng.1004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22057234	Green Accepted, Green Submitted			2022-12-17	WOS:000297931400023
J	Blow, MJ; McCulley, DJ; Li, ZR; Zhang, T; Akiyama, JA; Holt, A; Plajzer-Frick, I; Shoukry, M; Wright, C; Chen, F; Afzal, V; Bristow, J; Ren, B; Black, BL; Rubin, EM; Visel, A; Pennacchio, LA				Blow, Matthew J.; McCulley, David J.; Li, Zirong; Zhang, Tao; Akiyama, Jennifer A.; Holt, Amy; Plajzer-Frick, Ingrid; Shoukry, Malak; Wright, Crystal; Chen, Feng; Afzal, Veena; Bristow, James; Ren, Bing; Black, Brian L.; Rubin, Edward M.; Visel, Axel; Pennacchio, Len A.			ChIP-Seq identification of weakly conserved heart enhancers	NATURE GENETICS			English	Article							REGULATORY ELEMENTS; GENOME; DATABASE; MECHANISMS; VERTEBRATE; CONSTRAINT; PROMOTERS; EVOLUTION; SEQUENCES; 1-PERCENT	Accurate control of tissue-specific gene expression plays a pivotal role in heart development, but few cardiac transcriptional enhancers have thus far been identified. Extreme noncoding-sequence conservation has successfully predicted enhancers that are active in many tissues but has failed to identify substantial numbers of heart-specific enhancers. Here, we used ChIP-Seq with the enhancer-associated protein p300 from mouse embryonic day 11.5 heart tissue to identify over 3,000 candidate heart enhancers genome wide. Compared to enhancers active in other tissues we studied at this time point, most candidate heart enhancers were less deeply conserved in vertebrate evolution. Nevertheless, transgenic mouse assays of 130 candidate regions revealed that most function reproducibly as enhancers active in the heart, irrespective of their degree of evolutionary constraint. These results provide evidence for a large population of poorly conserved heart enhancers and suggest that the evolutionary conservation of embryonic enhancers can vary depending on tissue type.	[Blow, Matthew J.; Akiyama, Jennifer A.; Holt, Amy; Plajzer-Frick, Ingrid; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; Visel, Axel; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Blow, Matthew J.; Zhang, Tao; Wright, Crystal; Chen, Feng; Bristow, James; Rubin, Edward M.; Visel, Axel; Pennacchio, Len A.] Energy Joint Genome Inst, US Dept, Walnut Creek, CA USA; [McCulley, David J.; Black, Brian L.] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; [McCulley, David J.; Black, Brian L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Li, Zirong; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint Genome Institute - JGI; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Visel, A (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA.	avisel@lbl.gov; lapennacchio@lbl.gov	Blow, Matthew/G-6369-2012; Visel, Axel/A-9398-2009	Blow, Matthew/0000-0002-8844-9149; Visel, Axel/0000-0002-4130-7784; Black, Brian/0000-0002-6664-8913; Pennacchio, Len/0000-0002-8748-3732	National Heart, Lung, and Blood Institute [HL066681, HL64658, HL89707]; National Human Genome Research Institute [HG003988]; Ludwig Institute for Cancer Research; Department of Energy, University of California [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089707, U01HL066681, R01HL064658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019118] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Ludwig Institute for Cancer Research; Department of Energy, University of California(United States Department of Energy (DOE)University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors wish to thank R. Hosseini and S. Phouanenavong for technical support. L. A. P. and E. M. R. were supported by grant HL066681, Berkeley Program for Genomic Applications, which is funded by the National Heart, Lung, and Blood Institute. L. A. P. was also supported by grant HG003988, which is funded by the National Human Genome Research Institute. B. L. B was supported by grants HL64658 and HL89707 from the National Heart, Lung, and Blood Institute. B. R. is supported by funding from the National Human Genome Research Institute and the Ludwig Institute for Cancer Research. Research was conducted at the E.O. Lawrence Berkeley National Laboratory and was performed under the Department of Energy Contract DE-AC02-05CH11231, University of California.	APARICIO S, 1995, P NATL ACAD SCI USA, V92, P1684, DOI 10.1073/pnas.92.5.1684; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808; Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng Y, 2008, GENOME RES, V18, P1896, DOI 10.1101/gr.083089.108; Cooper GM, 2008, GENOME RES, V18, P201, DOI 10.1101/gr.7205808; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; King DC, 2007, GENOME RES, V17, P775, DOI 10.1101/gr.5592107; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Narlikar L, 2010, GENOME RES, V20, P381, DOI 10.1101/gr.098657.109; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; SCHINKE M, 2009, GENOMICS CARDIOVASCU; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Valouev A, 2008, NAT METHODS, V5, P829, DOI [10.1038/nmeth.1246, 10.1038/NMETH.1246]; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	45	322	335	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					806	U107		10.1038/ng.650	http://dx.doi.org/10.1038/ng.650			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20729851	Green Submitted, Green Accepted			2022-12-17	WOS:000281388400020
J	Yan, JB; Kandianis, CB; Harjes, CE; Bai, L; Kim, EH; Yang, XH; Skinner, DJ; Fu, ZY; Mitchell, S; Li, Q; Fernandez, MGS; Zaharieva, M; Babu, R; Fu, Y; Palacios, N; Li, JS; DellaPenna, D; Brutnell, T; Buckler, ES; Warburton, ML; Rocheford, T				Yan, Jianbing; Kandianis, Catherine Bermudez; Harjes, Carlos E.; Bai, Ling; Kim, Eun-Ha; Yang, Xiaohong; Skinner, Debra J.; Fu, Zhiyuan; Mitchell, Sharon; Li, Qing; Fernandez, Maria G. Salas; Zaharieva, Maria; Babu, Raman; Fu, Yang; Palacios, Natalia; Li, Jiansheng; DellaPenna, Dean; Brutnell, Thomas; Buckler, Edward S.; Warburton, Marilyn L.; Rocheford, Torbert			Rare genetic variation at Zea mays crtRB1 increases beta-carotene in maize grain	NATURE GENETICS			English	Article							BIOFORTIFICATION; BIOSYNTHESIS; ARABIDOPSIS; HYDROXYLASE; PROVITAMIN; GERMPLASM; LOCUS; CROPS	Breeding to increase beta-carotene levels in cereal grains, termed provitamin A biofortification, is an economical approach to address dietary vitamin A deficiency in the developing world. Experimental evidence from association and linkage populations in maize (Zea mays L.) demonstrate that the gene encoding beta-carotene hydroxylase 1 (crtRB1) underlies a principal quantitative trait locus associated with beta-carotene concentration and conversion in maize kernels. crtRB1 alleles associated with reduced transcript expression correlate with higher beta-carotene concentrations. Genetic variation at crtRB1 also affects hydroxylation efficiency among encoded allozymes, as observed by resultant carotenoid profiles in recombinant expression assays. The most favorable crtRB1 alleles, rare in frequency and unique to temperate germplasm, are being introgressed via inexpensive PCR marker-assisted selection into tropical maize germplasm adapted to developing countries, where it is most needed for human health.	[Kandianis, Catherine Bermudez; Skinner, Debra J.; Fu, Yang; Rocheford, Torbert] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Yan, Jianbing; Zaharieva, Maria; Babu, Raman; Palacios, Natalia; Warburton, Marilyn L.] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Mexico; [Yan, Jianbing; Yang, Xiaohong; Fu, Zhiyuan; Li, Qing; Fu, Yang; Li, Jiansheng] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Yan, Jianbing; Harjes, Carlos E.; Mitchell, Sharon; Fernandez, Maria G. Salas; Buckler, Edward S.] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Kandianis, Catherine Bermudez; Skinner, Debra J.; Fu, Yang; Rocheford, Torbert] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Bai, Ling; Brutnell, Thomas] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Kim, Eun-Ha; DellaPenna, Dean] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Fernandez, Maria G. Salas] Iowa State Univ, Dept Agron, Ames, IA USA; [Buckler, Edward S.] USDA ARS, Plant Soil & Nutr Res Unit, Ithaca, NY 14853 USA; [Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY USA; [Warburton, Marilyn L.] USDA ARS, Corn Host Plant Resistance Res Unit, Starkville, MS USA; [Harjes, Carlos E.] Monsanto Co, Leesburg, GA USA	University of Illinois System; University of Illinois Urbana-Champaign; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); China Agricultural University; Cornell University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cornell University; Boyce Thompson Institute for Plant Research; Michigan State University; Iowa State University; United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA); Monsanto	Rocheford, T (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	marilyn.warburton@ars.usda.gov; torbert@purdue.edu	Brutnell, Thomas/M-2840-2013; Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022; Pillay, Nischalan/F-9536-2012; Warburton, Marilyn/J-2250-2017	Brutnell, Thomas/0000-0002-3581-8211; Buckler, Edward/0000-0002-3100-371X; palacios rojas, natalia/0000-0002-3072-4611; Skinner, Debra/0000-0003-4715-670X; Warburton, Marilyn/0000-0002-9542-9912	US Agency for International Development; HarvestPlus; National Science Foundation (NSF) [DBI-0321467, DBI-0820619, DBI-0604923, DBI-0501713, 30821140352]; USDA-ARS; TRIAD Foundation; China Scholarship Fund; JBT Fellowship-UIUC	US Agency for International Development(United States Agency for International Development (USAID)); HarvestPlus; National Science Foundation (NSF)(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); TRIAD Foundation; China Scholarship Fund; JBT Fellowship-UIUC	We thank K. Pixley and J. Chandler for seed and field experiment coordination and W. White, P. Bermudez, S. Islam, C. Paul, W. Liu, S. Xu and Y. Zhou for carotenoid HPLC profiling. Helpful comments on the manuscript from J. Wilkinson and J. Yu are appreciated. This research was supported by the US Agency for International Development (T. R.), HarvestPlus (T. R., D. D. P., J. Y., J. L., M. L. W.), National Science Foundation (NSF) DBI-0321467, DBI-0820619 (E. S. B.), NSF DBI-0604923 (T. R.), USDA-ARS (E. S. B.), NSF DBI-0501713 (T. B.), TRIAD Foundation (T. B.), China NSF-30821140352 (J. L., J. Y.), China Scholarship Fund (Y. F.) and JBT Fellowship-UIUC (C. B. K.).	Aluru M, 2008, J EXP BOT, V59, P3551, DOI 10.1093/jxb/ern212; Bai L, 2009, PLANT J, V59, P588, DOI 10.1111/j.1365-313X.2009.03899.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chander S, 2008, THEOR APPL GENET, V116, P223, DOI 10.1007/s00122-007-0661-7; Cunningham FX, 2007, EUKARYOT CELL, V6, P533, DOI 10.1128/EC.00265-06; Fierce Y, 2008, ARCH BIOCHEM BIOPHYS, V472, P126, DOI 10.1016/j.abb.2008.02.010; Fu Y, 2005, P NATL ACAD SCI USA, V102, P12282, DOI 10.1073/pnas.0503394102; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; KANDIANIS C, THESIS U ILLINOIS UR; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d; Li FQ, 2007, PLANT PHYSIOL, V144, P1181, DOI 10.1104/PP.107.098996; MATTHEWS PD, 2007, FOOD COLORANTS CHEM, P361; Ooijen J., 2001, JOINMAP VERSION 3 0; Pfeiffer WH, 2007, CROP SCI, V47, pS88, DOI 10.2135/cropsci2007.09.0020IPBS; Pritchard JK, 2000, GENETICS, V155, P945; SAS Institute, 2008, SAS STAT US GUID VER; Sun ZR, 1996, J BIOL CHEM, V271, P24349, DOI 10.1074/jbc.271.40.24349; Tanumihardjo SA, 2008, COMPR REV FOOD SCI F, V7, P329; Tian L, 2001, PLANT MOL BIOL, V47, P379, DOI 10.1023/A:1011623907959; UTZ HF, 1993, PLABQTL COMPUTER PRO; Vallabhaneni R, 2009, PLANT PHYSIOL, V151, P1635, DOI 10.1104/pp.109.145177; Vallabhaneni R, 2009, PLANT PHYSIOL, V150, P562, DOI 10.1104/pp.109.137042; Wang S.C.J.B., 2005, WINDOWS QTL CARTOGRA; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	25	322	348	2	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2010	42	4					322	U74		10.1038/ng.551	http://dx.doi.org/10.1038/ng.551			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	576NE	20305664	Green Published			2022-12-17	WOS:000276150500011
J	Cox, NJ; Frigge, M; Nicolae, DL; Concannon, P; Hanis, CL; Bell, GI; Kong, A				Cox, NJ; Frigge, M; Nicolae, DL; Concannon, P; Hanis, CL; Bell, GI; Kong, A			Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; COMPLEX TRAITS; EARLY-ONSET; GENE; MUTATIONS; MELLITUS; GLUCOKINASE; MODELS; MICE	Complex disorders such as diabetes, cardiovascular disease, asthma, hypertension and psychiatric illnesses account for a large and disproportionate share of health care costs, but remain poorly characterized with respect to aetiology. The transmission of such disorders is complex, reflecting the actions and interactions of multiple genetic and environmental factors. Genetic analyses that allow for the simultaneous consideration of susceptibility from multiple regions may improve the ability to map genes for complex disorders(1,2), but such analyses are currently computationally intensive and narrowly focused. We describe here an approach to assessing the evidence for statistical interactions between unlinked regions that allows multipoint allele-sharing analysis to take the evidence for linkage at one region into account in assessing the evidence for linkage over the rest of the genome. Using this method, we show that the interaction of genes on chromosomes 2 (NIDDM1) and 15 (near CYP19) makes a contribution to susceptibility to type 2 diabetes in Mexican Americans from Starr County, Texas.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; DeCODE Genet, IS-110 Reykjavik, Iceland; Virginia Mason Res Ctr, Seattle, WA 98101 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA	University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; Virginia Mason Medical Center; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston	Cox, NJ (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.			Concannon, Patrick/0000-0002-5801-1859; Nicolae, Dan/0000-0002-0918-4630	NIDDK NIH HHS [DK-47481, DK-20595] Funding Source: Medline; NIGMS NIH HHS [GM-46800] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047481, P60DK020595, P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046800] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bell GI, 1997, DIABETES REV, V5, P277; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Buhler J, 1997, HUM HERED, V47, P211, DOI 10.1159/000154415; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Iwasaki N, 1997, DIABETES, V46, P1504, DOI 10.2337/diabetes.46.9.1504; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MACLEAN CJ, 1993, AM J HUM GENET, V53, P353; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; RISCH N, 1990, AM J HUM GENET, V46, P229; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Terauchi Y, 1997, J CLIN INVEST, V99, P861, DOI 10.1172/JCI119250; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	21	322	336	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					213	215		10.1038/6002	http://dx.doi.org/10.1038/6002			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	9988276				2022-12-17	WOS:000078399500026
J	Reddy, PH; Williams, M; Charles, V; Garrett, L; Pike-Buchanan, L; Whetsell, WO; Miller, G; Tagle, DA				Reddy, PH; Williams, M; Charles, V; Garrett, L; Pike-Buchanan, L; Whetsell, WO; Miller, G; Tagle, DA			Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA	NATURE GENETICS			English	Article							HUNTINGTONS-DISEASE GENE; INTRANUCLEAR INCLUSIONS; CAG REPEAT; NEUROLOGICAL PHENOTYPE; WIDESPREAD EXPRESSION; TRINUCLEOTIDE REPEAT; PROTEIN; BRAIN; ONSET; AGE	Huntington disease (HD) is an adult-onset, autosomal dominant inherited human neurodegenerative disorder characterized by hyperkinetic involuntary movements, including motor restlessness and chorea, slowing of voluntary movements and cognitive impairment. Selective regional neuron loss and gliosis in striatum. cerebral cortex, thalamus, subthalamus and hippocampus(1-4) are well recognized as neuropathological correlates for the clinical manifestations of HD. The underlying genetic mutation is the expansion of CAG trinucleotide repeats (coding for polyglutamines) to 36-121 copies in exon 1 of the HD gene(5-8). The HD mRNA and protein product (huntingtin) show widespread distribution(9-11), and thus much remains to be understood about the selective and progressive neurodegeneration in HD. To create an experimental animal model for HD, transgenic mice were generated showing widespread expression of full-length human HD cDNA with either 16, 48 or 89 CAG repeats. Only mice with 48 or 89 CAG repeats manifested progressive behavioural and motor dysfunction with neuron loss and gliosis in striatum, cerebral cortex, thalamus and hippocampus. These animals represent clinically relevant models for HD pathogenesis, and may provide insights into the underlying pathophysiological mechanisms of other triplet repeat disorders.	Natl Human Genome Res Inst, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; Natl Human Genome Res Inst, Lab Genet Dis Res, Bethesda, MD 20892 USA; NIH, Off Res Serv, Vet Resources Program, Bethesda, MD 20892 USA; Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; Vanderbilt University	Tagle, DA (corresponding author), Natl Human Genome Res Inst, Genet & Mol Biol Branch, Bldg 49,Room 3A26,49 Convent Dr MSC 4442, Bethesda, MD 20892 USA.	datagle@helix.nih.gov			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028236] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-28236] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Borlongan CV, 1997, NEUROSCI BIOBEHAV R, V21, P289, DOI 10.1016/S0149-7634(96)00027-9; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DRAGUNOW M, 1995, NEUROREPORT, V6, P1053, DOI 10.1097/00001756-199505090-00026; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Folstein S.E., 1990, HUNTINGTONS DIS; HEDREEN JC, 1991, NEUROSCI LETT, V133, P257, DOI 10.1016/0304-3940(91)90583-F; JOU YS, 1995, HUM MOL GENET, V4, P465, DOI 10.1093/hmg/4.3.465; Kosinski CM, 1997, EXP NEUROL, V144, P239, DOI 10.1006/exnr.1997.6441; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Paxinos G., 1997, MOUSE BRAIN STEREOTA; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; SPARGO E, 1993, J NEUROL NEUROSUR PS, V56, P487, DOI 10.1136/jnnp.56.5.487; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; THOMAS LB, 1995, EXP NEUROL, V133, P265, DOI 10.1006/exnr.1995.1029; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Wood JD, 1996, HUM MOL GENET, V5, P481, DOI 10.1093/hmg/5.4.481	30	322	328	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1998	20	2					198	202		10.1038/2510	http://dx.doi.org/10.1038/2510			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	125HL	9771716				2022-12-17	WOS:000076231300025
J	Alvarez, MJ; Shen, Y; Giorgi, FM; Lachmann, A; Ding, BB; Ye, BH; Califano, A				Alvarez, Mariano J.; Shen, Yao; Giorgi, Federico M.; Lachmann, Alexander; Ding, B. Belinda; Ye, B. Hilda; Califano, Andrea			Functional characterization of somatic mutations in cancer using network-based inference of protein activity	NATURE GENETICS			English	Article							GENE SET ENRICHMENT; TRANSCRIPTION FACTOR ACTIVITY; DIFFERENTIAL EXPRESSION; REGULATORY PROGRAMS; SMALL MOLECULES; PATHWAYS; IDENTIFICATION; PROGRESSION; DISEASE	Identifying the multiple dysregulated oncoproteins that contribute to tumorigenesis in a given patient is crucial for developing personalized treatment plans. However, accurate inference of aberrant protein activity in biological samples is still challenging as genetic alterations are only partially predictive and direct measurements of protein activity are generally not feasible. To address this problem we introduce and experimentally validate a new algorithm, virtual inference of protein activity by enriched regulon analysis ( VIPER), for accurate assessment of protein activity from gene expression data. We used VIPER to evaluate the functional relevance of genetic alterations in regulatory proteins across all samples in The Cancer Genome Atlas ( TCGA). In addition to accurately infer aberrant protein activity induced by established mutations, we also identified a fraction of tumors with aberrant activity of druggable oncoproteins despite a lack of mutations, and vice versa. In vitro assays confirmed that VIPER-inferred protein activity outperformed mutational analysis in predicting sensitivity to targeted inhibitors.	[Alvarez, Mariano J.; Shen, Yao; Giorgi, Federico M.; Lachmann, Alexander; Califano, Andrea] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Alvarez, Mariano J.; Shen, Yao] DarwinHealth Inc, New York, NY 11040 USA; [Ding, B. Belinda; Ye, B. Hilda] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA; [Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Motor Neuron Ctr, New York, NY 10027 USA; [Califano, Andrea] Columbia Univ, Columbia Initiat Stem Cells, New York, NY 10027 USA	Columbia University; Yeshiva University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Alvarez, MJ; Califano, A (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.; Alvarez, MJ (corresponding author), DarwinHealth Inc, New York, NY 11040 USA.; Califano, A (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Motor Neuron Ctr, New York, NY 10027 USA.; Califano, A (corresponding author), Columbia Univ, Columbia Initiat Stem Cells, New York, NY 10027 USA.	malvarez@darwinhealth.com; ac2248@cumc.columbia.edu	Lachmann, Alexander/AAF-1940-2020; Giorgi, Federico M./AAD-5797-2020	Lachmann, Alexander/0000-0002-1982-7652; Giorgi, Federico M./0000-0002-7325-9908; Califano, Andrea/0000-0003-4742-3679	National Institutes of Health (NIH) Roadmap National Centers for Biomedical Computing [5U54CA121852]; NIH Library of Integrated Network-based Cellular Signatures program [1U01CA164184]; National Cancer Institute (NCI) Cancer Target Discovery and Development program [1U01CA168426]; NIH [S10OD012351, S10OD021764, R01CA85573]; Lauri Strauss Leukemia Foundation; NATIONAL CANCER INSTITUTE [R01CA085573, P30CA013330, U01CA168426, U54CA121852, R35CA197745, U01CA164184] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012351, S10OD021764] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Roadmap National Centers for Biomedical Computing; NIH Library of Integrated Network-based Cellular Signatures program; National Cancer Institute (NCI) Cancer Target Discovery and Development program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lauri Strauss Leukemia Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Riekhof for critical insight and help with drafting the manuscript. This work was supported by the National Institutes of Health (NIH) Roadmap National Centers for Biomedical Computing (5U54CA121852), the NIH Library of Integrated Network-based Cellular Signatures program (1U01CA164184), the National Cancer Institute (NCI) Cancer Target Discovery and Development program (1U01CA168426), and the NIH instrumentation grants (S10OD012351 and S10OD021764). Additional support was from NIH (R01CA85573) to B.H.Y. and a fellowship grant from the Lauri Strauss Leukemia Foundation to B.B.D. The results published here are in whole or part based upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI as of January 2011.	Abatangelo L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-275; Adjibade P, 2014, SEMIN CELL DEV BIOL, V34, P15, DOI 10.1016/j.semcdb.2014.05.013; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alvarez MJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r143; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Benaglia T, 2009, J STAT SOFTW, V32, P1; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Boorsma A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003112; Bozovic A, 2013, CLIN BIOCHEM, V46, P444, DOI 10.1016/j.clinbiochem.2012.09.024; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen JC, 2014, CELL, V159, P402, DOI 10.1016/j.cell.2014.09.021; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Dudoit S, 2003, BIOTECHNIQUES, P45; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kundaje A, 2007, ANN NY ACAD SCI, V1115, P178, DOI 10.1196/annals.1407.020; Kushwaha R, 2015, STEM CELLS, V33, P367, DOI 10.1002/stem.1870; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MacConaill LE, 2014, J MOL DIAGN, V16, P660, DOI 10.1016/j.jmoldx.2014.06.004; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; R Development Core Team, 2012, R LANG ENV STAT COMP; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Rodriguez JA, 2014, SEMIN CANCER BIOL, V27, P11, DOI 10.1016/j.semcancer.2014.03.005; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang K, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P264; Wang XF, 2014, CLIN CANCER RES, V20, P21, DOI 10.1158/1078-0432.CCR-13-0280; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wolf-Yadlin A, 2009, CURR OPIN CHEM BIOL, V13, P398, DOI 10.1016/j.cbpa.2009.06.027; Yoruk E, 2011, IEEE ACM T COMPUT BI, V8, P592, DOI 10.1109/TCBB.2010.87	62	321	325	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2016	48	8					838	+		10.1038/ng.3593	http://dx.doi.org/10.1038/ng.3593			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DS4ML	27322546	Green Published, Green Accepted			2022-12-17	WOS:000380755100006
J	Flanagan, SE; Haapaniemi, E; Russell, MA; Caswell, R; Allen, HL; De Francol, E; McDonald, TJ; Rajala, H; Ramelius, A; Barton, J; Heiskanen, K; Heiskanen-Kosmal, T; Kajosaari, M; Murphyli, NP; Milenkovic, T; Seppanen, M; Lemmark, A; Mustjoki, S; Otonkoski, T; Kere, J; Morgan, NG; Ellard, S; Hattersley, AT				Flanagan, Sarah E.; Haapaniemi, Emma; Russell, Mark A.; Caswell, Richard; Allen, Hana Lango; De Francol, Elisa; McDonald, Timothy J.; Rajala, Hanna; Ramelius, Anita; Barton, John; Heiskanen, Kaarina; Heiskanen-Kosmal, Tarja; Kajosaari, Merja; Murphyli, Nuala P.; Milenkovic, Tatjana; Seppanen, Mikko; Lemmark, Ake; Mustjoki, Satu; Otonkoski, Timo; Kere, Juha; Morgan, Noel G.; Ellard, Sian; Hattersley, Andrew T.			Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HYPER IGE SYNDROME; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCI; TH17 CELLS; VARIANTS; RISK	Monogenic causes of autoimmunity provide key insights into the complex regulation of the immune system. We report a new monogenic cause of autoimmunity resulting from de novo germline activating STAT3 mutations in five individuals with a spectrum of early-onset autoimmune disease, including type 1 diabetes. These findings emphasize the critical role of STAT3 in autoimmune disease and contrast with the germline inactivating STAT3 mutations that result in hyper IgE syndrome.	[Flanagan, Sarah E.; Russell, Mark A.; Caswell, Richard; Allen, Hana Lango; De Francol, Elisa; McDonald, Timothy J.; Morgan, Noel G.; Ellard, Sian; Hattersley, Andrew T.] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [Haapaniemi, Emma; Ellard, Sian] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Haapaniemi, Emma; Heiskanen, Kaarina; Otonkoski, Timo] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Rajala, Hanna] Univ Helsinki, Hematol Res Unit Helsinki, Dept Hematol, Helsinki, Finland; [Rajala, Hanna; Mustjoki, Satu] Univ Helsinki, Cent Hosp, Ctr Canc, Helsinki, Finland; [Ramelius, Anita; Lemmark, Ake] Lund Univ, Dept Clin Sci, Lund, Sweden; [Ramelius, Anita; Lemmark, Ake] Skane Univ Hosp, Clin Res Ctr, Malmo, Sweden; [Barton, John] Bristol Royal Hosp Children, Bristol, Avon, England; [Heiskanen, Kaarina; Kere, Juha] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Heiskanen-Kosmal, Tarja] Kuopio Univ Hosp, Dept Pediat, Helsinki, Finland; [Murphyli, Nuala P.] Childrens Univ Hosp, Dept Endocrinol & Diabet, Dublin, Ireland; [Milenkovic, Tatjana] Inst Mother & Child Hlth Care Serbia Dr Vukan Cup, Dept Endocrinol, Belgrade, Serbia; [Seppanen, Mikko] Univ Helsinki, Cent Hosp, Div Infect Dis, Immunodeficiency Unit, Helsinki, Finland; [Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Kere, Juha] Karolinska Inst, Ctr Innovat Med, Huddinge, Sweden	University of Exeter; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Lund University; Lund University; Skane University Hospital; Bristol Royal Hospital For Children; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland; Childrens University Hospital - Temple Street; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Karolinska Institutet	Hattersley, AT (corresponding author), Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England.	juha.kere@ki.se; n.g.morgan@exeterac.uk; a.hattersley@exeterac.uk	Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021; Lernmark, Åke/F-8140-2015; Mustjoki, Satu/AAD-9974-2020	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Lernmark, Åke/0000-0003-1735-0499; Mustjoki, Satu/0000-0002-0816-8241; Russell, Mark/0000-0003-3706-7383; Haapaniemi, Emma/0000-0002-6693-8208; Seppanen, Mikko/0000-0001-9733-3650; Flanagan, Sarah/0000-0002-8670-6340; Lango Allen, Hana/0000-0002-7803-8688; Ellard, Sian/0000-0002-7620-5526; Caswell, Richard/0000-0003-0713-4602; McDonald, Timothy James/0000-0003-3559-6660; Morgan, Noel/0000-0003-1537-8113; Hattersley, Andrew/0000-0001-5620-473X; Rajala, Hanna/0000-0003-2675-2385	UK National Institute for Health Research (NIHR); Wellcome Trust; Diabetes UK; Finnish Medical Foundation; National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0010719, NNF13OC0005565] Funding Source: researchfish; Cancer Foundation Finland sr [130127, 120107] Funding Source: researchfish	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); Finnish Medical Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); Cancer Foundation Finland sr	We thank J. Chilton, A. Damhuis, R. Raman and B. Yang for technical assistance. This work was supported by the UK National Institute for Health Research (NIHR) Exeter Clinical Research Facility through funding for S.E. and A.T.H. A.T.H. is an NIHR Senior Investigator. S.E. and A.T.H. are supported by Wellcome Trust Senior Investigator awards. Further funding was provided by Diabetes UK and the Finnish Medical Foundation.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Heimall J, 2011, CLIN IMMUNOL, V139, P75, DOI 10.1016/j.clim.2011.01.001; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Rubio-Cabezas O, 2009, DIABETES CARE, V32, P111, DOI 10.2337/dc08-1188; Seddighzadeh M, 2012, J RHEUMATOL, V39, P1509, DOI 10.3899/jrheum.111284; Shao SY, 2012, CELL IMMUNOL, V280, P16, DOI 10.1016/j.cellimm.2012.11.001; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200	21	321	334	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2014	46	8					812	814		10.1038/ng.3040	http://dx.doi.org/10.1038/ng.3040			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM2TT	25038750	Green Submitted, Green Accepted			2022-12-17	WOS:000339704400007
J	Northcott, PA; Nakahara, Y; Wu, XC; Feuk, L; Ellison, DW; Croul, S; Mack, S; Kongkham, PN; Peacock, J; Dubuc, A; Ra, YS; Zilberberg, K; Mcleod, J; Scherer, SW; Rao, JS; Eberhart, CG; Grajkowska, W; Gillespie, Y; Lach, B; Grundy, R; Pollack, IF; Hamilton, RL; Van Meter, T; Carlotti, CG; Boop, F; Bigner, D; Gilbertson, RJ; Rutka, JT; Taylor, MD				Northcott, Paul A.; Nakahara, Yukiko; Wu, Xiaochong; Feuk, Lars; Ellison, David W.; Croul, Sid; Mack, Stephen; Kongkham, Paul N.; Peacock, John; Dubuc, Adrian; Ra, Young-Shin; Zilberberg, Karen; Mcleod, Jessica; Scherer, Stephen W.; Rao, J. Sunil; Eberhart, Charles G.; Grajkowska, Wiesia; Gillespie, Yancey; Lach, Boleslaw; Grundy, Richard; Pollack, Ian F.; Hamilton, Ronald L.; Van Meter, Timothy; Carlotti, Carlos G.; Boop, Frederick; Bigner, Darrell; Gilbertson, Richard J.; Rutka, James T.; Taylor, Michael D.			Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SMALL-MOLECULE INHIBITOR; CEREBELLAR DEVELOPMENT; COMPLEX; CELLS; DIFFERENTIATION; ABNORMALITIES; TRANSCRIPTION; LEUKEMIA; PROTEIN	We used high-resolution SNP genotyping to identify regions of genomic gain and loss in the genomes of 212 medulloblastomas, malignant pediatric brain tumors. We found focal amplifications of 15 known oncogenes and focal deletions of 20 known tumor suppressor genes (TSG), most not previously implicated in medulloblastoma. Notably, we identified previously unknown amplifications and homozygous deletions, including recurrent, mutually exclusive, highly focal genetic events in genes targeting histone lysine methylation, particularly that of histone 3, lysine 9 (H3K9). Post-translational modification of histone proteins is critical for regulation of gene expression, can participate in determination of stem cell fates and has been implicated in carcinogenesis. Consistent with our genetic data, restoration of expression of genes controlling H3K9 methylation greatly diminishes proliferation of medulloblastoma in vitro. Copy number aberrations of genes with critical roles in writing, reading, removing and blocking the state of histone lysine methylation, particularly at H3K9, suggest that defective control of the histone code contributes to the pathogenesis of medulloblastoma.	[Northcott, Paul A.; Nakahara, Yukiko; Wu, Xiaochong; Mack, Stephen; Kongkham, Paul N.; Peacock, John; Dubuc, Adrian; Ra, Young-Shin; Zilberberg, Karen; Mcleod, Jessica; Rutka, James T.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Northcott, Paul A.; Nakahara, Yukiko; Wu, Xiaochong; Mack, Stephen; Peacock, John; Dubuc, Adrian; Zilberberg, Karen; Mcleod, Jessica; Taylor, Michael D.] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Northcott, Paul A.; Mack, Stephen; Kongkham, Paul N.; Dubuc, Adrian; Zilberberg, Karen; Rutka, James T.; Taylor, Michael D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Feuk, Lars; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; [Feuk, Lars; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Ellison, David W.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Croul, Sid] Univ Toronto, Dept Pathol, Univ Hlth Network, Toronto, ON, Canada; [Rao, J. Sunil] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Eberhart, Charles G.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Grajkowska, Wiesia] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Gillespie, Yancey] Univ Alabama, Dept Surg, Birmingham, AL 35294 USA; [Lach, Boleslaw] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Grundy, Richard] Univ Nottingham, Nottingham NG7 2RD, England; [Pollack, Ian F.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Hamilton, Ronald L.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Van Meter, Timothy] Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA; [Carlotti, Carlos G.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg, Div Neurosurg, Sao Paulo, Brazil; [Boop, Frederick] St Jude Childrens Hosp, Div Pediat Neurosurg, Memphis, TN 38105 USA; [Bigner, Darrell] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Case Western Reserve University; Johns Hopkins University; Children's Memorial Health Institute; University of Alabama System; University of Alabama Birmingham; McMaster University; University of Nottingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Virginia Commonwealth University; Universidade de Sao Paulo; St Jude Children's Research Hospital; Duke University; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Taylor, MD (corresponding author), Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mdtaylor@sickkids.ca	Gilbertson, Richard James/ABE-1346-2021; Northcott, Paul A/N-4022-2018; Scherer, Stephen W./B-3785-2013; Carlotti, Carlos G/C-1608-2012; Ellison, David/N-4806-2018	Gilbertson, Richard James/0000-0001-7539-9472; Northcott, Paul A/0000-0002-1220-5252; Scherer, Stephen W./0000-0002-8326-1999; Carlotti, Carlos G/0000-0002-7055-0564; Mack, Stephen C./0000-0001-9620-4742; Croul, Sidney/0000-0002-2224-5485; Kongkham, Paul/0000-0002-1047-9305; Gillespie, George/0000-0001-6436-9542; Taylor, Michael/0000-0001-7009-3466; Grajkowska, Wieslawa/0000-0001-8318-5781	Hospital for Sick Children Foundation; Neurosurgery Research and Education Foundation; BRAINCHILD; Laurie Berman fund in Brain Tumor Research; American Brain Tumor Association; Canadian Institutes of Health Research; Hospital for Sick Children; NATIONAL CANCER INSTITUTE [R01CA129541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055089] Funding Source: NIH RePORTER	Hospital for Sick Children Foundation; Neurosurgery Research and Education Foundation; BRAINCHILD; Laurie Berman fund in Brain Tumor Research; American Brain Tumor Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children(University of Toronto); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the individuals and families who agreed to take part in these studies. We thank S. Egan, J. Ellis and R. Bremner for critical review of the manuscript. We thank R. Wechsler- Reya (Duke), A. M. Kenney (Memorial- Sloan Kettering) and D. Rowitch (University of California San Francisco) for reagents and helpful discussions. We are grateful to K. Helin (University of Copenhagen) for providing JMJD2C expression constructs. We thank P. Paroutis for artwork and S. Archer for editing. We are grateful to C. Marshall and J. Wei for assistance with copy number analysis. This work was supported by the Canadian Cancer Society and the Pediatric Brain Tumor Foundation. M. D. T. is supported by a Sontag Foundation Distinguished Scholar award. Additional research support was obtained from the Hospital for Sick Children Foundation, The Neurosurgery Research and Education Foundation, BRAINCHILD, the 407 Express Toll Route, and the Walker family. M. D. T. was supported by the Laurie Berman fund in Brain Tumor Research, the American Brain Tumor Association and a ClinicianScientist award from the Canadian Institutes of Health Research. P. A. N. was supported by a Restracomp salary award from the Hospital for Sick Children.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bayani J, 2000, J NEUROSURG, V93, P437, DOI 10.3171/jns.2000.93.3.0437; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Cartwright P, 1998, ONCOGENE, V17, P611, DOI 10.1038/sj.onc.1201975; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Marino S, 2000, GENE DEV, V14, P994; Marino S, 2003, DEVELOPMENT, V130, P3359, DOI 10.1242/dev.00553; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Olson MV, 2007, CANCER RES, V67, P4005, DOI 10.1158/0008-5472.CAN-06-2973; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Reardon DA, 1997, CANCER RES, V57, P4042; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06	30	321	328	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					465	472		10.1038/ng.336	http://dx.doi.org/10.1038/ng.336			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19270706	Green Accepted			2022-12-17	WOS:000264659000022
J	Weedon, MN; Lettre, G; Freathy, RM; Lindgren, CM; Voight, BF; Perry, JRB; Elliott, KS; Hackett, R; Guiducci, C; Shields, B; Zeggini, E; Lango, H; Lyssenko, V; Timpson, NJ; Burtt, NP; Rayner, NW; Saxena, R; Ardlie, K; Tobias, JH; Ness, AR; Ring, SM; Palmer, CNA; Morris, AD; Peltonen, L; Salomaa, V; Smith, GD; Groop, LC; Hattersley, AT; McCarthy, MI; Hirschhorn, JN; Frayling, TM				Weedon, Michael N.; Lettre, Guillaume; Freathy, Rachel M.; Lindgren, Cecilia M.; Voight, Benjamin F.; Perry, John R. B.; Elliott, Katherine S.; Hackett, Rachel; Guiducci, Candace; Shields, Beverley; Zeggini, Eleftheria; Lango, Hana; Lyssenko, Valeriya; Timpson, Nicholas J.; Burtt, Noel P.; Rayner, Nigel W.; Saxena, Richa; Ardlie, Kristin; Tobias, Jonathan H.; Ness, Andrew R.; Ring, Susan M.; Palmer, Colin N. A.; Morris, Andrew D.; Peltonen, Leena; Salomaa, Veikko; Smith, George Davey; Groop, Leif C.; Hattersley, Andrew T.; McCarthy, Mark I.; Hirschhorn, Joel N.; Frayling, Timothy M.		Diabet Genetics Initiative; Wellcome Trust Case Control Con	A common variant of HMGA2 is associated with adult and childhood height in the general population	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY HEIGHT; C GENE; RISK; HERITABILITY; DISEASE; STRATIFICATION; SUSCEPTIBILITY; METHODOLOGY; PHENOTYPE	Human height is a classic, highly heritable quantitative trait. To begin to identify genetic variants influencing height, we examined genome-wide association data from 4,921 individuals. Common variants in the HMGA2 oncogene, exemplified by rs1042725, were associated with height (P= 4x10(-8)). HMGA2 is also a strong biological candidate for height, as rare, severe mutations in this gene alter body size in mice and humans, so we tested rs1042725 in additional samples. We confirmed the association in 19,064 adults from four further studies (P= 3x10(-11), overall P= 4x10(-16), including the genome-wide association data). We also observed the association in children (P=1x 10(-6), N= 6,827) and a tall/short case-control study (P= 4x10(-6), N=3,207). We estimate that rs1042725 explains similar to 0.3% of population variation in height (similar to 0.4 cm increased adult height per C allele). There are few examples of common genetic variants reproducibly associated with human quantitative traits; these results represent, to our knowledge, the first consistently replicated association with adult and childhood height.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; Childrens Hosp, Div Genet & Endocrinol, Program Genom, Boston, MA 02115 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Churchill Hosp, Oxford Ctr Diab Endocrinol & Metab, Oxford OX3 7LJ, England; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diab & Endocrinol, S-20502 Malmo, Sweden; Univ Helsinki, Helsinki Univ Cent Hosp,Dep Med, Folkhalsan Genet Inst,Folkhalsan Res Ctr, Res Program Mol Med, Helsinki, Finland; Univ Bristol, MRC Ctr Causal Analyses Translat Epidemiol, Bristol BS8 2PR, Avon, England; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Univ Bristol, Clin Sci S Bristol, Bristol BS2 8AE, Avon, England; Univ Bristol, Bristol Dent Sch, Dept Oral & Dent Sci, Bristol BS1 2LY, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Dundee, Ninewells Hosp, Sch Med,Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp, Sch Med, Div Med & Therapeut,Diab Res Grp, Dundee DD1 9SY, Scotland; Natl Publ Hlth Inst, Dept Mol Med, FI-00290 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FI-00014 Helsinki, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FI-00300 Helsinki, Finland; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Exeter; University of Exeter; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Harvard University; Massachusetts General Hospital; Lund University; Skane University Hospital; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Bristol; Harvard University; Massachusetts General Hospital; University of Bristol; University of Bristol; University of Bristol; University of Dundee; University of Dundee; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; Harvard University; Harvard Medical School	Frayling, TM (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Magdalen Rd, Exeter EX1 2LU, Devon, England.	Tim.Frayling@pms.ac.uk	Allen, Hana Lango/G-9026-2012; Saxena, Richa/AAG-7279-2020; Attrill, Lauren/V-1688-2018; Ness, Andy R/M-7612-2013; Fox, Laura J/C-6249-2016; Palmer, Colin NA/C-7053-2008; Voight, Benjamin/F-1775-2011; Morris, Andrew D/C-2837-2009; Tobias, Jon/E-2832-2014; Study, GoDARTS/K-9448-2016; Davey Smith, George/A-7407-2013; Timpson, Nicholas John/O-7548-2015; Berryman, Katie/J-4236-2014; McCarthy, Mark/M-3763-2015	Allen, Hana Lango/0000-0002-7803-8688; Ness, Andy R/0000-0003-3548-9523; Palmer, Colin NA/0000-0002-6415-6560; Tobias, Jon/0000-0002-7475-3932; Davey Smith, George/0000-0002-1407-8314; Timpson, Nicholas John/0000-0002-7141-9189; Weedon, Michael/0000-0002-6174-6135; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Voight, Benjamin/0000-0002-6205-9994; Zeggini, Eleftheria/0000-0003-4238-659X; Lindgren, Cecilia/0000-0002-4903-9374; McCarthy, Mark/0000-0002-4393-0510; Frayling, Timothy/0000-0001-8362-2603; Freathy, Rachel/0000-0003-4152-2238; Saxena, Richa/0000-0003-2233-1065; Hattersley, Andrew/0000-0001-5620-473X; s, hema/0000-0002-3440-9475	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004171] Funding Source: NIH RePORTER; Medical Research Council [G9815508(74882), G0600705, G9815508, G0500070] Funding Source: Medline; NHGRI NIH HHS [U01 HG004171] Funding Source: Medline; Wellcome Trust [GR072960, 079557, 090532, 076113, 072960, 076467] Funding Source: Medline; MRC [G0600705, G0500070] Funding Source: UKRI	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Battista S, 1999, CANCER RES, V59, P4793; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; Leary SD, 2006, OBESITY, V14, P2284, DOI 10.1038/oby.2006.268; Ligon AH, 2005, AM J HUM GENET, V76, P340, DOI 10.1086/427565; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Preece MA, 1996, HORM RES, V45, P56, DOI 10.1159/000184849; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rogers IS, 2006, AM J CLIN NUTR, V84, P739, DOI 10.1093/ajcn/84.4.739; Ruyter-Spira CP, 1998, J HERED, V89, P295, DOI 10.1093/jhered/89.4.295; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	30	321	341	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1245	1250		10.1038/ng2121	http://dx.doi.org/10.1038/ng2121			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17767157	Green Accepted			2022-12-17	WOS:000249737400020
J	Roix, JJ; McQueen, PG; Munson, PJ; Parada, LA; Misteli, T				Roix, JJ; McQueen, PG; Munson, PJ; Parada, LA; Misteli, T			Spatial proximity of translocation-prone gene loci in human lymphomas	NATURE GENETICS			English	Article							HUMAN LEUKEMIC-CELLS; C-MYC; CHROMOSOME-ABERRATIONS; NUCLEAR TOPOGRAPHY; CANCER; INTERPHASE; LOCATION; ABL; BCR; DIFFERENTIATION	Cancer cells frequently have disease-specific chromosome rearrangements(1-4). It is poorly understood why translocations between chromosomes recur at specific breakpoints in the genome. Here we provide evidence that higher-order spatial genome organization is a contributing factor in the formation of recurrent translocations. We show that MYC, BCL and immunoglobulin loci, which are recurrently translocated in various B-cell lymphomas, are preferentially positioned in close spatial proximity relative to each other in normal B cells. Loci in spatial proximity are non-randomly positioned towards the nuclear interior in normal B cells. This locus proximity is the consequence of higher-order genome structure rather than a property of individual genes. Our results suggest that the formation of specific translocations in human lymphomas, and perhaps other tissues, is determined in part by higher-order spatial organization of the genome.	NCI, NIH, Bethesda, MD 20892 USA; NIH, Math & Stat Lab, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov			CENTER FOR INFORMATION TECHNOLOGY [ZIACT000227, Z01CT000227] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC010309, ZIABC010309] Funding Source: NIH RePORTER	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartova E, 2000, LEUKEMIA RES, V24, P233, DOI 10.1016/S0145-2126(99)00174-5; Bartova E, 2000, GENE, V244, P1, DOI 10.1016/S0378-1119(99)00572-7; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Fienberg S. E, 1982, ENCY STAT SCI, V2, P161; Haigis KM, 2003, NAT GENET, V33, P33, DOI 10.1038/ng1055; Harris N L, 2001, Hematology Am Soc Hematol Educ Program, P194, DOI 10.1182/asheducation-2001.1.194; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kozubek S, 2002, CHROMOSOMA, V111, P321, DOI 10.1007/s00412-002-0210-8; Lukasova E, 1997, HUM GENET, V100, P525, DOI 10.1007/s004390050547; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Parada LA, 2002, TRENDS CELL BIOL, V12, P425, DOI 10.1016/S0962-8924(02)02351-6; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Parreira L, 1997, HUM GENET, V100, P588, DOI 10.1007/s004390050558; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Sachs RK, 1997, INT J RADIAT BIOL, V71, P1, DOI 10.1080/095530097144364; Siebert R, 2001, CURR OPIN ONCOL, V13, P316, DOI 10.1097/00001622-200109000-00002; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Stamatopoulos K, 2000, IMMUNOL TODAY, V21, P298, DOI 10.1016/S0167-5699(00)01650-9; STEVENS MA, 1982, ENCY STAT SCI, V4, P393; TEUOLSKKY WH, 1992, NUMERICAL RECIPES C, P609; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Willis TG, 2000, BLOOD, V96, P808, DOI 10.1182/blood.V96.3.808.015k30_808_822; Yoshida S, 1999, ONCOGENE, V18, P7994, DOI 10.1038/sj.onc.1203293; Zhou J, 2002, MOL CELL BIOL, V22, P4876, DOI 10.1128/MCB.22.13.4876-4889.2002	29	321	332	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2003	34	3					287	291		10.1038/ng1177	http://dx.doi.org/10.1038/ng1177			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12808455				2022-12-17	WOS:000183815300015
J	Bufe, B; Hofmann, T; Krautwurst, D; Raguse, JD; Meyerhof, W				Bufe, B; Hofmann, T; Krautwurst, D; Raguse, JD; Meyerhof, W			The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides	NATURE GENETICS			English	Article							ADAPTATION; IDENTIFICATION; TRANSDUCTION; EXPRESSION; FAMILY; CELLS	Bitter taste generally causes aversion, which protects humans from ingesting toxic substances. But bitter flavors also contribute to the palatability of food and beverages, thereby influencing nutritional habits in humans(1). Although many studies have examined bitter taste(2-6), the underlying receptor mechanisms remain poorly understood. Anatomical, functional and genetic data from rodents suggest the existence of a family of receptors that are responsive to bitter compounds(7-9). Here we report that a human member of this family, TAS2R16, is present in taste receptor cells on the tongue and is activated by bitter beta-glucopyranosides. Responses to these phytonutrients show a similar concentration dependence and desensitization in transfected cells and in experiments assessing taste perception in humans. Bitter compounds consisting of a hydrophobic residue attached to glucose by a beta-glycosidic bond activate TAS2R16. Thus, TAS2R16 links the recognition of a specific chemical structure to the perception of bitter taste. If the ability of TAS2R16 to detect substances with common molecular properties is typical of the bitter receptor family, it may explain how a few receptors permit the perception of numerous bitter substances.	German Inst Human Nutr, Dept Mol Genet, D-14558 Potsdam, Germany; German Res Ctr Food Chem, Garching, Germany; Clin & Policlin Oral & Maxillofacial Surg & Plast, Charite, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Leibniz-Institute for Food Systems Biology at the Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Meyerhof, W (corresponding author), German Inst Human Nutr, Dept Mol Genet, Arthur Scheunert Allee 114-116, D-14558 Potsdam, Germany.	meyerhof@mail.dife.de	Krautwurst, Dietmar/AAD-5579-2019; Bufe, Bernd/N-6685-2018	Krautwurst, Dietmar/0000-0002-3350-8682; Bufe, Bernd/0000-0003-1610-0658				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Ammon C, 2001, ARCH PHYSIOL BIOCHEM, V110, P137; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Caicedo A, 2001, SCIENCE, V291, P1557, DOI 10.1126/science.1056670; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Drewnowski A, 2001, NUTR REV, V59, P163, DOI 10.1111/j.1753-4887.2001.tb07007.x; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Dulac C, 2000, CELL, V100, P607, DOI 10.1016/S0092-8674(00)80697-2; Ferguson SSG, 1998, SEMIN CELL DEV BIOL, V9, P119, DOI 10.1006/scdb.1997.0216; Frank O, 2001, J AGR FOOD CHEM, V49, P231, DOI 10.1021/jf0010073; Keast RSJ, 2002, CHEM SENSES, V27, P123, DOI 10.1093/chemse/27.2.123; Kinnamon SC, 2000, NEURON, V25, P507, DOI 10.1016/S0896-6273(00)81054-5; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; KUBO I, 1994, PHYSIOL BEHAV, V56, P1203, DOI 10.1016/0031-9384(94)90367-0; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; MAILGAARD M, 1999, SENSORY EVALUATION T, P122; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; MEYERHOF W, 1992, P NATL ACAD SCI USA, V89, P10267, DOI 10.1073/pnas.89.21.10267; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Roosterman D, 1997, J NEUROENDOCRINOL, V9, P741, DOI 10.1046/j.1365-2826.1997.00632.x; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Torre V, 1995, J NEUROSCI, V15, P7757; Vane JR, 2000, J PHYSIOL PHARMACOL, V51, P573; VONLEIBIG J, 1844, CHEM BRIEFE; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999	26	321	361	8	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					397	401		10.1038/ng1014	http://dx.doi.org/10.1038/ng1014			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX	12379855				2022-12-17	WOS:000179034800015
J	Bickhart, DM; Rosen, BD; Koren, S; Sayre, BL; Hastie, AR; Chan, S; Lee, J; Lam, ET; Liachko, I; Sullivan, ST; Burton, JN; Huson, HJ; Nystrom, JC; Kelley, CM; Hutchison, JL; Zhou, Y; Sun, J; Crisa, A; de Leon, FAP; Schwartz, JC; Hammond, JA; Waldbieser, GC; Schroeder, SG; Liu, GE; Dunham, MJ; Shendure, J; Sonstegard, TS; Phillippy, AM; Van Tassell, CP; Smith, TPL				Bickhart, Derek M.; Rosen, Benjamin D.; Koren, Sergey; Sayre, Brian L.; Hastie, Alex R.; Chan, Saki; Lee, Joyce; Lam, Ernest T.; Liachko, Ivan; Sullivan, Shawn T.; Burton, Joshua N.; Huson, Heather J.; Nystrom, John C.; Kelley, Christy M.; Hutchison, Jana L.; Zhou, Yang; Sun, Jiajie; Crisa, Alessandra; de Leon, F. Abel Ponce; Schwartz, John C.; Hammond, John A.; Waldbieser, Geoffrey C.; Schroeder, Steven G.; Liu, George E.; Dunham, Maitreya J.; Shendure, Jay; Sonstegard, Tad S.; Phillippy, Adam M.; Van Tassell, Curtis P.; Smith, Timothy P. L.			Single-molecule sequencing and chromatin conformation capture enable de novo reference assembly of the domestic goat genome	NATURE GENETICS			English	Article							CHROMOSOMES; ANNOTATION; CATTLE; RECONSTRUCTION; TRANSCRIPTOME; COMPLEXITY; ALIGNMENT; TIME	The decrease in sequencing cost and increased sophistication of assembly algorithms for short-read platforms has resulted in a sharp increase in the number of species with genome assemblies. However, these assemblies are highly fragmented, with many gaps, ambiguities, and errors, impeding downstream applications. We demonstrate current state of the art for de novo assembly using the domestic goat (Capra hircus) based on long reads for contig formation, short reads for consensus validation, and scaffolding by optical and chromatin interaction mapping. These combined technologies produced what is, to our knowledge, the most continuous de novo mammalian assembly to date, with chromosome-length scaffolds and only 649 gaps. Our assembly represents a similar to 400-fold improvement in continuity due to properly assembled gaps, compared to the previously published C. hircus assembly, and better resolves repetitive structures longer than 1 kb, representing the largest repeat family and immune gene complex yet produced for an individual of a ruminant species.	[Bickhart, Derek M.] USDA ARS, Cell Wall Biol & Utilizat Lab, Madison, WI USA; [Rosen, Benjamin D.; Hutchison, Jana L.; Zhou, Yang; Schroeder, Steven G.; Liu, George E.; Van Tassell, Curtis P.] USDA ARS, Anim Genom & Improvement Lab, Beltsville, MD USA; [Koren, Sergey; Phillippy, Adam M.] Natl Human Genome Res Inst, Computat & Stat Genom Branch, Genome Informat Sect, Bethesda, MD USA; [Sayre, Brian L.] Virginia State Univ, Dept Biol, Petersburg, VA USA; [Hastie, Alex R.; Chan, Saki; Lee, Joyce; Lam, Ernest T.] BioNano Genom, San Diego, CA USA; [Liachko, Ivan; Burton, Joshua N.; Dunham, Maitreya J.; Shendure, Jay] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Sullivan, Shawn T.] Phase Genom, Seattle, WA USA; [Huson, Heather J.; Nystrom, John C.] Cornell Univ, Dept Anim Sci, Ithaca, NY USA; [Kelley, Christy M.; Smith, Timothy P. L.] USDA ARS, Meat Anim Res Ctr, Clay Ctr, NE USA; [Zhou, Yang] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Agr Mol Biol, Yangling, Peoples R China; [Sun, Jiajie] China Agr Univ, Guangzhou, Peoples R China; [Crisa, Alessandra] CREA, Anim Prod Res Ctr, Rome, Italy; [de Leon, F. Abel Ponce] Univ Minnesota, Dept Anim Sci, St Paul, MN USA; [Schwartz, John C.; Hammond, John A.] Pirbright Inst, Livestock Viral Dis Programme, Woking, Surrey, England; [Waldbieser, Geoffrey C.] USDA ARS, Warmwater Aquaculture Res Unit, Stoneville, MS USA; [Shendure, Jay] Howard Hughes Med Inst, Seattle, WA USA; [Sonstegard, Tad S.] Recombinet Inc, St Paul, MN USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Virginia State University; University of Washington; University of Washington Seattle; Cornell University; United States Department of Agriculture (USDA); Northwest A&F University - China; China Agricultural University; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Minnesota System; University of Minnesota Twin Cities; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; United States Department of Agriculture (USDA); Howard Hughes Medical Institute	Van Tassell, CP (corresponding author), USDA ARS, Anim Genom & Improvement Lab, Beltsville, MD USA.; Phillippy, AM (corresponding author), Natl Human Genome Res Inst, Computat & Stat Genom Branch, Genome Informat Sect, Bethesda, MD USA.; Smith, TPL (corresponding author), USDA ARS, Meat Anim Res Ctr, Clay Ctr, NE USA.	adam.phillippy@nih.gov; curt.vantassell@ars.usda.gov; tim.smith@ars.usda.gov	Van Tassell, Curtis P./O-4247-2019; Koren, Sergey/AAE-8314-2019; Schwartz, John/I-3002-2019; Liu, George/K-3371-2019; Phillippy, Adam M/U-5731-2018; Shendure, Jay/AAU-3684-2021; Sayre, Brian/V-7889-2019; Crisà, Alessandra/AAL-1469-2021	Van Tassell, Curtis P./0000-0002-8416-2087; Schwartz, John/0000-0003-2057-1831; Liu, George/0000-0003-0192-6705; Phillippy, Adam M/0000-0003-2983-8934; Crisà, Alessandra/0000-0003-4218-2407; Huson, Heather/0000-0001-8299-0447; Hammond, John/0000-0002-2213-3248; Koren, Sergey/0000-0002-1472-8962; Bickhart, Derek/0000-0003-2223-9285; Schroeder, Steven/0000-0001-9103-5150	US Agency for International Development Feed the Future program; Norman Borlaug Commemorative Research Initiative; Livestock Improvement Program; Agriculture and Food Research Initiative (AFRI) competitive grant from the USDA National Institute of Food and Agriculture (NIFA) Animal Genome Program [2011-67015-30183, 2015-67015-22970]; USDA CRIS project [8042-31000-104-00, 3040-31320-012-00, 6402-31000-006-00D]; NIH [R01HG006283, P41 GM103533]; UW Commercialization Gap Fund and Commercialization Fellows Program; MN Experiment Station Project [MIN-16-103]; UK Biotechnology and Biological Sciences Research Council Institute Strategic Program on Livestock Viral Diseases award; NIH Intramural Research Program of the National Human Genome Research Institute; BBSRC [BB/M027155/1, BBS/E/I/00001710] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001710, BB/M027155/1] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200398, R01HG006283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	US Agency for International Development Feed the Future program(United States Agency for International Development (USAID)); Norman Borlaug Commemorative Research Initiative(United States Agency for International Development (USAID)United States Department of Agriculture (USDA)); Livestock Improvement Program(Livestock Improvement Corporation); Agriculture and Food Research Initiative (AFRI) competitive grant from the USDA National Institute of Food and Agriculture (NIFA) Animal Genome Program; USDA CRIS project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW Commercialization Gap Fund and Commercialization Fellows Program; MN Experiment Station Project; UK Biotechnology and Biological Sciences Research Council Institute Strategic Program on Livestock Viral Diseases award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH Intramural Research Program of the National Human Genome Research Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study used the computational resources of the Biowulf system at the National Institutes of Health (NIH). We thank R. Lee for technical assistance. This project was supported by the US Agency for International Development Feed the Future program, the Norman Borlaug Commemorative Research Initiative, and the Livestock Improvement Program. This work was also supported in part by Agriculture and Food Research Initiative (AFRI) competitive grant 2011-67015-30183 and 2015-67015-22970 from the USDA National Institute of Food and Agriculture (NIFA) Animal Genome Program. D.M.B., B.D.R., S.G.S., and C.P.V.T. were supported by USDA CRIS project number 8042-31000-104-00. C.M.K. and T.P.L.S. were supported by USDA CRIS project number 3040-31320-012-00. G.C.W. was supported by USDA CRIS project number 6402-31000-006-00D. J. Shendure was supported in part by NIH grant R01HG006283. M.J.D. and I.L. were supported in part by NIH grant P41 GM103533. M.J.D. is a Senior Fellow in the Genetic Networks program at the Canadian Institute for Advanced Research and a Rita Allen Foundation Scholar. I.L. is supported by the UW Commercialization Gap Fund and Commercialization Fellows Program. F.A.P.d.L. was supported by MN Experiment Station Project MIN-16-103. J.C.S. and J.A.H. were funded by a UK Biotechnology and Biological Sciences Research Council Institute Strategic Program on Livestock Viral Diseases award to the Pirbright Institute. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the US Department of Agriculture. S.K. and A.M.P. were supported by the NIH Intramural Research Program of the National Human Genome Research Institute.	Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Barriere A, 2009, GENOME RES, V19, P470, DOI 10.1101/gr.081851.108; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Boetzer M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-211; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burton JN, 2014, G3-GENES GENOM GENET, V4, P1339, DOI 10.1534/g3.114.011825; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Chaisson MJP, 2015, NAT REV GENET, V16, P627, DOI 10.1038/nrg3933; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Du XY, 2012, SMALL RUMINANT RES, V105, P114, DOI 10.1016/j.smallrumres.2011.11.023; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Garrison E., 2012, ARXIV12073907QBIO; Gordon D, 2016, SCIENCE, V352, DOI 10.1126/science.aae0344; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; HANSEN KM, 1973, HEREDITAS, V75, P119; Hastie AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055864; Hoff KJ, 2016, BIOINFORMATICS, V32, P767, DOI 10.1093/bioinformatics/btv661; IANNUZZI L, 1995, CHROMOSOME RES, V3, P291, DOI 10.1007/BF00713067; Kaplan N, 2013, NAT BIOTECHNOL, V31, P1143, DOI 10.1038/nbt.2768; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ma WX, 2015, NAT METHODS, V12, P71, DOI [10.1038/nmeth.3205, 10.1038/NMETH.3205]; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCoy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106689; Melters DP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r10; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Nagarajan N, 2008, BIOINFORMATICS, V24, P1229, DOI 10.1093/bioinformatics/btn102; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/NMETH.3454, 10.1038/nmeth.3454]; Perez-Pardal L, 2010, HEREDITY, V105, P511, DOI 10.1038/hdy.2010.30; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55; Pop M, 2004, GENOME RES, V14, P149; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Riley MC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-252; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sanderson ND, 2014, J IMMUNOL, V193, P6016, DOI 10.4049/jimmunol.1401980; Sayre B.L., 2013, 50 ANN M BRAZ SOC AN; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schneider V.A., 2016, EVALUATION GRCH38 NO; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Tomaszkiewicz M, 2016, GENOME RES, V26, P530, DOI 10.1101/gr.199448.115; Tosser-Klopp G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086227; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Vezzi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052210; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Zhang GJ, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-26; Zhou J, 2011, GENOME BIOL EVOL, V3, P1014, DOI 10.1093/gbe/evr023; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	71	320	335	3	101	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2017	49	4					643	+		10.1038/ng.3802	http://dx.doi.org/10.1038/ng.3802			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EP8CO	28263316	Green Accepted, Green Submitted			2022-12-17	WOS:000397603700030
J	Taylor, KR; Mackay, A; Truffaux, N; Butterfield, YS; Morozova, O; Philippe, C; Castel, D; Grasso, CS; Vinci, M; Carvalho, D; Carcaboso, AM; de Torres, C; Cruz, O; Mora, J; Entz-Werle, N; Ingram, WJ; Monje, M; Hargrave, D; Bullock, AN; Puget, S; Yip, S; Jones, C; Grill, J				Taylor, Kathryn R.; Mackay, Alan; Truffaux, Nathalene; Butterfield, Yaron S.; Morozova, Olena; Philippe, Cathy; Castel, David; Grasso, Catherine S.; Vinci, Maria; Carvalho, Diana; Carcaboso, Angel M.; de Torres, Carmen; Cruz, Ofelia; Mora, Jaume; Entz-Werle, Natacha; Ingram, Wendy J.; Monje, Michelle; Hargrave, Darren; Bullock, Alex N.; Puget, Stephanie; Yip, Stephen; Jones, Chris; Grill, Jacques			Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma	NATURE GENETICS			English	Article							FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; INHIBITION; GENES; ALK2	Diffuse intrinsic pontine gliomas (DIPGs) are highly infiltrative malignant glial neoplasms of the ventral pons that, due to their location within the brain, are unsuitable for surgical resection and consequently have a universally dismal clinical outcome. The median survival time is 9-12 months, with neither chemotherapeutic nor targeted agents showing substantial survival benefit in clinical trials in children with these tumorsl. We report the identification of recurrent activating mutations in the ACVR I gene, which encodes a type I activin receptor serine/threonine kinase, in 21% of DIPG samples. Strikingly, these somatic mutations (encoding p.Arg206His, p.Arg258Gly, p.Gly328G1u, p.Gly328Val, p.Gly328Trp and p.Gly356Asp substitutions) have not been reported previously in cancer but are identical to mutations found in the germ line of individuals with the congenital childhood developmental disorder fibrodysplasia ossificans progressiva (FOP)(2) and have been shown to constitutively activate the BMP-TGF-beta signaling pathway. These mutations represent new targets for therapeutic intervention in this otherwise incurable disease.	[Taylor, Kathryn R.; Mackay, Alan; Vinci, Maria; Carvalho, Diana; Jones, Chris] Inst Canc Res, London SW3 6JB, England; [Truffaux, Nathalene; Philippe, Cathy; Castel, David; Grill, Jacques] Univ Paris Sud, CNRS, UMR 8203, Villejuif, France; [Butterfield, Yaron S.; Yip, Stephen] BC Canc Agcy, Vancouver, BC, Canada; [Morozova, Olena] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Grasso, Catherine S.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Carcaboso, Angel M.; de Torres, Carmen; Cruz, Ofelia; Mora, Jaume] Hosp San Juan Dios, Barcelona, Spain; [Entz-Werle, Natacha] Ctr Hosp Reg & Univ Hautepierre, Strasbourg, France; [Ingram, Wendy J.] Univ Queensland, Queensland Childrens Med Res Inst, Queensland Childrens Tumour Bank, Brisbane, Qld, Australia; [Monje, Michelle] Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Hargrave, Darren] Great Ormond St Hosp Sick Children, London, England; [Bullock, Alex N.] Univ Oxford, Oxford, England; [Puget, Stephanie] Necker Sick Childrens Hosp, Paris, France	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; British Columbia Cancer Agency; University of California System; University of California Santa Cruz; Oregon Health & Science University; University of Barcelona; CHU Strasbourg; University of Queensland; Stanford University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Jones, C (corresponding author), Inst Canc Res, London SW3 6JB, England.	chris.jones@icr.ac.uk; grill@igr.fr	Ingram, Wendy J/F-7317-2010; Hargrave, Darren R/H-1066-2014; PHILIPPE, Cathy/GRY-4381-2022; vinci, maria/AAI-1092-2019; Jones, Chris/ABE-6059-2021; Grill, Jacques/R-8093-2019; Castel, David/D-5353-2018; Yip, Stephen/E-9994-2012	Ingram, Wendy J/0000-0002-7063-1081; Hargrave, Darren R/0000-0001-8219-9807; vinci, maria/0000-0002-7952-6771; Jones, Chris/0000-0001-8118-2296; Castel, David/0000-0003-0247-080X; Yip, Stephen/0000-0002-8514-9861; Vaske, Olena/0000-0002-1677-417X; PHILIPPE, Cathy/0000-0002-3262-4390; Carvalho, Diana/0000-0001-6881-6151; Mora, Jaume/0000-0002-9386-5980; cruz, ofelia/0000-0001-7102-3283; Carcaboso, Angel/0000-0002-8485-426X	Cancer Research UK Genomics Initiative [A14078]; Stavros Niarchos Foundation; Abbie's Army; Lyla Nsouli Foundation; Royal Marsden Hospital Children's Department Fund; Fondo Alicia Pueyo; National Institutes of Neurological Disease and Stroke (NINDS) [K08NS070926]; Alex's Lemonade Stand Foundation; McKenna Claire Foundation; charity l'Etoile de Martin; Agence National de la Recherche; Enfants et Sante; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer; Children's Health Foundation Queensland; Brainchild Foundation; Canada Foundation for Innovation; GlaxoSmithKline, Janssen, Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; National Health Service (NHS); Cure Starts Now; Dylan Jewett; Elizabeth Stein; Connor Johnson; Zoey Ganesh Memorial Funds; Structural Genomics Consortium [1097737]; Canadian Institutes for Health Research, Genome Canada; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; Cancer Research UK [13982] Funding Source: researchfish; Rosetrees Trust [M200-F1] Funding Source: researchfish; The Brain Tumour Charity [16/193] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS070926] Funding Source: NIH RePORTER	Cancer Research UK Genomics Initiative; Stavros Niarchos Foundation; Abbie's Army; Lyla Nsouli Foundation; Royal Marsden Hospital Children's Department Fund; Fondo Alicia Pueyo; National Institutes of Neurological Disease and Stroke (NINDS); Alex's Lemonade Stand Foundation; McKenna Claire Foundation; charity l'Etoile de Martin; Agence National de la Recherche(French National Research Agency (ANR)); Enfants et Sante; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer; Children's Health Foundation Queensland; Brainchild Foundation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); GlaxoSmithKline, Janssen, Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; National Health Service (NHS); Cure Starts Now; Dylan Jewett; Elizabeth Stein; Connor Johnson; Zoey Ganesh Memorial Funds; Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research, Genome Canada; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust); The Brain Tumour Charity; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the Cancer Research UK Genomics Initiative (A14078) and makes use of data generated by the St.Jude Children's Research Hospital Washington University Pediatric Cancer Genome Project.Wears grateful to the DIPG Preclinical Consortium funded by The Cure Starts Now and the Lyla Nsouli Foundation for RNA-seq data.This work is supported by the Stavros Niarchos Foundation, Abbie's Army, the Lyla Nsouli Foundation, the Royal Marsden Hospital Children's Department Fund and Fondo Alicia Pueyo.M.M.gratefully acknowledges funding by the National Institutes of Neurological Disease and Stroke (NINDS; grant K08NS070926), Alex's Lemonade Stand Foundation, the McKenna Claire Foundation and the Dylan Jewett, Elizabeth Stein, Connor Johnson and Zoey Ganesh Memorial Funds.C.P.acknowledges funding from the Agence National de la Recherche.N.T., C.P.and J.G.acknowledge funding from the charity l'Etoile de Martin, and N.E.-W acknowledges support from Enfants et Sante.A.M.C.acknowledges funding from the Fundacion Cientifica de la Asociacion Espanola Contra el Cancer.W.J.I. acknowledges funding from the Children's Health Foundation Queensland and the Brainchild Foundation.The Structural Genomics Consortium is a registered charity (1097737) that receives funds from Abb Vie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda and the Wellcome Trust (092809/Z/10/Z). K.R.T., A.M., M.V., D.Carvalho, D.H.and C.J. acknowledge National Health Service (NHS) funding to the National Institute of Health Research Biomedical Research Centres.	Bocciardi R, 2009, EUR J HUM GENET, V17, P311, DOI 10.1038/ejhg.2008.178; Chaikuad A, 2012, J BIOL CHEM, V287, P36990, DOI 10.1074/jbc.M112.365932; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fukuda T, 2008, BIOCHEM BIOPH RES CO, V377, P905, DOI 10.1016/j.bbrc.2008.10.093; Jones C, 2012, NAT REV CLIN ONCOL, V9, P400, DOI 10.1038/nrclinonc.2012.87; Kan LX, 2012, J NEUROL, V259, P2644, DOI 10.1007/s00415-012-6563-x; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Katagiri T, 2012, J ORAL BIOSCI, V54, P119, DOI 10.1016/j.job.2012.03.004; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Petrie KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005005; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Roujeau T, 2007, J NEUROSURG, V107, P1, DOI 10.3171/PED-07/07/001; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shore EM, 2010, NAT REV RHEUMATOL, V6, P518, DOI 10.1038/nrrheum.2010.122; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Tumolo M, 2006, BRIT J ANAESTH, V97, P701, DOI 10.1093/bja/ael251; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	20	320	334	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2014	46	5					457	461		10.1038/ng.2925	http://dx.doi.org/10.1038/ng.2925			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG4XE	24705252	Green Submitted, Green Accepted			2022-12-17	WOS:000335422900011
J	Thompson, BA; Spurdle, AB; Plazzer, JP; Greenblatt, MS; Akagi, K; Al-Mulla, F; Bapat, B; Bernstein, I; Capella, G; den Dunnen, JT; du Sart, D; Fabre, A; Farrell, MP; Farrington, SM; Frayling, IM; Frebourg, T; Goldgar, DE; Heinen, CD; Holinski-Feder, E; Kohonen-Corish, M; Robinson, KL; Leung, SY; Martins, A; Moller, P; Morak, M; Nystrom, M; Peltomaki, P; Pineda, M; Qi, M; Ramesar, R; Rasmussen, LJ; Royer-Pokora, B; Scott, RJ; Sijmons, R; Tavtigian, SV; Tops, CM; Weber, T; Wijnen, J; Woods, MO; Macrae, F; Genuardi, M				Thompson, Bryony A.; Spurdle, Amanda B.; Plazzer, John-Paul; Greenblatt, Marc S.; Akagi, Kiwamu; Al-Mulla, Fahd; Bapat, Bharati; Bernstein, Inge; Capella, Gabriel; den Dunnen, Johan T.; du Sart, Desiree; Fabre, Aurelie; Farrell, Michael P.; Farrington, Susan M.; Frayling, Ian M.; Frebourg, Thierry; Goldgar, David E.; Heinen, Christopher D.; Holinski-Feder, Elke; Kohonen-Corish, Maija; Robinson, Kristina Lagerstedt; Leung, Suet Yi; Martins, Alexandra; Moller, Pal; Morak, Monika; Nystrom, Minna; Peltomaki, Paivi; Pineda, Marta; Qi, Ming; Ramesar, Rajkumar; Rasmussen, Lene Juel; Royer-Pokora, Brigitte; Scott, Rodney J.; Sijmons, Rolf; Tavtigian, Sean V.; Tops, Carli M.; Weber, Thomas; Wijnen, Juul; Woods, Michael O.; Macrae, Finlay; Genuardi, Maurizio		InSiGHT	Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database	NATURE GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; UNKNOWN CLINICAL-SIGNIFICANCE; MSH6 GERMLINE MUTATIONS; HUMAN GENOME VARIATION; LYNCH-SYNDROME; SEQUENCE VARIANTS; MICROSATELLITE INSTABILITY; COLON-CANCER; MISSENSE SUBSTITUTIONS; TUMOR CHARACTERISTICS	The clinical classification of hereditary sequence variants identified in disease-related genes directly affects clinical management of patients and their relatives. The International Society for Gastrointestinal Hereditary Tumours (InSiGHT) undertook a collaborative effort to develop, test and apply a standardized classification scheme to constitutional variants in the Lynch syndrome-associated genes MLH1, MSH2, MSH6 and PMS2. Unpublished data submission was encouraged to assist in variant classification and was recognized through microattribution. The scheme was refined by multidisciplinary expert committee review of the clinical and functional data available for variants, applied to 2,360 sequence alterations, and disseminated online. Assessment using validated criteria altered classifications for 66% of 12,006 database entries. Clinical recommendations based on transparent evaluation are now possible for 1,370 variants that were not obviously protein truncating from nomenclature. This large-scale endeavor will facilitate the consistent management of families suspected to have Lynch syndrome and demonstrates the value of multidisciplinary collaboration in the curation and classification of variants in public locus-specific databases.	[Thompson, Bryony A.; Spurdle, Amanda B.] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia; [Thompson, Bryony A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Plazzer, John-Paul; Macrae, Finlay] Royal Melbourne Hosp, Dept Colorectal Med & Genet, Melbourne, Vic, Australia; [Greenblatt, Marc S.] Univ Vermont, Coll Med, Vermont Canc Ctr, Burlington, VT USA; [Akagi, Kiwamu] Saitama Canc Ctr, Div Mol Diag & Canc Prevent, Saitama, Japan; [Al-Mulla, Fahd] Kuwait Univ, Hlth Sci Ctr, Fac Med, Dept Pathol, Safat, Kuwait; [Bapat, Bharati] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Bernstein, Inge] Danish Hereditary Nonpolyposis Colorectal Canc Re, Copenhagen, Denmark; [Bernstein, Inge] Aalborg Univ Hosp, Dept Surg Gastroenterol, Aalborg, Denmark; [Capella, Gabriel; Pineda, Marta] Bellvitge Inst Biomed Res IDIBELL, Catalan Inst Oncol, Hereditary Canc Program, Barcelona, Spain; [den Dunnen, Johan T.; Tops, Carli M.; Wijnen, Juul] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands; [du Sart, Desiree] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Mol Genet Lab, Melbourne, Vic, Australia; [Fabre, Aurelie] INSERM, Dept Med Genet & Funct Genom, UMR S910, F-13258 Marseille, France; [Farrell, Michael P.] Mater Private Hosp, Dept Canc Genet, Dublin, Ireland; [Farrington, Susan M.] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; [Frayling, Ian M.] Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; [Frebourg, Thierry; Martins, Alexandra] Univ Rouen, Inst Res & Innovat Biomed, INSERM, U1079, Rouen, France; [Frebourg, Thierry] Rouen Univ Hosp, Dept Genet, Rouen, France; [Goldgar, David E.] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [Goldgar, David E.; Tavtigian, Sean V.] Huntsman Canc Inst, Salt Lake City, UT USA; [Heinen, Christopher D.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT USA; [Heinen, Christopher D.] Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT USA; [Holinski-Feder, Elke; Morak, Monika] Med Genet Zentrum, Munich, Germany; [Holinski-Feder, Elke; Morak, Monika] Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Kohonen-Corish, Maija] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW, Australia; [Kohonen-Corish, Maija] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [Kohonen-Corish, Maija] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Robinson, Kristina Lagerstedt] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Leung, Suet Yi] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hereditary Gastrointestinal Canc Genet Diag Lab, Pokfulam, Hong Kong, Peoples R China; [Moller, Pal] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Med Genet, Res Grp Inherited Canc, Oslo, Norway; [Nystrom, Minna] Univ Helsinki, Dept Biosci, Div Genet, Helsinki, Finland; [Peltomaki, Paivi] Univ Helsinki, Haartman Inst, Dept Med Genet, Helsinki, Finland; [Qi, Ming] Zhejiang Univ, Sch Med, Affiliated Hosp 1, James Watson Inst Genom Sci,Beijing Genome Inst,C, Beijing, Peoples R China; [Qi, Ming] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA; [Ramesar, Rajkumar] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Div Human Genet,MRC,Human Genet Res Unit, ZA-7925 Cape Town, South Africa; [Rasmussen, Lene Juel] Univ Copenhagen, Ctr Healthy Aging, Copenhagen, Denmark; [Royer-Pokora, Brigitte] Univ Dusseldorf, Inst Human Genet, Dusseldorf, Germany; [Scott, Rodney J.] Univ Newcastle, Hunter Med Res Inst, Fac Hlth, Discipline Med Genet, Newcastle, NSW 2300, Australia; [Scott, Rodney J.] John Hunter Hosp, Hunter Area Pathol Serv, Div Mol Med, Newcastle, NSW, Australia; [Sijmons, Rolf] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Weber, Thomas] State Univ New York Downstate, Dept Surg, Brooklyn, NY USA; [Woods, Michael O.] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Genuardi, Maurizio] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy; [Genuardi, Maurizio] Fiorgen Fdn Pharmacogen, Florence, Italy	QIMR Berghofer Medical Research Institute; University of Queensland; Royal Melbourne Hospital; University of Vermont; Kuwait University; University of Toronto; Aalborg University; Aalborg University Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Murdoch Children's Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Mater Private Hospital; University of Edinburgh; Cardiff University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Rouen; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; University of Connecticut; University of Connecticut; University of Munich; Garvan Institute of Medical Research; Western Sydney University; University of New South Wales Sydney; Karolinska Institutet; Karolinska University Hospital; University of Hong Kong; University of Oslo; University of Helsinki; University of Helsinki; Beijing Genomics Institute (BGI); Zhejiang University; University of Rochester; University of Cape Town; University of Copenhagen; Heinrich Heine University Dusseldorf; Hunter Medical Research Institute; University of Newcastle; John Hunter Hospital; University of Groningen; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Memorial University Newfoundland; University of Florence	Genuardi, M (corresponding author), Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy.	maurizio.genuardi@unifi.it	dunnen, johan den/ABH-4228-2020; Kohonen-Corish, Maija/Q-9763-2019; Bernstein, Inge/AAD-8159-2020; Silva, Felipe/B-2943-2011; Frebourg, Thierry/AAK-8390-2020; Ward, Robyn L/I-2313-2013; Castillo, Adela Castillejo/AAD-3477-2020; Farrington, Susan M/Q-2710-2019; Zahary, Mohd Nizam/K-7280-2015; Ramesar, Raj S/I-6941-2015; Bapat, Bharati/B-5839-2014; Fabre, Aurelie/M-1660-2016; Riu, Marta Pineda/I-1497-2015; Genuardi, Maurizio/K-3049-2018; Ligtenberg, Marjolijn/N-9666-2013; Leung, Suet Yi/C-4340-2009; Capella, Gabriel/I-1879-2015; Al-Mulla, Fahd/E-2068-2015; Spurdle, Amanda B/A-4978-2011; Blanco, Ignacio/AAN-5426-2021; Martins, Alexandra/J-9592-2013; Farrington, Susan M/C-7319-2013; martinez, joaquin/AAN-6939-2020; Mensenkamp, Arjen/L-4520-2015; Viel, Alessandra/J-7116-2018; Jenkins, Mark/P-7803-2015; Scott, Rodney/B-2827-2013; Pedroni, Monica/C-9384-2015; Leung, Suet Yi/T-9620-2019; Dunlop, Malcolm/F-1973-2011	dunnen, johan den/0000-0002-6304-1710; Kohonen-Corish, Maija/0000-0002-4073-1479; Bernstein, Inge/0000-0003-4095-432X; Silva, Felipe/0000-0002-4241-3036; Ward, Robyn L/0000-0002-6877-8906; Castillo, Adela Castillejo/0000-0002-9581-6285; Farrington, Susan M/0000-0001-5955-7389; Ramesar, Raj S/0000-0001-5688-1634; Fabre, Aurelie/0000-0002-6748-0147; Riu, Marta Pineda/0000-0002-5403-5845; Genuardi, Maurizio/0000-0002-7410-8351; Ligtenberg, Marjolijn/0000-0003-1290-1474; Capella, Gabriel/0000-0002-4669-7320; Al-Mulla, Fahd/0000-0001-5409-3829; Spurdle, Amanda B/0000-0003-1337-7897; Blanco, Ignacio/0000-0002-7414-7481; Martins, Alexandra/0000-0003-4322-8497; martinez, joaquin/0000-0001-7908-0063; Mensenkamp, Arjen/0000-0003-3805-877X; Viel, Alessandra/0000-0003-2804-0840; Jenkins, Mark/0000-0002-8964-6160; Hofstra, Robert/0000-0001-7498-3829; Peltomaki, Paivi/0000-0001-8819-2980; Parsons, Michael/0000-0003-3242-8477; Scott, Rodney/0000-0001-7724-3404; Sarin, Rajiv/0000-0002-6405-8282; Nystrom, Minna/0000-0003-0827-0243; Engel, Christoph/0000-0002-7247-282X; Lagerstedt Robinson, Kristina/0000-0001-9848-0468; Rasmussen, Lene Juel/0000-0001-6864-963X; Buchanan, Daniel/0000-0003-2225-6675; Potter, John/0000-0001-5439-1500; Soto, Jose Luis/0000-0003-0234-9188; Frayling, Ian/0000-0002-3420-0794; Pedroni, Monica/0000-0001-5374-5362; Glaser, Elizabeth/0000-0002-1918-057X; Chialina, Sergio/0000-0001-5320-454X; Sexton, Adrienne/0000-0001-8749-1639; tops, funnel/0000-0003-3116-4203; TRICARICO, ROSSELLA/0000-0001-7055-7208; Frebourg, Thierry/0000-0003-0399-4007; Leung, Suet Yi/0000-0001-8614-4619; Dunlop, Malcolm/0000-0002-3033-5851; Gille, Johan/0000-0003-4526-298X; Barbera, Victor-Manuel/0000-0002-4012-6973; Thompson, Bryony/0000-0001-8655-1839; Shia, Jinru/0000-0002-4351-2511; Alenda, Cristina/0000-0002-0560-1759; Garcia-Planells, Javier/0000-0002-3224-2966; Valenzuela, Cristian/0000-0002-8694-9174; Zahary, Mohd Nizam/0000-0001-7449-2501	Cancer Council of Victoria; Cancer Council of Queensland PhD scholarship; Queensland Institute of Medical Research PhD Top-Up award; National Health and Medical Research Council Senior Research Fellow [1010859]; Cancer Australia; Tuscan Tumor Institute (ITT); Royal Melbourne Hospital Foundation; National Cancer Institute/US National Institutes of Health (NCI/US NIH) [1R01CA164944]; Ministerio de Ciencia e Innovacion [SAF 12-33636]; Fundacion Cient fica de la Asociacion Espanola Contra el Cancer; French National Cancer Institute; Institut National du Cancer (INCa) French MMR Committee; Association of International Cancer Research [12-1087]; Medical Research Council UK [MR/K018647/1]; NHS Wales National Institute for Health and Social Care (NIHSCR); Mayo Specialized Programs of Research Excellence (SPORE) grant [P50CA11620106]; US NIH [R01 CA115783-02/CA/NCI]; German Cancer Aid (Deutsche Krebshilfe); Wilhelm Sander Foundation; Cancer Institute NSW; Hong Kong Cancer Fund; Direction Generale de l'Offre des Soins (INCa/DGOS); European Research Council [FP7-ERC-232635]; Nordea-Fonden; German Cancer Aid; Canadian Cancer Society Research Institute [18223]; Cancer Research UK [12076] Funding Source: researchfish; Medical Research Council [MC_PC_U127527198, MR/K018647/1, MC_U127527198] Funding Source: researchfish; Worldwide Cancer Research [12-1087] Funding Source: researchfish; MRC [MC_U127527198, MC_PC_U127527198, MR/K018647/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [U01CA074799, UM1CA167551, R01CA164944, U01CA097735, U24CA074799, U01CA074783, U24CA074783, U24CA074794, U24CA097735, U24CA074800, U01CA074800, U01CA074794, P50CA116201, R01CA115783] Funding Source: NIH RePORTER	Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council of Queensland PhD scholarship(Cancer Council Queensland); Queensland Institute of Medical Research PhD Top-Up award; National Health and Medical Research Council Senior Research Fellow(National Health and Medical Research Council (NHMRC) of Australia); Cancer Australia; Tuscan Tumor Institute (ITT); Royal Melbourne Hospital Foundation; National Cancer Institute/US National Institutes of Health (NCI/US NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Cient fica de la Asociacion Espanola Contra el Cancer; French National Cancer Institute(Institut National du Cancer (INCA) France); Institut National du Cancer (INCa) French MMR Committee; Association of International Cancer Research; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHS Wales National Institute for Health and Social Care (NIHSCR); Mayo Specialized Programs of Research Excellence (SPORE) grant; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Wilhelm Sander Foundation; Cancer Institute NSW; Hong Kong Cancer Fund; Direction Generale de l'Offre des Soins (INCa/DGOS); European Research Council(European Research Council (ERC)European Commission); Nordea-Fonden; German Cancer Aid(Deutsche Krebshilfe); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all submitters of data to the InSiGHT database (retrospective and prospective), the Colon Cancer Family Registry and the German Hereditary Non-polyposis Colorectal Cancer Consortium for their contributions of unpublished data, acknowledged formally through microattribution. We would also like to acknowledge L. Marquart for providing statistical advice and T. O'Mara for providing advice and assistance with the statistical package R. We are extremely grateful to the Hicks Foundation (Australia) for inaugural support of InSiGHT database curator J.-P.P. Funding for VIC teleconferences was provided by the Cancer Council of Victoria. B.A.T. is supported by a Cancer Council of Queensland PhD scholarship and by a Queensland Institute of Medical Research PhD Top-Up award. A.B.S. is a National Health and Medical Research Council Senior Research Fellow. The work performed by A.B.S. and B.A.T. was additionally supported by Cancer Australia (1010859). M.G. is supported by a grant from the Tuscan Tumor Institute (ITT). J.-P.P. is currently supported by the Royal Melbourne Hospital Foundation. S.V.T., M.S.G., A.B.S., L.J.R. and R.S. are supported by grant 1R01CA164944 from the National Cancer Institute/US National Institutes of Health (NCI/US NIH). G.C. and M.P. were supported by the Ministerio de Ciencia e Innovacion (SAF 12-33636) and by the Fundacion Cient fica de la Asociacion Espanola Contra el Cancer. A.F. is supported by the French National Cancer Institute and by the Institut National du Cancer (INCa) French MMR Committee. S.M.F. is supported by grants from the Association of International Cancer Research (12-1087) and by the Medical Research Council UK (MR/K018647/1). NHS Wales National Institute for Health and Social Care (NIHSCR) funding was provided to I.M.F. via the Cardiff & Vale University Health Board. D.E.G. is supported by funding from Mayo Specialized Programs of Research Excellence (SPORE) grant P50CA11620106 (principal investigator J. Ingle). C.D.H. is funded by US NIH grant R01 CA115783-02/CA/NCI. E. H.-F. and M. M. are supported by German Cancer Aid (Deutsche Krebshilfe) and by the Wilhelm Sander Foundation. M.K.-C. is funded by Cancer Institute NSW. S.Y.L. is supported by the Hong Kong Cancer Fund. A. M. is supported by the French National Cancer Institute and by the Direction Generale de l'Offre des Soins (INCa/DGOS). The Sigrid Juselius Foundation funds M. N. Funding for P. P. is provided by the European Research Council (FP7-ERC-232635). L.J.R. is funded by Nordea-Fonden. B.R.-P. is supported by German Cancer Aid. M.O.W. was supported by the Canadian Cancer Society Research Institute (grant 18223).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnold S, 2009, HUM MUTAT, V30, P757, DOI 10.1002/humu.20936; Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; Bonadona V, 2011, JAMA-J AM MED ASSOC, V305, P2304, DOI 10.1001/jama.2011.743; Buerki N, 2012, GENE CHROMOSOME CANC, V51, P83, DOI 10.1002/gcc.20935; Couch FJ, 2008, HUM MUTAT, V29, P1314, DOI 10.1002/humu.20899; Drost M, 2012, HUM MUTAT, V33, P488, DOI 10.1002/humu.22000; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Fox BI, 2013, J BIOMED INFORM, V46, P795, DOI 10.1016/j.jbi.2013.05.006; Giardine B, 2011, NAT GENET, V43, P295, DOI 10.1038/ng.785; Goldgar DE, 2008, HUM MUTAT, V29, P1265, DOI 10.1002/humu.20897; Goldgar DE, 2004, AM J HUM GENET, V75, P535, DOI 10.1086/424388; Greenblatt MS, 2008, HUM MUTAT, V29, P1273, DOI 10.1002/humu.20889; Grindedal EM, 2009, CANCER EPIDEM BIOMAR, V18, P2460, DOI 10.1158/1055-9965.EPI-09-0058; Heinen CD, 2012, HERED CANCER CLIN PR, V10, DOI 10.1186/1897-4287-10-9; Hinrichsen I, 2013, CLIN CANCER RES, V19, P2432, DOI 10.1158/1078-0432.CCR-12-3299; Jarvinen HJ, 2009, J CLIN ONCOL, V27, P4793, DOI 10.1200/JCO.2009.23.7784; Kohonen-Corish MRJ, 2011, HUM MUTAT, V32, P491, DOI 10.1002/humu.21450; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; Leenen CHM, 2011, CLIN GENET, V80, P558, DOI 10.1111/j.1399-0004.2010.01608.x; Mangold E, 2005, INT J CANCER, V116, P692, DOI 10.1002/ijc.20863; Mead LJ, 2007, CLIN CANCER RES, V13, P2865, DOI 10.1158/1078-0432.CCR-06-2174; Ou J, 2007, HUM MUTAT, V28, P1047, DOI 10.1002/humu.20580; Patrinos GP, 2012, HUM MUTAT, V33, P1503, DOI 10.1002/humu.22144; Peltomaki P, 2004, DIS MARKERS, V20, P269, DOI 10.1155/2004/305058; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Plaschke J, 2004, J CLIN ONCOL, V22, P4486, DOI 10.1200/JCO.2004.02.033; Plazzer JP, 2013, FAM CANCER, V12, P175, DOI 10.1007/s10689-013-9616-0; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Rasmussen LJ, 2012, HUM MUTAT, V33, P1617, DOI 10.1002/humu.22168; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Scott RJ, 2001, AM J HUM GENET, V68, P118, DOI 10.1086/316942; Senter L, 2008, GASTROENTEROLOGY, V135, P419, DOI 10.1053/j.gastro.2008.04.026; Spurdle AB, 2008, HUM MUTAT, V29, P1304, DOI 10.1002/humu.20901; Spurdle AB, 2012, J MED GENET, V49, P525, DOI 10.1136/jmedgenet-2012-101037; Spurdle AB, 2010, CURR OPIN GENET DEV, V20, P315, DOI 10.1016/j.gde.2010.03.009; Takahashi M, 2007, CANCER RES, V67, P4595, DOI 10.1158/0008-5472.CAN-06-3509; Tavtigian SV, 2008, HUM MUTAT, V29, P1261, DOI 10.1002/humu.20903; Thompson BA, 2013, HUM MUTAT, V34, P255, DOI 10.1002/humu.22214; Thompson BA, 2013, HUM MUTAT, V34, P200, DOI 10.1002/humu.22213; Thompson D, 2003, AM J HUM GENET, V73, P652, DOI 10.1086/378100; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vallee MP, 2012, HUM MUTAT, V33, P22, DOI 10.1002/humu.21629; van Oers JMM, 2010, P NATL ACAD SCI USA, V107, P13384, DOI 10.1073/pnas.1008589107; Vasen HFA, 2013, GUT, V62, P812, DOI 10.1136/gutjnl-2012-304356; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Wimmer K, 2008, HUM GENET, V124, P105, DOI 10.1007/s00439-008-0542-4; Win AK, 2012, JNCI-J NATL CANCER I, V104, P1363, DOI 10.1093/jnci/djs351; Win AK, 2012, J CLIN ONCOL, V30, P958, DOI 10.1200/JCO.2011.39.5590; Woods MO, 2007, HUM MUTAT, V28, P669, DOI 10.1002/humu.20502; Wu Y, 1999, AM J HUM GENET, V65, P1291, DOI 10.1086/302612; Xie J, 2010, CANCER PREV RES, V3, P1409, DOI 10.1158/1940-6207.CAPR-10-0118; You JF, 2010, BRIT J CANCER, V103, P1840, DOI 10.1038/sj.bjc.6605988	55	320	324	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2014	46	2					107	+		10.1038/ng.2854	http://dx.doi.org/10.1038/ng.2854			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AA6KX	24362816	Green Accepted			2022-12-17	WOS:000331208300006
J	Bellenguez, C; Bevan, S; Gschwendtner, A; Spencer, CCA; Burgess, AI; Pirinen, M; Jackson, CA; Traylor, M; Strange, A; Su, Z; Band, G; Syme, PD; Malik, R; Pera, J; Norrving, B; Lemmens, R; Freeman, C; Schanz, R; James, T; Poole, D; Murphy, L; Segal, H; Cortellini, L; Cheng, YC; Woo, D; Nalls, MA; Muller-Myhsok, B; Meisinger, C; Seedorf, U; Ross-Adams, H; Boonen, S; Wloch-Kopec, D; Valant, V; Slark, J; Furie, K; Delavaran, H; Langford, C; Deloukas, P; Edkins, S; Hunt, S; Gray, E; Dronov, S; Peltonen, L; Gretarsdottir, S; Thorleifsson, G; Thorsteinsdottir, U; Stefansson, K; Boncoraglio, GB; Parati, EA; Attia, J; Holliday, E; Levi, C; Franzosi, MG; Goel, A; Helgadottir, A; Blackwell, JM; Bramon, E; Brown, MA; Casas, JP; Corvin, A; Duncanson, A; Jankowski, J; Mathew, CG; Palmer, CNA; Plomin, R; Rautanen, A; Sawcer, SJ; Trembath, RC; Viswanathan, AC; Wood, NW; Worrall, BB; Kittner, SJ; Mitchell, BD; Kissela, B; Meschia, JF; Thijs, V; Lindgren, A; Macleod, MJ; Slowik, A; Walters, M; Rosand, J; Sharma, P; Farrall, M; Sudlow, CLM; Rothwell, PM; Dichgans, M; Donnelly, P; Markus, HS				Bellenguez, Celine; Bevan, Steve; Gschwendtner, Andreas; Spencer, Chris C. A.; Burgess, Annette I.; Pirinen, Matti; Jackson, Caroline A.; Traylor, Matthew; Strange, Amy; Su, Zhan; Band, Gavin; Syme, Paul D.; Malik, Rainer; Pera, Joanna; Norrving, Bo; Lemmens, Robin; Freeman, Colin; Schanz, Renata; James, Tom; Poole, Deborah; Murphy, Lee; Segal, Helen; Cortellini, Lynelle; Cheng, Yu-Ching; Woo, Daniel; Nalls, Michael A.; Mueller-Myhsok, Bertram; Meisinger, Christa; Seedorf, Udo; Ross-Adams, Helen; Boonen, Steven; Wloch-Kopec, Dorota; Valant, Valerie; Slark, Julia; Furie, Karen; Delavaran, Hossein; Langford, Cordelia; Deloukas, Panos; Edkins, Sarah; Hunt, Sarah; Gray, Emma; Dronov, Serge; Peltonen, Leena; Gretarsdottir, Solveig; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Kari; Boncoraglio, Giorgio B.; Parati, Eugenio A.; Attia, John; Holliday, Elizabeth; Levi, Chris; Franzosi, Maria-Grazia; Goel, Anuj; Helgadottir, Anna; Blackwell, Jenefer M.; Bramon, Elvira; Brown, Matthew A.; Casas, Juan P.; Corvin, Aiden; Duncanson, Audrey; Jankowski, Janusz; Mathew, Christopher G.; Palmer, Colin N. A.; Plomin, Robert; Rautanen, Anna; Sawcer, Stephen J.; Trembath, Richard C.; Viswanathan, Ananth C.; Wood, Nicholas W.; Worrall, Bradford B.; Kittner, Steven J.; Mitchell, Braxton D.; Kissela, Brett; Meschia, James F.; Thijs, Vincent; Lindgren, Arne; Macleod, Mary Joan; Slowik, Agnieszka; Walters, Matthew; Rosand, Jonathan; Sharma, Pankaj; Farrall, Martin; Sudlow, Cathie L. M.; Rothwell, Peter M.; Dichgans, Martin; Donnelly, Peter; Markus, Hugh S.		ISGC; WTCCC2	Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke	NATURE GENETICS			English	Article							ATRIAL-FIBRILLATION; HISTONE DEACETYLASES; SUSCEPTIBILITY LOCI; ALGORITHM; GENETICS; DISEASE; SIGNALS; ROLES; RISK	Genetic factors have been implicated in stroke risk, but few replicated associations have been reported. We conducted a genome-wide association study (GWAS) for ischemic stroke and its subtypes in 3,548 affected individuals and 5,972 controls, all of European ancestry. Replication of potential signals was performed in 5,859 affected individuals and 6,281 controls. We replicated previous associations for cardioembolic stroke near PITX2 and ZFHX3 and for large vessel stroke at a 9p21 locus. We identified a new association for large vessel stroke within HDAC9 (encoding histone deacetylase 9) on chromosome 7p21.1 (including further replication in an additional 735 affected individuals and 28,583 controls) (rs11984041; combined P = 1.87 x 10(-11); odds ratio (OR) = 1.42, 95% confidence interval (CI) = 1.28-1.57). All four loci exhibited evidence for heterogeneity of effect across the stroke subtypes, with some and possibly all affecting risk for only one subtype. This suggests distinct genetic architectures for different stroke subtypes.	[Bellenguez, Celine; Spencer, Chris C. A.; Pirinen, Matti; Strange, Amy; Su, Zhan; Band, Gavin; Freeman, Colin; Goel, Anuj; Helgadottir, Anna; Rautanen, Anna; Farrall, Martin; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Bevan, Steve; Traylor, Matthew; James, Tom; Markus, Hugh S.] St Georges Univ London, Stroke & Dementia Res Grp, London, England; [Gschwendtner, Andreas; Malik, Rainer; Dichgans, Martin] Univ Munich, Univ Munchen Klinikum, Inst Stroke & Dementia Res, Munich, Germany; [Burgess, Annette I.; Poole, Deborah; Segal, Helen; Rothwell, Peter M.] Univ Oxford, Nuffield Dept Clin Neurosci, Stroke Prevent Res Unit, Oxford, England; [Jackson, Caroline A.; Sudlow, Cathie L. M.] Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland; [Syme, Paul D.; Macleod, Mary Joan] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland; [Pera, Joanna; Ross-Adams, Helen; Wloch-Kopec, Dorota; Slowik, Agnieszka] Jagiellonian Univ, Coll Med, Dept Neurol, Krakow, Poland; [Norrving, Bo; Delavaran, Hossein; Lindgren, Arne] Lund Univ, Dept Clin Sci, Lund, Sweden; [Norrving, Bo; Delavaran, Hossein; Lindgren, Arne] Skane Univ Hosp, Dept Neurol, Lund, Sweden; [Lemmens, Robin; Thijs, Vincent] Univ Hosp Leuven, Dept Neurol, Louvain, Belgium; [Lemmens, Robin; Thijs, Vincent] VIB, Vesalius Res Ctr, Louvain, Belgium; [Schanz, Renata; Slark, Julia; Sharma, Pankaj] Univ London Imperial Coll Sci Technol & Med, ICCRU, London, England; [Murphy, Lee] Univ Edinburgh, Western Gen Hosp, Wellcome Trust Clin Res Facil Genet Core Lab, Edinburgh, Midlothian, Scotland; [Cortellini, Lynelle; Valant, Valerie; Furie, Karen; Rosand, Jonathan] Massachusetts Gen Hosp, Dept Neurol, Ctr Human Genet Res, Boston, MA 02114 USA; [Cortellini, Lynelle; Valant, Valerie; Rosand, Jonathan] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Cheng, Yu-Ching; Mitchell, Braxton D.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Cheng, Yu-Ching; Mitchell, Braxton D.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Woo, Daniel; Kissela, Brett] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA; [Nalls, Michael A.] NIA, Neurogenet Lab, Intramural Res Program, Bethesda, MD 20892 USA; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Meisinger, Christa] German Res Ctr Environm Hlth, Inst Epidemiol 2, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Seedorf, Udo] Univ Munster, Leibniz Inst Arterioskleroseforsch, Munster, Germany; [Boonen, Steven] Univ Hosp Leuven, Div Geriatr Med, Louvain, Belgium; [Langford, Cordelia; Deloukas, Panos; Edkins, Sarah; Hunt, Sarah; Gray, Emma; Dronov, Serge; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Gretarsdottir, Solveig; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Kari; Helgadottir, Anna] deCODE Genet, Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Boncoraglio, Giorgio B.; Parati, Eugenio A.] Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Ist Neurol Carlo Besta, Milan, Italy; [Attia, John; Holliday, Elizabeth; Levi, Chris] Univ Newcastle, Hunter Med Res Inst, Ctr Brain & Mental Hlth Res, Newcastle, NSW 2300, Australia; [Franzosi, Maria-Grazia] Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy; [Goel, Anuj; Helgadottir, Anna; Farrall, Martin] Univ Oxford, Dept Cardiovasc Med, Oxford, England; [Blackwell, Jenefer M.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA, Australia; [Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge, England; [Bramon, Elvira] Kings Coll London, Inst Psychiat, Biomed Res Ctr Mental Hlth, Div Psychol Med & Psychiat, London WC2R 2LS, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Casas, Juan P.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Jankowski, Janusz] Barts & London Queen Marys Sch Med & Dent, Ctr Gastroenterol, London, England; [Jankowski, Janusz] Univ Oxford, Div Clin Pharmacol, Oxford, England; [Mathew, Christopher G.; Trembath, Richard C.] Kings Coll London, Guys Hosp, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Viswanathan, Ananth C.] Natl Hlth Serv NHS Fdn Trust, Moorfields Eye Hosp, Biomed Res Ctr Ophthalmol, Natl Inst Hlth Res NIHR, London, England; [Viswanathan, Ananth C.] UCL, Inst Ophthalmol, London, England; [Wood, Nicholas W.] UCL, Inst Neurol, Dept Mol Neuroscience, London, England; [Worrall, Bradford B.] Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA 22908 USA; [Worrall, Bradford B.] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Kittner, Steven J.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Kittner, Steven J.] Baltimore Vet Affairs Med Ctr, Baltimore Geriatr Res Educ & Clin Ctr, Baltimore, MD USA; [Meschia, James F.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Walters, Matthew] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; Wellcome Centre for Human Genetics; St Georges University London; University of Munich; University of Oxford; University of Edinburgh; University of Aberdeen; Jagiellonian University; Collegium Medicum Jagiellonian University; Lund University; Lund University; Skane University Hospital; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); Imperial College London; University of Edinburgh; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munster; KU Leuven; University Hospital Leuven; Wellcome Trust Sanger Institute; University of Iceland; IRCCS Istituto Neurologico Besta; Hunter Medical Research Institute; University of Newcastle; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Oxford; University of Western Australia; University of Cambridge; University of London; King's College London; University of Queensland; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Trinity College Dublin; University of London; Queen Mary University London; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Dundee; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Virginia; University of Virginia; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Mayo Clinic; University of Glasgow; University of Oxford	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	peter.donnelly@well.ox.ac.uk; hmarkus@sgul.ac.uk	Wood, Nicholas W/C-2505-2009; Deloukas, Panos/B-2922-2013; Bramon, Elvira/HHC-3809-2022; Rothwell, Peter/ABE-5913-2020; Plomin, Robert/B-8911-2008; Stefansson, Kari/AAE-7187-2019; Meschia, James/GPP-1636-2022; Mathew, Christopher G/G-3434-2015; Bramon, Elvira/A-9463-2011; Study, GoDARTS/K-9448-2016; Mitchell, Braxton/CAF-0876-2022; Belllenguez, Céline/Y-3183-2018; Parati, Eugenio Agostino/AAN-5893-2021; Bellenguez, Céline/X-4004-2019; Sander-Effron, Samuel/AAX-2231-2020; Müller-Myhsok, Bertram/A-3289-2013; Attia, John R/F-5376-2013; sharma, pankaj/HGE-4423-2022; Pera, Joanna/U-5552-2018; Boncoraglio, Giorgio Battista/B-8647-2011; Dichgans, Martin/HCH-3247-2022; Jackson, Caroline/B-5954-2012; Thijs, Vincent/C-3647-2009; Brown, Matthew A/E-5749-2010; Palmer, Colin NA/C-7053-2008; Blackwell, Jenefer M/H-3015-2015; Meisinger, Christine/B-5358-2014; Jankowski, Janusz/H-2706-2012	Wood, Nicholas W/0000-0002-9500-3348; Deloukas, Panos/0000-0001-9251-070X; Bramon, Elvira/0000-0003-1369-5983; Rothwell, Peter/0000-0001-9739-9211; Meschia, James/0000-0002-4475-8142; Mathew, Christopher G/0000-0003-4178-1838; Belllenguez, Céline/0000-0002-1240-7874; Parati, Eugenio Agostino/0000-0001-5020-6523; Bellenguez, Céline/0000-0002-1240-7874; Attia, John R/0000-0001-9800-1308; Pera, Joanna/0000-0001-6142-2969; Boncoraglio, Giorgio Battista/0000-0002-2551-525X; Dichgans, Martin/0000-0002-0654-387X; Jackson, Caroline/0000-0002-2067-2811; Thijs, Vincent/0000-0002-6614-8417; Brown, Matthew A/0000-0003-0538-8211; Palmer, Colin NA/0000-0002-6415-6560; Jankowski, Janusz/0000-0003-2130-9181; Traylor, Matthew/0000-0001-6624-8621; Norrving, Bo/0000-0002-8024-5096; Corvin, Aiden/0000-0001-6717-4089; Seedorf, Udo/0000-0003-4652-5358; Levi, Christopher/0000-0002-9474-796X; Pirinen, Matti/0000-0002-1664-1350; Lemmens, Robin/0000-0002-4948-5956; Sudlow, Cathie/0000-0002-7725-7520; Walters, James/0000-0002-6980-4053; Meisinger, Christa/0000-0002-9026-6544; Plomin, Robert/0000-0002-0756-3629; Bevan, Steve/0000-0003-0490-6830; Murphy, Lee/0000-0001-6467-7449; Macleod, Mary Joan/0000-0003-2115-8184; Edkins, Sarah/0000-0003-0717-1972; Mitchell, Braxton/0000-0003-4920-4744; Slark, Julia/0000-0003-4261-3254; Ross-Adams, Helen/0000-0003-1338-742X; Trembath, Richard/0000-0003-0550-3400; Kissela, Brett/0000-0002-9773-4013; Malik, Rainer/0000-0001-9212-2520; Hunt, Sarah/0000-0002-8350-1235	Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02, 085475/B/08/Z, 085475/Z/08/Z, WT084724MA, WTCCC2]; Medical Research Council [G1001799, G9817803B, G0901310] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/016, NF-SI-0507-10379] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; MRC [G0000934, G1001799, G0901310] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Bertrand, J. Bryant, S. L. Clark, J. S. Conquer, T. Dibling, J. C. Eldred, S. Gamble, C. Hind, M. L. Perez, C. R. Stribling, S. Taylor and A. Wilk of the Wellcome Trust Sanger Institute's Sample and Genotyping Facilities for technical assistance. We acknowledge use of the British 1958 Birth Cohort DNA collection, which is funded by the Medical Research Council (G0000934) and the Wellcome Trust (068545/Z/02), and of the UK National Blood Service controls funded by the Wellcome Trust. We thank W. Bodmer and B. Winney for use of the People of the British Isles DNA collection, which was funded by the Wellcome Trust. We thank the following individuals who contributed to collection, phenotyping, sample processing and data management for the different cohorts: A. Burgess, A. Syed and N. Paul (Oxford Vascular Study); M. Dennis, P. Sandercock, C. Warlow, S. Hart, S. Keir, J. Wardlaw, A. Farrall, G. Potter, A. Hutchison and M. McDowall (Edinburgh Stroke Study); A. Pasdar and H. Clinkscale (Aberdeen); P. Higgins (Glasgow); T. G. Brott, R. D. Brown, S. Silliman, M. Frankel, D. Case, S. Rich, J. Hardy, A. Singleton (ISGS); M. J. Sparks, K. Ryan, J. Cole, M. Wozniak, B. Stern, R. Wityk, C. Johnson and D. Buchholz (GEOS); and J. Maguire, S. Koblar, J. Golledge, J. Surm, G. Hankey, J. Jannes, M. Lewis, R. Scott, L. Lincz; P. Moscato and R. Baker (Australian Stroke Genetics Collaborative membership). The principal funding for this study was provided by the Wellcome Trust as part of the WTCCC2 project (085475/B/08/Z, 085475/Z/08/Z and WT084724MA). For details of other funding support, see the Supplementary Note.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen Kuo, 2010, Beijing Da Xue Xue Bao Yi Xue Ban, V42, P498; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Department of Health, 2005, RED BRAIN DAM FAST A; Dichgans M, 2007, LANCET NEUROL, V6, P149, DOI 10.1016/S1474-4422(07)70028-5; Glaser KB, 2003, MOL CANCER THER, V2, P151; Gretarsdottir S, 2008, ANN NEUROL, V64, P402, DOI 10.1002/ana.21480; Gschwendtner A, 2009, ANN NEUROL, V65, P531, DOI 10.1002/ana.21590; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Jerrard-Dunne P, 2003, STROKE, V34, P1364, DOI 10.1161/01.STR.0000069723.17984.FD; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kubo M, 2007, NAT GENET, V39, P212, DOI 10.1038/ng1945; Langley B, 2009, STROKE, V40, P2899, DOI 10.1161/STROKEAHA.108.540229; Lemmens R, 2010, STROKE, V41, P1850, DOI 10.1161/STROKEAHA.110.587980; Markus HS, 2010, TRANSL STROKE RES, V1, P238, DOI 10.1007/s12975-010-0041-5; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Olsson S, 2011, STROKE, V42, P214, DOI 10.1161/STROKEAHA.110.594010; Rosand J, 2010, NEW ENGL J MED, V362, P1547, DOI 10.1056/NEJMc0910050; SACCO RL, 1989, ANN NEUROL, V25, P382, DOI 10.1002/ana.410250410; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Su Z, 2009, STAT SCI, V24, P430, DOI 10.1214/09-STS311; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609	30	320	324	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2012	44	3					328	U141		10.1038/ng.1081	http://dx.doi.org/10.1038/ng.1081			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	899VC	22306652	Green Accepted, Green Submitted			2022-12-17	WOS:000300843600021
J	Pfeufer, A; van Noord, C; Marciante, KD; Arking, DE; Larson, MG; Smith, AV; Tarasov, KV; Muller, M; Sotoodehnia, N; Sinner, MF; Verwoert, GC; Li, M; Kao, WHL; Kottgen, A; Coresh, J; Bis, JC; Psaty, BM; Rice, K; Rotter, JI; Rivadeneira, F; Hofman, A; Kors, JA; Stricker, BHC; Uitterlinden, AG; van Duijn, CM; Beckmann, BM; Sauter, W; Gieger, C; Lubitz, SA; Newton-Cheh, C; Wang, TJ; Magnani, JW; Schnabel, RB; Chung, MK; Barnard, J; Smith, JD; Van Wagoner, DR; Vasan, RS; Aspelund, T; Eiriksdottir, G; Harris, TB; Launer, LJ; Najjar, SS; Lakatta, E; Schlessinger, D; Uda, M; Abecasis, GR; Muller-Myhsok, B; Ehret, GB; Boerwinkle, E; Chakravarti, A; Soliman, EZ; Lunetta, KL; Perz, S; Wichmann, HE; Meitinger, T; Levy, D; Gudnason, V; Ellinor, PT; Sanna, S; Kaab, S; Witteman, JCM; Alonso, A; Benjamin, EJ; Heckbert, SR				Pfeufer, Arne; van Noord, Charlotte; Marciante, Kristin D.; Arking, Dan E.; Larson, Martin G.; Smith, Albert Vernon; Tarasov, Kirill V.; Mueller, Martina; Sotoodehnia, Nona; Sinner, Moritz F.; Verwoert, Germaine C.; Li, Man; Kao, W. H. Linda; Koettgen, Anna; Coresh, Josef; Bis, Joshua C.; Psaty, Bruce M.; Rice, Kenneth; Rotter, Jerome I.; Rivadeneira, Fernando; Hofman, Albert; Kors, Jan A.; Stricker, Bruno H. C.; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Beckmann, Britt M.; Sauter, Wiebke; Gieger, Christian; Lubitz, Steven A.; Newton-Cheh, Christopher; Wang, Thomas J.; Magnani, Jared W.; Schnabel, Renate B.; Chung, Mina K.; Barnard, John; Smith, Jonathan D.; Van Wagoner, David R.; Vasan, Ramachandran S.; Aspelund, Thor; Eiriksdottir, Gudny; Harris, Tamara B.; Launer, Lenore J.; Najjar, Samer S.; Lakatta, Edward; Schlessinger, David; Uda, Manuela; Abecasis, Goncalo R.; Mueller-Myhsok, Bertram; Ehret, Georg B.; Boerwinkle, Eric; Chakravarti, Aravinda; Soliman, Elsayed Z.; Lunetta, Kathryn L.; Perz, Siegfried; Wichmann, H-Erich; Meitinger, Thomas; Levy, Daniel; Gudnason, Vilmundur; Ellinor, Patrick T.; Sanna, Serena; Kaeaeb, Stefan; Witteman, Jacqueline C. M.; Alonso, Alvaro; Benjamin, Emelia J.; Heckbert, Susan R.			Genome-wide association study of PR interval	NATURE GENETICS			English	Article							ATRIAL-FIBRILLATION; COMMON VARIANTS; SODIUM-CHANNEL; HEART-RATE; ATHEROSCLEROSIS RISK; NATIONAL HEART; SYSTEM; DESIGN; INDIVIDUALS; VARIABILITY	The electrocardiographic PR interval (or PQ interval) reflects atrial and atrioventricular nodal conduction, disturbances of which increase risk of atrial fibrillation. We report a meta-nalysis of genome-wide association studies for PR interval from seven population-based European studies in the CHARGE Consortium: AGES, ARIC, CHS, FHS, KORA, Rotterdam Study, and SardiNIA (N = 28,517). We identified nine loci associated with PR interval at P < 5 x 10(-8). At the 3p22.2 locus, we observed two independent associations in voltage-gated sodium channel genes, SCN10A and SCN5A. Six of the loci were near cardiac developmental genes, including CAV1-CAV2, NKX25 (CSX1), SOX5, WNT11, MEIS1, and TBX5-TBX3, providing pathophysiologically interesting candidate genes. Five of the loci, SCN5A, SCN10A, NKX2-5, CAV1-CAV2, and SOX5, were also associated with atrial fibrillation (N = 5,741 cases, P < 0.0056). This suggests a role for common variation in ion channel and developmental genes in atrial and atrioventricular conduction as well as in susceptibility to atrial fibrillation.	[Pfeufer, Arne; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-80804 Munich, Germany; [Pfeufer, Arne; Meitinger, Thomas] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [van Noord, Charlotte; Verwoert, Germaine C.; Rivadeneira, Fernando; Hofman, Albert; Stricker, Bruno H. C.; Uitterlinden, Andre G.; van Duijn, Cornelia M.; Witteman, Jacqueline C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [van Noord, Charlotte] Dutch Med Evaluat Board, The Hague, Netherlands; [van Noord, Charlotte; Witteman, Jacqueline C. M.] Netherlands Consortium Healthy Aging Leiden, Leiden, Netherlands; [Sotoodehnia, Nona] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Arking, Dan E.; Ehret, Georg B.; Chakravarti, Aravinda] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Larson, Martin G.; Wang, Thomas J.; Schnabel, Renate B.; Vasan, Ramachandran S.; Levy, Daniel; Benjamin, Emelia J.] Natl Heart Lung & Blood Inst Framingham Heart Stu, Framingham, MA USA; [Smith, Albert Vernon; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Heart Prevent Clin & Res Inst, Iceland Heart Assoc, Kopavogur, Iceland; [Tarasov, Kirill V.; Najjar, Samer S.; Lakatta, Edward] NIA, Cardiovasc Sci Lab, Baltimore, MD 21224 USA; [Tarasov, Kirill V.; Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Mueller, Martina; Sauter, Wiebke; Gieger, Christian; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Mueller, Martina; Sinner, Moritz F.; Beckmann, Britt M.; Kaeaeb, Stefan] Univ Munich, Klinikum Grosshadern, Dept Med 1, D-80804 Munich, Germany; [Verwoert, Germaine C.; Rivadeneira, Fernando; Stricker, Bruno H. C.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Li, Man; Kao, W. H. Linda; Koettgen, Anna; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Psaty, Bruce M.; Heckbert, Susan R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.; Heckbert, Susan R.] Grp Hlth Res Inst, Seattle, WA USA; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Dept Common Dis Genet Program, Inst Med Genet, W Hollywood, CA USA; [Kors, Jan A.] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Stricker, Bruno H. C.] Inspectorate Hlth Care, The Hague, Netherlands; [Lubitz, Steven A.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Lubitz, Steven A.; Newton-Cheh, Christopher; Wang, Thomas J.; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Ellinor, Patrick T.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Wang, Thomas J.; Ellinor, Patrick T.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Schnabel, Renate B.] Johannes Gutenberg Univ Mainz, Med Clin Cardiol 2, Mainz, Germany; [Chung, Mina K.; Barnard, John; Smith, Jonathan D.; Van Wagoner, David R.] Cleveland Clin, Heart & Vasc Res Inst, Cleveland, OH 44106 USA; [Chung, Mina K.; Barnard, John; Smith, Jonathan D.; Van Wagoner, David R.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Heart Prevent Clin & Res Inst, Reykjavik, Iceland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol Demog & Biometry, Baltimore, MD 21224 USA; [Uda, Manuela; Sanna, Serena] CNR, Ist Neurogenet Neurofarmacol, Cagliari, Italy; [Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Chakravarti, Aravinda] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Soliman, Elsayed Z.] Wake Forest Univ, Div Publ Hlth Sci, Dept Epidemiol & Prevent, Epidemiol Cardiol Res Ctr EPICARE,Med Ctr, Winston Salem, NC 27109 USA; [Perz, Siegfried] Helmholtz Ctr, Inst Biol & Med Imaging, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, Munich, Germany; [Lunetta, Kathryn L.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Cardiol & Prevent Med Div,Evans Dept Med, Boston, MA 02118 USA	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; Johns Hopkins University; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Icelandic Heart Association; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Erasmus University Rotterdam; Erasmus MC; Johns Hopkins University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Johannes Gutenberg University of Mainz; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Consiglio Nazionale delle Ricerche (CNR); University of Michigan System; University of Michigan; Max Planck Society; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; Wake Forest University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Minnesota System; University of Minnesota Twin Cities; Boston University; Boston University	Pfeufer, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-80804 Munich, Germany.	arne.pfeufer@web.de; heckbert@u.washington.edu	Meitinger, Thomas/O-1318-2015; Schnabel, Renate B/F-6527-2014; Rice, Kenneth M/A-4150-2013; Soliman, Elsayed Z/AAD-7135-2020; Schnabel, Renate B/ABE-6668-2021; Alonso, Alvaro/A-4917-2010; Soliman, Elsayed/D-8124-2011; Rotter, Jerome/AAY-6598-2021; Wichmann, Heinz Erich/AAA-5695-2022; sanna, serena/H-3009-2019; Rivadeneira, Fernando/O-5385-2015; Van Wagoner, David R/C-6783-2008; Levy, Daniel/ABF-6873-2021; EHRET, Georg B/A-9532-2009; Uda, Manuela/AAC-2645-2019; Lakatta, Edward G/AAL-1447-2020; Li, Man/AAX-3400-2020; Kaab, Stefan/H-3915-2012; Aspelund, Thor/F-4826-2011; Smith, Albert Vernon/K-5150-2015; Aspelund, Thor/C-5983-2008; Aspelund, Thor/K-7022-2019; Ramachandran, Vasan/Y-2527-2019; Müller-Nurasyid, Martina/I-8735-2018; Gudnason, Vilmundur/K-6885-2015; Müller-Myhsok, Bertram/A-3289-2013; Abecasis, Goncalo R/B-7840-2010; Levy, Daniel/ABB-2752-2021; Pfeufer, Arne/B-6634-2013; Sinner, Moritz/AAW-5043-2020; Kottgen, Anna/D-2920-2012; Launer, Lenore J/A-8218-2010; Gudnason, Vilmundur/AAE-7126-2019; Smith, Jonathan D./H-9723-2013; Benjamin, Emelia/E-7103-2011	Rice, Kenneth M/0000-0001-5779-4495; Soliman, Elsayed Z/0000-0001-5632-8150; Schnabel, Renate B/0000-0001-7170-9509; Alonso, Alvaro/0000-0002-2225-8323; Soliman, Elsayed/0000-0001-5632-8150; sanna, serena/0000-0002-3768-1749; Rivadeneira, Fernando/0000-0001-9435-9441; Van Wagoner, David R/0000-0001-8250-9828; Levy, Daniel/0000-0003-1843-8724; EHRET, Georg B/0000-0002-5730-0675; Uda, Manuela/0000-0002-4890-6456; Li, Man/0000-0002-3839-0281; Smith, Albert Vernon/0000-0003-1942-5845; Aspelund, Thor/0000-0002-7998-5433; Aspelund, Thor/0000-0002-7998-5433; Ramachandran, Vasan/0000-0001-7357-5970; Müller-Nurasyid, Martina/0000-0003-3793-5910; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Tarasov, Kirill/0000-0001-7799-4670; Gieger, Christian/0000-0001-6986-9554; Larson, Martin/0000-0002-9631-1254; Smith, Jonathan D./0000-0002-0415-386X; Lakatta, Edward/0000-0002-4772-0035; Wang, Thomas/0000-0003-4063-6508; Ellinor, Patrick/0000-0002-2067-0533; Benjamin, Emelia/0000-0003-4076-2336; Meitinger, Thomas/0000-0002-8838-8403; Van Duijn, Cornelia/0000-0002-2374-9204; Ballantyne, Christie/0000-0002-6432-1730; Lunetta, Kathryn/0000-0002-9268-810X; Abecasis, Goncalo/0000-0003-1509-1825	US National Institutes of Health [N01-AG-12100]; US National Institute on Aging (NIA); Hjartavernd (Icelandic Heart Association); Althingi (Icelandic parliament); US National Heart, Lung, and Blood Institute (NHLBI); US National Eye Institute; US National Institute on Deafness and Other Communication Disorders; NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55022, R01-HL-087641, R01-HL-59367, R01-HL-086694, R01-HL-054512, R01-HL090620, P50-HL077107, N01-HC85079, N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, U01-HL-080295, R01-HL-087652]; US National Human Genome Research Institute (NHGRI) [U01-HG004402]; NIH [HHSN268200625226C, UL1-RR025005, N01-HC-25195, HL-076784, AG-028321, N01-HC25195, HL-080025, 6R01-NS-17950]; Donald W. Reynolds Cardiovascular Clinical Research Center; Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic; US National Center for Research Resources [M01-RR-00425]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; US National Institute of Neurological Disorders and Stroke; Cedars-Sinai Board of Governors; Boston University School of Medicine and Boston Medical Center (LINGA-II); Robert Dawson Evans Endowment; Doris Duke Charitable Foundation; Deutsche Forschungsgemeinschaft [SCHN 1149/1-1]; Pfizer; Bundesministerium fur Bildung und Forschung Nationales Genomforschungsnetz; Leducq Foundation [07-03 Ludvig 03]; Ludwig-Maximilians University (LMU) [FuFoLe 557/569]; Helmholtz Zentrum Munchen fur Gesundheit und Umwelt; The Netherlands Organisation for Scientific Research [175.010.2005.011, 911.03.012, 050-060-810]; European Commission; Erasmus Medical Center, Erasmus University Rotterdam; NIA [NO1-AG-1-2109, 263-MA-410953];  [01-GS-0499];  [01-GR-0103];  [01-GR-0803];  [AFNET 01-GI-0204 01-GS-0838]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675, ZIAAG007270, ZIAAG000799, ZIAAG006000] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hjartavernd (Icelandic Heart Association); Althingi (Icelandic parliament); US National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Cardiovascular Clinical Research Center; Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic; US National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Cedars-Sinai Board of Governors; Boston University School of Medicine and Boston Medical Center (LINGA-II); Robert Dawson Evans Endowment; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Pfizer(Pfizer); Bundesministerium fur Bildung und Forschung Nationales Genomforschungsnetz(Federal Ministry of Education & Research (BMBF)); Leducq Foundation(Leducq Foundation); Ludwig-Maximilians University (LMU); Helmholtz Zentrum Munchen fur Gesundheit und Umwelt; The Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Commission(European CommissionEuropean Commission Joint Research Centre); Erasmus Medical Center, Erasmus University Rotterdam; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge all of the participants in the studies. AGES: US National Institutes of Health (NIH) N01-AG-12100, US National Institute on Aging (NIA) and NIH Intramural Research Programs, Hjartavernd (Icelandic Heart Association), Althingi (Icelandic parliament), US National Heart, Lung, and Blood Institute (NHLBI), US National Eye Institute and US National Institute on Deafness and Other Communication Disorders. ARIC: NHLBI N01-HC-55015, N01-HC-55016, N01-HC-55018 through N01-HC-55022, R01-HL-087641, R01-HL-59367, R01-HL-086694 and R01-HL-054512; US National Human Genome Research Institute (NHGRI) U01-HG004402; NIH HHSN268200625226C; and the Donald W. Reynolds Cardiovascular Clinical Research Center. Infrastructure was supported by NIH UL1-RR025005. CCAF: NHLBI R01-HL090620 and P50-HL077107, and intramural funding from the Heart and Vascular Institute, Department of Cardiovascular Medicine, Cleveland Clinic. CHS: NHLBI N01-HC85079 through N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, U01-HL-080295, R01-HL-087652 and R01-HL088456; US National Center for Research Resources M01-RR-00425; National Institute of Diabetes and Digestive and Kidney Diseases DK063491; US National Institute of Neurological Disorders and Stroke; and the Cedars-Sinai Board of Governors. FHS: NIH N01-HC-25195, HL-076784, AG-028321, N01-HC25195, HL-080025 and 6R01-NS-17950; NHLBI N01-HC-25195; Boston University School of Medicine and Boston Medical Center (LINGA-II); the Robert Dawson Evans Endowment; the Doris Duke Charitable Foundation; the SHARe project; Deutsche Forschungsgemeinschaft fellowship SCHN 1149/1-1; Affymetrix contract for genotyping services (N02-HL-6-4278); and Pfizer. KORA/AFNET: We thank B. Putz, M. Putz and G. Fischer for their contributions to genotyping and imputation. Bundesministerium fur Bildung und Forschung Nationales Genomforschungsnetz; 01-GS-0499, 01-GR-0103, 01-GR-0803, AFNET 01-GI-0204 01-GS-0838, the Leducq Foundation 07-03 Ludvig 03, Ludwig-Maximilians University (LMU) FuFoLe 557/569, the LMU Excellence Initiative, MC Health as part of LMUinnovativ, the Helmholtz Zentrum Munchen fur Gesundheit und Umwelt and the state of Bavaria. Rotterdam Study: We thank P. Arp, M. Jhamai, M. Moorhouse, M. Verkerk and S. Bervoets for their help in creating the database, K. Estrada for his help with the analyses and M. Struchalin for contributions to genotype imputation. Nederlandse Organisatie voor Wetenschappelijk Onderzoek (The Netherlands Organisation for Scientific Research) 175.010.2005.011, 911.03.012 and 050-060-810, the Research Institute of Diseases in the Elderly, Netherlands Genome Initiative, Stichting Zorgonderzoek Nederland-Medische Wetenschappen (The Netherlands Organisation for Health Research and Development), Netherlands Hartstichting, Netherlands Ministry of Education Culture and Science, Netherlands Ministry of Health Welfare and Sports; the European Commission; Erasmus Medical Center, Erasmus University Rotterdam and the municipality of Rotterdam. SardiNIA: We thank A. Scuteri and M. Orr for longstanding, continual support of the project and for phenotype characterization. NIA NO1-AG-1-2109, 263-MA-410953, NIH and NIA Intramural Research Programs, NHGRI and NHLBI. Role of the sponsors: None of the funding organizations had any role in the design and conduct of the study; collection, management, analysis and interpretation of the data; or preparation, review or approval of the manuscript. More detailed acknowledgments can be found in the Supplementary Note.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; HANSON B, 1989, AM J CARDIOL, V63, P606, DOI 10.1016/0002-9149(89)90907-7; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; HAVLIK RJ, 1980, J ELECTROCARDIOL, V13, P45, DOI 10.1016/S0022-0736(80)80008-2; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Jay PY, 2004, ANAT REC PART A, V280A, P966, DOI 10.1002/ar.a.20102; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Mesbah K, 2008, CIRC RES, V103, P743, DOI 10.1161/CIRCRESAHA.108.172858; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Moskowitz IPG, 2007, CELL, V129, P1365, DOI 10.1016/j.cell.2007.04.036; Newton-Cheh C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S7; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nothnagel M, 2009, HUM GENET, V125, P163, DOI 10.1007/s00439-008-0606-5; OLSSON SB, 1971, ACTA MED SCAND, V190, P381; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; PERZ S, 2004, ANAL BIOMEDICAL SIGN, P47; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Rabert DK, 1998, PAIN, V78, P107, DOI 10.1016/S0304-3959(98)00120-1; Remme CA, 2008, TRENDS CARDIOVAS MED, V18, P78, DOI 10.1016/j.tcm.2008.01.002; SCHINZEL A, 1987, J MED GENET, V24, P778, DOI 10.1136/jmg.24.12.778; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sinner MF, 2008, EUR HEART J, V29, P907, DOI 10.1093/eurheartj/ehm619; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Su ZJ, 2004, P NATL ACAD SCI USA, V101, P12212, DOI 10.1073/pnas.0404631101; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; WILLEMS JL, 1991, NEW ENGL J MED, V325, P1767, DOI 10.1056/NEJM199112193252503; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880	51	320	324	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2010	42	2					153	U89		10.1038/ng.517	http://dx.doi.org/10.1038/ng.517			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549WG	20062060	Green Accepted			2022-12-17	WOS:000274084400013
J	Hogan, BM; Bos, FL; Bussmann, J; Witte, M; Chi, NC; Duckers, HJ; Schulte-Merker, S				Hogan, Benjamin M.; Bos, Frank L.; Bussmann, Jeroen; Witte, Merlijn; Chi, Neil C.; Duckers, Henricus J.; Schulte-Merker, Stefan			ccbe1 is required for embryonic lymphangiogenesis and venous sprouting	NATURE GENETICS			English	Article							ENDOTHELIAL-GROWTH-FACTOR; LYMPHATIC-SYSTEM; ZEBRAFISH; RECEPTOR; PROX1; MICE	Lymphatic vessels have important roles in fluid homeostasis, fat absorption, inflammation and cancer metastasis and develop in a dynamic process (called lymphangiogenesis) involving budding, migration and proliferation of lymphangioblasts. Using a genetic screen in zebrafish we identify ccbe1 (collagen and calcium-binding EGF domain-1) as indispensible for embryonic lymphangiogenesis. Ccbe1 acts at the same stage of development as Vegfc and is required for lymphangioblast budding and angiogenic sprouting from venous endothelium.	[Hogan, Benjamin M.; Bos, Frank L.; Bussmann, Jeroen; Witte, Merlijn; Schulte-Merker, Stefan] KNAW, Hubrecht Inst, Utrecht, Netherlands; [Hogan, Benjamin M.; Bos, Frank L.; Bussmann, Jeroen; Witte, Merlijn; Schulte-Merker, Stefan] Univ Med Ctr, Utrecht, Netherlands; [Bos, Frank L.; Duckers, Henricus J.] Erasmus Univ, Med Ctr, Thoraxctr, Rotterdam, Netherlands; [Chi, Neil C.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Chi, Neil C.] Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; [Chi, Neil C.] Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; [Chi, Neil C.] Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94143 USA; [Chi, Neil C.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schulte-Merker, S (corresponding author), KNAW, Hubrecht Inst, Utrecht, Netherlands.	s.schulte@niob.knaw.nl	Hogan, Benjamin/AAD-7410-2022; Bussmann, Jeroen/D-8106-2011; Hogan, Benjamin M/J-1807-2014	Hogan, Benjamin/0000-0002-0651-7065; Bussmann, Jeroen/0000-0003-2814-3305; Hogan, Benjamin M/0000-0002-0651-7065	NHLBI, GSK Research & Education Foundation Cardiovascular Awards [K08]; NWO VIDI	NHLBI, GSK Research & Education Foundation Cardiovascular Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NWO VIDI(Netherlands Organization for Scientific Research (NWO))	M. H. was supported by an EMBO long term fellowship and an NH&MRC CJ Martin Fellowship and J. B. by the Stichting Vrienden van het Hubrecht. N. C. C. is supported by K08 grants from the NHLBI, GSK Research & Education Foundation Cardiovascular Awards, and Fellow to Faculty AHA postdoctoral awards. N. C. C. also thanks D. Stainier for support. H. J. D. received an NWO VIDI grant. The authors thank the Hubrecht Screen Team, J. Korving for sectioning, R. Korswagen, A. MacInnes, K. Smith and H. Clevers for critical reading of the manuscript.	Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bussmann J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000064; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Prevo R, 2004, J BIOL CHEM, V279, P52580, DOI 10.1074/jbc.M406897200; Salmi M, 2004, BLOOD, V104, P3849, DOI 10.1182/blood-2004-01-0222; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	14	320	331	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					396	398		10.1038/ng.321	http://dx.doi.org/10.1038/ng.321			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19287381				2022-12-17	WOS:000264659000011
J	Inoue, K; Khajavi, M; Ohyama, T; Hirabayashi, S; Wilson, J; Reggin, JD; Mancias, P; Butler, IJ; Wilkinson, MF; Wegner, M; Lupski, JR				Inoue, K; Khajavi, M; Ohyama, T; Hirabayashi, S; Wilson, J; Reggin, JD; Mancias, P; Butler, IJ; Wilkinson, MF; Wegner, M; Lupski, JR			Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR SOX10; WAARDENBURG-HIRSCHSPRUNG-DISEASE; MESSENGER-RNA DECAY; CHRONIC INTESTINAL PSEUDOOBSTRUCTION; NONSENSE-MEDIATED DECAY; MARIE-TOOTH-DISEASE; REGULATORY MECHANISM; CLINICAL PHENOTYPES; FUNCTIONAL-ANALYSIS; P-0 MUTATIONS	The molecular mechanisms by which different mutations in the same gene can result in distinct disease phenotypes remain largely unknown. Truncating mutations of SOX10 cause either a complex neurocristopathy designated PCWH or a more restricted phenotype known as Waardenburg-Shah syndrome (WS4; OMIM 277580). Here we report that although all nonsense and frameshift mutations that cause premature termination of translation generate truncated SOX10 proteins with potent dominant-negative activity, the more severe disease phenotype, PCWH, is realized only when the mutant mRNAs escape the nonsense-mediated decay (NMD) pathway. We observe similar results for truncating mutations of MPZ that convey distinct myelinopathies. Our experiments show that triggering NMD and escaping NMD may cause distinct neurological phenotypes.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Nagano Childrens Hosp, Div Pediat Neurol, Nagano, Japan; Great Ormond St Hosp Children, Dept Neurol, London WC1N 3JH, England; Meritcare Neurosci Clin, Fargo, ND USA; Univ Texas, Sch Med, Dept Neurol, Houston, TX USA; Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Erlangen Nurnberg, Inst Biochem, Erlangen, Germany; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Texas System; University of Texas System; UTMD Anderson Cancer Center; University of Erlangen Nuremberg; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 604B, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu		Wegner, Michael/0000-0002-4586-3294; Ohyama, Tomoko/0000-0003-1697-1138				BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; Bondurand N, 1999, HUM MOL GENET, V8, P1785, DOI 10.1093/hmg/8.9.1785; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Byers PH, 2002, J CLIN INVEST, V109, P3, DOI 10.1172/JCI14841; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; FORGET BG, 1974, NATURE, V247, P379, DOI 10.1038/247379a0; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Inoue K, 2002, ANN NEUROL, V52, P836, DOI 10.1002/ana.10404; Inoue K, 1999, ANN NEUROL, V46, P313, DOI 10.1002/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7; JACOBS JM, 1992, ACTA NEUROPATHOL, V83, P670, DOI 10.1007/BF00299420; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Korkko J, 1998, AM J HUM GENET, V62, P98, DOI 10.1086/301689; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P23033, DOI 10.1074/jbc.273.36.23033; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; OMENN GS, 1979, AM J MED GENET, V3, P217, DOI 10.1002/ajmg.1320030302; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Pingault V, 2000, ANN NEUROL, V48, P671, DOI 10.1002/1531-8249(200010)48:4<671::AID-ANA17>3.0.CO;2-8; Pingault V, 2002, HUM GENET, V111, P198, DOI 10.1007/s00439-002-0765-8; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Saifi GM, 2003, J INVEST MED, V51, P261, DOI 10.1136/jim-51-05-14; Schrijver I, 2002, AM J HUM GENET, V71, P223, DOI 10.1086/341581; Sham MH, 2001, J MED GENET, V38, DOI 10.1136/jmg.38.9.e30; Shames I, 2003, J NEUROPATH EXP NEUR, V62, P751, DOI 10.1093/jnen/62.7.751; Snead MP, 1999, J MED GENET, V36, P353; Sonnenberg-Riethmacher E, 2001, MECH DEVELOP, V109, P253, DOI 10.1016/S0925-4773(01)00547-0; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Southard-Smith EM, 1999, GENOME RES, V9, P215; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Toki F, 2003, PEDIATR SURG INT, V19, P725, DOI 10.1007/s00383-003-1057-7; Touraine RL, 2000, AM J HUM GENET, V66, P1496, DOI 10.1086/302895; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; Wong MH, 1996, J CELL BIOL, V134, P1531, DOI 10.1083/jcb.134.6.1531; Yoshida M, 2001, NEUROCHEM RES, V26, P703, DOI 10.1023/A:1010999622760	44	320	334	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2004	36	4					361	369		10.1038/ng1322	http://dx.doi.org/10.1038/ng1322			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	809OY	15004559	Bronze			2022-12-17	WOS:000220647200019
J	McCarroll, SA; Murphy, CT; Zou, SG; Pletcher, SD; Chin, CS; Jan, YN; Kenyon, C; Bargmann, CI; Li, H				McCarroll, SA; Murphy, CT; Zou, SG; Pletcher, SD; Chin, CS; Jan, YN; Kenyon, C; Bargmann, CI; Li, H			Comparing genomic expression patterns across species identifies shared transcriptional profile in aging	NATURE GENETICS			English	Article							MESSENGER-RNA DECAY; GENE-EXPRESSION; C-ELEGANS; CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; LIFE-SPAN; CALORIC RESTRICTION; OXIDATIVE STRESS; INSULIN-RECEPTOR; WIDE ANALYSIS	We developed a method for systematically comparing gene expression patterns across organisms using genome-wide comparative analysis of DNA microarray experiments. We identified analogous gene expression programs comprising shared patterns of regulation across orthologous genes. Biological features of these patterns could be identified as highly conserved subpatterns that correspond to Gene Ontology categories. Here, we demonstrate these methods by analyzing a specific biological process, aging, and show that similar analysis can be applied to a range of biological processes. We found that two highly diverged animals, the nematode Caenorhabditis elegans and the fruit fly Drosophila melanogaster, implement a shared adult-onset expression program of genes involved in mitochondrial metabolism, DNA repair, catabolism, peptidolysis and cellular transport. Most of these changes were implemented early in adulthood. Using this approach to search databases of gene expression data, we found conserved transcriptional signatures in larval development, embryogenesis, gametogenesis and mRNA degradation.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; UCL, Dept Biol, London, England; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol & Med Informat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of London; University College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Li, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	haoli@genome.ucsf.edu	McCarroll, Steven A/A-8433-2009	Kenyon, Cynthia/0000-0003-3446-2636; Murphy, Coleen/0000-0002-8257-984X; McCarroll, Steven/0000-0002-6954-8184; Jan, Yuh Nung/0000-0003-1367-6299; Bargmann, Cornelia/0000-0002-8484-0618				Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Cuadras MA, 2002, J VIROL, V76, P4467, DOI 10.1128/JVI.76.9.4467-4482.2002; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Detweiler CS, 2001, P NATL ACAD SCI USA, V98, P5850, DOI 10.1073/pnas.091110098; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lewis JA, 1995, METHOD CELL BIOL, V48, P4; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; SOMANI SM, 1992, INT J CLIN PHARM TH, V30, P1; Stoeckert CJ, 2002, NAT GENET, V32, P469, DOI 10.1038/ng1028; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Teichmann SA, 2002, TRENDS BIOTECHNOL, V20, P407, DOI 10.1016/S0167-7799(02)02032-2; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Wang W, 2002, P NATL ACAD SCI USA, V99, P16893, DOI 10.1073/pnas.252638199; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	50	320	336	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2004	36	2					197	204		10.1038/ng1291	http://dx.doi.org/10.1038/ng1291			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	768KT	14730301	Bronze			2022-12-17	WOS:000188542700024
J	Oshima, K; Kakizawa, S; Nishigawa, H; Jung, HY; Wei, W; Suzuki, S; Arashida, R; Nakata, D; Miyata, S; Ugaki, M; Namba, S				Oshima, K; Kakizawa, S; Nishigawa, H; Jung, HY; Wei, W; Suzuki, S; Arashida, R; Nakata, D; Miyata, S; Ugaki, M; Namba, S			Reductive evolution suggested from the complete genome sequence of a plant-pathogenic phytoplasma	NATURE GENETICS			English	Article							DIVERSITY	The minimal gene set essential for life has long been sought. We report the 860-kb genome of the obligate intracellular plant pathogen phytoplasma (Candidatus Phytoplasma asteris, OY strain). The phytoplasma genome encodes even fewer metabolic functions than do mycoplasma genomes. It lacks the pentose phosphate cycle and, more unexpectedly, ATP-synthase subunits, which are thought to be essential for life. This may be the result of reductive evolution as a consequence of life as an intracellular parasite in a nutrient-rich environment.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Namba, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, 202 Biosci Bldg,5-1-5 Kashiwanoha, Chiba 2778562, Japan.		Suzuki, Shiho/Z-4458-2019; kakizawa, shigeyuki/L-8901-2018	kakizawa, shigeyuki/0000-0003-3885-4434; Oshima, Kenro/0000-0001-7327-4481; WEI, WEI/0000-0003-3561-913X; Suzuki, Shiho/0000-0003-3168-1729				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; DOI Y., 1967, Annals of the Phytopathological Society of Japan, V33, P259; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; NAMBA S, 1993, INT J SYST BACTERIOL, V43, P461, DOI 10.1099/00207713-43-3-461; Nishigawa H, 2002, MICROBIOL-SGM, V148, P1389, DOI 10.1099/00221287-148-5-1389; Oshima K, 2001, PHYTOPATHOLOGY, V91, P1024, DOI 10.1094/PHYTO.2001.91.11.1024; Oshima Kenro, 2002, Journal of General Plant Pathology, V68, P225, DOI 10.1007/PL00013081; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; SANTANA M, 1994, J BACTERIOL, V176, P6802, DOI 10.1128/JB.176.22.6802-6811.1994; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931	15	320	485	0	34	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2004	36	1					27	29		10.1038/ng1277	http://dx.doi.org/10.1038/ng1277			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	758TT	14661021	Bronze			2022-12-17	WOS:000187666800010
J	Seri, M; Cusano, R; Gangarossa, S; Caridi, G; Bordo, D; Lo Nigro, C; Ghiggeri, GM; Ravazzolo, R; Savino, M; Del Vecchio, M; d'Apolito, M; Iolascon, A; Zelante, LL; Savoia, A; Balduini, CL; Noris, P; Magrini, U; Belletti, S				Seri, M; Cusano, R; Gangarossa, S; Caridi, G; Bordo, D; Lo Nigro, C; Ghiggeri, GM; Ravazzolo, R; Savino, M; Del Vecchio, M; d'Apolito, M; Iolascon, A; Zelante, LL; Savoia, A; Balduini, CL; Noris, P; Magrini, U; Belletti, S		May-Hegglin Fechtner Syndrome Cors	Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes	NATURE GENETICS			English	Article							MYOSIN HEAVY-CHAINS; LEUKOCYTE INCLUSIONS; NONMUSCLE; MACROTHROMBOCYTOPENIA; VARIANT; PROTEIN; GENE	The autosomal dominant, giant-platelet disorders(1), May-Hegglin anomaly(2,3) (MHA; MIM 155100). Fechtner syndrome(4) (FTNS; MIM 153640) and Sebastian syndrome(5) (SBS), share the triad of thrombocytopenia. large platelets and characteristic leukocyte inclusions ('Dohle-like' bodies). MHA and SBS can be differentiated by subtle ultrastructural leukocyte inclusion features, whereas FTNS is distinguished by the additional Alport-like clinical features of sensorineural deafness, cataracts and nephritis(4). The similarities between these platelet disorders and our recent refinement of the MHA (ref. 6) and FTNS (ref. 7) disease loci to an overlapping region of 480 kb on chromosome 22 suggested that all three disorders are allelic. Among the identified candidate genes is the gene encoding nonmuscle myosin heavy chain 9 (MYH9; refs 8-10). which is expressed in platelets(9) and upregulated during granulocyte differentiation(10). We identified six MYH9 mutations (one nonsense and five missense) in seven unrelated probands from MHA. SBS and FTNS families. On the basis of molecular modelling, the two mutations affecting the myosin head were predicted to impose electrostatic and conformational changes, whereas the truncating mutation deleted the unique carboxyterminal tailpiece. The remaining missense mutations, all affecting highly conserved coiled-coil domain positions, imparted destabilizing electrostatic and polar changes. Thus, our results suggest that mutations in MYH9 result in three megakaryocyte/platelet/leukocyte syndromes and are important in the pathogenesis of sensorineural deafness, cataracts and nephritis.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY USA; Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, Struct Neurobiol & Proteom Lab, New York, NY USA; Osped Civile, Clin Pathol Lab, Venice, Italy; Univ Pavia, IRCCS San Matteo, Dept Internal Med, I-27100 Pavia, Italy; Univ Pavia, IRCCS San Matteo, Dept Pathol, I-27100 Pavia, Italy; Univ Bari, Dept Biomed Evolut Age, Bari, Italy; IRCCS Hosp CSS, Med Genet Serv, Foggia, Italy; Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy; IST, Adv Biotechnol Ctr, Genoa, Italy; Inst G Gaslini, Lab Nephrol, Genoa, Italy; Inst G Gaslini, Genet Mol Lab, Genoa, Italy	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; Universita degli Studi di Bari Aldo Moro; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Seri, M (corresponding author), Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA.		Ghiggeri, Gian Marco/N-4712-2015; Savoia, Anna/AIC-4560-2022; Caridi, Gianluca/F-7052-2010; Balduini, Carlo L/D-9299-2015; d'Apolito, Maria/G-5793-2012; Iolascon, Achille/A-4461-2014; Savoia, Anna/B-6463-2014; Heath, K. E./ABG-4658-2020; d'Apolito, Maria/AAQ-9290-2021; Heath, Karen Elise/K-7760-2014; Seri, Marco/A-4339-2014	Ghiggeri, Gian Marco/0000-0003-3659-9062; Savoia, Anna/0000-0002-2407-2696; Caridi, Gianluca/0000-0001-6700-3001; Balduini, Carlo L/0000-0001-6121-9311; Savoia, Anna/0000-0002-2407-2696; Heath, K. E./0000-0002-5816-7044; Heath, Karen Elise/0000-0002-5816-7044; Noris, Patrizia/0000-0002-5035-3707; Cusano, Roberto/0000-0001-5543-7881; Seri, Marco/0000-0003-2425-2176	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034045] Funding Source: NIH RePORTER; NCRR NIH HHS [5 M01 RR00071] Funding Source: Medline; NICHD NIH HHS [5 P30 HD28822] Funding Source: Medline; NIDDK NIH HHS [5 R37 DK34045] Funding Source: Medline; Telethon [E.1313] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Telethon(Fondazione Telethon)		BIZZARO N, 1997, MED LAB, V5, P165; CITI S, 1988, J MUSCLE RES CELL M, V9, P306, DOI 10.1007/BF01773874; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; CUSANO R, IN PRESS EUR J HUM G; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; EPSTEIN CJ, 1972, AM J MED, V52, P299, DOI 10.1016/0002-9343(72)90017-4; GREINACHER A, 1990, BLUT, V61, P282, DOI 10.1007/BF01732878; HARRINGTON WF, 1984, ANNU REV BIOCHEM, V53, P35, DOI 10.1146/annurev.bi.53.070184.000343; HEGGLIN R, 1945, Helv Med Acta, V12, P439; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; Kunishima S, 1999, HUM GENET, V105, P379, DOI 10.1007/s004390051119; Lalwani AK, 1999, AM J HUM GENET, V64, P318, DOI 10.1086/302216; LUCAS RC, 1975, PROTIDES BIOL FLUIDS, P465; Martignetti JA, 2000, AM J HUM GENET, V66, P1449, DOI 10.1086/302873; May R, 1909, DTSCH ARCH KLIN MED, V96, P1; Mhawech P, 2000, AM J CLIN PATHOL, V113, P176, DOI 10.1309/FC4H-LM5V-VCW8-DNJU; Moxey-Mims MM, 1999, PEDIATR NEPHROL, V13, P782, DOI 10.1007/s004670050700; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; Noris P, 1998, AM J MED, V104, P355, DOI 10.1016/S0002-9343(98)00062-X; PETERSON LC, 1985, BLOOD, V65, P397; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; TOOTHAKER LE, 1991, BLOOD, V78, P1826; Toren A, 1999, AM J HUM GENET, V65, P1711, DOI 10.1086/302654; Urato AC, 1998, AM J OBSTET GYNECOL, V179, P260, DOI 10.1016/S0002-9378(98)70283-2; Willems PJ, 2000, NEW ENGL J MED, V342, P1101, DOI 10.1056/NEJM200004133421506	30	320	331	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2000	26	1					103	105						3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973259				2022-12-17	WOS:000089078000028
J	Smith, AN; Skaug, J; Choate, KA; Nayir, A; Bakkaloglu, A; Ozen, S; Hulton, SA; Sanjad, SA; Al-Sabban, EA; Lifton, RP; Scherer, SW; Karet, FE				Smith, AN; Skaug, J; Choate, KA; Nayir, A; Bakkaloglu, A; Ozen, S; Hulton, SA; Sanjad, SA; Al-Sabban, EA; Lifton, RP; Scherer, SW; Karet, FE			Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing	NATURE GENETICS			English	Article							H+-ATPASE; GENE; HYPERTENSION; LINKAGE; VPH1P	The multi-subunit H+-ATPase pump is present at particularly high density on the apical (luminal) surface of alpha-intercalated cells of the cortical collecting duct of the distal nephron, where vectorial proton transport is required for urinary acidification(1). The complete subunit composition of the apical ATPase, however, has not been fully agreed upon. Functional failure of alpha-intercalated cells results in a group of disorders, the distal renal tubular acidoses (dRTA), whose features include metabolic acidosis accompanied by disturbances of potassium balance, urinary calcium solubility, bone physiology and growth(2). Mutations in the gene encoding the B-subunit of the apical pump (ATP6B1) cause dRTA accompanied by deafness(3). We previously localized a gene for dRTA with preserved hearing to 7q33-34 (ref. 4). We report here the identification of this gene, ATP6N1B, which encodes an 840 amino acid novel kidney-specific isoform of ATP6N1A, the 116-kD non-catalytic accessory subunit of the proton pump. Northern-blot analysis demonstrated ATP6N1B expression in kidney but not other main organs. Immunofluorescence studies in human kidney cortex revealed that ATP6N1B localizes almost exclusively to the apical surface of alpha-intercalated cells. We screened nine dRTA kindreds with normal audiometry that linked to the ATP6N1B locus, and identified different homozygous mutations in ATP6N1B in eight. These include nonsense, deletion and splice-site changes, all of which will truncate the protein. Our findings identify a new kidney-specific proton pump 116-kD accessory subunit that is highly expressed in proton-secreting cells in the distal nephron, and illustrate its essential role in normal vectorial acid transport into the urine by the kidney.	Univ Cambridge, Wellcome Trust Ctr Mol Mechanisms Dis, Cambridge, England; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Istanbul Univ, Dept Pediat Nephrol, Istanbul, Turkey; Univ Hacettepe, Dept Pediat Nephrol, TR-06100 Ankara, Turkey; Birmingham Childrens Hosp, Dept Nephrol, Birmingham, W Midlands, England; Amer Univ Beirut, Dept Pediat, Med Ctr, Beirut, Lebanon; King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia	University of Cambridge; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; Istanbul University; Hacettepe University; University of Birmingham; American University of Beirut; King Faisal Specialist Hospital & Research Center	Karet, FE (corresponding author), Univ Cambridge, Wellcome Trust Ctr Mol Mechanisms Dis, Cambridge, England.		OZEN, SEZA/I-9096-2013; Scherer, Stephen W./B-3785-2013; NAYIR, AHMET NEVZAT/A-9276-2019	Scherer, Stephen W./0000-0002-8326-1999; Karet, Fiona/0000-0002-2457-2869				Bastani B, 1996, MINER ELECTROL METAB, V22, P396; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BRODY LC, 1995, GENOMICS, V25, P238, DOI 10.1016/0888-7543(95)80131-5; Brown D, 2000, AM J PHYSIOL-RENAL, V278, pF192, DOI 10.1152/ajprenal.2000.278.2.F192; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; GILLESPIE J, 1991, FEBS LETT, V282, P69, DOI 10.1016/0014-5793(91)80446-A; GLUCK S, 1987, J BIOL CHEM, V262, P15780; Gluck SL, 1996, ANNU REV PHYSIOL, V58, P427, DOI 10.1146/annurev.physiol.58.1.427; Heinemann T, 1999, GENOMICS, V57, P398, DOI 10.1006/geno.1999.5751; Karet FE, 1999, AM J HUM GENET, V65, P1656, DOI 10.1086/302679; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; MUNROE DJ, 1994, GENOMICS, V19, P506, DOI 10.1006/geno.1994.1100; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; PENG SB, 1994, J BIOL CHEM, V269, P17262; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X	21	320	340	1	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2000	26	1					71	75		10.1038/79208	http://dx.doi.org/10.1038/79208			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	350AK	10973252				2022-12-17	WOS:000089078000021
J	Huettner, CS; Zhang, P; Van Etten, RA; Tenen, DG				Huettner, CS; Zhang, P; Van Etten, RA; Tenen, DG			Reversibility of acute B-cell leukaemia induced by BCR-ABL1	NATURE GENETICS			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; TRANSGENIC MICE; BCR-ABL; TYROSINE KINASE; GENE-EXPRESSION; BONE-MARROW; P210(BCR/ABL); PROMOTER; ANTIGEN	Cancer is thought to arise from multiple genetic events that establish irreversible malignancy. A different mechanism might be present in certain leukaemias initiated by a chromosomal translocation. We have taken a new approach to determine if ablation of the genetic abnormality is sufficient for reversion by generating a conditional transgenic model of BCR-ABL1 (also known as BCR-ABL)-induced leukaemia. This oncogene(1) is the of a reciprocal translocation and is associated with differ-ent forms of leukaemia(2). The most common form, p210 BCR-ABL1, is found in more than 90% of patients with chronic myelogenous leukaemia(3,4) (CML) and in up to 15% of adult patients with de novo acute lymphoblastic leukaemia(5) (ALL). Efforts to establish a useful transgenic model have been hampered by embryonic lethality when the oncogene is expressed during embryogenesis(6,7), by reduced penetrance or by extremely long latency periods(8,9). One model uses the 'knock-in' approach to induce leukaemia by p190 BCR-ABL1 (ref. 10). Given the limitations of models with p210, we used a different experimental approach(11) Lethal leukaemia developed within an acceptable time frame in all animals, and complete remission was achieved by suppression of BCR-ABL1 expression, even after multiple rounds of induction and reversion. Our results demonstrate that BCR-ABL1 is required for both induction and maintenance of leukaemia.	Harvard Univ, Inst Med, Div Hematol Oncol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA USA	Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Tenen, DG (corresponding author), Harvard Univ, Inst Med, Div Hematol Oncol, Cambridge, MA 02138 USA.	dtenen@caregroup.harvard.edu		Tenen, Daniel/0000-0002-6423-3888				BEDI A, 1994, BLOOD, V83, P2038; Castellanos A, 1997, BLOOD, V90, P2168, DOI 10.1182/blood.V90.6.2168.2168_2168_2174; CHEN YY, 1992, P NATL ACAD SCI USA, V89, P6683, DOI 10.1073/pnas.89.15.6683; CLARK SS, 1988, SCIENCE, V239, P775, DOI 10.1126/science.3422516; CROSS NCP, 1993, BRIT J HAEMATOL, V84, P67, DOI 10.1111/j.1365-2141.1993.tb03026.x; DALEY GQ, 1991, P NATL ACAD SCI USA, V88, P11335, DOI 10.1073/pnas.88.24.11335; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Ewald D, 1996, SCIENCE, V273, P1384, DOI 10.1126/science.273.5280.1384; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; Heisterkamp Nora, 1991, Transgenic Research, V1, P45, DOI 10.1007/BF02512996; Hennighausen L, 1995, J CELL BIOCHEM, V59, P463, DOI 10.1002/jcb.240590407; HONDA H, 1995, BLOOD, V85, P2853, DOI 10.1182/blood.V85.10.2853.bloodjournal85102853; Honda H, 1998, BLOOD, V91, P2067, DOI 10.1182/blood.V91.6.2067.2067_2067_2075; ILARIA RL, 1995, BLOOD, V86, P3897, DOI 10.1182/blood.V86.10.3897.bloodjournal86103897; KRAIG E, 1983, J EXP MED, V158, P192, DOI 10.1084/jem.158.1.192; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; Melo JV, 1996, LEUKEMIA, V10, P751; NOWELL PC, 1960, SCIENCE, V132, P1497; Radomska HS, 1998, GENE, V222, P305, DOI 10.1016/S0378-1119(98)00491-0; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; VANETTEN RA, 1993, LEUKEMIA ADV TREATME, P294; VANETTEN RA, 1998, MED MANAGEMENT CHRON, P77	27	320	347	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2000	24	1					57	60		10.1038/71691	http://dx.doi.org/10.1038/71691			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	271TH	10615128				2022-12-17	WOS:000084609200016
J	Gebbia, M; Ferrero, GB; Pilia, G; Bassi, MT; Aylsworth, AS; PenmanSplitt, M; Bird, LM; Bamforth, JS; Burn, J; Schlessinger, D; Nelson, DL; Casey, B				Gebbia, M; Ferrero, GB; Pilia, G; Bassi, MT; Aylsworth, AS; PenmanSplitt, M; Bird, LM; Bamforth, JS; Burn, J; Schlessinger, D; Nelson, DL; Casey, B			X-linked situs abnormalities result from mutations in ZIC3	NATURE GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; NODAL EXPRESSION; GENE FAMILY; LATERALITY; DEFECTS; EMBRYOS; XENOPUS; MEMBER; DNA	Vertebrates position unpaired organs of the chest and abdomen asymmetrically along the left-right (LR) body axis. Each structure comes to lie non-randomly with respect to the midline in an overall position designated sites solitus, exemplified in humans by placement of the heart, stomach and spleen consistently to the left. Aberrant LR axis development can lead to randomization of individual organ position (sites ambiguus) or to mirror-image reversal of all lateralized structures (sites inversus)(1). Previously we mapped a locus for sites abnormalities in humans, HTX1, to Xq26.2 by linkage analysis in a single family (LR1) and by detection of a deletion in an unrelated sites ambiguus male (Family LR2; refs 2,3). From this chromosomal region we have positionally cloned ZIC3, a gene encoding a putative zinc-finger transcription factor. One frameshift, two missense and two nonsense mutations have been identified in familial and sporadic sites ambiguus. The frameshift allele is also associated with sites inverses among some heterozygous females, suggesting that ZIC3 functions in the earliest stages of LR-axis formation. ZIC3, which has not been previously implicated in vertebrate LR-axis development, is the first gene unequivocally associated with human sites abnormalities.	BAYLOR COLL MED, DEPT PATHOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MOL & HUMAN GENET, HOUSTON, TX 77030 USA; WASHINGTON UNIV, DEPT MOL MICROBIOL, ST LOUIS, MO 63130 USA; UNIV N CAROLINA, DEPT PEDIAT, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, CTR NEUROSCI, CHAPEL HILL, NC 27599 USA; UNIV NEWCASTLE UPON TYNE, DEPT HUMAN GENET, NEWCASTLE UPON TYNE NE2 4AA, TYNE & WEAR, ENGLAND; CHILDRENS HOSP & HLTH CTR, SAN DIEGO, CA 92123 USA; UNIV ALBERTA HOSP, DEPT MED GENET, EDMONTON, AB T6G 2B7, CANADA	Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Newcastle University - UK; University of Alberta			Bird, Lynne/AAG-9533-2021; Bassi, Maria Teresa T/A-3517-2014; Ferrero, Giovanni Battista/K-5265-2018	Bassi, Maria Teresa T/0000-0002-8236-1197; Ferrero, Giovanni Battista/0000-0002-3793-5788; Bird, Lynne/0000-0003-4833-3747	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001078] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00201] Funding Source: Medline; NICHD NIH HHS [P30 HD24064, 5K08 HD01078] Funding Source: Medline; Telethon [E.0110, TGM06S01] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon)		Aruga J, 1996, GENE, V172, P291, DOI 10.1016/0378-1119(96)00111-4; Aruga J, 1996, J BIOL CHEM, V271, P1043, DOI 10.1074/jbc.271.2.1043; BENEDYK MJ, 1994, GENE DEV, V8, P105, DOI 10.1101/gad.8.1.105; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; Casey B, 1996, AM J MED GENET, V61, P325, DOI 10.1002/(SICI)1096-8628(19960202)61:4<325::AID-AJMG5>3.0.CO;2-T; CASEY B, 1993, NAT GENET, V5, P403, DOI 10.1038/ng1293-403; CIMBORA DM, 1995, DEV BIOL, V169, P580, DOI 10.1006/dbio.1995.1171; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; DANOS MC, 1995, DEVELOPMENT, V121, P1467; Danos MC, 1996, DEV BIOL, V177, P96, DOI 10.1006/dbio.1996.0148; Ferrero GB, 1997, AM J HUM GENET, V61, P395, DOI 10.1086/514857; Gebbia M, 1996, CIRCULATION, V94, P1909, DOI 10.1161/01.CIR.94.8.1909; Hyatt BA, 1996, NATURE, V384, P62, DOI 10.1038/384062a0; Isaac A, 1997, SCIENCE, V275, P1301, DOI 10.1126/science.275.5304.1301; KOSAKI K, IN PRESS SEMIN CELL; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Larsen WJ, 1993, HUMAN EMBRYOLOGY; Levin M, 1997, BIOESSAYS, V19, P287, DOI 10.1002/bies.950190406; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Lohr JL, 1997, DEVELOPMENT, V124, P1465; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Pilia G, 1996, GENOMICS, V34, P55, DOI 10.1006/geno.1996.0240; Splitt MP, 1997, HEART, V77, P369, DOI 10.1136/hrt.77.4.369; WAPENAAR MC, 1994, HUM MOL GENET, V3, P1155, DOI 10.1093/hmg/3.7.1155	28	320	329	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1997	17	3					305	308		10.1038/ng1197-305	http://dx.doi.org/10.1038/ng1197-305			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354794				2022-12-17	WOS:A1997YD66700024
J	MOISES, HW; YANG, L; KRISTBJARNARSON, H; WIESE, C; BYERLEY, W; MACCIARDI, F; AROLT, V; BLACKWOOD, D; LIU, X; SJOGREN, S; ASCHAUER, HN; HWU, HG; JANG, K; LIVESLEY, WJ; KENNEDY, JL; ZOEGA, T; IVARSSON, O; BUI, MT; YU, MH; HAVSTEEN, B; COMMENGES, D; WEISSENBACH, J; SCHWINGER, E; GOTTESMAN, II; PAKSTIS, AJ; WETTERBERG, L; KIDD, KK; HELGASON, T				MOISES, HW; YANG, L; KRISTBJARNARSON, H; WIESE, C; BYERLEY, W; MACCIARDI, F; AROLT, V; BLACKWOOD, D; LIU, X; SJOGREN, S; ASCHAUER, HN; HWU, HG; JANG, K; LIVESLEY, WJ; KENNEDY, JL; ZOEGA, T; IVARSSON, O; BUI, MT; YU, MH; HAVSTEEN, B; COMMENGES, D; WEISSENBACH, J; SCHWINGER, E; GOTTESMAN, II; PAKSTIS, AJ; WETTERBERG, L; KIDD, KK; HELGASON, T			AN INTERNATIONAL 2-STAGE GENOME-WIDE SEARCH FOR SCHIZOPHRENIA SUSCEPTIBILITY GENES	NATURE GENETICS			English	Letter							LINKAGE	Schizophrenia is thought to be a multifactorial disease with complex mode of inheritance (1,2). Using a two-stage strategy for another complex disorder, a number of putative IDDM-susceptibility genes have recently been mapped(3). We now report the results of a two-stage genome-wide search for genes conferring susceptibility to schizophrenia. In stage I, model-free linkage analyses of large pedigrees from Iceland, a geographical isolate, revealed 26 loci suggestive of linkage. In stage II, ten of these were followed-up in a second international collaborative study comprising families from Austria, Canada, Germany, Italy, Scotland, Sweden, Taiwan and the United States. Potential linkage findings of stage I on chromosomes 6p, 9 and 20 were observed again in the second sample. Furthermore, in a third sample from China, fine mapping of the 6p region by association studies also showed evidence for linkage or linkage disequilibrium. Combining our results with other recent findings(4,5) revealed significant evidence for linkage to an area distal of the HLA region on chromosome 6p. However, in a fourth sample from Europe, the 6p fine mapping finding observed in the Chinese sample could not be replicated. Finally evidence suggestive of locus heterogeneity and oligogenic transmission in schizophrenia was obtained.	NATL UNIV HOSP REYKJAVIK,DEPT PSYCH,IS-121 REYKJAVIK,ICELAND; UNIV UTAH,DEPT PSYCH,SALT LAKE CITY,UT 84132; UNIV MILAN,SCI INST HOSP ST RAFFAEL,DEPT NEUROSCI,I-20127 MILAN,ITALY; UNIV LUBECK,DEPT PSYCH,D-23538 LUBECK,GERMANY; UNIV EDINBURGH,DEPT PSYCH,EDINBURGH EH10 5HF,MIDLOTHIAN,SCOTLAND; W CHINA UNIV MED SCI,DEPT PSYCH RES,CHENGDU 610041,PEOPLES R CHINA; KAROLINSKA INST,ST GORANS HOSP,DEPT PSYCH,S-11281 STOCKHOLM,SWEDEN; UNIV HOSP VIENNA,DEPT GEN PSYCH,A-1090 VIENNA,AUSTRIA; NATL TAIWAN UNIV HOSP,DEPT PSYCH,TAIPEI 100,TAIWAN; UNIV BRITISH COLUMBIA,DEPT PSYCH,VANCOUVER,BC V6T 2A1,CANADA; UNIV TORONTO,CLARKE INST PSYCH,TORONTO,ON M5T 1R8,CANADA; CHRISTIAN ALBRECHTS UNIV KIEL,DEPT BIOCHEM,D-24118 KIEL,GERMANY; UNIV BORDEAUX 2,INSERM,F-33077 BORDEAUX,FRANCE; GENETHON SA,F-91000 EVRY,FRANCE; UNIV LUBECK,DEPT HUMAN GENET,D-23538 LUBECK,GERMANY; UNIV VIRGINIA,DEPT PSYCH,CHARLOTTESVILLE,VA 22903; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510	Landspitali National University Hospital; Utah System of Higher Education; University of Utah; University of Milan; University of Lubeck; University of Edinburgh; Sichuan University; Karolinska Institutet; Saint Goran's Hospital; University Hospital Vienna; National Taiwan University; National Taiwan University Hospital; University of British Columbia; University of Toronto; University of Kiel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Lubeck; University of Virginia; Yale University	MOISES, HW (corresponding author), UNIV HOSP KIEL,DEPT PSYCH,NIEMANNSWEG 147,D-24105 KIEL,GERMANY.		Commenges, Daniel/T-6536-2019; Macciardi, Fabio/N-3768-2014; G, I/D-8042-2011; Aschauer, Harald/G-8850-2016; Kennedy, James Lowery/AAZ-6947-2020	Macciardi, Fabio/0000-0003-0537-4266; Aschauer, Harald/0000-0002-4449-372X; Kennedy, James Lowery/0000-0002-8733-3806; HWU, HAI-GWO/0000-0002-2582-2807; Moises, Hans/0000-0003-1522-3226				BLOSSEY H, 1993, GENET EPIDEMIOL, V10, P377, DOI 10.1002/gepi.1370100608; BROWN DL, 1994, AM J HUM GENET, V54, P544; COMMENGES D, 1994, GENET EPIDEMIOL, V11, P201, DOI 10.1002/gepi.1370110209; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; ELSTON RC, 1992, 16TH P INT BIOM C HA, P39; GOTTESMAN II, 1991, SCHIZOPHRENIA GENETI; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; LASSETER VK, 1995, AM J MED GENET, V60, P172, DOI 10.1002/ajmg.1320600217; MOISES HW, IN PRESS AM J MED GE; MOISES HW, 1995, ADV NEUROBIOLOGY SCH, P59; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPITZER RL, 1988, SCHEDULE AFFECTIVE D; Spitzer RL, 1978, RES DIAGNOSTIC CRITE; STRAUB RE, NATURE GENET, V11; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; VALLADA HP, 1995, AM J MED GENET, V60, P139, DOI 10.1002/ajmg.1320600210; VINOGRADOV S, 1991, SCHIZOPHRENIA BULL, V17, P669, DOI 10.1093/schbul/17.4.669; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	20	320	332	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					321	324		10.1038/ng1195-321	http://dx.doi.org/10.1038/ng1195-321			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581457				2022-12-17	WOS:A1995TC63900022
J	Hendrickson, PG; Dorais, JA; Grow, EJ; Whiddon, JL; Lim, JW; Wike, CL; Weaver, BD; Pflueger, C; Emery, BR; Wilcox, AL; Nix, DA; Peterson, CM; Tapscott, SJ; Carrell, DT; Cairns, BR				Hendrickson, Peter G.; Dorais, Jessie A.; Grow, Edward J.; Whiddon, Jennifer L.; Lim, Jong-Won; Wike, Candice L.; Weaver, Bradley D.; Pflueger, Christian; Emery, Benjamin R.; Wilcox, Aaron L.; Nix, David A.; Peterson, C. Matthew; Tapscott, Stephen J.; Carrell, Douglas T.; Cairns, Bradley R.			Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; MUERV-L; CELL; GENOME; TOTIPOTENCY; EXPRESSION; CHROMATIN; ELEMENTS; PROTEINS; REVEALS	To better understand transcriptional regulation during human oogenesis and preimplantation development, we defined stage-specific transcription, which highlighted the cleavage stage as being highly distinctive. Here, we present multiple lines of evidence that a eutherian-specific multicopy retrogene, DUX4, encodes a transcription factor that activates hundreds of endogenous genes (for example, ZSCAN4, KDM4E and PRAMEF-family genes) and retroviral elements (MERVL/HERVL family) that define the cleavage-specific transcriptional programs in humans and mice. Remarkably, mouse Dux expression is both necessary and sufficient to convert mouse embryonic stem cells (mESCs) into 2-cell-embryo-like ('2C-like') cells, measured here by the reactivation of '2C' genes and repeat elements, the loss of POU5F1 (also known as OCT4) protein and chromocenters, and the conversion of the chromatin landscape (as assessed by transposase-accessible chromatin using sequencing (ATAC-seq)) to a state strongly resembling that of mouse 2C embryos. Thus, we propose mouse DUX and human DUX4 as major drivers of the cleavage or 2C state.	[Hendrickson, Peter G.; Dorais, Jessie A.; Grow, Edward J.; Wike, Candice L.; Weaver, Bradley D.; Pflueger, Christian; Nix, David A.; Cairns, Bradley R.] Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84103 USA; [Hendrickson, Peter G.; Dorais, Jessie A.; Grow, Edward J.; Wike, Candice L.; Weaver, Bradley D.; Pflueger, Christian; Nix, David A.; Cairns, Bradley R.] Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Dorais, Jessie A.; Emery, Benjamin R.; Wilcox, Aaron L.; Peterson, C. Matthew; Carrell, Douglas T.] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA; [Dorais, Jessie A.; Emery, Benjamin R.; Wilcox, Aaron L.; Peterson, C. Matthew; Carrell, Douglas T.] Univ Utah, Sch Med, Dept Surg, Salt Lake City, UT 84112 USA; [Whiddon, Jennifer L.; Lim, Jong-Won; Tapscott, Stephen J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA	Huntsman Cancer Institute; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Fred Hutchinson Cancer Center	Cairns, BR (corresponding author), Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84103 USA.; Cairns, BR (corresponding author), Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.; Carrell, DT (corresponding author), Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA.; Carrell, DT (corresponding author), Univ Utah, Sch Med, Dept Surg, Salt Lake City, UT 84112 USA.; Tapscott, SJ (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	stapscot@fredhutch.org; douglas.carrell@hsc.utah.edu; brad.cairns@hci.utah.edu	Lim, Jong-Won/AAB-3761-2021; Pflueger, Christian/AAD-9877-2020	Pflueger, Christian/0000-0002-5039-2714; Tapscott, Stephen/0000-0002-0319-0968	HHMI; Eunice Kennedy Shriver NIH NICHD [K12HD000849]; NIH NIAMS [R01AR045203]; NIH NINDS [P01NS069539]; Friends of FSH Research; National Science Foundation Graduate Research Fellowship Program [DGE-1256082]; University of Washington Interdisciplinary Training in Genome Sciences grant from NHGRI [T32 HG00035]; University of Utah [CA042014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS069539] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Eunice Kennedy Shriver NIH NICHD; NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Friends of FSH Research; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); University of Washington Interdisciplinary Training in Genome Sciences grant from NHGRI; University of Utah; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Kuerten (NuGen) for assistance with preparing the RNA-seq libraries, B. Dalley for sequencing services, and T. Parnell for bioinformatic assistance. We give special thanks to M.-E. Torres-Padilla (IGBMC) for generously providing the MERVL::GFP reporter mESC line, and we thank D. Root (Broad Institute) for providing materials. Functional genomics work was supported by HHMI. J.A.D. was further supported by Eunice Kennedy Shriver NIH NICHD K12HD000849. S.J.T. and J.-W.L. were supported by NIH NIAMS R01AR045203, NIH NINDS P01NS069539, and the Friends of FSH Research. J.L.W. was supported by the National Science Foundation Graduate Research Fellowship Program DGE-1256082 and the University of Washington Interdisciplinary Training in Genome Sciences grant T32 HG00035 from NHGRI. Finally, we acknowledge CA042014 for support of the University of Utah core facilities.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Borsos M, 2016, GENE DEV, V30, P611, DOI 10.1101/gad.273805.115; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burglin TR, 2016, CHROMOSOMA, V125, P497, DOI 10.1007/s00412-015-0543-8; Choi YJ, 2017, SCIENCE, V355, DOI 10.1126/science.aag1927; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; De Paepe C, 2014, MOL HUM REPROD, V20, P599, DOI 10.1093/molehr/gau027; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dunwell TL, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0140-y; Eckersley-Maslin MA, 2016, CELL REP, V17, P179, DOI 10.1016/j.celrep.2016.08.087; Eidahl JO, 2016, HUM MOL GENET, V25, P4577, DOI 10.1093/hmg/ddw287; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Gertz J, 2012, GENOME RES, V22, P134, DOI 10.1101/gr.127373.111; Gifford WD, 2013, TRENDS CELL BIOL, V23, P218, DOI 10.1016/j.tcb.2013.01.001; Goke J, 2015, CELL STEM CELL, V16, P135, DOI 10.1016/j.stem.2015.01.005; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Ishiuchi T, 2015, NAT STRUCT MOL BIOL, V22, P662, DOI 10.1038/nsmb.3066; Ishiuchi T, 2013, CURR OPIN GENET DEV, V23, P512, DOI 10.1016/j.gde.2013.06.006; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Jouhilahti EM, 2016, DEVELOPMENT, V143, P3459, DOI 10.1242/dev.134510; Kalmbach K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925121; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Ko MSH, 2016, CURR TOP DEV BIOL, V120, P103, DOI 10.1016/bs.ctdb.2016.04.004; Leidenroth A, 2012, CHROMOSOMA, V121, P489, DOI 10.1007/s00412-012-0380-y; Leidenroth A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-364; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Madissoon E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28995; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morgani SM, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0549; Niakan K. K., 2012, DEV BIOL, V375, P454; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ribet D, 2008, J VIROL, V82, P1622, DOI 10.1128/JVI.02097-07; Schoorlemmer J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00014; Sun YJ, 2015, GENOME RES, V25, P1703, DOI 10.1101/gr.192542.115; Tohonen V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9207; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yasuda T, 2016, NAT GENET, V48, P569, DOI 10.1038/ng.3535; Young JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003947; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhang JH, 2016, NAT GENET, V48, P1481, DOI 10.1038/ng.3691; Zhou LQ, 2015, TRENDS CELL BIOL, V25, P82, DOI 10.1016/j.tcb.2014.09.006	50	319	325	10	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2017	49	6					925	+		10.1038/ng.3844	http://dx.doi.org/10.1038/ng.3844			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV8VM	28459457	Green Accepted, Green Submitted			2022-12-17	WOS:000402062300017
J	Al Olama, AA; Kote-Jarai, Z; Berndt, SI; Conti, DV; Schumacher, F; Han, Y; Benlloch, S; Hazelett, DJ; Wang, ZM; Saunders, E; Leongamornlert, D; Lindstrom, S; Jugurnauth-Little, S; Dadaev, T; Tymrakiewicz, M; Stram, DO; Rand, K; Wan, P; Stram, A; Sheng, X; Pooler, LC; Park, K; Xia, L; Tyrer, J; Kolonel, LN; Le Marchand, L; Hoover, RN; Machiela, MJ; Yeager, M; Burdette, L; Chung, CC; Hutchinson, A; Yu, K; Goh, C; Ahmed, M; Govindasami, K; Guy, M; Tammela, TLJ; Auvinen, A; Wahlfors, T; Schleutker, J; Visakorpi, T; Leinonen, KA; Xu, JF; Aly, M; Donovan, J; Travis, RC; Key, TJ; Siddiq, A; Canzian, F; Khaw, KT; Takahashi, A; Kubo, M; Pharoah, P; Pashayan, N; Weischer, M; Nordestgaard, BG; Nielsen, SF; Klarskov, P; Roder, MA; Iversen, P; Thibodeau, SN; McDonnell, SK; Schaid, DJ; Stanford, JL; Kolb, S; Holt, S; Knudsen, B; Coll, AH; Gapstur, SM; Diver, WR; Stevens, VL; Maier, C; Luedeke, M; Herkommer, K; Rinckleb, AE; Strom, SS; Pettaway, C; Yeboah, ED; Tettey, Y; Biritwum, RB; Adjei, AA; Tay, E; Truelove, A; Niwa, S; Choklcalingam, AP; Cannon-Albright, L; Cybulski, C; Wokolorczyk, D; Kluzniak, W; Park, J; Sellers, T; Lin, HY; Isaacs, WB; Partin, AW; Brenner, H; Dieffenbach, AK; Stegmaier, C; Chen, C; Giovannucci, EL; Ma, J; Stampfer, M; Penney, KL; Mucci, L; John, EM; Ingles, SA; Kittles, RA; Murphy, AB; Pandha, H; Michael, A; Kierzek, AM; Blot, W; Signorello, LB; Zheng, W; Albanes, D; Virtamo, J; Weinstein, S; Nemesure, B; Carpten, J; Leske, C; Wu, SY; Hennis, A; Kibel, AS; Rybicki, BA; Neslund-Dudas, C; Hsing, AW; Chu, L; Goodman, PJ; Klein, EA; Zheng, SL; Batra, J; Clements, J; Spurdle, A; Teixeira, MR; Paulo, P; Maia, S; Slavov, C; Kaneva, R; Mitev, V; Witte, JS; Casey, G; Gillanders, EM; Seminara, D; Riboli, E; Hamdy, FC; Coetzee, GA; Li, QY; Freedman, ML; Hunter, DJ; Muir, K; Gronberg, H; Nea, DE; Southey, M; Giles, GG; Severi, G; Cook, MB; Nakagawa, H; Wiklund, F; Kraft, P; Chanock, SJ; Henderson, BE; Easton, DF; Eeles, RA; Haiman, CA				Al Olama, Ali Amin; Kote-Jarai, Zsofia; Berndt, Sonja I.; Conti, David V.; Schumacher, Fredrick; Han, Ying; Benlloch, Sara; Hazelett, Dennis J.; Wang, Zhaoming; Saunders, Ed; Leongamornlert, Daniel; Lindstrom, Sara; Jugurnauth-Little, Sara; Dadaev, Tokhir; Tymrakiewicz, Malgorzata; Stram, Daniel O.; Rand, Kristin; Wan, Peggy; Stram, Alex; Sheng, Xin; Pooler, Loreall C.; Park, Karen; Xia, Lucy; Tyrer, Jonathan; Kolonel, Laurence N.; Le Marchand, Loic; Hoover, Robert N.; Machiela, Mitchell J.; Yeager, Merideth; Burdette, Laurie; Chung, Charles C.; Hutchinson, Amy; Yu, Kai; Goh, Chee; Ahmed, Mahbubl; Govindasami, Koveela; Guy, Michelle; Tammela, Teuvo L. J.; Auvinen, Anssi; Wahlfors, Tlina; Schleutker, Johanna; Visakorpi, Tapio; Leinonen, Katri A.; Xu, Jianfeng; Aly, Markus; Donovan, Jenny; Travis, Ruth C.; Key, Tim J.; Siddiq, Afshan; Canzian, Federico; Khaw, Kay-Tee; Takahashi, Atsushi; Kubo, Michiaki; Pharoah, Paul; Pashayan, Nora; Weischer, Maren; Nordestgaard, Borge G.; Nielsen, Sune F.; Klarskov, Peter; Roder, Martin Andreas; Iversen, Peter; Thibodeau, Stephen N.; McDonnell, Shannon K.; Schaid, Daniel J.; Stanford, Janet L.; Kolb, Suzanne; Holt, Sarah; Knudsen, Beatrice; Coll, Antonio Hurtado; Gapstur, Susan M.; Diver, W. Ryan; Stevens, Victoria L.; Maier, Christiane; Luedeke, Manuel; Herkommer, Kathleen; Rinckleb, Antje E.; Strom, Sara S.; Pettaway, Curtis; Yeboah, Edward D.; Tettey, Yao; Biritwum, Richard B.; Adjei, Andrew A.; Tay, Evelyn; Truelove, Ann; Niwa, Shelley; Choklcalingam, Anand P.; Cannon-Albright, Lisa; Cybulski, Cezary; Wokolorczyk, Dominika; Kluzniak, Wojciech; Park, Jong; Sellers, Thomas; Lin, Hui-Yi; Isaacs, William B.; Partin, Alan W.; Brenner, Hermann; Dieffenbach, Aida Karina; Stegmaier, Christa; Chen, Constance; Giovannucci, Edward L.; Ma, Jing; Stampfer, Meir; Penney, Kathryn L.; Mucci, Lorelei; John, Esther M.; Ingles, Sue A.; Kittles, Rick A.; Murphy, Adam B.; Pandha, Hardev; Michael, Agnieszka; Kierzek, Andrzej M.; Blot, William; Signorello, Lisa B.; Zheng, Wei; Albanes, Demetrius; Virtamo, Jarmo; Weinstein, Stephanie; Nemesure, Barbara; Carpten, John; Leske, Cristina; Wu, Suh-Yuh; Hennis, Anselm; Kibel, Adam S.; Rybicki, Benjamin A.; Neslund-Dudas, Christine; Hsing, Ann W.; Chu, Lisa; Goodman, Phyllis J.; Klein, Eric A.; Zheng, S. Lilly; Batra, Jyotsna; Clements, Judith; Spurdle, Amanda; Teixeira, Manuel R.; Paulo, Paula; Maia, Sofia; Slavov, Chavdar; Kaneva, Radka; Mitev, Vanio; Witte, John S.; Casey, Graham; Gillanders, Elizabeth M.; Seminara, Daniella; Riboli, Elio; Hamdy, Freddie C.; Coetzee, Gerhard A.; Li, Qiyuan; Freedman, Matthew L.; Hunter, David J.; Muir, Kenneth; Gronberg, Henrik; Nea, David E.; Southey, Melissa; Giles, Graham G.; Severi, Gianluca; Cook, Michael B.; Nakagawa, Hidewaki; Wiklund, Fredrik; Kraft, Peter; Chanock, Stephen J.; Henderson, Brian E.; Easton, Douglas F.; Eeles, Rosalind A.; Haiman, Christopher A.		Breast Prostate Canc Cohort Consor; Practical Prostate Canc Associatio; COGS Consortium; GAME-ON ELLIPSE Consortium	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; MYOSIN VI; RISK; JAPANESE; GLIOMA; 22Q13; MEN	Genome-wide association studies (GWAS) have identified 76 variants associated with prostate cancer risk predominantly in populations of European ancestry. To identify additional susceptibility loci for this common cancer, we conducted a meta-analysis of >10 million SNPs in 43,303 prostate cancer cases and 43,737 controls from studies in populations of European, African, Japanese and Latino ancestry. Twenty-three new susceptibility loci were identified at association P < 5 x 10(-8); 15 variants were identified among men of European ancestry, 7 were identified in multi-ancestry analyses and 1 was associated with early-onset prostate cancer. These 23 variants, in combination with known prostate cancer risk variants, explain 33% of the familial risk for this disease in European-ancestry populations. These findings provide new regions for investigation into the pathogenesis of prostate cancer and demonstrate the usefulness of combining ancestrally diverse populations to discover risk loci for disease.	[Al Olama, Ali Amin; Benlloch, Sara; Tyrer, Jonathan; Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Kote-Jarai, Zsofia; Saunders, Ed; Leongamornlert, Daniel; Jugurnauth-Little, Sara; Dadaev, Tokhir; Tymrakiewicz, Malgorzata; Goh, Chee; Ahmed, Mahbubl; Govindasami, Koveela; Guy, Michelle; Eeles, Rosalind A.] Inst Canc Res, London SW3 6JB, England; [Berndt, Sonja I.; Wang, Zhaoming; Hoover, Robert N.; Machiela, Mitchell J.; Yeager, Merideth; Burdette, Laurie; Chung, Charles C.; Hutchinson, Amy; Yu, Kai; Cook, Michael B.; Chanock, Stephen J.] Natl Canc Inst, US NIH, Div Canc Epidemiol & Genet, Bethesda, MD USA; [Conti, David V.; Schumacher, Fredrick; Han, Ying; Hazelett, Dennis J.; Stram, Daniel O.; Rand, Kristin; Wan, Peggy; Stram, Alex; Sheng, Xin; Pooler, Loreall C.; Park, Karen; Xia, Lucy; Ingles, Sue A.; Casey, Graham; Coetzee, Gerhard A.; Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Conti, David V.; Schumacher, Fredrick; Hazelett, Dennis J.; Stram, Daniel O.; Ingles, Sue A.; Casey, Graham; Coetzee, Gerhard A.; Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Wang, Zhaoming] SAIC Frederick Inc, Natl Canc Inst, Div Canc Epidemiol & Genet, Canc Genom Res Lab, Frederick, MD USA; [Lindstrom, Sara; Chen, Constance; Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Tammela, Teuvo L. J.] Univ Tampere, Tampere Univ Hosp, Dept Urol, FIN-33101 Tampere, Finland; [Tammela, Teuvo L. J.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Auvinen, Anssi] Univ Tampere, Sch Hlth Sci, Dept Epidemiol, FIN-33101 Tampere, Finland; [Wahlfors, Tlina; Schleutker, Johanna] Univ Tampere, BioMediTech, Tampere, Finland; [Wahlfors, Tlina; Schleutker, Johanna] Univ Tampere, FimLab Labs, Tampere, Finland; [Schleutker, Johanna] Univ Turku, Inst Biomed, Dept Biochem Med, Turku, Finland; [Visakorpi, Tapio; Leinonen, Katri A.] Univ Tampere, BioMediTech, Inst Biomed Technol, Tampere, Finland; [Visakorpi, Tapio; Leinonen, Katri A.] Tampere Univ Hosp, Tampere, Finland; [Xu, Jianfeng; Zheng, S. Lilly] Wake Forest Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Aly, Markus; Gronberg, Henrik; Wiklund, Fredrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Aly, Markus] Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden; [Donovan, Jenny] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Travis, Ruth C.; Key, Tim J.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England; [Siddiq, Afshan] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Khaw, Kay-Tee] Univ Cambridge, Clin Gerontol Unit, Cambridge, England; [Takahashi, Atsushi] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Pharoah, Paul; Pashayan, Nora] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England; [Weischer, Maren; Nordestgaard, Borge G.; Nielsen, Sune F.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark; [Nordestgaard, Borge G.; Nielsen, Sune F.] Univ Copenhagen, Fac Hlth & Med Sci, Herlev, Denmark; [Klarskov, Peter] Copenhagen Univ Hosp, Herlev Hosp, Dept Urol, Herlev, Denmark; [Roder, Martin Andreas; Iversen, Peter] Copenhagen Univ Hosp, Rigshosp, Copenhagen Prostate Canc Ctr, Dept Urol, Copenhagen, Denmark; [Thibodeau, Stephen N.; McDonnell, Shannon K.; Schaid, Daniel J.] Mayo Clin, Rochester, MN USA; [Stanford, Janet L.; Kolb, Suzanne] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Stanford, Janet L.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Holt, Sarah] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Knudsen, Beatrice] Cedars Sinai, Translat Pathol, Los Angeles, CA USA; [Coll, Antonio Hurtado] Prostate Ctr, Vancouver, BC, Canada; [Gapstur, Susan M.; Diver, W. Ryan] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Maier, Christiane; Luedeke, Manuel] Univ Hosp Ulm, Dept Urol, Ulm, Germany; [Herkommer, Kathleen] Tech Univ Munich, Klinikum Rechts Isar, Dept Urol, D-80290 Munich, Germany; [Rinckleb, Antje E.; Strom, Sara S.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Pettaway, Curtis] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Yeboah, Edward D.; Tettey, Yao; Biritwum, Richard B.; Adjei, Andrew A.; Tay, Evelyn] Univ Ghana, Sch Med, Accra, Ghana; [Yeboah, Edward D.; Tettey, Yao; Biritwum, Richard B.; Adjei, Andrew A.; Tay, Evelyn] Korle Bu Teaching Hosp, Accra, Ghana; [Truelove, Ann; Niwa, Shelley] Westat Corp, Rockville, MD USA; [Choklcalingam, Anand P.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Cannon-Albright, Lisa] Univ Utah, Sch Med, Dept Med, Div Genet Epidemiol, Salt Lake City, UT USA; [Cannon-Albright, Lisa] Vet Affairs Med Ctr, George E Wahlen Dept, Salt Lake City, UT 84148 USA; [Cybulski, Cezary; Wokolorczyk, Dominika; Kluzniak, Wojciech] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Park, Jong; Sellers, Thomas] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Lin, Hui-Yi] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA; [Isaacs, William B.; Partin, Alan W.] Johns Hopkins Hosp & Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD USA; [Brenner, Hermann; Dieffenbach, Aida Karina] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann; Dieffenbach, Aida Karina] German Canc Consortium, Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany; [Giovannucci, Edward L.; Stampfer, Meir; Penney, Kathryn L.; Mucci, Lorelei; Signorello, Lisa B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ma, Jing; Stampfer, Meir; Penney, Kathryn L.; Mucci, Lorelei; Signorello, Lisa B.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Div Network Med, Boston, MA 02115 USA; [John, Esther M.; Hsing, Ann W.; Chu, Lisa] Cancer Prevent Inst Calif, Fremont, CA USA; [John, Esther M.; Hsing, Ann W.; Chu, Lisa] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Kittles, Rick A.] Univ Illinois, Dept Med, Chicago, IL USA; [Murphy, Adam B.] Northwestern Univ, Dept Urol, Chicago, IL 60611 USA; [Pandha, Hardev; Michael, Agnieszka; Kierzek, Andrzej M.] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England; [Blot, William] Int Epidemiol Inst, Rockville, MD USA; [Blot, William; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Dept Med,Div Epidemiol, Nashville, TN 37235 USA; [Albanes, Demetrius; Weinstein, Stephanie] US Natl Inst Hlth, Natl Canc Inst, Div Canc Epidemiol & Genet, Nutr Epidemiol Branch, Bethesda, MD USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Nemesure, Barbara; Leske, Cristina; Wu, Suh-Yuh; Hennis, Anselm] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Hennis, Anselm] Translat Genom Res Inst, Phoenix, AZ USA; [Kibel, Adam S.] Univ W Indies, Chron Dis Res Ctr, Bridgetown, Barbados; [Rybicki, Benjamin A.; Neslund-Dudas, Christine] Brigham & Womens Hosp, Dana Farber Canc Inst, Div Urol Surg, Boston, MA 02115 USA; [Goodman, Phyllis J.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Klein, Eric A.] Fred Hutchinson Canc Res Ctr, Ctr Stat, Southwest Oncol Grp, Seattle, WA 98104 USA; [Batra, Jyotsna; Clements, Judith] Cleveland Clin, Glickman Urol & Kidney Inst, Dept Urol, Cleveland, OH 44106 USA; [Spurdle, Amanda] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Australian Prostate Canc Res Ctr Queensland, Brisbane, Qld 4001, Australia; [Teixeira, Manuel R.; Paulo, Paula; Maia, Sofia] Queensland Univ Technol, Sch Biomed Sci, Translat Res Inst, Brisbane, Qld 4001, Australia; [Teixeira, Manuel R.] QIMR Berghofer Med Res Inst, Mol Canc Epidemiol Lab, Brisbane, Qld, Australia; [Slavov, Chavdar] Portuguese Oncol Inst, Dept Genet, Oporto, Portugal; [Kaneva, Radka; Mitev, Vanio] Univ Porto, Biomed Sci Inst, Oporto, Portugal; [Witte, John S.] Med Univ Sofia, Dept Urol, Sofia, Bulgaria; [Witte, John S.] Med Univ Sofia, Mol Med Ctr, Dept Med Chem & Biochem, Sofia, Bulgaria; [Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Gillanders, Elizabeth M.; Seminara, Daniella] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Li, Qiyuan; Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Muir, Kenneth] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Nea, David E.] Canc Res UK, Li Ka Shing Ctr, Cambridge Res Inst, Cambridge, England; [Nea, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 2QQ, England; [Southey, Melissa] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Giles, Graham G.; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Giles, Graham G.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia; [Severi, Gianluca] Human Genet Fdn, Turin, Italy; [Nakagawa, Hidewaki] RIKEN, Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Tokyo, Japan; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Eeles, Rosalind A.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, London, England; [Eeles, Rosalind A.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, Sutton, Surrey, England	University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Harvard T.H. Chan School of Public Health; Cancer Research Center of Hawaii; University of Hawaii System; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University; Tampere University; University of Turku; Tampere University; Tampere University; Tampere University Hospital; Wake Forest University; Karolinska Institutet; Danderyds Hospital; University of Bristol; University of Oxford; Imperial College London; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cambridge; RIKEN; RIKEN; University of Cambridge; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Mayo Clinic; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Cedars Sinai Medical Center; American Cancer Society; Ulm University; Technical University of Munich; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Ghana; Westat; University of California System; University of California Berkeley; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pomeranian Medical University; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Johns Hopkins University; Johns Hopkins Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Stanford Cancer Institute; Stanford University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; University of Surrey; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Finland National Institute for Health & Welfare; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Translational Genomics Research Institute; University West Indies Mona Jamaica; University of the West Indies Open Campus; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Henry Ford Health System; Henry Ford Hospital; Fred Hutchinson Cancer Center; Southwest Oncology Group; Cleveland Clinic Foundation; Queensland University of Technology (QUT); Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute; Portuguese Institute of Oncology; Universidade do Porto; Medical University Sofia; Medical University Sofia; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Imperial College London; University of Oxford; Harvard University; Dana-Farber Cancer Institute; University of Manchester; University of Warwick; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Melbourne; Cancer Council Victoria; University of Melbourne; RIKEN; Harvard University; Harvard T.H. Chan School of Public Health; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Haiman, CA (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	rosalind.eeles@icr.ac.uk; haiman@usc.edu	Teixeira, Manuel AC/AAZ-7251-2020; Batra, Jyotsna/B-4130-2011; Brenner, Hermann/B-4627-2017; zhang, weihua/GXV-1334-2022; Kaneva, Radka P/V-6535-2017; Kaneva, Radka P/AGS-5076-2022; Coetzee, Gerhard/AAG-8439-2019; coetzee, Gerhard/AAT-6203-2020; Auvinen, Anssi/AAD-9311-2020; Auvinen, Anssi/AAL-2111-2020; Kubo, Michiaki/N-7947-2015; Severi, Gianluca/Q-1824-2019; Schumacher, Fredrick/R-6043-2019; Albanes, Demetrius/B-9749-2015; Weinstein, Stephanie J/P-1627-2017; Nordestgaard, Borge Gronne/ABF-1310-2020; Kaneva, Radka/AAT-5322-2021; Pharoah, Paul/V-6658-2019; Berndt, Sonja I/J-8423-2016; Yeager, Meredith/AAA-5322-2020; Cook, Michael B/A-5641-2009; Brenner, Hermann/ABE-6383-2020; Severi, Gianluca/H-3774-2018; Zheng, Wei/O-3351-2013; Diver, Ryan/AAG-3469-2019; Spurdle, Amanda B/A-4978-2011; Wang, Zhaoming/R-5527-2018; Machiela, Mitchell J/H-7335-2019; Paulo, Paula/F-1441-2016; Røder, M. Andreas/H-7701-2019; Khaw, Kay-Tee/AAZ-3209-2021; Teixeira, Manuel António Rodrigues/E-4885-2011; Rybicki, Benjamin/L-4614-2019; Wahlfors, Tiina/U-7635-2018	Teixeira, Manuel AC/0000-0002-1959-0624; Brenner, Hermann/0000-0002-6129-1572; Kaneva, Radka P/0000-0002-1437-1393; Kaneva, Radka P/0000-0002-1437-1393; Auvinen, Anssi/0000-0003-1125-4818; Severi, Gianluca/0000-0001-7157-419X; Schumacher, Fredrick/0000-0002-3073-7463; Weinstein, Stephanie J/0000-0002-3834-1535; Pharoah, Paul/0000-0001-8494-732X; Cook, Michael B/0000-0002-0533-7302; Brenner, Hermann/0000-0002-6129-1572; Severi, Gianluca/0000-0001-7157-419X; Zheng, Wei/0000-0003-1226-070X; Diver, Ryan/0000-0002-5418-9000; Spurdle, Amanda B/0000-0003-1337-7897; Wang, Zhaoming/0000-0001-7556-3869; Machiela, Mitchell J/0000-0001-6538-9705; Paulo, Paula/0000-0001-8387-2127; Røder, M. Andreas/0000-0002-0019-5333; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Rybicki, Benjamin/0000-0003-3190-3467; Aly, Markus/0000-0002-7602-9198; Saunders, Ed/0000-0003-4343-3570; Nordestgaard, Borge/0000-0002-1954-7220; Michael, Agnieszka/0000-0002-7262-6227; Siddiq, Afshan/0000-0002-9110-1434; Visakorpi, Tapio/0000-0002-5004-0364; albright, lisa/0000-0003-2602-3668; Clements, Judith/0000-0001-6026-1964; Coetzee, Gerhard/0000-0001-8820-8364; Mitev, Vanyo/0000-0001-7528-590X; Hamdy, Freddie/0000-0003-2627-2154; Canzian, Federico/0000-0002-4261-4583; Southey, Melissa/0000-0002-6313-9005; Lin, Hui-Yi/0000-0002-3307-5549; Eeles, Rosalind/0000-0002-3698-6241; Riboli, Elio/0000-0001-6795-6080; Adjei, Andrew Anthony/0000-0001-5109-2919; Giles, Graham/0000-0003-4946-9099; Hazelett, Dennis/0000-0003-0749-9935; Schleutker, Johanna/0000-0002-1863-0305; Pashayan, Nora/0000-0003-0843-2468; Wahlfors, Tiina/0000-0002-3910-796X; McDonnell, Shannon/0000-0001-6201-369X; Leongamornlert, Daniel/0000-0002-3486-3168; batra, Jyotsna/0000-0003-4646-6247; Kierzek, Andrzej/0000-0002-2605-9057	Cancer Research UK [15007, 16561, 17528, 16563, 16491] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10242, NF-SI-0512-10114] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; MRC [G0900871] Funding Source: UKRI; Cancer Research UK [10118, 14136, 13065, 11022, 10124] Funding Source: Medline; Medical Research Council [G1000143, G0900871, G0401527] Funding Source: Medline; NCI NIH HHS [U10 CA037429, R01 CA082664, U01 CA136792, U01 CA098233, UM1 CA182883, U01 CA063464, P30 CA068485, R01 CA128813, R37 CA054281, R01 CA088164, R01 CA092579, R01 CA092447, U01 CA089600, R01 CA068578, R01 CA128978, P30 CA076292, U01 CA098758, RC2 CA148085, R01 CA084979, R01 CA136924, P50 CA140388, U19 CA148065, U19 CA148537, R01 CA072818, R01 CA056678, U01 CA098216, U01 CA098710, U19 CA148112, P30 CA042014, UG1 CA189974, U01 CA127298] Funding Source: Medline; NHGRI NIH HHS [U01 HG004726, U01 HG004446] Funding Source: Medline; NIEHS NIH HHS [R01 ES011126, P30 ES007784] Funding Source: Medline; NIGMS NIH HHS [S06 GM008016, P01 GM099568] Funding Source: Medline; Prostate Cancer UK [G2012/48, G2011/36] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U19CA148112, U19CA148537, U01CA063464, U01CA098710, R01CA136924, U01CA136792, U01CA098233, R01CA056678, U01CA127298, UG1CA189974, P50CA140388, R01CA072818, P30CA076292, R01CA088164, U01CA098216, R01CA092447, P30CA042014, U01CA089600, RC2CA148085, R37CA054281, UM1CA182883, ZIACP010180, U19CA148065, R01CA068578, R01CA082664, U01CA098758, R01CA128978, R01CA084979, P30CA068485, R01CA092579, U10CA037429, R01CA128813] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004726, U01HG004446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011126, P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568, S06GM008016] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Prostate Cancer UK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Akamatsu S, 2012, NAT GENET, V44, P426, DOI 10.1038/ng.1104; Cheng I, 2012, CANCER EPIDEM BIOMAR, V21, P2048, DOI 10.1158/1055-9965.EPI-12-0598; Cook MB, 2014, HUM GENET, V133, P509, DOI 10.1007/s00439-013-1387-z; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Eeles R, 2014, NAT REV UROL, V11, P18, DOI 10.1038/nrurol.2013.266; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001387; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Loikkanen I, 2009, ONCOL REP, V22, P991, DOI 10.3892/or_00000526; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Morris DS, 2008, BJU INT, V102, P276, DOI 10.1111/j.1464-410X.2008.07665.x; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Puri C, 2010, ONCOGENE, V29, P188, DOI 10.1038/onc.2009.328; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Sun JL, 2009, CANCER RES, V69, P10, DOI 10.1158/0008-5472.CAN-08-3464; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Wei SZ, 2008, PROSTATE, V68, P1387, DOI 10.1002/pros.20806; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408	29	319	324	2	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1103	1109		10.1038/ng.3094	http://dx.doi.org/10.1038/ng.3094			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25217961	Green Accepted, Green Submitted			2022-12-17	WOS:000342554100013
J	Yang, SK; Hong, M; Baek, J; Choi, H; Zhao, WT; Jung, YS; Haritunians, T; Ye, BD; Kim, KJ; Park, SH; Park, SK; Yang, DH; Dubinsky, M; Lee, I; McGovern, DPB; Liu, JJ; Song, K				Yang, Suk-Kyun; Hong, Myunghee; Baek, Jiwon; Choi, Hyunchul; Zhao, Wanting; Jung, Yusun; Haritunians, Talin; Ye, Byong Duk; Kim, Kyung-Jo; Park, Sang Hyoung; Park, Soo-Kyung; Yang, Dong-Hoon; Dubinsky, Marla; Lee, Inchul; McGovern, Dermot P. B.; Liu, Jianjun; Song, Kyuyoung			A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; S-METHYLTRANSFERASE; AZATHIOPRINE; MYELOSUPPRESSION; MANAGEMENT; FREQUENCY; TOXICITY; GENOTYPE; JAPANESE; GENE	Thiopurine therapy, commonly used in autoimmune conditions, can be complicated by life-threatening leukopenia. This leukopenia is associated with genetic variation in TPMT (encoding thiopurine S-methyltransferase). Despite a lower frequency of TPMT mutations in Asians, the incidence of thiopurine-induced leukopenia is higher in Asians than in individuals of European descent. Here we performed an Immunochip-based 2-stage association study in 978 Korean subjects with Crohn's disease treated with thiopurines. We identified a nonsynonymous SNP in NUDT15 (encoding p.Arg139Cys) that was strongly associated with thiopurine-induced early leukopenia (odds ratio (OR) = 35.6; P-combined = 4.88 x 10(-94)). In Koreans, this variant demonstrated sensitivity and specificity of 89.4% and 93.2%, respectively, for thiopurine-induced early leukopenia (in comparison to 12.1% and 97.6% for TPMT variants). Although rare, this SNP was also strongly associated with thiopurine-induced leukopenia in subjects with inflammatory bowel disease of European descent (OR = 9.50; P = 4.64 x 10(-4)). Thus, NUDT15 is a pharmacogenetic determinant for thiopurine-induced leukopenia in diverse populations.	[Yang, Suk-Kyun; Ye, Byong Duk; Kim, Kyung-Jo; Park, Sang Hyoung; Park, Soo-Kyung; Yang, Dong-Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Hong, Myunghee; Baek, Jiwon; Choi, Hyunchul; Jung, Yusun; Song, Kyuyoung] Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Zhao, Wanting; Liu, Jianjun] Genome Inst Singapore, Human Genet Grp, Singapore, Singapore; [Haritunians, Talin; McGovern, Dermot P. B.] F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Dubinsky, Marla] Cedars Sinai Med Ctr, Pediat Inflammatory Bowel Dis Ctr, Los Angeles, CA 90048 USA; [Lee, Inchul] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Ulsan; Asan Medical Center	Song, K (corresponding author), Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea.	kysong@amc.seoul.kr	Ye, Byong Duk/AAF-4955-2020; Liu, Jianjun/AAK-4989-2020; Park, Sang Hyoung/CAH-4735-2022; Yang, Dong-Hoon/B-3437-2015	Ye, Byong Duk/0000-0001-6647-6325; Liu, Jianjun/0000-0002-3255-3019; Yang, Dong-Hoon/0000-0001-7756-2704; McGovern, Dermot/0000-0001-5621-759X	Biomedical Research Council, the Agency for Science, Technology and Research (A*STAR; BMRC) Singapore [SPF2014/001]; US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [P01DK046763, U01DK062413, U01AI067068, R01HS021747]; European Union (IBD-BIOM) [305479]; Leona M. and Harry B. Helmsley Charitable Trust [2011PG-MED004, 2014PG-IBD014]; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute; NRF (National Research Foundation of Korea) - Ministry of Science, Information and Communication Technology (ICT) and Future Planning [2010-0015648, 2014R1A2A1A09005824]; Korean Health Technology R&D Project from the Ministry of Health and Welfare, the Republic of Korea [A120176]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS021747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062413, P01DK046763] Funding Source: NIH RePORTER	Biomedical Research Council, the Agency for Science, Technology and Research (A*STAR; BMRC) Singapore; US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Union (IBD-BIOM); Leona M. and Harry B. Helmsley Charitable Trust; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute; NRF (National Research Foundation of Korea) - Ministry of Science, Information and Communication Technology (ICT) and Future Planning; Korean Health Technology R&D Project from the Ministry of Health and Welfare, the Republic of Korea; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank all participants who provided the DNA and clinical information necessary for this study. J.L. and W.Z. are supported by the Biomedical Research Council, the Agency for Science, Technology and Research (A*STAR; BMRC SPF2014/001), Singapore. D.P.B.M., T.H. and M.D. are supported by the US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (P01DK046763, U01DK062413, U01AI067068, R01HS021747), the European Union (IBD-BIOM 305479), the Leona M. and Harry B. Helmsley Charitable Trust (2011PG-MED004, 2014PG-IBD014) and internal funding from the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute. This work was supported by a Mid-Career Researcher Program grant through NRF (National Research Foundation of Korea) to K.S. (2010-0015648, 2014R1A2A1A09005824) funded by the Ministry of Science, Information and Communication Technology (ICT) and Future Planning and by a Korean Health Technology R&D Project grant to S.-K.Y. (A120176) from the Ministry of Health and Welfare, the Republic of Korea.	Booth RA, 2011, ANN INTERN MED, V154, P814, DOI 10.7326/0003-4819-154-12-201106210-00009; Cao Q, 2009, DIGESTION, V79, P58, DOI 10.1159/000205268; Collie-Duguid ESR, 1999, PHARMACOGENETICS, V9, P37, DOI 10.1097/00008571-199902000-00006; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; CONNELL WR, 1993, GUT, V34, P1081, DOI 10.1136/gut.34.8.1081; Dewit O, 2011, CLIN BIOCHEM, V44, P1062, DOI 10.1016/j.clinbiochem.2011.06.079; Fraser AG, 2002, GUT, V50, P485, DOI 10.1136/gut.50.4.485; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kim JH, 2010, J CLIN GASTROENTEROL, V44, pE242, DOI 10.1097/MCG.0b013e3181d6baf5; Kumagai K, 2001, PHARMACOGENETICS, V11, P275, DOI 10.1097/00008571-200104000-00012; Lee HJ, 2009, INTEST RES, V7, P22; Lewis JD, 2009, CLIN GASTROENTEROL H, V7, P1195, DOI 10.1016/j.cgh.2009.07.019; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; PRESENT DH, 1989, ANN INTERN MED, V111, P641, DOI 10.7326/0003-4819-111-8-641; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; Takatsu N, 2009, J GASTROEN HEPATOL, V24, P1258, DOI 10.1111/j.1440-1746.2009.05917.x; Timmer A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub3; Zhang FB, 2012, THER DRUG MONIT, V34, P695, DOI 10.1097/FTD.0b013e3182731925	19	319	339	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2014	46	9					1017	+		10.1038/ng.3060	http://dx.doi.org/10.1038/ng.3060			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO8CE	25108385	Green Accepted			2022-12-17	WOS:000341579400018
J	Warinner, C; Rodrigues, JFM; Vyas, R; Trachsel, C; Shved, N; Grossmann, J; Radini, A; Hancock, Y; Tito, RY; Fiddyment, S; Speller, C; Hendy, J; Charlton, S; Luder, HU; Salazar-Garcia, DC; Eppler, E; Seiler, R; Hansen, LH; Castruita, JAS; Barkow-Oesterreicher, S; Teoh, KY; Kelstrup, CD; Olsen, JV; Nanni, P; Kawai, T; Willerslev, E; von Mering, C; Lewis, CM; Collins, MJ; Gilbert, MTP; Ruhli, F; Cappellini, E				Warinner, Christina; Rodrigues, Joao F. Matias; Vyas, Rounak; Trachsel, Christian; Shved, Natallia; Grossmann, Jonas; Radini, Anita; Hancock, Y.; Tito, Raul Y.; Fiddyment, Sarah; Speller, Camilla; Hendy, Jessica; Charlton, Sophy; Luder, Hans Ulrich; Salazar-Garcia, Domingo C.; Eppler, Elisabeth; Seiler, Roger; Hansen, Lars H.; Castruita, Jose Alfredo Samaniego; Barkow-Oesterreicher, Simon; Teoh, Kai Yik; Kelstrup, Christian D.; Olsen, Jesper V.; Nanni, Paolo; Kawai, Toshihisa; Willerslev, Eske; von Mering, Christian; Lewis, Cecil M., Jr.; Collins, Matthew J.; Gilbert, M. Thomas P.; Ruehli, Frank; Cappellini, Enrico			Pathogens and host immunity in the ancient human oral cavity	NATURE GENETICS			English	Article							STABLE-ISOTOPE EVIDENCE; ANTIBIOTIC-RESISTANCE; PORPHYROMONAS-GINGIVALIS; TANNERELLA-FORSYTHIA; PERIODONTAL-DISEASES; FUNCTIONAL-ANALYSIS; MICROBIOTA; DATABASE; CALCULUS; BACTERIA	Calcified dental plaque (dental calculus) preserves for millennia and entraps biomolecules from all domains of life and viruses. We report the first, to our knowledge, high-resolution taxonomic and protein functional characterization of the ancient oral microbiome and demonstrate that the oral cavity has long served as a reservoir for bacteria implicated in both local and systemic disease. We characterize (i) the ancient oral microbiome in a diseased state, (ii) 40 opportunistic pathogens, (iii) ancient human-associated putative antibiotic resistance genes, (iv) a genome reconstruction of the periodontal pathogen Tannerella forsythia, (v) 239 bacterial and 43 human proteins, allowing confirmation of a long-term association between host immune factors, 'red complex' pathogens and periodontal disease, and (vi) DNA sequences matching dietary sources. Directly datable and nearly ubiquitous, dental calculus permits the simultaneous investigation of pathogen activity, host immunity and diet, thereby extending direct investigation of common diseases into the human evolutionary past.	[Warinner, Christina; Shved, Natallia; Seiler, Roger; Ruehli, Frank] Univ Zurich, Ctr Evolutionary Med, Inst Anat, Zurich, Switzerland; [Warinner, Christina; Tito, Raul Y.; Lewis, Cecil M., Jr.] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; [Rodrigues, Joao F. Matias; Vyas, Rounak; von Mering, Christian] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Rodrigues, Joao F. Matias; Vyas, Rounak; von Mering, Christian] Swiss Inst Bioinformat, Lausanne, Switzerland; [Trachsel, Christian; Grossmann, Jonas; Barkow-Oesterreicher, Simon; Nanni, Paolo] Univ Zurich, Swiss Fed Inst Technol ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Radini, Anita; Fiddyment, Sarah; Speller, Camilla; Hendy, Jessica; Charlton, Sophy; Teoh, Kai Yik; Collins, Matthew J.] Univ York, BioArCh, Dept Archaeol, York YO10 5DD, N Yorkshire, England; [Radini, Anita] Univ Leicester, Univ Leicester Archaeol Serv, Sch Archaeol & Ancient Hist, Leicester, Leics, England; [Hancock, Y.] Univ York, Dept Phys, York YO10 5DD, N Yorkshire, England; [Luder, Hans Ulrich] Univ Zurich, Ctr Dent Med, Inst Oral Biol, Zurich, Switzerland; [Salazar-Garcia, Domingo C.] Max Planck Inst Evolutionary Anthropol, Res Grp Plant Foods Hominin Dietary Ecol, Leipzig, Germany; [Salazar-Garcia, Domingo C.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Salazar-Garcia, Domingo C.] Univ Valencia, Dept Archaeol & Prehist, Valencia, Spain; [Eppler, Elisabeth] Univ Zurich, Inst Anat, Res Grp Neuroendocrine Immune Interact, Zurich, Switzerland; [Eppler, Elisabeth] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Hansen, Lars H.] Univ Copenhagen, Dept Biol Microbiol, Copenhagen, Denmark; [Hansen, Lars H.] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Castruita, Jose Alfredo Samaniego; Willerslev, Eske; Gilbert, M. Thomas P.; Cappellini, Enrico] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen, Denmark; [Kelstrup, Christian D.; Olsen, Jesper V.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Kawai, Toshihisa] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA; [Kawai, Toshihisa] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Gilbert, M. Thomas P.] Murdoch Univ, Ancient DNA Lab, Perth, WA, Australia	University of Zurich; University of Oklahoma System; University of Oklahoma - Norman; University of Zurich; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of York - UK; University of Leicester; University of York - UK; University of Zurich; Max Planck Society; Max Planck Society; University of Valencia; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Aarhus University; University of Copenhagen; University of Copenhagen; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Murdoch University	Warinner, C (corresponding author), Univ Zurich, Ctr Evolutionary Med, Inst Anat, Zurich, Switzerland.	twarinner@gmail.com; ecappellini@gmail.com	Collins, Matthew James/O-1095-2019; von Mering, Christian/B-3300-2008; Tito, Raul/CAG-3546-2022; Cappellini, Enrico/F-9346-2013; Samaniego Castruita, José Alfredo/B-9033-2015; Olsen, Jesper/ABH-4638-2020; Speller, Camilla/D-2830-2014; Speller, Camilla/GLV-4769-2022; Collins, Matthew J/A-7534-2008; Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Gilbert, Marcus TP/A-8936-2013; Salazar-García, Domingo C./AAB-1115-2019	Collins, Matthew James/0000-0003-4226-5501; von Mering, Christian/0000-0001-7734-9102; Cappellini, Enrico/0000-0001-7885-7811; Samaniego Castruita, José Alfredo/0000-0001-5904-1198; Olsen, Jesper/0000-0002-4747-4938; Speller, Camilla/0000-0001-7128-9903; Collins, Matthew J/0000-0003-4226-5501; Willerslev, Eske/0000-0002-7081-6748; Gilbert, Marcus TP/0000-0002-5805-7195; Fiddyment, Sarah/0000-0002-8991-2318; Matias Rodrigues, Joao F/0000-0001-8413-9920; Warinner, Christina/0000-0002-4528-5877; Salazar-Garcia, Domingo C./0000-0002-8017-0194; feigelman, rounak/0000-0002-1830-9300; Tito Tadeo, Raul Yhossef/0000-0001-9660-7621; Charlton, Sophy/0000-0001-7487-2635; Hendy, Jessica/0000-0002-3718-1058; Nanni, Paolo/0000-0001-8429-3557; Kelstrup, Christian Dahl/0000-0003-4647-1425; Hestbjerg Hansen, Lars/0000-0003-0027-1524	Maxi Foundation Zurich,; Swiss Foundation for Nutritional Research; Danish Research Foundation [29396]; Danish Council for Independent Research [10-081390]; Lundbeck Foundation [R52-A5062, R44-A4384]; US National Institutes of Health [R01-HG005172, R01-GM089886, R01-DE018499, R21-DE018310,]; European Research Council [UMICIS/242870]; Wellcome Trust [097829]; Swiss National Science Foundation [31003A-135688]; Novartis Foundation; Novo Nordisk Foundation; Max Planck Society; University of York;  [EUROTAST FP7-PEOPLE-2010 MC ITN];  [PALIMPSEST FP7-PEOPLE-2011-IEF 299101];  [ORCA FP7-PEOPLE-2011-IOF 299075]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018310, R01DE018499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089886] Funding Source: NIH RePORTER; Lundbeck Foundation [R44-2009-4384] Funding Source: researchfish; Natural Environment Research Council [1219549] Funding Source: researchfish	Maxi Foundation Zurich,; Swiss Foundation for Nutritional Research; Danish Research Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Max Planck Society(Max Planck SocietyFoundation CELLEX); University of York(European Commission); ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Lundbeck Foundation(Lundbeckfonden); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Kantonale Ethik- Kommission Zurich, the Functional Genomics Center Zurich, the Center for Microscopy and Image Analysis, and the Institute of Oral Biology at the University of Zurich; the PRIDE Team; G. Akgul, K. Alt, D. Ashford, P. Ashton, H. Barton, A. Bouwman, C. Burger, D. Coulthard, J. Hublin, V. Meskenaite, F. Najar, M. Richards, K. Sankaranarayanan, R. Schlapbach, L. Shillito, T. Stollner, O. Ullrich and H. Zbinden for assistance with data collection, analysis and management; and M. Carver, F. Dewhirst, A. Tanner, K. Hardy and A. Henry for helpful comments on early drafts and data analyses. This work was supported by the Maxi Foundation Zurich, the Swiss Foundation for Nutritional Research, Danish Research Foundation grant 29396, Danish Council for Independent Research grant 10-081390, Lundbeck Foundation grants R52-A5062 and R44-A4384, US National Institutes of Health grants R01-HG005172, R01-GM089886, R01-DE018499 and R21-DE018310, European Research Council grant UMICIS/242870, Marie Curie grants EUROTAST FP7-PEOPLE-2010 MC ITN, PALIMPSEST FP7-PEOPLE-2011-IEF 299101 and ORCA FP7-PEOPLE-2011-IOF 299075, a C2D2 Research Priming Fund grant partly funded by Wellcome Trust 097829, Swiss National Science Foundation grant 31003A-135688, the Novartis Foundation, the Novo Nordisk Foundation, the Max Planck Society and the University of York.	Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; Bocherens H, 1997, Anthropol Anz, V55, P121; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Cappellini E, 2014, ZOOL J LINN SOC-LOND, V170, P222, DOI 10.1111/zoj12084; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Coxon A, 1999, J EXP MED, V190, P923, DOI 10.1084/jem.190.7.923; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; De La Fuente C, 2013, ARCHAEOMETRY, V55, DOI 10.1111/j.1475-4754.2012.00707.x; Deguchi T, 2012, ANTIMICROB AGENTS CH, V56, P4039, DOI 10.1128/AAC.00505-12; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Emonts M, 2003, LANCET INFECT DIS, V3, P565, DOI 10.1016/S1473-3099(03)00740-0; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Frei R, 2012, ALLERGY, V67, P451, DOI 10.1111/j.1398-9995.2011.02783.x; Furugen R, 2013, ORAL DIS, V19, P479, DOI 10.1111/odi.12027; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Goker M, 2010, STAND GENOMIC SCI, V3, P76, DOI 10.4056/sigs.1082860; Gorr SU, 2009, PERIODONTOL 2000, V51, P152, DOI 10.1111/j.1600-0757.2009.00310.x; Gracia-Arnaiz M, 2010, APPETITE, V55, P219, DOI 10.1016/j.appet.2010.06.002; Hardy K, 2009, J ARCHAEOL SCI, V36, P248, DOI 10.1016/j.jas.2008.09.015; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Hujoel P, 2009, J DENT RES, V88, P490, DOI 10.1177/0022034509337700; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jin Y, 2002, CRIT REV ORAL BIOL M, V13, P426, DOI 10.1177/154411130201300506; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Kuo LC, 2008, PUBLIC HEALTH, V122, P417, DOI 10.1016/j.puhe.2007.07.004; Kusminski CM, 2005, CLIN SCI, V109, P243, DOI 10.1042/CS20050078; Lee SW, 2006, GENE, V371, P102, DOI 10.1016/j.gene.2005.11.027; Leishman Shaneen J, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5781; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; LINOSSIER A, 1996, SCANNING MICROSCOPY, V10, P1014; Linossier Alfredo, 1996, Scanning Microscopy, V10, P1005; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mitra S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S21; Munro CL, 2004, AM J CRIT CARE, V13, P25, DOI 10.4037/ajcc2004.13.1.25; Nakano K, 2009, ORAL MICROBIOL IMMUN, V24, P64, DOI 10.1111/j.1399-302X.2008.00479.x; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; O'Brien-Simpson NM, 2004, PERIODONTOL 2000, V35, P101, DOI 10.1111/j.0906-6713.2004.003559.x; Oelze VM, 2012, AM J PHYS ANTHROPOL, V148, P406, DOI 10.1002/ajpa.22063; Oelze VM, 2011, J ARCHAEOL SCI, V38, P270, DOI 10.1016/j.jas.2010.08.027; Palmer RJ, 2014, PERIODONTOL 2000, V64, P20, DOI 10.1111/j.1600-0757.2012.00453.x; Palmer SA, 2012, ANN ANAT, V194, P146, DOI 10.1016/j.aanat.2011.03.012; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Richards MP, 1999, J ARCHAEOL SCI, V26, P717, DOI 10.1006/jasc.1998.0387; Ryder MI, 2010, PERIODONTOL 2000, V53, P124, DOI 10.1111/j.1600-0757.2009.00327.x; Savitski MM, 2010, J PROTEOME RES, V9, P5511, DOI 10.1021/pr1006813; Schutkowski H, 1999, J ARCHAEOL SCI, V26, P675, DOI 10.1006/jasc.1998.0384; Sharma A, 2010, PERIODONTOL 2000, V54, P106, DOI 10.1111/j.1600-0757.2009.00332.x; Shay K, 2002, CLIN INFECT DIS, V34, P1215, DOI 10.1086/339865; Shimotahira N, 2013, INFECT IMMUN, V81, P1198, DOI 10.1128/IAI.00983-12; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stelzer Gil, 2011, Human Genomics, V5, P709; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tanner ACR, 2006, PERIODONTOL 2000, V42, P88, DOI 10.1111/j.1600-0757.2006.00184.x; Turner-Walker G., 2008, ADV HUMAN PALEOPATHO, P29; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang JF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01843; Willner D, 2011, P NATL ACAD SCI USA, V108, P4547, DOI 10.1073/pnas.1000089107; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; Xie G, 2010, MOL ORAL MICROBIOL, V25, P391, DOI 10.1111/j.2041-1014.2010.00587.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	73	319	326	3	150	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2014	46	4					336	+		10.1038/ng.2906	http://dx.doi.org/10.1038/ng.2906			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AF1YP	24562188	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000334510100008
J	Hon, GC; Rajagopal, N; Shen, Y; McCleary, DF; Yue, F; Dang, MD; Ren, B				Hon, Gary C.; Rajagopal, Nisha; Shen, Yin; McCleary, David F.; Yue, Feng; Dang, My D.; Ren, Bing			Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues	NATURE GENETICS			English	Article							PLURIPOTENT STEM-CELLS; CPG ISLAND SHORES; HUMAN GENOME; REGULATORY SEQUENCES; GENE-EXPRESSION; HUMAN PLACENTA; CHROMATIN; CANCER; HYPOMETHYLATION; METHYLOME	Mammalian development requires cytosine methylation, a heritable epigenetic mark of cellular memory believed to maintain a cell's unique gene expression pattern. However, it remains unclear how dynamic DNA methylation relates to cell type-specific gene expression and animal development. Here, by mapping base-resolution methylomes in 17 adult mouse tissues at shallow coverage, we identify 302,864 tissue-specific differentially methylated regions (tsDMRs) and estimate that >6.7% of the mouse genome is variably methylated. Supporting a prominent role for DNA methylation in gene regulation, most tsDMRs occur at distal cis-regulatory elements. Unexpectedly, some tsDMRs mark enhancers that are dormant in adult tissues but active in embryonic development. These 'vestigial' enhancers are hypomethylated and lack active histone modifications in adult tissues but nevertheless exhibit activity during embryonic development. Our results provide new insights into the role of DNA methylation at tissue-specific enhancers and suggest that epigenetic memory of embryonic development may be retained in adult tissues.	[Hon, Gary C.; Shen, Yin; McCleary, David F.; Yue, Feng; Dang, My D.; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA USA; [Rajagopal, Nisha; Ren, Bing] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Inst Gen Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, San Diego Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, La Jolla, CA USA.	biren@ucsd.edu			Ludwig Institute for Cancer Research; US National Institutes of Health [R01 HG003991, ES017166]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003991, U54HG006997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Kuan, Z. Ye and L. Edsall for their assistance in sequencing and the initial processing of sequencing reads. This work is funded by the Ludwig Institute for Cancer Research and the US National Institutes of Health (R01 HG003991 and ES017166).	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Gilbert SF, 2000, DEV BIOL; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; MONK M, 1987, DEVELOPMENT, V99, P371; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Novakovic B, 2010, J BIOL CHEM, V285, P9583, DOI 10.1074/jbc.M109.064956; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 2002, J NUTR, V132, p2462S, DOI 10.1093/jn/132.8.2462S; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Reichert H, 2009, BIOL LETTERS, V5, P112, DOI 10.1098/rsbl.2008.0337; Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035	59	319	322	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2013	45	10			SI		1198	U340		10.1038/ng.2746	http://dx.doi.org/10.1038/ng.2746			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	225UQ	23995138	Green Accepted, Green Submitted			2022-12-17	WOS:000324989600016
J	Miotto, O; Almagro-Garcia, J; Manske, M; MacInnis, B; Campino, S; Rockett, KA; Amaratunga, C; Lim, P; Suon, S; Sreng, S; Anderson, JM; Duong, S; Nguon, C; Chuor, CM; Saunders, D; Se, Y; Lon, C; Fukuda, MM; Amenga-Etego, L; Hodgson, AVO; Asoala, V; Imwong, M; Takala-Harrison, S; Nosten, F; Su, XZ; Ringwald, P; Ariey, F; Dolecek, C; Hien, TT; Boni, MF; Thai, CQ; Amambua-Ngwa, A; Conway, DJ; Djimde, AA; Doumbo, OK; Zongo, I; Ouedraogo, JB; Alcock, D; Drury, E; Auburn, S; Koch, O; Sanders, M; Hubbart, C; Maslen, G; Ruano-Rubio, V; Jyothi, D; Miles, A; O'Brien, J; Gamble, C; Oyola, SO; Rayner, JC; Newbold, CI; Berriman, M; Spencer, CCA; McVean, G; Day, NP; White, NJ; Bethell, D; Dondorp, AM; Plowe, CV; Fairhurst, RM; Kwiatkowski, DP				Miotto, Olivo; Almagro-Garcia, Jacob; Manske, Magnus; MacInnis, Bronwyn; Campino, Susana; Rockett, Kirk A.; Amaratunga, Chanaki; Lim, Pharath; Suon, Seila; Sreng, Sokunthea; Anderson, Jennifer M.; Duong, Socheat; Nguon, Chea; Chuor, Char Meng; Saunders, David; Se, Youry; Lon, Chantap; Fukuda, Mark M.; Amenga-Etego, Lucas; Hodgson, Abraham V. O.; Asoala, Victor; Imwong, Mallika; Takala-Harrison, Shannon; Nosten, Francois; Su, Xin-zhuan; Ringwald, Pascal; Ariey, Frederic; Dolecek, Christiane; Tran Tinh Hien; Boni, Maciej F.; Cao Quang Thai; Amambua-Ngwa, Alfred; Conway, David J.; Djimde, Abdoulaye A.; Doumbo, Ogobara K.; Zongo, Issaka; Ouedraogo, Jean-Bosco; Alcock, Daniel; Drury, Eleanor; Auburn, Sarah; Koch, Oliver; Sanders, Mandy; Hubbart, Christina; Maslen, Gareth; Ruano-Rubio, Valentin; Jyothi, Dushyanth; Miles, Alistair; O'Brien, John; Gamble, Chris; Oyola, Samuel O.; Rayner, Julian C.; Newbold, Chris I.; Berriman, Matthew; Spencer, Chris C. A.; McVean, Gilean; Day, Nicholas P.; White, Nicholas J.; Bethell, Delia; Dondorp, Arjen M.; Plowe, Christopher V.; Fairhurst, Rick M.; Kwiatkowski, Dominic P.			Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia	NATURE GENETICS			English	Article							CHLOROQUINE RESISTANCE; PARASITE CLEARANCE; DIHYDROPTEROATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; DRUG-RESISTANCE; MALARIA; SPREAD; PYRIMETHAMINE; PFCRT; GENE	We describe an analysis of genome variation in 825 P. falciparum samples from Asia and Africa that identifies an unusual pattern of parasite population structure at the epicenter of artemisinin resistance in western Cambodia. Within this relatively small geographic area, we have discovered several distinct but apparently sympatric parasite subpopulations with extremely high levels of genetic differentiation. Of particular interest are three subpopulations, all associated with clinical resistance to artemisinin, which have skewed allele frequency spectra and high levels of haplotype homozygosity, indicative of founder effects and recent population expansion. We provide a catalog of SNPs that show high levels of differentiation in the artemisinin-resistant subpopulations, including codon variants in transporter proteins and DNA mismatch repair proteins. These data provide a population-level genetic framework for investigating the biological origins of artemisinin resistance and for defining molecular markers to assist in its elimination.	[Miotto, Olivo; Almagro-Garcia, Jacob; Rockett, Kirk A.; Amenga-Etego, Lucas; Koch, Oliver; Miles, Alistair; Newbold, Chris I.; Spencer, Chris C. A.; Kwiatkowski, Dominic P.] Univ Oxford, MRC, Ctr Genom & Global Hlth, Oxford, England; [Miotto, Olivo; Imwong, Mallika; Nosten, Francois; Day, Nicholas P.; White, Nicholas J.; Dondorp, Arjen M.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Miotto, Olivo; Almagro-Garcia, Jacob; Manske, Magnus; MacInnis, Bronwyn; Campino, Susana; Rockett, Kirk A.; Alcock, Daniel; Drury, Eleanor; Sanders, Mandy; Maslen, Gareth; Ruano-Rubio, Valentin; Jyothi, Dushyanth; Oyola, Samuel O.; Rayner, Julian C.; Newbold, Chris I.; Berriman, Matthew; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge, England; [Almagro-Garcia, Jacob; Rockett, Kirk A.; Hubbart, Christina; Ruano-Rubio, Valentin; Miles, Alistair; O'Brien, John; Spencer, Chris C. A.; McVean, Gilean; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Amaratunga, Chanaki; Lim, Pharath; Anderson, Jennifer M.; Su, Xin-zhuan; Fairhurst, Rick M.] NIAID, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Lim, Pharath; Suon, Seila; Sreng, Sokunthea; Duong, Socheat; Nguon, Chea; Chuor, Char Meng] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Saunders, David; Fukuda, Mark M.; Bethell, Delia] US Army Med Component, Armed Forces Res Inst Med Sci USAMC AFRIMS, Dept Immunol & Med, Bangkok, Thailand; [Se, Youry; Lon, Chantap] USAMC AFRIMS, Phnom Penh, Cambodia; [Fukuda, Mark M.] Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA; [Amenga-Etego, Lucas; Hodgson, Abraham V. O.; Asoala, Victor] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Takala-Harrison, Shannon; Plowe, Christopher V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21201 USA; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand; [Nosten, Francois; Dolecek, Christiane; Tran Tinh Hien; Boni, Maciej F.; Day, Nicholas P.; White, Nicholas J.; Dondorp, Arjen M.] Univ Oxford, Ctr Trop Med, Oxford, England; [Ringwald, Pascal] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Ariey, Frederic] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France; [Dolecek, Christiane; Tran Tinh Hien; Boni, Maciej F.; Cao Quang Thai] Oxford Univ Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Amambua-Ngwa, Alfred; Conway, David J.] MRC Labs, Fajara, Gambia; [Conway, David J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Djimde, Abdoulaye A.; Doumbo, Ogobara K.] Univ Sci Tech & Technol Bamako, Fac Pharm, Malaria Res & Training Ctr, Bamako, Mali; [Zongo, Issaka; Ouedraogo, Jean-Bosco] Direct Reg Ouest, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Auburn, Sarah] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Gamble, Chris] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Newbold, Chris I.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England	University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Center Parasitology, Entomology & Malaria Control; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Navrongo Health Research Center; Mahidol University; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; Mahidol University; University of Oxford; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine; University of Science & Technology of Bamako; Charles Darwin University; Menzies School of Health Research; University of Oxford; University of Oxford	Kwiatkowski, DP (corresponding author), Univ Oxford, MRC, Ctr Genom & Global Hlth, Oxford, England.	dominic@sanger.ac.uk	Imwong, Mallika/ABE-6493-2020; Jyothi, Dushyanth/H-9517-2014; ariey, frederic/P-1185-2017; Berriman, Matthew/A-7618-2011; Campino, Susana/AAM-2577-2020; Lim, Pharath/AAF-6699-2020; Koch, Oliver/A-9480-2016; Amambua-Ngwa, Alfred/ABA-7305-2020; Amambua-Ngwa, Alfred/AHD-7882-2022; Amambua-Ngwa, Alfred/HGU-8062-2022; Miotto, Olivo/AAE-7124-2019; White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019; Mead, Daniel/AAE-6629-2019; Auburn, Sarah/N-2266-2013	Jyothi, Dushyanth/0000-0002-0448-5303; ariey, frederic/0000-0002-0680-1090; Berriman, Matthew/0000-0002-9581-0377; Campino, Susana/0000-0003-1403-6138; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Miotto, Olivo/0000-0001-8060-6771; White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Mead, Daniel/0000-0001-7717-4330; Kwiatkowski, Dominic/0000-0002-5023-0176; Takala-Harrison, Shannon/0000-0003-4674-8500; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Miles, Alistair/0000-0001-9018-4680; Oyola, Samuel O./0000-0002-6425-7345; McVean, Gil/0000-0002-5012-4162; Conway, David/0000-0002-8711-3037; Newbold, Chris/0000-0002-9274-3789; Auburn, Sarah/0000-0002-4638-536X; Rayner, Julian/0000-0002-9835-1014; Su, Xinzhuan/0000-0003-3246-3248; Manske, Magnus/0000-0001-5916-0947; Lim, Pharath/0000-0002-1012-2461; Koch, Oliver/0000-0003-3454-2855; Maslen, Gareth/0000-0001-7318-3678	Wellcome Trust through core funding of the Wellcome Trust Sanger Institute [098051]; Wellcome Trust through core funding of the Wellcome Trust Centre for Human Genetics [090532/Z/09/Z]; Wellcome Trust through a Strategic Award [090770/Z/09/Z]; MRC through the MRC Centre for Genomics and Global Health [G0600718]; MRC through an MRC Professorship [G19/9]; Wellcome Trust; MRC; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health; Howard Hughes Medical Institute International Scholarship [55005502]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001066, ZIAAI000892, ZIAAI001000, R01AI101713] Funding Source: NIH RePORTER; MRC [MC_EX_MR/K02440X/1, G19/9, G0600718, MC_U190081987] Funding Source: UKRI; Medical Research Council [G0600718, G19/9, MC_EX_MR/K02440X/1, 1252410, MC_U190081987] Funding Source: researchfish	Wellcome Trust through core funding of the Wellcome Trust Sanger Institute; Wellcome Trust through core funding of the Wellcome Trust Centre for Human Genetics; Wellcome Trust through a Strategic Award(Wellcome Trust); MRC through the MRC Centre for Genomics and Global Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC through an MRC Professorship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute International Scholarship(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank V. Cornelius and R. Giacomantonio for their support in producing and reviewing this manuscript; S. Uk and E.S. Phelps for their contributions in the Cambodian studies; and T. Anderson for helpful review comments. The sequencing, genotyping and analysis components of this study were supported by the Wellcome Trust through core funding of the Wellcome Trust Sanger Institute (098051), core funding of the Wellcome Trust Centre for Human Genetics (090532/Z/09/Z) and a Strategic Award (090770/Z/09/Z) and the MRC through the MRC Centre for Genomics and Global Health (G0600718) and an MRC Professorship to D.P.K. (G19/9). Other parts of this study were partly supported by the Wellcome Trust; the MRC; the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health; and a Howard Hughes Medical Institute International Scholarship (55005502) to A.A.D. P.R. is a staff member of the World Health Organization; he alone is responsible for the views expressed in this publication, and they do not necessarily represent the decisions, policy or views of the World Health Organization.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 2005, ANTIMICROB AGENTS CH, V49, P2180, DOI 10.1128/AAC.49.6.2180-2188.2005; [Anonymous], 2011, GLOB PLAN ART RES CO; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bethell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019283; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Hall MC, 1998, EMBO J, V17, P1535, DOI 10.1093/emboj/17.5.1535; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Isozumi R, 2010, J CLIN MICROBIOL, V48, P70, DOI 10.1128/JCM.01449-09; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; Kublin JG, 1998, LANCET, V351, P1629, DOI 10.1016/S0140-6736(98)24022-0; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lim P, 2003, ANTIMICROB AGENTS CH, V47, P87, DOI 10.1128/AAC.47.1.87-94.2003; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Mita T, 2011, J INFECT DIS, V204, P1980, DOI 10.1093/infdis/jir664; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; PAYNE D, 1988, PARASITOL TODAY, V4, P112, DOI 10.1016/0169-4758(88)90042-7; PEEL SA, 1994, AM J TROP MED HYG, V51, P648, DOI 10.4269/ajtmh.1994.51.648; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Plowe Christopher V, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS11, DOI 10.1016/j.trstmh.2008.11.002; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Preechapornkul P, 2009, ANTIMICROB AGENTS CH, V53, P1509, DOI 10.1128/AAC.00241-08; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Shankar J, 2008, GENE, V410, P223, DOI 10.1016/j.gene.2007.12.015; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; VERDRAGER J, 1986, J TROP MED HYG, V89, P277; Vinayak S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000830; White NJ, 2010, LANCET, V376, P2051, DOI 10.1016/S0140-6736(10)61963-0	45	319	327	0	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2013	45	6					648	+		10.1038/ng.2624	http://dx.doi.org/10.1038/ng.2624			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	152XA	23624527	Green Accepted			2022-12-17	WOS:000319563900012
J	Chen, WJ; Lin, Y; Xiong, ZQ; Wei, W; Ni, W; Tan, GH; Guo, SL; He, J; Chen, YF; Zhang, QJ; Li, HF; Lin, Y; Murong, SX; Xu, JF; Wang, N; Wu, ZY				Chen, Wan-Jin; Lin, Yu; Xiong, Zhi-Qi; Wei, Wei; Ni, Wang; Tan, Guo-He; Guo, Shun-Ling; He, Jin; Chen, Ya-Fang; Zhang, Qi-Jie; Li, Hong-Fu; Lin, Yi; Murong, Shen-Xing; Xu, Jianfeng; Wang, Ning; Wu, Zhi-Ying			Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia	NATURE GENETICS			English	Article							HUMAN-CHROMOSOME 16; CHOREOATHETOSIS; DISORDERS; LINKAGE; LOCUS; CHANNELOPATHIES; GENES; MAPS	Paroxysmal kinesigenic dyskinesia is the most common type of paroxysmal movement disorder and is often misdiagnosed clinically as epilepsy. Using whole-exome sequencing followed by Sanger sequencing, we identified three truncating mutations within PRRT2 (NM_145239.2) in eight Han Chinese families with histories of paroxysmal kinesigenic dyskinesia: c.514_517delTCTG (p.Ser172Argfs*3) in one family, c.649dupC (p.Arg217Profs*8) in six families and c.972delA (p.Val325Serfs*12) in one family. These truncating mutations co-segregated exactly with the disease in these families and were not observed in 1,000 control subjects of matched ancestry. PRRT2 is a newly discovered gene consisting of four exons encoding the proline-rich transmembrane protein 2, which encompasses 340 amino acids and contains two predicted transmembrane domains. PRRT2 is highly expressed in the developing nervous system, and a truncating mutation alters the subcellular localization of the PRRT2 protein. The function of PRRT2 and its role in paroxysmal kinesigenic dyskinesia should be further investigated.	[Chen, Wan-Jin; Ni, Wang; Li, Hong-Fu; Wu, Zhi-Ying] Fudan Univ, Inst Brain Sci, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Chen, Wan-Jin; Ni, Wang; Li, Hong-Fu; Wu, Zhi-Ying] Fudan Univ, Inst Brain Sci, Huashan Hosp, Inst Neurol, Shanghai 200433, Peoples R China; [Chen, Wan-Jin; Ni, Wang; Li, Hong-Fu; Wu, Zhi-Ying] Fudan Univ, State Key Lab Med Neurobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Chen, Wan-Jin; Lin, Yu; Wei, Wei; Ni, Wang; He, Jin; Chen, Ya-Fang; Zhang, Qi-Jie; Lin, Yi; Murong, Shen-Xing; Wang, Ning] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Peoples R China; [Chen, Wan-Jin; Lin, Yu; Wei, Wei; Ni, Wang; He, Jin; Chen, Ya-Fang; Zhang, Qi-Jie; Lin, Yi; Murong, Shen-Xing; Wang, Ning] Fujian Med Univ, Affiliated Hosp 1, Inst Neurol, Fuzhou, Peoples R China; [Xiong, Zhi-Qi; Tan, Guo-He; Guo, Shun-Ling] Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Xu, Jianfeng] Fudan Univ, Fudan Inst Urol, Shanghai Med Coll, Huashan Hosp, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Fudan Van Andel Res Inst VARI, Ctr Genet Epidemiol, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fujian Medical University; Fujian Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Fudan University	Wu, ZY (corresponding author), Fudan Univ, Inst Brain Sci, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	ningwang63@yahoo.com; zhiyingwu@fudan.edu.cn	Chen, yafang/GVS-0304-2022		National Natural Science Foundation (China) [81125009]; Huashan Hospital; Fudan University; Fujian Medical University [2009D064]	National Natural Science Foundation (China)(National Natural Science Foundation of China (NSFC)); Huashan Hospital; Fudan University; Fujian Medical University	The authors sincerely thank the participants for their help and willingness to take part in this study. The authors also thank the Beijing Genomics Institute (BGI)-Shenzhen for assistance in the analysis of exome sequence data. This work was supported by a grant from the National Natural Science Foundation (China; 81125009 to Z.-Y.W.) and a grant from Huashan Hospital for the special professorship of Fudan University (to Z.-Y.W.) and by a key program of scientific research of Fujian Medical University (2009D064 to N.W.).	Bennett LB, 2000, NEUROLOGY, V54, P125, DOI 10.1212/WNL.54.1.125; Bhatia KP, 2000, MOVEMENT DISORD, V15, P429, DOI 10.1002/1531-8257(200005)15:3<429::AID-MDS1001>3.0.CO;2-R; Bruno MK, 2004, NEUROLOGY, V63, P2280, DOI 10.1212/01.WNL.0000147298.05983.50; Celesia GG, 2001, CLIN NEUROPHYSIOL, V112, P2, DOI 10.1016/S1388-2457(00)00496-X; GOODENOUGH DJ, 1978, ARCH NEUROL-CHICAGO, V35, P827, DOI 10.1001/archneur.1978.00500360051010; Hu XL, 2011, CEREB CORTEX, V21, P2158, DOI 10.1093/cercor/bhq284; KERTESZ AZ, 1967, NEUROLOGY, V17, P680, DOI 10.1212/WNL.17.7.680; Kikuchi T, 2007, J HUM GENET, V52, P334, DOI 10.1007/s10038-007-0116-7; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ono S, 2011, MOVEMENT DISORD, V26, P761, DOI 10.1002/mds.23475; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Swoboda KJ, 2000, NEUROLOGY, V55, P224, DOI 10.1212/WNL.55.2.224; Tomita H, 1999, AM J HUM GENET, V65, P1688, DOI 10.1086/302682; Valente EM, 2000, BRAIN, V123, P2040, DOI 10.1093/brain/123.10.2040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484	20	319	371	3	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2011	43	12					1252	U116		10.1038/ng.1008	http://dx.doi.org/10.1038/ng.1008			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	860EK	22101681				2022-12-17	WOS:000297931400022
J	Krieger, U; Lippman, ZB; Zamir, D				Krieger, Uri; Lippman, Zachary B.; Zamir, Dani			The flowering gene SINGLE FLOWER TRUSS drives heterosis for yield in tomato	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; GROWTH; MAIZE; OVERDOMINANT; LYCOPERSICON; POPULATION; DROSOPHILA; MUTATIONS; ORTHOLOG; SIGNALS	Intercrossing different varieties of plants frequently produces hybrid offspring with superior vigor and increased yields, in a poorly understood phenomenon known as heterosis(1,2). One classical unproven model for heterosis is overdominance, which posits in its simplest form that improved vigor can result from a single heterozygous gene(3-8). Here we report that heterozygosity for tomato loss-of-function alleles of SINGLE FLOWER TRUSS (SFT), which is the genetic originator of the flowering hormone florigen, increases yield by up to 60%. Yield overdominance from SFT heterozygosity is robust, occurring in distinct genetic backgrounds and environments. We show that several traits integrate pleiotropically to drive heterosis in a multiplicative manner(9), and these effects derive from a suppression of growth termination mediated by SELF PRUNING (SP), an antagonist of SFT. Our findings provide the first example of a single overdominant gene for yield and suggest that single heterozygous mutations may improve productivity in other agricultural organisms.	[Krieger, Uri; Zamir, Dani] Hebrew Univ Jerusalem, Fac Agr, Inst Plant Sci, IL-76100 Rehovot, Israel; [Lippman, Zachary B.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Hebrew University of Jerusalem; Cold Spring Harbor Laboratory	Zamir, D (corresponding author), Hebrew Univ Jerusalem, Fac Agr, Inst Plant Sci, IL-76100 Rehovot, Israel.	lippman@cshl.edu; zamir@agri.huji.ac.il		Lippman, Zachary/0000-0001-7668-9025	European Commission; Israel Science Foundation (ISF); United States National Science Foundation [DBI-0922442]	European Commission(European CommissionEuropean Commission Joint Research Centre); Israel Science Foundation (ISF)(Israel Science Foundation); United States National Science Foundation(National Science Foundation (NSF))	We thank D. Jackson, R. Martienssen, Y. Semel, Y. Eshed and members of the Lippman laboratory for comments and discussion. We also thank the researchers and field crew at the Western Galilee experimental station in Akko, Israel, Kibbutz Kfar Masaryk, Israel and Cornell University's Long Island Horticultural Research and Extension Center in Riverhead, New York. This research was supported by individual grants from the European Commission EU-SOL Project and The Israel Science Foundation (ISF) to D.Z. and from a Heterosis Challenge Grant DBI-0922442 from the United States National Science Foundation Plant Genome Research Program to Z. B. L.	Belo A, 2010, THEOR APPL GENET, V120, P355, DOI 10.1007/s00122-009-1128-9; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Birchler JA, 2007, BBA-GENE STRUCT EXPR, V1769, P422, DOI 10.1016/j.bbaexp.2006.12.002; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Crow J. F., 1952, Heterosis., P282; Crow JF, 2008, ANNU REV GENET, V42, P1, DOI 10.1146/annurev.genet.42.110807.091612; Darwin CR, 1876, EFFECTS CROSS SELF F; Delneri D, 2008, NAT GENET, V40, P113, DOI 10.1038/ng.2007.49; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doganlar S, 2002, GENOME, V45, P1189, DOI 10.1139/G02-091; Duvick DN, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P19; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; Gemmell NJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000125; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; MULLER HJ, 1961, GENETICS, V46, P727; MULLER HJ, 1961, GENETICS, V46, P737; Pnueli L, 1998, DEVELOPMENT, V125, P1979; REDEI GP, 1962, Z VEREBUNGSL, V93, P164; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; SCHWARTZ D, 1973, THEOR APPL GENET, V43, P117, DOI 10.1007/BF00306560; Semel Y, 2006, P NATL ACAD SCI USA, V103, P12981, DOI 10.1073/pnas.0604635103; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Shull G.H., 1908, J HERED, V4, P296, DOI [10.1093/jhered/os-4.1.296, DOI 10.1093/JHERED/OS-4.1.296]; Veitia RA, 2008, TRENDS GENET, V24, P390, DOI 10.1016/j.tig.2008.05.005; WALLACE B, 1957, P NATL ACAD SCI USA, V43, P404, DOI 10.1073/pnas.43.5.404; WALLACE B, 1959, 10 P INT C GEN MONTR, V1, P408; Whaley WG, 1939, AM J BOT, V26, P609, DOI 10.2307/2436798; WILLIAMS W, 1959, NATURE, V184, P527, DOI 10.1038/184527a0; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226	36	319	355	14	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2010	42	5					459	U138		10.1038/ng.550	http://dx.doi.org/10.1038/ng.550			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	589UK	20348958				2022-12-17	WOS:000277179500020
J	Luo, GB; Santoro, IM; McDaniel, LD; Nishijima, I; Mills, M; Youssoufian, H; Vogel, H; Schultz, RA; Bradley, A				Luo, GB; Santoro, IM; McDaniel, LD; Nishijima, I; Mills, M; Youssoufian, H; Vogel, H; Schultz, RA; Bradley, A			Cancer predisposition caused by elevated mitotic recombination in Bloom mice	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; WERNERS-SYNDROME GENES; INTESTINAL ADENOMAS; RECQ FAMILY; HELICASE; CLONING; MOUSE; HOMOLOG; LOCALIZATION; DISRUPTION	Bloom syndrome is a disorder associated with genomic instability that causes affected people to be prone to cancer. Bloom cell lines show increased sister chromatid exchange, yet are proficient in the repair of various DNA lesions. The underlying cause of this disease are mutations in a gene encoding a RECQ DNA helicase. Using embryonic stem cell technology, we have generated viable Bloom mice that are prone to a wide variety of cancers. Cell lines from these mice show elevations in the rates of mitotic recombination. We demonstrate that the increased rate of loss of heterozygosity (LOH) resulting from mitotic recombination in vivo constitutes the underlying mechanism causing tumour susceptibility in these mice.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bradley, A (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge, England.			Bradley, Allan/0000-0002-2349-8839; Vogel, Otto Hannes/0000-0002-0960-3508				Abuin A, 1996, MOL CELL BIOL, V16, P1851; Bilger A, 1996, SEMIN CANCER BIOL, V7, P249, DOI 10.1006/scbi.1996.0033; Chakraverty RK, 1999, BIOESSAYS, V21, P286; Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382; COLLET B, 1995, INTERNET WORLD, V6, P8; Davey S, 1998, MOL CELL BIOL, V18, P2721, DOI 10.1128/MCB.18.5.2721; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO;2-Z; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GERMAN J, 1994, CURRENT PROTOCOLS HU; Gharibyan V, 1999, MOL CARCINOGEN, V26, P261, DOI 10.1002/(SICI)1098-2744(199912)26:4<261::AID-MC5>3.0.CO;2-A; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; HASTY P, 1991, MOL CELL BIOL, V11, P4509, DOI 10.1128/MCB.11.9.4509; Jacoby RF, 1996, CANCER RES, V56, P710; Jones SN, 1996, P NATL ACAD SCI USA, V93, P14106, DOI 10.1073/pnas.93.24.14106; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; LUONGO C, 1994, CANCER RES, V54, P5947; Luria SE, 1943, GENETICS, V28, P491; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Watt PM, 1996, GENETICS, V144, P935; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	34	319	335	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2000	26	4					424	429		10.1038/82548	http://dx.doi.org/10.1038/82548			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	379YX	11101838				2022-12-17	WOS:000165671700013
J	Leveillard, T; Mohand-Said, S; Lorentz, O; Hicks, D; Fintz, AC; Clerin, E; Simonutti, M; Forster, V; Cavusoglu, N; Chalmel, F; Dolle, P; Poch, O; Lambrou, G; Sahel, JA				Leveillard, T; Mohand-Said, S; Lorentz, O; Hicks, D; Fintz, AC; Clerin, E; Simonutti, M; Forster, V; Cavusoglu, N; Chalmel, F; Dolle, P; Poch, O; Lambrou, G; Sahel, JA			Identification and characterization of rod-derived cone viability factor	NATURE GENETICS			English	Article							RETINITIS-PIGMENTOSA; SURVIVAL; DEGENERATION; THIOREDOXIN; MOUSE; CELLS; PHOTORECEPTORS; MUTATIONS; PROTEINS	Retinitis pigmentosa is an untreatable, inherited retinal disease that leads to blindness. The disease initiates with the loss of night vision due to rod photoreceptor degeneration, followed by irreversible, progressive loss of cone photoreceptor(1-3). Cone loss is responsible for the main visual handicap, as cones are essential for day and high-acuity vision(4). Their loss is indirect, as most genes associated with retinitis pigmentosa are not expressed by these cells. We previously showed that factors secreted from rods are essential for cone viability(5-8). Here we identified one such trophic factor by expression cloning and named it rod-derived cone viability factor (RdCVF). RdCVF is a truncated thioredoxin-like protein specifically expressed by photoreceptors. The identification of this protein offers new treatment possibilities for retinitis pigmentosa.	Univ Paris 06, Hop St Antoine, INSERM, U592,Lab Physiopathol Cellulaire & Mol & Retine, F-75571 Paris 12, France; Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Novartis Pharma AG Ophthalmol Res WKL127 1 04, CH-4002 Basel, Switzerland; UCL, Inst Ophthalmol, London WC1E 6BT, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Novartis; University of London; University College London	Leveillard, T (corresponding author), Univ Paris 06, Hop St Antoine, INSERM, U592,Lab Physiopathol Cellulaire & Mol & Retine, 184 Rue Faubourg St Antoine, F-75571 Paris 12, France.	leveilla@st-antoine.inserm.fr	Chalmel, Frédéric/L-5360-2018; Dolle, Pascal/A-8037-2010; Chalmel, Frederic/M-1297-2016; Sahel, Jose-Alain/F-3172-2017; Chalmel, Frédéric/AAM-1079-2021; Léveillard, Thierry/AAR-1804-2020	Chalmel, Frédéric/0000-0002-0535-3628; Dolle, Pascal/0000-0002-9294-9090; Sahel, Jose-Alain/0000-0002-4831-1153; Chalmel, Frédéric/0000-0002-0535-3628; Léveillard, Thierry/0000-0001-5692-8770; Clerin, Emmanuelle/0000-0003-1451-6051; Cavusoglu, Nukhet/0000-0001-9350-5312				ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Cau E, 1997, DEVELOPMENT, V124, P1611; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Dixon W. J., 1969, INTRO STAT ANAL; DOWLING JE, 1987, RETINAL CELLS PROCES; Fintz AC, 2003, INVEST OPHTH VIS SCI, V44, P818, DOI 10.1167/iovs.01-1144; Fontaine V, 1998, J NEUROSCI, V18, P9662; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Mohand-Said S, 2000, ARCH OPHTHALMOL-CHIC, V118, P807, DOI 10.1001/archopht.118.6.807; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; MohandSaid S, 1997, OPHTHALMIC RES, V29, P290, DOI 10.1159/000268027; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; WAKASUGI N, 1990, P NATL ACAD SCI USA, V87, P8282, DOI 10.1073/pnas.87.21.8282; Zack DJ, 2000, NEURON, V26, P285, DOI 10.1016/S0896-6273(00)81160-5	21	318	340	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2004	36	7					755	759		10.1038/ng1386	http://dx.doi.org/10.1038/ng1386			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15220920	Bronze, Green Submitted			2022-12-17	WOS:000222354100028
J	Vervoort, R; Lennon, A; Bird, AC; Tulloch, B; Axton, R; Miano, MG; Meindl, A; Meitinger, T; Ciccodicola, A; Wright, AF				Vervoort, R; Lennon, A; Bird, AC; Tulloch, B; Axton, R; Miano, MG; Meindl, A; Meitinger, T; Ciccodicola, A; Wright, AF			Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa	NATURE GENETICS			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; POSITIONAL CLONING; GENE; IDENTIFICATION; SEQUENCES; FAMILIES; DNA; RP3; TRANSCRIPTION; HOMOLOGY	The gene RPGR was previously identified in the RP3 region of Xp21.1 and shown to be mutated in 10-20% of patients with the progressive retinal degeneration X-linked retinitis pigmentosa(1,2) (XLRP). The mutations predominantly affected a domain homologous to RCC1, a guanine nucleotide exchange factor for the small GTPase Ran, although they were present in fewer than the 70-75% of XLRP patients predicted from linkage studies(3-6) Mutations in the RP2 locus at Xp11.3 were found in a further 10-20% of XLRP patients, as predicted from linkage studies(6-8). Because the mutations in the remainder of the XLRP patients may reside in undiscovered exons of RPGR, we sequenced a 172-kb region containing the entire gene. Analysis of the sequence disclosed a new 3' terminal exon that was mutated in 60% of XLRP patients examined. This exon encodes 567 amino acids, with a repetitive domain rich in glutamic acid residues. The sequence is conserved in the mouse, bovine and Fugu rubripes genes. it is preferentially expressed in mouse and bovine retina, further supporting its importance for retinal function. Our results suggest that mutations in RPGR are the only cause of RP3 type XLRP and account for the disease in over 70% of XLRP patients and an estimated 11% of all retinitis pigmentosa patients.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; UCL, Dept Clin Ophthalmol, London WC1E 6BT, England; Moorfields Eye Hosp, London, England; CNR, Int Inst Genet & Biophys, I-80125 Naples, Italy; Univ Munich, Dept Med Genet, Munich, Germany; GSF, Res Ctr, Clin Ophthalmol Res Cooperat, Neuherberg, Germany	University of Edinburgh; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Wright, AF (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland.	alan.wright@hgu.mrc.ac.uk	Miano, Maria Giuseppina/E-9056-2011; Giuseppina, Miano Maria/B-9169-2015; Miano, Maria Giuseppina/AAX-8437-2020; Meitinger, Thomas/O-1318-2015	Miano, Maria Giuseppina/0000-0003-1396-9673; Miano, Maria Giuseppina/0000-0003-1396-9673; Ciccodicola, Alfredo/0000-0002-9924-1482; Meitinger, Thomas/0000-0002-8838-8403	Telethon [E.1093] Funding Source: Medline	Telethon(Fondazione Telethon)		Buraczynska M, 1997, AM J HUM GENET, V61, P1287, DOI 10.1086/301646; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cooper D. N., 1993, HUMAN GENE MUTATION; Dry KL, 1999, HUM MUTAT, V13, P141, DOI 10.1002/(SICI)1098-1004(1999)13:2<141::AID-HUMU6>3.3.CO;2-H; DRY KL, 1995, HUM MOL GENET, V4, P2347, DOI 10.1093/hmg/4.12.2347; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Hardcastle AJ, 1999, AM J HUM GENET, V64, P1210, DOI 10.1086/302325; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Kirschner R, 1999, HUM MOL GENET, V8, P1571, DOI 10.1093/hmg/8.8.1571; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MEINDL A, 1995, HUM MOL GENET, V4, P2339, DOI 10.1093/hmg/4.12.2339; Miano MG, 1999, EUR J HUM GENET, V7, P687, DOI 10.1038/sj.ejhg.5200352; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Roepman R, 1996, HUM MOL GENET, V5, P1035, DOI 10.1093/hmg/5.7.1035; Roepman R, 1996, HUM MOL GENET, V5, P827, DOI 10.1093/hmg/5.6.827; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; TEAGUE PW, 1994, AM J HUM GENET, V55, P105; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; WEAVER DT, 1982, J BIOL CHEM, V257, P2075; WOOTTON JC, 1994, CURR OPIN STRUC BIOL, V4, P413, DOI 10.1016/S0959-440X(94)90111-2; Xu Y, 1994, Genet Eng (N Y), V16, P241; Zhang MQ, 1997, P NATL ACAD SCI USA, V94, P565, DOI 10.1073/pnas.94.2.565	23	318	333	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2000	25	4					462	466		10.1038/78182	http://dx.doi.org/10.1038/78182			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	341WY	10932196				2022-12-17	WOS:000088615000027
J	ADAMS, MD; SOARES, MB; KERLAVAGE, AR; FIELDS, C; VENTER, JC				ADAMS, MD; SOARES, MB; KERLAVAGE, AR; FIELDS, C; VENTER, JC			RAPID CDNA SEQUENCING (EXPRESSED SEQUENCE TAGS) FROM A DIRECTIONALLY CLONED HUMAN INFANT BRAIN CDNA LIBRARY	NATURE GENETICS			English	Article							PHENOL-CHLOROFORM EXTRACTION; SINGLE-STEP METHOD; RNA ISOLATION; IDENTIFICATION; PRECURSOR	A human infant brain cDNA library, made specifically for production of expressed sequence tags (ESTs) was evaluated by partial sequencing of over 1,600 clones. Advantages of this library, constructed for EST sequencing, include the use of directional cloning, size selection, very low numbers of mitochondrial and ribosomal transcripts, short polyA tails, few non-recombinants and a broad representation of transcripts. 37% of the clones were identified, based on matches to over 320 different genes in the public databases. Of these, two proteins similar to the Alzheimer's disease amyloid precursor protein were identified.	NINCDS, RECEPTOR & BIOCHEM & MOLEC BIOL SECT, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA; INST GENOM RES, GAITHERSBURG, MD 20878 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT PSYCHIAT, NEW YORK, NY 10032 USA; NEW YORK STATE PSYCHIAT INST & HOSP, NEW YORK, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); J. Craig Venter Institute; Columbia University; New York State Psychiatry Institute				Kerlavage, Anthony/0000-0002-3954-9653; Fields, Chris/0000-0002-4812-0744				ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ADAMS MD, 1992, NATURE, V357, P367, DOI 10.1038/357367b0; ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DALESSIO JM, 1987, FOCUS, V9, P1; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KERLAVAGE A, 1993, 26TH P HAW INT C SYS, P585; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; Maniatis T., 1982, MOL CLONING; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; SMITH CL, 1987, METHOD ENZYMOL, V155, P449; SUTCLIFFE JG, 1988, ANNU REV NEUROSCI, V11, P157, DOI 10.1146/annurev.ne.11.030188.001105; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VIDAL F, 1992, BIOCHEM BIOPH RES CO, V189, P1336, DOI 10.1016/0006-291X(92)90220-F; WASCO W, 1993, GENOMICS, V15, P237, DOI 10.1006/geno.1993.1047; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758	21	318	392	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1993	4	4					373	386		10.1038/ng0893-373	http://dx.doi.org/10.1038/ng0893-373			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401585				2022-12-17	WOS:A1993LQ17800015
J	Casali, N; Nikolayevskyy, V; Balabanova, Y; Harris, SR; Ignatyeva, O; Kontsevaya, I; Corander, J; Bryant, J; Parkhill, J; Nejentsev, S; Horstmann, RD; Brown, T; Drobniewski, F				Casali, Nicola; Nikolayevskyy, Vladyslav; Balabanova, Yanina; Harris, Simon R.; Ignatyeva, Olga; Kontsevaya, Irina; Corander, Jukka; Bryant, Josephine; Parkhill, Julian; Nejentsev, Sergey; Horstmann, Rolf D.; Brown, Timothy; Drobniewski, Francis			Evolution and transmission of drug-resistant tuberculosis in a Russian population	NATURE GENETICS			English	Article							MYCOBACTERIUM-TUBERCULOSIS; STREPTOMYCIN RESISTANCE; NUCLEOTIDE POLYMORPHISMS; COMPENSATORY MUTATIONS; BEIJING STRAIN; GENE; ETHIONAMIDE; FITNESS; STRATEGIES; KANAMYCIN	The molecular mechanisms determining the transmissibility and prevalence of drug-resistant tuberculosis in a population were investigated through whole-genome sequencing of 1,000 prospectively obtained patient isolates from Russia. Two-thirds belonged to the Beijing lineage, which was dominated by two homogeneous clades. Multidrug-resistant (MDR) genotypes were found in 48% of isolates overall and in 87% of the major clades. The most common rpoB mutation was associated with fitness-compensatory mutations in rpoA or rpoC, and a new intragenic compensatory substitution was identified. The proportion of MDR cases with extensively drug-resistant (XDR) tuberculosis was 16% overall, with 65% of MDR isolates harboring eis mutations, selected by kanamycin therapy, which may drive the expansion of strains with enhanced virulence. The combination of drug resistance and compensatory mutations displayed by the major clades confers clinical resistance without compromising fitness and transmissibility, showing that, in addition to weaknesses in the tuberculosis control program, biological factors drive the persistence and spread of MDR and XDR tuberculosis in Russia and beyond.	[Casali, Nicola; Nikolayevskyy, Vladyslav; Balabanova, Yanina; Brown, Timothy; Drobniewski, Francis] Queen Mary Univ London, Blizard Inst, Clin TB & HIV Grp, Publ Hlth England PHE Natl Mycobacterium Referenc, London, England; [Harris, Simon R.; Bryant, Josephine; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Ignatyeva, Olga; Kontsevaya, Irina] Samara Oblast TB Dispensary, Samara, Russia; [Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Nejentsev, Sergey] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, D-20359 Hamburg, Germany; [Drobniewski, Francis] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London, England	University of London; Queen Mary University London; Wellcome Trust Sanger Institute; University of Helsinki; University of Cambridge; Bernhard Nocht Institut fur Tropenmedizin; Imperial College London	Drobniewski, F (corresponding author), Queen Mary Univ London, Blizard Inst, Clin TB & HIV Grp, Publ Hlth England PHE Natl Mycobacterium Referenc, London, England.	f.drobniewski@qmul.ac.uk	Nikolayevskyy, Vladyslav/HFZ-7738-2022; Parkhill, Julian/G-4703-2011; Kontsevaya, Irina/AAJ-8173-2020; Harris, Simon R/K-1318-2013; Bryant, Josephine/ABC-8288-2021	Nikolayevskyy, Vladyslav/0000-0002-9502-0332; Parkhill, Julian/0000-0002-7069-5958; Harris, Simon R/0000-0003-1512-6194; Ignatyeva, Olga/0000-0003-2020-4206; Kontsevaya, Irina/0000-0003-3421-7550; Drobniewski, Francis/0000-0002-5661-2490	European Union Framework Programme 7 (TB-EUROGEN) [201483]; Wellcome Trust [098051]; EUROGEN; Wellcome Trust Senior Research Fellow in Basic Biomedical Science [095198/Z/10/Z]; European Research Council Starting Grant [260477]; Medical Research Council [974668] Funding Source: researchfish	European Union Framework Programme 7 (TB-EUROGEN); Wellcome Trust(Wellcome TrustEuropean Commission); EUROGEN; Wellcome Trust Senior Research Fellow in Basic Biomedical Science(Wellcome Trust); European Research Council Starting Grant(European Research Council (ERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to members of the Public Health England National Mycobacterium Reference Laboratory and the Samara Regional Tuberculosis Laboratory for bacteriological work, particularly M. Stone, X. Gonzalo and A. Broda. We would also like to thank the Samara Tuberculosis Service, particularly I. Fedorin, as well as V. Kulichenko. We thank R. Hooper for expert statistical advice, S. Hoffner for bacteriological advice and S. Bentley for sequencing advice. This study was supported by European Union Framework Programme 7 (grant 201483; TB-EUROGEN), with sequencing funded by the Wellcome Trust (grant 098051) and EUROGEN. S.N. is a Wellcome Trust Senior Research Fellow in Basic Biomedical Science (095198/Z/10/Z) and is also supported by European Research Council Starting Grant 260477.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Balabanova Y, 2005, EUR J CLIN MICROBIOL, V24, P136, DOI 10.1007/s10096-004-1268-4; Balabanova Y, 2011, BMJ OPEN, V1, DOI [10.1136/bmjopen-2011-0003511, 10.1136/bmjopen-2011-000351]; Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020531; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bottger EC, 2008, EUR J PEDIATR, V167, P141, DOI 10.1007/s00431-007-0606-9; Borrell S, 2011, CLIN MICROBIOL INFEC, V17, P815, DOI 10.1111/j.1469-0691.2011.03556.x; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Brown T, 2010, EMERG INFECT DIS, V16, P272, DOI 10.3201/eid1602.091032; Cai JJ, 2008, J HERED, V99, P438, DOI 10.1093/jhered/esm127; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Cohen T, 2003, LANCET INFECT DIS, V3, P13, DOI 10.1016/S1473-3099(03)00483-3; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; FINKEN M, 1993, MOL MICROBIOL, V9, P1239, DOI 10.1111/j.1365-2958.1993.tb01253.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Ginsburg AS, 2003, LANCET INFECT DIS, V3, P432, DOI 10.1016/S1473-3099(03)00671-6; Hall AR, 2010, P ROY SOC B-BIOL SCI, V277, P643, DOI 10.1098/rspb.2009.1630; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Health Protection Agency, 2012, TUB UK 2012 REP; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kruuner A, 2006, J CLIN MICROBIOL, V44, P811, DOI 10.1128/JCM.44.3.811-818.2006; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Maruri F, 2012, J ANTIMICROB CHEMOTH, V67, P819, DOI 10.1093/jac/dkr566; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P3192, DOI 10.1128/AAC.49.8.3192-3197.2005; Mokrousov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041318; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Nei M., 1987, MOL EVOLUTIONARY GEN; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Reynolds MG, 2000, GENETICS, V156, P1471; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Shen X, 2007, ANTIMICROB AGENTS CH, V51, P2618, DOI 10.1128/AAC.01516-06; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Tang J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000455; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Udwadia ZF, 2012, THORAX, V67, P286, DOI 10.1136/thoraxjnl-2012-201663; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wong SY, 2011, ANTIMICROB AGENTS CH, V55, P2515, DOI 10.1128/AAC.01814-10; Wu SP, 2009, MICROBIOL-SGM, V155, P1272, DOI 10.1099/mic.0.024638-0; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	64	317	331	1	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2014	46	3					279	+		10.1038/ng.2878	http://dx.doi.org/10.1038/ng.2878			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AB8JR	24464101	Green Accepted, Green Submitted			2022-12-17	WOS:000332036700012
J	Thomson, W; Barton, A; Ke, X; Eyre, S; Hinks, A; Bowes, J; Donn, R; Symmons, D; Hider, S; Bruce, IN; Wilson, AG; Marinou, I; Morgan, A; Emery, P; Carter, A; Steer, S; Hocking, L; Reid, DM; Wordsworth, P; Harrison, P; Strachan, D; Worthington, J				Thomson, Wendy; Barton, Anne; Ke, Xiayi; Eyre, Steve; Hinks, Anne; Bowes, John; Donn, Rachelle; Symmons, Deborah; Hider, Samantha; Bruce, Ian N.; Wilson, Anthony G.; Marinou, Ioanna; Morgan, Ann; Emery, Paul; Carter, Angela; Steer, Sophia; Hocking, Lynne; Reid, David M.; Wordsworth, Paul; Harrison, Pille; Strachan, David; Worthington, Jane		Consortium, WTCC; Consortium, Y	Rheumatoid arthritis association at 6q23	NATURE GENETICS			English	Article							NF-KAPPA-B; POPULATION; RESPONSES; PTPN22; RISK; GENE; A20	The Wellcome Trust Case Control Consortium (WTCCC) identified nine single SNPs putatively associated with rheumatoid arthritis at P = 1 x 10(-5)-5 x 10(-7) in a genome-wide association screen. One, rs6920220, was unequivocally replicated ( trend P = 1.1 x 10(-8)) in a validation study, as described here. This SNP maps to 6q23, between the genes oligodendrocyte lineage transcription factor 3 (OLIG3) and tumor necrosis factor-alpha-induced protein 3 ( TNFAIP3).	Univ Manchester, Arthritis Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England; Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2JF, S Yorkshire, England; Chapel Allerton Hosp, Acad Unit Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England; Univ Leeds, Inst Genet, Acad Unit Mol Vasc Med, Hlth & Therapeut Labs, Leeds LS2 9JT, W Yorkshire, England; Kings Coll Hosp London, Natl Hlth Serv Fdn Trust, London SE5 9RS, England; Univ Aberdeen, Dept Med & Therapeut, Bone Res Grp, Aberdeen AB25 2ZD, Scotland; Univ Oxford, Botnar Res Ctr, Inst Musculoskeletal Sci, Oxford OX3 7LD, England; St Georges Univ London, Div Community Hlth Sci, London SW17 0RE, England	University of Manchester; University of Sheffield; Chapel Allerton Hospital; University of Leeds; University of Leeds; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Aberdeen; University of Oxford; St Georges University London	Worthington, J (corresponding author), Univ Manchester, Arthritis Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England.	jane.worthington@manchester.ac.uk	Ke, Xiayi/C-7674-2009; Hinks, Anne/E-1853-2015; Barton, Anne/N-2053-2014; Brown, Matthew A/E-5749-2010; Bowes, John/B-3472-2015; Attrill, Lauren/V-1688-2018; Dominiczak, Anna F/P-9390-2017; Timpson, Nicholas John/O-7548-2015; Worthington, Jane/M-9770-2014; eyre, stephen/K-3776-2017; O'Donovan, Michael C/P-7005-2018; emery, paul/B-3560-2013; McCarthy, Mark/M-3763-2015; Prescott, Natalie/F-6490-2011; Yuldasheva, Nadira Yusupovna/GXM-9013-2022; dobson, richard/C-9269-2011; Robinson, James/D-9096-2016; Evans, David/H-6325-2013	Hinks, Anne/0000-0001-8843-3967; Barton, Anne/0000-0003-3316-2527; Brown, Matthew A/0000-0003-0538-8211; Bowes, John/0000-0003-4659-031X; Dominiczak, Anna F/0000-0003-4913-3608; Timpson, Nicholas John/0000-0002-7141-9189; Worthington, Jane/0000-0003-0544-042X; eyre, stephen/0000-0002-1251-6974; O'Donovan, Michael C/0000-0001-7073-2379; Wilson, Anthony Gerard/0000-0003-4855-3926; McCarthy, Mark/0000-0002-4393-0510; Prescott, Natalie/0000-0002-5901-7371; Lango Allen, Hana/0000-0002-7803-8688; Yuldasheva, Nadira Yusupovna/0000-0001-6213-6358; Zeggini, Eleftheria/0000-0003-4238-659X; Lindgren, Cecilia/0000-0002-4903-9374; Munroe, Patricia/0000-0002-4176-2947; Dunger, Professor David/0000-0002-2566-9304; Harrison, Pille/0000-0003-4117-6910; dobson, richard/0000-0003-4224-9245; Bruce, Ian/0000-0003-3047-500X; Donn, Rachelle/0000-0001-6976-9828; Parkes, Miles/0000-0002-6467-0631; Hattersley, Andrew/0000-0001-5620-473X; Symmons, Deborah/0000-0002-8625-1200; Bishop, Tim/0000-0002-8752-8785; Weedon, Michael/0000-0002-6174-6135; Walker, Neil/0000-0001-9796-7688; Caulfield, Mark/0000-0001-9295-3594; Tobin, Martin/0000-0002-3596-7874; Thomson, Wendy/0000-0002-9022-5179; Robinson, James/0000-0001-5425-7520; Hensor, Elizabeth/0000-0002-5245-4755; Lees, Charlie/0000-0002-0732-8215; Conaghan, Philip/0000-0002-3478-5665; Morgan, Ann/0000-0003-1109-624X; Hocking, Lynne J/0000-0002-2414-2826; Newport, Melanie/0000-0002-8946-7525; Evans, David/0000-0003-0663-4621; Hall, Alistair/0000-0003-0306-7887; Grozeva, Detelina/0000-0003-3239-8415; Jones, Lisa/0000-0002-5122-8334	MRC [G0000934] Funding Source: UKRI; Arthritis Research UK [17552] Funding Source: Medline; Medical Research Council [G0000934(68341), G0000934] Funding Source: Medline; Wellcome Trust [068545, 090532, 076113, 068545/Z/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Filippi A, 2005, P NATL ACAD SCI USA, V102, P4377, DOI 10.1073/pnas.0407284102; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harrison P, 2006, RHEUMATOLOGY, V45, P1009, DOI 10.1093/rheumatology/kei250; Hinks A, 2005, ARTHRITIS RHEUM-US, V52, P1694, DOI 10.1002/art.21049; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Steer S, 2005, ARTHRITIS RHEUM, V52, P358, DOI 10.1002/art.20737; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	13	317	323	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1431	1433		10.1038/ng.2007.32	http://dx.doi.org/10.1038/ng.2007.32			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17982455	Green Accepted			2022-12-17	WOS:000251267400007
J	Moseley, ML; Zu, T; Ikeda, Y; Gao, WC; Mosemiller, AK; Daughters, RS; Chen, G; Weatherspoon, MR; Clark, HB; Ebner, TJ; Day, JW; Ranum, LPW				Moseley, Melinda L.; Zu, Tao; Ikeda, Yoshio; Gao, Wangcai; Mosemiller, Anne K.; Daughters, Randy S.; Chen, Gang; Weatherspoon, Marcy R.; Clark, H. Brent; Ebner, Timothy J.; Day, John W.; Ranum, Laura P. W.			Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8	NATURE GENETICS			English	Article							SCA8 REPEAT EXPANSION; CEREBELLAR CORTEX; MYOTONIC-DYSTROPHY; TRANSGENIC MICE; ANTISENSE TRANSCRIPTION; BINDING PROTEIN; PARALLEL FIBER; CTG EXPANSION; LOCUS; RNA	We previously reported that a (CTG)(n) expansion causes spinocerebellar ataxia type 8 (SCA8), a slowly progressive ataxia with reduced penetrance. We now report a transgenic mouse model in which the full-length human SCA8 mutation is transcribed using its endogenous promoter. (CTG)(116) expansion, but not (CTG)(11) control lines, develop a progressive neurological phenotype with in vivo imaging showing reduced cerebellar-cortical inhibition. 1C2-positive intranuclear inclusions in cerebellar Purkinje and brainstem neurons in SCA8 expansion mice and human SCA8 autopsy tissue result from translation of a polyglutamine protein, encoded on a previously unidentified antiparallel transcript (ataxin 8, ATXN8) spanning the repeat in the CAG direction. The neurological phenotype in SCA8 BAC expansion but not BAC control lines demonstrates the pathogenicity of the (CTG-CAG)(n) expansion. Moreover, the expression of noncoding (CUG)(n) expansion transcripts (ataxin 8 opposite strand, ATXN8OS) and the discovery of intranuclear polyglutamine inclusions suggests SCA8 pathogenesis involves toxic gain-of-function mechanisms at both the protein and RNA levels.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ranum, LPW (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	ranum001@umn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040389] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS040389, R01 NS40389] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benzow KA, 2002, MAMM GENOME, V13, P134, DOI 10.1007/s0033501-2105-2; Brusco A, 2002, J NEUROL, V249, P923, DOI 10.1007/s00415-002-0760-y; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Day JW, 2000, NEUROLOGY, V55, P649, DOI 10.1212/WNL.55.5.649; Dorsman JC, 2002, HUM MOL GENET, V11, P1487, DOI 10.1093/hmg/11.13.1487; Dunbar RL, 2004, NEUROSCIENCE, V126, P213, DOI 10.1016/j.neuroscience.2004.02.020; Ebner TJ, 2005, PROG BRAIN RES, V148, P125, DOI 10.1016/S0079-6123(04)48011-X; Gao WC, 2003, J NEUROSCI, V23, P1859; Hanson CL, 2000, NEUROSCIENCE, V96, P317, DOI 10.1016/S0306-4522(99)00470-4; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Ikeda Y, 2000, NEUROLOGY, V54, P950, DOI 10.1212/WNL.54.4.950; Ikeda Y, 2004, AM J HUM GENET, V75, P3, DOI 10.1086/422014; Ikeda Y, 2000, J NEUROL SCI, V182, P76, DOI 10.1016/S0022-510X(00)00446-9; Izumi Y, 2003, AM J HUM GENET, V72, P704, DOI 10.1086/367775; Juvonen V, 2000, ANN NEUROL, V48, P354, DOI 10.1002/1531-8249(200009)48:3<354::AID-ANA10>3.0.CO;2-A; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Margolis RL, 2004, ANN NEUROL, V56, P670, DOI 10.1002/ana.20248; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Martins S, 2005, AM J MED GENET B, V139B, P109, DOI 10.1002/ajmg.b.30235; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Moseley ML, 2000, HUM MOL GENET, V9, P2125, DOI 10.1093/hmg/9.14.2125; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Nemes JP, 2000, HUM MOL GENET, V9, P1543, DOI 10.1093/hmg/9.10.1543; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Orr HT, 2000, NEUROBIOL DIS, V7, P129, DOI 10.1006/nbdi.2000.0305; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2004, TRENDS GENET, V20, P506, DOI 10.1016/j.tig.2004.08.004; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Reinert KC, 2004, J NEUROPHYSIOL, V92, P199, DOI 10.1152/jn.01275.2003; Schols L, 2003, ANN NEUROL, V54, P110, DOI 10.1002/ana.10608; Shakkottai VG, 2004, J CLIN INVEST, V113, P582, DOI 10.1172/JCI200420216; Silveira I, 2000, AM J HUM GENET, V66, P830, DOI 10.1086/302827; Sobrido MJ, 2001, NEUROLOGY, V57, P1310, DOI 10.1212/WNL.57.7.1310; Stevanin G, 2000, NAT GENET, V24, P213, DOI 10.1038/73408; Sulek A, 2003, AM J HUM GENET, V73, P972, DOI 10.1086/378524; Suter KJ, 2004, NEUROSCIENCE, V124, P305, DOI 10.1016/j.neuroscience.2003.11.015; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Vincent JB, 2000, AM J HUM GENET, V66, P819, DOI 10.1086/302803; Worth PF, 2000, NAT GENET, V24, P214, DOI 10.1038/73411; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	50	317	330	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					758	769		10.1038/ng1827	http://dx.doi.org/10.1038/ng1827			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16804541				2022-12-17	WOS:000238669300011
J	Horwitz, M; Benson, KF; Person, RE; Aprikyan, AG; Dale, DC				Horwitz, M; Benson, KF; Person, RE; Aprikyan, AG; Dale, DC			Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis	NATURE GENETICS			English	Article							CELLS; SPECIFICITY; THROMBIN; COMPLEX; GENE	Human cyclic haematopoiesis (cyclic neutropenia, MIM 162800) is an autosomal dominant disease in which blood-cell production from the bone marrow oscillates with 21-day periodicity(1,2). Circulating neutrophils vary between almost normal numbers and zero. During intervals of neutropenia, affected individuals are at risk for opportunistic infection(3). Monocytes, platelets, lymphocytes and reticulocytes also cycle with the same frequency. Here we use a genome-wide screen and positional cloning to map the locus to chromosome 19p13.3. We identified 7 different single-base substitutions in the gene (ELA2) encoding neutrophil elastase (EC 3.4.21.37, also known as leukocyte elastase, elastase 2 and medullasin), a serine protease of neutrophil and monocyte granules, on unique haplotypes in 13 of 13 families as well as a new mutation in a sporadic case. Neutrophil elastase (a 240-aa mature protein predominantly found in neutrophil granules(4)) is the target for protease inhibition by alpha(1)-antitrypsin, and its unopposed release destroys tissue at sites of inflammation. We hypothesize that a perturbed interaction between neutrophil elastase and serpins or other substrates may regulate mechanisms governing the clock-like timing of haematopoiesis.	Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Horwitz, M (corresponding author), Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA.			Horwitz, Marshall/0000-0002-1683-1680	NIDDK NIH HHS [DK18951] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018951] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Berger SP, 1996, J AM SOC NEPHROL, V7, P694; BIETH JG, 1998, HDB PROTEOLYTIC ENZY, P54; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cregge RJ, 1998, J MED CHEM, V41, P2461, DOI 10.1021/jm970812e; DALE DC, 1988, BLOOD REV, V2, P178, DOI 10.1016/0268-960X(88)90023-9; Fasman KH, 1997, NUCLEIC ACIDS RES, V25, P72, DOI 10.1093/nar/25.1.72; Haurie C, 1998, BLOOD, V92, P2629, DOI 10.1182/blood.V92.8.2629.420a35_2629_2640; Hung SH, 1998, PROTEIN ENG, V11, P669, DOI 10.1093/protein/11.8.669; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LeBonniec BF, 1996, BIOCHEMISTRY-US, V35, P7114, DOI 10.1021/bi952701s; NAVIA MA, 1989, P NATL ACAD SCI USA, V86, P7, DOI 10.1073/pnas.86.1.7; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; Ohno K, 1999, AM J HUM GENET, V65, P635, DOI 10.1086/302551; Palmer SE, 1996, AM J MED GENET, V66, P413, DOI 10.1002/(SICI)1096-8628(19961230)66:4<413::AID-AJMG5>3.0.CO;2-L; PERLMUTTER DH, 1990, P NATL ACAD SCI USA, V87, P3753, DOI 10.1073/pnas.87.10.3753; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; SINHA S, 1987, P NATL ACAD SCI USA, V84, P2228, DOI 10.1073/pnas.84.8.2228; TAKAHASHI H, 1988, J BIOL CHEM, V263, P2543; TAKAHASHI H, 1988, J BIOL CHEM, V263, P14739; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Whisstock J, 1996, PROTEINS, V26, P288, DOI 10.1002/(SICI)1097-0134(199611)26:3<288::AID-PROT5>3.0.CO;2-A	23	317	327	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1999	23	4					433	436		10.1038/70544	http://dx.doi.org/10.1038/70544			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	261RZ	10581030				2022-12-17	WOS:000084023900019
J	Kohlhase, J; Wischermann, A; Reichenbach, H; Froster, U; Engel, W				Kohlhase, J; Wischermann, A; Reichenbach, H; Froster, U; Engel, W			Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome	NATURE GENETICS			English	Article							HOMEOTIC GENE; DROSOPHILA EMBRYO; SPALT; REGION; HOMOLOG; SYSTEM; HEAD; DPP; EYE	Townes-Brocks syndrome (TBS, OMIM #107480) is a rare autosomal-dominant malformation syndrome with a combination of anal, renal, limb and ear anomalies(1), Cytogenetic findings(2) suggested that the gene mutated in TBS maps to chromosome 16q12.1, where SALL1 (previously known as HSAL1), a human homologue of spalt (sal), is located(3). SAL is a developmental regulator in Drosophila melanogaster(4-8) and is conserved throughout evolution(3,9-11). No phenotype has yet been attributed to mutations in vertebrate sal-like genes. The expression patterns of sal-like genes in mouse(9), Xenopus(10) and the fish Medaka(11), and the finding that Medaka sal is regulated by Sonic hedgehog (Shh; ref. 11), prompted us to examine SALL1 as a TBS candidate gene. Here we demonstrate that SALL1 mutations cause TBS in a family with vertical transmission of TBS12 and in an unrelated family with a sporadic case of TBS. Both mutations are predicted to result in a prematurely terminated SALL1 protein lacking all putative DNA binding domains. TBS therefore represents another human developmental disorder caused by mutations in a putative C2H2 zinc-finger transcription factor.	Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; Kinderkrankenhaus, Kinderchirurg Klin, D-50735 Cologne, Germany; Univ Leipzig Klinikum, Inst Human Genet, D-04103 Leipzig, Germany	University of Gottingen; Leipzig University	Kohlhase, J (corresponding author), Univ Gottingen, Inst Human Genet, Gosslerstr 12D, D-37073 Gottingen, Germany.							CAMERON TH, 1991, AM J MED GENET, V41, P1, DOI 10.1002/ajmg.1320410102; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; DEPINANETO JM, 1984, AM J MED GENET, V18, P147, DOI 10.1002/ajmg.1320180118; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; FERRAZ FG, 1989, ANN GENET-PARIS, V32, P120; Hollemann T, 1996, MECH DEVELOP, V55, P19, DOI 10.1016/0925-4773(95)00485-8; Ishikiriyama S, 1996, AM J MED GENET, V61, P191, DOI 10.1002/ajmg.1320610203; JURGENS G, 1988, EMBO J, V7, P189, DOI 10.1002/j.1460-2075.1988.tb02799.x; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Koster R, 1997, DEVELOPMENT, V124, P3147; Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Newman WG, 1997, CLIN DYSMORPHOL, V6, P57; Ott T, 1996, MECH DEVELOP, V56, P117, DOI 10.1016/0925-4773(96)00516-3; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; ROSSMILLER DR, 1994, OTOLARYNG HEAD NECK, V111, P175, DOI 10.1016/S0194-5998(94)70588-7; Serville F., 1993, Genetic Counseling, V4, P109; Sturtevant MA, 1997, DEVELOPMENT, V124, P21; Tickle C, 1996, DEV GENET, V19, P1, DOI 10.1002/(SICI)1520-6408(1996)19:1&lt;1::AID-DVG1&gt;3.0.CO;2-D; TOWNES PL, 1972, J PEDIATR-US, V81, P321, DOI 10.1016/S0022-3476(72)80302-0; Valentini RP, 1997, J BIOL CHEM, V272, P8466, DOI 10.1074/jbc.272.13.8466; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Wischermann A, 1997, MONATSSCHR KINDERH, V145, P382, DOI 10.1007/s001120050137	28	317	332	1	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1998	18	1					81	83		10.1038/ng0198-81	http://dx.doi.org/10.1038/ng0198-81			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YP265	9425907				2022-12-17	WOS:000071259600028
J	Smith, FJD; Eady, RAJ; Leigh, IM; McMillan, JR; Rugg, EL; Kelsell, DP; Bryant, SP; Spurr, NK; Geddes, JF; Kirtschig, G; Milana, G; deBono, AG; Owaribe, K; Wiche, G; Pulkkinen, L; Uitto, J; McLean, WHI; Lane, EB				Smith, FJD; Eady, RAJ; Leigh, IM; McMillan, JR; Rugg, EL; Kelsell, DP; Bryant, SP; Spurr, NK; Geddes, JF; Kirtschig, G; Milana, G; deBono, AG; Owaribe, K; Wiche, G; Pulkkinen, L; Uitto, J; McLean, WHI; Lane, EB			Plectin deficiency results in muscular dystrophy with epidermolysis bullosa	NATURE GENETICS			English	Article							MONOCLONAL-ANTIBODY; RAT PLECTIN; SIMPLEX; GENE; IDENTIFICATION; HEMIDESMOSOMES; DISEASES; LINKAGE; PANEL; IMMUNOLOCALIZATION	We report that mutation in the gene for plectin, a cytoskeleton-membrane anchorage protein, is a cause of autosomal recessive muscular dystrophy associated with skin blistering (epidermolysis bullosa simplex). The evidence comes from absence of plectin by antibody staining in affected individuals from four families, supportive genetic analysis (localization of the human plectin gene to chromosome 8q24.13-qter and evidence for disease segregation with markers in this region) and finally the identification of a homozygous frameshift mutation detected in plectin cDNA. Absence of the large multifunctional cytoskeleton protein plectin can simultaneously account for structural failure in both muscle and skin.	UNIV DUNDEE, DEPT ANAT & PHYSIOL, CANC RES CAMPAIGN, CRC CELL STRUCT RES GRP, DUNDEE DD1 4HN, SCOTLAND; UNITED MED & DENT SCH, ST THOMAS HOSP, ST JOHNS INST DERMATOL, LONDON SE1 7EH, ENGLAND; UNIV LONDON QUEEN MARY & WESTFIELD COLL, ROYAL LONDON SCH MED, ACAD DEPT DERMATOL, LONDON E1 2BL, ENGLAND; UNIV LONDON QUEEN MARY & WESTFIELD COLL, ROYAL LONDON SCH MED, DEPT MORBID ANAT, LONDON E1 2BL, ENGLAND; IMPERIAL CANC RES FUND, CLARE HALL LABS, POTTERS BAR EN6 3LD, HERTS, ENGLAND; UNIV MARBURG, DERMATOL CLIN, D-35037 MARBURG, GERMANY; CITTA UNIV CATANIA, MOL BIOL LAB, PEDIAT CLIN, I-95100 CATANIA, ITALY; ST LUKES HOSP, GUARDAMANGIA, MALTA; NAGOYA UNIV, GRAD SCH HUMAN INFORMAT, NAGOYA, AICHI 46401, JAPAN; VIENNA BIOCTR, INST BIOCHEM & MOL CELL BIOL, A-1030 VIENNA, AUSTRIA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT DERMATOL & CUTANEOUS BIOL, PHILADELPHIA, PA 19107 USA; KUOPIO UNIV HOSP, DIV MED GENET, SF-70210 KUOPIO, FINLAND	University of Dundee; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; Queen Mary University London; University of London; Queen Mary University London; Philipps University Marburg; University of Catania; Nagoya University; Vienna Biocenter (VBC); Jefferson University; Kuopio University Hospital; University of Eastern Finland			Kelsell, David P/F-8767-2011; McLean, William HI/C-6352-2009; WICHE, Gerhard/AAA-3227-2021; McMillan, James R/C-6657-2009	Kelsell, David/0000-0002-9910-7144; Wiche, Gerhard/0000-0001-9550-5463; McLean, William Henry Irwin/0000-0001-5539-5757	NIAMS NIH HHS [P01-AR38923] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Banchroft J.D., 1996, THEORY PRACTICE HIST, V4 th; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Christiano A M, 1996, Exp Dermatol, V5, P1, DOI 10.1111/j.1600-0625.1996.tb00086.x; COOPER DN, 1993, ANN MED, V25, P11, DOI 10.3109/07853899309147851; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; DORIGUZZI C, 1993, EUR NEUROL, V33, P454, DOI 10.1159/000116993; Eady R. A. J., 1985, METHODS SKIN RES, P1; EADY RAJ, 1994, ARCH DERMATOL RES, V287, P2, DOI 10.1007/BF00370710; FINE JD, 1989, ARCH DERMATOL, V125, P931, DOI 10.1001/archderm.125.7.931; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; FINE JD, 1989, ARCH DERMATOL, V125, P520, DOI 10.1001/archderm.125.4.520; Foisner R, 1995, J STRUCT BIOL, V115, P304, DOI 10.1006/jsbi.1995.1055; FOISNER R, 1994, ACTA HISTOCHEM, V96, P421, DOI 10.1016/S0065-1281(11)80029-2; Gache Y, 1996, J CLIN INVEST, V97, P2289, DOI 10.1172/JCI118671; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HIEDA Y, 1992, J CELL BIOL, V116, P1497, DOI 10.1083/jcb.116.6.1497; ISHIDAYAMAMOTO A, 1991, J INVEST DERMATOL, V97, P959, DOI 10.1111/1523-1747.ep12491885; Jones JCR, 1991, CURR OPIN CELL BIOL, V3, P127, DOI 10.1016/0955-0674(91)90175-X; JONES SAV, 1995, J CUTAN PATHOL, V22, P365, DOI 10.1111/j.1600-0560.1995.tb01421.x; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; KELSELL DP, 1995, ANN HUM GENET, V59, P233, DOI 10.1111/j.1469-1809.1995.tb00743.x; KENNEDY AR, 1985, BRIT J DERMATOL, V113, P651, DOI 10.1111/j.1365-2133.1985.tb02400.x; KENNEL SJ, 1990, HYBRIDOMA, V9, P243, DOI 10.1089/hyb.1990.9.243; KURPAKUS MA, 1991, EXP CELL RES, V194, P139, DOI 10.1016/0014-4827(91)90143-I; LANE EB, 1994, CURR OPIN GENET DEV, V4, P412, DOI 10.1016/0959-437X(94)90030-2; LEGAN PK, 1992, BIOESSAYS, V14, P385, DOI 10.1002/bies.950140608; LEIGH IM, 1993, ARCH DERMATOL, V129, P1571, DOI 10.1001/archderm.129.12.1571; Liu CG, 1996, P NATL ACAD SCI USA, V93, P4278, DOI 10.1073/pnas.93.9.4278; MATSUI C, 1995, J INVEST DERMATOL, V105, P648, DOI 10.1111/1523-1747.ep12324108; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, IN PRESS GENES DEV; McMillan JR, 1996, ARCH DERMATOL RES, V288, P91, DOI 10.1007/s004030050029; NIEMI KM, 1988, ARCH DERMATOL, V124, P551, DOI 10.1001/archderm.124.4.551; OLAISEN B, 1973, HUM HERED, V23, P189, DOI 10.1159/000152573; PARRISH JE, 1994, SOMAT CELL MOLEC GEN, V20, P143, DOI 10.1007/BF02290684; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; SHIMIZU H, 1989, ARCH DERMATOL RES, V281, P443, DOI 10.1007/BF00510078; SONNENBERG A, 1987, J BIOL CHEM, V262, P10376; TANAKA T, 1990, J INVEST DERMATOL, V94, P617, DOI 10.1111/1523-1747.ep12876200; VERRANDO P, 1991, LAB INVEST, V64, P85; WICHE G, 1991, J CELL BIOL, V114, P83, DOI 10.1083/jcb.114.1.83; WICHE G, 1989, CRIT REV BIOCHEM MOL, V24, P41, DOI 10.3109/10409238909082551; WICHE G, 1983, J CELL BIOL, V97, P887, DOI 10.1083/jcb.97.3.887; WICHE G, 1984, EXP CELL RES, V155, P43, DOI 10.1016/0014-4827(84)90766-3; WICHE G, 1993, J CELL BIOL, V121, P607, DOI 10.1083/jcb.121.3.607; WICHE G, 1989, BIOCHEM J, V259, P1	50	317	319	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1996	13	4					450	457		10.1038/ng0896-450	http://dx.doi.org/10.1038/ng0896-450			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696340				2022-12-17	WOS:A1996VB62000026
J	Lessard, CJ; Li, H; Adrianto, I; Ice, JA; Rasmussen, A; Grundahl, KM; Kelly, JA; Dozmorov, MG; Miceli-Richard, C; Bowman, S; Lester, S; Eriksson, P; Eloranta, ML; Brun, JG; Goransson, LG; Harboe, E; Guthridge, JM; Kaufman, KM; Kvarnstrom, M; Jazebi, H; Graham, DSC; Grandits, ME; Nazmul-Hossain, ANM; Patel, K; Adler, AJ; Maier-Moore, JS; Farris, AD; Brennan, MT; Lessard, JA; Chodosh, J; Gopalakrishnan, R; Hefner, KS; Houston, GD; Huang, AJW; Hughes, PJ; Lewis, DM; Radfar, L; Rohrer, MD; Stone, DU; Wren, JD; Vyse, TJ; Gaffney, PM; James, JA; Omdal, R; Wahren-Herlenius, M; Illei, GG; Witte, T; Jonsson, R; Rischmueller, M; Ronnblom, L; Nordmark, G; Ng, WF; Mariette, X; Anaya, JM; Rhodus, NL; Segal, BM; Scofield, RH; Montgomery, CG; Harley, JB; Sivils, KL				Lessard, Christopher J.; Li, He; Adrianto, Indra; Ice, John A.; Rasmussen, Astrid; Grundahl, Kiely M.; Kelly, Jennifer A.; Dozmorov, Mikhail G.; Miceli-Richard, Corinne; Bowman, Simon; Lester, Sue; Eriksson, Per; Eloranta, Maija-Leena; Brun, Johan G.; Goransson, Lasse G.; Harboe, Erna; Guthridge, Joel M.; Kaufman, Kenneth M.; Kvarnstrom, Marika; Jazebi, Helmi; Graham, Deborah S. Cunninghame; Grandits, Martha E.; Nazmul-Hossain, Abu N. M.; Patel, Ketan; Adler, Adam J.; Maier-Moore, Jacen S.; Farris, A. Darise; Brennan, Michael T.; Lessard, James A.; Chodosh, James; Gopalakrishnan, Rajaram; Hefner, Kimberly S.; Houston, Glen D.; Huang, Andrew J. W.; Hughes, Pamela J.; Lewis, David M.; Radfar, Lida; Rohrer, Michael D.; Stone, Donald U.; Wren, Jonathan D.; Vyse, Timothy J.; Gaffney, Patrick M.; James, Judith A.; Omdal, Roald; Wahren-Herlenius, Marie; Illei, Gabor G.; Witte, Torsten; Jonsson, Roland; Rischmueller, Maureen; Ronnblom, Lars; Nordmark, Gunnel; Wan-Fai Ng; Mariette, Xavier; Anaya, Juan-Manuel; Rhodus, Nelson L.; Segal, Barbara M.; Scofield, R. Hal; Montgomery, Courtney G.; Harley, John B.; Sivils, Kathy L.		UK Primary Sjogren's Syndrome Regi	Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; STRONG RISK-FACTOR; RHEUMATOID-ARTHRITIS; GENETIC RISK; FUNCTIONAL POLYMORPHISM; SUSCEPTIBILITY LOCI; CLASS-II; B-CELLS; IRF5	Sjogren's syndrome is a common autoimmune disease (affecting similar to 0.7% of European Americans) that typically presents as keratoconjunctivitis sicca and xerostomia. Here we report results of a large-scale association study of Sjogren's syndrome. In addition to strong association within the human leukocyte antigen (HLA) region at 6p21 (P-meta = 7.65 x 10(-114)), we establish associations with IRF5-TNPO3 (P-meta = 2.73 x 10(-19)), STAT4 (Pmeta = 6.80 x 10-15), IL12A (P-meta = 1.17 x 10(-10)), FAM167ABLK (P-meta = 4.97 x 10(-10)), DDX6-CXCR5 (P-meta = 1.10 x 10(-8)) and TNIP1 (P-meta = 3.30 x 10(-8)). We also observed suggestive associations (P-meta < 5 x 10(-5)) with variants in 29 other regions, including TNFAIP3, PTTG1, PRDM1, DGKQ, FCGR2A, IRAK1BP1, ITSN2 and PHIP, among others. These results highlight the importance of genes that are involved in both innate and adaptive immunity in Sjogren's syndrome.	[Lessard, Christopher J.; Li, He; Adrianto, Indra; Ice, John A.; Rasmussen, Astrid; Grundahl, Kiely M.; Kelly, Jennifer A.; Dozmorov, Mikhail G.; Guthridge, Joel M.; Adler, Adam J.; Maier-Moore, Jacen S.; Farris, A. Darise; Wren, Jonathan D.; Gaffney, Patrick M.; James, Judith A.; Scofield, R. Hal; Montgomery, Courtney G.; Sivils, Kathy L.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Lessard, Christopher J.; Li, He; James, Judith A.; Sivils, Kathy L.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Miceli-Richard, Corinne; Mariette, Xavier] Univ Paris 11, AP HP, Hop Univ Paris Sud, INSERM,U1012, Paris, France; [Bowman, Simon] Univ Hosp Birmingham, Dept Rheumatol, Birmingham, W Midlands, England; [Lester, Sue; Rischmueller, Maureen] Queen Elizabeth Hosp, Dept Rheumatol, Woodville South, SA, Australia; [Eriksson, Per] Linkoping Univ, Fac Hlth Sci, Dept Rheumatol Clin & Expt Med, Linkoping, Sweden; [Eloranta, Maija-Leena; Ronnblom, Lars; Nordmark, Gunnel] Uppsala Univ, Dept Med Sci, Rheumatol & Sci Life Lab, Uppsala, Sweden; [Brun, Johan G.] Univ Bergen, Dept Clin Sci, Rheumatol Sect, Bergen, Norway; [Brun, Johan G.; Jonsson, Roland] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway; [Goransson, Lasse G.; Harboe, Erna; Omdal, Roald] Stavanger Univ Hosp, Dept Internal Med, Clin Immunol Unit, Stavanger, Norway; [Kaufman, Kenneth M.; Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA; [Kaufman, Kenneth M.; Harley, John B.] Dept Vet Affairs Med Ctr, Cincinnati, OH USA; [Kvarnstrom, Marika; Jazebi, Helmi; Wahren-Herlenius, Marie] Karolinska Inst, Dept Med, Stockholm, Sweden; [Jazebi, Helmi] Orebro Univ Hosp, Dept Rheumatol, Orebro, Sweden; [Graham, Deborah S. Cunninghame; Vyse, Timothy J.] Kings Coll London, Dept Med & Mol Genet, London, England; [Grandits, Martha E.] United Med Specialties, St Paul, MN USA; [Nazmul-Hossain, Abu N. M.] Univ Colorado, Sch Dent Med, Denver, CO 80202 USA; [Patel, Ketan] Univ Minnesota, Sch Dent, Dept Dev & Surg Sci, Div Oral & Maxillofacial Surg, Minneapolis, MN 55455 USA; [Maier-Moore, Jacen S.; James, Judith A.; Scofield, R. Hal] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Brennan, Michael T.] Carolinas Med Ctr, Dept Oral Med, Charlotte, NC 28203 USA; [Lessard, James A.] Valley Bone & Joint Clin, Grand Forks, ND USA; [Chodosh, James] Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA USA; [Gopalakrishnan, Rajaram] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Div Oral & Maxillofacial Pathol, Minneapolis, MN 55455 USA; [Hefner, Kimberly S.] Hefner Eye Care & Opt Ctr, Oklahoma City, OK USA; [Houston, Glen D.; Lewis, David M.] Univ Oklahoma, Coll Dent, Dept Oral & Maxillofacial Pathol, Oklahoma City, OK USA; [Huang, Andrew J. W.] Washington Univ, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA; [Radfar, Lida] Univ Oklahoma, Coll Dent, Oral Diag & Radiol Dept, Oklahoma City, OK USA; [Rohrer, Michael D.] Univ Minnesota, Sch Dent, Hard Tissue Res Lab, Minneapolis, MN 55455 USA; [Stone, Donald U.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK USA; [Wren, Jonathan D.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Illei, Gabor G.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA; [Witte, Torsten] Hannover Med Sch, Dept Clin Immunol & Rheumatol, Hannover, Germany; [Jonsson, Roland] Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, Bergen, Norway; [Rischmueller, Maureen] Univ Adelaide, Queen Elizabeth Hosp, Dept Rheumatol, Adelaide, SA 5005, Australia; [Rischmueller, Maureen] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia; [Wan-Fai Ng] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Anaya, Juan-Manuel] Univ Rosario, Ctr Autoimmune Dis Res CREA, Bogota, Colombia; [Rhodus, Nelson L.] Univ Minnesota, Sch Dent, Dept Oral Surg, Minneapolis, MN 55455 USA; [Segal, Barbara M.] Univ Minnesota, Sch Med, Div Rheumatol, Minneapolis, MN 55455 USA; [Scofield, R. Hal] Dept Vet Affairs Med Ctr, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Birmingham; Linkoping University; Uppsala University; University of Bergen; University of Bergen; Haukeland University Hospital; Stavanger University Hospital; Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; Karolinska Institutet; Orebro University; University of London; King's College London; University of Colorado System; University of Colorado Denver; University of Minnesota System; University of Minnesota Twin Cities; University of Oklahoma System; University of Oklahoma Health Sciences Center; Carolinas Medical Center; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Minnesota System; University of Minnesota Twin Cities; University of Oklahoma System; University of Oklahoma Health Sciences Center; Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Minnesota System; University of Minnesota Twin Cities; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Hannover Medical School; University of Bergen; University of Adelaide; University of Adelaide; Newcastle University - UK; Universidad del Rosario; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Oklahoma System; University of Oklahoma Health Sciences Center	Sivils, KL (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	sivilsk@omrf.org	Wren, Jonathan D/E-5611-2011; Anaya, Juan-Manuel/J-1960-2016; Rasmussen, Astrid/A-4878-2013; Brennan, Michael/AAZ-2891-2020; Scofield, Robert Hal/AEJ-8314-2022; Witte, Torsten/B-5783-2016; Wahren-Herlenius, Marie/AAN-6942-2021; Dozmorov, Mikhail/B-1374-2009; Ng, Wan-Fai/R-8083-2016; Adrianto, Indra/D-4214-2013	Wren, Jonathan D/0000-0003-2776-3545; Anaya, Juan-Manuel/0000-0002-6444-1249; Rasmussen, Astrid/0000-0001-7744-2948; Wahren-Herlenius, Marie/0000-0002-0915-7245; Dozmorov, Mikhail/0000-0002-0086-8358; Kvarnstrom, Marika/0000-0002-4948-8380; Montgomery, Courtney/0000-0002-9606-3772; Lessard, Christopher J./0000-0003-2440-3843; Porter, Stephen/0000-0002-3328-2759; Kelly, Jennifer/0000-0002-3203-2467; Fedele, Stefano/0000-0001-9006-9412; Li, He (Hurley)/0000-0002-1766-5311; Houston, Graeme/0000-0002-9786-7975; Huang, Andrew JW/0000-0003-1939-9149; Universidad del Rosario, Biblioteca/0000-0003-3491-9392; Guthridge, Joel/0000-0002-9308-237X; Gaffney, Patrick/0000-0002-1580-869X; Ng, Wan-Fai/0000-0002-5539-388X; Adrianto, Indra/0000-0002-9973-3057	NIH [P50 AR0608040, 5P01 AR049084-10, 5P30 AR053483, 1U01 AI101934, 5P30 GM103510]; Intramural Research Program of the National Institute of Dental and Craniofacial Research; American College of Rheumatology Research and Education Foundation/Abbott Health Professional Graduate Student Preceptorship Award; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083194, U01AI101934, U19AI082714, R37AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053483, RC2AR058959, RC1AR058554, P01AR049084, P50AR060804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018209, R01DE015223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456, P30GM103510, P20GM103636] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001834] Funding Source: NIH RePORTER; Medical Research Council [G0800629, MR/J002720/1] Funding Source: researchfish; MRC [MR/J002720/1, G0800629] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American College of Rheumatology Research and Education Foundation/Abbott Health Professional Graduate Student Preceptorship Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the following funding agencies for their support: this publication was made possible by grants P50 AR0608040 (K. L. S., C. J. L., R. H. S. and A. D. F.), 5R01 DE015223 (K. L. S. and J. B. H.), 5RC2 AR058959 (P. M. G.), 5P01 AR049084-10 (J. B. H.), 5P30 AR053483 (J. A. J. and J. M. G.), 5U19 AI082714 (K. L. S., J. A. J. and C. J. L.), 1R01 DE018209-02 (K. L. S. and J. B. H.), 5R01 DE018209 (K. L. S.), 8P20 GM103456 (P. M. G., C. J. L., J. D. W. and I. A.), P20 GM103636 (M. G. D. and J. D. W.), 5R37 AI024717-25 (J. B. H.), 5P01 AI083194-03 (K. L. S. and J. B. H.), 7S10 RR027190-02 (J. B. H.), 1U01 AI101934 (J. A. J. and J. M. G.), 1RC1 AR058554 (J. A. J. and J. M. G.) and 5P30 GM103510 (J. A. J. and J. M. G.) from the NIH. The contents are the sole responsibility of the authors and do not necessarily represent the official views of the NIH. Additional funding was obtained from Intramural Research Program of the National Institute of Dental and Craniofacial Research (G. G. I.), US Department of Veterans Affairs IMMA 9 (J. B. H.), US Department of Defense PR094002 (J. B. H.), American College of Rheumatology Research and Education Foundation/Abbott Health Professional Graduate Student Preceptorship Award 2009 (C. J. L. and K. L. S.), Oklahoma Medical Research Foundation (C. J. L. and K. L. S.), Sjogren's Syndrome Foundation (K. L. S.), Phileona Foundation (K. L. S.), the French ministry of health (PHRC 2006-AOM06133) and the French ministry of research (ANR-2010-BLAN-1133) (X. M. and C. M.-R.), The Strategic Research Program at Helse Bergen, Western Norway Regional Health Authority (L. G. G., J. G. B. and R. J.), The Broegelmann Foundation (J. G. B. and R. J.), Norwegian Foundation for Health and Rehabilitation (E. H.), KFO 250 TP03, WI 1031/6-1 (T. W.), KFO 250, Z1 (T. W.), Medical Research Council, UK G0800629 (W.-F. N. and S. B.), Northumberland, Tyne and Wear Comprehensive Local Research Network (CLRN) (W.-F. N.), The Swedish Research Council (M. W.-H. and L. R~nnblom), The King Gustaf the V-th 80-year Foundation (M. W.-H.), Knut and Alice Wallenberg Foundation (L. Ronnblom) and The Swedish Rheumatism Association (M. W.-H., G. N., L. Ronnblom and P. E.). This study made use of genotypes available through dbGAP, with acknowledgments provided in the Supplementary Note.	Adrianto I, 2012, ARTHRITIS RHEUM-US, V64, P3695, DOI 10.1002/art.34642; Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cobb BL, 2008, RHEUM DIS CLIN N AM, V34, P847, DOI 10.1016/j.rdc.2008.08.003; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cornall RJ, 1998, CIBA F SYMP, V215, P21; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Cruz-Tapias P, 2012, AUTOIMMUN REV, V11, P281, DOI 10.1016/j.autrev.2011.10.002; Dawidowicz K, 2011, ANN RHEUM DIS, V70, P117, DOI 10.1136/ard.2010.129171; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P225, DOI 10.1002/art.24183; Dozmorov MG, 2012, BIOINFORMATICS, V28, P419, DOI 10.1093/bioinformatics/btr666; Emamian ES, 2009, GENES IMMUN, V10, P285, DOI 10.1038/gene.2009.20; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frisch M, 2009, NUCLEIC ACIDS RES, V37, pW135, DOI 10.1093/nar/gkp303; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gestermann N, 2010, GENES IMMUN, V11, P432, DOI 10.1038/gene.2010.29; Gottenberg JE, 2006, P NATL ACAD SCI USA, V103, P2770, DOI 10.1073/pnas.0510837103; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hansen A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2210; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hjelmervik TOR, 2005, ARTHRITIS RHEUM, V52, P1534, DOI 10.1002/art.21006; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Ice JA, 2012, J AUTOIMMUN, V39, P57, DOI 10.1016/j.jaut.2012.01.008; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jonsson R, 2011, IMMUNOL LETT, V141, P1, DOI 10.1016/j.imlet.2011.06.007; KANG HI, 1993, J IMMUNOL, V150, P3615; Kaplan MH, 2005, IMMUNOL RES, V31, P231, DOI 10.1385/IR:31:3:231; Korman BD, 2008, GENES IMMUN, V9, P267, DOI 10.1038/gene.2008.1; Kristjansdottir G, 2008, J MED GENET, V45, P362, DOI 10.1136/jmg.2007.055012; Lessard CJ, 2012, AM J HUM GENET, V90, P648, DOI 10.1016/j.ajhg.2012.02.023; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Loiseau P, 2001, HUM IMMUNOL, V62, P725, DOI 10.1016/S0198-8859(01)00253-1; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; Meissner TB, 2012, J IMMUNOL, V188, P4951, DOI 10.4049/jimmunol.1103160; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Miceli-Richard C, 2007, ARTHRITIS RHEUM, V56, P3989, DOI 10.1002/art.23142; Miceli-Richard C, 2009, ARTHRITIS RHEUM-US, V60, P1991, DOI 10.1002/art.24662; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nekrep N, 2002, NAT IMMUNOL, V3, P1075, DOI 10.1038/ni840; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Nordmark G, 2011, GENES IMMUN, V12, P100, DOI 10.1038/gene.2010.44; Nordmark G, 2009, GENES IMMUN, V10, P68, DOI 10.1038/gene.2008.94; Novljan MP, 2004, ANN RHEUM DIS, V63, P874, DOI 10.1136/ard.2003.014027; Perez P, 2009, J AUTOIMMUN, V33, P99, DOI 10.1016/j.jaut.2009.05.001; Pillemer SR, 2001, MAYO CLIN PROC, V76, P593; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Rueda B, 2009, HUM MOL GENET, V18, P2071, DOI 10.1093/hmg/ddp119; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sigurdsson S, 2008, HUM MOL GENET, V17, P872, DOI 10.1093/hmg/ddm359; Sigurdsson S, 2007, ARTHRITIS RHEUM-US, V56, P2202, DOI 10.1002/art.22704; Simpfendorfer KR, 2012, HUM MOL GENET, V21, P3918, DOI 10.1093/hmg/dds220; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Thanou-Stavraki A, 2008, SEMIN ARTHRITIS RHEU, V37, P273, DOI 10.1016/j.semarthrit.2007.06.002; Uddin M, 2011, J RHEUMATOL, V38, P797, DOI 10.3899/jrheum.100758; Via M, 2010, GENOME MED, V2, DOI 10.1186/gm124; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Zheng X, 2014, PHARMACOGENOMICS J, V14, P192, DOI 10.1038/tpj.2013.18	84	316	322	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2013	45	11					1284	+		10.1038/ng.2792	http://dx.doi.org/10.1038/ng.2792			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	244JL	24097067	Green Accepted, Green Submitted			2022-12-17	WOS:000326384100008
J	Newton-Cheh, C; Eijgelsheim, M; Rice, KM; de Bakker, PIW; Yin, XY; Estrada, K; Bis, JC; Marciante, K; Rivadeneira, F; Noseworthy, PA; Sotoodehnia, N; Smith, NL; Rotter, JI; Kors, JA; Witteman, JCM; Hofman, A; Heckbert, SR; O'Donnell, CJ; Uitterlinden, AG; Psaty, BM; Lumley, T; Larson, MG; Stricker, BHC				Newton-Cheh, Christopher; Eijgelsheim, Mark; Rice, Kenneth M.; de Bakker, Paul I. W.; Yin, Xiaoyan; Estrada, Karol; Bis, Joshua C.; Marciante, Kristin; Rivadeneira, Fernando; Noseworthy, Peter A.; Sotoodehnia, Nona; Smith, Nicholas L.; Rotter, Jerome I.; Kors, Jan A.; Witteman, Jacqueline C. M.; Hofman, Albert; Heckbert, Susan R.; O'Donnell, Christopher J.; Uitterlinden, Andre G.; Psaty, Bruce M.; Lumley, Thomas; Larson, Martin G.; Stricker, Bruno H. Ch			Common variants at ten loci influence QT interval duration in the QTGEN Study	NATURE GENETICS			English	Article							NOS1 REGULATOR NOS1AP; SUDDEN CARDIAC DEATH; PHOSPHOLAMBAN GENE; HEART; ASSOCIATION; SCN5A; KCNH2; REPOLARIZATION; POLYMORPHISM; MUTATION	QT interval duration, reflecting myocardial repolarization on the electrocardiogram, is a heritable risk factor for sudden cardiac death and drug-induced arrhythmias. We conducted a meta-analysis of three genome-wide association studies in 13,685 individuals of European ancestry from the Framingham Heart Study, the Rotterdam Study and the Cardiovascular Health Study, as part of the QTGEN consortium. We observed associations at P < 5 x 10(-8) with variants in NOS1AP, KCNQ1, KCNE1, KCNH2 and SCN5A, known to be involved in myocardial repolarization and mendelian long-QT syndromes. Associations were found at five newly identified loci, including 16q21 near NDRG4 and GINS3, 6q22 near PLN, 1p36 near RNF207, 16p13 near LITAF and 17q12 near LIG3 and RFFL. Collectively, the 14 independent variants at these 10 loci explain 5.4-6.5% of the variation in QT interval. These results, together with an accompanying paper, offer insights into myocardial repolarization and suggest candidate genes that could predispose to sudden cardiac death and drug-induced arrhythmias.	[Newton-Cheh, Christopher; Noseworthy, Peter A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Ctr Human Genet Res, Boston, MA 02114 USA; [Newton-Cheh, Christopher; de Bakker, Paul I. W.] Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA; [Newton-Cheh, Christopher; de Bakker, Paul I. W.] MIT, Cambridge, MA 02139 USA; [Newton-Cheh, Christopher; Yin, Xiaoyan; O'Donnell, Christopher J.; Larson, Martin G.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Eijgelsheim, Mark; Rivadeneira, Fernando; Witteman, Jacqueline C. M.; Hofman, Albert; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Rice, Kenneth M.; Lumley, Thomas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [de Bakker, Paul I. W.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Yin, Xiaoyan; Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Estrada, Karol; Rivadeneira, Fernando; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Bis, Joshua C.; Marciante, Kristin; Sotoodehnia, Nona; Smith, Nicholas L.; Heckbert, Susan R.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Sotoodehnia, Nona] Univ Washington, Dept Med, Sch Med, Div Cardiol, Seattle, WA 98195 USA; [Smith, Nicholas L.; Heckbert, Susan R.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Smith, Nicholas L.] Vet Adm Off Res & Dev, Seattle Epidemiol Res Ctr, Seattle, WA USA; [Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Kors, Jan A.; Stricker, Bruno H. Ch] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands; [Witteman, Jacqueline C. M.; Hofman, Albert; Uitterlinden, Andre G.; Stricker, Bruno H. Ch] Netherlands Genom Initiat Sponsored Netherlands C, NL-3000 CA Rotterdam, Netherlands; [Heckbert, Susan R.; Psaty, Bruce M.] Grp Hlth, Ctr Hlth Studies, Seattle, WA USA; [O'Donnell, Christopher J.] NHLBI, Bethesda, MD 20892 USA; [O'Donnell, Christopher J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Stricker, Bruno H. Ch] Inspectorate Hlth Care, The Hague, Netherlands	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Boston University; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle	Newton-Cheh, C (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Ctr Human Genet Res, Boston, MA 02114 USA.	b.stricker@erasmusmc.nl	Rivadeneira, Fernando/O-5385-2015; de Bakker, Paul IW/B-8730-2009; Rice, Kenneth M/A-4150-2013; Rotter, Jerome/AAY-6598-2021	Rivadeneira, Fernando/0000-0001-9435-9441; de Bakker, Paul IW/0000-0001-7735-7858; Rice, Kenneth M/0000-0001-5779-4495; Larson, Martin/0000-0002-9631-1254	Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health; Boston University School of Medicine [N01-HC-25195]; Affymetrix [N02-HL-6-4278]; Doris Duke Charitable Foundation; Burroughs Wellcome Fund; Department of Medicine at Boston University School of Medicine; Boston Medical Center; Pfizer; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports, the European Commission (DG XII); Municipality of Rotterdam; Netherlands Organisation of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]; CHS [N01-HC85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133]; National Institute of Neurological Disorders and Stroke [U01 HL080295, R01 HL087652]; National Center for Research Resources [M01RR00069]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology); US National Institutes of Health [K23-HL-080025]; Doris Duke Charitable Foundation Clinical Scientist Development Award; Burroughs Wellcome Fund Career Award; Netherlands Heart Foundation [2007B221]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC055222, N01HC075150, N01HC085084, N01HC085085, N01HC085083, N01HC045133, N01HC085080, N01HC085086, N01HC085082, N01HC015103, N01HC035129, N01HC085081, N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL080025, U01HL080295, R01HL064278, R01HL087652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University School of Medicine; Affymetrix; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Department of Medicine at Boston University School of Medicine; Boston Medical Center; Pfizer(Pfizer); Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports, the European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Organisation of Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); CHS; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); Netherlands Heart Foundation(Netherlands Heart Foundation); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Framingham Heart Study work was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine (contract #N01-HC-25195), its contract with Affymetrix for genotyping services (contract #N02-HL-6-4278), and the Doris Duke Charitable Foundation (C.N.-C.) and Burroughs Wellcome Fund (C.N.-C.). The Framingham analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The measurement of ECG intervals in Framingham Heart Study generation 1 and 2 samples was done by eResearch Technology and supported by an unrestricted grant from Pfizer. The measurement of ECG intervals in the Framingham Heart Study generation 3 sample was completed by A. Hirji and S. Kovvali using AMPS software provided through an unrestricted academic license by Analyzing Medical Parameters for Solutions (A.M.P.S., LLC). The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (#175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), and the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project #050-060-810. The CHS research reported in this article was supported by contract numbers N01-HC85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01RR00069 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. The authors acknowledge the essential role of the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium in development and support of this manuscript. CHARGE members include the Netherland's Rotterdam Study, the NHLBI's Atherosclerosis Risk in Communities (ARIC) Study, Cardiovascular Health Study (CHS) and Framingham Heart Study (FHS), and the NIA's Iceland Age, Gene/Environment Susceptibility (AGES) Study. C. N.-C. is supported by US National Institutes of Health grant K23-HL-080025, a Doris Duke Charitable Foundation Clinical Scientist Development Award, and a Burroughs Wellcome Fund Career Award for Medical Scientists. M. E.; is funded by the Netherlands Heart Foundation (#2007221). J.I.R. is supported by the Cedars-Sinai Board of Governors' Chair in Medical Genetics. The authors wish to thank the following people: G. Crawford and C. Guiducci (Broad Institute of Harvard and Massachusetts Institute of Technology) who completed the Sequenom-based technical validation genotyping of the Framingham Heart Study samples; P. Arp and M. Jhamai (Erasmus Medical Center) for Illumina array genotyping and Taqman-based technical validation genotyping of the Rotterdam Study samples; and Dr. M. Moorhouse, M. Verkerk and S. Bervoets (Erasmus Medical Center) for database management in the Rotterdam Study; and the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. The QTGEN consortium would like to thank the QTSCD consortium for the opportunity to exchange top results pre-publication.	Aarnoudse AJLHJ, 2007, CIRCULATION, V116, P10, DOI 10.1161/CIRCULATIONAHA.106.676783; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Bezzina CR, 2003, CARDIOVASC RES, V59, P27, DOI 10.1016/S0008-6363(03)00342-0; Burke A, 2005, CIRCULATION, V112, P798, DOI 10.1161/CIRCULATIONAHA.104.482760; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eijgelsheim M, 2009, HUM MOL GENET, V18, P347, DOI 10.1093/hmg/ddn341; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gouas L, 2005, EUR J HUM GENET, V13, P1213, DOI 10.1038/sj.ejhg.5201489; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Lehtinen AB, 2008, DIABETES, V57, P1108, DOI 10.2337/db07-1365; Li Y, 2006, AM J HUM GENET S, VS79, P2290; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Marjamaa A, 2009, J INTERN MED, V265, P448, DOI 10.1111/j.1365-2796.2008.02026.x; Milan DJ, 2003, CIRCULATION, V107, P1355, DOI 10.1161/01.CIR.0000061912.88753.87; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Newton-Cheh C, 2007, CIRCULATION, V116, P1128, DOI 10.1161/CIRCULATIONAHA.107.710780; Newton-Cheh C, 2007, CURR OPIN GENET DEV, V17, P213, DOI 10.1016/j.gde.2007.04.010; Paulussen ADC, 2004, J MOL MED, V82, P182, DOI 10.1007/s00109-003-0522-z; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pfeufer A, 2005, CIRC RES, V96, P693, DOI 10.1161/01.RES.0000161077.53751.e6; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Pietila E, 2002, J AM COLL CARDIOL, V40, P511, DOI 10.1016/S0735-1097(02)01979-4; Post W, 2007, HUM HERED, V64, P214, DOI 10.1159/000103630; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; SALISBURY BA, 2006, HEART RHYTHM, V3, pS98, DOI DOI 10.1016/J.HRTHM.2006.02.297; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sotoodehnia N, 2005, CIRCULATION, V111, pE223; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Tobin MD, 2008, INT J EPIDEMIOL, V37, P1132, DOI 10.1093/ije/dyn091; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P346; Wei J, 1999, CIRCULATION, V100, P495	45	316	324	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2009	41	4					399	406		10.1038/ng.364	http://dx.doi.org/10.1038/ng.364			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	425TC	19305408	Green Accepted			2022-12-17	WOS:000264659000012
J	Kanno, T; Huettel, B; Mette, MF; Aufsatz, W; Jaligot, E; Daxinger, L; Kreil, DP; Matzke, M; Matzke, AJM				Kanno, T; Huettel, B; Mette, MF; Aufsatz, W; Jaligot, E; Daxinger, L; Kreil, DP; Matzke, M; Matzke, AJM			Atypical RNA polymerase subunits required for RNA-directed DNA methylation	NATURE GENETICS			English	Article							SMALL INTERFERING RNA; HUMAN-CELLS; GENE; ARABIDOPSIS; TRANSCRIPTION; TRANSPOSON; THALIANA; NUCLEAR; VIRUS	RNA- directed DNA methylation, one of several RNA interference - mediated pathways in the nucleus(1), has been documented in plants(2,3) and in human cells(4,5). Despite progress in identifying the DNA methyltransferases, histone-modifying enzymes and RNA interference proteins needed for RNA- directed DNA methylation(1), the mechanism remains incompletely understood. We screened for mutants defective in RNA- directed DNA methylation and silencing of a transgene promoter in Arabidopsis thaliana and identified three drd complementation groups(6). DRD1 is a SNF2- like protein(6) required for RNA- directed de novo methylation. We report here that DRD2 and DRD3 correspond to the second- largest subunit and largest subunit, respectively, of a fourth class of DNA- dependent RNA polymerase ( polymerase IV) that is unique to plants. DRD3 is a functionally diversified homolog of NRPD1a or SDE4, identified in a separate screen for mutants defective in post- transcriptional gene silencing(7,8). The identical DNA methylation patterns observed in all three drd mutants suggest that DRD proteins cooperate to create a substrate for RNA- directed de novo methylation.	Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Pharm Zentrum, A-1090 Vienna, Austria; IAM, WWTF Vienna Sci Chair Bioinformat, Dept Biotechnol, A-1190 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Matzke, M (corresponding author), Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Pharm Zentrum, UZA2,Althanstr 14-2D-541, A-1090 Vienna, Austria.	marjori.matzke@gmi.oeaw.ac.at	Matzke, Antonius/H-8698-2015; Matzke, Marjori/H-8689-2015; Jaligot, Estelle/A-9035-2011; Kreil, D/O-1783-2013; Daxinger, Lucia/A-6840-2013	Jaligot, Estelle/0000-0002-9252-5271; Kreil, D/0000-0001-7538-2056; KANNO, Tatsuo/0000-0001-5958-4686; Daxinger, Lucia/0000-0001-6557-6201				Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Bellaoui M, 2004, PLANTA, V219, P819, DOI 10.1007/s00425-004-1295-5; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; KANNO T, IN PRESS EMBO REP; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Lahmy S, 2004, PLANT J, V39, P809, DOI 10.1111/j.1365-313X.2004.02166.x; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; Matzke M, 2004, BBA-GENE STRUCT EXPR, V1677, P129, DOI 10.1016/j.bbaexp.2003.10.015; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Melquist S, 2003, GENE DEV, V17, P2036, DOI 10.1101/gad.1081603; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zorio DAR, 2001, CURR BIOL, V11, pR144, DOI 10.1016/S0960-9822(01)00063-X	29	316	330	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2005	37	7					761	765		10.1038/ng1580	http://dx.doi.org/10.1038/ng1580			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15924141				2022-12-17	WOS:000230196400025
J	Roepman, P; Wessels, LFA; Kettelarij, N; Kemmeren, P; Miles, AJ; Lijnzaad, P; Tilanus, MGJ; Koole, R; Hordijk, GJ; van der Vliet, PC; Reinders, MJT; Slootweg, PJ; Holstege, FCP				Roepman, P; Wessels, LFA; Kettelarij, N; Kemmeren, P; Miles, AJ; Lijnzaad, P; Tilanus, MGJ; Koole, R; Hordijk, GJ; van der Vliet, PC; Reinders, MJT; Slootweg, PJ; Holstege, FCP			An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas	NATURE GENETICS			English	Article							GENE-EXPRESSION; MOLECULAR CLASSIFICATION; TUMOR PROGRESSION; SHOULDER PAIN; CANCER; DISSECTION; SITES; PRESERVATION; REVEALS	Metastasis is the process by which cancers spread to distinct sites in the body. It is the principal cause of death in individuals suffering from cancer. For some types of cancer, early detection of metastasis at lymph nodes close to the site of the primary tumor is pivotal for appropriate treatment. Because it can be difficult to detect lymph node metastases reliably, many individuals currently receive inappropriate treatment. We show here that DNA microarray gene-expression profiling can detect lymph node metastases for primary head and neck squamous cell carcinomas that arise in the oral cavity and oropharynx. The predictor, established with an 82-tumor training set, outperforms current clinical diagnosis when independently validated. The 102 predictor genes offer unique insights into the processes underlying metastasis. The results show that the metastatic state can be deciphered from the primary tumor gene-expression pattern and that treatment can be substantially improved.	Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Delft Univ Technol, Fac Elect Engn Math & Comp Sci, NL-2628 CD Delft, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; Univ Med Ctr utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr utrecht, Dept Oral & Maxillofacial Surg, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr utrecht, Dept Otorhinolaryngol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Delft University of Technology; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Holstege, FCP (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	f.c.p.holstege@med.uu.nl	Holstege, Frank/AAM-9944-2021; Slootweg, P.J./H-8089-2014; Lijnzaad, Philip/ABE-4205-2021	Lijnzaad, Philip/0000-0002-7535-583X; Kemmeren, Patrick/0000-0003-2237-7354				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Freier K, 2003, CANCER RES, V63, P1179; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HAHN SS, 1987, INT J RADIAT ONCOL, V13, P1143, DOI 10.1016/0360-3016(87)90186-6; Hoffman EP, 2004, NAT REV GENET, V5, P229, DOI 10.1038/nrg1297; Huang Q, 2002, GENE CHROMOSOME CANC, V34, P224, DOI 10.1002/gcc.10062; JONES AS, 1994, CLIN OTOLARYNGOL, V19, P63, DOI 10.1111/j.1365-2273.1994.tb01150.x; JONES AS, 1993, EUR ARCH OTO-RHINO-L, V250, P446; JONES KR, 1992, ARCH OTOLARYNGOL, V118, P483; Matsuo S, 1999, PATHOL INT, V49, P383, DOI 10.1046/j.1440-1827.1999.00887.x; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pillsbury HC, 1997, LARYNGOSCOPE, V107, P1294, DOI 10.1097/00005537-199710000-00004; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Robbins KT, 2002, ARCH OTOLARYNGOL, V128, P751, DOI 10.1001/archotol.128.7.751; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; SHORT SO, 1984, AM J SURG, V148, P478, DOI 10.1016/0002-9610(84)90373-8; Simon R, 2003, J NATL CANCER I, V95, P14, DOI 10.1093/jnci/95.1.14; Takes RP, 2001, J PATHOL, V194, P298, DOI 10.1002/1096-9896(200107)194:3<298::AID-PATH900>3.0.CO;2-Q; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Wilgen CP, 2003, J CRANIO MAXILL SURG, V31, P183, DOI 10.1016/S1010-5182(03)00030-1; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Woolgar JA, 1999, BRIT J ORAL MAX SURG, V37, P205, DOI 10.1054/bjom.1999.0035	30	316	334	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					182	186		10.1038/ng1502	http://dx.doi.org/10.1038/ng1502			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15640797				2022-12-17	WOS:000226690100026
J	Moreira, MC; Barbot, C; Tachi, N; Kozuka, N; Uchida, E; Gibson, T; Mendonca, P; Costa, M; Barros, J; Yanagisawa, T; Watanabe, M; Ikeda, Y; Aoki, M; Nagata, T; Coutinho, P; Sequeiros, J; Koenig, M				Moreira, MC; Barbot, C; Tachi, N; Kozuka, N; Uchida, E; Gibson, T; Mendonca, P; Costa, M; Barros, J; Yanagisawa, T; Watanabe, M; Ikeda, Y; Aoki, M; Nagata, T; Coutinho, P; Sequeiros, J; Koenig, M			The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin	NATURE GENETICS			English	Article							CEREBELLAR ATROPHY HMSNCA; DNA STRAND BREAKS; POLY(ADP-RIBOSE) POLYMERASE; HEREDITARY MOTOR; LIGASE-III; NEUROPATHY; TELANGIECTASIA; KINASE; ATM	The newly recognized ataxia-ocular apraxia 1 (AOA1; MIM 208920)(1-4) is the most frequent cause of autosomal recessive ataxia in Japan(2,4-9) and is second only to Friedreich ataxia in Portugal(10). It shares several neurological features with ataxia-telanglectasia, including early onset ataxia, oculomotor apraxia and cerebellar atrophy, but does not share its extraneurological features (immune deficiency, chromosomal instability and hypersensitivity to X-rays). AOA1 is also characterized by axonal motor neuropathy(3,5,9) and the later decrease of serum albumin levels and elevation of total cholesterol(2,4,5,9). We have identified the gene causing AOA1 and the major Portuguese and Japanese mutations. This gene encodes a new, ubiquitously expressed protein that we named aprataxin. This protein is composed of three domains that share distant homology with the amino-terminal domain of polynucleotide kinase 3'-phosphatase (PNKP), with histidine-triad (HIT) proteins and with DNA-binding C2H2 zinc-finger proteins, respectively. PNKP is involved in DNA single-strand break repair (SSBR)(11) following exposure to ionizing radiation and reactive oxygen species. Fragile-HIT proteins (FHIT) cleave diadenosine tetraphosphate, which is potentially produced during activation of the SSBR complex(12). The results suggest that aprataxin is a nuclear protein with a role in DNA repair reminiscent of the function of the protein defective in ataxia-telangiectasia, but that would cause a phenotype restricted to neurological signs when mutant.	Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; Univ Porto, IBMC, UnIGENe, Oporto, Portugal; Univ Porto, ICBAS, Oporto, Portugal; Hosp Maria Pia, Dept Neurol, Oporto, Portugal; Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido, Japan; European Mol Biol Lab, Heidelberg, Germany; Hosp Divino Espirito Santo, Dept Hematol, Azores, Portugal; Hosp Pedro Hispano, Dept Neurol, Matosinhos, Portugal; Hosp Geral Sto Antonio, Dept Neurol, Oporto, Portugal; Isesaki Fukushima Hosp, Dept Neurol, Iseaki, Japan; Gunma Univ, Sch Med, Dept Neurol, Maebashi, Gumma, Japan; Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; Hosp S Sebastiao, Div Neurol, Santa Maria da Feira, Portugal	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universidade do Porto; Universidade do Porto; Sapporo Medical University; European Molecular Biology Laboratory (EMBL); Gunma University; Tohoku University	Koenig, M (corresponding author), Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, CU Strasbourg, Illkirch Graffenstaden, France.		Barbot, Clara/K-6378-2013; Coutinho, Paula/K-6053-2013	Barbot, Clara/0000-0002-5597-107X; Barros, Jose/0000-0001-6183-5050; Franco Mendonca, Pedro/0000-0002-3850-2909; Coutinho, Paula/0000-0002-3461-230X; Gibson, Toby James/0000-0003-0657-5166; Sequeiros, Jorge/0000-0002-9846-1037				AICARDI J, 1988, ANN NEUROL, V24, P497, DOI 10.1002/ana.410240404; Barbot C, 2001, ARCH NEUROL-CHICAGO, V58, P201, DOI 10.1001/archneur.58.2.201; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; FUKUHARA N, 1995, J NEUROL SCI, V133, P140, DOI 10.1016/0022-510X(95)00176-3; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; GIBSON TJ, 1988, PROTEIN ENG, V2, P209, DOI 10.1093/protein/2.3.209; Hanihara T, 1995, Rinsho Shinkeigaku, V35, P83; Hawley RS, 1996, GENE DEV, V10, P2383, DOI 10.1101/gad.10.19.2383; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kubota H, 1995, No To Shinkei, V47, P289; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; McLennan AG, 2000, PHARMACOL THERAPEUT, V87, P73, DOI 10.1016/S0163-7258(00)00041-3; MOREIRA MC, 1999, ARQ MED, V13, P39; Moreira MD, 2001, AM J HUM GENET, V68, P501, DOI 10.1086/318191; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Sekijima Y, 1998, J NEUROL SCI, V158, P30, DOI 10.1016/S0022-510X(98)00103-8; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Tachi N, 2000, EUR NEUROL, V43, P82, DOI 10.1159/000008140; UEKAWA K, 1992, CLIN NEUROL, V32, P1067; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; YOSHIHARA K, 1981, J BIOL CHEM, V256, P6756	26	316	328	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2001	29	2					189	193		10.1038/ng1001-189	http://dx.doi.org/10.1038/ng1001-189			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	478XP	11586300				2022-12-17	WOS:000171374100026
J	Hoglund, P; Haila, S; Socha, J; Tomaszewski, L; SaarialhoKere, U; KarjalainenLindsberg, ML; Airola, K; Holmberg, C; delaChapelle, A; Kere, J				Hoglund, P; Haila, S; Socha, J; Tomaszewski, L; SaarialhoKere, U; KarjalainenLindsberg, ML; Airola, K; Holmberg, C; delaChapelle, A; Kere, J			Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea	NATURE GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; LINKAGE DISEQUILIBRIUM; DIASTROPHIC DYSPLASIA; EXPRESSION; HYBRIDIZATION; LOCALIZATION; POPULATIONS; TRANSPORT; ENCODES; FINLAND		CHILD HLTH CTR,DEPT GASTROENTEROL & NUTR,WARSAW,POLAND; UNIV HELSINKI,DEPT DERMATOL,FIN-00014 HELSINKI,FINLAND; UNIV HELSINKI,HAARTMAN INST,DEPT PATHOL,FIN-00014 HELSINKI,FINLAND; UNIV HELSINKI,CHILDRENS HOSP,FIN-00014 HELSINKI,FINLAND	Children's Memorial Health Institute; University of Helsinki; University of Helsinki; University of Helsinki	Hoglund, P (corresponding author), UNIV HELSINKI,HAARTMAN INST,DEPT MED GENET,HAARTMANINKATU 3,FIN-00014 HELSINKI,FINLAND.		Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271				BIEBERDO.FA, 1972, J CLIN INVEST, V51, P1958, DOI 10.1172/JCI107002; BUCHAN AMJ, 1989, TXB PHYSL, P1438; Byeon MK, 1996, ONCOGENE, V12, P387; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOGLUND P, 1995, AM J HUM GENET, V57, P95; Hoglund P, 1996, GENOME RES, V6, P202, DOI 10.1101/gr.6.3.202; HOLMBERG C, 1975, J CLIN INVEST, V56, P302, DOI 10.1172/JCI108094; KERE J, 1993, P NATL ACAD SCI USA, V90, P10686, DOI 10.1073/pnas.90.22.10686; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; NORIO R, 1971, Clinical Genetics, V2, P182; PEARSON AJG, 1973, Q J MED, V167, P453; PROSSER IW, 1989, AM J PATHOL, V135, P1073; SAARIALHOKERE UK, 1993, J CLIN INVEST, V92, P2858, DOI 10.1172/JCI116906; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; SILBERG DG, 1995, J BIOL CHEM, V270, P11897, DOI 10.1074/jbc.270.20.11897; STRONG TV, 1994, J CLIN INVEST, V93, P347, DOI 10.1172/JCI116966; TOMASZEWSKI L, 1987, MAT MED POL, V4, P271; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; TURNBERG LA, 1971, GUT, V12, P544, DOI 10.1136/gut.12.7.544	22	316	321	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1996	14	3					316	319		10.1038/ng1196-316	http://dx.doi.org/10.1038/ng1196-316			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VQ146	8896562				2022-12-17	WOS:A1996VQ14600027
J	XU, H; WU, XR; WEWER, UM; ENGVALL, E				XU, H; WU, XR; WEWER, UM; ENGVALL, E			MURINE MUSCULAR-DYSTROPHY CAUSED BY A MUTATION IN THE LAMININ ALPHA-2 (LAMA2) GENE	NATURE GENETICS			English	Article							A-CHAIN; EPIDERMOLYSIS-BULLOSA; MOLECULAR-GENETICS; MEROSIN; PROTEIN; LOCALIZATION; EXPRESSION; JUNCTION; VARIANTS; CLONING	The classic murine muscular dystrophy strain, dy, was first described almost 40 years ago. We have identified the molecular basis of an allele of dy, called dy(2J), by detecting a mutation in the laminin alpha 2 chain gene - the first identified mutation in laminin-2. The G to A mutation in a splice site consensus sequence causes abnormal splicing and expression of multiple mRNAs. One mRNA is translated into an alpha 2 polypeptide with a deletion in domain VI. The truncated protein apparently lacks important qualities of the wild type protein and is unable to provide sufficient muscle stability.	LA JOLLA CANC RES FDN,LA JOLLA,CA 92037; UNIV STOCKHOLM,WENNER GREN INST,DEPT DEV BIOL,S-10691 STOCKHOLM,SWEDEN; UNIV COPENHAGEN,INST PATHOL ANAT,DK-2100 COPENHAGEN,DENMARK	Sanford Burnham Prebys Medical Discovery Institute; Stockholm University; University of Copenhagen								ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; AMBRUSTMACHER VW, 1994, PATHOLOGY, P1349; BEAULIEU JF, 1994, GASTROENTEROLOGY, V106, P829, DOI 10.1016/0016-5085(94)90740-4; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; CHANG AC, 1993, J IMMUNOL, V151, P1789; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001; ENGVALL E, 1992, EXP CELL RES, V198, P115, DOI 10.1016/0014-4827(92)90156-3; ENGVALL E, 1983, ARCH BIOCHEM BIOPHYS, V222, P649, DOI 10.1016/0003-9861(83)90562-3; ENGVALL E, 1993, KIDNEY INT, V43, P2, DOI 10.1038/ki.1993.2; EPSTEIN EH, 1992, SCIENCE, V256, P799, DOI 10.1126/science.1375393; FARNOUD MR, 1994, LAB INVEST, V70, P399; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; HAAPARANTA T, 1991, MATRIX, V11, P151, DOI 10.1016/S0934-8832(11)80153-8; HAGG T, 1989, NEURON, V3, P721, DOI 10.1016/0896-6273(89)90241-9; HAYASHI YK, 1993, J NEUROL SCI, V119, P53, DOI 10.1016/0022-510X(93)90191-Z; HILLAIRE D, 1994, HUM MOL GENET, V3, P1657, DOI 10.1093/hmg/3.9.1657; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; LELVO I, 1988, P NATL ACAD SCI USA, V85, P1544; MACPIKE AD, 1976, P SOC EXP BIOL MED, V151, P670, DOI 10.3181/00379727-151-39283; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MARINKOVICH MP, 1992, J CELL BIOL, V119, P695, DOI 10.1083/jcb.119.3.695; MELER H, 1970, LIFE SCI, V9, P137; MICHELSON AM, 1955, P NATL ACAD SCI USA, V41, P1079, DOI 10.1073/pnas.41.12.1079; NISSINEN M, 1991, BIOCHEM J, V276, P369, DOI 10.1042/bj2760369; PAULSSON M, 1991, J BIOL CHEM, V266, P17545; PUIKKINEN L, 1994, NAT GENET, V6, P293; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SIMONASSMANN P, 1994, DEV DYNAM, V201, P71, DOI 10.1002/aja.1002010108; STIRLING CA, 1975, J ANAT, V119, P169; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; UITTO J, 1992, J CLIN INVEST, V90, P687, DOI 10.1172/JCI115938; UTANI A, 1994, J BIOL CHEM, V269, P19167; VUOLTEENAHO R, 1994, J CELL BIOL, V124, P381, DOI 10.1083/jcb.124.3.381; WEINBERG HJ, 1975, BRAIN RES, V88, P532, DOI 10.1016/0006-8993(75)90666-6; WEST WT, 1960, ANAT REC, V137, P279, DOI 10.1002/ar.1091370306; XU H, 1994, P NATL ACAD SCI USA, V91, P5572, DOI 10.1073/pnas.91.12.5572; YURCHENCO PD, 1993, J BIOL CHEM, V268, P17286	40	316	321	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					297	302		10.1038/ng1194-297	http://dx.doi.org/10.1038/ng1194-297			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7874173				2022-12-17	WOS:A1994PP76500022
J	DUPREZ, L; PARMA, J; VANSANDE, J; ALLGEIER, A; LECLERE, J; SCHVARTZ, C; DELISLE, MJ; DECOULX, M; ORGIAZZI, J; DUMONT, J; VASSART, G				DUPREZ, L; PARMA, J; VANSANDE, J; ALLGEIER, A; LECLERE, J; SCHVARTZ, C; DELISLE, MJ; DECOULX, M; ORGIAZZI, J; DUMONT, J; VASSART, G			GERMLINE MUTATIONS IN THE THYROTROPIN RECEPTOR GENE CAUSE NON-AUTOIMMUNE AUTOSOMAL-DOMINANT HYPERTHYROIDISM	NATURE GENETICS			English	Article							CONSTITUTIVELY ACTIVE MUTANTS; TSH RECEPTOR; CYCLIC-AMP; CELL-PROLIFERATION; THYROID ADENOMAS; POINT MUTATIONS; ACTIVATION; PHOSPHATIDYLINOSITOL; AUTOANTIBODIES; RHODOPSIN	The thyrotropin receptor (TSHR), a member of the large family of G protein-coupled receptors, controls both the function and growth of thyroid cells via stimulation of adenylyl cyclase. We report two different mutations in the TSHR gene of affected members of two large pedigrees with non-autoimmune autosomal dominant hyperthyroidism (toxic thyroid hyperplasia), that involve residues in the third (Val509Ala) and seventh (Cys672Tyr) transmembrane segments. When expressed by transfection in COS-7 cells, the mutated receptors display a higher constitutive activation of adenylyl cyclase than wild type. This new disease entity is the germline counterpart of hyperfunctioning thyroid adenomas, in which different somatic mutations with similar functional characteristics have been demonstrated.	FREE UNIV BRUSSELS,FAC MED,INST RECH INTERDISCIPLINAIRE,BRUSSELS,BELGIUM; CHU NANCY,SERV ENDOCRINOL,NANCY,FRANCE; INST JEAN GODINOT,UNITE MED NUCL & BIOPHYS,REIMS,FRANCE; CTR HOSP REG & UNIV LILLE,SERV CLIN MED,F-59037 LILLE,FRANCE; CTR HOSP LYON SUD,HOSPICES CIVILS LYON,SERV MED INTERNE,PIERRE BENITE,FRANCE; FREE UNIV BRUSSELS,SERV GENET MED,B-1070 BRUSSELS,BELGIUM	Universite Libre de Bruxelles; Vrije Universiteit Brussel; CHU de Nancy; UNICANCER; Institut Jean Godinot; Universite de Lille - ISITE; CHU Lille; CHU Lyon; Universite Libre de Bruxelles; Vrije Universiteit Brussel								BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P67, DOI 10.1016/0968-0004(89)90046-7; DUMONT JE, 1992, PHYSIOL REV, V72, P667, DOI 10.1152/physrev.1992.72.3.667; DUMONT JE, 1989, METABOLIC BASIS INHE, P1843; FRIEDMAN JM, 1987, WERNERS THYROID, P634; GROSS B, 1991, BIOCHEM BIOPH RES CO, V177, P679, DOI 10.1016/0006-291X(91)91842-Z; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; KOSUGI S, 1992, J BIOL CHEM, V267, P24153; KOSUGI S, 1993, MOL ENDOCRINOL, V7, P1009, DOI 10.1210/me.7.8.1009; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LECLERE J, 1984, J CLIN ENDOCR METAB, V59, P175, DOI 10.1210/jcem-59-1-175; LECLERE J, 1982, ANN ENDOCRINOL-PARIS, V43, P553; LIBERT F, 1989, BIOCHEM BIOPH RES CO, V165, P1250, DOI 10.1016/0006-291X(89)92736-8; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MCKENZIE JM, 1989, J CLIN ENDOCR METAB, V69, P1093, DOI 10.1210/jcem-69-6-1093; OSULLIVAN C, 1991, MOL CARCINOGEN, V4, P345, DOI 10.1002/mc.2940040503; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; REN Q, 1993, J BIOL CHEM, V268, P16483; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; RUF J, 1985, EUR J IMMUNOL, V15, P268, DOI 10.1002/eji.1830150311; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; SUAREZ HG, 1991, ONCOGENE, V6, P677; THOMAS JL, 1982, ACTA ENDOCRINOL-COP, V100, P512, DOI 10.1530/acta.0.1000512; VANSANDE J, 1990, MOL CELL ENDOCRINOL, V74, pR1, DOI 10.1016/0303-7207(90)90209-Q; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596	33	316	331	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					396	401		10.1038/ng0794-396	http://dx.doi.org/10.1038/ng0794-396			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920658				2022-12-17	WOS:A1994NU30600014
J	Watson, HJ; Yilmaz, Z; Thorntont, LM; Hubel, C; Coleman, JRI; Gaspar, HA; Bryois, J; Hinney, A; Leppa, VM; Mattheisen, M; Medland, SE; Ripke, S; Yao, SY; Giusti-Rodriguez, P; Hanscombe, KB; Purves, KL; Adan, RAH; Alfredsson, L; Ando, T; Andreassen, OA; Baker, JH; Berrettini, WH; Boehm, I; Boni, C; Perica, VB; Buehren, K; Burghardt, R; Cassina, M; Cichon, S; Clementi, M; Cone, RD; Courtet, P; Crow, S; Crowley, JJ; Danner, UN; Davis, OSP; de Zwaan, M; Dedoussis, G; Degortes, D; DeSocio, JE; Dick, DM; Dikeos, D; Dina, C; Dmitrzak-Weglarz, M; Docampo, E; Duncan, LE; Egberts, K; Ehrlich, S; Escaramis, G; Eskos, T; Estivill, X; Farmer, A; Favaro, A; Fernandez-Aranda, F; Fichter, MM; Fischer, K; Focker, M; Foretova, L; Forstner, AJ; Forzan, M; Franklin, CS; Gallinger, S; Giegling, I; Giuranna, J; Gonidakis, F; Gorwood, P; Mayora, MG; Guillaume, S; Guo, YR; Hakonarson, H; Hatzikotoulas, K; Hauser, J; Hebebrand, J; Helder, SG; Herms, S; Herpertz-Dahlmann, B; Herzog, W; Huckins, LM; Hudson, JI; Imgart, H; Inoko, H; Janout, V; Jimenez-Murcia, S; Julia, A; Kalsi, G; Kaminska, D; Kaprio, J; Karhunen, L; Karwautz, A; Kas, MJH; Kennedy, JL; Keski-Rahkonen, A; Kiezebrink, K; Kim, YR; Klareskog, L; Klump, KL; Knudsen, GPS; La Via, MC; Le Hellard, S; Levitan, RD; Li, D; Lilenfeld, L; Lin, BD; Lissowska, J; Luykx, J; Magistretti, PJ; Maj, M; Mannik, K; Marsal, S; Marshall, CR; Mattingsdal, M; McDevitt, S; McGuffin, P; Metspalu, A; Meulenbelt, I; Micali, N; Mitchell, K; Monteleone, AM; Monteleone, P; Munn-Chernoff, MA; Nacmias, B; Navratilova, M; Ntalla, I; O'Toole, JK; Ophoff, RA; Padyukov, L; Palotie, A; Pantel, J; Papezova, H; Pinto, D; Rabionet, R; Raevuori, A; Ramoz, N; Reichborn-Kjennerud, T; Ricca, V; Ripatti, S; Ritschel, F; Roberts, M; Rotondo, A; Rujescu, D; Rybakowski, F; Santonastaso, P; Scherag, A; Scherer, SW; Schmidt, U; Schork, NJ; Schosser, A; Seitz, J; Slachtova, L; Slagboom, PE; 't Landt, MCTSO; Slopien, A; Sorbi, S; Swiatkowska, B; Szatkiewicz, JP; Tachmazidou, I; Tenconi, E; Tortorella, A; Tozzi, F; Treasure, J; Tsitsika, A; Tyszkiewicz-Nwafor, M; Tziouvas, K; van Elbur, AA; van Furth, EF; Wagner, G; Walton, E; Widen, E; Zeggini, E; Zerwas, S; Zipfel, S; Bergen, AW; Boden, JM; Brandt, H; Crawford, S; Halmi, KA; Horwood, LJ; Johnson, C; Kaplan, AS; Kaye, WH; Mitchell, JE; Olsen, CM; Pearson, JF; Pedersen, NL; Strober, M; Werge, T; Whiteman, DC; Woodside, DB; Stuber, GD; Gordon, S; Grove, J; Henders, AK; Jureus, A; Kirk, KM; Larsen, JT; Parker, R; Petersen, L; Jordan, J; Kennedy, M; Montgomery, GW; Wade, TD; Birgegard, A; Lichtenstein, P; Norring, C; Landen, M; Martin, NG; Mortensen, PB; Sullivan, PF; Breen, G; Bulik, CM				Watson, Hunna J.; Yilmaz, Zeynep; Thorntont, Laura M.; Hubel, Christopher; Coleman, Jonathan R., I; Gaspar, Helena A.; Bryois, Julien; Hinney, Anke; Leppa, Virpi M.; Mattheisen, Manuel; Medland, Sarah E.; Ripke, Stephan; Yao, Shuyang; Giusti-Rodriguez, Paola; Hanscombe, Ken B.; Purves, Kirstin L.; Adan, Roger A. H.; Alfredsson, Lars; Ando, Tetsuya; Andreassen, Ole A.; Baker, Jessica H.; Berrettini, Wade H.; Boehm, Ilka; Boni, Claudette; Perica, Vesna Boraska; Buehren, Katharina; Burghardt, Roland; Cassina, Matteo; Cichon, Sven; Clementi, Maurizio; Cone, Roger D.; Courtet, Philippe; Crow, Scott; Crowley, James J.; Danner, Unna N.; Davis, Oliver S. P.; de Zwaan, Martina; Dedoussis, George; Degortes, Daniela; DeSocio, Janiece E.; Dick, Danielle M.; Dikeos, Dimitris; Dina, Christian; Dmitrzak-Weglarz, Monika; Docampo, Elisa; Duncan, Laramie E.; Egberts, Karin; Ehrlich, Stefan; Escaramis, Georgia; Eskos, Tonu; Estivill, Xavier; Farmer, Anne; Favaro, Angela; Fernandez-Aranda, Fernando; Fichter, Manfred M.; Fischer, Krista; Foecker, Manuel; Foretova, Lenka; Forstner, Andreas J.; Forzan, Monica; Franklin, Christopher S.; Gallinger, Steven; Giegling, Ina; Giuranna, Johanna; Gonidakis, Fragiskos; Gorwood, Philip; Mayora, Monica Gratacos; Guillaume, Sebastien; Guo, Yiran; Hakonarson, Hakon; Hatzikotoulas, Konstantinos; Hauser, Joanna; Hebebrand, Johannes; Helder, Sietske G.; Herms, Stefan; Herpertz-Dahlmann, Beate; Herzog, Wolfgang; Huckins, Laura M.; Hudson, James, I; Imgart, Hartmut; Inoko, Hidetoshi; Janout, Vladimir; Jimenez-Murcia, Susana; Julia, Antonio; Kalsi, Gursharan; Kaminska, Deborah; Kaprio, Jaakko; Karhunen, Leila; Karwautz, Andreas; Kas, Martien J. H.; Kennedy, James L.; Keski-Rahkonen, Anna; Kiezebrink, Kirsty; Kim, Youl-Ri; Klareskog, Lars; Klump, Kelly L.; Knudsen, Gun Peggy S.; La Via, Maria C.; Le Hellard, Stephanie; Levitan, Robert D.; Li, Dong; Lilenfeld, Lisa; Lin, Bochao Danae; Lissowska, Jolanta; Luykx, Jurjen; Magistretti, Pierre J.; Maj, Mario; Mannik, Katrin; Marsal, Sara; Marshall, Christian R.; Mattingsdal, Morten; McDevitt, Sara; McGuffin, Peter; Metspalu, Andres; Meulenbelt, Ingrid; Micali, Nadia; Mitchell, Karen; Monteleone, Alessio Maria; Monteleone, Palmiero; Munn-Chernoff, Melissa A.; Nacmias, Benedetta; Navratilova, Marie; Ntalla, Ioanna; O'Toole, Julie K.; Ophoff, Roel A.; Padyukov, Leonid; Palotie, Aarno; Pantel, Jacques; Papezova, Hana; Pinto, Dalila; Rabionet, Raquel; Raevuori, Anu; Ramoz, Nicolas; Reichborn-Kjennerud, Ted; Ricca, Valdo; Ripatti, Samuli; Ritschel, Franziska; Roberts, Marion; Rotondo, Alessandro; Rujescu, Dan; Rybakowski, Filip; Santonastaso, Paolo; Scherag, Andre; Scherer, Stephen W.; Schmidt, Ulrike; Schork, Nicholas J.; Schosser, Alexandra; Seitz, Jochen; Slachtova, Lenka; Slagboom, P. Eline; 't Landt, Margarita C. T. Slof-Op; Slopien, Agnieszka; Sorbi, Sandro; Swiatkowska, Beata; Szatkiewicz, Jin P.; Tachmazidou, Ioanna; Tenconi, Elena; Tortorella, Alfonso; Tozzi, Federica; Treasure, Janet; Tsitsika, Artemis; Tyszkiewicz-Nwafor, Marta; Tziouvas, Konstantinos; van Elbur, Annemarie A.; van Furth, Eric F.; Wagner, Gudrun; Walton, Esther; Widen, Elisabeth; Zeggini, Eleftheria; Zerwas, Stephanie; Zipfel, Stephan; Bergen, Andrew W.; Boden, Joseph M.; Brandt, Harry; Crawford, Steven; Halmi, Katherine A.; Horwood, L. John; Johnson, Craig; Kaplan, Allan S.; Kaye, Walter H.; Mitchell, James E.; Olsen, Catherine M.; Pearson, John F.; Pedersen, Nancy L.; Strober, Michael; Werge, Thomas; Whiteman, David C.; Woodside, D. Blake; Stuber, Garret D.; Gordon, Scott; Grove, Jakob; Henders, Anjali K.; Jureus, Anders; Kirk, Katherine M.; Larsen, Janne T.; Parker, Richard; Petersen, Liselotte; Jordan, Jennifer; Kennedy, Martin; Montgomery, Grant W.; Wade, Tracey D.; Birgegard, Andreas; Lichtenstein, Paul; Norring, Claes; Landen, Mikael; Martin, Nicholas G.; Mortensen, Preben Bo; Sullivan, Patrick F.; Breen, Gerome; Bulik, Cynthia M.		Anorexia Nervosa Genetics Initiati; Psychiat Genomics Consortium	Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa	NATURE GENETICS			English	Article							LD SCORE REGRESSION; EATING-DISORDERS; GENETIC CORRELATIONS; POLYGENIC RISK; COMORBIDITY; PREVALENCE; HERITABILITY; VARIANTS; INSIGHTS; MYC	Characterized primarily by a low body-mass index, anorexia nervosa is a complex and serious illness(1), affecting 0.9-4% of women and 0.3% of men(2-4), with twin-based heritability estimates of 50-60%(5). Mortality rates are higher than those in other psychiatric disorders(6), and outcomes are unacceptably poor(7). Here we combine data from the Anorexia Nervosa Genetics Initiative (ANGI)(8,9) and the Eating Disorders Working Group of the Psychiatric Genomics Consortium (PGC-ED) and conduct a genome-wide association study of 16,992 cases of anorexia nervosa and 55,525 controls, identifying eight significant loci. The genetic architecture of anorexia nervosa mirrors its clinical presentation, showing significant genetic correlations with psychiatric disorders, physical activity, and metabolic (including glycemic), lipid and anthropometric traits, independent of the effects of common variants associated with body-mass index. These results further encourage a reconceptualization of anorexia nervosa as a metabo-psychiatric disorder. Elucidating the metabolic component is a critical direction for future research, and paying attention to both psychiatric and metabolic components may be key to improving outcomes.	[Watson, Hunna J.; Yilmaz, Zeynep; Thorntont, Laura M.; Baker, Jessica H.; La Via, Maria C.; Munn-Chernoff, Melissa A.; Zerwas, Stephanie; Stuber, Garret D.; Sullivan, Patrick F.; Bulik, Cynthia M.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA; [Watson, Hunna J.] Curtin Univ, Sch Psychol, Perth, WA, Australia; [Watson, Hunna J.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA, Australia; [Yilmaz, Zeynep; Giusti-Rodriguez, Paola; Crowley, James J.; Szatkiewicz, Jin P.; Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Hubel, Christopher; Coleman, Jonathan R., I; Gaspar, Helena A.; Purves, Kirstin L.; Farmer, Anne; Helder, Sietske G.; Kalsi, Gursharan; McGuffin, Peter; Roberts, Marion; Breen, Gerome] Kings Coll London, Inst Psychiat Psychol & Neurosci, Social Genet & Dev Psychiat SGDP Ctr, London, England; [Hubel, Christopher; Bryois, Julien; Leppa, Virpi M.; Yao, Shuyang; Pedersen, Nancy L.; Jureus, Anders; Lichtenstein, Paul; Landen, Mikael; Sullivan, Patrick F.; Bulik, Cynthia M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Coleman, Jonathan R., I; Gaspar, Helena A.; Schmidt, Ulrike; Treasure, Janet; Breen, Gerome] Kings Coll London, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Coleman, Jonathan R., I; Gaspar, Helena A.; Schmidt, Ulrike; Treasure, Janet; Breen, Gerome] South London & Maudsley Natl Hlth Serv Fdn Trust, London, England; [Hinney, Anke; Foecker, Manuel; Giuranna, Johanna; Hebebrand, Johannes] Univ Duisburg Essen, Univ Hosp Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Mattheisen, Manuel; Grove, Jakob] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Mattheisen, Manuel; Crowley, James J.; Birgegard, Andreas; Norring, Claes] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Mattheisen, Manuel; Birgegard, Andreas; Norring, Claes] Stockholm City Council, Ctr Psychiat Res, Stockholm Hlth Care Serv, Stockholm, Sweden; [Mattheisen, Manuel] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Medland, Sarah E.; Olsen, Catherine M.; Whiteman, David C.; Gordon, Scott; Kirk, Katherine M.; Parker, Richard; Montgomery, Grant W.; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Ripke, Stephan] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ripke, Stephan] Broad Inst MIT & Harvard Univ, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Ripke, Stephan] Charite, Dept Psychiat & Psychotherapy, Berlin, Germany; [Hanscombe, Ken B.] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London, England; [Adan, Roger A. H.; Kas, Martien J. H.; Lin, Bochao Danae; Luykx, Jurjen; Ophoff, Roel A.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [Adan, Roger A. H.; Danner, Unna N.; van Elbur, Annemarie A.] Altrecht Mental Hlth Inst, Ctr Eating Disorders Rintveld, Zeist, Netherlands; [Adan, Roger A. H.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Ando, Tetsuya] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Behav Med, Tokyo, Japan; [Andreassen, Ole A.; Mattingsdal, Morten] Univ Oslo, Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT KG Jebsen Ctr, Oslo, Norway; [Berrettini, Wade H.] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Perelman Sch Med, Philadelphia, PA 19104 USA; [Boehm, Ilka; Ehrlich, Stefan; Ritschel, Franziska; Walton, Esther] Tech Univ Dresden, Fac Med, Div Psychol & Social Med & Dev Neurosci, Dresden, Germany; [Boni, Claudette; Gorwood, Philip; Pantel, Jacques; Ramoz, Nicolas] INSERM 1266, Inst Psychiat & Neurosci Paris, Paris, France; [Perica, Vesna Boraska; Franklin, Christopher S.; Hatzikotoulas, Konstantinos; Huckins, Laura M.; Tachmazidou, Ioanna; Zeggini, Eleftheria] Wellcome Sanger Inst, Hinxton, England; [Perica, Vesna Boraska] Univ Split, Sch Med, Dept Med Biol, Split, Croatia; [Buehren, Katharina; Herpertz-Dahlmann, Beate; Seitz, Jochen] Rhein Westfal TH Aachen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Aachen, Germany; [Burghardt, Roland] Klinikum Frankfurt Oder, Dept Child & Adolescent Psychiat, Frankfurt, Germany; [Cassina, Matteo; Clementi, Maurizio; Forzan, Monica] Univ Padua, Dept Woman & Child Hlth, Clin Genet Unit, Padua, Italy; [Cichon, Sven; Forstner, Andreas J.; Herms, Stefan] Univ Hosp Basel, Inst Med Genet & Pathol, Basel, Switzerland; [Cone, Roger D.] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Cone, Roger D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Courtet, Philippe; Guillaume, Sebastien] Univ Montpellier, CHRU Montpellier, Dept Emergency Psychiat & Postacute Care, Montpellier, France; [Crow, Scott] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Davis, Oliver S. P.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Davis, Oliver S. P.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [de Zwaan, Martina] Hannover Med Sch, Dept Psychosomat Med & Psychotherapy, Hannover, Germany; [Dedoussis, George; Ntalla, Ioanna] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Degortes, Daniela; Favaro, Angela; Tenconi, Elena] Univ Padua, Dept Neurosci, Padua, Italy; [DeSocio, Janiece E.] Seattle Univ, Coll Nursing, Seattle, WA USA; [Dick, Danielle M.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Dikeos, Dimitris] Univ Athens, Med Sch, Dept Psychiat, Athens, Greece; [Dina, Christian] Univ Nantes, CHU Nantes, INSERM, Inst Thorax,CNRS, Nantes, France; [Dmitrzak-Weglarz, Monika] Poznan Univ Med Sci, Dept Psychiat Genet, Poznan, Poland; [Docampo, Elisa; Escaramis, Georgia; Estivill, Xavier; Mayora, Monica Gratacos] Barcelona Inst Sci & Technol, Barcelona, Spain; [Docampo, Elisa; Escaramis, Georgia; Estivill, Xavier; Mayora, Monica Gratacos] Univ Pompeu Fabra, Barcelona, Spain; [Docampo, Elisa; Escaramis, Georgia; Estivill, Xavier; Mayora, Monica Gratacos] CIBERESP, Barcelona, Spain; [Duncan, Laramie E.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Egberts, Karin] Univ Hosp Wurzburg, Ctr Mental Hlth, Dept Child & Adolescent Psychiat Psychosomat & Ps, Wurzburg, Germany; [Eskos, Tonu; Fischer, Krista; Mannik, Katrin; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Eskos, Tonu; Palotie, Aarno; Ripatti, Samuli] Broad Inst MIT & Harvard Univ, Program Med & Populat Genet, Cambridge, MA USA; [Estivill, Xavier] Ctr Genom Regulat, Genom & Dis Bioinformat & Genom Programme, Barcelona, Spain; [Fernandez-Aranda, Fernando; Jimenez-Murcia, Susana] Univ Hosp Bellvitge, Dept Psychiat, IDIBELL, Barcelona, Spain; [Fernandez-Aranda, Fernando; Jimenez-Murcia, Susana] CIBERobn, Barcelona, Spain; [Fernandez-Aranda, Fernando; Jimenez-Murcia, Susana] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Fichter, Manfred M.; Rujescu, Dan] LMU, Dept Psychiat & Psychotherapy, Munich, Germany; [Fichter, Manfred M.] Univ Munich LMU, Med Fac, Schon Klin Roseneck, Munich, Germany; [Foretova, Lenka; Navratilova, Marie] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Forstner, Andreas J.] Univ Bonn, Sch Med, Inst Human Genet, Bonn, Germany; [Forstner, Andreas J.] Univ Hosp Bonn, Bonn, Germany; [Forstner, Andreas J.; Herms, Stefan] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Forstner, Andreas J.] Univ Basel, Dept Psychiat UPK, Basel, Switzerland; [Forstner, Andreas J.; Herms, Stefan] Univ Basel, Dept Biomed, Basel, Switzerland; [Gallinger, Steven] Univ Toronto, Fac Med, Dept Surg, Toronto, ON, Canada; [Giegling, Ina; Rujescu, Dan] Martin Luther Univ Halle Wittenberg, Dept Psychiat Psychotherapy & Psychosomat, Halle, Germany; [Gonidakis, Fragiskos] Univ Athens, Med Sch, Eginit Hosp, Psychiat Dept 1, Athens, Greece; [Gorwood, Philip] Paris Descartes Univ, GHU Paris Psychiat & Neurosci, Hop St Anne, CMME, Paris, France; [Guo, Yiran; Hakonarson, Hakon; Li, Dong] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hatzikotoulas, Konstantinos; Zeggini, Eleftheria] Helmholtz Zentrum Munchen, Inst Translat Genom, Neuherberg, Germany; [Hauser, Joanna] Poznan Univ Med Sci, Dept Adult Psychiat, Poznan, Poland; [Helder, Sietske G.] Zorg Op Orde, Leidschendam, Netherlands; [Herzog, Wolfgang] Heidelberg Univ, Heidelberg Univ Hosp, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany; [Huckins, Laura M.; Pinto, Dalila] Icahn Sch Med Mt Sinai, Div Psychiat Genom, Dept Psychiat & Genet & Genom Sci, New York, NY 10029 USA; [Hudson, James, I] Harvard Med Sch, McLean Hosp, Biol Psychiat Lab, Boston, MA 02115 USA; [Imgart, Hartmut] Parklandklin, Eating Disorders Unit, Bad Wildungen, Germany; [Inoko, Hidetoshi] Tokai Univ, Sch Med, Div Basic Med Sci & Mol Med, Dept Mol Life Sci, Isehara, Kanagawa, Japan; [Janout, Vladimir] Palacky Univ, Fac Hlth Sci, Olomouc, Czech Republic; [Julia, Antonio; Marsal, Sara] Vall dHebron Res Inst, Rheumatol Res Grp, Barcelona, Spain; [Kaminska, Deborah; Papezova, Hana] Charles Univ Prague, Dept Psychiat, Fac Med 1, Prague, Czech Republic; [Kaprio, Jaakko; Keski-Rahkonen, Anna; Raevuori, Anu; Ripatti, Samuli] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Kaprio, Jaakko; Palotie, Aarno; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland, Helsinki Inst Life Sci, Helsinki, Finland; [Karhunen, Leila] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland; [Karwautz, Andreas; Wagner, Gudrun] Med Univ Vienna, Dept Child & Adolescent Psychiat, Eating Disorders Unit, Vienna, Austria; [Kas, Martien J. H.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [Kennedy, James L.; Levitan, Robert D.; Kaplan, Allan S.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Kennedy, James L.; Levitan, Robert D.; Kaplan, Allan S.; Woodside, D. Blake] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Kennedy, James L.; Levitan, Robert D.; Kaplan, Allan S.; Woodside, D. Blake] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Kiezebrink, Kirsty] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Kim, Youl-Ri] Inje Univ, Seoul Paik Hosp, Dept Psychiat, Seoul, South Korea; [Klareskog, Lars; Padyukov, Leonid] Karolinska Inst, Ctr Mol Med, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Klareskog, Lars; Padyukov, Leonid] Karolinska Univ Hosp, Stockholm, Sweden; [Klump, Kelly L.] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; [Knudsen, Gun Peggy S.; Reichborn-Kjennerud, Ted] Norwegian Inst Publ Hlth, Dept Mental Disorders, Oslo, Norway; [Le Hellard, Stephanie] Univ Bergen, Norwegian Ctr Mental Disorders Res NORMENT, KG Jebsen Ctr Psychosis Res, Dept Clin Sci, Bergen, Norway; [Le Hellard, Stephanie] Haukeland Hosp, Ctr Med Genet & Mol Med, Dr Einar Martens Res Grp Biol Psychiat, Bergen, Norway; [Le Hellard, Stephanie] Haukeland Hosp, Dept Clin Med, Lab Bldg, Bergen, Norway; [Lilenfeld, Lisa] Argosy Univ, Amer Sch Profess Psychol, Arlington, VA USA; [Lissowska, Jolanta] M Sklodowska Curie Canc Ctr, Oncol Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Magistretti, Pierre J.] King Abdullah Univ Sci & Technol, BESE Div, Thuwal, Saudi Arabia; [Magistretti, Pierre J.] Univ Lausanne, Univ Hosp Lausanne UNIL CHUV, Dept Psychiat, Lausanne, Switzerland; [Maj, Mario; Monteleone, Alessio Maria] Univ Campania Luigi Vanvitelli, Dept Psychiat, Naples, Italy; [Mannik, Katrin] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Marshall, Christian R.] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON, Canada; [McDevitt, Sara] Univ Coll Cork, Dept Psychiat, Cork, Ireland; [McDevitt, Sara] HSE Natl Clin Programme Eating Disorders, Cork, Ireland; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Meulenbelt, Ingrid; Slagboom, P. Eline] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [Micali, Nadia] Univ Geneva, Fac Med, Dept Psychiat, Geneva, Switzerland; [Micali, Nadia] Geneva Univ Hosp, Div Child & Adolescent Psychiat, Geneva, Switzerland; [Micali, Nadia] UCL, Great Ormond St Inst Child Hlth, London, England; [Mitchell, Karen] Boston Univ, Sch Med, Dept Psychiat, Natl Ctr PTSD,VA Boston Healthcare Syst, Boston, MA 02118 USA; [Monteleone, Palmiero] Univ Salerno, Scuola Med Salernitana, Dept Med Surg & Dent, Salerno, Italy; [Nacmias, Benedetta; Ricca, Valdo; Sorbi, Sandro] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth NEURO, Florence, Italy; [O'Toole, Julie K.] Kartini Clin, Portland, OR USA; [Ophoff, Roel A.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA 90024 USA; [Palotie, Aarno] Massachusetts Gen Hosp, Ctr Human Genome Res, Boston, MA 02114 USA; [Rabionet, Raquel] St Joan de Deu Barcelona Childrens Hosp, St Joan de Deu Res Inst, Barcelona, Spain; [Rabionet, Raquel] Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain; [Rabionet, Raquel] Univ Barcelona, Dept Genet Microbiol & Stat, Barcelona, Spain; [Reichborn-Kjennerud, Ted] Univ Oslo, Inst Clin Med, Oslo, Norway; [Ricca, Valdo] Univ Florence, Dept Hlth Sci, Florence, Italy; [Ripatti, Samuli] Univ Helsinki, HiLIFE Unit, Inst Mol Med Finland FIMM, Helsinki, Finland; [Ritschel, Franziska] Tech Univ Dresden, Fac Med, Eating Disorders Res & Treatment Ctr, Dept Child & Adolescent Psychiat, Dresden, Germany; [Roberts, Marion; Jordan, Jennifer] Univ Otago, Dept Psychol Med, Christchurch, New Zealand; [Roberts, Marion] Univ Aukland, Fac Med & Hlth Sci, Auckland, New Zealand; [Rotondo, Alessandro] Univ Pisa, Dept Psychiat Neurobiol Pharmacol & Biotechnol, Pisa, Italy; [Rybakowski, Filip] Poznan Univ Med Sci, Dept Psychiat, Poznan, Poland; [Santonastaso, Paolo] Univ Padua, Padua Neurosci Ctr, Dept Neurosci, Padua, Italy; [Scherag, Andre] Jena Univ Hosp, Inst Med Stat Comp & Data Sci, Jena, Germany; [Scherer, Stephen W.] Hosp Sick Children, Dept Genet & Genom Biol, Toronto, ON, Canada; [Schmidt, Ulrike; Treasure, Janet] Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, London, England; [Schork, Nicholas J.] JCVI, La Jolla, CA USA; [Schosser, Alexandra] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria; [Slachtova, Lenka] Charles Univ Prague, Dept Pediat, Prague, Czech Republic; [Slachtova, Lenka] Charles Univ Prague, Ctr Appl Genom, Fac Med 1, Prague, Czech Republic; ['t Landt, Margarita C. T. Slof-Op; van Furth, Eric F.] Rivierduinen, Ctr Eating Disorders Ursula, Leiden, Netherlands; ['t Landt, Margarita C. T. Slof-Op; van Furth, Eric F.] Leiden Univ, Dept Psychiat, Med Ctr, Leiden, Netherlands; [Slopien, Agnieszka; Tyszkiewicz-Nwafor, Marta] Poznan Univ Med Sci, Dept Child & Adolescent Psychiat, Poznan, Poland; [Sorbi, Sandro] IRCSS Fdn Don Carlo Gnocchi, Florence, Italy; [Swiatkowska, Beata] Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland; [Tortorella, Alfonso] Univ Naples SUN, Dept Psychiat, Naples, Italy; [Tortorella, Alfonso] Univ Perugia, Dept Psychiat, Perugia, Italy; [Tozzi, Federica] Stremble Ventures, Brain Sci Dept, Limassol, Cyprus; [Tsitsika, Artemis] Univ Athens, P&A Kyriakou Childrens Hosp, Dept Pediat 2, Adolescent Hlth Unit, Athens, Greece; [Tziouvas, Konstantinos] Univ Athens, P&A Kyriakou Childrens Hosp, Pediat Intens Care Unit, Athens, Greece; [van Elbur, Annemarie A.] Univ Utrecht, Fac Social & Behav Sci, Utrecht, Netherlands; [Zipfel, Stephan] Univ Med Hosp Tuebingen, Dept Internal Med 6, Psychosomat Med & Psychotherapy, Tubingen, Germany; [Bergen, Andrew W.] BioRealm LLC, Walnut, CA USA; [Bergen, Andrew W.] Oregon Res Inst, Eugene, OR 97403 USA; [Boden, Joseph M.; Horwood, L. John] Univ Otago, Christchurch Hlth & Dev Study, Christchurch, New Zealand; [Brandt, Harry; Crawford, Steven] Ctr Eating Disorders Sheppard Pratt, Baltimore, MD USA; [Halmi, Katherine A.] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA; [Johnson, Craig] Eating Recovery Ctr, Denver, CO USA; [Kaye, Walter H.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Mitchell, James E.] Univ North Dakota, Dept Psychiat & Behav Sci, Sch Med & Hlth Sci, Fargo, ND USA; [Pearson, John F.] Univ Otago, Biostat & Computat Biol Unit, Christchurch, New Zealand; [Strober, Michael] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Strober, Michael] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Werge, Thomas] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Woodside, D. Blake] Univ Hlth Network, Ctr Mental Hlth, Toronto, ON, Canada; [Woodside, D. Blake] Univ Hlth Network, Program Eating Disorders, Toronto, ON, Canada; [Stuber, Garret D.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Grove, Jakob; Larsen, Janne T.; Petersen, Liselotte; Mortensen, Preben Bo] Lundbeck Fdn Initiat Integrat Psychiat Res iPSYCH, Aarhus, Denmark; [Grove, Jakob] Aarhus Univ, Ctr Integrat Sequencing, iSEQ, Aarhus, Denmark; [Grove, Jakob] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Henders, Anjali K.; Montgomery, Grant W.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Larsen, Janne T.; Petersen, Liselotte; Mortensen, Preben Bo] Aarhus Univ, Natl Ctr Register Based Res, Aarhus BSS, Aarhus, Denmark; [Larsen, Janne T.; Petersen, Liselotte; Mortensen, Preben Bo] Aarhus Univ, Ctr Integrated Register Based Res CIRRAU, Aarhus, Denmark; [Jordan, Jennifer] Canterbury Dist Hlth Board, Christchurch, New Zealand; [Kennedy, Martin] Univ Otago, Dept Pathol & Biomed Sci, Christchurch, New Zealand; [Montgomery, Grant W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Wade, Tracey D.] Flinders Univ S Australia, Sch Psychol, Adelaide, SA, Australia; [Landen, Mikael] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Gothenburg, Sweden; [Yilmaz, Zeynep; Thorntont, Laura M.; Hubel, Christopher; Coleman, Jonathan R., I; Landen, Mikael; Martin, Nicholas G.; Mortensen, Preben Bo; Sullivan, Patrick F.; Bulik, Cynthia M.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; Curtin University; University of Western Australia; University of North Carolina; University of North Carolina Chapel Hill; University of London; King's College London; Karolinska Institutet; University of London; King's College London; South London & Maudsley NHS Trust; University of Duisburg Essen; Aarhus University; Karolinska Institutet; Stockholm County Council; University of Wurzburg; QIMR Berghofer Medical Research Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Utrecht University; Utrecht University Medical Center; University of Gothenburg; Karolinska Institutet; National Center for Neurology & Psychiatry - Japan; University of Oslo; University of Pennsylvania; Pennsylvania Medicine; Technische Universitat Dresden; UDICE-French Research Universities; Universite Paris Cite; Wellcome Trust Sanger Institute; University of Split; RWTH Aachen University; University of Padua; University of Basel; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universite de Montpellier; CHU de Montpellier; University of Minnesota System; University of Minnesota Twin Cities; University of Bristol; University of Bristol; Hannover Medical School; Harokopio University Athens; University of Padua; Seattle University; Virginia Commonwealth University; National & Kapodistrian University of Athens; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Poznan University of Medical Sciences; Barcelona Institute of Science & Technology; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Stanford University; University of Wurzburg; University of Tartu; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Barcelona; University of Munich; University of Munich; Masaryk Memorial Cancer Institute; University of Bonn; University of Bonn; University of Bonn; University of Basel; University of Basel; University of Toronto; Martin Luther University Halle Wittenberg; National & Kapodistrian University of Athens; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Poznan University of Medical Sciences; Ruprecht Karls University Heidelberg; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; McLean Hospital; Tokai University; Palacky University Olomouc; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Charles University Prague; General University Hospital Prague; University of Helsinki; University of Helsinki; University of Eastern Finland; Medical University of Vienna; University of Groningen; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Aberdeen; Inje University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Michigan State University; Norwegian Institute of Public Health (NIPH); University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Argosy University; Maria Sklodowska-Curie National Research Institute of Oncology; King Abdullah University of Science & Technology; University of Lausanne; Universita della Campania Vanvitelli; University of Lausanne; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University College Cork; University of Tartu; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Geneva; University of Geneva; University of London; University College London; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Salerno; University of Florence; University of California System; University of California Los Angeles; Harvard University; Massachusetts General Hospital; University of Barcelona; University of Barcelona; University of Oslo; University of Florence; University of Helsinki; Technische Universitat Dresden; University of Otago; University of Auckland; University of Pisa; Poznan University of Medical Sciences; University of Padua; Friedrich Schiller University of Jena; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of London; King's College London; J. Craig Venter Institute; Medical University of Vienna; Charles University Prague; Charles University Prague; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Poznan University of Medical Sciences; Nofer Institute of Occupational Medicine; Universita della Campania Vanvitelli; University of Perugia; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; Utrecht University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Oregon Research Institute; University of Otago; Cornell University; University of California System; University of California San Diego; University of North Dakota Grand Forks; University of Otago; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Copenhagen; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of North Carolina; University of North Carolina Chapel Hill; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Aarhus University; University of Queensland; Aarhus University; Aarhus University; University of Otago; University of Queensland; Flinders University South Australia; University of Gothenburg; University of North Carolina; University of North Carolina Chapel Hill	Bulik, CM (corresponding author), Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA.; Bulik, CM (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.; Bulik, CM (corresponding author), Univ N Carolina, Dept Nutr, Chapel Hill, NC 27515 USA.	cynthia_bulik@med.unc.edu	Tsitsika, Artemis/AAD-5545-2020; Fernandez-Aranda, Fernando/L-9762-2014; Lissowska, Jolanta/AAH-3252-2020; Olsen, Catherine/C-8785-2009; Hübel, Christopher/L-3888-2019; Nacmias, Benedetta/J-5084-2018; Rybakowski, Filip/AAC-5517-2019; Ehrlich, Stefan/ABB-4650-2020; Duncan, Laramie/AAW-5306-2021; Duncan, Laramie/AAG-6605-2019; Mattheisen, Manuel/S-3725-2019; Ripke, Stephan/AAK-5486-2021; Scherer, Stephen W./B-3785-2013; Walton, Esther/GSN-8429-2022; Medland, Sarah/AAT-7595-2020; Gaspar, Héléna Alexandra/H-5104-2016; Seitz, Jochen/AAE-7363-2019; Birgegård, Andreas/H-3194-2019; Rabionet, Raquel/C-8379-2009; Dedoussis, George/AAN-7252-2021; Jordan, Jennifer/H-8227-2019; Andreassen, Ole A./AAY-7531-2020; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Föcker, Manuel/CAF-0365-2022; Alfredsson, Lars/AAC-9007-2019; Kennedy, James Lowery/AAZ-6947-2020; Tozzi, Federica/AAP-5462-2021; Kaprio, Jaakko/A-1820-2008; Walton, Esther/P-9832-2019; Yao, Shuyang/AHB-4518-2022; Purves, Kirstin L./AAG-2443-2020; Zerwas, Stephanie/AAG-1595-2020; Lin, Bochao/AAB-2318-2019; Kas, Martien J./G-8269-2018; Cassina, Matteo/AAB-2669-2019; Escaramis, Georgia/AAR-5586-2020; Dina, Christian R/D-3535-2015; Kennedy, Martin A/A-4942-2008; Rujescu, Dan/GRS-3875-2022; Tortorella, Alfonso Antonio Vincenzo/AAC-4694-2022; Egberts, Karin Maria/AAV-4042-2020; gonidakis, fragiskos/AAC-5296-2020; Landen, Mikael/AAD-7917-2020; Micali, Nadia/E-6829-2010; Mortensen, Preben B/D-2358-2015; Kim, Youl-Ri/AAE-5170-2021; Huckins, Laura/GPX-8325-2022; Coleman, Jonathan/T-9412-2019; Pantel, Jacques/C-6563-2014; van Furth, Eric F/M-9849-2015; Whiteman, David C/P-2728-2014; Giegling, Ina/ABA-3677-2021; Hinney, Anke/D-6953-2011; ramoz, nicolas/K-3316-2015; JIMENEZ-MURCIA, SUSANA/L-9786-2014; Boden, Joseph/C-3316-2009; Estivill, Xavier/A-3125-2013; Favaro, Angela/J-2966-2012; Keski-Rahkonen, Anna/C-7073-2013; Breen, Gerome/A-5540-2010; Watson, Hunna/P-9708-2016; Grove, Jakob/K-8112-2015	Tsitsika, Artemis/0000-0002-8436-640X; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Lissowska, Jolanta/0000-0003-2695-5799; Olsen, Catherine/0000-0003-4483-1888; Hübel, Christopher/0000-0002-1267-8287; Nacmias, Benedetta/0000-0001-9338-9040; Rybakowski, Filip/0000-0001-5503-3019; Ehrlich, Stefan/0000-0003-2132-4445; Mattheisen, Manuel/0000-0002-8442-493X; Scherer, Stephen W./0000-0002-8326-1999; Medland, Sarah/0000-0003-1382-380X; Gaspar, Héléna Alexandra/0000-0002-5540-2707; Seitz, Jochen/0000-0002-0110-7980; Birgegård, Andreas/0000-0003-1220-9680; Rabionet, Raquel/0000-0001-5006-8140; Dedoussis, George/0000-0002-7798-6221; Jordan, Jennifer/0000-0003-4699-6301; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Alfredsson, Lars/0000-0003-1688-6697; Kennedy, James Lowery/0000-0002-8733-3806; Tozzi, Federica/0000-0002-3536-2920; Kaprio, Jaakko/0000-0002-3716-2455; Walton, Esther/0000-0002-0935-2200; Purves, Kirstin L./0000-0002-8110-5554; Zerwas, Stephanie/0000-0002-8927-3755; Kas, Martien J./0000-0002-4471-8618; Cassina, Matteo/0000-0003-0270-1698; Dina, Christian R/0000-0002-7722-7348; Kennedy, Martin A/0000-0002-6445-8526; Egberts, Karin Maria/0000-0002-0270-0954; Micali, Nadia/0000-0001-5571-2273; Mortensen, Preben B/0000-0002-5230-9865; Huckins, Laura/0000-0002-5369-6502; Coleman, Jonathan/0000-0002-6759-0944; Pantel, Jacques/0000-0002-9015-6281; van Furth, Eric F/0000-0002-1131-0886; Whiteman, David C/0000-0003-2563-9559; Hinney, Anke/0000-0001-5659-0706; ramoz, nicolas/0000-0002-8070-9938; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; Duncan, Laramie/0000-0003-1131-661X; Imgart, Hartmut/0000-0002-3997-0376; guillaume, sebastien/0000-0002-6769-9982; Davis, Oliver/0000-0002-6448-3684; Pedersen, Nancy/0000-0001-8057-3543; Kim, Youl-Ri/0000-0002-5538-7180; Foretova, Lenka/0000-0003-0494-2620; Slof-Op 't Landt, Rita/0000-0001-6135-2163; Leppa, Virpi/0000-0003-2942-2656; Boden, Joseph/0000-0003-1502-1608; Estivill, Xavier/0000-0002-0723-2256; Swiatkowska, Beata/0000-0003-3757-3868; ripke, stephan/0000-0003-3622-835X; Kiezebrink, Kirsty/0000-0002-9154-426X; Treasure, Janet/0000-0003-0871-4596; karwautz, andreas/0000-0001-9053-998X; marsal, sara/0000-0001-5515-3854; Schork, Nicholas/0000-0003-0920-5013; , Ken/0000-0002-3715-6805; Magistretti, Pierre Julius/0000-0002-6678-320X; Favaro, Angela/0000-0002-6540-5194; Petersen, Liselotte Vogdrup/0000-0002-0479-5379; Yao, Shuyang/0000-0001-9669-4470; Wade, Tracey/0000-0003-4402-770X; Munn-Chernoff, Melissa/0000-0001-9368-9457; Larsen, Janne Tidselbak/0000-0002-0385-1017; Keski-Rahkonen, Anna/0000-0002-6713-7488; Palotie, Aarno/0000-0002-2527-5874; Tziouvas, Konstantinos M/0000-0002-6863-7708; sorbi, sandro/0000-0002-0380-6670; Wagner, Gudrun/0000-0002-4845-9684; Julia Cano, Antonio/0000-0001-6064-3620; McDevitt, Sara/0000-0002-6319-8582; Hatzikotoulas, Konstantinos/0000-0002-4699-3672; Breen, Gerome/0000-0003-2053-1792; Watson, Hunna/0000-0001-8405-381X; Luykx, Jurjen/0000-0002-6439-2774; TORTORELLA, Alfonso Antonio Vincenzo/0000-0002-8095-2305; Grove, Jakob/0000-0003-2284-5744; ricca, valdo/0000-0002-9291-2124; Raevuori, Anu/0000-0001-7704-9441; Monteleone, Alessio Maria/0000-0002-6786-4458; Dmitrzak-Weglarz, Monika/0000-0002-0493-8325	National Institute of Mental Health; North Carolina Translational and Clinical Sciences Institute (NC TraCS); Carolina Data Warehouse; Foundation of Hope, Raleigh, North Carolina; Enabling Grant from the NHMRC [310667]; English National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; NIHR BioResource; GSTT Charity [TR130505]; Maudsley Charity [980]; National Institute of Mental Health of the US National Institutes of Health [U01MH109528, U01MH109514]; MRC [1668713] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH109782, R21MH115397, K01MH109772, K01MH106675, U01MH109536, U01MH109528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA025113] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); North Carolina Translational and Clinical Sciences Institute (NC TraCS); Carolina Data Warehouse; Foundation of Hope, Raleigh, North Carolina; Enabling Grant from the NHMRC; English National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; NIHR BioResource; GSTT Charity; Maudsley Charity; National Institute of Mental Health of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Grant support for ANGI, the PGC-ED and its component groups is shown in Supplementary Table 17. We thank all study volunteers, study coordinators and research staff who enabled this study. ANGI: The Anorexia Nervosa Genetics Initiative is an initiative of the Klarman Family Foundation. Additional support was offered by the National Institute of Mental Health. We are deeply grateful to all of the individuals who, through their participation, made ANGI a success. The goodwill that permeated the eating disorders community fueled by the enthusiasm of prominent bloggers, advocates, clinicians, treatment centers, scientists, organizations, families and especially those who have suffered from anorexia nervosa, yielded in an unprecedented and inspired global movement to complete this science. ANGI (United States): We thank Walden Behavioral Care, McCallum Place and the Renfrew Center for assisting with recruitment. We express our gratitude to J. Alexander (http://www.junealexander.com/) and C. Arnold (http://carriearnold.com/), who helped us disseminate information about ANGI. We acknowledge support from the North Carolina Translational and Clinical Sciences Institute (NC TraCS), the Carolina Data Warehouse and the Foundation of Hope, Raleigh, North Carolina. ANGI (Australia and New Zealand): We thank the Australia & and New Zealand Academy for Eating Disorders for assistance with recruitment and publicity. We thank VIVA! Communications for their efforts in promoting the study and the Butterfly Foundation for their ongoing support of anorexia nervosa research in Australia and EDANZ in New Zealand. We thank the QSkin Sun and Health Study for controls. We also acknowledge the assistance of S. Maguire and J. Russell (University of Sydney), P. Hay (Western Sydney University), S. Madden (Western Sydney University and the Sydney Children's Hospital Network), S. Sawyer and E. Hughes (Royal Children's Hospital, Melbourne), K. Fairweather-Schmidt (Flinders University), A. Fursland (Centre for Clinical Interventions and Curtin University), J. McCormack (Princess Margaret Hospital for Children), F. Wagg (Royal Hobart Hospital) and W. Ward (Royal Brisbane and Women's Hospital) in recruitment. We also thank L. Nunn for validation work on the ED100Kv1 Questionnaire. Additionally, administrative support for data collection was received from the Australian Twin Registry, which is supported by an Enabling Grant (ID 310667) from the NHMRC administered by the University of Melbourne. In New Zealand, we also acknowledge assistance with recruitment from M. Roberts (University of Auckland), R. Lawson (South Island Eating Disorders Service), M. Meiklejohn (Auckland District Health Board) and R. Mysliwiec. Special thanks to those who provided their stories in relation to publicity about ANGI. ANGI (Sweden): We acknowledge the assistance of the Stockholm Centre for Eating Disorders (SCA) and thank the Swedish National Quality Register for Eating Disorders (Riksat) and Lifegene. We would also like to thank the research nurses and data collectors at the Department of Medical Epidemiology and Biostatistics who worked on ANGI. ANGI (Denmark): We thank the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH). PGC: We are deeply indebted to the investigators who comprise the PGC and to the hundreds of thousands of individuals who have shared their life experiences with PGC investigators and the contributing studies.; We are grateful to the Children's Hospital of Philadelphia (CHOP), the Price Foundation Collaborative Group (PFCG), Genetic Consortium for Anorexia Nervosa (GCAN), Wellcome Trust Case-Control Consortium-3 (WTCCC-3), the UK Biobank and all PGC-ED members for their support in providing individual samples used in this study. We thank SURFsara (http://www.surf.nl) for support in using the Lisa Compute Cluster. We thank M. Lam for Ricopili consultation. This study also represents independent research partly funded by the English National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and the NIHR BioResource. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the English Department of Health and Social Care. High performance computing facilities were funded with capital equipment grants from the GSTT Charity (TR130505) and Maudsley Charity (980). Research reported in this publication was also supported by the National Institute of Mental Health of the US National Institutes of Health under Award Numbers U01MH109528 and U01MH109514. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arcelus J, 2011, ARCH GEN PSYCHIAT, V68, P724, DOI 10.1001/archgenpsychiatry.2011.74; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bello V, 2015, DEV BIOL, V401, P132, DOI 10.1016/j.ydbio.2014.07.006; Boraska V, 2014, MOL PSYCHIATR, V19, P1085, DOI 10.1038/mp.2013.187; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cederlof M, 2015, WORLD PSYCHIATRY, V14, P333, DOI 10.1002/wps.20251; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chang D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113596, 10.1371/journal.pone.0113684]; Dalle Grave R, 2008, COMPR PSYCHIAT, V49, P346, DOI 10.1016/j.comppsych.2007.12.007; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Dekker J, 2016, NAT REV MOL CELL BIO, V17, P741, DOI 10.1038/nrm.2016.151; Duncan L, 2017, AM J PSYCHIAT, V174, P850, DOI 10.1176/appi.ajp.2017.16121402; Ethier SD, 2012, BBA-GENE REGUL MECH, V1819, P401, DOI 10.1016/j.bbagrm.2011.12.004; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Giusti-Rodriguez P., 2019, USING 3 DIMENSIONAL, P406330, DOI [10.1101/406330, DOI 10.1101/406330]; Ho EV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166756; Hubel C, 2019, AM J MED GENET B, V180, P428, DOI 10.1002/ajmg.b.32709; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Kaye WH, 2004, AM J PSYCHIAT, V161, P2215, DOI 10.1176/appi.ajp.161.12.2215; Keski-Rahkonen A, 2016, CURR OPIN PSYCHIATR, V29, P340, DOI 10.1097/YCO.0000000000000278; Kim J, 2017, NEURON, V93, P1464, DOI 10.1016/j.neuron.2017.02.034; Kirk KM, 2017, AUST NZ J PSYCHIAT, V51, P583, DOI 10.1177/0004867417700731; Levinson DF, 2014, BIOL PSYCHIAT, V76, P510, DOI 10.1016/j.biopsych.2014.07.029; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lu L., 2018, BIORXIV, DOI [10.1101/245688, DOI 10.1101/245688]; Martin J, 2018, PSYCHOL MED, V48, P1759, DOI 10.1017/S0033291717003440; Micali N, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0766-4; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Moskvina V, 2005, ANN HUM GENET, V69, P566, DOI 10.1111/j.1529-8817.2005.00175.x; O'Connor EC, 2015, NEURON, V88, P553, DOI 10.1016/j.neuron.2015.09.038; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Schaumberg K, 2017, EUR EAT DISORD REV, V25, P432, DOI 10.1002/erv.2553; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thornton LM, 2018, CONTEMP CLIN TRIALS, V74, P61, DOI 10.1016/j.cct.2018.09.015; Watson HJ, 2013, PSYCHOL MED, V43, P2477, DOI 10.1017/S0033291712002620; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yilmaz Zeynep, 2015, Adv Genomics Genet, V5, P131; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhu ZH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02317-2	55	315	317	9	135	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2019	51	8					1207	+		10.1038/s41588-019-0439-2	http://dx.doi.org/10.1038/s41588-019-0439-2			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IM4EE	31308545	Green Accepted, Green Submitted			2022-12-17	WOS:000477946700007
J	Martin, M; Masshofer, L; Temming, P; Rahmann, S; Metz, C; Bornfeld, N; van de Nes, J; Klein-Hitpass, L; Hinnebusch, AG; Horsthemke, B; Lohmann, DR; Zeschnigk, M				Martin, Marcel; Masshoefer, Lars; Temming, Petra; Rahmann, Sven; Metz, Claudia; Bornfeld, Norbert; van de Nes, Johannes; Klein-Hitpass, Ludger; Hinnebusch, Alan G.; Horsthemke, Bernhard; Lohmann, Dietmar R.; Zeschnigk, Michael			Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3	NATURE GENETICS			English	Article							MICROSATELLITE ANALYSIS; SPLICING FACTOR; INITIATION; REVEALS; BINDING; ABERRATIONS; FIDELITY; CELLS; GNAQ	Gene expression profiles and chromosome 3 copy number divide uveal melanomas into two distinct classes correlating with prognosis(1-3). Using exome sequencing, we identified recurrent somatic mutations in EIF1AX and SF3B1, specifically occurring in uveal melanomas with disomy 3, which rarely metastasize. Targeted resequencing showed that 24 of 31 tumors with disomy 3 (77%) had mutations in either EIF1AX (15; 48%) or SF3B1 (9; 29%). Mutations were infrequent (2/35; 5.7%) in uveal melanomas with monosomy 3, which are associated with poor prognosis(2). Resequencing of 13 uveal melanomas with partial monosomy 3 identified 8 tumors with a mutation in either SF3B1 (7; 54%) or EIF1AX (1; 8%). All EIF1AX mutations caused in-frame changes affecting the N terminus of the protein, whereas 17 of 19 SF3B1 mutations encoded an alteration of Arg625. Resequencing of ten uveal melanomas with disomy 3 that developed metastases identified SF3B1 mutations in three tumors, none of which targeted Arg625.	[Martin, Marcel; Masshoefer, Lars; Rahmann, Sven; Horsthemke, Bernhard; Lohmann, Dietmar R.; Zeschnigk, Michael] Univ Duisburg Essen, Fac Med, Inst Human Genet, Essen, Germany; [Martin, Marcel] Tech Univ Dortmund, Dortmund, Germany; [Temming, Petra] Univ Hosp Essen, Dept Pediat Haematol & Oncol, Essen, Germany; [Metz, Claudia; Bornfeld, Norbert] Univ Duisburg Essen, Dept Ophthalmol, Fac Med, Essen, Germany; [van de Nes, Johannes] Univ Duisburg Essen, Inst Pathol & Neuropathol, Fac Med, Essen, Germany; [Klein-Hitpass, Ludger] Univ Duisburg Essen, Inst Cell Biol, Biochip Lab, Fac Med, Essen, Germany; [Hinnebusch, Alan G.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, US Natl Inst Hlth, Bethesda, MD USA; [Lohmann, Dietmar R.; Zeschnigk, Michael] Univ Duisburg Essen, Eye Canc Res Grp, Fac Med, Essen, Germany	University of Duisburg Essen; Dortmund University of Technology; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Duisburg Essen	Zeschnigk, M (corresponding author), Univ Duisburg Essen, Fac Med, Inst Human Genet, Essen, Germany.	michael.zeschnigk@uni-due.de	Ketteler, Petra/M-4743-2016; Lohmann, Dietmar R./X-4895-2019	Ketteler, Petra/0000-0002-8138-0441; Lohmann, Dietmar R./0000-0002-2624-9889; Martin, Marcel/0000-0002-0680-200X	Deutsche Krebshilfe (DKF) [108612]; Mercator Research Center Ruhr [Pr-2010-0016]; Wilhelm Sander Stiftung [2012.006.1]; US National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	Deutsche Krebshilfe (DKF); Mercator Research Center Ruhr; Wilhelm Sander Stiftung; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Klutz and D. Falkenstein for technical assistance and H.-J. Ludecke for elaborate discussion. This work was supported by the Deutsche Krebshilfe (DKF, 108612), the Mercator Research Center Ruhr (Pr-2010-0016) and the Wilhelm Sander Stiftung (2012.006.1) and by the Intramural Research Program of the US National Institutes of Health.	Abdel-Rahman MH, 2011, MODERN PATHOL, V24, P954, DOI 10.1038/modpathol.2011.51; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Bauer J, 2009, BRIT J CANCER, V101, P813, DOI 10.1038/sj.bjc.6605226; Chaudhuri J, 1997, J BIOL CHEM, V272, P7883, DOI 10.1074/jbc.272.12.7883; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Damato B, 2010, CLIN CANCER RES, V16, P6083, DOI 10.1158/1078-0432.CCR-10-2076; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fekete CA, 2005, EMBO J, V24, P3588, DOI 10.1038/sj.emboj.7600821; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Hahn CN, 2012, NAT GENET, V44, P9, DOI 10.1038/ng.1045; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; MCLEAN IW, 1982, HUM PATHOL, V13, P123; Olsen DS, 2003, EMBO J, V22, P193, DOI 10.1093/emboj/cdg030; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Prescher G, 1996, LANCET, V347, P1222; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rossi D, 2011, BLOOD, V118, P6904, DOI 10.1182/blood-2011-08-373159; Thomas S, 2012, BRIT J CANCER, V106, P1171, DOI 10.1038/bjc.2012.54; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tschentscher F, 2003, CANCER RES, V63, P2578; Tschentscher F, 2000, CANCER GENET CYTOGEN, V122, P13, DOI 10.1016/S0165-4608(00)00266-1; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	34	315	324	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2013	45	8					933	U296		10.1038/ng.2674	http://dx.doi.org/10.1038/ng.2674			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	190WW	23793026	Green Accepted			2022-12-17	WOS:000322374900019
J	Yang, HN; Wang, JR; Didion, JP; Buus, RJ; Bell, TA; Welsh, CE; Bonhomme, F; Yu, AHT; Nachman, MW; Pialek, J; Tucker, P; Boursot, P; McMillan, L; Churchill, GA; de Villena, FPM				Yang, Hyuna; Wang, Jeremy R.; Didion, John P.; Buus, Ryan J.; Bell, Timothy A.; Welsh, Catherine E.; Bonhomme, Francois; Yu, Alex Hon-Tsen; Nachman, Michael W.; Pialek, Jaroslav; Tucker, Priscilla; Boursot, Pierre; McMillan, Leonard; Churchill, Gary A.; de Villena, Fernando Pardo-Manuel			Subspecific origin and haplotype diversity in the laboratory mouse	NATURE GENETICS			English	Article							INBRED STRAINS; HOUSE MICE; RESOURCE; GENOME; GENES; SNPS	Here we provide a genome-wide, high-resolution map of the phylogenetic origin of the genome of most extant laboratory mouse inbred strains. Our analysis is based on the genotypes of wild-caught mice from three subspecies of Mus musculus. We show that classical laboratory strains are derived from a few fancy mice with limited haplotype diversity. Their genomes are overwhelmingly Mus musculus domesticus in origin, and the remainder is mostly of Japanese origin. We generated genome-wide haplotype maps based on identity by descent from fancy mice and show that classical inbred strains have limited and non-randomly distributed genetic diversity. In contrast, wild-derived laboratory strains represent a broad sampling of diversity within M. musculus. Intersubspecific introgression is pervasive in these strains, and contamination by laboratory stocks has played a role in this process. The subspecific origin, haplotype diversity and identity by descent maps can be visualized using the Mouse Phylogeny Viewer (see URLs).	[Didion, John P.; Buus, Ryan J.; Bell, Timothy A.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Yang, Hyuna; Churchill, Gary A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Wang, Jeremy R.; Welsh, Catherine E.; McMillan, Leonard] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA; [Didion, John P.; Buus, Ryan J.; Bell, Timothy A.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Didion, John P.; Buus, Ryan J.; Bell, Timothy A.; de Villena, Fernando Pardo-Manuel] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Bonhomme, Francois; Boursot, Pierre] Univ Montpellier 2, CNRS, Inst Sci Evolut, UMR5554, Montpellier, France; [Yu, Alex Hon-Tsen] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Yu, Alex Hon-Tsen] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Nachman, Michael W.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Pialek, Jaroslav] Acad Sci Czech Republic, Dept Populat Biol, Inst Vertebrate Biol, Brno, Czech Republic; [Pialek, Jaroslav] Acad Sci Czech Republic, Dept Populat Biol, Inst Vertebrate Biol, Studenec, Czech Republic; [Tucker, Priscilla] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of North Carolina; University of North Carolina Chapel Hill; Jackson Laboratory; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; University of Arizona; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Czech Academy of Sciences; University of Michigan System; University of Michigan	de Villena, FPM (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	garyc@jax.org; fernando@med.unc.edu	Bonhomme, Francois/AAG-6558-2021; Bonhomme, Francois/C-6290-2012; Pialek, Jaroslav/B-1237-2008; Wang, Jeremy/L-7971-2019; Churchill, Gary/AAY-7496-2020; Piálek, Jaroslav/AAP-8636-2020; Boursot, Pierre/D-5860-2011	Bonhomme, Francois/0000-0002-8792-9239; Bonhomme, Francois/0000-0002-8792-9239; Wang, Jeremy/0000-0002-0673-9418; Churchill, Gary/0000-0001-9190-9284; Boursot, Pierre/0000-0001-6366-2341; Pialek, Jaroslav/0000-0002-0829-7481; Mott, Richard/0000-0002-1022-9330; Didion, John/0000-0002-8111-6261	National Institute of General Medical Sciences (NIGMS) [GM-076468]; US National Institutes of Health (NIH) [R01 GM74245]; Czech Science Foundation [206-08-0640]; NIH [GM067553-04, P50 MH090338]; University of North Carolina (UNC);  [ISEM 2010-141]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067553, R01GM074245, P50GM076468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090338] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Czech Science Foundation(Grant Agency of the Czech Republic); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina (UNC); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of General Medical Sciences (NIGMS) Centers of Excellence in Systems Biology program, grant GM-076468, by a US National Institutes of Health (NIH) grant to M.W.N. (R01 GM74245), by a grant to F.B. (ISEM 2010-141) and by a Czech Science Foundation grant to J.P. (206-08-0640). J.P.D. was partially supported by NIH Training Grant Number GM067553-04, University of North Carolina (UNC) Bioinformatics and Computational Biology Training Grant. J.P.D., R.J.B. and T.A.B. are partially supported by an NIH grant to F.P.-M.d.V. (P50 MH090338). We also thank F. Oyola for help annotating the samples genotyped in this study.	Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BOURSOT P, 1993, ANNU REV ECOL SYST, V24, P119, DOI 10.1146/annurev.es.24.110193.001003; Boursot P, 2006, GENOME RES, V16, P1191, DOI 10.1101/gr.5541806; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Harr B, 2006, GENOME RES, V16, P730, DOI 10.1101/gr.5045006; Ideraabdullah FY, 2004, GENOME RES, V14, P1880, DOI 10.1101/gr.2519704; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; NAGAMINE CM, 1992, MAMM GENOME, V3, P84, DOI 10.1007/BF00431251; Sudbery I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r112; Szatkiewicz JP, 2008, MAMM GENOME, V19, P199, DOI 10.1007/s00335-008-9098-9; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; TUCKER PK, 1992, MAMM GENOME, V3, P254, DOI 10.1007/BF00292153; Wang J., 2010, P ACM INT C BIOINF C; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; White MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000729; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Yonekawa Hiromichi, 1994, P25	22	315	315	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2011	43	7					648	U173		10.1038/ng.847	http://dx.doi.org/10.1038/ng.847			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	784UV	21623374	Green Accepted, Green Submitted			2022-12-17	WOS:000292184600008
J	Freedman, ML; Monteiro, ANA; Gayther, SA; Coetzee, GA; Risch, A; Plass, C; Casey, G; De Biasi, M; Carlson, C; Duggan, D; James, M; Liu, PY; Tichelaar, JW; Vikis, HG; You, M; Mills, IG				Freedman, Matthew L.; Monteiro, Alvaro N. A.; Gayther, Simon A.; Coetzee, Gerhard A.; Risch, Angela; Plass, Christoph; Casey, Graham; De Biasi, Mariella; Carlson, Chris; Duggan, David; James, Michael; Liu, Pengyuan; Tichelaar, Jay W.; Vikis, Haris G.; You, Ming; Mills, Ian G.			Principles for the post-GWAS functional characterization of cancer risk loci	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LONG-RANGE INTERACTION; HUMAN GENE-EXPRESSION; GERMLINE EPIMUTATION; VARIANTS; BREAST; IDENTIFICATION; EPIGENOMICS; ELEMENTS; UNDERLIE		[Mills, Ian G.] Univ Oslo, Nord European Mol Biol Lab EMBL Partnership, Norwegian Ctr Mol Med, Oslo, Norway; [Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Freedman, Matthew L.] Eli & Edythe L Broad Inst MIT & Harvard, Cambridge, MA USA; [Monteiro, Alvaro N. A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL 33612 USA; [Gayther, Simon A.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Gayther, Simon A.] UCL, Elizabeth Garrett Anderson Inst Womens Hlth EGA, Translat Res Lab, London, England; [Coetzee, Gerhard A.] Univ So Calif, Dept Urol, Norris Canc Ctr, Los Angeles, CA USA; [Risch, Angela; Plass, Christoph] German Canc Res Ctr, Div Epigenom & Canc Risk Factors, D-6900 Heidelberg, Germany; [Casey, Graham] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [De Biasi, Mariella] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Carlson, Chris] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Duggan, David] Translat Genom Res Inst TGen, Phoenix, AZ USA; [James, Michael; Liu, Pengyuan; Tichelaar, Jay W.; Vikis, Haris G.; You, Ming] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Mills, Ian G.] Canc Res UK Cambridge Res Inst, Urooncol Res Grp, Cambridge, England	University of Oslo; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Southern California; University of London; University College London; University of Southern California; Helmholtz Association; German Cancer Research Center (DKFZ); University of Southern California; Baylor College of Medicine; Fred Hutchinson Cancer Center; Translational Genomics Research Institute; Medical College of Wisconsin; Cancer Research UK; CRUK Cambridge Institute	Mills, IG (corresponding author), Univ Oslo, Nord European Mol Biol Lab EMBL Partnership, Norwegian Ctr Mol Med, Oslo, Norway.	ian.mills@ncmm.uio.no	De Biasi, Mariella/M-7646-2017; Monteiro, Alvaro N. A./A-7566-2009; Mills, Ian/AAK-9292-2020; Plass, Christoph/H-7192-2014; Coetzee, Gerhard/AAG-8439-2019; Risch, Angela/H-2669-2013; James, Michael/L-7772-2019; coetzee, Gerhard/AAT-6203-2020; Pillay, Nischalan/F-9536-2012	De Biasi, Mariella/0000-0002-0687-8872; Monteiro, Alvaro N. A./0000-0002-8448-4801; Mills, Ian/0000-0001-5347-5083; Risch, Angela/0000-0002-8026-5505; James, Michael/0000-0002-8112-1108; Coetzee, Gerhard/0000-0001-8820-8364	NIH Post-Genome Wide Association Initiative [1U19CA148537-01, 1U19CA148065-01, 1U19CA148112-01, 1U19CA148107-01, 1U19CA148127-01]; MRC [G0801875] Funding Source: UKRI; Medical Research Council [G0801875] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U19CA148065, U19CA148107, U19CA148112, U19CA148537, U19CA148127] Funding Source: NIH RePORTER	NIH Post-Genome Wide Association Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank F. Bunz and all the members of the NIH Post-Genome Wide Association Initiative for helpful discussions and, in particular, I. Tomlinson (Wellcome Trust Centre for Human Genetics, Oxford). The contributing groups are supported by funding made available through the NIH Post-Genome Wide Association Initiative in response to Call (http://grants.nih.gov./grants/oer.htm). This Call sustains research across five cancer organ sites (prostate: 1U19CA148537-01; breast: 1U19CA148065-01; ovarian: 1U19CA148112-01; colorectal: 1U19CA148107-01; and lung: 1U19CA148127-01). For further information on this Initiative, please refer to the website: (http://epi.grants.cancer.gov/). In addition, this article is the product of the first attempt to engage the entire scientific community in the drafting of a scientific paper through open-access websites. We would like to thank R. Hoffmann at WikiGenes for hosting the pre-submission version of this submission (http://www.wikigenes.org/e/pub/e/84.html) and his unstinting energy and enthusiasm for this project and also Nature Precedings for hosting the same version (http://precedings.nature.com/documents/5162/version/1).	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; [Anonymous], 2010, NAT GENET, V42, P551, DOI 10.1038/ng0710-551; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bumgarner Roger E., 2009, V541, P225, DOI 10.1007/978-1-59745-243-4_11; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; COETZEE GA, 2010, CELL CYCLE, V9, P47; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hesson LB, 2010, CURR OPIN GENET DEV, V20, P290, DOI 10.1016/j.gde.2010.02.005; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pelletier C, 2010, EXPERT REV MOL DIAGN, V10, P817, DOI [10.1586/erm.10.59, 10.1586/ERM.10.59]; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pomerantz MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001204; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Saccone NL, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-58; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Via M, 2010, GENOME MED, V2, DOI 10.1186/gm124; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932	57	315	328	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					513	518		10.1038/ng.840	http://dx.doi.org/10.1038/ng.840			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21614091	Green Accepted			2022-12-17	WOS:000291017000006
J	Onouchi, Y; Gunji, T; Burns, JC; Shimizu, C; Newburger, JW; Yashiro, M; Nakamura, Y; Yanagawa, H; Wakui, K; Fukushima, Y; Kishi, F; Hamamoto, K; Terai, M; Sato, Y; Ouchi, K; Saji, T; Nariai, A; Kaburagi, Y; Yoshikawa, T; Suzuki, K; Tanaka, T; Nagai, T; Cho, H; Fujino, A; Sekine, A; Nakamichi, R; Tsunoda, T; Kawasaki, T; Nakamura, Y; Hata, A				Onouchi, Yoshihiro; Gunji, Tomohiko; Burns, Jane C.; Shimizu, Chisato; Newburger, Jane W.; Yashiro, Mayumi; Nakamura, Yoshikazu; Yanagawa, Hiroshi; Wakui, Keiko; Fukushima, Yoshimitsu; Kishi, Fumio; Hamamoto, Kunihiro; Terai, Masaru; Sato, Yoshitake; Ouchi, Kazunobu; Saji, Tsutomu; Nariai, Akiyoshi; Kaburagi, Yoichi; Yoshikawa, Tetsushi; Suzuki, Kyoko; Tanaka, Takeo; Nagai, Toshiro; Cho, Hideo; Fujino, Akihiro; Sekine, Akihiro; Nakamichi, Reiichiro; Tsunoda, Tatsuhiko; Kawasaki, Tomisaku; Nakamura, Yusuke; Hata, Akira			ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms	NATURE GENETICS			English	Article							BASE-PAIR SUBSTITUTIONS; T-LYMPHOCYTES; HUMAN GENES; REGULATORY ELEMENTS; SIGNAL-TRANSDUCTION; MESSENGER; RNA; CONSEQUENCES; PREDICTION; EXPRESSION	Kawasaki disease is a pediatric systemic vasculitis of unknown etiology for which a genetic influence is suspected. We identified a functional SNP (itpkc_3) in the inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) gene on chromosome 19q13.2 that is significantly associated with Kawasaki disease susceptibility and also with an increased risk of coronary artery lesions in both Japanese and US children. Transfection experiments showed that the C allele of itpkc_3 reduces splicing efficiency of the ITPKC mRNA. ITPKC acts as a negative regulator of T-cell activation through the Ca2+/NFAT signaling pathway, and the C allele may contribute to immune hyper-reactivity in Kawasaki disease. This finding provides new insights into the mechanisms of immune activation in Kawasaki disease and emphasizes the importance of activated T cells in the pathogenesis of this vasculitis.	[Onouchi, Yoshihiro; Gunji, Tomohiko; Hata, Akira] RIKEN, SNP Res Ctr, Lab Gastrointestinal Dis, Kanagawa 2300045, Japan; [Gunji, Tomohiko] Tokyo Med & Dent Univ, Grad Sch, Dept Hard Tissue Engn, Tokyo 1138549, Japan; [Burns, Jane C.; Shimizu, Chisato] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Shimizu, Chisato] Rady Childrens Hosp, La Jolla, CA 92093 USA; [Newburger, Jane W.] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Yashiro, Mayumi; Nakamura, Yoshikazu] Jichi Med Sch, Dept Publ Hlth, Minamimaki, Tochigi 3290498, Japan; [Yanagawa, Hiroshi] Saitama Prefectural Univ, Koshigaya, Saitama 3438540, Japan; [Wakui, Keiko; Fukushima, Yoshimitsu] Shinshu Univ, Sch Med, Dept Prevent Med, Matsumoto, Nagano 3908621, Japan; [Kishi, Fumio] Kawasaki Med Sch, Dept Mol Genet, Kurashiki, Okayama 7010192, Japan; [Hamamoto, Kunihiro] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 8318501, Japan; [Terai, Masaru] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pediat, Chiba 2768524, Japan; [Sato, Yoshitake] Fuji Heavy Ind Co Ltd, Dept Pediat, Fuji Heavy Ind Ltd, Gunma 3738585, Japan; [Ouchi, Kazunobu] Kawasaki Med Sch, Dept Pediat, Okayama 7010192, Japan; [Saji, Tsutomu] Toho Univ, Sch Med, Dept Pediat, Tokyo 1438541, Japan; [Nariai, Akiyoshi; Kaburagi, Yoichi] Yokohama Minami Kyousai Hosp, Dept Pediat, Yokohama, Kanagawa 2360037, Japan; [Yoshikawa, Tetsushi] Fujita Hlth Univ, Dept Pediat, Toyoake, Aichi 4701192, Japan; [Suzuki, Kyoko] Toyokawa Citizens Hosp, Dept Pediat, Aichi 4428561, Japan; [Tanaka, Takeo] Kure Med Ctr, NAtl Hosp Org, Dept Pediat, Okayama 7370023, Japan; [Nagai, Toshiro] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Koshigaya, Saitama 3438555, Japan; [Cho, Hideo] Kawasaki Municipal Hosp, Dept Pediat, Kawasaki, Kanagawa 2100013, Japan; [Fujino, Akihiro] Keio Univ, Sch Med, Dept Surg, Tokyo 1608582, Japan; [Sekine, Akihiro] RIKEN, Lab Genotyping, Kanagawa 2300045, Japan; [Nakamichi, Reiichiro; Tsunoda, Tatsuhiko] RIKEN, SNP Res Ctr, Lab Med Informat, Kanagawa 2300045, Japan; [Kawasaki, Tomisaku] Japan Kawasaki Dis Res Ctr, Tokyo 1110031, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan; [Nakamura, Yusuke] RIKEN, SNP Res Ctr, Kanagawa 2300045, Japan	RIKEN; Tokyo Medical & Dental University (TMDU); University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Harvard University; Boston Children's Hospital; Jichi Medical University; Shinshu University; Kawasaki Medical School; Fukuoka University; Tokyo Women's Medical University; Subaru Corporation; Kawasaki Medical School; Toho University; Fujita Health University; Dokkyo Medical University; Keio University; RIKEN; RIKEN; University of Tokyo; RIKEN	Onouchi, Y (corresponding author), RIKEN, SNP Res Ctr, Lab Gastrointestinal Dis, Kanagawa 2300045, Japan.	onouchi@src.riken.jp	Burns, Jane C/J-6167-2015; Shimizu, Chisato/J-6516-2015; Tsunoda, Tatsuhiko/K-2061-2014; Fujino, Akihiro/AAH-2243-2019	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Fujino, Akihiro/0000-0003-2987-5081; Shimizu, Chisato/0000-0002-3149-2699	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069413] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL069413-08, R01 HL069413, HL69413] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Brown TJ, 2001, J INFECT DIS, V184, P940, DOI 10.1086/323155; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Burns JC, 2005, GENES IMMUN, V6, P438, DOI 10.1038/sj.gene.6364225; Cogan JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/hmg/6.6.909; COOK DH, 1989, CAN J CARDIOL, V5, P389; Dergun M, 2005, ARCH PEDIAT ADOL MED, V159, P876, DOI 10.1001/archpedi.159.9.876; Dewaste V, 2000, BIOCHEM J, V352, P343, DOI 10.1042/0264-6021:3520343; Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050; FUJITA Y, 1989, PEDIATRICS, V84, P666; Fukunishi M, 2000, J PEDIATR-US, V137, P172, DOI 10.1067/mpd.2000.104815; HARNICK DJ, 1995, J BIOL CHEM, V270, P2833, DOI 10.1074/jbc.270.6.2833; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; IMBODEN JB, 1987, J CLIN INVEST, V79, P1538, DOI 10.1172/JCI112986; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4; Kawasaki T., 1967, PEDIATR INFECT DIS J, V16, P178; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; KRAWCZAK M, 1992, HUM GENET, V90, P41; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Louie E, 2003, GENOME RES, V13, P2594, DOI 10.1101/gr.1317703; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; MORISAKI H, 1993, J CLIN INVEST, V91, P2275, DOI 10.1172/JCI116455; Onouchi Y, 2007, J HUM GENET, V52, P179, DOI 10.1007/s10038-006-0092-3; Raman V, 2001, PEDIATR INFECT DIS J, V20, P635, DOI 10.1097/00006454-200106000-00022; Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Uehara R, 2003, ACTA PAEDIATR, V92, P694, DOI 10.1080/08035320310002768; Ueijma H, 2000, NAT GENET, V25, P375, DOI 10.1038/78040; Varani L, 1999, P NATL ACAD SCI USA, V96, P8229, DOI 10.1073/pnas.96.14.8229; von Ahsen N, 2004, BLOOD, V103, P586, DOI 10.1182/blood-2003-02-0419; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101; Yoshioka T, 1999, IMMUNOLOGY, V96, P465, DOI 10.1046/j.1365-2567.1999.00695.x	40	315	335	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					35	42		10.1038/ng.2007.59	http://dx.doi.org/10.1038/ng.2007.59			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18084290	Green Accepted			2022-12-17	WOS:000252118600016
J	Lupski, JR				Lupski, James R.			Genomic rearrangements and sporadic disease	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; MARIE-TOOTH-DISEASE; CHROMOSOMAL REARRANGEMENTS; HOMOLOGOUS RECOMBINATION; STRUCTURAL VARIATION; CONGENITAL-MALFORMATIONS; CONSTITUTIONAL T(11/22); SEGMENTAL DUPLICATIONS; SPONTANEOUS MUTATION; DNA REARRANGEMENTS	Many clinical phenotypes occur sporadically despite genetics contributing partly or entirely to their cause. To what extent are de novo mutations the cause of sporadic traits? Locus-specific mutation rates for genomic rearrangements appear to be two to four orders of magnitude greater than nucleotide-specific rates for base substitutions. Widespread implementation of high-resolution genome analyses to detect de novo copy-number variation may identify the cause of traits previously intractable to conventional genetic analyses.	[Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Baylor Univ, Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor University	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Pl,604B, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu						BAIRD PA, 1988, AM J HUM GENET, V42, P677; Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Bort S, 1997, AM J HUM GENET, V60, P230; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; KALTER H, 1983, NEW ENGL J MED, V308, P424, DOI 10.1056/NEJM198302243080804; KALTER H, 1983, NEW ENGL J MED, V308, P491, DOI 10.1056/NEJM198303033080904; Kato T, 2006, SCIENCE, V311, P971, DOI 10.1126/science.1121452; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; Kurahashi H, 2001, NAT GENET, V29, P139, DOI 10.1038/ng1001-139; Lam KWG, 2006, P NATL ACAD SCI USA, V103, P8921, DOI 10.1073/pnas.0602690103; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lee JA, 2006, HUM MOL GENET, V15, P2250, DOI 10.1093/hmg/ddl150; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 2003, AM J HUM GENET, V72, P246, DOI 10.1086/346217; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Lupski JR, 2001, METABOLIC MOL BASES, P5759; Lupski JR, 2005, PERIPHERAL NEUROPATH, P1659, DOI DOI 10.1016/B978-0-7216-9491-7.50073-9; Marques W, 2005, J NEUROL, V252, P972, DOI 10.1007/s00415-005-0797-9; Nachman MW, 2000, GENETICS, V156, P297; Nelis E, 1996, EUR J HUM GENET, V4, P25; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Potocki L, 1999, AM J HUM GENET, V64, P471, DOI 10.1086/302240; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw CJ, 2004, AM J HUM GENET, V75, P75, DOI 10.1086/422016; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; SHY ME, 2005, PERIPHERAL NEUROPATH, V1, P1623; SKRE H, 1974, CLIN GENET, V6, P98; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stankiewicz P, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P179, DOI 10.1007/978-1-59745-039-3_12; Szigeti K, 2006, GENET MED, V8, P86, DOI 10.1097/01.gim.0000200160.29385.73; van Ommen GJB, 2005, NAT GENET, V37, P333, DOI 10.1038/ng0405-333; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; WISE CA, 1993, AM J HUM GENET, V53, P853; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560	69	315	375	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S43	S47		10.1038/ng2084	http://dx.doi.org/10.1038/ng2084			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597781				2022-12-17	WOS:000253974400008
J	Guo, DH; Li, MY; Zhang, Y; Yang, P; Eckenrode, S; Hopkins, D; Zheng, WP; Purohit, S; Podolsky, RH; Muir, A; Wang, JZ; Dong, Z; Brusko, T; Atkinson, M; Pozzilli, P; Zeidler, A; Raffel, LJ; Jacob, CO; Park, Y; Serrano-Rios, M; Larrad, MTM; Zhang, ZX; Garchon, HJ; Bach, JF; Rotter, JI; She, JX; Wang, CY				Guo, DH; Li, MY; Zhang, Y; Yang, P; Eckenrode, S; Hopkins, D; Zheng, WP; Purohit, S; Podolsky, RH; Muir, A; Wang, JZ; Dong, Z; Brusko, T; Atkinson, M; Pozzilli, P; Zeidler, A; Raffel, LJ; Jacob, CO; Park, Y; Serrano-Rios, M; Larrad, MTM; Zhang, ZX; Garchon, HJ; Bach, JF; Rotter, JI; She, JX; Wang, CY			A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes	NATURE GENETICS			English	Article							CHROMOSOME 11Q13; LINKAGE-DISEQUILIBRIUM; SUSCEPTIBILITY LOCUS; SIGNAL-TRANSDUCTION; ACTIVATION; GENES; MELLITUS; IDDM4; TAB2; RECEPTOR	Previous studies have suggested more than 20 genetic intervals that are associated with susceptibility to type 1 diabetes (T1D)(1,2), but identification of specific genes has been challenging and largely limited to known candidate genes. Here, we report evidence for an association between T1D and multiple single-nucleotide polymorphisms in 197 kb of genomic DNA in the IDDM5 interval. We cloned a new gene (SUMO4), encoding small ubiquitin-like modifier 4 protein, in the interval. A substitution (M55V) at an evolutionarily conserved residue of the crucial CUE domain of SUMO4 was strongly associated with T1D (P = 1.9 x 10(-7)). SUMO4 conjugates to IkappaBalpha and negatively regulates NFkappaB transcriptional activity. The M55V substitution resulted in 5.5 times greater NFkappaB transcriptional activity and similar to2 times greater expression of IL12B, an NFkappaB-dependent gene. These findings suggest a new pathway that may be implicated in the pathogenesis of T1D.	Med Coll Georgia, Ctr Biotechnol & Gen Med, Augusta, GA 30912 USA; Med Coll Georgia, Off Biostat & Bioinformat, Augusta, GA 30912 USA; Med Coll Georgia, Childrens Med Ctr, Augusta, GA 30912 USA; Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA; Univ Roma La Sapienza, Ist Clin Med 2, Rome, Italy; Univ So Calif, Sch Med, Dept Med, Los Angeles, CA 90033 USA; Hanyang Univ Hosp, Seoul, South Korea; Univ Complutense, Fac Med, E-28040 Madrid, Spain; Beijing Red Cross Blood Ctr, HLA Lab, Beijing, Peoples R China; INSERM, Unite Rech, U580, Ctr Assoc Claude Bernard, Paris, France	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; State University System of Florida; University of Florida; Sapienza University Rome; University of Southern California; Hanyang University; Hanyang University Hospital; Complutense University of Madrid; Institut National de la Sante et de la Recherche Medicale (Inserm)	She, JX (corresponding author), Med Coll Georgia, Ctr Biotechnol & Gen Med, 1120 15th St,CA4098, Augusta, GA 30912 USA.	jshe@mail.mcg.edu; cwang@mail.mcg.edu	Purohit, Sharad/ABA-8054-2021; zhang, yan/AAG-7349-2019; Podolsky, Robert/GRY-0740-2022; Pozzilli, Paolo/A-5235-2010	zhang, yan/0000-0003-0906-9410; Brusko, Todd/0000-0003-2878-9296; Purohit, Sharad/0000-0003-0385-3829; Wang, Cong-Yi/0000-0001-7914-168X				Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Delepine M, 1997, AM J HUM GENET, V60, P174; DENG GY, 1995, AM J HUM GENET, V56, P528; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Eckenrode S, 2000, HUM GENET, V106, P14, DOI 10.1007/s004399900186; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; LUO DF, 1995, AM J HUM GENET, V57, P911; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Matunis MJ, 2002, MOL CELL, V10, P441, DOI 10.1016/S1097-2765(02)00653-6; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Melchior F, 2002, CELL CYCLE, V1, P243, DOI 10.4161/cc.1.4.131; Nakagawa Y, 1998, AM J HUM GENET, V63, P547, DOI 10.1086/301974; Onengut-Gumuscu S, 2002, IMMUNOL REV, V190, P182, DOI 10.1034/j.1600-065X.2002.19014.x; Owerbach D, 2000, DIABETES, V49, P508, DOI 10.2337/diabetes.49.3.508; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Rogers RS, 2003, J BIOL CHEM, V278, P30091, DOI 10.1074/jbc.M301344200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tian S, 2002, BIOCHEM J, V367, P907, DOI 10.1042/BJ20021085; Twells RCJ, 2003, HUM GENET, V113, P99, DOI 10.1007/s00439-003-0940-6; Twells RCJ, 2001, GENOMICS, V72, P231, DOI 10.1006/geno.2000.6492; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6	30	315	352	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					837	841		10.1038/ng1391	http://dx.doi.org/10.1038/ng1391			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15247916				2022-12-17	WOS:000222974000015
J	Ono, T; Isobe, K; Nakada, K; Hayashi, JI				Ono, T; Isobe, K; Nakada, K; Hayashi, JI			Human cells are protected from mitochondrial dysfunction by complementation of DNA products in fused mitochondria	NATURE GENETICS			English	Letter							DEGENERATIVE DISEASES; MOUSE MTDNA; HUMAN BRAIN; MUTATIONS; RECOMBINATION; EMBRYOGENESIS; ELIMINATION; ORGANELLES; DELETIONS; GENETICS	Extensive complementation between fused mitochondria is indicated by recombination of 'parental' mitochondrial (mt) DNA (refs, 1,2) of yeast and plant cells. It has been difficult, however, to demonstrate the occurrence of complementation between fused mitochondria in mammalian species through the presence of recombinant mtDNA molecules(3), because sequence of mtDNA throughout an individual tends to be uniform(4) owing to its strictly maternal inheritance(5-7). We isolated two types of respiration-deficient cell lines, with pathogenic mutations in mitochondrial tRNA(lle) or tRNA(Leu(UUR)) genes from patients with mitochondrial diseases. The coexistence of their mitochondria within hybrids restored their normal morphology and respiratory enzyme activity by 10-14 days after fusion, indicating the presence of an extensive and continuous exchange of genetic contents between the mitochondria. This complementation between fused mitochondria may represent a defence of highly oxidative organelles against mitochondrial dysfunction caused by the accumulation of mtDNA lesions with age.	Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba; University of Tsukuba	Hayashi, JI (corresponding author), Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan.							BELLIARD G, 1979, NATURE, V281, P401, DOI 10.1038/281401a0; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; DUJON B, 1974, GENETICS, V78, P415; Enriquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HAYASHI JI, 1994, J BIOL CHEM, V269, P19060; HAYASHI JI, 1985, EXP CELL RES, V160, P387, DOI 10.1016/0014-4827(85)90185-5; HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43; Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826; Inoue K, 1997, BIOCHEM BIOPH RES CO, V239, P257, DOI 10.1006/bbrc.1997.7446; Isobe K, 1998, J BIOL CHEM, V273, P4601, DOI 10.1074/jbc.273.8.4601; Ito S, 1999, P NATL ACAD SCI USA, V96, P2099, DOI 10.1073/pnas.96.5.2099; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Lightowlers RH, 1999, TRENDS GENET, V15, P91, DOI 10.1016/S0168-9525(98)01684-9; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; MONNAT RJ, 1986, GENE, V43, P205, DOI 10.1016/0378-1119(86)90208-8; Nagley P, 1998, TRENDS GENET, V14, P513, DOI 10.1016/S0168-9525(98)01580-7; NAKADA K, IN PRESS NATURE MED; NONAKA I, 1989, J NEUROL SCI, V92, P193, DOI 10.1016/0022-510X(89)90136-6; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; SHAY JW, 1987, MUTAT RES, V186, P149, DOI 10.1016/0165-1110(87)90028-5; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Shitara H, 2000, GENETICS, V156, P1277; Shitara H, 1998, GENETICS, V148, P851; SOONG NW, 1992, NAT GENET, V2, P318; Takai D, 1997, J BIOL CHEM, V272, P6028, DOI 10.1074/jbc.272.9.6028; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699	29	315	321	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2001	28	3					272	275		10.1038/90116	http://dx.doi.org/10.1038/90116			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	448XZ	11431699				2022-12-17	WOS:000169656400021
J	Nezer, C; Moreau, L; Brouwers, B; Coppieters, W; Detilleux, J; Hanset, R; Karim, L; Kvasz, A; Leroy, P; Georges, M				Nezer, C; Moreau, L; Brouwers, B; Coppieters, W; Detilleux, J; Hanset, R; Karim, L; Kvasz, A; Leroy, P; Georges, M			An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs	NATURE GENETICS			English	Letter							SEQUENCE		Univ Liege, Fac Vet Med, Dept Genet, B-4000 Liege, Belgium	University of Liege	Nezer, C (corresponding author), Univ Liege, Fac Vet Med, Dept Genet, B43,20 Bd Colonster, B-4000 Liege, Belgium.		Coppieters, Wouter/AAF-5030-2021	Coppieters, Wouter/0000-0001-8109-7825; Georges, Michel/0000-0003-4124-2375				Andersson-Eklund L, 1998, J ANIM SCI, V76, P694; CATCHPOLE IR, 1990, NUCLEIC ACIDS RES, V18, P6430, DOI 10.1093/nar/18.21.6430; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Dunger DB, 1998, NAT GENET, V19, P98, DOI 10.1038/ng0598-98; FEIL R, 1997, PP70 GENOMIC IMPRINT, P70; Florini JR, 1995, DIABETES REV, V3, P73; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Goureau A, 1996, GENOMICS, V36, P252, DOI 10.1006/geno.1996.0460; GROSSMAN PD, 1994, NUCLEIC ACIDS RES, V22, P4527, DOI 10.1093/nar/22.21.4527; HANSET R, 1995, GENET SEL EVOL, V27, P63, DOI 10.1051/gse:19950105; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; KNOLL A, 1997, ANIMAL GENET, V28, P308; Paquette J, 1998, J BIOL CHEM, V273, P14158, DOI 10.1074/jbc.273.23.14158; RETTENBERGER G, 1995, GENOMICS, V26, P372, DOI 10.1016/0888-7543(95)80222-8	14	315	356	1	29	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					155	156		10.1038/5935	http://dx.doi.org/10.1038/5935			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	163MH	9988262				2022-12-17	WOS:000078399500012
J	MARQUIS, ST; RAJAN, JV; WYNSHAWBORIS, A; XU, TJ; YIN, GY; ABEL, KJ; WEBER, BL; CHODOSH, LA				MARQUIS, ST; RAJAN, JV; WYNSHAWBORIS, A; XU, TJ; YIN, GY; ABEL, KJ; WEBER, BL; CHODOSH, LA			THE DEVELOPMENTAL PATTERN OF BRCA1 EXPRESSION IMPLIES A ROLE IN DIFFERENTIATION OF THE BREAST AND OTHER TISSUES	NATURE GENETICS			English	Article							CELLULAR TUMOR-ANTIGEN; FAMILIAL BREAST; GENE-EXPRESSION; OVARIAN-CANCER; P53; LACTOFERRIN	We have examined the developmental expression of the murine breast and ovarian cancer susceptibility gene, Brca1, to investigate its role in the control of cell growth and differentiation. Specifically, we have analysed Brca1 expression during embryonic development, in adult tissues, and during postnatal mammary gland development, particularly in response to ovarian hormones. Our results suggest that Brca1 is expressed in rapidly proliferating cell types undergoing differentiation. In the mammary gland, Brca1 expression is induced during puberty, pregnancy, and following treatment of ovariectomized animals with 17 beta-estradiol and progesterone. These observations imply that Brca1 is involved in the processes of proliferation and differentiation in multiple tissues, notably in the mammary gland in response to ovarian hormones.	UNIV PENN, SCH MED, DEPT MOLEC & CELLULAR ENGN, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, INST HUMAN GENE THERAPY, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT INTERNAL MED, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT GENET, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DIV ENDOCRINOL DIABET & METAB, PHILADELPHIA, PA 19104 USA; NIH, NATL CTR HUMAN GENOME RES, GENET DIS RES LAB, BETHESDA, MD 20892 USA; UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan					NCI NIH HHS [CA57601, 1P20CA66179] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P20CA066179, R01CA057601] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMON E, 1993, DEV BIOL, V156, P107, DOI 10.1006/dbio.1993.1062; BOICE JD, 1977, J NATL CANCER I, V59, P823, DOI 10.1093/jnci/59.3.823; BUHLER TA, 1993, DEV BIOL, V155, P87, DOI 10.1006/dbio.1993.1009; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; EASTON DF, 1993, AM J HUM GENET, V52, P678; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; HOBBS AA, 1982, J BIOL CHEM, V257, P3598; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; LANE DP, 1994, BRIT MED BULL, V50, P582, DOI 10.1093/oxfordjournals.bmb.a072911; MACMAHON B, 1970, B WORLD HEALTH ORGAN, V43, P209; MCGREGOR DH, 1977, J NATL CANCER I, V59, P799, DOI 10.1093/jnci/59.3.799; MCMASTER MT, 1992, MOL ENDOCRINOL, V6, P101, DOI 10.1210/me.6.1.101; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MERRITT AJ, 1994, CANCER RES, V54, P614; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MORRISON BW, 1994, ONCOGENE, V9, P3417; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; Russo J, 1993, Eur J Cancer Prev, V2 Suppl 3, P85; SCHMID P, 1991, DEVELOPMENT, V113, P857; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; WALMER DK, 1992, ENDOCRINOLOGY, V131, P1458, DOI 10.1210/en.131.3.1458; WILKINSON DG, 1992, INSITUHYBRIDIZATION	29	315	328	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1995	11	1					17	26		10.1038/ng0995-17	http://dx.doi.org/10.1038/ng0995-17			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550308				2022-12-17	WOS:A1995RR72800010
J	JOUTEL, A; BOUSSER, MG; BIOUSSE, V; LABAUGE, P; CHABRIAT, H; NIBBIO, A; MACIAZEK, J; MEYER, B; BACH, MA; WEISSENBACH, J; LATHROP, GM; TOURNIERLASSERVE, E				JOUTEL, A; BOUSSER, MG; BIOUSSE, V; LABAUGE, P; CHABRIAT, H; NIBBIO, A; MACIAZEK, J; MEYER, B; BACH, MA; WEISSENBACH, J; LATHROP, GM; TOURNIERLASSERVE, E			A GENE FOR FAMILIAL HEMIPLEGIC MIGRAINE MAPS TO CHROMOSOME-19	NATURE GENETICS			English	Article							LINKAGE; COMA	Familial hemiplegic migraine is an autosomal dominant disorder of unknown pathogenesis in which the migrainous attacks are marked by the occurrence of a transient hemiplegia during the aura, While investigating CADASIL, mapped previously to chromosome 19, we observed that some patients had recurrent attacks of migraine with aura. Although the clinical and neuroimaging features of familial hemiplegic migraine differ markedly from CADASIL, we hypothesized that the same gene could be involved in the pathogenesis of both conditions. We chose two large pedigrees for linkage analysis of familial hemiplegic migraine. A maximum lod score > 8 was found with two markers that are also strongly linked to CADASIL. Multilocus linkage analysis suggested that the loci responsible for the two diseases reside within an interval of about 30 cM on chromosome 19.	UNIV PARIS 05,PATHOL IMMUNITE LAB,156 RUE VAUGIRARD,F-75730 PARIS 15,FRANCE; HOP ST ANTOINE,SERV NEUROL,F-75571 PARIS 12,FRANCE; CHU MONTPELLIER,NEUROL CLIN,F-34059 MONTPELLIER,FRANCE; INST PASTEUR,UNITE GENET MOLEC HUMAINE,CNRS,URA 1445,F-75724 PARIS 15,FRANCE; CEPH,INSERM,U358,PARIS,FRANCE; GENETHON,F-91000 EURY,FRANCE	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)			Joutel, Anne/K-5601-2017; Chabriat, Hugues/G-5699-2010	Joutel, Anne/0000-0003-3963-3860; Chabriat, Hugues/0000-0001-8436-6074				BAUDRIMONT M, 1993, STROKE, V24, P122, DOI 10.1161/01.STR.24.1.122; BLAU JN, 1955, LANCET, V2, P1115; Clarke J M, 1910, Br Med J, V1, P1534; CODINA A, 1971, REV NEUROL, V124, P526; FITZSIMONS RB, 1985, BRAIN, V108, P555, DOI 10.1093/brain/108.3.555-a; GLISTA GG, 1975, MAYO CLIN PROC, V50, P307; HENRY P, 1990, Circulation et Metabolisme du Cerveau, V7, P229; LANCE JW, 1982, MECHANISM MANAGEMENT; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MUNTE TF, 1990, J NEUROL, V237, P59, DOI 10.1007/BF00319672; OHTA M, 1967, NEUROLOGY, V17, P813, DOI 10.1212/WNL.17.8.813; PAGES M, 1993, SEM HOP PARIS, V12, P337; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; TOURNIERLASSERVE E, 1991, STROKE, V22, P1297, DOI 10.1161/01.STR.22.10.1297; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITTY CWM, 1953, J NEUROL NEUROSUR PS, V16, P172, DOI 10.1136/jnnp.16.3.172; YOUNG GF, 1970, ARCH NEUROL-CHICAGO, V23, P201, DOI 10.1001/archneur.1970.00480270011002; ZIFKIN B, 1980, ANN NEUROL, V8, P329, DOI 10.1002/ana.410080319; 1988, CEPHALALGIA S7, V8, P19	20	315	325	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					40	45		10.1038/ng0993-40	http://dx.doi.org/10.1038/ng0993-40			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220421				2022-12-17	WOS:A1993LV56500013
J	Liu, DJ; Peloso, GM; Yu, H; Butterworth, AS; Wang, X; Mahajan, A; Saleheen, D; Emdin, C; Alam, D; Alves, AC; Amouyel, P; Di Angelantonio, E; Arveiler, D; Assimes, TL; Auer, PL; Baber, U; Ballantyne, CM; Bang, LE; Benn, M; Bis, JC; Boehnke, M; Boerwinkle, E; Bork-Jensen, J; Bottinger, EP; Brandslund, I; Brown, M; Busonero, F; Caulfield, MJ; Chambers, JC; Chasman, DI; Chen, YE; Chen, YDI; Chowdhury, R; Christensen, C; Chu, AY; Connell, JM; Cucca, F; Cupples, LA; Damrauer, SM; Davies, G; Deary, IJ; Dedoussis, G; Denny, JC; Dominiczak, A; Dube, MP; Ebeling, T; Eiriksdottir, G; Esko, T; Farmaki, AE; Feitosa, MF; Ferrario, M; Ferrieres, J; Ford, I; Fornage, M; Franks, PW; Frayling, TM; Frikke-Schmidt, R; Fritsche, LG; Frossard, P; Fuster, V; Ganesh, SK; Gao, W; Garcia, ME; Gieger, C; Giulianini, F; Goodarzi, MO; Grallert, H; Grarup, N; Groop, L; Grove, ML; Gudnason, V; Hansen, T; Harris, TB; Hayward, C; Hirschhorn, JN; Holmen, OL; Huffman, J; Huo, Y; Hveem, K; Jabeen, S; Jackson, AU; Jakobsdottir, J; Jarvelin, MR; Jensen, GB; Jorgensen, ME; Jukema, JW; Justesen, JM; Kamstrup, PR; Kanoni, S; Karpe, F; Kee, F; Khera, AV; Klarin, D; Koistinen, HA; Kooner, JS; Kooperberg, C; Kuulasmaa, K; Kuusisto, J; Laakso, M; Lakka, T; Langenberg, C; Langsted, A; Launer, LJ; Lauritzen, T; Liewald, DCM; Lin, LA; Linneberg, A; Loos, RJF; Lu, YC; Lu, XF; Magi, R; Malarstig, A; Manichaikul, A; Manning, AK; Mantyselka, P; Marouli, E; Masca, NGD; Maschio, A; Meigs, JB; Melander, O; Metspalu, A; Morris, AP; Morrison, AC; Mulas, A; Muller-Nurasyid, M; Munroe, PB; Neville, MJ; Nielsen, JB; Nielsen, SF; Nordestgaard, BG; Ordovas, JM; Mehran, R; O'Donnell, CJ; Orho-Melander, M; Molony, CM; Muntendam, P; Padmanabhan, S; Palmer, CNA; Pasko, D; Patel, AP; Pedersen, O; Perola, M; Peters, A; Pisinger, C; Pistis, G; Polasek, O; Poulter, N; Psaty, BM; Rader, DJ; Rasheed, A; Rauramaa, R; Reilly, DF; Reiner, AP; Renstrom, F; Rich, SS; Ridker, PM; Rioux, JD; Robertson, NR; Roden, DM; Rotter, JI; Rudan, I; Salomaa, V; Samani, NJ; Sanna, S; Sattar, N; Schmidt, EM; Scott, RA; Sever, P; Sevilla, RS; Shaffer, CM; Sim, XL; Sivapalaratnam, S; Small, KS; Smith, AV; Smith, BH; Somayajula, S; Southam, L; Spector, TD; Speliotes, EK; Starr, JM; Stirrups, KE; Stitziel, N; Strauch, K; Stringham, HM; Surendran, P; Tada, H; Tall, AR; Tang, H; Tardif, JC; Taylor, KD; Trompet, S; Tsao, PS; Tuomilehto, J; Tybjaerg-Hansen, A; van Zuydam, NR; Varbo, A; Varga, TV; Virtamo, J; Waldenberger, M; Wang, N; Wareham, NJ; Warren, HR; Weeke, PE; Weinstock, J; Wessel, J; Wilson, JG; Wilson, PWF; Xu, M; Yaghootkar, H; Young, R; Zeggini, E; Zhang, H; Zheng, NS; Zhang, WH; Zhang, Y; Zhou, W; Zhou, Y; Zoledziewska, M; Howson, JMM; Danesh, J; McCarthy, MI; Cowan, CA; Abecasis, G; Deloukas, P; Musunuru, K; Willer, CJ; Kathiresan, S				Liu, Dajiang J.; Peloso, Gina M.; Yu, Haojie; Butterworth, Adam S.; Wang, Xiao; Mahajan, Anubha; Saleheen, Danish; Emdin, Connor; Alam, Dewan; Alves, Alexessander Couto; Amouyel, Philippe; Di Angelantonio, Emanuele; Arveiler, Dominique; Assimes, Themistocles L.; Auer, Paul L.; Baber, Usman; Ballantyne, Christie M.; Bang, Lia E.; Benn, Marianne; Bis, Joshua C.; Boehnke, Michael; Boerwinkle, Eric; Bork-Jensen, Jette; Bottinger, Erwin P.; Brandslund, Ivan; Brown, Morris; Busonero, Fabio; Caulfield, Mark J.; Chambers, John C.; Chasman, Daniel I.; Chen, Y. Eugene; Chen, Yii-Der Ida; Chowdhury, Rajiv; Christensen, Cramer; Chu, Audrey Y.; Connell, John M.; Cucca, Francesco; Cupples, L. Adrienne; Damrauer, Scott M.; Davies, Gail; Deary, Ian J.; Dedoussis, George; Denny, Joshua C.; Dominiczak, Anna; Dube, Marie-Pierre; Ebeling, Tapani; Eiriksdottir, Gudny; Esko, Tonu; Farmaki, Aliki-Eleni; Feitosa, Mary F.; Ferrario, Marco; Ferrieres, Jean; Ford, Ian; Fornage, Myriam; Franks, Paul W.; Frayling, Timothy M.; Frikke-Schmidt, Ruth; Fritsche, Lars G.; Frossard, Philippe; Fuster, Valentin; Ganesh, Santhi K.; Gao, Wei; Garcia, Melissa E.; Gieger, Christian; Giulianini, Franco; Goodarzi, Mark O.; Grallert, Harald; Grarup, Niels; Groop, Leif; Grove, Megan L.; Gudnason, Vilmundur; Hansen, Torben; Harris, Tamara B.; Hayward, Caroline; Hirschhorn, Joel N.; Holmen, Oddgeir L.; Huffman, Jennifer; Huo, Yong; Hveem, Kristian; Jabeen, Sehrish; Jackson, Anne U.; Jakobsdottir, Johanna; Jarvelin, Marjo-Riitta; Jensen, Gorm B.; Jorgensen, Marit E.; Jukema, J. Wouter; Justesen, Johanne M.; Kamstrup, Pia R.; Kanoni, Stavroula; Karpe, Fredrik; Kee, Frank; Khera, Amit V.; Klarin, Derek; Koistinen, Heikki A.; Kooner, Jaspal S.; Kooperberg, Charles; Kuulasmaa, Kari; Kuusisto, Johanna; Laakso, Markku; Lakka, Timo; Langenberg, Claudia; Langsted, Anne; Launer, Lenore J.; Lauritzen, Torsten; Liewald, David C. M.; Lin, Li An; Linneberg, Allan; Loos, Ruth J. F.; Lu, Yingchang; Lu, Xiangfeng; Magi, Reedik; Malarstig, Anders; Manichaikul, Ani; Manning, Alisa K.; Mantyselka, Pekka; Marouli, Eirini; Masca, Nicholas G. D.; Maschio, Andrea; Meigs, James B.; Melander, Olle; Metspalu, Andres; Morris, Andrew P.; Morrison, Alanna C.; Mulas, Antonella; Mueller-Nurasyid, Martina; Munroe, Patricia B.; Neville, Matt J.; Nielsen, Jonas B.; Nielsen, Sune F.; Nordestgaard, Borge G.; Ordovas, Jose M.; Mehran, Roxana; O'Donnell, Christoper J.; Orho-Melander, Marju; Molony, Cliona M.; Muntendam, Pieter; Padmanabhan, Sandosh; Palmer, Colin N. A.; Pasko, Dorota; Patel, Aniruddh P.; Pedersen, Oluf; Perola, Markus; Peters, Annette; Pisinger, Charlotta; Pistis, Giorgio; Polasek, Ozren; Poulter, Neil; Psaty, Bruce M.; Rader, Daniel J.; Rasheed, Asif; Rauramaa, Rainer; Reilly, Dermot F.; Reiner, Alex P.; Renstrom, Frida; Rich, Stephen S.; Ridker, Paul M.; Rioux, John D.; Robertson, Neil R.; Roden, Dan M.; Rotter, Jerome I.; Rudan, Igor; Salomaa, Veikko; Samani, Nilesh J.; Sanna, Serena; Sattar, Naveed; Schmidt, Ellen M.; Scott, Robert A.; Sever, Peter; Sevilla, Raquel S.; Shaffer, Christian M.; Sim, Xueling; Sivapalaratnam, Suthesh; Small, Kerrin S.; Smith, Albert V.; Smith, Blair H.; Somayajula, Sangeetha; Southam, Lorraine; Spector, Timothy D.; Speliotes, Elizabeth K.; Starr, John M.; Stirrups, Kathleen E.; Stitziel, Nathan; Strauch, Konstantin; Stringham, Heather M.; Surendran, Praveen; Tada, Hayato; Tall, Alan R.; Tang, Hua; Tardif, Jean-Claude; Taylor, Kent D.; Trompet, Stella; Tsao, Philip S.; Tuomilehto, Jaakko; Tybjaerg-Hansen, Anne; van Zuydam, Natalie R.; Varbo, Anette; Varga, Tibor V.; Virtamo, Jarmo; Waldenberger, Melanie; Wang, Nan; Wareham, Nick J.; Warren, Helen R.; Weeke, Peter E.; Weinstock, Joshua; Wessel, Jennifer; Wilson, James G.; Wilson, Peter W. F.; Xu, Ming; Yaghootkar, Hanieh; Young, Robin; Zeggini, Eleftheria; Zhang, He; Zheng, Neil S.; Zhang, Weihua; Zhang, Yan; Zhou, Wei; Zhou, Yanhua; Zoledziewska, Magdalena; Howson, Joanna M. M.; Danesh, John; McCarthy, Mark I.; Cowan, Chad A.; Abecasis, Goncalo; Deloukas, Panos; Musunuru, Kiran; Willer, Cristen J.; Kathiresan, Sekar		Charge Diabet Working Grp; EPIC-InterAct Consortium; EPIC-CVD Consortium; GOLD Consortium; VA Million Veteran Program	Exome-wide association study of plasma lipids in > 300,000 individuals	NATURE GENETICS			English	Letter							APOBEC-1 COMPLEMENTATION FACTOR; CODING-SEQUENCE VARIANTS; TYROSINE KINASE JAK2; B MESSENGER-RNA; MACULAR DEGENERATION; GENETIC ARCHITECTURE; LOW-FREQUENCY; MYELOPROLIFERATIVE DISORDERS; CARDIOVASCULAR-DISEASE; CLONAL HEMATOPOIESIS	We screened variants on an exome-focused genotyping array in >300,000 participants (replication in >280,000 participants) and identified 444 independent variants in 250 loci significantly associated with total cholesterol (TC), high-density-lipoprotein cholesterol (HDL-C), low-densitylipoprotein cholesterol (LDL-C), and/or triglycerides (TG). At two loci (JAK2 and A1CF), experimental analysis in mice showed lipid changes consistent with the human data. We also found that: (i) beta-thalassemia trait carriers displayed lower TC and were protected from coronary artery disease (CAD); (ii) excluding the CETP locus, there was not a predictable relationship between plasma HDL-C and risk for age-related macular degeneration; (iii) only some mechanisms of lowering LDL-C appeared to increase risk for type 2 diabetes (T2D); and (iv) TG-lowering alleles involved in hepatic production of TG-rich lipoproteins (TM6SF2 and PNPLA3) tracked with higher liver fat, higher risk for T2D, and lower risk for CAD, whereas TG-lowering alleles involved in peripheral lipolysis (LPL and ANGPTL4) had no effect on liver fat but decreased risks for both T2D and CAD.	[Liu, Dajiang J.] Penn State Coll Med, Inst Personalized Med, Dept Publ Hlth Sci, Hershey, PA USA; [Peloso, Gina M.; Cupples, L. Adrienne; Zhou, Yanhua] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Peloso, Gina M.; Emdin, Connor; Esko, Tonu; Hirschhorn, Joel N.; Khera, Amit V.; Klarin, Derek; Manning, Alisa K.; Meigs, James B.; Patel, Aniruddh P.; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Yu, Haojie; Cowan, Chad A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, MRC BHF Cardiovasc Epidemiol Unit, Cambridge, England; [Butterworth, Adam S.; Di Angelantonio, Emanuele; Danesh, John] Univ Cambridge, Natl Inst Hlth Res Blood & Transplant Res Unit NI, Donor Hlth & Genom, Cambridge, England; [Wang, Xiao; Musunuru, Kiran] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Mahajan, Anubha; Morris, Andrew P.; Robertson, Neil R.; Southam, Lorraine; van Zuydam, Natalie R.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Saleheen, Danish] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Saleheen, Danish; Frossard, Philippe; Jabeen, Sehrish; Rasheed, Asif] Ctr Noncommunicable Dis, Karachi, Pakistan; [Emdin, Connor; Khera, Amit V.; Klarin, Derek; Manning, Alisa K.; Patel, Aniruddh P.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Alam, Dewan] ICDDR B, Dhaka, Bangladesh; [Alves, Alexessander Couto; Jarvelin, Marjo-Riitta] Imperial Coll London, London, England; [Amouyel, Philippe] Univ Lille, INSERM, CHU Lille, Inst Pasteur Lille,Risk Factors & Mol Determinant, Lille, France; [Arveiler, Dominique] Univ Strasbourg, Dept Epidemiol & Publ Hlth, EA 3430, Strasbourg, France; [Assimes, Themistocles L.; Tsao, Philip S.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Assimes, Themistocles L.; Tsao, Philip S.] Stanford Univ, Sch Med, Dept Med, Stanford, CA USA; [Auer, Paul L.] Univ Wisconsin Milwaukee, Zilber Sch Publ Hlth, Milwaukee, WI USA; [Baber, Usman; Fuster, Valentin; Mehran, Roxana] Mt Sinai Med Ctr, Icahn Sch Med Mt Sinai, Cardiovasc Inst, New York, NY 10029 USA; [Ballantyne, Christie M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Bang, Lia E.] Copenhagen Univ Hosp, Dept Cardiol, Rigshosp, Copenhagen, Denmark; [Benn, Marianne; Frikke-Schmidt, Ruth; Tybjaerg-Hansen, Anne] Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Benn, Marianne; Frikke-Schmidt, Ruth; Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Boehnke, Michael; Fritsche, Lars G.; Jackson, Anne U.; Sim, Xueling; Stringham, Heather M.; Weinstock, Joshua; Abecasis, Goncalo] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Boerwinkle, Eric; Grove, Megan L.; Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Bork-Jensen, Jette; Grarup, Niels; Hansen, Torben; Justesen, Johanne M.; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Bottinger, Erwin P.; Loos, Ruth J. F.; Lu, Yingchang] Ichan Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY USA; [Brandslund, Ivan] Lillebaelt Hosp, Dept Clin Biochem, Vejle, Denmark; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Brown, Morris; Caulfield, Mark J.; Munroe, Patricia B.; Warren, Helen R.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol, London, England; [Pistis, Giorgio; Sanna, Serena; Zoledziewska, Magdalena] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Caulfield, Mark J.] Queen Mary Univ London, William Harvey Res Inst, Barts Heart Ctr, London, England; [Caulfield, Mark J.; Munroe, Patricia B.; Warren, Helen R.] Queen Mary Univ London, NIHR Barts Cardiovasc Biomed Res Unit, London, England; [Chambers, John C.; Zhang, Weihua] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Chambers, John C.; Kooner, Jaspal S.] Ealing Hosp NHS Trust, Dept Cardiol, Southall, Middx, England; [Chambers, John C.; Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, London, England; [Chasman, Daniel I.; Chu, Audrey Y.; Giulianini, Franco; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Chasman, Daniel I.] Harvard Med Sch, Dept Med, Boston, MA USA; [Chen, Y. Eugene; Ganesh, Santhi K.; Lu, Xiangfeng; Nielsen, Jonas B.; Zhang, He; Willer, Cristen J.] Univ Michigan, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Chen, Yii-Der Ida; Rotter, Jerome I.; Taylor, Kent D.] LABioMed Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Dept Pediat, Los Angeles, CA USA; [Chen, Yii-Der Ida; Rotter, Jerome I.; Taylor, Kent D.] LABioMed Harbor UCLA Med Ctr, Inst Translat Genom & Populat Sci, Dept Med, Los Angeles, CA USA; [Christensen, Cramer] Lillebaelt Hosp, Med Dept, Vejle, Denmark; [Chu, Audrey Y.; Cupples, L. Adrienne] NHLBI Framingham Heart Study, Framingham, MA USA; [Connell, John M.; Palmer, Colin N. A.; van Zuydam, Natalie R.] Univ Dundee, Med Res Inst, Ninewells Hosp & Med Sch, Dundee, Scotland; [Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy; [Damrauer, Scott M.] Corporal Michael Crescenz VA Med Ctr, Philadelphia, PA USA; [Damrauer, Scott M.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Davies, Gail; Deary, Ian J.; Liewald, David C. M.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Davies, Gail; Deary, Ian J.; Liewald, David C. M.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Dedoussis, George; Farmaki, Aliki-Eleni] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens, Greece; [Denny, Joshua C.; Roden, Dan M.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Denny, Joshua C.; Roden, Dan M.; Shaffer, Christian M.; Weeke, Peter E.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Dominiczak, Anna; Padmanabhan, Sandosh; Sattar, Naveed] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Dube, Marie-Pierre; Rioux, John D.; Tardif, Jean-Claude] Montreal Heart Inst, Montreal, PQ, Canada; [Dube, Marie-Pierre] Univ Montreal, Beaulieu Saucier Pharmacogen Ctr, Montreal, PQ, Canada; [Dube, Marie-Pierre; Tardif, Jean-Claude] Univ Montreal, Montreal, PQ, Canada; [Ebeling, Tapani] Oulu Univ Hosp, Dept Med, Oulu, Finland; [Ebeling, Tapani] Univ Oulu, Oulu, Finland; [Eiriksdottir, Gudny; Gudnason, Vilmundur; Jakobsdottir, Johanna; Smith, Albert V.] Iceland Heart Assoc, Kopavogur, Iceland; [Esko, Tonu; Magi, Reedik; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Feitosa, Mary F.] Washington Univ, Sch Med, Dept Genet, Div Stat Gen, St Louis, MO 63110 USA; [Ferrario, Marco] Univ Insubria, Dept Med & Surg, Res Ctr Epidemiol & Prevent Med EPIMED, Varese, Italy; [Ferrieres, Jean] CHU Toulouse, Dept Epidemiol, INSERM, UMR 1027,Toulouse Univ, Toulouse, France; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Fornage, Myriam; Lin, Li An] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Franks, Paul W.; Renstrom, Frida; Varga, Tibor V.] Lund Univ, Genet & Mol Epidemiol Unit, Dept Clin Sci, Malmo, Sweden; [Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Franks, Paul W.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Frayling, Timothy M.; Pasko, Dorota; Yaghootkar, Hanieh] Univ Exeter, Genet Complex Traits, Univ Exeter Med Sch, Exeter, Devon, England; [Fuster, Valentin] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Ganesh, Santhi K.; Willer, Cristen J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Gao, Wei] Peking Univ, Hosp 3, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Minist Hlth,Dept Cardiol, Beijing, Peoples R China; [Garcia, Melissa E.] NHLBI, Bldg 10, Bethesda, MD 20892 USA; [Gieger, Christian; Grallert, Harald; Peters, Annette] German Ctr Diabet Res DZD & V, Neuherberg, Germany; [Gieger, Christian; Grallert, Harald; Waldenberger, Melanie] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Gieger, Christian; Grallert, Harald; Mueller-Nurasyid, Martina; Peters, Annette; Waldenberger, Melanie] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Groop, Leif] Lund Univ, Clin Res Ctr, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Gudnason, Vilmundur; Smith, Albert V.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Harris, Tamara B.; Launer, Lenore J.] Natl Inst Aging, Lab Epidemiol & Populat Sci, Bethesda, MD USA; [Hayward, Caroline; Huffman, Jennifer] Univ Edinburgh, Inst Genet & Mol Med, Med Res Council Human Genet Unit, Edinburgh, Midlothian, Scotland; [Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Holmen, Oddgeir L.] Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, Levanger, Norway; [Holmen, Oddgeir L.] Univ Trondheim Hosp, St Olavs Hosp, Trondheim, Norway; [Huo, Yong; Zhang, Yan] Peking Univ, Hosp 1, Dept Cardiol, Beijing, Peoples R China; [Hveem, Kristian] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway; [Jakobsdottir, Johanna] Univ Iceland, Dept Hlth Sci, Reykjavik, Iceland; [Jensen, Gorm B.] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Jorgensen, Marit E.] Steno Diabet Ctr, Gentofte, Denmark; [Jorgensen, Marit E.] Southern Denmark Univ, Natl Inst Publ Hlth, Copenhagen, Denmark; [Jukema, J. Wouter; Trompet, Stella] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Kamstrup, Pia R.; Langsted, Anne; Nielsen, Sune F.; Nordestgaard, Borge G.; Varbo, Anette] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Kamstrup, Pia R.; Langsted, Anne; Nielsen, Sune F.; Nordestgaard, Borge G.; Varbo, Anette] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Kanoni, Stavroula; Marouli, Eirini; Stirrups, Kathleen E.; Deloukas, Panos] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Karpe, Fredrik; Neville, Matt J.; Robertson, Neil R.; Sattar, Naveed; McCarthy, Mark I.] Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Karpe, Fredrik; McCarthy, Mark I.] Oxford Univ Hosp, Oxford NIHR Biomed Res Ctr, Oxford, England; [Kee, Frank] Queens Univ, UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland; [Klarin, Derek; O'Donnell, Christoper J.] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr MA, Boston, MA USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Hlth, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Dept Med, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Abdominal Ctr Endocrinol, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Koistinen, Heikki A.] Minerva Fdn, Helsinki, Finland; [Kooner, Jaspal S.] Imperial Coll London, Hammersmith Hosp, Natl Heart & Lung Inst, London, England; [Kooperberg, Charles; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Inst Clin Med Internal Med, Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Kuopio, Finland; [Lakka, Timo] Univ Eastern Finland, Inst Biomed, Dept Physiol, Kuopio Campus, Kuopio, Finland; [Lakka, Timo; Rauramaa, Rainer] Kuopio Res Inst Exercise Med, Kuopio, Finland; [Lakka, Timo; Rauramaa, Rainer] Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, Kuopio, Finland; [Langenberg, Claudia; Scott, Robert A.; Wareham, Nick J.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Langsted, Anne; Nielsen, Sune F.; Nordestgaard, Borge G.; Varbo, Anette] Univ Denmark, Fac Hlth & Med Sci, Copenhagen, Denmark; [Lauritzen, Torsten] Univ Aarhus, Sect Gen Practice, Dept Publ Hlth, Aarhus, Denmark; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Linneberg, Allan; Pisinger, Charlotta] Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Loos, Ruth J. F.] Ichan Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY USA; [Lu, Xiangfeng] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing, Peoples R China; [Lu, Xiangfeng] Peking Union Med Coll, Beijing, Peoples R China; [Malarstig, Anders] Karolinska Inst, Dept Med, Cardiovasc Med Unit, Cardiovasc Genet & Genom Grp, Stockholm, Sweden; [Malarstig, Anders] Pfizer Worldwide R&D, Pharmatherapeut Clin Res, Sollentuna, Sweden; [Manichaikul, Ani; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA USA; [Manning, Alisa K.; Meigs, James B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Mantyselka, Pekka] Univ Eastern Finland, Unit Primary Hlth Care, Kuopio, Finland; [Mantyselka, Pekka] Kuopio Univ Hosp, Kuopio, Finland; [Masca, Nicholas G. D.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Masca, Nicholas G. D.; Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England; [Meigs, James B.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Melander, Olle; Orho-Melander, Marju] Lund Univ, Clin Res Ctr, Univ Hosp Malmo, Dept Clin Sci, Malmo, Sweden; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Mueller-Nurasyid, Martina] Ludwig Maximilians Univ Munchen, Dept Med 1, Munich, Germany; [Mueller-Nurasyid, Martina; Peters, Annette; Waldenberger, Melanie] Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany; [Ordovas, Jose M.] Natl Ctr Cardiovasc Invest, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Ordovas, Jose M.] IMDEA Alimentac, Madrid, Spain; [Ordovas, Jose M.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr, Nutr & Genom Lab, Boston, MA 02111 USA; [O'Donnell, Christoper J.; Patel, Aniruddh P.; Kathiresan, Sekar] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Molony, Cliona M.; Reilly, Dermot F.] Merck Sharp & Dohme Corp, Genet, Kenilworth, NJ USA; [Muntendam, Pieter] G3 Pharmaceut, Lexington, MA USA; [Patel, Aniruddh P.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Perola, Markus] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland; [Polasek, Ozren] Univ Split, Fac Med, Split, Croatia; [Polasek, Ozren; Rudan, Igor] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Poulter, Neil; Sever, Peter] Imperial Coll London, Internat Ctr Circulatory Hlth, London, England; [Psaty, Bruce M.] Kaiser Permanente, Washington Hlth Res Inst, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Rader, Daniel J.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA USA; [Rader, Daniel J.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Renstrom, Frida] Umea Univ, Dept Biobank Res, Umea, Sweden; [Schmidt, Ellen M.; Speliotes, Elizabeth K.; Zhou, Wei; Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Sevilla, Raquel S.] Merck Sharp & Dohme Corp, Imaging, Kenilworth, NJ USA; [Sim, Xueling] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Sivapalaratnam, Suthesh] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Small, Kerrin S.; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Smith, Blair H.] Univ Dundee, Ninewells Hosp & Med Sch, Div Populat Hlth Sci, Dundee, Scotland; [Smith, Blair H.] Univ Edinburgh, Ctr Genom & Expt Med, Generat Scotland, Edinburgh, Midlothian, Scotland; [Somayajula, Sangeetha] Merck Sharp & Dohme Corp, Sci Informat, Kenilworth, NJ USA; [Southam, Lorraine; Zeggini, Eleftheria; Danesh, John] Wellcome Trust Sanger Inst, Genome Campus, Hinxton, England; [Speliotes, Elizabeth K.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Stirrups, Kathleen E.] Univ Cambridge, Dept Haematol, Cambridge, England; [Stitziel, Nathan] Washington Univ, Sch Med, Div Cardiovasc, Dept Med, St Louis, MO 63110 USA; [Stitziel, Nathan] Washington Univ, Sch Med, Div Cardiovasc, Dept Genet, St Louis, MO 63110 USA; [Stitziel, Nathan] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO USA; [Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Fac Med, IBE, Munich, Germany; [Strauch, Konstantin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Genet Epidemiol, Neuherberg, Germany; [Tada, Hayato] Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa, Japan; [Tall, Alan R.; Wang, Nan] Columbia Univ, Div Mol Med, Dept Med, New York, NY USA; [Tang, Hua] Stanford Univ, Sch Med, Dept Genet, Stanford, CA USA; [Trompet, Stella] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland; [Tuomilehto, Jaakko] Dasman Diabet Inst, Dasman, Kuwait; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Fahd Med Res Ctr, Saudi Diabet Res Grp, Jeddah, Saudi Arabia; [Weeke, Peter E.] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Heart Ctr, Copenhagen, Denmark; [Wessel, Jennifer] Indiana Univ, Dept Epidemiol, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Wessel, Jennifer] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Wilson, Peter W. F.] Atlanta VA Med Ctr, Decatur, GA USA; [Wilson, Peter W. F.] Emory Clin, Cardiovasc Res Inst, Atlanta, GA 30322 USA; [Xu, Ming] Peking Univ, Hosp 3, Inst Vasc Med, Dept Cardiol,Key Lab Mol Cardiovasc Sci,Minist Ed, Beijing, Peoples R China; [Zheng, Neil S.] Yale Univ, Yale Coll, New Haven, CT USA; [Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Deloukas, Panos] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Cambridge; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine; University of Oxford; Wellcome Centre for Human Genetics; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital; International Centre for Diarrhoeal Disease Research (ICDDR); Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of Wisconsin System; University of Wisconsin Milwaukee; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; Novo Nordisk Foundation; University of Copenhagen; Icahn School of Medicine at Mount Sinai; University of Southern Denmark; University of London; Queen Mary University London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of London; Queen Mary University London; University of London; Queen Mary University London; Imperial College London; Imperial College London; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Dundee; University of Sassari; University of Pennsylvania; Pennsylvania Medicine; University of Edinburgh; University of Edinburgh; Harokopio University Athens; Vanderbilt University; Vanderbilt University; University of Glasgow; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Oulu; University of Oulu; Icelandic Heart Association; University of Tartu; Washington University (WUSTL); University of Insubria; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); University of Glasgow; University of Texas System; University of Texas Health Science Center Houston; Lund University; Umea University; Harvard University; Harvard T.H. Chan School of Public Health; University of Exeter; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Michigan System; University of Michigan; Peking University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Lund University; University of Iceland; University of Southern Denmark; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Edinburgh; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Peking University; Norwegian University of Science & Technology (NTNU); University of Iceland; Steno Diabetes Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Copenhagen; University of Copenhagen; University of London; Queen Mary University London; University of Oxford; University of Oxford; Queens University Belfast; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Imperial College London; Fred Hutchinson Cancer Center; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Cambridge; Aarhus University; Rigshospitalet; University of Copenhagen; Icahn School of Medicine at Mount Sinai; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Karolinska Institutet; Pfizer; University of Virginia; Harvard University; Massachusetts General Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Harvard University; Massachusetts General Hospital; Lund University; Skane University Hospital; University of Liverpool; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Tufts University; United States Department of Agriculture (USDA); Harvard University; Harvard Medical School; Merck & Company; Harvard University; Massachusetts General Hospital; University of Helsinki; University of Split; University of Edinburgh; Imperial College London; Kaiser Permanente; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle; Umea University; University of Michigan System; University of Michigan; Merck & Company; National University of Singapore; University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London; University of Dundee; University of Edinburgh; Merck & Company; Wellcome Trust Sanger Institute; University of Michigan System; University of Michigan; University of Edinburgh; University of Cambridge; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Kanazawa University; Columbia University; Stanford University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Finland National Institute for Health & Welfare; Danube University Krems; King Abdulaziz University; Rigshospitalet; University of Copenhagen; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Mississippi; University of Mississippi Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; Peking University; Yale University; Harvard University; Massachusetts General Hospital; King Abdulaziz University	Kathiresan, S (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA.; Willer, CJ (corresponding author), Univ Michigan, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI 48109 USA.; Willer, CJ (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.; Kathiresan, S (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA.; Willer, CJ (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.		Dominiczak, Anna F/P-9390-2017; Polasek, Ozren/B-6002-2011; Tall, Alan/AAT-8528-2021; Stitziel, Nathan/AAL-8413-2021; Mulas, Antonella/B-4231-2015; Justesen, Johanne Marie/AAY-4210-2021; DiAngelantonio, Emanuele/ABE-6852-2020; Study, GoDARTS/K-9448-2016; Ballantyne, Christie/A-6599-2008; Loos, Ruth/GON-5877-2022; Smith, Albert Vernon/AHC-3838-2022; Maschio, Andrea/AAX-8185-2020; Kanoni, Stavroula/AAN-7161-2021; Hveem, Kristian/AFV-4683-2022; Loos, Ruth J F/Q-2862-2016; Ferrario, Marco M./ABH-2115-2021; Grarup, Niels/K-2807-2015; Manning, Alisa Knodle/ABC-7711-2021; Varga, Tibor/AAE-8035-2020; Mägi, Reedik/AAJ-9679-2021; Palmer, Colin NA/C-7053-2008; Meigs, James/P-3927-2019; Deary, Ian J/C-6297-2009; Waldenberger, Melanie/B-5355-2014; zhang, weihua/GXV-1334-2022; Sim, Xueling/AAZ-6652-2020; Rudan, Igor/I-1467-2012; Müller-Nurasyid, Martina/I-8735-2018; Rotter, Jerome/AAY-6598-2021; Chowdhury, Rajiv/AHB-1253-2022; Jabeen, Sehrish/AAH-4233-2019; Pedersen, Oluf/AAG-8015-2020; Langenberg, Claudia/ABG-9067-2021; Peters, Annette/A-6117-2011; Smith, Blair H/G-2834-2012; Ford, Ian/ABE-6145-2020; Mehran, Roxana/ABF-4160-2021; Justesen, Johanne Marie/L-6023-2015; Gudnason, Vilmundur/AAE-7126-2019; Jukema, J. Wouter/ABD-6503-2021; Fuster, Valentin/H-4319-2015; Nordestgaard, Borge Gronne/ABF-1310-2020; Dina, Christian R/D-3535-2015; Grallert, Harald/B-3424-2013; Benn, Marianne/O-4164-2019; Rioux, John D/A-9599-2015; Fritsche, Lars G/AAF-9387-2019; Auer, Paul/AAC-5060-2019; Assimes, Themistocles Leonard/D-9696-2015; Dedoussis, George/AAN-7252-2021; Roden, Dan/ABD-5412-2021; Franks, Paul/AAA-3300-2020; Feitosa, Mary F/K-8044-2012; Pedersen, Oluf/Z-1731-2019; Goodarzi, Mark/AAH-7106-2021; sanna, serena/H-3009-2019; Denny, Josh/AAL-3359-2021; Dube, Marie-Pierre/B-9364-2008; Koistinen, Heikki/J-7313-2016; McCarthy, Mark/M-3763-2015	Dominiczak, Anna F/0000-0003-4913-3608; Polasek, Ozren/0000-0002-5765-1862; Stitziel, Nathan/0000-0002-4963-8211; Justesen, Johanne Marie/0000-0002-0484-8522; Smith, Albert Vernon/0000-0003-1942-5845; Kanoni, Stavroula/0000-0002-1691-9615; Loos, Ruth J F/0000-0002-8532-5087; Grarup, Niels/0000-0001-5526-1070; Palmer, Colin NA/0000-0002-6415-6560; Meigs, James/0000-0002-2439-2657; Deary, Ian J/0000-0002-1733-263X; Waldenberger, Melanie/0000-0003-0583-5093; Sim, Xueling/0000-0002-1233-7642; Rudan, Igor/0000-0001-6993-6884; Müller-Nurasyid, Martina/0000-0003-3793-5910; Langenberg, Claudia/0000-0002-5017-7344; Peters, Annette/0000-0001-6645-0985; Smith, Blair H/0000-0002-5362-9430; Justesen, Johanne Marie/0000-0002-0484-8522; Gudnason, Vilmundur/0000-0001-5696-0084; Jukema, J. Wouter/0000-0002-3246-8359; Fuster, Valentin/0000-0002-9043-9986; Dina, Christian R/0000-0002-7722-7348; Benn, Marianne/0000-0002-1701-595X; Rioux, John D/0000-0001-7560-8326; Fritsche, Lars G/0000-0002-2110-1690; Assimes, Themistocles Leonard/0000-0003-2349-0009; Dedoussis, George/0000-0002-7798-6221; Feitosa, Mary F/0000-0002-0933-2410; Pedersen, Oluf/0000-0002-3321-3972; Goodarzi, Mark/0000-0001-6364-5103; sanna, serena/0000-0002-3768-1749; Denny, Josh/0000-0002-3049-7332; V. Varga, Tibor/0000-0002-2383-699X; Malarstig, Anders/0000-0003-2608-1358; Howson, Joanna/0000-0001-7618-0050; Cupples, L. Adrienne/0000-0003-0273-7965; Morrison, Alanna/0000-0001-6381-4296; Couto Alves, Alex/0000-0001-8519-7356; Zoledziewska, Magdalena/0000-0002-3033-6133; Hansen, Torben/0000-0001-8748-3831; Schmidt, Ellen/0000-0003-1198-7536; Liu, Dajiang/0000-0001-6553-858X; CUCCA, Francesco/0000-0002-7414-1995; Brandslund, Ivan/0000-0002-4203-5442; Franks, Paul/0000-0002-0520-7604; Patel, Aniruddh/0000-0001-7871-9638; Klarin, Derek/0000-0002-4636-5780; Morris, Andrew/0000-0002-6805-6014; Kuulasmaa, Kari/0000-0003-2165-1411; Ballantyne, Christie/0000-0002-6432-1730; Dube, Marie-Pierre/0000-0001-8442-4393; maschio, andrea/0000-0002-4238-9144; Di Angelantonio, Emanuele/0000-0001-8776-6719; Melander, Olle/0000-0002-2581-484X; Padmanabhan, Sandosh/0000-0003-3869-5808; Rich, Stephen/0000-0003-3872-7793; Mahajan, Anubha/0000-0001-5585-3420; , Hanieh/0000-0001-9672-9477; Yu, Haojie/0000-0002-0559-0252; Mulas, Antonella/0000-0002-6856-1483; Ferrario, Marco M/0000-0003-2741-7124; Nordestgaard, Borge/0000-0002-1954-7220; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Nielsen, Jonas Bille/0000-0002-6654-2852; Koistinen, Heikki/0000-0001-7870-070X; Ebeling, Tapani/0000-0003-0323-8893; xu, ming/0000-0002-3920-8947; Small, Kerrin/0000-0003-4566-0005; Zhang, He/0000-0001-9198-6503; Caulfield, Mark/0000-0001-9295-3594; Gao, Wei/0000-0003-3541-9568; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Amouyel, Philippe/0000-0001-9088-234X; Damrauer, Scott/0000-0001-8009-1632; Pisinger, Charlotta/0000-0002-7970-3168; Jakobsdottir, Johanna/0000-0002-8019-9683; Marouli, Eirini/0000-0001-6179-1609; McCarthy, Mark/0000-0002-4393-0510; Deloukas, Panos/0000-0001-9251-070X; Linneberg, Allan/0000-0002-0994-0184; Weinstock, Joshua/0000-0001-7013-1899; Jorgensen, Marit Eika/0000-0001-8356-5565	National Human Genome Research Institute of the National Institute of Health [R01HG008983]; National Institute of Drug Abuse of the National Institute of Health [R21DA040177, R01DA037904]; National Heart, Lung, and Blood Institute of the National Institutes of Health [K01HL125751]; Stanley J. Sarnoff Cardiovascular Research Foundation; Japanese Circulation Society; National Institute for Health Research (NIHR) Exeter Clinical Research Facility; ERC [323195, SZ-245 50371-GLUCOSEGENES-FP7-IDEAS-ERC]; NIH [R01 DK106621, R01 DK107904, HL117491, HL129778, HL122684, HL094535, HL109946, R01 HL127564, R33 HL120781]; University of Michigan Biological Sciences Scholars Program; University of Michigan Department of Internal Medicine; ERC Advanced Principal Investigator award; Wellcome Trust Senior Fellow in Basic Biomedical Science [WT098017]; NHLBI R21 from the NIH [HL121422-02]; Medical Research Council, UK [MC_UU_12015/1]; British Heart Foundation; European Research Council Senior Investigator; National Institute for Health Research (NIHR) Senior Investigator; Massachusetts General Hospital; Donovan Family Foundation; British Heart Foundation [RG/16/4/32218, RG/08/014/24067, RG/14/5/30893] Funding Source: researchfish; Medical Research Council [MC_PC_13046, MR/K006584/1, MR/L003120/1, MC_UU_12015/1, MC_PC_14089, MR/M009203/1, MR/P02811X/1, MC_EX_MR/M009203/1, MR/P013880/1, MR/K026992/1, G9521010, MC_PC_U127561128, MR/N005813/1, G0601261, MC_PC_13048, G0600237] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10059, NF-SI-0512-10113, NF-SI-0512-10165, NF-SI-0512-10135, NF-SI-0611-10099] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Grarup Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF17OC0026936, NNF14OC0009819] Funding Source: researchfish; Steno Diabetes Center Copenhagen (SDCC) [SDCC 3.A Complications] Funding Source: researchfish; MRC [MC_EX_MR/M009203/1, MR/P02811X/1, MR/N005813/1, MC_PC_U127561128, MC_UU_12015/1, MR/P013880/1, G0600237, MC_PC_14089, MR/M009203/1, G9521010, G0601261, MR/L003120/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [UM1CA182913] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100, UL1TR001881] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756, R01HL122684, R21HL121422, R01HL117491, R01HL109946, R01HL118567, R00HL094535, K01HL125751, R01HL129778, R01HL127564, K99HL094535] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040, R01HG008983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062370, U01DK078616, P30DK020572, K24DK080140, R01DK106621, P30DK063491, P30DK020541, R01DK107904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM115428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA040177, R01DA037904] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522, S10OD020069] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Drug Abuse of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stanley J. Sarnoff Cardiovascular Research Foundation; Japanese Circulation Society(Japanese Circulation Society); National Institute for Health Research (NIHR) Exeter Clinical Research Facility; ERC(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Biological Sciences Scholars Program(University of Michigan System); University of Michigan Department of Internal Medicine; ERC Advanced Principal Investigator award(European Research Council (ERC)); Wellcome Trust Senior Fellow in Basic Biomedical Science(Wellcome Trust); NHLBI R21 from the NIH; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); European Research Council Senior Investigator; National Institute for Health Research (NIHR) Senior Investigator(National Institute for Health Research (NIHR)); Massachusetts General Hospital(General Electric); Donovan Family Foundation; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation); Steno Diabetes Center Copenhagen (SDCC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	D.J.L. is partially supported by R01HG008983 from the National Human Genome Research Institute of the National Institute of Health, and R21DA040177 and R01DA037904 from the National Institute of Drug Abuse of the National Institute of Health. G.M.P. is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health award K01HL125751. A.P.P. is supported by a research fellowship from the Stanley J. Sarnoff Cardiovascular Research Foundation. H. Tada is supported by a grant from the Japanese Circulation Society to study in the United States. The research was supported by the National Institute for Health Research (NIHR) Exeter Clinical Research Facility and ERC grant 323195; SZ-245 50371-GLUCOSEGENES-FP7-IDEAS-ERC to T.M.F. E.K.S. is supported by NIH grants R01 DK106621 and R01 DK107904, the University of Michigan Biological Sciences Scholars Program, and the University of Michigan Department of Internal Medicine. T.D.S. is supported by an ERC Advanced Principal Investigator award. A.P.M. is supported as a Wellcome Trust Senior Fellow in Basic Biomedical Science (grant no. WT098017). Y.E.C. is supported by HL117491 and HL129778 from the NIH. S.K.G. is supported by HL122684 from the NIH. P.L.A. is supported by NHLBI R21 HL121422-02 from the NIH. C.L., N.J.W., and R.A.S. acknowledge funding from the Medical Research Council, UK (MC_UU_12015/1). J.D. is supported as a British Heart Foundation Professor, European Research Council Senior Investigator, and National Institute for Health Research (NIHR) Senior Investigator. C.J.W. is supported by HL094535 and HL109946 from the NIH. S. Kathiresan is supported by a research scholar award from the Massachusetts General Hospital, the Donovan Family Foundation, and R01 HL127564 and R33 HL120781 from the NIH.	Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asselbergs FW, 2012, AM J HUM GENET, V91, P823, DOI 10.1016/j.ajhg.2012.08.032; Baber U, 2015, J AM COLL CARDIOL, V65, P1065, DOI 10.1016/j.jacc.2015.01.017; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI 10.1172/JCI44213; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Cheng CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7063; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Feng S, 2014, BIOINFORMATICS, V30, P2828, DOI 10.1093/bioinformatics/btu367; Ference BA, 2016, NEW ENGL J MED, V375, P2144, DOI 10.1056/NEJMoa1604304; FESSAS P, 1963, LANCET, V1, P1182; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Galanello R, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-11; Galloway CA, 2010, BBA-MOL BASIS DIS, V1802, P976, DOI 10.1016/j.bbadis.2010.06.003; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Holmen OL, 2014, NAT GENET, V46, P345, DOI 10.1038/ng.2926; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lotta LA, 2016, JAMA-J AM MED ASSOC, V316, P1383, DOI 10.1001/jama.2016.14568; Lu X., 2017, NAT GENET; Mahajan A., 2017, REFINING ACCURACY VA; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Momozawa Y, 2016, HUM MOL GENET, V25, P5027, DOI 10.1093/hmg/ddw335; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Schmidt AF, 2017, LANCET DIABETES ENDO, V5, P97, DOI 10.1016/S2213-8587(16)30396-5; Shen X, 2012, ATHEROSCLEROSIS, V222, P154, DOI 10.1016/j.atherosclerosis.2012.02.012; Sidore C, 2015, NAT GENET, V47, P1272, DOI 10.1038/ng.3368; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Stitziel NO., 2016, NEW ENGL J MED, V374, P1134; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Tang CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10206; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; The UK Biobank, 2015, GEN QUAL CONTR UK BI; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15711; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Zhan XW, 2015, GENET EPIDEMIOL, V39, P619, DOI 10.1002/gepi.21918	52	314	318	3	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2017	49	12					1758	+		10.1038/ng.3977	http://dx.doi.org/10.1038/ng.3977			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FO0XY	29083408	Green Submitted, Green Accepted			2022-12-17	WOS:000416480600016
J	van Rheenen, W; Shatunov, A; Dekker, AM; McLaughlin, RL; Diekstra, FP; Pulit, SL; van der Spek, RAA; Vosa, U; de Jong, S; Robinson, MR; Yang, J; Fogh, I; van Doormaal, PTC; Tazelaar, GHP; Koppers, M; Blokhuis, AM; Sproviero, W; Jones, AR; Kenna, KP; van Eijk, KR; Harschnitz, O; Schellevis, RD; Brands, WJ; Medic, J; Menelaou, A; Vajda, A; Ticozzi, N; Lin, K; Rogelj, B; Vrabec, K; Ravnik-Glavac, M; Koritnik, B; Zidar, J; Leonardis, L; Groselj, LD; Millecamps, S; Salachas, F; Meininger, V; de Carvalho, M; Pinto, S; Mora, JS; Rojas-Garcia, R; Polak, M; Chandran, S; Colville, S; Swingler, R; Morrison, KE; Shaw, PJ; Hardy, J; Orrell, RW; Pittman, A; Sidle, K; Fratta, P; Malaspina, A; Topp, S; Petri, S; Abdulla, S; Drepper, C; Sendtner, M; Meyer, T; Ophoff, RA; Staats, KA; Wiedau-Pazos, M; Lomen-Hoerth, C; Van Deerlin, VM; Trojanowski, JQ; Elman, L; McCluskey, L; Basak, AN; Tunca, C; Hanizeiy, H; Parman, Y; Meitinger, T; Lichtner, P; Radivojkov-Blagojevic, M; Andres, CR; Maurel, C; Bensimon, G; Landwehrmeyer, B; Brice, A; Payan, CAM; Saker-Delye, S; Durr, A; Wood, NW; Tittmann, L; Lieb, W; Franke, A; Rietschel, M; Cichon, S; Nothen, MM; Amouyel, P; Tzourio, C; Dartigues, JF; Uitterlinden, AG; Rivadeneira, F; Estrada, K; Hofman, A; Curtis, C; Blauw, HM; van der Kooi, AJ; de Visser, M; Goris, A; Weber, M; Shaw, CE; Smith, BN; Pansarasa, O; Cereda, C; Del Bo, R; Comi, GP; D'Alfonso, S; Bertolin, C; Soraru, G; Mazzini, L; Pensato, V; Gellera, C; Tiloca, C; Ratti, A; Calvo, A; Moglia, C; Brunetti, M; Arcuti, S; Capozzo, R; Zecca, C; Lunetta, C; Penco, S; Riva, N; Padovani, A; Filosto, M; Muller, B; Stuit, RJ; Blair, I; Zhang, K; McCann, EP; Fifita, JA; Nicholson, GA; Rowe, DB; Pamphlett, R; Kiernan, MC; Grosskreutz, J; Witte, OW; Ringer, T; Prell, T; Stubendorff, B; Kurth, I; Hubner, CA; Leigh, PN; Casale, F; Chio, A; Beghi, E; Pupillo, E; Tortelli, R; Logroscino, G; Powell, J; Ludolph, AC; Weishaupt, JH; Robberecht, W; Van Damme, P; Franke, L; Pers, TH; Brown, RH; Glass, JD; Landers, JE; Hardiman, O; Andersen, PM; Corcia, P; Vourc'h, P; Silani, V; Wray, NR; Visscher, PM; de Bakker, PIW; van Es, MA; Pasterkamp, RJ; Lewis, CM; Breen, G; Al-Chalabi, A; van den Berg, LH; Veldink, JH				van Rheenen, Wouter; Shatunov, Aleksey; Dekker, Annelot M.; McLaughlin, Russell L.; Diekstra, Frank P.; Pulit, Sara L.; van der Spek, Rick A. A.; Vosa, Urmo; de Jong, Simone; Robinson, Matthew R.; Yang, Jian; Fogh, Isabella; van Doormaal, Perry T. C.; Tazelaar, Gijs H. P.; Koppers, Max; Blokhuis, Anna M.; Sproviero, William; Jones, Ashley R.; Kenna, Kevin P.; van Eijk, Kristel R.; Harschnitz, Oliver; Schellevis, Raymond D.; Brands, William J.; Medic, Jelena; Menelaou, Androniki; Vajda, Alice; Ticozzi, Nicola; Lin, Kuang; Rogelj, Boris; Vrabec, Katarina; Ravnik-Glavac, Metka; Koritnik, Blazi; Zidar, Janez; Leonardis, Lea; Groselj, Leja Dolenc; Millecamps, Stephanie; Salachas, Francois; Meininger, Vincent; de Carvalho, Mamede; Pinto, Susana; Mora, Jesus S.; Rojas-Garcia, Ricardo; Polak, Meraida; Chandran, Siddharthan; Colville, Shuna; Swingler, Robert; Morrison, Karen E.; Shaw, Pamela J.; Hardy, John; Orrell, Richard W.; Pittman, Alan; Sidle, Katie; Fratta, Pietro; Malaspina, Andrea; Topp, Simon; Petri, Susanne; Abdulla, Susanne; Drepper, Carsten; Sendtner, Michael; Meyer, Thomas; Ophoff, Roel A.; Staats, Kim A.; Wiedau-Pazos, Martina; Lomen-Hoerth, Catherine; Van Deerlin, Vivianna M.; Trojanowski, John Q.; Elman, Lauren; McCluskey, Leo; Basak, A. Nazli; Tunca, Ceren; Hamzeiy, Hamid; Parman, Yesim; Meitinger, Thomas; Lichtner, Peter; Radivojkov-Blagojevic, Milena; Andres, Christian R.; Maurel, Cindy; Bensimon, Gilbert; Landwehrmeyer, Bernhard; Brice, Alexis; Payan, Christine A. M.; Saker-Delye, Safaa; Duerr, Alexandra; Wood, Nicholas W.; Tittmann, Lukas; Lieb, Wolfgang; Franke, Andre; Rietschel, Marcella; Cichon, Sven; Noethen, Markus M.; Amouyel, Philippe; Tzourio, Christophe; Dartigues, Jean-Francois; Uitterlinden, Andre G.; Rivadeneira, Fernando; Estrada, Karol; Hofman, Albert; Curtis, Charles; Blauw, Hylke M.; van der Kooi, Anneke J.; de Visser, Marianne; Goris, An; Weber, Markus; Shaw, Christopher E.; Smith, Bradley N.; Pansarasa, Orietta; Cereda, Cristina; Del Bo, Roberto; Comi, Giacomo P.; D'Alfonso, Sandra; Bertolin, Cinzia; Soraru, Gianni; Mazzini, Letizia; Pensato, Viviana; Gellera, Cinzia; Tiloca, Cinzia; Ratti, Antonia; Calvo, Andrea; Moglia, Cristina; Brunetti, Maura; Arcuti, Simona; Capozzo, Rosa; Zecca, Chiara; Lunetta, Christian; Penco, Silvana; Riva, Nilo; Padovani, Alessandro; Filosto, Massimiliano; Muller, Bernard; Stuit, Robbert Jan; Blair, Ian; Zhang, Katharine; McCann, Emily P.; Fifita, Jennifer A.; Nicholson, Garth A.; Rowe, Dominic B.; Pamphlett, Roger; Kiernan, Matthew C.; Grosskreutz, Julian; Witte, Otto W.; Ringer, Thomas; Prell, Tino; Stubendorff, Beatrice; Kurth, Ingo; Huebner, Christian A.; Leigh, P. Nigel; Casale, Federico; Chio, Adrian; Beghi, Ettore; Pupillo, Elisabetta; Tortelli, Rosanna; Logroscino, Giancarlo; Powell, John; Ludolph, Albert C.; Weishaupt, Jochen H.; Robberecht, Wim; Van Damme, Philip; Franke, Lude; Pers, Tune H.; Brown, Robert H.; Glass, Jonathan D.; Landers, John E.; Hardiman, Orla; Andersen, Peter M.; Corcia, Philippe; Vourc'h, Patrick; Silani, Vincenzo; Wray, Naomi R.; Visscher, Peter M.; de Bakker, Paul I. W.; van Es, Michael A.; Pasterkamp, R. Jeroen; Lewis, Cathryn M.; Breen, Gerome; Al-Chalabi, Ammar; van den Berg, Leonard H.; Veldink, Jan H.		PARALS Registry; SLALOM Grp; SLAP Registry; FALS Sequencing Consortium; SLAGEN Consortium; NNIPPS Study Grp	Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							FRONTOTEMPORAL DEMENTIA; HEXANUCLEOTIDE REPEAT; ALS; SUSCEPTIBILITY; POPULATION; EFFICIENT; PATHWAYS; PITFALLS; SEQUENCE; COMPLEX	To elucidate the genetic architecture of amyotrophic lateral sclerosis (ALS) and find associated loci, we assembled a custom imputation reference panel from whole-genome-sequenced patients with ALS and matched controls (n = 1,861). Through imputation and mixed-model association analysis in 12,577 cases and 23,475 controls, combined with 2,579 cases and 2,767 controls in an independent replication cohort, we fine-mapped a new risk locus on chromosome 21 and identified C21orf2 as a gene associated with ALS risk. In addition, we identified MOBP and SCFD1 as new associated risk loci. We established evidence of ALS being a complex genetic trait with a polygenic architecture. Furthermore, we estimated the SNP-based heritability at 8.5%, with a distinct and important role for low-frequency variants (frequency 1-10%). This study motivates the interrogation of larger samples with full genome coverage to identify rare causal variants that underpin ALS risk.	[van Rheenen, Wouter; Dekker, Annelot M.; Diekstra, Frank P.; van der Spek, Rick A. A.; van Doormaal, Perry T. C.; Tazelaar, Gijs H. P.; Koppers, Max; Blokhuis, Anna M.; van Eijk, Kristel R.; Harschnitz, Oliver; Schellevis, Raymond D.; Brands, William J.; Medic, Jelena; Blauw, Hylke M.; van Es, Michael A.; Al-Chalabi, Ammar; van den Berg, Leonard H.; Veldink, Jan H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands; [Shatunov, Aleksey; Fogh, Isabella; Sproviero, William; Jones, Ashley R.; Lin, Kuang; Topp, Simon; Shaw, Christopher E.; Smith, Bradley N.; Powell, John] Kings Coll London, Maurice Wohl Clin Neurosci Inst, Dept Basic & Clin Neurosci, London, England; [McLaughlin, Russell L.] Trinity Coll Dublin, Smurfit Inst Genet, Populat Genet Lab, Dublin, Ireland; [Pulit, Sara L.; Menelaou, Androniki; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Med Genet, Utrecht, Netherlands; [Vosa, Urmo; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [de Jong, Simone; Curtis, Charles; Lewis, Cathryn M.; Breen, Gerome] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England; [de Jong, Simone; Curtis, Charles; Breen, Gerome] Kings Coll London, Maudsley Hosp, NIFIR Biomed Res Ctr Mental Hlth, London, England; [de Jong, Simone; Curtis, Charles; Breen, Gerome] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Robinson, Matthew R.; Yang, Jian; Wray, Naomi R.; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Fogh, Isabella; Ticozzi, Nicola; Tiloca, Cinzia; Ratti, Antonia; Silani, Vincenzo] IRCCS Ist Auxol Italiano, Dept Neurol & Lab Neurosci, Milan, Italy; [Koppers, Max; Blokhuis, Anna M.; Harschnitz, Oliver; Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [Kenna, Kevin P.; Brown, Robert H.; Landers, John E.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Vajda, Alice; Hardiman, Orla] Trinity Coll Dublin, Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin, Ireland; [Vajda, Alice; Hardiman, Orla] Beaumont Hosp, Dept Neurol, Dublin, Ireland; [Ticozzi, Nicola; Ratti, Antonia; Silani, Vincenzo] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Tranplantat, Milan, Italy; [Rogelj, Boris] Jozef Stefan Inst, Dept Biotechnol, Ljubljana, Slovenia; [Rogelj, Boris] Biomed Res Inst BRIS, Ljubljana, Slovenia; [Vrabec, Katarina; Ravnik-Glavac, Metka] Univ Ljubljana, Fac Med, Inst Pathol, Dept Mol Genet, Ljubljana, Slovenia; [Ravnik-Glavac, Metka] Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana, Slovenia; [Koritnik, Blazi; Zidar, Janez; Leonardis, Lea; Groselj, Leja Dolenc] Univ Med Ctr Ljubljana, Ljubljana ALS Ctr, Inst Clin Neurophysiol, Ljubljana, Slovenia; [Millecamps, Stephanie; Salachas, Francois] Univ Paris 06, Sorbonne Univ, Inst Cerveau & Moelle Epiniere, CNRS UMR 7225,INSERM U1127,UMRS 1127, Paris, France; [Salachas, Francois] Hop La Pitie Salpetriere, Ctr Reference Malad Races SLA Ile France, Dept Neurol, Paris, France; [Salachas, Francois] GRC UPMC SEA & Malad Motoneurone, Paris, France; [Meininger, Vincent] Hop Peupliers, Ramsay Gen Sante, Paris, France; [Meininger, Vincent] Reseau SEA Ile France, Paris, France; [de Carvalho, Mamede; Pinto, Susana] Univ Lisbon, Fac Med, Inst Mol Med, Inst Physiol, Lisbon, Portugal; [de Carvalho, Mamede; Pinto, Susana] Hosp Santa Maria CHLN, Dept Neurosci, Lisbon, Portugal; [Mora, Jesus S.] Hosp San Rafael, Dept Neurol, Madrid, Spain; [Rojas-Garcia, Ricardo] Autonomous Univ Barcelona, Hosp Santa Creu & St Pau Barcelona, Dept Neurol, Barcelona, Spain; [Rojas-Garcia, Ricardo] Ctr Invest Red Enfermedades Raras CIBFRFR, Madrid, Spain; [Polak, Meraida; Glass, Jonathan D.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Polak, Meraida; Glass, Jonathan D.] Emory Univ, Sch Med, Emory ALS Ctr, Atlanta, GA USA; [Chandran, Siddharthan; Colville, Shuna; Swingler, Robert] Euan MacDonald Ctr Motor Neuron Dis Res, Edinburgh, Midlothian, Scotland; [Chandran, Siddharthan] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh, Midlothian, Scotland; [Chandran, Siddharthan; Basak, A. Nazli] Univ Edinburgh, Ctr Regenerat Med, MRC, Edinburgh, Midlothian, Scotland; [Morrison, Karen E.] Univ Southampton, Fac Med, Southampton, Hants, England; [Shaw, Pamela J.] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Sheffield, S Yorkshire, England; [Hardy, John; Pittman, Alan] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Orrell, Richard W.; Sidle, Katie] UCL, Inst Neurol, Dept Clin Neurosci, London, England; [Pittman, Alan] UCL, Inst Neurol, Reta Lila Weston Inst, London, England; [Fratta, Pietro] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Malaspina, Andrea] Queen Mary Univ London, Ctr Neurosci & Trauma, Blizard Inst, London, England; [Malaspina, Andrea] North East London & Essex Reg Motor Neuron Dis Ca, London, England; [Petri, Susanne] Hannover Med Sch, Dept Neurol, Hannover, Germany; [Abdulla, Susanne] Univ Magdeburg, Dept Neurol, Magdeburg, Germany; [Drepper, Carsten; Sendtner, Michael] Univ Hosp Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany; [Meyer, Thomas] Humboldt Univ, Charite Univ Hosp, Dept Neurol, Berlin, Germany; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Ophoff, Roel A.; Staats, Kim A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Sernel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Wiedau-Pazos, Martina] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Lomen-Hoerth, Catherine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Van Deerlin, Vivianna M.; Trojanowski, John Q.] Univ Penn, Perelman Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Elman, Lauren; McCluskey, Leo] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA USA; [Basak, A. Nazli; Tunca, Ceren; Hamzeiy, Hamid] Bogazici Univ, Neurodegenerat Res Lab, Istanbul, Turkey; [Parman, Yesim] Istanbul Univ, Istanbul Med Sch, Dept Neurol, Istanbul, Turkey; [Meitinger, Thomas; Lichtner, Peter; Radivojkov-Blagojevic, Milena] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Andres, Christian R.; Maurel, Cindy; Corcia, Philippe; Vourc'h, Patrick] Univ Tours, INSERM U930, Tours, France; [Bensimon, Gilbert; Payan, Christine A. M.] Hop La Pitie Salpetriere, AP HP, Dept Clin Pharmacol, Paris, France; [Bensimon, Gilbert] Univ Paris 06, Pharmacol, Paris, France; [Bensimon, Gilbert; Payan, Christine A. M.] CHU Nimes, BESPIM, Nimes, France; [Landwehrmeyer, Bernhard; Ludolph, Albert C.; Weishaupt, Jochen H.; Andersen, Peter M.] Univ Ulm, Dept Neurol, Ulm, Germany; [Brice, Alexis] Hop La Pitie Salpetriere, INSERM U1127, Paris, France; [Brice, Alexis] Hop La Pitie Salpetriere, CNRS UMR 7225, Paris, France; [Brice, Alexis] Univ Paris 06, Sorbonne Univ, Hop Pitie Salpetriere, UMRS 1127, Paris, France; [Brice, Alexis] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Paris, France; [Brice, Alexis] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France; [Saker-Delye, Safaa] Genethon, CNRS UMR 8587, Evry, France; [Duerr, Alexandra] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Dept Med Genet, Paris, France; [Wood, Nicholas W.] Univ College London, Inst Neurol, Dept Neurogenet, London, England; [Tittmann, Lukas; Lieb, Wolfgang] Christian Albrechts Univ Kiel, PopGen Biobarik, Kiel, Germany; [Tittmann, Lukas; Lieb, Wolfgang] Christian Albrechts Univ Kiel, Inst Epidemiol, Kiel, Germany; [Basak, A. Nazli; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Rietschel, Marcella] Heidelberg Univ, Fac Med Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Heidelberg, Germany; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Cichon, Sven; Noethen, Markus M.] Life & Brain Ctr, Dept Genom, Bonn, Germany; [Cichon, Sven] Univ Basel, Univ Basel Hosp, Div Med Genet, Basel, Switzerland; [Cichon, Sven] Univ Basel, Dept Biomed, Basel, Switzerland; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, Julich, Germany; [Amouyel, Philippe] Univ Lille, CHU Lille, INSERM, Inst Pasteur Lille,RID AGE Risk Factor & Mol Dete, Lille, France; [Tzourio, Christophe; Dartigues, Jean-Francois] Univ Bordeaux, ISPED, INSERM U1219, Epidemiol Biostat, Bordeaux, France; [Tzourio, Christophe; Dartigues, Jean-Francois] CHU Bordeaux, CIC 1401, Pole Sante Publ, Bordeaux, France; [Uitterlinden, Andre G.; Rivadeneira, Fernando; Estrada, Karol] Erasmus MC, Dept Internal Med, Genet Lab, Rotterdam, Netherlands; [Uitterlinden, Andre G.; Rivadeneira, Fernando; Hofman, Albert] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [van der Kooi, Anneke J.; de Visser, Marianne] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Goris, An; Robberecht, Wim; Van Damme, Philip] Katholieke Univ Leuven, Univ Leuven, Leuven Res Inst Neurosci & Dis LIND, Dpet Neurosci Expt Neurol, Leuven, Belgium; [Weber, Markus] Kantonsspital St Gallen, ALS Clin, Neuromuscular Dis Unit, St Gallen, Switzerland; [Pansarasa, Orietta; Cereda, Cristina] IRCCS C Mondino Natl Inst Neurol Fdn, Lab Expt Neurobiol, Pavia, Italy; [Del Bo, Roberto; Comi, Giacomo P.] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Neurol Unit, Milan, Italy; [D'Alfonso, Sandra] Univ Piemonte Orientale, Interdisciplinary Res Ctr Autoimmune Dis, Dept Hlth Sci, Novara, Italy; [Bertolin, Cinzia; Soraru, Gianni] Univ Padua, Dept Neurosci, Padua, Italy; [Mazzini, Letizia] Univ Piemonte Orientals, Dept Neurol, Novara, Italy; [Pensato, Viviana; Gellera, Cinzia] Fdn IRCCS Ist Neurol Carlo Besta, Unit Genet Neurodegenerat & Metab Dis, Milan, Italy; [Calvo, Andrea; Moglia, Cristina; Brunetti, Maura; Casale, Federico; Chio, Adrian] Univ Turin, ALS Ctr, Rita Levi Montalcini Dept Neurosci, Turin, Italy; [Calvo, Andrea; Moglia, Cristina; Brunetti, Maura; Chio, Adrian] Azienda Osped Citta Salute & Sci, Turin, Italy; [Arcuti, Simona; Capozzo, Rosa; Zecca, Chiara; Tortelli, Rosanna] Univ Bari A Moro, Dept Clin Res Neurol, Tricase, Italy; [Arcuti, Simona; Capozzo, Rosa; Zecca, Chiara; Tortelli, Rosanna] Pia Fdn Card G Panico, Tricase, Italy; [Lunetta, Christian] Niguarda Ca Granda Hostipal, Serena Onlins Fdn, NEMO Clin Ctr, Milan, Italy; [Penco, Silvana] Osped Niguarda Ca Granda, Dept Lab Med, Med Genet Unit, Milan, Italy; [Riva, Nilo] Ist Sci San Raffaele, Inst Expt Neurol INSPE, Dept Neurol, Div Neurosci, Milan, Italy; [Padovani, Alessandro; Filosto, Massimiliano] Univ Brescia, Dept Clin & Expt Sci, Neurol Unit, Brescia, Italy; [Muller, Bernard; Stuit, Robbert Jan] Project MinE Fdn, Rotterdam, Netherlands; [Blair, Ian; Zhang, Katharine; McCann, Emily P.; Fifita, Jennifer A.; Nicholson, Garth A.; Rowe, Dominic B.] Macquarie Univ, Fac Med & Hlth Sci, Dept Biomed Sci, Sydney, NSW, Australia; [Nicholson, Garth A.] Univ Sydney, ANZAC Res Inst, Sydney, NSW, Australia; [Pamphlett, Roger] Univ Sydney, Dept Pathol, Stacey MND Lab, Sydney, NSW, Australia; [Kiernan, Matthew C.] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Grosskreutz, Julian; Witte, Otto W.; Ringer, Thomas; Prell, Tino; Stubendorff, Beatrice] Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Germany; [Kurth, Ingo; Huebner, Christian A.] Jena Univ Hosp, Inst Human Genet, Jena, Germany; [Leigh, P. Nigel] Univ Sussex, Trafford Ctr Biomed Res, Brighton & Sussex Med Sch, Dept Neurol, Falmer, England; [Beghi, Ettore; Pupillo, Elisabetta] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Lab Neurol Dis, Milan, Italy; [Logroscino, Giancarlo] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Logroscino, Giancarlo] Univ Bari Aldo Moro, Pia Fdn Cardinale G Panico, Dept Clin Res Neurol, Unit Neurodegenerat Dis, Tricase, Italy; [Robberecht, Wim; Van Damme, Philip] VIB, Vesalius Res Ctr, Neurobiol Lab, Leuven, Belgium; [Robberecht, Wim; Van Damme, Philip] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium; [Pers, Tune H.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Pers, Tune H.] Boston Childrens Hosp, Div Genet, Boston, MA USA; [Pers, Tune H.] Boston Childrens Hosp, Ctr Basic Translat Obes Res, Boston, MA USA; [Pers, Tune H.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Pers, Tune H.] Broad Inst, Program Med & Populat Genet, Carnbridge, MA USA; [Andersen, Peter M.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Corcia, Philippe] CHRU Tours, Ctr SLA, Tours, France; [Corcia, Philippe] LITORALS, Federat Ctr SLA Tours & Limoges, Tours, France; [Visscher, Peter M.] Univ Queensland, Translat Res Inst, Diarnantina Inst, Brisbane, Qld, Australia; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Lewis, Cathryn M.] Kings Coll London, Dept Med & Mol Genet, London, England	Utrecht University; Utrecht University Medical Center; University of London; King's College London; Trinity College Dublin; Utrecht University; Utrecht University Medical Center; University of Groningen; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; University of Queensland; IRCCS Istituto Auxologico Italiano; Utrecht University; Utrecht University Medical Center; University of Massachusetts System; University of Massachusetts Worcester; Trinity College Dublin; University of Milan; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; University of Ljubljana; University Medical Centre Ljubljana; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Emory University; Emory University; University of Edinburgh; University of Edinburgh; University of Southampton; University of Sheffield; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; Queen Mary University London; Hannover Medical School; Otto von Guericke University; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Bogazici University; Istanbul University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; CHU de Nimes; Ulm University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; CEA; CY Cergy Paris Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; University of Kiel; University of Kiel; University of Kiel; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Bonn; University of Bonn; University of Basel; University of Basel; Helmholtz Association; Research Center Julich; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; Kantonsspital St. Gallen; IRCCS Fondazione Casimiro Mondino; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Eastern Piedmont Amedeo Avogadro; University of Padua; IRCCS Istituto Neurologico Besta; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Universita degli Studi di Bari Aldo Moro; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Brescia; Macquarie University; University of Sydney; ANZAC Research Institute; University of Sydney; University of Sydney; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Brighton; University of Sussex; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Umea University; CHU Tours; University of Queensland; Utrecht University; Utrecht University Medical Center; University of London; King's College London	Al-Chalabi, A; Veldink, JH (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands.	ammar.al-chalabi@kcl.ac.uk; j.h.veldink@umcutrecht.nl	Weber, Markus/AAI-7138-2020; Pupillo, Elisabetta/ABD-2698-2020; Mazzini, Letizia/AAA-2262-2021; Filosto, Massimiliano/S-9446-2019; Leigh, Peter/AAD-5638-2019; Hardiman, Orla/Y-3441-2019; Silani, Vincenzo/P-4421-2017; Breen, Gerome D/A-5540-2010; Sendtner, Michael/J-1542-2012; Koritnik, Blaž/N-7487-2019; Millecamps, Stéphanie/W-7184-2018; Wray, Naomi/C-8639-2015; Arcuti, Simona/J-8587-2016; Gellera, Cinzia/J-7887-2016; Witte, Otto/P-4127-2018; Franke, Lude/P-7036-2016; Brice, Alexis/A-2170-2009; moglia, cristina/K-4142-2016; Research Institute, ANZAC/CAE-9030-2022; Pensato, Viviana/J-6533-2016; Rivadeneira, Fernando/O-5385-2015; Grosskreutz, Julian/G-2293-2010; Williams, Kelly L/A-5545-2010; Lieb, Wolfgang/AAC-7650-2022; Capozzo, Rosa/AAC-2716-2019; Fratta, Pietro/G-1296-2019; Tzourio, christophe/L-6344-2019; McCann, Emily P/A-2563-2016; Lewis, Cathryn/M-8766-2019; Visscher, Peter/ABB-6151-2020; Comi, Giacomo P/K-5702-2016; Ticozzi, Nicola/K-8094-2016; Hübner, Christian/A-2950-2017; van+Es, Michael/AAC-5772-2021; Drepper, Carsten/GSN-2009-2022; Wood, Nicholas W/C-2505-2009; Pinto, Susana/L-8394-2019; Franke, Andre/B-2151-2010; Yang, Jian/A-5852-2010; Kiernan, Matthew C/E-4460-2011; Goris, An/F-2943-2010; Landwehrmeyer, Georg Bernhard/AHB-4443-2022; Rogelj, Boris/G-9252-2011; Van Damme, Philip/A-6464-2009; Petri, Susanne/AID-7665-2022; CEREDA, CRISTINA/G-8208-2011; CALVO, Andrea/K-4141-2016; DARTIGUES, Jean François/T-4513-2019; de Carvalho, Mamede/I-6295-2019; Pittman, Alan M/D-6231-2012; Cotelli, Maria Sofia/K-4534-2017; Meitinger, Thomas/O-1318-2015; Lewis, Cathryn M/A-5225-2010; Beghi, Ettore/AAA-7426-2020; ravnik-glavac, metka/ABH-8339-2020; Tunca, Ceren/GPX-7306-2022; Sendtner, Michael/M-8137-2014; Pansarasa, Orietta/A-2012-2019; Rowe, Dominic B/B-6661-2011; Padovani, Alessandro/ABI-7312-2020; Sorarù, Gianni/AAB-8891-2019; Hardy, John/C-2451-2009; Pupillo, Elisabetta/AAA-7385-2020; Goris, An/L-5852-2019; brice, alexis/AAE-8275-2019; Tzourio, christophe/B-4015-2009; Prell, Tino/AAE-5492-2020; Pittman, Alan/AAP-2534-2020; Breen, Gerome/Y-2706-2019; Moglia, Cristina/AAB-9643-2019; Powell, John F/G-4412-2011; Võsa, Urmo/AAJ-5928-2020; Tittmann, Lukas/A-7295-2017; Al-Chalabi, Ammar/E-5361-2010; D'Alfonso, Sandra/K-7295-2014; Cichon, Sven/B-9618-2014	Pupillo, Elisabetta/0000-0003-4420-8076; Mazzini, Letizia/0000-0003-2479-9120; Filosto, Massimiliano/0000-0002-2852-7512; Hardiman, Orla/0000-0003-2610-1291; Silani, Vincenzo/0000-0002-7698-3854; Breen, Gerome D/0000-0003-2053-1792; Sendtner, Michael/0000-0002-4737-2974; Koritnik, Blaž/0000-0002-5083-8261; Millecamps, Stéphanie/0000-0002-0745-6735; Wray, Naomi/0000-0001-7421-3357; Arcuti, Simona/0000-0002-0132-3296; Gellera, Cinzia/0000-0002-3582-665X; Witte, Otto/0000-0003-2101-4105; Franke, Lude/0000-0002-5159-8802; moglia, cristina/0000-0001-7377-7222; Pensato, Viviana/0000-0001-9798-2669; Rivadeneira, Fernando/0000-0001-9435-9441; Grosskreutz, Julian/0000-0001-9525-1424; Williams, Kelly L/0000-0001-6319-9473; Capozzo, Rosa/0000-0002-7672-8669; Fratta, Pietro/0000-0002-8762-8188; Tzourio, christophe/0000-0002-6517-2984; McCann, Emily P/0000-0002-8200-3525; Lewis, Cathryn/0000-0002-8249-8476; Visscher, Peter/0000-0002-2143-8760; Comi, Giacomo P/0000-0002-1383-5248; Ticozzi, Nicola/0000-0001-5963-7426; Hübner, Christian/0000-0002-1030-4943; Wood, Nicholas W/0000-0002-9500-3348; Pinto, Susana/0000-0002-0727-5897; Franke, Andre/0000-0003-1530-5811; Yang, Jian/0000-0003-2001-2474; Goris, An/0000-0002-1276-6682; Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Rogelj, Boris/0000-0003-3898-1943; Van Damme, Philip/0000-0002-4010-2357; CEREDA, CRISTINA/0000-0001-9571-0862; CALVO, Andrea/0000-0002-5122-7243; de Carvalho, Mamede/0000-0001-7556-0158; Pittman, Alan M/0000-0002-8112-2987; Cotelli, Maria Sofia/0000-0002-7010-2809; Lewis, Cathryn M/0000-0002-8249-8476; Beghi, Ettore/0000-0003-2542-0469; Tunca, Ceren/0000-0002-0657-6348; Sendtner, Michael/0000-0002-4737-2974; Rowe, Dominic B/0000-0003-0912-2146; Padovani, Alessandro/0000-0002-0119-3639; Hardy, John/0000-0002-3122-0423; Pupillo, Elisabetta/0000-0003-4420-8076; Goris, An/0000-0002-1276-6682; brice, alexis/0000-0002-0941-3990; Tzourio, christophe/0000-0002-6517-2984; Prell, Tino/0000-0002-6423-3108; Pittman, Alan/0000-0002-8112-2987; Breen, Gerome/0000-0003-2053-1792; Moglia, Cristina/0000-0001-7377-7222; Powell, John F/0000-0001-6124-439X; Võsa, Urmo/0000-0003-3476-1652; Morrison, Karen Elaine/0000-0003-0216-5717; Staats, Kim/0000-0001-8392-7992; Hamzeiy, Hamid/0000-0001-7990-2530; Tittmann, Lukas/0000-0002-8731-4592; Fifita, Jennifer/0000-0002-0814-0118; fratta, pietro/0000-0002-7554-1632; van Es, Michael/0000-0002-7709-5883; Jones, Ashley/0000-0003-0470-0058; Shaw, Pamela/0000-0002-8925-2567; VOURC'H, Patrick/0000-0001-7960-8139; Andres, Christian/0000-0002-5062-3156; Soraru, Gianni/0000-0001-9691-6328; Nothen, Markus/0000-0002-8770-2464; Vajda, Alice/0000-0001-9105-6680; Blair, Ian/0000-0003-3083-0075; de Jong, Simone/0000-0002-8002-7195; Kurth, Ingo/0000-0002-5642-8378; Curtis, Charles/0000-0002-2992-1941; Al-Chalabi, Ammar/0000-0002-4924-7712; Fogh, Isabella/0000-0002-6266-8933; van der Kooi, Anneke/0000-0002-5261-5512; Chio, Adriano/0000-0001-9579-5341; Landers, John/0000-0001-8084-5043; Rapa, Anna/0000-0002-5523-5224; Nicholson, Garth/0000-0001-9694-066X; D'Alfonso, Sandra/0000-0002-3983-9925; Kiernan, Matthew/0000-0001-9054-026X; Shatunov, Aleksey/0000-0002-2671-8040; Pulit, Sara/0000-0002-2502-3669; Koppers, Max/0000-0002-7751-1082; Cichon, Sven/0000-0002-9475-086X; Meitinger, Thomas/0000-0002-8838-8403; Robinson, Matthew/0000-0001-8982-8813; topp, simon/0000-0002-5200-3284; McLaughlin, Russell/0000-0003-3915-2135; Maurel, Cindy/0000-0003-1487-9987; Pers, Tune/0000-0003-0207-4831; Veldink, Jan/0000-0001-5572-9657; Shaw, Christopher/0000-0003-0251-0146; Harschnitz, Oliver/0000-0001-6496-881X; Amouyel, Philippe/0000-0001-9088-234X; Drepper, Carsten/0000-0002-7883-6479; Sproviero, William/0000-0002-9335-9260; Smith, Bradley/0000-0002-6980-2453	governmental and charitable bodies; ESRC [ES/L008238/1] Funding Source: UKRI; MRC [G0600974, G0901254, MC_G0901330, MR/K000039/1, G0900688, MR/M008606/1, MC_G1000733] Funding Source: UKRI; Economic and Social Research Council [ES/L008238/1] Funding Source: researchfish; Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish; Medical Research Council [MC_G0901330, MR/K000039/1, G0900688, G0901254, G0600974, MR/M008606/1, MC_G1000733, MR/L501529/1] Funding Source: researchfish; Medical Research Foundation [MRF-060-0003-RG-SMITH] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10082, NF-SI-0513-10064, NF-SI-0507-10376] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish; Parkinson&quot;s UK [G-1107] Funding Source: researchfish; Motor Neurone Disease Association [McLaughlin/Oct15/957-799, Fratta/Jan15/946-795, Jones/Oct15/958-799, Malaspina/Apr13/817-791] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG032953, P01AG017586] Funding Source: NIH RePORTER	governmental and charitable bodies; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Parkinson&quot;s UK(Parkinson&apos;s UK); Motor Neurone Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work of the contributing groups was supported by various grants from governmental and charitable bodies. Details are provided in the Supplementary Note.	Al-Chalabi A, 2010, J NEUROL NEUROSUR PS, V81, P1324, DOI 10.1136/jnnp.2010.207464; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Fang X, 2015, ACTA BIOCH BIOPH SIN, V47, P834, DOI 10.1093/abbs/gmv076; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Fogh I, 2014, HUM MOL GENET, V23, P2220, DOI 10.1093/hmg/ddt587; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Irwin DJ, 2014, NEUROLOGY, V83, P502, DOI 10.1212/WNL.0000000000000668; Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y; Krohn K, 1997, BIOCHEM BIOPH RES CO, V238, P806, DOI 10.1006/bbrc.1997.7352; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Ma XX, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-71; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Ramakrishnan NA, 2012, MOL CELL NEUROSCI, V50, P58, DOI 10.1016/j.mcn.2012.03.009; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Shatunov A, 2010, LANCET NEUROL, V9, P986, DOI 10.1016/S1474-4422(10)70197-6; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Veriepe J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8319; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876	32	314	315	3	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2016	48	9					1043	+		10.1038/ng.3622	http://dx.doi.org/10.1038/ng.3622			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DU7MQ	27455348	Green Accepted, Green Submitted, Green Published			2022-12-17	WOS:000382398800015
J	Wain, LV; Verwoert, GC; O'Reilly, PF; Shi, G; Johnson, T; Johnson, AD; Bochud, M; Rice, KM; Henneman, P; Smith, AV; Ehret, GB; Amin, N; Larson, MG; Mooser, V; Hadley, D; Dorr, M; Bis, JC; Aspelund, T; Esko, T; Janssens, ACJW; Zhao, JH; Heath, S; Laan, M; Fu, JY; Pistis, G; Luan, JA; Arora, P; Lucas, G; Pirastu, N; Pichler, I; Jackson, AU; Webster, RJ; Zhang, F; Peden, JF; Schmidt, H; Tanaka, T; Campbell, H; Igl, W; Milaneschi, Y; Hottenga, JJ; Vitart, V; Chasman, DI; Trompet, S; Bragg-Gresham, JL; Alizadeh, BZ; Chambers, JC; Guo, XQ; Lehtimaki, T; Kuhnel, B; Lopez, LM; Polasek, O; Boban, M; Nelson, CP; Morrison, AC; Pihur, V; Ganesh, SK; Hofman, A; Kundu, S; Mattace-Raso, FUS; Rivadeneira, F; Sijbrands, EJG; Uitterlinden, AG; Hwang, SJ; Vasan, RS; Wang, TJ; Bergmann, S; Vollenweider, P; Waeber, G; Laitinen, J; Pouta, A; Zitting, P; McArdle, WL; Kroemer, HK; Volker, U; Volzke, H; Glazer, NL; Taylor, KD; Harris, TB; Alavere, H; Haller, T; Keis, A; Tammesoo, ML; Aulchenko, Y; Barroso, I; Khaw, KT; Galan, P; Hercberg, S; Lathrop, M; Eyheramendy, S; Org, E; Sober, S; Lu, XW; Nolte, IM; Penninx, BW; Corre, T; Masciullo, C; Sala, C; Groop, L; Voight, BF; Melander, O; O'Donnell, CJ; Salomaa, V; d'Adamo, AP; Fabretto, A; Faletra, F; Ulivi, S; Del Greco, MF; Facheris, M; Collins, FS; Bergman, RN; Beilby, JP; Hung, J; Musk, AW; Mangino, M; Shin, SY; Soranzo, N; Watkins, H; Goel, A; Hamsten, A; Gider, P; Loitfelder, M; Zeginigg, M; Hernandez, D; Najjar, SS; Navarro, P; Wild, SH; Corsi, AM; Singleton, A; de Geus, EJC; Willemsen, G; Parker, AN; Rose, LM; Buckley, B; Stott, D; Orru, M; Uda, M; van der Klauw, MM; Zhang, WH; Li, XZ; Scott, J; Chen, YDI; Burke, GL; Kahonen, M; Viikari, J; Doring, A; Meitinger, T; Davies, G; Starr, JM; Emilsson, V; Plump, A; Lindeman, JH; 't Hoen, PAC; Konig, IR; Felix, JF; Clarke, R; Hopewell, JC; Ongen, H; Breteler, M; Debette, S; DeStefano, AL; Fornage, M; Mitchell, GF; Smith, NL; Holm, H; Stefansson, K; Thorleifsson, G; Thorsteinsdottir, U; Samani, NJ; Preuss, M; Rudan, I; Hayward, C; Deary, IJ; Wichmann, HE; Raitakari, OT; Palmas, W; Kooner, JS; Stolk, RP; Jukema, JW; Wright, AF; Boomsma, DI; Bandinelli, S; Gyllensten, UB; Wilson, JF; Ferrucci, L; Schmidt, R; Farrall, M; Spector, TD; Palmer, LJ; Tuomilehto, J; Pfeufer, A; Gasparini, P; Siscovick, D; Altshuler, D; Loos, RJF; Toniolo, D; Snieder, H; Gieger, C; Meneton, P; Wareham, NJ; Oostra, BA; Metspalu, A; Launer, L; Rettig, R; Strachan, DP; Beckmann, JS; Witteman, JCM; Erdmann, J; van Dijk, KW; Boerwinkle, E; Boehnke, M; Ridker, PM; Jarvelin, MR; Chakravarti, A; Abecasis, GR; Gudnason, V; Newton-Cheh, C; Levy, D; Munroe, PB; Psaty, BM; Caulfield, MJ; Rao, DC; Tobin, MD; Elliott, P; van Duijn, CM				Wain, Louise V.; Verwoert, Germaine C.; O'Reilly, Paul F.; Shi, Gang; Johnson, Toby; Johnson, Andrew D.; Bochud, Murielle; Rice, Kenneth M.; Henneman, Peter; Smith, Albert V.; Ehret, Georg B.; Amin, Najaf; Larson, Martin G.; Mooser, Vincent; Hadley, David; Doerr, Marcus; Bis, Joshua C.; Aspelund, Thor; Esko, Tonu; Janssens, A. Cecile J. W.; Zhao, Jing Hua; Heath, Simon; Laan, Maris; Fu, Jingyuan; Pistis, Giorgio; Luan, Jian'an; Arora, Pankaj; Lucas, Gavin; Pirastu, Nicola; Pichler, Irene; Jackson, Anne U.; Webster, Rebecca J.; Zhang, Feng; Peden, John F.; Schmidt, Helena; Tanaka, Toshiko; Campbell, Harry; Igl, Wilmar; Milaneschi, Yuri; Hottenga, Jouke-Jan; Vitart, Veronique; Chasman, Daniel I.; Trompet, Stella; Bragg-Gresham, Jennifer L.; Alizadeh, Behrooz Z.; Chambers, John C.; Guo, Xiuqing; Lehtimaki, Terho; Kuehnel, Brigitte; Lopez, Lorna M.; Polasek, Ozren; Boban, Mladen; Nelson, Christopher P.; Morrison, Alanna C.; Pihur, Vasyl; Ganesh, Santhi K.; Hofman, Albert; Kundu, Suman; Mattace-Raso, Francesco U. S.; Rivadeneira, Fernando; Sijbrands, Eric J. G.; Uitterlinden, Andre G.; Hwang, Shih-Jen; Vasan, Ramachandran S.; Wang, Thomas J.; Bergmann, Sven; Vollenweider, Peter; Waeber, Gerard; Laitinen, Jaana; Pouta, Anneli; Zitting, Paavo; McArdle, Wendy L.; Kroemer, Heyo K.; Voelker, Uwe; Voelzke, Henry; Glazer, Nicole L.; Taylor, Kent D.; Harris, Tamara B.; Alavere, Helene; Haller, Toomas; Keis, Aime; Tammesoo, Mari-Liis; Aulchenko, Yurii; Barroso, Ines; Khaw, Kay-Tee; Galan, Pilar; Hercberg, Serge; Lathrop, Mark; Eyheramendy, Susana; Org, Elin; Sober, Siim; Lu, Xiaowen; Nolte, Ilja M.; Penninx, Brenda W.; Corre, Tanguy; Masciullo, Corrado; Sala, Cinzia; Groop, Leif; Voight, Benjamin F.; Melander, Olle; O'Donnell, Christopher J.; Salomaa, Veikko; d'Adamo, Adamo Pio; Fabretto, Antonella; Faletra, Flavio; Ulivi, Sheila; Del Greco, Fabiola M.; Facheris, Maurizio; Collins, Francis S.; Bergman, Richard N.; Beilby, John P.; Hung, Joseph; Musk, A. William; Mangino, Massimo; Shin, So-Youn; Soranzo, Nicole; Watkins, Hugh; Goel, Anuj; Hamsten, Anders; Gider, Pierre; Loitfelder, Marisa; Zeginigg, Marion; Hernandez, Dena; Najjar, Samer S.; Navarro, Pau; Wild, Sarah H.; Corsi, Anna Maria; Singleton, Andrew; de Geus, Eco J. C.; Willemsen, Gonneke; Parker, Alex N.; Rose, Lynda M.; Buckley, Brendan; Stott, David; Orru, Marco; Uda, Manuela; van der Klauw, Melanie M.; Zhang, Weihua; Li, Xinzhong; Scott, James; Chen, Yii-Der Ida; Burke, Gregory L.; Kahonen, Mika; Viikari, Jorma; Doering, Angela; Meitinger, Thomas; Davies, Gail; Starr, John M.; Emilsson, Valur; Plump, Andrew; Lindeman, Jan H.; 't Hoen, Peter A. C.; Koenig, Inke R.; Felix, Janine F.; Clarke, Robert; Hopewell, Jemma C.; Ongen, Halit; Breteler, Monique; Debette, Stephanie; DeStefano, Anita L.; Fornage, Myriam; Mitchell, Gary F.; Smith, Nicholas L.; Holm, Hilma; Stefansson, Kari; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Samani, Nilesh J.; Preuss, Michael; Rudan, Igor; Hayward, Caroline; Deary, Ian J.; Wichmann, H-Erich; Raitakari, Olli T.; Palmas, Walter; Kooner, Jaspal S.; Stolk, Ronald P.; Jukema, J. Wouter; Wright, Alan F.; Boomsma, Dorret I.; Bandinelli, Stefania; Gyllensten, Ulf B.; Wilson, James F.; Ferrucci, Luigi; Schmidt, Reinhold; Farrall, Martin; Spector, Tim D.; Palmer, Lyle J.; Tuomilehto, Jaakko; Pfeufer, Arne; Gasparini, Paolo; Siscovick, David; Altshuler, David; Loos, Ruth J. F.; Toniolo, Daniela; Snieder, Harold; Gieger, Christian; Meneton, Pierre; Wareham, Nicholas J.; Oostra, Ben A.; Metspalu, Andres; Launer, Lenore; Rettig, Rainer; Strachan, David P.; Beckmann, Jacques S.; Witteman, Jacqueline C. M.; Erdmann, Jeanette; van Dijk, Ko Willems; Boerwinkle, Eric; Boehnke, Michael; Ridker, Paul M.; Jarvelin, Marjo-Riitta; Chakravarti, Aravinda; Abecasis, Goncalo R.; Gudnason, Vilmundur; Newton-Cheh, Christopher; Levy, Daniel; Munroe, Patricia B.; Psaty, Bruce M.; Caulfield, Mark J.; Rao, Dabeeru C.; Tobin, Martin D.; Elliott, Paul; van Duijn, Cornelia M.		LifeLines Cohort Study; EchoGen Consortium; AortaGen Consortium; CHARGE Consortium Heart Failure; KidneyGen Consortium; CKDGen Consortium; Cardiogenics Consortium; CardioGram	Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure	NATURE GENETICS			English	Article							ADRENERGIC-RECEPTOR TRAFFICKING; CARDIOVASCULAR-DISEASE RISK; BLOOD-PRESSURE; HEART-FAILURE; HYPERTENSION; METAANALYSIS; MORTALITY; GENE; MICE; RELEVANCE	Numerous genetic loci have been associated with systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Europeans(1-3). We now report genome-wide association studies of pulse pressure (PP) and mean arterial pressure (MAP). In discovery (N = 74,064) and follow-up studies (N = 48,607), we identified at genome-wide significance (P = 2.7 x 10(-8) to P = 2.3 x 10(-13)) four new PP loci (at 4q12 near CHIC2, 7q22.3 near PIK3CG, 8q24.12 in NOV and 11q24.3 near ADAMTS8), two new MAP loci (3p21.31 in MAP4 and 10q25.3 near ADRB1) and one locus associated with both of these traits (2q24.3 near FIGN) that has also recently been associated with SBP in east Asians. For three of the new PP loci, the estimated effect for SBP was opposite of that for DBP, in contrast to the majority of common SBP- and DBP-associated variants, which show concordant effects on both traits. These findings suggest new genetic pathways underlying blood pressure variation, some of which may differentially influence SBP and DBP.	[O'Reilly, Paul F.; Chambers, John C.; Zhang, Weihua; Li, Xinzhong; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Wain, Louise V.; Tobin, Martin D.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Verwoert, Germaine C.; Mattace-Raso, Francesco U. S.; Rivadeneira, Fernando; Sijbrands, Eric J. G.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Shi, Gang; Rao, Dabeeru C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Shi, Gang; Rao, Dabeeru C.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Johnson, Toby; Munroe, Patricia B.; Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Genome Ctr, London, England; [Johnson, Andrew D.; Larson, Martin G.; Hwang, Shih-Jen; Vasan, Ramachandran S.; Wang, Thomas J.; O'Donnell, Christopher J.; Levy, Daniel] NHLBI, Framingham Heart Study, Framingham, MA USA; [Hwang, Shih-Jen; Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20892 USA; [Bochud, Murielle] CHU Vaudois, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Henneman, Peter; 't Hoen, Peter A. C.; van Dijk, Ko Willems] Leiden Univ Med Ctr, Dept Human Genet, Leiden, Netherlands; [Smith, Albert V.; Aspelund, Thor; Emilsson, Valur; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykajvik, Iceland; [Ehret, Georg B.; Pihur, Vasyl; Chakravarti, Aravinda] Johns Hopkins Univ Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD USA; [Ehret, Georg B.] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Ehret, Georg B.] Univ Hosp Geneva, Dept Specialties Internal Med, Geneva, Switzerland; [Amin, Najaf; Janssens, A. Cecile J. W.; Hofman, Albert; Kundu, Suman; Mattace-Raso, Francesco U. S.; Sijbrands, Eric J. G.; Aulchenko, Yurii; Felix, Janine F.; Breteler, Monique; Witteman, Jacqueline C. M.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Larson, Martin G.] Boston Univ, Dept Math, Boston, MA 02215 USA; [Mooser, Vincent] GlaxoSmithKline, Genet Div R&D, King Of Prussia, PA USA; [Hadley, David; Strachan, David P.] St Georges Univ London, Div Community Hlth Sci, London, England; [Hadley, David] Univ S Florida, Pediat Epidemiol Ctr, Tampa, FL USA; [Doerr, Marcus] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med B, Greifswald, Germany; [Bis, Joshua C.; Siscovick, David; Psaty, Bruce M.] Univ Washington, Dept Med, Div Internal Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Esko, Tonu; Alavere, Helene; Haller, Toomas; Keis, Aime; Tammesoo, Mari-Liis; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Estonian Bioctr, Tartu, Estonia; [Esko, Tonu; Laan, Maris; Org, Elin; Sober, Siim; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Zhao, Jing Hua; Luan, Jian'an; Loos, Ruth J. F.; Wareham, Nicholas J.] Inst Metab Sci, Med Res Council MRC Epidemiol Unit, Cambridge, England; [Heath, Simon; Lathrop, Mark] Inst Genom, Commissariat Energie Atom, Ctr Natl Genotypage, Evry, France; [Fu, Jingyuan; Alizadeh, Behrooz Z.; Lu, Xiaowen; Nolte, Ilja M.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands; [Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Pistis, Giorgio; Corre, Tanguy; Masciullo, Corrado; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Arora, Pankaj; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Ctr Human Genet Res, Boston, MA 02114 USA; [Lucas, Gavin] Inst Municipal Invest Med, E-08003 Barcelona, Spain; [Pirastu, Nicola; d'Adamo, Adamo Pio; Gasparini, Paolo] Univ Trieste, Ist Ricovero & Cura Carattere Sci IRCCS Burlo Gar, Inst Maternal & Child Hlth, Trieste, Italy; [Pichler, Irene; Del Greco, Fabiola M.; Facheris, Maurizio; Pfeufer, Arne] European Acad Bozen Bolzano EURAC, Inst Genet Med, Bolzano, Italy; [Pichler, Irene; Del Greco, Fabiola M.; Facheris, Maurizio; Pfeufer, Arne] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Jackson, Anne U.; Bragg-Gresham, Jennifer L.; Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Webster, Rebecca J.; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Crawley, WA, Australia; [Zhang, Feng; Mangino, Massimo; Shin, So-Youn; Soranzo, Nicole; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Peden, John F.; Watkins, Hugh; Goel, Anuj; Ongen, Halit; Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford, England; [Peden, John F.; Watkins, Hugh; Goel, Anuj; Farrall, Martin] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Schmidt, Helena; Gider, Pierre; Zeginigg, Marion] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Tanaka, Toshiko; Milaneschi, Yuri; Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21224 USA; [Campbell, Harry; Wild, Sarah H.; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Igl, Wilmar; Gyllensten, Ulf B.] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Hottenga, Jouke-Jan] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Vitart, Veronique; Navarro, Pau; Hayward, Caroline; Wright, Alan F.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Chasman, Daniel I.; Rose, Lynda M.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Chasman, Daniel I.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA USA; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ Med Ctr, Dept Cardiol, Leiden, Netherlands; [Trompet, Stella] Leiden Univ Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Chambers, John C.; Zhang, Weihua; Kooner, Jaspal S.] Ealing Hosp Natl Hlth Serv NHS Trust, Middlesex, England; [Guo, Xiuqing; Taylor, Kent D.; Chen, Yii-Der Ida] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, FIN-33101 Tampere, Finland; [Lehtimaki, Terho; Kahonen, Mika] Tampere Univ Hosp, Tampere, Finland; [Kuehnel, Brigitte; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Lopez, Lorna M.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Lopez, Lorna M.; Davies, Gail; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Polasek, Ozren] Univ Split, Sch Med, Dept Publ Hlth, Split, Croatia; [Boban, Mladen] Univ Split, Sch Med, Dept Pharmacol, Split, Croatia; [Nelson, Christopher P.; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Morrison, Alanna C.] Univ Texas Houston Hlth Sci Ctr, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Ganesh, Santhi K.] Univ Michigan Med Ctr, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI USA; [Vasan, Ramachandran S.] Boston Univ Sch Med, Div Epidemiol & Prevent, Boston, MA USA; [Wang, Thomas J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Bergmann, Sven; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Vollenweider, Peter; Waeber, Gerard] CHU Vaudois, Dept Internal Med, Lausanne, Switzerland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland; [Pouta, Anneli] Natl Inst Hlth & Welf, Dept Children Young People & Families, Oulu, Finland; [Pouta, Anneli] Univ Oulu, Inst Clin Med Obstet & Gynaecol, Oulu, Finland; [Zitting, Paavo] Lapland Cent Hosp, Dept Physiatr, Rovaniemi, Finland; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, Avon Longitudinal Study Parents & Children ALSPAC, Bristol, Avon, England; [Kroemer, Heyo K.] Ernst Moritz Arndt Univ Greifswald, Inst Pharmacol, Greifswald, Germany; [Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Inst Genet & Funct Genom, Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Glazer, Nicole L.] Boston Univ Sch Med, Dept Med, Sect Prevent Med & Epidemiol, Boston, MA USA; [Harris, Tamara B.; Launer, Lenore] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Barroso, Ines; Shin, So-Youn; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge, England; [Barroso, Ines] Univ Cambridge Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge, England; [Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Galan, Pilar; Hercberg, Serge] INSERM, U557, Paris, France; [Galan, Pilar; Hercberg, Serge] INRA, U1125, Paris, France; [Galan, Pilar; Hercberg, Serge] Univ Paris 13, Bobigny, France; [Eyheramendy, Susana] Pontificia Univ Catolica Chile, Dept Stat, Santiago, Chile; [Penninx, Brenda W.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Psychiat, Amsterdam, Netherlands; [Penninx, Brenda W.] Leiden Univ Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Groop, Leif] Lund Univ, Malmo Univ Hosp, Diabet & Endocrinol Res Unit, Dept Clin Sci, Malmo, Sweden; [Voight, Benjamin F.; Altshuler, David; Newton-Cheh, Christopher] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Melander, Olle] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Hypertens & Cardiovasc Dis, Malmo, Sweden; [Salomaa, Veikko] THL Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Beilby, John P.] PathW Lab Med, Nedlands, WA, Australia; [Beilby, John P.; Hung, Joseph; Musk, A. William; Palmer, Lyle J.] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn, Nedlands, WA 6009, Australia; [Hung, Joseph; Musk, A. William] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Musk, A. William] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Hamsten, Anders] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Loitfelder, Marisa; Schmidt, Reinhold] Med Univ Graz, Sect Special Neurol, Dept Neurol, Graz, Austria; [Hernandez, Dena; Singleton, Andrew] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Najjar, Samer S.] NIA, Cardiovasc Sci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Najjar, Samer S.] Washington Hosp Ctr, MedStar Hlth Res Inst, Cardiovasc Res Inst, Washington, DC 20010 USA; [Corsi, Anna Maria] Tuscany Reg Hlth Agcy, Florence, Italy; [de Geus, Eco J. C.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, EMGO Inst, Amsterdam, Netherlands; [Parker, Alex N.] Amgen Inc, Cambridge, MA USA; [Buckley, Brendan] Univ Coll Cork, Dept Pharmacol & Therapeut, Cork, Ireland; [Stott, David] Univ Glasgow, Sch Med, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Orru, Marco; Uda, Manuela] CNR, Ist Neurogenet & Neurofarmacol, Monserrato, Italy; [van der Klauw, Melanie M.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London, England; [Burke, Gregory L.] Wake Forest Univ Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [Doering, Angela; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Doering, Angela] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Meitinger, Thomas; Pfeufer, Arne] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Starr, John M.] Univ Edinburgh, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Plump, Andrew] Merck Res Lab, Rahway, NJ USA; [Lindeman, Jan H.] Leiden Univ Med Ctr, Dept Vasc Surg, Leiden, Netherlands; ['t Hoen, Peter A. C.] Leiden Univ Med Ctr, Leiden Genome Technol Ctr, Leiden, Netherlands; [Koenig, Inke R.; Preuss, Michael] Univ Lubeck, Inst Med Biometrie & Stat, Lubeck, Germany; [Felix, Janine F.] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany; [Clarke, Robert; Hopewell, Jemma C.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Clarke, Robert; Hopewell, Jemma C.] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Debette, Stephanie] Boston Univ Sch Med, Dept Neurol, Boston, MA USA; [DeStefano, Anita L.] Boston Univ Sch Publ Hlth, Boston, MA USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Mitchell, Gary F.] Cardiovasc Engn Inc, Norwood, MA USA; [Smith, Nicholas L.; Siscovick, David; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Smith, Nicholas L.] Ctr Dept Vet Affairs Off Res & Dev, Seattle, WA USA; [Smith, Nicholas L.; Psaty, Bruce M.] Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA USA; [Holm, Hilma; Stefansson, Kari; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur] deCODE Genet Inc, Reykjavik, Iceland; [Stefansson, Kari; Thorsteinsdottir, Unnur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Samani, Nilesh J.] Glenfield Hosp, Leicester Natl Inst Hlth Res NIHR Biomed Res Unit, Leicester, Leics, England; [Preuss, Michael; Erdmann, Jeanette] Univ Lubeck, Med Klin 2, Lubeck, Germany; [Rudan, Igor] Univ Split Med Sch, Croatian Ctr Global Hlth, Split, Croatia; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Palmas, Walter] Columbia Univ, New York, NY USA; [Jukema, J. Wouter] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Bandinelli, Stefania] ASF, Geriatr Unit, Florence, Italy; [Palmer, Lyle J.] Ontario Canc Inst Res, Toronto, ON, Canada; [Palmer, Lyle J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Pfeufer, Arne] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; [Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Toniolo, Daniela] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Meneton, Pierre] Ctr Rech Cordeliers, INSERM, U872, Paris, France; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Rettig, Rainer] Ernst Moritz Arndt Univ Greifswald, Inst Physiol, Greifswald, Germany; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, Lausanne, Switzerland; [van Dijk, Ko Willems] Leiden Univ Med Ctr, Dept Internal Med, Leiden, Netherlands; [Boerwinkle, Eric] Ctr Human Genet, Houston, TX USA; [Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr, Oulu, Finland; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Rao, Dabeeru C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Rao, Dabeeru C.] Washington Univ, Dept Math, Sch Med, St Louis, MO 63130 USA; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC Hlth Protect Agcy HPA Ctr Environm & Hlth, London, England; [van Duijn, Cornelia M.] Erasmus MC, Ctr Med Syst Biol, Rotterdam, Netherlands	Imperial College London; University of Leicester; University of Leicester; Erasmus University Rotterdam; Erasmus MC; Washington University (WUSTL); Washington University (WUSTL); University of London; Queen Mary University London; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Washington; University of Washington Seattle; Leiden University; Leiden University Medical Center (LUMC); Icelandic Heart Association; University of Iceland; Johns Hopkins University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Erasmus University Rotterdam; Erasmus MC; Boston University; GlaxoSmithKline; St Georges University London; State University System of Florida; University of South Florida; Ernst Moritz Arndt Universitat Greifswald; University of Washington; University of Washington Seattle; University of Tartu; Estonian Biocentre; University of Tartu; University of Cambridge; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; University of Groningen; University of Groningen; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Harvard University; Massachusetts General Hospital; IRCCS Burlo Garofolo; University of Trieste; European Academy of Bozen-Bolzano; University of Lubeck; University of Michigan System; University of Michigan; University of Western Australia; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Medical University of Graz; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Edinburgh; Uppsala University; Vrije Universiteit Amsterdam; University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Cedars Sinai Medical Center; Tampere University; Tampere University; Tampere University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Edinburgh; University of Edinburgh; University of Split; University of Split; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Michigan System; University of Michigan; Boston University; Harvard University; Massachusetts General Hospital; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Finnish Institute of Occupational Health; Finland National Institute for Health & Welfare; University of Oulu; University of Bristol; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Universite Paris 13; Pontificia Universidad Catolica de Chile; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); University of Groningen; Lund University; Skane University Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Lund University; Skane University Hospital; Finland National Institute for Health & Welfare; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Southern California; University of Western Australia; University of Western Australia; University of Western Australia; Karolinska Institutet; Karolinska University Hospital; Medical University of Graz; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); MedStar Health Research Institute; MedStar Washington Hospital Center; Vrije Universiteit Amsterdam; Amgen; University College Cork; University of Glasgow; Consiglio Nazionale delle Ricerche (CNR); University of Groningen; Imperial College London; Wake Forest University; Tampere University; University of Turku; University of Turku; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Edinburgh; Merck & Company; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); University of Lubeck; Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford; University of Oxford; Boston University; Boston University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Cardiovascular Engineering; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Iceland; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Split; University of Munich; University of Munich; University of Turku; Columbia University; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Finland National Institute for Health & Welfare; University of Helsinki; Technical University of Munich; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Erasmus University Rotterdam; Erasmus MC; Ernst Moritz Arndt Universitat Greifswald; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Leiden University; Leiden University Medical Center (LUMC); Harvard University; Brigham & Women's Hospital; University of Oulu; University of Oulu; University of Washington; University of Washington Seattle; Washington University (WUSTL); Washington University (WUSTL); Imperial College London; Erasmus University Rotterdam; Erasmus MC	Elliott, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	mt47@leicester.ac.uk; p.elliott@imperial.ac.uk; c.vanduijn@erasmusmc.nl	Toniolo, Daniela/AAE-2969-2019; Navarro, Pau/AAJ-8091-2021; Uda, Manuela/AAC-2645-2019; Kronenberg, Florian/B-1736-2008; Gillebert, Thierry C/F-5551-2014; Bakker, Stephan J. L./J-4023-2015; Pfeufer, Arne/B-6634-2013; Colaus, PsyColaus/K-6607-2013; König, Inke R/A-4544-2009; Fu, Jingyuan/E-8980-2012; 't Hoen, Peter/A-4857-2012; Amin, Najaf N/D-1859-2012; Aulchenko, Yurii/M-8270-2013; Newman, Anne B./C-6408-2013; Peters, Annette/A-6117-2011; Lucas, Gavin/D-4346-2012; Smith, Albert Vernon/K-5150-2015; Penninx, Brenda WJH/S-7627-2017; Mangino, Massimo/F-5134-2011; Polasek, Ozren/B-6002-2011; Hypponen, Elina/B-2596-2014; Fu, Jingyuan/ABE-6868-2020; EHRET, Georg B/A-9532-2009; Palmer, Lyle John/N-1948-2019; Kundu, Suman/I-2603-2019; Rice, Kenneth M/A-4150-2013; Palmer, Lyle John/K-3196-2014; Ramachandran, Vasan/Y-2527-2019; Gale, Daniel/D-5594-2013; d'Adamo, Adamo Pio/G-4064-2011; Jukema, J. Wouter/ABD-6503-2021; Wilson, James F/A-5704-2009; Rivadeneira, Fernando/O-5385-2015; Feitosa, Mary F/K-8044-2012; Dörr, Marcus/F-1919-2010; Boomsma, Dorret I/AAX-4470-2020; Hoen, Peter A 't/D-3950-2018; Johnson, Andrew D/G-6520-2013; Stefansson, Kari/AAE-7187-2019; Boban, Mladen/E-2777-2017; van Dijk, Ko Willems/AAT-4681-2021; Haller, Toomas/N-3797-2019; Alizadeh, Behrooz Z Ziad/J-2921-2017; Zgaga, Lina/Q-9415-2018; Lopez, Lorna/AAR-4912-2020; Abecasis, Goncalo R/B-7840-2010; Hadley, David/I-6902-2012; Dominiczak, Anna F/P-9390-2017; Lehtimäki, Terho/AAD-1094-2022; zhang, weihua/GXV-1334-2022; Li, Man/AAX-3400-2020; Fu, JY/GRR-6179-2022; Pilar, Galan/F-2908-2017; bandinelli, stefania/AAL-4570-2020; Meitinger, Thomas/O-1318-2015; Arora, Pankaj/F-3437-2011; Munzel, Thomas/A-2912-2014; Aspelund, Thor/K-7022-2019; Erdmann, Jeanette/A-4417-2009; Deary, Ian J/C-6297-2009; van der Klauw, M. M./A-2138-2014; Pirastu, Nicola/AHB-6226-2022; Pirastu, Nicola/G-4358-2011; de Geus, Eco J.C./M-9318-2015; Aspelund, Thor/C-5983-2008; Org, Elin/AAJ-9631-2021; Campbell, Harry/E-2959-2010; Hwang, Shih-Jen/HGU-5826-2022; Meneton, Pierre/T-1216-2019; Breteler, Monique M.B./J-5058-2014; Schalling, Martin/F-1518-2015; Schmidt, Reinhold/E-1137-2014; Khaw, Kay-Tee/AAZ-3209-2021; Wichmann, Heinz Erich/AAA-5695-2022; Maria, Hernandez-Fuentes/B-5011-2010; Loos, Ruth J F/Q-2862-2016; Gudnason, Vilmundur/K-6885-2015; Erdmann, Jeanette/P-7513-2014; Beckmann, Jacques S/A-9772-2008; Heath, Simon C/J-4138-2012; Ulivi, Sheila/H-3700-2013; Maxwell, Patrick H/C-5557-2008; Serge, Hercberg/F-3038-2017; Raitakari, Olli/AAQ-7389-2021; Sijbrands, Eric/A-1065-2009; Giallauria, Francesco/B-5681-2013; Sala, Cinzia Felicita/AAN-1900-2020; Rudan, Igor/I-1467-2012; Lopez, Lorna M/F-7265-2010; Gasparini, Paolo/B-6173-2014; Levy, Daniel/ABF-6873-2021; van Dijk, Ko Willems/A-1798-2008; Raso, Francesco Mattace-/L-2541-2015; Levy, Daniel/ABB-2752-2021; Shi, Gang/D-3301-2016; Eggermann, Thomas/F-3807-2014; Bochud, Murielle/A-3981-2010; Singleton, Andrew B/C-3010-2009; Stolk, Ronald P/B-2341-2013; HERCBERG, Serge/B-4429-2008; Loos, Ruth/GON-5877-2022; Hayward, Caroline/M-8818-2016; Altshuler, David M/A-4476-2009; Debette, Stephanie/T-4946-2019; Laan, Maris/A-4100-2011; Gudnason, Vilmundur/AAE-7126-2019; Lightstone, Liz/M-4331-2014; Ziegler, Andreas/G-4246-2012	Toniolo, Daniela/0000-0001-9545-6032; Navarro, Pau/0000-0001-5576-8584; Uda, Manuela/0000-0002-4890-6456; Kronenberg, Florian/0000-0003-2229-1120; Gillebert, Thierry C/0000-0002-3832-919X; Bakker, Stephan J. L./0000-0003-3356-6791; König, Inke R/0000-0003-0504-6465; Aulchenko, Yurii/0000-0002-7899-1575; Newman, Anne B./0000-0002-0106-1150; Peters, Annette/0000-0001-6645-0985; Smith, Albert Vernon/0000-0003-1942-5845; Penninx, Brenda WJH/0000-0001-7779-9672; Mangino, Massimo/0000-0002-2167-7470; Polasek, Ozren/0000-0002-5765-1862; Hypponen, Elina/0000-0003-3670-9399; Fu, Jingyuan/0000-0001-5578-1236; EHRET, Georg B/0000-0002-5730-0675; Palmer, Lyle John/0000-0002-1628-3055; Kundu, Suman/0000-0002-6305-2559; Rice, Kenneth M/0000-0001-5779-4495; Palmer, Lyle John/0000-0002-1628-3055; Ramachandran, Vasan/0000-0001-7357-5970; Gale, Daniel/0000-0002-9170-1579; d'Adamo, Adamo Pio/0000-0001-9367-4909; Jukema, J. Wouter/0000-0002-3246-8359; Wilson, James F/0000-0001-5751-9178; Rivadeneira, Fernando/0000-0001-9435-9441; Feitosa, Mary F/0000-0002-0933-2410; Dörr, Marcus/0000-0001-7471-475X; Hoen, Peter A 't/0000-0003-4450-3112; Johnson, Andrew D/0000-0001-6369-5178; Boban, Mladen/0000-0003-1570-9621; van Dijk, Ko Willems/0000-0002-2172-7394; Haller, Toomas/0000-0002-5069-6523; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; Zgaga, Lina/0000-0003-4089-9703; Lopez, Lorna/0000-0002-0241-9783; Dominiczak, Anna F/0000-0003-4913-3608; Lehtimäki, Terho/0000-0002-2555-4427; Li, Man/0000-0002-3839-0281; Pilar, Galan/0000-0003-1706-3107; Arora, Pankaj/0000-0003-2420-3550; Munzel, Thomas/0000-0001-5503-4150; Aspelund, Thor/0000-0002-7998-5433; Deary, Ian J/0000-0002-1733-263X; van der Klauw, M. M./0000-0001-7178-009X; de Geus, Eco J.C./0000-0001-6022-2666; Aspelund, Thor/0000-0002-7998-5433; Campbell, Harry/0000-0002-6169-6262; Breteler, Monique M.B./0000-0002-0626-9305; Schalling, Martin/0000-0001-5011-2922; Maria, Hernandez-Fuentes/0000-0002-7558-9441; Loos, Ruth J F/0000-0002-8532-5087; Gudnason, Vilmundur/0000-0001-5696-0084; Erdmann, Jeanette/0000-0002-4486-6231; Beckmann, Jacques S/0000-0002-9741-1900; Heath, Simon C/0000-0002-9550-0897; Ulivi, Sheila/0000-0003-3606-835X; Maxwell, Patrick H/0000-0002-0338-2679; Serge, Hercberg/0000-0002-3168-1350; Sijbrands, Eric/0000-0001-8857-7389; Giallauria, Francesco/0000-0003-4119-9397; Rudan, Igor/0000-0001-6993-6884; Levy, Daniel/0000-0003-1843-8724; van Dijk, Ko Willems/0000-0002-2172-7394; Bochud, Murielle/0000-0002-5727-0218; Stolk, Ronald P/0000-0002-0518-1205; HERCBERG, Serge/0000-0002-3168-1350; Hayward, Caroline/0000-0002-9405-9550; Altshuler, David M/0000-0002-7250-4107; Debette, Stephanie/0000-0001-8675-7968; Laan, Maris/0000-0002-8519-243X; Gudnason, Vilmundur/0000-0001-5696-0084; Devuyst, Olivier/0000-0003-3744-4767; Stritzke, Jan/0000-0003-3143-7005; Nitsch, Dorothea/0000-0001-5767-248X; Felix, Janine/0000-0002-9801-5774; Faletra, Flavio/0000-0003-1483-3612; Voight, Benjamin/0000-0002-6205-9994; wilkinson, ian/0000-0001-6598-9399; Wild, Philipp/0000-0003-4413-9752; Lightstone, Liz/0000-0002-4603-4076; Pramstaller, Peter P/0000-0002-9831-8302; Willemsen, Gonneke/0000-0003-3755-0236; Goel, Anuj/0000-0003-2307-4021; Beilby, John/0000-0002-4915-2254; Stewart, Alexandre/0000-0003-2673-9164; Bergman, Richard/0000-0003-1539-4471; Emilsson, Valur/0000-0001-9982-0524; Hopewell, Jemma/0000-0002-3870-8018; DeStefano, Anita/0000-0002-9335-2819; Kahonen, Mika/0000-0002-4510-7341; De Meyer, Tim/0000-0003-2994-9693; SCUTERI, ANGELO/0000-0003-4784-5441; Lucas, Gavin/0000-0003-4166-9416; Koenig, Wolfgang/0000-0002-2064-9603; Forouhi, Nita/0000-0002-5041-248X; Elliott, Paul/0000-0002-7511-5684; Eyheramendy, Susana/0000-0003-4723-9660; Lord, Graham/0000-0003-2069-4743; Kovacs, Peter/0000-0002-0290-5423; Aherrahrou, Zouhair/0000-0002-1241-8733; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Wain, Louise/0000-0003-4951-1867; Lawlor, Debbie A/0000-0002-6793-2262; Janssens, A Cecile/0000-0002-6153-4976; Zemunik, Tatijana/0000-0001-8120-2891; Wang, Thomas/0000-0003-4063-6508; Waeber, Gerard/0000-0003-4193-788X; Magi, Reedik/0000-0002-2964-6011; Org, Elin/0000-0001-8688-9717; Bergmann, Sven/0000-0002-6785-9034; Morrison, Alanna/0000-0001-6381-4296; Kleber, Marcus/0000-0003-0663-7275; Pilz, Stefan/0000-0002-7959-1311; s, hema/0000-0002-3440-9475; Preuss, Michael/0000-0001-5266-8465; Kleefstra, Nanne/0000-0003-1473-8519; Gieger, Christian/0000-0001-6986-9554; De Bacquer, Dirk/0000-0002-3202-7238; Stumvoll, Michael/0000-0001-6225-8240; Meitinger, Thomas/0000-0002-8838-8403; Loehr, Laura/0000-0002-9054-1825; Abecasis, Goncalo/0000-0003-1509-1825; Munroe, Patricia/0000-0002-4176-2947; Wallace, Chris/0000-0001-9755-1703; Kloss-Brandstatter, Anita/0000-0002-0873-6704; Caulfield, Mark/0000-0001-9295-3594; Amin, Najaf/0000-0002-8944-1771; Ouwehand, Willem/0000-0002-7744-1790; Barroso, Ines/0000-0001-5800-4520; Couper, David/0000-0002-4313-9235; Johnson, Toby/0000-0002-5998-3270; Fuchsberger, Christian/0000-0002-5918-8947; ELOSUA, ROBERTO/0000-0001-8235-0095; Esko, Tonu/0000-0003-1982-6569; Brown, Morris/0000-0001-8409-1082; Hamburg, Naomi/0000-0001-5504-5589; Mattace-Raso, Francesco/0000-0002-1688-6497; Ongen, Halit/0000-0002-4197-5790; Tobin, Martin/0000-0002-3596-7874; Lakatta, Edward/0000-0002-4772-0035; Zeller, Tanja/0000-0003-3379-2641; Glazer, Nicole/0000-0002-6397-609X; O'Reilly, Paul/0000-0001-7515-0845; Org, Elin/0000-0003-1451-9375; Volker, Uwe/0000-0002-5689-3448; Melander, Olle/0000-0002-2581-484X; Pichler, Irene/0000-0001-8251-0757; Soranzo, Nicole/0000-0003-1095-3852; Nelson, Christopher/0000-0001-8025-2897; Van Duijn, Cornelia/0000-0002-2374-9204; Larson, Martin/0000-0002-9631-1254; Pirastu, Nicola/0000-0002-5363-3886; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Ziegler, Andreas/0000-0002-8386-5397; Gasparini, Paolo/0000-0002-0859-0856	US National Institutes of Health; National Heart, Lung, and Blood Institute, European; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC095159, N01HC085079, N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, R01HL105756, ZIAHL006002, R01HL086694, K23HL080025, R01HL087647, U10HL054512] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG001050, ZIAAG007480] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 20545] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Kidney Research UK [RP24/2/2006] Funding Source: researchfish; Medical Research Council [G0902313, G0601966, MC_U127592696, MC_U127561128, G0401527, MC_PC_U127592696, G0700931, G0701863, MC_U106179471, G0801056, G0700704, G9521010, MC_U106188470, G0801056B, MC_PC_U127561128, G1000143, G0700704B, MC_U137686857] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish; Chief Scientist Office [CZB/4/505, CZB/4/710, ETM/55] Funding Source: researchfish; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0701863, MC_U137686857, G0700931, MC_U127592696, G0601966, G9521010, G0902313, G0801056, MC_U106188470, MC_U127561128, MC_PC_U127561128, MC_PC_U127592696, G0700704] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, European; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	A number of the participating studies and authors are members of the CHARGE and Global BPgen consortia. Many funding mechanisms by the US National Institutes of Health and National Heart, Lung, and Blood Institute, European and private funding agencies contributed to this work, and a full list of acknowledgements is provided in the Supplementary Note.	Blacher J, 2005, NAT CLIN PRACT CARD, V2, P450, DOI 10.1038/ncpcardio0307; Cheng GM, 2005, AM J PHYSIOL-HEART C, V288, pH1193, DOI 10.1152/ajpheart.00109.2004; Cools J, 1999, BLOOD, V94, P1820, DOI 10.1182/blood.V94.5.1820.417k09_1820_1824; DARNE B, 1989, HYPERTENSION, V13, P392, DOI 10.1161/01.HYP.13.4.392; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Domanski M, 2002, JAMA-J AM MED ASSOC, V287, P2677, DOI 10.1001/jama.287.20.2677; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P951, DOI 10.1016/S0735-1097(98)00679-2; Dorn GW, 2010, PHYSIOL REV, V90, P1013, DOI 10.1152/physrev.00001.2010; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ellis PD, 2000, ARTERIOSCL THROM VAS, V20, P1912, DOI 10.1161/01.ATV.20.8.1912; Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kitsios GD, 2010, AM J HYPERTENS, V23, P305, DOI 10.1038/ajh.2009.251; Lawes CMM, 2006, J HYPERTENS, V24, P423, DOI 10.1097/01.hjh.0000209973.67746.f0; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Perrino C, 2007, CIRCULATION, V116, P2571, DOI 10.1161/CIRCULATIONAHA.107.706515; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Rose G, 2005, CORONARY HEART DIS E, P631; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Sesso HD, 2000, HYPERTENSION, V36, P801, DOI 10.1161/01.HYP.36.5.801; Shimoyama T, 2010, ARTERIOSCL THROM VAS, V30, P675, DOI 10.1161/ATVBAHA.110.203356; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Soranzo N, 2009, BLOOD, V113, P3831, DOI 10.1182/blood-2008-10-184234; Wagsater D, 2008, ATHEROSCLEROSIS, V196, P514, DOI 10.1016/j.atherosclerosis.2007.05.018	33	314	319	1	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2011	43	10					1005	U122		10.1038/ng.922	http://dx.doi.org/10.1038/ng.922			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	825XT	21909110	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000295316200017
J	Burdon, KP; Macgregor, S; Hewitt, AW; Sharma, S; Chidlow, G; Mills, RA; Danoy, P; Casson, R; Viswanathan, AC; Liu, JZ; Landers, J; Henders, AK; Wood, J; Souzeau, E; Crawford, A; Leo, P; Wang, JJ; Rochtchina, E; Nyholt, DR; Martin, NG; Montgomery, GW; Mitchell, P; Brown, MA; Mackey, DA; Craig, JE				Burdon, Kathryn P.; Macgregor, Stuart; Hewitt, Alex W.; Sharma, Shiwani; Chidlow, Glyn; Mills, Richard A.; Danoy, Patrick; Casson, Robert; Viswanathan, Ananth C.; Liu, Jimmy Z.; Landers, John; Henders, Anjali K.; Wood, John; Souzeau, Emmanuelle; Crawford, April; Leo, Paul; Wang, Jie Jin; Rochtchina, Elena; Nyholt, Dale R.; Martin, Nicholas G.; Montgomery, Grant W.; Mitchell, Paul; Brown, Matthew A.; Mackey, David A.; Craig, Jamie E.			Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1	NATURE GENETICS			English	Article							VISUALIZATION; GENOTYPE; FAMILY; ANRIL; GENE	We report a genome-wide association study for open-angle glaucoma (OAG) blindness using a discovery cohort of 590 individuals with severe visual field loss (cases) and 3,956 controls. We identified associated loci at TMCO1 (rs4656461[G] odds ratio (OR) = 1.68, P = 6.1 x 10(-10)) and CDKN2B-AS1 (rs4977756[A] OR = 1.50, P = 4.7 x 10(-9)). We replicated these associations in an independent cohort of cases with advanced OAG (rs4656461 P = 0.010; rs4977756 P = 0.042) and two additional cohorts of less severe OAG (rs4656461 combined discovery and replication P = 6.00 x 10(-14), OR = 1.51, 95% CI 1.35-1.68; rs4977756 combined P = 1.35 x 10(-14), OR = 1.39, 95% CI 1.28-1.51). We show retinal expression of genes at both loci in human ocular tissues. We also show that CDKN2A and CDKN2B are upregulated in the retina of a rat model of glaucoma.	[Burdon, Kathryn P.; Hewitt, Alex W.; Sharma, Shiwani; Mills, Richard A.; Landers, John; Souzeau, Emmanuelle; Crawford, April; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr, Adelaide, SA 5001, Australia; [Macgregor, Stuart; Liu, Jimmy Z.; Henders, Anjali K.; Nyholt, Dale R.; Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Hewitt, Alex W.; Wang, Jie Jin; Mackey, David A.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Chidlow, Glyn; Casson, Robert; Wood, John] Univ Adelaide, Adelaide, SA, Australia; [Chidlow, Glyn; Casson, Robert; Wood, John] Hanson Inst, S Australian Inst Ophthalmol, Adelaide, SA, Australia; [Danoy, Patrick; Leo, Paul; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld, Australia; [Viswanathan, Ananth C.] Moorfields Eye Hosp, London, England; [Wang, Jie Jin; Rochtchina, Elena; Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Wang, Jie Jin; Rochtchina, Elena; Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Westmead, NSW 2145, Australia; [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Mackey, David A.] Univ Tasmania, Discipline Med, Hobart, Tas, Australia	Flinders Medical Centre; Flinders University South Australia; QIMR Berghofer Medical Research Institute; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Adelaide; Hanson Institute; University of Queensland; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Lions Eye Institute; University of Western Australia; University of Tasmania	Craig, JE (corresponding author), Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr, Adelaide, SA 5001, Australia.	jamie.craig@flinders.edu.au	Montgomery, Grant W/B-7148-2008; Martin, Nicholas/R-9235-2019; Burdon, Kathryn/AAD-2334-2022; Macgregor, Stuart/C-6442-2009; Mitchell, Paul/P-1498-2014; wang, jie/GRS-0942-2022; Casson, Robert/D-1561-2013; Hewitt, Alex W/D-1936-2013; Mackey, David A/H-5340-2014; Wang, Jie Jin/P-1499-2014; Leo, Paul/R-4464-2019; Nyholt, Dale Robert/J-3174-2017; Leo, Paul J/B-3470-2011; Souzeau, Emmanuelle/AAB-5608-2022; Brown, Matthew A/E-5749-2010; Burdon, Kathryn/A-5026-2009; Henders, Anjali/E-3126-2017	Montgomery, Grant W/0000-0002-4140-8139; Martin, Nicholas/0000-0003-4069-8020; Burdon, Kathryn/0000-0001-8217-1249; Macgregor, Stuart/0000-0001-6731-8142; Hewitt, Alex W/0000-0002-5123-5999; Mackey, David A/0000-0001-7914-4709; Wang, Jie Jin/0000-0001-9491-4898; Nyholt, Dale Robert/0000-0001-7159-3040; Leo, Paul J/0000-0001-8325-4134; Souzeau, Emmanuelle/0000-0002-2015-6577; Brown, Matthew A/0000-0003-0538-8211; Burdon, Kathryn/0000-0001-8217-1249; Henders, Anjali/0000-0003-3672-1451; Craig, Jamie/0000-0001-9955-9696; Sharma, Shiwani/0000-0002-0828-025X; Mills, Richard/0000-0002-7386-2571	National Health and Medical Research Council (NHMRC) of Australia [535074]; Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Eye Foundation; Clifford Craig Medical Research Trust; Ophthalmic Research Institute of Australia (ORIA); Pfizer Australia; Glaucoma Australia; American Health Assistance Foundation (AHAF); Peggy and Leslie Cranbourne Foundation; Jack Brockhoff Foundation; National Eye Institute (NEI); NHMRC [241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496610, 496739, 552485, 552498, 496674, 613705, 595944, 613674]; Cooperative Research Centre for Discovery of Genes for Common Human Diseases; Cerylid Biosciences (Melbourne); Australian Research Council [FT0991022]; Glaucoma Australia and Endometriosis Associations	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Eye Foundation; Clifford Craig Medical Research Trust; Ophthalmic Research Institute of Australia (ORIA); Pfizer Australia(PfizerPfizer Australia); Glaucoma Australia; American Health Assistance Foundation (AHAF); Peggy and Leslie Cranbourne Foundation; Jack Brockhoff Foundation; National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Discovery of Genes for Common Human Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cerylid Biosciences (Melbourne); Australian Research Council(Australian Research Council); Glaucoma Australia and Endometriosis Associations	This research was funded by the National Health and Medical Research Council (NHMRC) of Australia, project grant 535074 to J.E.C., A. W. H., S. M., D. A. M. and K. P. B. We also thank the following organizations for their financial support: Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Eye Foundation, Clifford Craig Medical Research Trust, Ophthalmic Research Institute of Australia (ORIA), Pfizer Australia, Glaucoma Australia, American Health Assistance Foundation (AHAF), Peggy and Leslie Cranbourne Foundation, Jack Brockhoff Foundation, and National Eye Institute (NEI) Project Grant (2007-2010). The Australian Twin Registry is supported by an NHMRC Enabling Grant (2004-2009). The Queensland Institute of Medical Research (QIMR) Study was also supported by grants from the NHMRC (241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496610, 496739, 552485 and 552498), the Cooperative Research Centre for Discovery of Genes for Common Human Diseases, Cerylid Biosciences (Melbourne) and donations from N. and S. Hawkins.; S. M. and K. P. B. are supported by NHMRC Career Development Awards (496674, 613705 and 595944). D. R. N. was supported by the NHMRC Fellowship (339462 and 613674) and Australian Research Council Future Fellowship (FT0991022) schemes. G. W. M., M. A. B. and J.E.C. are supported by the NHMRC Fellowships Scheme. D. A. M. is a recipient of the Pfizer Australia Senior Research Fellowship.; We thank all participants of the Australian and New Zealand Registry of Advanced Glaucoma (ANZRAG), the Glaucoma Inheritance Study in Tasmania (GIST), the Blue Mountains Eye study (BMES), the Queensland Institute of Medical Research (QIMR) study, Oxford Endometriosis Gene Study (OXEGENE), the Nurses Health Study (NHS) and the Brisbane Adolescent Twin Study (BATS) and the staff who have collated clinical data and DNA samples over many years. We thank Glaucoma Australia and Endometriosis Associations for supporting study recruitment. We thank S. Nicolaides, Queensland Medical Laboratory and SA Pathology for pro bono collection and delivery of blood samples and other pathology services for assistance with blood collection.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beavis W.D., 1994, P 49 ANN CORN SORGH, P250; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901; Green CM, 2007, CLIN EXP OPHTHALMOL, V35, P793, DOI 10.1111/j.1442-9071.2007.01612.x; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hewitt AW, 2009, CLIN EXP OPHTHALMOL, V37, P836, DOI 10.1111/j.1442-9071.2009.02181.x; HEWITT AW, 2009, CLIN EXPT OPHTHALMOL, V37, P903; Iwamuro S, 1999, J BIOCHEM-TOKYO, V126, P48, DOI 10.1093/oxfordjournals.jbchem.a022435; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Painter JN, 2011, NAT GENET, V43, P51, DOI 10.1038/ng.731; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Rao KN, 2010, INVEST OPHTH VIS SCI, V51, P4937, DOI 10.1167/iovs.10-5553; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Team RC., 2022, R LANG ENV STAT COMP; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Williams TM, 2004, J BIOL CHEM, V279, P24745, DOI 10.1074/jbc.M402064200; Xin BZ, 2010, P NATL ACAD SCI USA, V107, P258, DOI 10.1073/pnas.0908457107; Zhang ZS, 2010, MOL BIOL REP, V37, P1611, DOI 10.1007/s11033-009-9573-8	32	314	329	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2011	43	6					574	U110		10.1038/ng.824	http://dx.doi.org/10.1038/ng.824			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	769ME	21532571	Green Accepted			2022-12-17	WOS:000291017000016
J	Eminli, S; Foudi, A; Stadtfeld, M; Maherali, N; Ahfeldt, T; Mostoslavsky, G; Hock, H; Hochedlinger, K				Eminli, Sarah; Foudi, Adlen; Stadtfeld, Matthias; Maherali, Nimet; Ahfeldt, Tim; Mostoslavsky, Gustavo; Hock, Hanno; Hochedlinger, Konrad			Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells	NATURE GENETICS			English	Article							HUMAN SOMATIC-CELLS; HUMAN FIBROBLASTS; PROGENITOR CELLS; NUCLEAR TRANSFER; MATURE B; GENERATION; INDUCTION; SYSTEM; OCT4; EXPRESSION	The reprogramming of somatic cells into induced pluripotent stem (iPS) cells upon overexpression of the transcription factors Oct4, Sox2, Klf4 and cMyc is inefficient. It has been assumed that the somatic differentiation state provides a barrier for efficient reprogramming; however, direct evidence for this notion is lacking. Here, we tested the potential of mouse hematopoietic cells at different stages of differentiation to be reprogrammed into iPS cells. We show that hematopoietic stem and progenitor cells give rise to iPS cells up to 300 times more efficiently than terminally differentiated B and T cells do, yielding reprogramming efficiencies of up to 28%. Our data provide evidence that the differentiation stage of the starting cell has a critical influence on the efficiency of reprogramming into iPS cells. Moreover, we identify hematopoietic progenitors as an attractive cell type for applications of iPS cell technology in research and therapy.	[Eminli, Sarah; Foudi, Adlen; Stadtfeld, Matthias; Maherali, Nimet; Ahfeldt, Tim; Hock, Hanno; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Eminli, Sarah; Foudi, Adlen; Stadtfeld, Matthias; Maherali, Nimet; Ahfeldt, Tim; Hock, Hanno; Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA USA; [Eminli, Sarah; Stadtfeld, Matthias; Maherali, Nimet; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Eminli, Sarah; Foudi, Adlen; Stadtfeld, Matthias; Maherali, Nimet; Hock, Hanno; Hochedlinger, Konrad] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Eminli, Sarah] Free Univ Berlin, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Maherali, Nimet] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ahfeldt, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol 2, Hamburg, Germany; [Mostoslavsky, Gustavo] Boston Univ, Sch Med, Gastroenterol Sect, Dept Med, Boston, MA 02118 USA; [Mostoslavsky, Gustavo] Boston Univ, Ctr Regenerat Med, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Free University of Berlin; Harvard University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Boston University; Boston University	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	hock.hanno@mgh.harvard.edu; khochedlinger@helix.mgh.harvard.edu	Ahfeldt, Tim/E-2935-2017; Foudi, Adlen/L-7251-2018	Foudi, Adlen/0000-0001-5002-5490; Ahfeldt, Tim/0000-0001-6377-7376; Stadtfeld, Matthias/0000-0002-5852-9906; Mostoslavsky, Gustavo/0000-0002-0784-2169	Ellison Foundation to Massachusetts General Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Ellison Foundation to Massachusetts General Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Xie for sharing the C/ EBPa overexpression vector, R. Mostoslavsky for critical reading of the manuscript, L. Prickett and K. Folz- Donahue for help with FACS and P. Follett for help with blastocyst injections. A. F. was the recipient of the Lady Tata Memorial Trust Award. A Postdoctoral Fellowship from Schering Foundation supported M. S. This work was supported by a contribution from the Ellison Foundation to Massachusetts General Hospital start- up funds for H. H., by an American Society of Hematology ( ASH) Scholar Award to H. H. and by the Harvard Stem Cell Institute. Support to K. H. came from the US National Institutes of Health ( NIH) Director's Innovator Award, the Harvard Stem Cell Institute, the Kimmel Foundation and the V Foundation.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2007, NAT GENET, V39, P136, DOI 10.1038/ng0207-136; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Li JS, 2007, P NATL ACAD SCI USA, V104, P2738, DOI 10.1073/pnas.0611358104; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; RAMSDELL F, 2006, CURR PROTOC IMMUNOL, V71; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sitnicka E, 1996, BLOOD, V87, P4998, DOI 10.1182/blood.V87.12.4998.bloodjournal87124998; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	51	314	333	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2009	41	9					968	U29		10.1038/ng.428	http://dx.doi.org/10.1038/ng.428			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488WX	19668214	Green Accepted			2022-12-17	WOS:000269382100007
J	Wai, T; Teoli, D; Shoubridge, EA				Wai, Timothy; Teoli, Daniella; Shoubridge, Eric A.			The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes	NATURE GENETICS			English	Article							BALBIANI BODY; RAPID SEGREGATION; MOUSE; CELLS; REDUCTION; MOLECULES; VARIANCES; SELECTION; GENOTYPES; EQUALITY	In mammals, mitochondrial DNA (mtDNA) sequence variants are observed to segregate rapidly between generations despite the high mtDNA copy number in the oocyte. This has led to the concept of a genetic bottleneck for the transmission of mtDNA(1-3), but the mechanism remains contentious. Several studies have suggested that the bottleneck occurs during embryonic development, as a result of a marked reduction in germline mtDNA copy number(4,5). Mitotic segregation of mtDNAs during preimplantation(5), or during the expansion of primordial germ cells (PGCs) before they colonize the gonad(4,5), is thought to account for the increase in genotypic variance observed among mature oocytes from heteroplasmic mothers. This view has, however, been challenged by studies suggesting that the bottleneck occurs without a reduction in germline mtDNA content(6). To resolve this controversy, we measured mtDNA heteroplasmy and copy number in single germ cells isolated from heteroplasmic mice. By directly tracking the evolution of mtDNA genotypic variance during oogenesis, we show that the genetic bottleneck occurs during postnatal folliculogenesis and not during embryonic oogenesis.	[Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	eric@ericpc.mni.mcgill.ca	Wai, Timothy/AAA-7226-2019	Wai, Timothy/0000-0002-6770-6222	Canadian Institutes of Health Research; US National Institutes of Health; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050794] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank L. Villeneuve for help with confocal microscopy; J. Mui for assistance with electron microscopy; T. Johns, F. Jones and D. Sabour for technical assistance; and J. Correa for statistical design. We are grateful for antibodies directed against TFAM (B. Kaufman, MNI), mt-SSB (M. Zeviani, Instituto Carlo Besta) and POLG (W. Copeland, US National Institutes of Health). The OCT4 Delta PE-EGFP mice were obtained from H. R. Scholer (University of Pennsylvania). This research was supported by the Canadian Institutes of Health Research and the US National Institutes of Health. E. A. S. is an International Scholar of the Howard Hughes Medical Institute.	Battersby BJ, 2005, HUM MOL GENET, V14, P2587, DOI 10.1093/hmg/ddi293; Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; El Shourbagy SH, 2006, REPRODUCTION, V131, P233, DOI 10.1530/rep.1.00551; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Jansen R P, 2000, Hum Reprod, V15 Suppl 2, P112; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Lim TS, 1996, COMPUT STAT DATA AN, V22, P287, DOI 10.1016/0167-9473(95)00054-2; MCKEE MD, 1995, MICROSC RES TECHNIQ, V31, P44, DOI 10.1002/jemt.1070310105; MICHAELS GS, 1982, DEV BIOL, V94, P246, DOI 10.1016/0012-1606(82)90088-4; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; PAN G, 2007, J NONPARAMETR STAT, V14, P459; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Shoubridge EA, 2008, SCIENCE, V319, P914, DOI 10.1126/science.1154515; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Yeom YI, 1996, DEVELOPMENT, V122, P881; Zhang YH, 2006, MOL GENET METAB, V89, P164, DOI 10.1016/j.ymgme.2006.03.014	30	314	321	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1484	1488		10.1038/ng.258	http://dx.doi.org/10.1038/ng.258			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	19029901				2022-12-17	WOS:000261215900027
J	Rahimov, F; Marazita, ML; Visel, A; Cooper, ME; Hitchler, MJ; Rubini, M; Domann, FE; Govil, M; Christensen, K; Bille, C; Melbye, M; Jugessur, A; Lie, RT; Wilcox, AJ; Fitzpatrick, DR; Green, ED; Mossey, PA; Little, J; Steegers-Theunissen, RP; Pennacchio, LA; Schutte, BC; Murray, JC				Rahimov, Fedik; Marazita, Mary L.; Visel, Axel; Cooper, Margaret E.; Hitchler, Michael J.; Rubini, Michele; Domann, Frederick E.; Govil, Manika; Christensen, Kaare; Bille, Camille; Melbye, Mads; Jugessur, Astanand; Lie, Rolv T.; Wilcox, Allen J.; Fitzpatrick, David R.; Green, Eric D.; Mossey, Peter A.; Little, Julian; Steegers-Theunissen, Regine P.; Pennacchio, Len A.; Schutte, Brian C.; Murray, Jeffrey C.		NISC Comparative Sequencing Pr	Disruption of an AP-2 alpha binding site in an IRF6 enhancer is associated with cleft lip	NATURE GENETICS			English	Article							OROFACIAL CLEFTS; ORAL CLEFTS; PALATE; GENE; POPULATION; SEQUENCES; POLYMORPHISMS; CONTRIBUTES; EXPRESSION; MUTATIONS	Previously we have shown that nonsyndromic cleft lip with or without cleft palate (NSCL/P)(1) is strongly associated with SNPs in IRF6 (interferon regulatory factor 6)(2). Here, we use multispecies sequence comparisons to identify a common SNP (rs642961, G>A) in a newly identified IRF6 enhancer. The A allele is significantly overtransmitted (P = 1 x 10(-11)) in families with NSCL/P, in particular those with cleft lip but not cleft palate. Further, there is a dosage effect of the A allele, with a relative risk for cleft lip of 1.68 for the AG genotype and 2.40 for the AA genotype. EMSA and ChIP assays demonstrate that the risk allele disrupts the binding site of transcription factor AP-2a and expression analysis in the mouse localizes the enhancer activity to craniofacial and limb structures. Our findings place IRF6 and AP-2a in the same developmental pathway and identify a high-frequency variant in a regulatory element contributing substantially to a common, complex disorder.	[Rahimov, Fedik; Schutte, Brian C.; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Marazita, Mary L.; Cooper, Margaret E.; Govil, Manika] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15219 USA; [Visel, Axel; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genome Div, Berkeley, CA 94720 USA; [Hitchler, Michael J.; Domann, Frederick E.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Rubini, Michele] Univ Ferrara, Med Genet Unit, Dept Expt Diagnost Med, I-44100 Ferrara, Italy; [Christensen, Kaare; Bille, Camille] Univ So Denmark, Inst Publ Hlth, Ctr Prevent Congenital Malinformat, DK-5000 Odense C, Denmark; [Melbye, Mads] Danish Epidemiol Sci Ctr, State Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Jugessur, Astanand; Lie, Rolv T.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, N-5018 Bergen, Norway; [Wilcox, Allen J.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Fitzpatrick, David R.] Western Gen Hosp, Med Res Council Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Green, Eric D.; NISC Comparative Sequencing Pr] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Green, Eric D.; NISC Comparative Sequencing Pr] NHGRI, US Natl Inst Hlth Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Mossey, Peter A.] Univ Dundee, Dent Hosp & Sch, Dundee DD1 4HR, Scotland; [Little, Julian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; [Steegers-Theunissen, Regine P.] Univ Med Ctr, NL-3015 GD Rotterdam, Netherlands	University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Iowa; University of Ferrara; University of Southern Denmark; Aarhus University; Statens Serum Institut; University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Dundee; University of Ottawa	Murray, JC (corresponding author), Univ Iowa, Dept Pediat, 2182 ML,S Grand Ave, Iowa City, IA 52242 USA.	jeff-murray@uiowa.edu	FitzPatrick, David R/C-7301-2013; Christensen, Kaare/C-2360-2009; Rahimov, Fedik/H-2685-2013; Visel, Axel/A-9398-2009; Wilcox, Allen J/C-7723-2019; Rubini, Michele/AFF-8477-2022; Little, Julian/AAR-6117-2020	Christensen, Kaare/0000-0002-5429-5292; Visel, Axel/0000-0002-4130-7784; Wilcox, Allen J/0000-0002-3376-1311; Rubini, Michele/0000-0003-1448-9516; Little, Julian/0000-0001-5026-5531; FitzPatrick, David R./0000-0003-4861-969X; Domann, Frederick/0000-0002-0489-2179; melbye, mads/0000-0001-8264-6785; Mossey, Peter/0000-0002-9914-6901; Pennacchio, Len/0000-0002-8748-3732; Rahimov, Fedik/0000-0001-6519-7404	National Institutes of Health (NIH) [P50 DE16215, P30 ES05605, R37 DE08559, R01-DE13513, 1 UL1 RR024979-01, R01-CA73612, R01-HG003988]; Intramural Research Program of the National Human Genome Research Institute; Intramural Research Program of the NIH; National Institute of Environmental Health Sciences; European Commission FP5; EUROCRAN [QLG1-CT-2000-01019]; American Heart Association;  [DE-AC02-05CH11231];  [T32 CA078586]; NATIONAL CANCER INSTITUTE [T32CA078586, R01CA073612] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, R01HG003988, ZIAHG000060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559, R01DE016148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559, P50DE009170, P50DE016215, R01DE013513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010876, P30ES005605, ZIAES049027] Funding Source: NIH RePORTER; MRC [MC_U127561093] Funding Source: UKRI; Medical Research Council [MC_U127561093] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); European Commission FP5(European CommissionEuropean Commission Joint Research Centre); EUROCRAN; American Heart Association(American Heart Association); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank A. Kinoshita, K. Frees, A. Mansilla, J. L'Heureux, M. Johnson, H. Morrison, G. Wehby, N. Rorick, K. Bedell and L. Powers for technical assistance and S. McConnell, D. Benton and M. DeVore for their administrative assistance. We would also like to thank A. Klingelhutz (University of Iowa) for kindly providing us with HFK cell line. This work was supported by grants from the National Institutes of Health (NIH): P50 DE16215 (J.C.M., M.L.M., B.C.S.), P30 ES05605 (J.C.M.), R37 DE08559 (J.C.M., M.L.M.), R01-DE13513 (B.C.S.), 1 UL1 RR024979-01 (J.C.M., B.C.S.), R01-CA73612 (F.E.D.), R01-HG003988 administered under Department of Energy Contract DE-AC02-05CH11231 (L.A.P.) as well as by the Intramural Research Program of the National Human Genome Research Institute (E.D.G.), in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (A.J.W.), and European Commission FP5: EUROCRAN Project (contract no. QLG1-CT-2000-01019) (M.R., P.A.M., J.L., R.P.S.-T.). A.V. was supported by the American Heart Association. M.J.H. received salary support from T32 CA078586.	Bille C, 2007, EUR J EPIDEMIOL, V22, P173, DOI 10.1007/s10654-006-9099-5; Blanton SH, 2005, AM J MED GENET A, V137A, P259, DOI 10.1002/ajmg.a.30887; Cirulli ET, 2007, HUM MOL GENET, V16, P1931, DOI 10.1093/hmg/ddm140; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Ghassibe M, 2005, EUR J HUM GENET, V13, P1239, DOI 10.1038/sj.ejhg.5201486; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Harville EW, 2005, AM J EPIDEMIOL, V162, P448, DOI 10.1093/aje/kwi214; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Milunsky JM, 2008, AM J HUM GENET, V82, P1171, DOI 10.1016/j.ajhg.2008.03.005; Mitchell LE, 2002, CLEFT PALATE-CRAN J, V39, P93, DOI 10.1597/1545-1569(2002)039<0093:GFTDAA>2.0.CO;2; Mossey P, 2007, ORTHOD CRANIOFAC RES, V10, P114, DOI 10.1111/j.1601-6343.2007.00398.x; Nguyen RHN, 2007, ANN EPIDEMIOL, V17, P763, DOI 10.1016/j.annepidem.2007.04.008; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Park JW, 2007, GENET MED, V9, P219, DOI 10.1097/GIM.0b013e3180423cca; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Provenzano MJ, 2007, EXP MOL PATHOL, V83, P277, DOI 10.1016/j.yexmp.2007.06.001; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Scapoli L, 2005, AM J HUM GENET, V76, P180, DOI 10.1086/427344; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	30	314	331	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1341	1347		10.1038/ng.242	http://dx.doi.org/10.1038/ng.242			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836445	Green Accepted			2022-12-17	WOS:000260501500028
J	Lowe, CE; Cooper, JD; Brusko, T; Walker, NM; Smyth, DJ; Bailey, R; Bourget, K; Plagnol, V; Field, S; Atkinson, M; Clayton, DG; Wicker, LS; Todd, JA				Lowe, Christopher E.; Cooper, Jason D.; Brusko, Todd; Walker, Neil M.; Smyth, Deborah J.; Bailey, Rebecca; Bourget, Kirsi; Plagnol, Vincent; Field, Sarah; Atkinson, Mark; Clayton, David G.; Wicker, Linda S.; Todd, John A.			Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; INSULIN GENE; T-CELLS; INTERLEUKIN-2; SEQUENCE; RECEPTOR; LOCUS; HLA; SUSCEPTIBILITY	Genome- wide association studies are now identifying disease- associated chromosome regions. However, even after convincing replication, the localization of the causal variant( s) requires comprehensive resequencing, extensive genotyping and statistical analyses in large sample sets leading to targeted functional studies. Here, we have localized the type 1 diabetes ( T1D) association in the interleukin 2 receptor alpha ( IL2RA) gene region to two independent groups of SNPs, spanning overlapping regions of 14 and 40 kb, encompassing IL2RA intron 1 and the 5' regions of IL2RA and RBM17 ( odds ratio 2.04, 95% confidence interval 1.70 - 2.45; P 1.92 x 10(-28); control frequency 0.635). Furthermore, we have associated IL2RA T1D susceptibility genotypes with lower circulating levels of the biomarker, soluble IL- 2RA ( P 6.28 x 10(-28)), suggesting that an inherited lower immune responsiveness predisposes to T1D.	Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England; Univ Florida, Coll Med, Gainesville, FL 32610 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; State University System of Florida; University of Florida	Todd, JA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England.	john.todd@cimr.cam.ac.uk	Plagnol, Vincent/A-5667-2011; Todd, John A/A-3542-2010; Wicker, Linda S/F-7384-2010	Todd, John A/0000-0003-2740-8148; Brusko, Todd/0000-0003-2878-9296; smyth, deborah/0000-0002-6330-2669; Walker, Neil/0000-0001-9796-7688; Plagnol, Vincent/0000-0002-5597-9215	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [061859, 068545/Z/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bleesing J, 2007, ARTHRITIS RHEUM-US, V56, P965, DOI 10.1002/art.22416; Bonfield JK, 1998, NUCLEIC ACIDS RES, V26, P3404, DOI 10.1093/nar/26.14.3404; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Burren Oliver S., 2004, Human Genomics, V1, P98; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Feltbower RG, 2003, DIABETIC MED, V20, P437, DOI 10.1046/j.1464-5491.2003.00960.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GIORDANO C, 1989, DIABETES, V38, P310, DOI 10.2337/diabetes.38.3.310; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Ionescu-Tirgoviste C, 2001, DIABETOLOGIA, V44, pB60, DOI 10.1007/PL00002956; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; KLOSE RJ, 1993, TRENDS BIOCHEM SCI, V52, P506; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; Makis AC, 2005, J INFECTION, V51, P206, DOI 10.1016/j.jinf.2004.10.013; Naranjo-Gomez M, 2007, EUR J IMMUNOL, V37, P1764, DOI 10.1002/eji.200636980; Patterson CC, 1996, DIABETOLOGIA, V39, P1063, DOI 10.1007/BF00400655; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Qu HQ, 2007, DIABETES, V56, P1174, DOI 10.2337/db06-1555; ROBB RJ, 1987, J IMMUNOL, V139, P855; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; She JX, 1999, P NATL ACAD SCI USA, V96, P8116, DOI 10.1073/pnas.96.14.8116; Smink LJ, 2005, NUCLEIC ACIDS RES, V33, pD544; Smyth DJ, 2005, NAT GENET, V37, P110, DOI 10.1038/ng0205-110; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tree TIM, 2006, ANN NY ACAD SCI, V1079, P9, DOI 10.1196/annals.1375.002; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; UNDLIEN DE, 1995, AM J HUM GENET, V57, P1511; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	49	314	323	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1074	1082		10.1038/ng2102	http://dx.doi.org/10.1038/ng2102			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17676041				2022-12-17	WOS:000249122400016
J	Dunoyer, P; Himber, C; Voinnet, O				Dunoyer, P; Himber, C; Voinnet, O			DICER-LIKE 4 is required for RNA interference and produces the 21-nucleotide small interfering RNA component of the plant cell-to-cell silencing signal	NATURE GENETICS			English	Article							TRANS-ACTING SIRNAS; GENE; ARABIDOPSIS; VIRUS; BIOGENESIS; MICRORNAS; ELEGANS; SGS3	In RNA interference(1,2), the RNase-III enzyme Dicer(3) processes exogenous double-stranded RNA into small interfering RNAs (siRNAs). siRNAs guide RNA-induced silencing complexes to cleave homologous transcripts, enabling gene-specific knockdown(4). In plants, double-stranded RNA is processed into siRNA species of 21 nucleotides (nt) and 24 nt (ref. 5), but, unlike in nematodes(6), the Dicer enzymes involved in this processing have not been identified. Additionally, in both plants and nematodes, systemic signals(7-10) with RNA components convey the sequence-specific effects of RNA interference between cells. Here, we describe Arabidopsis thaliana mutants with altered silencing cell-to-cell movement beyond the vasculature. At least three SILENCING MOVEMENT DEFICIENT genes (SMD1, SMD2 and SMD3) are required for trafficking, the extent of which correlates with siRNA levels in the veins. Five alleles defective in synthesis of 21-nt, but not 24-nt, siRNAs carry mutations in Dicer-like 4 (DCL4) that are involved in biogenesis of trans-acting siRNAs(11,12). We show that the biogenesis and function of trans-acting siRNA can be genetically uncoupled from a bona fide DCL4-dependent pathway that accounts for RNA interference and for production of the 21-nt siRNA component of the plant cell-to-cell silencing signal.	CNRS, UPR 2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Voinnet, O (corresponding author), CNRS, UPR 2357, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr		Voinnet, Olivier/0000-0001-6982-9544				Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Waterhouse PM, 2003, NAT REV GENET, V4, P29, DOI 10.1038/nrg982; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	25	314	340	1	46	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2005	37	12					1356	1360		10.1038/ng1675	http://dx.doi.org/10.1038/ng1675			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16273107				2022-12-17	WOS:000233657300016
J	Grachtchouk, M; Rong, M; Yu, S; Zhang, XY; Sasaki, H; Hui, CC; Dlugosz, AA				Grachtchouk, M; Rong, M; Yu, S; Zhang, XY; Sasaki, H; Hui, CC; Dlugosz, AA			Basal cell carcinomas in mice overexpressing Gli2 in skin	NATURE GENETICS			English	Article							SONIC HEDGEHOG; TRANSCRIPTION FACTOR; HUMAN HOMOLOG; NEURAL-TUBE; EXPRESSION; MUTATIONS; GENE		Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Osaka Univ, Inst Mol & Cellular Biol, Dev Biol Lab, Osaka, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Osaka University	Dlugosz, AA (corresponding author), Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.				NCI NIH HHS [CA46592] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Booth DR, 1999, CANCER METAST REV, V18, P261, DOI 10.1023/A:1006377425099; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Ding Q, 1998, DEVELOPMENT, V125, P2533; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Lee J, 1997, DEVELOPMENT, V124, P2537; MARKEY AC, 1992, BRIT J DERMATOL, V126, P154, DOI 10.1111/j.1365-2133.1992.tb07813.x; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; SMOLLER BR, 1994, BRIT J DERMATOL, V131, P28, DOI 10.1111/j.1365-2133.1994.tb08453.x; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	16	314	328	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2000	24	3					216	217		10.1038/73417	http://dx.doi.org/10.1038/73417			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	288XW	10700170				2022-12-17	WOS:000085590600009
J	Wijnen, J; de Leeuw, W; Vasen, H; van der Klift, H; Moller, P; Stormorken, A; Meijers-Heijboer, H; Lindhout, D; Menko, F; Vossen, S; Moslein, G; Tops, C; Brocker-Vriends, A; Wu, Y; Hofstra, R; Sijmons, R; Cornelisse, C; Morreau, H; Fodde, R				Wijnen, J; de Leeuw, W; Vasen, H; van der Klift, H; Moller, P; Stormorken, A; Meijers-Heijboer, H; Lindhout, D; Menko, F; Vossen, S; Moslein, G; Tops, C; Brocker-Vriends, A; Wu, Y; Hofstra, R; Sijmons, R; Cornelisse, C; Morreau, H; Fodde, R			Familial endometrial cancer in female carriers of MSH6 germline mutations	NATURE GENETICS			English	Letter							NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH-REPAIR; GENE; CELLS; HNPCC; BETA		Leiden Univ, Med Ctr, Dept Human & Clin Genet, MGC, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Fdn Detect Hereditary Tumors, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Gastroenterol, NL-2300 RA Leiden, Netherlands; Norwegian Radium Hosp, Unit Med Genet, Oslo, Norway; Erasmus Univ, Dept Clin Genet, MGC, NL-3000 DR Rotterdam, Netherlands; Free Univ Amsterdam Hosp, Dept Clin Genet, Amsterdam, Netherlands; Univ Dusseldorf, Dept Surg, D-4000 Dusseldorf, Germany; Leiden Univ, Med Ctr, Clin Genet Ctr Leiden, NL-2300 RA Leiden, Netherlands; Univ Groningen, Dept Med Genet, Groningen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oslo; Erasmus University Rotterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Heinrich Heine University Dusseldorf; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen	Fodde, R (corresponding author), Leiden Univ, Med Ctr, Dept Human & Clin Genet, MGC, NL-2300 RA Leiden, Netherlands.	fodde@ruly46.medfac.leidenuniv.nl	Sijmons, Rolf/E-5829-2012; Lindhout, Dick/AAH-5765-2019; Fodde, Riccardo/AAW-9394-2021	Sijmons, Rolf/0000-0001-8446-2779; Fodde, Riccardo/0000-0001-9839-4324; Lindhout, Dick/0000-0001-9580-624X; Hofstra, Robert/0000-0001-7498-3829; Vasen, Hans/0000-0003-2682-2603				Akiyama Y, 1997, CANCER RES, V57, P3920; Boland CR, 1998, CANCER RES, V58, P5248; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; LU SL, 1995, BIOCHEM BIOPH RES CO, V216, P452, DOI 10.1006/bbrc.1995.2644; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wijnen J, 1998, NAT GENET, V20, P326, DOI 10.1038/3795; Wijnen J, 1997, AM J HUM GENET, V61, P329, DOI 10.1086/514847; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; WU Y, IN PRESS AM J HUM GE	15	314	332	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1999	23	2					142	144		10.1038/13773	http://dx.doi.org/10.1038/13773			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	240LM	10508506				2022-12-17	WOS:000082827500010
J	Munroe, PB; Olgunturk, RO; Fryns, JP; Van Maldergem, L; Ziereisen, F; Yuksel, B; Gardiner, RM; Chung, E				Munroe, PB; Olgunturk, RO; Fryns, JP; Van Maldergem, L; Ziereisen, F; Yuksel, B; Gardiner, RM; Chung, E			Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome	NATURE GENETICS			English	Article							VITAMIN-K; ASSIGNMENT; MOUSE; MAP	Keutel syndrome (KS, MIM 245150) is an autosomal recessive disorder characterized by abnormal cartilage calcification, peripheral pulmonary stenosis and midfacial hypoplasia(1). A genome search using homozygosity mapping provided evidence of linkage to chromosome 12p12.3-13.1 (maximum multipoint lod score, 4.06). MGP was a candidate on the basis of its localization to this chromosomal region and the known function of its protein(2-4). MGP maps to chromosome 12p near D12S363 (refs 2,3). Human MCP is a 10-kD skeletal extracellular matrix (ECM) protein that consists of an 84-aa mature protein and a 19-aa transmembrane signal peptide(5). It is a member of the Gla protein family, which includes osteocalcin(6), another skeletal ECM protein, and a number of coagulation factors(7) (factors II, VII, IX, X and proteins S and C). All members of this family have glutamic acid residues modified to gamma-carboxyglutamic acids (Gla) by a specific gamma-carboxylase using Vitamin K as a cofactors(8,9). The modified glutamic acid residues of Gla proteins confer a high affinity for mineral ions such as calcium, phosphate and hydroxyapatite crystals, the mineral components of the skeletal ECM. The pattern and tissue distribution of Mgp expression in mice suggest a role for Mgp in regulating ECM calcification(10). Mglap-deficient mice (Mglap(-/-)) have been reported to have inappropriate calcification of cartilage(4). Mutational analysis of MGP in three unrelated probands identified three different mutations: c.69delG, IVS1-2A-->G and c.113T-->A. All three mutations predict a non-functional MGP. Our data indicate that mutations in MGP are responsible for KS and confirm its role in the regulation of extracellular matrix calcification.	UCL Royal Free & Univ Coll Med Sch, Dept Paediat, Rayne Inst, London, England; Gazi Univ Hosp, Dept Paediat Cardiol, Ankara, Turkey; Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; Inst Pathol & Genet, Ctr Human Genet, Loverval, Belgium; Hop Univ Enfants Reine Fabiola, Dept Radiol, Brussels, Belgium; Chase Farm Hosp NHS Trust, Dept Paediat, London, England	University of London; King's College London; University College London; UCL Medical School; Gazi University; KU Leuven; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Munroe, PB (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Paediat, Rayne Inst, Univ St, London, England.	p.munroe@ucl.ac.uk	Van Maldergem, Lionel/G-9849-2017; Van Maldergem, Lionel/O-3242-2019	Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Munroe, Patricia/0000-0002-4176-2947				CANCELA L, 1990, J BIOL CHEM, V265, P15040; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; CORMODE EJ, 1986, AM J MED GENET, V24, P289, DOI 10.1002/ajmg.1320240209; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOWD P, 1995, SCIENCE, V269, P1684, DOI 10.1126/science.7569894; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; FASCO MJ, 1982, J BIOL CHEM, V257, P1210; FRANKE TF, 1995, CELL, V81, P1; FRASER JD, 1988, J BIOL CHEM, V263, P11033; FRYNS JP, 1984, EUR J PEDIATR, V142, P201, DOI 10.1007/BF00442449; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GALLOP PM, 1980, NEW ENGL J MED, V302, P1460, DOI 10.1056/NEJM198006263022608; HALE JE, 1988, J BIOL CHEM, V263, P5820; HOWE AM, 1995, AM J MED GENET, V58, P238, DOI 10.1002/ajmg.1320580309; JOHNSON TL, 1991, GENOMICS, V11, P770, DOI 10.1016/0888-7543(91)90089-W; KEUTEL J, 1972, Birth Defects Original Article Series, V8, P60; KHOSROSHAHI HE, 1989, EUR J PEDIATR, V149, P188, DOI 10.1007/BF01958278; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LUO GB, 1995, J BONE MINER RES, V10, P325; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Munroe PB, 1997, AM J HUM GENET, V61, P310, DOI 10.1086/514846; PAULI RM, 1987, AM J HUM GENET, V41, P566; PETTIFOR JM, 1975, J PEDIATR-US, V86, P459; Say B, 1973, Pediatr Radiol, V1, P127, DOI 10.1007/BF00973228; SHEFFIELD LJ, 1976, J PEDIATR-US, V89, P916, DOI 10.1016/S0022-3476(76)80596-3; SPRANGER JW, 1970, HUM GENET, V11, P190; Watanabe I, 1998, J HUM GENET, V43, P75, DOI 10.1007/s100380050044	27	314	323	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1999	21	1					142	144		10.1038/5102	http://dx.doi.org/10.1038/5102			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	155RT	9916809				2022-12-17	WOS:000077960700027
J	SchulzeBahr, E; Wang, Q; Wedekind, H; Haverkamp, W; Chen, QY; Sun, YL; Rubie, C; Hordt, M; Towbin, JA; Borggrefe, M; Assmann, G; Qu, XD; Somberg, JC; Breithardt, G; Oberti, C; Funke, H				SchulzeBahr, E; Wang, Q; Wedekind, H; Haverkamp, W; Chen, QY; Sun, YL; Rubie, C; Hordt, M; Towbin, JA; Borggrefe, M; Assmann, G; Qu, XD; Somberg, JC; Breithardt, G; Oberti, C; Funke, H			KCNE1 mutations cause Jervell and Lange-Nielsen syndrome	NATURE GENETICS			English	Letter							LONG-QT SYNDROME; CARDIAC-ARRHYTHMIA; POTASSIUM CHANNEL; GENE; MINK; ISK; K(V)LQT1; PROTEINS; FORM		UNIV MUNSTER,INST ARTERIOSCLEROSIS RES,D-48129 MUNSTER,GERMANY; UNIV MUNSTER,DEPT CARDIOL & ANGIOL,D-48129 MUNSTER,GERMANY; UNIV MUNSTER,INST CLIN CHEM & LAB MED,D-48129 MUNSTER,GERMANY; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; FAC MED,DEPT FISIOL,LAB CARDIOVASC,MONTEVIDEO,URUGUAY; FINCH UNIV HLTH SCI CHICAGO MED SCH,DEPT MED,N CHICAGO,IL 60064	University of Munster; University of Munster; University of Munster; Baylor College of Medicine; Universidad de la Republica, Uruguay; Chicago Medical School			Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X				Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; LAI LP, 1994, GENE, V151, P339, DOI 10.1016/0378-1119(94)90685-8; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; RUST S, 1993, NUCLEIC ACIDS RES, V21, P3623, DOI 10.1093/nar/21.16.3623; SAKAGAMI M, 1991, HEARING RES, V56, P168, DOI 10.1016/0378-5955(91)90166-7; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SchulzeBahr E, 1995, NEW ENGL J MED, V333, P1783; SCHULZEBAHR E, 1995, J MOL MED, V73, P565; SCHULZEBAHR E, IN PRESS HUM GENET; Splawski I, 1997, NEW ENGL J MED, V336, P1562, DOI 10.1056/NEJM199705293362204; Tesson F, 1996, J MOL CELL CARDIOL, V28, P2051, DOI 10.1006/jmcc.1996.0198; WANG KW, 1995, NEURON, V14, P1303, DOI 10.1016/0896-6273(95)90277-5; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17	16	314	332	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					267	268		10.1038/ng1197-267	http://dx.doi.org/10.1038/ng1197-267			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354783				2022-12-17	WOS:A1997YD66700013
J	MOULTON, T; CRENSHAW, T; HAO, Y; MOOSIKASUWAN, J; LIN, N; DEMBITZER, F; HENSLE, T; WEISS, L; MCMORROW, L; LOEW, T; KRAUS, W; GERALD, W; TYCKO, B				MOULTON, T; CRENSHAW, T; HAO, Y; MOOSIKASUWAN, J; LIN, N; DEMBITZER, F; HENSLE, T; WEISS, L; MCMORROW, L; LOEW, T; KRAUS, W; GERALD, W; TYCKO, B			EPIGENETIC LESIONS AT THE H19 LOCUS IN WILMS-TUMOR PATIENTS	NATURE GENETICS			English	Article							GROWTH FACTOR-II; BECKWITH-WIEDEMANN SYNDROME; REPEAT POLYMORPHISM; HUMAN CANCERS; GENE; EXPRESSION; MOUSE; RNA; CELLS; HYPOMETHYLATION	To test the potential role of H19 as a tumour suppressor gene we have examined its expression and DNA methylation in Wilms' tumours (WTs). In most WTs (18/25), H19 RNA was reduced at least 20-fold from fetal kidney levels. Of the expression-negative tumours ten retained 11p15.5 heterozygosity: in nine of these, H19 DNA was biallelically hypermethylated and in two cases hypermethylation locally restricted to H19 sequences was also present in the non-neoplastic kidney parenchyma. IGF2 mRNA was expressed in most but not all WTs and expression patterns were consistent with IGF2/H19 enhancer competition without obligate inverse coupling. These observations implicate genetic and epigenetic inactivation of H19 in Wilms' tumorigenesis.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,DIV ONCOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PEDIAT,DIV PEDIAT HEMATOL ONCOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,DIV NEUROPATHOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT SURG,DIV PEDIAT SURG,NEW YORK,NY 10032; CITY HOPE NATL MED CTR,DEPT PATHOL,DUARTE,CA 91010; UNIV MED & DENT NEW JERSEY,COOPER HOSP,MED CTR,DEPT PEDIAT,DIV HEMATOL ONCOL,CAMDEN,NJ 08103; SO ILLINOIS UNIV,SCH MED,DEPT PEDIAT,DIV PEDIAT HEMATOL ONCOL,SPRINGFIELD,IL 62702; SCOTTISH RITE CHILDRENS HOSP,DEPT PEDIAT,DIV GENET,ATLANTA,GA 30342; MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021	Columbia University; Columbia University; Columbia University; Columbia University; City of Hope; Rutgers State University New Brunswick; Rutgers State University Medical Center; Southern Illinois University System; Southern Illinois University; Memorial Sloan Kettering Cancer Center								BACCARINI P, 1993, AM J PATHOL, V143, P1535; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BRUNKOW ME, 1991, GENE DEV, V5, P1092, DOI 10.1101/gad.5.6.1092; CHAO LY, 1993, NAT GENET, V3, P127, DOI 10.1038/ng0293-127; COPPES MJ, 1992, GENE CHROMOSOME CANC, V5, P326, DOI 10.1002/gcc.2870050408; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FIDLER AE, 1992, LANCET, V339, P243, DOI 10.1016/0140-6736(92)90042-2; GOSHEN R, 1993, MOL REPROD DEV, V34, P374, DOI 10.1002/mrd.1080340405; HAN DKM, 1992, CIRC RES, V71, P711, DOI 10.1161/01.RES.71.3.711; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; HASELBACHER GK, 1987, P NATL ACAD SCI USA, V84, P1104, DOI 10.1073/pnas.84.4.1104; HENRY I, 1989, HUM GENET, V81, P273, DOI 10.1007/BF00279003; KLINEDINST DK, 1991, MUTAT RES, V250, P365, DOI 10.1016/0027-5107(91)90193-R; LITTLE MH, 1992, EUR J CANCER, V28A, P1876, DOI 10.1016/0959-8049(92)90027-Y; LUSTIG O, IN PRESS MOL REP DEV; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; POIRIER F, 1991, DEVELOPMENT, V113, P1105; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P3753, DOI 10.1093/nar/19.13.3753; RACHMILEWITZ J, 1992, MOL REPROD DEV, V32, P196, DOI 10.1002/mrd.1080320303; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RASTINEJAD F, 1993, CELL, V75, P1107, DOI 10.1016/0092-8674(93)90320-P; REEVE AE, 1985, NATURE, V317, P258, DOI 10.1038/317258a0; Riggins Gregory J., 1992, Human Molecular Genetics, V1, P775, DOI 10.1093/hmg/1.9.775; SCOTT J, 1985, NATURE, V317, P260, DOI 10.1038/317260a0; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TARTOF KD, 1991, CELL, V65, P201, DOI 10.1016/0092-8674(91)90153-P; TYCKO B, 1994, AM J PATHOL, V144, P431; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; WILES MV, 1988, DEVELOPMENT, V104, P403; YANDELL DW, 1986, SOMAT CELL MOLEC GEN, V12, P255, DOI 10.1007/BF01570784; ZHANG YH, 1993, AM J HUM GENET, V53, P113; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	40	314	321	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					440	447		10.1038/ng0794-440	http://dx.doi.org/10.1038/ng0794-440			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920666				2022-12-17	WOS:A1994NU30600022
J	GISPERT, S; TWELLS, R; OROZCO, G; BRICE, A; WEBER, J; HEREDERO, L; SCHEUFLER, K; RILEY, B; ALLOTEY, R; NOTHERS, C; HILLERMANN, R; LUNKES, A; KHATI, C; STEVANIN, G; HERNANDEZ, A; MAGARINO, C; KLOCKGETHER, T; DURR, A; CHNEIWEISS, H; ENCZMANN, J; FARRALL, M; BECKMANN, J; MULLAN, M; WERNET, P; AGID, Y; FREUND, HJ; WILLIAMSON, R; AUBURGER, G; CHAMBERLAIN, S				GISPERT, S; TWELLS, R; OROZCO, G; BRICE, A; WEBER, J; HEREDERO, L; SCHEUFLER, K; RILEY, B; ALLOTEY, R; NOTHERS, C; HILLERMANN, R; LUNKES, A; KHATI, C; STEVANIN, G; HERNANDEZ, A; MAGARINO, C; KLOCKGETHER, T; DURR, A; CHNEIWEISS, H; ENCZMANN, J; FARRALL, M; BECKMANN, J; MULLAN, M; WERNET, P; AGID, Y; FREUND, HJ; WILLIAMSON, R; AUBURGER, G; CHAMBERLAIN, S			CHROMOSOMAL ASSIGNMENT OF THE 2ND LOCUS FOR AUTOSOMAL-DOMINANT CEREBELLAR-ATAXIA (SCA2) TO CHROMOSOME 12Q23-24.1	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; LINKAGE; SYSTEM	The autosomal dominant cerebellar ataxias (ADCA) are a group of neurodegenerative disorders characterized by onset with gait ataxia, dysarthria, dysmetria and dysdiadochokinesia. We have demonstrated previously genetic heterogeneity within these disorders by excluding the disease locus from the documented spinocerebellar ataxia locus (SCA1) on chromosome 6p in a large Cuban founder population. We now report the assignment of a second locus for ADCA (SCA2) to chromosome 12q23-24.1 following linkage analyses carried out for the Cuban pedigrees, with probable flanking markers D12S58 and phospholipase A2. Investigation of linkage to the interval containing SCA2 for seven French ADCA families, previously excluded from linkage to SCA1, provides preliminary data suggesting the existence of a third ADCA locus (SCA3).	UNIV HOSP DUESSELDORF, DEPT NEUROL, MOORENSTR 5, W-4000 DUSSELDORF, GERMANY; UNIV LONDON IMPERIAL COLL SCI & TECHNOL, ST MARYS HOSP, SCH MED, DEPT BIOCHEM & MOLEC GENET, LONDON W2 1PG, ENGLAND; NATL CTR MED GENET, HAVANA, CUBA; LENIN HOSP, DEPT NEUROL, HOLGUIN, CUBA; MARSHFIELD MED RES FDN, MARSHFIELD, WI 54449 USA; INST HAEMATOL & IMMUNOL, HAVANA, CUBA; UNIV HOSP TUEBINGEN, DEPT NEUROL, TUBINGEN, GERMANY; UNIV HOSP DUESSELDORF, INST TRANSFUS MED, IMMUNOL LAB, DUSSELDORF, GERMANY; CTR ETUD POLYMORPHISME HUMAIN, F-75010 PARIS, FRANCE; UNIV S FLORIDA, SUNCOAST GERONTOL CTR, TAMPA, FL 33612 USA; ROYAL POSTGRAD MED SCH, DEPT MED, MRC, MOLEC MED GRP, LONDON W12 0HS, ENGLAND; COLL FRANCE, INSERM, U114, F-75231 PARIS 05, FRANCE; HOP LA PITIE SALPETRIERE, INSERM, U289, F-75651 PARIS 13, FRANCE; HOP LA PITIE SALPETRIERE, SERV NEUROL & NEUROPSYCHOL, F-75651 PARIS 13, FRANCE	Imperial College London; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; State University System of Florida; University of South Florida; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite			brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; Stevanin, Giovanni/E-5038-2016; herve, chneiweiss/Q-6818-2019; Beckmann, Jacques S/A-9772-2008	brice, alexis/0000-0002-0941-3990; Stevanin, Giovanni/0000-0001-9368-8657; herve, chneiweiss/0000-0001-7675-5061; Beckmann, Jacques S/0000-0002-9741-1900				AUBURGER G, 1990, AM J HUM GENET, V46, P1163; Brown S., 1892, BRAIN, V15, P250; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; COUTINHO P, 1978, NEUROLOGY, V28, P703, DOI 10.1212/WNL.28.7.703; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; GIPSERT S, 1993, HUM HERED, V43, P12; HOPPENER JWM, 1985, HUM GENET, V69, P157, DOI 10.1007/BF00293288; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; KHATI C, IN PRESS NEUROLOGY; KONIGSMARK BW, 1971, BRITH DEFECTS ORIG A, V1, P178; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; OTT J, 1979, TRANSPLANT P, V11, P1689; POGACAR S, 1978, ARCH NEUROL-CHICAGO, V35, P156, DOI 10.1001/archneur.1978.00500270038008; POLYMEROPOULOS MH, 1990, NUCLEIC ACIDS RES, V18, P7468, DOI 10.1093/nar/18.24.7468-a; RANUM LPW, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171-a; ROMANUL FCA, 1977, NEW ENGL J MED, V296, P1505, DOI 10.1056/NEJM197706302962606; WEATHERALL DJ, 1984, NEW GENETICS CLIN PR; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1991, CYTOGENET CELL GENET, V58, P1864; WEINER LP, 1967, ARCH NEUROL-CHICAGO, V16, P364, DOI 10.1001/archneur.1967.00470220028004; YAKURA H, 1974, NEW ENGL J MED, V291, P154	23	314	321	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1993	4	3					295	299		10.1038/ng0793-295	http://dx.doi.org/10.1038/ng0793-295			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358438				2022-12-17	WOS:A1993LJ84200019
J	HINDS, HL; ASHLEY, CT; SUTCLIFFE, JS; NELSON, DL; WARREN, ST; HOUSMAN, DE; SCHALLING, M				HINDS, HL; ASHLEY, CT; SUTCLIFFE, JS; NELSON, DL; WARREN, ST; HOUSMAN, DE; SCHALLING, M			TISSUE SPECIFIC EXPRESSION OF FMR-1 PROVIDES EVIDENCE FOR A FUNCTIONAL-ROLE IN FRAGILE-X SYNDROME	NATURE GENETICS			English	Article							LINKED MENTAL-RETARDATION; DNA; PREVALENCE	We have performed mRNA in situ hybridization studies and northern blot analysis in the mouse and human, respectively, to determine the normal gene expression patterns of FMR-1. Expression in the adult mouse was localized to several regions of the brain and the tubules of the testes, which are two of the major organs affected in fragile X syndrome. Universal and very strong expression was observed in early mouse embryos, with differentially decreasing expression during subsequent stages of embryonic development. The early embryonic onset and tissue specificity of FMR-1 gene expression is consistent with involvement in the fragile X phenotype, and also suggests additional organ systems in which clinical manifestations of reduced FMR-1 gene expression may occur.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139; BAYLOR COLL MED,HOUSTON,TX 77030; HOWARD HUGHES MED INST,CTR HUMAN GENOME,INST MOLEC GENET,HOUSTON,TX; EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT PEDIAT,ATLANTA,GA 30322	Massachusetts Institute of Technology (MIT); Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Emory University; Howard Hughes Medical Institute; Emory University; Howard Hughes Medical Institute			Warren, Stephen T/A-2498-2012; Sutcliffe, James S/C-1348-2012	Sutcliffe, James S/0000-0001-5200-6007	NHLBI NIH HHS [5P01-HL41484] Funding Source: Medline; NICHD NIH HHS [HD20521, 1R01-HD29256] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020521, R37HD020521, R01HD029256] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041484] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; BENNETT DOROTHEA, 1956, J MORPH, V98, P199, DOI 10.1002/jmor.1050980202; Davies KE, 1989, FRAGILE X SYNDROME; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GUSTAVSON KH, 1986, AM J MED GENET, V23, P581, DOI 10.1002/ajmg.1320230152; HARRISON CJ, 1983, J MED GENET, V20, P280, DOI 10.1136/jmg.20.4.280; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; KAHKONEN M, 1987, HUM GENET, V77, P85; LUBS HA, 1969, AM J HUM GENET, V21, P231; Maino D M, 1990, J Am Optom Assoc, V61, P316; MANDEL JL, AM J MED GENET, V43, P5; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PEMBREY ME, 1986, TRENDS NEUROSCI, V9, P58, DOI 10.1016/0166-2236(86)90021-4; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1990, J AM ACAD CHILD PSY, V29, P885, DOI 10.1097/00004583-199011000-00007; REISS AL, 1991, ANN NEUROL, V29, P26, DOI 10.1002/ana.410290107; REISS AL, 1990, BIOL PSYCHIAT, V27, P223, DOI 10.1016/0006-3223(90)90652-I; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; Sambrook J., 1989, MOL CLONING LAB MANU; SCHALLING M, 1992, GENE EXPRESSION NEUR, P231; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; TURNER G, 1980, AM J MED GENET, V7, P407, DOI 10.1002/ajmg.1320070403; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151; WILLEMS PJ, 1993, NATURE GENET, V3, P31; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	33	314	323	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					36	43		10.1038/ng0193-36	http://dx.doi.org/10.1038/ng0193-36			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490651				2022-12-17	WOS:A1993KF37200010
J	Romberg, N; Al Moussawi, K; Nelson-Williams, C; Stiegler, AL; Loring, E; Choi, M; Overton, J; Meffre, E; Khokhal, MK; Huttner, AJ; West, B; Podoltsev, NA; Boggon, TJ; Kazmierczak, BI; Lifton, RP				Romberg, Neil; Al Moussawi, Khatoun; Nelson-Williams, Carol; Stiegler, Amy L.; Loring, Erin; Choi, Murim; Overton, John; Meffre, Eric; Khokhal, Mustafa K.; Huttner, Anita J.; West, Brian; Podoltsev, Nikolai A.; Boggon, Titus J.; Kazmierczak, Barbara I.; Lifton, Richard P.			Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation	NATURE GENETICS			English	Article							MUCKLE-WELLS-SYNDROME; CELL-DEATH; INFLAMMASOME; ACTIVATION; CASPASE-1; INTERLEUKIN-1-BETA; MECHANISM; BACTERIA; DISEASES; ADAPTERS	Upon detection of pathogen-associated molecular patterns, innate immune receptors initiate inflammatory responses. These receptors include cytoplasmic NOD-like receptors (NLRs) whose stimulation recruits and proteolytically activates caspase-1 within the inflammasome, a multiprotein complex. Caspase-1 mediates the production of interleukin-1 family cytokines (IL1FCs), leading to fever and inflammatory cell death (pyroptosis)(1,2). Mutations that constitutively activate these pathways underlie several autoinflammatory diseases with diverse clinical features(3). We describe a family with a previously unreported syndrome featuring neonatal-onset enterocolitis, periodic fever, and fatal or near-fatal episodes of autoinflammation. We show that the disease is caused by a de novo gain-of-function mutation in NLRC4 encoding a p.Val341Ala substitution in the HD1 domain of the protein that cosegregates with disease. Mutant NLRC4 causes constitutive IL1FC production and macrophage cell death. Infected macrophages from affected individuals are polarized toward pyroptosis and exhibit abnormal staining for inflammasome components. These findings identify and describe the cause of a life-threatening but treatable autoinflammatory disease that underscores the divergent roles of the NLRC4 inflammasome.	[Romberg, Neil] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Al Moussawi, Khatoun; Meffre, Eric; Podoltsev, Nikolai A.; Kazmierczak, Barbara I.; Lifton, Richard P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Nelson-Williams, Carol; Loring, Erin; Choi, Murim; Overton, John; Khokhal, Mustafa K.; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Nelson-Williams, Carol; Choi, Murim; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Stiegler, Amy L.; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Meffre, Eric] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Huttner, Anita J.; West, Brian] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Kazmierczak, Barbara I.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	barbara.kazmierczak@yale.edu; richard.lifton@yale.edu	Wang, Guilin/G-8794-2018; Choi, Murim/AAP-9120-2021	Kazmierczak, Barbara/0000-0002-8162-803X; Romberg, Neil/0000-0002-1881-5318	US National Institutes of Health/National Institute of Child Health and Human Development [K12HD0141401-10]; Yale Center for Mendelian Genomics [U54HG006504 01]; US National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01AI081825]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001401] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081825] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Yale Center for Mendelian Genomics; US National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the patients and their families for their participation. We thank the Yale pediatric and medicine intensive care teams for providing access to patients. We thank the staff of the Yale Center for Genome Analysis for the generation of the exome sequence data and the Yale Center for Clinical Investigation for statistical assistance. We thank C. Roy (Yale School of Medicine) for the CASP1 and ASC constructs and L. Devine for multiplex cytokine detection. This work was supported by grants K12HD0141401-10 (US National Institutes of Health/National Institute of Child Health and Human Development) to N.R., U54HG006504 01 (Yale Center for Mendelian Genomics) to R.P.L. and R01AI081825 (US National Institutes of Health/National Institute of Allergy and Infectious Diseases) to B.I.K. B.I.K. is a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hoffman HM, 2008, ARTHRITIS RHEUM, V58, P2443, DOI 10.1002/art.23687; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Jordan MB, 2011, BLOOD, V118, P4041, DOI 10.1182/blood-2011-03-278127; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Neven B, 2008, NAT CLIN PRACT RHEUM, V4, P481, DOI 10.1038/ncprheum0874; Ozen S, 2014, NAT REV RHEUMATOL, V10, P135, DOI 10.1038/nrrheum.2013.174; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	25	313	327	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2014	46	10					1135	1139		10.1038/ng.3066	http://dx.doi.org/10.1038/ng.3066			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ1PU	25217960	Green Accepted			2022-12-17	WOS:000342554100019
J	Wu, XM; Viveiros, MM; Eppig, JJ; Bai, YC; Fitzpatrick, SL; Matzuk, MM				Wu, XM; Viveiros, MM; Eppig, JJ; Bai, YC; Fitzpatrick, SL; Matzuk, MM			Zygote arrest 1 (Zar1) is a novel maternal-effect gene critical for the oocyte-to-embryo transition	NATURE GENETICS			English	Article							MOUSE; ACTIVATION; PHD; DEFICIENT; MUTATION; DEFECTS; MOTIF	The female gamete (the oocyte) serves the distinct purpose of transmitting the maternal genome and other maternal factors that are critical for post-ovulation events(1-4). Through the identification and characterization of oocyte-specific factors, we are beginning to appreciate the diverse functions of oocytes in ovarian folliculogenesis, fertilization and embryogenesis(5),(6). To understand these processes further, we identified genes called zygote arrest 1 (Zar1 and ZAR1 in mouse and human, respectively) as novel oocyte-specific genes. These encode proteins of 361 amino acids and 424 amino acids, respectively, which share 59% amino-acid identity and an atypical plant homeo-domain (PHD) motif(7). Although Zar1-null (Zar1(-/-)) mice are viable and grossly normal, Zar1(-/-) females are infertile. Ovarian development and oogenesis through the early stages of fertilization are evidently unimpaired, but most embryos from Zar1(-/-) females arrest at the one-cell stage. Distinct pronuclei form and DNA replication initiates, but the maternal and paternal genomes remain separate in arrested zygotes. Fewer than 20% of the embryos derived from Zar1(-/-) females progress to the two-cell stage and show marked reduction in the synthesis of the transcription-requiring complex(8), and no embryos develop to the four-cell stage. Thus, Zar1 is the first identified oocyte-specific maternal-effect gene that functions at the oocyte-to-embryo transition and, as such, offers new insights into the initiation of embryonic development and fertility control in mammals.	Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Wyeth Ayerst Res, Collegeville, PA USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Jackson Laboratory; Pfizer; Baylor College of Medicine; Baylor College of Medicine	Matzuk, MM (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.	nnnatzuk@bcm.tmc.edu	Viveiros, Maria/P-4120-2015					AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Albrecht U, 1997, MOL CELLULAR METHODS, P23; Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; BRADLEY A, 1987, PRODUCTION ANAL CHIM, P113; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; CONOVER JC, 1991, DEV BIOL, V144, P392, DOI 10.1016/0012-1606(91)90431-2; Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO;2-Z; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1018, DOI 10.1210/me.13.6.1018; Eppig JJ, 1999, ADV MOLEC BIOL, P3; Ferreira J, 1997, J CELL SCI, V110, P889; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Gibbons RJ, 1997, NAT GENET, V17, P146, DOI 10.1038/ng1097-146; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Kumar TR, 2000, ENDOCRINOLOGY, V141, P4270, DOI 10.1210/en.141.11.4270; Latham KE, 1999, INT REV CYTOL, V193, P71; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Matzuk MM, 2002, NAT MED, V8, P41, DOI 10.1038/nm-fertilityS41; MATZUK MM, 1992, BIOCHEM BIOPH RES CO, V185, P404, DOI 10.1016/S0006-291X(05)81000-9; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Prolla TA, 1998, NAT GENET, V18, P276, DOI 10.1038/ng0398-276; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 2002, HUM REPROD, V17, P903, DOI 10.1093/humrep/17.4.903; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yan W, 2002, MOL ENDOCRINOL, V16, P1168, DOI 10.1210/me.16.6.1168	29	313	340	6	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2003	33	2					187	191		10.1038/ng1079	http://dx.doi.org/10.1038/ng1079			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641YB	12539046				2022-12-17	WOS:000180773700018
J	Daluiski, A; Engstrand, T; Bahamonde, ME; Gamer, LW; Agius, E; Stevenson, SL; Cox, K; Rosen, V; Lyons, KM				Daluiski, A; Engstrand, T; Bahamonde, ME; Gamer, LW; Agius, E; Stevenson, SL; Cox, K; Rosen, V; Lyons, KM			Bone morphogenetic protein-3 is a negative regulator of bone density	NATURE GENETICS			English	Article							SIGNALING PATHWAYS; II RECEPTORS; ACTIVIN-A; DIFFERENTIATION; EXPRESSION; CELLS; IDENTIFICATION; CULTURES; OSTEOPOROSIS; DROSOPHILA	Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-beta (TGF-beta) superfamily. Many BMPs are produced in bone and show osteogenic activity, suggesting that they may be determinants of bone mass. BMP3 was originally purified from bone as osteogenin, which induces osteogenic differentiation(1). Recombinant BMP3 (rhBMP3) has no biological activity, however, leaving its role in skeletal growth unclear. Here we show that BMP3 is an antagonist of osteogenic BMPs: BMP3 dorsalizes Xenopus laevis embryos, inhibits BMP2-mediated induction of Msx2 and blocks BMP2-mediated differentiation of osteoprogenitor cells into osteoblasts. These effects appear to be mediated through activin receptors. Finally, Smp3(-/-) mice have twice as much trabecular bone as wild-type littermates, indicating that BMP3, the most abundant BMP in adult bone, is a negative determinant of bone density.	Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; Inst Genet, Cambridge, MA USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Case Western Reserve University	Lyons, KM (corresponding author), Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90024 USA.		agius, Eric/AHC-9705-2022	Agius, Eric/0000-0003-2123-9283	NIAMS NIH HHS [AR44528] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044528] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Candia AF, 1997, DEVELOPMENT, V124, P4467; CENTRELLA M, 1991, MOL CELL BIOL, V11, P250, DOI 10.1128/MCB.11.1.250; CENTRELLA M, 1995, MOL CELL BIOL, V15, P3273; Engstrand T, 2000, HUM GENE THER, V11, P205, DOI 10.1089/10430340050016274; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; HARLAND RM, 1994, P NATL ACAD SCI USA, V91, P10243, DOI 10.1073/pnas.91.22.10243; HAZAMA M, 1995, BIOCHEM BIOPH RES CO, V209, P859, DOI 10.1006/bbrc.1995.1578; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Ikenoue T, 1999, J CELL BIOCHEM, V75, P206, DOI 10.1002/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.3.CO;2-K; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Li BJ, 2000, NAT GENET, V24, P304, DOI 10.1038/73542; LIU YH, 1995, P NATL ACAD SCI USA, V92, P6137, DOI 10.1073/pnas.92.13.6137; LUYTEN FP, 1989, J BIOL CHEM, V264, P13377; LUYTEN FP, 1992, J BIOL CHEM, V267, P3691; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1; Piek E, 1999, J CELL PHYSIOL, V180, P141, DOI 10.1002/(SICI)1097-4652(199908)180:2<141::AID-JCP1>3.0.CO;2-I; Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2; Takao M, 1996, BIOCHEM BIOPH RES CO, V219, P656, DOI 10.1006/bbrc.1996.0289; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; Wozney J. M., 1993, PHYSL PHARM BONE, P725; Yi SE, 2000, DEVELOPMENT, V127, P621; Zhao RB, 1999, DEV BIOL, V212, P68, DOI 10.1006/dbio.1999.9326; Zmuda JM, 1999, GENET EPIDEMIOL, V16, P356, DOI 10.1002/(SICI)1098-2272(1999)16:4<356::AID-GEPI3>3.0.CO;2-I	30	313	358	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2001	27	1					84	88		10.1038/83810	http://dx.doi.org/10.1038/83810			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	388NP	11138004				2022-12-17	WOS:000166187900021
J	Okawa, A; Nakamura, I; Goto, S; Moriya, H; Nakamura, Y; Ikegawa, S				Okawa, A; Nakamura, I; Goto, S; Moriya, H; Nakamura, Y; Ikegawa, S			Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine	NATURE GENETICS			English	Article							NUCLEOSIDE-TRIPHOSPHATE PYROPHOSPHATASE; MEMBRANE GLYCOPROTEIN PC-1; INORGANIC PYROPHOSPHATE; EPIPHYSEAL CARTILAGE; PARATHYROID-HORMONE; ANTIGEN PC-1; PYROPHOSPHOHYDROLASE; GENERATION; CELLS; BONE	Ossification of the posterior longitudinal ligament of the spine (OPLL) is a common form of human myelopathy caused by a compression of the spinal cord by ectopic ossification of spinal ligaments(1,2). To elucidate the genetic basis for OPLL, we have been studying the ttw (tiptoe walking; previously designated twy) mouse, a naturally occurring mutant which exhibits ossification of the spinal ligaments very similar to human OPLL (refs 3,4). Using a positional candidate-gene approach, we determined the ttw phenotype is caused by a nonsense mutation (glycine 568 to stop) in the Npps gene which encodes nucleotide pyrophosphatase. This enzyme regulates soft-tissue calcification and bone mineralization by producing inorganic pyrophosphate, a major inhibitor of calcification(5-8). The accelerated bone formation characteristic of ttw mice is likely to result from dysfunction of NPPS caused by predicted truncation of the gene product, resulting in the loss of more than one-third of the native protein. Our results may lead to novel insights into the mechanism of ectopic ossification and the aetiology of human OPLL.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 108, Japan; Chiba Univ, Sch Med, Dept Orthopaed Surg, Chyuo Ku, Chiba 260, Japan; Shinshu Univ, Sch Med, Dept Orthopaed Surg, Matsumoto, Nagano 390, Japan	University of Tokyo; Chiba University; Shinshu University	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, 4-6-1 Shirokanedai, Tokyo 108, Japan.	yusuke@ims.u-tokyo.ac.jp						ALBINNI U, 1982, CHIR ORG MOVIMENTO, V70, P15; BELLI SI, 1993, EUR J BIOCHEM, V217, P421, DOI 10.1111/j.1432-1033.1993.tb18261.x; CASWELL AM, 1987, BIOCHIM BIOPHYS ACTA, V924, P276, DOI 10.1016/0304-4165(87)90023-7; CASWELL AM, 1988, BIOCHIM BIOPHYS ACTA, V966, P310, DOI 10.1016/0304-4165(88)90080-3; DIETRICH W, 1992, GENETICS, V131, P423; FIROOZNIA H, 1982, NEW YORK STATE J MED, V82, P1193; FLEISCH H, 1981, METAB BONE DIS RELAT, V3, P279, DOI 10.1016/0221-8747(81)90044-8; GOTO S, 1997, OSSIFICATION POSTERI, P29; HARAHAP AR, 1988, J IMMUNOL, V141, P2317; Hosoda Y, 1981, Ryumachi, V21 Suppl, P157; HSU HHT, 1983, J BIOL CHEM, V258, P3463; HUANG R, 1994, J CLIN INVEST, V94, P560, DOI 10.1172/JCI117370; OHTSUKA K, 1987, ARCH ORTHOP TRAUM SU, V106, P89, DOI 10.1007/BF00435420; Okawa A, 1998, MAMM GENOME, V9, P155, DOI 10.1007/s003359900707; ONO K, 1977, Spine, V2, P126, DOI 10.1097/00007632-197706000-00005; OYAJOBI BO, 1994, J BONE MINER RES, V9, P1259; REBBE NF, 1991, P NATL ACAD SCI USA, V88, P5192, DOI 10.1073/pnas.88.12.5192; SAKOU T, 1991, SPINE, V16, P1249, DOI 10.1097/00007632-199111000-00001; SIEGEL SA, 1983, J BIOL CHEM, V258, P8601; TERAKADO A, 1995, CALCIFIED TISSUE INT, V56, P135, DOI 10.1007/BF00296345; TERAYAMA K, 1989, SPINE, V14, P1184, DOI 10.1097/00007632-198911000-00009; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; VANDRIEL IR, 1987, J BIOL CHEM, V262, P4882; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; YAMAZAKI M, 1991, CALCIFIED TISSUE INT, V48, P182, DOI 10.1007/BF02570553	26	313	328	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1998	19	3					271	273		10.1038/956	http://dx.doi.org/10.1038/956			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZX892	9662402				2022-12-17	WOS:000074565900025
J	Swain, A; Zanaria, E; Hacker, A; LovellBadge, R; Camerino, G				Swain, A; Zanaria, E; Hacker, A; LovellBadge, R; Camerino, G			Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function	NATURE GENETICS			English	Article							DETERMINING REGION; DETERMINING GENE; EVOLUTION; MICE; ACID; SRY	Duplications of a chromosome Xp21 locus DSS (dosage sensitive sex reversal) are associated with male to female sex reversal. An unusual member of the nuclear hormone receptor superfamily, DAX1, maps to the DSS critical region and is responsible for X-linked adrenal hypoplasia congenita. Here we describe the isolation of the mouse Dax1 gene and its pattern of expression during development. Expression was detected in the first stages of gonadal and adrenal differentiation and in the developing hypothalamus. Moreover, Dax1 expression is down-regulated coincident with overt differentiation in the testis, but persists in the developing ovary. Comparison of the predicted protein products of the human and mouse genes show that specific domains are evolving rapidly. Our results suggest a basis for adrenal insufficiency and hypogonadotropic hypogonadism in males affected by adrenal hypoplasia congenita and are consistent with a role for DAX1 in gonadal sex determination.	UNIV PAVIA, I-27100 PAVIA, ITALY; NATL INST MED RES, MRC, LAB DEV GENET, LONDON NW7 1AA, ENGLAND; UNIV SASSARI, IST ISTOL & EMBRIOL, I-07100 SASSARI, ITALY	University of Pavia; MRC National Institute for Medical Research; University of Sassari				Swain, Amanda/0000-0001-8666-1608; Lovell-Badge, Robin/0000-0001-9364-4179	Telethon [B.05] Funding Source: Medline	Telethon(Fondazione Telethon)		BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; BOUGET W, 1995, NATURE, V375, P377; BUEHR M, 1993, DEVELOPMENT, V117, P273; CAPEL B, 1993, ADV DEV BIOL, V2, P1; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DABOVIC B, IN PRESS MAMMALIAN G; DRESSER DW, 1995, HUM MOL GENET, V4, P1613, DOI 10.1093/hmg/4.9.1613; FECHNER PY, 1993, J CLIN ENDOCR METAB, V76, P1248, DOI 10.1210/jc.76.5.1248; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GERMAN J, 1978, SCIENCE, V202, P53, DOI 10.1126/science.567843; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HACKER A, 1995, DEVELOPMENT, V121, P1603; HAQQ CM, 1994, SCIENCE, V266, P1494, DOI 10.1126/science.7985018; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; INGRAHAM HA, 1994, GENE DEV, V8, P2302, DOI 10.1101/gad.8.19.2302; JESKE YWA, 1995, NAT GENET, V10, P480, DOI 10.1038/ng0895-480; KLETTER GB, 1991, TRENDS ENDOCRIN MET, V2, P123, DOI 10.1016/1043-2760(91)90001-4; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LovellBadge R, 1995, PHILOS T R SOC B, V350, P205, DOI 10.1098/rstb.1995.0153; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MUELLER RF, 1994, J MED GENET, V31, P471, DOI 10.1136/jmg.31.6.471; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; NORDQVIST K, 1994, NAT GENET, V7, P7, DOI 10.1038/ng0594-7; ROGLER LE, 1993, MOL ENDOCRINOL, V7, P453, DOI 10.1210/me.7.3.453; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SEIDL K, 1989, DEV BIOL, V136, P481, DOI 10.1016/0012-1606(89)90273-X; SHEN WH, 1994, CELL, V77, P651, DOI 10.1016/0092-8674(94)90050-7; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; TUCKER PK, 1993, NATURE, V364, P715, DOI 10.1038/364715a0; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; ZANARIA E, 1994, NATURE, V372, P635, DOI 10.1038/372635a0	40	313	322	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1996	12	4					404	409		10.1038/ng0496-404	http://dx.doi.org/10.1038/ng0496-404			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630494				2022-12-17	WOS:A1996UC55300019
J	GROMPE, M				GROMPE, M			THE RAPID DETECTION OF UNKNOWN MUTATIONS IN NUCLEIC-ACIDS	NATURE GENETICS			English	Review							GRADIENT GEL-ELECTROPHORESIS; CYSTIC-FIBROSIS MUTATIONS; SINGLE BASE SUBSTITUTIONS; POLYMERASE CHAIN-REACTION; MULTIPLEX DNA AMPLIFICATION; PCR-AMPLIFIED DNA; POINT MUTATIONS; CHEMICAL CLEAVAGE; DYSTROPHIN GENE; GENOMIC DNA	The task of identifying mutations in nucleic acid sequences is a vital component of research in mammalian genetics. With the advent of the polymerase chain reaction, several useful mutation detection techniques have evolved in recent years. The different methods have complementing strengths and a suitable procedure for virtually any experimental situation is now available.	OREGON HLTH SCI UNIV,DEPT PEDIAT,PORTLAND,OR 97201	Oregon Health & Science University	GROMPE, M (corresponding author), OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,3181 SW SAM JACKSON PK RD,PORTLAND,OR 97201, USA.			Grompe, Markus/0000-0002-6616-4345				ABBS S, 1992, J MED GENET, V29, P191, DOI 10.1136/jmg.29.3.191; AINSWORTH PJ, 1991, NUCLEIC ACIDS RES, V19, P405, DOI 10.1093/nar/19.2.405; ARTLICH A, 1992, AM J HUM GENET, V50, P876; BALLABIO A, 1989, GENOMICS, V4, P36, DOI 10.1016/0888-7543(89)90311-X; BALLABIO A, 1990, HUM GENET, V84, P571; BAUMANN H, 1993, LEUKEMIA, V7, P384; Bevan I S, 1992, PCR Methods Appl, V1, P222; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CHEHAB FF, 1992, HUM GENET, V89, P163; CHELLY J, 1991, J CLIN INVEST, V88, P1161, DOI 10.1172/JCI115417; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; CRAXTON M, 1991, METHODS, V3; FODDE R, 1992, GENOMICS, V13, P1162, DOI 10.1016/0888-7543(92)90032-N; FORREST SM, 1991, AM J HUM GENET, V49, P175; GANGULY A, 1990, NUCLEIC ACIDS RES, V18, P3933, DOI 10.1093/nar/18.13.3933; GIBBS RA, 1990, GENOMICS, V7, P235, DOI 10.1016/0888-7543(90)90545-6; GIBBS RA, 1987, SCIENCE, V236, P303, DOI 10.1126/science.3563511; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; GROMPE M, 1991, J BACTERIOL, V173, P1268, DOI 10.1128/jb.173.3.1268-1278.1991; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HATTORI M, 1992, ELECTROPHORESIS, V13, P560, DOI 10.1002/elps.11501301114; IWAHANA H, 1992, BIOTECHNIQUES, V12, P64; JACKSON DP, 1991, PCR PRACTICAL APPROA, P41; KEEN J, 1991, TRENDS GENET, V7, P5; KILIMANN MW, 1992, HUM GENET, V89, P253; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KUWANO A, 1991, AM J HUM GENET, V49, P707; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LIN B, 1992, J VIROL METHODS, V40, P205, DOI 10.1016/0166-0934(92)90069-P; LU AL, 1992, GENOMICS, V14, P249, DOI 10.1016/S0888-7543(05)80213-7; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; MYERS RM, 1985, SCIENCE, V230, P1242, DOI 10.1126/science.4071043; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; NG ISL, 1991, HUM GENET, V87, P613; NIEMANNSEYDE S, 1992, HUM GENET, V90, P65; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PELLEGATA NS, 1992, ANTICANCER RES, V12, P1731; PERRY DJ, 1992, J CLIN PATHOL, V45, P158, DOI 10.1136/jcp.45.2.158; Rooney DE, 1992, HUMAN CYTOGENETICS P; ROSATELLI MC, 1992, AM J HUM GENET, V50, P422; Rosenthal A, 1992, DNA Seq, V3, P61, DOI 10.3109/10425179209039697; ROSSITER JFR, 1991, PCR PRACTICAL APPROA, P75; RUANO G, 1991, P NATL ACAD SCI USA, V88, P2815, DOI 10.1073/pnas.88.7.2815; Saleeba Jennifer A., 1992, Human Mutation, V1, P63, DOI 10.1002/humu.1380010110; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARKAR G, 1992, NUCLEIC ACIDS RES, V20, P871, DOI 10.1093/nar/20.4.871; SARKAR G, 1992, GENOMICS, V13, P441, DOI 10.1016/0888-7543(92)90266-U; SHEFFIELD VC, 1991, AM J HUM GENET, V49, P699; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SHEFFIELD VC, 1992, ANAL EFFICIENCY SING; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STOFLET ES, 1988, SCIENCE, V239, P491, DOI 10.1126/science.3340835; SYVANEN AC, 1989, FEBS LETT, V258, P71, DOI 10.1016/0014-5793(89)81618-7; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TAYLOR C, 1993, BRIT J CANCER, V67, P128, DOI 10.1038/bjc.1993.22; TEE MK, 1992, ANIM GENET, V23, P431, DOI 10.1111/j.1365-2052.1992.tb02162.x; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; VERES G, 1987, SCIENCE, V237, P415, DOI 10.1126/science.3603027; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5; YAP EP, 1992, TRENDS GENET, V8, P4; ZHANG FR, 1990, CHROMOSOMA, V99, P436, DOI 10.1007/BF01726696; ZHENG H, 1991, P NATL ACAD SCI USA, V88, P8067, DOI 10.1073/pnas.88.18.8067	70	313	370	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					111	117		10.1038/ng1093-111	http://dx.doi.org/10.1038/ng1093-111			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252035				2022-12-17	WOS:A1993MA05600006
J	Anson-Cartwright, L; Dawson, K; Holmyard, D; Fisher, SJ; Lazzarini, RA; Cross, JC				Anson-Cartwright, L; Dawson, K; Holmyard, D; Fisher, SJ; Lazzarini, RA; Cross, JC			The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; MOUSE; DROSOPHILA; DIFFERENTIATION; EXPRESSION; GENE; IMPLANTATION; SWITCH; GCM1	Trophoblast cells of the placenta are established at the blastocyst stage and differentiate into specialized subtypes after implantation(1,2). In mice, the outer layer of the placenta consists of trophoblast giant cells that invade the uterus and promote maternal blood flow to the implantation site by producing cytokines with angiogenic(3) and vasodilatory(4) actions. The innermost layer, called the labyrinth, consists of branched villi that provide a large surface area for nutrient transport and are composed of trophoblast cells and underlying mesodermal cells derived from the allantois. The chorioallantoic villi develop after embryonic day (E) 8.5 through extensive folding and branching of an initially flat sheet of trophoblast cells, the chorionic plate, in response to contact with the allantois. We show here that Gcm1. encoding the transcription factor glial cells missing-1 (Gcm1). is expressed in small clusters of chorionic trophoblast cells at the flat chorionic plate stage and at sites of chorioallantoic folding and extension when morphogenesis begins. Mutation of Gcm1 in mice causes a complete block to branching of the chorioallantoic interface, resulting in embryonic mortality by E10 due to the absence of the placental labyrinth. In addition, chorionic trophoblast cells in Gcm1-deficient placentas do not fuse to form syncytiotrophoblast. Abnormal development of placental villi is frequently associated with fetal death and intrauterine growth restriction in humans, and our studies provide the earliest molecular insight into this aspect of placental development.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Dev & Fetal Hlth, Toronto, ON M5G 1X5, Canada; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA; Mt Sinai Sch Med, Brookdale Ctr Dev & Mol Biol, New York, NY USA; Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; University of Toronto; University of Toronto	Cross, JC (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Genes & Dev Res Grp, Calgary, AB, Canada.		Cross, James/AAU-2973-2020; Cross, James/F-4814-2011	Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378				Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Altshuller Y, 1996, FEBS LETT, V393, P201, DOI 10.1016/0014-5793(96)00890-3; Basyuk E, 1999, DEV DYNAM, V214, P303, DOI 10.1002/(SICI)1097-0177(199904)214:4<303::AID-AJA3>3.3.CO;2-2; BECKER M, 1995, CREATIVITY RES J, V8, P219, DOI 10.1207/s15326934crj0803_2; Bernardoni R, 1998, DEVELOPMENT, V125, P3189; Bernardoni R, 1997, DEV BIOL, V191, P118; COLOSI P, 1987, MOL ENDOCRINOL, V1, P767, DOI 10.1210/mend-1-11-767; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; CROSS JC, IN PRESS SEMIN CELL; Cross JC, 1996, FETAL MATERNAL MED R, V8, P57, DOI DOI 10.1017/S0965539500001492; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HERNANDE.D, 1974, CELL TISSUE RES, V148, P381; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Hunter PJ, 1999, DEVELOPMENT, V126, P1247; JACKSON D, 1994, SCIENCE, V266, P1581, DOI 10.1126/science.7527157; Jacquemin P, 1998, DEV DYNAM, V212, P423, DOI 10.1002/(SICI)1097-0177(199807)212:3<423::AID-AJA10>3.0.CO;2-1; Janatpour MJ, 1999, DEV GENET, V25, P146, DOI 10.1002/(SICI)1520-6408(1999)25:2<146::AID-DVG9>3.0.CO;2-K; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Krebs C, 1996, AM J OBSTET GYNECOL, V175, P1534, DOI 10.1016/S0002-9378(96)70103-5; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; ROSSANT J, 1977, J EMBRYOL EXP MORPH, V39, P183; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Wurst W., 1993, Gene targeting: a practical approach., P33; Yotsumoto S, 1998, DEV BIOL, V203, P264, DOI 10.1006/dbio.1998.9073	30	312	322	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2000	25	3					311	314		10.1038/77076	http://dx.doi.org/10.1038/77076			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	329RD	10888880				2022-12-17	WOS:000087920900020
J	Zhang, QG; Siebert, R; Yan, MH; Hinzmann, B; Cui, XL; Xue, LQ; Rakestraw, KM; Naeve, CW; Beckmann, G; Weisenburger, DD; Sanger, WG; Nowotny, H; Vesely, M; Callet-Bauchu, E; Salles, G; Dixit, VM; Rosenthal, A; Schlegelberger, B; Morris, SW				Zhang, QG; Siebert, R; Yan, MH; Hinzmann, B; Cui, XL; Xue, LQ; Rakestraw, KM; Naeve, CW; Beckmann, G; Weisenburger, DD; Sanger, WG; Nowotny, H; Vesely, M; Callet-Bauchu, E; Salles, G; Dixit, VM; Rosenthal, A; Schlegelberger, B; Morris, SW			Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)	NATURE GENETICS			English	Article							NF-KAPPA-B; SOMATIC HYPERMUTATION; TRANSCRIPTION FACTORS; CELL LYMPHOMA; ACTIVATION; TRANSFORMATION; REQUIREMENT; APOPTOSIS; DISEASE; CARD	Mucosa-associated lymphoid tissue (MALT) lymphomas most frequently involve the gastrointestinal tract and are the most common subset of extranodal non-Hodgkin lymphoma(1) (NHL). Here we describe overexpression of BCL10, a novel apoptotic signalling gene that encodes an amino-terminal caspase recruitment domain (CARD; ref. 2), in MALT lymphomas due to the recurrent t(1;14)(p22;q32) (ref. 3). BCL10 cDNAs from t(1;14)-positive MALT tumours contained a variety of mutations, most resulting in truncations either in or carboxy terminal to the CARD. Wild-type BCL10 activated NF-kappa B but induced apoptosis of MCF7 and 293 cells. CARD-truncation mutants were unable to induce cell death or activate NF-kappa B, whereas mutants with C-terminal truncations retained NF-kappa B activation but did not induce apoptosis, Mutant BCL10 overexpression might have a twofold lymphomagenic effect: loss of BCL10 pro-apoptosis may confer a survival advantage to MALT B-cells, and constitutive NF-kappa B activation may provide both anti-apoptotic and proliferative signals mediated via its transcriptional targets.	St Jude Childrens Res Hosp, Dept Pathol & Lab Med, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Ctr Biotechnol, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN 38163 USA; Genentech Inc, Dept Mol Oncol, S San Francisco, CA 94080 USA; MetaGen Gesell Genomforsch mbH, D-14195 Berlin, Germany; Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pediat, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Ctr Human Genet, Omaha, NE 68198 USA; Hanusch Hosp, Ludwig Boltzmann Inst Leukemia Res & Hematol, A-1140 Vienna, Austria; Lainz Hosp, Jakob Erdheim Inst Pathol, A-1130 Vienna, Austria; Univ Lyon 1, Ctr Hosp Lyon Sud, Hematol Lab, F-69495 Pierre Benite, France; Univ Lyon 1, Ctr Hosp Lyon Sud, Serv Hematol, F-69495 Pierre Benite, France; Univ Kiel, Dept Human Genet, D-24105 Kiel, Germany	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Roche Holding; Genentech; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Ludwig Boltzmann Institute; WGKK - Hanusch Hospital; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Kiel	Morris, SW (corresponding author), St Jude Childrens Res Hosp, Dept Pathol & Lab Med, 332 N Lauderdale St, Memphis, TN 38105 USA.		Siebert, Reiner/A-8049-2010; Salles, Gilles/Z-2336-2019; dixit, vishva m/A-4496-2012	Salles, Gilles/0000-0002-9541-8666; dixit, vishva m/0000-0001-6983-0326	NCI NIH HHS [CA-27165] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Besancon F, 1998, P NATL ACAD SCI USA, V95, P8081, DOI 10.1073/pnas.95.14.8081; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Gerondakis S, 1998, CURR OPIN IMMUNOL, V10, P353, DOI 10.1016/S0952-7915(98)80175-1; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Lee H, 1995, Curr Top Microbiol Immunol, V194, P247; Luque I, 1997, SEMIN CANCER BIOL, V8, P103, DOI 10.1006/scbi.1997.0061; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; OFFIT K, 1991, GENE CHROMOSOME CANC, V3, P189, DOI 10.1002/gcc.2870030304; Reuther JY, 1998, GENE DEV, V12, P968, DOI 10.1101/gad.12.7.968; SCHLEGELBERGER B, 1994, LEUKEMIA, V8, P72; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Siebert R, 1998, BLOOD, V91, P984, DOI 10.1182/blood.V91.3.984.984_984_990; Snow EC, 1997, CURR TOP MICROBIOL, V224, P211; Sonenshein GE, 1997, SEMIN CANCER BIOL, V8, P113, DOI 10.1006/scbi.1997.0062; Storb U, 1998, IMMUNOL REV, V162, P5, DOI 10.1111/j.1600-065X.1998.tb01424.x; TELFORD EAR, 1995, J MOL BIOL, V249, P520, DOI 10.1006/jmbi.1995.0314; TILLY H, 1994, BLOOD, V84, P1043; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Willis TG, 1997, BLOOD, V90, P2456; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; WOTHERSPOON AC, 1992, CANCER GENET CYTOGEN, V58, P35, DOI 10.1016/0165-4608(92)90130-Z; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; Zucca E, 1998, BRIT J HAEMATOL, V100, P3, DOI 10.1046/j.1365-2141.1998.00513.x	27	312	326	1	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1999	22	1					63	68		10.1038/8767	http://dx.doi.org/10.1038/8767			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192TU	10319863				2022-12-17	WOS:000080096300024
J	LASPADA, AR; ROLING, DB; HARDING, AE; WARNER, CL; SPIEGEL, R; HAUSMANOWAPETRUSEWICZ, I; YEE, WC; FISCHBECK, KH				LASPADA, AR; ROLING, DB; HARDING, AE; WARNER, CL; SPIEGEL, R; HAUSMANOWAPETRUSEWICZ, I; YEE, WC; FISCHBECK, KH			MEIOTIC STABILITY AND GENOTYPE-PHENOTYPE CORRELATION OF THE TRINUCLEOTIDE REPEAT IN X-LINKED SPINAL AND BULBAR MUSCULAR-ATROPHY	NATURE GENETICS			English	Article							FRAGILE-X; GENE; LOCALIZATION	Expansion of the trinucleotide repeat (CAG)n in the first exon of the androgen receptor gene is associated with a rare motor neuron disorder, X-linked spinal and bulbar muscular atrophy. We have found that expanded (CAG)n alleles undergo alteration in length when transmitted from parent to offspring. Of 45 meioses examined, 12 (27%) demonstrated a change in CAG repeat number. Both expansions and contractions were observed, although their magnitude was small. There was a greater rate of instability in male meiosis than in female meiosis. We also found evidence for a correlation between disease severity and CAG repeat length, but other factors seem to contribute to the phenotypic variability in this disorder.	NATL HOSP,INST NEUROL,LONDON WC1N 3BG,ENGLAND; MILLARD FILLMORE HOSP,INST DENT NEUROL,BUFFALO,NY 14209; UNIV ZURICH,INST MED GENET,CH-8001 ZURICH,SWITZERLAND; POLISH ACAD SCI,NEUROMUSCULAR UNIT,PL-02097 WARSAW,POLAND; WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; State University of New York (SUNY) System; University of Zurich; Polish Academy of Sciences; Washington University (WUSTL)	LASPADA, AR (corresponding author), UNIV PENN,SCH MED,DEPT NEUROL,CRB 250,U22 CURIE BLVD,PHILADELPHIA,PA 19104, USA.		La Spada, Albert/AAG-8809-2020					ARBIZU T, 1983, J NEUROL SCI, V59, P371, DOI 10.1016/0022-510X(83)90022-9; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROWN CJ, 1989, AM J HUM GENET, V44, P264; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FISCHBECK KH, 1991, ADV NEUROL, V56, P209; FISCHBECK KH, 1986, NEUROLOGY, V36, P1595, DOI 10.1212/WNL.36.12.1595; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HARDING AE, 1982, J NEUROL NEUROSUR PS, V45, P1012, DOI 10.1136/jnnp.45.11.1012; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H	21	312	317	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					301	304		10.1038/ng1292-301	http://dx.doi.org/10.1038/ng1292-301			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303283				2022-12-17	WOS:A1992KB49500014
J	Maccaferri, M; Harris, NS; Twardziok, SO; Pasam, RK; Gundlach, H; Spannagl, M; Ormanbekova, D; Lux, T; Prade, VM; Milner, SG; Himmelbach, A; Mascher, M; Bagnaresi, P; Faccioli, P; Cozzi, P; Lauria, M; Lazzari, B; Stella, A; Manconi, A; Gnocchi, M; Moscatelli, M; Avni, R; Deek, J; Biyiklioglu, S; Frascaroli, E; Corneti, S; Salvi, S; Sonnante, G; Desiderio, F; Mare, C; Crosatti, C; Mica, E; Ozkan, H; Kilian, B; De Vita, P; Marone, D; Joukhadar, R; Mazzucotelli, E; Nigro, D; Gadaleta, A; Chao, SM; Faris, JD; Melo, ATO; Pumphrey, M; Pecchioni, N; Milanesi, L; Wiebe, K; Ens, J; MacLachlan, RP; Clarke, JM; Sharpe, AG; Koh, CS; Liang, KYH; Taylor, GJ; Knox, R; Budak, H; Mastrangelo, AM; Xu, SS; Stein, N; Hale, I; Distelfeld, A; Hayden, MJ; Tuberosa, R; Walkowiak, S; Mayer, KFX; Ceriotti, A; Pozniak, CJ; Cattivelli, L				Maccaferri, Marco; Harris, Neil S.; Twardziok, Sven O.; Pasam, Raj K.; Gundlach, Heidrun; Spannagl, Manuel; Ormanbekova, Danara; Lux, Thomas; Prade, Verena M.; Milner, Sara G.; Himmelbach, Axel; Mascher, Martin; Bagnaresi, Paolo; Faccioli, Primetta; Cozzi, Paolo; Lauria, Massimiliano; Lazzari, Barbara; Stella, Alessandra; Manconi, Andrea; Gnocchi, Matteo; Moscatelli, Marco; Avni, Raz; Deek, Jasline; Biyiklioglu, Sezgi; Frascaroli, Elisabetta; Corneti, Simona; Salvi, Silvio; Sonnante, Gabriella; Desiderio, Francesca; Mare, Caterina; Crosatti, Cristina; Mica, Erica; Ozkan, Hakan; Kilian, Benjamin; De Vita, Pasquale; Marone, Daniela; Joukhadar, Reem; Mazzucotelli, Elisabetta; Nigro, Domenica; Gadaleta, Agata; Chao, Shiaoman; Faris, Justin D.; Melo, Arthur T. O.; Pumphrey, Mike; Pecchioni, Nicola; Milanesi, Luciano; Wiebe, Krystalee; Ens, Jennifer; MacLachlan, Ron P.; Clarke, John M.; Sharpe, Andrew G.; Koh, Chu Shin; Liang, Kevin Y. H.; Taylor, Gregory J.; Knox, Ron; Budak, Hikmet; Mastrangelo, Anna M.; Xu, Steven S.; Stein, Nils; Hale, Iago; Distelfeld, Assaf; Hayden, Matthew J.; Tuberosa, Roberto; Walkowiak, Sean; Mayer, Klaus F. X.; Ceriotti, Aldo; Pozniak, Curtis J.; Cattivelli, Luigi			Durum wheat genome highlights past domestication signatures and future improvement targets	NATURE GENETICS			English	Article							CHROMOSOME CONFORMATION CAPTURE; CADMIUM UPTAKE; WILD EMMER; TETRAPLOID WHEAT; POLYPLOID WHEAT; HIGH-DENSITY; GENE; NUCLEOTIDE; RESISTANCE; DIVERSITY	The domestication of wild emmer wheat led to the selection of modern durum wheat, grown mainly for pasta production. We describe the 10.45 gigabase (Gb) assembly of the genome of durum wheat cultivar Svevo. The assembly enabled genome-wide genetic diversity analyses revealing the changes imposed by thousands of years of empirical selection and breeding. Regions exhibiting strong signatures of genetic divergence associated with domestication and breeding were widespread in the genome with several major diversity losses in the pericentromeric regions. A locus on chromosome 5B carries a gene encoding a metal transporter (TdHMA3-B1) with a non-functional variant causing high accumulation of cadmium in grain. The high-cadmium allele, widespread among durum cultivars but undetected in wild emmer accessions, increased in frequency from domesticated emmer to modern durum wheat. The rapid cloning of TdHMA3-B1 rescues a wild beneficial allele and demonstrates the practical use of the Svevo genome for wheat improvement.	[Maccaferri, Marco; Ormanbekova, Danara; Frascaroli, Elisabetta; Corneti, Simona; Salvi, Silvio; Tuberosa, Roberto] Univ Bologna, Dept Agr & Food Sci, Bologna, Italy; [Maccaferri, Marco; De Vita, Pasquale; Marone, Daniela; Pecchioni, Nicola; Mastrangelo, Anna M.] CREA Res Ctr Cereal & Ind Crops, Foggia, Italy; [Harris, Neil S.; Liang, Kevin Y. H.; Taylor, Gregory J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Twardziok, Sven O.; Gundlach, Heidrun; Spannagl, Manuel; Ormanbekova, Danara; Lux, Thomas; Prade, Verena M.; Mayer, Klaus F. X.] Helmholtz Zentrum Munchen, Plant Genome & Syst Biol, Neuherberg, Germany; [Pasam, Raj K.; Joukhadar, Reem; Hayden, Matthew J.] Agribio Ctr AgriBiosci, Agr Victoria, Bundoora, Vic, Australia; [Milner, Sara G.; Himmelbach, Axel; Mascher, Martin; Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res, Gatersleben, Germany; [Mascher, Martin] German Ctr Integrat Biodivers Res Halle Jena Leip, Leipzig, Germany; [Bagnaresi, Paolo; Faccioli, Primetta; Desiderio, Francesca; Mare, Caterina; Crosatti, Cristina; Mica, Erica; Mazzucotelli, Elisabetta; Cattivelli, Luigi] CREA Res Ctr Genom & Bioinformat, Fiorenzuola Darda, Italy; [Cozzi, Paolo; Lauria, Massimiliano; Lazzari, Barbara; Stella, Alessandra; Ceriotti, Aldo] Natl Res Council Inst Agr Biol & Biotechnol, Milan, Italy; [Manconi, Andrea; Gnocchi, Matteo; Moscatelli, Marco; Milanesi, Luciano] Natl Res Council Inst Biomed Technol, Segrate, Italy; [Avni, Raz; Deek, Jasline; Distelfeld, Assaf] Tel Aviv Univ, Sch Plant Sci & Food Secur, Tel Aviv, Israel; [Biyiklioglu, Sezgi; Budak, Hikmet] Montana State Univ, Bozeman, MT 59717 USA; [Sonnante, Gabriella] Natl Res Council Inst Biosci & Bioresources, Bari, Italy; [Ozkan, Hakan] Cukurova Univ, Fac Agr, Dept Field Crops, Adana, Turkey; [Kilian, Benjamin] Global Crop Divers Trust, Bonn, Germany; [Joukhadar, Reem] La Trobe Univ, Dept Anim Plant & Soil Sci, Bundoora, Vic, Australia; [Nigro, Domenica] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy; [Gadaleta, Agata] Univ Bari Aldo Moro, Dept Agr & Environm Sci, Bari, Italy; [Chao, Shiaoman; Faris, Justin D.; Xu, Steven S.] ARS, USDA, Edward T Schafer Agr Res Ctr, Fargo, ND USA; [Melo, Arthur T. O.; Hale, Iago] Univ New Hampshire, Dept Agr Nutr & Food Syst, Durham, NH 03824 USA; [Pumphrey, Mike] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Wiebe, Krystalee; Ens, Jennifer; MacLachlan, Ron P.; Clarke, John M.; Walkowiak, Sean; Pozniak, Curtis J.] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK, Canada; [Wiebe, Krystalee; Ens, Jennifer; MacLachlan, Ron P.; Clarke, John M.; Walkowiak, Sean; Pozniak, Curtis J.] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Sharpe, Andrew G.; Koh, Chu Shin] Univ Saskatchewan, Global Inst Food Secur, Saskatoon, SK, Canada; [Knox, Ron] Agr & Agri Food Canada, Swift Current Res & Dev Ctr, Swift Current, SK, Canada; [Mastrangelo, Anna M.] CREA Res Ctr Cereal & Ind Crops, Bergamo, Italy; [Hayden, Matthew J.] La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia; [Mayer, Klaus F. X.] Tech Univ Munich, Sch Life Sci Weihenstephan, Freising Weihenstephan, Germany	University of Bologna; University of Alberta; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Tel Aviv University; Montana State University System; Montana State University Bozeman; Cukurova University; La Trobe University; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; United States Department of Agriculture (USDA); University System Of New Hampshire; University of New Hampshire; Washington State University; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; Agriculture & Agri Food Canada; La Trobe University; Technical University of Munich	Mayer, KFX (corresponding author), Helmholtz Zentrum Munchen, Plant Genome & Syst Biol, Neuherberg, Germany.; Cattivelli, L (corresponding author), CREA Res Ctr Genom & Bioinformat, Fiorenzuola Darda, Italy.; Ceriotti, A (corresponding author), Natl Res Council Inst Agr Biol & Biotechnol, Milan, Italy.; Pozniak, CJ (corresponding author), Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada.; Mayer, KFX (corresponding author), Tech Univ Munich, Sch Life Sci Weihenstephan, Freising Weihenstephan, Germany.	k.mayer@helmholtz-muenchen.de; ceriotti@ibba.cnr.it; curtis.pozniak@usask.ca; luigi.cattivelli@crea.gov.it	Milanesi, Luciano/AAE-7230-2019; Harris, Neil S/A-6999-2009; ÖZKAN, Hakan/C-8510-2011; stella, Alessandra/ABB-1952-2021; Stella, Alessandra/AAY-7322-2020; Stein, Nils/F-7507-2017; mica, erica/AAA-3931-2020; Pumphrey, Michael/V-8830-2019; stella, Alessandra/AAG-6401-2021; Lux, Thomas/AAB-4452-2019; Budak, Hikmet/U-8517-2019; Cozzi, Paolo/AFM-1008-2022; cattivelli, luigi/AAE-7046-2020; Ceriotti, Aldo/A-1448-2016	Milanesi, Luciano/0000-0002-1201-3939; Harris, Neil S/0000-0002-1320-282X; ÖZKAN, Hakan/0000-0003-3530-2626; stella, Alessandra/0000-0003-2850-3964; Stein, Nils/0000-0003-3011-8731; stella, Alessandra/0000-0003-2850-3964; Lux, Thomas/0000-0002-5543-1911; Budak, Hikmet/0000-0002-2556-2478; cattivelli, luigi/0000-0002-6067-4600; Liang, Kevin/0000-0003-3268-0058; Koh, ChuShin/0000-0001-7313-2125; MACCAFERRI, MARCO/0000-0002-1935-3282; De Vita, Pasquale/0000-0002-9573-0510; Gundlach, Heidrun/0000-0002-6757-0943; Prade, Verena/0000-0001-6387-3982; Twardziok, Sven/0000-0002-0326-5704; Bagnaresi, Paolo/0000-0001-8466-4805; Hayden, Matthew/0000-0003-3117-5500; Ceriotti, Aldo/0000-0002-8230-8863; Desiderio, Francesca/0000-0002-1991-5249; Spannagl, Manuel/0000-0003-0701-7035; Kilian, Benjamin/0000-0002-9145-6980; frascaroli, elisabetta/0000-0003-1699-2764; Pasam, Raj/0000-0003-0908-1882; Mastrangelo, Anna Maria/0000-0002-3618-0301; Manconi, Andrea/0000-0002-1287-2768; Himmelbach, Axel/0000-0001-7338-0946; Pumphrey, Michael/0000-0001-7524-9634; MARE, CATERINA/0000-0001-8181-5321; Faris, Justin/0000-0002-9653-3287	Italian Ministry of Education and Research [PB05, PIR01_ 00017]; CREA project Interomics; Fondazione in rete per la ricerca agroalimentare AGER project From Seed to Pasta; FP7-KBBE Project DROPS [244347]; Genome Canada; Western Grain Research Foundation; Manitoba Wheat and Barley Commission; Saskatchewan Wheat Development Commission; Alberta Wheat Development Commission; Saskatchewan Ministry of Agriculture; Binational Science Foundation [2015409]; Israel Science Foundation [1137/17]; USDA-Agricultural Research Service Current Research Information System project [3060-21000-038-00-D]; German Federal Ministry of Food and Agriculture [2819103915]; German Ministry of Education and Research [031A536]; Natural Sciences and Engineering Council of Canada [SPG 336119-06, RGPIN 92787]	Italian Ministry of Education and Research(Ministry of Education, Universities and Research (MIUR)); CREA project Interomics; Fondazione in rete per la ricerca agroalimentare AGER project From Seed to Pasta; FP7-KBBE Project DROPS; Genome Canada(Genome Canada); Western Grain Research Foundation; Manitoba Wheat and Barley Commission; Saskatchewan Wheat Development Commission; Alberta Wheat Development Commission; Saskatchewan Ministry of Agriculture; Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); USDA-Agricultural Research Service Current Research Information System project; German Federal Ministry of Food and Agriculture; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We acknowledge the funding support of: the Italian Ministry of Education and Research with projects CNR Flagship InterOmics PB05 (L.M., A.C., G.S.), PON ELIXIR CNR-BiOmics PIR01_ 00017 (L.M., M.G., M.Mo.) and PON ISCOCEM (P.D.); CREA project Interomics (L.C.); Fondazione in rete per la ricerca agroalimentare AGER project From Seed to Pasta (R.T.); FP7-KBBE Project DROPS ID244347 (R.T.); Genome Canada (A.G.S., C.P.); the Western Grain Research Foundation (A.G.S., C.P.); the Manitoba Wheat and Barley Commission (A.G.S., C.P.); the Saskatchewan Wheat Development Commission (A.G.S., C.P.); the Alberta Wheat Development Commission (A.G.S., C.P.); the Saskatchewan Ministry of Agriculture (A.G.S., C.P.); the administrative support of Genome Prairie (A.G.S., C.P.); Canadian Triticum Applied Genomics -CTAG2-(A.G.S., C.P.); Binational Science Foundation grant no. 2015409 (I.H., A.D.); Israel Science Foundation grant no. 1137/17 (A.D.); USDA-Agricultural Research Service Current Research Information System project 3060-21000-038-00-D (J.D.F., S.S.X.); German Federal Ministry of Food and Agriculture grant no. 2819103915 (N.S., K.F.X.M.); German Ministry of Education and Research grant no. 031A536 (K.F.X.M.); and Natural Sciences and Engineering Council of Canada grant nos. SPG 336119-06 and RGPIN 92787 (G.J.T., C.P.). The authors are grateful to E. Elias (North Dakota State University) for providing nine DW cultivars, included in the Global Tetraploid Wheat Collection and E. Scarpella (University of Alberta, Edmonton, Canada) for assistance with confocal microscopy.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2010, BMC GENET, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-11]; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Avni R, 2017, SCIENCE, V357, P93, DOI 10.1126/science.aan0032; Avni R, 2014, MOL BREEDING, V34, P1549, DOI 10.1007/s11032-014-0176-2; Beier S, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.44; Brozynska M, 2016, PLANT BIOTECHNOL J, V14, P1070, DOI 10.1111/pbi.12454; Cakmak I, 1996, PLANT SOIL, V180, P165, DOI 10.1007/BF00015299; Chapman JA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0582-8; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; DVORAK J, 1988, GENOME, V30, P680, DOI 10.1139/g88-115; Ellis JG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00641; Fariello MI, 2013, GENETICS, V193, P929, DOI 10.1534/genetics.112.147231; Faris J., 2014, GENOMICS PLANT GENET; Faris JD, 2014, GENE, V542, P198, DOI 10.1016/j.gene.2014.03.034; Frichot E, 2014, GENETICS, V196, P973, DOI 10.1534/genetics.113.160572; Gaut BS, 2015, MOL BIOL EVOL, V32, P1661, DOI 10.1093/molbev/msv105; Harris NS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-103; Hart JJ, 2005, NEW PHYTOL, V167, P391, DOI 10.1111/j.1469-8137.2005.01416.x; He XY, 2009, MOL BREEDING, V23, P553, DOI 10.1007/s11032-009-9255-1; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Knox RE, 2009, GENOME, V52, P741, DOI [10.1139/G09-042, 10.1139/g09-042]; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Luo MC, 2007, THEOR APPL GENET, V114, P947, DOI 10.1007/s00122-006-0474-0; Maccaferri M, 2008, THEOR APPL GENET, V117, P1225, DOI 10.1007/s00122-008-0857-5; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Miyadate H, 2011, NEW PHYTOL, V189, P190, DOI 10.1111/j.1469-8137.2010.03459.x; Montenegro JD, 2017, PLANT J, V90, P1007, DOI 10.1111/tpj.13515; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Ozkan H, 2002, MOL BIOL EVOL, V19, P1797, DOI 10.1093/oxfordjournals.molbev.a004002; Pankin A, 2018, NEW PHYTOL, V218, P1247, DOI 10.1111/nph.15077; PENNER GA, 1995, GENOME, V38, P543, DOI 10.1139/g95-070; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; Steffenson BJ, 2007, AUST J AGR RES, V58, P532, DOI 10.1071/AR07123; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; Varshney RK, 2017, NAT GENET, V49, P1082, DOI 10.1038/ng.3872; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wicker T, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1479-0; Wiebe K, 2010, THEOR APPL GENET, V121, P1047, DOI 10.1007/s00122-010-1370-1; Yan JL, 2016, PLANT CELL ENVIRON, V39, P1941, DOI 10.1111/pce.12747; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Zhang WJ, 2017, P NATL ACAD SCI USA, V114, pE9483, DOI 10.1073/pnas.1706277114	48	311	315	18	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2019	51	5					885	+		10.1038/s41588-019-0381-3	http://dx.doi.org/10.1038/s41588-019-0381-3			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW7AK	30962619	Green Published, hybrid			2022-12-17	WOS:000466842000016
J	Yu, W; Gwinn, M; Clyne, M; Yesupriya, A; Khoury, MJ				Yu, Wei; Gwinn, Marta; Clyne, Melinda; Yesupriya, Ajay; Khoury, Muin J.			A navigator for human genome epidemiology	NATURE GENETICS			English	Letter							ASSOCIATION		[Yu, Wei; Gwinn, Marta; Clyne, Melinda; Yesupriya, Ajay; Khoury, Muin J.] Ctr Dis Control & Prevent, Natl Off Publ Hlth Genom, Atlanta, GA 30309 USA	Centers for Disease Control & Prevention - USA	Yu, W (corresponding author), Ctr Dis Control & Prevent, Natl Off Publ Hlth Genom, Atlanta, GA 30309 USA.	wby0@cdc.gov		Clyne, Mindy/0000-0001-9884-7856				Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Frayling TM, 2007, DIABETOLOGIA, V50, P2229, DOI 10.1007/s00125-007-0825-7; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Lin BK, 2006, AM J EPIDEMIOL, V164, P1, DOI 10.1093/aje/kwj175; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Yu W, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-436; Yu W, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-17	7	311	321	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					124	125		10.1038/ng0208-124	http://dx.doi.org/10.1038/ng0208-124			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18227866				2022-12-17	WOS:000252732900004
J	Devriendt, K; Kim, AS; Mathijs, G; Frints, SGM; Schwartz, M; Van den Oord, JJ; Verhoef, GEG; Boogaerts, MA; Fryns, JP; You, DQ; Rosen, MK; Vandenberghe, P				Devriendt, K; Kim, AS; Mathijs, G; Frints, SGM; Schwartz, M; Van den Oord, JJ; Verhoef, GEG; Boogaerts, MA; Fryns, JP; You, DQ; Rosen, MK; Vandenberghe, P			Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia	NATURE GENETICS			English	Letter							WISKOTT-ALDRICH-SYNDROME; SYNDROME PROTEIN WASP; ACTIN NUCLEATION; ARP2/3 COMPLEX; N-WASP; CDC42; EXPRESSION; GENE; BINDING; CELLS	The Wiskott-Aldrich syndrome protein (WASP; encoded by the gene WAS) and its homologs are important regulators of the actin cytoskeleton, mediating communication between Rho-family GTPases and the actin nucleation/crosslinking factor. the Arp2/3 complex(1). Many WAS mutations impair cytoskeletal control in hematopoietic tissues, resulting in functional and developmental defects that define the X-linked Wiskott-Aldrich syndrome (NAS) and the related X-linked thrombocytopenia(2) (XLT), These diseases seem to result from reduced WASP signaling, often through decreased transcription or translation of the gene(3-8). Here we describe a new disease, X-linked severe congenital neutropenia (XLN), caused by a novel L270P mutation in the region of WAS encoding the conserved GTPase binding domain (GBD), In vitro. the mutant protein is constitutively activated through disruption of an autoinhibitory domain in the wild-type protein, indicating that loss of WASP autoinhibition is a key event in XLN. Our findings highlight the importance of precise regulation of WASP in hematopoietic development and function, as impairment versus enhancement of its activity give rise to distinct spectra of cellular defects and clinical phenotypes.	Katholieke Univ Leuven, Lab Expt Hematol, Louvain, Belgium; Katholieke Univ Leuven Hosp, Ctr Human Genet, Louvain, Belgium; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Copenhagen Univ Hosp, Rigshosp, Dept Clin Genet, DK-4062 Copenhagen, Denmark; Katholieke Univ Leuven Hosp, Dept Pathol, Lab Histo & Cytochem, Louvain, Belgium	KU Leuven; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Memorial Sloan Kettering Cancer Center; Rigshospitalet; University of Copenhagen; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Vandenberghe, P (corresponding author), Katholieke Univ Leuven, Lab Expt Hematol, Louvain, Belgium.	rosen@mrnmr1.mskcc.org; peter.vandenberghe@med.kuleuven.ac.be		Vandenberghe, Peter/0000-0003-4719-1935; Frints, Suzanna G.M./0000-0002-5027-8364; Matthijs, Gert/0000-0001-6710-1912				Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Coakley G, 2000, ARTHRITIS RHEUM, V43, P834, DOI 10.1002/1529-0131(200004)43:4<834::AID-ANR14>3.0.CO;2-H; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Devriendt K, 1997, AM J HUM GENET, V60, P581; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; ELSNER J, 1993, EXP HEMATOL, V21, P38; Facchetti F, 1998, J PATHOL, V185, P99, DOI 10.1002/(SICI)1096-9896(199805)185:1<99::AID-PATH48>3.0.CO;2-L; Geller DS, 2000, SCIENCE, V289, P119, DOI 10.1126/science.289.5476.119; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lemahieu V, 1999, HUM MUTAT, V14, P54, DOI 10.1002/(SICI)1098-1004(1999)14:1<54::AID-HUMU7>3.3.CO;2-5; MacCarthy-Morrogh L, 1998, CLIN IMMUNOL IMMUNOP, V88, P22, DOI 10.1006/clin.1998.4557; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Parolini O, 1997, BLOOD, V90, P70; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Scherbina A, 1999, J IMMUNOL, V163, P6314; Schwartz M, 1996, THROMB HAEMOSTASIS, V75, P546; Snapper SB, 1999, ANNU REV IMMUNOL, V17, P905, DOI 10.1146/annurev.immunol.17.1.905; Stewart DM, 1996, J CLIN INVEST, V97, P2627, DOI 10.1172/JCI118712; Zhu QL, 1997, BLOOD, V90, P2680, DOI 10.1182/blood.V90.7.2680.2680_2680_2689	30	311	323	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2001	27	3					313	317		10.1038/85886	http://dx.doi.org/10.1038/85886			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	408AK	11242115				2022-12-17	WOS:000167304200025
J	KANG, S; JAWORSKI, A; OHSHIMA, K; WELLS, RD				KANG, S; JAWORSKI, A; OHSHIMA, K; WELLS, RD			EXPANSION AND DELETION OF CTG REPEATS FROM HUMAN-DISEASE GENES ARE DETERMINED BY THE DIRECTION OF REPLICATION IN ESCHERICHIA-COLI	NATURE GENETICS			English	Article							UNUSUAL DNA STRUCTURES; MYOTONIC-DYSTROPHY; ESCHERICHIA-COLI; TYPE-1	Several human hereditary neurological and neurodegenerative disease genes are associated with the expansion of CTG repeats. Here we show that the frequency of genetic expansions or deletions in Escherichia coli depends on the direction of replication. Large expansions occur predominantly when the CTGs are in the leading strand template rather than the lagging strand. However, deletions are more prominant when the CTGs are in the opposite orientation. Most deletions generated products of defined size classes. Strand slippage coupled with non-classical DNA structures may account for these observations and relate to expansion-deletion mechanisms in eukaryotic chromosomes for disease genes.	TEXAS A&M UNIV, MED CTR, INST BIOSCI & TECHNOL, HOUSTON, TX 77030 USA	Texas A&M University System					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030822] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30822] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; COVERLEY D, 1994, ANNU REV BIOCHEM, V63, P745, DOI 10.1146/annurev.bi.63.070194.003525; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; KANG S, 1992, J BIOL CHEM, V267, P19435; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PODHAJSKA AJ, 1985, GENE, V40, P163, DOI 10.1016/0378-1119(85)90038-1; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; WELLS RD, 1988, J BIOL CHEM, V263, P1095; WELLS RD, 1993, GENOME ANAL, V7, P107; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; WIERINGA B, 1994, HUM MOL GENET, V3, P1, DOI 10.1093/hmg/3.1.1-a; WOHLRAB F, 1987, J BIOL CHEM, V262, P6407	25	311	315	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1995	10	2					213	218		10.1038/ng0695-213	http://dx.doi.org/10.1038/ng0695-213			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663518				2022-12-17	WOS:A1995RA85700020
J	GREEN, AJ; SMITH, M; YATES, JRW				GREEN, AJ; SMITH, M; YATES, JRW			LOSS OF HETEROZYGOSITY ON CHROMOSOME 16P13.3 IN HAMARTOMAS FROM TUBEROUS SCLEROSIS PATIENTS	NATURE GENETICS			English	Article							GENE LOCUS	Tuberous sclerosis (TSC) is an autosomal dominant condition with characteristic skin lesions, mental handicap, seizures and the development of hamartomas in the brain, heart, kidneys and other organs. Linkage studies have shown locus heterogeneity with a TSC gene mapped to chromosome 9q34 and a second, recently identified on 16p13.3. We have analysed DNA markers in eight hamartomas and one tumour from TSC patients and found allele loss on 16p13.3 in three angiomyolipomas, one cardiac rhabdomyoma, one cortical tuber and one giant cell astrocytoma. We suggest that the RSC gene on 16p13.3 functions like a tumour suppressor gene, in accordance with Knudsen's hypothesis.	ADDENBROOKES HOSP,DEPT CLIN GENET,CAMBRIDGE CB2 2QQ,CAMBS,ENGLAND; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QP,CAMBS,ENGLAND; UNIV CALIF IRVINE,IRVINE,CA 92717	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of California System; University of California Irvine			Green, Andrew/AAJ-7592-2020	Green, Andrew/0000-0002-1077-7417				ALPER JC, 1983, PAEDIAT DERMATOLOGY, V1, P56; BURLEY MW, 1993, IN PRESS CYTOGENET C; COMINGS DE, 1980, AM J HUM GENET, V32, P285; FAHSOLD R, 1991, HUM GENET, V88, P85, DOI 10.1007/BF00204934; FRYER AE, 1987, LANCET, V1, P659; GOMEZ MR, 1991, ANN NY ACAD SCI, V615, P1; HARDING CO, 1990, AM J MED GENET, V37, P443, DOI 10.1002/ajmg.1320370402; KANDT RS, 1992, NAT GENET, V2, P37, DOI 10.1038/ng0992-37; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; Maniatis T., 1982, MOL CLONING; Neumann H. P. H., 1992, American Journal of Human Genetics, V51, pA104; ROCHA G, 1962, ARCH DERMATOL, V85, P722, DOI 10.1001/archderm.1962.01590060032006; SEIZINGER BR, 1993, NAT GENET, V3, P97, DOI 10.1038/ng0293-97; SMITH M, 1990, GENOMICS, V6, P105, DOI 10.1016/0888-7543(90)90454-3; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; WEBB DW, 1993, ARCH DIS CHILD, V68, P367, DOI 10.1136/adc.68.3.367; 1993, CELL, V75, P1	18	311	318	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					193	196		10.1038/ng0294-193	http://dx.doi.org/10.1038/ng0294-193			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162074	Green Published			2022-12-17	WOS:A1994MU76300016
J	Eleveld, TF; Oldridge, DA; Bernard, V; Koster, J; Daage, LC; Diskin, SJ; Schild, L; Bentahar, NB; Bellini, A; Chicard, M; Lapouble, E; Combaret, V; Legoix-Ne, P; Michon, J; Pugh, TJ; Hart, LS; Rader, J; Attiyeh, EF; Wei, JS; Zhang, SL; Naranjo, A; Gastier-Foster, JM; Hogarty, MD; Asgharzadeh, S; Smith, MA; Auvil, JMG; Watkins, TBK; Zwijnenburg, DA; Ebus, ME; van Sluis, P; Hakkert, A; van Wezel, E; van der Schoot, CE; Westerhout, EM; Schulte, JH; Tytgat, GA; Dolman, MEM; Janoueix-Lerosey, I; Gerhard, DS; Caron, HN; Delattre, O; Khan, J; Versteeg, R; Schleiermacher, G; Molenaar, JJ; Maris, JM				Eleveld, Thomas F.; Oldridge, Derek A.; Bernard, Virginie; Koster, Jan; Daage, Leo Colmet; Diskin, Sharon J.; Schild, Linda; Bentahar, Nadia Bessoltane; Bellini, Angela; Chicard, Mathieu; Lapouble, Eve; Combaret, Valerie; Legoix-Ne, Patricia; Michon, Jean; Pugh, Trevor J.; Hart, Lori S.; Rader, JulieAnn; Attiyeh, Edward F.; Wei, Jun S.; Zhang, Shile; Naranjo, Arlene; Gastier-Foster, Julie M.; Hogarty, Michael D.; Asgharzadeh, Shahab; Smith, Malcolm A.; Auvil, Jaime M. Guidry; Watkins, Thomas B. K.; Zwijnenburg, Danny A.; Ebus, Marli E.; van Sluis, Peter; Hakkert, Anne; van Wezel, Esther; van der Schoot, C. Ellen; Westerhout, Ellen M.; Schulte, Johannes H.; Tytgat, Godelieve A.; Dolman, M. Emmy M.; Janoueix-Lerosey, Isabelle; Gerhard, Daniela S.; Caron, Huib N.; Delattre, Olivier; Khan, Javed; Versteeg, Rogier; Schleiermacher, Gudrun; Molenaar, Jan J.; Maris, John M.			Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations	NATURE GENETICS			English	Article							SEQUENCING DATA; CHROMOSOME 1P; ALK MUTATIONS; HUMAN CANCER; THERAPY; COMBINATION; PROGRESSION; ASSOCIATION; SENSITIVITY; CRIZOTINIB	The majority of patients with neuroblastoma have tumors that initially respond to chemotherapy, but a large proportion will experience therapy-resistant relapses. The molecular basis of this aggressive phenotype is unknown. Whole-genome sequencing of 23 paired diagnostic and relapse neuroblastomas showed clonal evolution from the diagnostic tumor, with a median of 29 somatic mutations unique to the relapse sample. Eighteen of the 23 relapse tumors (78%) showed mutations predicted to activate the RAS-MAPK pathway. Seven of these events were detected only in the relapse tumor, whereas the others showed clonal enrichment. In neuroblastoma cell lines, we also detected a high frequency of activating mutations in the RAS-MAPK pathway (11/18; 61%), and these lesions predicted sensitivity to MEK inhibition in vitro and in vivo. Our findings provide a rationale for genetic characterization of relapse neuroblastomas and show that RAS-MAPK pathway mutations may function as a biomarker for new therapeutic approaches to refractory disease.	[Eleveld, Thomas F.; Koster, Jan; Schild, Linda; Zwijnenburg, Danny A.; Ebus, Marli E.; van Sluis, Peter; Hakkert, Anne; Westerhout, Ellen M.; Dolman, M. Emmy M.; Versteeg, Rogier; Molenaar, Jan J.] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Oldridge, Derek A.; Diskin, Sharon J.; Hart, Lori S.; Rader, JulieAnn; Attiyeh, Edward F.; Hogarty, Michael D.; Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Oldridge, Derek A.; Diskin, Sharon J.; Hart, Lori S.; Rader, JulieAnn; Attiyeh, Edward F.; Hogarty, Michael D.; Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Oldridge, Derek A.; Diskin, Sharon J.; Attiyeh, Edward F.; Hogarty, Michael D.; Maris, John M.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bernard, Virginie; Daage, Leo Colmet; Bentahar, Nadia Bessoltane; Legoix-Ne, Patricia] Inst Curie, ICGEX Platform, Paris, France; [Daage, Leo Colmet; Bellini, Angela; Chicard, Mathieu; Schleiermacher, Gudrun] Inst Curie, Transfer Dept, Lab RTOP, Paris, France; [Lapouble, Eve] Inst Curie, Unite Genet Somat, Paris, France; [Combaret, Valerie] Ctr Leon Berard, Lab Rech Translat Lyon, F-69373 Lyon, France; [Michon, Jean; Schleiermacher, Gudrun] Inst Curie, Dept Pediat, Paris, France; [Pugh, Trevor J.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Pugh, Trevor J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Wei, Jun S.; Zhang, Shile; Khan, Javed] NIH, Pediat Oncol Branch, Oncogen Sect, Ctr Canc Res, Gaithersburg, MD USA; [Naranjo, Arlene] Univ Florida, Dept Biostat, COG, Gainesville, FL USA; [Gastier-Foster, Julie M.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Gastier-Foster, Julie M.; Gerhard, Daniela S.] Nationwide Childrens Hosp, Biopathol Ctr, Columbus, OH USA; [Asgharzadeh, Shahab] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Smith, Malcolm A.] NCI, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [Auvil, Jaime M. Guidry] NCI, Off Canc Genom, Bethesda, MD 20892 USA; [Watkins, Thomas B. K.] Canc Res UK, Translat Canc Therapeut Lab, London, England; [van Wezel, Esther; van der Schoot, C. Ellen] Sanquin Res, Dept Expt Immunohematol, Amsterdam, Netherlands; [van Wezel, Esther; van der Schoot, C. Ellen] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Schulte, Johannes H.] Charite, Dept Pediat Oncol & Hematol, D-13353 Berlin, Germany; [Schulte, Johannes H.] German Consortium Translat Canc Res DKTK, Heidelberg, Germany; [Schulte, Johannes H.] Univ Childrens Hosp Essen, Dept Pediat Oncol & Hematol, Essen, Germany; [Schulte, Johannes H.] Univ Hosp Essen, West German Canc Ctr WTZ, Translat Neurooncol, Essen, Germany; [Tytgat, Godelieve A.; Caron, Huib N.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands; [Janoueix-Lerosey, Isabelle; Delattre, Olivier; Schleiermacher, Gudrun] Inst Curie, Lab Genet & Biol Canc, INSERM U830, Paris, France	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University System of Florida; University of Florida; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Cancer Research UK; University of Amsterdam; Academic Medical Center Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; University of Duisburg Essen; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Schleiermacher, G (corresponding author), Inst Curie, Transfer Dept, Lab RTOP, Paris, France.	gudrun.schleiermacher@curie.fr; j.j.molenaar@amc.uva.nl; maris@chop.edu	Khan, Javed/P-9157-2014; Koster, Jan/C-5934-2008; Schulte, Johannes H./V-2474-2018; Eleveld, Thomas/AGV-7775-2022; tytgat, g/ABF-6481-2020; Eleveld, Thomas/AAA-5416-2021; Pugh, Trevor/Y-2535-2019; Schleiermacher, Gudrun/AAN-4711-2021; Versteeg, Rogier/AAQ-1765-2020; Janoueix-Lerosey, Isabelle/G-1758-2018	Koster, Jan/0000-0002-0890-7585; Eleveld, Thomas/0000-0001-8580-4822; Pugh, Trevor/0000-0002-8073-5888; Schleiermacher, Gudrun/0000-0002-0133-5879; Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; Smith, Malcolm/0000-0001-9880-9876; Chicard, Mathieu/0000-0002-0697-8611; Versteeg, Rogier/0000-0001-7172-0388; Tytgat, Lieve/0000-0003-4452-0748; delattre, olivier/0000-0002-8730-2276; Schulte, Johannes Hubertus/0000-0003-0671-1201; COLMET DAAGE, Leo/0000-0002-5472-4616; Dolman, Emmy/0000-0002-0567-5918	US National Institutes of Health [RC1MD004418, HHSN261200800001E]; University of Pennsylvania Genome Frontiers Institute; National Cancer Institute; Annenberg Foundation; Nelia and Amadeo Barletta Foundation; SiRIC/INCa [INCa-DGOS-4654]; Comite d'Evaluation et Suivi des Projets de Recherche de Transfert (CEST) of Institut Curie; Associations Enfants et Sante; Association Hubert Gouin Enfance et Cancer; Les Bagouz a Manon; Les Amis de Claire; EQUIPEX Investissements d'Avenir program [ANR-10-EQPX-03]; Agence Nationale de le Recherche [ANR10-INBS-09-08]; Canceropole Ile-de-France; Villa Joep Foundation; Kinderen Kankervrij Foundation; Netherlands Cancer Foundation; NATIONAL CANCER INSTITUTE [U10CA098413, U10CA098543, U10CA180886, F30CA192831] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC1MD004418] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Genome Frontiers Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Annenberg Foundation; Nelia and Amadeo Barletta Foundation; SiRIC/INCa; Comite d'Evaluation et Suivi des Projets de Recherche de Transfert (CEST) of Institut Curie; Associations Enfants et Sante; Association Hubert Gouin Enfance et Cancer; Les Bagouz a Manon; Les Amis de Claire; EQUIPEX Investissements d'Avenir program(French National Research Agency (ANR)); Agence Nationale de le Recherche(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); Villa Joep Foundation; Kinderen Kankervrij Foundation; Netherlands Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to thank N. Ross for sample preparation and quality control. This study was supported in part by US National Institutes of Health grants RC1MD004418 to the TARGET consortium and CA98543 and CA98413 to the Children's Oncology Group and was supported in part by a grant throughout the University of Pennsylvania Genome Frontiers Institute. In addition, this project was funded in part with federal funds from the National Cancer Institute, US National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services nor does mention of trade names, commercial products or organizations imply endorsement by the US government. The binimetinib xenograft studies were supported through a research collaborative agreement between the Children's Hospital of Philadelphia and Novartis Pharmaceuticals. In France, this study was supported by the Annenberg Foundation and the Nelia and Amadeo Barletta Foundation. Funding was also obtained from SiRIC/INCa (grant INCa-DGOS-4654) and from the Comite d'Evaluation et Suivi des Projets de Recherche de Transfert (CEST) of Institut Curie. This study was also funded by the Associations Enfants et Sante, Association Hubert Gouin Enfance et Cancer, Les Bagouz a Manon and Les Amis de Claire. Deep sequencing experiments were conducted on the ICGex next-generation sequencing platform at the Institut Curie funded by the EQUIPEX Investissements d'Avenir program (ANR-10-EQPX-03) and ANR10-INBS-09-08 from the Agence Nationale de le Recherche and by the Canceropole Ile-de-France. In the Netherlands, this study was supported by grants from the Villa Joep Foundation, the Kinderen Kankervrij Foundation and the Netherlands Cancer Foundation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Boca SM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r112; Bown N, 1999, NEW ENGL J MED, V340, P1954, DOI 10.1056/NEJM199906243402504; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Caron H, 1996, NEW ENGL J MED, V334, P225, DOI 10.1056/NEJM199601253340404; Carr-Wilkinson J, 2010, CLIN CANCER RES, V16, P1108, DOI 10.1158/1078-0432.CCR-09-1865; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hero B, 2008, J CLIN ONCOL, V26, P1504, DOI 10.1200/JCO.2007.12.3349; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamers F, 2012, EUR J CANCER, V48, P763, DOI 10.1016/j.ejca.2011.10.012; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Long GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6694; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Moore NF, 2014, ONCOTARGET, V5, P8737, DOI 10.18632/oncotarget.2372; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schleiermacher G, 2014, J CLIN ONCOL, V32, P2727, DOI 10.1200/JCO.2013.54.0674; Schleiermacher G, 2010, J CLIN ONCOL, V28, P3122, DOI 10.1200/JCO.2009.26.7955; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Simon T, 2011, PEDIATR BLOOD CANCER, V56, P578, DOI 10.1002/pbc.22693; Taggart D, 2008, Q J NUCL MED MOL IM, V52, P403; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	42	310	317	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2015	47	8					864	+		10.1038/ng.3333	http://dx.doi.org/10.1038/ng.3333			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN8FG	26121087	Green Accepted			2022-12-17	WOS:000358674100008
J	Wierzbicki, AT; Ream, TS; Haag, JR; Pikaard, CS				Wierzbicki, Andrzej T.; Ream, Thomas S.; Haag, Jeremy R.; Pikaard, Craig S.			RNA polymerase V transcription guides ARGONAUTE4 to chromatin	NATURE GENETICS			English	Article							DIRECTED DNA METHYLATION; PROCESSING CENTER; ARABIDOPSIS; SIRNA; IV; PROTEIN	Retrotransposons and repetitive DNA elements in eukaryotes are silenced by small RNA-directed heterochromatin formation. In Arabidopsis, this process involves 24-nt siRNAs that bind to ARGONAUTE4 (AGO4) and facilitate the targeting of complementary loci(1,2) via unknown mechanisms. Nuclear RNA polymerase V (Pol V) is an RNA silencing enzyme recently shown to generate noncoding transcripts at loci silenced by 24-nt siRNAs(3). We show that AGO4 physically interacts with these Pol V transcripts and is thereby recruited to the corresponding chromatin. We further show that DEFECTIVE IN MERISTEM SILENCING3 (DMS3), a structural maintenance of chromosomes (SMC) hinge-domain protein(4), functions in the assembly of Pol V transcription initiation or elongation complexes. Collectively, our data suggest that AGO4 is guided to target loci through base-pairing of associated siRNAs with nascent Pol V transcripts.	[Wierzbicki, Andrzej T.; Ream, Thomas S.; Haag, Jeremy R.; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pikaard, CS (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	pikaard@biology.wustl.edu	Pikaard, Craig S/K-8772-2012	Pikaard, Craig S/0000-0001-8204-7459	US National Institutes of Health [GM077590]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Our work is supported by US National Institutes of Health grant GM077590. The content of the paper is the sole responsibility of the authors and does not necessarily reflect the views of the NIH. We thank T. Blevins (Washington University, St. Louis), S. Jacobsen (University of California, Los Angeles) and T. Jenuwein (Max Planck Institute of Immunobiology) for providing reagents.	Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Haag JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004110; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kanno T, 2005, EMBO REP, V6, P649, DOI 10.1038/sj.embor.7400446; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Peric-Hupkes D, 2008, CELL, V132, P925, DOI 10.1016/j.cell.2008.03.001; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	21	310	330	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2009	41	5					630	634		10.1038/ng.365	http://dx.doi.org/10.1038/ng.365			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	438SL	19377477	Green Accepted			2022-12-17	WOS:000265575600028
J	Pasternack, SM; von Kugelgen, I; Al Aboud, K; Lee, YA; Ruschendorf, F; Voss, K; Hillmer, AM; Molderings, GJ; Franz, T; Ramirez, A; Nuernberg, P; Nothen, MM; Betz, RC				Pasternack, Sandra M.; von Kuegelgen, Ivar; Al Aboud, Khalid; Lee, Young-Ae; Rueschendorf, Franz; Voss, Katrin; Hillmer, Axel M.; Molderings, Gerhard J.; Franz, Thomas; Ramirez, Alfredo; Nuernberg, Peter; Noethen, Markus M.; Betz, Regina C.			G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth	NATURE GENETICS			English	Article							LYSOPHOSPHATIDIC ACID; INTERNATIONAL UNION; GENE; IDENTIFICATION; HYPOTRICHOSIS; PHARMACOLOGY; MUTATIONS; GPR92; 6H1	Hypotrichosis simplex is a group of nonsyndromic human alopecias. We mapped an autosomal recessive form of this disorder to chromosome 13q14.11-13q21.33, and identified homozygous truncating mutations in P2RY5, which encodes an orphan G protein-coupled receptor. Furthermore, we identified oleoyl-L-alpha-lysophosphatidic acid (LPA), a bioactive lipid, as a ligand for P2Y5 in reporter gene and radioligand binding experiments. Homology and studies of signaling transduction pathways suggest that P2Y5 is a member of a subgroup of LPA receptors, which also includes LPA4 and LPA5. Our study is the first to implicate a G protein-coupled receptor as essential for and specific to the maintenance of human hair growth. This finding may provide opportunities for new therapeutic approaches to the treatment of hair loss in humans.	[Pasternack, Sandra M.; Noethen, Markus M.; Betz, Regina C.] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; [Pasternack, Sandra M.; Molderings, Gerhard J.] Univ Bonn, Dept Pharmacol, D-53113 Bonn, Germany; [Al Aboud, Khalid] King Faisal Hosp, Dept Dermatol, Mecca 5592, Saudi Arabia; [Lee, Young-Ae] Humboldt Univ, Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany; [Lee, Young-Ae; Rueschendorf, Franz] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Voss, Katrin] Univ Wurzburg, Dept Human Genet, D-97074 Wurzburg, Germany; [Hillmer, Axel M.; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Franz, Thomas] Univ Bonn, Dept Anat, D-53115 Bonn, Germany; [Ramirez, Alfredo] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Ramirez, Alfredo] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Ramirez, Alfredo; Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany	University of Bonn; University of Bonn; King Faisal Specialist Hospital & Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; University of Bonn; University of Bonn; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Betz, RC (corresponding author), Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany.	regina.betz@uni-bonn.de	Hillmer, Axel M/B-7485-2015; Betz, Regina C/E-8591-2011; Ramirez, Alfredo/S-5126-2019; von Kügelgen, Ivar/D-2989-2019; Nöthen, Markus/B-2027-2009; Hillmer, Axel M/N-2927-2014	Hillmer, Axel M/0000-0002-3381-7266; Betz, Regina C/0000-0001-5024-3623; Ramirez, Alfredo/0000-0003-4991-763X; von Kügelgen, Ivar/0000-0002-2021-4028; Nöthen, Markus/0000-0002-8770-2464; Hillmer, Axel M/0000-0002-3381-7266	Direct For Biological Sciences [0749004] Funding Source: National Science Foundation; Division Of Environmental Biology [0746560] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; Al Aboud D, 2005, SUDAN J DERMATOL, V3, P128; Al Aboud K, 2002, CLIN EXP DERMATOL, V27, P654, DOI 10.1046/j.1365-2230.2002.01088.x; BETZ RC, 2006, PROGR MONOGENIC HAIR, P43; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Cichon S, 1998, HUM MOL GENET, V7, P1671, DOI 10.1093/hmg/7.11.1671; Herzog H, 1996, GENOME RES, V6, P858, DOI 10.1101/gr.6.9.858; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; Li Q, 1997, BIOCHEM BIOPH RES CO, V236, P455, DOI 10.1006/bbrc.1997.6984; Miller J, 2001, J INVEST DERMATOL, V117, P612, DOI 10.1046/j.0022-202x.2001.01438.x; Molderings GJ, 2007, NEUROCHEM INT, V51, P476, DOI 10.1016/j.neuint.2007.04.022; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Sobel E, 1996, AM J HUM GENET, V58, P1323; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Takahashi T, 2003, J INVEST DERMATOL, V121, P448, DOI 10.1046/j.1523-1747.2003.12426.x; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wali A, 2007, CLIN GENET, V72, P23, DOI 10.1111/j.1399-0004.2007.00818.x; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Webb TE, 1996, BIOCHEM BIOPH RES CO, V219, P105, DOI 10.1006/bbrc.1996.0189; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	30	310	326	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					329	334		10.1038/ng.84	http://dx.doi.org/10.1038/ng.84			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18297070				2022-12-17	WOS:000253548400024
J	Sackton, TB; Lazzaro, BP; Schlenke, TA; Evans, JD; Hultmark, D; Clark, AG				Sackton, Timothy B.; Lazzaro, Brian P.; Schlenke, Todd A.; Evans, Jay D.; Hultmark, Dan; Clark, Andrew G.			Dynamic evolution of the innate immune system in Drosophila	NATURE GENETICS			English	Article							MOLECULAR POPULATION-GENETICS; DETECTING POSITIVE SELECTION; ANTIMICROBIAL PEPTIDES; TRANSMEMBRANE PROTEIN; ADAPTIVE EVOLUTION; SIGNALING PATHWAYS; GENES; FAMILY; PATTERN; PHAGOCYTOSIS	The availability of complete genome sequence from 12 Drosophila species presents the opportunity to examine how natural selection has affected patterns of gene family evolution and sequence divergence among different components of the innate immune system. We have identified orthologs and paralogs of 245 Drosophila melanogaster immune-related genes in these recently sequenced genomes. Genes encoding effector proteins, and to a lesser extent genes encoding recognition proteins, are much more likely to vary in copy number across species than genes encoding signaling proteins. Furthermore, we can trace the apparent recent origination of several evolutionarily novel immune-related genes and gene families. Using codon-based likelihood methods, we show that immune-system genes, and especially those encoding recognition proteins, evolve under positive darwinian selection. Positively selected sites within recognition proteins cluster in domains involved in recognition of microorganisms, suggesting that molecular interactions between hosts and pathogens may drive adaptive evolution in the Drosophila immune system.	Cornell Univ, New York, NY 14853 USA; Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; Emory Univ, Dept Biol, Atlanta, GA 30322 USA; USDA, Agr Res Serv Bee Res Lab, Beltsville, MD 20705 USA; Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University; Emory University; United States Department of Agriculture (USDA); Umea University; Cornell University	Sackton, TB (corresponding author), Cornell Univ, New York, NY 14853 USA.	tbs7@cornell.edu	Evans, Jay D/C-8408-2012; Hultmark, Dan/C-5058-2013	Evans, Jay D/0000-0002-0036-4651; Hultmark, Dan/0000-0002-6506-5855; Clark, Andrew/0000-0001-7159-8511; Schlenke, Todd/0000-0003-3091-3057; Sackton, Timothy/0000-0003-1673-9216	NIGMS NIH HHS [F32 GM067504] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067504] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Begun DJ, 2000, GENETICS, V154, P1231; Blandin S, 2004, MOL IMMUNOL, V40, P903, DOI 10.1016/j.molimm.2003.10.010; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; CHEN CI, 2006, SCIENCE, V311, P1761; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Clark AG, 1997, GENETICS, V147, P713; Daibo S, 2001, GENE, V278, P177, DOI 10.1016/S0378-1119(01)00713-2; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; *DROS 12 GEN CONS, 2007, NATURE, DOI DOI 10.1038/06341; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Jiggins FM, 2005, GENETICS, V171, P1847, DOI 10.1534/genetics.105.045435; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lazzaro BP, 2003, MOL BIOL EVOL, V20, P914, DOI 10.1093/molbev/msg109; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000442; Little TJ, 2005, INSECT MOL BIOL, V14, P599, DOI 10.1111/j.1365-2583.2005.00588.x; Little TJ, 2004, J MOL EVOL, V59, P498, DOI 10.1007/s00239-004-2641-8; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Ramos-Onsins S, 1998, GENETICS, V150, P157; Schlenke TA, 2003, GENETICS, V164, P1471; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Tennessen JA, 2005, J EVOLUTION BIOL, V18, P1387, DOI 10.1111/j.1420-9101.2005.00925.x; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Werner T, 2003, J BIOL CHEM, V278, P26319, DOI 10.1074/jbc.C300184200; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	50	310	319	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1461	1468		10.1038/ng.2007.60	http://dx.doi.org/10.1038/ng.2007.60			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17987029				2022-12-17	WOS:000251267400013
J	Spinazzola, A; Viscomi, C; Fernandez-Vizarra, E; Carrara, F; D'Adamo, P; Calvo, S; Marsano, RM; Donnini, C; Weiher, H; Strisciuglio, P; Parini, R; Sarzi, E; Chan, A; DiMauro, S; Rotig, A; Gasparini, P; Ferrero, I; Mootha, VK; Tiranti, V; Zeviani, M				Spinazzola, A; Viscomi, C; Fernandez-Vizarra, E; Carrara, F; D'Adamo, P; Calvo, S; Marsano, RM; Donnini, C; Weiher, H; Strisciuglio, P; Parini, R; Sarzi, E; Chan, A; DiMauro, S; Rotig, A; Gasparini, P; Ferrero, I; Mootha, VK; Tiranti, V; Zeviani, M			MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; KIDNEY-DISEASE; GENE MPV17; MUTATIONS; IMPORT; DEFICIENCY; KINASE; CHAIN	The mitochondrial (mt) DNA depletion syndromes (MDDS) are genetic disorders characterized by a severe, tissue-specific decrease of mtDNA copy number, leading to organ failure. There are two main clinical presentations: myopathic (OMIM 609560) and hepatocerebral(1) (OMIM 251880). Known mutant genes, including TK2 (ref. 2), SUCLA2 (ref. 3), DGUOK (ref. 4) and POLG(5,6), account for only a fraction of MDDS cases(7). We found a new locus for hepatocerebral MDDS on chromosome 2p21-23 and prioritized the genes on this locus using a new integrative genomics strategy. One of the top-scoring candidates was the human ortholog of the mouse kidney disease gene Mpv17 (ref. 8). We found disease-segregating mutations in three families with hepatocerebral MDDS and demonstrated that, contrary to the alleged peroxisomal localization of the MPV17 gene product(9), MPV17 is a mitochondrial inner membrane protein, and its absence or malfunction causes oxidative phosphorylation (OXPHOS) failure and mtDNA depletion, not only in affected individuals but also in Mpv17(-/-) mice.	Natl Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, I-20126 Milan, Italy; Telethon Inst Genet Med TIGEM, Linkage Unit & Serv, I-80131 Naples, Italy; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Syst Biol, Cambridge, MA 02138 USA; MIT, Broad Inst, Cambridge, MA 02446 USA; Harvard Univ, Cambridge, MA 02446 USA; Univ Parma, Dept Genet Anthropol Evolut, I-43100 Parma, Italy; Univ Appl Sci Bonn Rhein Sieg, D-53359 Bonn, Germany; Univ Catanzaro Magna Graecia, Dept Clin & Expt Med, I-88100 Catanzaro, Italy; Milano Bicocca State Univ, Univ Hosp, Pediat Unit, Pierfranco & Luisa Mariani Ctr Study Childrens Me, I-20052 Monza, Italy; Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM Unit U393, F-75015 Paris, France; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Univ Trieste, Dept Med Genet, I-34137 Trieste, Italy	IRCCS Istituto Neurologico Besta; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Parma; Hochschule Bonn Rhein Sieg; Magna Graecia University of Catanzaro; University of Milano-Bicocca; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Alberta; Columbia University; University of Trieste	Zeviani, M (corresponding author), Natl Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, I-20126 Milan, Italy.	zeviani@istituto-besta.it	Gasparini, Paolo/B-6173-2014; viscomi, Carlo/R-1940-2016; Fernandez-Vizarra, Erika/AAE-5600-2020; Zeviani, Massimo/AAU-2632-2021; Marsano, René Massimiliano/B-9640-2012; Parini, Rossella/J-9202-2018; Spinazzola, Antonella/P-5791-2019; Tiranti, Valeria/J-8233-2016; d'Adamo, Adamo Pio/G-4064-2011; Tiranti, Valeria/AFN-5783-2022; Donnini, Claudia/B-5548-2015; Zeviani, Massimo/K-2891-2014; Rötig, Agnès/G-9592-2017; Spinazzola, Antonella/P-5298-2017	Zeviani, Massimo/0000-0002-9067-5508; Marsano, René Massimiliano/0000-0001-8450-1010; Parini, Rossella/0000-0003-4505-1306; Spinazzola, Antonella/0000-0003-4242-8091; Tiranti, Valeria/0000-0002-3584-7338; d'Adamo, Adamo Pio/0000-0001-9367-4909; Tiranti, Valeria/0000-0002-3584-7338; Donnini, Claudia/0000-0002-4901-2358; Rötig, Agnès/0000-0003-0589-0703; Spinazzola, Antonella/0000-0003-4242-8091; Sarzi, Emmanuelle/0000-0002-7623-6699; Gasparini, Paolo/0000-0002-0859-0856; Fernandez-Vizarra, Erika/0000-0002-2469-142X; Viscomi, Carlo/0000-0001-6050-0566	Telethon [TGM06S01, TGM03P12, GGP030039] Funding Source: Medline	Telethon(Fondazione Telethon)		Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gallet PF, 1999, BBA-BIOMEMBRANES, V1418, P61, DOI 10.1016/S0005-2736(99)00022-X; GOTTESBERGE AMM, 1996, EUR ARCH OTO-RHINO-L, V253, P470; HAMMEN PK, 1994, BIOCHEMISTRY-US, V33, P8610, DOI 10.1021/bi00194a028; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; MOUNOLOU JC, 1966, BIOCHEM BIOPH RES CO, V24, P218, DOI 10.1016/0006-291X(66)90723-6; Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70; OHBA M, 1987, EMBO J, V6, P2117, DOI 10.1002/j.1460-2075.1987.tb02478.x; OTSUKA M, 1988, NUCLEIC ACIDS RES, V16, P10916, DOI 10.1093/nar/16.22.10916; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Rehling P, 2003, J MOL BIOL, V326, P639, DOI 10.1016/S0022-2836(02)01440-7; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284; Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025; Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004; WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A; ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x	30	310	317	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					570	575		10.1038/ng1765	http://dx.doi.org/10.1038/ng1765			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16582910	Green Published			2022-12-17	WOS:000237147500020
J	Weiss, LA; Pan, L; Abney, M; Ober, C				Weiss, LA; Pan, L; Abney, M; Ober, C			The sex-specific genetic architecture of quantitative traits in humans	NATURE GENETICS			English	Article							WHOLE-BLOOD SEROTONIN; FOUNDER POPULATION; LINKAGE ANALYSIS; SUSCEPTIBILITY ALLELES; GENDER-DIFFERENCES; LOCI; HOMOZYGOSITY; ASSOCIATION; EXPRESSION; DEPRESSION	Mapping genetically complex traits remains one of the greatest challenges in human genetics today. In particular, gene-environment and gene-gene interactions, genetic heterogeneity and incomplete penetrance make thorough genetic dissection of complex traits difficult, if not impossible. Sex could be considered an environmental factor that can modify both penetrance and expressivity of a wide variety of traits. Sex is easily determined and has measurable effects on recognizable morphology; neurobiological circuits; susceptibility to autoimmune disease, diabetes, asthma, cardiovascular and psychiatric disease; and quantitative traits like blood pressure, obesity and lipid levels, among others. In this study, we evaluated sex-specific heritability and genome-wide linkages for 17 quantitative traits in the Hutterites. The results of this study could have important implications for mapping complex trait genes.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu		Ober, Carole/0000-0003-4626-9809				Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Abney MA, 2000, AM J HUM GENET, V67, P327; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Cairney J, 2002, SOC PSYCH PSYCH EPID, V37, P401, DOI 10.1007/s00127-002-0569-0; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chen Y, 2003, J CLIN EPIDEMIOL, V56, P180, DOI 10.1016/S0895-4356(02)00593-0; Fisher SA, 2002, EUR J HUM GENET, V10, P259, DOI 10.1038/sj.ejhg.5200792; Fullerton J, 2003, AM J HUM GENET, V72, P879, DOI 10.1086/374178; Korstanje R, 2004, J LIPID RES, V45, P881, DOI 10.1194/jlr.M300460-JLR200; Kurina LM, 2005, J CLIN ENDOCR METAB, V90, P4747, DOI 10.1210/jc.2005-0384; Loughlin J, 2000, RHEUMATOLOGY, V39, P377, DOI 10.1093/rheumatology/39.4.377; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Newman DL, 2004, EUR J HUM GENET, V12, P584, DOI 10.1038/sj.ejhg.5201191; Newman DL, 2003, HUM MOL GENET, V12, P137, DOI 10.1093/hmg/ddg012; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Stromberg Anna, 2003, Eur J Cardiovasc Nurs, V2, P7; Towne B, 1997, GENET EPIDEMIOL, V14, P1053, DOI 10.1002/(SICI)1098-2272(1997)14:6<1053::AID-GEPI82>3.0.CO;2-G; Ueno T, 2004, PHYSIOL GENOMICS, V17, P38, DOI 10.1152/physiolgenomics.00043.2003; Weiss LA, 2005, HUM GENET, V117, P81, DOI 10.1007/s00439-004-1250-3; Weiss LA, 2005, AM J HUM GENET, V76, P33, DOI 10.1086/426697; Weiss LA, 2004, EUR J HUM GENET, V12, P949, DOI 10.1038/sj.ejhg.5201239; Williams AJK, 2003, DIABETOLOGIA, V46, P1354, DOI 10.1007/s00125-003-1197-2; Woods SC, 2003, EXP BIOL MED, V228, P1175; Zubenko GS, 2003, AM J MED GENET B, V123B, P1, DOI 10.1002/ajmg.b.20073	30	310	317	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					218	222		10.1038/ng1726	http://dx.doi.org/10.1038/ng1726			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16429159				2022-12-17	WOS:000234953200018
J	Bystrykh, L; Weersing, E; Dontje, B; Sutton, S; Pletcher, MT; Wiltshire, T; Su, AI; Vellenga, E; Wang, JT; Manly, KF; Lu, L; Chesler, EJ; Alberts, R; Jansen, RC; Williams, RW; Cooke, MP; de Haan, G				Bystrykh, L; Weersing, E; Dontje, B; Sutton, S; Pletcher, MT; Wiltshire, T; Su, AI; Vellenga, E; Wang, JT; Manly, KF; Lu, L; Chesler, EJ; Alberts, R; Jansen, RC; Williams, RW; Cooke, MP; de Haan, G			Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'	NATURE GENETICS			English	Article							MICE; DISSECTION; LESSONS; MOUSE	We combined large-scale mRNA expression analysis and gene mapping to identify genes and loci that control hematopoietic stem cell (HSC) function. We measured mRNA expression levels in purified HSCs isolated from a panel of densely genotyped recombinant inbred mouse strains. We mapped quantitative trait loci (QTLs) associated with variation in expression of thousands of transcripts. By comparing the physical transcript position with the location of the controlling QTL, we identified polymorphic cis-acting stem cell genes. We also identified multiple trans-acting control loci that modify expression of large numbers of genes. These groups of coregulated transcripts identify pathways that specify variation in stem cells. We illustrate this concept with the identification of candidate genes involved with HSC turnover. We compared expression QTLs in HSCs and brain from the same mice and identified both shared and tissue- specific QTLs. Our data are accessible through WebQTL, a web-based interface that allows custom genetic linkage analysis and identification of coregulated transcripts.	Univ Groningen, Dept Stem Cell Biol, NL-9713 AV Groningen, Netherlands; Novartis Res Fdn, Gen Inst, San Diego, CA 92121 USA; Acad Hosp, Dept Haematol, Groningen, Netherlands; Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; Univ Groningen, Groningen Bioinformat Ctr, Groningen, Netherlands	University of Groningen; Novartis; University of Groningen; Roswell Park Cancer Institute; University of Tennessee System; University of Tennessee Health Science Center; University of Groningen	de Haan, G (corresponding author), Univ Groningen, Dept Stem Cell Biol, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	g.de.haan@med.rug.nl	Chesler, Elissa/K-4641-2019; de Haan, Gerald/D-2081-2015; Jansen, Ritsert C/C-1160-2013; de Haan, Gerald/AAF-8963-2019; Williams, Robert W./H-8789-2016	Chesler, Elissa/0000-0002-5642-5062; de Haan, Gerald/0000-0001-9706-0138; Jansen, Ritsert C/0000-0003-2977-9110; de Haan, Gerald/0000-0001-9706-0138; Su, Andrew I./0000-0002-9859-4104; Williams, Robert W./0000-0001-8924-4447				BENDAVID Y, 1990, P NATL ACAD SCI USA, V87, P1332, DOI 10.1073/pnas.87.4.1332; BOULTWOOD J, 1994, BLOOD, V84, P3253; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; de Haan G, 2002, BLOOD, V100, P2056, DOI 10.1182/blood-2002-03-0808; deHaan G, 1997, J EXP MED, V186, P529, DOI 10.1084/jem.186.4.529; Fortunel NO, 2003, SCIENCE, V302, P393; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kamminga LM, 2000, EXP HEMATOL, V28, P1451, DOI 10.1016/S0301-472X(00)00543-9; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Lai F, 2001, GENOMICS, V71, P235, DOI 10.1006/geno.2000.6414; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Muller-Sieburg CE, 2000, BLOOD, V95, P2446, DOI 10.1182/blood.V95.7.2446.007k13_2446_2448; PEARCE SR, 1995, MAMM GENOME, V6, P537, DOI 10.1007/BF00356172; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Scherer A, 2003, BIOTECHNIQUES, V34, P546, DOI 10.2144/03343rr01; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	26	310	319	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					225	232		10.1038/ng1497	http://dx.doi.org/10.1038/ng1497			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15711547				2022-12-17	WOS:000227297800013
J	Kobayashi, K; Sinasac, DS; Iijima, M; Boright, AP; Begum, L; Lee, JR; Yasuda, T; Ikeda, S; Hirano, R; Terazono, H; Crackower, MA; Kondo, I; Tsui, LC; Scherer, SW; Saheki, T				Kobayashi, K; Sinasac, DS; Iijima, M; Boright, AP; Begum, L; Lee, JR; Yasuda, T; Ikeda, S; Hirano, R; Terazono, H; Crackower, MA; Kondo, I; Tsui, LC; Scherer, SW; Saheki, T			The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein	NATURE GENETICS			English	Article							ORTHOTOPIC LIVER-TRANSPLANTATION; SECRETORY TRYPSIN-INHIBITOR; ARGININOSUCCINATE SYNTHETASE; CLASSICAL CITRULLINEMIA; MESSENGER-RNA; UREA CYCLE; MUTATIONS; CLONING; CALCIUM; DNA	Citrullinaemia (CTLN) is an autosomal recessive disease caused by deficiency of argininosuccinate synthetase (ASS). Adultonset type II citrullinaemia (CTLN2) is characterized by a liverspecific ASS deficiency with no abnormalities in hepatic ASS mRNA or the gene ASS (refs 1-17). CTLN2 patients (1/100.000 in Japan(13)) suffer from a disturbance of consciousness and coma, and most die with cerebral edema within a few years of onset. CTLN2 differs from classical citrullinaemia (CTLN1, OMIM 215700) in that CTLN1 is neonatal or infantile in onset, with ASS enzyme defects (in all tissues) arising due to mutations in ASS on chromosome 9q34 (refs 18-21). We collected 118 CTLN2 families, and localized the CTLN2 locus to chromosome 7q21.3 by homozygosity mapping analysis of individuals from 18 consanguineous unions. Using positional cloning we identified a novel gene, SLC5A13, and found five different DNA sequence alterations that account for mutations in all consanguineous patients examined. SLC25A13 encodes a 3.4-kb transcript expressed most abundantly in liver. The protein encoded by SLC25A13, named citrin, is bipartite in structure, containing a mitochondrial carrier motif and four EF-hand domains, suggesting it is a calcium-dependent mitochondrial solute transporter with a role in urea cycle function.	Kagoshima Univ, Fac Med, Dept Biochem, Kagoshima 890820, Japan; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Yagi Clin, Aira 8995400, Japan; Ehime Univ, Sch Med, Dept Hyg, Shigenobu, Ehime 7910295, Japan	Kagoshima University; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ehime University	Kobayashi, K (corresponding author), Kagoshima Univ, Fac Med, Dept Biochem, 8-35-1 Sakuragaoka, Kagoshima 890820, Japan.		Scherer, Stephen W./B-3785-2013; Tsui, Lap-chee/A-1081-2010	Scherer, Stephen W./0000-0002-8326-1999; Sinasac, David/0000-0002-3749-5989				Crackower MA, 1999, GENOMICS, V55, P257, DOI 10.1006/geno.1998.5665; del Arco A, 1998, J BIOL CHEM, V273, P23327, DOI 10.1074/jbc.273.36.23327; Hegele RA, 1997, J CLIN ENDOCR METAB, V82, P3373, DOI 10.1210/jc.82.10.3373; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; IMAMURA Y, 1987, CLIN CHIM ACTA, V164, P201, DOI 10.1016/0009-8981(87)90071-4; Kakinoki H, 1997, HUM MUTAT, V9, P250, DOI 10.1002/(SICI)1098-1004(1997)9:3<250::AID-HUMU6>3.3.CO;2-K; Kawamoto S, 1997, CLIN TRANSPLANT, V11, P453; KAWASAKI H, 1994, PROTEIN PROFILE, V1, P343; KOBAYASHI K, 1986, AM J HUM GENET, V38, P667; KOBAYASHI K, 1995, FEBS LETT, V372, P69, DOI 10.1016/0014-5793(95)00948-9; KOBAYASHI K, 1994, AM J HUM GENET, V55, P1103; KOBAYASHI K, 1995, HUM GENET, V96, P454; Kobayashi K, 1997, HEPATOLOGY, V25, P1160, DOI 10.1002/hep.510250519; KOBAYASHI K, 1993, AM J HUM GENET, V53, P1024; KOBAYASHI K, 1990, J BIOL CHEM, V265, P11361; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KUAN J, 1993, CRIT REV BIOCHEM MOL, V28, P209, DOI 10.3109/10409239309086795; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376; SAHEKI T, 1982, CLIN CHIM ACTA, V118, P93; SAHEKI T, 1987, CLIN CHIM ACTA, V170, P297, DOI 10.1016/0009-8981(87)90140-9; SAHEKI T, 1987, REV PHYSIOL BIOCH P, V108, P21, DOI 10.1007/BFb0034071; SAHEKI T, 1981, CLIN CHIM ACTA, V109, P325, DOI 10.1016/0009-8981(81)90318-1; Saheki T, 1983, ADV EXP MED BIOL, V153, P63; SAHEKI T, 1985, GUANIDINES, P149; Sameshima Y., 1986, J CLIN BIOCHEM NUTR, V1, P129; SASE M, 1985, HUM GENET, V69, P130, DOI 10.1007/BF00293282; TODO S, 1992, HEPATOLOGY, V15, P419, DOI 10.1002/hep.1840150311; YAGI Y, 1988, AM J CLIN PATHOL, V89, P735, DOI 10.1093/ajcp/89.6.735; Yazaki M, 1996, TRANSPLANTATION, V62, P1679, DOI 10.1097/00007890-199612150-00027	30	310	356	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					159	163		10.1038/9667	http://dx.doi.org/10.1038/9667			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369257				2022-12-17	WOS:000080680900020
J	Guillam, MT; Hummler, E; Schaerer, E; Wu, JY; Birnbaum, MJ; Beermann, F; Schmidt, A; Deriaz, N; Thorens, B				Guillam, MT; Hummler, E; Schaerer, E; Wu, JY; Birnbaum, MJ; Beermann, F; Schmidt, A; Deriaz, N; Thorens, B			Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2	NATURE GENETICS			English	Article							BETA-CELLS; GLUCOSE-TRANSPORTER; INSULIN-SECRETION; RAT PANCREAS; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TRANSGENIC MICE; MOUSE; HYPERGLYCEMIA; SIGNAL	Glut-2 is a low-affinity transporter present in the plasma membrane of pancreatic beta-cells, hepatocytes and intestine and kidney absorptive epithelial cells of mice(1). In beta-cells, Glut-2 has been proposed to be active in the control of glucose-stimulated insulin secretion (GSIS; ref. 2), and its expression is strongly reduced in glucose-unresponsive islets from different animal models of diabetes(2-4). However, recent investigations have yielded conflicting data on the possible role of Glut-2 in GSIS. Whereas some reports have supported a specific role for Glut-2 (refs 5,6), others have suggested that GSIS could proceed normally even in the presence of low(7) or almost undetectable(8) levels of this transporter. Here we show that homozygous, but not heterozygous, mice deficient in Glut-2 are hyperglycaemic and relatively hypo-insulinaemic and have elevated plasma levels of glucagon, free fatty acids and beta-hydroxybutyrate. In vivo, their glucose tolerance is abnormal. In vitro, beta-cells display loss of control of insulin gene expression by glucose and impaired GSIS with a loss of first phase but preserved second phase of secretion, while the secretory response to non-glucidic nutrients or to D-glyceraldehyde is normal. This is accompanied by alterations in the postnatal development of pancreatic islets, evidenced by an inversion of the alpha- to beta-cell ratio. Glut-2 is thus required to maintain normal glucose homeostasis and normal function and development of the endocrine pancreas. Its absence leads to symptoms characteristic of non-insulin-dependent diabetes mellitus.	UNIV LAUSANNE,INST PHARMACOL & TOXICOL,CH-1005 LAUSANNE,SWITZERLAND; NATL TAIWAN UNIV HOSP,DEPT FAMILY MED,TAIPEI,TAIWAN; UNIV PENN,SCH MED,HOWARD HUGHES MED INST,PHILADELPHIA,PA 19104; SWISS INST EXPT CANC RES,CH-1066 EPALINGES,SWITZERLAND	University of Lausanne; National Taiwan University; National Taiwan University Hospital; Howard Hughes Medical Institute; University of Pennsylvania; Swiss Institute Experimental Cancer Research				Birnbaum, Morris/0000-0001-9972-8680				CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; DOCHERTY K, 1994, FASEB J, V8, P20, DOI 10.1096/fasebj.8.1.8299887; GERMAN MS, 1994, MOL CELL BIOL, V14, P4067, DOI 10.1128/MCB.14.6.4067; GIROIX MH, 1991, DIABETES, V40, P227, DOI 10.2337/diabetes.40.2.227; HOLE RL, 1988, AM J PHYSIOL, V254, pE167, DOI 10.1152/ajpendo.1988.254.2.E167; HOPCROFT DW, 1985, HORM METAB RES, V17, P559, DOI 10.1055/s-2007-1013606; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; KERVRAN A, 1980, DIABETES, V29, P673, DOI 10.2337/diabetes.29.9.673; LEAHY JL, 1992, DIABETES CARE, V15, P442, DOI 10.2337/diacare.15.3.442; Liang H, 1996, MOL BIOL CELL, V7, P1953, DOI 10.1091/mbc.7.12.1953; MA YH, 1995, EUR J ENDOCRINOL, V132, P370, DOI 10.1530/eje.0.1320370; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Offield MF, 1996, DEVELOPMENT, V122, P983; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; PANG K, 1994, P NATL ACAD SCI USA, V91, P9559, DOI 10.1073/pnas.91.20.9559; PHILIPPE J, 1994, DIABETES, V43, P523, DOI 10.2337/diabetes.43.4.523; RAHIER J, 1983, DIABETOLOGIA, V24, P366; RHOTEN WB, 1980, AM J PHYSIOL, V239, pE57, DOI 10.1152/ajpendo.1980.239.1.E57; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SUZUE K, 1989, NUCLEIC ACIDS RES, V17, P10099, DOI 10.1093/nar/17.23.10099; SWENNE I, 1985, DIABETES, V34, P803, DOI 10.2337/diabetes.34.8.803; TAL M, 1992, P NATL ACAD SCI USA, V89, P5744, DOI 10.1073/pnas.89.13.5744; THORENS B, 1992, INT REV CYTOL, V137A, P209; THORENS B, 1990, P NATL ACAD SCI USA, V87, P6492, DOI 10.1073/pnas.87.17.6492; THORENS B, 1992, J CLIN INVEST, V90, P77, DOI 10.1172/JCI115858; UNGER RH, 1991, SCIENCE, V251, P1200, DOI 10.1126/science.2006409; VALERA A, 1994, J BIOL CHEM, V269, P28543; WEIHEL ER, 1979, STEREOLOGICAL METHOD, P101; ZHOU YP, 1995, ENDOCRINOLOGY, V136, P3546, DOI 10.1210/en.136.8.3546	30	310	318	1	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					327	330		10.1038/ng1197-327	http://dx.doi.org/10.1038/ng1197-327			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354799				2022-12-17	WOS:A1997YD66700029
J	Markel, P; Shu, P; Ebeling, C; Carlson, GA; Nagle, DL; Smutko, JS; Moore, KJ				Markel, P; Shu, P; Ebeling, C; Carlson, GA; Nagle, DL; Smutko, JS; Moore, KJ			Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains	NATURE GENETICS			English	Article							APOLIPOPROTEIN-E; DEFICIENT MICE; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; SUSCEPTIBILITY; INTERVALS	Congenic breeding strategies are becoming increasingly important as a greater number of complex trait linkages are identified. Traditionally, the development od a congenic strain Ras been a time-consuming endeavour, requiring ten generations of backcrosses. The recent advent of a dense molecular genetic map of the mouse permits methods that can reduce the time needed for congenic-strain production by 18-24 months. We present a theoretical evaluation of marker-assisted congenic production and provide the empirical data that support it. We present this 'speed congenic' method in a user-friendly manner to encourage other investigators to pursue this or similar methods of congenic production.	MILLENNIUM PHARMACEUT,CAMBRIDGE,MA 02139; MCLAUGHLIN RES INST,GREAT FALLS,MT 59405	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; McLaughlin Research Institute for Biomedical Sciences, Inc.								GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; Green EL., 1966, BIOL LAB MOUSE; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Markel PD, 1997, GENOME RES, V7, P92, DOI 10.1101/gr.7.2.92; Morel L, 1996, MAMM GENOME, V7, P335, DOI 10.1007/s003359900098; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Silver L.M., 1995, MOUSE GENETICS CONCE; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; Threadgill DW, 1997, MAMM GENOME, V8, P441, DOI 10.1007/s003359900464; York B, 1996, MAMM GENOME, V7, P677, DOI 10.1007/s003359900204; Yui MA, 1996, MAMM GENOME, V7, P331, DOI 10.1007/s003359900097; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	15	310	318	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					280	284		10.1038/ng1197-280	http://dx.doi.org/10.1038/ng1197-280			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354790				2022-12-17	WOS:A1997YD66700020
J	Kalchman, MA; Koide, HB; McCutcheon, K; Graham, RK; Nichol, K; Nishiyama, K; KazemiEsfarjani, P; Lynn, FC; Wellington, C; Metzler, M; Goldberg, YP; Kanazawa, I; Gietz, RD; Hayden, MR				Kalchman, MA; Koide, HB; McCutcheon, K; Graham, RK; Nichol, K; Nishiyama, K; KazemiEsfarjani, P; Lynn, FC; Wellington, C; Metzler, M; Goldberg, YP; Kanazawa, I; Gietz, RD; Hayden, MR			HIP1, a human homologue of S-cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; REPEAT LENGTH; LEUCINE-ZIPPER; DISEASE; PROTEIN; GENE; EXPRESSION; CYTOSKELETON; EXPANSION; IDENTIFY	Huntington disease (HD) is associated with the expansion of a polyglutamine tract, greater than 35 repeats, in the HD gene product, huntingtin. Here we describe a novel huntingtin interacting protein, HIP1, which co-localizes with huntingtin and shares sequence homology and biochemical characteristics with Sla2p, a protein essential for function of the cytoskeleton in Saccharomyces cerevisiae. The huntingtin-HIP1 interaction is restricted to the brain and is inversely correlated to the polyglutamine length in huntingtin. This provides the first molecular link between huntingtin and the neuronal cytoskeleton and suggests that, in HD, loss of normal huntingtin-HIP1 interaction may contribute to a defect in membrane-cytoskeletal integrity in the brain.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC V6T 1Z4,CANADA; UNIV TOKYO,FAC MED,DEPT CLIN NEUROL & NEUROSCI,TOKYO 113,JAPAN; UNIV MANITOBA,FAC MED,DEPT HUMAN GENET,WINNIPEG,MB R3E 0W3,CANADA	University of British Columbia; University of Tokyo; University of Manitoba			Metzler, Markus/AAS-2066-2021; Hayden, Michael R/D-8581-2011; Graham, Rona K/R-7358-2018	Metzler, Markus/0000-0002-4523-1676; Hayden, Michael R/0000-0001-5159-1419; Graham, Rona K/0000-0003-3722-6241; Lynn, Francis/0000-0001-9318-1063				ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ARAI M, 1994, J NEUROSCI RES, V38, P348, DOI 10.1002/jnr.490380313; ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; Bhide PG, 1996, J NEUROSCI, V16, P5523; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GIETZ RD, 1996, IN PRESS CELL BIOL L; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; HARPER PS, 1991, HUNTINGTONS DIS, P31; Hayden MR, 1981, HUNTINGTONS CHOREA, P59, DOI [10.1007/978-1-4471-1308-9_5, DOI 10.1007/978-1-4471-1308-9_5]; Hodgson JG, 1996, HUM MOL GENET, V5, P1875, DOI 10.1093/hmg/5.12.1875; HOLTZMAN DA, 1993, J CELL BIOL, V122, P635, DOI 10.1083/jcb.122.3.635; *HUNT DIS COLL RES, 1993, CELL, V72, P971; JOHN M, 1994, J BIOL CHEM, V269, P16247; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; Koshy B, 1996, HUM MOL GENET, V5, P1311, DOI 10.1093/hmg/5.9.1311; KREMER HPH, 1994, NEW ENGL J MED, V330, P1401; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; LIN BY, 1993, HUM MOL GENET, V2, P1541, DOI 10.1093/hmg/2.10.1541; MacLennan D H, 1987, Soc Gen Physiol Ser, V41, P287; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; NA S, 1995, J BIOL CHEM, V270, P375; Nasir J, 1996, HUM MOL GENET, V5, P1431, DOI 10.1093/hmg/5.Supplement_1.1431; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; PEARLMAN JA, 1994, FEBS LETT, V354, P183, DOI 10.1016/0014-5793(94)01119-2; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; REES DJ, 1990, NATURE, V347, P18; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; SCHILLING G, 1995, HUM MOL GENET, V4, P1365, DOI 10.1093/hmg/4.8.1365; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; SHULL GE, 1985, NATURE, V316, P33; Sirover MA, 1996, LIFE SCI, V58, P2271, DOI 10.1016/0024-3205(96)00123-3; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Suzuki T, 1996, BIOCHEM BIOPH RES CO, V219, P708, DOI 10.1006/bbrc.1996.0299; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P100; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Wood J. D., 1996, American Journal of Human Genetics, V59, pA295; WOOD JD, 1996, HUM MOL GENET, V5, P418; Zoghbi HY, 1996, NAT GENET, V14, P237, DOI 10.1038/ng1196-237	49	310	319	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1997	16	1					44	53		10.1038/ng0597-44	http://dx.doi.org/10.1038/ng0597-44			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX024	9140394				2022-12-17	WOS:A1997WX02400021
J	MHATRE, AN; TRIFIRO, MA; KAUFMAN, M; KAZEMIESFARJANI, P; FIGLEWICZ, D; ROULEAU, G; PINSKY, L				MHATRE, AN; TRIFIRO, MA; KAUFMAN, M; KAZEMIESFARJANI, P; FIGLEWICZ, D; ROULEAU, G; PINSKY, L			REDUCED TRANSCRIPTIONAL REGULATORY COMPETENCE OF THE ANDROGEN RECEPTOR IN X-LINKED SPINAL AND BULBAR MUSCULAR-ATROPHY	NATURE GENETICS			English	Article							GLUCOCORTICOID RECEPTOR; TRINUCLEOTIDE REPEAT; MOLECULAR-BASIS; GENE; ACTIVATION; EXPRESSION; BINDING; LOCALIZATION; TESTOSTERONE; PROTEIN	Expansion of the long (CAG; glutamine)n repeat in the first exon of the X-linked human androgen receptor gene (hAR) causes spinal and bulbar muscular atrophy, frequently in association with mild androgen insensitivity. The relevant normal motor neurons are preferentially stimulated by androgen, however no motor neuron disorder occurs with any other known AR mutation, including those that cause complete androgen insensitivity. We have found that a polyglutamine (Gln) expanded AR transactivates an androgen-responsive reporter gene subnormally. Other groups have reported that a poly Gln-deleted AR transactivates normally. A parsimonious interpretation of all these facts is that poly Gln expansion causes the AR to lose a function that is necessary for full androgen sensitivity and to gain a function that is selectively motor neuronotoxic.	SIR MORTIMER B DAVIS JEWISH HOSP,LADY DAVIS INST MED RES,3755 COTE ST,MONTREAL H3T 1E2,QUEBEC,CANADA; MONTREAL GEN HOSP,CTR RES NEUROSCI,MONTREAL H3G 1A4,QUEBEC,CANADA; MCGILL UNIV,DEPT BIOL,MONTREAL H3A 1B1,QUEBEC,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3A 1B1,QUEBEC,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 1B1,QUEBEC,CANADA; MCGILL UNIV,DEPT NEUROSCI,MONTREAL H3A 1B1,QUEBEC,CANADA	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University								ARAKI I, 1991, J NEUROSCI, V11, P3025; ARBIZU T, 1983, J NEUROL SCI, V59, P371, DOI 10.1016/0022-510X(83)90022-9; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BREEDLOVE SM, 1986, J NEUROBIOL, V17, P157, DOI 10.1002/neu.480170304; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROWN CJ, 1989, AM J HUM GENET, V44, P264; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DOYU M, 1992, ANN NEUROL, V32, P707, DOI 10.1002/ana.410320517; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FABER PW, 1989, MOL CELL ENDOCRINOL, V61, P257, DOI 10.1016/0303-7207(89)90137-8; FABER PW, 1991, BIOCHEM J, V278, P269, DOI 10.1042/bj2780269; FISCHBECK KH, 1986, NEUROLOGY, V36, P1595, DOI 10.1212/WNL.36.12.1595; FRANKEL AD, 1991, CELL, V65, P717, DOI 10.1016/0092-8674(91)90378-C; GOLDSTEIN LA, 1992, J COMP NEUROL, V326, P147, DOI 10.1002/cne.903260113; GOTTLIEB B, 1987, J STEROID BIOCHEM, V28, P279, DOI 10.1016/0022-4731(87)91019-3; HAUSER KF, 1987, BRAIN RES, V406, P62, DOI 10.1016/0006-8993(87)90769-4; HIGUCHI R, 1989, SIMPLE RAPID PREPARA; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; ING NH, 1992, J BIOL CHEM, V267, P17617; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; KAO CC, 1990, SCIENCE, V248, P1646, DOI 10.1126/science.2194289; KAZEMIESFARJANI P, 1993, MOL ENDOCRINOL, V7, P37, DOI 10.1210/me.7.1.37; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; KUJAWA KA, 1989, EXP NEUROL, V105, P80, DOI 10.1016/0014-4886(89)90174-X; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MATSUURA T, 1992, NEUROLOGY, V42, P1724, DOI 10.1212/WNL.42.9.1724; MCPHAUL MJ, 1991, J CLIN INVEST, V87, P1413, DOI 10.1172/JCI115147; MHATRE A, 1992, AM J HUM GENET, V51; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; OLNEY RK, 1990, NEUROLOGY, V47, P1111; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PIROTTA V, 1987, EMBO J, V6, P791; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; SAR M, 1977, SCIENCE, V197, P77, DOI 10.1126/science.867053; SHERIDAN PJ, 1982, BRAIN RES, V235, P225, DOI 10.1016/0006-8993(82)91002-2; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; STRAHLE U, 1988, COLD SPRING HARB SYM, V53, P835, DOI 10.1101/SQB.1988.053.01.095; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARNER CL, 1992, NEUROLOGY, V42, P2181, DOI 10.1212/WNL.42.11.2181; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YU WHA, 1989, J NEUROSCI, V9, P3908; YU WHA, 1986, J NEUROSCI, V6, P1302; YU WHA, 1983, EXP NEUROL, V80, P349, DOI 10.1016/0014-4886(83)90288-1; 1993, CELL, V72, P971	53	310	317	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					184	188		10.1038/ng1093-184	http://dx.doi.org/10.1038/ng1093-184			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252045				2022-12-17	WOS:A1993MA05600018
J	Warren, HR; Evangelou, E; Cabrera, CP; Gao, H; Ren, MX; Mifsud, B; Ntalla, I; Surendran, P; Liu, CY; Cook, JP; Kraja, AT; Drenos, F; Loh, M; Verweij, N; Marten, J; Karaman, I; Lepe, MPS; O'Reilly, PF; Knight, J; Snieder, H; Kato, N; He, J; Tai, ES; Said, MA; Porteous, D; Alver, M; Poulter, N; Farrall, M; Gansevoort, RT; Padmanabhan, S; Magi, R; Stanton, A; Connell, J; Bakker, SJL; Metspalu, A; Shields, DC; Thom, S; Brown, M; Sever, P; Esko, T; Hayward, C; van der Harst, P; Saleheen, D; Chowdhury, R; Chambers, JC; Chasman, DI; Chakravarti, A; Newton-Cheh, C; Lindgren, CM; Levy, D; Kooner, JS; Keavney, B; Tomaszewski, M; Samani, NJ; Howson, JMM; Tobin, MD; Munroe, PB; Ehret, GB; Wain, LV; Barnes, MR; Tzoulaki, J; Caulfield, MJ; Elliott, P; Wain, LV; Vaez, A; Jansen, R; Joehanes, R; van der Most, PJ; Erzurumluoglu, AM; O'Reilly, P; Cabrera, CP; Warren, HR; Rose, LM; Verwoert, GC; Hottenga, JJ; Strawbridge, RJ; Esko, T; Arking, DE; Hwang, SJ; Guo, XQ; Kutalik, Z; Trompet, S; Shrine, N; Teumer, A; Ried, JS; Bis, JC; Smith, AV; Amin, N; Nolte, IM; Lyytikainen, LP; Mahajan, A; Wareham, NJ; Hofer, E; Joshi, PK; Kristiansson, K; Traglia, M; Havulinna, AS; Goel, A; Nalls, MA; Sober, S; Vuckovic, D; Luan, JA; Del Greco, F; Ayers, KL; Marrugat, J; Ruggiero, D; Lopez, LM; Niiranen, T; Enroth, S; Jackson, AU; Nelson, CP; Huffman, JE; Zhang, WH; Marten, J; Gandin, I; Harris, SE; Zemonik, T; Lu, YC; Evangelou, E; Shah, N; de Borst, MH; Mangino, M; Prins, BP; Campbell, A; Li-Gao, RF; Chauhan, G; Oldmeadow, C; Abecasis, G; Abedi, M; Barbieri, CM; Barnes, MR; Batini, C; Blake, T; Boehnke, M; Bottinger, EP; Braund, PS; Brown, M; Brumat, M; Campbell, H; Chambers, JC; Cocca, M; Collins, F; Connell, J; Cordell, HJ; Damman, JJ; Davies, G; de Geus, EJ; de Mutsert, R; Deelen, J; Demirkale, Y; Doney, ASF; Dorr, M; Farrall, M; Ferreira, T; Franberg, M; Gao, H; Giedraitis, V; Gieger, C; Giulianini, F; Gow, AJ; Hamsten, A; Harris, TB; Hofman, A; Holliday, EG; Jarvelin, MR; Johansson, A; Johnson, AD; Jousilahti, P; Jula, A; Kahonen, M; Kathiresan, S; Khaw, KT; Kolcic, I; Koskinen, S; Langenberg, C; Larson, M; Launer, LJ; Lehne, B; Liewald, DCM; Lin, L; Lind, L; Mach, F; Mamasoula, C; Menni, C; Mifsud, B; Milaneschi, Y; Morgan, A; Morris, AD; Morrison, AC; Munson, PJ; Nandakumar, P; Nguyen, QT; Nutile, T; Oldehinkel, AJ; Oostra, BA; Org, E; Padmanabhan, S; Palotie, A; Pare, G; Pattie, A; Penninx, BWJH; Poulter, N; Pramstaller, PP; Raitakari, OT; Ren, MX; Rice, K; Ridker, PM; Riese, H; Ripatti, S; Robino, A; Rotter, JI; Rudan, I; Saba, Y; Saint Pierre, A; Sala, CF; Sarin, AP; Schmidt, R; Scott, R; Seelen, MA; Shields, DC; Siscovick, D; Sorice, R; Stanton, A; Stott, DJ; Sundstrom, J; Swertz, M; Taylor, KD; Thom, S; Tzoulaki, I; Tzourio, C; Uitterlinden, AG; Volker, U; Vollenweider, P; Wild, S; Willemsen, G; Wright, AF; Yao, J; Theriault, S; Conen, D; John, A; Sever, P; Debette, S; Mook-Kanamori, DO; Zeggini, E; Spector, TD; van der Harst, P; Palmer, CNA; Vergnaud, AC; Loos, RJF; Polasek, O; Starr, JM; Girotto, G; Hayward, C; Kooner, JS; Lindgren, CM; Vitart, V; Samani, NJ; Tuomilehto, J; Gyllensten, U; Knekt, P; Deary, IJ; Ciullo, M; Elosua, R; Keavney, BD; Hicks, AA; Scott, RA; Gasparini, P; Laan, M; Liu, YM; Watkins, H; Hartman, CA; Salomaa, V; Toniolo, D; Perola, M; Wilson, JF; Schmidt, H; Zhao, JH; Lehtimaki, T; van Duijn, CM; Gudnason, V; Psaty, BM; Peters, A; Rettig, R; James, A; Jukema, JW; Strachan, DP; Palmas, W; Metspalu, A; Ingelsson, E; Boomsma, DI; Franco, OH; Bochud, M; Newton-Cheh, C; Munroe, PB; Elliott, P; Chasman, DI; Chakravarti, A; Knight, J; Morris, AP; Levy, D; Tobin, MD; Snieder, H; Caulfield, MJ; Ehret, GB				Warren, Helen R.; Evangelou, Evangelos; Cabrera, Claudia P.; Gao, He; Ren, Meixia; Mifsud, Borbala; Ntalla, Ioanna; Surendran, Praveen; Liu, Chunyu; Cook, James P.; Kraja, Aldi T.; Drenos, Fotios; Loh, Marie; Verweij, Niek; Marten, Jonathan; Karaman, Ibrahim; Lepe, Marcelo P. Segura; O'Reilly, Paul F.; Knight, Joanne; Snieder, Harold; Kato, Norihiro; He, Jiang; Tai, E. Shyong; Said, M. Abdullah; Porteous, David; Alver, Maris; Poulter, Neil; Farrall, Martin; Gansevoort, Ron T.; Padmanabhan, Sandosh; Magi, Reedik; Stanton, Alice; Connell, John; Bakker, Stephan J. L.; Metspalu, Andres; Shields, Denis C.; Thom, Simon; Brown, Morris; Sever, Peter; Esko, Tonu; Hayward, Caroline; van der Harst, Pim; Saleheen, Danish; Chowdhury, Rajiv; Chambers, John C.; Chasman, Daniel I.; Chakravarti, Aravinda; Newton-Cheh, Christopher; Lindgren, Cecilia M.; Levy, Daniel; Kooner, Jaspal S.; Keavney, Bernard; Tomaszewski, Maciej; Samani, Nilesh J.; Howson, Joanna M. M.; Tobin, Martin D.; Munroe, Patricia B.; Ehret, Georg B.; Wain, Louise V.; Barnes, Michael R.; Tzoulaki, Joanna; Caulfield, Mark J.; Elliott, Paul; Wain, Louise V.; Vaez, Ahmad; Jansen, Rick; Joehanes, Roby; van der Most, Peter J.; Erzurumluoglu, A. Mesut; O'Reilly, Paul; Cabrera, Claudia P.; Warren, Helen R.; Rose, Lynda M.; Verwoert, Germaine C.; Hottenga, Jouke-Jan; Strawbridge, Rona J.; Esko, Tonu; Arking, Dan E.; Hwang, Shih-Jen; Guo, Xiuqing; Kutalik, Zoltan; Trompet, Stella; Shrine, Nick; Teumer, Alexander; Ried, Janina S.; Bis, Joshua C.; Smith, Albert V.; Amin, Najaf; Nolte, Ilja M.; Lyytikainen, Leo-Pekka; Mahajan, Anubha; Wareham, Nicholas J.; Hofer, Edith; Joshi, Peter K.; Kristiansson, Kati; Traglia, Michela; Havulinna, Aki S.; Goel, Anuj; Nalls, Mike A.; Sober, Siim; Vuckovic, Dragana; Luan, Jian'an; Del Greco M, Fabiola; Ayers, Kristin L.; Marrugat, Jaume; Ruggiero, Daniela; Lopez, Lorna M.; Niiranen, Teemu; Enroth, Stefan; Jackson, Anne U.; Nelson, Christopher P.; Huffman, Jennifer E.; Zhang, Weihua; Marten, Jonathan; Gandin, Ilaria; Harris, Sarah E.; Zemonik, Tatijana; Lu, Yingchang; Evangelou, Evangelos; Shah, Nabi; de Borst, Martin H.; Mangino, Massimo; Prins, Bram P.; Campbell, Archie; Li-Gao, Ruifang; Chauhan, Ganesh; Oldmeadow, Christopher; Abecasis, Goncalo; Abedi, Maryam; Barbieri, Caterina M.; Barnes, Michael R.; Batini, Chiara; Blake, Tineka; Boehnke, Michael; Bottinger, Erwin P.; Braund, Peter S.; Brown, Morris; Brumat, Marco; Campbell, Harry; Chambers, John C.; Cocca, Massimiliano; Collins, Francis; Connell, John; Cordell, Heather J.; Damman, Jeffrey J.; Davies, Gail; de Geus, Eco J.; de Mutsert, Renee; Deelen, Joris; Demirkale, Yusuf; Doney, Alex S. F.; Dorr, Marcus; Farrall, Martin; Ferreira, Teresa; Franberg, Mattias; Gao, He; Giedraitis, Vilmantas; Gieger, Christian; Giulianini, Franco; Gow, Alan J.; Hamsten, Anders; Harris, Tamara B.; Hofman, Albert; Holliday, Elizabeth G.; Jarvelin, Marjo-Riitta; Johansson, Asa; Johnson, Andrew D.; Jousilahti, Pekka; Jula, Antti; Kahonen, Mika; Kathiresan, Sekar; Khaw, Kay-Tee; Kolcic, Ivana; Koskinen, Seppo; Langenberg, Claudia; Larson, Marty; Launer, Lenore J.; Lehne, Benjamin; Liewald, David C. M.; Lin, Li; Lind, Lars; Mach, Francois; Mamasoula, Chrysovalanto; Menni, Cristina; Mifsud, Borbala; Milaneschi, Yuri; Morgan, Anna; Morris, Andrew D.; Morrison, Alanna C.; Munson, Peter J.; Nandakumar, Priyanka; Quang Tri Nguyen; Nutile, Teresa; Oldehinkel, Albertine J.; Oostra, Ben A.; Org, Elin; Padmanabhan, Sandosh; Palotie, Aarno; Pare, Guillaume; Pattie, Alison; Penninx, Brenda W. J. H.; Poulter, Neil; Pramstaller, Peter P.; Raitakari, Olli T.; Ren, Meixia; Rice, Kenneth; Ridker, Paul M.; Riese, Harriette; Ripatti, Samuli; Robino, Antonietta; Rotter, Jerome I.; Rudan, Igor; Saba, Yasaman; Saint Pierre, Aude; Sala, Cinzia F.; Sarin, Antti-Pekka; Schmidt, Reinhold; Scott, Rodney; Seelen, Marc A.; Shields, Denis C.; Siscovick, David; Sorice, Rossella; Stanton, Alice; Stott, David J.; Sundstrom, Johan; Swertz, Morris; Taylor, Kent D.; Thom, Simon; Tzoulaki, Ioanna; Tzourio, Christophe; Uitterlinden, Andre G.; Volker, Uwe; Vollenweider, Peter; Wild, Sarah; Willemsen, Gonneke; Wright, Alan F.; Yao, Jie; Theriault, Sebastien; Conen, David; John, Attia; Sever, Peter; Debette, Stephanie; Mook-Kanamori, Dennis O.; Zeggini, Eleftheria; Spector, Tim D.; van der Harst, Pim; Palmer, Colin N. A.; Vergnaud, Anne-Claire; Loos, Ruth J. F.; Polasek, Ozren; Starr, John M.; Girotto, Giorgia; Hayward, Caroline; Kooner, Jaspal S.; Lindgren, Cecila M.; Vitart, Veronique; Samani, Nilesh J.; Tuomilehto, Jaakko; Gyllensten, Ulf; Knekt, Paul; Deary, Ian J.; Ciullo, Marina; Elosua, Roberto; Keavney, Bernard D.; Hicks, Andrew A.; Scott, Robert A.; Gasparini, Paolo; Laan, Maris; Liu, YongMei; Watkins, Hugh; Hartman, Catharina A.; Salomaa, Veikko; Toniolo, Daniela; Perola, Markus; Wilson, James F.; Schmidt, Helena; Zhao, Jing Hua; Lehtimaki, Terho; van Duijn, Cornelia M.; Gudnason, Vilmundur; Psaty, Bruce M.; Peters, Annette; Rettig, Rainer; James, Alan; Jukema, J. Wouter; Strachan, David P.; Palmas, Walter; Metspalu, Andres; Ingelsson, Erik; Boomsma, Dorret I.; Franco, Oscar H.; Bochud, Murielle; Newton-Cheh, Christopher; Munroe, Patricia B.; Elliott, Paul; Chasman, Daniel I.; Chakravarti, Aravinda; Knight, Joanne; Morris, Andrew P.; Levy, Daniel; Tobin, Martin D.; Snieder, Harold; Caulfield, Mark J.; Ehret, Georg B.		Int Consortium Blood Pressure ICBP; CHD Exome Consortium; ExomeBP Consortium; T2D-GENES Consortium; GoT2D Genes Consortium; CHARGE BP Exome Consortium; iGEN-BP Consortium; UK Biobank CardioMetab Consortium; BIOS Consortium; Lifelines Cohort Study; Understanding Soc Sci Grp	Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk	NATURE GENETICS			English	Article							CORONARY-ARTERY-DISEASE; ENDOTHELIAL-CELL; NEUROTROPHIC FACTOR; KEY ROLE; HYPERTENSION; COMMON; GENE; NOX4; METAANALYSIS; INHIBITION	Elevated blood pressure is the leading heritable risk factor for cardiovascular disease worldwide. We report genetic association of blood pressure (systolic, diastolic, pulse pressure) among UK Biobank participants of European ancestry with independent replication in other cohorts, and robust validation of 107 independent loci. We also identify new independent variants at 11 previously reported blood pressure loci. In combination with results from a range of in silico functional analyses and wet bench experiments, our findings highlight new biological pathways for blood pressure regulation enriched for genes expressed in vascular tissues and identify potential therapeutic targets for hypertension. Results from genetic risk score models raise the possibility of a precision medicine approach through early lifestyle intervention to offset the impact of blood pressure-raising genetic variants on future cardiovascular disease risk.	[Warren, Helen R.; Cabrera, Claudia P.; Ren, Meixia; Mifsud, Borbala; Ntalla, Ioanna; Barnes, Michael R.; Caulfield, Mark J.; Cabrera, Claudia P.; Warren, Helen R.; Barnes, Michael R.; Mifsud, Borbala; Ren, Meixia; Caulfield, Mark J.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Warren, Helen R.; Cabrera, Claudia P.; Ren, Meixia; Barnes, Michael R.; Caulfield, Mark J.; Cabrera, Claudia P.; Warren, Helen R.; Barnes, Michael R.; Caulfield, Mark J.] Queen Mary Univ London, Barts Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, London, England; [Evangelou, Evangelos; Gao, He; Loh, Marie; Karaman, Ibrahim; Lepe, Marcelo P. Segura; Chambers, John C.; Tzoulaki, Joanna; Elliott, Paul; Zhang, Weihua; Evangelou, Evangelos; Chambers, John C.; Gao, He; Lehne, Benjamin; Tzoulaki, Ioanna; Vergnaud, Anne-Claire] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Evangelou, Evangelos; Tzoulaki, Joanna; Evangelou, Evangelos] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Ioannina, Greece; [Gao, He; Tzoulaki, Joanna; Elliott, Paul; Jarvelin, Marjo-Riitta; Elliott, Paul] Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England; [Surendran, Praveen; Chowdhury, Rajiv; Howson, Joanna M. M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England; [Liu, Chunyu; Levy, Daniel; Levy, Daniel] NHLBI, Populat Sci Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Liu, Chunyu] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Liu, Chunyu; Levy, Daniel; Joehanes, Roby; Johnson, Andrew D.; Larson, Marty] NHLBI, Framingham Heart Study, Framingham, MA USA; [Cook, James P.; Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Kraja, Aldi T.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA; [Kraja, Aldi T.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Drenos, Fotios] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Drenos, Fotios] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England; [Loh, Marie] ASTAR, Translat Lab Genet Med, Singapore, Singapore; [Verweij, Niek; Said, M. Abdullah; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Verweij, Niek; Esko, Tonu; Newton-Cheh, Christopher; Lindgren, Cecilia M.; Kathiresan, Sekar; Newton-Cheh, Christopher] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Verweij, Niek; Newton-Cheh, Christopher; Kathiresan, Sekar; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Verweij, Niek; Newton-Cheh, Christopher; Kathiresan, Sekar; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Marten, Jonathan; Hayward, Caroline; Huffman, Jennifer E.; Wright, Alan F.; Hayward, Caroline; Vitart, Veronique; Wilson, James F.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Lepe, Marcelo P. Segura] Bayer Pharma, Berlin, Germany; [O'Reilly, Paul F.; O'Reilly, Paul] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Knight, Joanne] Univ Lancaster, Data Sci Inst, Lancaster, England; [Snieder, Harold; Vaez, Ahmad; van der Most, Peter J.; Nolte, Ilja M.; Damman, Jeffrey J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Kato, Norihiro] Natl Ctr Global Hlth & Med, Res Inst, Dept Gene Diagnost & Therapeut, Tokyo, Japan; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Tai, E. Shyong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Tai, E. Shyong] Natl Univ Hlth Syst, Singapore, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Porteous, David; Harris, Sarah E.; Campbell, Archie] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Alver, Maris; Magi, Reedik; Metspalu, Andres; Esko, Tonu; Esko, Tonu; Org, Elin] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; Imperial Coll London, Sch Publ Hlth, Imperial Clin Trials Unit, London, England; [Farrall, Martin] Univ Oxford, Radcliffe Dept Med, Wellcome Trust Ctr Human Genet, Div Cardiovasc Med, Oxford, England; [Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Padmanabhan, Sandosh; Stott, David J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Stanton, Alice] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, Dublin, Ireland; [Connell, John] Univ Dundee, Ninewells Hosp & Med Sch, Dundee, Scotland; [Bakker, Stephan J. L.; de Borst, Martin H.; Seelen, Marc A.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Shields, Denis C.] Univ Coll Dublin, Conway Inst, Sch Med, Dublin, Ireland; [Thom, Simon; Sever, Peter; Kooner, Jaspal S.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Saleheen, Danish] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Saleheen, Danish] Ctr Noncommun Dis, Karachi, Pakistan; [Saleheen, Danish; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Chambers, John C.] Ealing Hosp Natl Hlth Serv NHS Trust, Southall, Middx, England; [Chambers, John C.; Kooner, Jaspal S.; Chambers, John C.; Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, London, England; [Chambers, John C.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Rose, Lynda M.; Giulianini, Franco; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Ridker, Paul M.] Harvard Med Sch, Boston, MA USA; [Chakravarti, Aravinda; Arking, Dan E.; Nandakumar, Priyanka] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD USA; [Lindgren, Cecilia M.; Mahajan, Anubha; Goel, Anuj; Farrall, Martin; Ferreira, Teresa; Lindgren, Cecila M.; Watkins, Hugh; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lindgren, Cecilia M.] Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Kooner, Jaspal S.; Zhang, Weihua; Chambers, John C.; Kooner, Jaspal S.] Ealing Hosp NHS Trust, Dept Cardiol, Southall, Middx, England; [Kooner, Jaspal S.] Imperial Coll London, Cardiovasc Sci, Natl Heart & Lung Inst, Hammersmith Campus, London, England; [Keavney, Bernard; Tomaszewski, Maciej; Keavney, Bernard D.] Univ Manchester, Fac Biol Med & Hlth, Div Cardiovasc Sci, Manchester, Lancs, England; [Keavney, Bernard; Tomaszewski, Maciej] Cent Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Div Med, Manchester, Lancs, England; [Nelson, Christopher P.; Braund, Peter S.] Univ Leicester, Glenfield Hosp, BHF Cardiovasc Res Ctr, Dept Cardiovasc Sci, Leicester, Leics, England; [Nelson, Christopher P.; Braund, Peter S.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Tobin, Martin D.; Wain, Louise V.; Erzurumluoglu, A. Mesut; Shrine, Nick; Batini, Chiara; Blake, Tineka] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Lin, Li; Mach, Francois] Univ Hosp Geneva, Dept Med, Cardiol, Geneva, Switzerland; [Vaez, Ahmad] Isfahan Univ Med Sci, Res Inst Primordial Prevent Noncommun Dis, Esfahan, Iran; [Jansen, Rick] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Joehanes, Roby] Harvard Med Sch, Hebrew SeniorLife, Boston, MA USA; [Verwoert, Germaine C.; Hofman, Albert; Uitterlinden, Andre G.; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Hottenga, Jouke-Jan; de Geus, Eco J.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ, Dept Biol Psychol, Amsterdam, Netherlands; [Hottenga, Jouke-Jan; de Geus, Eco J.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst, Amsterdam, Netherlands; [Strawbridge, Rona J.; Franberg, Mattias; Hamsten, Anders] Karolinska Inst, Dept Med Solna, Cardiovasc Med Unit, Stockholm, Sweden; [Strawbridge, Rona J.; Franberg, Mattias; Hamsten, Anders] Karolinska Univ Sjukhuset, Ctr Mol Med, Solna, Sweden; [Esko, Tonu] Childrens Hosp, Div Endocrinol, 300 Longwood Ave, Boston, MA 02115 USA; [Esko, Tonu; Lindgren, Cecila M.; Newton-Cheh, Christopher] Broad Inst Harvard & MIT, Cambridge, England; [Hwang, Shih-Jen] NHLBI, Populat Sci Branch, US NIH, Bldg 10, Bethesda, MD 20892 USA; [Hwang, Shih-Jen; Levy, Daniel] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Guo, Xiuqing; Rotter, Jerome I.; Yao, Jie] Harbor UCLA Med Ctr, LABioMed, Dept Pediat, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Kutalik, Zoltan; Bochud, Murielle] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Trompet, Stella] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Teumer, Alexander] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Teumer, Alexander; Dorr, Marcus; Volker, Uwe] DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Ried, Janina S.; Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Amin, Najaf; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, Tampere, Finland; [Wareham, Nicholas J.; Luan, Jian'an; Langenberg, Claudia; Scott, Robert A.; Zhao, Jing Hua] Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Inst Metab Sci, Cambridge Biomed Campus, Cambridge, England; [Hofer, Edith; Schmidt, Reinhold; Loos, Ruth J. F.] Med Univ Graz, Dept Neurol, Clin Div Neurogeriatr, Graz, Austria; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Joshi, Peter K.; Campbell, Harry; Rudan, Igor; Wild, Sarah; Perola, Markus; Wilson, James F.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland; [Kristiansson, Kati; Havulinna, Aki S.; Niiranen, Teemu; Jousilahti, Pekka; Jula, Antti; Koskinen, Seppo; Knekt, Paul; Salomaa, Veikko] Natl Inst Hlth & Welf THL, Dept Hlth, Helsinki, Finland; [Traglia, Michela; Barbieri, Caterina M.; Sala, Cinzia F.; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, Milan, Italy; [Goel, Anuj; Farrall, Martin; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Nalls, Mike A.] NIA, Neurogenet Lab, US NIH, Bethesda, MD 20892 USA; [Nalls, Mike A.] Kelly Serv, Rockville, MD USA; [Sober, Siim; Laan, Maris] Univ Tartu, Inst Mol & Cell Biol, Human Mol Genet Res Grp, Tartu, Estonia; [Vuckovic, Dragana; Girotto, Giorgia; Gasparini, Paolo] Sidra Med & Res Ctr, Expt Genet Div, Doha, Qatar; [Vuckovic, Dragana; Gandin, Ilaria; Brumat, Marco; Cocca, Massimiliano; Morgan, Anna; Girotto, Giorgia; Gasparini, Paolo] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Del Greco M, Fabiola; Pramstaller, Peter P.; Saint Pierre, Aude; Hicks, Andrew A.] European Acad Bozen Bolzano EURAC, Ctr Biomed, Bolzano, Italy; [Del Greco M, Fabiola; Pramstaller, Peter P.; Saint Pierre, Aude; Hicks, Andrew A.] Univ Lubeck, Lubeck, Germany; [Ayers, Kristin L.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Marrugat, Jaume; Elosua, Roberto; Int Consortium Blood Pressure ICBP] IMIM, Cardiovasc Epidemiol & Genet, Barcelona, Spain; [Ruggiero, Daniela; Nutile, Teresa; Sorice, Rossella; Ciullo, Marina] CNR, Inst Genet & Biophys Buzzati Traverso, Naples, Italy; [Lopez, Lorna M.; Harris, Sarah E.; Davies, Gail; Gow, Alan J.; Liewald, David C. M.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Lopez, Lorna M.] Beaumont Hosp, Educ & Res Ctr, Royal Coll Surg Ireland, Dept Psychiat, Dublin, Ireland; [Lopez, Lorna M.] UCD, Ctr Proteome Res, UCD Conway Inst, Dublin, Ireland; [Enroth, Stefan; Johansson, Asa; Gyllensten, Ulf] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Jackson, Anne U.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Zemonik, Tatijana] Univ Split, Fac Med, Dept Biol, Split, Croatia; [Lu, Yingchang; Bottinger, Erwin P.; Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Shah, Nabi; Doney, Alex S. F.; Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee, Scotland; [Shah, Nabi] COMSATS Inst Informat Technol, Dept Pharm, Abbottabad, Pakistan; [Mangino, Massimo; Menni, Cristina; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Mangino, Massimo] Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Prins, Bram P.; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Dept Human Genet, Cambridge, England; [Campbell, Archie; Padmanabhan, Sandosh; Hayward, Caroline] Univ Edinburgh, Ctr Genom & Expt Med, Generat Scotland, Edinburgh, Midlothian, Scotland; [Li-Gao, Ruifang; de Mutsert, Renee; Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Chauhan, Ganesh; Tzourio, Christophe; Debette, Stephanie] Bordeaux Populat Hlth Ctr, INSERM, U1219, Bordeaux, France; [Chauhan, Ganesh; Tzourio, Christophe; Debette, Stephanie] Bordeaux Univ, Bordeaux, France; [Oldmeadow, Christopher; Holliday, Elizabeth G.; Scott, Rodney; John, Attia] Hunter Med Res Inst, New Lambton, NSW, Australia; [Abecasis, Goncalo] SPH II, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI USA; [Abedi, Maryam] Isfahan Univ Med Sci, Dept Genet & Mol Biol, Esfahan, Iran; [Collins, Francis] NHGRI, Med Genom & Metab Genet Branch, US NIH, Bethesda, MD 20892 USA; [Cordell, Heather J.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Damman, Jeffrey J.] Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Davies, Gail; Liewald, David C. M.; Pattie, Alison; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Deelen, Joris] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Demirkale, Yusuf; Munson, Peter J.; Quang Tri Nguyen] US NIH, Ctr Informat Technol, Bethesda, MD USA; [Dorr, Marcus] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Franberg, Mattias] Stockholm Univ, Dept Numer Anal & Comp Sci, Stockholm, Sweden; [Giedraitis, Vilmantas] Dept Publ Hlth & Caring Sci, Geriatr, Uppsala, Sweden; [Gieger, Christian] Helmholtz Zentrum Munchen, Deutsch Forsch Zentrum Gesundheit & Umwelt, Neuherberg, Germany; [Gow, Alan J.] Heriot Watt Univ, Sch Life Sci, Dept Psychol, Edinburgh, Midlothian, Scotland; [Harris, Tamara B.; Launer, Lenore J.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Hofman, Albert] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Johnson, Andrew D.] NHLBI, Cardiovasc Epidemiol & Human Genom Branch, Bldg 10, Bethesda, MD 20892 USA; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, Tampere, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, Tampere, Finland; [Kolcic, Ivana; Polasek, Ozren] Univ Split, Fac Med, Dept Publ Hlth, Split, Croatia; [Lind, Lars; Sundstrom, Johan] Uppsala Univ, Cardiovasc Epidemiol, Dept Med Sci, Uppsala, Sweden; [Mamasoula, Chrysovalanto] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Milaneschi, Yuri; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Psychiat, Amsterdam, Netherlands; [Morris, Andrew D.] Univ Edinburgh, Sch Med, Sch Mol Genet & Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Oldehinkel, Albertine J.; Riese, Harriette; Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Padmanabhan, Sandosh] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Palotie, Aarno; Ripatti, Samuli; Sarin, Antti-Pekka; Perola, Markus] Univ Helsinki, FIMM, Helsinki, Finland; [Pare, Guillaume; Theriault, Sebastien] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Ren, Meixia] Fujian Med Univ, Fujian Prov Hosp, Dept Cardiol, Fuzhou, Peoples R China; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Robino, Antonietta] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Rotter, Jerome I.] Harbor UCLA Med Ctr, LABioMed, Dept Med, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Saba, Yasaman; Schmidt, Helena] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria; [Saint Pierre, Aude] Etab Francais Sang, INSERM, U1078, Brest, France; [Scott, Rodney; John, Attia] Univ Newcastle, Fac Hlth, Callaghan, NSW, Australia; [Scott, Rodney; John, Attia] John Hunter Hosp, Sch Biomed Sci & Pharm, New Lambton, NSW, Australia; [Siscovick, David] New York Acad Med, New York, NY USA; [Sorice, Rossella; Ciullo, Marina] IRCCS Neuromed, Pozzilli, Italy; [Swertz, Morris] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Taylor, Kent D.] Harbor UCLA Med Ctr, Los Angeles BioMed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Taylor, Kent D.] Harbor UCLA Med Ctr, Dept Pediat, Div Genet Outcomes, Torrance, CA 90509 USA; [Thom, Simon] Imperial Coll London, Int Ctr Circulatory Hlth, London, England; [Tzourio, Christophe] Bordeaux Univ Hosp, Dept Publ Hlth, Bordeaux, France; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Volker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Gen, Greifswald, Germany; [Vollenweider, Peter] CHU Vaudois, Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland; [Conen, David] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Debette, Stephanie] Bordeaux Univ Hosp, Dept Neurol, Bordeaux, France; [Mook-Kanamori, Dennis O.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth Dev Inst, New York, NY 10029 USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Tuomilehto, Jaakko] South Ostrobothnia Cent Hosp, Seinajoki, Finland; [Tuomilehto, Jaakko] Hosp Univ La Paz, Red RECAVA Grp RD06 0014 0015, Madrid, Spain; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Laan, Maris] Univ Tartu, Inst Biomed & Translat Med, Tartu, Estonia; [Liu, YongMei] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Perola, Markus] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Schmidt, Helena] Med Univ Graz, Dept Neurol, Graz, Austria; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA; [Rettig, Rainer] Univ Med Greifswald, Inst Physiol, Karlsburg, Germany; [James, Alan] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep, Nedlands, WA, Australia; [James, Alan] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Strachan, David P.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Palmas, Walter] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Ingelsson, Erik] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA	University of London; Queen Mary University London; University of London; Queen Mary University London; Imperial College London; University of Ioannina; Imperial College London; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Liverpool; Washington University (WUSTL); Washington University (WUSTL); University of Bristol; University of London; University College London; Agency for Science Technology & Research (A*STAR); University of Groningen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Edinburgh; Bayer AG; Bayer Healthcare Pharmaceuticals; University of London; King's College London; Lancaster University; University of Groningen; National Center for Global Health & Medicine - Japan; Tulane University; National University of Singapore; National University of Singapore; National University of Singapore; University of Edinburgh; University of Tartu; Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; University of Groningen; University of Glasgow; Royal College of Surgeons - Ireland; University of Dundee; University of Groningen; University College Dublin; Imperial College London; University of Pennsylvania; Pennsylvania Medicine; University of Cambridge; Imperial College London; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Imperial College London; University of Manchester; University of Manchester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Leicester; University of Geneva; Isfahan University Medical Science; Vrije Universiteit Amsterdam; Harvard University; Harvard Medical School; Hebrew SeniorLife; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Karolinska Institutet; Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Greifswald Medical School; German Centre for Cardiovascular Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Washington; University of Washington Seattle; Icelandic Heart Association; University of Iceland; Erasmus University Rotterdam; Erasmus MC; Tampere University; University of Cambridge; Medical University of Graz; Medical University of Graz; University of Edinburgh; Finland National Institute for Health & Welfare; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Tartu; Sidra Medical & Research Center; University of Trieste; European Academy of Bozen-Bolzano; University of Lubeck; Icahn School of Medicine at Mount Sinai; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Edinburgh; Royal College of Surgeons - Ireland; University College Dublin; Uppsala University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Split; Icahn School of Medicine at Mount Sinai; University of Dundee; COMSATS University Islamabad (CUI); University of London; King's College London; Wellcome Trust Sanger Institute; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Hunter Medical Research Institute; University of Newcastle; Isfahan University Medical Science; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Newcastle University - UK; University of Amsterdam; Academic Medical Center Amsterdam; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Greifswald Medical School; Stockholm University; Uppsala University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Heriot Watt University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Harvard T.H. Chan School of Public Health; University of Oulu; University of Oulu; University of Oulu; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tampere University; Tampere University Hospital; Tampere University; University of Split; Uppsala University; Newcastle University - UK; Vrije Universiteit Amsterdam; University of Edinburgh; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Groningen; University of Glasgow; University of Helsinki; McMaster University; Krankenhaus Bozen; University of Lubeck; University of Turku; University of Turku; Fujian Medical University; Fujian Provincial Hospital; University of Washington; University of Washington Seattle; IRCCS Burlo Garofolo; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Medical University of Graz; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; University of Newcastle; John Hunter Hospital; New York Academy of Medicine; IRCCS Neuromed; University of Groningen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Imperial College London; CHU Bordeaux; Erasmus University Rotterdam; Erasmus MC; Greifswald Medical School; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); McMaster University; Population Health Research Institute; CHU Bordeaux; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Icahn School of Medicine at Mount Sinai; University of Edinburgh; Finland National Institute for Health & Welfare; Hospital Universitario La Paz; Danube University Krems; University of Tartu; Wake Forest University; University of Tartu; Medical University of Graz; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Greifswald Medical School; University of Western Australia; University of Western Australia; St Georges University London; Columbia University; Uppsala University; Stanford University	Caulfield, MJ (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England.; Caulfield, MJ (corresponding author), Queen Mary Univ London, Barts Cardiovasc Biomed Res Unit, Natl Inst Hlth Res, London, England.; Elliott, P (corresponding author), Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England.	p.elliott@imperial.ac.uk; m.j.caulfield@qmul.ac.uk	Polasek, Ozren/B-6002-2011; Chowdhury, Rajiv/AHB-1253-2022; Shah, Nabi/Q-1008-2016; Deary, Ian J/C-6297-2009; Ciullo, Marina/AAE-3041-2020; Khaw, Kay-Tee/AAZ-3209-2021; Kolcic, Ivana/E-2713-2017; Jukema, J. Wouter/ABD-6503-2021; Laan, Maris/A-4100-2011; Toniolo, Daniela/AAE-2969-2019; Strawbridge, Rona/H-5422-2012; Gandin, Ilaria/B-2634-2017; Gudnason, Vilmundur/AAE-7126-2019; Traglia, Michela/AAX-5816-2020; Dörr, Marcus/F-1919-2010; Tzourio, christophe/L-6344-2019; Hwang, Shih-Jen/HGU-5826-2022; Study, GoDARTS/K-9448-2016; Palmer, Colin NA/C-7053-2008; Rotter, Jerome/AAY-6598-2021; Tzourio, christophe/B-4015-2009; Franco, Óscar H/ABE-2305-2020; Sundstrom, Johan/R-2139-2019; Schmidt, Reinhold/E-1137-2014; ruggiero, daniela/K-5638-2016; Smith, Albert Vernon/AHC-3838-2022; Morgan, Anna/K-2238-2018; Gasparini, Paolo/B-6173-2014; Johnson, Andrew D/G-6520-2013; Loos, Ruth/GON-5877-2022; Evangelou, Evangelos/C-3033-2013; Loos, Ruth J F/Q-2862-2016; de Geus, Eco J.C./M-9318-2015; Raitakari, Olli/AAQ-7389-2021; Tzoulaki, Ioanna/ABE-6269-2020; Levy, Daniel/ABF-6873-2021; Erzurumluoglu, A Mesut/E-4445-2018; Sundström, Johan/A-6286-2009; Cocca, Massimiliano/J-2951-2018; Riese, Harriëtte/E-7234-2012; Lopez, Lorna/AAR-4912-2020; He, Jiang/AAF-5303-2020; Doney, Alexander SF/P-7437-2017; Wilson, James F/A-5704-2009; EHRET, Georg B/A-9532-2009; Pare, Guillaume/T-9631-2018; Shah, Nabi/AAG-7378-2021; Mifsud, Borbala/AAB-5379-2020; Rudan, Igor/I-1467-2012; Verweij, Niek/ABC-6249-2021; Enroth, Stefan/C-7396-2009; Mägi, Reedik/AAJ-9679-2021; Porteous, David/AAA-3446-2021; Org, Elin/AAJ-9631-2021; Lehtimäki, Terho/AAD-1094-2022; Levy, Daniel/ABB-2752-2021; Peters, Annette/A-6117-2011; Campbell, Harry/E-2959-2010; Johansson, Åsa/AAG-6799-2021; Gow, Alan J/A-6070-2009; Campbell, Archie/AAZ-1757-2021; zhang, weihua/GXV-1334-2022; Colaus, PsyColaus/K-6607-2013; Teumer, Alexander/S-7438-2019; Deelen, Joris/H-3201-2019; Hicks, Andrew Anthony/E-9518-2017; Vaez, Ahmad/B-4336-2018; Li-Gao, Ruifang/B-7172-2018; Debette, Stephanie/T-4946-2019; Stanton, Alice V/F-4697-2012; CHAUHAN, GANESH/AAI-5110-2021; Havulinna, Aki/AAM-4769-2021; Johansson, Åsa/G-5270-2011; Boomsma, Dorret I/AAX-4470-2020; Sala, Cinzia Felicita/AAN-1900-2020; Scott, Rodney/B-2827-2013; Niiranen, Teemu/R-1507-2017; Charchar, Fadi/I-6656-2017; Robino, Antonietta/K-9398-2016; Girotto, Giorgia/I-9452-2018	Polasek, Ozren/0000-0002-5765-1862; Shah, Nabi/0000-0003-2764-3615; Deary, Ian J/0000-0002-1733-263X; Ciullo, Marina/0000-0002-9621-9984; Kolcic, Ivana/0000-0001-7918-6052; Jukema, J. Wouter/0000-0002-3246-8359; Laan, Maris/0000-0002-8519-243X; Toniolo, Daniela/0000-0001-9545-6032; Strawbridge, Rona/0000-0001-8506-3585; Gandin, Ilaria/0000-0003-3196-2491; Gudnason, Vilmundur/0000-0001-5696-0084; Dörr, Marcus/0000-0001-7471-475X; Tzourio, christophe/0000-0002-6517-2984; Palmer, Colin NA/0000-0002-6415-6560; Tzourio, christophe/0000-0002-6517-2984; Franco, Óscar H/0000-0002-4606-4929; Sundstrom, Johan/0000-0003-2247-8454; ruggiero, daniela/0000-0003-3898-7827; Smith, Albert Vernon/0000-0003-1942-5845; Morgan, Anna/0000-0001-6290-445X; Johnson, Andrew D/0000-0001-6369-5178; Evangelou, Evangelos/0000-0002-5488-2999; Loos, Ruth J F/0000-0002-8532-5087; de Geus, Eco J.C./0000-0001-6022-2666; Tzoulaki, Ioanna/0000-0002-4275-9328; Levy, Daniel/0000-0003-1843-8724; Erzurumluoglu, A Mesut/0000-0003-1322-8138; Sundström, Johan/0000-0003-2247-8454; Cocca, Massimiliano/0000-0002-1127-7596; Riese, Harriëtte/0000-0003-3661-3151; Lopez, Lorna/0000-0002-0241-9783; He, Jiang/0000-0002-8286-9652; Doney, Alexander SF/0000-0002-6210-5620; Wilson, James F/0000-0001-5751-9178; EHRET, Georg B/0000-0002-5730-0675; Pare, Guillaume/0000-0002-6795-4760; Shah, Nabi/0000-0003-2764-3615; Rudan, Igor/0000-0001-6993-6884; Verweij, Niek/0000-0002-4303-7685; Enroth, Stefan/0000-0002-5056-9137; Porteous, David/0000-0003-1249-6106; Lehtimäki, Terho/0000-0002-2555-4427; Peters, Annette/0000-0001-6645-0985; Campbell, Harry/0000-0002-6169-6262; Johansson, Åsa/0000-0002-2915-4498; Gow, Alan J/0000-0002-3320-4531; Teumer, Alexander/0000-0002-8309-094X; Deelen, Joris/0000-0003-4483-3701; Hicks, Andrew Anthony/0000-0001-6320-0411; Vaez, Ahmad/0000-0001-9048-3795; Li-Gao, Ruifang/0000-0003-0650-1351; Debette, Stephanie/0000-0001-8675-7968; Johansson, Åsa/0000-0002-2915-4498; Magi, Reedik/0000-0002-2964-6011; De Borst, Martin/0000-0002-4127-8733; Amin, Najaf/0000-0002-8944-1771; Scott, Rodney/0000-0001-7724-3404; Shrine, Nick/0000-0003-3641-4371; Shields, Denis/0000-0003-4015-2474; Org, Elin/0000-0001-8688-9717; Barnes, Michael/0000-0001-9097-7381; Stanton, Alice/0000-0002-4961-165X; Niiranen, Teemu/0000-0002-7394-7487; Said, M. Abdullah/0000-0003-2920-7745; Drenos, Fotios/0000-0003-2469-5516; Willemsen, Gonneke/0000-0003-3755-0236; Karaman, Ibrahim/0000-0001-9341-8155; Tomaszewski, Maciej/0000-0001-8215-6567; Charchar, Fadi/0000-0002-6164-9941; Padmanabhan, Sandosh/0000-0003-3869-5808; Van Duijn, Cornelia/0000-0002-2374-9204; Robino, Antonietta/0000-0003-2152-2353; Pramstaller, Peter P/0000-0002-9831-8302; Loh, Marie/0000-0003-3626-8466; Theriault, Sebastien/0000-0003-1893-8307; Marten, Jonathan/0000-0001-6916-2014; Knight, Joanne/0000-0002-7148-1660; Morrison, Alanna/0000-0001-6381-4296; NUTILE, TERESA/0000-0001-7062-8352; Palotie, Aarno/0000-0002-2527-5874; Jansen, Rick/0000-0002-3333-6737; O'Reilly, Paul/0000-0001-7515-0845; Joshi, Peter/0000-0002-6361-5059; Tobin, Martin/0000-0002-3596-7874; Mifsud, Borbala/0000-0003-3429-3094; Tai, E Shyong/0000-0003-2929-8966; Oldmeadow, Christopher/0000-0001-6104-1322; Wain, Louise/0000-0003-4951-1867; Lindgren, Cecilia/0000-0002-4903-9374; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Caulfield, Mark/0000-0001-9295-3594; ELOSUA, ROBERTO/0000-0001-8235-0095; Girotto, Giorgia/0000-0003-4507-6589; Vitart, Veronique/0000-0002-4991-3797; Keavney, Bernard/0000-0001-9573-0812; Kahonen, Mika/0000-0002-4510-7341; Gasparini, Paolo/0000-0002-0859-0856; Vuckovic, Dragana/0000-0001-9343-6142; Cordell, Heather/0000-0002-1879-5572; Elliott, Paul/0000-0002-7511-5684; Howson, Joanna/0000-0001-7618-0050	National Institute for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Unit at Barts and The London School of Medicine and Dentistry; NIHR Imperial College Health Care NHS Trust and Imperial College London Biomedical Research Centre; China Scholarship Council [2011632047]; UK Medical Research Council [G0800270, MR/N015746/1]; British Heart Foundation [SP/09/002, SP/13/2/30111]; UK National Institute for Health Research Cambridge Biomedical Research Centre; European Research Council [268834]; European Commission Framework Programme 7 [HEALTH-F2-2012-279233]; MRC Unit at the University of Bristol [MC_UU_12013/1-9]; NHLBI; National Institutes of Health [HL113933, HL124262, HL128782, HL086694]; ZonMw [90.700.441]; Marie Sklodowska-Curie GF [H2020-MSCA-IF-2014, 661395]; Marie Sklodowska-Curie GF grant [661395]; ICIN-NHI; UK National Institute for Health Research Biomedical Research Centre at Imperial College Healthcare NHS Trust; NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London; Wellcome Trust [109863/Z/15/Z]; EU PhenoMeNal project (Horizon) [654241]; Wellcome Trust core award [090532/Z/09/Z]; BHF Centre of Research Excellence, Oxford [RE/13/1/30181]; MRC core grant for QTL in Health and Disease programme; NIHR Health Protection Research Unit in Health Impact of Environmental Hazards [HPRU-2012-10141]; Public Health England [MR/L01341X/1]; Medical Research Council [MR/L01632X/1];  [MR/L016311/1]; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; British Heart Foundation [RG/15/12/31616, PG/16/49/32176, RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0600237, MR/K026992/1, MC_qA137853, MC_UU_12013/3, MR/L003120/1, MR/N015746/1, MC_UU_12015/1, MR/K006584/1, G0800270, MR/L016311/1, MC_PC_U127561128, MR/L01341X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10059, NF-SI-0507-10228, NF-SI-0512-10165, NF-SI-0611-10170, NF-SI-0512-10113, NF-SI-0514-10027, NF-SI-0611-10136] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4] Funding Source: researchfish; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [MR/L003120/1, MC_UU_12013/3, MC_UU_12015/1, G0600237, MR/L016311/1, MC_PC_U127561128, MR/L01341X/1, MR/N015746/1, G0800270, MR/L01632X/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113933, R01HL128782, R01HL086694, R01HL124262] Funding Source: NIH RePORTER	National Institute for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Unit at Barts and The London School of Medicine and Dentistry; NIHR Imperial College Health Care NHS Trust and Imperial College London Biomedical Research Centre; China Scholarship Council(China Scholarship Council); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); UK National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); European Research Council(European Research Council (ERC)European Commission); European Commission Framework Programme 7; MRC Unit at the University of Bristol(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZonMw(Netherlands Organization for Health Research and Development); Marie Sklodowska-Curie GF; Marie Sklodowska-Curie GF grant; ICIN-NHI; UK National Institute for Health Research Biomedical Research Centre at Imperial College Healthcare NHS Trust; NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London; Wellcome Trust(Wellcome Trust); EU PhenoMeNal project (Horizon); Wellcome Trust core award(Wellcome Trust); BHF Centre of Research Excellence, Oxford; MRC core grant for QTL in Health and Disease programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Health Protection Research Unit in Health Impact of Environmental Hazards; Public Health England; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	H.R.W., C.P.C., M.R., M.R.B., P.B.M., M.B. and M.J.C. were funded by the National Institute for Health Research (NIHR) as part of the portfolio of translational research of the NIHR Biomedical Research Unit at Barts and The London School of Medicine and Dentistry. H.G. was funded by the NIHR Imperial College Health Care NHS Trust and Imperial College London Biomedical Research Centre. M.R. was a recipient of a grant from the China Scholarship Council (2011632047). B.M. holds an MRC eMedLab Medical Bioinformatics Career Development Fellowship, funded from award MR/L016311/1. J.M.M.H. was funded by the UK Medical Research Council (G0800270), British Heart Foundation (SP/09/002), UK National Institute for Health Research Cambridge Biomedical Research Centre, European Research Council (268834) and European Commission Framework Programme 7 (HEALTH-F2-2012-279233). B.K. holds a British Heart Foundation Personal Chair (CH/13/2/30154). N.J.S. holds a chair funded by the British Heart Foundation and is an NIHR Senior Investigator. F.D. was funded by the MRC Unit at the University of Bristol (MC_UU_12013/1-9). P. Surendran was funded by the UK Medical Research Council (G0800270). C.L. and A.K. were funded by NHLBI intramural funding. C.N.-C. was funded by the National Institutes of Health (HL113933, HL124262). P.v.d.H. was funded by ZonMw grant 90.700.441, Marie Sklodowska-Curie GF (call, H2020-MSCA-IF-2014; project ID, 661395). N.V. was supported by a Marie Sklodowska-Curie GF grant (661395) and ICIN-NHI. N.P. received funding from the UK National Institute for Health Research Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London and also from his Senior Investigator Award. P. Sever was supported by the NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London. S.T. was supported by the NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London. P.F.O'R. received funding from the UK Medical Research Council (MR/N015746/1) and the Wellcome Trust (109863/Z/15/Z). I.K. was supported by the EU PhenoMeNal project (Horizon 2020, 654241). A.C. was funded by the National Institutes of Health (HL128782, HL086694). M.F. was supported by a Wellcome Trust core award (090532/Z/09/Z) and the BHF Centre of Research Excellence, Oxford (RE/13/1/30181). C.H. was funded by an MRC core grant for QTL in Health and Disease programme. Some of this work used the ALICE and SPECTRE High-Performance Computing Facilities at the University of Leicester. M.J.C. is a National Institute for Health Research (NIHR) senior investigator. P.E. is a National Institute for Health Research (NIHR) senior investigator and acknowledges support from the NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London, and the NIHR Health Protection Research Unit in Health Impact of Environmental Hazards (HPRU-2012-10141). As director of the MRC-PHE Centre for Environment and Health, P.E. acknowledges support from the Medical Research Council and Public Health England (MR/L01341X/1). This work used the computing resources of the UK Medical Bioinformatics partnership-aggregation, integration, visualisation and analysis of large, complex data (UK MED-BIO), which is supported by the Medical Research Council (MR/L01632X/1). This research was supported by the British Heart Foundation (grant SP/13/2/30111).; Project title: Large-Scale Comprehensive Genotyping of UK Biobank for Cardiometabolic Traits and Diseases: UK CardioMetabolic Consortium (UKCMC). This research has been conducted using the UK Biobank Resource under application number 236.	Akashi M, 2011, BIOCHEM BIOPH RES CO, V413, P224, DOI 10.1016/j.bbrc.2011.08.073; Cabrera CP, 2015, WIRES SYST BIOL MED, V7, P73, DOI 10.1002/wsbm.1290; Cakstina I, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-10; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Chan EC, 2013, BIOCHEM BIOPH RES CO, V430, P918, DOI 10.1016/j.bbrc.2012.11.138; Chan Q, 2016, J ATHEROSCLER THROMB, V23, P276, DOI 10.5551/jat.30000; Chan SHH, 2010, CIRC RES, V107, P1127, DOI 10.1161/CIRCRESAHA.110.225573; Crespo K, 2016, CLIN EXP HYPERTENS, V38, P533, DOI 10.3109/10641963.2016.1163373; den Hoed M, 2013, NAT GENET, V45, P621, DOI 10.1038/ng.2610; DeStefano AL, 1998, AM J HUM GENET, V63, P1425, DOI 10.1086/302096; Dietrich T, 2007, BASIC RES CARDIOL, V102, P298, DOI 10.1007/s00395-007-0652-5; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Erdos B, 2015, AM J PHYSIOL-HEART C, V308, pH612, DOI 10.1152/ajpheart.00776.2014; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P284, DOI 10.1093/oxfordjournals.aje.a112464; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gale DP, 2008, BLOOD, V112, P919, DOI 10.1182/blood-2008-04-153718; Hamilton CA, 2001, HYPERTENSION, V37, P529, DOI 10.1161/01.HYP.37.2.529; Hoffmann TJ, 2017, NAT GENET, V49, P54, DOI 10.1038/ng.3715; Hong X, 2007, METHOD FIND EXP CLIN, V29, P3, DOI 10.1358/mf.2007.29.1.1063490; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kazenwadel J, 2012, BLOOD, V119, P1283, DOI 10.1182/blood-2011-08-374363; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; MONGEAU JG, 1986, CLIN EXP HYPERTENS A, V8, P653, DOI 10.3109/10641968609046581; Munoz M, 2016, NAT GENET, V48, P980, DOI 10.1038/ng.3618; Munroe PB, 2013, CIRC RES, V112, P1365, DOI 10.1161/CIRCRESAHA.112.300387; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Oliver JJ, 2006, HYPERTENSION, V48, P622, DOI 10.1161/01.HYP.0000239816.13007.c9; Perez NG, 2007, HYPERTENSION, V49, P1095, DOI 10.1161/HYPERTENSIONAHA.107.087759; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Pu XY, 2013, AM J HUM GENET, V92, P366, DOI 10.1016/j.ajhg.2013.01.012; Raffler J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005487; Ray R, 2011, ARTERIOSCL THROM VAS, V31, P1368, DOI 10.1161/ATVBAHA.110.219238; Rizzoni D, 2012, INTERN EMERG MED, V7, P205, DOI 10.1007/s11739-011-0548-0; Ronaldson PT, 2015, BRAIN RES, V1623, P39, DOI 10.1016/j.brainres.2015.03.018; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Steppan J, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/263585; Stoynev N, 2014, J CARDIOVASC MED, V15, P702, DOI 10.2459/JCM.0b013e32835dbcc8; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Takimoto E, 2002, FASEB J, V16, DOI 10.1096/fj.01-0735com; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tian X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018136; Touyz RM, 2012, CIRC RES, V110, P1159, DOI 10.1161/CIRCRESAHA.112.269068; van Meurs JBJ, 2013, AM J CLIN NUTR, V98, P668, DOI 10.3945/ajcn.112.044545; van Setten J, 2013, ATHEROSCLEROSIS, V228, P400, DOI 10.1016/j.atherosclerosis.2013.02.039; Vasa-Nicotera M, 2011, ATHEROSCLEROSIS, V217, P326, DOI 10.1016/j.atherosclerosis.2011.03.034; Wang JH, 2013, DEV BIOL, V382, P427, DOI 10.1016/j.ydbio.2013.08.012; Watanabe Y, 2010, HYPERTENS RES, V33, P129, DOI 10.1038/hr.2009.193; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.551; Yndestad A, 2009, J APPL PHYSIOL, V106, P1356, DOI 10.1152/japplphysiol.90719.2008	62	309	316	5	143	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2017	49	3					403	415		10.1038/ng.3768	http://dx.doi.org/10.1038/ng.3768			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL9CU	28135244	Green Accepted, Green Submitted			2022-12-17	WOS:000394917800014
J	Ionita-Laza, I; McCallum, K; Xu, B; Buxbaum, JD				Ionita-Laza, Iuliana; McCallum, Kenneth; Xu, Bin; Buxbaum, Joseph D.			A spectral approach integrating functional genomic annotations for coding and noncoding variants	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; ESTIMATING RELATIVE RISKS; INTELLECTUAL DISABILITY; GENETIC-VARIANTS; WHOLE-GENOME; EXOME; AUTISM; SCHIZOPHRENIA; PATTERNS; NETWORK	Over the past few years, substantial effort has been put into the functional annotation of variation in human genome sequences. Such annotations can have a critical role in identifying putatively causal variants for a disease or trait among the abundant natural variation that occurs at a locus of interest. The main challenges in using these various annotations include their large numbers and their diversity. Here we develop an unsupervised approach to integrate these different annotations into one measure of functional importance (Eigen) that, unlike most existing methods, is not based on any labeled training data. We show that the resulting meta-score has better discriminatory ability using disease-associated and putatively benign variants from published studies (in both coding and noncoding regions) than the recently proposed CADD score. Across varied scenarios, the Eigen score performs generally better than any single individual annotation, representing a powerful single functional score that can be incorporated in fine-mapping studies.	[Ionita-Laza, Iuliana; McCallum, Kenneth] Columbia Univ, Dept Biostat, New York, NY USA; [Xu, Bin] Columbia Univ, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ionita-Laza, I (corresponding author), Columbia Univ, Dept Biostat, New York, NY USA.	ii2135@columbia.edu	Buxbaum, Joseph D/G-6001-2010	Buxbaum, Joseph/0000-0001-8898-8313	US National Institutes of Health [R01 MH095797, R01 MH100233]; Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095797] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by US National Institutes of Health grants R01 MH095797 and R01 MH100233 and by the Seaver Foundation. All analyses were conducted on the Minerva HPC complex at the Icahn School of Medicine at Mount Sinai.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Capanu M, 2008, STAT MED, V27, P1973, DOI 10.1002/sim.3196; Capanu M, 2011, BIOMETRICS, V67, P371, DOI 10.1111/j.1541-0420.2010.01469.x; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dong S, 2014, CELL REP, V9, P16, DOI 10.1016/j.celrep.2014.08.068; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0089-z; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Gulko B, 2015, NAT GENET, V47, P276, DOI 10.1038/ng.3196; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Ionita-Laza I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004729; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Ko A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4983; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003	46	309	317	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					214	220		10.1038/ng.3477	http://dx.doi.org/10.1038/ng.3477			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26727659	Green Accepted			2022-12-17	WOS:000369043900021
J	Verhoeven, VJM; Hysi, PG; Wojciechowski, R; Fan, Q; Guggenheim, JA; Hohn, R; MacGregor, S; Hewitt, AW; Nag, A; Cheng, CY; Yonova-Doing, E; Zhou, X; Ikram, MK; Buitendijk, GHS; McMahon, G; Kemp, JP; St Pourcain, B; Simpson, CL; Makela, KM; Lehtimaki, T; Kahonen, M; Paterson, AD; Hosseini, SM; Wong, HS; Xu, L; Jonas, JB; Parssinen, O; Wedenoja, J; Yip, SP; Ho, DWH; Pang, CP; Chen, LJ; Burdon, KP; Craig, JE; Klein, BEK; Klein, R; Haller, T; Metspalu, A; Khor, CC; Tai, ES; Aung, T; Vithana, E; Tay, WT; Barathi, VA; Chen, P; Li, RY; Liao, JM; Zheng, YF; Ong, RT; Doring, A; Evans, DM; Timpson, NJ; Verkerk, AJMH; Meitinger, T; Raitakari, O; Hawthorne, F; Spector, TD; Karssen, LC; Pirastu, M; Murgia, F; Ang, W; Mishra, A; Montgomery, GW; Pennell, CE; Cumberland, PM; Cotlarciuc, I; Mitchell, P; Wang, JJ; Schache, M; Janmahasathian, S; Igo, RP; Lass, JH; Chew, E; Iyengar, SK; Gorgels, TGMF; Rudan, I; Hayward, C; Wright, AF; Polasek, O; Vatavuk, Z; Wilson, JF; Fleck, B; Zeller, T; Mirshahi, A; Muller, C; Uitterlinden, AG; Rivadeneira, F; Vingerling, JR; Hofman, A; Oostra, B; Amin, N; Bergen, AAB; Teo, YY; Rahi, JS; Vitart, V; Williams, C; Baird, PN; Wong, TY; Oexle, K; Pfeiffer, N; Mackey, DA; Young, TL; van Duijn, CM; Saw, SM; Bailey-Wilson, JE; Stambolian, D; Klaver, CC; Hammond, CJ				Verhoeven, Virginie J. M.; Hysi, Pirro G.; Wojciechowski, Robert; Fan, Qiao; Guggenheim, Jeremy A.; Hoehn, Rene; MacGregor, Stuart; Hewitt, Alex W.; Nag, Abhishek; Cheng, Ching-Yu; Yonova-Doing, Ekaterina; Zhou, Xin; Ikram, M. Kamran; Buitendijk, Gabrielle H. S.; McMahon, George; Kemp, John P.; St Pourcain, Beate; Simpson, Claire L.; Makela, Karl-Matti; Lehtimaki, Terho; Kahonen, Mika; Paterson, Andrew D.; Hosseini, S. Mohsen; Wong, Hoi Suen; Xu, Liang; Jonas, Jost B.; Parssinen, Olavi; Wedenoja, Juho; Yip, Shea Ping; Ho, Daniel W. H.; Pang, Chi Pui; Chen, Li Jia; Burdon, Kathryn P.; Craig, Jamie E.; Klein, Barbara E. K.; Klein, Ronald; Haller, Toomas; Metspalu, Andres; Khor, Chiea-Chuen; Tai, E-Shyong; Aung, Tin; Vithana, Eranga; Tay, Wan-Ting; Barathi, Veluchamy A.; Chen, Peng; Li, Ruoying; Liao, Jiemin; Zheng, Yingfeng; Ong, Rick T.; Doering, Angela; Evans, David M.; Timpson, Nicholas J.; Verkerk, Annemieke J. M. H.; Meitinger, Thomas; Raitakari, Olli; Hawthorne, Felicia; Spector, Tim D.; Karssen, Lennart C.; Pirastu, Mario; Murgia, Federico; Ang, Wei; Mishra, Aniket; Montgomery, Grant W.; Pennell, Craig E.; Cumberland, Phillippa M.; Cotlarciuc, Ioana; Mitchell, Paul; Wang, Jie Jin; Schache, Maria; Janmahasathian, Sarayut; Igo, Robert P., Jr.; Lass, Jonathan H.; Chew, Emily; Iyengar, Sudha K.; Gorgels, Theo G. M. F.; Rudan, Igor; Hayward, Caroline; Wright, Alan F.; Polasek, Ozren; Vatavuk, Zoran; Wilson, James F.; Fleck, Brian; Zeller, Tanja; Mirshahi, Alireza; Mueller, Christian; Uitterlinden, Andre G.; Rivadeneira, Fernando; Vingerling, Johannes R.; Hofman, Albert; Oostra, Ben A.; Amin, Najaf; Bergen, Arthur A. B.; Teo, Yik-Ying; Rahi, Jugnoo S.; Vitart, Veronique; Williams, Cathy; Baird, Paul N.; Wong, Tien-Yin; Oexle, Konrad; Pfeiffer, Norbert; Mackey, David A.; Young, Terri L.; van Duijn, Cornelia M.; Saw, Seang-Mei; Bailey-Wilson, Joan E.; Stambolian, Dwight; Klaver, Caroline C.; Hammond, Christopher J.		CREAM; Diabet Control Complications Trial; WTCCC2; Fuchs' Genetics Multi-Ctr Study Gr	Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia	NATURE GENETICS			English	Article							RETINAL-PIGMENT EPITHELIUM; ADAPTED MOUSE RETINA; EYE GROWTH; POTASSIUM CHANNEL; SERINE-PROTEASE; ASSOCIATION; ACID; EXPRESSION; VARIANTS; GENE	Refractive error is the most common eye disorder worldwide and is a prominent cause of blindness. Myopia affects over 30% of Western populations and up to 80% of Asians. The CREAM consortium conducted genome-wide meta-analyses, including 37,382 individuals from 27 studies of European ancestry and 8,376 from 5 Asian cohorts. We identified 16 new loci for refractive error in individuals of European ancestry, of which 8 were shared with Asians. Combined analysis identified 8 additional associated loci. The new loci include candidate genes with functions in neurotransmission (GRIA4), ion transport (KCNQ5), retinoic acid metabolism (RDH5), extracellular matrix remodeling (LAMA2 and BMP2) and eye development (SIX6 and PRSS56). We also confirmed previously reported associations with GJD2 and RASGRF1. Risk score analysis using associated SNPs showed a tenfold increased risk of myopia for individuals carrying the highest genetic load. Our results, based on a large meta-analysis across independent multiancestry studies, considerably advance understanding of the mechanisms involved in refractive error and myopia.	[Verhoeven, Virginie J. M.; Buitendijk, Gabrielle H. S.; Vingerling, Johannes R.; Klaver, Caroline C.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Verhoeven, Virginie J. M.; Buitendijk, Gabrielle H. S.; Karssen, Lennart C.; Uitterlinden, Andre G.; Rivadeneira, Fernando; Vingerling, Johannes R.; Hofman, Albert; Amin, Najaf; van Duijn, Cornelia M.; Klaver, Caroline C.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Hysi, Pirro G.; Nag, Abhishek; Yonova-Doing, Ekaterina; Spector, Tim D.; Hammond, Christopher J.] Kings Coll London, Sch Med, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Wojciechowski, Robert; Simpson, Claire L.; Bailey-Wilson, Joan E.] NHGRI, Inherited Dis Res Branch, US Natl Inst Hlth, Baltimore, MD USA; [Wojciechowski, Robert] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Fan, Qiao; Cheng, Ching-Yu; Zhou, Xin; Ikram, M. Kamran; Khor, Chiea-Chuen; Tai, E-Shyong; Chen, Peng; Li, Ruoying; Ong, Rick T.; Teo, Yik-Ying; Wong, Tien-Yin; Saw, Seang-Mei] Natl Univ Singapore, Natl Univ Hlth Syst, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Guggenheim, Jeremy A.; Ho, Daniel W. H.] Hong Kong Polytech Univ, Sch Optometry, Ctr Myopia Res, Hong Kong, Hong Kong, Peoples R China; [Hoehn, Rene; Mirshahi, Alireza; Pfeiffer, Norbert] Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany; [MacGregor, Stuart; Mishra, Aniket] Queensland Inst Med Res, Dept Stat Genet, Brisbane, Qld 4006, Australia; [Hewitt, Alex W.; Wang, Jie Jin; Schache, Maria; Baird, Paul N.; Mackey, David A.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, CERA, Melbourne, Vic, Australia; [Hewitt, Alex W.; Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Cheng, Ching-Yu; Ikram, M. Kamran; Khor, Chiea-Chuen; Aung, Tin; Barathi, Veluchamy A.; Liao, Jiemin; Wong, Tien-Yin; Saw, Seang-Mei] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Ophthalmol, Singapore 117548, Singapore; [Cheng, Ching-Yu; Ikram, M. Kamran; Aung, Tin; Vithana, Eranga; Tay, Wan-Ting; Barathi, Veluchamy A.; Zheng, Yingfeng; Wong, Tien-Yin; Saw, Seang-Mei] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [McMahon, George; Kemp, John P.; Evans, David M.; Timpson, Nicholas J.] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England; [St Pourcain, Beate; Williams, Cathy] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Makela, Karl-Matti; Lehtimaki, Terho] Univ Tampere, Fimlab Labs, Dept Clin Chem, FIN-33101 Tampere, Finland; [Makela, Karl-Matti; Lehtimaki, Terho; Kahonen, Mika] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kahonen, Mika] Univ Tampere, Tampere Univ Hosp, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Paterson, Andrew D.; Hosseini, S. Mohsen; Wong, Hoi Suen] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Paterson, Andrew D.; Hosseini, S. Mohsen; Wong, Hoi Suen] Univ Toronto, Toronto, ON, Canada; [Xu, Liang] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Parssinen, Olavi] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Parssinen, Olavi] Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland; [Parssinen, Olavi] Cent Hosp Cent Finland, Dept Ophthalmol, Jyvaskyla, Finland; [Wedenoja, Juho] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Yip, Shea Ping] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Ho, Daniel W. H.; Pang, Chi Pui] Chinese Univ Hong Kong, Hong Kong Eye Hosp, Dept Ophthalmol & Visual Sci, Kowloon, Hong Kong, Peoples R China; [Chen, Li Jia] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Ophthalmol & Visual Sci, Shatin, Hong Kong, Peoples R China; [Burdon, Kathryn P.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA 5001, Australia; [Klein, Barbara E. K.; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Haller, Toomas; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Khor, Chiea-Chuen] Natl Univ Singapore, Dept Pediat, Singapore 117548, Singapore; [Khor, Chiea-Chuen] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Tai, E-Shyong] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Tai, E-Shyong; Barathi, Veluchamy A.; Saw, Seang-Mei] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Doering, Angela] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany; [Doering, Angela; Uitterlinden, Andre G.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Verkerk, Annemieke J. M. H.; Rivadeneira, Fernando] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Meitinger, Thomas; Oexle, Konrad] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Med, Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland; [Hawthorne, Felicia; Young, Terri L.] Duke Eye Ctr Human Genet, Dept Pediat Ophthalmol, Durham, NC USA; [Pirastu, Mario; Murgia, Federico; Bergen, Arthur A. B.] CNR, Inst Populat Genet, Sassari, Italy; [Ang, Wei; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Montgomery, Grant W.; Rahi, Jugnoo S.] Queensland Inst Med Res, Dept Mol Epidemiol, Brisbane, Qld 4006, Australia; [Cumberland, Phillippa M.] UCL, Inst Child Hlth, MRC, Ctr Epidemiol Child Hlth, London, England; [Cumberland, Phillippa M.; Rahi, Jugnoo S.] UCL, Ulverscroft Vis Res Grp, London, England; [Cotlarciuc, Ioana] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, ICCRU, London, England; [Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Janmahasathian, Sarayut; Igo, Robert P., Jr.; Lass, Jonathan H.; Iyengar, Sudha K.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Lass, Jonathan H.; Iyengar, Sudha K.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Lass, Jonathan H.; Iyengar, Sudha K.] Univ Hosp Eye Inst, Cleveland, OH USA; [Chew, Emily] NEI, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Iyengar, Sudha K.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Gorgels, Theo G. M. F.; Bergen, Arthur A. B.] NIN, Dept Clin & Mol Ophthalmogenet, Amsterdam, Netherlands; [Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Hayward, Caroline; Wright, Alan F.; Vitart, Veronique] Univ Edinburgh, Human Genet Unit, MRC, Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Polasek, Ozren] Univ Split, Fac Med, Split, Croatia; [Vatavuk, Zoran] Sisters Mercy Univ Hosp, Dept Ophthalmol, Zagreb, Croatia; [Fleck, Brian] Princess Alexandra Eye Pavil, Edinburgh, Midlothian, Scotland; [Zeller, Tanja; Mueller, Christian] Univ Heart Ctr Hamburg, Clin Gen & Intervent Cardiol, Hamburg, Germany; [Uitterlinden, Andre G.; Rivadeneira, Fernando; Hofman, Albert] Netherlands Genom Initiat, Netherlands Consortium Hlth Ageing, The Hague, Netherlands; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Bergen, Arthur A. B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Bergen, Arthur A. B.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Rahi, Jugnoo S.] Moorfields Eye Hosp, Inst Ophthalmol, London, England; [Stambolian, Dwight] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National University of Singapore; Hong Kong Polytechnic University; Johannes Gutenberg University of Mainz; QIMR Berghofer Medical Research Institute; Royal Victorian Eye & Ear Hospital; University of Melbourne; Lions Eye Institute; University of Western Australia; National University of Singapore; National University of Singapore; Singapore National Eye Center; University of Bristol; University of Bristol; Tampere University; Tampere University; Tampere University; Tampere University Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Capital Medical University; Ruprecht Karls University Heidelberg; University of Jyvaskyla; University of Jyvaskyla; Central Finland Central Hospital; University of Helsinki; Hong Kong Polytechnic University; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Flinders University South Australia; University of Wisconsin System; University of Wisconsin Madison; University of Tartu; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; Technical University of Munich; University of Turku; University of Turku; Consiglio Nazionale delle Ricerche (CNR); University of Western Australia; QIMR Berghofer Medical Research Institute; University of London; University College London; University of London; University College London; Imperial College London; University of Sydney; Westmead Institute for Medical Research; Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Case Western Reserve University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Edinburgh; University of Edinburgh; University of Split; University of Hamburg; University Medical Center Hamburg-Eppendorf; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; National University of Singapore; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Pennsylvania	Klaver, CC (corresponding author), Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands.	c.c.w.klaver@erasmusmc.nl	Evans, David M/H-6325-2013; Wilson, James F/A-5704-2009; Belllenguez, Céline/Y-3183-2018; /S-1190-2019; wang, jie/GRS-0942-2022; Wedenoja, Juho/AAX-7008-2020; Mishra, Aniket/T-7966-2019; Kemp, John P./R-3091-2018; Burdon, Kathryn/AAD-2334-2022; Chen, Peng/E-5546-2015; Zheng, Yingfeng/AAE-2983-2022; Pennell, Craig/ABD-6902-2020; Zheng, Yingfeng/CAE-9225-2022; Chen, Li Jia/I-5078-2014; Polasek, Ozren/B-6002-2011; Raitakari, Olli/AAQ-7389-2021; Cheng, Ching-Yu/Y-2229-2019; Blackwell, Jenefer M/H-3015-2015; Hayward, Caroline/M-8818-2016; Paterson, Andrew/AAQ-7511-2020; Haller, Toomas/N-3797-2019; Delcourt, Cecile/I-2627-2013; Macgregor, Stuart/C-6442-2009; Yip, Shea Ping/A-1185-2016; Mackey, David A/H-5340-2014; Pang, Chi P/I-5388-2014; Rivadeneira, Fernando/O-5385-2015; Wong, Tien Yin/AAC-9724-2020; Paterson, Andrew D/A-4088-2011; Rudan, Igor/I-1467-2012; Fox, Laura J/C-6249-2016; Timpson, Nicholas John/O-7548-2015; Meitinger, Thomas/O-1318-2015; Montgomery, Grant W/B-7148-2008; Study, Raine/K-4517-2013; Pfeiffer, Norbert/AAO-7586-2020; Mitchell, Paul/P-1498-2014; Cheng, Ching-Yu/K-7017-2013; Jankowski, Janusz/H-2706-2012; DeAngelis, e/J-7863-2015; Igo, Rob/P-3438-2019; Wojciechowski, Robert/L-4970-2017; Wegner, Aharon/H-8448-2019; Hewitt, Alex W/D-1936-2013; Ho, Daniel Wai Hung WH/O-1194-2016; Wang, Jie Jin/P-1499-2014; Klaver, Caroline C.W./A-2013-2016; Deloukas, Panos/B-2922-2013; Tai, E Shyong/J-9831-2013; W, Robert/AAE-4192-2019; St Pourcain, Beate/K-8004-2017; Mishra, Aniket/T-6886-2019; Bergen, Arthur/J-3637-2013; Attrill, Lauren/V-1688-2018; Burdon, Kathryn/A-5026-2009; Lehtimäki, Terho/AAD-1094-2022; Bellenguez, Céline/X-4004-2019; Northstone, Kate/A-8165-2011; Hosseini, S. Mohsen/K-7133-2013; Biino, Ginevra/B-5334-2013; Williams, Cathy/K-4919-2015	Evans, David M/0000-0003-0663-4621; Wilson, James F/0000-0001-5751-9178; Belllenguez, Céline/0000-0002-1240-7874; /0000-0001-7488-250X; Wedenoja, Juho/0000-0002-6155-0378; Mishra, Aniket/0000-0002-8141-1543; Kemp, John P./0000-0002-9105-2249; Burdon, Kathryn/0000-0001-8217-1249; Chen, Peng/0000-0002-1422-4641; Pennell, Craig/0000-0002-0937-6165; Zheng, Yingfeng/0000-0002-0914-7864; Chen, Li Jia/0000-0003-3500-5840; Polasek, Ozren/0000-0002-5765-1862; Cheng, Ching-Yu/0000-0003-0655-885X; Hayward, Caroline/0000-0002-9405-9550; Paterson, Andrew/0000-0002-9169-118X; Haller, Toomas/0000-0002-5069-6523; Delcourt, Cecile/0000-0002-2099-0481; Macgregor, Stuart/0000-0001-6731-8142; Yip, Shea Ping/0000-0002-2170-8185; Mackey, David A/0000-0001-7914-4709; Rivadeneira, Fernando/0000-0001-9435-9441; Wong, Tien Yin/0000-0002-8448-1264; Paterson, Andrew D/0000-0002-9169-118X; Rudan, Igor/0000-0001-6993-6884; Timpson, Nicholas John/0000-0002-7141-9189; Montgomery, Grant W/0000-0002-4140-8139; Cheng, Ching-Yu/0000-0003-0655-885X; Jankowski, Janusz/0000-0003-2130-9181; Igo, Rob/0000-0002-0024-1993; Wojciechowski, Robert/0000-0002-9593-4652; Wegner, Aharon/0000-0002-1969-3076; Hewitt, Alex W/0000-0002-5123-5999; Ho, Daniel Wai Hung WH/0000-0003-3884-296X; Wang, Jie Jin/0000-0001-9491-4898; Deloukas, Panos/0000-0001-9251-070X; W, Robert/0000-0002-9593-4652; St Pourcain, Beate/0000-0002-4680-3517; Mishra, Aniket/0000-0002-8141-1543; Burdon, Kathryn/0000-0001-8217-1249; Lehtimäki, Terho/0000-0002-2555-4427; Bellenguez, Céline/0000-0002-1240-7874; Northstone, Kate/0000-0002-0602-1983; Hosseini, S. Mohsen/0000-0003-3626-9928; Biino, Ginevra/0000-0002-9936-946X; Hysi, Pirro/0000-0001-5752-2510; Ikram, Mohammad Kamran/0000-0003-0173-9571; Simpson, Claire/0000-0003-2244-7690; Verkerk, Annemieke JMH/0000-0002-7523-3656; Karssen, Lennart C./0000-0002-1959-342X; Van Duijn, Cornelia/0000-0002-2374-9204; Murgia, Federico/0000-0002-3608-845X; Klein, Ronald/0000-0002-4428-6237; Craig, Jamie/0000-0001-9955-9696; Meitinger, Thomas/0000-0002-8838-8403; Kahonen, Mika/0000-0002-4510-7341; Hohn, Rene/0000-0003-2870-1469; Rahi, Jugnoo/0000-0002-5718-9209; Plomin, Robert/0000-0002-0756-3629; Bailey-Wilson, Joan/0000-0002-9153-2920; Williams, Cathy/0000-0002-9133-2021; Baird, Paul/0000-0002-1305-3502; Vitart, Veronique/0000-0002-4991-3797; Verhoeven, Virginie/0000-0001-7359-7862; Amin, Najaf/0000-0002-8944-1771; Makela, Kari-Matti/0000-0002-8318-8584; Kiss, Szilard/0000-0003-3433-8432; Portas, Laura/0000-0003-1789-1893; Khor, Chiea Chuen/0000-0002-1128-4729; Tai, E Shyong/0000-0003-2929-8966; Gillman, Matthew S./0000-0002-2340-6930; Guggenheim, Jeremy/0000-0001-5164-340X; Klaver, Caroline/0000-0002-2355-5258; Bergen, Arthur/0000-0002-6333-9576; Zeller, Tanja/0000-0003-3379-2641; Hammond, Christopher/0000-0002-3227-2620; Oexle, Konrad/0000-0001-7447-2252; Muller, Christian/0000-0002-9449-6865	Intramural NIH HHS Funding Source: Medline; Medical Research Council [MC_PC_U127561128, 4882, MC_U127584475, G9815508] Funding Source: Medline; NCATS NIH HHS [UL1 TR000041, UL1 TR001449] Funding Source: Medline; NEI NIH HHS [R01 EY020483, K08 EY022943, EY016379, 1K08EY022943‐01, P30EY11373, N01EY92109, R01 EY023196, R21EY015145, 1R01EY018246, R01EY03083, R01 EY018246, R01EY16482, R01 EY016482, P30 EY014800, N01EY22112, R01EY01824601, R01EY020483] Funding Source: Medline; NHLBI NIH HHS [N02HL64278, N01HC25195] Funding Source: Medline; NIDDK NIH HHS [N01 DK062204-A, N01‐DK‐6‐2204, R01 DK077510, R01 DK‐077510] Funding Source: Medline; Wellcome Trust [092731, WT083431MA, 090532, 076467, 083478, 076113, 085475B08Z, 08547508Z] Funding Source: Medline; Department of Health [SRF/01/010, CDF-2009-02-35] Funding Source: Medline; Chief Scientist Office [CZB/4/438, CZB/4/710] Funding Source: Medline; National Institute for Health Research [SRF/01/010] Funding Source: researchfish; Fight for Sight [1329/30] Funding Source: researchfish; MRC [MC_U127584475, MC_PC_U127561128] Funding Source: UKRI; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023196, R01EY018246, N01EY092109, R21EY015145, K08EY022943, R01EY020483, P30EY014800, R01EY016482, R01EY016379, R01EY003083, R01EY002294, P30EY011373] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK062204, R01DK077510, N01DK002204] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); Department of Health; Chief Scientist Office; National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abd-El-Barr MM, 2009, J NEUROPHYSIOL, V102, P1945, DOI 10.1152/jn.00142.2009; Beyer B, 2008, HUM MOL GENET, V17, P1738, DOI 10.1093/hmg/ddn064; Connaughton V, 1995, WEBVISION ORG RETINA; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002753; Fernandez-Medarde A, 2009, J NEUROCHEM, V110, P641, DOI 10.1111/j.1471-4159.2009.06162.x; Fogel BL, 2012, HUM MOL GENET, V21, P4171, DOI 10.1093/hmg/dds240; Gal A, 2011, AM J HUM GENET, V88, P382, DOI 10.1016/j.ajhg.2011.02.006; Gallardo ME, 2004, AM J MED GENET A, V129A, P92, DOI 10.1002/ajmg.a.30126; Hysi PG, 2010, NAT GENET, V42, P902, DOI 10.1038/ng.664; Li YJ, 2011, OPHTHALMOLOGY, V118, P368, DOI 10.1016/j.ophtha.2010.06.016; Li ZQ, 2011, HUM MOL GENET, V20, P2861, DOI 10.1093/hmg/ddr169; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; Mertz JR, 2000, EXP EYE RES, V70, P519, DOI 10.1006/exer.1999.0813; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; Nair KS, 2011, NAT GENET, V43, P579, DOI 10.1038/ng.813; Nakanishi H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000660; Orr A, 2011, MOL VIS, V17; Parker RO, 2010, EXP EYE RES, V91, P788, DOI 10.1016/j.exer.2010.08.013; Pattnaik BR, 2012, AM J PHYSIOL-CELL PH, V302, pC821, DOI 10.1152/ajpcell.00269.2011; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Shi Y, 2011, AM J HUM GENET, V88, P805, DOI 10.1016/j.ajhg.2011.04.022; SMITH EL, 1991, VISION RES, V31, P833, DOI 10.1016/0042-6989(91)90150-4; Smith TST, 2009, B WORLD HEALTH ORGAN, V87, P431, DOI 10.2471/BLT.08.055673; Solouki AM, 2010, NAT GENET, V42, P897, DOI 10.1038/ng.663; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tonini R, 1999, EUR J NEUROSCI, V11, P959, DOI 10.1046/j.1460-9568.1999.00504.x; Troilo D, 2006, INVEST OPHTH VIS SCI, V47, P1768, DOI 10.1167/iovs.05-0298; Verhoeven VJM, 2012, HUM GENET, V131, P1467, DOI 10.1007/s00439-012-1176-0; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wojciechowski R, 2011, CLIN GENET, V79, P301, DOI 10.1111/j.1399-0004.2010.01592.x; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, BRAIN RES, V1390, P70, DOI 10.1016/j.brainres.2011.03.017; Zhang XM, 2011, AM J PHYSIOL-CELL PH, V301, pC1017, DOI 10.1152/ajpcell.00185.2011; Zhang Y, 2012, INVEST OPHTH VIS SCI, V53, P6072, DOI 10.1167/iovs.12-9917	39	309	319	1	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2013	45	3					314	318		10.1038/ng.2554	http://dx.doi.org/10.1038/ng.2554			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099ZP	23396134	Green Accepted, Green Published, Green Submitted			2022-12-17	WOS:000315664800018
J	Gerdes, JM; Liu, Y; Zaghloul, NA; Leitch, CC; Lawson, SS; Kato, M; Beachy, PA; Beales, PL; Demartino, GN; Fisher, S; Badano, JL; Katsanis, N				Gerdes, Jantje M.; Liu, Yangfan; Zaghloul, Norann A.; Leitch, Carmen C.; Lawson, Shaneka S.; Kato, Masaki; Beachy, Philip A.; Beales, Philip L.; Demartino, George N.; Fisher, Shannon; Badano, Jose L.; Katsanis, Nicholas			Disruption of the basal body comprises proteasomal function and perturbs intracellular Wnt response	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; PLANAR CELL POLARITY; INTRAFLAGELLAR TRANSPORT PROTEINS; NEURAL-TUBE DEFECTS; BETA-CATENIN; LOOP-TAIL; TRANSCRIPTION FACTORS; CONVERGENT EXTENSION; SIGNALING PATHWAYS; MOUSE	Primary cilia and basal bodies are evolutionarily conserved organelles that mediate communication between the intracellular and extracellular environments. Here we show that bbs1, bbs4 and mkks ( also known as bbs6), which encode basal body proteins, are required for convergence and extension in zebrafish and interact with wnt11 and wnt5b. Suppression of bbs1, bbs4 and mkks transcripts results in stabilization of beta-catenin with concomitant upregulation of T-cell factor ( TCF)-dependent transcription in both zebrafish embryos and mammalian ciliated cells, a defect phenocopied by the silencing of the axonemal kinesin subunit KIF3A but not by chemical disruption of the cytoplasmic microtubule network. These observations are attributable partly to defective degradation by the proteasome; suppression of BBS4 leads to perturbed proteasomal targeting and concomitant accumulation of cytoplasmic beta-catenin. Cumulatively, our data indicate that the basal body is an important regulator of Wnt signal interpretation through selective proteolysis and suggest that defects in this system may contribute to phenotypes pathognomonic of human ciliopathies.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Univ Texas, Southwestern Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Inst Pasteur, Montevideo, Uruguay; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Stanford University; University of London; University College London; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Katsanis, N (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Fisher, Shannon/K-7351-2012; Katsanis, Nicholas/E-1837-2012; lawson, shaneka/AAV-1569-2021; Beales, Philip L/C-7367-2009; Gerdes, Jantje Mareike/M-9868-2014; Masaki, Kato/AAW-2603-2020	Gerdes, Jantje Mareike/0000-0001-6885-5441; Badano, Jose/0000-0002-0706-8652; Katsanis, Nicholas/0000-0002-2480-0171	Medical Research Council [G0801843] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; ITOH K, 2005, J BIOL, V4, P1; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kibar Z, 2001, GENOMICS, V72, P331, DOI 10.1006/geno.2000.6493; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marlow F, 2004, DEVELOPMENT, V131, P203, DOI 10.1242/dev.00915; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Nojima H, 2004, MECH DEVELOP, V121, P371, DOI 10.1016/j.mod.2004.02.003; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; OLSON DJ, 1994, CELL GROWTH DIFFER, V5, P197; ROSENBAUM JL, 1967, J CELL BIOL, V34, P345, DOI 10.1083/jcb.34.1.345; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; THISSE C, 1993, DEVELOPMENT, V119, P1203; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; Wigley WC, 1999, J CELL BIOL, V145, P481; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498	50	309	318	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1350	1360		10.1038/ng.2007.12	http://dx.doi.org/10.1038/ng.2007.12			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17906624				2022-12-17	WOS:000250575900019
J	Cabral, WA; Chang, W; Barnes, AM; Weis, M; Scott, MA; Leikin, S; Makareeva, E; Kuznetsova, NV; Rosenbaum, KN; Tifft, CJ; Bulas, DI; Kozma, C; Smith, PA; Eyre, DR; Marini, JC				Cabral, Wayne A.; Chang, Weizhong; Barnes, Aileen M.; Weis, MaryAnn; Scott, Melissa A.; Leikin, Sergey; Makareeva, Elena; Kuznetsova, Natalia V.; Rosenbaum, Kenneth N.; Tifft, Cynthia J.; Bulas, Dorothy I.; Kozma, Chahira; Smith, Peter A.; Eyre, David R.; Marini, Joan C.			Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta	NATURE GENETICS			English	Article							MEMBRANE-ASSOCIATED PROTEOGLYCAN; CARTILAGE-ASSOCIATED PROTEIN; COLLAGEN TRIPLE-HELIX; I COLLAGEN; RESIDUES; MUTATIONS; LEPRECAN; IDENTIFICATION; FIBRILS; DISEASE	A recessive form of severe osteogenesis imperfecta that is not caused by mutations in type I collagen has long been suspected. Mutations in human CRTAP (cartilage-associated protein) causing recessive bone disease have been reported. CRTAP forms a complex with cyclophilin B and prolyl 3-hydroxylase 1, which is encoded by LEPRE1 and hydroxylates one residue in type I collagen, alpha 1(I) Pro986. We present the first five cases of a new recessive bone disorder resulting from null LEPRE1 alleles; its phenotype overlaps with lethal/severe osteogenesis imperfecta but has distinctive features. Furthermore, a mutant allele from West Africa, also found in African Americans, occurs in four of five cases. All proband LEPRE1 mutations led to premature termination codons and minimal mRNA and protein. Proband collagen had minimal 3-hydroxylation of alpha 1(I) Pro986 but excess lysyl hydroxylation and glycosylation along the collagen helix. Proband collagen secretion was moderately delayed, but total collagen secretion was increased. Prolyl 3-hydroxylase 1 is therefore crucial for bone development and collagen helix formation.	NICHHD, Bione & Extracellular Matrix Branach, NIH, Bethesda, MD 20892 USA; Univ Washington, Orthopaed Res Labs, Seattle, WA 98195 USA; NICHHD, Sect Phys Biochem, NIH, Bethesda, MD 20892 USA; Childrens Natl Med Ctr, Washington, DC 20010 USA; Childrens Natl Med Ctr, Dept Diagnost Imaging & Radiol, Washington, DC 20010 USA; Georgetown Univ Hosp, Dept Pediat, Washington, DC 20007 USA; Shriners Hosp Children, Chicago, IL 60707 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Children's National Health System; Children's National Health System; Georgetown University	Marini, JC (corresponding author), NICHHD, Bione & Extracellular Matrix Branach, NIH, Bethesda, MD 20892 USA.	oidoc@helix.nih.gov	Leikin, Sergey/A-5518-2008; Makareeva, Elena/F-5183-2011	Leikin, Sergey/0000-0001-7095-0739; Makareeva, Elena/0000-0002-5815-0760; Barnes, Aileen/0000-0001-8021-4997	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008830] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008830, P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037318, R37AR037318, R01AR036794] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HD008830] Funding Source: Medline; NIAMS NIH HHS [R01 AR036794, R01 AR037318, R37 AR037318, AR37318] Funding Source: Medline; NICHD NIH HHS [HD22657, P01 HD022657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AITCHISON K, 1988, HUM GENET, V78, P233, DOI 10.1007/BF00291667; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Cabral WA, 2003, J BIOL CHEM, V278, P10006, DOI 10.1074/jbc.M212523200; DAW S, 1988, J MED GENET, V25, P275; FIETZEK PP, 1972, EUR J BIOCHEM, V30, P163, DOI 10.1111/j.1432-1033.1972.tb02083.x; Forlino A, 1997, BIOCHEM MOL MED, V62, P26, DOI 10.1006/bmme.1997.2620; Jarnum S, 2004, BIOCHEM BIOPH RES CO, V317, P342, DOI 10.1016/j.bbrc.2004.03.060; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; Kaul SC, 2000, ONCOGENE, V19, P3576, DOI 10.1038/sj.onc.1203696; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; Labuda M, 2002, BONE, V31, P19, DOI 10.1016/S8756-3282(02)00808-6; Marini JC, 2004, NELSON TXB PEDIAT, P2336; Mizuno K, 2004, J BIOL CHEM, V279, P282, DOI 10.1074/jbc.M308181200; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; ROYCE PM, 1985, BIOCHEM J, V230, P475, DOI 10.1042/bj2300475; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Tonachini L, 1999, CYTOGENET CELL GENET, V87, P191, DOI 10.1159/000015463; TORREBLANCO A, 1992, J BIOL CHEM, V267, P2650; TRYGGVASON K, 1979, BIOCHEM J, V183, P303, DOI 10.1042/bj1830303; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; WALLIS GA, 1993, J MED GENET, V30, P492, DOI 10.1136/jmg.30.6.492; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Ward LM, 2002, BONE, V31, P12, DOI 10.1016/S8756-3282(02)00790-1; Wassnehove-McCarthy DJ, 1999, J BIOL CHEM, V274, P25004, DOI 10.1074/jbc.274.35.25004; Wu J, 2006, EXP CELL RES, V312, P3485, DOI 10.1016/j.yexcr.2006.07.013	30	309	330	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					359	365		10.1038/ng1968	http://dx.doi.org/10.1038/ng1968			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17277775	Green Accepted			2022-12-17	WOS:000244480000018
J	Boutros, PC; Fraser, M; Harding, NJ; de Borja, R; Trudel, D; Lalonde, E; Meng, A; Hennings-Yeomans, PH; McPherson, A; Sabelnykova, VY; Zia, AM; Fox, NS; Livingstone, J; Shiah, YJ; Wang, JX; Beck, TA; Have, CL; Chong, T; Sam, M; Johns, J; Timms, L; Buchner, N; Wong, A; Watson, JD; Simmons, TT; P'ng, C; Zafarana, G; Nguyen, F; Luo, XM; Chu, KC; Prokopec, SD; Sykes, J; Dal Pra, A; Berlin, A; Brown, A; Chan-Seng-Yue, MA; Yousif, F; Denroche, RE; Chong, LC; Chen, GM; Jung, E; Fung, C; Starmans, MHW; Chen, H; Govind, SK; Hawley, J; D'Costa, A; Pintilie, M; Waggott, D; Hach, F; Lambin, P; Muthuswamy, LB; Cooper, C; Eeles, R; Neal, D; Tetu, B; Sahinalp, C; Stein, LD; Fleshner, N; Shah, SP; Collins, CC; Hudson, TJ; McPherson, JD; van der Kwast, T; Bristow, RG				Boutros, Paul C.; Fraser, Michael; Harding, Nicholas J.; de Borja, Richard; Trudel, Dominique; Lalonde, Emilie; Meng, Alice; Hennings-Yeomans, Pablo H.; McPherson, Andrew; Sabelnykova, Veronica Y.; Zia, Amin; Fox, Natalie S.; Livingstone, Julie; Shiah, Yu-Jia; Wang, Jianxin; Beck, Timothy A.; Have, Cherry L.; Chong, Taryne; Sam, Michelle; Johns, Jeremy; Timms, Lee; Buchner, Nicholas; Wong, Ada; Watson, John D.; Simmons, Trent T.; P'ng, Christine; Zafarana, Gaetano; Nguyen, Francis; Luo, Xuemei; Chu, Kenneth C.; Prokopec, Stephenie D.; Sykes, Jenna; Dal Pra, Alan; Berlin, Alejandro; Brown, Andrew; Chan-Seng-Yue, Michelle A.; Yousif, Fouad; Denroche, Robert E.; Chong, Lauren C.; Chen, Gregory M.; Jung, Esther; Fung, Clement; Starmans, Maud H. W.; Chen, Hanbo; Govind, Shaylan K.; Hawley, James; D'Costa, Alister; Pintilie, Melania; Waggott, Daryl; Hach, Faraz; Lambin, Philippe; Muthuswamy, Lakshmi B.; Cooper, Colin; Eeles, Rosalind; Neal, David; Tetu, Bernard; Sahinalp, Cenk; Stein, Lincoln D.; Fleshner, Neil; Shah, Sohrab P.; Collins, Colin C.; Hudson, Thomas J.; McPherson, John D.; van der Kwast, Theodorus; Bristow, Robert G.			Spatial genomic heterogeneity within localized, multifocal prostate cancer	NATURE GENETICS			English	Article							COPY-NUMBER ALTERATION; C-MYC; GENE; MUTATIONS; LANDSCAPE; GENERATION; EXPRESSION; RELAPSE; RECURRENCE; DISCOVERY	Herein we provide a detailed molecular analysis of the spatial heterogeneity of clinically localized, multifocal prostate cancer to delineate new oncogenes or tumor suppressors. We initially determined the copy number aberration (CNA) profiles of 74 patients with index tumors of Gleason score 7. Of these, 5 patients were subjected to whole-genome sequencing using DNA quantities achievable in diagnostic biopsies, with detailed spatial sampling of 23 distinct tumor regions to assess intraprostatic heterogeneity in focal genomics. Multifocal tumors are highly heterogeneous for single-nucleotide variants (SNVs), CNAs and genomic rearrangements. We identified and validated a new recurrent amplification of MYCL, which is associated with TP53 deletion and unique profiles of DNA damage and transcriptional dysregulation. Moreover, we demonstrate divergent tumor evolution in multifocal cancer and, in some cases, tumors of independent clonal origin. These data represent the first systematic relation of intraprostatic genomic heterogeneity to predicted clinical outcome and inform the development of novel biomarkers that reflect individual prognosis.	[Boutros, Paul C.; Harding, Nicholas J.; de Borja, Richard; Lalonde, Emilie; Hennings-Yeomans, Pablo H.; Sabelnykova, Veronica Y.; Zia, Amin; Fox, Natalie S.; Livingstone, Julie; Shiah, Yu-Jia; Wang, Jianxin; Beck, Timothy A.; Chong, Taryne; Sam, Michelle; Johns, Jeremy; Timms, Lee; Buchner, Nicholas; Wong, Ada; Watson, John D.; Simmons, Trent T.; P'ng, Christine; Nguyen, Francis; Luo, Xuemei; Chu, Kenneth C.; Prokopec, Stephenie D.; Brown, Andrew; Chan-Seng-Yue, Michelle A.; Yousif, Fouad; Denroche, Robert E.; Chong, Lauren C.; Chen, Gregory M.; Jung, Esther; Fung, Clement; Starmans, Maud H. W.; Chen, Hanbo; Govind, Shaylan K.; Hawley, James; D'Costa, Alister; Waggott, Daryl; Muthuswamy, Lakshmi B.; Stein, Lincoln D.; Hudson, Thomas J.; McPherson, John D.] Ontario Inst Canc Res, Toronto, ON, Canada; [Boutros, Paul C.; Lalonde, Emilie; Fox, Natalie S.; Bristow, Robert G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Boutros, Paul C.; Meng, Alice] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Fraser, Michael; Zafarana, Gaetano; Bristow, Robert G.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON, Canada; [Trudel, Dominique; Have, Cherry L.; van der Kwast, Theodorus] Univ Hlth Network, Toronto Gen Hosp, Dept Pathol & Lab Med, Toronto, ON, Canada; [McPherson, Andrew; Hach, Faraz; Sahinalp, Cenk] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; [Sykes, Jenna; Pintilie, Melania] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada; [Dal Pra, Alan; Berlin, Alejandro; Bristow, Robert G.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Lambin, Philippe] Maastricht Univ, Dept Radiotherapy, NL-6200 MD Maastricht, Netherlands; [Cooper, Colin; Eeles, Rosalind] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Cooper, Colin] Univ E Anglia, Dept Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Cooper, Colin] Univ E Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England; [Eeles, Rosalind] Royal Marsden Natl Hlth Serv NHS Fdn Trust, London, England; [Eeles, Rosalind] Royal Marsden Natl Hlth Serv NHS Fdn Trust, Sutton, England; [Neal, David] Canc Res UK Cambridge Res Inst, Urol Res Lab, Cambridge, England; [Neal, David] Univ Cambridge, Addenbrookes Hosp, Dept Surg Oncol, Cambridge CB2 2QQ, England; [Tetu, Bernard] Univ Laval, Dept Pathol, Quebec City, PQ, Canada; [Fleshner, Neil] Univ Hlth Network, Princess Margaret Canc Ctr, Div Urol, Toronto, ON, Canada; [Shah, Sohrab P.] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Shah, Sohrab P.] Univ British Columbia, Dept Comp Sci, Vancouver, BC V5Z 1M9, Canada; [Shah, Sohrab P.] British Columbia Canc Agcy Res Ctr, Vancouver, BC, Canada; [Collins, Colin C.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Collins, Colin C.] Vancouver Prostate Ctr, Lab Adv Genome Anal, Vancouver, BC, Canada	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Simon Fraser University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Maastricht University; University of London; Institute of Cancer Research - UK; University of East Anglia; University of East Anglia; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Cancer Research UK; CRUK Cambridge Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Laval University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Boutros, PC (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.	paul.boutros@oicr.on.ca; rob.bristow@rmp.uhn.on.ca	McPherson, John D/D-2633-2017; Dal Pra, Alan/AAN-9511-2020; wang, edwin/G-5372-2010; Hawley, James/E-6220-2017; Trudel, Dominique/AAS-4455-2020; Dal Pra, Alan/AAM-9352-2021; McPherson, Andrew W/J-6552-2015; Sahinalp, Suleyman Cenk/X-7843-2018	McPherson, John D/0000-0001-8049-9347; Hawley, James/0000-0003-4744-5552; Dal Pra, Alan/0000-0002-1648-6557; McPherson, Andrew W/0000-0002-5654-5101; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Nguyen, Francis/0000-0003-2521-450X; Boutros, Paul/0000-0003-0553-7520; Trudel, Dominique/0000-0001-9820-1772; Beck, Timothy/0000-0003-0145-3557; Livingstone, Julie/0000-0002-8424-3768; Chan-Seng-Yue, Michelle/0000-0003-3773-9354; Van der Kwast, Theodorus/0000-0001-8640-5786; Harding, Nicholas/0000-0001-5907-0773; Bristow, Robert/0000-0002-8553-9544; Lambin, Philippe/0000-0001-7961-0191; Hach, Faraz/0000-0003-1143-0172; Berlin, Alejandro/0000-0002-1880-6905; Eeles, Rosalind/0000-0002-3698-6241; Lalonde, Emilie/0000-0002-8573-1966; de Borja, Richard/0000-0002-8181-6348	Movember funds through Prostate Cancer Canada; Ontario Institute for Cancer Research; government of Ontario; Ontario Institute for Cancer Research through government of Ontario; Canadian Institutes of Health Research (CIHR); Princess Margaret Cancer Centre Foundation; Radiation Medicine Program Academic Enrichment Fund; Canadian Cancer Society Research Scientist Award; Prostate Cancer Canada; Movember Foundation [RS2014-01]; Terry Fox Research Institute New Investigator Award; Genome Canada through a Large-Scale Applied Project; Cancer Research UK [15007, 17528] Funding Source: researchfish	Movember funds through Prostate Cancer Canada; Ontario Institute for Cancer Research; government of Ontario; Ontario Institute for Cancer Research through government of Ontario; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Princess Margaret Cancer Centre Foundation(University of Toronto); Radiation Medicine Program Academic Enrichment Fund; Canadian Cancer Society Research Scientist Award; Prostate Cancer Canada; Movember Foundation; Terry Fox Research Institute New Investigator Award; Genome Canada through a Large-Scale Applied Project(Genome Canada); Cancer Research UK(Cancer Research UK)	The authors thank all members of the Boutros and Bristow laboratories for helpful suggestions. This study was conducted with the support of Movember funds through Prostate Cancer Canada and with the additional support of the Ontario Institute for Cancer Research, funded by the government of Ontario. This study was conducted with the support of the Ontario Institute for Cancer Research to P.C.B. through funding provided by the government of Ontario. This work has been funded by a Doctoral Fellowship from the Canadian Institutes of Health Research (CIHR) to E.L. The authors gratefully thank the Princess Margaret Cancer Centre Foundation and the Radiation Medicine Program Academic Enrichment Fund for support (to R.G.B.). R.G.B. is a recipient of a Canadian Cancer Society Research Scientist Award. This work was supported by Prostate Cancer Canada and is proudly funded by the Movember Foundation, grant RS2014-01. P.C.B. was supported by a Terry Fox Research Institute New Investigator Award and a CIHR New Investigator Award. This project was supported by Genome Canada through a Large-Scale Applied Project contract to P.C.B., S.P.S. and R. Morin.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkv1290, 10.1093/nar/gkx1095]; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Buyyounouski MK, 2012, J CLIN ONCOL, V30, P1857, DOI 10.1200/JCO.2011.35.1924; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cooper CS, 2015, NAT GENET, V47, P367, DOI 10.1038/ng.3221; Cortese R, 2012, HUM MOL GENET, V21, P3619, DOI 10.1093/hmg/dds192; D'Amico AV, 2003, J CLIN ONCOL, V21, P2163, DOI 10.1200/JCO.2003.01.075; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Djulbegovic M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4543; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fajardo KVF, 2012, HUM MUTAT, V33, P609, DOI 10.1002/humu.22033; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishkanian AS, 2009, PROSTATE, V69, P1091, DOI 10.1002/pros.20959; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lalonde E, 2014, LANCET ONCOL, V15, P1521, DOI 10.1016/S1470-2045(14)71021-6; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindberg J, 2013, EUR UROL, V63, P702, DOI 10.1016/j.eururo.2012.11.053; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Locke JA, 2012, PROSTATE, V72, P1295, DOI 10.1002/pros.22478; Locke JA, 2012, CLIN CANCER RES, V18, P308, DOI 10.1158/1078-0432.CCR-11-2147; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson A, 2012, GENOME RES, V22, P2250, DOI 10.1101/gr.136572.111; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mohler JL, 2010, J NATL COMPR CANC NE, V8, P145, DOI 10.6004/jnccn.2010.0010; Nichol AM, 2005, CANCER-AM CANCER SOC, V104, P891, DOI 10.1002/cncr.21257; O'Connor BD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S2; Olmos D, 2012, LANCET ONCOL, V13, P1114, DOI 10.1016/S1470-2045(12)70372-8; Ouedraogo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050653; Paris PL, 2004, HUM MOL GENET, V13, P1303, DOI 10.1093/hmg/ddh155; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; Penney KL, 2011, J CLIN ONCOL, V29, P2391, DOI 10.1200/JCO.2010.32.6421; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Ruijter ET, 1996, J PATHOL, V180, P295; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sangai T, 2012, CLIN CANCER RES, V18, P5816, DOI 10.1158/1078-0432.CCR-12-1141; Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027/MACHINEREADABLECITATION/RIS]; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; VILLERS A, 1992, CANCER, V70, P2313, DOI 10.1002/1097-0142(19921101)70:9<2313::AID-CNCR2820700917>3.0.CO;2-T; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/NMETH.1628, 10.1038/nmeth.1628]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Zafarana G, 2012, CANCER-AM CANCER SOC, V118, P4053, DOI 10.1002/cncr.26729; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	65	308	313	2	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2015	47	7					736	+		10.1038/ng.3315	http://dx.doi.org/10.1038/ng.3315			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CL6PW	26005866	Green Published			2022-12-17	WOS:000357090300010
J	Garcia-Closas, M; Couch, FJ; Lindstrom, S; Michailidouo, K; Schmidt, MK; Brook, MN; Orr, N; Rhie, SK; Riboli, E; Feigelson, HS; Le Marchand, L; Buring, JE; Eccles, D; Miron, P; Fasching, PA; Brauch, H; Chang-Claude, J; Carpenter, J; Godwin, AK; Nevanlinna, H; Giles, GG; Cox, A; Hopper, JL; Bolla, MK; Wang, Q; Dennis, J; Dicks, E; Howat, WJ; Schoof, N; Bojesen, SE; Lambrechts, D; Broeks, A; Andrulis, IL; Guenel, P; Burwinkel, B; Sawyer, EJ; Hollestelle, A; Fletcher, O; Winqvist, R; Brenner, H; Mannermaa, A; Hamann, U; Meindl, A; Lindblom, A; Zheng, W; Devillee, P; Goldberg, MS; Lubinski, J; Kristensen, V; Swerdlow, A; Anton-Culver, H; Doerk, T; Muir, K; Matsuo, K; Wu, AH; Radice, P; Teo, SH; Shu, XO; Blot, W; Kang, D; Hartman, M; Sangrajrang, S; Shen, CY; Southey, MC; Park, DJ; Hammet, F; Stone, J; Van't Veer, LJ; Rutgers, EJ; Lophatananon, A; Stewart-Brown, S; Siriwanarangsan, P; Peto, J; Schrauder, MG; Ekici, AB; Beckmann, MW; Silva, ID; Johnson, N; Warren, H; Tomlins, I; Kerin, MJ; Miller, N; Marme, F; Schneeweiss, A; Sohn, C; Truong, T; Laurent-Puig, P; Kerbrat, P; Nordestgaard, BG; Nielsen, SF; Flyger, H; Milne, RL; Perez, JIA; Menendez, P; Muller, H; Arndt, V; Stegmaier, C; Lichtner, P; Lochmann, M; Justenhoven, C; Ko, YD; Muranen, TA; Aittomaki, K; Blomqvist, C; Greco, D; Heikkinen, T; Ito, H; Iwata, H; Yatabe, Y; Antonenkova, NN; Margolin, S; Kataja, V; Kosma, VM; Hartikainen, JM; Balleine, R; Tseng, CC; Van den Berg, D; Stram, DO; Neven, P; Dieudonne, AS; Leunen, K; Rudolph, A; Nickels, S; Flesch-Janys, D; Peterlongo, P; Peissel, B; Bernard, L; Olson, JE; Wang, XS; Stevens, K; Severi, G; Baglietto, L; McLean, C; Coetzee, GA; Feng, Y; Henderson, BE; Schumacher, F; Bogdanova, NV; Labreche, F; Dumont, M; Yip, CH; Taib, NAM; Cheng, CY; Shrubsole, M; Long, JR; Pylkas, K; Jukkola-Vuorinen, A; Kauppila, S; Knight, JA; Glendon, G; Mulligan, AM; Tollenaar, RAEM; Seynaeve, CM; Kriege, M; Hooning, MJ; van den Ouweland, AMW; van Deurzen, CHM; Lu, W; Gao, YT; Cai, H; Balasubramanian, SP; Cross, SS; Reed, MWR; Signorello, L; Cai, QY; Shah, M; Miao, H; Chan, CW; Chia, KS; Jakubowska, A; Jaworska, K; Durda, K; Hsiung, CN; Wu, P; Yu, JC; Ashworth, A; Jones, M; Tessier, DC; Gonzalez-Neira, A; Pita, G; Alonso, MR; Vincent, D; Bacot, F; Ambrosone, CB; Bandera, EV; John, EM; Chen, GK; Hu, JJ; Rodriguez-Gil, JL; Bernstein, L; Press, MF; Ziegler, RG; Millikan, RM; Deming-Halverson, SL; Nyante, S; Ingles, SA; Waisfisz, Q; Tsimiklis, H; Makalic, E; Schmidt, D; Bui, M; Gibson, L; Muller-Myhsok, B; Schmutzler, RK; Hein, R; Dahmen, N; Beckmann, L; Aaltonen, K; Czene, K; Irwanto, A; Liu, JJ; Turnbull, C; Rahman, N; Meijers-Heijboer, H; Uitterlinden, AG; Rivadeneira, F; Olswold, C; Slager, S; Pilarski, R; Ademuyiwa, F; Konstantopoulou, I; Martin, NG; Montgomery, GW; Slamon, DJ; Rauh, C; Lux, MP; Jud, SM; Bruning, T; Weaver, J; Harma, P; Pathak, H; Tapper, W; Gerty, S; Durcan, L; Trichopoulos, D; Tumino, R; Peeters, PH; Kaaks, R; Campa, D; Canzian, F; Weiderpass, E; Johansson, M; Khaw, KT; Travis, R; Clavel-Chapelon, F; Kolonel, LN; Chen, C; Beck, A; Hankinson, SE; Berg, CD; Hoover, RN; Lissowska, J; Figueroa, JD; Chasman, DI; Gaudet, MM; Diver, WR; Willett, WC; Hunter, DJ; Simard, J; Benitez, J; Dunning, AM; Sherman, ME; Chenevix-Trench, G; Chanock, SJ; Hall, P; Pharoah, PDP; Vachon, C; Easton, DF; Haiman, CA; Kraft, P				Garcia-Closas, Montserrat; Couch, Fergus J.; Lindstrom, Sara; Michailidouo, Kyriaki; Schmidt, Marjanka K.; Brook, Mark N.; Orr, Nick; Rhie, Suhn Kyong; Riboli, Elio; Feigelson, Heather S.; Le Marchand, Loic; Buring, Julie E.; Eccles, Diana; Miron, Penelope; Fasching, Peter A.; Brauch, Hiltrud; Chang-Claude, Jenny; Carpenter, Jane; Godwin, Andrew K.; Nevanlinna, Heli; Giles, Graham G.; Cox, Angela; Hopper, John L.; Bolla, Manjeet K.; Wang, Qin; Dennis, Joe; Dicks, Ed; Howat, Will J.; Schoof, Nils; Bojesen, Stig E.; Lambrechts, Diether; Broeks, Annegien; Andrulis, Irene L.; Guenel, Pascal; Burwinkel, Barbara; Sawyer, Elinor J.; Hollestelle, Antoinette; Fletcher, Olivia; Winqvist, Robert; Brenner, Hermann; Mannermaa, Arto; Hamann, Ute; Meindl, Alfons; Lindblom, Annika; Zheng, Wei; Devillee, Peter; Goldberg, Mark S.; Lubinski, Jan; Kristensen, Vessela; Swerdlow, Anthony; Anton-Culver, Hoda; Doerk, Thilo; Muir, Kenneth; Matsuo, Keitaro; Wu, Anna H.; Radice, Paolo; Teo, Soo Hwang; Shu, Xiao-Ou; Blot, William; Kang, Daehee; Hartman, Mikael; Sangrajrang, Suleeporn; Shen, Chen-Yang; Southey, Melissa C.; Park, Daniel J.; Hammet, Fleur; Stone, Jennifer; Van't Veer, Laura J.; Rutgers, Emiel J.; Lophatananon, Artitaya; Stewart-Brown, Sarah; Siriwanarangsan, Pornthep; Peto, Julian; Schrauder, Michael G.; Ekici, Arif B.; Beckmann, Matthias W.; Silva, Isabel dos Santos; Johnson, Nichola; Warren, Helen; Tomlins, Ian; Kerin, Michael J.; Miller, Nicola; Marme, Federick; Schneeweiss, Andreas; Sohn, Christof; Therese Truong; Laurent-Puig, Pierre; Kerbrat, Pierre; Nordestgaard, Borge G.; Nielsen, Sune F.; Flyger, Henrik; Milne, Roger L.; Arias Perez, Jose Ignacio; Menendez, Primitiva; Mueller, Heiko; Arndt, Volker; Stegmaier, Christa; Lichtner, Peter; Lochmann, Magdalena; Justenhoven, Christina; Ko, Yon-Dschun; Muranen, Taru A.; Aittomaki, Kristiina; Blomqvist, Carl; Greco, Dario; Heikkinen, Tuomas; Ito, Hidemi; Iwata, Hiroji; Yatabe, Yasushi; Antonenkova, Natalia N.; Margolin, Sara; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.; Balleine, Rosemary; Tseng, Chiu-Chen; Van den Berg, David; Stram, Daniel O.; Neven, Patrick; Dieudonne, Anne-Sophie; Leunen, Karin; Rudolph, Anja; Nickels, Stefan; Flesch-Janys, Dieter; Peterlongo, Paolo; Peissel, Bernard; Bernard, Loris; Olson, Janet E.; Wang, Xianshu; Stevens, Kristen; Severi, Gianluca; Baglietto, Laura; McLean, Catriona; Coetzee, Gerhard A.; Feng, Ye; Henderson, Brian E.; Schumacher, Fredrick; Bogdanova, Natalia V.; Labreche, France; Dumont, Martine; Yip, Cheng Har; Taib, Nur Aishah Mohd; Cheng, Ching-Yu; Shrubsole, Martha; Long, Jirong; Pylkas, Katri; Jukkola-Vuorinen, Arja; Kauppila, Saila; Knight, Julia A.; Glendon, Gord; Mulligan, Anna Marie; Tollenaar, Robertus A. E. M.; Seynaeve, Caroline M.; Kriege, Mieke; Hooning, Maartje J.; van den Ouweland, Ans M. W.; van Deurzen, Carolien H. M.; Lu, Wei; Gao, Yu-Tang; Cai, Hui; Balasubramanian, Sabapathy P.; Cross, Simon S.; Reed, Malcolm W. R.; Signorello, Lisa; Cai, Qiuyin; Shah, Mitul; Miao, Hui; Chan, Ching Wan; Chia, Kee Seng; Jakubowska, Anna; Jaworska, Katarzyna; Durda, Katarzyna; Hsiung, Chia-Ni; Wu, Peiei; Yu, Jyh-Cherng; Ashworth, Alan; Jones, Michael; Tessier, Daniel C.; Gonzalez-Neira, Anna; Pita, Guillermo; Alonso, M. Rosario; Vincent, Daniel; Bacot, Francois; Ambrosone, Christine B.; Bandera, Elisa V.; John, Esther M.; Chen, Gary K.; Hu, Jennifer J.; Rodriguez-Gil, Jorge L.; Bernstein, Leslie; Press, Michael F.; Ziegler, Regina G.; Millikan, Robert M.; Deming-Halverson, Sandra L.; Nyante, Sarah; Ingles, Sue A.; Waisfisz, Quinten; Tsimiklis, Helen; Makalic, Enes; Schmidt, Daniel; Bui, Minh; Gibson, Lorna; Mueller-Myhsok, Bertram; Schmutzler, Rita K.; Hein, Rebecca; Dahmen, Norbert; Beckmann, Lars; Aaltonen, Kirsimari; Czene, Kamila; Irwanto, Astrid; Liu, Jianjun; Turnbull, Clare; Rahman, Nazneen; Meijers-Heijboer, Hanne; Uitterlinden, Andre G.; Rivadeneira, Fernando; Olswold, Curtis; Slager, Susan; Pilarski, Robert; Ademuyiwa, Foluso; Konstantopoulou, Irene; Martin, Nicholas G.; Montgomery, Grant W.; Slamon, Dennis J.; Rauh, Claudia; Lux, Michael P.; Jud, Sebastian M.; Bruning, Thomas; Weaver, JoEllen; Harma, Priyanka; Pathak, Harsh; Tapper, Will; Gerty, Sue; Durcan, Lorraine; Trichopoulos, Dimitrios; Tumino, Rosario; Peeters, Petra H.; Kaaks, Rudolf; Campa, Daniele; Canzian, Federico; Weiderpass, Elisabete; Johansson, Mattias; Khaw, Kay-Tee; Travis, Ruth; Clavel-Chapelon, Francoise; Kolonel, Laurence N.; Chen, Constance; Beck, Andy; Hankinson, Susan E.; Berg, Christine D.; Hoover, Robert N.; Lissowska, Jolanta; Figueroa, Jonine D.; Chasman, Daniel I.; Gaudet, Mia M.; Diver, W. Ryan; Willett, Walter C.; Hunter, David J.; Simard, Jacques; Benitez, Javier; Dunning, Alison M.; Sherman, Mark E.; Chenevix-Trench, Georgia; Chanock, Stephen J.; Hall, Per; Pharoah, Paul D. P.; Vachon, Celine; Easton, Douglas F.; Haiman, Christopher A.; Kraft, Peter		Gene ENvironm Interaction Breast; KConFab Investigators; Familial Breast Canc Study FBCS; Australian Breast Canc Tissue Bank	Genome-wide association studies identify four ER negative-specific breast cancer risk loci	NATURE GENETICS			English	Article							COMMON VARIANT; SUSCEPTIBILITY; EXPRESSION; ESTROGEN; GENE	Estrogen receptor (ER)-negative tumors represent 20-30% of all breast cancers, with a higher proportion occurring in younger women and women of African ancestry. The etiology and clinical behavior of ER-negative tumors are different from those of tumors expressing ER (ER positive), including differences in genetic predisposition. To identify susceptibility loci specific to ER-negative disease, we combined in a metaanalysis 3 genome-wide association studies of 4,193 ER-negative breast cancer cases and 35,194 controls with a series of 40 follow-up studies (6,514 cases and 41,455 controls), genotyped using a custom Illumina array, iCOGS, developed by the Collaborative Oncological Gene-environment Study (COGS). SNPs at four loci, 1q32.1 (MDM4, P= 2.1 x 10(-12) and LGR6, P = 1.4 x 10(-8)), 2p24.1 (P = 4.6 x 10(-8)) and 16q12.2 (FTO, P = 4.0 x 10(-8)), were associated with ER-negative but not ER-positive breast cancer (P> 0.05). These findings provide further evidence for distinct etiological pathways associated with invasive ER-positive and ER-negative breast cancers.	[Garcia-Closas, Montserrat; Brook, Mark N.; Swerdlow, Anthony; Jones, Michael; Turnbull, Clare; Rahman, Nazneen] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Garcia-Closas, Montserrat; Orr, Nick; Fletcher, Olivia; Johnson, Nichola; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Couch, Fergus J.; Olson, Janet E.; Wang, Xianshu; Stevens, Kristen; Olswold, Curtis; Slager, Susan; Vachon, Celine] Mayo Clin, Coll Med, Rochester, MN USA; [Lindstrom, Sara; Trichopoulos, Dimitrios; Chen, Constance; Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Michailidouo, Kyriaki; Bolla, Manjeet K.; Wang, Qin; Dennis, Joe; Dicks, Ed; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Schmidt, Marjanka K.; Broeks, Annegien; Van't Veer, Laura J.; Rutgers, Emiel J.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; [Rhie, Suhn Kyong; Wu, Anna H.; Tseng, Chiu-Chen; Van den Berg, David; Stram, Daniel O.; Coetzee, Gerhard A.; Feng, Ye; Henderson, Brian E.; Schumacher, Fredrick; Chen, Gary K.; Ingles, Sue A.; Haiman, Christopher A.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Feigelson, Heather S.] Kaiser Permanente, Inst Hlth Res, Denver, CO USA; [Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; [Buring, Julie E.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Eccles, Diana; Tapper, Will; Gerty, Sue; Durcan, Lorraine] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Miron, Penelope] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Fasching, Peter A.; Schrauder, Michael G.; Beckmann, Matthias W.; Rauh, Claudia; Lux, Michael P.; Jud, Sebastian M.] Univ Breast Ctr Franconia, Dept Gynecol & Obstet, Univ Hosp Erlangen, Erlangen, Germany; [Fasching, Peter A.; Slamon, Dennis J.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Brauch, Hiltrud; Justenhoven, Christina] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Brauch, Hiltrud; Justenhoven, Christina] Univ Tubingen, Tubingen, Germany; [Chang-Claude, Jenny; Rudolph, Anja; Nickels, Stefan; Hein, Rebecca; Kaaks, Rudolf; Campa, Daniele; Canzian, Federico] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Carpenter, Jane] Univ Sydney, Westmead Millennium Inst, Australian Breast Canc Tissue Bank, Westmead, NSW 2145, Australia; [Godwin, Andrew K.; Pathak, Harsh] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Nevanlinna, Heli; Muranen, Taru A.; Greco, Dario; Heikkinen, Tuomas; Aaltonen, Kirsimari] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Nevanlinna, Heli; Muranen, Taru A.; Greco, Dario; Heikkinen, Tuomas; Aaltonen, Kirsimari] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Giles, Graham G.; Severi, Gianluca; Baglietto, Laura] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Giles, Graham G.; Makalic, Enes; Schmidt, Daniel; Bui, Minh] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Cox, Angela; Balasubramanian, Sabapathy P.; Reed, Malcolm W. R.] Univ Sheffield, Dept Oncol, Canc Res UK Yorkshire Canc Res Sheffield Canc Res, Sheffield, S Yorkshire, England; [Hopper, John L.; Stone, Jennifer; Severi, Gianluca; Baglietto, Laura; Makalic, Enes; Schmidt, Daniel; Bui, Minh] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Howat, Will J.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Schoof, Nils; Czene, Kamila; Weiderpass, Elisabete; Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Univ Copenhagen, Dept Clin Biochem, Herlev Hosp, Copenhagen Gen Populat Study,Copenhagen Univ Hosp, Copenhagen, Denmark; [Lambrechts, Diether] VIB, VRC, Louvain, Belgium; [Lambrechts, Diether] Katholieke Univ Leuven, Dept Oncol, Louvain, Belgium; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Andrulis, Irene L.; Knight, Julia A.; Glendon, Gord] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ontario Canc Genet Network, Fred A Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; [Guenel, Pascal; Therese Truong; Clavel-Chapelon, Francoise] Univ Paris Sud, UMRS 1018, Villejuif, France; [Guenel, Pascal; Therese Truong; Clavel-Chapelon, Francoise] Environm Epidemiol Canc, INSERM, Natl Inst Hlth & Med Res, CESP Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Burwinkel, Barbara; Marme, Federick; Schneeweiss, Andreas; Sohn, Christof] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Burwinkel, Barbara] DKFZ, Mol Epidemiol Grp, Heidelberg, Germany; [Sawyer, Elinor J.] Kings Coll London, Div Canc Studies, Natl Inst Hlth Res NIHR Comprehens Biomed Res Ctr, Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, London WC2R 2LS, England; [Hollestelle, Antoinette; Seynaeve, Caroline M.; Kriege, Mieke; Hooning, Maartje J.] Erasmus Univ, Med Ctr, Dept Med Oncol, Daniel Den Hoed Canc Ctr, Rotterdam, Netherlands; [Winqvist, Robert; Pylkas, Katri] Univ Oulu, Lab Canc Genet & Tumor Biol, Dept Clin Genet, Bioctr Oulu,Oulu Univ Hosp, Oulu, Finland; [Brenner, Hermann; Mueller, Heiko; Arndt, Volker] DKFZ, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Mannermaa, Arto; Kosma, Veli-Matti; Hartikainen, Jaana M.] Kuopio Univ Hosp, Dept Clin Pathol, Imaging Ctr, SF-70210 Kuopio, Finland; [Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.] Inst Clin Med Pathol & Forens Med, Sch Med, Kuopio, Finland; [Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.] Univ Eastern Finland, Bioctr Kuopio, Canc Ctr Eastern Finland, Kuopio, Finland; [Hamann, Ute] DKFZ, Heidelberg, Germany; [Meindl, Alfons] Tech Univ Munich, Div Gynaecol Tumor Genet, Clin Gynaecol & Obstet, D-80290 Munich, Germany; [Meindl, Alfons; Lochmann, Magdalena] Tech Univ Munich, Div Gynaecol & Obstet, D-80290 Munich, Germany; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Zheng, Wei; Shu, Xiao-Ou; Blot, William; Shrubsole, Martha; Long, Jirong; Cai, Hui; Signorello, Lisa; Deming-Halverson, Sandra L.] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med,Vanderbilt Epidemiol Ctr,Vanderbilt Ingr, Nashville, TN 37212 USA; [Devillee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Devillee, Peter; van Deurzen, Carolien H. M.] Erasmus Univ, Med Ctr, Dept Pathol, Rotterdam, Netherlands; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goldberg, Mark S.; Cai, Qiuyin] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; [Lubinski, Jan; Jakubowska, Anna; Jaworska, Katarzyna; Durda, Katarzyna] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Kristensen, Vessela] Radiumhospitalet, Oslo Univ Hosp, Inst Canc Res, Dept Genet, Oslo, Norway; [Kristensen, Vessela] Univ Oslo, Fac Med, Fac Div Ahus, Oslo, Norway; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Doerk, Thilo; Bogdanova, Natalia V.] Hannover Med Sch, Dept Obstet & Gynaecol, Hannover, Germany; [Muir, Kenneth; Lophatananon, Artitaya; Stewart-Brown, Sarah] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Matsuo, Keitaro; Ito, Hidemi] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Radice, Paolo; Peterlongo, Paolo] Fdn IRCCS Ist Nazl Tumori INT, Unit Mol Bases Genet Risk & Genet Testing, Dept Prevent & Predict Med, Milan, Italy; [Radice, Paolo; Peterlongo, Paolo] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Teo, Soo Hwang] Sime Darby Med Ctr, Canc Res Initiat Fdn, Subang Jaya, Malaysia; [Teo, Soo Hwang] Univ Malaya, Canc Res Inst, Kuala Lumpur, Malaysia; [Teo, Soo Hwang; Yip, Cheng Har; Taib, Nur Aishah Mohd] Univ Malaya, Canc Res Inst, Breast Canc Res Unit, Kuala Lumpur, Malaysia; [Blot, William] Int Epidemiol Inst, Rockville, MD USA; [Kang, Daehee] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Hartman, Mikael; Cheng, Ching-Yu] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Hartman, Mikael; Cheng, Ching-Yu; Miao, Hui; Chia, Kee Seng] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Sangrajrang, Suleeporn] Natl Canc Inst, Bangkok, Thailand; [Shen, Chen-Yang] China Med Univ, Coll Publ Hlth, Taichong, Taiwan; [Shen, Chen-Yang; Hsiung, Chia-Ni] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Southey, Melissa C.; Park, Daniel J.; Hammet, Fleur] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Siriwanarangsan, Pornthep] Minist Publ Hlth, Bangkok, Thailand; [Peto, Julian; Silva, Isabel dos Santos; Warren, Helen; Gibson, Lorna] London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Dept, London WC1, England; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Erlangen, Germany; [Tomlins, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Tomlins, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Kerin, Michael J.; Miller, Nicola] Univ Hosp, Inst Clin Sci, Dept Surg, Galway, Ireland; [Kerin, Michael J.; Miller, Nicola] Natl Univ Ireland, Galway, Ireland; [Marme, Federick; Schneeweiss, Andreas] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany; [Laurent-Puig, Pierre] Univ Paris Sorbonne Cite, INSERM, UMRS 775, Paris, France; [Kerbrat, Pierre] Ctr Eugene Marquis, Dept Med Oncol, Rennes, France; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, Copenhagen, Denmark; [Milne, Roger L.] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Genet & Mol Epidemiol Grp, Madrid, Spain; [Arias Perez, Jose Ignacio] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo, Spain; [Menendez, Primitiva] Hosp Monte Naranco, Serv Anat Patol, Oviedo, Spain; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany; [Lichtner, Peter] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Lichtner, Peter] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Human Genet, Neuherberg, Germany; [Ko, Yon-Dschun] Johanniter Krankenhaus, Evangel Kliniken Bonn, Dept Internal Med, Bonn, Germany; [Aittomaki, Kristiina; Aaltonen, Kirsimari] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Blomqvist, Carl; Aaltonen, Kirsimari] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Nagoya, Aichi 464, Japan; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi 464, Japan; [Antonenkova, Natalia N.] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland; [Balleine, Rosemary] Univ Sydney, Westmead Millennium Inst Med Res, Sydney, NSW 2006, Australia; [Neven, Patrick; Dieudonne, Anne-Sophie; Leunen, Karin] Katholieke Univ Leuven, Dept Oncol, Univ Hosp Gasthuisberg, Multidisciplinary Breast Ctr, Louvain, Belgium; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Dept Canc Epidemiol Clin Canc Registry, Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Peissel, Bernard] Fdn IRCCS INT, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy; [Wang, Xianshu] Ist Europeo Oncol, Dept Expt Oncol, Milan, Italy; [Bernard, Loris] Cogentech Canc Genet Test Lab, Milan, Italy; [Wang, Xianshu] Mayo Clin, Div Expt Pathol, Dept Lab Med & Pathol, Rochester, MN USA; [McLean, Catriona] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic, Australia; [Coetzee, Gerhard A.] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA 90033 USA; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, Hannover, Germany; [Labreche, France; Kolonel, Laurence N.] Univ Montreal, Dept Med Sociale & Prevent, Dept Sante Environm & Sante Travail, Montreal, PQ, Canada; [Dumont, Martine; Simard, Jacques] CHU Quebec, Canc Genom Lab, Quebec City, PQ, Canada; [Dumont, Martine; Simard, Jacques] Univ Laval, Quebec City, PQ, Canada; [Cheng, Ching-Yu] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore; [Jukkola-Vuorinen, Arja] Univ Oulu, Oulu Univ Hosp, Dept Oncol, Oulu, Finland; [Kauppila, Saila] Univ Oulu, Dept Pathol, Oulu Univ Hosp, Oulu, Finland; [Knight, Julia A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Knight, Julia A.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mulligan, Anna Marie] St Michaels Hosp, Dept Lab Med, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Tollenaar, Robertus A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands; [van den Ouweland, Ans M. W.] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Lu, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Gao, Yu-Tang] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Cross, Simon S.] Univ Sheffield, Acad Unit Pathol, Dept Neurosci, Sheffield, S Yorkshire, England; [Shah, Mitul; Dunning, Alison M.; Pharoah, Paul D. P.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Chan, Ching Wan] Natl Univ Hlth Syst, Dept Surg, Singapore, Singapore; [Wu, Peiei] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei, Taiwan; [Yu, Jyh-Cherng] Triserv Gen Hosp, Dept Surg, Taipei, Taiwan; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois] McGill Univ, Montreal, PQ, Canada; [Tessier, Daniel C.; Vincent, Daniel; Bacot, Francois] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Gonzalez-Neira, Anna; Pita, Guillermo; Alonso, M. Rosario; Benitez, Javier] CNIO, Human Canc Genet Programme, Human Genotyping Unit CEGEN, Madrid, Spain; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Bandera, Elisa V.] Canc Inst New Jersey, New Brunswick, NJ USA; [John, Esther M.] Canc Prevent Inst Calif, Fremont, CA USA; [John, Esther M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Epidemiol,Stanford Canc Inst, Stanford, CA 94305 USA; [Hu, Jennifer J.; Rodriguez-Gil, Jorge L.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Hu, Jennifer J.; Rodriguez-Gil, Jorge L.] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Bernstein, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Div Canc Etiol, Duarte, CA USA; [Press, Michael F.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Ziegler, Regina G.; Hoover, Robert N.; Figueroa, Jonine D.; Sherman, Mark E.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Epidemiol & Biostat Program, Bethesda, MD 20892 USA; [Millikan, Robert M.; Nyante, Sarah] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Waisfisz, Quinten; Meijers-Heijboer, Hanne] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Sect Oncogenet, Amsterdam, Netherlands; [Tsimiklis, Helen] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic, Australia; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, Stat Genet Res Grp, D-80804 Munich, Germany; [Schmutzler, Rita K.] Univ Hosp, Ctr Hereditary Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp, Ctr Integrated Oncol, Cologne, Germany; [Hein, Rebecca] Univ Cologne, Dept Child & Adolescent Psychiat & Psychotherapy, PMV Primarmed Versorgung Res Grp, D-50931 Cologne, Germany; [Dahmen, Norbert] Johannes Gutenberg Univ Mainz, Dept Psychiat, Mainz, Germany; [Beckmann, Lars] Inst Qual & Efficiency Hlth Care IQWiG, Cologne, Germany; [Irwanto, Astrid; Liu, Jianjun] Genome Inst Singapore, Human Genet Div, Singapore, Singapore; [Uitterlinden, Andre G.; Rivadeneira, Fernando] Erasmus MC, Dept Internal Med & Epidemiol, Rotterdam, Netherlands; [Pilarski, Robert] Ohio State Univ, Dept Internal Med, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Ademuyiwa, Foluso] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Konstantopoulou, Irene] Natl Ctr Sci Res Demokritos, Inst Radioisotopes & Radiodiagnost Prod IRRP, Mol Diagnost Lab, Athens, Greece; [Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, QIMR GWAS Collect, Brisbane, Qld 4006, Australia; [Slamon, Dennis J.] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90024 USA; [Bruning, Thomas] Inst Prevent & Occupat Med German Social Accident, Bochum, Germany; [Weaver, JoEllen] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Harma, Priyanka] Univ Kansas, Med Ctr, Dept Internal Med, Div Hematol & Oncol, Kansas City, KS USA; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Trichopoulos, Dimitrios] Hellen Hlth Fdn, Athens, Greece; [Tumino, Rosario] Civile MPArezzo Hosp, Canc Registry, Histopathol Unit, Ragusa, Italy; [Peeters, Petra H.] Univ Med Ctr Utrecht, Julius Ctr, Utrecht, Netherlands; [Weiderpass, Elisabete] Univ Tromso, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Folkhalsan Res Canc Ctr, Helsinki, Finland; [Weiderpass, Elisabete] Canc Registry Norway, Oslo, Norway; [Johansson, Mattias] World Hlth Org, Int Agcy Res Canc, Genet Epidemiol Grp, Lyon, France; [Khaw, Kay-Tee] Univ Cambridge, Clin Gerontol Unit, Cambridge, England; [Travis, Ruth] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Beck, Andy] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Beck, Andy] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Hankinson, Susan E.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Div Biostat & Epidemiol, Amherst, MA 01003 USA; [Hankinson, Susan E.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Berg, Christine D.] NCI, Div Canc Prevent, Bethesda, MD 20892 USA; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Gaudet, Mia M.; Diver, W. Ryan] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Benitez, Javier] CNIO, Human Genet Grp, Madrid, Spain; [Benitez, Javier] Ctr Invest Red Enfermedades Raras CIBERER, Madrid, Spain; [Chenevix-Trench, Georgia] Queensland Inst Med Res, Dept Genet, Brisbane, Qld 4006, Australia	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Mayo Clinic; Harvard University; Harvard T.H. Chan School of Public Health; University of Cambridge; Netherlands Cancer Institute; University of Southern California; Imperial College London; Kaiser Permanente; Cancer Research Center of Hawaii; University of Hawaii System; Harvard University; Brigham & Women's Hospital; University of Southampton; Harvard University; Dana-Farber Cancer Institute; University of Erlangen Nuremberg; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Sydney; Westmead Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Cancer Council Victoria; University of Melbourne; University of Sheffield; University of Melbourne; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Karolinska Institutet; University of Copenhagen; Herlev & Gentofte Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Oulu; Helmholtz Association; German Cancer Research Center (DKFZ); Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; Technical University of Munich; Karolinska Institutet; Vanderbilt University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; McGill University; McGill University; Royal Victoria Hospital; Pomeranian Medical University; University of Oslo; University of Oslo; University of California System; University of California Irvine; Hannover Medical School; University of Warwick; University of Manchester; Aichi Cancer Center; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; Universiti Malaya; Universiti Malaya; Seoul National University (SNU); National University of Singapore; National University of Singapore; National Cancer Institute - Thailand; China Medical University Taiwan; Academia Sinica - Taiwan; University of Melbourne; Ministry of Public Health - Thailand; University of London; London School of Hygiene & Tropical Medicine; University of Erlangen Nuremberg; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Eugene Marquis; University of Copenhagen; Herlev & Gentofte Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Aichi Cancer Center; Aichi Cancer Center; Karolinska Institutet; Kuopio University Hospital; University of Eastern Finland; University of Sydney; KU Leuven; University Hospital Leuven; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; IRCCS European Institute of Oncology (IEO); Mayo Clinic; Florey Institute of Neuroscience & Mental Health; University of Southern California; Hannover Medical School; Universite de Montreal; Laval University; Laval University; National University of Singapore; Singapore National Eye Center; University of Oulu; University of Oulu; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Shanghai Center for Disease Control & Prevention; Shanghai Jiao Tong University; University of Sheffield; University of Cambridge; National University of Singapore; Academia Sinica - Taiwan; Tri-Service General Hospital; McGill University; Centro Nacional de Investigaciones Oncologicas (CNIO); Roswell Park Cancer Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Cancer Prevention Institute of California; Stanford Cancer Institute; Stanford University; University of Miami; University of Miami; City of Hope; Beckman Research Institute of City of Hope; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; Vrije Universiteit Amsterdam; University of Melbourne; Max Planck Society; University of Cologne; University of Cologne; University of Cologne; Johannes Gutenberg University of Mainz; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Erasmus University Rotterdam; Erasmus MC; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Roswell Park Cancer Institute; National Centre of Scientific Research "Demokritos"; QIMR Berghofer Medical Research Institute; University of California System; University of California Los Angeles; Ruhr University Bochum; Fox Chase Cancer Center; University of Kansas; University of Kansas Medical Center; Academy of Athens; Civile M.P. Arezzo Hospital; Utrecht University; Utrecht University Medical Center; UiT The Arctic University of Tromso; Folkhalsan Research Center; University of Oslo; World Health Organization; International Agency for Research on Cancer (IARC); University of Cambridge; University of Oxford; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; American Cancer Society; Harvard University; Harvard T.H. Chan School of Public Health; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; QIMR Berghofer Medical Research Institute	Garcia-Closas, M (corresponding author), Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England.	montse.garciaclosas@icr.ac.uk	Weiderpass, Elisabete/AAP-2747-2021; Guenel, Pascal/AAS-7688-2021; Berg, Christine/K-1047-2014; Miller, Nicola/F-4009-2018; Andrulis, Irene L./E-7267-2013; Flyger, Henrik/AAM-6494-2021; Laurent-Puig, Pierre/K-3641-2019; coetzee, Gerhard/AAT-6203-2020; Baglietto, Laura/AAB-9051-2019; Brüning, Thomas/G-8120-2015; Khaw, Kay-Tee/AAZ-3209-2021; Coetzee, Gerhard/AAG-8439-2019; Stone, Jennifer/AAS-3805-2020; Pharoah, Paul/V-6658-2019; Guenel, Pascal/H-3728-2018; Liu, Jianjun/AAK-4989-2020; Campa, Daniele/K-1617-2016; Margolin, Sara/AAX-9034-2020; Bernard, Loris/K-5953-2014; Severi, Gianluca/Q-1824-2019; zhang, weihua/GXV-1334-2022; Lu, Wei/AAE-2921-2022; Peissel, Bernard/E-8187-2017; Canzian, Federico/I-2804-2014; laurent-puig, pierre/B-2226-2013; Purrington, Kristen/AAN-6494-2021; Muranen, Taru/AAC-8418-2019; Lissowska, Jolanta/AAH-3252-2020; Gao, Y./GWZ-3665-2022; Garcia-Closas, Montserrat/F-3871-2015; Gonzalez-Neira, Anna/C-5791-2015; Weiderpass, Elisabete/M-4029-2016; Arndt, Volker/B-4999-2014; /AAM-5330-2020; Jud, Sebastian Michael/G-2752-2010; Figueroa, Jonine/AAG-1065-2022; truong, therese/A-2837-2013; Bandera, Elisa V/M-4169-2014; Eccles, Diana/K-6327-2019; Reed, Malcolm Walter/AAG-9219-2020; Brenner, Hermann/ABE-6383-2020; Lambrechts, Diether/AAJ-3167-2020; Peterlongo, Paolo/Q-4717-2018; Cheng, Ching-Yu/Y-2229-2019; Teo, Soo-hwang/H-2353-2014; Jorge L. Rodriguez-Gil, D.Phil/AAD-3523-2020; Verdrengh, Evelien/H-4571-2012; Pilarski, Robert/X-3256-2019; Arndt, Volker/AAI-7282-2020; Cheng, Ching-Yu/K-7017-2013; Chenevix-Trench, Georgia/AAV-2014-2020; Jakubowska, Anna/O-8050-2014; Ekici, Arif B/C-3971-2013; Hartikainen, Jaana M/E-6256-2015; Rivadeneira, Fernando/O-5385-2015; Figueroa, Jonine/AFK-2752-2022; Turnbull, Clare/AAA-6596-2019; gao, yi/HCI-8298-2022; Yip, Cheng-Har/B-1909-2010; Van Den Berg, David J/G-8598-2017; Brenner, Hermann/B-4627-2017; Rutgers, Emiel J T/C-5934-2015; Clavel-Chapelon, Francoise/G-6733-2014; Michailidou, Kyriaki/ABD-5122-2020; Montgomery, Grant W/B-7148-2008; Greco, Dario/T-7113-2019; Gao, Yu/HGE-1937-2022; Radice, Paolo/O-3119-2013; Schumacher, Fredrick/R-6043-2019; Matsuo, Keitaro/H-6758-2019; Martin, Nicholas/R-9235-2019; Johansson, Mattias/ABF-3365-2020; Kerin, Michael J/D-6748-2013; Bogdanova, Natalia V./Y-2205-2019; YATABE, Yasushi/J-6461-2014; Knight, Julia/A-6843-2012; balasubramanian, saba prakash/H-2830-2019; Pilarski, Robert/E-3871-2011; Chan, Ching Wan/C-7606-2011; Figueroa, Jonine/GWD-1322-2022; Knight, Julia/R-5617-2019; Zheng, Wei/O-3351-2013; Dörk, Thilo/J-8620-2012; Taib, Nur Aishah Mohd/B-2370-2010; Schmidt, Marjanka K/G-9058-2011; Nordestgaard, Borge Gronne/ABF-1310-2020; Bujan, Pablo Menendez/W-3736-2017; Shrubsole, Martha J/K-5052-2015; Severi, Gianluca/H-3774-2018; Fasching, Peter A/ABH-9912-2020; Diver, Ryan/AAG-3469-2019; Garcia-Closas, Montserrat/AAZ-6930-2021; Hartman, Mikael/B-4324-2011; Konstantopoulou, Irene/B-5309-2009; Rahman, Nazneen/D-2802-2013	Weiderpass, Elisabete/0000-0003-2237-0128; Guenel, Pascal/0000-0002-8359-518X; Miller, Nicola/0000-0002-5416-7047; Laurent-Puig, Pierre/0000-0001-8475-5459; Brüning, Thomas/0000-0001-9560-5464; Pharoah, Paul/0000-0001-8494-732X; Guenel, Pascal/0000-0002-8359-518X; Liu, Jianjun/0000-0002-3255-3019; Campa, Daniele/0000-0003-3220-9944; Severi, Gianluca/0000-0001-7157-419X; Lu, Wei/0000-0002-4150-8674; Peissel, Bernard/0000-0001-9233-3571; laurent-puig, pierre/0000-0001-8475-5459; Purrington, Kristen/0000-0002-5710-1692; Muranen, Taru/0000-0002-5895-1808; Lissowska, Jolanta/0000-0003-2695-5799; Garcia-Closas, Montserrat/0000-0003-1033-2650; Gonzalez-Neira, Anna/0000-0002-5421-2020; Weiderpass, Elisabete/0000-0003-2237-0128; Arndt, Volker/0000-0001-9320-8684; Jud, Sebastian Michael/0000-0002-8894-2785; Figueroa, Jonine/0000-0002-5100-623X; truong, therese/0000-0002-2943-6786; Bandera, Elisa V/0000-0002-8789-2755; Eccles, Diana/0000-0002-9935-3169; Reed, Malcolm Walter/0000-0001-7442-2132; Brenner, Hermann/0000-0002-6129-1572; Lambrechts, Diether/0000-0002-3429-302X; Peterlongo, Paolo/0000-0001-6951-6855; Cheng, Ching-Yu/0000-0003-0655-885X; Jorge L. Rodriguez-Gil, D.Phil/0000-0002-1125-1281; Arndt, Volker/0000-0001-9320-8684; Cheng, Ching-Yu/0000-0003-0655-885X; Chenevix-Trench, Georgia/0000-0002-1878-2587; Jakubowska, Anna/0000-0002-5650-0501; Ekici, Arif B/0000-0001-6099-7066; Hartikainen, Jaana M/0000-0001-8267-1905; Rivadeneira, Fernando/0000-0001-9435-9441; Figueroa, Jonine/0000-0002-5100-623X; Van Den Berg, David J/0000-0002-5404-5218; Brenner, Hermann/0000-0002-6129-1572; Michailidou, Kyriaki/0000-0001-7065-1237; Montgomery, Grant W/0000-0002-4140-8139; Greco, Dario/0000-0001-9195-9003; Radice, Paolo/0000-0001-6298-4111; Schumacher, Fredrick/0000-0002-3073-7463; Matsuo, Keitaro/0000-0003-1761-6314; Martin, Nicholas/0000-0003-4069-8020; YATABE, Yasushi/0000-0003-1788-559X; balasubramanian, saba prakash/0000-0001-5953-2843; Chan, Ching Wan/0000-0002-9250-1296; Figueroa, Jonine/0000-0002-5100-623X; Knight, Julia/0000-0002-7610-7635; Zheng, Wei/0000-0003-1226-070X; Dörk, Thilo/0000-0002-9458-0282; Taib, Nur Aishah Mohd/0000-0001-8419-0478; Schmidt, Marjanka K/0000-0002-2228-429X; Bujan, Pablo Menendez/0000-0001-9372-1007; Shrubsole, Martha J/0000-0002-5591-7575; Severi, Gianluca/0000-0001-7157-419X; Fasching, Peter A/0000-0003-4885-8471; Diver, Ryan/0000-0002-5418-9000; Garcia-Closas, Montserrat/0000-0003-1033-2650; Giles, Graham/0000-0003-4946-9099; Swerdlow, Anthony/0000-0001-5550-4159; Pylkas, Katri/0000-0002-2449-0521; Bui, Minh/0000-0002-9099-6870; Hollestelle, Antoinette/0000-0003-1166-1966; Southey, Melissa/0000-0002-6313-9005; Margolin, Sara/0000-0002-5526-5570; Blomqvist, Carl/0000-0003-3041-1938; Lux, Michael Patrick/0000-0002-2781-2178; Hartman, Mikael/0000-0001-5726-9965; Lubinski, Jan/0000-0003-2931-3003; Brauch, Hiltrud/0000-0001-7531-2736; ADEMUYIWA, FOLUSO/0000-0002-6766-2258; Coetzee, Gerhard/0000-0001-8820-8364; Sharma, Priyanka/0000-0001-8592-2239; Turnbull, Clare/0000-0002-1734-5772; Long, Jirong/0000-0002-7433-9766; Brook, Mark/0000-0002-8969-2378; dos Santos Silva, Isabel/0000-0002-6596-8798; Rudolph, Anja/0000-0001-7520-2035; Czene, Kamila/0000-0002-3233-5695; Kerin, Michael/0000-0003-4164-5561; Park, Daniel/0000-0002-6354-0931; Rhie, Suhn/0000-0002-5522-5296; Ito, Hidemi/0000-0002-8023-4581; Dunning, Alison Margaret/0000-0001-6651-7166; Jones, Michael/0000-0001-7479-3451; Winqvist, Robert/0000-0003-0932-9104; Canzian, Federico/0000-0002-4261-4583; Dennis, Joe/0000-0003-4591-1214; Roth, Rebecca/0000-0002-2841-4921; tumino, rosario/0000-0003-2666-414X; McLean, Catriona/0000-0002-0302-5727; Arias Perez, Jose Ignacio/0000-0003-4500-397X; Nevanlinna, Heli/0000-0002-0916-2976; Konstantopoulou, Irene/0000-0002-0470-0309; Nordestgaard, Borge/0000-0002-1954-7220; Bojesen, Stig/0000-0002-4061-4133; Stone, Jennifer/0000-0001-5077-0124; Johansson, Mattias/0000-0002-3116-5081; Baglietto, Laura/0000-0002-8193-7529; Cox, Angela/0000-0002-5138-1099; Durocher, Francine/0000-0001-8012-4641; Rahman, Nazneen/0000-0003-4376-0440; Riboli, Elio/0000-0001-6795-6080; Nyante, Sarah/0000-0002-1770-5993; Schoof, Nils/0000-0003-0509-9217; Waisfisz, Quinten/0000-0002-7384-9182; Makalic, Enes/0000-0003-3017-0871; Simard, Jacques/0000-0001-6906-3390; Heikkinen, Tuomas/0000-0003-1154-6204; Cross, Simon/0000-0003-2044-1754; Kataja, Vesa/0000-0003-4846-4843; Mulligan, Anna Marie/0000-0002-7239-5297; Fletcher, Olivia/0000-0001-9387-7116; Kang, Daehee/0000-0003-4031-5878; Tapper, William/0000-0002-5896-1889; Pita, Guillermo/0000-0003-2393-0510	Cancer Research UK [C1287/A10118, C1287/Al2014]; European Community's Seventh Framework Programme [223175, HEALTH-F2-2009-223175]; European Union European Cooperation in Science and Technology (COST) [BM0606]; US National Cancer Institute [U01-CA98233, U01-CA98710, U01CA98216, U01-CA98758]; Intramural Research Program of the US National Institutes of Health (NIH)/National Cancer Institute, Division of Cancer Epidemiology and Genetics; Mayo Clinic Breast Cancer Study (MCBCS); US NIH [CA122340, CA116201]; Komen Foundation; European Union [HEALTH-F2-2009223175]; Breast Cancer Research Foundation; Canadian Institutes of Health Research (CIHR); Ministry of Economic Development, Innovation and Export Trade of Quebec [PSR-SIIRI701]; US NIH Cancer Post-Cancer GWAS initiative [U19 CA 148065-01]; Cancer Research UK [11022, 14136, 22310, 10118, 16561, 15106, 16565] Funding Source: researchfish; Medical Research Council [G1000143, G0401527] Funding Source: researchfish; National Institute for Health Research [03/DHCS/03/G121/51] Funding Source: researchfish; National Breast Cancer Foundation [PF-11-20, IF-12-06, IF-12-05] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; Cancer Foundation Finland sr [110135] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R25CA092049, R01CA122340, K05CA136967, U01CA098216, P30CA016086, U19CA148065, R01CA077398, R01CA077305, R01CA128978, K07CA092044, R01CA073629, U01CA098758, R01CA136924, R01CA058860, R37CA054281, P50CA058223, R01CA148667, U01CA069631, U01CA098233, R01CA132839, P50CA116201, U01CA069417, U01CA069638, P30CA016056, R01CA100374, R37CA070867, R01CA064277, R01CA100598, U01CA069446, U01CA098710, R01CA092447, R01CA063464] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); European Community's Seventh Framework Programme(European Commission); European Union European Cooperation in Science and Technology (COST); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the US National Institutes of Health (NIH)/National Cancer Institute, Division of Cancer Epidemiology and Genetics; Mayo Clinic Breast Cancer Study (MCBCS); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Foundation(Susan G. Komen Breast Cancer Foundation); European Union(European Commission); Breast Cancer Research Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Export Trade of Quebec; US NIH Cancer Post-Cancer GWAS initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); National Breast Cancer Foundation; The Francis Crick Institute; Cancer Foundation Finland sr; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors wish to thank all the individuals who took part in these studies and all the researchers, clinicians and administrative staff who have enabled this work to be carried out. We are very grateful to Illumina, in particular J. Stone, S. McBean, J. Hadlington, A. Mustafa and K. Cook, for their help with designing the array. BCAC is funded by Cancer Research UK (C1287/A10118 and C1287/Al2014) and by the European Community's Seventh Framework Programme under grant agreement 223175 (HEALTH-F2-2009-223175) (COGS). Meetings of BCAC have been funded by the European Union European Cooperation in Science and Technology (COST) programme (BM0606). BPC3 is funded by US National Cancer Institute cooperative agreements U01-CA98233, U01-CA98710, U01CA98216 and U01-CA98758 and the Intramural Research Program of the US National Institutes of Health (NIH)/National Cancer Institute, Division of Cancer Epidemiology and Genetics. TNBCC is supported by Mayo Clinic Breast Cancer Study (MCBCS) (US NIH grants CAl22340 and a Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201)), grants from the Komen Foundation for the Cure and the Breast Cancer Research Foundation. Genotyping on the iCOGS array was funded by the European Union (HEALTH-F2-2009223175), Cancer Research UK (C1287/A10710), US NIH grant CAl22340, the Komen Foundation for the Cure, the Breast Cancer Research Foundation, the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer program (J. Simiard and D.E.) and Ministry of Economic Development, Innovation and Export Trade of Quebec grant PSR-SIIRI701 (J. Simiard, D.E. and P.H.). J. Simiard holds the Canada Research Chair in Oncogenetics. Combination of the GWAS data was supported in part by US NIH Cancer Post-Cancer GWAS initiative grant U19 CA 148065-01 (DRIVE, part of the GAME-ON initiative) and Breakthrough Breast Cancer Research.	Atwal GS, 2009, P NATL ACAD SCI USA, V106, P10236, DOI 10.1073/pnas.0901298106; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Chu KC, 2002, BREAST CANCER RES TR, V74, P199, DOI 10.1023/A:1016361932220; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Graham K, 2010, BRIT J CANCER, V102, P1284, DOI 10.1038/sj.bjc.6605576; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Shen H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2629; Siddiq A, 2012, HUM MOL GENET, V21, P5373, DOI 10.1093/hmg/dds381; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Wang HB, 2011, NEOPLASIA, V13, P611, DOI 10.1593/neo.11438; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526	17	308	314	0	138	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2013	45	4					392	398		10.1038/ng.2561	http://dx.doi.org/10.1038/ng.2561			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	115VS	23535733	Green Published, Green Accepted			2022-12-17	WOS:000316840600009
J	Greenway, SC; Pereira, AC; Lin, JC; DePalma, SR; Israel, SJ; Mesquita, SM; Ergul, E; Conta, JH; Korn, JM; McCarroll, SA; Gorham, JM; Gabriel, S; Altshuler, DM; Quintanilla-Dieck, MD; Artunduaga, MA; Eavey, RD; Plenge, RM; Shadick, NA; Weinblatt, ME; De Jager, PL; Hafler, DA; Breitbart, RE; Seidman, JG; Seidman, CE				Greenway, Steven C.; Pereira, Alexandre C.; Lin, Jennifer C.; DePalma, Steven R.; Israel, Samuel J.; Mesquita, Sonia M.; Ergul, Emel; Conta, Jessie H.; Korn, Joshua M.; McCarroll, Steven A.; Gorham, Joshua M.; Gabriel, Stacey; Altshuler, David M.; Quintanilla-Dieck, Maria de Lourdes; Artunduaga, Maria Alexandra; Eavey, Roland D.; Plenge, Robert M.; Shadick, Nancy A.; Weinblatt, Michael E.; De Jager, Philip L.; Hafler, David A.; Breitbart, Roger E.; Seidman, Jonathan G.; Seidman, Christine E.			De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot	NATURE GENETICS			English	Article							CONGENITAL HEART-DISEASE; DEPENDENT PROBE AMPLIFICATION; MUTATIONS CAUSE NOONAN; HYPERTROPHIC CARDIOMYOPATHY; CHROMOSOME 1Q21.1; ALAGILLE-SYNDROME; HUMAN GENOME; SCHIZOPHRENIA; DELETIONS; DUPLICATIONS	Tetralogy of Fallot (TOF), the most common severe congenital heart malformation, occurs sporadically, without other anomaly, and from unknown cause in 70% of cases. Through a genome-wide survey of 114 subjects with TOF and their unaffected parents, we identified 11 de novo copy number variants (CNVs) that were absent or extremely rare (<0.1%) in 2,265 controls. We then examined a second, independent TOF cohort (n = 398) for additional CNVs at these loci. We identified CNVs at chromosome 1q21.1 in 1% (5/512, P = 0.0002, OR = 22.3) of nonsyndromic sporadic TOF cases. We also identified recurrent CNVs at 3p25.1, 7p21.3 and 22q11.2. CNVs in a single subject with TOF occurred at six loci, two that encode known (NOTCH1, JAG1) disease-associated genes. Our findings predict that at least 10% (4.5-15.5%, 95% confidence interval) of sporadic nonsyndromic TOF cases result from de novo CNVs and suggest that mutations within these loci might be etiologic in other cases of TOF.	[Greenway, Steven C.; Lin, Jennifer C.; DePalma, Steven R.; Israel, Samuel J.; Korn, Joshua M.; McCarroll, Steven A.; Gorham, Joshua M.; Altshuler, David M.; Quintanilla-Dieck, Maria de Lourdes; Artunduaga, Maria Alexandra; Seidman, Jonathan G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Pereira, Alexandre C.; Mesquita, Sonia M.] Univ Sao Paulo, Sch Med, Inst Heart, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; [Ergul, Emel; Conta, Jessie H.; Breitbart, Roger E.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Korn, Joshua M.; McCarroll, Steven A.; Gabriel, Stacey; Altshuler, David M.; Plenge, Robert M.; De Jager, Philip L.; Hafler, David A.] Broad Inst Harvard, Cambridge, MA USA; [Korn, Joshua M.; McCarroll, Steven A.; Gabriel, Stacey; Altshuler, David M.; Plenge, Robert M.; De Jager, Philip L.; Hafler, David A.] MIT, Cambridge, MA 02139 USA; [Quintanilla-Dieck, Maria de Lourdes; Artunduaga, Maria Alexandra; Eavey, Roland D.] Massachusetts Eye & Ear Infirm, Dept Otol & Laryngol, Boston, MA 02114 USA; [Plenge, Robert M.; Shadick, Nancy A.; Weinblatt, Michael E.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [De Jager, Philip L.; Hafler, David A.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Universidade de Sao Paulo; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	Altshuler, David M/A-4476-2009; Pereira, Alexandre/HHN-1038-2022; Greenway, Steven C/S-7777-2019	Altshuler, David M/0000-0002-7250-4107; DePalma, Steven/0000-0002-0381-5016	Howard Hughes Medical Institute; US National Institutes of Health; Broad Institute; Pediatric Scientist Development Program; Sarnoff Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074734] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; Pediatric Scientist Development Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Sarnoff Cardiovascular Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge the participation of families. We also thank C. Sougnez and M. Parkin for technical assistance and R. Geggel for supplying TOF images. This work was supported by grants from the Howard Hughes Medical Institute (C. E. S.), US National Institutes of Health (to C. E. S., J. G. S. and R. E. B. and to the Broad Institute (National Center for Research Resources)), Pediatric Scientist Development Program (S. C. G.) and Sarnoff Cardiovascular Research Foundation (J. C. L.). Multiple sclerosis controls were genotyped in collaboration with Affymetrix, Inc.	Bassett AS, 2005, AM J MED GENET A, V138A, P307, DOI 10.1002/ajmg.a.30984; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Eldadah ZA, 2001, HUM MOL GENET, V10, P163, DOI 10.1093/hmg/10.2.163; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Krantz ID, 1998, AM J HUM GENET, V62, P1361, DOI 10.1086/301875; Loffredo CA, 2000, AM J MED GENET, V97, P319, DOI 10.1002/1096-8628(200024)97:4<319::AID-AJMG1283>3.0.CO;2-E; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Richards AA, 2008, PEDIATR RES, V64, P358, DOI 10.1203/PDR.0b013e31818095d0; Sato M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1921; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stern RF, 2004, BIOTECHNIQUES, V37, P399, DOI 10.2144/04373ST04; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Thienpont B, 2007, EUR HEART J, V28, P2778, DOI 10.1093/eurheartj/ehl560; Tomita-Mitchell A, 2007, J MED GENET, V44, P779, DOI 10.1136/jmg.2007.052183; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yau SC, 1996, J MED GENET, V33, P550, DOI 10.1136/jmg.33.7.550	38	308	322	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2009	41	8					931	U98		10.1038/ng.415	http://dx.doi.org/10.1038/ng.415			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	476IM	19597493	Green Accepted			2022-12-17	WOS:000268432900020
J	Sakamoto, H; Yoshimura, K; Saeki, N; Katai, H; Shimoda, T; Matsuno, Y; Saito, D; Sugimura, H; Tanioka, F; Kato, S; Matsukura, N; Matsuda, N; Nakamura, T; Hyodo, I; Nishina, T; Yasui, W; Hirose, H; Hayashi, M; Toshiro, E; Ohnami, S; Sekine, A; Sato, Y; Totsuka, H; Ando, M; Takemura, R; Takahashi, Y; Ohdaira, M; Aoki, K; Honmyo, I; Chiku, S; Aoyagi, K; Sasaki, H; Ohnami, S; Yanagihara, K; Yoon, KA; Kook, MC; Lee, YS; Park, SR; Kim, CG; Choi, IJ; Yoshida, T; Nakamura, Y; Hirohashi, S				Sakamoto, Hiromi; Yoshimura, Kimio; Saeki, Norihisa; Katai, Hitoshi; Shimoda, Tadakazu; Matsuno, Yoshihiro; Saito, Daizo; Sugimura, Haruhiko; Tanioka, Fumihiko; Kato, Shunji; Matsukura, Norio; Matsuda, Noriko; Nakamura, Tsuneya; Hyodo, Ichinosuke; Nishina, Tomohiro; Yasui, Wataru; Hirose, Hiroshi; Hayashi, Matsuhiko; Toshiro, Emi; Ohnami, Sumiko; Sekine, Akihiro; Sato, Yasunori; Totsuka, Hirohiko; Ando, Masataka; Takemura, Ryo; Takahashi, Yoriko; Ohdaira, Minoru; Aoki, Kenichi; Honmyo, Izumi; Chiku, Suenori; Aoyagi, Kazuhiko; Sasaki, Hiroki; Ohnami, Shumpei; Yanagihara, Kazuyoshi; Yoon, Kyong-Ah; Kook, Myeong-Cherl; Lee, Yeon-Su; Park, Sook Ryun; Kim, Chan Gyoo; Choi, Il Ju; Yoshida, Teruhiko; Nakamura, Yusuke; Hirohashi, Setsuo		Study Grp Millennium Genome Projec	Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer	NATURE GENETICS			English	Article							STEM-CELL ANTIGEN; MILLENNIUM GENOME; TUMOR-GROWTH; EXPRESSION; RISK; POLYMORPHISM; METASTASIS; CARCINOMA; INFERENCE; PROJECT	Gastric cancer is classified into intestinal and diffuse types, the latter including a highly malignant form, linitis plastica. A two-stage genome-wide association study (stage 1: 85,576 SNPs on 188 cases and 752 references; stage 2: 2,753 SNPs on 749 cases and 750 controls) in Japan identified a significant association between an intronic SNP (rs2976392) in PSCA (prostate stem cell antigen) and diffuse-type gastric cancer (allele-specific odds ratio (OR) 1.62, 95% CI = 1.38-1.89, P = 1.11 x 10(-9)). The association was far less significant in intestinal-type gastric cancer. We found that PSCA is expressed in differentiating gastric epithelial cells, has a cell-proliferation inhibition activity in vitro and is frequently silenced in gastric cancer. Substitution of the C allele with the risk allele T at a SNP in the first exon (rs2294008, which has r(2) = 0.995, D' = 0.999 with rs2976392) reduces transcriptional activity of an upstream fragment of the gene. The same risk allele was also significantly associated with diffuse-type gastric cancer in 457 cases and 390 controls in Korea (allele-specific OR 1.90, 95% CI = 1.56-2.33, P = 8.01 x 10(-11)). The polymorphism of the PSCA gene, which is possibly involved in regulating gastric epithelial-cell proliferation, influences susceptibility to diffuse-type gastric cancer.	[Sakamoto, Hiromi; Yoshimura, Kimio; Saeki, Norihisa; Ohnami, Sumiko; Sato, Yasunori; Aoyagi, Kazuhiko; Sasaki, Hiroki; Yoshida, Teruhiko] Natl Canc Ctr, Inst Res, Div Genet, Chuo Ku, Tokyo 1040045, Japan; [Yoshimura, Kimio] Keio Univ, Sch Med, Dept Hlth Policy & Management, Shinjuku Ku, Tokyo 1608582, Japan; [Katai, Hitoshi; Saito, Daizo; Toshiro, Emi] Natl Canc Ctr, Dept Surg Oncol, Chuo Ku, Tokyo 1040045, Japan; [Shimoda, Tadakazu; Matsuno, Yoshihiro] Natl Canc Ctr, Pathol Clin Lab Div, Chuo Ku, Tokyo 1040045, Japan; [Sugimura, Haruhiko] Hamamatsu Univ Sch Med, Dept Pathol 1, Hamamatsu, Shizuoka 4313192, Japan; [Tanioka, Fumihiko] Iwata City Hosp, Iwata, Shizuoka 4388550, Japan; [Kato, Shunji; Matsukura, Norio; Matsuda, Noriko] Nippon Med Coll Hosp, Dept Surg, Bunkyo Ku, Tokyo 1138602, Japan; [Nakamura, Tsuneya] Aichi Canc Ctr Hosp, Dept Endoscopy, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Hyodo, Ichinosuke; Nishina, Tomohiro] Shikoku Canc Ctr, Dept Internal Med, Matsuyama, Ehime 7910280, Japan; [Yasui, Wataru] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Pathol, Minami Ku, Hiroshima 7348551, Japan; [Hirose, Hiroshi; Hayashi, Matsuhiko] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan; [Sekine, Akihiro; Nakamura, Yusuke] RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Totsuka, Hirohiko] Hitachi Govt & Publ Corp Syst Engn Ltd, Bioinformat Grp, Ctr Res & Dev, Solut Div 4,Koto Ku, Tokyo 1358633, Japan; [Ando, Masataka] NEC Corp Ltd, BioIT Business Promot Ctr, Solut Dev Labs, Minato Ku, Tokyo 1088001, Japan; [Takemura, Ryo] StaGen Co Ltd, Stat Genet Anal Div, Taito Ku, Tokyo 1110051, Japan; [Takahashi, Yoriko; Ohdaira, Minoru; Aoki, Kenichi; Honmyo, Izumi] Mitsui Knowledge Ind Co Ltd, Chiyoda Ku, Tokyo 1010054, Japan; [Chiku, Suenori] Mizuho Informat & Res Inst Inc, Sci Solut Div, Chiyoda Ku, Tokyo 1018443, Japan; [Ohnami, Shumpei] Natl Canc Ctr, Res Inst, Cent RI Lab, Chuo Ku, Tokyo 1040045, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Res Inst, Cent Anim Lab, Chuo Ku, Tokyo 1040045, Japan; [Yoon, Kyong-Ah; Kook, Myeong-Cherl; Lee, Yeon-Su; Park, Sook Ryun; Kim, Chan Gyoo; Choi, Il Ju] Natl Canc Ctr, Res Inst & Hosp, Goyang Si 411764, Gyeonggi Do, South Korea; [Nakamura, Yusuke] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	National Cancer Center - Japan; Keio University; National Cancer Center - Japan; National Cancer Center - Japan; Hamamatsu University School of Medicine; Nippon Medical School; Aichi Cancer Center; Hiroshima University; Keio University; RIKEN; NEC Corporation; Mizuho Research & Technologies, Ltd.; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Korea (NCC); University of Tokyo	Yoshida, T (corresponding author), Natl Canc Ctr, Inst Res, Div Genet, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tyoshida@ncc.go.jp	Hirose, Hiroshi/F-8556-2014; Hayashi, Matsuhiko/J-4748-2013	Kim, Chan Gyoo/0000-0002-1651-2559				Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Bahrenberg G, 2000, BIOCHEM BIOPH RES CO, V275, P783, DOI 10.1006/bbrc.2000.3393; CORREA P, 1994, CANCER RES, V54, pS1941; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dalen AGD, 2003, INT J CANCER, V103, P768, DOI 10.1002/ijc.10903; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; Falush D, 2003, GENETICS, V164, P1567; Fenoglio-Preiser C, 2000, WHO CLASSIFICATION T, P39; Fukaya M, 2006, GASTROENTEROLOGY, V131, P14, DOI 10.1053/j.gastro.2006.05.008; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Gu ZN, 2005, CANCER RES, V65, P9495, DOI 10.1158/0008-5472.CAN-05-2086; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Henson DE, 2004, ARCH PATHOL LAB MED, V128, P765; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Humar B, 2002, ONCOGENE, V21, P8192, DOI 10.1038/sj.onc.1205921; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Japanese Gastric Cancer Association Registration Committee, 2006, Gastric Cancer, V9, P51; Kamangar F, 2006, CANCER EPIDEM BIOMAR, V15, P1920, DOI 10.1158/1055-9965.EPI-06-0267; KARAM S, 1995, MICROSC RES TECHNIQ, V31, P193, DOI 10.1002/jemt.1070310304; Karam SM, 2003, STEM CELLS, V21, P322, DOI 10.1634/stemcells.21-3-322; Kato N, 2008, HUM MOL GENET, V17, P617, DOI 10.1093/hmg/ddm335; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Machado JC, 1999, LAB INVEST, V79, P459; Nei M., 1987, MOL EVOLUTIONARY GEN; Noguchi M, 1997, PATHOL INT, V47, P685, DOI 10.1111/j.1440-1827.1997.tb04442.x; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Pharoah PDP, 2002, INT J CANCER, V101, P196, DOI 10.1002/ijc.10590; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; ROSAI J, 2004, ROSAI ACKERMANS SURG, P648; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saffran DC, 2001, P NATL ACAD SCI USA, V98, P2658, DOI 10.1073/pnas.051624698; Saito A, 2001, PATHOL INT, V51, P165, DOI 10.1046/j.1440-1827.2001.01179.x; Sasazuki S, 2006, CANCER EPIDEM BIOMAR, V15, P1341, DOI 10.1158/1055-9965.EPI-05-0901; Sato Y, 2004, J HUM GENET, V49, P669, DOI 10.1007/s10038-004-0205-9; Schier S, 2005, ONCOLOGY-BASEL, V69, P9, DOI 10.1159/000086625; Sharom FJ, 2004, SUB CELL BIOCHEM, V37, P285; Shinmura K, 1999, CARCINOGENESIS, V20, P1127, DOI 10.1093/carcin/20.6.1127; Smith MG, 2006, WORLD J GASTROENTERO, V12, P2979, DOI 10.3748/wjg.v12.i19.2979; Tran CP, 2002, MOL CANCER RES, V1, P113; Ushijima T, 2004, CANCER CELL, V5, P121, DOI 10.1016/S1535-6108(04)00033-9; Wang GY, 2008, AM J EPIDEMIOL, V167, P7, DOI 10.1093/aje/kwm264; Yokota T, 1999, CAN J SURG, V42, P371; Yoshida T, 2003, P JPN ACAD B-PHYS, V79, P34, DOI 10.2183/pjab.79B.34; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	49	308	324	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					730	740		10.1038/ng.152	http://dx.doi.org/10.1038/ng.152			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18488030				2022-12-17	WOS:000256212000015
J	Barrett, JC; Cardon, LR				Barrett, Jeffrey C.; Cardon, Lon R.			Evaluating coverage of genome-wide association studies	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; COMPLEX DISEASE; POLYMORPHISM; FUTURE; POWER	Genome-wide association studies involving hundreds of thousands of SNPs in thousands of cases and controls are now underway. The first of many analytical challenges in these studies involves the choice of SNPs to genotype. It is not practical to construct a different panel of tag SNPs for each study, so the first generation of genome-wide scans will use predefined, commercially available marker panels, which will in part dictate their success or failure. We compare different approaches in use today, and show that although many of them provide substantial coverage of common variation in non-African populations, the precise extent is strongly dependent on the frequencies of alleles of interest and on specific considerations of study design. Overall, despite substantial differences in genotyping technologies, marker selection strategies and number of markers assayed, the first-generation high-throughput platforms all offer similar levels of genome coverage.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Cardon, LR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	lon.cardon@well.ox.ac.uk		Barrett, Jeffrey/0000-0002-1152-370X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; DALY M, 2006, NAT GENET       0521; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dong SL, 2001, GENOME RES, V11, P1418, DOI 10.1101/gr.171101; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Jorgenson E, 2006, AM J HUM GENET, V78, P884, DOI 10.1086/503751; Ke XY, 2005, HUM MOL GENET, V14, P2757, DOI 10.1093/hmg/ddi309; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	19	308	338	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					659	662		10.1038/ng1801	http://dx.doi.org/10.1038/ng1801			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16715099				2022-12-17	WOS:000237954800019
J	Simone, C; Forcales, SV; Hill, DA; Imbalzano, AN; Latella, L; Puri, PL				Simone, C; Forcales, SV; Hill, DA; Imbalzano, AN; Latella, L; Puri, PL			p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci	NATURE GENETICS			English	Article							TRANSCRIPTIONAL ACTIVATION; MAP KINASE; MYOD; DIFFERENTIATION; BINDING; FAMILY; ACETYLATION; ROLES; MEF2C; PCAF	During skeletal myogenesis, genomic reprogramming toward terminal differentiation is achieved by recruiting chromatin-modifying enzymes to muscle-specific loci(1,2). The relative contribution of extracellular signaling cascades in targeting these enzymes to individual genes is unknown. Here we show that the differentiation-activated p38 pathway(3-5) targets the SWI-SNF chromatin-remodeling complex to myogenic loci. Upon differentiation, p38 kinases were recruited to the chromatin of muscle-regulatory elements. Blockade of p38alpha/beta repressed the transcription of muscle genes by preventing recruitment of the SWI-SNF complex at these elements without affecting chromatin binding of muscle-regulatory factors and acetyltransferases. The SWI-SNF subunit BAF60 could be phosphorylated by p38alpha-beta in vitro, and forced activation of p38alpha/beta in myoblasts by expression of a constitutively active MKK6 (refs. 5-7) promoted unscheduled SWI-SNF recruitment to the myogenin promoter. Conversely, inactivation of SWI-SNF enzymatic subunits abrogated MKK6-dependent induction of muscle gene expression. These results identify an unexpected function of differentiation-activated p38 in converting external cues into chromatin modifications at discrete loci, by selectively targeting SWI-SNF to muscle-regulatory elements.	Fdn A Cesalpino, Inst Cell Biol & Tissue Engn, Dulbecco Telethon Inst, Gene Express Lab, I-00128 Rome, Italy; Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92093 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Salk Institute; University of Massachusetts System; University of Massachusetts Worcester	Puri, PL (corresponding author), Fdn A Cesalpino, Inst Cell Biol & Tissue Engn, Dulbecco Telethon Inst, Gene Express Lab, San Raffaele Biomed Sci Pk Rome, I-00128 Rome, Italy.	plpuri@dti.telethon.it	Forcales, Sonia-V./B-2157-2013; Forcales, Sonia/AAU-8996-2020; Latella, Lucia/K-7834-2016; Simone, Cristiano/K-3452-2018	Forcales, Sonia-V./0000-0002-7111-4959; Forcales, Sonia/0000-0002-7111-4959; Simone, Cristiano/0000-0002-2628-7658; Puri, Pier Lorenzo/0000-0003-4964-0095; LATELLA, LUCIA/0000-0003-1317-9233	NIGMS NIH HHS [R01 GM056244] Funding Source: Medline; Telethon [GFP01009, TCP00081] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056244] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; DEBRIL MB, 2003, J BIOL CHEM, V16, P16677; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Puri PL, 2000, GENE DEV, V14, P574; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Roy K, 2002, J BIOL CHEM, V277, P33818, DOI 10.1074/jbc.M205159200; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Sartorelli V, 2001, FRONT BIOSCI-LANDMRK, V6, pD1024, DOI 10.2741/Sartorel; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Wilson CJ, 1996, CELL, V84, P235, DOI 10.1016/S0092-8674(00)80978-2; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhao M, 1999, MOL CELL BIOL, V19, P21	29	308	319	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2004	36	7					738	743		10.1038/ng1378	http://dx.doi.org/10.1038/ng1378			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15208625	Bronze			2022-12-17	WOS:000222354100025
J	Wang, HW; Trotter, MWB; Lagos, D; Bourboulia, D; Henderson, S; Makinen, T; Elliman, S; Flanagan, AM; Alitalo, K; Boshoff, C				Wang, HW; Trotter, MWB; Lagos, D; Bourboulia, D; Henderson, S; Makinen, T; Elliman, S; Flanagan, AM; Alitalo, K; Boshoff, C			Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma	NATURE GENETICS			English	Article							GROWTH-FACTOR; CELLS; HUMAN-HERPESVIRUS-8; TRANSFORMATION; INFECTION; CULTURE; LESIONS; VEGF	The biology of Kaposi sarcoma is poorly understood because the dominant cell type in Kaposi sarcoma lesions is not known(1-4). We show by gene expression microarrays that neoplastic cells of Kaposi sarcoma are closely related to lymphatic endothelial cells (LECs) and that Kaposi sarcoma herpesvirus (KSHV)(5,6) infects both LECs and blood vascular endothelial cells (BECs) in vitro. The gene expression microarray profiles of infected LECs and BECs show that KSHV induces transcriptional reprogramming of both cell types. The lymphangiogenic molecules VEGF-D and angiopoietin-2 were elevated in the plasma of individuals with acquired immune deficiency syndrome and Kaposi sarcoma. These data show that the gene expression profile of Kaposi sarcoma resembles that of LECs, that KSHV induces a transcriptional drift in both LECs and BECs and that lymphangiogenic molecules are involved in the pathogenesis of Kaposi sarcoma.	UCL, Wolfson Inst Biomed Res, Viral Oncol Grp, Canc Res UK, London WC1E 6BT, England; Univ Helsinki, Biomedicum Helsinki, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland; Univ Helsinki, Helsinki Univ Cent Hosp, FIN-00014 Helsinki, Finland; UCL, Inst Orthopaed, London WC1E 6BT, England	Cancer Research UK; University of London; University College London; University of Helsinki; Ludwig Institute for Cancer Research; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of London; University College London	Boshoff, C (corresponding author), UCL, Wolfson Inst Biomed Res, Viral Oncol Grp, Canc Res UK, Cruciform Bldg,Gower St, London WC1E 6BT, England.	c.boshoff@ucl.ac.uk	Makinen, Taija/C-5765-2014; Alitalo, Kari K/J-5013-2014; Makinen, Taija/CAI-2233-2022	Makinen, Taija/0000-0002-9338-1257; Alitalo, Kari K/0000-0002-7331-0902; Makinen, Taija/0000-0002-9338-1257; Henderson, Stephen/0000-0002-9032-3828; Flanagan, Adrienne/0000-0002-2832-1303; Trotter, Matthew/0000-0003-3702-915X; Lagos, Dimitris/0000-0003-0637-281X				Ascherl G, 1999, BLOOD, V93, P4232; Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Brockmeyer N H, 1999, Eur J Med Res, V4, P95; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Ciufo DM, 2001, J VIROL, V75, P5614, DOI 10.1128/JVI.75.12.5614-5626.2001; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Flore O, 1998, NATURE, V394, P588, DOI 10.1038/29093; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gallo RC, 1998, SCIENCE, V282, P1837, DOI 10.1126/science.282.5395.1837; Ganem D, 1997, CELL, V91, P157, DOI 10.1016/S0092-8674(00)80398-0; HONG YK, 2004, NAT GENET       0627, DOI DOI 10.1038/NG1383; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; KAAYA EE, 1995, J ACQ IMMUN DEF SYND, V10, P295; Kahn HJ, 2002, MODERN PATHOL, V15, P434, DOI 10.1038/modpathol.3880543; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lebbe C, 1997, ARCH DERMATOL RES, V289, P421, DOI 10.1007/s004030050215; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Moses AV, 1999, J VIROL, V73, P6892, DOI 10.1128/JVI.73.8.6892-6902.1999; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Poole LJ, 2002, J VIROL, V76, P3395, DOI 10.1128/JVI.76.7.3395-3420.2002; REGEZI JA, 1993, AM J PATHOL, V143, P240; Renwick N, 2002, AIDS RES HUM RETROV, V18, P695, DOI 10.1089/088922202760072302; Samaniego F, 1997, J IMMUNOL, V158, P1887; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; [No title captured]	30	308	320	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2004	36	7					687	693		10.1038/ng1384	http://dx.doi.org/10.1038/ng1384			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833QT	15220918	Bronze			2022-12-17	WOS:000222354100017
J	Repping, S; Skaletsky, H; Brown, L; van Daalen, SKM; Korver, CM; Pyntikova, T; Kuroda-Kawaguchi, T; de Vries, JWA; Oates, RD; Silber, S; van der Veen, F; Page, DC; Rozen, S				Repping, S; Skaletsky, H; Brown, L; van Daalen, SKM; Korver, CM; Pyntikova, T; Kuroda-Kawaguchi, T; de Vries, JWA; Oates, RD; Silber, S; van der Veen, F; Page, DC; Rozen, S			Polymorphism for a 1.6-Mb deletion of the human Y chromosome persists through balance between recurrent mutation and haploid selection	NATURE GENETICS			English	Article							INTRACHROMOSOMAL RECOMBINATION; HUMAN-POPULATIONS; INFERTILE MEN; COPY NUMBER; AZFC REGION; DAZ GENES; MICRODELETIONS; MARKER; MALES; YQ11	Many human Y-chromosomal deletions are thought to severely impair reproductive fitness, which precludes their transmission to the next generation and thus ensures their rarity in the population. Here we report a 1.6-Mb deletion that persists over generations and is sufficiently common to be considered a polymorphism. We hypothesized that this deletion might affect spermatogenesis because it removes almost half of the Y chromosome's AZFc region, a gene-rich segment that is critical for sperm production(1,2). An association study established that this deletion, called gr/gr, is a significant risk factor for spermatogenic failure. The gr/gr deletion has far lower penetrance with respect to spermatogenic failure than previously characterized Y-chromosomal deletions; it is often transmitted from father to son. By studying the distribution of gr/gr-deleted chromosomes across the branches of the Y chromosome's genealogical tree, we determined that this deletion arose independently at least 14 times in human history. We suggest that the existence of this deletion as a polymorphism reflects a balance between haploid selection, which culls gr/gr-deleted Y chromosomes from the population, and homologous recombination, which continues to generate new gr/gr deletions.	MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Dept Obstet & Gynecol, NL-1105 AZ Amsterdam, Netherlands; Ichikawa Gen Hosp, Tokyo Dent Coll, Reprod Ctr, Chiba, Japan; Boston Univ, Med Ctr, Dept Urol, Boston, MA 02118 USA; St Lukes Hosp, Infertil Ctr, St Louis, MO 63017 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Amsterdam; Academic Medical Center Amsterdam; Tokyo Dental College; Boston University; Saint Luke's Hospital - Missouri	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA.	page_admin@wi.mit.edu	; Rozen, Steven G./J-5939-2013	Oates, Robert/0000-0003-2330-6697; Rozen, Steven G./0000-0002-4288-0056; Repping, Sjoerd/0000-0002-6959-149X				Bienvenu T, 2001, ANN GENET-PARIS, V44, P125, DOI 10.1016/S0003-3995(01)01078-4; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; de Vries JWA, 2002, FERTIL STERIL, V77, P68, DOI 10.1016/S0015-0282(01)02935-1; Ellis N, 2002, GENOME RES, V12, P339; Ewis AA, 2002, J HUM GENET, V47, P257, DOI 10.1007/s100380200035; Fernandes S, 2002, MOL HUM REPROD, V8, P286, DOI 10.1093/molehr/8.3.286; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Kuroki Y, 1999, J HUM GENET, V44, P289, DOI 10.1007/s100380050162; Oates RD, 2002, HUM REPROD, V17, P2813, DOI 10.1093/humrep/17.11.2813; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Soucie JM, 1998, AM J HEMATOL, V59, P288, DOI 10.1002/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; World Health Organization, 1992, WHO LAB MAN EX HUM S, V3rd; Yen P, 2001, NAT GENET, V29, P243, DOI 10.1038/ng1101-243	28	308	333	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2003	35	3					247	251		10.1038/ng1250	http://dx.doi.org/10.1038/ng1250			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	738EG	14528305				2022-12-17	WOS:000186273300020
J	Toyo-oka, K; Shionoya, A; Gambello, MJ; Cardoso, C; Leventer, R; Ward, HL; Ayala, R; Tsai, LH; Dobyns, W; Ledbetter, D; Hirotsune, S; Wynshaw-Boris, A				Toyo-oka, K; Shionoya, A; Gambello, MJ; Cardoso, C; Leventer, R; Ward, HL; Ayala, R; Tsai, LH; Dobyns, W; Ledbetter, D; Hirotsune, S; Wynshaw-Boris, A			14-3-3 epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome	NATURE GENETICS			English	Article							PROTEIN PHOSPHATASE 2A; CYTOPLASMIC DYNEIN; CORTICAL DEVELOPMENT; EMBRYONIC LETHALITY; LISSENCEPHALY GENE; LIS1 GENE; PHOSPHORYLATION; DROSOPHILA; CDK5; MALFORMATION	Heterozygous deletions of 17p13.3 result in the human neuronal migration disorders isolated lissencephaly sequence (ILS) and the more severe Miller Dieker syndrome (MDS). Mutations in PAFAH1B1 (the gene encoding LIS1) are responsible for ILS and contribute to MDS, but the genetic causes of the greater severity of MDS are unknown. Here, we show that the gene encoding 14-3-3epsilon (YWHAE), one of a family of ubiquitous phosphoserine/threonine binding proteins, is always deleted in individuals with MDS. Mice deficient in Ywhae have defects in brain development and neuronal migration, similar to defects observed in mice heterozygous with respect to Pafah1b1. Mice heterozygous with respect to both genes have more severe migration defects than single heterozygotes. 14-3-3epsilon binds to CDK5/p35-phosphorylated NUDEL and this binding maintains NUDEL phosphorylation. Similar to LIS1, deficiency of 14-3-3epsilon results in mislocalization of NUDEL and LIS1, consistent with reduction of cytoplasmic dynein function. These results establish a crucial role for 14-3-3epsilon in neuronal development by sustaining the effects of CDK5 phosphorylation and provide a molecular explanation for the differences in severity of human neuronal migration defects with 17p13.3 deletions.	Univ Calif San Diego, Sch Med, Dept Pediat, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Ctr Canc, La Jolla, CA 92093 USA; Japan Sci & Technol Corp, Ctr Genome Med Sci, Saitama Med Sch, PRESTO, Hidaka, Saitama 3501241, Japan; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Harvard Univ, Sch Med, Dept Pathol, Howard Hughes Med Inst, Boston, MA 02115 USA; Fac Med Timone, INSERM, U491, F-13385 Marseille 05, France; Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of California System; University of California San Diego; University of California System; University of California San Diego; Japan Science & Technology Agency (JST); Saitama Medical University; University of Chicago; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Wynshaw-Boris, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, Ctr Canc, 9500 Gilman Dr,Mailstop 0627, La Jolla, CA 92093 USA.		Dobyns, William Brian/ABC-6525-2021; Toyooka, Kazuhito/AAH-7175-2019; Cardoso, Carlos/H-4520-2016; Cardoso, Carlos/M-2767-2019; Dobyns, William/AAI-2768-2020; Toyooka, Kazuhito/AAQ-6928-2020	Toyooka, Kazuhito/0000-0002-0173-0430; Cardoso, Carlos/0000-0003-1914-9553; Cardoso, Carlos/0000-0003-1914-9553; Dobyns, William/0000-0002-7681-2844; Toyooka, Kazuhito/0000-0002-0173-0430				Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Cardoso C, 2003, AM J HUM GENET, V72, P918, DOI 10.1086/374320; Cardoso C, 2000, HUM MOL GENET, V9, P3019, DOI 10.1093/hmg/9.20.3019; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chang HC, 1997, GENE DEV, V11, P1132, DOI 10.1101/gad.11.9.1132; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; DOBYNS WB, 1992, NEUROLOGY, V42, P1375, DOI 10.1212/WNL.42.7.1375; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.3.CO;2-5; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Fleck MW, 2000, J NEUROSCI, V20, P2439; Floyd SR, 2001, J BIOL CHEM, V276, P8104, DOI 10.1074/jbc.M008932200; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hirotsune S, 1997, GENOME RES, V7, P625, DOI 10.1101/gr.7.6.625; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Huang DQ, 1999, P NATL ACAD SCI USA, V96, P14445, DOI 10.1073/pnas.96.25.14445; LEDBETTER SA, 1992, AM J HUM GENET, V50, P182; LIN FC, 1995, EMBO J, V14, P2745, DOI 10.1002/j.1460-2075.1995.tb07275.x; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; OSHIMA T, 1996, P NATL ACAD SCI USA, V93, P11173; Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029; Price NE, 1999, MOL BRAIN RES, V73, P68, DOI 10.1016/S0169-328X(99)00237-5; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Tsuda M, 2002, CELL GROWTH DIFFER, V13, P131; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; VEERANNA, 1995, J NEUROCHEM, V64, P2681; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Weinstein DE, 1999, DEV BRAIN RES, V116, P29, DOI 10.1016/S0165-3806(99)00072-3; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003	50	308	326	0	23	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2003	34	3					274	285		10.1038/ng1169	http://dx.doi.org/10.1038/ng1169			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	695DF	12796778				2022-12-17	WOS:000183815300014
J	KAMBOH, MI; SANGHERA, DK; FERRELL, RE; DEKOSKY, ST				KAMBOH, MI; SANGHERA, DK; FERRELL, RE; DEKOSKY, ST			APOE-ASTERISK-4-ASSOCIATED ALZHEIMERS-DISEASE RISK IS MODIFIED BY ALPHA-1-ANTICHYMOTRYPSIN POLYMORPHISM	NATURE GENETICS			English	Letter							PROTEASE INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN; APOLIPOPROTEIN-E; AMYLOID DEPOSITS; BETA-PROTEIN; BRAIN; EXPRESSION; DIAGNOSIS; PEPTIDES; SEQUENCE; BINDING							Sanghera, Dharambir/0000-0001-7203-8655; Kamboh, M. Ilyas/0000-0002-3453-1438; DeKosky, Steven/0000-0003-3743-2758	NIA NIH HHS [AG09202, AG07562, AG05133] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005133, R01AG009202, R01AG007562] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAHAM CR, 1990, NEUROBIOL AGING, V11, P123, DOI 10.1016/0197-4580(90)90045-2; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; DEKOSKY ST, 1994, NEUROLOGY, V44, pA354; EICHNER JE, 1990, ARTERIOSCLEROSIS, V10, P379, DOI 10.1161/01.ATV.10.3.379; FABER JP, 1993, J HEPATOL, V18, P313, DOI 10.1016/S0168-8278(05)80275-2; FRASER PE, 1993, J NEUROCHEM, V61, P298, DOI 10.1111/j.1471-4159.1993.tb03568.x; ISHIGURO K, 1993, VIRCHOWS ARCH B, V64, P221, DOI 10.1007/BF02915116; KAMBOH MI, 1995, HUM BIOL, V67, P195; KAMBOH MI, 1995, ATHEROSCLEROSIS, V112, P145, DOI 10.1016/0021-9150(94)05409-C; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MATSUBARA E, 1990, ANN NEUROL, V28, P561, DOI 10.1002/ana.410280414; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; PICKEN MM, 1990, J NEUROPATH EXP NEUR, V49, P41, DOI 10.1097/00005072-199001000-00005; RANDALL LL, 1989, SCIENCE, V243, P1156, DOI 10.1126/science.2646712; RAYFORD A, 1992, J NEUROCHEM, V58, P88, DOI 10.1111/j.1471-4159.1992.tb09281.x; ROZEMULLER JM, 1991, ACTA NEUROPATHOL, V82, P200, DOI 10.1007/BF00294446; SANAN DA, 1994, J CLIN INVEST, V94, P880; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SHOJI M, 1991, AM J PATHOL, V138, P247; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; STRITTMATTER WJ, 1994, EXP NEUROL, V125, P163, DOI 10.1006/exnr.1994.1019; WISNIEWSKI KE, 1990, EXP NEUROL, V110, P121, DOI 10.1016/0014-4886(90)90056-X; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; 1987, DIAGNOSTIC STATISTIC	26	308	312	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					486	488		10.1038/ng0895-486	http://dx.doi.org/10.1038/ng0895-486			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670501				2022-12-17	WOS:A1995RM37500026
J	VIDAL, F; ABERDAM, D; MIQUEL, C; CHRISTIANO, AM; PULKKINEN, L; UITTO, J; ORTONNE, JP; MENEGUZZI, G				VIDAL, F; ABERDAM, D; MIQUEL, C; CHRISTIANO, AM; PULKKINEN, L; UITTO, J; ORTONNE, JP; MENEGUZZI, G			INTEGRIN BETA-4 MUTATIONS ASSOCIATED WITH JUNCTIONAL EPIDERMOLYSIS-BULLOSA WITH PYLORIC ATRESIA	NATURE GENETICS			English	Article							MESSENGER-RNA; ALPHA-6-BETA-4 INTEGRIN; PEMPHIGOID ANTIGEN; CYTOPLASMIC DOMAIN; NONSENSE MUTATIONS; EPITHELIAL-CELLS; HEMIDESMOSOMES; EXPRESSION; ADHESION; SUBUNIT	Pyloric atresia associated with junctional epidermolysis bullosa (PA-JEB), is a rare inherited disorder characterized by pyloric stenosis and blistering of the skin as primary manifestations. We demonstrate that in one PA-JEB patient the disease resulted from two distinct mutations in the beta 4 integrin gene alleles. The paternal mutation consists of a one base pair deletion causing a shift in the open reading frame, and a downstream premature termination codon. The maternal mutation occurs in a donor splice site, and results in in-frame exon skipping involving the cytoplasmic domain of the polypeptide. Our results implicate mutations in the beta 4 integrin gene in some forms of PA-JEB.	FAC MED NICE,INSERM,U385,F-06107 NICE 2,FRANCE; HOP LOUIS PASTEUR,SERV DERMATOL,F-06002 NICE 1,FRANCE; THOMAS JEFFERSON UNIV,DEPT DERMATOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Jefferson University; Jefferson University			Aberdam, Daniel/G-3299-2013	Aberdam, Daniel/0000-0002-4019-5418; Meneguzzi, Guerrino/0000-0002-1609-6540	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01-AR-38923] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; BAUDOIN C, 1994, J CLIN INVEST, V93, P862, DOI 10.1172/JCI117041; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; CARTER WG, 1990, J CELL BIOL, V110, P1387, DOI 10.1083/jcb.110.4.1387; CARTER WG, 1990, J CELL BIOL, V111, P3141, DOI 10.1083/jcb.111.6.3141; Chang C H, 1983, Pediatr Pathol, V1, P449; DELUCA M, 1990, P NATL ACAD SCI USA, V87, P6888, DOI 10.1073/pnas.87.17.6888; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; FRIEDEN IJ, 1986, J AM ACAD DERMATOL, V14, P646, DOI 10.1016/S0190-9622(86)70082-0; Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5; GEORGE JN, 1990, BLOOD, V75, P1383; GIANCOTTI FG, 1992, J CELL BIOL, V118, P951, DOI 10.1083/jcb.118.4.951; GIPSON IK, 1993, EXP CELL RES, V207, P86, DOI 10.1006/excr.1993.1166; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; HERTLE MD, 1992, J CLIN INVEST, V89, P1892, DOI 10.1172/JCI115794; HIEDA Y, 1992, J CELL BIOL, V116, P1497, DOI 10.1083/jcb.116.6.1497; HOGERVORST F, 1991, EUR J BIOCHEM, V199, P425, DOI 10.1111/j.1432-1033.1991.tb16140.x; HOGERVORST F, 1990, EMBO J, V9, P765, DOI 10.1002/j.1460-2075.1990.tb08171.x; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JONES JCR, 1991, CELL REGUL, V2, P427, DOI 10.1091/mbc.2.6.427; JONKMAN MF, 1992, J INVEST DERMATOL, V99, P489, DOI 10.1111/1523-1747.ep12616168; KENNEL SJ, 1990, HYBRIDOMA, V9, P243, DOI 10.1089/hyb.1990.9.243; KURPAKUS MA, 1991, J CELL BIOL, V115, P1737, DOI 10.1083/jcb.115.6.1737; LACOUR JP, 1992, EUR J PEDIATR, V151, P252, DOI 10.1007/BF02072223; LARJAVA H, 1990, J CELL BIOL, V110, P803, DOI 10.1083/jcb.110.3.803; LARJAVA H, 1993, J CLIN INVEST, V92, P1425, DOI 10.1172/JCI116719; LESTRINGANT GG, 1992, ARCH DERMATOL, V128, P1083, DOI 10.1001/archderm.128.8.1083; MARCHISIO PC, 1991, J CELL BIOL, V112, P761, DOI 10.1083/jcb.112.4.761; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; McKusick V.A., 1992, MENDELIAN INHERITANC; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MUELLER S, 1989, J INVEST DERMATOL, V92, P33, DOI 10.1111/1523-1747.ep13070476; NIESSEN CM, 1994, J CELL SCI, V107, P543; ORTONNE JP, 1990, J INVEST DERMATOL, V94, P400; OWARIBE K, 1991, EXP CELL RES, V192, P622, DOI 10.1016/0014-4827(91)90084-8; PHILLIPS RJ, 1994, HISTOPATHOLOGY, V24, P571; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; Sambrook J., 1989, MOL CLONING LAB MANU; SOLOWSKA J, 1991, J CELL BIOL, V114, P1079, DOI 10.1083/jcb.114.5.1079; SONNENBERG A, 1988, NATURE, V336, P487, DOI 10.1038/336487a0; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; SPINARDI L, 1993, MOL BIOL CELL, V4, P871, DOI 10.1091/mbc.4.9.871; STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970; SUZUKI S, 1990, EMBO J, V9, P757, DOI 10.1002/j.1460-2075.1990.tb08170.x; TAMURA RN, 1990, J CELL BIOL, V111, P1593, DOI 10.1083/jcb.111.4.1593; TANAKA T, 1989, J INVEST DERMATOL, V94, P617	50	308	310	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					229	234		10.1038/ng0695-229	http://dx.doi.org/10.1038/ng0695-229			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7545057				2022-12-17	WOS:A1995RA85700023
J	TELENIUS, H; KREMER, B; GOLDBERG, YP; THEILMANN, J; ANDREW, SE; ZEISLER, T; ADAM, S; GREENBERG, C; IVES, EJ; CLARKE, LA; HAYDEN, MR				TELENIUS, H; KREMER, B; GOLDBERG, YP; THEILMANN, J; ANDREW, SE; ZEISLER, T; ADAM, S; GREENBERG, C; IVES, EJ; CLARKE, LA; HAYDEN, MR			SOMATIC AND GONADAL MOSAICISM OF THE HUNTINGTON DISEASE GENE CAG REPEAT IN BRAIN AND SPERM	NATURE GENETICS			English	Article							FRAGILE-X; MYOTONIC-DYSTROPHY; CTG REPEAT; INSTABILITY	Huntington disease is associated with an unstable and expanded (CAG) trinucleotide repeat. We have analysed the CAG expansion in different tissues from 12 affected individuals. All tissues examined were found to display some repeat mosaicism, with the greatest levers detected in brain and sperm. Regions within the brain showing most obvious neuropathology, such as the basal ganglia and the cerebral cortex, displayed the greatest mosaicism, whereas the cerebellar cortex, which is seldom involved, displayed the lowest degree of CAG instability. In two cases of childhood onset disease we detected differences of 8 and 13 trinucleotides between the cerebellum and other regions of the brain. Our results provide evidence for tissue specific instability of the CAG repeat, with the largest CAG repeat lengths in affected regions of the brain.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1Z4,BC,CANADA; CHILDRENS HOSP,HLTH SCI CTR,GENET & METAB SECT,WINNIPEG R3A 1S1,MB,CANADA; MEM UNIV NEWFOUNDLAND,FAC MED,HLTH SCI CTR,DIV COMMUNITY MED,ST JOHNS A1B 3V6,NF,CANADA	University of British Columbia; University of Manitoba; Children's Hospital Research Institute of Manitoba; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba			Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Clarke, Lorne/0000-0003-0512-7281; Adam, Shelin/0000-0002-4401-6157				ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ANVRET M, 1993, HUM MOL GENET, V2, P1397, DOI 10.1093/hmg/2.9.1397; BLINKOV SM, 1968, HUMAN BRAIN FIGURES, P416; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GOLDBERG YP, 1993, HUM MOL GENET, V2, P635, DOI 10.1093/hmg/2.6.635; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; Harper PS, 1991, HUNTINGTONS DISEASE; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KREMER, IN PRESS NEW ENGL J; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MCDONALD ME, 1993, J MED GENET, V30, P982; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NORREMOLLE A, 1993, HUM MOL GENET, V2, P1475, DOI 10.1093/hmg/2.9.1475; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; ZHULKE C, 1993, HUM MOL GENET, V2, P2063; ZUHLKE C, 1993, HUM MOL GENET, V2, P1467; 1983, CELL, V72, P971	33	308	312	1	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					409	414		10.1038/ng0494-409	http://dx.doi.org/10.1038/ng0494-409			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054984				2022-12-17	WOS:A1994ND87000023
J	Blakely, CM; Watkins, TBK; Wu, W; Gini, B; Chabon, JJ; McCoach, CE; McGranahan, N; Wilson, GA; Birkbak, NJ; Olivas, VR; Rotow, J; Maynard, A; Wang, V; Gubens, MA; Banks, KC; Lanman, RB; Caulin, AF; St John, J; Cordero, AR; Giannikopoulos, P; Simmons, AD; Mack, PC; Gandara, DR; Husain, H; Doebele, RC; Riess, JW; Diehn, M; Swanton, C; Bivona, TG				Blakely, Collin M.; Watkins, Thomas B. K.; Wu, Wei; Gini, Beatrice; Chabon, Jacob J.; McCoach, Caroline E.; McGranahan, Nicholas; Wilson, Gareth A.; Birkbak, Nicolai J.; Olivas, Victor R.; Rotow, Julia; Maynard, Ashley; Wang, Victoria; Gubens, Matthew A.; Banks, Kimberly C.; Lanman, Richard B.; Caulin, Aleah F.; St John, John; Cordero, Anibal R.; Giannikopoulos, Petros; Simmons, Andrew D.; Mack, Philip C.; Gandara, David R.; Husain, Hatim; Doebele, Robert C.; Riess, Jonathan W.; Diehn, Maximilian; Swanton, Charles; Bivona, Trever G.			Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers	NATURE GENETICS			English	Article							CIRCULATING TUMOR DNA; ACQUIRED-RESISTANCE; MET AMPLIFICATION; MUTATIONS; HETEROGENEITY; ACTIVATION; EXPRESSION; INHIBITOR; AZD9291; CELLS	A widespread approach to modern cancer therapy is to identify a single oncogenic driver gene and target its mutant-protein product (for example, EGFR-inhibitor treatment in EGFR-mutant lung cancers). However, genetically driven resistance to targeted therapy limits patient survival. Through genomic analysis of 1,122 EGFR-mutant lung cancer cell-free DNA samples and whole-exome analysis of seven longitudinally collected tumor samples from a patient with EGFR-mutant lung cancer, we identified critical co-occurring oncogenic events present in most advanced-stage EGFR-mutant lung cancers. We defined new pathways limiting EGFR-inhibitor response, including WNT/beta-catenin alterations and cell-cycle-gene (CDK4 and CDK6) mutations. Tumor genomic complexity increases with EGFR-inhibitor treatment, and co-occurring alterations in CTNNB1 and PIK3CA exhibit nonredundant functions that cooperatively promote tumor metastasis or limit EGFR-inhibitor response. This study calls for revisiting the prevailing single-gene driver-oncogene view and links clinical outcomes to co-occurring genetic alterations in patients with advanced-stage EGFR-mutant lung cancer.	[Blakely, Collin M.; Wu, Wei; Gini, Beatrice; Olivas, Victor R.; Rotow, Julia; Maynard, Ashley; Wang, Victoria; Gubens, Matthew A.; Bivona, Trever G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Blakely, Collin M.; Wu, Wei; Gini, Beatrice; Olivas, Victor R.; Rotow, Julia; Maynard, Ashley; Wang, Victoria; Gubens, Matthew A.; Bivona, Trever G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Watkins, Thomas B. K.; McGranahan, Nicholas; Wilson, Gareth A.; Birkbak, Nicolai J.; Swanton, Charles] UCL Canc Inst, Canc Res UK Lung Canc Ctr Excellence, Francis Crick Inst, London, England; [Chabon, Jacob J.; Diehn, Maximilian] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA USA; [McCoach, Caroline E.; Doebele, Robert C.] Univ Colorado, Div Med Oncol, Dept Med, Aurora, CO USA; [Banks, Kimberly C.; Lanman, Richard B.] Guardant Hlth Inc, Redwood City, CA USA; [Caulin, Aleah F.; St John, John; Cordero, Anibal R.; Giannikopoulos, Petros] Driver Inc, San Francisco, CA USA; [Simmons, Andrew D.] Clovis Oncol Inc, Boulder, CO USA; [Mack, Philip C.; Gandara, David R.; Riess, Jonathan W.] Univ Calif Davis, Canc Ctr, Sacramento, CA 95817 USA; [Husain, Hatim] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Cancer Research UK; Francis Crick Institute; University of London; University College London; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Davis; University of California System; University of California San Diego	Bivona, TG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Bivona, TG (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Swanton, C (corresponding author), UCL Canc Inst, Canc Res UK Lung Canc Ctr Excellence, Francis Crick Inst, London, England.	charles.swanton@crick.ac.uk; trever.bivona@ucsf.edu	McGranahan, Nicholas/ABD-6561-2021; wu, wei/J-2797-2019; Doebele, Robert C./I-8230-2019; Lanman, Richard B/D-8290-2016	McGranahan, Nicholas/0000-0001-9537-4045; wu, wei/0000-0002-6556-067X; Doebele, Robert C./0000-0001-6728-6857; Lanman, Richard B/0000-0001-8122-4329; Maynard, Ashley/0000-0002-3588-3080; Birkbak, Nicolai/0000-0003-1613-9587; Diehn, Maximilian/0000-0003-2032-0581; Banks, Kimberly/0000-0002-1290-3114; Swanton, Charles/0000-0002-4299-3018	NIH [NCI-R01CA169338, NCI-DP2CA174497]; Pew Charitable Trust; Stewart Foundation; Searle Foundation; AACR; Lung Cancer Research Foundation; Cancer Research UK [19310, 20466, 17786] Funding Source: researchfish; Medical Research Council [MR/P014712/1] Funding Source: researchfish; Rosetrees Trust [M445, M231-CD1, M391, M640, M179] Funding Source: researchfish; The Francis Crick Institute [10170, VEG 108844, 10172, 10359, 10174, A1278, C28575/A25223, 10485, 10467, C60895/A23896, 10169] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U54CA224081, DP2CA174497, R01CA169338, P50CA058187, R01CA211052, R01CA204302, U01CA217882] Funding Source: NIH RePORTER; MRC [MR/P014712/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trust; Stewart Foundation; Searle Foundation; AACR; Lung Cancer Research Foundation; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge funding support from the NIH (NCI-R01CA169338, NIH Director's New Innovator Award NCI-DP2CA174497), the Pew Charitable Trust, Stewart Foundation, and Searle Foundation (to T.G.B.), and the AACR and Lung Cancer Research Foundation (C.M.B.). The authors thank J. Blakely for artwork and A. Sabnis, R. Okimoto, A. Tulpule, and M. Hutchinson for critical review and input on the manuscript. The authors acknowledge the following researchers for providing plasmids through Addgene: E. Campeau (University of Massachusetts Medical School); H. Land and J. Morgenstern (Imperial Cancer Research Fund); B. Weinberg (Whitehead Institute for Biomedical Research); J. Zhao (Dana-Farber Cancer Institute, Harvard Medical School); and E. Fearon (University of Michigan School of Medicine).	Blakely CM, 2015, CELL REP, V11, P98, DOI 10.1016/j.celrep.2015.03.012; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Canale M, 2017, CLIN CANCER RES, V23, P2195, DOI 10.1158/1078-0432.CCR-16-0966; Chabon JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11815; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Dorantes-Heredia R, 2016, TRANSL LUNG CANCER R, V5, P401, DOI 10.21037/tlcr.2016.07.10; Eberlein CA, 2015, CANCER RES, V75, P2489, DOI 10.1158/0008-5472.CAN-14-3167; Gamallo C, 1999, AM J PATHOL, V155, P527, DOI 10.1016/S0002-9440(10)65148-6; Ho CC, 2017, J THORAC ONCOL, V12, P567, DOI 10.1016/j.jtho.2016.11.2231; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Lanman RB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140712; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Okimoto RA, 2017, NAT GENET, V49, P87, DOI 10.1038/ng.3728; Ortmann CA, 2015, NEW ENGL J MED, V372, P601, DOI 10.1056/NEJMoa1412098; Ou SHI, 2016, LUNG CANCER, V98, P59, DOI 10.1016/j.lungcan.2016.05.015; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Politi K, 2010, DIS MODEL MECH, V3, P111, DOI 10.1242/dmm.003681; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson JC, 2016, CLIN CANCER RES, V22, P5772, DOI 10.1158/1078-0432.CCR-16-1231; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Trejo CL, 2013, CANCER RES, V73, P6448, DOI 10.1158/0008-5472.CAN-13-0681; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; VanderLaan PA, 2017, LUNG CANCER, V106, P17, DOI 10.1016/j.lungcan.2017.01.011; Villaflor V, 2016, ONCOTARGET, V7, P66880, DOI 10.18632/oncotarget.11801; Wang XY, 1999, EXP CELL RES, V250, P253, DOI 10.1006/excr.1999.4529; Yu HA, 2014, ANN ONCOL, V25, P423, DOI 10.1093/annonc/mdt573; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhao JJ, 2005, P NATL ACAD SCI USA, V102, P18443, DOI 10.1073/pnas.0508988102	37	307	316	3	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2017	49	12					1693	+		10.1038/ng.3990	http://dx.doi.org/10.1038/ng.3990			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FO0XY	29106415	Green Submitted, Green Accepted			2022-12-17	WOS:000416480600008
J	Lotta, LA; Gulati, P; Day, FR; Payne, F; Ongen, H; van de Bunt, M; Gaulton, KJ; Eicher, JD; Sharp, SJ; Luan, JA; Rolfe, ED; Stewart, ID; Wheeler, E; Willems, SM; Adams, C; Yaghootkar, H; Forouhi, NG; Khaw, KT; Johnson, AD; Semple, RK; Frayling, T; Perry, JRB; Dermitzakis, E; McCarthy, MI; Barroso, I; Wareham, NJ; Savage, DB; Langenberg, C; O'Rahilly, S; Scott, RA				Lotta, Luca A.; Gulati, Pawan; Day, Felix R.; Payne, Felicity; Ongen, Halit; van de Bunt, Martijn; Gaulton, Kyle J.; Eicher, John D.; Sharp, Stephen J.; Luan, Jian'an; Rolfe, Emanuella De Lucia; Stewart, Isobel D.; Wheeler, Eleanor; Willems, Sara M.; Adams, Claire; Yaghootkar, Hanieh; Forouhi, Nita G.; Khaw, Kay-Tee; Johnson, Andrew D.; Semple, Robert K.; Frayling, Timothy; Perry, John R. B.; Dermitzakis, Emmanouil; McCarthy, Mark I.; Barroso, Ines; Wareham, Nicholas J.; Savage, David B.; Langenberg, Claudia; O'Rahilly, Stephen; Scott, Robert A.		EPIC-InterAct Consortium; Cambridge FPLD1 Consortium	Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance	NATURE GENETICS			English	Article							BODY-FAT DISTRIBUTION; TISSUE EXPANDABILITY; LIPOPROTEIN-LIPASE; METABOLIC SYNDROME; DIABETES-MELLITUS; ABDOMINAL OBESITY; WIDE ASSOCIATION; GENETIC-EVIDENCE; GLYCEMIC TRAITS; ECTOPIC FAT	Insulin resistance is a key mediator of obesity-related cardiometabolic disease, yet the mechanisms underlying this link remain obscure. Using an integrative genomic approach, we identify 53 genomic regions associated with insulin resistance phenotypes (higher fasting insulin levels adjusted for BMI, lower HDL cholesterol levels and higher triglyceride levels) and provide evidence that their link with higher cardiometabolic risk is underpinned by an association with lower adipose mass in peripheral compartments. Using these 53 loci, we show a polygenic contribution to familial partial lipodystrophy type 1, a severe form of insulin resistance, and highlight shared molecular mechanisms in common/mild and rare/severe insulin resistance. Population-level genetic analyses combined with experiments in cellular models implicate CCDC92, DNAH10 and L3MBTL3 as previously unrecognized molecules influencing adipocyte differentiation. Our findings support the notion that limited storage capacity of peripheral adipose tissue is an important etiological component in insulin-resistant cardiometabolic disease and highlight genes and mechanisms underpinning this link.	[Lotta, Luca A.; Day, Felix R.; Sharp, Stephen J.; Luan, Jian'an; Rolfe, Emanuella De Lucia; Stewart, Isobel D.; Willems, Sara M.; Forouhi, Nita G.; Perry, John R. B.; Wareham, Nicholas J.; Langenberg, Claudia; Scott, Robert A.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Gulati, Pawan; Adams, Claire; Semple, Robert K.; Barroso, Ines; Savage, David B.; O'Rahilly, Stephen] Univ Cambridge, Metabol Res Labs, Cambridge, England; [Payne, Felicity; Wheeler, Eleanor; Barroso, Ines] Wellcome Trust Sanger Inst, Hinxton, England; [Ongen, Halit; Dermitzakis, Emmanouil] Univ Geneva, Sch Med, Dept Genet Med & Dev, Geneva, Switzerland; [van de Bunt, Martijn; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [van de Bunt, Martijn; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Gaulton, Kyle J.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Eicher, John D.; Johnson, Andrew D.] NHLBI, Populat Sci Branch, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA; [Yaghootkar, Hanieh; Frayling, Timothy] Univ Exeter, Sch Med, Royal Devon & Exeter Hosp, Genet Complex Traits,Inst Biomed & Clin Sci, Exeter, Devon, England; [Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; University of Geneva; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Exeter; University of Cambridge	Wareham, NJ; Langenberg, C; Scott, RA (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.; Barroso, I; Savage, DB; O'Rahilly, S (corresponding author), Univ Cambridge, Metabol Res Labs, Cambridge, England.; Barroso, I (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	ib1@sanger.ac.uk; nick.wareham@mrc-epid.cam.ac.uk; dbs23@medschl.cam.ac.uk; claudia.langenberg@mrc-epid.cam.ac.uk; so104@medschl.cam.ac.uk; robert.scott@mrc-epid.cam.ac.uk	Langenberg, Claudia/ABG-9067-2021; Salamanca-Fernandez, Elena/R-5943-2016; Khaw, Kay-Tee/AAZ-3209-2021; O'Rahilly, Stephen/ABF-6509-2020; Grioni, Sara/K-5320-2016; Johnson, Andrew D/G-6520-2013; Payne, Felicity/GKF-2573-2022; Semple, Robert/AAB-2948-2019; McCarthy, Mark/M-3763-2015; duvnjak, lea/S-8581-2018	Langenberg, Claudia/0000-0002-5017-7344; Salamanca-Fernandez, Elena/0000-0002-1795-2206; O'Rahilly, Stephen/0000-0003-2199-4449; Grioni, Sara/0000-0002-5891-8426; Johnson, Andrew D/0000-0001-6369-5178; Payne, Felicity/0000-0003-4228-581X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Lotta, Luca Andrea/0000-0002-2619-5956; Overvad, Kim/0000-0001-6429-7921; , Hanieh/0000-0001-9672-9477; Sacerdote, Carlotta/0000-0002-8008-5096; van de Bunt, Martijn/0000-0002-6744-6125; Semple, Robert Kenneth/0000-0001-6539-3069; McCarthy, Mark/0000-0002-4393-0510; Savage, David Bousfield/0000-0002-7857-7032; Ongen, Halit/0000-0002-4197-5790; Franks, Paul/0000-0002-0520-7604; duvnjak, lea/0000-0001-8173-5348; Forouhi, Nita/0000-0002-5041-248X; tumino, rosario/0000-0003-2666-414X; Wheeler, Eleanor/0000-0002-8616-6444; Tjonneland, Anne/0000-0003-4385-2097; Day, Felix/0000-0003-3789-7651; Riboli, Elio/0000-0001-6795-6080; Kerrison, Nicola/0000-0002-1471-953X; Barroso, Ines/0000-0001-5800-4520; Gulati, Pawan/0000-0002-0902-8072; Ellard, Sian/0000-0002-7620-5526; Frayling, Timothy/0000-0001-8362-2603; Mukhtar, Rasha/0000-0003-0749-6814	UK Medical Research Council [MC_UU_12015/1, MC_PC_13046, MC_PC_13048, MR/L00002/1]; MRC Metabolic Diseases Unit [MC_UU_12012/5]; Cambridge NIHR Biomedical Research Centre; EU/EFPIA Innovative Medicines Initiative (EMIF grant ) [115372]; EU FP6 program [LSHM_CT_2006_037197]; Novo Nordisk; Wellcome Trust [107064, 090532, 098381, WT098051, 095515/Z/11/Z, 100574/Z/12/Z]; University of Oxford; MRC [MC_UU_12015/2, MC_U106179472, MC_UP_A100_1003, MR/N003284/1, MC_UU_12012/5, MC_UU_12015/1, MC_UU_12015/5] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006170] Funding Source: NIH RePORTER; Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [MR/L00002/1, MC_PC_13048, MR/N003284/1, MC_UU_12012/5, G0401527, MC_UU_12015/1, G1000143, MC_UP_A100_1003, MC_UU_12012/5/B, MC_U106179472, MC_UU_12015/2, MC_UU_12015/5, MC_U106179471, MC_qA137853, MC_PC_13046] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10109, NF-SI-0512-10114, NF-SI-0507-10380, CL-2011-18-004, NF-SI-0512-10135] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Metabolic Diseases Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); EU/EFPIA Innovative Medicines Initiative (EMIF grant ); EU FP6 program(European Commission); Novo Nordisk(Novo Nordisk); Wellcome Trust(Wellcome Trust); University of Oxford; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the UK Medical Research Council through grants MC_UU_12015/1, MC_PC_13046, MC_PC_13048 and MR/L00002/1. This work was supported by the MRC Metabolic Diseases Unit (MC_UU_12012/5) and the Cambridge NIHR Biomedical Research Centre and EU/EFPIA Innovative Medicines Initiative Joint Undertaking (EMIF grant 115372). Funding for the InterAct project was provided by the EU FP6 program (grant LSHM_CT_2006_037197). This work was funded, in part, through an EFSD Rising Star award to R.A.S. supported by Novo Nordisk. D.B.S. is supported by Wellcome Trust grant 107064. M.I.M. is a Wellcome Trust Senior Investigator and is supported by the following grants from the Wellcome Trust: 090532 and 098381. M.v.d.B. is supported by a Novo Nordisk postdoctoral fellowship run in partnership with the University of Oxford. I.B. is supported by Wellcome Trust grant WT098051. S.O'R. acknowledges funding from the Wellcome Trust (Wellcome Trust Senior Investigator Award 095515/Z/11/Z and Wellcome Trust Strategic Award 100574/Z/12/Z).	Arner P, 2003, TRENDS ENDOCRIN MET, V14, P137, DOI 10.1016/S1043-2760(03)00024-9; Avila M, 2015, CLIN GENET; Baughman BM, 2016, ACS CHEM BIOL, V11, P722, DOI 10.1021/acschembio.5b00632; Biggs ML, 2010, JAMA-J AM MED ASSOC, V303, P2504, DOI 10.1001/jama.2010.843; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chudasama KK, 2013, AM J HUM GENET, V93, P150, DOI 10.1016/j.ajhg.2013.05.023; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Dahlman I, 2016, DIABETES, V65, P433, DOI 10.2337/db15-0828; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Dyment DA, 2013, AM J HUM GENET, V93, P158, DOI 10.1016/j.ajhg.2013.06.005; FDA, 2008, GUID IND DIAB MELL E; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Gray SL, 2006, DIABETES, V55, P2669, DOI 10.2337/db06-0389; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Karpe F, 2015, NAT REV ENDOCRINOL, V11, P90, DOI 10.1038/nrendo.2014.185; Kernan WN, 2016, NEW ENGL J MED, V374, P1321, DOI 10.1056/NEJMoa1506930; Kilpelainen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Knowles JW, 2016, J CLIN INVEST, V126, P403, DOI 10.1172/JCI85921; KOZAKI K, 1993, J LIPID RES, V34, P1765; Lane JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112123; LILLIOJA S, 1988, DIABETES METAB REV, V4, P517, DOI 10.1002/dmr.5610040508; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lu YC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10495; MAILLY F, 1995, ARTERIOSCL THROM VAS, V15, P468, DOI 10.1161/01.ATV.15.4.468; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Paternoster L, 2011, HUM MOL GENET, V20, P4069, DOI 10.1093/hmg/ddr309; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pinnick KE, 2014, DIABETES, V63, P3785, DOI 10.2337/db14-0385; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Robbins AL, 2015, TRENDS MOL MED, V21, P433, DOI 10.1016/j.molmed.2015.04.004; ROBBINS DC, 1979, METABOLISM, V28, P908, DOI 10.1016/0026-0495(79)90090-8; Ryden M, 2014, J CLIN ENDOCR METAB, V99, pE1870, DOI 10.1210/jc.2014-1526; Salazar MR, 2013, DIABETES VASC DIS RE, V10, P346, DOI 10.1177/1479164113479809; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Scott RA, 2014, DIABETES, V63, P4378, DOI 10.2337/db14-0319; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Semple RK, 2011, ENDOCR REV, V32, P498, DOI 10.1210/er.2010-0020; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Singaraja RR, 2014, J LIPID RES, V55, P1693, DOI 10.1194/jlr.M048710; Smith U, 2015, J CLIN INVEST, V125, P1790, DOI 10.1172/JCI81507; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Stitziel NO, 2014, NEW ENGL J MED, V371, P2072, DOI 10.1056/NEJMoa1405386; Stitziel NO., 2016, NEW ENGL J MED, V374, P1134; Swerdlow DI, 2015, LANCET, V385, P351, DOI 10.1016/S0140-6736(14)61183-1; Thauvin-Robinet C, 2013, AM J HUM GENET, V93, P141, DOI 10.1016/j.ajhg.2013.05.019; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yaghootkar H, 2016, DIABETES, V65, P2448, DOI 10.2337/db15-1671; Yaghootkar H, 2014, DIABETES, V63, P4369, DOI 10.2337/db14-0318	77	307	310	4	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2017	49	1					17	26		10.1038/ng.3714	http://dx.doi.org/10.1038/ng.3714			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EG3WY	27841877	Green Accepted, Green Submitted			2022-12-17	WOS:000390976600007
J	Luo, DP; Xu, H; Liu, ZL; Guo, JX; Li, HY; Chen, LT; Fang, C; Zhang, QY; Bai, M; Yao, N; Wu, H; Wu, H; Ji, CH; Zheng, HQ; Chen, YL; Ye, S; Li, XY; Zhao, XC; Li, RQ; Liu, YG				Luo, Dangping; Xu, Hong; Liu, Zhenlan; Guo, Jingxin; Li, Heying; Chen, Letian; Fang, Ce; Zhang, Qunyu; Bai, Mei; Yao, Nan; Wu, Hong; Wu, Hao; Ji, Chonghui; Zheng, Huiqi; Chen, Yuanling; Ye, Shan; Li, Xiaoyu; Zhao, Xiucai; Li, Riqing; Liu, Yao-Guang			A detrimental mitochondrial-nuclear interaction causes cytoplasmic male sterility in rice	NATURE GENETICS			English	Article							PROGRAMMED-CELL-DEATH; GENE-EXPRESSION; MOLECULAR-BASIS; FERTILITY; PROTEIN; TRANSFORMATION; AGROBACTERIUM	Plant cytoplasmic male sterility (CMS) results from incompatibilities between the organellar and nuclear genomes and prevents self pollination, enabling hybrid crop breeding to increase yields(1-6). The Wild Abortive CMS (CMS-WA) has been exploited in the majority of 'three-line' hybrid rice production since the 1970s, but the molecular basis of this trait remains unknown. Here we report that a new mitochondrial gene, WA352, which originated recently in wild rice, confers CMS-WA because the protein it encodes interacts with the nuclear-encoded mitochondrial protein COX11. In CMS-WA lines, WA352 accumulates preferentially in the anther tapetum, thereby inhibiting COX11 function in peroxide metabolism and triggering premature tapetal programmed cell death and consequent pollen abortion. WA352-induced sterility can be suppressed by two restorer-of-fertility (Rf) genes, suggesting the existence of different mechanisms to counteract deleterious cytoplasmic factors. Thus, CMS-related cytoplasmic-nuclear incompatibility is driven by a detrimental interaction between a newly evolved mitochondrial gene and a conserved, essential nuclear gene.	[Luo, Dangping; Xu, Hong; Liu, Zhenlan; Guo, Jingxin; Li, Heying; Chen, Letian; Zhang, Qunyu; Bai, Mei; Wu, Hong; Wu, Hao; Ji, Chonghui; Zheng, Huiqi; Chen, Yuanling; Ye, Shan; Li, Xiaoyu; Zhao, Xiucai; Li, Riqing; Liu, Yao-Guang] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Key Lab Plant Funct Genom & Biotechnol, Guangdong Prov Higher Educ Inst,Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Luo, Dangping] Guangxi Univ, Coll Forestry, Nanning 530004, Peoples R China; [Fang, Ce; Yao, Nan] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangdong Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Hong; Wu, Hong] Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China	South China Agricultural University; Guangxi University; Sun Yat Sen University; Northwest A&F University - China	Liu, YG (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Key Lab Plant Funct Genom & Biotechnol, Guangdong Prov Higher Educ Inst,Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	ygliu@scau.edu.cn	yao, nan/F-2095-2011; Liu, Yao-Guang/B-1719-2015; Chen, Yuanling/C-7353-2015; hao, wu/HDM-1705-2022; Li, Xiaoyu/E-3267-2016; Chen, Letian/B-1263-2015; Wu, Hao/H-3115-2017; hao, wu/GXV-6924-2022; Luo, Dangping/Z-3973-2019	yao, nan/0000-0002-2045-5462; Chen, Letian/0000-0001-6413-636X; Ji, Chonghui/0000-0003-2724-0859	Ministry of Science and Technology of China [2011CB100203/2013CBA01401, 31230052, 2013CB126900]; National Natural Science Foundation of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank G. Zhang, X. Liu (South China Agricultural University) and Q. Qian (China National Rice Research Institute) for providing some rice materials, H. Pang for technical assistance (GIBH, CAS) and H. Ma (Fudan University), J.-M. Li (University of Michigan) and Z.-H. He (San Francisco State University) for critical reading of the manuscript. This work was supported by grants (2011CB100203/2013CBA01401, 31230052 and 2013CB126900) from the Ministry of Science and Technology of China and the National Natural Science Foundation of China to Y.-G.L.	ABAD AR, 1995, PLANT CELL, V7, P271, DOI 10.1105/tpc.7.3.271; Balk J, 2001, PLANT CELL, V13, P1803, DOI 10.1105/tpc.13.8.1803; Banting GS, 2006, EUKARYOT CELL, V5, P568, DOI 10.1128/EC.5.3.568-578.2006; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Carlsson J, 2011, ADVAN PL BIO, V1, P469; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Delph LF, 2007, TRENDS ECOL EVOL, V22, P17, DOI 10.1016/j.tree.2006.09.013; Diamond M, 2011, ADVAN PL BIO, V1, P439; Fan LM, 2001, J EXP BOT, V52, P1603, DOI 10.1093/jexbot/52.361.1603; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Guo JY, 2009, CHINESE SCI BULL, V54, P46, DOI 10.1007/s11434-008-0504-1; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; He SC, 1996, P NATL ACAD SCI USA, V93, P11763, DOI 10.1073/pnas.93.21.11763; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hu LF, 2011, PLANT CELL, V23, P515, DOI 10.1105/tpc.110.074369; [胡旭霞 Hu Xuxia], 2006, [分子植物育种, Molecular Plant Breeding], V4, P621; LASER KD, 1972, BOT REV, V38, P425, DOI 10.1007/BF02860010; LEVINGS CS, 1993, PLANT CELL, V5, P1285, DOI 10.2307/3869781; Li N, 2006, PLANT CELL, V18, P2999, DOI 10.1105/tpc.106.044107; Li SQ, 2005, ANN BOT-LONDON, V96, P461, DOI 10.1093/aob/mci197; Lin S. C., 1980, Innovative approaches to rice breeding. Selected papers from the 1979 International Rice Research Conference, P35; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; Liu ZL, 2007, J INTEGR PLANT BIOL, V49, P908, DOI 10.1111/j.1744-7909.2007.00493.x; Lu Y, 1997, THEOR APPL GENET, V94, P27, DOI 10.1007/s001220050377; Luo H, 2006, PLANT MOL BIOL, V62, P397, DOI 10.1007/s11103-006-9031-0; Papini A, 1999, PROTOPLASMA, V207, P213, DOI 10.1007/BF01283002; Sabar M, 2003, EMBO REP, V4, P381, DOI 10.1038/sj.embor.embor800; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Veniamin S, 2011, FREE RADICAL BIO MED, V51, P1589, DOI 10.1016/j.freeradbiomed.2011.06.024; Virmani S. S., 2003, Hybrid rice for food security, poverty alleviation and environmental protection. Proceedings of the 4th International Symposium on Hybrid Rice, Hanoi, Vietnam, 14-17 May, 2002, P7; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; WARMKE HE, 1978, SCIENCE, V200, P561, DOI 10.1126/science.200.4341.561; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Yao N, 2002, PLANT J, V30, P567, DOI 10.1046/j.1365-313X.2002.01314.x; Zhang QY, 2006, J INTEGR PLANT BIOL, V48, P1473, DOI 10.1111/j.1744-7909.2006.00384.x; Zhang Qun-Yu, 2002, Acta Genetica Sinica, V29, P1001; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x	43	307	370	14	337	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2013	45	5					573	U157		10.1038/ng.2570	http://dx.doi.org/10.1038/ng.2570			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133RU	23502780				2022-12-17	WOS:000318158200024
J	Xu, B; Ionita-Laza, J; Roos, JL; Boone, B; Woodrick, S; Sun, Y; Levy, S; Gogos, JA; Karayiorgou, M				Xu, Bin; Ionita-Laza, Juliana; Roos, J. Louw; Boone, Braden; Woodrick, Scarlet; Sun, Yan; Levy, Shawn; Gogos, Joseph A.; Karayiorgou, Maria			De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia	NATURE GENETICS			English	Article							ARCHITECTURE; PHENOTYPE; VARIANT	To evaluate evidence for de novo etiologies in schizophrenia, we sequenced at high coverage the exomes of families recruited from two populations with distinct demographic structures and history. We sequenced a total of 795 exomes from 231 parent-proband trios enriched for sporadic schizophrenia cases, as well as 34 unaffected trios. We observed in cases an excess of de novo nonsynonymous single-nucleotide variants as well as a higher prevalence of gene-disruptive de novo mutations relative to controls. We found four genes (LAMA2, DPYD, TRRAP and VPS39) affected by recurrent de novo events within or across the two populations, which is unlikely to have occurred by chance. We show that de novo mutations affect genes with diverse functions and developmental profiles, but we also find a substantial contribution of mutations in genes with higher expression in early fetal life. Our results help define the genomic and neural architecture of schizophrenia.	[Xu, Bin; Woodrick, Scarlet; Sun, Yan; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Ionita-Laza, Juliana] Columbia Univ, Dept Biostat, New York, NY USA; [Roos, J. Louw] Weskoppies Hosp, Pretoria, South Africa; [Roos, J. Louw] Univ Pretoria, Dept Psychiat, ZA-0002 Pretoria, South Africa; [Boone, Braden; Levy, Shawn] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Woodrick, Scarlet; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY USA	Columbia University; Columbia University; University of Pretoria; HudsonAlpha Institute for Biotechnology; Columbia University; Columbia University	Karayiorgou, M (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	jag90@columbia.edu; mk2758@columbia.edu		Roos, Johannes/0000-0002-0572-1072; Levy, Shawn/0000-0002-1369-5740	National Institute of Mental Health (NIMH) [MH061399, MH077235]; Lieber Center for Schizophrenia Research at Columbia University; National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077235, R01MH095797, R01MH061399] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lieber Center for Schizophrenia Research at Columbia University; National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are enormously grateful to all the families who participated in this research. We thank H. Pretorius and nursing sisters R. van Wyk, C. Botha and H. van den Berg for their assistance with subject recruitment, family history assessments and diagnostic evaluations. We thank S.L. Lundy for valuable assistance with clinical database maintenance and L. Rodriguez-Murillo for help with Supplementary Figure 9. We also thank B. Plummer and NI. Robinson and the HudsonAlpha Genomics Services Laboratory for experimental support. Finally, we thank L.J. Mienie for the thymine loading test. This work was partially supported by National Institute of Mental Health (NIMH) grants MH061399 (to MAC) and MH077235 (to J.A.G.) and the Lieber Center for Schizophrenia Research at Columbia University. B.X. was partially supported by a National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Award.	Arguello PA, 2012, TRENDS NEUROSCI, V35, P3, DOI 10.1016/j.tins.2011.11.007; Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283; Carter MT, 2011, CLIN GENET, V80, P435, DOI 10.1111/j.1399-0004.2010.01578.x; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gilman S.R., NAT NEUROSC IN PRESS; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Karayiorgou M, 2012, NAT NEUROSCI, V15, P811, DOI 10.1038/nn.3115; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; McGrath JJ, 2009, MED J AUSTRALIA, V190, pS7, DOI 10.5694/j.1326-5377.2009.tb02366.x; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rodriguez-Murillo L, 2012, ANNU REV MED, V63, P63, DOI 10.1146/annurev-med-072010-091100; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sobin C, 2003, PSYCHIAT RES, V117, P113, DOI 10.1016/S0165-1781(02)00321-9; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Tiedje KE, 2010, NEUROCHEM INT, V57, P177, DOI 10.1016/j.neuint.2010.06.001; Van Kuilenburg ABP, 1999, HUM GENET, V104, P1, DOI 10.1007/PL00008711; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Xu B, 2009, P NATL ACAD SCI USA, V106, P16746, DOI 10.1073/pnas.0908584106	31	307	312	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2012	44	12					1365	1369		10.1038/ng.2446	http://dx.doi.org/10.1038/ng.2446			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	045QZ	23042115	Green Accepted			2022-12-17	WOS:000311713200017
J	Young, ND; Jex, AR; Li, B; Liu, SP; Yang, LF; Xiong, ZJ; Li, YR; Cantacessi, C; Hall, RS; Xu, X; Chen, FY; Wu, X; Zerlotini, A; Oliveira, G; Hofmann, A; Zhang, GJ; Fang, XD; Kang, Y; Campbell, BE; Loukas, A; Ranganathan, S; Rollinson, D; Rinaldi, G; Brindley, PJ; Yang, HM; Wang, J; Wang, J; Gasser, RB				Young, Neil D.; Jex, Aaron R.; Li, Bo; Liu, Shiping; Yang, Linfeng; Xiong, Zijun; Li, Yingrui; Cantacessi, Cinzia; Hall, Ross S.; Xu, Xun; Chen, Fangyuan; Wu, Xuan; Zerlotini, Adhemar; Oliveira, Guilherme; Hofmann, Andreas; Zhang, Guojie; Fang, Xiaodong; Kang, Yi; Campbell, Bronwyn E.; Loukas, Alex; Ranganathan, Shoba; Rollinson, David; Rinaldi, Gabriel; Brindley, Paul J.; Yang, Huanming; Wang, Jun; Wang, Jian; Gasser, Robin B.			Whole-genome sequence of Schistosoma haematobium	NATURE GENETICS			English	Article							HUMAN BLOOD FLUKE; GENETIC MANIPULATION; MANSONI; JAPONICUM; PATHOGEN; IMMUNITY; TARGETS; HEALTH	Schistosomiasis is a neglected tropical disease caused by blood flukes (genus Schistosoma; schistosomes) and affecting 200 million people worldwide(1). No vaccines are available, and treatment relies on one drug, praziquantel(2). Schistosoma haematobium has come into the spotlight as a major cause of urogenital disease, as an agent linked to bladder cancer(1,3) and as a predisposing factor for HIV/AIDS(4,5). The parasite is transmitted to humans from freshwater snails'. Worms dwell in blood vessels and release eggs that become embedded in the bladder wall to elicit chronic immune-mediated disease(6) and induce squamous cell carcinoma(7). Here we sequenced the 385-Mb genome of S. haematobium using Illumina-based technology at 74-fold coverage and compared it to sequences from related parasites(8,9). We included genome annotation based on function, gene ontology, networking and pathway mapping. This genome now provides an unprecedented resource for many fundamental research areas and shows great promise for the design of new disease interventions.	[Young, Neil D.; Jex, Aaron R.; Cantacessi, Cinzia; Hall, Ross S.; Hofmann, Andreas; Campbell, Bronwyn E.; Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Melbourne, Vic 3010, Australia; [Li, Bo; Liu, Shiping; Yang, Linfeng; Xiong, Zijun; Li, Yingrui; Xu, Xun; Chen, Fangyuan; Wu, Xuan; Zhang, Guojie; Fang, Xiaodong; Kang, Yi; Yang, Huanming; Wang, Jun; Wang, Jian] BGI Shenzhen, Shenzhen, Peoples R China; [Zerlotini, Adhemar; Oliveira, Guilherme] Inst Pesquisa Rene Rachou Fiocruz, Inst Nacl Ciencia & Tecnol Doencas Tropicais, Belo Horizonte, MG, Brazil; [Hofmann, Andreas] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Loukas, Alex] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Cairns, Qld, Australia; [Ranganathan, Shoba] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Ranganathan, Shoba] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Rollinson, David] Nat Hist Museum, London SW7 5BD, England; [Rinaldi, Gabriel] Univ Republica, Dept Genet, Montevideo, Uruguay; [Rinaldi, Gabriel; Brindley, Paul J.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA	University of Melbourne; Beijing Genomics Institute (BGI); Fundacao Oswaldo Cruz; Griffith University; James Cook University; Macquarie University; National University of Singapore; Natural History Museum London; Universidad de la Republica, Uruguay; George Washington University	Gasser, RB (corresponding author), Univ Melbourne, Fac Vet Sci, Melbourne, Vic 3010, Australia.	wangjian@genomics.org.cn wangjian@genomics.org.cn; wangjian@genomics.org.cn wangjian@genomics.org.cn	Zhang, Guojie/B-6188-2014; Yang, Linfeng/AAZ-8792-2020; Cantacessi, Cinzia/B-7356-2014; Fang, Xiaodong/K-6743-2018; Wang, Jun/A-7261-2013; Hofmann, Andreas/B-9515-2008; DoenÃas Tropicais, Inct/K-2308-2013; Zerlotini, Adhemar/E-6533-2012; Gasser, Robin/ABH-6185-2020; Loukas, Alex/B-7355-2014; Young, Neil David/AAU-4572-2020; Li, Yingrui/K-1064-2015; Rollinson, David/C-7406-2009; Xu, Xun/AAI-6763-2020; Zhang, Guojie/J-7273-2019; Hofmann, Andreas/M-9870-2019; Jex, Aaron/AGZ-7897-2022; Oliveira, Guilherme/E-2624-2014; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Zhang, Guojie/0000-0001-6860-1521; Cantacessi, Cinzia/0000-0001-6863-2950; Fang, Xiaodong/0000-0001-7061-3337; Hofmann, Andreas/0000-0003-4408-5467; Zerlotini, Adhemar/0000-0002-7739-0284; Gasser, Robin/0000-0002-4423-1690; Loukas, Alex/0000-0002-0896-8441; Young, Neil David/0000-0001-8756-229X; Xu, Xun/0000-0002-5338-5173; Zhang, Guojie/0000-0001-6860-1521; Hofmann, Andreas/0000-0003-4408-5467; Jex, Aaron/0000-0002-1285-7947; LIU, Shiping/0000-0003-0019-619X; Brindley, Paul J./0000-0003-1765-0002; Oliveira, Guilherme/0000-0003-0054-3438; Campbell, Bronwyn/0000-0001-9090-764X; Wang, Jun/0000-0002-8540-8931; Rinaldi, Gabriel/0000-0002-7767-4922; Wang, Jun/0000-0002-2113-5874; Xiong, Zijun/0000-0003-3923-0703; Ranganathan, Shoba/0000-0002-8290-813X	Australian Research Council; BGI; National Health and Medical Research Council (NHMRC) of Australia; Australian Academy of Science; Australian-American Fulbright Commission; Melbourne Water Corporation; Victorian Life Sciences Computation Initiative (VLSCI); IBM Collaboratory; NHMRC; Liang of the Biomedical Research Institute, under NIAID-NIH [HHSN272201000005I]; NIH-Fogarty [TW007012]; FAPEMIG [CBB-1181/08]; CNPq [573839/2008-5]; FOGARTY INTERNATIONAL CENTER [D43TW007012] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); BGI; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Academy of Science; Australian-American Fulbright Commission; Melbourne Water Corporation; Victorian Life Sciences Computation Initiative (VLSCI); IBM Collaboratory(International Business Machines (IBM)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Liang of the Biomedical Research Institute, under NIAID-NIH; NIH-Fogarty(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was funded by the Australian Research Council (R.B.G. and H.M.Y.) and BGI. We are grateful for other support from the National Health and Medical Research Council (NHMRC) of Australia (R.B.G.), the Australian Academy of Science, the Australian-American Fulbright Commission, Melbourne Water Corporation, the Victorian Life Sciences Computation Initiative (VLSCI) and the IBM Collaboratory. N.D.Y. (Early Career Research Fellow) and A.R.J. (CDA1 Fellow) were supported by NHMRC fellowships. We thank staff of BGI-Shenzhen, including Q. Nan, P. Na, B. Min and P. Ni for their contributions. Schistosoma haematobium-infected hamsters were provided by F.A. Lewis and Y.-S. Liang of the Biomedical Research Institute, under NIAID-NIH contract HHSN272201000005I. G.O. is supported by NIH-Fogarty TW007012, FAPEMIG CBB-1181/08 and CNPq 573839/2008-5.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Botelho MC, 2010, VIRULENCE, V1, P84, DOI 10.4161/viru.1.2.10487; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brindley PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000538; Caffrey CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004413; Criscione CD, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r71; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Fitzpatrick JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000543; Geyer KK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1433; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; Gomes MD, 2011, GENOMICS, V98, P96, DOI 10.1016/j.ygeno.2011.05.007; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000430; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Liu F, 2009, MOL CELL PROTEOMICS, V8, P1236, DOI 10.1074/mcp.M800538-MCP200; Mann VH, 2010, PARASITOLOGY, V137, P451, DOI 10.1017/S0031182009991211; Mathieson W, 2010, INT J PARASITOL, V40, P617, DOI 10.1016/j.ijpara.2009.10.014; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Palumbo E, 2007, INFECT DIS CLIN PRAC, V15, P145, DOI 10.1097/01.idc.0000269904.90155.ce; Rinaldi G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001348; Rollinson D, 2009, PARASITOLOGY, V136, P1593, DOI 10.1017/S0031182009990552; Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium, 2009, NATURE, V460, P345; Schramm G, 2007, J IMMUNOL, V178, P6023, DOI 10.4049/jimmunol.178.10.6023; SHORT RB, 1960, J PARASITOL, V46, P273, DOI 10.2307/3275488; Valentim CLL, 2009, MOL BIOCHEM PARASIT, V166, P81, DOI 10.1016/j.molbiopara.2009.02.010; Verjovski-Almeida S, 2011, J PROTEOMICS, V74, P1515, DOI 10.1016/j.jprot.2011.03.022; Webster BL, 2006, INT J PARASITOL, V36, P947, DOI 10.1016/j.ijpara.2006.03.005	30	307	319	6	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2012	44	2					221	225		10.1038/ng.1065	http://dx.doi.org/10.1038/ng.1065			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883WA	22246508	Green Accepted, hybrid, Green Published			2022-12-17	WOS:000299664400024
J	Li, M; Zhao, H; Zhang, XS; Wood, LD; Anders, RA; Choti, MA; Pawlik, TM; Daniel, HD; Kannangai, R; Offerhaus, GJA; Velculescu, VE; Wang, LF; Zhou, SB; Vogelstein, B; Hruban, RH; Papadopoulos, N; Cai, JQ; Torbenson, MS; Kinzler, KW				Li, Meng; Zhao, Hong; Zhang, Xiaosong; Wood, Laura D.; Anders, Robert A.; Choti, Michael A.; Pawlik, Timothy M.; Daniel, Hubert D.; Kannangai, Rajesh; Offerhaus, G. Johan A.; Velculescu, Victor E.; Wang, Linfang; Zhou, Shibin; Vogelstein, Bert; Hruban, Ralph H.; Papadopoulos, Nick; Cai, Jianqiang; Torbenson, Michael S.; Kinzler, Kenneth W.			Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma	NATURE GENETICS			English	Article							HEPATITIS-B-VIRUS; EXPRESSION; HEPATOCARCINOGENESIS; AFLATOXIN	Through exomic sequencing of ten hepatitis C virus (HCV)-associated hepatocellular carcinomas (HCC) and subsequent evaluation of additional affected individuals, we discovered novel inactivating mutations of ARID2 in four major subtypes of HCC (HCV-associated HCC, hepatitis B virus (HBV)-associated HCC, alcohol-associated HCC and HCC with no known etiology). Notably, 18.2% of individuals with HCV-associated HCC in the United States and Europe harbored ARID2 inactivation mutations, suggesting that ARID2 is a tumor suppressor gene that is relatively commonly mutated in this tumor subtype.	[Li, Meng; Velculescu, Victor E.; Zhou, Shibin; Vogelstein, Bert; Papadopoulos, Nick; Kinzler, Kenneth W.] Johns Hopkins Univ, Sch Med, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21218 USA; [Zhao, Hong; Cai, Jianqiang] Chinese Acad Med Sci, Dept Abdominal Surg Oncol, Canc Hosp, Beijing 100730, Peoples R China; [Zhao, Hong; Wang, Linfang; Cai, Jianqiang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Xiaosong] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Wood, Laura D.; Anders, Robert A.; Daniel, Hubert D.; Kannangai, Rajesh; Hruban, Ralph H.; Torbenson, Michael S.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Choti, Michael A.; Pawlik, Timothy M.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Offerhaus, G. Johan A.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Wang, Linfang] Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100730, Peoples R China	Johns Hopkins University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Harvard University; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins University; Utrecht University; Utrecht University Medical Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Kinzler, KW (corresponding author), Johns Hopkins Univ, Sch Med, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21218 USA.	caijianqiang188@sina.com; mtorben@jhmi.edu; kinzlke@jhmi.edu	Pawlik, Timothy/AAO-9335-2020; Wood, Laura/ABF-1531-2020; Velculescu, Victor/ABF-4846-2020; Daniel, Hubert Darius/B-7430-2011; Papadopoulos, Nickolas/K-7272-2012	Velculescu, Victor/0000-0003-1195-438X; 	Virginia and D.K. Ludwig Fund for Cancer Research; US National Institutes of Health [CA43460, CA57345, CA62924, CA121113, DK078686, DK080736, DK081417]; AACR; National Science and Technology Major Project [2008ZX10002-025]; NATIONAL CANCER INSTITUTE [R01CA043460, P50CA062924, R01CA057345, R37CA043460, R37CA057345, R01CA121113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081417, R01DK078686, R01DK080736] Funding Source: NIH RePORTER	Virginia and D.K. Ludwig Fund for Cancer Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AACR; National Science and Technology Major Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Silliman, J. Ptak, L. Dobbyn, J. Schaeffer, M. Whalen, Z. Khan, J. Ma, Z. Wang and R. Mi for expert technical assistance. This work was supported by The Virginia and D.K. Ludwig Fund for Cancer Research and US National Institutes of Health grants CA43460, CA57345, CA62924, CA121113, DK078686, DK080736, DK081417, AACR Stand Up to Cancer Dream Team Translational Cancer Research Grant and National Science and Technology Major Project Grant 2008ZX10002-025.	American Cancer Society, 2009, CANC FACTS FIG 2009; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kew MC, 2003, LIVER INT, V23, P405, DOI 10.1111/j.1478-3231.2003.00869.x; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Melen K, 2004, J MED VIROL, V73, P536, DOI 10.1002/jmv.20123; Ming L, 2002, HEPATOLOGY, V36, P1214, DOI 10.1053/jhep.2002.36366; Mohrmann L, 2004, MOL CELL BIOL, V24, P3077, DOI 10.1128/MCB.24.8.3077-3088.2004; Okada T, 2003, FEBS LETT, V555, P583, DOI 10.1016/S0014-5793(03)01345-0; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805	14	307	331	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2011	43	9					828	829		10.1038/ng.903	http://dx.doi.org/10.1038/ng.903			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	812XE	21822264	Green Accepted			2022-12-17	WOS:000294325800006
J	Mikkers, H; Allen, J; Knipscheer, P; Romeijn, L; Hart, A; Vink, E; Berns, A				Mikkers, H; Allen, J; Knipscheer, P; Romeijn, L; Hart, A; Vink, E; Berns, A			High-throughput retroviral tagging to identify components of specific signaling pathways in cancer (vol 32, pg 153, 2002)	NATURE GENETICS			English	Correction																		Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b	1	307	335	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2002	32	3					459	459		10.1038/ng1102-459b	http://dx.doi.org/10.1038/ng1102-459b			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	611TX		Bronze			2022-12-17	WOS:000179034800028
J	Esterbauer, H; Schneitler, C; Oberkofler, H; Ebenbichler, C; Paulweber, B; Sandhofer, F; Ladurner, G; Hell, E; Strosberg, AD; Patsch, JR; Krempler, F; Patsch, W				Esterbauer, H; Schneitler, C; Oberkofler, H; Ebenbichler, C; Paulweber, B; Sandhofer, F; Ladurner, G; Hell, E; Strosberg, AD; Patsch, JR; Krempler, F; Patsch, W			A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans	NATURE GENETICS			English	Letter							UNCOUPLING PROTEIN-3 GENE; MESSENGER-RNA EXPRESSION; BODY-MASS INDEX; ENERGY-METABOLISM; PIMA-INDIANS; WEIGHT; REGION; TISSUE; DIET	Obesity is the most common nutritional disorder in Western society. Uncoupling protein-2 (UCP2) is a recently identified member of the mitochondrial transporter superfamily that is expressed in many tissues, including adipose tissue(1,2). Like its close relatives UCP1 and UCP3. UCP2 uncouples proton entry in the mitochondrial matrix from ATP synthesis(1,3) and is therefore a candidate gene for obesity(4-6). We show here that a common G/A polymorphism in the UCP2 promoter region is associated with enhanced adipose tissue mRNA expression in vivo and results in increased transcription of a reporter gene in the human adipocyte cell line PAZ-6. In analyzing 340 obese and 256 never-obese middle-aged subjects, we found a modest but significant reduction in obesity prevalence associated with the less-common allele. We confirmed this association in a population-based sample of 791 middle-aged subjects from the same geographic area. Despite its modest effect, but because of its high frequency (similar to 63%). the more-common risk allele conferred a relatively large population-attributable risk accounting for 15% of the obesity in the population studied.	Landskliniken Salzburg, Dept Lab Med, Salzburg, Austria; Univ Innsbruck, Dept Internal Med, A-6020 Innsbruck, Austria; Landskliniken Salzburg, Dept Internal Med, Salzburg, Austria; Landskliniken Salzburg, Dept Neurol, Salzburg, Austria; Inst Cochin Genet Mol, F-75014 Paris, France	University of Innsbruck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Patsch, W (corresponding author), Landskliniken Salzburg, Dept Lab Med, Salzburg, Austria.	w.patsch@lks.at		Esterbauer, Harald/0000-0001-7343-7455; Ebenbichler, Christoph/0000-0001-5025-7929				Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Bouchard C, 1997, HUM MOL GENET, V6, P1887, DOI 10.1093/hmg/6.11.1887; BRADBURN MJ, 1998, STATA TECHNICAL B, V44, P4; Cassell PG, 2000, DIABETOLOGIA, V43, P1558, DOI 10.1007/s001250051569; Chiano MN, 1998, ANN HUM GENET, V62, P55, DOI 10.1046/j.1469-1809.1998.6210055.x; Dalgaard LT, 1999, DIABETOLOGIA, V42, P1413, DOI 10.1007/s001250051312; Esterbauer H, 2000, J BIOL CHEM, V275, P36394, DOI 10.1074/jbc.M005713200; Esterbauer H, 1999, DIABETOLOGIA, V42, P302, DOI 10.1007/s001250051155; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; Kiefer I, 1998, ACTA MED AUST, V25, P126; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kozak LP, 2000, NAT MED, V6, P1092, DOI 10.1038/80412; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; MANDER AP, 2000, STAT TECH B, V55, P10; Oberkofler H, 1998, DIABETOLOGIA, V41, P940, DOI 10.1007/s001250051011; Otabe S, 2000, DIABETOLOGIA, V43, P245, DOI 10.1007/s001250050037; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; ROBINS J, 1986, AM J EPIDEMIOL, V124, P719, DOI 10.1093/oxfordjournals.aje.a114447; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Schrauwen P, 1999, INT J OBESITY, V23, P1242, DOI 10.1038/sj.ijo.0801057; Terwilliger J., 1994, HDB HUMAN GENETIC LI; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Walder K, 1998, HUM MOL GENET, V7, P1431, DOI 10.1093/hmg/7.9.1431; Zilberfarb V, 1997, J CELL SCI, V110, P801	30	307	321	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2001	28	2					178	183		10.1038/88911	http://dx.doi.org/10.1038/88911			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	437UK	11381268				2022-12-17	WOS:000169011800023
J	Delpire, E; Lu, JM; England, R; Dull, C; Thorne, T				Delpire, E; Lu, JM; England, R; Dull, C; Thorne, T			Deafness and imbalance associated with inactivation of the secretory Ma-K-2Cl co-transporter	NATURE GENETICS			English	Article							K-CL COTRANSPORTER; INNER-EAR; NA-K-2CL COTRANSPORTER; MOLECULAR-CLONING; LOOP DIURETICS; LOCALIZATION; CELLS; GENE; EXPRESSION; MUTATION	Deaf ness can result from a variety of gene defects'. Some genes involved in the physiology of hearing encode membrane transporters that regulate the ionic composition of the fluid bathing the inner ear. The endolymph is an extracellular fluid with an atypical composition that resembles the intracellular milieu, high in K+ and low in Na+. Recent studies have emphasized the prominent role of K+ channels in endolymph secretion(2-4) and mechanical transduction(5). Coupled electroneutral transport of Na+, K+ and Cl- is: mediated by two isoforms of the. Na-K-2Cl cotransporter:the absorptive isoform BSC1 (also called NKCC2, encoded by SIc12a1 in mouse) that is exclusively expressed in kidney;- and BSC2/NKCC1 (encoded by SIc12a2 in mouse).: the secretory isoform which has a wider pattern of expression including epithelia, muscle cells; neurons, and red blood cells(6,7). These Eo-transporters: share 57% homology at the amino acid level(8-11) and are pharmacologically inhibited by loop diuretics. There is functional(12-14) and histochemical(15-17) evidence for the presence of the secretory isoform of the Na-K-2Cl co-transporter in gerbil. rat and rabbit inner ear. We disrupted mouse SIc12a2 and report here that SIc12a2(-/-) mice are deaf and exhibit classic shaker/waltzer behaviour, indicative of inner-ear defects. We localized the co-transporter to key secreting epithelia of the mouse inner ear and-show that absence of functional co-transporter leads to structural damages in the inner ear consistent with a decrease in endolymph secretion.	Vanderbilt Univ, Med Ctr, Anesthesiol Res Div, Labs Cellular & Mol Physiol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Delpire, E (corresponding author), Vanderbilt Univ, Med Ctr, Anesthesiol Res Div, Labs Cellular & Mol Physiol, Nashville, TN 37232 USA.							Alvarez-Leefmans F.J., 1998, PRESYNAPTIC INHIBITI, P50; Belal A Jr, 1980, Am J Otolaryngol, V1, P275, DOI 10.1016/S0196-0709(80)80030-5; COOPERMAN LB, 1973, AM HEART J, V85, P831, DOI 10.1016/0002-8703(73)90434-1; Crouch JJ, 1997, J HISTOCHEM CYTOCHEM, V45, P773, DOI 10.1177/002215549704500601; DELPIRE E, 1994, J BIOL CHEM, V269, P25677; Deol M S, 1968, J Med Genet, V5, P137, DOI 10.1136/jmg.5.2.137; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Goto S, 1997, BRAIN RES, V765, P324, DOI 10.1016/S0006-8993(97)00679-3; Haas M, 1998, J BIOENERG BIOMEMBR, V30, P161, DOI 10.1023/A:1020521308985; Ikeda K, 1997, HEARING RES, V107, P1, DOI 10.1016/S0378-5955(97)00009-9; Kalatzis V, 1998, HUM MOL GENET, V7, P1589, DOI 10.1093/hmg/7.10.1589; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; MARCUS DC, 1987, HEARING RES, V30, P55, DOI 10.1016/0378-5955(87)90183-3; MARCUS NY, 1987, AM J PHYSIOL, V253, pF613, DOI 10.1152/ajprenal.1987.253.4.F613; Mizuta K, 1997, HEARING RES, V106, P154, DOI 10.1016/S0378-5955(97)00010-5; Mount DB, 1998, J EXP BIOL, V201, P2091; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Randall J, 1997, AM J PHYSIOL-CELL PH, V273, pC1267, DOI 10.1152/ajpcell.1997.273.4.C1267; ROSE BD, 1991, KIDNEY INT, V39, P336, DOI 10.1038/ki.1991.43; RYBAK LP, 1993, OTOLARYNG CLIN N AM, V26, P829; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; SHIGA N, 1995, BBA-BIOMEMBRANES, V1240, P48, DOI 10.1016/0005-2736(95)00175-1; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; WANGEMANN P, 1995, HEARING RES, V84, P19, DOI 10.1016/0378-5955(95)00009-S	30	307	328	1	46	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	1999	22	2					192	195		10.1038/9713	http://dx.doi.org/10.1038/9713			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202YX	10369265				2022-12-17	WOS:000080680900028
J	Hatada, I; Ohashi, H; Fukushima, Y; Kaneko, Y; Inoue, M; Komoto, Y; Okada, A; Ohishi, S; Nabetani, A; Morisaki, H; Nakayama, M; Niikawa, N; Mukai, T				Hatada, I; Ohashi, H; Fukushima, Y; Kaneko, Y; Inoue, M; Komoto, Y; Okada, A; Ohishi, S; Nabetani, A; Morisaki, H; Nakayama, M; Niikawa, N; Mukai, T			An imprinted gene p57(KIP2) is mutated in Beckwith-Wiedemann syndrome	NATURE GENETICS			English	Letter							AUTOSOMAL-DOMINANT INHERITANCE; DEPENDENT KINASE INHIBITOR; WILMS-TUMOR; CHROMOSOME-11; ALLELES; FAMILY; P21		SAITAMA CHILDRENS MED CTR,IWATSUKI,SAITAMA 339,JAPAN; SHINSHU UNIV,SCH MED,MATSUMOTO,NAGANO 390,JAPAN; SAITAMA CANC CTR,INA,SAITAMA 362,JAPAN; OSAKA UNIV,SCH MED,SUITA,OSAKA 565,JAPAN; NAGASAKI UNIV,SCH MED,NAGASAKI 852,JAPAN; OSAKA MED CTR,IZUMI,OSAKA 565,JAPAN; RES INST MATERNAL & CHILD HLTH,IZUMI,OSAKA 565,JAPAN	Saitama Children's Medical Center; Shinshu University; Osaka University; Nagasaki University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Hatada, I (corresponding author), NATL CARDIOVASC CTR,RES INST,5-7-1 FUJISHIRO DAI,SUITA,OSAKA 565,JAPAN.			da shi, xiang zi/0000-0002-2256-905X				BARLOW DP, 1994, TRENDS GENET, V10, P194, DOI 10.1016/0168-9525(94)90255-0; BEST LG, 1981, AM J MED GENET, V9, P291, DOI 10.1002/ajmg.1320090405; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; HARPER JW, 1993, CELL, V75, P805; Hatada I, 1996, HUM MOL GENET, V5, P783, DOI 10.1093/hmg/5.6.783; HATADA I, 1995, NAT GENET, V11, P204, DOI 10.1038/ng1095-204; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; Hoovers JMN, 1995, P NATL ACAD SCI USA, V92, P12456, DOI 10.1073/pnas.92.26.12456; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KOI M, 1993, SCIENCE, V260, P361, DOI 10.1126/science.8469989; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LUBINSKY M, 1974, LANCET, V1, P932; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; MONGHONG L, 1995, GENE DEV, V9, P639; MOUTOU C, 1992, J MED GENET, V29, P217, DOI 10.1136/jmg.29.4.217; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; NIIKAWA N, 1986, AM J MED GENET, V24, P41, DOI 10.1002/ajmg.1320240107; OHLSSON R, 1994, TRENDS GENET, V10, P415, DOI 10.1016/0168-9525(94)90100-7; OKANO Y, 1986, JPN J HUM GENET, V31, P365, DOI 10.1007/BF01907937; PAL N, 1990, ONCOGENE, V5, P1665; PING AJ, 1989, AM J HUM GENET, V44, P720; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; PUESCHEL SM, 1984, J PEDIATR-US, V104, P484, DOI 10.1016/S0022-3476(84)81127-0; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; SEIZINGER BR, 1991, CYTOGENET CELL GENET, V58, P1080, DOI 10.1159/000133722; SOLTER D, 1988, ANNU REV GENET, V22, P127; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; WAZIRI M, 1983, J PEDIATR-US, V102, P873, DOI 10.1016/S0022-3476(83)80014-6; WIEDEMANN HR, 1983, EUR J PEDIATR, V141, P129, DOI 10.1007/BF00496807	34	307	313	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1996	14	2					171	173		10.1038/ng1096-171	http://dx.doi.org/10.1038/ng1096-171			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL446	8841187				2022-12-17	WOS:A1996VL44600021
J	REED, PW; DAVIES, JL; COPEMAN, JB; BENNETT, ST; PALMER, SM; PRITCHARD, LE; GOUGH, SCL; KAWAGUCHI, Y; CORDELL, HJ; BALFOUR, KM; JENKINS, SC; POWELL, EE; VIGNAL, A; TODD, JA				REED, PW; DAVIES, JL; COPEMAN, JB; BENNETT, ST; PALMER, SM; PRITCHARD, LE; GOUGH, SCL; KAWAGUCHI, Y; CORDELL, HJ; BALFOUR, KM; JENKINS, SC; POWELL, EE; VIGNAL, A; TODD, JA			CHROMOSOME-SPECIFIC MICROSATELLITE SETS FOR FLUORESCENCE-BASED, SEMIAUTOMATED GENOME MAPPING	NATURE GENETICS			English	Article							MARKERS; LOCI	To facilitate large-scale genetic mapping of the human genome, we have developed chromosome-specific sets of microsatellite marker loci suitable for use with a fluorescence-based automated DNA fragment analyser. We present 254 dinucleotide repeat marker loci (80% from the Genethon genetic linkage map) arranged into 39 sets, covering all 22 autosomes and the X chromosome. The average distance between adjacent markers is 13 centiMorgans, and less than 4% of the genome lies more than 20 cM from the nearest marker. Each set of microsatellites consists of up to nine marker loci, with allele size ranges that do not overlap. We selected marker loci on the basis of their reliability in the polymerase chain reaction, polymorphism content, map position and the accuracy with which alleles can be scored automatically by the Genotyper(TM) program.	UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT SURG,OXFORD OX3 9DU,ENGLAND; UNIV OXFORD,NUFFIELD ORTHOPAED CTR,WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7LD,ENGLAND; GENETHON,F-91000 EVRY,FRANCE	University of Oxford; Nuffield Orthopaedic Centre; University of Oxford; Wellcome Centre for Human Genetics			Powell, Elizabeth/B-4455-2011; Vignal, Alain/I-6253-2017; Todd, John A/A-3542-2010	Powell, Elizabeth/0000-0001-5008-8061; Vignal, Alain/0000-0002-6797-2125; Todd, John A/0000-0003-2740-8148; Cordell, Heather/0000-0002-1879-5572	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BECKMANN JS, 1993, HUM MOL GENET, V2, P2019, DOI 10.1093/hmg/2.12.2019; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CALLEN DF, 1993, AM J HUM GENET, V52, P922; DIEHL SR, 1990, AM J HUM GENET, V47, pA177; EDWARDS A, 1991, AM J HUM GENET, V49, P746; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; SCHWENGEL DA, IN PRESS GENOMICS; SMEETS HJM, 1989, HUM GENET, V83, P245, DOI 10.1007/BF00285165; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; Weber J, 1989, AM J HUM GENET, V44, P338; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	19	307	315	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					390	395		10.1038/ng0794-390	http://dx.doi.org/10.1038/ng0794-390			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920657				2022-12-17	WOS:A1994NU30600013
J	Rahbari, R; Wuster, A; Lindsay, SJ; Hardwick, RJ; Alexandrov, LB; Al Turki, S; Dominiczak, A; Morris, A; Porteous, D; Smith, B; Stratton, MR; Hurles, ME				Rahbari, Raheleh; Wuster, Arthur; Lindsay, Sarah J.; Hardwick, Robert J.; Alexandrov, Ludmil B.; Al Turki, Saeed; Dominiczak, Anna; Morris, Andrew; Porteous, David; Smith, Blair; Stratton, Michael R.; Hurles, Matthew E.		UK10K Consortium	Timing, rates and spectra of human germline mutation	NATURE GENETICS			English	Article							HUMAN-DISEASE; GONADAL MOSAICISM; RECURRENCE RISK; AGE; INHERITANCE; EVOLUTION; VARIANTS; PATTERNS; GENETICS; GENOMES	Germline mutations are a driving force behind genome evolution and genetic disease. We investigated genome-wide mutation rates and spectra in multi-sibling families. The mutation rate increased with paternal age in all families, but the number of additional mutations per year differed by more than twofold between families. Meta-analysis of 6,570 mutations showed that germline methylation influences mutation rates. In contrast to somatic mutations, we found remarkable consistency in germline mutation spectra between the sexes and at different paternal ages. In parental germ line, 3.8% of mutations were mosaic, resulting in 1.3% of mutations being shared by siblings. The number of these shared mutations varied significantly between families. Our data suggest that the mutation rate per cell division is higher during both early embryogenesis and differentiation of primordial germ cells but is reduced substantially during post-pubertal spermatogenesis. These findings have important consequences for the recurrence risks of disorders caused by de novo mutations.	[Rahbari, Raheleh; Wuster, Arthur; Lindsay, Sarah J.; Hardwick, Robert J.; Alexandrov, Ludmil B.; Al Turki, Saeed; Stratton, Michael R.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Hinxton, England; [Wuster, Arthur] Genentech Inc, Dept Human Genet, San Francisco, CA 94080 USA; [Wuster, Arthur] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Dominiczak, Anna] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Morris, Andrew; Smith, Blair] Univ Dundee, Med Res Inst, Dundee, Scotland; [Porteous, David] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	Wellcome Trust Sanger Institute; Roche Holding; Genentech; Roche Holding; Genentech; University of Glasgow; University of Dundee; University of Edinburgh	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	meh@sanger.ac.uk	Lindsay, Sarah/CAF-4613-2022; Jamshidi, Yalda/AAL-1377-2020; Dominiczak, Anna F/P-9390-2017; Porteous, David/AAA-3446-2021; Alexandrov, Ludmil/AAS-1454-2021; McQuillin, Andrew/C-1623-2008; Zheng, Houfeng/K-4424-2012; Smith, Blair H/G-2834-2012; Soler Artigas, Maria/L-6529-2013; Collier, David/D-1649-2011; Schmidts, Miriam/A-3777-2012	Jamshidi, Yalda/0000-0003-0151-6482; Dominiczak, Anna F/0000-0003-4913-3608; Porteous, David/0000-0003-1249-6106; Alexandrov, Ludmil/0000-0003-3596-4515; McQuillin, Andrew/0000-0003-1567-2240; Zheng, Houfeng/0000-0001-5681-8598; Smith, Blair H/0000-0002-5362-9430; Kelly, Kirsten/0000-0003-4234-543X; Rahbari, Raheleh/0000-0002-1839-7785; Soler Artigas, Maria/0000-0002-3213-1107; Bochukova, Elena/0000-0003-0275-1548; Lindsay, Sarah/0000-0002-0965-3070; MacArthur, Daniel/0000-0002-5771-2290; Wuster, Arthur/0000-0003-4162-5931; Kilpinen, Helena/0000-0001-6692-6154; Collier, David/0000-0003-4087-1559; Wain, Louise/0000-0003-4951-1867; Wilson, Scott/0000-0002-0357-1373; Futema, Marta/0000-0002-2120-2088; Schmidts, Miriam/0000-0002-1714-6749; Farooqi, Sadaf/0000-0001-7609-3504; Swerdlow, Harold/0000-0002-9510-160X	Wellcome Trust [WT098051, WT091310]; Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6]; Scottish Funding Council [HR03006]; Medical Research Council [MC_UU_12012/5/B, MR/N005813/1, MC_PC_15018] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4] Funding Source: researchfish; MRC [MR/N005813/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Chief Scientist Office of the Scottish Government Health Directorates; Scottish Funding Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Conrad and A. Ramu for their responsive development of the DeNovoGear software and A. Campbell and S. Kerr for their support in identifying relevant families. This research was funded by the Wellcome Trust (grant WT098051). Generation Scotland has received core funding from the Chief Scientist Office of the Scottish Government Health Directorates CZD/16/6 and the Scottish Funding Council HR03006. This study makes use of data generated by the UK10K Consortium, derived from samples from ALSPAC and TwinsUK. A full list of the investigators who contributed to the generation of the data is available from http://www.uk10k.org. Funding for UK10K was provided by the Wellcome Trust under award WT091310. Data can be accessed at the European Genome-phenome Archive (EGA) under accessions EGAS00001000108 and EGAS00001000090.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anazi S, 2014, CLIN GENET, V85, P278, DOI 10.1111/cge.12156; Bachetti T, 2014, PEDIATR PULM, V49, pE45, DOI 10.1002/ppul.22790; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; Campbell IM, 2014, AM J HUM GENET, V95, P345, DOI 10.1016/j.ajhg.2014.08.010; Campbell IM, 2014, AM J HUM GENET, V95, P173, DOI 10.1016/j.ajhg.2014.07.003; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; Coticchio G., 2013, OOGENESIS; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dhamija R, 2014, AM J MED GENET A, V164, P2356, DOI 10.1002/ajmg.a.36621; DROST JB, 1995, ENVIRON MOL MUTAGEN, V25, P48, DOI 10.1002/em.2850250609; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Liu G, 2014, MOL VIS, V20, P15; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Momand JR, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103440; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sayres MAW, 2011, BIOESSAYS, V33, P938, DOI 10.1002/bies.201100091; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schaibley VM, 2013, GENOME RES, V23, P1974, DOI 10.1101/gr.154971.113; Segurel L, 2014, ANNU REV GENOM HUM G, V15, P47, DOI 10.1146/annurev-genom-031714-125740; Tajir M, 2013, GENE, V518, P476, DOI 10.1016/j.gene.2012.12.105; Venn O, 2014, SCIENCE, V344, P1272, DOI 10.1126/science.344.6189.1272; Voet T, 2011, CYTOGENET GENOME RES, V133, P160, DOI 10.1159/000324235; Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030	36	306	317	1	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					126	133		10.1038/ng.3469	http://dx.doi.org/10.1038/ng.3469			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26656846	Green Accepted, Green Submitted			2022-12-17	WOS:000369043900009
J	Zhou, KX; Bellenguez, C; Spencer, CCA; Bennett, AJ; Coleman, RL; Tavendale, R; Hawley, SA; Donnelly, LA; Schofield, C; Groves, CJ; Burch, L; Carr, F; Strange, A; Freeman, C; Blackwell, JM; Bramon, E; Brown, MA; Casas, JP; Corvin, A; Craddock, N; Deloukas, P; Dronov, S; Duncanson, A; Edkins, S; Gray, E; Hunt, S; Jankowski, J; Langford, C; Markus, HS; Mathew, CG; Plomin, R; Rautanen, A; Sawcer, SJ; Samani, NJ; Trembath, R; Viswanathan, AC; Wood, NW; Harries, LW; Hattersley, AT; Doney, ASF; Colhoun, H; Morris, AD; Sutherland, C; Hardie, DG; Peltonen, L; McCarthy, MI; Holman, RR; Palmer, CNA; Donnelly, P; Pearson, ER				Zhou, Kaixin; Bellenguez, Celine; Spencer, Chris C. A.; Bennett, Amanda J.; Coleman, Ruth L.; Tavendale, Roger; Hawley, Simon A.; Donnelly, Louise A.; Schofield, Chris; Groves, Christopher J.; Burch, Lindsay; Carr, Fiona; Strange, Amy; Freeman, Colin; Blackwell, Jenefer M.; Bramon, Elvira; Brown, Matthew A.; Casas, Juan P.; Corvin, Aiden; Craddock, Nicholas; Deloukas, Panos; Dronov, Serge; Duncanson, Audrey; Edkins, Sarah; Gray, Emma; Hunt, Sarah; Jankowski, Janusz; Langford, Cordelia; Markus, Hugh S.; Mathew, Christopher G.; Plomin, Robert; Rautanen, Anna; Sawcer, Stephen J.; Samani, Nilesh J.; Trembath, Richard; Viswanathan, Ananth C.; Wood, Nicholas W.; Harries, Lorna W.; Hattersley, Andrew T.; Doney, Alex S. F.; Colhoun, Helen; Morris, Andrew D.; Sutherland, Calum; Hardie, D. Grahame; Peltonen, Leena; McCarthy, Mark I.; Holman, Rury R.; Palmer, Colin N. A.; Donnelly, Peter; Pearson, Ewan R.		GoDARTS UKPDS Diabet Pharmacogenet; Wellcome Trust Case Control Consor; MAGIC Investigators	Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes	NATURE GENETICS			English	Article							ACTIVATED PROTEIN-KINASE; GENOME-WIDE ASSOCIATION; ATAXIA-TELANGIECTASIA; CANCER; CELLS; RISK; AMPK; IDENTIFICATION; HOMEOSTASIS; REDUCTASE	Metformin is the most commonly used pharmacological therapy for type 2 diabetes. We report a genome-wide association study for glycemic response to metformin in 1,024 Scottish individuals with type 2 diabetes with replication in two cohorts including 1,783 Scottish individuals and 1,113 individuals from the UK Prospective Diabetes Study. In a combined meta-analysis, we identified a SNP, rs11212617, associated with treatment success (n = 3,920, P = 2.9 x 10(-9), odds ratio = 1.35, 95% CI 1.22-1.49) at a locus containing ATM, the ataxia telangiectasia mutated gene. In a rat hepatoma cell line, inhibition of ATM with KU-55933 attenuated the phosphorylation and activation of AMP-activated protein kinase in response to metformin. We conclude that ATM, a gene known to be involved in DNA repair and cell cycle control, plays a role in the effect of metformin upstream of AMP-activated protein kinase, and variation in this gene alters glycemic response to metformin.	[Zhou, Kaixin; Tavendale, Roger; Donnelly, Louise A.; Schofield, Chris; Burch, Lindsay; Carr, Fiona; Colhoun, Helen; Morris, Andrew D.; Sutherland, Calum; Palmer, Colin N. A.; Pearson, Ewan R.] Univ Dundee, Biomed Res Inst, Dundee, Scotland; [Bellenguez, Celine; Spencer, Chris C. A.; Strange, Amy; Freeman, Colin; Rautanen, Anna; McCarthy, Mark I.; Donnelly, Peter] UK Wellcome Trust Ctr Human Genet, Oxford, England; [Bennett, Amanda J.; Coleman, Ruth L.; Groves, Christopher J.; McCarthy, Mark I.; Holman, Rury R.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Coleman, Ruth L.; Holman, Rury R.] Univ Oxford, Diabet Trials Unit, Oxford, England; [Hawley, Simon A.; Hardie, D. Grahame] Univ Dundee, Coll Life Sci, Dundee, Scotland; [Blackwell, Jenefer M.] Univ Western Australia, Ctr Child Hlth Res, Inst Child Hlth Res, Subiaco, WA, Australia; [Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge, England; [Bramon, Elvira] Kings Coll London, Dept Psychosis Studies, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth,Inst Psychiat, London WC2R 2LS, England; [Bramon, Elvira] S London & Maudsley Natl Hlth Serv Fdn Trust, London, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Casas, Juan P.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Craddock, Nicholas] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff, S Glam, Wales; [Deloukas, Panos; Dronov, Serge; Edkins, Sarah; Gray, Emma; Hunt, Sarah; Langford, Cordelia; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Duncanson, Audrey] Wellcome Trust Res Labs, Mol & Physiol Sci, London, England; [Jankowski, Janusz] Queen Mary Univ London, Ctr Digest Dis, London, England; [Jankowski, Janusz] Leicester Royal Infirm, Ctr Digest Dis, Leicester, Leics, England; [Jankowski, Janusz] Univ Oxford, Dept Clin Pharmacol, Oxford, England; [Markus, Hugh S.] St Georges Univ London, London, England; [Mathew, Christopher G.; Trembath, Richard] Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; [Plomin, Robert] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Viswanathan, Ananth C.] Moorfields Eye Hosp Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Ophthalmol, London, England; [Viswanathan, Ananth C.] UCL, Inst Ophthalmol, London, England; [Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Harries, Lorna W.; Hattersley, Andrew T.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Doney, Alex S. F.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [McCarthy, Mark I.] Churchill Hosp, UK Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford OX3 7LJ, England; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Dundee; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Dundee; Telethon Kids Institute; University of Western Australia; University of Cambridge; University of London; King's College London; South London & Maudsley NHS Trust; University of Queensland; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Trinity College Dublin; Cardiff University; Wellcome Trust Sanger Institute; University of London; Queen Mary University London; University of Leicester; University of Oxford; St Georges University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Exeter; University of Plymouth; University of Dundee; University of Oxford; University of Oxford	Pearson, ER (corresponding author), Univ Dundee, Biomed Res Inst, Dundee, Scotland.	e.pearson@cpse.dundee.ac.uk	Brown, Matthew A/E-5749-2010; Palmer, Colin NA/C-7053-2008; Deloukas, Panos/B-2922-2013; Hardie, David/Z-1979-2019; Mathew, Christopher G/G-3434-2015; Plomin, Robert/B-8911-2008; Blackwell, Jenefer M/H-3015-2015; Wood, Nicholas W/C-2505-2009; Belllenguez, Céline/Y-3183-2018; Doney, Alexander SF/P-7437-2017; Bramon, Elvira/A-9463-2011; Harries, Lorna/D-2241-2014; Study, GoDARTS/K-9448-2016; Jankowski, Janusz/H-2706-2012; Bellenguez, Céline/X-4004-2019; Bramon, Elvira/HHC-3809-2022; McCarthy, Mark/M-3763-2015	Brown, Matthew A/0000-0003-0538-8211; Palmer, Colin NA/0000-0002-6415-6560; Deloukas, Panos/0000-0001-9251-070X; Mathew, Christopher G/0000-0003-4178-1838; Wood, Nicholas W/0000-0002-9500-3348; Belllenguez, Céline/0000-0002-1240-7874; Doney, Alexander SF/0000-0002-6210-5620; Jankowski, Janusz/0000-0003-2130-9181; Bellenguez, Céline/0000-0002-1240-7874; Bramon, Elvira/0000-0003-1369-5983; Hunt, Sarah/0000-0002-8350-1235; Coleman, Ruth/0000-0002-5194-8550; McCarthy, Mark/0000-0002-4393-0510; Hardie, Grahame/0000-0002-8373-7379; Plomin, Robert/0000-0002-0756-3629; Walters, James/0000-0002-6980-4053; Hattersley, Andrew/0000-0001-5620-473X; Pearson, Ewan/0000-0001-9237-8585; Sutherland, Calum/0000-0003-4398-7434; Corvin, Aiden/0000-0001-6717-4089; bennett, amanda/0000-0003-2140-8710; Trembath, Richard/0000-0003-0550-3400; Colhoun, Helen/0000-0002-8345-3288	Wellcome Trust [084726/Z/08/Z, 085475/Z/08/Z, 085475/B/08/Z]; Diabetes UK [07/0003525]; MRC [G0601261]; National Institute for Health Research; Wolfson-Royal Society Merit Award; Henry Wellcome Post-Doctoral Fellowship; European Commission [LSHM-CT-2004-005272]; MRC [G19/2, G0901310] Funding Source: UKRI; Medical Research Council [G19/2, G0901310, G0601261, G9817803B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379, PDA/02/06/016] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wolfson-Royal Society Merit Award(Royal Society of London); Henry Wellcome Post-Doctoral Fellowship; European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We are grateful to all the participants who took part in this study, to the general practitioners, to the Scottish School of Primary Care for their help in recruiting the participants, and to the whole team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The Wellcome Trust provides support for the Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection (GoDARTS) and informatics support was provided by the Chief Scientist Office. The Wellcome Trust funds the Scottish Health Informatics Programme, provides core support for the Wellcome Trust Centre for Human Genetics in Oxford and funds the Wellcome Trust Case Control Consortium 2. This research was specifically funded by Diabetes UK (07/0003525), MRC (G0601261) and the Wellcome Trust (084726/Z/08/Z, 085475/Z/08/Z, 085475/B/08/Z). We also acknowledge support from the National Institute for Health Research award to Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology (to A. C. V.). P. Donnelly was supported in part by a Wolfson-Royal Society Merit Award. K.Z. holds a Henry Wellcome Post-Doctoral Fellowship. S. A. H. and D. G. H. were supported by the EXGENESIS consortium (LSHM-CT-2004-005272) funded by the European Commission.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BAR RS, 1978, NEW ENGL J MED, V298, P1164, DOI 10.1056/NEJM197805252982103; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; BODER E, 1985, ATAXIA TELANGIECTASI, V19, P1; Crescenzi E, 2008, CLIN CANCER RES, V14, P1877, DOI 10.1158/1078-0432.CCR-07-4298; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Donnelly LA, 2006, DIABETIC MED, V23, P128, DOI 10.1111/j.1464-5491.2005.01755.x; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Fukao T, 1999, BLOOD, V94, P1998; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hardie DG, 2000, METH MOL B, V99, P63; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Miles PD, 2007, AM J PHYSIOL-ENDOC M, V293, pE70, DOI 10.1152/ajpendo.00259.2006; Morris AD, 1997, BMJ-BRIT MED J, V315, P524, DOI 10.1136/bmj.315.7107.524; *NAT I HLTH CLIN E, 2009, NICE CLIN GUID 87 TY; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Savitsky K, 1997, NUCLEIC ACIDS RES, V25, P1678, DOI 10.1093/nar/25.9.1678; SCHALCH DS, 1970, NEW ENGL J MED, V282, P1396, DOI 10.1056/NEJM197006182822503; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; Sun Y, 2007, MOL CELL BIOCHEM, V306, P239, DOI 10.1007/s11010-007-9575-6; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P854; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	36	306	316	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					117	U57		10.1038/ng.735	http://dx.doi.org/10.1038/ng.735			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21186350	Green Submitted, Green Accepted			2022-12-17	WOS:000286623800008
J	Newton-Cheh, C; Larson, MG; Vasan, RS; Levy, D; Bloch, KD; Surti, A; Guiducci, C; Kathiresan, S; Benjamin, EJ; Struck, J; Morgenthaler, NG; Bergmann, A; Blankenberg, S; Kee, F; Nilsson, P; Yin, XY; Peltonen, L; Vartiainen, E; Salomaa, V; Hirschhorn, JN; Melander, O; Wang, TJ				Newton-Cheh, Christopher; Larson, Martin G.; Vasan, Ramachandran S.; Levy, Daniel; Bloch, Kenneth D.; Surti, Aarti; Guiducci, Candace; Kathiresan, Sekar; Benjamin, Emelia J.; Struck, Joachim; Morgenthaler, Nils G.; Bergmann, Andreas; Blankenberg, Stefan; Kee, Frank; Nilsson, Peter; Yin, Xiaoyan; Peltonen, Leena; Vartiainen, Erkki; Salomaa, Veikko; Hirschhorn, Joel N.; Melander, Olle; Wang, Thomas J.			Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure	NATURE GENETICS			English	Article							CARDIOVASCULAR-DISEASE; RISK; IMPACT; HYPERTENSION; CONTRIBUTE; MUTATIONS; MORTALITY; FINLAND; PROJECT; LINKAGE	We examined the association of common variants at the NPPA-NPPB locus with circulating concentrations of the natriuretic peptides, which have blood pressure-lowering properties. We genotyped SNPs at the NPPA-NPPB locus in 14,743 individuals of European ancestry, and identified associations of plasma atrial natriuretic peptide with rs5068 (P = 8 x 10(-70)), rs198358 (P = 8 x 10(-30)) and rs632793 (P = 2 x 10(-10)), and of plasma B-type natriuretic peptide with rs5068 (P = 3 x 10(-12)), rs198358 (P = 1 x 10(-25)) and rs632793 (P = 2 x 10(-68)). In 29,717 individuals, the alleles of rs5068 and rs198358 that showed association with increased circulating natriuretic peptide concentrations were also found to be associated with lower systolic (P = 2 x 10(-6) and 6 x 10(-5), respectively) and diastolic blood pressure (P = 1 x 10(-6) and 5 x 10(-5)), as well as reduced odds of hypertension (OR = 0.85, 95% CI = 0.79-0.92, P = 4 x 10(-5); OR = 0.90, 95% CI = 0.85-0.95, P = 2 x 10(-4), respectively). Common genetic variants at the NPPA-NPPB locus found to be associated with circulating natriuretic peptide concentrations contribute to interindividual variation in blood pressure and hypertension.	[Newton-Cheh, Christopher; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Bloch, Kenneth D.; Kathiresan, Sekar; Wang, Thomas J.] Massachusetts Gen Hosp, Div Cardiol, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Newton-Cheh, Christopher; Surti, Aarti; Guiducci, Candace; Kathiresan, Sekar; Hirschhorn, Joel N.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Newton-Cheh, Christopher; Larson, Martin G.; Vasan, Ramachandran S.; Levy, Daniel; Kathiresan, Sekar; Benjamin, Emelia J.; Yin, Xiaoyan; Wang, Thomas J.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Larson, Martin G.] Boston Univ, Sch Med, Dept Math, Boston, MA 02215 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Prevent Med Sect, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; [Levy, Daniel] NHLBI, Bethesda, MD 20892 USA; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Dept Anesthesia, Boston, MA 02114 USA; [Struck, Joachim; Morgenthaler, Nils G.; Bergmann, Andreas] BRAHMS AG, Dept Res, D-16761 Hennigsdorf, Germany; [Blankenberg, Stefan] Johannes Gutenberg Univ Mainz, Dept Med 2, D-55131 Mainz, Germany; [Kee, Frank] Royal Victoria Hosp, Ctr Excellence Publ Hlth NI, A UKCRC, Belfast BT12 6BJ, Antrim, North Ireland; [Nilsson, Peter; Melander, Olle] Malmo Univ Hosp, CRC, SE-20502 Malmo, Sweden; [Peltonen, Leena; Vartiainen, Erkki; Salomaa, Veikko] KTL Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, FI-00300 Helsinki, Finland; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Peltonen, Leena] Inst Mol Med Finland FIMM, Biomedicum Helsinki, FI-00290 Helsinki, Finland; [Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts General Hospital; Thermo Fisher Scientific; Brahms AG; Johannes Gutenberg University of Mainz; Lund University; Skane University Hospital; Finland National Institute for Health & Welfare; Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Newton-Cheh, C (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 55 Fruit St, Boston, MA 02114 USA.	cnewtoncheh@chgr.mgh.harvard.edu; tjwang@partners.org	Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Ramachandran, Vasan/Y-2527-2019; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Larson, Martin/0000-0002-9631-1254; Wang, Thomas/0000-0003-4063-6508; Benjamin, Emelia/0000-0003-4076-2336; Melander, Olle/0000-0002-2581-484X	ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093328, K24HL004334, U01HL066582, R01HL083197, ZIAHL006001, K23HL080025, R01HL070896, R01HL086875, K23HL074077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081572] Funding Source: NIH RePORTER	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Berglund G, 2000, J INTERN MED, V247, P19, DOI 10.1046/j.1365-2796.2000.00568.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Conen D, 2007, HYPERTENSION, V50, P1114, DOI 10.1161/HYPERTENSIONAHA.107.097634; Cupples LA, 1987, SOME RISK FACTORS RE; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kastarinen MJ, 1998, J HYPERTENS, V16, P1379, DOI 10.1097/00004872-199816090-00019; Kato N, 2008, HUM MOL GENET, V17, P617, DOI 10.1093/hmg/ddm335; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lynch AI, 2008, JAMA-J AM MED ASSOC, V299, P296, DOI 10.1001/jama.299.3.296; Nilsson PM, 2007, DIABETIC MED, V24, P464, DOI 10.1111/j.1464-5491.2007.02142.x; Numata Y, 1998, CLIN CHEM, V44, P1008; Schillinger KJ, 2005, P NATL ACAD SCI USA, V102, P13789, DOI 10.1073/pnas.0506807102; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; von Wowern F, 2005, KIDNEY INT, V68, P2164, DOI 10.1111/j.1523-1755.2005.00672.x; Wang TJ, 2007, CIRCULATION, V115, P1345, DOI 10.1161/CIRCULATIONAHA.106.655142; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Wang TJ, 2003, CIRCULATION, V108, P13, DOI 10.1161/01.CIR.0000081657.83724.A7; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5	30	306	321	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2009	41	3					348	353		10.1038/ng.328	http://dx.doi.org/10.1038/ng.328			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	411HL	19219041	Green Accepted			2022-12-17	WOS:000263640200017
J	Fritsche, LG; Loenhardt, T; Janssen, A; Fisher, SA; Rivera, A; Keilhauer, CN; Weber, BHF				Fritsche, Lars G.; Loenhardt, Thomas; Janssen, Andreas; Fisher, Sheila A.; Rivera, Andrea; Keilhauer, Claudia N.; Weber, Bernhard H. F.			Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA	NATURE GENETICS			English	Article							COMPLEMENT FACTOR-H; X-LINKED RETINOSCHISIS; MACULOPATHY; HTRA1; SUSCEPTIBILITY; POLYMORPHISM; HAPLOTYPE; DISEASE; VARIANT; GENE	Age-related macular degeneration (AMD) is a prevalent multifactorial disorder of the central retina(1-3). Genetic variants at two chromosomal loci, 1q31 and 10q26, confer major disease risks, together accounting for more than 50% of AMD pathology(4-9). Signals at 10q26 center over two nearby genes, ARMS2 (age-related maculopathy susceptibility 2, also known as LOC387715)(8,9) and HTRA1 (high-temperature requirement factor A1)(10,11), suggesting two equally probable candidates. Here we show that a deletion-insertion polymorphism in ARMS2 (NM_001099667.1: c.*372_815del443ins54) is strongly associated with AMD, directly affecting the transcript by removing the polyadenylation signal and inserting a 54-bp element known to mediate rapid mRNA turnover. As a consequence, expression of ARMS2 in homozygous carriers of the indel variant is not detectable. Confirming previous findings(12), we demonstrate a mitochondrial association of the normal protein and further define its retinal localization to the ellipsoid region of the photoreceptors. Our data suggest that ARMS2 has a key role in AMD, possibly through mitochondria-related pathways.	[Fritsche, Lars G.; Loenhardt, Thomas; Janssen, Andreas; Rivera, Andrea; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Fisher, Sheila A.] St Thomas Hosp, London WC2R 2LS, England; [Fisher, Sheila A.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Keilhauer, Claudia N.] Univ Wurzburg, Dept Ophthalmol, D-97080 Wurzburg, Germany	University of Regensburg; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Wurzburg	Weber, BHF (corresponding author), Univ Regensburg, Inst Human Genet, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.	bweb@klinik.uni-regensburg.de	Fritsche, Lars G/AAF-9387-2019	Fritsche, Lars G/0000-0002-2110-1690; Weber, Bernhard H.F./0000-0002-8808-7723				Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; DUDBRIDGE F, 2006, 5 MRC BIOST UN; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Fisher SA, 2007, HUM MUTAT, V28, P406, DOI 10.1002/humu.20464; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GEYSEN HM, 1987, J IMMUNOL METHODS, V102, P259, DOI 10.1016/0022-1759(87)90085-8; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Molday LL, 2001, INVEST OPHTH VIS SCI, V42, P816; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wu WWH, 2003, J BIOL CHEM, V278, P28139, DOI 10.1074/jbc.M302464200; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	28	306	319	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					892	896		10.1038/ng.170	http://dx.doi.org/10.1038/ng.170			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18511946				2022-12-17	WOS:000257166500025
J	Dyer, MA; Livesey, FJ; Cepko, CL; Oliver, G				Dyer, MA; Livesey, FJ; Cepko, CL; Oliver, G			Prox1 function controls progenitor cell proliferation and horizontal, cell genesis in the mammalian retina	NATURE GENETICS			English	Article							RAT RETINA; AMACRINE CELLS; GANGLION-CELL; HOMEOBOX; MATH5; DIFFERENTIATION; ANTIBODIES	Retinal progenitor cells regulate their proliferation during development so that the correct number of each cell type is made at the appropriate time. We found that the homeodomain protein Prox1 regulates the exit of progenitor cells from the cell cycle in the embryonic mouse retina. Cells lacking Prox1 are less likely to stop dividing, and ectopic expression of Prox1 forces progenitor cells to exit the cell cycle. During retinogenesis, Prox1 can be detected in differentiating horizontal, bipolar and All amacrine cells. Horizontal cells are absent in retinae of. Prox1(-/-) mice and misexpression of Prox1 in postnatal progenitor cells promotes horizontal-cell formation. Thus, Prox1 activity is both necessary and sufficient for progenitor-cell proliferation and cell-fate determination in the vertebrate retina.	St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Cambridge	Oliver, G (corresponding author), St Jude Childrens Res Hosp, Dept Genet, 332 N Lauderdale St, Memphis, TN 38105 USA.	cepko@rascal.med.harvard.edu; guillermo.oliver@stjude.org	Dyer, Michael/N-8134-2018	Livesey, Rick/0000-0001-6128-3372				Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; DELEEUW AM, 1990, J NEUROCYTOL, V19, P253, DOI 10.1007/BF01217303; Dyer MA, 2000, DEVELOPMENT, V127, P3593; Dyer MA, 2001, J COMP NEUROL, V429, P601; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; FIELDSBERRY SC, 1992, P NATL ACAD SCI USA, V89, P693, DOI 10.1073/pnas.89.2.693; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Morrow EM, 1998, J NEUROSCI, V18, P3738; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; WASSLE H, 1993, J COMP NEUROL, V332, P407; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844	22	306	316	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2003	34	1					53	58		10.1038/ng1144	http://dx.doi.org/10.1038/ng1144			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	674ZK	12692551				2022-12-17	WOS:000182667900016
J	Koishi, R; Ando, Y; Ono, M; Shimamura, M; Yasumo, H; Fujiwara, T; Horikoshi, H; Furukawa, H				Koishi, R; Ando, Y; Ono, M; Shimamura, M; Yasumo, H; Fujiwara, T; Horikoshi, H; Furukawa, H			Angptl3 regulates lipid metabolism in mice	NATURE GENETICS			English	Article							TRIGLYCERIDE-TRANSFER-PROTEIN; DEPENDENT DIABETES-MELLITUS; LIPOPROTEIN METABOLISM; APOLIPOPROTEIN-B; TANGIER-DISEASE; IN-VIVO; GENE; MUTATIONS; IDENTIFICATION; ABETALIPOPROTEINEMIA	The KK obese mouse is moderately obese and has abnormally high levels of plasma insulin (hyperinsulinemia), glucose (hyperglycemia) and lipids (hyperlipidemia). In one strain (KK/San), we observed abnormally low plasma lipid levels (hypolipidemia). This mutant phenotype is inherited recessively as a mendelian trait. Here we report the mapping of the hypolipidemia (hypo locus to the middle of chromosome 4 and positional cloning of the autosomal recessive mutation responsible for the hypolipidemia. The hypl locus encodes a unique angiopoietin-like lipoprotein modulator, which we named Allm1. it is identical to angiopoietin-like protein 3, encoded by Angptl3, and has a highly conserved counterpart in humans. Overexpression of Angpl3 or intravenous injection of the purified protein in KK/San mice elicited an increase in circulating plasma lipid levels. This increase was also observed in C57BL/6J normal mice. Taken together, these data suggest that Angptl3 regulates lipid metabolism in animals.	Sankyo Co Ltd, Biomed Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; Sankyo Co Ltd, Med Safety Res Labs, Shizuoka 4370065, Japan; Sankyo Co Ltd, Pharmacol & Mol Biol Res Labs, Shinagawa Ku, Tokyo 1408710, Japan; Sankyo Pharma Res Inst, La Jolla, CA 92037 USA	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Koishi, R (corresponding author), Sankyo Co Ltd, Biomed Res Labs, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	koishi@shina.sankyo.co.jp		Ando, Yukio/0000-0001-7115-9105				Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BRUNZELL JD, 1976, METABOLISM, V25, P313, DOI 10.1016/0026-0495(76)90089-5; Conklin D, 1999, GENOMICS, V62, P477, DOI 10.1006/geno.1999.6041; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; FARESE RV, 1992, J INTERN MED, V231, P643, DOI 10.1111/j.1365-2796.1992.tb01253.x; Fujiwara T, 1998, GENOMICS, V54, P155, DOI 10.1006/geno.1998.5554; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GREENFIELD M, 1980, DIABETOLOGIA, V18, P441; GREENFIELD MS, 1982, ARCH INTERN MED, V142, P1498, DOI 10.1001/archinte.142.8.1498; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Kondo K., 1957, B EXP ANIM, V6, P107; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; NAKAMURA M, 1962, P JPN ACAD, V38, P348, DOI 10.2183/pjab1945.38.348; Nakamura M, 1967, Diabetologia, V3, P212, DOI 10.1007/BF01222198; NARCISI TME, 1995, AM J HUM GENET, V57, P1298; Parhofer KG, 1996, J LIPID RES, V37, P844; Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196; PURCELLHUYNH DA, 1995, J CLIN INVEST, V96, P1845, DOI 10.1172/JCI118230; REAVEN GM, 1987, METABOLISM, V36, P1, DOI 10.1016/0026-0495(87)90193-4; Rehberg EF, 1996, J BIOL CHEM, V271, P29945, DOI 10.1074/jbc.271.47.29945; Reue K, 1996, J LIPID RES, V37, P1387; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SCHAEFER EJ, 1994, ATHEROSCLEROSIS, V108, pS41, DOI 10.1016/0021-9150(94)90152-X; SCHONFELD G, 1995, ANNU REV NUTR, V15, P23, DOI 10.1146/annurev.nu.15.070195.000323; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; SHIRAKI T, 1993, DIABETES FRONTIER, V4, P641; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; STANBURY JB, 1983, METABOLIC BASIS INHE, P589; TALMUD PJ, 1994, J LIPID RES, V35, P468; Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904; Welch CL, 1996, J LIPID RES, V37, P1406; WELTY FK, 1995, CIRCULATION, V92, P2036, DOI 10.1161/01.CIR.92.8.2036; WETTERAU JR, 1992, SCIENCE, V258, P999	38	306	351	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2002	30	2					151	157		10.1038/ng814	http://dx.doi.org/10.1038/ng814			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	519CY	11788823				2022-12-17	WOS:000173708700014
J	Jacobs, JJL; Keblusek, P; Robanus-Maandag, E; Kristel, P; Lingbeek, M; Nederlof, PM; van Welsem, T; van de Vijver, MJ; Koh, EY; Daley, GQ; van Lohuizen, M				Jacobs, JJL; Keblusek, P; Robanus-Maandag, E; Kristel, P; Lingbeek, M; Nederlof, PM; van Welsem, T; van de Vijver, MJ; Koh, EY; Daley, GQ; van Lohuizen, M			Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers	NATURE GENETICS			English	Article							ARF TUMOR-SUPPRESSOR; CELL-CYCLE ARREST; INK4A LOCUS; C-MYC; STABILIZES P53; GENE FAMILY; MDM2; APOPTOSIS; LYMPHOMAGENESIS; AMPLIFICATION	To identify new immortalizing genes with potential roles in tumorigenesis, we performed a genetic screen aimed to bypass the rapid and tight senescence arrest of primary fibroblasts deficient for the oncogene Bmi1. We identified the T-box member TBX2 as a potent immortalizing gene that acts by downregulating Cdkn2a (p19(ARF)). TBX2 represses the Cdkn2a (p19(ARF)) promoter and attenuates E2F1, Myc or HRAS-mediated induction of Cdkn2a (p19(ARF)). We found TBX2 to be amplified in a subset of primary human breast cancers, indicating that it might contribute to breast cancer development.	Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands; Whitehead Inst, Cambridge, MA 02142 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	van Lohuizen, M (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands.	lohuizen@nki.nl	Jacobs, Jacqueline/ABA-5652-2020	Jacobs, Jacqueline/0000-0002-7704-4795; van de Vijver, Marc/0000-0002-0385-4787	NATIONAL CANCER INSTITUTE [R29CA076418] Funding Source: NIH RePORTER; NCI NIH HHS [CA76418-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alkema MJ, 1997, ONCOGENE, V15, P899, DOI 10.1038/sj.onc.1201262; Barlund M, 1997, GENE CHROMOSOME CANC, V20, P372, DOI 10.1002/(SICI)1098-2264(199712)20:4<372::AID-GCC8>3.0.CO;2-Z; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; CAMPBELL C, 1995, GENOMICS, V28, P255, DOI 10.1006/geno.1995.1139; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Clahsen PC, 1998, J CLIN ONCOL, V16, P470, DOI 10.1200/JCO.1998.16.2.470; Couch FJ, 1999, CANCER RES, V59, P1408; Courjal F, 1997, CANCER RES, V57, P4368; Cuny M, 2000, CANCER RES, V60, P1077; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; HAUPT Y, 1993, ONCOGENE, V8, P3161; He ML, 1999, P NATL ACAD SCI USA, V96, P10212, DOI 10.1073/pnas.96.18.10212; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; LAW DJ, 1995, MAMM GENOME, V6, P793, DOI 10.1007/BF00539006; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; PEDEUTOUR F, 1995, CANCER RES, V55, P2400; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; QUELLE DE, 1995, CELL, V83, P993; QUELLE DE, 1995, ONCOGENE, V11, P635; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber RG, 1997, P NATL ACAD SCI USA, V94, P14719, DOI 10.1073/pnas.94.26.14719; Wicking C, 1999, ONCOGENE, V18, P7844, DOI 10.1038/sj.onc.1203282; Wynford-Thomas D, 1999, J PATHOL, V187, P100; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	50	306	320	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2000	26	3					291	299		10.1038/81583	http://dx.doi.org/10.1038/81583			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	371JU	11062467				2022-12-17	WOS:000165176500016
J	Graham, M; Shutter, JR; Sarmiento, U; Sarosi, I; Stark, KL				Graham, M; Shutter, JR; Sarmiento, U; Sarosi, I; Stark, KL			Overexpression of Agrt leads to obesity in transgenic mice	NATURE GENETICS			English	Letter							ECTOPIC EXPRESSION; AGOUTI		AMGEN INC,DEPT MOL GENET,THOUSAND OAKS,CA 91320; AMGEN INC,DEPT PATHOL,THOUSAND OAKS,CA 91320	Amgen; Amgen								BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fong TM, 1997, BIOCHEM BIOPH RES CO, V237, P629, DOI 10.1006/bbrc.1997.7200; Friedman JM, 1997, NATURE, V385, P119, DOI 10.1038/385119a0; HESTON WE, 1962, J NATL CANCER I, V29, P197; Hogan B., 1986, MANIPULATING MOUSE E; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; KLEBIG ML, 1995, P NATL ACAD SCI USA, V92, P4728, DOI 10.1073/pnas.92.11.4728; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; RAY P, 1991, GENE DEV, V5, P2265, DOI 10.1101/gad.5.12a.2265; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; WARBRITTON A, 1994, P SOC EXP BIOL MED, V206, P145, DOI 10.3181/00379727-206-43733	12	306	310	1	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1997	17	3					273	274		10.1038/ng1197-273	http://dx.doi.org/10.1038/ng1197-273			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YD667	9354787				2022-12-17	WOS:A1997YD66700017
J	MEYERS, GA; ORLOW, SJ; MUNRO, IR; PRZYLEPA, KA; JABS, EW				MEYERS, GA; ORLOW, SJ; MUNRO, IR; PRZYLEPA, KA; JABS, EW			FIBROBLAST-GROWTH-FACTOR-RECEPTOR-3 (FGFR3) TRANSMEMBRANE MUTATION IN CROUZON-SYNDROME WITH ACANTHOSIS NIGRICANS	NATURE GENETICS			English	Note							EXPRESSION PATTERN		NYU,SCH MED,RONALD O PERELMAN DEPT DERMATOL,DEPT CELL BIOL,NEW YORK,NY 10016; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT PEDIAT,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT MED,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT SURG,BALTIMORE,MD 21287; MED CITY DALLAS HOSP,CTR CHILDREN,CTR CRANIOFACIAL,DALLAS,TX 75230	New York University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Medical City Dallas Hospital				Jabs, Ethylin/0000-0001-8983-5466; Orlow, Seth/0000-0003-2548-7380	NICHD NIH HHS [HD24061] Funding Source: Medline; NIDCR NIH HHS [DE10180, DE11131] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010180, P50DE011131] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AVIVI A, 1993, FEBS LETT, V330, P249, DOI 10.1016/0014-5793(93)80882-U; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; BELLUS GA, 1995, AM J HUM GENET, V56, P368; BREITBART AS, 1989, ANN PLAS SURG, V22, P310, DOI 10.1097/00000637-198904000-00005; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; GORRY MC, 1995, HUM MOL GENET, V4, P1387, DOI 10.1093/hmg/4.8.1387; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; LI X, 1995, NAT GENET, V9, P232, DOI 10.1038/ng0395-232; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; MURGUE B, 1994, CANCER RES, V54, P5206; NOJI S, 1993, PROG CLIN BIOL RES, V63, P645; ORLOW SJ, 1992, ARCH DERMATOL, V128, P1379, DOI 10.1001/archderm.128.10.1379; PARK WJ, 1995, AM J HUM GENET, V57, P321; PARK WJ, 1995, HUM MOL GENET, V4, P1229, DOI 10.1093/hmg/4.7.1229; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; RENDON MI, 1989, J AM ACAD DERMATOL, V21, P461, DOI 10.1016/S0190-9622(89)70208-5; ROUSSEAU F, 1995, NAT GENET, V10, P11, DOI 10.1038/ng0595-11; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; SHI DL, 1994, J CELL SCI, V107, P417; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; STOILOV I, 1995, AM J MED GENET, V55, P127, DOI 10.1002/ajmg.1320550132; SUPERTIFURGA A, 1995, EUR J PEDIATR, V154, P215, DOI 10.1007/BF01954274; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165	30	306	319	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					462	464		10.1038/ng1295-462	http://dx.doi.org/10.1038/ng1295-462			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493034				2022-12-17	WOS:A1995TH62900031
J	WAYMIRE, KG; MAHUREN, JD; JAJE, JM; GUILARTE, TR; COBURN, SP; MACGREGOR, GR				WAYMIRE, KG; MAHUREN, JD; JAJE, JM; GUILARTE, TR; COBURN, SP; MACGREGOR, GR			MICE LACKING TISSUE NONSPECIFIC ALKALINE-PHOSPHATASE DIE FROM SEIZURES DUE TO DEFECTIVE METABOLISM OF VITAMIN-B-6	NATURE GENETICS			English	Article							DEVELOPING RAT-BRAIN; CENTRAL-NERVOUS-SYSTEM; ADULT HYPOPHOSPHATASIA; GENE; PYRIDOXAL-5'-PHOSPHATE; DEFICIENCY; SEQUENCE; PROTEIN	In humans, deficiency of the tissue non-specific alkaline phosphatase (TNAP) gene is associated with defective skeletal mineralization. In contrast, mice lacking TNAP generated by homologous recombination using embryonic stem (ES) cells have normal skeletal development. However, at approximately two weeks after birth, homozygous mutant mice develop seizures which are subsequently fatal. Defective metabolism of pyridoxal 5'-phosphate (PLP), characterized by elevated serum PLP levels, results in reduced levels of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the brain. The mutant seizure phenotype can be rescued by the administration of pyridoxal and a semi-solid diet. Rescued animals subsequently develop defective dentition. This study reveals essential physiological functions of TNAP in the mouse.	EMORY UNIV,SCH MED,DEPT MOLEC & MED GENET,ATLANTA,GA 30322; FT WAYNE STATE DEV CTR,FT WAYNE,IN 46835; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT ENVIRONM HLTH SCI,BALTIMORE,MD 21205	Emory University; Johns Hopkins University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020939] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20939] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBIN RL, 1987, NEUROLOGY, V37, P1729, DOI 10.1212/WNL.37.11.1729; BAYOUMI RA, 1972, J NEUROCHEM, V19, P1883, DOI 10.1111/j.1471-4159.1972.tb01477.x; BELL RR, 1971, ARCH BIOCHEM BIOPHYS, V147, P588, DOI 10.1016/0003-9861(71)90417-6; BRUCKNER R. J. N. H. RICKLES, 1962, ORAL SURG ORAL MED AND ORAL PATHOL, V15, P1351, DOI 10.1016/0030-4220(62)90356-0; BUKIN YV, 1976, BIOKHIMIYA, V41, P81; CASWELL AM, 1991, CRIT REV CL LAB SCI, V28, P175, DOI 10.3109/10408369109106862; DAKSHINAMURTI K, 1969, J NEUROCHEM, V16, P1515, DOI 10.1111/j.1471-4159.1969.tb09906.x; EASTMAN CL, 1992, J NUTR BIOCHEM, V3, P618, DOI 10.1016/0955-2863(92)90081-S; EBADI M, 1981, Neurochemistry International, V3, P181, DOI 10.1016/0197-0186(81)90001-2; FEDDE KN, 1990, AM J HUM GENET, V47, P776; FEDDE KN, 1990, AM J HUM GENET, V47, P767; FONDA ML, 1980, EXP GERONTOL, V15, P473, DOI 10.1016/0531-5565(80)90055-8; FRIEDRICH GA, 1990, GENE DEV, V5, P1513; Gould Bernard S., 1944, ARCH BIOCHEM, V4, P175; GUILARTE TR, 1989, NEUROCHEM RES, V14, P889, DOI 10.1007/BF00964820; HAHNEL AC, 1990, DEVELOPMENT, V110, P555; HAHNEL AC, 1989, CLIN CHIM ACTA, V186, P171; HENTHORN PS, 1988, J BIOL CHEM, V263, P12011; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; HOUPT MI, 1970, J DENT CHILD, V27, P126; KNOLL BJ, 1988, J BIOL CHEM, V263, P12020; KRINKE G, 1985, J NEUROPATH EXP NEUR, V44, P117, DOI 10.1097/00005072-198503000-00001; KRINKE G, 1980, NEUROTOXICOLOGY, V2, P13; LANGMAN MJS, 1966, NATURE, V212, P41, DOI 10.1038/212041a0; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; MACFARLANE JD, 1992, AM J MED GENET, V42, P117, DOI 10.1002/ajmg.1320420124; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; MAHUREN JD, 1990, J NUTR BIOCHEM, V1, P659, DOI 10.1016/0955-2863(90)90028-J; MANES T, 1990, GENOMICS, V8, P541, DOI 10.1016/0888-7543(90)90042-S; McComb R.B., 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; Meldrum B S, 1975, Int Rev Neurobiol, V17, P1, DOI 10.1016/S0074-7742(08)60205-6; MILLAN JL, 1988, P NATL ACAD SCI USA, V85, P3024, DOI 10.1073/pnas.85.9.3024; ORNOY A, 1985, AM J MED GENET, V22, P743, DOI 10.1002/ajmg.1320220410; RASMUSSEN K, 1968, DANISH MED B, V15, P1; RITCHIE GM, 1964, ARCH DIS CHILD, V39, P584, DOI 10.1136/adc.39.208.584; ROXBURGH STD, 1983, T OPHTHAL SOC UK, V103, P513; SALHANY JM, 1993, J BIOL CHEM, V268, P7643; SALHANY JM, 1987, J BIOL CHEM, V262, P15965; SASAKI T, 1990, CELL BIOL TOOTH ENAM, P1; SHIDELER CE, 1983, AM J MED TECHNOL, V49, P17; Slocum RH, 1991, TECHNIQUES DIAGNOSTI, P87; SNELL EE, 1971, COMPREHENSIVE BIOCH, P47; STEPHENS MC, 1971, J NEUROCHEM, V18, P2407, DOI 10.1111/j.1471-4159.1971.tb00196.x; TAKAHASHI T, 1984, ENDOCRINE CONTROL BO, P93; TERAO M, 1987, P NATL ACAD SCI USA, V84, P7051, DOI 10.1073/pnas.84.20.7051; Voet D VJ, 1990, BIOCHEMISTRY; WADA H, 1961, J BIOL CHEM, V236, P2089; WARSHAW JB, 1971, J CLIN INVEST, V50, P2137, DOI 10.1172/JCI106707; WASYNCZUK A, 1983, J NUTR, V113, P746, DOI 10.1093/jn/113.4.746; WEISS MJ, 1988, J BIOL CHEM, V263, P12002; Whyte M, 1995, METABOLIC MOL BASES, P4095; WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814; WHYTE MP, 1988, J CLIN INVEST, V81, P1234, DOI 10.1172/JCI113440; WHYTE MP, 1979, MEDICINE, V58, P329, DOI 10.1097/00005792-197909000-00001; WHYTE MP, 1982, AM J MED, V72, P631, DOI 10.1016/0002-9343(82)90474-0; WHYTE MP, 1985, J CLIN INVEST, V76, P752, DOI 10.1172/JCI112031	56	306	328	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					45	51		10.1038/ng0995-45	http://dx.doi.org/10.1038/ng0995-45			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550313				2022-12-17	WOS:A1995RR72800014
J	Barcia, G; Fleming, MR; Deligniere, A; Gazula, VR; Brown, MR; Langouet, M; Chen, HJ; Kronengold, J; Abhyankar, A; Cilio, R; Nitschke, P; Kaminska, A; Boddaert, N; Casanova, JL; Desguerre, I; Munnich, A; Dulac, O; Kaczmarek, LK; Colleaux, L; Nabbout, R				Barcia, Giulia; Fleming, Matthew R.; Deligniere, Aline; Gazula, Valeswara-Rao; Brown, Maile R.; Langouet, Maeva; Chen, Haijun; Kronengold, Jack; Abhyankar, Avinash; Cilio, Roberta; Nitschke, Patrick; Kaminska, Anna; Boddaert, Nathalie; Casanova, Jean-Laurent; Desguerre, Isabelle; Munnich, Arnold; Dulac, Olivier; Kaczmarek, Leonard K.; Colleaux, Laurence; Nabbout, Rima			De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy	NATURE GENETICS			English	Article							ACTIVATED POTASSIUM CHANNEL; AUTISM SPECTRUM DISORDERS; SCN1A MUTATIONS; FOCAL SEIZURES; K+ CHANNELS; SLACK; EPILEPSY; SODIUM; LEVETIRACETAM; PHENOTYPE	Malignant migrating partial seizures of infancy (MMPSI) is a rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay(1). We performed exome sequencing in three probands with MMPSI and identified de novo gain-of-function mutations affecting the C-terminal domain of the KCNT1 potassium channel. We sequenced KCNT1 in 9 additional individuals with MMPSI and identified mutations in 4 of them, in total identifying mutations in 6 out of 12 unrelated affected individuals. Functional studies showed that the mutations led to constitutive activation of the channel, mimicking the effects of phosphorylation of the C-terminal domain by protein kinase C. In addition to regulating ion flux, KCNT1 has a non-conducting function, as its C terminus interacts with cytoplasmic proteins involved in developmental signaling pathways. These results provide a focus for future diagnostic approaches and research for this devastating condition.	[Barcia, Giulia; Deligniere, Aline; Desguerre, Isabelle; Dulac, Olivier; Nabbout, Rima] Hop Necker Enfants Malad, AP HP, Ctr Reference Epilepsies Rares, Dept Pediat Neurol, Paris, France; [Barcia, Giulia; Dulac, Olivier; Nabbout, Rima] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U663, Paris, France; [Fleming, Matthew R.; Gazula, Valeswara-Rao; Brown, Maile R.; Kronengold, Jack; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Fleming, Matthew R.; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Langouet, Maeva; Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781,Inst Imagine, Paris, France; [Chen, Haijun] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Abhyankar, Avinash; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Cilio, Roberta] Bambino Gesu Pediat Hosp, Div Neurol, Rome, Italy; [Nitschke, Patrick] Hop Necker Enfants Malad, Dept Biostat, Paris, France; [Kaminska, Anna] Hop Necker Enfants Malad, AP HP, Clin Electrophysiol Unit, Paris, France; [Boddaert, Nathalie] Hop Necker Enfants Malad, AP HP, Dept Paediat Radiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Yale University; Yale University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Rockefeller University; IRCCS Bambino Gesu; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Nabbout, R (corresponding author), Hop Necker Enfants Malad, AP HP, Ctr Reference Epilepsies Rares, Dept Pediat Neurol, Paris, France.	rimanabbout@yahoo.com	COLLEAUX, LAURENCE/AAA-8144-2022; boddaert, nathalie/GWV-2865-2022; Barcia, Giulia/H-7907-2017; COLLEAUX, Laurence/H-6455-2017; Casanova, Jean-Laurent/I-3418-2017	COLLEAUX, LAURENCE/0000-0002-0987-7648; Barcia, Giulia/0000-0001-6657-5040; boddaert, nathalie/0000-0003-0991-7774; Casanova, Jean-Laurent/0000-0002-7782-4169; Kaminska, Anna/0000-0003-3805-6651	Centre National de la Recherche Scientifique; French National Research Agency [ANR-08-MNP-010]; US National Institutes of Health (NIH) [HD067517, DC01919, NS073943]; FRAXA foundation; St. Giles Foundation; Rockefeller University Center for Clinical and Translational Science [5UL1RR024143]; Rockefeller University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067517] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001919] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French National Research Agency(French National Research Agency (ANR)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRAXA foundation; St. Giles Foundation; Rockefeller University Center for Clinical and Translational Science; Rockefeller University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to the affected individuals and their families for their participation in the study. The team of L.C. was supported in part by the Centre National de la Recherche Scientifique and the French National Research Agency (ANR-08-MNP-010). Work by the team of L.K.K. is supported by the US National Institutes of Health (NIH) grants HD067517, DC01919 and NS073943 and a grant from the FRAXA foundation. The Laboratory of Human Genetics of Infectious Diseases is supported in part by grants from the St. Giles Foundation, the Rockefeller University Center for Clinical and Translational Science grant 5UL1RR024143 and the Rockefeller University.	Bhattacharjee A, 2005, TRENDS NEUROSCI, V28, P422, DOI 10.1016/j.tins.2005.06.003; Bolton PF, 2002, BRAIN, V125, P1247, DOI 10.1093/brain/awf124; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Brown MR, 2010, NAT NEUROSCI, V13, P819, DOI 10.1038/nn.2563; Caraballo RH, 2008, J CHILD NEUROL, V23, P497, DOI 10.1177/0883073807309771; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; Coppola G, 2006, BRAIN DEV-JPN, V28, P76, DOI 10.1016/j.braindev.2005.05.002; COPPOLA G, 1995, EPILEPSIA, V36, P1017, DOI 10.1111/j.1528-1157.1995.tb00961.x; Djuric M, 2011, EPILEPTIC DISORD, V13, P22, DOI 10.1684/epd.2011.0402; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Fleming MR, 2009, J RECEPT SIG TRANSD, V29, P173, DOI 10.1080/10799890903056883; Freilich ER, 2011, ARCH NEUROL-CHICAGO, V68, P665, DOI 10.1001/archneurol.2011.98; Friocourt G, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00004; Gerard F, 1999, EPILEPTIC DISORD, V1, P135; Gilhuis HJ, 2011, EPILEPTIC DISORD, V13, P185, DOI 10.1684/epd.2011.0424; Gross-Tsur V, 2004, PEDIATR NEUROL, V31, P287, DOI 10.1016/j.pediatrneurol.2004.05.001; Hamdan FF, 2011, EUR J HUM GENET, V19, P607, DOI 10.1038/ejhg.2010.183; Hmaimess G, 2006, PEDIATR NEUROL, V34, P55, DOI 10.1016/j.pediatrneurol.2005.06.011; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Lee EH, 2012, BRAIN DEV-JPN, V34, P768, DOI 10.1016/j.braindev.2011.11.011; Marsh E, 2005, EPILEPSIA, V46, P568, DOI 10.1111/j.0013-9580.2005.34104.x; Nabbout R, 2003, NEUROLOGY, V60, P1961, DOI 10.1212/01.WNL.0000069463.41870.2F; Nabbout R, 2008, CURR OPIN NEUROL, V21, P161, DOI 10.1097/WCO.0b013e3282f7007e; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Okuda K, 2000, BRAIN DEV-JPN, V22, P56, DOI 10.1016/S0387-7604(99)00108-4; Poduri A, 2011, CURR OPIN GENET DEV, V21, P325, DOI 10.1016/j.gde.2011.01.005; Rojo DC, 2011, NEUROLOGY, V77, P380, DOI 10.1212/WNL.0b013e318227046d; Ruffin VA, 2008, NEUROSCIENCE, V151, P410, DOI 10.1016/j.neuroscience.2007.10.031; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; Steinlein OK, 2007, EPILEPSY RES, V73, P245, DOI 10.1016/j.eplepsyres.2006.10.010; Vendrame M, 2011, EPILEPTIC DISORD, V13, P18, DOI 10.1684/epd.2011.0406; Veneselli E, 2001, EPILEPSY RES, V46, P27, DOI 10.1016/S0920-1211(01)00197-8; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Wilmshurst JM, 2000, J CHILD NEUROL, V15, P717, DOI 10.1177/088307380001501102; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI.5308-06.2007; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Zamponi N, 2008, NEUROSURG REV, V31, P291, DOI 10.1007/s10143-008-0134-8	39	305	320	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2012	44	11					1255	1259		10.1038/ng.2441	http://dx.doi.org/10.1038/ng.2441			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	029KZ	23086397	Green Accepted			2022-12-17	WOS:000310495800019
J	Noma, K; Sugiyama, T; Cam, H; Verdel, A; Zofall, M; Jia, ST; Moazed, D; Grewal, SIS				Noma, K; Sugiyama, T; Cam, H; Verdel, A; Zofall, M; Jia, ST; Moazed, D; Grewal, SIS			RITS acts in cis to promote RNA interference-mediated transcriptional and post-transcriptional silencing	NATURE GENETICS			English	Article							FISSION YEAST CENTROMERES; HISTONE H3 METHYLATION; EPIGENETIC CONTROL; HETEROCHROMATIN DOMAIN; LYSINE-9 METHYLATION; DROSOPHILA; DNA; PLANTS; RECOGNITION; PATHWAYS	RNA interference is a conserved mechanism by which double-stranded RNA is processed into short interfering RNAs (siRNAs) that can trigger both post-transcriptional and transcriptional gene silencing. In fission yeast, the RNA-induced initiation of transcriptional gene silencing (RITS) complex contains Dicer-generated siRNAs and is required for heterochromatic silencing. Here we show that BITS components, including Argonaute protein, bind to all known heterochromatic loci. At the mating-type region, BITS is recruited to the centromere-homologous repeat cenH in a Dicer-dependent manner, whereas the spreading of BITS across the entire 20-kb silenced domain, as well as its subsequent maintenance, requires heterochromatin machinery including Swi6 and occurs even in the absence of Dicer. Furthermore, our analyses suggest that RNA interference machinery operates in cis as a stable component of heterochromatic domains with BITS tethered to silenced loci by methylation of histone H3 at Lys9. This tethering promotes the processing of transcripts and generation of additional siRNAs for heterochromatin maintenance.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Verdel, André/M-5201-2013	Sugiyama, Tomoyasu/0000-0001-5704-6606; VERDEL, Andre/0000-0001-6048-3794	NATIONAL CANCER INSTITUTE [Z01BC010523, ZIABC010523] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grewal SIS, 1997, GENETICS, V146, P1221; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hall Ira M., 2003, P205; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	35	305	319	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2004	36	11					1174	1180		10.1038/ng1452	http://dx.doi.org/10.1038/ng1452			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15475954	Bronze			2022-12-17	WOS:000224832800020
J	Sollars, V; Lu, XY; Xiao, L; Wang, XY; Garfinkel, MD; Ruden, DM				Sollars, V; Lu, XY; Xiao, L; Wang, XY; Garfinkel, MD; Ruden, DM			Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; KRUPPEL ACTIVITY; MODIFIER SCREEN; EYE DEVELOPMENT; MUTATIONS; POLYCOMB; GENES	Morphological alterations have been shown to occur in Drosophila melanogaster when function of Hsp90 (heat shock 90-kDa protein 1alpha, encoded by Hsp83) is compromised during development(1). Genetic selection maintains the altered phenotypes in subsequent generations(1). Recent experiments have shown, however, that phenotypic variation still occurs in nearly isogenic recombinant inbred strains of Arabidopsis thaliana(2). Using a sensitized isogenic D. melanogaster strain, iso-Krlf-1, we confirm this finding and present evidence supporting an epigenetic mechanism for Hsp90's capacitor function, whereby reduced activity of Hsp90 induces a heritably altered chromatin state. The altered chromatin state is evidenced by ectopic expression of the morphogen wingless in eye imaginal discs and a corresponding abnormal eye phenotype, both of which are epigenetically heritable in subsequent generations, even when function of Hsp90 is restored. Mutations in nine different genes of the trithorax group that encode chromatin-remodeling proteins also induce the abnormal phenotype. These findings suggest that Hsp90 acts as a capacitor for morphological evolution through epigenetic and genetic mechanisms.	Univ Alabama, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	University of Alabama System; University of Alabama Birmingham; Jefferson University; Columbia University	Ruden, DM (corresponding author), Univ Alabama, Dept Environm Hlth Sci, RPHB 530, Birmingham, AL 35294 USA.		Sollars, Vincent/R-3769-2019; Ruden, Douglas/A-5008-2016; Ruden, Douglas/ABE-1418-2021	Ruden, Douglas/0000-0002-0070-437X; Sollars, Vincent/0000-0002-5602-3610	NCI NIH HHS [R01 CA105349] Funding Source: Medline; NIAAA NIH HHS [R01 AA012276] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abrell S, 2000, CHROMOSOMA, V109, P334, DOI 10.1007/s004120000092; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M., 1989, DROSOPHILA LAB HDB; Bender J, 2002, CURR BIOL, V12, pR412, DOI 10.1016/S0960-9822(02)00910-7; Carrera P, 1998, P NATL ACAD SCI USA, V95, P10779, DOI 10.1073/pnas.95.18.10779; Dickson BJ, 1996, GENETICS, V142, P163; Gibson MC, 2002, DEV CELL, V3, P451, DOI 10.1016/S1534-5807(02)00264-2; Goldstein LSB, 1994, DROSOPHILA MELANOGAS; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; JACKLE H, 1985, COLD SPRING HARB SYM, V50, P465, DOI 10.1101/SQB.1985.050.01.058; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kohler C, 2002, CURR BIOL, V12, pR129, DOI 10.1016/S0960-9822(02)00705-4; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Mollaaghababa R, 2001, P NATL ACAD SCI USA, V98, P3958, DOI 10.1073/pnas.061497798; Paro R, 1998, CIBA F SYMP, V214, P51; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747	22	305	321	0	56	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2003	33	1					70	74		10.1038/ng1067	http://dx.doi.org/10.1038/ng1067			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	630XH	12483213				2022-12-17	WOS:000180136100020
J	Gripp, KW; Wotton, D; Edwards, MC; Roessler, E; Ades, L; Meinecke, P; Richieri-Costa, A; Zackai, EH; Massague, J; Muenke, M; Elledge, SJ				Gripp, KW; Wotton, D; Edwards, MC; Roessler, E; Ades, L; Meinecke, P; Richieri-Costa, A; Zackai, EH; Massague, J; Muenke, M; Elledge, SJ			Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination	NATURE GENETICS			English	Article							BRAIN; GENE; PROTEINS; HEDGEHOG; LAYER	Holoprosencephaly (HPE) is the most common structural defect of the developing forebrain in humans (1 in 250 conceptuses, 1 in 16,000 live-born infants(1-3)). HPE is aetiologically heterogeneous, with both environmental and genetic causes(4,5). So far, three human HPE genes are known: SHH at chromosome region 7q36 (ref. 6); ZIC2 at 13q32 (ref. 7); and SIX3 at 2p21 (ref. 8). In animal models, genes in the Nodal signalling pathway, such as those mutated in the zebrafish mutants cyclops (refs 9,10), squint (ref. Il)and one-eyed pinhead (oep: ref. 12), cause HPE. Mice heterozygous for null alleles of both Nodal and Smad2 have cyclopia(13) Here we describe the involvement of the TO-interacting factor (TGIF), a homeodomain protein, in human HPE. We mapped TGIF to the HPE minimal critical region in 18p11.3. Heterozygous mutations in individuals with HPE affect the transcriptional repression domain of TGIF, the DNA-binding domain or the domain that interacts with SMAD2. (The latter is an effector in the signalling path-way of the neural axis developmental factor NODAL, a member of the transforming growth factor-beta (TGF-beta) family.) Several of these mutations cause a loss of TGIF function. Thus, TGIF links the NODAL signalling pathway to the bifurcation of the human forebrain and the establishment of ventral midline structures.	Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Genet & Neurol, Philadelphia, PA 19104 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Cell Biol Program, New York, NY 10021 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Natl Human Genome Res Inst, Dept Mol & Human Genet, NIH, Bethesda, MD USA; Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD USA; Royal Alexandra Hosp Children, Parramatta, Australia; Altonauer Kinderkrankenhaus, Hamburg, Germany; Univ Sao Paulo, Sao Paulo, Brazil	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Baylor College of Medicine; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Universidade de Sao Paulo	Muenke, M (corresponding author), Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA.		Richieri-Costa, Antonio/B-2514-2013; Ades, lionel/T-6882-2019	Massague, Joan/0000-0001-9324-8408; Wotton, David/0000-0002-4652-5350; Muenke, Maximilian/0000-0002-7719-6545				BARR M, 1983, J PEDIATR-US, V102, P565, DOI 10.1016/S0022-3476(83)80185-1; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Bertolino E, 1996, DEV DYNAM, V205, P410, DOI 10.1002/(SICI)1097-0177(199604)205:4<410::AID-AJA5>3.0.CO;2-L; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Edwards MC, 1997, GENETICS, V147, P1063; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Golden JA, 1998, J NEUROPATH EXP NEUR, V57, P991, DOI 10.1097/00005072-199811000-00001; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Liu F, 1998, NAT GENET, V20, P325, DOI 10.1038/3793; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Ming JE, 1998, CLIN GENET, V53, P155; MUENKE M, IN PRESS METABOLIC M; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; OVERHAUSER J, 1995, AM J HUM GENET, V57, P1080; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Roessler E, 1998, J INHERIT METAB DIS, V21, P481, DOI 10.1023/A:1005406719292; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; VARLET I, 1997, CURR OPIN GENE DEV, V7, P518; Wallis DE, 1999, NAT GENET, V22, P196, DOI 10.1038/9718; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6	24	305	318	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2000	25	2					205	208		10.1038/76074	http://dx.doi.org/10.1038/76074			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	321ML	10835638				2022-12-17	WOS:000087459200022
J	Hager, J; Dina, C; Francke, S; Dubois, S; Houari, M; Vatin, V; Vaillant, E; Lorentz, N; Basdevant, A; Clement, K; Guy-Grand, B; Froguel, P				Hager, J; Dina, C; Francke, S; Dubois, S; Houari, M; Vatin, V; Vaillant, E; Lorentz, N; Basdevant, A; Clement, K; Guy-Grand, B; Froguel, P			A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10	NATURE GENETICS			English	Article							LEPTIN RECEPTOR GENE; HUMAN OB GENE; QUANTITATIVE TRAIT; MARKERS FLANKING; EXTREME OBESITY; PIMA-INDIANS; LINKAGE; MUTATION; ABSENCE; WEIGHT	Obesity, a common multifactorial disorder, is a major risk factor for type 2 diabetes, hypertension and coronary heart disease(1) (CHD). According to the definition of the World Health Organization (WHO), approximately 6-10% of the population in Westernized countries are considered obese(2). Epidemiological studies have shown that 30-70% of the variation in body weight may be attributable to genetic factors. To date, two genome-wide scans using different obesity-related quantitative traits have provided candidate regions for obesity(3,4). We have undertaken a genome-wide scan in affected sibpairs to identify chromosomal regions linked to obesity in a collection of French families. Model-free multipoint linkage analyses revealed evidence for linkage to a region on chromosome 10p (MLS=4.85). Two further loci on chromosomes 5cen-q and 2p showed suggestive evidence for linkage of serum leptin levels in a genome-wide context. The peak on chromosome 2 coincided with the region containing the gene (POMC) encoding pro-opiome-lanocortin, a locus previously linked to leptin levels and fat mass in a Mexican-American population(3) and shown to be mutated in obese humans(5). Our results suggest that there is a major gene on chromosome 10p implicated in the development of human obesity, and the existence of two further loci influencing leptin levels.	Inst Biol, CNRS EP 10, F-59019 Lille, France; Hop Hotel Dieu, Dept Nutr, Paris, France; Univ Bonn, Inst Klin Biochem, D-5300 Bonn, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Bonn	Froguel, P (corresponding author), Inst Biol, CNRS EP 10, 1 Rue Prof Calmette, F-59019 Lille, France.	jorg.hager@xenope.pasteur.lille.fr; froguel@xenope.pasteur-lille.fr	Dina, Christian R/D-3535-2015; FROGUEL, Philippe/O-6799-2017; Clément, karine/R-1120-2017	Dina, Christian R/0000-0002-7722-7348; FROGUEL, Philippe/0000-0003-2972-0784; 				Chagnon YC, 1998, OBES RES, V6, P76, DOI 10.1002/j.1550-8528.1998.tb00318.x; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Clement K, 1996, DIABETES, V45, P687, DOI 10.2337/diabetes.45.5.687; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2986, DOI 10.1172/JCI118007; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Francke S, 1997, HUM GENET, V100, P491, DOI 10.1007/s004390050540; FRAYN KN, 1992, CLIN SCI, V82, P1, DOI 10.1042/cs0820001; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KLEBIG ML, 1995, P NATL ACAD SCI USA, V92, P4728, DOI 10.1073/pnas.92.11.4728; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Meunier F, 1997, GENET EPIDEMIOL, V14, P1107, DOI 10.1002/(SICI)1098-2272(1997)14:6<1107::AID-GEPI91>3.0.CO;2-K; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; NAGGERT JK, 1995, NAT GENET, V10, P153; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Norman RA, 1996, DIABETES, V45, P1229, DOI 10.2337/diabetes.45.9.1229; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; NORMAN RA, 1995, J CLIN INVEST, V96, P158, DOI 10.1172/JCI118016; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Reed DR, 1996, DIABETES, V45, P691, DOI 10.2337/diabetes.45.5.691; TIRET L, 1992, GENET EPIDEMIOL, V9, P389, DOI 10.1002/gepi.1370090603; TRAN LD, 1994, SAGE STAT ANAL GENET; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	27	305	321	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1998	20	3					304	308		10.1038/3123	http://dx.doi.org/10.1038/3123			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133QW	9806554				2022-12-17	WOS:000076698100029
J	Igarashi, S; Koide, R; Shimohata, T; Yamada, M; Hayashi, Y; Takano, H; Date, H; Oyake, M; Sato, T; Sato, A; Egawa, S; Ikeuchi, T; Tanaka, H; Nakano, R; Tanaka, K; Hozumi, I; Inuzuka, T; Takahashi, H; Tsuji, S				Igarashi, S; Koide, R; Shimohata, T; Yamada, M; Hayashi, Y; Takano, H; Date, H; Oyake, M; Sato, T; Sato, A; Egawa, S; Ikeuchi, T; Tanaka, H; Nakano, R; Tanaka, K; Hozumi, I; Inuzuka, T; Takahashi, H; Tsuji, S			Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch	NATURE GENETICS			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; SPINOCEREBELLAR ATAXIA TYPE-1; TRINUCLEOTIDE CAG REPEAT; CATALYZED CROSS-LINKING; MACHADO-JOSEPH DISEASE; GLUTAMINE REPEATS; NEURODEGENERATIVE DISEASES; HUNTINGTONS-DISEASE; COMPLEMENTARY-DNA; TRANSGENIC MICE	To elucidate the molecular mechanisms whereby expanded polyglutamine stretches elicit a gain of toxic function, we expressed full-length and truncated DRPLA (dentatorubral-pallidoluysian atrophy) cDNAs with or without expanded CAG repeats in COS-7 cells. We found that truncated DRPLA proteins containing an expanded polyglutamine stretch form filamentous peri-and intranuclear aggregates and undergo apoptosis. The apoptotic cell death was partially suppressed by the transglutaminase inhibitors cystamine and monodansyl cadaverine (but not putrescine), suggesting involvement of a transglutaminase reaction and providing a potential basis for the development of therapeutic measures for GAG-repeat expansion diseases.	Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 951, Japan	Niigata University; Niigata University	Tsuji, S (corresponding author), Niigata Univ, Brain Res Inst, Dept Neurol, 1-757 Asahimachi, Niigata 951, Japan.	tsuji@cc.niigata-u.ac.jp		Sato, Toshiya/0000-0001-7844-9930; Hozumi, Isao/0000-0003-0984-6291				BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DICKSON RB, 1981, J BIOL CHEM, V256, P3454; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; IKEUCHI T, 1995, ANN NEUROL, V37, P769, DOI 10.1002/ana.410370610; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; JACKSON M, 1995, NEUROPATH APPL NEURO, V21, P18, DOI 10.1111/j.1365-2990.1995.tb01024.x; Kahlem P, 1996, P NATL ACAD SCI USA, V93, P14580, DOI 10.1073/pnas.93.25.14580; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KLEMAN JP, 1995, BIOCHEMISTRY-US, V34, P13768, DOI 10.1021/bi00042a007; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LORAND L, 1979, BIOCHEMISTRY-US, V18, P1756, DOI 10.1021/bi00576a019; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; ONODERA O, 1995, AM J HUM GENET, V57, P1050; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; STOTT K, 1995, P NATL ACAD SCI USA, V92, P6509, DOI 10.1073/pnas.92.14.6509; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	38	305	317	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1998	18	2					111	117		10.1038/ng0298-111	http://dx.doi.org/10.1038/ng0298-111			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YV010	9462738				2022-12-17	WOS:000071779500017
J	Lyons, LA; Laughlin, TF; Copeland, NG; Jenkins, NA; Womack, JE; OBrien, SJ				Lyons, LA; Laughlin, TF; Copeland, NG; Jenkins, NA; Womack, JE; OBrien, SJ			Comparative anchor tagged sequences (CATS) for integrative mapping of mammalian genomes	NATURE GENETICS			English	Article							GENETIC-LINKAGE MAP; BOVINE GENOME; POLYMORPHISMS; MOUSE; LOCI	Precise comparisons of mammalian gene maps require common anchor loci as landmarks for conserved chromosomal segments. Using a computer script that automates DNA sequence database alignments. we designed 410 evolutionarily conserved primer pair sequences which are specific for anchor locus gene amplification from any mammalian species' DNA. Primer pairs were designed to span introns for polymorphism ascertainment. and to include sufficient exonic sequence (25-400 bp) to allow for gene identification. A total of 318 primer pairs were optimized for domestic cats, and 86% of the sequenced feline PCR products showed homology to the gene of primer origin. A screen of 20 mammals from 11 orders revealed that 35-52% of the 318 primers yielded a single PCR product without further optimization suggesting that nearly 75% can be optimized for any eutherian mammal.	NCI,FREDERICK CANC RES & DEV CTR,LAB GENOM DIVERS,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,BIOL CARCINOGENESIS & DEV PROGRAM,SAIC FREDERICK,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,MAMMALIAN GENET LAB,ABL BASIC RES PROGRAM,FREDERICK,MD 21702; TEXAS A&M UNIV,DEPT VET PATHOBIOL,COLLEGE STN,TX 77843	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Texas A&M University System; Texas A&M University College Station			OBRIEN, STEPHEN/ABD-1346-2020	Lyons, Leslie/0000-0002-1628-7726; OBRIEN, STEPHEN/0000-0001-7857-0757				ADAMS MD, 1995, ANTURE, V377, pS654; BARENDSE W, 1994, NAT GENET, V6, P227, DOI 10.1038/ng0394-227; BENSON DA, 1994, NUCLEIC ACIDS RES, V22, P3441, DOI 10.1093/nar/22.17.3441; BISHOP MD, 1994, GENETICS, V136, P619; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BURT DW, 1995, TRENDS GENET, V11, P190, DOI 10.1016/S0168-9525(00)89042-3; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; CRAWFORD AM, 1995, GENETICS, V140, P703; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Fasman KH, 1996, NUCLEIC ACIDS RES, V24, P57, DOI 10.1093/nar/24.1.57; Genetic Computer Group, 1994, PROGR MAN WISC PACK; GLAVAC D, 1993, HUM MUTAT, V2, P404, DOI 10.1002/humu.1380020513; HINO O, 1993, P NATL ACAD SCI USA, V90, P730, DOI 10.1073/pnas.90.2.730; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; JOHANSSON M, 1995, GENOMICS, V25, P682, DOI 10.1016/0888-7543(95)80011-A; Lincoln S.E., 1991, PRIMER COMPUTER PROG; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Lyons L. A., 1994, Animal Biotechnology, V5, P103, DOI 10.1080/10495399409525811; MAZZARELLA R, 1992, P NATL ACAD SCI USA, V89, P3681, DOI 10.1073/pnas.89.9.3681; NADEAU JH, 1995, NATURE, V373, P363, DOI 10.1038/373363a0; O'Brien S.J., 1991, Current Opinion in Genetics & Development, V1, P105, DOI 10.1016/0959-437X(91)80050-V; OBRIEN SJ, 1988, ANNU REV GENET, V22, P323, DOI 10.1146/annurev.ge.22.120188.001543; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; OBRIEN SJ, 1993, GENETIC MAPS; PODUSLO SE, 1991, AM J HUM GENET, V49, P106; WOMACK JE, 1995, CURR OPIN GENET DEV, V5, P725, DOI 10.1016/0959-437X(95)80004-O; 1996, MAMM GENOME, V7, P717	29	305	313	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1997	15	1					47	56		10.1038/ng0197-47	http://dx.doi.org/10.1038/ng0197-47			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA373	8988168				2022-12-17	WOS:A1997WA37300020
J	Lemaire, M; Fremeaux-Bacchi, V; Schaefer, F; Choi, MR; Tang, WH; Le Quintrec, M; Fakhouri, F; Taque, S; Nobili, F; Martinez, F; Ji, WZ; Overton, JD; Mane, SM; Nurnberg, G; Altmuller, J; Thiele, H; Morin, D; Deschenes, G; Baudouin, V; Llanas, B; Collard, L; Majid, MA; Simkova, E; Nurnberg, P; Rioux-Leclercq, N; Moeckel, GW; Gubler, MC; Hwa, J; Loirat, C; Lifton, RP				Lemaire, Mathieu; Fremeaux-Bacchi, Veronique; Schaefer, Franz; Choi, Murim; Tang, Wai Ho; Le Quintrec, Moglie; Fakhouri, Fadi; Taque, Sophie; Nobili, Franois; Martinez, Frank; Ji, Weizhen; Overton, John D.; Mane, Shrikant M.; Nuernberg, Gudrun; Altmueller, Janine; Thiele, Holger; Morin, Denis; Deschenes, Georges; Baudouin, Veronique; Llanas, Brigitte; Collard, Laure; Majid, Mohammed A.; Simkova, Eva; Nuernberg, Peter; Rioux-Leclercq, Nathalie; Moeckel, Gilbert W.; Gubler, Marie Claire; Hwa, John; Loirat, Chantal; Lifton, Richard P.			Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome	NATURE GENETICS			English	Article							PROTEIN-KINASE-C; ENDOTHELIAL-CELLS; DIACYLGLYCEROL; EPSILON; EXPRESSION; INHIBITOR; SECRETION; RELEASE; GLUCOSE; TOOL	Pathologic thrombosis is a major cause of mortality. Hemolytic-uremic syndrome (HUS) features episodes of small-vessel thrombosis resulting in microangiopathic hemolytic anemia, thrombocytopenia and renal failure(1). Atypical HUS (aHUS) can result from genetic or autoimmune factors(2) that lead to pathologic complement cascade activation(3). Using exome sequencing, we identified recessive mutations in DGKE (encoding diacylglycerol kinase epsilon) that co-segregated with aHUS in nine unrelated kindreds, defining a distinctive Mendelian disease. Affected individuals present with aHUS before age 1 year, have persistent hypertension, hematuria and proteinuria (sometimes in the nephrotic range), and develop chronic kidney disease with age. DGKE is found in endothelium, platelets and podocytes. Arachidonic acid-containing diacylglycerols (DAG) activate protein kinase C (PKC), which promotes thrombosis, and DGKE normally inactivates DAG signaling. We infer that loss of DGKE function results in a prothrombotic state. These findings identify a new mechanism of pathologic thrombosis and kidney failure and have immediate implications for treating individuals with aHUS.	[Lemaire, Mathieu; Choi, Murim; Ji, Weizhen; Overton, John D.; Mane, Shrikant M.; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lemaire, Mathieu; Choi, Murim; Ji, Weizhen; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Fremeaux-Bacchi, Veronique] Hop Europeen Georges Pompidou, AP HP, Dept Immunol, Paris, France; [Fremeaux-Bacchi, Veronique; Le Quintrec, Moglie] Ctr Rech Cordeliers, UMR S 872, Paris, France; [Schaefer, Franz] Heidelberg Univ, Med Ctr, Div Pediat Nephrol, Heidelberg, Germany; [Schaefer, Franz] Heidelberg Univ, Med Ctr, Ctr Pediat & Adolescent Med, Heidelberg, Germany; [Choi, Murim; Overton, John D.; Mane, Shrikant M.; Lifton, Richard P.] Yale Univ, Sch Med, Yale Ctr Mendelian Genom, New Haven, CT USA; [Tang, Wai Ho; Hwa, John] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Sect Cardiovasc Med, New Haven, CT 06510 USA; [Fakhouri, Fadi] CHU Nantes, Dept Nephrol, F-44035 Nantes 01, France; [Taque, Sophie] CHU Rennes, Dept Pediat, Rennes, France; [Nobili, Franois] CHU Besancon, Dept Pediat, F-25030 Besancon, France; [Martinez, Frank] Hop Necker Enfants Malad, AP HP, Dept Nephrol, Paris, France; [Nuernberg, Gudrun; Altmueller, Janine; Thiele, Holger; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Morin, Denis] CHU Montpellier, Dept Pediat Nephrol, Montpellier, France; [Deschenes, Georges; Baudouin, Veronique; Loirat, Chantal] Hop Univ Robert Debre, AP HP, Dept Pediat Nephrol, Paris, France; [Llanas, Brigitte] CHU Bordeaux, Dept Pediat Nephrol, Bordeaux, France; [Collard, Laure] CHC, Dept Pediat, Liege, Belgium; [Majid, Mohammed A.; Simkova, Eva] Dubai Hosp, Pediat Nephrol Unit, Dept Pediat, Dubai, U Arab Emirates; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuernberg, Peter] ATLAS Biolabs GmbH, Berlin, Germany; [Rioux-Leclercq, Nathalie] CHU Rennes, Dept Pathol, Rennes, France; [Moeckel, Gilbert W.] Yale Univ, Sch Med, Renal Pathol & Electron Microscopy Lab, New Haven, CT USA; [Gubler, Marie Claire] Hop Necker Enfants Malad, INSERM, U983, Paris, France	Yale University; Howard Hughes Medical Institute; Yale University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Yale University; Yale University; Nantes Universite; CHU de Nantes; CHU Rennes; Universite de Franche-Comte; CHU Besancon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Cologne; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; CHU Bordeaux; Dubai Hospital; University of Cologne; CHU Rennes; Yale University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fremeaux-Bacchi, V (corresponding author), Hop Europeen Georges Pompidou, AP HP, Dept Immunol, Paris, France.	veronique.fremeaux-bacchi@egp.aphp.fr; richard.lifton@yale.edu	Thiele, Holger/ABE-6792-2020; Wang, Guilin/G-8794-2018; Choi, Murim/AAP-9120-2021; Lemaire, Mathieu/N-5253-2015	Thiele, Holger/0000-0002-0169-998X; Lemaire, Mathieu/0000-0001-7593-6418; deschenes, georges/0000-0002-5158-2915; Moeckel, Gilbert/0000-0002-6059-0837; Gubler, Marie-Claire/0000-0002-3526-5661; Fakhouri, Fadi/0000-0001-5390-8002; Le Quintrec, Moglie/0000-0002-5857-1207; Altmuller, Janine/0000-0003-4372-1521	US National Institutes of Health (NIH) [U54 HG006504 01, P30 DK079310 05, UL1TR00142 07]; Delegation Regionale a la Recherche Clinique; Assistance Publique-Hopitaux de Paris; Programme Hospitalier de Recherche Clinique [AOM08198]; Association pour l'Information et la Recherche dans les maladies Renales genetiques (AIRG France); European Community [2012-305608]; Kidney Foundation of Canada; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115247] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Delegation Regionale a la Recherche Clinique; Assistance Publique-Hopitaux de Paris; Programme Hospitalier de Recherche Clinique; Association pour l'Information et la Recherche dans les maladies Renales genetiques (AIRG France); European Community(European Commission); Kidney Foundation of Canada; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the subjects with aHUS, their families and the health care professionals whose participation made this study possible; J. Zhang, C. Nelson-Williams, S. Mentone, D. Beury and other members of the complement laboratory at Hopital Europeen Georges-Pompidou for technical support; the staff of the Yale Center for Genome Analysis for exome sequencing; S. Ishibe, S. Shibata, U. Scholl, M.-A. Dragon-Durey, L. Roumenina, M. Malina, Q. Vincent and L. Abel for helpful discussions; and D. Damotte (Assistance Publique-Hopitaux de Paris, Hopital Hotel-Dieu, Service d'Anatomie Pathologique) for the anti-CD34 staining. This work was supported by US National Institutes of Health (NIH) grants U54 HG006504 01 (Yale Center for Mendelian Genomics), P30 DK079310 05 (Yale O'Brien Center for Kidney Research) and UL1TR00142 07 (Yale Center for Translational Science Award), grants from the Delegation Regionale a la Recherche Clinique, Assistance Publique-Hopitaux de Paris to V.F.-B., such as Programme Hospitalier de Recherche Clinique (AOM08198) and the Association pour l'Information et la Recherche dans les maladies Renales genetiques (AIRG France), and a European Community FP7 Grant 2012-305608 (EURenOmics) to F. S. and V.F.-B. M. L. is the recipient of a Kidney Research Scientist Core Education and National Training (KRESCENT) Program Post-Doctoral Fellowship Award from the Kidney Foundation of Canada and is a member of the Investigative Medicine PhD program at Yale University School of Medicine.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; CAREW MA, 1992, BIOCHEM J, V286, P631, DOI 10.1042/bj2860631; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P2334; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Fremeaux-Bacchi V., 2013, CLIN J AM SOC NEPHRO; Ganesan C, 2011, J NEPHROL, V24, P554, DOI 10.5301/JN.2011.6250; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HERBERT JM, 1993, THROMB RES, V71, P487, DOI 10.1016/0049-3848(93)90122-5; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hoshi S, 2002, BIOCHEM BIOPH RES CO, V290, P177, DOI 10.1006/bbrc.2001.6138; Lansigan F, 2011, RHEUMATOLOGY, V50, P824, DOI 10.1093/rheumatology/keq395; LEVIN EG, 1989, J BIOL CHEM, V264, P16030; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; NEILD GH, 1994, LANCET, V343, P398, DOI 10.1016/S0140-6736(94)91228-9; Norholm MHH, 2011, J BIOL CHEM, V286, P25284, DOI 10.1074/jbc.M111.244616; Noris M, 2012, NAT REV NEPHROL, V8, P622, DOI 10.1038/nrneph.2012.195; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; NUNN DL, 1987, BIOCHEM J, V243, P809, DOI 10.1042/bj2430809; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Ozaltin F, 2013, J AM SOC NEPHROL, V24, P377, DOI 10.1681/ASN.2012090903; Pettitt TR, 1997, J BIOL CHEM, V272, P17354, DOI 10.1074/jbc.272.28.17354; Pettitt TR, 1999, J BIOL CHEM, V274, P36181, DOI 10.1074/jbc.274.51.36181; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P919, DOI 10.1161/ATVBAHA.108.162842; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; Ren S, 2000, AM J PHYSIOL-ENDOC M, V278, pE656, DOI 10.1152/ajpendo.2000.278.4.E656; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Roumenina LT, 2011, J IMMUNOL METHODS, V365, P8, DOI 10.1016/j.jim.2010.12.020; Sellier-Leclerc AL, 2007, J AM SOC NEPHROL, V18, P2392, DOI 10.1681/ASN.2006080811; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Skerka C, 2009, MOL IMMUNOL, V46, P2801, DOI 10.1016/j.molimm.2009.05.018; SOLDIN SJ, 2005, PEDIAT REFERENCE INT; Tang W, 1996, J BIOL CHEM, V271, P10237, DOI 10.1074/jbc.271.17.10237; Tang WH, 2011, J CLIN INVEST, V121, P4462, DOI 10.1172/JCI59291; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; WHATLEY RE, 1989, J BIOL CHEM, V264, P6325; YADA Y, 1990, J BIOL CHEM, V265, P19237; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214	46	304	318	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2013	45	5					531	+		10.1038/ng.2590	http://dx.doi.org/10.1038/ng.2590			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	133RU	23542698	Green Accepted			2022-12-17	WOS:000318158200016
J	Syvanen, AC				Syvanen, AC			Toward genome-wide SNP genotyping	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; OLIGONUCLEOTIDE ARRAYS; HAPLOTYPE DIVERSITY; MUTATION DETECTION; PRIMER EXTENSION; PADLOCK PROBES; DNA; DENSITY; ASSAY; GENE	Genome-wide association studies with SNP markers are expected to allow identification of genes that underlie complex disorders. Hundreds of thousands of SNP markers will be required for comprehensive genome-wide association studies. The development of microarray-based methods for SNP genotyping on this scale remains a demanding task, despite many recent advances in technology for the production of high-density microarrays. A key technical obstacle is the PCR amplification step, which is required to reduce the complexity of and gain sufficient sensitivity for genotyping SNPs in large, diploid genomes. The multiplexing level that can be achieved in PCR does not match that of current microarray-based methods, making PCR the limiting step in the assays. Highly multiplexed microarray systems for SNP genotyping have recently been developed by combining well-known reaction principles for DNA amplification and SNP genotyping in clever ways. These new methods offer the potential of genome-wide SNP mapping of genes involved in complex diseases in the foreseeable future, provided that issues related to selection of the optimal SNP markers, sample throughput and the cost of the assays can be addressed.	Uppsala Univ, Dept Med Sci Mol Med, Univ Hosp, S-75185 Uppsala, Sweden	Uppsala University; Uppsala University Hospital	Syvanen, AC (corresponding author), Uppsala Univ, Dept Med Sci Mol Med, Univ Hosp, Entr 70, S-75185 Uppsala, Sweden.	Ann-Christine.Syvanen@medsci.uu.se						Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Baner J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng104; Bell PA, 2002, BIOTECHNIQUES, P70; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Cai H, 2000, GENOMICS, V66, P135, DOI 10.1006/geno.2000.6218; Chen JW, 2000, GENOME RES, V10, P549, DOI 10.1101/gr.10.4.549; Chen XN, 1997, NUCLEIC ACIDS RES, V25, P347, DOI 10.1093/nar/25.2.347; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dong SL, 2001, GENOME RES, V11, P1418, DOI 10.1101/gr.171101; Evans DM, 2004, GENET EPIDEMIOL, V27, P375, DOI 10.1002/gepi.20045; Evans DM, 2004, AM J HUM GENET, V75, P687, DOI 10.1086/424696; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fan JB, 2000, GENOME RES, V10, P853, DOI 10.1101/gr.10.6.853; Favis R, 2000, NAT BIOTECHNOL, V18, P561, DOI 10.1038/75452; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gerry NP, 1999, J MOL BIOL, V292, P251, DOI 10.1006/jmbi.1999.3063; Gunderson KL, 2004, GENOME RES, V14, P870, DOI 10.1101/gr.2255804; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hinds David A., 2004, Human Genomics, V1, P421; Hirschhorn JN, 2000, P NATL ACAD SCI USA, V97, P12164, DOI 10.1073/pnas.210394597; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Koed K, 2005, CANCER RES, V65, P34; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kurg A, 2000, GENET TEST, V4, P1, DOI 10.1089/109065700316408; Kwok PY, 2001, ANNU REV GENOM HUM G, V2, P235, DOI 10.1146/annurev.genom.2.1.235; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; Lin ZW, 1996, P NATL ACAD SCI USA, V93, P2582, DOI 10.1073/pnas.93.6.2582; Lindroos K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf069; Liu WM, 2003, BIOINFORMATICS, V19, P2397, DOI 10.1093/bioinformatics/btg332; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pastinen T, 1997, GENOME RES, V7, P606, DOI 10.1101/gr.7.6.606; Pastinen T, 2000, GENOME RES, V10, P1031, DOI 10.1101/gr.10.7.1031; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Saba TG, 2005, HUM GENET, V116, P167, DOI 10.1007/s00439-004-1193-8; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; Schaid DJ, 2004, AM J HUM GENET, V75, P948, DOI 10.1086/425870; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Shumaker JM, 1996, HUM MUTAT, V7, P346, DOI 10.1002/(SICI)1098-1004(1996)7:4<346::AID-HUMU9>3.3.CO;2-9; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; SOUTHERN EM, 1992, GENOMICS, V13, P1008, DOI 10.1016/0888-7543(92)90014-J; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	68	304	374	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37			S			S5	S10		10.1038/ng1558	http://dx.doi.org/10.1038/ng1558			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	15920530	Bronze			2022-12-17	WOS:000229590000003
J	Robertson, SP; Twigg, SRF; Sutherland-Smith, AJ; Biancalana, V; Gorlin, RJ; Horn, D; Kenwrick, SJ; Kim, CA; Morava, E; Newbury-Ecob, R; Orstavik, KH; Quarrell, OWJ; Schwartz, CE; Shears, DJ; Suri, M; Kendrick-Jones, J; Wilkie, AOM				Robertson, SP; Twigg, SRF; Sutherland-Smith, AJ; Biancalana, V; Gorlin, RJ; Horn, D; Kenwrick, SJ; Kim, CA; Morava, E; Newbury-Ecob, R; Orstavik, KH; Quarrell, OWJ; Schwartz, CE; Shears, DJ; Suri, M; Kendrick-Jones, J; Wilkie, AOM		OPD-Spectrum Disorders Clinical Co	Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans	NATURE GENETICS			English	Article							MELNICK-NEEDLES-SYNDROME; SYNDROME TYPE-II; PERIVENTRICULAR HETEROTOPIA; DIGITAL SYNDROME; INACTIVATION; MIGRATION; NEURONS; DOMAIN; LOCUS; MALES	Remodeling of the cytoskeleton is central to the modulation of cell shape and migration. Filamin A, encoded by the gene FLNA, is a widely expressed protein that regulates re-organization of the actin cytoskeleton by interacting with integrins, transmembrane receptor complexes and second messengers(1,2). We identified localized mutations in FLNA that conserve the reading frame and lead to a broad range of congenital malformations, affecting craniofacial structures, skeleton, brain, viscera and urogenital tract, in four X-linked human disorders: otopalatodigital syndrome types 1 (OPD1; OMIM 311300) and 2 (OPD2; OMIM 304120), frontometaphyseal dysplasia (FMD; OMIM 305620) and Melnick-Needles syndrome (MNS; OMIM 309350). Several mutations are recurrent, and all are clustered into four regions of the gene: the actin-binding domain and rod domain repeats 3, 10 and 14/15. Our findings contrast with previous observations that loss of function of FLNA is embryonic lethal in males but manifests in females as a localized neuronal migration disorder, called periventricular nodular heterotopia (PVNH; refs. 3-6). The patterns of mutation, X-chromosome inactivation and phenotypic manifestations in the newly described mutations indicate that they have gain-of-function effects, implicating. filamin A in signaling pathways that mediate organogenesis in multiple systems during embryonic development.	City Hosp, Clin Genet Serv, Nottingham NG5 1PB, England; Inst Child Hlth, Clin & Mol Genet Unit, London, England; Greenwood Genet Ctr, Greenwood, SC 29646 USA; Sheffield Childrens Hosp, N Trent Clin Genet Serv, Sheffield, S Yorkshire, England; Univ Oslo, Inst Grp Clin Med, Oslo, Norway; United Bristol Hosp Trust, Clin Genet Serv, Bristol, Avon, England; Univ Pecs, Dept Med Genet, Pecs, Hungary; Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, Brazil; Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England; Humboldt Univ, Inst Humangenet, Berlin, Germany; Univ Minnesota, Dept Oral Pathol & Genet, Minneapolis, MN USA; CHRU, Strasbourg, France; Fac Med, Lab Diagnost Genet, Strasbourg, France; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Nottingham; University of London; University College London; Greenwood Genetic Center; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Oslo; University of Pecs; Universidade de Sao Paulo; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Humboldt University of Berlin; University of Minnesota System; University of Minnesota Twin Cities; CHU Strasbourg; MRC Laboratory Molecular Biology; University of Oxford	Robertson, SP (corresponding author), Univ Otago, Dept Paediat & Child Hlth, Dunedin, New Zealand.		Twigg, Stephen/AAU-1135-2021; Biancalana, Valerie/O-2351-2016; Wilkie, Andrew/AAC-3820-2020; Sutherland-Smith, Andrew/F-1813-2011; VERLOES, Alain/E-7287-2014	Twigg, Stephen/0000-0001-5024-049X; Wilkie, Andrew/0000-0002-2972-5481; Sutherland-Smith, Andrew/0000-0001-9485-1428; Kim, Chong/0000-0002-1754-1300; Robertson, Stephen/0000-0002-5181-7809; VERLOES, Alain/0000-0003-4819-0264; Lacombe, Didier/0000-0002-8956-2207				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ANDRE M, 1981, J PEDIATR-US, V98, P747, DOI 10.1016/S0022-3476(81)80835-9; BIANCALANA V, 1991, HUM GENET, V88, P228, DOI 10.1007/BF00206078; Carugo KD, 1997, NAT STRUCT BIOL, V4, P175, DOI 10.1038/nsb0397-175; DONNENFELD AE, 1987, AM J MED GENET, V27, P159, DOI 10.1002/ajmg.1320270117; DUDDING BA, 1967, AM J DIS CHILD, V113, P214, DOI 10.1001/archpedi.1967.02090170078006; Eksioglu YZ, 1996, NEURON, V16, P77, DOI 10.1016/S0896-6273(00)80025-2; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FITCH N, 1983, AM J MED GENET, V15, P655, DOI 10.1002/ajmg.1320150416; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; GORLIN RJ, 1969, AM J DIS CHILD, V118, P487, DOI 10.1001/archpedi.1969.02100040489014; Hassoun H, 1997, BLOOD, V90, P398; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kosho T, 2002, J Med Genet, V39, pE7, DOI 10.1136/jmg.39.2.e7; Kristiansen M, 2002, AM J MED GENET, V108, P120, DOI 10.1002/ajmg.10245; LEMAREC B, 1988, ANN GENET-PARIS, V31, P155; McCoy AJ, 1999, NAT STRUCT BIOL, V6, P836; MELNICK JC, 1966, AMER J ROENTGENOL RA, V97, P39, DOI 10.2214/ajr.97.1.39; Moro F, 2002, NEUROLOGY, V58, P916, DOI 10.1212/WNL.58.6.916; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; Robertson S, 1997, AM J MED GENET, V71, P341, DOI 10.1002/(SICI)1096-8628(19970822)71:3<341::AID-AJMG16>3.0.CO;2-K; Robertson SP, 2001, AM J HUM GENET, V69, P223, DOI 10.1086/321280; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; STRATTON RF, 1991, AM J MED GENET, V41, P169, DOI 10.1002/ajmg.1320410206; TAYBI H, 1962, AMER J ROENTGENOL RA, V88, P450; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Verloes A, 2000, AM J MED GENET, V90, P407, DOI 10.1002/(SICI)1096-8628(20000228)90:5<407::AID-AJMG11>3.0.CO;2-D	29	304	325	0	17	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	APR	2003	33	4					487	491		10.1038/ng1119	http://dx.doi.org/10.1038/ng1119			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662CM	12612583	Bronze			2022-12-17	WOS:000181928600019
J	McCormick, C; Leduc, Y; Martindale, D; Mattison, K; Esford, LE; Dyer, AP; Tufaro, F				McCormick, C; Leduc, Y; Martindale, D; Mattison, K; Esford, LE; Dyer, AP; Tufaro, F			The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate	NATURE GENETICS			English	Article							HERPES-SIMPLEX VIRUS; HEREDITARY MULTIPLE EXOSTOSES; GLYCOPROTEIN-C; GENE; PROTEOGLYCANS; BIOSYNTHESIS; BINDING; MUTANTS	Hereditary multiple exostoses (HME) is an autosomal dominant disorder characterized by the formation of cartilage-capped tumours (exostoses) that develop from the growth plate of endochondral bone(1). This condition can lead to skeletal abnormalities, short stature and malignant transformation of exostoses to chondrosarcomas(2,3) or osteosarcomas(4,5). Linkage analyses have identified three different genes for HME, EXT1 on 8q24.1, EXT2 on 11p11-13 and EXT3 on 19p (refs 6-9). Most HME cases have been attributed to missense or frameshift mutations in these tumour-supressor genes, whose functions have remained obscure. Here, we show that EXT1 is an ER-resident type II transmembrane glycoprotein whose expression in cells results in the alteration of the synthesis and display of cell surface heparan sulfate glycosaminoglycans (GAGs). Two EXT1 variants containing aetiologic missense mutations(10) failed to alter cell-surface glycosaminoglycans, despite retaining their ER-localization.	Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Tufaro, F (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.	tufaro@unixg.ubc.ca	McCormick, Craig/AAH-9069-2019	McCormick, Craig/0000-0003-2794-3722				AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; BAME KJ, 1989, J BIOL CHEM, V264, P8059; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Bernstein Lori R., 1994, Current Opinion in Oncology, V6, P106, DOI 10.1097/00001622-199401000-00015; CAL WH, 1988, J VIROL, V62, P2596, DOI 10.1128/JVI.62.8.2596-2604.1988; COOK A, 1993, AM J HUM GENET, V53, P71; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; Hecht JT, 1997, AM J HUM GENET, V60, P80; HENNEKAM RCM, 1991, J MED GENET, V28, P262, DOI 10.1136/jmg.28.4.262; HEROLD BC, 1994, J GEN VIROL, V75, P1211, DOI 10.1099/0022-1317-75-6-1211; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Iida J, 1996, SEMIN CANCER BIOL, V7, P155, DOI 10.1006/scbi.1996.0021; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; LEONE NC, 1987, J HERED, V78, P171, DOI 10.1093/oxfordjournals.jhered.a110351; Philippe C, 1997, AM J HUM GENET, V61, P520, DOI 10.1086/515505; Schamhart DHJ, 1997, UROL RES, V25, pS89, DOI 10.1007/BF00941994; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; SOLOMON L, 1963, J BONE JOINT SURG BR, V45, P292, DOI 10.1302/0301-620X.45B2.292; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tuszynski GP, 1997, ACTA HAEMATOL-BASEL, V97, P29; Van Hul W, 1998, GENOMICS, V47, P230, DOI 10.1006/geno.1997.5101; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; Wise CA, 1997, GENOME RES, V7, P10, DOI 10.1101/gr.7.1.10; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Wuyts W, 1997, EUR J HUM GENET, V5, P382, DOI 10.1159/000484796	30	304	322	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1998	19	2					158	161		10.1038/514	http://dx.doi.org/10.1038/514			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZQ468	9620772				2022-12-17	WOS:000073865100023
J	SIMARD, J; TONIN, P; DUROCHER, F; MORGAN, K; ROMMENS, J; GINGRAS, S; SAMSON, C; LEBLANC, JF; BELANGER, C; DION, F; LIU, Q; SKOLNICK, M; GOLDGAR, D; SHATTUCKEIDENS, D; LABRIE, F; NAROD, SA				SIMARD, J; TONIN, P; DUROCHER, F; MORGAN, K; ROMMENS, J; GINGRAS, S; SAMSON, C; LEBLANC, JF; BELANGER, C; DION, F; LIU, Q; SKOLNICK, M; GOLDGAR, D; SHATTUCKEIDENS, D; LABRIE, F; NAROD, SA			COMMON ORIGINS OF BRCA1 MUTATIONS IN CANADIAN BREAST AND OVARIAN-CANCER FAMILIES	NATURE GENETICS			English	Article							CHROMOSOME-17Q21; LINKAGE	Women who carry mutations in the BRCA1 gene on chromosome 17q have an 85% lifetime risk of breast cancer, and a 60% risk of ovarian cancer, We have identified BRCA1 mutations in 12 of 30 (40%) Canadian families with breast and/or ovarian cancer, including six of the eight families (75%) that contained two cases of early-onset breast cancer and two cases of ovarian cancer, Six frameshift mutations account for all 12 mutant alleles, including nucleotide insertions (two mutations) and deletions (four mutations), Four independent families carried the same 1 basepair (bp) insertion mutation in codon 1755 and four other families shared a 2 bp deletion mutation in codons 22-23. These families were not known to be related, but haplotype analysis suggests that the carriers of each of these mutations have common ancestors.	MCGILL UNIV,DEPT MED,DIV MED GENET,MONTREAL H3G 1A4,PQ,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL H3G 1A4,PQ,CANADA; MCGILL UNIV,DEPT BIOSTAT & EPIDEMIOL,MONTREAL H3G 1A4,PQ,CANADA; CHU LAVAL,RES CTR,MOLEC ENDOCRINOL LAB,QUEBEC CITY G1V 4G2,PQ,CANADA; UNIV LAVAL,QUEBEC CITY G1V 4G2,PQ,CANADA; HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ON,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; MYRIAD GENET INC,SALT LAKE CITY,UT; UNIV UTAH,DEPT MED INFORMAT,SALT LAKE CITY,UT 84112	McGill University; McGill University; McGill University; Laval University; Laval University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Myriad Genetics, Inc; Utah System of Higher Education; University of Utah			Narod, Steven A/AAA-6112-2022	Leblanc, Jean-Francois/0000-0003-4568-2335; Durocher, Francine/0000-0001-8012-4641; Simard, Jacques/0000-0001-6906-3390				ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; EASTON DF, 1993, AM J HUM GENET, V52, P678; FEUNTEUN J, 1993, AM J HUM GENET, V52, P736; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1991, LANCET, V338, P82; NAROD SA, IN PRESS AM J HUM GE; NEUHAUSEN SL, 1994, HUM MOL GENET, V3, P1919, DOI 10.1093/hmg/3.11.1919; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193; TONIN P, IN PRESS HUM GENET; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	14	304	319	1	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					392	398		10.1038/ng1294-392	http://dx.doi.org/10.1038/ng1294-392			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894492				2022-12-17	WOS:A1994PV68200022
J	TSILFIDIS, C; MACKENZIE, AE; METTLER, G; BARCELO, J; KORNELUK, RG				TSILFIDIS, C; MACKENZIE, AE; METTLER, G; BARCELO, J; KORNELUK, RG			CORRELATION BETWEEN CTG TRINUCLEOTIDE REPEAT LENGTH AND FREQUENCY OF SEVERE CONGENITAL MYOTONIC-DYSTROPHY	NATURE GENETICS			English	Article							BRITAIN	The myotonic dystrophy (DM) mutation has recently been identified as an unstable trinucleotide CTG repeat which is present 5-30 times in the normal population but which is amplified up to 2,000 times in DM. We have determined the status of the CTG repeat in 272 DM individuals. Infants with severe congenital DM, as well as their mothers, are shown to have on average a greater amplification of the CTG repeat than is seen in the noncongenital DM population. This fact, when viewed in conjunction with the tendency to increased CTG repeat length in our DM kindreds, provides evidence for the existence of genetic anticipation in the transmission of DM.	UNIV OTTAWA,DEPT MICROBIOL & IMMUNOL,OTTAWA K1H 8M5,ONTARIO,CANADA; UNIV OTTAWA,DEPT BIOCHEM,OTTAWA K1H 8M5,ONTARIO,CANADA; CHILDRENS HOSP EASTERN ONTARIO,OTTAWA K1H 8L1,ONTARIO,CANADA	University of Ottawa; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario								ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; DODGE PR, 1965, PEDIATRICS, V365, P3; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GLANZ A, 1984, J MED GENET, V21, P186, DOI 10.1136/jmg.21.3.186; GRIGGS RC, 1989, NEUROLOGY, V39, P420, DOI 10.1212/WNL.39.3.420; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 1989, MYOTONIC DYSTROPHY; HARPER PS, 1975, ARCH DIS CHILD, V50, P514, DOI 10.1136/adc.50.7.514; HARPER PS, 1975, ARCH DIS CHILD, V50, P505, DOI 10.1136/adc.50.7.505; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; KOCH MC, 1991, AM J HUM GENET, V48, P1084; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACKENZIE AE, 1989, AM J HUM GENET, V44, P140; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MATHIEU J, 1990, NEUROLOGY, V40, P839, DOI 10.1212/WNL.40.5.839; MCCOMAS AJ, 1978, J NEUROL NEUROSUR PS, V41, P882, DOI 10.1136/jnnp.41.10.882; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; TSILFIDIS C, 1991, AM J HUM GENET, V49, P961; VANIER TM, 1960, BRIT MED J, V2, P1284, DOI 10.1136/bmj.2.5208.1284; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	24	304	313	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					192	195		10.1038/ng0692-192	http://dx.doi.org/10.1038/ng0692-192			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303233				2022-12-17	WOS:A1992JC98200011
J	Buch, S; Stickel, F; Trepo, E; Way, M; Herrmann, A; Nischalke, HD; Brosch, M; Rosendahl, J; Berg, T; Ridinger, M; Rietschel, M; McQuillin, A; Frank, J; Kiefer, F; Schreiber, S; Lieb, W; Soyka, M; Semmo, N; Aigner, E; Datz, C; Schmelz, R; Bruckner, S; Zeissig, S; Stephan, AM; Wodarz, N; Deviere, J; Clumeck, N; Sarrazin, C; Lammert, F; Gustot, T; Deltenre, P; Volzke, H; Lerch, MM; Mayerle, J; Eyer, F; Schafmayer, C; Cichon, S; Nothen, MM; Nothnagel, M; Ellinghaus, D; Huse, K; Franke, A; Zopf, S; Hellerbrand, C; Moreno, C; Franchimont, D; Morgan, MY; Hampe, J				Buch, Stephan; Stickel, Felix; Trepo, Eric; Way, Michael; Herrmann, Alexander; Nischalke, Hans Dieter; Brosch, Mario; Rosendahl, Jonas; Berg, Thomas; Ridinger, Monika; Rietschel, Marcella; McQuillin, Andrew; Frank, Josef; Kiefer, Falk; Schreiber, Stefan; Lieb, Wolfgang; Soyka, Michael; Semmo, Nasser; Aigner, Elmar; Datz, Christian; Schmelz, Renate; Brueckner, Stefan; Zeissig, Sebastian; Stephan, Anna-Magdalena; Wodarz, Norbert; Deviere, Jacques; Clumeck, Nicolas; Sarrazin, Christoph; Lammert, Frank; Gustot, Thierry; Deltenre, Pierre; Voelzke, Henry; Lerch, Markus M.; Mayerle, Julia; Eyer, Florian; Schafmayer, Clemens; Cichon, Sven; Noethen, Markus M.; Nothnagel, Michael; Ellinghaus, David; Huse, Klaus; Franke, Andre; Zopf, Steffen; Hellerbrand, Claus; Moreno, Christophe; Franchimont, Denis; Morgan, Marsha Y.; Hampe, Jochen			A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis	NATURE GENETICS			English	Article							LIVER-DISEASE; GENETIC PREDISPOSITION; CONFERS SUSCEPTIBILITY; END-POINTS; FIBROSIS; PROGRESSION; VARIANT; TRANSPLANTATION; POLYMORPHISM; GENOTYPE	Alcohol misuse is the leading cause of cirrhosis and the second most common indication for liver transplantation in the Western world(1-3). We performed a genome-wide association study for alcohol-related cirrhosis in individuals of European descent (712 cases and 1,426 controls) with subsequent validation in two independent European cohorts (1,148 cases and 922 controls). We identified variants in the MBOAT7 (P = 1.03 x 10(-9)) and TM6SF2 (P = 7.89 x 10(-10)) genes as new risk loci and confirmed rs738409 in PNPLA3 as an important risk locus for alcohol-related cirrhosis (P = 1.54 x 10(-48)) at a genome-wide level of significance. These three loci have a role in lipid processing, suggesting that lipid turnover is important in the pathogenesis of alcohol-related cirrhosis.	[Buch, Stephan; Herrmann, Alexander; Brosch, Mario; Schmelz, Renate; Brueckner, Stefan; Zeissig, Sebastian; Stephan, Anna-Magdalena; Hampe, Jochen] Tech Univ Dresden, Univ Hosp Dresden, Dept Med 1, Dresden, Germany; [Stickel, Felix] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Trepo, Eric; Deviere, Jacques; Gustot, Thierry; Deltenre, Pierre; Moreno, Christophe; Franchimont, Denis] Univ Libre Bruxelles, CUB Hop Erasme, Dept Gastroenterol Hepatopancreatol & Digest Onco, Brussels, Belgium; [Trepo, Eric; Deviere, Jacques; Gustot, Thierry; Moreno, Christophe; Franchimont, Denis] Univ Libre Bruxelles, Lab Expt Gastroenterol, Brussels, Belgium; [Way, Michael; Morgan, Marsha Y.] UCL, UCL Inst Liver & Digest Hlth, Div Med, London, England; [Way, Michael; McQuillin, Andrew] UCL, Div Psychiat, Mol Psychiat Lab, London, England; [Nischalke, Hans Dieter] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Rosendahl, Jonas; Berg, Thomas] Univ Hosp Leipzig, Sect Hepatol, Leipzig, Germany; [Ridinger, Monika; Wodarz, Norbert] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany; [Ridinger, Monika] Psychiat Dienste Aargau, Psychiat Hlth Care Aargau, Windisch, Switzerland; [Rietschel, Marcella; Frank, Josef; Kiefer, Falk] Heidelberg Univ, Fac Med Mannheim, Cent Inst Mental Hlth, Mannheim, Germany; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Internal Med 1, Kiel, Germany; [Lieb, Wolfgang] Univ Kiel, Inst Epidemiol, Kiel, Germany; [Lieb, Wolfgang] Univ Kiel, Biobank PopGen, Kiel, Germany; [Soyka, Michael] Univ Munich, Hosp Psychiat, D-80539 Munich, Germany; [Semmo, Nasser] Inselspital Bern, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland; [Aigner, Elmar; Datz, Christian] Salzburg Univ, Teaching Hosp Paracelsus Private, Hosp Oberndorf, Dept Internal Med, A-5020 Salzburg, Austria; [Clumeck, Nicolas] Univ Libre Bruxelles, Ctr Hosp Le Domaine, Braine Lalleud, Belgium; [Sarrazin, Christoph] Univ Hosp Frankfurt, Dept Gastroenterol, Frankfurt, Germany; [Lammert, Frank] Saarland Univ Hosp, Dept Med 2, Homburg, Germany; [Deltenre, Pierre] Hop Jolimont, Serv Hepatogastroenterol, Haine St Paul, Belgium; [Deltenre, Pierre] Univ Lausanne, CHU Vaudois, Div Gastroenterol & Hepatol, Lausanne, Switzerland; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Lerch, Markus M.; Mayerle, Julia] Univ Med Greifswald, Dept Internal Med A, Greifswald, Germany; [Eyer, Florian] Tech Univ Munich, Klinikum Rechts Isar, Dept Clin Toxicol, D-80290 Munich, Germany; [Schafmayer, Clemens] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, Kiel, Germany; [Cichon, Sven] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Nothnagel, Michael] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Ellinghaus, David; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Huse, Klaus] Fritz Lipmann Inst Age Res FLI, Jena, Germany; [Zopf, Steffen] Univ Hosp Erlangen, Dept Internal Med 1, Erlangen, Germany; [Hellerbrand, Claus] Univ Hosp Regensburg, Dept Internal Med 1, Regensburg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Zurich; University Zurich Hospital; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of London; University College London; University of London; University College London; University of Bonn; Leipzig University; University of Regensburg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Kiel; University of Munich; University of Bern; University Hospital of Bern; Salzburg University; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Universitatsklinikum des Saarlandes; Groupe Jolimont; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Greifswald Medical School; Greifswald Medical School; Technical University of Munich; University of Kiel; Schleswig Holstein University Hospital; University of Basel; University of Bonn; University of Bonn; University of Cologne; University of Kiel; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Erlangen Nuremberg; University of Regensburg	Stickel, F (corresponding author), Univ Zurich Hosp, Dept Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	felix.stickel@ikp.unibe.ch	Lerch, Markus M./E-2206-2016; Mayerle, Julia/W-7907-2019; Ellinghaus, David/G-4467-2012; Nothnagel, Michael/G-6545-2014; Wodarz, Norbert/E-1805-2011; McQuillin, Andrew/C-1623-2008; Lieb, Wolfgang/AAC-7650-2022; Trépo, Eric/ABD-9339-2021; Franke, Andre/B-2151-2010; Eyer, Florian/S-5801-2019; Buch, Stephan/AAV-5028-2021; Zeissig, Sebastian/B-6297-2012; Hampe, Jochen/A-2555-2010; Nothnagel, Michael/L-7187-2019; Ellinghaus, David/ABC-3610-2020	Lerch, Markus M./0000-0002-9643-8263; McQuillin, Andrew/0000-0003-1567-2240; Franke, Andre/0000-0003-1530-5811; Eyer, Florian/0000-0002-4753-2747; Zeissig, Sebastian/0000-0001-5124-0897; Hampe, Jochen/0000-0002-2421-6127; Nothnagel, Michael/0000-0001-8305-7114; Ellinghaus, David/0000-0002-4332-6110; Brosch, Mario/0000-0001-8983-6557; Nischalke, Hans Dieter/0000-0002-3457-0023; Gustot, Thierry/0000-0002-5537-9607; Trepo, Eric/0000-0003-0475-3934; Mayerle, Julia/0000-0002-3666-6459; Nothen, Markus/0000-0002-8770-2464; Huse, Klaus/0000-0003-3854-1884; Way, Michael/0000-0001-7750-5857	German Ministry of Education and Research through the Virtual Liver Network; PopGen 2.0 network biobank [01EY1103]; medical faculties of TU Dresden and Christian Albrechts University Kiel; Swiss National Funds [310030_138747]; Federal Ministry of Education and Research; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Federal Ministry of Education and Research [BMBF GANI-MED 03152061A, BMBF 0314107]; European Union; EFRE-State Ministry of Economics [V-630-S-150-2012/132/133]; German Federal Ministry of Education and Research (BMBF) through the Integrated Networks IntegraMent and Sysmed Alcohol [01ZX1314A, 01ZX1311A]; DFG (Deutsche Forschungsgemeinschaft)-funded Excellence Cluster ImmunoSensation; Deutsche Krebshilfe [107865]; German Federal Ministry of Education and Research (BMBF) within the framework of the e: Med research and funding concept [01ZX1306A]; DFG Excellence Cluster, 'Inflammation at Interfaces' [306]; Foundation for Experimental Medicine (Zurich, Switzerland); University College London; Avon and Wiltshire Mental Health Partnership; Lincolnshire Partnership; Belgian Medical Genomics Initiative (BeMGI) - phase VII Interuniversity Attraction Poles (IAP) program of the Belgian Federal Science Policy Office (BELSPO); Fund for Scientific Research-FNRS (F.R.S.-FNRS)	German Ministry of Education and Research through the Virtual Liver Network; PopGen 2.0 network biobank; medical faculties of TU Dresden and Christian Albrechts University Kiel; Swiss National Funds(Swiss National Science Foundation (SNSF)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); EFRE-State Ministry of Economics; German Federal Ministry of Education and Research (BMBF) through the Integrated Networks IntegraMent and Sysmed Alcohol(Federal Ministry of Education & Research (BMBF)); DFG (Deutsche Forschungsgemeinschaft)-funded Excellence Cluster ImmunoSensation(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); German Federal Ministry of Education and Research (BMBF) within the framework of the e: Med research and funding concept(Federal Ministry of Education & Research (BMBF)); DFG Excellence Cluster, 'Inflammation at Interfaces'(German Research Foundation (DFG)); Foundation for Experimental Medicine (Zurich, Switzerland); University College London(General Electric); Avon and Wiltshire Mental Health Partnership; Lincolnshire Partnership; Belgian Medical Genomics Initiative (BeMGI) - phase VII Interuniversity Attraction Poles (IAP) program of the Belgian Federal Science Policy Office (BELSPO); Fund for Scientific Research-FNRS (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS)	This study was supported by the German Ministry of Education and Research through the Virtual Liver Network (to J.H.), the PopGen 2.0 network biobank (grant 01EY1103) and institutional funds from the medical faculties of TU Dresden and Christian Albrechts University Kiel and by Swiss National Funds (grant 310030_138747 to F.S.). The Community Medicine Research network of the University of Greifswald, Germany, is funded by the Federal Ministry of Education and Research, the Ministry of Cultural Affairs and the Social Ministry of the Federal State of Mecklenburg-West Pomerania. M.M.L. and J.M. were supported by the Federal Ministry of Education and Research (BMBF GANI-MED 03152061A and BMBF 0314107), the European Union (EU-FP-7: EPC-TM and EU-FP-7-REGPOT-2010-1) and the EFRE-State Ministry of Economics (V-630-S-150-2012/132/133). S.C., M.M.N. and M. Rietschel were supported by the German Federal Ministry of Education and Research (BMBF) through the Integrated Networks IntegraMent and Sysmed Alcohol under the auspices of the e: Med Programme (grant 01ZX1314A to M.M.N. and S.C. and grant 01ZX1311A to M.M.N. and M. Rietschel). M.M.N. is a member of the DFG (Deutsche Forschungsgemeinschaft)-funded Excellence Cluster ImmunoSensation. Research by H.D.N. related to this project was funded by the Deutsche Krebshilfe (107865). The work of A.F. and D.E. was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e: Med research and funding concept (SysInflame grant 01ZX1306A). This project received infrastructure support from DFG Excellence Cluster 306, 'Inflammation at Interfaces'. A.F. receives an endowment professorship from the Foundation for Experimental Medicine (Zurich, Switzerland). The UK research effort was funded by a PhD studentship award jointly funded by University College London and an anonymous donor. We thank colleagues from the following centers for obtaining samples from alcohol-dependent cases for genotyping: the Bexley Substance Misuse Service, South London and Maudsley National Health Service (NHS) Trust; the East Hertfordshire Community Drug Action Team; the Max Glatt Unit, Southall; Renfrew and Inverclyde Alcohol Services, Strathclyde; the Newcastle North Tyneside Drug and Alcohol Service, Tyne and Wear; and the Acute Admissions Unit and the Centre for Hepatology at the Royal Free Hospital, London. We also thank colleagues associated with the National Institute for Health Research (NIHR) Mental Health Research Network for their assistance in identifying cases, obtaining consent and collecting samples at the following NHS trusts: Sandwell Mental Health and Social Care; Northamptonshire Healthcare; Avon and Wiltshire Mental Health Partnership, Sheffield Health and Social Care; Tees Esk and Wear Valleys; Lincolnshire Partnership; Nottinghamshire Healthcare; Central and North West London; South Staffordshire and Shropshire Healthcare; Coventry and Warwickshire; and Dudley and Walsall Mental Health Partnership. We are grateful to J. Saini, K. Ruparelia, S. Montagnese, R. Kandaswamy, A. Jarram, G. Quadri and N. O'Brien for assisting with the collection and processing of samples and DNA extraction.; The Belgian research effort was supported by the Belgian Medical Genomics Initiative (BeMGI) funded by the phase VII Interuniversity Attraction Poles (IAP) program of the Belgian Federal Science Policy Office (BELSPO) and the Fund for Scientific Research-FNRS (F.R.S.-FNRS). E.T. is a Postdoctoral Researcher of the F.R.S.-FNRS, and D.F. is a Research Director of the F.R.S.-FNRS. We are grateful to O. Lemoine, D. Degre, A. Lemmers and M. Amrani for identifying cases and controls, obtaining consent and collecting samples at CUB Hopital Erasme, Universite Libre de Bruxelles. We also thank E. Quertinmont at the Laboratory of Experimental Gastroenterology, Universite Libre de Bruxelles, for his help with the collection and processing of samples and DNA extraction.	Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101; Burra P, 2010, AM J TRANSPLANT, V10, P138, DOI 10.1111/j.1600-6143.2009.02869.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chamorro AJ, 2014, ALIMENT PHARM THER, V40, P571, DOI 10.1111/apt.12890; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Di Martino V, 2012, NEW ENGL J MED, V366, P478, DOI 10.1056/NEJMc1114241; Dongiovanni P, 2015, HEPATOLOGY, V61, P506, DOI 10.1002/hep.27490; Edenberg HJ, 2013, NAT REV GASTRO HEPAT, V10, P487, DOI 10.1038/nrgastro.2013.86; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Han SZ, 2013, AM J HUM GENET, V93, P1027, DOI 10.1016/j.ajhg.2013.10.021; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; HRUBEC Z, 1981, ALCOHOL CLIN EXP RES, V5, P207, DOI 10.1111/j.1530-0277.1981.tb04890.x; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; ISHAK KG, 1991, ALCOHOL CLIN EXP RES, V15, P45, DOI 10.1111/j.1530-0277.1991.tb00518.x; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Liu YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5309; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Nguyen-Khac E, 2008, ALIMENT PHARM THER, V28, P1188, DOI 10.1111/j.1365-2036.2008.03831.x; Nischalke HD, 2014, J HEPATOL, V61, P1073, DOI 10.1016/j.jhep.2014.06.006; Patin E, 2012, GASTROENTEROLOGY, V143, P1244, DOI 10.1053/j.gastro.2012.07.097; Patsenker E, 2011, MOL MED, V17, P1285, DOI 10.2119/molmed.2011.00149; Pirazzi C, 2014, HUM MOL GENET, V23, P4077, DOI 10.1093/hmg/ddu121; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Reed T, 1996, ALCOHOL CLIN EXP RES, V20, P1528, DOI 10.1111/j.1530-0277.1996.tb01695.x; Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Roshyara NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097589; Salameh H, 2015, AM J GASTROENTEROL, V110, P846, DOI 10.1038/ajg.2015.137; Sinnott JA, 2012, HUM GENET, V131, P111, DOI 10.1007/s00439-011-1054-1; Smagris E, 2015, HEPATOLOGY, V61, P108, DOI 10.1002/hep.27242; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Tam J, 2011, HEPATOLOGY, V53, P346, DOI 10.1002/hep.24077; TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2013, J HEPATOL, V59, P344, DOI 10.1016/j.jhep.2013.03.024; Treutlein J, 2009, ARCH GEN PSYCHIAT, V66, P773, DOI 10.1001/archgenpsychiatry.2009.83; Vanlemmens C, 2009, ANN INTERN MED, V150, P153, DOI 10.7326/0003-4819-150-3-200902030-00004; Way M, 2015, ADDICT BIOL, V20, P594, DOI 10.1111/adb.12141; Yamashita A, 2003, J BIOL CHEM, V278, P30382, DOI 10.1074/jbc.M303391200; Zintzaras E, 2006, HEPATOLOGY, V43, P352, DOI 10.1002/hep.21023	49	303	313	1	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1443	+		10.1038/ng.3417	http://dx.doi.org/10.1038/ng.3417			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26482880	Green Accepted			2022-12-17	WOS:000365813200016
J	Ming, R; VanBuren, R; Wai, CM; Tang, HB; Schatz, MC; Bowers, JE; Lyons, E; Wang, ML; Chen, J; Biggers, E; Zhang, JS; Huang, LX; Zhang, LM; Miao, WJ; Zhang, J; Ye, ZY; Miao, CY; Lin, ZC; Wang, H; Zhou, HY; Yim, WC; Priest, HD; Zheng, CF; Woodhouse, M; Edger, PP; Guyot, R; Guo, HB; Guo, H; Zheng, GY; Singh, R; Sharma, A; Min, XJ; Zheng, Y; Lee, H; Gurtowski, J; Sedlazeck, FJ; Harkess, A; McKain, MR; Liao, ZY; Fang, JP; Liu, J; Zhang, XD; Zhang, Q; Hu, WC; Qin, Y; Wang, K; Chen, LY; Shirley, N; Lin, YR; Liu, LY; Hernandez, AG; Wright, CL; Bulone, V; Tuskan, GA; Heath, K; Zee, F; Moore, PH; Sunkar, R; Leebens-Mack, JH; Mockler, T; Bennetzen, JL; Freeling, M; Sankoff, D; Paterson, AH; Zhu, XG; Yang, XH; Smith, JAC; Cushman, JC; Paull, RE; Yu, QY				Ming, Ray; VanBuren, Robert; Wai, Ching Man; Tang, Haibao; Schatz, Michael C.; Bowers, John E.; Lyons, Eric; Wang, Ming-Li; Chen, Jung; Biggers, Eric; Zhang, Jisen; Huang, Lixian; Zhang, Lingmao; Miao, Wenjing; Zhang, Jian; Ye, Zhangyao; Miao, Chenyong; Lin, Zhicong; Wang, Hao; Zhou, Hongye; Yim, Won C.; Priest, Henry D.; Zheng, Chunfang; Woodhouse, Margaret; Edger, Patrick P.; Guyot, Romain; Guo, Hao-Bo; Guo, Hong; Zheng, Guangyong; Singh, Ratnesh; Sharma, Anupma; Min, Xiangjia; Zheng, Yun; Lee, Hayan; Gurtowski, James; Sedlazeck, Fritz J.; Harkess, Alex; McKain, Michael R.; Liao, Zhenyang; Fang, Jingping; Liu, Juan; Zhang, Xiaodan; Zhang, Qing; Hu, Weichang; Qin, Yuan; Wang, Kai; Chen, Li-Yu; Shirley, Neil; Lin, Yann-Rong; Liu, Li-Yu; Hernandez, Alvaro G.; Wright, Chris L.; Bulone, Vincent; Tuskan, Gerald A.; Heath, Katy; Zee, Francis; Moore, Paul H.; Sunkar, Ramanjulu; Leebens-Mack, James H.; Mockler, Todd; Bennetzen, Jeffrey L.; Freeling, Michael; Sankoff, David; Paterson, Andrew H.; Zhu, Xinguang; Yang, Xiaohan; Smith, J. Andrew C.; Cushman, John C.; Paull, Robert E.; Yu, Qingyi			The pineapple genome and the evolution of CAM photosynthesis	NATURE GENETICS			English	Article							CRASSULACEAN ACID METABOLISM; EXPRESSION ANALYSIS; GENE; SEQUENCE; PLANTS; IDENTIFICATION; ARABIDOPSIS; DIVERGENCE; C-4; DIVERSIFICATION	Pineapple (Ananas comosus (L.) Merr.) is the most economically valuable crop possessing crassulacean acid metabolism (CAM), a photosynthetic carbon assimilation pathway with high water-use efficiency, and the second most important tropical fruit. We sequenced the genomes of pineapple varieties F153 and MD2 and a wild pineapple relative, Ananas bracteatus accession CB5. The pineapple genome has one fewer ancient whole-genome duplication event than sequenced grass genomes and a conserved karyotype with seven chromosomes from before the. duplication event. The pineapple lineage has transitioned from C-3 photosynthesis to CAM, with CAM-related genes exhibiting a diel expression pattern in photosynthetic tissues. CAM pathway genes were enriched with cis-regulatory elements associated with the regulation of circadian clock genes, providing the first cis-regulatory link between CAM and circadian clock regulation. Pineapple CAM photosynthesis evolved by the reconfiguration of pathways in C-3 plants, through the regulatory neofunctionalization of preexisting genes and not through the acquisition of neofunctionalized genes via whole-genome or tandem gene duplication.	[Ming, Ray; VanBuren, Robert; Wai, Ching Man; Tang, Haibao; Zhang, Jisen; Huang, Lixian; Zhang, Lingmao; Miao, Wenjing; Zhang, Jian; Ye, Zhangyao; Miao, Chenyong; Lin, Zhicong; Liao, Zhenyang; Fang, Jingping; Liu, Juan; Zhang, Xiaodan; Zhang, Qing; Hu, Weichang; Qin, Yuan; Wang, Kai; Chen, Li-Yu] Fujian Agr & Forestry Univ, Fujian Agr & Forestry Univ & Univ Illinois Urbana, Fuzhou, Peoples R China; [Ming, Ray; VanBuren, Robert; Wai, Ching Man; Tang, Haibao; Zhang, Jisen; Huang, Lixian; Zhang, Lingmao; Miao, Wenjing; Zhang, Jian; Ye, Zhangyao; Miao, Chenyong; Lin, Zhicong; Liao, Zhenyang; Fang, Jingping; Liu, Juan; Zhang, Xiaodan; Zhang, Qing; Hu, Weichang; Qin, Yuan; Wang, Kai; Chen, Li-Yu] Fujian Agr & Forestry Univ, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou, Peoples R China; [Ming, Ray; VanBuren, Robert; Wai, Ching Man; Heath, Katy] Univ Illinois, Dept Plant Biol, Urbana, IL USA; [VanBuren, Robert; Priest, Henry D.; McKain, Michael R.; Mockler, Todd] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Tang, Haibao; Lyons, Eric] Univ Arizona, iPlant Collaborat, Tucson, AZ USA; [Schatz, Michael C.; Biggers, Eric; Lee, Hayan; Gurtowski, James; Sedlazeck, Fritz J.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Bowers, John E.; Wang, Hao; Zhou, Hongye; Harkess, Alex; Leebens-Mack, James H.; Bennetzen, Jeffrey L.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Wang, Ming-Li; Moore, Paul H.] Hawaii Agr Res Ctr, Kunia, HI USA; [Chen, Jung; Paull, Robert E.] Univ Hawaii, Dept Trop Plant & Soil Sci, Honolulu, HI 96822 USA; [Yim, Won C.; Cushman, John C.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Zheng, Chunfang; Sankoff, David] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada; [Woodhouse, Margaret; Edger, Patrick P.; Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Guyot, Romain] IRD, Divers Adaptat & Dev Plantes, Montpellier, France; [Guo, Hao-Bo; Guo, Hong] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA; [Zheng, Guangyong; Zhu, Xinguang] Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Gesell Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Singh, Ratnesh; Sharma, Anupma; Yu, Qingyi] Texas A&M Univ Syst, Dept Plant Pathol & Microbiol, Texas A&M AgriLife Res, Dallas, TX USA; [Min, Xiangjia] Youngstown State Univ, Dept Biol Sci, Youngstown, OH 44555 USA; [Zheng, Yun] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Peoples R China; [Shirley, Neil; Bulone, Vincent] Univ Adelaide, Sch Agr Food & Wine, Australian Res Council ARC Ctr Excellence Plant C, Adelaide, SA, Australia; [Lin, Yann-Rong; Liu, Li-Yu] Natl Taiwan Univ, Dept Agron, Taipei, Taiwan; [Hernandez, Alvaro G.; Wright, Chris L.] Univ Illinois, WM Keck Ctr, Urbana, IL USA; [Tuskan, Gerald A.; Yang, Xiaohan] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Zee, Francis] USDA ARS, Pacific Basin Agr Res Ctr, Hilo, HI USA; [Sunkar, Ramanjulu] Oklahoma State Univ, Dept Biochem & Mol Biol, Noble Res Ctr, Stillwater, OK 74078 USA; [Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Smith, J. Andrew C.] Univ Oxford, Dept Plant Sci, Oxford, England	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; University of Illinois System; University of Illinois Urbana-Champaign; Donald Danforth Plant Science Center; University of Arizona; Cold Spring Harbor Laboratory; University System of Georgia; University of Georgia; University of Hawaii System; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Ottawa; University of California System; University of California Berkeley; Institut de Recherche pour le Developpement (IRD); University of Tennessee System; University of Tennessee Knoxville; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University System of Ohio; Youngstown State University; Kunming University of Science & Technology; University of Adelaide; National Taiwan University; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Agriculture (USDA); Oklahoma State University System; Oklahoma State University - Stillwater; University System of Georgia; University of Georgia; University of Oxford	Ming, R (corresponding author), Fujian Agr & Forestry Univ, Fujian Agr & Forestry Univ & Univ Illinois Urbana, Fuzhou, Peoples R China.	rming@life.uiuc.edu; qyu@ag.tamu.edu	Zheng, Yun/AAS-1149-2021; guyot, romain/AAE-2262-2021; Wang, Kai/A-2143-2011; Yang, Xiaohan/AAM-2449-2020; Bulone, Vincent/C-8492-2019; Edger, Patrick/AAP-3846-2021; Leebens-Mack, James/AAF-6770-2019; guyot, romain/M-1118-2015; Yim, Won Cheol/K-9100-2016; Tuskan, Gerald/A-6225-2011; Smith, J.A.C./M-3338-2014; Mockler, Todd C/L-2609-2013; Bowers, John/AAD-7601-2019; Schatz, Michael/L-2690-2019; Sedlazeck, Fritz J/E-4548-2018; Bulone, Vincent/D-7469-2013; Edger, Patrick/ABE-6442-2020; Guo, Hao-Bo/B-7486-2009; Zheng, Yun/I-7011-2012; Yu, Qingyi/E-8899-2019; Bowers, John/B-9245-2009; Yang, Xiaohan/A-6975-2011; LIN, Yann-rong/AAI-4096-2020; Min, Xiangjia Jack/O-9509-2014; Tang, Haibao/A-6715-2011; Singh, Ratnesh/I-1392-2015	Zheng, Yun/0000-0003-4292-9806; guyot, romain/0000-0002-7016-7485; Wang, Kai/0000-0002-1074-0438; Yang, Xiaohan/0000-0001-5207-4210; Bulone, Vincent/0000-0003-2809-4160; Leebens-Mack, James/0000-0003-4811-2231; guyot, romain/0000-0002-7016-7485; Yim, Won Cheol/0000-0002-7489-0435; Tuskan, Gerald/0000-0003-0106-1289; Smith, J.A.C./0000-0001-9188-0258; Mockler, Todd C/0000-0002-0462-5775; Schatz, Michael/0000-0002-4118-4446; Sedlazeck, Fritz J/0000-0001-6040-2691; Guo, Hao-Bo/0000-0003-1321-1758; Zheng, Yun/0000-0003-4292-9806; Yu, Qingyi/0000-0001-5393-5764; Bowers, John/0000-0001-8984-9796; Yang, Xiaohan/0000-0001-5207-4210; LIN, Yann-rong/0000-0001-6833-8276; Min, Xiangjia Jack/0000-0001-7978-0596; Tang, Haibao/0000-0002-3460-8570; chen, li yu/0000-0002-5199-6237; Liu, Li-yu/0000-0001-6997-8101; Zhang, Xiaodan/0000-0001-8192-0666; Zhang, Jian/0000-0002-0790-4462; Lyons, Eric/0000-0002-3348-8845; Zhou, Hongye/0000-0003-4373-8083; Singh, Ratnesh/0000-0001-5647-3390; Bowers, John/0000-0001-5693-2796; Lee, Hayan/0000-0003-0571-3192; Shirley, Neil/0000-0001-8114-9891; Miao, Chenyong/0000-0002-0904-3707	Fujian Agriculture and Forestry University; USDA T-START grant through the University of Hawaii; University of Illinois at Urbana-Champaign; Fujian provincial government; US National Science Foundation (NSF) Plant Genome Program [0922545]; NSF [DBI-1401572, IOS-1444567]; US National Institutes of Health [R01-HG006677]; US NSF [DBI-1350041, DBI-1265383]; US Department of Energy, Office of Science, Genomic Science Program [DE-SC0008834]; Direct For Biological Sciences [1442199] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1401572, 0922742] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1627442] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006677] Funding Source: NIH RePORTER	Fujian Agriculture and Forestry University; USDA T-START grant through the University of Hawaii; University of Illinois at Urbana-Champaign; Fujian provincial government; US National Science Foundation (NSF) Plant Genome Program(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NSF(National Science Foundation (NSF)); US Department of Energy, Office of Science, Genomic Science Program(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank R. Kai and C. Mayo Riley for maintaining the pineapple plants and the collection of leaf tissues; M. Conway at Dole Plantation for assistance in time-course leaf sample collection; G. Sanewski for providing the MD2 pedigree; and M. Cushman for providing clarifying comments on the manuscript. This project is supported by funding from the Fujian Agriculture and Forestry University to R. M.; a USDA T-START grant through the University of Hawaii to Q.Y., R.M., P.H.M. and R.E.P.; and funding from the University of Illinois at Urbana-Champaign to R.M. H.T. is supported by the 100 Talent Plan award from the Fujian provincial government. Analyses of the pineapple genome are supported by the following funding sources: US National Science Foundation (NSF) Plant Genome Program grant 0922545 to R.M., P.H.M. and Q.Y. and NSF grant DBI-1401572 to R.V.; NSF grant IOS-1444567 to J.H.L.-M.; and US National Institutes of Health award R01-HG006677 and US NSF awards DBI-1350041 and DBI-1265383 to M.C.S. W.C.Y., H.-B.G., H.G., G.A.T., X.Y. and J.C.C. acknowledge support from the US Department of Energy, Office of Science, Genomic Science Program, under award DE-SC0008834.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Antony E, 2008, J EXP BOT, V59, P1895, DOI 10.1093/jxb/ern077; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [DOI 10.1007/BF02672069, 10.1007/BF02672069]; Bartholomew D.P., 2002, PINEAPPLE BOT PRODUC; Beauman Fran, 2006, PINEAPPLE KING FRUIT; Borland AM, 2014, TRENDS PLANT SCI, V19, P327, DOI 10.1016/j.tplants.2014.01.006; BREWBAKER JL, 1967, AM J BOT, V54, P611, DOI 10.2307/2440666; Cai J, 2015, NAT GENET, V47, P65, DOI 10.1038/ng.3149; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; CARNAL NW, 1983, PLANT PHYSIOL, V71, P150, DOI 10.1104/pp.71.1.150; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; Christin PA, 2014, J EXP BOT, V65, P3609, DOI 10.1093/jxb/eru087; Clement C. R., 2010, Diversity, V2, P72; Collins JL, 1960, PINEAPPLE BOT CULTIV; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; DITTRICH P, 1973, PLANT PHYSIOL, V52, P357, DOI 10.1104/pp.52.4.357; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Edwards EJ, 2012, INT J PLANT SCI, V173, P724, DOI 10.1086/666098; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Givnish TJ, 2014, MOL PHYLOGENET EVOL, V71, P55, DOI 10.1016/j.ympev.2013.10.010; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Holtum JAM, 2005, FUNCT PLANT BIOL, V32, P429, DOI 10.1071/FP04189; Hudson ME, 2003, PLANT PHYSIOL, V133, P1605, DOI 10.1104/pp.103.030437; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiao YN, 2014, PLANT CELL, V26, P2792, DOI 10.1105/tpc.114.127597; KENYON WH, 1985, PLANT PHYSIOL, V77, P183, DOI 10.1104/pp.77.1.183; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kramer EM, 1998, GENETICS, V149, P765; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; McRae SR, 2002, FUNCT PLANT BIOL, V29, P717, DOI 10.1071/PP01227; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Michael TP, 2002, PLANT PHYSIOL, V130, P627, DOI 10.1104/pp.004929; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Mirarab S., 2015, RES COMPUTATIONAL MO, P177; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; NOBEL PS, 1991, NEW PHYTOL, V119, P183, DOI 10.1111/j.1469-8137.1991.tb01022.x; OSMOND CB, 1978, ANNU REV PLANT PHYS, V29, P379, DOI 10.1146/annurev.pp.29.060178.002115; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Silvera K, 2010, FUNCT PLANT BIOL, V37, P995, DOI 10.1071/FP10084; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tang HB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-102; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VanBuren R., 2011, Tropical Plant Biology, V4, P228, DOI 10.1007/s12042-011-9084-3; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Wang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4311; Wang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r68; Woodhouse MR, 2011, PLANT CELL, V23, P4241, DOI 10.1105/tpc.111.093567; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang XH, 2015, NEW PHYTOL, V207, P491, DOI 10.1111/nph.13393; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	66	303	327	10	210	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1435	+		10.1038/ng.3435	http://dx.doi.org/10.1038/ng.3435			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26523774	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-17	WOS:000365813200015
J	Huang, J; Deng, Q; Wang, Q; Li, KY; Dai, JH; Li, N; Zhu, ZD; Zhou, B; Liu, XY; Liu, RF; Fei, QL; Chen, H; Cai, B; Zhou, BP; Xiao, HS; Qin, LX; Han, ZG				Huang, Jian; Deng, Qing; Wang, Qun; Li, Kun-Yu; Dai, Ji-Hong; Li, Niu; Zhu, Zhi-Dong; Zhou, Bo; Liu, Xiao-Yan; Liu, Rui-Fang; Fei, Qian-Lan; Chen, Hui; Cai, Bing; Zhou, Boping; Xiao, Hua-Sheng; Qin, Lun-Xiu; Han, Ze-Guang			Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma	NATURE GENETICS			English	Article							ARISTOLOCHIC ACID; FREQUENT MUTATIONS; LIVER-CANCER; HUMAN BREAST; TP53; GENE; ARID1A; PFTK1	Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and shows a propensity to metastasize and infiltrate adjacent and more distant tissues(1). HCC is associated with multiple risk factors, including hepatitis B virus (HBV) infection, which is especially prevalent in China. Here, we used exome sequencing to identify somatic mutations in ten HBV-positive individuals with HCC with portal vein tumor thromboses (PVTTs), intrahepatic metastases. Both C:G>A: T and T:A>A:T transversions were frequently found among the 331 non-silent mutations. Notably, ARID1A, which encodes a component of the SWI/SNF chromatin remodeling complex, was mutated in 14 of 110 (13%) HBV-associated HCC specimens. We used RNA interference to assess the roles of 91 of the confirmed mutated genes in cellular survival. The results suggest that seven of these genes, including VCAM1 and CDK14, may confer growth and infiltration capacity to HCC cells. This study provides a view of the landscape of somatic mutations that may be implicated in advanced HCC.	[Huang, Jian; Deng, Qing; Wang, Qun; Li, Niu; Zhou, Bo; Liu, Xiao-Yan; Liu, Rui-Fang; Han, Ze-Guang] Shanghai Jiao Tong Univ, Sch Med, Human Genome Ctr, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Huang, Jian; Deng, Qing; Wang, Qun; Li, Kun-Yu; Dai, Ji-Hong; Li, Niu; Zhou, Bo; Liu, Xiao-Yan; Liu, Rui-Fang; Fei, Qian-Lan; Chen, Hui; Han, Ze-Guang] Chinese Natl Human Genome Ctr, Shanghai Minist Sci & Technol MOST, Key Lab Dis & Hlth Genom, Shanghai, Peoples R China; [Huang, Jian; Zhu, Zhi-Dong; Xiao, Hua-Sheng] Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China; [Huang, Jian; Zhou, Boping] Guangdong Med Coll, Shenzhen Key Lab Diag & Treatment Infect Dis, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China; [Cai, Bing] Nanjing Med Univ, Dept Hepatobiliary Surg, Wuxi Peoples Hosp, Wuxi, Peoples R China; [Qin, Lun-Xiu] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Guangdong Medical University; Jiangnan University; Nanjing Medical University; Fudan University	Han, ZG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Human Genome Ctr, Rui Jin Hosp, Shanghai 200030, Peoples R China.	hanzg@chgc.sh.cn	Deng, Qing/H-6506-2019	Deng, Qing/0000-0001-5116-461X; Han, Ze-Guang/0000-0002-1018-1752	Chinese National Key Program on Basic Research [2010CB529204, 2010CB529206]; China National Key Projects for Infectious Disease [2012ZX10002012-008]; National Natural Science Foundation of China [81071722, 81101875]; Shanghai Commission for Science and Technology [11ZR1425300]; International Scientific Collaborative Project [2011ZR0001]; National High Technology Research and Development Program of China (863 Program) [2012AA02A205, SS2012AA020103]	Chinese National Key Program on Basic Research; China National Key Projects for Infectious Disease; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Commission for Science and Technology; International Scientific Collaborative Project; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	We gratefully acknowledge support from the Chinese National Key Program on Basic Research (2010CB529204 and 2010CB529206), the China National Key Projects for Infectious Disease (2012ZX10002012-008), the National Natural Science Foundation of China (81071722 and 81101875), the Shanghai Commission for Science and Technology (11ZR1425300), the International Scientific Collaborative Project (2011ZR0001) and the National High Technology Research and Development Program of China (863 Program, 2012AA02A205 and SS2012AA020103).	AGUILAR F, 1993, P NATL ACAD SCI USA, V90, P8586, DOI 10.1073/pnas.90.18.8586; Arlt VM, 2002, MUTAGENESIS, V17, P265, DOI 10.1093/mutage/17.4.265; Barbin A, 2000, MUTAT RES-REV MUTAT, V462, P55, DOI 10.1016/S1383-5742(00)00014-4; Besaratinia A, 2009, GASTROENTEROLOGY, V137, P1127, DOI 10.1053/j.gastro.2009.06.002; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Imbeaud S, 2010, SEMIN LIVER DIS, V30, P75, DOI 10.1055/s-0030-1247134; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Leung WKC, 2011, ONCOGENE, V30, P4464, DOI 10.1038/onc.2011.161; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9; Liver Cancer Study Group of Japan, 1990, Ann Surg, V211, P277; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moriya M, 2011, INT J CANCER, V129, P1532, DOI 10.1002/ijc.26077; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shu F, 2007, P NATL ACAD SCI USA, V104, P9248, DOI 10.1073/pnas.0703327104; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Staib F, 2003, HUM MUTAT, V21, P201, DOI 10.1002/humu.10176; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Topaz O, 2006, AM J HUM GENET, V79, P759, DOI 10.1086/508069; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang YY, 2011, MUTAGENESIS, V26, P619, DOI 10.1093/mutage/ger023; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	37	303	324	4	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2012	44	10					1117	+		10.1038/ng.2391	http://dx.doi.org/10.1038/ng.2391			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	016WJ	22922871				2022-12-17	WOS:000309550200011
J	Kong, A; Masson, G; Frigge, ML; Gylfason, A; Zusmanovich, P; Thorleifsson, G; Olason, PI; Ingason, A; Steinberg, S; Rafnar, T; Sulem, P; Mouy, M; Jonsson, F; Thorsteinsdottir, U; Gudbjartsson, DF; Stefansson, H; Stefansson, K				Kong, Augustine; Masson, Gisli; Frigge, Michael L.; Gylfason, Arnaldur; Zusmanovich, Pasha; Thorleifsson, Gudmar; Olason, Pall I.; Ingason, Andres; Steinberg, Stacy; Rafnar, Thorunn; Sulem, Patrick; Mouy, Magali; Jonsson, Frosti; Thorsteinsdottir, Unnur; Gudbjartsson, Daniel F.; Stefansson, Hreinn; Stefansson, Kari			Detection of sharing by descent, long-range phasing and haplotype imputation	NATURE GENETICS			English	Article							POPULATION GENOTYPE DATA; GENOME-WIDE ASSOCIATION; BREAST-CANCER FAMILIES; LUNG-CANCER; SUSCEPTIBILITY LOCUS; RECOMBINATION RATES; NICOTINE DEPENDENCE; GENES; RECONSTRUCTION; HUMANS	Uncertainty about the phase of strings of SNPs creates complications in genetic analysis, although methods have been developed for phasing population-based samples. However, these methods can only phase a small number of SNPs effectively and become unreliable when applied to SNPs spanning many linkage disequilibrium (LD) blocks. Here we show how to phase more than SNPs simultaneously for a large fraction of the 35,528 Icelanders genotyped by Illumina chips. Moreover, haplotypes that are identical by descent (IBD) between close and distant relatives, for example, those separated by ten meioses or more, can often be reliably detected. This method is particularly powerful in studies of the inheritance of recurrent mutations and fine-scale recombinations in large sample sets. A further extension of the method allows us to impute long haplotypes for individuals who are not genotyped.	[Kong, Augustine; Stefansson, Kari] deCODE genet, Reykjavik, Iceland		Kong, A (corresponding author), deCODE genet, Strulugata 8, Reykjavik, Iceland.	kong@decode.is; kari.stefansson@decode.is	Ingason, Andres/G-6817-2012; Stefansson, Kari/AAE-7187-2019	Kong, Augustine/0000-0001-8193-5438; Stefansson, Hreinn/0000-0002-9331-6666; Gudbjartsson, Daniel/0000-0002-5222-9857	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017932] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA017932] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; GOFFMAN C, 1969, AM MATH MON, V76, P791, DOI 10.2307/2317868; Gudmundsson J, 1996, AM J HUM GENET, V58, P749; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; STEFANSSON H, 2008, NATURE          0730; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	23	303	310	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1068	1075		10.1038/ng.216	http://dx.doi.org/10.1038/ng.216			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	19165921	Green Accepted			2022-12-17	WOS:000258761200019
J	Bitoun, M; Maugenre, S; Jeannet, PY; Lacene, E; Ferrer, X; Laforet, P; Martin, JJ; Laporte, J; Lochmuller, H; Beggs, AH; Fardeau, M; Eymard, B; Romero, NB; Guicheney, P				Bitoun, M; Maugenre, S; Jeannet, PY; Lacene, E; Ferrer, X; Laforet, P; Martin, JJ; Laporte, J; Lochmuller, H; Beggs, AH; Fardeau, M; Eymard, B; Romero, NB; Guicheney, P			Mutations in dynamin 2 cause dominant centronuclear myopathy	NATURE GENETICS			English	Article							DISEASE	Autosomal dominant centronuclear myopathy is a rare congenital myopathy characterized by delayed motor milestones and muscular weakness. In 11 families affected by centronuclear myopathy, we identified recurrent and de novo missense mutations in the gene dynamin 2 (DNM2, 19p13.2), which encodes a protein involved in endocytosis and membrane trafficking, actin assembly and centrosome cohesion. The transfected mutants showed reduced labeling in the centrosome, suggesting that DNM2 mutations might cause centronuclear myopathy by interfering with centrosome function.	UPMC, Grp Hosp Pitie Salpetriere, IFR14, Inst Myol,INSERM,U582, F-75651 Paris, France; CHU Vaudois, Dept Pediat, Neuropediat Unit, CH-1011 Lausanne, Switzerland; CHU Haut Leveque, Dept Neurol, Bordeaux, France; Born Bunge Inst, Neuropathol Lab, Antwerp, Belgium; Coll France, ULP, INSERM, CNRS,IGBMC,Dept Mol Pathol, Illkirch Graffenstaden, France; Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; Harvard Univ, Sch Med, Childrens Hosp Boston, Div Genet, Boston, MA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Munich; Harvard University; Boston Children's Hospital; Harvard Medical School	Guicheney, P (corresponding author), UPMC, Grp Hosp Pitie Salpetriere, IFR14, Inst Myol,INSERM,U582, 47 Blvd Hop, F-75651 Paris, France.	p.guicheney@myologie.chups.jussieu.fr	Guicheney, Pascale/D-1034-2017; Laporte, Jocelyn/H-6801-2016; Bitoun, Marc/M-4720-2017; laporte, jocelyn/J-7008-2012; laporte, jocelyn/O-4888-2019	Guicheney, Pascale/0000-0002-7663-2050; Bitoun, Marc/0000-0002-4188-7918; Beggs, Alan/0000-0001-8818-0568; Lochmuller, Hanns/0000-0003-2324-8001				Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; FARDEAU M, 1994, MYOLOGY, P1500; Jeannet PY, 2004, NEUROLOGY, V62, P1484, DOI 10.1212/01.WNL.0000124388.67003.56; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Reinsch S, 1998, J CELL SCI, V111, P2283; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; SPIRO AJ, 1966, ARCH NEUROL-CHICAGO, V14, P1, DOI 10.1001/archneur.1966.00470070005001; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Yoo JY, 2005, BIOCHEM BIOPH RES CO, V328, P424, DOI 10.1016/j.bbrc.2004.12.179; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	15	303	310	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1207	1209		10.1038/ng1657	http://dx.doi.org/10.1038/ng1657			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16227997	Green Submitted			2022-12-17	WOS:000233045200018
J	Ferland, RJ; Eyaid, W; Collura, RV; Tully, LD; Hill, RS; Al-Nouri, D; Al-Rumayyan, A; Topcu, M; Gascon, G; Bodell, A; Shugart, YY; Ruvolo, M; Walsh, CA				Ferland, RJ; Eyaid, W; Collura, RV; Tully, LD; Hill, RS; Al-Nouri, D; Al-Rumayyan, A; Topcu, M; Gascon, G; Bodell, A; Shugart, YY; Ruvolo, M; Walsh, CA			Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome	NATURE GENETICS			English	Article							EYE MOVEMENTS; VERMIS; LOCUS; RETARDATION; LIKELIHOOD; FAMILIES; FEATURES	Joubert syndrome is a congenital brain malformation of the cerebellar vermis and brainstem with abnormalities of axonal decussation (crossing in the brain) affecting the corticospinal tract and superior cerebellar peduncles(1-9). Individuals with Joubert syndrome have motor and behavioral abnormalities, including an inability to walk due to severe clumsiness and 'mirror' movements, and cognitive and behavioral disturbances(5-8,10-12). Here we identified a locus associated with Joubert syndrome, JBTS3, on chromosome 6q23.2-q23. 3 and found three deleterious mutations in AHI1, the first gene to be associated with Joubert syndrome. AHI1 is most highly expressed in brain, particularly in neurons that give rise to the crossing axons of the corticospinal tract and superior cerebellar peduncles. Comparative genetic analysis of AHI1 indicates that it has undergone positive evolutionary selection along the human lineage. Therefore, changes in AHI1 may have been important in the evolution of human-specific motor behaviors.	Harvard Univ, Sch Med, Div Neurogenet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst,Dept Neurol, Boston, MA 02115 USA; King Fahad Natl Guard Hosp, Dept Pediat, Riyadh 11426, Saudi Arabia; Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; King Fahad Natl Guard Hosp, Dept Neurol, Riyadh 11426, Saudi Arabia; Hacettepe Univ, Fac Med, Dept Pediat, Sect Child Neurol, TR-06100 Ankara, Turkey; King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Jeddah 21499, Saudi Arabia; Brown Univ, Sch Med, Providence, RI 02908 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Harvard University; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Hacettepe University; King Faisal Specialist Hospital & Research Center; Brown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Div Neurogenet, NRB 266,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu	Ferland, Russell/E-3500-2010; Ferland, Russell/Q-6793-2019	Ferland, Russell/0000-0002-8044-2479; YAO, YIN/0000-0003-3053-8429; Walsh, Christopher/0000-0002-0156-2238	NIMH NIH HHS [K01 MH071801, K01 MH071801-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH071801] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altman J, 2001, DEV HUMAN SPINAL COR; Blair IP, 2002, AM J MED GENET, V107, P190, DOI 10.1002/ajmg.10145; CANTANI A, 1990, ANN GENET-PARIS, V33, P96; Chance PF, 1999, J CHILD NEUROL, V14, P660, DOI 10.1177/088307389901401007; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Couch J, 2002, CURR BIOL, V12, pR741, DOI 10.1016/S0960-9822(02)01253-8; FRIEDE RL, 1978, DEV MED CHILD NEUROL, V20, P758; Jiang XY, 2002, J VIROL, V76, P9046, DOI 10.1128/JVI.76.18.9046-9059.2002; JOUBERT M, 1968, NEUROLOGY, V18, P302; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; KENDALL B, 1990, NEURORADIOLOGY, V31, P502, DOI 10.1007/BF00340131; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lagier-Tourenne C, 2004, J MED GENET, V41, P273, DOI 10.1136/jmg.2003.014787; Maria BL, 1999, J CHILD NEUROL, V14, P583, DOI 10.1177/088307389901400906; Maria BL, 1999, J CHILD NEUROL, V14, P368, DOI 10.1177/088307389901400605; Maria BL, 1999, J CHILD NEUROL, V14, P590; Merritt Linda, 2003, Adv Neonatal Care, V3, P178, DOI 10.1016/S1536-0903(03)00137-1; Niesen Charles E, 2002, Semin Pediatr Neurol, V9, P320, DOI 10.1053/spen.2002.32508; Ozonoff S, 1999, J CHILD NEUROL, V14, P636, DOI 10.1177/088307389901401003; Quisling RG, 1999, J CHILD NEUROL, V14, P628, DOI 10.1177/088307389901401002; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; SARAIVA JM, 1992, AM J MED GENET, V43, P726, DOI 10.1002/ajmg.1320430415; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; VANDORP DB, 1991, AM J MED GENET, V40, P100, DOI 10.1002/ajmg.1320400121; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Yachnis AT, 1999, J CHILD NEUROL, V14, P655, DOI 10.1177/088307389901401006; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957	31	303	309	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					1008	1013		10.1038/ng1419	http://dx.doi.org/10.1038/ng1419			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15322546	Bronze			2022-12-17	WOS:000223658100030
